STUDYID|DOMAIN|USUBJID|RESEQ|RETESTCD|RETEST|RECAT|REPOS|REORRES|REORRESU|RESTRESC|RESTRESN|RESTRESU|RELOC|RELAT|REDIR|REMETHOD|RELOBXFL|REBLFL|REDRVFL|REEVAL|REEVALID|VISITNUM|VISIT|VISITDY|TAETORD|EPOCH|REDTC|REDY|RETPT|RETPTNUM|REELTM|RETPTREF|RERFTDTC
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|1|FVCPP|Percent Predicted Forced Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|RNA copies/mL|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|RIGHT|SUBCORTICAL|MRS||Y|Y|SIGNIFICANT OTHER|NEUROLOGIST 1|1|Visit_1|10|4|FOLLOW-UP|2020-10-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|msec|[?]|1|U/dL|LIMB|LATERAL|TIP|FLUORIMETRY||Y||SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-10-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|3|PEF|Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|U/mL|[?]|1|mEq/day|PERIPHERAL NERVE|CONTRALATERAL|PARIETO-OCCIPITAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||VENDOR|UROLOGIST|2|Visit_2|25|1|WASHOUT|2020-11-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/ug|[?]|1|IU/dL|COLON, HEPATIC FLEXURE|LATERAL|LOWER|FLAME PHOTOMETRY||||DOMESTIC PARTNER|RADIOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-11-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|5|FVC6|Forced Vital Capacity in 6 Seconds|[?]|DECUBITUS|[?]|gtt|[?]|1|Newton|PREFRONTAL CORTEX|LATERAL|DORSAL|ENZYMATIC COLORIMETRY||||FAMILY MEMBER|MICROSCOPIST|3|Visit_3|40|3|TREATMENT|2020-11-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|6|SRAW|Specific Airway Resistance|[?]|SLING|[?]|ELISA unit/mL|[?]|1|Gauss|THORACIC AORTA|BILATERAL|PARIETO-OCCIPITAL|WHOLE EXOME SEQUENCING|Y|||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|7|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|DRINK|[?]|1|Ci|PLACENTA|IPSILATERAL|APICAL|PYROSEQUENCING||||ADJUDICATION COMMITTEE|READER 2|4|Visit_4|65|2|FOLLOW-UP|2020-12-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|8|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING, BENT FORWARD|[?]|TAMPON|[?]|1|GBq/ug|GASTROINTESTINAL TRACT, UPPER, WALL|LEFT|TEMPORAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||CAREGIVER|READER 3|4|Visit_4|65|4|FOLLOW-UP|2020-12-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|9|MALIND|Malignancy Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|s^-1(%O2)^-1|[?]|1|mol/g|PARATHYROID GLAND|BILATERAL|DISTAL|CELL BASED BIOASSAY||||ADJUDICATOR|NEUROLOGIST|5|Visit_5|90|4|SCREENING|2021-01-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|35f5401f-575a-44dc-9141-8084716a5b70|10|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING|[?]|BISCUIT|[?]|1|fL|INTERPHALANGEAL JOINT 4 OF THE FOOT|LEFT|BASAL|CELL OF ORIGIN ASSAY|Y|||HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|5|Visit_5|90|2|TREATMENT|2021-01-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|STANDING, BENT FORWARD|[?]|mg|[?]|1|g/animal/day|RETROCRURAL LYMPH NODE|LEFT|ROSTRAL|REBOUND TONOMETRY||||ADJUDICATOR|READER|1|Visit_1|10|6|TREATMENT|2020-12-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|2|SRAW|Specific Airway Resistance|[?]|SITTING|[?]|Arbitrary U|[?]|1|mol/L|ANKLE JOINT|LATERAL|DISTAL|ROMANOWSKY STAIN||||INVESTIGATOR|NEUROLOGIST 1|1|Visit_1|10|2|WASHOUT|2020-12-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|3|TV|Tidal Volume|[?]|SITTING, LEGS DEPENDENT|[?]|PNU/mL|[?]|1|kg/cm|MEDIAN OR LOWER CERVICAL LYMPH NODE|IPSILATERAL|CRANIAL|PAP STAIN||||FAMILY MEMBER|PATHOLOGIST|2|Visit_2|25|7|SCREENING|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|4|LOBVOL|Lobar Volume|[?]|SEMI-FOWLERS|[?]|U/cL|[?]|1|g/m2/day|GLOMERULUS|CONTRALATERAL|OCCIPITAL|HEMOCYTOMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|2|Visit_2|25|1|TREATMENT|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|5|EFFVOL|Effusion Volume|[?]|LEFT LATERAL DECUBITUS|[?]|GPL U/mL|[?]|1|mEq/day|URACHAL TRACT|IPSILATERAL|UPPER|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||PROXY|OPTOMETRIST|3|Visit_3|40|4|WASHOUT|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|6|FIVC|Forced Inspiratory Vital Capacity|[?]|SLING|[?]|pg/cell|[?]|1|nmol/g|SAPHENOUS VEIN|BILATERAL|HIND|ERGOSPIROMETRY||||NON-HEALTH CARE PROFESSIONAL|READER 3|3|Visit_3|40|5|TREATMENT|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|7|FIO2|Fraction of Inspired Oxygen|[?]|LEFT LATERAL DECUBITUS|[?]|/MBP|[?]|1|L/s|FEMORAL ARTERY|BILATERAL|INFERIOR|CELL BASED BIOASSAY||||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|4|Visit_4|65|6|SCREENING|2021-02-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|8|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|||[?]|1|kcal/day|BUCCAL LYMPH NODE|IPSILATERAL|PROXIMAL VOLAR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||Y|CLINICAL STUDY SPONSOR|ONCOLOGIST 2|4|Visit_4|65|6|FOLLOW-UP|2021-02-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|pg/dL|[?]|1|10^3 CFU/g|HEART, BASE|CONTRALATERAL|INTERMEDIATE|SPECTROPHOTOMETRY||Y||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2021-03-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|8a863a88-67d8-4e50-bafa-c3146591f046|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|SITTING|[?]|nmol/g|[?]|1|kg/m2|HAND DIGIT 4|LATERAL|ANTEROMEDIAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||FRIEND|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2021-03-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|FVC|Forced Vital Capacity|[?]|TRENDELENBURG|[?]|/2500 WBC|[?]|1|TRACE|LUNG|RIGHT|DISTAL VOLAR|WESTERGREN||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|1|Visit_1|10|2|WASHOUT|2020-08-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|2|MALEVDES|Malignancy Evidence Description|[?]|UNCONSTRAINED|[?]|10^10/L|[?]|1|mL*cmH2O|FACE|LATERAL|MIDLINE|MANUAL CLOT DETECTION||||DOMESTIC PARTNER|READER 1|1|Visit_1|10|7|TREATMENT|2020-08-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|3|FEV3PP|Percent Predicted FEV3|[?]|SEMI-FOWLERS|[?]|/LPF|[?]|1|fmol/L/sec|HEART, LEFT ATRIUM|LEFT|SUPERIOR|SMEAR|Y|Y||PROXY|RADIOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|4|FIFMAX|Maximum Forced Inspiratory Flow|[?]|PRONE|[?]|ug/kg/min|[?]|1|pmol/L|METACARPAL BONE 4|UNILATERAL|FRONTAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|3|TREATMENT|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|5|FRC|Functional Residual Capacity|[?]|SITTING|[?]|mL/cm3/min|[?]|1|sec|HYPOTHALAMUS|BILATERAL|SURFACE|COULOMETRIC TITRATION||Y||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|3|Visit_3|40|4|TREATMENT|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|||[?]|1|eq|CAPITATE BONE|LEFT|FORE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y||Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|3|Visit_3|40|2|SCREENING|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|7|ELSTNCE|Elastance|[?]|RIGHT LATERAL DECUBITUS|[?]|fL|[?]|1|Gy|LIVER, LEFT LOBE|LATERAL|ANTEROMEDIAL|DXA SCAN|Y|||VENDOR|NEUROLOGIST 2|4|Visit_4|65|4|TREATMENT|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|8|SGAW|Specific Airway Conductance|[?]|UNCONSTRAINED|[?]|dyn|[?]|1|dpm/0.5 mL|L6 VERTEBRA|LEFT|PROXIMAL VOLAR|FLUORESCENT MICROSCOPY||Y||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|4|Visit_4|65|1|FOLLOW-UP|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|9|FVC|Forced Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|Pack Year|[?]|1|IU/g|MESENTERY|UNILATERAL|PERIPHERAL|CINEANGIOGRAPHY||||SIBLING|CLINICAL PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-10-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|10|PEFREV|PEF Reversibility|[?]|TRENDELENBURG|[?]|mmol/min/kPa|[?]|1|vg/dose|OCCIPITAL LOBE|BILATERAL|SUPERIOR|PANENDOSCOPY||||SIGNIFICANT OTHER|UROLOGIST|5|Visit_5|90|4|WASHOUT|2020-10-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|m|POSTERIOR SUPERIOR ILIAC SPINE|BILATERAL|VOLAR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||Y|PARENT|RADIOLOGIST|1|Visit_1|10|1|WASHOUT|2020-12-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|2|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|mL/100g/min|[?]|1|Ci/ug|GENITAL TUBERCLE|CONTRALATERAL|CENTRAL|IRON HEMATOXYLIN STAIN|Y|||INVESTIGATOR|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-12-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|3|EFFVOL|Effusion Volume|[?]|PRONE|||[?]|1|MAC50|CARPOMETACARPAL JOINT 4|BILATERAL|PARIETO-OCCIPITAL|SCINTIGRAPHY|||Y|HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|2|Visit_2|25|4|TREATMENT|2021-01-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|4|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|STANDING|||[?]|1|mL/cm3/min|APPENDIX|LATERAL|UPPER FLEXOR SURFACE|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y||Y|FAMILY MEMBER|DERMATOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2021-01-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|5|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SUPINE|[?]|PIXELS/cm|[?]|1|h/wk|PERITONEAL CAVITY|LEFT|TEMPORAL|PERIODIC ACID SCHIFF STAIN||||STUDY SUBJECT|CLINICAL PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2021-01-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|6|MALIND|Malignancy Indicator|[?]|STANDING|[?]|MHz|[?]|1|BP|SKIN OF THE KNEE|UNILATERAL|DEEP|IMMUNOPRECIPITATION||||ADJUDICATION COMMITTEE|ONCOLOGIST 1|3|Visit_3|40|6|WASHOUT|2021-01-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|7|RAW|Airway Resistance|[?]|SUPINE|||[?]|1|CFU/mL|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL|ANTEROMEDIAL|WEBER GREEN STAIN|Y||Y|ADJUDICATION COMMITTEE|RADIOLOGIST 1|4|Visit_4|65|2|TREATMENT|2021-02-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|8|IVC|Inspiratory Vital Capacity|[?]|STANDING|[?]|10^8/L|[?]|1|10^6/L|CARDIAC WALL|BILATERAL|CAUDAL|PULSE OXIMETRY||||CAREGIVER|RATER 2|4|Visit_4|65|3|SCREENING|2021-02-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|DECUBITUS|[?]|STEPS|[?]|1|mL/dose|LOWER JUGULAR LYMPH NODE|CONTRALATERAL|FACIAL|WEBER GREEN STAIN||Y||CHILD|RADIOLOGIST 2|5|Visit_5|90|4|SCREENING|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|0558cb35-f542-4f9a-a7e7-18b1d71be69c|10|PEFREV|PEF Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|uL/dose|[?]|1|APPLICATION|FEMORAL VEIN|CONTRALATERAL|DISTAL|MRI WITHOUT CONTRAST||||CHILD|ADJUDICATOR 1|5|Visit_5|90|5|TREATMENT|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|TRENDELENBURG|[?]|ug/m2/min|[?]|1|fmol/g|RETROPHARYNGEAL LYMPH NODE|CONTRALATERAL|LATERAL|HEMOCYTOMETRY||||STUDY SUBJECT|PHYSIOTHERAPIST|1|Visit_1|10|5|SCREENING|2020-07-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|2|FEV1PP|Percent Predicted FEV1|[?]|SLING|[?]|atm|[?]|1|ms/mmHg|FIBULA SHAFT|BILATERAL|DISTAL VOLAR|SINGLE-MOLECULE ARRAY||||CHILD|FORENSIC PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-07-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|3|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|[?]|CUP|[?]|1|mL/dL|SKIN OF THE FOOT|BILATERAL|ANTERIOR|COMPUTERIZED CORNEAL TOPOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|2|Visit_2|25|2|TREATMENT|2020-07-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|4|PNIF|Peak Nasal Inspiratory Flow|[?]|UNCONSTRAINED|[?]|kg/m2|[?]|1|RATIO|PROFUNDA FEMORIS ARTERY|LEFT|UPPER EXTENSOR SURFACE|X-RAY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-07-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|AU/mL|APPENDICULAR SKELETON|IPSILATERAL|OCCIPITAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|CLINICAL STUDY SPONSOR|RADIOLOGIST|3|Visit_3|40|6|WASHOUT|2020-08-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|6|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|[?]|nU/cL|[?]|1|mL/m2/day|METACARPAL BONE 3|LATERAL|INNER|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||SPOUSE|FORENSIC PATHOLOGIST|3|Visit_3|40|4|WASHOUT|2020-08-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|7|AWVOLPP|Percent Predicted Airway Volume|[?]|SEMI-FOWLERS|[?]|mol|[?]|1|10^4/hpf|LUNG, RIGHT UPPER LOBE|BILATERAL|ANTEROMEDIAL|CLAUSS METHOD||Y||FRIEND|RADIOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|8|FEF2575|Forced Expiratory Flow 25-75%|[?]|REVERSE TRENDELENBURG|[?]|/VF|[?]|1|nmol/kg/day|FOREBRAIN|LEFT|DEEP|ICC||||FRIEND|ADJUDICATOR 3|4|Visit_4|65|4|WASHOUT|2020-08-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|9|TGV|Thoracic Gas Volume|[?]|LATERAL DECUBITUS|[?]|ug/mol|[?]|1|BEAM BREAKS|SACRUM|CONTRALATERAL|VOLAR|FLUORESCENT MICROSCOPY||||SIBLING|CLINICAL PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2020-09-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|a9cf4d21-c2a8-4f32-b932-f05d2d317400|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|[?]|BAU/mL|[?]|1|mL/h|ORAL MUCOSA|LATERAL|MEDIAL|AGAR PROPORTION||||NON-HEALTH CARE PROFESSIONAL|RATER|5|Visit_5|90|1|TREATMENT|2020-09-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|0389257f-50de-4a05-8f2a-69c068374337|1|PCF|Peak Cough Flow|[?]|PRONE|[?]|ug/mL/h|[?]|1|U/10^12 RBC|TYMPANIC MEMBRANE|CONTRALATERAL|FRONTAL|WESTERGREN||||SIGNIFICANT OTHER|ADJUDICATOR 2|1|Visit_1|10|2|TREATMENT|2020-10-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|0389257f-50de-4a05-8f2a-69c068374337|2|SALKA|Salazar-Knowles Equation Parameter A|[?]|PRONE|[?]|100 IU/mL|[?]|1|umol/L|MID-LAD ARTERY|BILATERAL|DORSAL|HEMATOXYLIN AND EOSIN STAIN||||INTERVIEWER|RADIOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-10-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|0389257f-50de-4a05-8f2a-69c068374337|3|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING, LEGS DEPENDENT|[?]|Tesla|[?]|1|ug/g/h|ASCENDING AORTA, SINUS OF VALSALVA|LATERAL|LOWER FLEXOR SURFACE|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||||INTERVIEWER|RATER|2|Visit_2|25|1|TREATMENT|2020-10-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|0389257f-50de-4a05-8f2a-69c068374337|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|||[?]|1|DNA copies/mL|GASTROCNEMIUS MUSCLE, LATERAL HEAD|IPSILATERAL|OCCIPITAL|JAFFE REACTION|||Y|FAMILY MEMBER|HEMATOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-10-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|0389257f-50de-4a05-8f2a-69c068374337|5|FIV1|Forced Inspiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|g/cage|MEDIASTINUM, ANTERIOR|CONTRALATERAL|PERIVENTRICULAR|SXA SCAN|||Y|CLINICAL RESEARCH COORDINATOR|READER 2|3|Visit_3|40|2|TREATMENT|2020-11-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|0389257f-50de-4a05-8f2a-69c068374337|6|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|%/min|[?]|1|uV|METATARSAL BONE|IPSILATERAL|DORSAL|PERIODIC ACID SCHIFF STAIN|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-11-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|0389257f-50de-4a05-8f2a-69c068374337|7|INFLTIND|Infiltrates Indicator|[?]|FOWLERS|[?]|% INHIBITION|[?]|1|kHz|BICEPS FEMORIS MUSCLE|UNILATERAL|ANTEROPOSTERIOR|ISHIHARA COLOR PLATES||Y||FAMILY MEMBER|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2020-12-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|0389257f-50de-4a05-8f2a-69c068374337|8|VO2|Oxygen Consumption|[?]|DECUBITUS|[?]|fmol/L|[?]|1|mL/cm H2O|GINGIVAL MUCOSA|CONTRALATERAL|TEMPORAL|PHOTOMETRIC CLOT DETECTION||||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|4|Visit_4|65|1|TREATMENT|2020-12-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|0389257f-50de-4a05-8f2a-69c068374337|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|Log10 ELISA unit/dose|[?]|1|pmol/10^9 cells|FOOT PHALANX|UNILATERAL|FORE|LAPAROSCOPY||||PROXY|PATHOLOGIST 1|5|Visit_5|90|4|TREATMENT|2020-12-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|0389257f-50de-4a05-8f2a-69c068374337|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|SLING|[?]|cg|[?]|1|MdFI|CAROTID ARTERY|UNILATERAL|ANTERIOR|FLUORESCENT ENZYME IMMUNOASSAY|Y|||GUARDIAN|RADIOLOGIST|5|Visit_5|90|2|SCREENING|2020-12-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|FOWLERS|||[?]|1|CFU/g|PERICARDIAL LYMPH NODE|UNILATERAL|CAUDAL|THIN SMEAR|||Y|INVESTIGATOR|CLINICAL PATHOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-12-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|2|RRS|Total Respiratory System Resistance|[?]|SLING|[?]|PFU/animal|[?]|1|C|ALVEOLUS|IPSILATERAL|SUBCORTICAL|AGAR PROPORTION|Y|Y||SIGNIFICANT OTHER|ENDOCRINOLOGIST|1|Visit_1|10|6|WASHOUT|2020-12-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|UNCONSTRAINED|||[?]|1|g/cage|RENAL PELVIS|CONTRALATERAL|ANTEROLATERAL|POPULATION SEQUENCING||Y|Y|INTERVIEWER|PATHOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-12-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|4|ERV|Expiratory Reserve Volume|[?]|STANDING|||[?]|1|BAG|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|LEFT|UPPER|HPLC-UV|Y||Y|CHILD|READER|2|Visit_2|25|5|TREATMENT|2020-12-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|5|PCF|Peak Cough Flow|[?]|SITTING|||[?]|1|U/g|RETROPHARYNGEAL LYMPH NODE|IPSILATERAL|DEEP|PHOROPTER|||Y|HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|4|TREATMENT|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|6|SVC|Slow Vital Capacity|[?]|PRONE|[?]|pg/L|[?]|1|10^3/hpf|LEFT MAIN CORONARY ARTERY BIFURCATION|RIGHT|NASAL|ETDRS EYE CHART|Y|||DOMESTIC PARTNER|ONCOLOGIST 1|3|Visit_3|40|4|WASHOUT|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|7|RV|Residual Volume|[?]|LATERAL DECUBITUS|[?]|RING|[?]|1|POUCH|SUBTALAR JOINT|CONTRALATERAL|ANTERIOR|CONTRAST ENHANCED PET SCAN||Y||ADJUDICATOR|ONCOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2021-02-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|8|FEV1FVC6|FEV1/FVC6|[?]|SLING|[?]|pmol/g|[?]|1|MPS U|SCAPULA|LATERAL|ANTEROPOSTERIOR|X-RAY|Y|Y||DOMESTIC PARTNER|ADJUDICATOR|4|Visit_4|65|5|TREATMENT|2021-02-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|9|ERVPP|Percent Predicted ERV|[?]|UNCONSTRAINED|||[?]|1|10^6/g|VAGINAL WALL|CONTRALATERAL|PERIVENTRICULAR|ELECTRICAL IMPEDANCE MYOGRAPHY|||Y|CAREGIVER|CLINICAL PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-03-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|10|ALVVOL|Alveolar Volume|[?]|SUPINE|[?]|APS U|[?]|1|%(w/v)|METACARPOPHALANGEAL JOINT 3|CONTRALATERAL|SURFACE|MULTIPLEXED BEAD BASED IMMUNOASSAY||||FRIEND|RADIOLOGIST 1|5|Visit_5|90|3|TREATMENT|2021-03-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|DNA copies/mL|WRIST JOINT EXTENSOR TENDONS|UNILATERAL|HIND|CALCULATION|Y||Y|PARENT|CARDIOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|2|PLMBLFLW|Pulmonary Blood Flow|[?]|PRONE|[?]|kcal|[?]|1|mol/g|SCLERA|RIGHT|INTERMEDIATE|HPLC/MS/MS||||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|3|DLCOPP|Percent Predicted DLCO|[?]|SUPINE|[?]|JDF Unit|[?]|1|Pa|LACRIMAL BONE|RIGHT|ANTEROTEMPORAL|RAJI CELL RIA||Y||ADJUDICATOR|READER|2|Visit_2|25|5|TREATMENT|2021-01-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|4|TGV|Thoracic Gas Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|/ms|[?]|1|cmH2O*s2/mL|VASTUS LATERALIS MUSCLE|CONTRALATERAL|DEEP|MANUAL COUNT|Y|||INDEPENDENT ASSESSOR|OPHTHALMOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2021-01-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|5|RAW|Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|HOMEOPATHIC DILUTION|[?]|1|10^11/L|FINGER EXTENSOR MUSCLES|RIGHT|ANTEROLATERAL|SNP ARRAY|Y|||GUARDIAN|FORENSIC PATHOLOGIST|3|Visit_3|40|3|SCREENING|2021-01-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|6|FEV3FVC|FEV3/FVC|[?]|FOWLERS|[?]|SQU/mL|[?]|1|kDa|FINGER|UNILATERAL|VOLAR|IMMUNORADIOMETRIC ASSAY||||PARENT|PATHOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2021-01-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ug/L|VAGUS NERVE|LATERAL|PROXIMAL|MIGET|||Y|CHILD|DERMATOLOGIST|4|Visit_4|65|1|SCREENING|2021-02-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|8|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mL/kg/min|CHEEK|LEFT|SURFACE|BRDU CELLULAR PROLIFERATION ASSAY|||Y|CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2021-02-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING|||[?]|1|log EID 50/dose|CHOROID|IPSILATERAL|VENTRAL|TOTAL BODY IRRADIATION|Y||Y|CLINICAL STUDY SPONSOR|CARDIOLOGIST|5|Visit_5|90|7|TREATMENT|2021-03-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|10|DLCOHC|HGB Corrected DLCO|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^4/L|GASTROINTESTINAL SYSTEM|CONTRALATERAL|VOLAR|DYNAMOMETRY||Y|Y|INTERVIEWER|MICROSCOPIST 3|5|Visit_5|90|6|WASHOUT|2021-03-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|1|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|||[?]|1|mg/min|LIVER FISSURE|LATERAL|LOWER FLEXOR SURFACE|GRAM STAIN||Y|Y|SIGNIFICANT OTHER|MICROSCOPIST|1|Visit_1|10|7|TREATMENT|2020-09-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|2|SGAW|Specific Airway Conductance|[?]|LATERAL DECUBITUS|||[?]|1|INHALATION|SCAPHOID-RADIUS JOINT|IPSILATERAL|OUTER|NEURAMINIDASE INHIBITION ASSAY|||Y|SPOUSE|RATER 2|1|Visit_1|10|7|SCREENING|2020-09-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|3|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-RECUMBENT|||[?]|1|Tesla|RIB 7|RIGHT|UPPER FLEXOR SURFACE|ZIEHL NEELSEN ACID FAST STAIN||Y|Y|CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|2|Visit_2|25|4|WASHOUT|2020-10-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|UNCONSTRAINED|[?]|anti-Xa IU|[?]|1|Gy/h|SKIN|RIGHT|PERIPHERAL|MICROBIAL CULTURE, LIQUID|Y|||FAMILY MEMBER|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-10-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|PRONE|[?]|umol/day|[?]|1|PACKAGE|ISCHIAL TUBEROSITY|RIGHT|ANTERIOR|IHC||||SPOUSE|READER 1|3|Visit_3|40|1|TREATMENT|2020-10-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|6|FVC|Forced Vital Capacity|[?]|SLING|[?]|days/wk|[?]|1|um/s|PROXIMAL PHALANX 3 OF THE HAND|BILATERAL|DORSOLATERAL|CARDIAC THERMODILUTION|Y|Y||FRIEND|READER 1|3|Visit_3|40|5|TREATMENT|2020-10-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|IU/g|CHOROID|BILATERAL|FACIAL|LYMPHANGIOGRAPHY|||Y|CHILD|RATER|4|Visit_4|65|7|FOLLOW-UP|2020-11-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|8|MIPPP|Percent Predicted MIP|[?]|STANDING|[?]|mEq/day|[?]|1|POINT|MEDIASTINUM|RIGHT|PROXIMAL|CLIP SEQUENCING|Y|||CAREGIVER|PATHOLOGIST|4|Visit_4|65|6|WASHOUT|2020-11-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|9|IRV|Inspiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|HEP|[?]|1|umol/day|WRIST JOINT FLEXOR MUSCLES|CONTRALATERAL|SUBCORTICAL|AGAR DILUTION||Y||GUARDIAN|ONCOLOGIST 2|5|Visit_5|90|5|SCREENING|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|ad402b62-0625-431b-9bd7-ffd6124610f3|10|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/animal/wk|ABDOMINAL CAVITY|UNILATERAL|TEMPORAL|TEST STRIP|Y||Y|PROXY|RATER 1|5|Visit_5|90|1|SCREENING|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|1|FVC|Forced Vital Capacity|[?]|LATERAL DECUBITUS|||[?]|1|ug/g/h|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|UNILATERAL|DORSOLATERAL|THIN SMEAR||Y|Y|SIGNIFICANT OTHER|OTOLARYNGOLOGIST|1|Visit_1|10|6|TREATMENT|2020-05-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|2|EFFVOL|Effusion Volume|[?]|LEFT LATERAL DECUBITUS|[?]|uOsm|[?]|1|mL/animal|APPENDICEAL TIP|CONTRALATERAL|HIND|BRDU CELLULAR PROLIFERATION ASSAY||||FRIEND|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|3|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|g/cage/wk|[?]|1|cpm|INTERPHALANGEAL JOINT 5|LATERAL|TEMPORAL|IMMUNORADIOMETRIC ASSAY|Y|||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|2|Visit_2|25|1|TREATMENT|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|4|AIRTRAP|Air Trapping|[?]|STANDING, BENT FORWARD|||[?]|1|U/animal|ASCENDING AORTA, AORTIC ROOT|LEFT|SURFACE|CYSTOMETRY||Y|Y|INDEPENDENT ASSESSOR|RADIOLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|5|RER|Respiratory Exchange Ratio|[?]|REVERSE TRENDELENBURG|[?]|oz|[?]|1|mm/2h|THORACIC VERTEBRA|RIGHT|LOWER EXTENSOR SURFACE|MRI WITHOUT CONTRAST||Y||PROXY|CLINICAL PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-06-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|6|SAWVOL|Specific Airway Volume|[?]|STANDING, BENT FORWARD|||[?]|1|/2000 RBC|SIGMOID SINUS|UNILATERAL|SUPERIOR|MASS SPECTROMETRY|||Y|VENDOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|WASHOUT|2020-06-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|7|RAW|Airway Resistance|[?]|DECUBITUS|||[?]|1|/mm2|SHIN|LEFT|UPPER EXTENSOR SURFACE|TRICHROME STAIN|||Y|SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|7|TREATMENT|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|8|DLCOVA|DLCO/VA|[?]|UNCONSTRAINED|[?]|%(v/v)|[?]|1|U.CARR|KIDNEY, MEDULLA|LEFT|OUTER|DOUBLE IMMUNODIFFUSION||||DOMESTIC PARTNER|RATER 2|4|Visit_4|65|1|TREATMENT|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|9|DLCOHC|HGB Corrected DLCO|[?]|FOWLERS|||[?]|1|mL/kg/day|T1 VERTEBRA|UNILATERAL|INNER|BAC ACGH|||Y|INTERVIEWER|MICROSCOPIST 3|5|Visit_5|90|1|TREATMENT|2020-08-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|d76b0f55-541c-491d-9162-4c133c9509f1|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|UNCONSTRAINED|[?]|MET*min|[?]|1|BP|NUCLEUS ACCUMBENS|BILATERAL|DISTAL VOLAR|POTENTIOMETRY||||PARENT|INTERNIST|5|Visit_5|90|5|WASHOUT|2020-08-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|1|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING, BENT FORWARD|[?]|STEPS|[?]|1|BAG|CARPOMETACARPAL JOINT 5|CONTRALATERAL|MEDIAL|ISHIHARA COLOR PLATES|Y|||SIGNIFICANT OTHER|DERMATOLOGIST|1|Visit_1|10|6|TREATMENT|2020-08-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|2|LOBVOL|Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mmol/mol|PERIPHERAL NERVE|LEFT|MIDLINE|TRIPLE-PHASE MRI SCAN|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|1|Visit_1|10|5|WASHOUT|2020-08-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|3|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|Bq/mg|[?]|1|K|AXILLARY LYMPH NODE LEVEL I|BILATERAL|CENTRAL|FUNCTIONAL MRI||Y||CHILD|OPTOMETRIST|2|Visit_2|25|6|WASHOUT|2020-09-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|4|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|REVERSE TRENDELENBURG|[?]|Enzyme U|[?]|1|mmol/min/kPa|TOOTH CANAL|LEFT|TIP|ORCHIDOMETERY|Y|||CHILD|RATER|2|Visit_2|25|2|WASHOUT|2020-09-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|5|SAWVOL|Specific Airway Volume|[?]|PRONE|[?]|mL/mmHg/min/L|[?]|1|gMFI|ULNAR ARTERY|LATERAL|LATERAL|HPLC||||PROXY|RATER 2|3|Visit_3|40|6|SCREENING|2020-09-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|U/kg/min|[?]|1|ng/L|INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL|ANTEROTEMPORAL|URANYL ACETATE STAIN||||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|3|Visit_3|40|3|SCREENING|2020-09-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|7|LOBVOL|Lobar Volume|[?]|SITTING, LEGS DEPENDENT|[?]|mgEq|[?]|1|pmol/g|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|RIGHT|INNER|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||FAMILY MEMBER|ADJUDICATOR 2|4|Visit_4|65|5|FOLLOW-UP|2020-10-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|8|MIPPP|Percent Predicted MIP|[?]|SITTING|||[?]|1|mmAL|CEREBRAL ARTERY|BILATERAL|CRANIAL|OBSERVATION|Y|Y|Y|FAMILY MEMBER|ADJUDICATOR 3|4|Visit_4|65|1|FOLLOW-UP|2020-10-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|9|AWWVOL|Airway Wall Volume|[?]|SUPINE|||[?]|1|VIAL|L6 VERTEBRA|CONTRALATERAL|ROSTRAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||Y|PARENT|RATER 1|5|Visit_5|90|6|TREATMENT|2020-11-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|146059d8-5652-41cd-b484-c6e5d8ea540f|10|FEV1FVC6|FEV1/FVC6|[?]|LEFT LATERAL DECUBITUS|||[?]|1|MPL U|SUBCARINAL LYMPH NODE|BILATERAL|FACIAL|SCINTIGRAPHY||Y|Y|VENDOR|ENDOCRINOLOGIST|5|Visit_5|90|6|SCREENING|2020-11-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|[?]|nmol/L/h|[?]|1|mL/cage|SCIATIC NERVE|RIGHT|PERIVENTRICULAR|CHROMOGENIC ASSAY||||SIBLING|DERMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-11-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|2|FIF50|Forced Inspiratory Flow at 50%|[?]|SLING|[?]|breaths/30s|[?]|1|cs|COLON, HEPATIC FLEXURE|UNILATERAL|TEMPORAL|ANTIMICROBIAL COMBINATION TESTING||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|1|Visit_1|10|2|TREATMENT|2020-11-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|3|PLMXRS|Pulmonary Reactance|[?]|SITTING, LEGS DEPENDENT|[?]|mL/(min*100mL)|[?]|1|10^6/hpf|GASTROINTESTINAL TRACT|LEFT|UPPER EXTENSOR SURFACE|SXA SCAN||Y||ADJUDICATOR|RADIOLOGIST 2|2|Visit_2|25|2|SCREENING|2020-11-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|4|FEF2575P|Percent Predicted FEF25-75|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mL/kg/min|ABDOMINAL WALL|BILATERAL|CAUDAL|ELISPOT|Y||Y|INVESTIGATOR|READER|2|Visit_2|25|1|SCREENING|2020-11-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|[?]|DRINK|[?]|1|tuberculin unit|SCIATIC NERVE|UNILATERAL|LOWER FLEXOR SURFACE|PERIPHERAL ANGIOGRAPHY||||INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-12-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|6|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|||[?]|1|mL/kg/min|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|UNILATERAL|NASAL|INDIA INK STAIN|||Y|CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|3|Visit_3|40|2|FOLLOW-UP|2020-12-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|7|FRCPP|Percent Predicted FRC|[?]|PRONE|[?]|beats/min|[?]|1|cal|SOFT PALATE|LEFT|LOWER FLEXOR SURFACE|FLUORESCENT ENZYME IMMUNOASSAY||||INTERVIEWER|RADIOLOGIST 2|4|Visit_4|65|5|WASHOUT|2020-12-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|8|LCI|Lung Clearance Index|[?]|SEMI-RECUMBENT|||[?]|1|uL/mL|COLON, HEPATIC FLEXURE|UNILATERAL|ANTEROMEDIAL|NUCLEIC ACID SEQUENCING|||Y|INVESTIGATOR|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2020-12-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|9|ERVPP|Percent Predicted ERV|[?]|SITTING, LEGS DEPENDENT|[?]|100 IU/mL|[?]|1|10^6 U|MEDIASTINUM|BILATERAL|DORSOLATERAL|MANUAL COUNT||||SPOUSE|READER|5|Visit_5|90|5|FOLLOW-UP|2021-01-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|3d5f1964-b65c-4a0a-bb5b-1689308754d8|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|U/kg/day|GONAD|RIGHT|OUTER|PAP STAIN|Y||Y|CAREGIVER|RATER 2|5|Visit_5|90|7|SCREENING|2021-01-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|129dc836-068a-463e-b789-a0d05c60605d|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|||[?]|1|Hz/s|PORTAL VEIN|UNILATERAL|APICAL|CRYOSCOPY|Y|Y|Y|DOMESTIC PARTNER|MICROSCOPIST 1|1|Visit_1|10|5|WASHOUT|2020-07-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|129dc836-068a-463e-b789-a0d05c60605d|2|FVC|Forced Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|g/animal/wk|[?]|1|kg/cm2|FOOT DIGIT 4|CONTRALATERAL|ANTEROMEDIAL|CISH||||GUARDIAN|CLINICAL PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-07-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|129dc836-068a-463e-b789-a0d05c60605d|3|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING, BENT FORWARD|||[?]|1|umol/L|PALATINE BONE|IPSILATERAL|LATERAL|CELL BASED BIOASSAY||Y|Y|SIGNIFICANT OTHER|MICROSCOPIST 3|2|Visit_2|25|5|FOLLOW-UP|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|129dc836-068a-463e-b789-a0d05c60605d|4|FIFMAXPP|Percent Predicted FIFmax|[?]|SUPINE|[?]|YEARS|[?]|1|GBq/ug|METACARPOPHALANGEAL JOINT 4|UNILATERAL|TEMPORAL|SEQUENCING||||SIGNIFICANT OTHER|ADJUDICATOR 3|2|Visit_2|25|1|TREATMENT|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|129dc836-068a-463e-b789-a0d05c60605d|5|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^6 DNA copies/mL|PARIETAL LOBE|UNILATERAL|LOWER EXTENSOR SURFACE|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||Y|INVESTIGATOR|CLINICAL PATHOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|129dc836-068a-463e-b789-a0d05c60605d|6|SGAW|Specific Airway Conductance|[?]|DECUBITUS|[?]|Enzyme U/g Hb|[?]|1|Ci|HIPPOCAMPUS|LATERAL|PERIVENTRICULAR|CAPILLARY ELECTROPHORESIS|Y|||INDEPENDENT ASSESSOR|DERMATOLOGIST|3|Visit_3|40|4|SCREENING|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|129dc836-068a-463e-b789-a0d05c60605d|7|AWVOL|Airway Volume|[?]|LATERAL DECUBITUS|[?]|PIXEL|[?]|1|ft2|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|IPSILATERAL|ANTEROLATERAL|IHC|Y|||ADJUDICATION COMMITTEE|NEUROLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|129dc836-068a-463e-b789-a0d05c60605d|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING, BENT FORWARD|[?]|Torr|[?]|1|mg/m2/day|ANAL CANAL|BILATERAL|OCCIPITAL|HEMATOXYLIN AND EOSIN STAIN||Y||INVESTIGATOR|RATER|4|Visit_4|65|3|TREATMENT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|129dc836-068a-463e-b789-a0d05c60605d|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|Arbitrary U|[?]|1|L/L|WRIST JOINT EXTENSOR MUSCLES|IPSILATERAL|LOWER FLEXOR SURFACE|U-HPLC/MS/MS||Y||SIGNIFICANT OTHER|READER 2|5|Visit_5|90|6|SCREENING|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|129dc836-068a-463e-b789-a0d05c60605d|10|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|||[?]|1|SYRINGE|FEMORAL ARTERY|CONTRALATERAL|INTERMEDIATE|CLIP||Y|Y|VENDOR|RADIOLOGIST 1|5|Visit_5|90|1|TREATMENT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|10^9/g|[?]|1|Bq/kg|MALLEUS|BILATERAL|CAUDAL|BIOIMPEDANCE SPECTROSCOPY||||PROXY|NEUROLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-11-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|2|RELSZCHG|Relative Size Change|[?]|SEMI-RECUMBENT|[?]|cL|[?]|1|mCi|HIP ADDUCTORS|CONTRALATERAL|CAUDAL|NUCLEIC ACID HYBRIDIZATION|Y|||STUDY SUBJECT|OPTOMETRIST|1|Visit_1|10|6|FOLLOW-UP|2020-11-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|3|FVC|Forced Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|umol/L/h|[?]|1|Roentgen|PALM|IPSILATERAL|MEDIAL|MIGET||Y||VENDOR|ADJUDICATOR 3|2|Visit_2|25|2|FOLLOW-UP|2020-11-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|4|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING|[?]|BE/mL|[?]|1|mmHg*min/L|ILIUM|IPSILATERAL|ANTERIOR|FLUORESCENT MICROSCOPY||||CLINICAL STUDY SPONSOR|RADIOLOGIST|2|Visit_2|25|6|TREATMENT|2020-11-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|5|FIF25|Forced Inspiratory Flow at 25%|[?]|RIGHT LATERAL DECUBITUS|[?]|mmol2/L2|[?]|1|PFU/animal|LIP|IPSILATERAL|ANTERIOR|BIOPSY||Y||ADJUDICATOR|READER 2|3|Visit_3|40|5|WASHOUT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|6|RELSZCHG|Relative Size Change|[?]|SITTING|[?]|log10 TCID 50/uL|[?]|1|MESF|CARDIOVASCULAR SYSTEM|IPSILATERAL|TIP|MICRODENSITOMETRY||Y||CLINICAL STUDY SPONSOR|READER|3|Visit_3|40|5|SCREENING|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|7|FEV6PP|Percent Predicted FEV6|[?]|STANDING, BENT FORWARD|[?]|mL/day|[?]|1|m/sec|GALLBLADDER|RIGHT|DEEP|PERIODIC ACID SCHIFF STAIN||||INTERVIEWER|ONCOLOGIST 2|4|Visit_4|65|3|TREATMENT|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|8|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|10^9 CFU|[?]|1|mL*cmH2O|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|IPSILATERAL|VENTRAL|ULTRASONOGRAPHIC ELASTOGRAPHY||||SPOUSE|MICROSCOPIST 3|4|Visit_4|65|6|WASHOUT|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|UNCONSTRAINED|||[?]|1|mmol/kg|PROXIMAL INTERPHALANGEAL JOINT 5|UNILATERAL|MEDIAL|TRIPLE-PHASE MRI SCAN|||Y|ADJUDICATOR|MICROSCOPIST|5|Visit_5|90|2|SCREENING|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|9ef8a6d4-8326-4050-be85-e9f8983f55c1|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|SLING|[?]|PIPE|[?]|1|uV|EXTRAHEPATIC BILE DUCT|IPSILATERAL|PROXIMAL|URANYL ACETATE STAIN||||ADJUDICATION COMMITTEE|MICROSCOPIST 2|5|Visit_5|90|1|TREATMENT|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|1|EFFVOL|Effusion Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|nmol BCE/mmol|GASTROINTESTINAL TRACT, WALL|IPSILATERAL|LOWER|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y||Y|GUARDIAN|MICROSCOPIST|1|Visit_1|10|4|SCREENING|2020-05-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SLING|[?]|ft|[?]|1|cycle/min|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|ROSTRAL|ELECTROGASTROGRAPHY||||DOMESTIC PARTNER|UROLOGIST|1|Visit_1|10|2|SCREENING|2020-05-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|3|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|[?]|mg/kg/week|[?]|1|U/kg/h|SUPRAGLOTTIS|LEFT|PROXIMAL|THICK SMEAR||||PROXY|RATER 2|2|Visit_2|25|2|WASHOUT|2020-06-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-16
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|4|EFFIND|Effusion Indicator|[?]|REVERSE TRENDELENBURG|[?]|uU/dL|[?]|1|nmol/mol|ABDUCENS NERVE|CONTRALATERAL|UPPER FLEXOR SURFACE|DUKE INCISION METHOD||Y||CHILD|ENDOCRINOLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-16
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mm3/mm2/year|[?]|1|dram|DENTAL ARCH|LATERAL|MIDLINE|REFLECTANCE SPECTROSCOPY||||CAREGIVER|RATER 2|3|Visit_3|40|4|TREATMENT|2020-06-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|TRENDELENBURG|[?]|RFU|[?]|1|YEARS|LEFT CIRCUMFLEX CORONARY ARTERY|LATERAL|SUPERFICIAL|ELECTROMYOGRAPHY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-06-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|7|ELSTNCE|Elastance|[?]|SUPINE|[?]|DAgU/mL|[?]|1|Siemens|BLADDER WALL|UNILATERAL|SUBCORTICAL|APPLANATION TONOMETRY|Y|||SIGNIFICANT OTHER|HEMATOLOGIST|4|Visit_4|65|2|WASHOUT|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|8|EFFIND|Effusion Indicator|[?]|LATERAL DECUBITUS|[?]|log10 TCID 50/dose|[?]|1|U/g|T2 VERTEBRA|IPSILATERAL|DEEP|MODIFIED ACID FAST STAIN||Y||INDEPENDENT ASSESSOR|READER|4|Visit_4|65|4|TREATMENT|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|9|FEV1SVC|FEV1/SVC|[?]|REVERSE TRENDELENBURG|[?]|kg/L|[?]|1|pmol/10^10 cells|PARAVERTEBRAL GANGLIA|BILATERAL|APICAL|PATHOLOGICAL EVALUATION||||PARENT|PATHOLOGIST 2|5|Visit_5|90|2|WASHOUT|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|b91c4469-b3be-467f-8512-b73cf561e168|10|PCF|Peak Cough Flow|[?]|TRENDELENBURG|[?]|DDU|[?]|1|mm/h|MIDBRAIN|RIGHT|OUTER|KARYOTYPING|Y|||HEALTH CARE PROFESSIONAL|PATHOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|1|ELSTNCE|Elastance|[?]|SITTING|[?]|um|[?]|1|tuberculin unit/mL|ANTERIOR INFERIOR CEREBELLAR ARTERY|BILATERAL|PROXIMAL VOLAR|HPLC-FL||||CLINICAL RESEARCH COORDINATOR|RATER 1|1|Visit_1|10|7|TREATMENT|2020-08-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|2|FEV3PP|Percent Predicted FEV3|[?]|SLING|[?]|um/day|[?]|1|fmol|PYLORIC SPHINCTER|CONTRALATERAL|ANTEROPOSTERIOR|PLETHYSMOGRAPHY||||GUARDIAN|FORENSIC PATHOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-08-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|3|OXYPULSE|Oxygen Pulse|[?]|SITTING|[?]|WAFER|[?]|1|mL/min|MUCOSA OF THE LIP|RIGHT|OUTER|CELL BASED BIOASSAY||||GUARDIAN|RADIOLOGIST 2|2|Visit_2|25|3|SCREENING|2020-09-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|4|FIV1PP|Percent Predicted FIV1|[?]|REVERSE TRENDELENBURG|[?]|tsp|[?]|1|ug/dL|SKIN OF THE ELBOW|LATERAL|ANTEROPOSTERIOR|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||CHILD|UROLOGIST|2|Visit_2|25|6|TREATMENT|2020-09-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|5|INTP|Interpretation|[?]|LATERAL DECUBITUS|||[?]|1|PACK|EXTRAHEPATIC BILE DUCT|CONTRALATERAL|TEMPORAL|DNA MICROARRAY|||Y|INTERVIEWER|READER 3|3|Visit_3|40|1|TREATMENT|2020-09-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING|[?]|mEq/g|[?]|1|BU/mL|FALCIFORM LIGAMENT|BILATERAL|PROXIMAL|DIFFUSION TENSOR MRI|Y|Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR|3|Visit_3|40|7|WASHOUT|2020-09-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|7|IVCPP|Percent Predicted IVC|[?]|SLING|[?]|CIGAR|[?]|1|cs|RIB 11|UNILATERAL|PERIVENTRICULAR|FLUORESCENT MICROSCOPY||||INDEPENDENT ASSESSOR|NEUROLOGIST 1|4|Visit_4|65|1|WASHOUT|2020-10-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|8|FRC|Functional Residual Capacity|[?]|TRENDELENBURG|[?]|10^3 CFU/g|[?]|1|TABLET|MEDIASTINUM, ANTERIOR|RIGHT|UPPER FLEXOR SURFACE|IMPULSE OSCILLOMETRY|Y|||PARENT|RATER 1|4|Visit_4|65|3|SCREENING|2020-10-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|9|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|PRONE|[?]|DAgU/mL|[?]|1|ppb|L1 VERTEBRA|RIGHT|DISTAL VOLAR|TRIPLE-PHASE SPIRAL CT SCAN|Y|||PROXY|HEMATOLOGIST|5|Visit_5|90|7|SCREENING|2020-11-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|3637e1e0-8c0c-45cc-b139-e812a589f940|10|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING|||[?]|1|fmol/g|RIB 11|LATERAL|TIP|IMMUNOBLOT|||Y|ADJUDICATOR|ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2020-11-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|TSUHYS|Tissue Hysteresivity|[?]|PRONE|[?]|mol/mg|[?]|1|U/kg/min|TARSAL JOINT|IPSILATERAL|LOWER FLEXOR SURFACE|SEQUENCING||||PARENT|DERMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-11-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|2|INFLTIND|Infiltrates Indicator|[?]|FOWLERS|||[?]|1|10^9 organisms/mg|SACRAL TUBEROSITY|IPSILATERAL|NASAL|CELLULOSE TAPE|||Y|ADJUDICATOR|ADJUDICATOR 3|1|Visit_1|10|1|WASHOUT|2020-11-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LATERAL DECUBITUS|[?]|GBq/mg|[?]|1|vg/kg|INTERNAL ILIAC ARTERY|BILATERAL|SUPERFICIAL|TEST STRIP||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|2|Visit_2|25|5|WASHOUT|2020-12-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|4|TVPP|Percent Predicted Tidal Volume|[?]|SUPINE|[?]|U/L|[?]|1|uV*sec|NOSTRIL|UNILATERAL|POSTERIOR|FLUORIMETRY|Y|||CAREGIVER|READER 1|2|Visit_2|25|7|FOLLOW-UP|2020-12-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|5|SALKB|Salazar-Knowles Equation Parameter B|[?]|FOWLERS|[?]|pg/dL|[?]|1|AMPULE|SHOULDER|RIGHT|VENTRAL|ORCHIDOMETERY||||FAMILY MEMBER|PATHOLOGIST 2|3|Visit_3|40|7|SCREENING|2020-12-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|PRONE|||[?]|1|mL/kg/min|RETINAL ARTERY|IPSILATERAL|FACIAL|IVY INCISION METHOD|Y|Y|Y|INDEPENDENT ASSESSOR|MICROSCOPIST 2|3|Visit_3|40|5|TREATMENT|2020-12-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|7|FEV3PP|Percent Predicted FEV3|[?]|PRONE|[?]|mL/day|[?]|1|Log10 ELISA unit|MESENTERIC ARTERY|RIGHT|INFERIOR|ACID FAST STAIN|Y|||PARENT|ONCOLOGIST 2|4|Visit_4|65|4|TREATMENT|2021-01-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|8|EFFVOL|Effusion Volume|[?]|PRONE|[?]|Bq|[?]|1|GBq/g|FORELIMB|LATERAL|ANTEROMEDIAL|GC/MS/MS||Y||ADJUDICATOR|READER 2|4|Visit_4|65|3|SCREENING|2021-01-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|[?]|JAR|[?]|1|cP|LIVER LOBE|LATERAL|TEMPORAL|NON-CONTACT SPECULAR MICROSCOPY||||STUDY SUBJECT|ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2021-02-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|23385974-5fcd-4c36-b9fa-2fbb3841f182|10|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|100 IU/mL|[?]|1|uV*sec|FIBULA|IPSILATERAL|HIND|ICP-MS||||SIGNIFICANT OTHER|MICROSCOPIST|5|Visit_5|90|2|WASHOUT|2021-02-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/s|[?]|1|L/kg|PARACOLIC GUTTER|LATERAL|SUBCORTICAL|TRANSVAGINAL ULTRASOUND|Y|||INTERVIEWER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-12-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|2|MEP|Maximal Expiratory Pressure|[?]|REVERSE TRENDELENBURG|[?]|uU/L|[?]|1|kHz|LIVER, CAUDATE LOBE|BILATERAL|UPPER EXTENSOR SURFACE|CHROMATOGRAPHY||||FRIEND|ONCOLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-12-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|DECUBITUS|||[?]|1|g/kg|MESENTERIC ARTERY|BILATERAL|LOWER FLEXOR SURFACE|TELLER ACUITY CARDS|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|2|Visit_2|25|3|SCREENING|2020-12-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING|||[?]|1|pg/L|HEART, RIGHT ATRIUM|BILATERAL|FORE|POTENTIOMETRY|Y||Y|NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|2|Visit_2|25|5|SCREENING|2020-12-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|5|PLMXRS|Pulmonary Reactance|[?]|STANDING|[?]|Absorbance U|[?]|1|mL/cm H2O|BUCCAL MUCOSA|LEFT|SUBCORTICAL|ANALYTICAL ULTRACENTRIFUGATION|Y|||INDEPENDENT ASSESSOR|READER|3|Visit_3|40|7|FOLLOW-UP|2021-01-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|6|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|uSiemens|[?]|1|Mile|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|IPSILATERAL|TIP|LAPAROSCOPY||||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2021-01-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|7|SRAW|Specific Airway Resistance|[?]|DECUBITUS|[?]|uCi|[?]|1|ug/dL|CILIARY BODY|LEFT|DISTAL|TEMPLATE INCISION METHOD|Y|||SIBLING|ENDOCRINOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2021-01-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|8|PLMXRS|Pulmonary Reactance|[?]|TRENDELENBURG|[?]|pkat|[?]|1|INHALATION|INTESTINE|LATERAL|OUTER|ENZYMATIC ULTRACENTRIFUGATION|Y|Y||ADJUDICATOR|RATER|4|Visit_4|65|1|WASHOUT|2021-01-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|9|SRAW|Specific Airway Resistance|[?]|SEMI-FOWLERS|[?]|mCi|[?]|1|mmol|RECTOVAGINAL SPACE|LEFT|MEDIAL|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|Y||SPOUSE|NEUROLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-02-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Enzyme U/L|HAIR ROOT|LATERAL|TIP|INDIA INK STAIN||Y|Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|5|Visit_5|90|2|TREATMENT|2021-02-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|1|RAW|Airway Resistance|[?]|STANDING|[?]|log10 TCID 50/uL|[?]|1|L/s|PATELLA|LEFT|MEDIAL|AURAMINE STAIN||||FRIEND|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|2|RELSZCHG|Relative Size Change|[?]|REVERSE TRENDELENBURG|||[?]|1|10^3 RNA copies/mL|HEART, APEX|CONTRALATERAL|POSTERIOR|HANSEL STAIN|||Y|DOMESTIC PARTNER|MICROSCOPIST 3|1|Visit_1|10|7|SCREENING|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|3|DLCOPP|Percent Predicted DLCO|[?]|STANDING|||[?]|1|kat|VENA CAVA|RIGHT|VENTRAL|IMMUNORADIOMETRIC ASSAY|Y||Y|INVESTIGATOR|RADIOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|4|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pkat/L|FIRST OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|SUBCORTICAL|IMMUNORADIOMETRIC ASSAY|||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 2|2|Visit_2|25|5|TREATMENT|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|5|FIF75|Forced Inspiratory Flow at 75%|[?]|SUPINE|[?]|mmHg/L/min|[?]|1|ft|SPINAL CORD|IPSILATERAL|CRANIAL|OPTICAL DENSITY MEASUREMENT|Y|||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|3|Visit_3|40|1|WASHOUT|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|6|LOBVOL|Lobar Volume|[?]|SEMI-FOWLERS|[?]|Hz|[?]|1|INHALATION|RESPIRATORY SYSTEM|BILATERAL|DISTAL|DISK DIFFUSION||||CHILD|OTOLARYNGOLOGIST|3|Visit_3|40|2|TREATMENT|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|PRONE|[?]|/500 WBC|[?]|1|umol/dL|PERONEAL ARTERY|LEFT|PROXIMAL|BALLPOINT PEN TECHNIQUE||||DOMESTIC PARTNER|OTOLARYNGOLOGIST|4|Visit_4|65|6|TREATMENT|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|8|PEFREV|PEF Reversibility|[?]|UNCONSTRAINED|[?]|breaths/30s|[?]|1|ug/m2/day|WRIST JOINT EXTENSOR MUSCLES|CONTRALATERAL|LOWER|POTENTIOMETRY||||INTERVIEWER|ONCOLOGIST|4|Visit_4|65|7|TREATMENT|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|9|ERVPP|Percent Predicted ERV|[?]|SITTING|||[?]|1|pmol/10^9 cells|PREAURICULAR LYMPH NODE|UNILATERAL|CRANIAL|NEURAMINIDASE INHIBITION ASSAY|||Y|INDEPENDENT ASSESSOR|RADIOLOGIST 1|5|Visit_5|90|1|FOLLOW-UP|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|f1327e16-08c6-4ef0-852e-13c095a94c00|10|FIV1PP|Percent Predicted FIV1|[?]|DECUBITUS|||[?]|1|mg/m2/day|DUCTUS ARTERIOSUS|LATERAL|ANTEROPOSTERIOR|CARDIAC THERMODILUTION||Y|Y|PARENT|RATER 1|5|Visit_5|90|1|FOLLOW-UP|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-FOWLERS|[?]|DAgU/mL|[?]|1|IU|TESTIS|UNILATERAL|SURFACE|SISH||Y||CAREGIVER|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2021-01-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|oz|[?]|1|PIXEL|MIDDLE PHALANX 5 OF THE HAND|LEFT|INFERIOR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y||SIBLING|ADJUDICATOR|1|Visit_1|10|6|FOLLOW-UP|2021-01-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|3|FEV1SVC|FEV1/SVC|[?]|STANDING|||[?]|1|breaths/min|FAT PAD|UNILATERAL|ANTERIOR|RADIAL IMMUNODIFFUSION|Y||Y|INVESTIGATOR|ENDOCRINOLOGIST|2|Visit_2|25|1|SCREENING|2021-01-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|[?]|/ms|[?]|1|dpm/mg|MEDULLA OBLONGATA|LATERAL|NASAL|MRI||Y||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|2|Visit_2|25|2|TREATMENT|2021-01-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|5|EFFVOL|Effusion Volume|[?]|UNCONSTRAINED|[?]|10^4/hpf|[?]|1|mL/animal/wk|PANCREAS, BODY|BILATERAL|UPPER FLEXOR SURFACE|INTERRUPTER TECHNIQUE||Y||PROXY|NEUROLOGIST 1|3|Visit_3|40|2|FOLLOW-UP|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|6|MIP|Maximal Inspiratory Pressure|[?]|TRENDELENBURG|||[?]|1|PIXELS/in|GASTROCNEMIUS MUSCLE|LEFT|VOLAR|MALDI|||Y|ADJUDICATOR|READER 1|3|Visit_3|40|3|FOLLOW-UP|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|7|AIRTRAP|Air Trapping|[?]|REVERSE TRENDELENBURG|[?]|mmol/min/kPa/L|[?]|1|cy/cm|HAIR|BILATERAL|FRONTAL|JAEGER EYE CHART||||INTERVIEWER|ADJUDICATOR 2|4|Visit_4|65|4|SCREENING|2021-03-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|8|TSUHYS|Tissue Hysteresivity|[?]|SLING|[?]|NEEDLE GAUGE|[?]|1|g/dL|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|BILATERAL|DEEP|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|||DOMESTIC PARTNER|RATER|4|Visit_4|65|4|TREATMENT|2021-03-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|9|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|[?]|mm/h|[?]|1|10^7 PFU|CAPITATE-LUNATE JOINT|UNILATERAL|PARIETO-OCCIPITAL|PERIODIC ACID SCHIFF STAIN|Y|Y||STUDY SUBJECT|RADIOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|10|ALVVOL|Alveolar Volume|[?]|DECUBITUS|||[?]|1|g/g/day|INCUS|IPSILATERAL|INTERMEDIATE|ATOMIC ABSORPTION SPECTROMETRY||Y|Y|PARENT|OTOLARYNGOLOGIST|5|Visit_5|90|4|TREATMENT|2021-04-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|TGV|Thoracic Gas Volume|[?]|LEFT LATERAL DECUBITUS|[?]|IU/kg/h|[?]|1|nsec|EYELASH|IPSILATERAL|VENTROLATERAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-12-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|2|MEP|Maximal Expiratory Pressure|[?]|SEMI-RECUMBENT|[?]|10^6 IU/mL|[?]|1|kIU|PREFRONTAL CORTEX|CONTRALATERAL|MEDIAL|LAPAROSCOPY||||PARENT|ADJUDICATOR 2|1|Visit_1|10|5|FOLLOW-UP|2020-12-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|PRONE|[?]|kBq/uL|[?]|1|log10 CFU/g|RECTOSIGMOID JUNCTION|CONTRALATERAL|INTERMEDIATE|IMMUNOBLOT|Y|||CHILD|MICROSCOPIST 3|2|Visit_2|25|2|WASHOUT|2020-12-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|4|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|10^3 copies/mL|CARPOMETACARPAL JOINT 4|CONTRALATERAL|FACIAL|GC/MS-EI|||Y|PROXY|RADIOLOGIST 1|2|Visit_2|25|1|WASHOUT|2020-12-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|5|FIO2|Fraction of Inspired Oxygen|[?]|FOWLERS|[?]|Bq/kg|[?]|1|mol/g|WRIST JOINT FLEXOR TENDONS|CONTRALATERAL|SUPERIOR|RADIAL IMMUNODIFFUSION||Y||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|3|Visit_3|40|5|SCREENING|2021-01-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|6|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|pg/dL|[?]|1|pt_us|LEFT CIRCUMFLEX CORONARY ARTERY|IPSILATERAL|UPPER|STATIC PERIMETRY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|3|Visit_3|40|7|FOLLOW-UP|2021-01-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|7|OXYPULSE|Oxygen Pulse|[?]|PRONE|[?]|mL/m2/min|[?]|1|mL/dose|SCIATIC NERVE|CONTRALATERAL|LOWER|ISHIHARA COLOR PLATES||||HEALTH CARE PROFESSIONAL|DERMATOLOGIST|4|Visit_4|65|4|WASHOUT|2021-02-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|8|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|LB|[?]|1|/500 WBC|STERNAL MANUBRIUM|BILATERAL|TEMPORAL|ELECTROMYOGRAPHY||||INDEPENDENT ASSESSOR|MICROSCOPIST|4|Visit_4|65|7|TREATMENT|2021-02-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|9|MIP|Maximal Inspiratory Pressure|[?]|SITTING|[?]|kcal|[?]|1|log EID 50/dose|ANAL CANAL|RIGHT|OUTER|ROMANOWSKY STAIN||||PROXY|OPTOMETRIST|5|Visit_5|90|3|SCREENING|2021-02-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|e8065021-c163-41c8-8a76-5f0c1c3a06c4|10|DLCOVA|DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|anti-Xa IU|[?]|1|ft2|ABDOMINAL SKIN|UNILATERAL|VENTRAL|SLOAN LETTER EYE CHART 100%|Y|||INVESTIGATOR|MICROSCOPIST 1|5|Visit_5|90|1|TREATMENT|2021-02-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|PFU/dose|[?]|1|vg/kg|ADDUCTOR MAGNUS MUSCLE|BILATERAL|APICAL|HPLC||Y||CAREGIVER|RATER 1|1|Visit_1|10|7|FOLLOW-UP|2020-11-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|STANDING|[?]|%/min|[?]|1|cm/min|TAIL|BILATERAL|TIP|MUGA||||CLINICAL RESEARCH ASSOCIATE|RATER 2|1|Visit_1|10|5|TREATMENT|2020-11-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|3|EFFIND|Effusion Indicator|[?]|STANDING|||[?]|1|km/h|CHIN|CONTRALATERAL|VOLAR|FREEZING POINT DEPRESSION|||Y|CHILD|RADIOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-12-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|TRENDELENBURG|||[?]|1|mg/kg/dose|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LEFT|CAUDAL|TEMPLATE INCISION METHOD||Y|Y|FRIEND|ADJUDICATOR 2|2|Visit_2|25|5|FOLLOW-UP|2020-12-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|[?]|ppth|[?]|1|copies/uL|RETINAL ARTERY|IPSILATERAL|PARIETO-OCCIPITAL|BIOPSY||||DOMESTIC PARTNER|OPHTHALMOLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|6|FRCPP|Percent Predicted FRC|[?]|STANDING|[?]|DPM|[?]|1|CCID 50/dose|IRIS|BILATERAL|OCCIPITAL|CALCULATION|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST|3|Visit_3|40|5|WASHOUT|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|7|INERTANC|Inertance|[?]|SUPINE|[?]|s*kPa|[?]|1|cm/min|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|RIGHT|ANTERIOR|PANENDOSCOPY||||INDEPENDENT ASSESSOR|READER 2|4|Visit_4|65|5|TREATMENT|2021-01-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|8|IRV|Inspiratory Reserve Volume|[?]|SUPINE|[?]|g/cm2|[?]|1|P|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT|UPPER FLEXOR SURFACE|PELLI-ROBSON EYE CHART||||SIBLING|RATER 2|4|Visit_4|65|2|FOLLOW-UP|2021-01-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|s/h|[?]|1|g/g|ACCESSORY RENAL ARTERY|LEFT|NASAL|WESTERGREN|Y|||GUARDIAN|NEUROLOGIST 2|5|Visit_5|90|5|TREATMENT|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|854a9218-995e-47f4-87ab-e58d20f56d19|10|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SLING|[?]|GLOBULE|[?]|1|10^6 RNA copies/mL|LIVER, LEFT LOBE|IPSILATERAL|PERIPHERAL|RADIAL IMMUNODIFFUSION||||FAMILY MEMBER|ONCOLOGIST 1|5|Visit_5|90|4|FOLLOW-UP|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|EXPRELTM|Expiration Relaxation Time|[?]|PRONE|[?]|kIU|[?]|1|mL/cm3/min|LYMPH NODE HILUM|LATERAL|INTERMEDIATE|MAGNETIC RESONANCE ENTEROGRAPHY||Y||FRIEND|PATHOLOGIST 1|1|Visit_1|10|3|FOLLOW-UP|2020-06-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|2|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|[?]|uL/kg/day|[?]|1|Ci/ug|ETHMOID SINUS|CONTRALATERAL|TIP|PERFUSION MRI||||PARENT|RADIOLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-06-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|3|TV|Tidal Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mmol/g|HARD PALATE|LEFT|MEDIAL|HPLC-FL||Y|Y|NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|2|Visit_2|25|6|TREATMENT|2020-07-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|4|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|UNCONSTRAINED|||[?]|1|mL/mmHg|LUMBAR SPINE|BILATERAL|PROXIMAL VOLAR|PALM METHOD|||Y|PROXY|RADIOLOGIST|2|Visit_2|25|5|SCREENING|2020-07-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|5|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|Ci/ug|[?]|1|g/m2|SCAPHOID-TRAPEZIUM JOINT|IPSILATERAL|SUBCORTICAL|SLIT LAMP|Y|||SPOUSE|RATER|3|Visit_3|40|7|FOLLOW-UP|2020-07-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|6|AWWVOL|Airway Wall Volume|[?]|SITTING|[?]|uU/dL|[?]|1|Tbsp|METATARSOPHALANGEAL JOINT 3|IPSILATERAL|VENTROLATERAL|FUNCTIONAL MRI||||ADJUDICATION COMMITTEE|RADIOLOGIST 1|3|Visit_3|40|4|SCREENING|2020-07-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|7|FEV1FVC|FEV1/FVC|[?]|STANDING, BENT FORWARD|[?]|Osm|[?]|1|Enzyme U/m2|ANKLE JOINT ANTERIOR FLEXOR TENDONS|LATERAL|PROXIMAL|PHASE CONTRAST MICROSCOPY||||INTERVIEWER|HEMATOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING|[?]|Bq/mL|[?]|1|NFIU|SECOND OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|LATERAL|IMPEDANCE CONDUCTIVITY||||CLINICAL STUDY SPONSOR|ONCOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|9|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|BE/mL|[?]|1|um|L6 VERTEBRA|IPSILATERAL|FORE|ENDPOINT DILUTION ASSAY||||PARENT|ONCOLOGIST 2|5|Visit_5|90|3|FOLLOW-UP|2020-09-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|10|FEV1FVC6|FEV1/FVC6|[?]|SEMI-FOWLERS|[?]|mEq/g|[?]|1|mL*cmH2O|DISTAL INTERPHALANGEAL JOINT 3|IPSILATERAL|UPPER|IMMUNOBLOT||||SIBLING|READER 2|5|Visit_5|90|5|FOLLOW-UP|2020-09-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|PRONE|||[?]|1|U/g Hb|PERIHILAR LYMPH NODE|LEFT|ANTEROLATERAL|IODINE STAIN|||Y|INDEPENDENT ASSESSOR|DERMATOLOGIST|1|Visit_1|10|6|TREATMENT|2020-12-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|2|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING, LEGS DEPENDENT|[?]|ng/day|[?]|1|kV|NUCLEUS OF DIAGONAL BAND|CONTRALATERAL|SUPERFICIAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||DOMESTIC PARTNER|READER|1|Visit_1|10|4|WASHOUT|2020-12-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|3|PEFREV|PEF Reversibility|[?]|SITTING|[?]|/min|[?]|1|Torr|METATARSOPHALANGEAL JOINT 5|CONTRALATERAL|FRONTAL|CYSTOMETRY||||FAMILY MEMBER|PHYSIOTHERAPIST|2|Visit_2|25|1|FOLLOW-UP|2021-01-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|4|GAW|Airway Conductance|[?]|TRENDELENBURG|[?]|10^6 U|[?]|1|Ci/ug|REGIONAL LYMPH NODE|CONTRALATERAL|PERIVENTRICULAR|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|2|Visit_2|25|5|FOLLOW-UP|2021-01-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|5|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|||[?]|1|Absorbance U|TRICUSPID VALVE|BILATERAL|VOLAR|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|||Y|CAREGIVER|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2021-01-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|6|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|[?]|nkat/L|[?]|1|g/animal/day|FLANK|BILATERAL|ANTEROPOSTERIOR|LANDOLT RING||Y||INDEPENDENT ASSESSOR|PATHOLOGIST 2|3|Visit_3|40|4|TREATMENT|2021-01-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|7|IRVPP|Percent Predicted IRV|[?]|PRONE|[?]|mmHg/sec|[?]|1|10^8 PFU|CEREBRAL ARTERY|UNILATERAL|ANTERIOR|IODINE STAIN|Y|Y||CHILD|OPHTHALMOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-02-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|8|VO2|Oxygen Consumption|[?]|DECUBITUS|[?]|deg2|[?]|1|IU/g|CORPUS CALLOSUM, BODY|BILATERAL|SUBCORTICAL|DUKE INCISION METHOD||||ADJUDICATOR|RATER 2|4|Visit_4|65|4|TREATMENT|2021-02-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-RECUMBENT|[?]|EP U|[?]|1|mg/cm2|SPLENIC VEIN|LATERAL|LOWER MEDIAL|MULTIPLE BREATH WASHOUT|Y|||DOMESTIC PARTNER|INTERNIST|5|Visit_5|90|4|FOLLOW-UP|2021-03-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|08944dcd-a62d-4932-bb15-a8f15cc73229|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING|[?]|EU|[?]|1|DPM|TARSUS BONE|RIGHT|MIDLINE|MEDIASTINOSCOPY||Y||FRIEND|RATER 1|5|Visit_5|90|5|FOLLOW-UP|2021-03-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|1|MIPPP|Percent Predicted MIP|[?]|PRONE|[?]|STRIP|[?]|1|mg/cm2|HEART, LEFT VENTRICULAR OUTFLOW TRACT|BILATERAL|MEDIAL|DISK DIFFUSION||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|1|Visit_1|10|6|FOLLOW-UP|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|2|FIF25|Forced Inspiratory Flow at 25%|[?]|TRENDELENBURG|[?]|mL/beat|[?]|1|pmol/dL|CORPUS CALLOSUM, BODY|UNILATERAL|PROXIMAL|PUPILLOMETRY|Y|Y||CHILD|ONCOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/mL/day|[?]|1|IU/mmol|PERIANAL REGION|BILATERAL|UPPER EXTENSOR SURFACE|MANUAL COUNT||||PARENT|NEUROLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|4|PLMBLFLW|Pulmonary Blood Flow|[?]|UNCONSTRAINED|[?]|gtt|[?]|1|fmol/g|DUODENUM|IPSILATERAL|VENTROLATERAL|TELLER ACUITY CARDS||Y||SPOUSE|ADJUDICATOR 2|2|Visit_2|25|3|FOLLOW-UP|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|5|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|[?]|10^9 organisms/mL|[?]|1|CAPLET|LUNG, HILUM|IPSILATERAL|UPPER|KLEIHAUER-BETKE|Y|||INVESTIGATOR|READER 3|3|Visit_3|40|7|FOLLOW-UP|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|6|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|||[?]|1|cmol|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|CONTRALATERAL|UPPER|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|||Y|CAREGIVER|NEUROLOGIST 2|3|Visit_3|40|7|SCREENING|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|7|IC|Inspiratory Capacity|[?]|SITTING|||[?]|1|ug/h|SKIN OF THE SOLE|UNILATERAL|VENTRAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|||[?]|1|nmol/mL/min|HYPOTHALAMUS|IPSILATERAL|NASAL|AUTOMATED COUNT|||Y|DOMESTIC PARTNER|NEUROLOGIST|4|Visit_4|65|3|SCREENING|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SLING|[?]|mL/m2|[?]|1|mmHg*min/L|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|CONTRALATERAL|ANTEROLATERAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y||PARENT|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|1d7df560-695a-41fe-9226-4cc206b05f48|10|RER|Respiratory Exchange Ratio|[?]|SLING|[?]|10^3 organisms/mL|[?]|1|yd|GASTROINTESTINAL TRACT, UPPER, WALL|UNILATERAL|OUTER|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||VENDOR|RATER 2|5|Visit_5|90|6|WASHOUT|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|1|LCI|Lung Clearance Index|[?]|DECUBITUS|[?]|mL/(min*100mL)|[?]|1|10^3 DNA copies/mL|LATERAL RAMUS INTERMEDIUS ARTERY|CONTRALATERAL|POSTERIOR|ELECTRONEUROGRAPHY||||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|LATERAL DECUBITUS|[?]|mL/cm|[?]|1|CAPLET|ANKLE JOINT|BILATERAL|CENTRAL|FLUORESCENCE ANGIOGRAPHY||Y||DOMESTIC PARTNER|HEMATOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|3|IVCPP|Percent Predicted IVC|[?]|STANDING, BENT FORWARD|[?]|Hounsfield Unit|[?]|1|nmol/kg/day|DISTAL INTERPHALANGEAL JOINT 3|RIGHT|SUPERFICIAL|IODINE STAIN||||GUARDIAN|ADJUDICATOR 1|2|Visit_2|25|1|SCREENING|2020-07-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|4|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LATERAL DECUBITUS|[?]|U/kg/h|[?]|1|U/mmol|PROXIMAL CIRCUMFLEX ARTERY|CONTRALATERAL|APICAL|DYNAMOMETRY||||INDEPENDENT ASSESSOR|RATER|2|Visit_2|25|1|TREATMENT|2020-07-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|/100 HPFs|CEREBRAL HEMISPHERE, RIGHT|CONTRALATERAL|PARIETO-OCCIPITAL|MALDI|||Y|PARENT|READER 3|3|Visit_3|40|7|WASHOUT|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING|[?]|U/L|[?]|1|mV/sec|PROXIMAL LAD ARTERY|BILATERAL|LOWER MEDIAL|TRANSMISSION ELECTRON MICROSCOPY||Y||PARENT|PEDIATRIC NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|[?]|/100 HPFs|[?]|1|EVENTS|FOOT DIGIT 2|BILATERAL|MIDLINE|RADIATION DOSIMETRY||Y||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-RECUMBENT|[?]|g|[?]|1|uU/dL|ILIAC LYMPH NODE|BILATERAL|BASAL|MICROBIAL CONCENTRATION||||GUARDIAN|UROLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|9|DLCOHC|HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|amu|[?]|1|mg/cm2|HUMERAL EPICONDYLE|IPSILATERAL|TIP|GC/MS||||PROXY|OTOLARYNGOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-09-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|12c802a8-862c-45a4-b12c-a6f920772534|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|SLING|||[?]|1|amol|RETINAL ARTERY|UNILATERAL|SUPERIOR|SXA SCAN|Y||Y|HEALTH CARE PROFESSIONAL|READER|5|Visit_5|90|4|SCREENING|2020-09-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING|[?]|Watt|[?]|1|mph|DUODENUM|IPSILATERAL|CAUDAL|MASS SPECTROMETRY|Y|||ADJUDICATOR|HEMATOLOGIST|1|Visit_1|10|2|SCREENING|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/cm3/min|[?]|1|mCi|MEDIAN OR LOWER CERVICAL LYMPH NODE|CONTRALATERAL|LOWER MEDIAL|PHYSICAL EXAMINATION||||INTERVIEWER|MICROSCOPIST|1|Visit_1|10|5|TREATMENT|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|3|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|||[?]|1|10^6 RNA copies/mL|PUPIL|UNILATERAL|SUPERFICIAL|SISH||Y|Y|SPOUSE|RADIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-12-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|EP U|[?]|1|mPa|BODY OF STOMACH|UNILATERAL|LOWER MEDIAL|SINGLE-SLICE SPIRAL CT||||HEALTH CARE PROFESSIONAL|RATER 2|2|Visit_2|25|1|SCREENING|2020-12-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|UNCONSTRAINED|[?]|CONTAINER|[?]|1|mL/m2/day|SCROTUM|BILATERAL|PARIETO-OCCIPITAL|MUGA|Y|||FRIEND|ONCOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|6|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|UNCONSTRAINED|||[?]|1|U/m2/min|EXTRAOCULAR MUSCLE|CONTRALATERAL|NASAL|SPIROMETRY||Y|Y|INVESTIGATOR|ONCOLOGIST|3|Visit_3|40|7|TREATMENT|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|7|MALEVDES|Malignancy Evidence Description|[?]|PRONE|||[?]|1|/ms|BRONCHUS|IPSILATERAL|BASAL|HIGH RESOLUTION MELT ANALYSIS|||Y|PARENT|UROLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-01-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|8|LOBVOL|Lobar Volume|[?]|SLING|||[?]|1|Siemens|RADIUS|UNILATERAL|ANTEROLATERAL|BIOIMPEDANCE SPECTROSCOPY||Y|Y|INVESTIGATOR|READER 3|4|Visit_4|65|1|TREATMENT|2021-01-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|9|INFLTIND|Infiltrates Indicator|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mm3/mm2/year|SKIN AROUND THE MOUTH|LEFT|PROXIMAL|JAEGER EYE CHART|||Y|SPOUSE|PHYSIOTHERAPIST|5|Visit_5|90|1|WASHOUT|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|10|SVC|Slow Vital Capacity|[?]|SEMI-RECUMBENT|[?]|mm/sec|[?]|1|dpm/mL|COLON, RECTOSIGMOID|RIGHT|TEMPORAL|PHOROPTER||||CLINICAL RESEARCH COORDINATOR|READER 3|5|Visit_5|90|4|TREATMENT|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|TSUELAS|Tissue Elastance|[?]|STANDING|[?]|DAgU/mL|[?]|1|10^9 organisms|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LATERAL|TIP|IMMUNOTURBIDIMETRY||Y||FAMILY MEMBER|READER|1|Visit_1|10|2|SCREENING|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|2|FEV1FVC|FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|PA|MUCOSA|UNILATERAL|ANTEROMEDIAL|CELL BASED BIOASSAY|Y||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 2|1|Visit_1|10|3|FOLLOW-UP|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|3|FRC|Functional Residual Capacity|[?]|UNCONSTRAINED|||[?]|1|uU/dL|LIVER, CAUDATE LOBE|BILATERAL|LOWER FLEXOR SURFACE|SPIRAL CT SCAN WITHOUT CONTRAST|Y|Y|Y|CAREGIVER|INTERNIST|2|Visit_2|25|4|TREATMENT|2020-08-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|4|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SLING|[?]|GBq/ug|[?]|1|mph|INTERNAL MAMMARY LYMPH NODE|BILATERAL|CENTRAL|DIGITAL PCR||||CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|WASHOUT|2020-08-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|5|FEV1PP|Percent Predicted FEV1|[?]|FOWLERS|[?]|mg/kg/day|[?]|1|mL/breath|DISTAL INTERPHALANGEAL JOINT 5|RIGHT|APICAL|ZIEHL NEELSEN ACID FAST STAIN|Y|||SIGNIFICANT OTHER|ONCOLOGIST 2|3|Visit_3|40|7|WASHOUT|2020-09-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|6|TGV|Thoracic Gas Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Bq/mg|URETHRAL SPHINCTER|CONTRALATERAL|DISTAL|HPLC-UV|Y||Y|GUARDIAN|READER 1|3|Visit_3|40|7|TREATMENT|2020-09-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|7|RVPP|Percent Predicted Residual Volume|[?]|REVERSE TRENDELENBURG|[?]|aMFI|[?]|1|fmol/g|HAND DIGIT 2|RIGHT|DORSOLATERAL|DYNAMIC CONTRAST ENHANCED MRI||||INDEPENDENT ASSESSOR|RATER|4|Visit_4|65|4|FOLLOW-UP|2020-10-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|8|TV|Tidal Volume|[?]|SEMI-RECUMBENT|||[?]|1|10^6 CFU/mL|MID-LAD ARTERY|UNILATERAL|ROSTRAL|ECHOCARDIOGRAPHY|||Y|DOMESTIC PARTNER|HEMATOLOGIST|4|Visit_4|65|2|TREATMENT|2020-10-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|9|IRV|Inspiratory Reserve Volume|[?]|SITTING|[?]|mg/mL/min|[?]|1|dpm/0.5 mL|SUDORIFEROUS GLAND|IPSILATERAL|HIND|COMPUTERIZED CORNEAL TOPOGRAPHY||||SIBLING|READER 3|5|Visit_5|90|7|FOLLOW-UP|2020-11-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|10|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING, LEGS DEPENDENT|[?]|/day|[?]|1|10^3 CFU|DISTAL FEMUR R1|LATERAL|SUPERIOR|NON-INVASIVE DIELECTRIC SENSING||||CHILD|MICROSCOPIST 1|5|Visit_5|90|5|TREATMENT|2020-11-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|1|MALIND|Malignancy Indicator|[?]|LATERAL DECUBITUS|[?]|log10 TCID 50/mL|[?]|1|nmol/g|BUTTOCK|RIGHT|VENTROLATERAL|CHROMOGENIC ASSAY||||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|1|Visit_1|10|4|TREATMENT|2020-11-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|2|DLCOHC|HGB Corrected DLCO|[?]|PRONE|[?]|10^9 organisms/g|[?]|1|/HPF|HEART, LEFT VENTRICULAR WALL|UNILATERAL|ANTEROMEDIAL|ACCELERATOR MASS SPECTROMETRY|Y|Y||SPOUSE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|3|TREATMENT|2020-11-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|3|PLMXRS|Pulmonary Reactance|[?]|TRENDELENBURG|[?]|ug/dL|[?]|1|/day|VULVA|LATERAL|ANTEROLATERAL|WEBER GREEN STAIN||||INDEPENDENT ASSESSOR|RATER|2|Visit_2|25|7|SCREENING|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|4|VO2|Oxygen Consumption|[?]|PRONE|||[?]|1|pmol/10^9 cells|HEART, RIGHT VENTRICULAR WALL|BILATERAL|INNER|TRANSTHORACIC ECHOCARDIOGRAPHY|Y||Y|SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|5|PLMXRS|Pulmonary Reactance|[?]|SEMI-RECUMBENT|||[?]|1|mm/2h|INCISOR|LEFT|PROXIMAL|CT SCAN WITHOUT CONTRAST|Y|Y|Y|ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|2|TREATMENT|2020-12-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|6|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|||[?]|1|mg/kg/dose|SACRUM|UNILATERAL|LOWER|OPTICAL DENSITY MEASUREMENT|Y||Y|CLINICAL STUDY SPONSOR|ONCOLOGIST 1|3|Visit_3|40|7|FOLLOW-UP|2020-12-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|7|FIVC|Forced Inspiratory Vital Capacity|[?]|PRONE|[?]|dram|[?]|1|APS U|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|CONTRALATERAL|UPPER|MICROBIAL CONCENTRATION||Y||CHILD|READER 1|4|Visit_4|65|3|FOLLOW-UP|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|8|RRS|Total Respiratory System Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|/MBP|[?]|1|10^9/L|SKIN OF THE FOOT|UNILATERAL|INFERIOR|PATHOLOGICAL EVALUATION||Y||SIGNIFICANT OTHER|ONCOLOGIST 1|4|Visit_4|65|6|WASHOUT|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING, BENT FORWARD|[?]|mgEq|[?]|1|mgEq|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|BILATERAL|UPPER FLEXOR SURFACE|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|Y||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-02-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|96114171-59a0-4543-b3ec-c7796ae8ee92|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|||[?]|1|pt_br|MITRAL VALVE, POSTERIOR ANNULUS|LEFT|VENTROLATERAL|IMMUNOBLOT|Y|Y|Y|SIGNIFICANT OTHER|RADIOLOGIST|5|Visit_5|90|5|TREATMENT|2021-02-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|ELSTNCE|Elastance|[?]|SEMI-RECUMBENT|[?]|cd/m2|[?]|1|Bq/L|MOTOR CORTEX|LEFT|NASAL|LANDOLT RING|Y|||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|4|TREATMENT|2020-08-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|2|FEV1FVC|FEV1/FVC|[?]|PRONE|[?]|nmol BCE/nmol|[?]|1|KIT|BRACHIORADIALIS MUSCLE|LATERAL|CRANIAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||ADJUDICATION COMMITTEE|MICROSCOPIST|1|Visit_1|10|5|TREATMENT|2020-08-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|PRONE|[?]|mN|[?]|1|mg/mL/day|ARM SKIN|CONTRALATERAL|HIND|FLUOROSCOPY||||INVESTIGATOR|RADIOLOGIST 2|2|Visit_2|25|5|FOLLOW-UP|2020-08-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|4|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|STANDING|||[?]|1|ug/kg/day|INFRATENTORIAL BRAIN|UNILATERAL|DORSOLATERAL|NUCLEAR RADIOLOGY|Y|Y|Y|INTERVIEWER|RATER|2|Visit_2|25|6|FOLLOW-UP|2020-08-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|5|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING|[?]|cal|[?]|1|mol/g|SKIN OF THE NECK|UNILATERAL|ANTEROLATERAL|TEMPLATE INCISION METHOD||||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|3|Visit_3|40|7|TREATMENT|2020-09-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|6|FEV3PP|Percent Predicted FEV3|[?]|SITTING, LEGS DEPENDENT|[?]|mmHg/sec|[?]|1|mEq|LUNG, LEFT|RIGHT|OCCIPITAL|OPTICAL COHERENCE TOMOGRAPHY|Y|Y||INDEPENDENT ASSESSOR|CARDIOLOGIST|3|Visit_3|40|6|TREATMENT|2020-09-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|7|AIRTRAP|Air Trapping|[?]|PRONE|[?]|GPS U|[?]|1|genEq/mL|RAPHE|LEFT|ANTEROTEMPORAL|BALLPOINT PEN TECHNIQUE||||SIGNIFICANT OTHER|ADJUDICATOR 2|4|Visit_4|65|7|TREATMENT|2020-10-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|8|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|uEq|[?]|1|SQU/mL|GREAT SAPHENOUS VEIN|BILATERAL|OUTER|ULTRASOUND||Y||FAMILY MEMBER|ENDOCRINOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-10-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|9|RAWPP|Percent Predicted Airway Resistance|[?]|PRONE|[?]|WEEKS|[?]|1|kg/cm2|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|BILATERAL|LOWER MEDIAL|ETDRS EYE CHART||||NON-HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-11-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|0070d42d-c864-4a83-a3c9-4c8ca7de51de|10|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|[?]|APL U/mL|[?]|1|mg/kg/min|MEDIASTINUM|LEFT|DORSAL|FLOW MICROSCOPY||||SIBLING|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2020-11-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|FIVC|Forced Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|pmol/g|[?]|1|GPL U|THYROID GLAND|UNILATERAL|ANTEROLATERAL|HPLC/MS|Y|Y||ADJUDICATION COMMITTEE|READER 1|1|Visit_1|10|1|FOLLOW-UP|2020-10-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|2|INERTANC|Inertance|[?]|SEMI-RECUMBENT|[?]|ng/day|[?]|1|IU/g Hb|QUADRICEPS MUSCLE|IPSILATERAL|FACIAL|EEG||||STUDY SUBJECT|READER 1|1|Visit_1|10|2|SCREENING|2020-10-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|3|ELSTNCE|Elastance|[?]|SLING|||[?]|1|U/kg/day|WRIST JOINT|UNILATERAL|LOWER|DIGITAL PCR ARRAY|Y||Y|CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|2|Visit_2|25|4|FOLLOW-UP|2020-11-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|4|FIF25|Forced Inspiratory Flow at 25%|[?]|TRENDELENBURG|[?]|cy/cm|[?]|1|mol/g|THORACIC SPINE|RIGHT|MEDIAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||||DOMESTIC PARTNER|RADIOLOGIST 1|2|Visit_2|25|7|WASHOUT|2020-11-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|PNU/mL|RADIUS SHAFT|LATERAL|PERIVENTRICULAR|HIGH RESOLUTION CT|||Y|CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|3|Visit_3|40|6|SCREENING|2020-11-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|6|DLCOPP|Percent Predicted DLCO|[?]|FOWLERS|||[?]|1|umol/L/h|NUCLEUS ACCUMBENS|RIGHT|VENTRAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y||Y|INDEPENDENT ASSESSOR|RATER 1|3|Visit_3|40|3|FOLLOW-UP|2020-11-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|7|IC|Inspiratory Capacity|[?]|PRONE|[?]|mL/animal/day|[?]|1|mm/min|INFRARENAL AORTA|CONTRALATERAL|SUPERFICIAL|MACRO BROTH DILUTION||||SIGNIFICANT OTHER|READER|4|Visit_4|65|2|TREATMENT|2020-12-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|8|LOBVOL|Lobar Volume|[?]|UNCONSTRAINED|[?]|mm2|[?]|1|10^4/L|CARPOMETACARPAL JOINT|LATERAL|UPPER EXTENSOR SURFACE|IN SITU HYBRIDIZATION||||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-12-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|9|FEV1FVC|FEV1/FVC|[?]|FOWLERS|[?]|CIGARETTE|[?]|1|mg|VERTEBRA|RIGHT|INNER|CONTRAST ENHANCED PET/CT SCAN||Y||PROXY|RATER|5|Visit_5|90|6|SCREENING|2021-01-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|a2ec3389-6f5f-44a3-a6dd-f6177a805791|10|INTP|Interpretation|[?]|STANDING|[?]|mm2|[?]|1|ug/dL|SPINAL CORD|LEFT|ANTERIOR|BETA LACTAMASE||Y||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|5|Visit_5|90|7|TREATMENT|2021-01-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|cc562042-9641-460d-862e-d6923dd4207d|1|SALKA|Salazar-Knowles Equation Parameter A|[?]|PRONE|[?]|mCi/kg|[?]|1|/4.0 mL|RIB 10|IPSILATERAL|DISTAL|X-RAY||Y||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|TREATMENT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|cc562042-9641-460d-862e-d6923dd4207d|2|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|[?]|IU/mmol|[?]|1|LB|SHOULDER|RIGHT|UPPER|TURBIDIMETRY|Y|||SIBLING|DERMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|cc562042-9641-460d-862e-d6923dd4207d|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|kg/cm|[?]|1|Gy/h|AORTIC VALVE ANNULUS|IPSILATERAL|OCCIPITAL|FLOCCULATION|Y|||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|cc562042-9641-460d-862e-d6923dd4207d|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|||[?]|1|mEq/uL|CALCANEUS|LEFT|ANTEROMEDIAL|KINYOUN STAIN|Y||Y|ADJUDICATION COMMITTEE|MICROSCOPIST 3|2|Visit_2|25|6|TREATMENT|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|cc562042-9641-460d-862e-d6923dd4207d|5|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|DECUBITUS|[?]|CUP|[?]|1|dmol|MEDIASTINUM, ANTERIOR|BILATERAL|PERIVENTRICULAR|CONTACT SPECULAR MICROSCOPY|Y|Y||CLINICAL RESEARCH ASSOCIATE|READER 2|3|Visit_3|40|2|TREATMENT|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|RE|cc562042-9641-460d-862e-d6923dd4207d|6|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|||[?]|1|CARTRIDGE|PARATHYROID GLAND|RIGHT|ANTERIOR|LC-FL||Y|Y|ADJUDICATION COMMITTEE|HEMATOLOGIST|3|Visit_3|40|7|SCREENING|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|RE|cc562042-9641-460d-862e-d6923dd4207d|7|IRV|Inspiratory Reserve Volume|[?]|DECUBITUS|||[?]|1|ng/day|PERIURETERAL REGION|IPSILATERAL|LOWER FLEXOR SURFACE|FLUORESCENT MICROSCOPY|||Y|DOMESTIC PARTNER|ONCOLOGIST|4|Visit_4|65|2|WASHOUT|2020-07-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|cc562042-9641-460d-862e-d6923dd4207d|8|ELSTNCE|Elastance|[?]|REVERSE TRENDELENBURG|||[?]|1|BISCUIT|UPPER URINARY SYSTEM|LEFT|PROXIMAL|TONOMETRY|||Y|ADJUDICATION COMMITTEE|PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-07-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|cc562042-9641-460d-862e-d6923dd4207d|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SLING|[?]|g/animal/wk|[?]|1|10^9 CFU/g|CORNEAL EPITHELIUM|LATERAL|DISTAL VOLAR|KINETIC CHROMOGENIC ASSAY||||PARENT|RATER 2|5|Visit_5|90|5|SCREENING|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|RE|cc562042-9641-460d-862e-d6923dd4207d|10|FEV1FVC6|FEV1/FVC6|[?]|SEMI-FOWLERS|[?]|RNA copies/mL|[?]|1|pkat|EXTRAHEPATIC BILE DUCT|LATERAL|DISTAL VOLAR|BIOIMPEDANCE SPECTROSCOPY||||INVESTIGATOR|RATER|5|Visit_5|90|3|TREATMENT|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|||[?]|1|pkat/L|LYMPH NODE|UNILATERAL|FORE|PHASE-CONTRAST MRI||Y|Y|VENDOR|FORENSIC PATHOLOGIST|1|Visit_1|10|2|SCREENING|2020-07-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|2|FEV_PEF|FEV at PEF|[?]|STANDING, BENT FORWARD|[?]|DPM|[?]|1|EU|BREAST|LEFT|TEMPORAL|HILLMEN COLOR CHART||Y||SIGNIFICANT OTHER|PATHOLOGIST 1|1|Visit_1|10|7|FOLLOW-UP|2020-07-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|3|LCI|Lung Clearance Index|[?]|DECUBITUS|[?]|atm|[?]|1|MBq/uL|GENITALIA|IPSILATERAL|LOWER EXTENSOR SURFACE|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||STUDY SUBJECT|CLINICAL PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|4|FEV_PEF|FEV at PEF|[?]|REVERSE TRENDELENBURG|||[?]|1|/h|SUBARACHNOID SPACE|IPSILATERAL|HIND|SANGER SEQUENCING|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-08-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|5|EVC|Expiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|cGy|[?]|1|Watt|BRONCHUS|CONTRALATERAL|ROSTRAL|HEMAGGLUTINATION ASSAY||||INTERVIEWER|ONCOLOGIST 2|3|Visit_3|40|7|WASHOUT|2020-08-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|6|LOBVOL|Lobar Volume|[?]|SEMI-RECUMBENT|[?]|lm|[?]|1|uSiemens|ILIAC CREST|CONTRALATERAL|ANTERIOR|ICP-MS||||GUARDIAN|READER 2|3|Visit_3|40|2|TREATMENT|2020-08-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|7|FEV1REV|FEV1 Reversibility|[?]|LATERAL DECUBITUS|[?]|kUSP|[?]|1|/kg|ABDOMINAL LYMPH NODE|UNILATERAL|NASAL|MICRONEUTRALIZATION ASSAY|Y|||FRIEND|PATHOLOGIST 1|4|Visit_4|65|7|FOLLOW-UP|2020-09-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|8|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|fraction of 1|[?]|1|gpELISA unit/mL|SKULL, BASE|LATERAL|VENTRAL|ENDPOINT DILUTION ASSAY||||VENDOR|MICROSCOPIST 3|4|Visit_4|65|6|TREATMENT|2020-09-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|9|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|[?]|um|[?]|1|cmH2O*s/mL|KIDNEY, MEDULLA|IPSILATERAL|LOWER|BIOIMPEDANCE SPECTROSCOPY||Y||STUDY SUBJECT|READER 2|5|Visit_5|90|1|TREATMENT|2020-10-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|kUSP|[?]|1|mL/s|T6 VERTEBRA|CONTRALATERAL|DORSOLATERAL|PALM METHOD||||CLINICAL STUDY SPONSOR|READER|5|Visit_5|90|7|TREATMENT|2020-10-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|TRANSDUCING UNIT|[?]|1|beats/min|ILIOTIBIAL BAND|RIGHT|PROXIMAL VOLAR|DIGITAL PCR||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|[?]|mL/min/1.73m2|[?]|1|Ci/ug|FALLOPIAN TUBE|LEFT|SUBCORTICAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|1|Visit_1|10|1|TREATMENT|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|3|FEV1REV|FEV1 Reversibility|[?]|SLING|||[?]|1|mJoule/cm2|RADIUS SHAFT|IPSILATERAL|CENTRAL|SPECULAR MICROSCOPY|||Y|VENDOR|FORENSIC PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|4|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|[?]|mOsm/kg|[?]|1|PFU/dose|JAW|UNILATERAL|CAUDAL|ERGOSPIROMETRY||||SPOUSE|NEUROLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|5|PEFREV|PEF Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|tuberculin unit/mL|[?]|1|kg/mol|VERTEBRAL ARTERY|IPSILATERAL|VENTROLATERAL|FLOCCULATION, CHARCOAL ENHANCED||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|3|Visit_3|40|3|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|6|FIO2|Fraction of Inspired Oxygen|[?]|SLING|||[?]|1|mol|CORPUS CALLOSUM, SPLENIUM|UNILATERAL|SUPERIOR|CONTRAST ENHANCED SPIRAL CT SCAN|||Y|SIGNIFICANT OTHER|OTOLARYNGOLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|7|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|cm H2O|[?]|1|10^5/L|SKIN OF THE SOLE|UNILATERAL|DEEP|GEL ELECTROPHORESIS|Y|||HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|4|Visit_4|65|7|SCREENING|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|[?]|nmol|[?]|1|ug/dose|PHARYNGEAL TONSIL|BILATERAL|APICAL|CENTRIFUGATION||||DOMESTIC PARTNER|INTERNIST|4|Visit_4|65|1|SCREENING|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|9|DLCOPP|Percent Predicted DLCO|[?]|SEMI-RECUMBENT|[?]|AU/mL|[?]|1|L/s|FLANK|LATERAL|UPPER|IRON HEMATOXYLIN STAIN||Y||INDEPENDENT ASSESSOR|PATHOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|d90f2824-692e-403f-b1ca-5b6462c93a75|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SITTING|[?]|U/animal|[?]|1|PIXEL|EXTRAHEPATIC BILE DUCT|LEFT|INTERMEDIATE|IODINE STAIN||||CHILD|CARDIOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|FRCPP|Percent Predicted FRC|[?]|STANDING, BENT FORWARD|[?]|hr/day|[?]|1|AgU/mL|THIGH|IPSILATERAL|VENTROLATERAL|THIN SMEAR||||HEALTH CARE PROFESSIONAL|DERMATOLOGIST|1|Visit_1|10|6|TREATMENT|2020-05-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|2|SALKK|Salazar-Knowles Equation, K|[?]|STANDING, BENT FORWARD|[?]|vg/mL|[?]|1|F|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|IPSILATERAL|VOLAR|ANALYTICAL ULTRACENTRIFUGATION||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|WASHOUT|2020-05-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|3|AIRTRAP|Air Trapping|[?]|STANDING|||[?]|1|/sec|UVEA|UNILATERAL|CRANIAL|IMMUNOBLOT|Y|Y|Y|FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|4|TREATMENT|2020-06-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|4|PIF|Peak Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|umol/h/mmol|[?]|1|/mm|PELVIS|RIGHT|SURFACE|IMMUNODIFFUSION|Y|||FAMILY MEMBER|MICROSCOPIST 2|2|Visit_2|25|1|TREATMENT|2020-06-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|DECUBITUS|||[?]|1|um|RETROPERITONEAL LYMPH NODE|LEFT|DISTAL VOLAR|NUCLEIC ACID SEQUENCING|Y||Y|PROXY|FORENSIC PATHOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-06-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|DECUBITUS|||[?]|1|CIGARETTE|ANTERIOR TIBIAL VEIN|IPSILATERAL|FORE|PATHOLOGICAL EVALUATION|Y|Y|Y|GUARDIAN|CARDIOLOGIST|3|Visit_3|40|5|TREATMENT|2020-06-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|7|FRCPP|Percent Predicted FRC|[?]|SLING|[?]|ECL unit|[?]|1|log10 IU/mL|CENTRAL NERVOUS SYSTEM|LEFT|CRANIAL|ATOMIC ABSORPTION SPECTROMETRY||Y||FRIEND|READER 3|4|Visit_4|65|3|FOLLOW-UP|2020-07-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|8|FEV3PP|Percent Predicted FEV3|[?]|SUPINE|[?]|cs|[?]|1|mmHg/sec|TEMPORAL BONE|LEFT|DISTAL|SXA SCAN||||PROXY|ONCOLOGIST 2|4|Visit_4|65|4|FOLLOW-UP|2020-07-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|9|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|TRENDELENBURG|[?]|DNA copies/ug|[?]|1|Pack Year|FEMUR SHAFT|LATERAL|APICAL|CONTRAST ENHANCED MRI|Y|Y||SIBLING|ONCOLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-08-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-01
e|RE|ee0e55e1-6107-4a3c-85b4-cb48300153e8|10|RER|Respiratory Exchange Ratio|[?]|SITTING|||[?]|1|pg/cell|TRAPEZIAL BONE|LEFT|VENTROLATERAL|NO INFORMATION|||Y|PARENT|OPTOMETRIST|5|Visit_5|90|6|TREATMENT|2020-08-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-01
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|1|INERTANC|Inertance|[?]|PRONE|[?]|yd|[?]|1|NFIU|ADDUCTOR MAGNUS MUSCLE|LATERAL|HIND|IMMUNOCHROMATOGRAPHY||||PROXY|RADIOLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-11-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|STANDING|[?]|mg/mL/day|[?]|1|mAnson U/mL|TROCHLEAR NERVE|CONTRALATERAL|LOWER|TURBIDIMETRY||||ADJUDICATION COMMITTEE|RADIOLOGIST|1|Visit_1|10|1|WASHOUT|2020-11-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|3|DLCOPP|Percent Predicted DLCO|[?]|UNCONSTRAINED|[?]|kg/mol|[?]|1|umol/kg/min|CARPOMETACARPAL JOINT 1|IPSILATERAL|PERIPHERAL|IHC||||SIGNIFICANT OTHER|CARDIOLOGIST|2|Visit_2|25|4|SCREENING|2020-11-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|4|PLMBLFLW|Pulmonary Blood Flow|[?]|FOWLERS|[?]|ug/kg/day|[?]|1|mPa|COLON|RIGHT|POSTERIOR|CISH|Y|||CLINICAL STUDY SPONSOR|PATHOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-11-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|5|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|||[?]|1|L/L|INTERPHALANGEAL JOINT 2|LEFT|FACIAL|MICROBIAL CULTURE||Y|Y|FRIEND|NEUROLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-12-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|6|SVC|Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|mL/m2/h|[?]|1|mL/animal/day|CORONARY SINUS|CONTRALATERAL|DEEP|ELECTROGASTROGRAPHY|Y|Y||CHILD|ONCOLOGIST|3|Visit_3|40|1|TREATMENT|2020-12-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|7|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|Ci/L|[?]|1|mL/cm|HAIR|IPSILATERAL|INTERMEDIATE|ANTIMICROBIAL COMBINATION TESTING||||VENDOR|ADJUDICATOR 1|4|Visit_4|65|1|TREATMENT|2021-01-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|8|PNIF|Peak Nasal Inspiratory Flow|[?]|SEMI-RECUMBENT|||[?]|1|g/cage/wk|MAXILLA|RIGHT|UPPER FLEXOR SURFACE|BRDU CELLULAR PROLIFERATION ASSAY|||Y|ADJUDICATOR|CARDIOLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|9|FEV1SVC|FEV1/SVC|[?]|SITTING|[?]|sec|[?]|1|g/cage|MAIN BRONCHUS, LEFT|BILATERAL|SURFACE|AUSCULTATION||Y||GUARDIAN|ADJUDICATOR 2|5|Visit_5|90|3|TREATMENT|2021-02-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|6aa37bb3-85aa-427f-9e56-a776257f1548|10|FEV3FVC|FEV3/FVC|[?]|SEMI-RECUMBENT|[?]|um/day|[?]|1|umol/L|HAND DIGIT 5|LEFT|UPPER EXTENSOR SURFACE|CYSTOSCOPY||Y||PROXY|READER|5|Visit_5|90|4|FOLLOW-UP|2021-02-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|FEU|[?]|1|mL/g/min|SUPRATENTORIAL BRAIN|IPSILATERAL|CAUDAL|X-RAY||||CAREGIVER|NEUROLOGIST 2|1|Visit_1|10|5|WASHOUT|2020-05-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|2|AIRTRAP|Air Trapping|[?]|SITTING|||[?]|1|lx|5TH LUMBAR SPINOUS PROCESS|LEFT|VENTROLATERAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||Y|INDEPENDENT ASSESSOR|READER|1|Visit_1|10|5|FOLLOW-UP|2020-05-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|3|PIF|Peak Inspiratory Flow|[?]|SLING|[?]|umol/mol|[?]|1|kV|ESOPHAGUS, CERVICAL|BILATERAL|CAUDAL|CELLULAR PROLIFERATION ASSAY||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|2|Visit_2|25|1|TREATMENT|2020-06-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|4|ELSTNCE|Elastance|[?]|FOWLERS|||[?]|1|g/cage/wk|LIVER, CAUDATE LOBE|CONTRALATERAL|CENTRAL|SINGLE-MOLECULE ARRAY|||Y|STUDY SUBJECT|MICROSCOPIST|2|Visit_2|25|2|SCREENING|2020-06-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|5|LCI|Lung Clearance Index|[?]|LEFT LATERAL DECUBITUS|[?]|Bq/mL|[?]|1|ugEq|BRACHIAL PLEXUS|RIGHT|MEDIAL|IMMUNOCHEMILUMINOMETRIC ASSAY||||SPOUSE|MICROSCOPIST 3|3|Visit_3|40|1|FOLLOW-UP|2020-06-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|6|ELSTNCE|Elastance|[?]|SEMI-FOWLERS|[?]|10^9 organisms|[?]|1|10^9/L|SOFT TISSUE|LATERAL|SUBCORTICAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||CLINICAL STUDY SPONSOR|HEMATOLOGIST|3|Visit_3|40|7|SCREENING|2020-06-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|7|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-FOWLERS|[?]|U/kg/h|[?]|1|dram|ANKLE MORTISE|UNILATERAL|OUTER|TURBIDIMETRY||||GUARDIAN|DERMATOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|8|FEV6PP|Percent Predicted FEV6|[?]|DECUBITUS|[?]|kcal|[?]|1|v/v|INTERNAL MAMMARY ARTERY|LEFT|UPPER|PET/CT SCAN WITHOUT CONTRAST||||CHILD|NEUROLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|uSiemens|HAIR FOLLICLE|LATERAL|SUPERFICIAL|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|CHILD|PATHOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|PRONE|[?]|L/min/m2|[?]|1|U/m2/day|RIB 10|LEFT|CENTRAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST 1|5|Visit_5|90|1|TREATMENT|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|1|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|m2|[?]|1|dpm/mg|SPLEEN|LEFT|PROXIMAL VOLAR|CORONARY ANGIOGRAPHY||Y||SPOUSE|ENDOCRINOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|AU/mL|[?]|1|NEBULE|LIMB, LOWER|BILATERAL|ANTEROLATERAL|SURFACE PLASMON RESONANCE||||PARENT|READER 2|1|Visit_1|10|3|TREATMENT|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|3|MIPPP|Percent Predicted MIP|[?]|STANDING|||[?]|1|10^6/g|OCCIPITAL LOBE|UNILATERAL|UPPER FLEXOR SURFACE|PET/MRI SCAN||Y|Y|INVESTIGATOR|NEUROLOGIST 2|2|Visit_2|25|3|SCREENING|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|4|ERV|Expiratory Reserve Volume|[?]|SUPINE|||[?]|1|kg/L|ABDOMINAL SKIN|LATERAL|CAUDAL|SLOAN LETTER EYE CHART 1.25%|||Y|NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|2|Visit_2|25|4|TREATMENT|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING|[?]|vp/mL|[?]|1|mmAL|LIP, UPPER|LEFT|ANTEROPOSTERIOR|CRYOSCOPY||||SPOUSE|RATER|3|Visit_3|40|4|WASHOUT|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|6|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|[?]|mL/s|[?]|1|ug/g/h|BUCCAL LYMPH NODE|BILATERAL|UPPER|ANALYTICAL ULTRACENTRIFUGATION||||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|3|Visit_3|40|5|SCREENING|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|7|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-RECUMBENT|[?]|cmol|[?]|1|copies/uL|CARDIAC WALL|UNILATERAL|DISTAL VOLAR|ANTIMICROBIAL COMBINATION TESTING||||SPOUSE|PATHOLOGIST 1|4|Visit_4|65|6|SCREENING|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|8|MALEVDES|Malignancy Evidence Description|[?]|FOWLERS|[?]|mL|[?]|1|mEq/mL|PALATE|RIGHT|LOWER FLEXOR SURFACE|INCISION-INDUCED BLEEDING METHOD||||INVESTIGATOR|UROLOGIST|4|Visit_4|65|3|WASHOUT|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|9|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SUPINE|||[?]|1|Rad|INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|OCCIPITAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|||Y|PARENT|ONCOLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|940d4614-b41a-44d3-b878-6e19ee22f24b|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|[?]|um2|[?]|1|kcal/day|SUBMANDIBULAR LYMPH NODE|BILATERAL|FACIAL|HEMATOXYLIN AND EOSIN STAIN||Y||SIBLING|PHYSIOTHERAPIST|5|Visit_5|90|1|WASHOUT|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|TRANSDUCING UNIT/mL|[?]|1|IU/mL|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|LATERAL|FORE|WEBER GREEN STAIN||||FRIEND|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-11-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|2|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|mL*cmH2O|[?]|1|g/day|ABDOMINAL CAVITY|LATERAL|UPPER FLEXOR SURFACE|TRICHROME STAIN|Y|||INTERVIEWER|FORENSIC PATHOLOGIST|1|Visit_1|10|5|SCREENING|2020-11-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|3|PIF|Peak Inspiratory Flow|[?]|FOWLERS|||[?]|1|mL/g/h|GASTROINTESTINAL TRACT, UPPER|UNILATERAL|LATERAL|SPECULAR MICROSCOPY|||Y|SIGNIFICANT OTHER|RADIOLOGIST 1|2|Visit_2|25|4|FOLLOW-UP|2020-11-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|4|RER|Respiratory Exchange Ratio|[?]|LATERAL DECUBITUS|[?]|BOWL|[?]|1|mEq/ug|PROXIMAL PHALANX 3 OF THE HAND|LATERAL|ANTEROLATERAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||INDEPENDENT ASSESSOR|NEUROLOGIST 1|2|Visit_2|25|2|SCREENING|2020-11-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SUPINE|||[?]|1|/7.5 mL|EYE, ANTERIOR CHAMBER|CONTRALATERAL|INNER|TEMPLATE INCISION METHOD|||Y|INTERVIEWER|ONCOLOGIST|3|Visit_3|40|7|TREATMENT|2020-12-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|6|FIF50|Forced Inspiratory Flow at 50%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|IU/g|HAIR|RIGHT|INNER|DIFFUSION WEIGHTED MRI|||Y|PROXY|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|7|FIO2|Fraction of Inspired Oxygen|[?]|FOWLERS|[?]|uL/mL|[?]|1|ukat|INTERTROCHANTERIC REGION|LATERAL|LATERAL|INCISION-INDUCED BLEEDING METHOD||||SIBLING|RADIOLOGIST|4|Visit_4|65|7|TREATMENT|2020-12-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|8|MEPPP|Percent Predicted MEP|[?]|TRENDELENBURG|[?]|10^9/L|[?]|1|DIP|SACRUM|LATERAL|ANTEROMEDIAL|MS/MS||||INTERVIEWER|DERMATOLOGIST|4|Visit_4|65|6|WASHOUT|2020-12-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|9|ERV|Expiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mg/mL/day|LATERAL SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|CENTRAL|ETDRS EYE CHART|||Y|SPOUSE|NEUROLOGIST 2|5|Visit_5|90|1|TREATMENT|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|e2edd4f0-926b-4514-bf3f-7449f248343f|10|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|[?]|kg/L|[?]|1|uEq|HEART, VENTRICULAR WALL|IPSILATERAL|VENTRAL|ACRIDINE ORANGE STAIN|Y|||GUARDIAN|MICROSCOPIST|5|Visit_5|90|1|SCREENING|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|||[?]|1|10^6 CFU/mL|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|BILATERAL|PERIPHERAL|ELECTROPHORESIS||Y|Y|DOMESTIC PARTNER|RADIOLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-06-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|um/s|[?]|1|mL/animal/wk|PALATE|RIGHT|INTERMEDIATE|HEMOCYTOMETRY|Y|Y||CLINICAL RESEARCH ASSOCIATE|UROLOGIST|1|Visit_1|10|4|SCREENING|2020-06-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|3|IRVPP|Percent Predicted IRV|[?]|SLING|[?]|mL/min|[?]|1|mPa|HAIR ROOT|BILATERAL|UPPER|TOTAL BODY RADIOGRAPHY||Y||CLINICAL STUDY SPONSOR|CARDIOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-07-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|4|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|Gy/min|[?]|1|cGy|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|UNILATERAL|ROSTRAL|NUCLEIC ACID AMPLIFICATION TEST||||VENDOR|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-07-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|5|GAW|Airway Conductance|[?]|REVERSE TRENDELENBURG|[?]|yd|[?]|1|Pa|FLEXOR POLLICIS LONGUS MUSCLE|BILATERAL|PROXIMAL|CONTRAST ENHANCED CT SCAN|Y|||FRIEND|MICROSCOPIST 3|3|Visit_3|40|3|SCREENING|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|6|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|[?]|nkat/g Hb|[?]|1|CARTRIDGE|SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|LOWER EXTENSOR SURFACE|ISHIHARA COLOR PLATES||||SPOUSE|INTERNIST|3|Visit_3|40|1|FOLLOW-UP|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|7|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING, BENT FORWARD|[?]|uCi/kg|[?]|1|PFU/mL|WRIST JOINT FLEXOR MUSCLES|LATERAL|UPPER EXTENSOR SURFACE|KLEIHAUER-BETKE||||ADJUDICATOR|PATHOLOGIST 2|4|Visit_4|65|5|WASHOUT|2020-08-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|8|VO2|Oxygen Consumption|[?]|TRENDELENBURG|[?]|/MBP|[?]|1|anti-Xa IU/mL|PENIS, GLANS|RIGHT|CRANIAL|HEMAGGLUTINATION ASSAY|Y|Y||PROXY|FORENSIC PATHOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-08-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|9|SRAW|Specific Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|yd|[?]|1|mmol/min/kPa|SIGMOID SINUS|LEFT|INFERIOR|HPLC-UV||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|5|Visit_5|90|5|TREATMENT|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-RECUMBENT|[?]|/h|[?]|1|U/m2/day|SOFT TISSUE|BILATERAL|SURFACE|CISH||||SPOUSE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|1|WASHOUT|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|PLMXRS|Pulmonary Reactance|[?]|SUPINE|[?]|PHERESIS UNIT|[?]|1|PACKET|CAUDAL VERTEBRA|LATERAL|LOWER FLEXOR SURFACE|CLINICAL EVALUATION|Y|||CLINICAL STUDY SPONSOR|UROLOGIST|1|Visit_1|10|4|TREATMENT|2020-07-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|2|SGAW|Specific Airway Conductance|[?]|PRONE|[?]|nkat/L|[?]|1|mEq|ISCHIUM|UNILATERAL|FORE|DIFFUSION WEIGHTED MRI||Y||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|1|Visit_1|10|3|WASHOUT|2020-07-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING|[?]|psec|[?]|1|ECL unit|UPPER URINARY SYSTEM|UNILATERAL|UPPER FLEXOR SURFACE|SXA SCAN|Y|Y||GUARDIAN|ADJUDICATOR 2|2|Visit_2|25|7|FOLLOW-UP|2020-07-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|10^7/L|SKIN OF THE AXILLA|LATERAL|UPPER|NEPHELOMETRY|||Y|STUDY SUBJECT|RATER 1|2|Visit_2|25|5|TREATMENT|2020-07-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|5|IVCPP|Percent Predicted IVC|[?]|STANDING|[?]|JAR|[?]|1|mV*min|PROXIMAL CIRCUMFLEX ARTERY|BILATERAL|BASAL|IMMUNO-PET SCAN||||INDEPENDENT ASSESSOR|RADIOLOGIST 1|3|Visit_3|40|3|WASHOUT|2020-08-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|6|RAWPP|Percent Predicted Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|Absorbance U/mL|[?]|1|ms2|SUPERIOR VENA CAVA|CONTRALATERAL|VOLAR|PHOTOMETRY||||GUARDIAN|INTERNIST|3|Visit_3|40|5|FOLLOW-UP|2020-08-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|7|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|ng/L|[?]|1|days/month|HAND DIGIT 1|IPSILATERAL|ANTEROMEDIAL|CT SCAN||||FRIEND|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|8|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|10^6 IU/mL|[?]|1|10^7 TCID 50/dose|RAPHE|LATERAL|SUBCORTICAL|IMMUNOCHROMATOGRAPHY||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|4|Visit_4|65|1|FOLLOW-UP|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|9|FEV1FVC6|FEV1/FVC6|[?]|SLING|[?]|10^9 CFU/mL|[?]|1|cd*s/m2|HEAD|RIGHT|APICAL|CONTRAST ENHANCED PET SCAN||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|5|Visit_5|90|4|WASHOUT|2020-10-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|493a53ef-01ab-470c-9bbe-7c2aa48b946b|10|MIP|Maximal Inspiratory Pressure|[?]|TRENDELENBURG|[?]|ng/L|[?]|1|Ci/ug|BRAIN, PERIVENTRICULAR REGION|LEFT|FACIAL|REFRACTOMETRY|Y|||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|5|Visit_5|90|1|WASHOUT|2020-10-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|1|LCI|Lung Clearance Index|[?]|UNCONSTRAINED|||[?]|1|mEq/mL|RAPHE|UNILATERAL|PERIPHERAL|GC/FID|||Y|SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-11-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|2|RRS|Total Respiratory System Resistance|[?]|SITTING|||[?]|1|Bq/uL|PENIS|LEFT|OCCIPITAL|ENDPOINT DILUTION ASSAY|||Y|DOMESTIC PARTNER|OPTOMETRIST|1|Visit_1|10|7|WASHOUT|2020-11-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|3|MALIND|Malignancy Indicator|[?]|SLING|[?]|10^4/hpf|[?]|1|/ms|PARATRACHEAL LYMPH NODE|RIGHT|OUTER|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||INDEPENDENT ASSESSOR|UROLOGIST|2|Visit_2|25|5|TREATMENT|2020-11-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|4|FEV1FVC|FEV1/FVC|[?]|SLING|[?]|mL/g/min|[?]|1|mV/sec|CORPUS UTERI|BILATERAL|ROSTRAL|CYSTOSCOPY||||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|2|Visit_2|25|7|SCREENING|2020-11-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|5|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING|[?]|/sec|[?]|1|Sv|SUBMANDIBULAR LYMPH NODE|RIGHT|DORSAL|COMPLEMENT FIXATION||||CHILD|ONCOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-12-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|6|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING|[?]|U/g/min|[?]|1|SQU/mL|PAROTID GLAND|LEFT|CENTRAL|FREEZING POINT DEPRESSION||||INVESTIGATOR|RATER|3|Visit_3|40|2|TREATMENT|2020-12-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|7|FEV6PP|Percent Predicted FEV6|[?]|STANDING, BENT FORWARD|[?]|DAYS|[?]|1|JDF Unit|LOCUS CERULEUS|BILATERAL|SURFACE|X-RAY|Y|||INVESTIGATOR|READER 3|4|Visit_4|65|1|WASHOUT|2020-12-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|8|ERVPP|Percent Predicted ERV|[?]|SITTING|[?]|DISK|[?]|1|steps/min|INTRAHEPATIC BILE DUCT|CONTRALATERAL|CENTRAL|PHOTOMETRIC CLOT DETECTION||||SIBLING|ADJUDICATOR 2|4|Visit_4|65|1|WASHOUT|2020-12-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|9|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|mL/mmHg/min/L|[?]|1|nm|MEDIAL FEMORAL CONDYLE|LEFT|OCCIPITAL|WESTERN BLOT|Y|||ADJUDICATOR|ADJUDICATOR 1|5|Visit_5|90|2|TREATMENT|2021-01-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|ba33de14-b676-4389-a863-a7fa3edb8543|10|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|[?]|mL/beat|[?]|1|mCi/L|PALPEBRAL CONJUNCTIVA|UNILATERAL|ANTEROLATERAL|PET/CT SCAN WITHOUT CONTRAST||||GUARDIAN|MICROSCOPIST 1|5|Visit_5|90|1|SCREENING|2021-01-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|24801f05-79be-433d-8124-85580bc14c4f|1|RVPP|Percent Predicted Residual Volume|[?]|SEMI-FOWLERS|[?]|mL/m2/h|[?]|1|ug/g/min|GENITALIA|RIGHT|BASAL|MICRO BROTH DILUTION||||SIGNIFICANT OTHER|ONCOLOGIST|1|Visit_1|10|3|SCREENING|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|24801f05-79be-433d-8124-85580bc14c4f|2|EXPRELTM|Expiration Relaxation Time|[?]|SITTING, LEGS DEPENDENT|||[?]|1|foz_us|LIVER, QUADRATE LOBE|LATERAL|VENTROLATERAL|CORONARY ANGIOGRAPHY|||Y|PARENT|PEDIATRIC NEUROLOGIST|1|Visit_1|10|7|WASHOUT|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|24801f05-79be-433d-8124-85580bc14c4f|3|SALKA|Salazar-Knowles Equation Parameter A|[?]|LATERAL DECUBITUS|[?]|IU/g|[?]|1|10^6 organisms/g|COLON, SPLENIC FLEXURE|LATERAL|PARIETO-OCCIPITAL|LINE PROBE ASSAY|Y|||INTERVIEWER|ADJUDICATOR 3|2|Visit_2|25|6|WASHOUT|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|24801f05-79be-433d-8124-85580bc14c4f|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|[?]|cd*s/m2|[?]|1|Log10 ELISA unit|FEMORAL CONDYLE|CONTRALATERAL|POSTERIOR|THIN SMEAR||||DOMESTIC PARTNER|MICROSCOPIST 1|2|Visit_2|25|4|TREATMENT|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|24801f05-79be-433d-8124-85580bc14c4f|5|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|REVERSE TRENDELENBURG|[?]|mg/L FEU|[?]|1|Ci/mL|SCAPHOID-TRAPEZIUM JOINT|RIGHT|NASAL|ANALYTICAL ULTRACENTRIFUGATION||||CAREGIVER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|2|SCREENING|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|24801f05-79be-433d-8124-85580bc14c4f|6|SVC|Slow Vital Capacity|[?]|SLING|[?]|BOTTLE|[?]|1|umol|CARPOMETACARPAL JOINT 2|LATERAL|ANTEROPOSTERIOR|DC SHEATH FLOW||||GUARDIAN|DERMATOLOGIST|3|Visit_3|40|4|WASHOUT|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|24801f05-79be-433d-8124-85580bc14c4f|7|RVPP|Percent Predicted Residual Volume|[?]|UNCONSTRAINED|||[?]|1|IU/mmol|MANDIBLE|CONTRALATERAL|ANTEROMEDIAL|DIRECT SEQUENCING|||Y|ADJUDICATOR|RADIOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|24801f05-79be-433d-8124-85580bc14c4f|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|SLING|[?]|mmol/L|[?]|1|U/animal|EXTENSOR HALLUCIS BREVIS MUSCLE|LATERAL|DEEP|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||ADJUDICATOR|ADJUDICATOR 3|4|Visit_4|65|3|TREATMENT|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|24801f05-79be-433d-8124-85580bc14c4f|9|RAW|Airway Resistance|[?]|UNCONSTRAINED|[?]|umol/L|[?]|1|mg/m2/min|LUNG LOBE|IPSILATERAL|POSTERIOR|MAMMOGRAPHY||||CLINICAL RESEARCH COORDINATOR|READER 1|5|Visit_5|90|3|SCREENING|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|24801f05-79be-433d-8124-85580bc14c4f|10|FIF75|Forced Inspiratory Flow at 75%|[?]|PRONE|[?]|HEP|[?]|1|uIU/L|PARAMETRIUM|IPSILATERAL|SURFACE|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||DOMESTIC PARTNER|NEUROLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|1|ICREV|IC Reversibility|[?]|UNCONSTRAINED|||[?]|1|10^7 TCID 50/dose|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|CONTRALATERAL|FORE|CONTRAST ENHANCED X-RAY|||Y|CAREGIVER|OPHTHALMOLOGIST|1|Visit_1|10|5|TREATMENT|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-RECUMBENT|[?]|ug/kg|[?]|1|ug/dose|TOE|RIGHT|UPPER FLEXOR SURFACE|EEG||Y||STUDY SUBJECT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|4|TREATMENT|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|3|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|[?]|10^10/L|[?]|1|tsp|TRICEPS BRACHII MUSCLE|RIGHT|HIND|ERGOSPIROMETRY|Y|||ADJUDICATOR|NEUROLOGIST 1|2|Visit_2|25|3|WASHOUT|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SITTING|||[?]|1|mN|UMBILICAL CORD|BILATERAL|VOLAR|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||Y|FAMILY MEMBER|RADIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|5|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SUPINE|||[?]|1|HEP|BRACHIORADIALIS MUSCLE|LATERAL|UPPER EXTENSOR SURFACE|DNA MICROARRAY|Y||Y|SIGNIFICANT OTHER|READER|3|Visit_3|40|6|FOLLOW-UP|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|6|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|nmol/mL/min|[?]|1|Bq/kg|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|LEFT|PERIVENTRICULAR|LEAD CITRATE STAIN|Y|||CHILD|PATHOLOGIST 2|3|Visit_3|40|1|WASHOUT|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|7|MALIND|Malignancy Indicator|[?]|REVERSE TRENDELENBURG|||[?]|1|EIA unit|FACET JOINT|IPSILATERAL|CAUDAL|X-RAY FLUORESCENCE SPECTROMETRY|||Y|INTERVIEWER|MICROSCOPIST 2|4|Visit_4|65|3|FOLLOW-UP|2020-09-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|8|PLMBLFLW|Pulmonary Blood Flow|[?]|LATERAL DECUBITUS|[?]|foz_us|[?]|1|ug/kg|PROXIMAL PHALANX 3 OF THE HAND|IPSILATERAL|INNER|CONTRAST ENHANCED PET SCAN||||SIGNIFICANT OTHER|RATER|4|Visit_4|65|4|TREATMENT|2020-09-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|PRONE|[?]|10^3 RNA copies/mL|[?]|1|mg/animal|SIGMOID SINUS|LEFT|LOWER|TEMPLATE INCISION METHOD|Y|Y||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|5|Visit_5|90|1|WASHOUT|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|02df80f9-2337-4abd-9452-41cd83dec8ba|10|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|[?]|dL|[?]|1|oz eq|RAPHE|BILATERAL|POSTERIOR|CHROMOGENIC ASSAY||||PROXY|ADJUDICATOR|5|Visit_5|90|6|SCREENING|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|INFLTIND|Infiltrates Indicator|[?]|REVERSE TRENDELENBURG|[?]|nkat/L|[?]|1|umol/mol|BRAIN STEM|CONTRALATERAL|LATERAL|PAP STAIN||Y||PROXY|ADJUDICATOR 2|1|Visit_1|10|5|SCREENING|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|PRONE|||[?]|1|IU/kg/h|GASTROINTESTINAL TRACT|UNILATERAL|VENTRAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||Y|VENDOR|MICROSCOPIST|1|Visit_1|10|6|SCREENING|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|3|ICREV|IC Reversibility|[?]|FOWLERS|[?]|10^3 copies/mL|[?]|1|cs|FIBULAR VEIN|RIGHT|PROXIMAL|CONGO RED STAIN|Y|||ADJUDICATOR|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-08-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|4|IVCPP|Percent Predicted IVC|[?]|FOWLERS|[?]|g/day|[?]|1|BP|INTERNAL ILIAC ARTERY|RIGHT|FRONTAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||INDEPENDENT ASSESSOR|PATHOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-08-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|5|FRCPP|Percent Predicted FRC|[?]|SITTING, LEGS DEPENDENT|[?]|kcal|[?]|1|ECL unit|ELBOW JOINT|LEFT|INFERIOR|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|Y||SIBLING|CARDIOLOGIST|3|Visit_3|40|1|WASHOUT|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING|||[?]|1|U/g/day|SEBACEOUS GLAND|UNILATERAL|ANTEROMEDIAL|PERIODIC ACID SCHIFF STAIN|Y||Y|HEALTH CARE PROFESSIONAL|READER|3|Visit_3|40|6|FOLLOW-UP|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|7|RAW|Airway Resistance|[?]|UNCONSTRAINED|[?]|K|[?]|1|copies/uL|CARPAL BONE|LATERAL|LOWER FLEXOR SURFACE|COMPUTERIZED CORNEAL TOPOGRAPHY||Y||CHILD|NEUROLOGIST 1|4|Visit_4|65|1|FOLLOW-UP|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|10^9 CFU/g|[?]|1|Hz/s|APPENDICEAL TIP|LATERAL|DORSAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||INTERVIEWER|MICROSCOPIST 2|4|Visit_4|65|5|SCREENING|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-FOWLERS|[?]|mmol/g|[?]|1|ks|INTRATHORACIC LYMPH NODE|LEFT|NASAL|CALIPER MEASUREMENT METHOD||Y||SIBLING|READER 2|5|Visit_5|90|4|SCREENING|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|d9eea93b-f9f9-466c-aa8a-a250baff18ef|10|FRCPP|Percent Predicted FRC|[?]|SLING|||[?]|1|WEEKS|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|UPPER FLEXOR SURFACE|OPTICAL DENSITY MEASUREMENT|||Y|INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|TREATMENT|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|EVC|Expiratory Vital Capacity|[?]|SLING|[?]|%(w/v)|[?]|1|h/wk|ADDUCTOR BREVIS MUSCLE|UNILATERAL|MIDLINE|REVERSE TRANSCRIPTASE PCR||Y||CAREGIVER|INTERNIST|1|Visit_1|10|4|TREATMENT|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|2|PEF|Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|log10 TCID 50/dose|[?]|1|scm|FIBULA|IPSILATERAL|DISTAL VOLAR|MEDIASTINOSCOPY|Y|Y||PARENT|CLINICAL PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|3|PEF|Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|mCi|[?]|1|U/mL|GASTROINTESTINAL TRACT, UPPER|BILATERAL|LOWER EXTENSOR SURFACE|PHOTOMETRY||||INVESTIGATOR|NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|4|MEP|Maximal Expiratory Pressure|[?]|DECUBITUS|[?]|cmHg|[?]|1|Henry|SKIN OF THE FOOT|IPSILATERAL|INTERMEDIATE|LIGHT SCATTERING SPECTROSCOPY||||VENDOR|OPHTHALMOLOGIST|2|Visit_2|25|2|WASHOUT|2020-11-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|5|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|[?]|U/g/day|[?]|1|Farad|RADIAL NERVE|BILATERAL|FACIAL|SPIRAL CT|Y|||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|3|Visit_3|40|5|SCREENING|2020-12-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|TRENDELENBURG|[?]|L/h|[?]|1|vg/dose|LATERAL FIRST DIAGONAL BRANCH ARTERY|LEFT|MIDLINE|ORCHIDOMETERY||Y||PROXY|OPHTHALMOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|7|SGAW|Specific Airway Conductance|[?]|DECUBITUS|[?]|anti-Xa IU/mL|[?]|1|10^9/L|SEMITENDINOSUS MUSCLE|LATERAL|PROXIMAL VOLAR|MRS||||STUDY SUBJECT|DERMATOLOGIST|4|Visit_4|65|4|SCREENING|2020-12-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING|||[?]|1|pmol/L/h|PROXIMAL PHALANX 5 OF THE HAND|UNILATERAL|MEDIAL|PHYSICAL EXAMINATION|Y||Y|PROXY|CARDIOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|9|EVC|Expiratory Vital Capacity|[?]|STANDING|[?]|mV*min|[?]|1|um2|MAXILLA|BILATERAL|VOLAR|CINEANGIOGRAPHY|Y|||PROXY|RADIOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|35a59f6a-2712-4d1b-a954-f1418d4b9168|10|FEV6PP|Percent Predicted FEV6|[?]|TRENDELENBURG|[?]|uOsm|[?]|1|10^3 organisms/g|BUTTOCK|RIGHT|BASAL|MAGNETIC RESONANCE ENTEROGRAPHY|Y|||HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|4|FOLLOW-UP|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING|||[?]|1|mL*cmH2O|ABDOMINAL CAVITY|IPSILATERAL|UPPER EXTENSOR SURFACE|OPTICAL DENSITY MEASUREMENT|||Y|CHILD|RATER 2|1|Visit_1|10|2|TREATMENT|2020-11-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|TRENDELENBURG|[?]|sec|[?]|1|/LPF|ACETABULUM|UNILATERAL|DISTAL VOLAR|GC/MS-EI||||INDEPENDENT ASSESSOR|ONCOLOGIST|1|Visit_1|10|7|WASHOUT|2020-11-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|DECUBITUS|[?]|mm|[?]|1|CARTRIDGE|SUBCUTIS|IPSILATERAL|DORSAL|PET/CT SCAN WITHOUT CONTRAST|Y|||INVESTIGATOR|READER|2|Visit_2|25|1|SCREENING|2020-11-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|4|SVC|Slow Vital Capacity|[?]|PRONE|[?]|/sec|[?]|1|uV2|TRICUSPID VALVE, POSTERIOR CUSP|UNILATERAL|ANTEROTEMPORAL|SURFACE PLASMON RESONANCE|Y|||FAMILY MEMBER|RADIOLOGIST 1|2|Visit_2|25|4|WASHOUT|2020-11-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|5|PEFREV|PEF Reversibility|[?]|SEMI-FOWLERS|[?]|MESF|[?]|1|cmH2O*s/mL|HEART, RIGHT ATRIUM|UNILATERAL|DISTAL|HILLMEN COLOR CHART||||STUDY SUBJECT|FORENSIC PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|6|FIF75|Forced Inspiratory Flow at 75%|[?]|SEMI-RECUMBENT|[?]|titer|[?]|1|mmHg/sec|CEREBRAL HEMISPHERE, RIGHT|UNILATERAL|CAUDAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||||INDEPENDENT ASSESSOR|NEUROLOGIST 1|3|Visit_3|40|4|WASHOUT|2020-12-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|7|SALKB|Salazar-Knowles Equation Parameter B|[?]|LATERAL DECUBITUS|[?]|DIOPTER|[?]|1|mMU/mL|URETHRA|LATERAL|ANTEROMEDIAL|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|||SIGNIFICANT OTHER|RADIOLOGIST|4|Visit_4|65|1|TREATMENT|2021-01-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|8|RER|Respiratory Exchange Ratio|[?]|UNCONSTRAINED|[?]|in|[?]|1|DISK|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|DORSOLATERAL|SIZE EXCLUSION CHROMATOGRAPHY||||STUDY SUBJECT|OTOLARYNGOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|BAU/mL|[?]|1|U.CARR|LACRIMAL BONE|UNILATERAL|LOWER|PHASE-CONTRAST MRI|Y|Y||DOMESTIC PARTNER|READER 2|5|Visit_5|90|6|TREATMENT|2021-01-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|10|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Watt|HEPATOBILIARY SYSTEM|CONTRALATERAL|FRONTAL|RYAN BLUE STAIN|||Y|PROXY|RADIOLOGIST|5|Visit_5|90|5|SCREENING|2021-01-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|FIO2|Fraction of Inspired Oxygen|[?]|PRONE|[?]|Gy/h|[?]|1|L/day|CELIAC LYMPH NODE|IPSILATERAL|UPPER|OLIGO ACGH||||INVESTIGATOR|ONCOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|2|TVPP|Percent Predicted Tidal Volume|[?]|SLING|[?]|/100 WBC|[?]|1|ug/L|INTRAHEPATIC BILE DUCT|BILATERAL|HIND|RADIATION DOSIMETRY|Y|||HEALTH CARE PROFESSIONAL|CARDIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|3|ALVVOL|Alveolar Volume|[?]|REVERSE TRENDELENBURG|[?]|10^3 organisms|[?]|1|mL/animal|LIMB, UPPER|BILATERAL|PROXIMAL VOLAR|SPIROMETRY||Y||SIGNIFICANT OTHER|READER 1|2|Visit_2|25|6|TREATMENT|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|4|RAW|Airway Resistance|[?]|SLING|[?]|copies/uL|[?]|1|Frames/s|LUNG, LEFT|BILATERAL|NASAL|BRDU CELLULAR PROLIFERATION ASSAY||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|5|VO2|Oxygen Consumption|[?]|SLING|[?]|pkat|[?]|1|mph|SKIN|LEFT|ANTEROMEDIAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y||INVESTIGATOR|READER 2|3|Visit_3|40|5|FOLLOW-UP|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|6|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|10^3 RNA copies/mL|[?]|1|mmHg|EAR|LEFT|ANTERIOR|IMMUNOFIXATION ELECTROPHORESIS||||SPOUSE|NEUROLOGIST 2|3|Visit_3|40|6|WASHOUT|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|7|RAW|Airway Resistance|[?]|SUPINE|[?]|10^5/L|[?]|1|L/L|ILIAC FOSSA|IPSILATERAL|PARIETO-OCCIPITAL|HIGH RESOLUTION MELT ANALYSIS||||FRIEND|PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|8|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|pkat/L|[?]|1|uL/kg/day|OCCIPITAL LYMPH NODE|CONTRALATERAL|DORSOLATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY||Y||PROXY|CLINICAL PATHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-07-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|9|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SUPINE|[?]|umol/mol|[?]|1|cycle/min|GASTROCNEMIUS MUSCLE, LATERAL HEAD|LATERAL|SUPERIOR|ANTIBIOTIC AGAR SCREEN||||INDEPENDENT ASSESSOR|RATER 1|5|Visit_5|90|5|TREATMENT|2020-08-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|10|MEP|Maximal Expiratory Pressure|[?]|RIGHT LATERAL DECUBITUS|[?]|mCi/kg|[?]|1|10^9 organisms/mg|FOOT|CONTRALATERAL|LATERAL|CYSTOSCOPY|Y|||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-08-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|1|IRVPP|Percent Predicted IRV|[?]|SEMI-RECUMBENT|[?]|BU/mL|[?]|1|kUSP|ABDUCENS NERVE|CONTRALATERAL|PARIETO-OCCIPITAL|GRADIENT DIFFUSION|Y|||GUARDIAN|ONCOLOGIST 1|1|Visit_1|10|7|FOLLOW-UP|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|PRONE|||[?]|1|ag|FORELIMB|CONTRALATERAL|LOWER|TEST STRIP|||Y|INTERVIEWER|OTOLARYNGOLOGIST|1|Visit_1|10|6|SCREENING|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|foz_br|SPLENIC HILAR LYMPH NODE|BILATERAL|VENTROLATERAL|TRANSVAGINAL ULTRASOUND|||Y|GUARDIAN|ADJUDICATOR 3|2|Visit_2|25|3|TREATMENT|2020-10-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|4|TGV|Thoracic Gas Volume|[?]|SUPINE|[?]|kg/m2|[?]|1|mEq/day|SHOULDER|BILATERAL|MIDLINE|SLIT LAMP PHOTOGRAPHY||Y||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-10-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|5|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|UNCONSTRAINED|[?]|IU/kg/h|[?]|1|mkat|FOREARM|CONTRALATERAL|MEDIAL|OBSERVATION||Y||SPOUSE|HEMATOLOGIST|3|Visit_3|40|3|SCREENING|2020-11-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-RECUMBENT|||[?]|1|Bq/mL|PRESACRAL LYMPH NODE|BILATERAL|OUTER|AGAR DILUTION|||Y|INVESTIGATOR|ADJUDICATOR 3|3|Visit_3|40|5|TREATMENT|2020-11-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|7|EFFVOL|Effusion Volume|[?]|STANDING, BENT FORWARD|[?]|mL/m2/min|[?]|1|Joule|UMBILICAL CORD|CONTRALATERAL|NASAL|HPLC-UV||||CAREGIVER|NEUROLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|8|RV|Residual Volume|[?]|SEMI-RECUMBENT|[?]|CIGARETTE|[?]|1|pmol/L/h|TRAPEZIAL BONE|IPSILATERAL|FACIAL|FARNSWORTH-MUNSELL 100 HUE TEST|Y|||CAREGIVER|MICROSCOPIST 1|4|Visit_4|65|1|WASHOUT|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|9|INFLTIND|Infiltrates Indicator|[?]|SITTING|||[?]|1|10^12/L|SUPRATENTORIAL BRAIN|LATERAL|PERIPHERAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y||Y|INVESTIGATOR|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-12-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|d041952e-4aa6-4b37-9cec-127adce2eabb|10|PNEUMIND|Pneumonia Indicator|[?]|SITTING, LEGS DEPENDENT|||[?]|1|PIPE|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|PROXIMAL|HPLC|||Y|VENDOR|OPHTHALMOLOGIST|5|Visit_5|90|6|WASHOUT|2020-12-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|MALEVDES|Malignancy Evidence Description|[?]|SLING|[?]|WEEKS|[?]|1|log EID 50/dose|SKIN OF THE BENDING JOINT|UNILATERAL|MEDIAL|KARYOTYPING|Y|Y||FRIEND|OPHTHALMOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|2|MEP|Maximal Expiratory Pressure|[?]|RIGHT LATERAL DECUBITUS|[?]|pkat|[?]|1|Henry|URETER|CONTRALATERAL|PERIPHERAL|NON-INVASIVE DIELECTRIC SENSING|Y|||INDEPENDENT ASSESSOR|DERMATOLOGIST|1|Visit_1|10|3|TREATMENT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|3|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|mL/mmHg|[?]|1|copies/mL|ULNA|LATERAL|INNER|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||INVESTIGATOR|INTERNIST|2|Visit_2|25|5|TREATMENT|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|4|DLCOPP|Percent Predicted DLCO|[?]|SUPINE|[?]|/100 HPFs|[?]|1|cm2|POSTERIOR TIBIAL VEIN|LATERAL|PROXIMAL VOLAR|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||FRIEND|RADIOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SUPINE|[?]|dpm/100mg|[?]|1|uV*sec|RECTUS FEMORIS MUSCLE|IPSILATERAL|BASAL|BRDU CELLULAR PROLIFERATION ASSAY||Y||STUDY SUBJECT|ONCOLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|6|FEF2575|Forced Expiratory Flow 25-75%|[?]|LEFT LATERAL DECUBITUS|[?]|CIGARETTE|[?]|1|Enzyme U|SUBCLAVIAN VEIN|LATERAL|ANTEROLATERAL|TEMPLATE INCISION METHOD||Y||SPOUSE|PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|7|ELSTNCE|Elastance|[?]|LATERAL DECUBITUS|||[?]|1|mJoule/cm2|ESOPHAGUS, LOWER THIRD|LEFT|LOWER FLEXOR SURFACE|PERFUSION MRI||Y|Y|NON-HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|4|Visit_4|65|1|TREATMENT|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|8|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING|[?]|nsec|[?]|1|FIU|PULMONARY ARTERY BRANCH|LATERAL|VENTROLATERAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||PROXY|ADJUDICATOR 2|4|Visit_4|65|4|SCREENING|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|9|INTP|Interpretation|[?]|DECUBITUS|[?]|PFU/dose|[?]|1|Ci/ug|PREAURICULAR LYMPH NODE|IPSILATERAL|ANTEROLATERAL|PET/CT SCAN|Y|Y||GUARDIAN|OTOLARYNGOLOGIST|5|Visit_5|90|1|WASHOUT|2020-08-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|10|FEF2575|Forced Expiratory Flow 25-75%|[?]|LEFT LATERAL DECUBITUS|[?]|umol/L/min|[?]|1|GLOBULE|PAROTID GLAND|BILATERAL|UPPER|TOTAL BODY RADIOGRAPHY|Y|||SIBLING|FORENSIC PATHOLOGIST|5|Visit_5|90|2|WASHOUT|2020-08-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|1|MIPPP|Percent Predicted MIP|[?]|TRENDELENBURG|||[?]|1|U/mmol|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|IPSILATERAL|TEMPORAL|CALCULATION|||Y|DOMESTIC PARTNER|MICROSCOPIST 3|1|Visit_1|10|3|TREATMENT|2020-06-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|2|VO2|Oxygen Consumption|[?]|REVERSE TRENDELENBURG|[?]|mEq/g|[?]|1|kIU|AMYGDALA|LEFT|LOWER FLEXOR SURFACE|KINETIC CHROMOGENIC ASSAY||Y||CHILD|MICROSCOPIST|1|Visit_1|10|4|TREATMENT|2020-06-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|3|EFFVOL|Effusion Volume|[?]|SEMI-FOWLERS|[?]|steps/min|[?]|1|g/g/day|THALAMUS|UNILATERAL|FRONTAL|SURFACE PLASMON RESONANCE||Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-07-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|4|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|cmHg|[?]|1|PUFF|HIP ADDUCTORS|IPSILATERAL|VENTRAL|SPECT/CT SCAN|Y|||CLINICAL RESEARCH COORDINATOR|RATER 2|2|Visit_2|25|4|WASHOUT|2020-07-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|5|IC|Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|mol/L|[?]|1|kPa/L/sec|THIGH|LEFT|FRONTAL|MODIFIED ACID FAST STAIN||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|3|Visit_3|40|6|TREATMENT|2020-07-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|6|SVC|Slow Vital Capacity|[?]|SITTING|[?]|mL/kg/h|[?]|1|10^6 organisms/mg|ANASTOMOSIS|CONTRALATERAL|OCCIPITAL|PET/MRI SCAN||||GUARDIAN|READER|3|Visit_3|40|6|TREATMENT|2020-07-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|||[?]|1|L/h|RIB 1|CONTRALATERAL|DORSOLATERAL|MICROSCOPY|||Y|PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|SCREENING|2020-08-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|8|SRAW|Specific Airway Resistance|[?]|FOWLERS|||[?]|1|/LPF|HAND DIGIT 4|CONTRALATERAL|PARIETO-OCCIPITAL|MICROBIAL CULTURE|||Y|ADJUDICATION COMMITTEE|NEUROLOGIST 2|4|Visit_4|65|6|TREATMENT|2020-08-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|TRENDELENBURG|[?]|BLOCKS|[?]|1|10^6/hpf|TROCHANTER|UNILATERAL|POSTERIOR|IMMUNOCHROMATOGRAPHY|Y|Y||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|TREATMENT|2020-09-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|RE|9fc393da-4665-4be5-a869-856c45ddcf13|10|RAW|Airway Resistance|[?]|TRENDELENBURG|[?]|um2|[?]|1|U/kg/day|COMMON FEMORAL VEIN|LATERAL|ANTEROTEMPORAL|SPIRAL CT||||CHILD|PATHOLOGIST 1|5|Visit_5|90|1|TREATMENT|2020-09-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|SVC|Slow Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|dpm/mL|[?]|1|SQU/mL|PENIS, RADIX|CONTRALATERAL|ANTERIOR|BIOIMPEDANCE SPECTROSCOPY||Y||SIBLING|RADIOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|2|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-FOWLERS|[?]|L/kg|[?]|1|10^4 CFU|LEFT ATRIOVENTRICULAR ARTERY|BILATERAL|ANTERIOR|MS/MS||||HEALTH CARE PROFESSIONAL|UROLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|3|FEV3FVC|FEV3/FVC|[?]|SLING|[?]|10^3 organisms|[?]|1|L/h/m2|TESTIS|BILATERAL|FORE|LIGHT MICROSCOPY||Y||SIBLING|NEUROLOGIST 2|2|Visit_2|25|1|TREATMENT|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|4|FRC|Functional Residual Capacity|[?]|REVERSE TRENDELENBURG|[?]|10^6 CFU|[?]|1|DISK|EYE, ANTERIOR SEGMENT|RIGHT|VENTROLATERAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||CHILD|PHYSIOTHERAPIST|2|Visit_2|25|5|TREATMENT|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|5|TLC|Total Lung Capacity|[?]|SLING|||[?]|1|steps/min|DURAL VENOUS SINUS|RIGHT|BASAL|OLIGO ACGH|||Y|PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|TREATMENT|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|6|EFFIND|Effusion Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|ug/cm2|[?]|1|mAnson U/mL|PROSTATE GLAND|LATERAL|POSTERIOR|ROMANOWSKY STAIN||||FAMILY MEMBER|MICROSCOPIST 2|3|Visit_3|40|4|TREATMENT|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|LATERAL DECUBITUS|[?]|dpm/0.5 mL|[?]|1|U/m2|FOREBRAIN|LEFT|DEEP|VIRUS PLAQUE ASSAY||||CHILD|PATHOLOGIST 1|4|Visit_4|65|6|SCREENING|2021-03-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|8|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|mmHg/L/min|[?]|1|CAN|GONAD|RIGHT|TEMPORAL|CLINICAL EVALUATION||||ADJUDICATOR|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2021-03-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|AgU/mL|[?]|1|PIXEL|HEEL OF THE HAND|BILATERAL|PROXIMAL|RAJI CELL EIA||||STUDY SUBJECT|ONCOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|cddc1541-4de9-45e7-bb61-15a2d5baca6f|10|VO2|Oxygen Consumption|[?]|SEMI-RECUMBENT|[?]|BP|[?]|1|g|ILIAC FOSSA|RIGHT|FORE|WEBER GREEN STAIN|Y|Y||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|SCREENING|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|TSUHYS|Tissue Hysteresivity|[?]|SEMI-FOWLERS|||[?]|1|PACKAGE|SCAPHOID-TRAPEZIUM JOINT|BILATERAL|CENTRAL|GRAM STAIN||Y|Y|VENDOR|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-12-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|2|SAWVOL|Specific Airway Volume|[?]|UNCONSTRAINED|||[?]|1|Enzyme U/g Hb|DISTAL INTERPHALANGEAL JOINT 3|BILATERAL|PERIVENTRICULAR|HEMAGGLUTINATION ASSAY|||Y|INVESTIGATOR|PATHOLOGIST 1|1|Visit_1|10|2|WASHOUT|2020-12-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|3|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-RECUMBENT|[?]|pmol/10^9 cells|[?]|1|kBq/uL|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|LEFT|ROSTRAL|ETDRS EYE CHART||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|2|Visit_2|25|3|TREATMENT|2021-01-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|4|INERTANC|Inertance|[?]|STANDING, BENT FORWARD|[?]|IU/g|[?]|1|mL/kg/h|PENIS, RADIX|IPSILATERAL|ANTEROLATERAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||FRIEND|CARDIOLOGIST|2|Visit_2|25|4|TREATMENT|2021-01-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|ms2|[?]|1|uEq/L|HEART, RIGHT VENTRICULAR FREE WALL|LATERAL|LOWER EXTENSOR SURFACE|IRON HEMATOXYLIN STAIN||||VENDOR|ENDOCRINOLOGIST|3|Visit_3|40|7|TREATMENT|2021-01-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|6|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|m3|[?]|1|Ci/mL|ADDUCTOR MAGNUS MUSCLE|BILATERAL|SUPERIOR|INTRAVASCULAR ULTRASOUND||||ADJUDICATION COMMITTEE|RADIOLOGIST 2|3|Visit_3|40|5|FOLLOW-UP|2021-01-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|U/kg/h|[?]|1|mCi/kg|SKIN OF THE NECK|CONTRALATERAL|VOLAR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||FRIEND|NEUROLOGIST|4|Visit_4|65|1|SCREENING|2021-02-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|8|INERTANC|Inertance|[?]|SLING|[?]|/2000 RBC|[?]|1|10^3 CFU/mL|ETHMOID BONE|RIGHT|VENTROLATERAL|MICRONEUTRALIZATION ASSAY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|4|Visit_4|65|2|TREATMENT|2021-02-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|9|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|g/dL|[?]|1|10^3 organisms/mL|METATARSOPHALANGEAL JOINT 1|LATERAL|PROXIMAL|BETA LACTAMASE||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-03-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|303c6dbe-59f9-4016-baa1-8506c0c1ee09|10|PNIF|Peak Nasal Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|Ejaculate U|[?]|1|mL/min/mmHg|ILIAC FOSSA|LEFT|VENTRAL|LIGHT MICROSCOPY||||SIBLING|NEUROLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-03-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|[?]|cd*s/m2|[?]|1|L/day|PALPEBRAL FISSURE|CONTRALATERAL|DISTAL|CALCULATION|Y|Y||GUARDIAN|ONCOLOGIST 2|1|Visit_1|10|5|TREATMENT|2020-12-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|2|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|[?]|nmol/L|[?]|1|Antibody Unit|MITRAL VALVE, ANTERIOR CUSP|RIGHT|NASAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||HEALTH CARE PROFESSIONAL|READER 1|1|Visit_1|10|5|TREATMENT|2020-12-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|3|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|APL U|[?]|1|/day|EAR, INNER|RIGHT|FACIAL|DOUBLE IMMUNODIFFUSION|Y|||PROXY|PHYSIOTHERAPIST|2|Visit_2|25|6|TREATMENT|2020-12-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|4|FEV6PP|Percent Predicted FEV6|[?]|PRONE|||[?]|1|m2|NASOPHARYNX|CONTRALATERAL|CRANIAL|U-HPLC/MS/MS||Y|Y|INTERVIEWER|DERMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-12-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|5|FEV1PP|Percent Predicted FEV1|[?]|SUPINE|[?]|v/v|[?]|1|nmol/day|OBTURATOR MUSCLE|RIGHT|DISTAL VOLAR|GC/MS/MS||||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|3|Visit_3|40|7|TREATMENT|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|TRENDELENBURG|[?]|CONTAINER|[?]|1|nmol BCE/mmol|FASCIA|LATERAL|FRONTAL|HEMAGGLUTINATION INHIBITION ASSAY|Y|Y||PARENT|ADJUDICATOR 2|3|Visit_3|40|1|FOLLOW-UP|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|7|SGAW|Specific Airway Conductance|[?]|UNCONSTRAINED|||[?]|1|umol/kg/min|UNCINATE PROCESS OF PANCREAS|BILATERAL|CAUDAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y||Y|SPOUSE|NEUROLOGIST 1|4|Visit_4|65|5|WASHOUT|2021-02-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|8|RELSZCHG|Relative Size Change|[?]|SITTING|[?]|eq|[?]|1|mL/g/day|HEART, LEFT VENTRICULAR WALL|UNILATERAL|DORSOLATERAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||Y||CHILD|MICROSCOPIST 2|4|Visit_4|65|4|FOLLOW-UP|2021-02-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|9|DLCOVA|DLCO/VA|[?]|SEMI-RECUMBENT|[?]|U/g/day|[?]|1|RNA copies/mL|RECTO-UTERINE POUCH|BILATERAL|CAUDAL|MRS|Y|||INVESTIGATOR|INTERNIST|5|Visit_5|90|4|TREATMENT|2021-03-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|fee3c810-3d76-4db4-9272-6b4e8fd14088|10|FEV3FVC|FEV3/FVC|[?]|STANDING, BENT FORWARD|[?]|U/cL|[?]|1|v/v|INFRARENAL AORTA|RIGHT|SUBCORTICAL|SPECULAR MICROSCOPY|Y|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|5|Visit_5|90|1|FOLLOW-UP|2021-03-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|||[?]|1|10^11/L|ABDUCTOR HALLUCIS MUSCLE|BILATERAL|OUTER|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||Y|Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|1|Visit_1|10|5|WASHOUT|2020-07-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|2|IC|Inspiratory Capacity|[?]|LATERAL DECUBITUS|[?]|HEP|[?]|1|mmHg|EYELID|LATERAL|LOWER MEDIAL|FISH|Y|Y||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|1|Visit_1|10|2|TREATMENT|2020-07-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|3|RAW|Airway Resistance|[?]|SUPINE|||[?]|1|pkat/L|GLOSSOPHARYNGEAL NERVE|LEFT|MIDLINE|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y||Y|PROXY|RADIOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-07-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|4|RELSZCHG|Relative Size Change|[?]|SITTING|[?]|um2|[?]|1|10^8 PFU|AORTIC VALVE|IPSILATERAL|FACIAL|ROMANOWSKY STAIN||||CLINICAL RESEARCH COORDINATOR|READER 3|2|Visit_2|25|6|TREATMENT|2020-07-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|5|TSUELAS|Tissue Elastance|[?]|TRENDELENBURG|[?]|mIU/L|[?]|1|/kg|CHOROID PLEXUS|LEFT|TIP|BAC ACGH||Y||SIBLING|PEDIATRIC NEUROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-08-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|6|FEV3PP|Percent Predicted FEV3|[?]|FOWLERS|[?]|Coulomb|[?]|1|ms2|OPPONENS POLLICIS MUSCLE|IPSILATERAL|OCCIPITAL|STRESS ECHOCARDIOGRAPHY||||INVESTIGATOR|ADJUDICATOR 1|3|Visit_3|40|1|FOLLOW-UP|2020-08-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|7|FEV1FVC|FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|mL/cage/wk|[?]|1|umol/day|ENDOMETRIUM|LEFT|FORE|AGAR PROPORTION||||ADJUDICATOR|FORENSIC PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-09-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|8|IC|Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|DAYS|MAMMARY GLAND|RIGHT|CAUDAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||Y|Y|CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-09-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|9|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|Torr|[?]|1|TCID 50/dose|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LEFT|TEMPORAL|CALIPER MEASUREMENT METHOD||||INTERVIEWER|FORENSIC PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|10|TLC|Total Lung Capacity|[?]|DECUBITUS|[?]|amol|[?]|1|/month|ISCHIAL TUBEROSITY|RIGHT|LOWER MEDIAL|DROPLET DIGITAL PCR||||GUARDIAN|NEUROLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-09-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|||[?]|1|Absorbance U/mL|METACARPOPHALANGEAL JOINT 3|BILATERAL|ANTEROPOSTERIOR|ACID FAST STAIN|||Y|ADJUDICATOR|ONCOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-08-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|2|IRV|Inspiratory Reserve Volume|[?]|SEMI-RECUMBENT|[?]|10^7 CFU|[?]|1|mol/mol|PERONEAL ARTERY|UNILATERAL|OUTER|LC-FL|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST 2|1|Visit_1|10|1|WASHOUT|2020-08-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|3|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|||[?]|1|%/s|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|BILATERAL|TEMPORAL|CISH|||Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|2|Visit_2|25|5|FOLLOW-UP|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SLING|[?]|pm|[?]|1|genEq/mL|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LATERAL|INNER|AGAR PROPORTION|Y|||CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|2|Visit_2|25|4|TREATMENT|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|PRONE|[?]|gtt|[?]|1|%|FEMORAL NECK|LATERAL|MEDIAL|ANTIBIOTIC AGAR SCREEN||||INTERVIEWER|NEUROLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|6|RV|Residual Volume|[?]|STANDING|[?]|KIT|[?]|1|GPL U/mL|CHEEK|UNILATERAL|CRANIAL|SLOAN LETTER EYE CHART 100%||||PROXY|NEUROLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|7|EFFVOL|Effusion Volume|[?]|PRONE|[?]|POUCH|[?]|1|MdFI|PERICARDIUM|LEFT|CAUDAL|MICRONEUTRALIZATION ASSAY||||DOMESTIC PARTNER|ADJUDICATOR 2|4|Visit_4|65|5|WASHOUT|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|8|FEF50|Forced Expiratory Flow 50%|[?]|SLING|||[?]|1|mL/100g/min|STRIATUM|LEFT|INFERIOR|MALDI||Y|Y|VENDOR|ENDOCRINOLOGIST|4|Visit_4|65|1|SCREENING|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|9|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|[?]|10^3 organisms/mL|[?]|1|uEq/L|FINGER FLEXOR MUSCLES|RIGHT|HIND|TEST STRIP||||PARENT|RATER|5|Visit_5|90|5|SCREENING|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|10|ERVPP|Percent Predicted ERV|[?]|STANDING, BENT FORWARD|[?]|fraction of 1|[?]|1|gpELISA unit/mL|SUBSTANTIA NIGRA|UNILATERAL|UPPER|QUANTITATIVE CORONARY ANGIOGRAPHY||Y||INVESTIGATOR|ONCOLOGIST|5|Visit_5|90|2|SCREENING|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|1|FIF25|Forced Inspiratory Flow at 25%|[?]|SEMI-RECUMBENT|||[?]|1|mg/kg|WRIST JOINT FLEXOR TENDONS|UNILATERAL|OUTER|GC/MS/MS||Y|Y|INTERVIEWER|RATER 2|1|Visit_1|10|7|TREATMENT|2020-10-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|FOWLERS|[?]|ug/kg/min|[?]|1|mEq/dL|CLAVICLE|BILATERAL|INTERMEDIATE|CLIP||||PROXY|READER 2|1|Visit_1|10|2|TREATMENT|2020-10-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|[?]|IU/day|[?]|1|BAR|SACRAL TUBEROSITY|IPSILATERAL|APICAL|RADIOGRAPHY||||FRIEND|RADIOLOGIST|2|Visit_2|25|7|TREATMENT|2020-10-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SLING|[?]|uIU/dL|[?]|1|mL/s|UTERINE ARTERY|UNILATERAL|VOLAR|ENZYMATIC ULTRACENTRIFUGATION|Y|||SIGNIFICANT OTHER|HEMATOLOGIST|2|Visit_2|25|3|SCREENING|2020-10-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|5|SAWVOL|Specific Airway Volume|[?]|DECUBITUS|||[?]|1|10^8/L|EYELASH|CONTRALATERAL|NASAL|LIGHT SCATTERING SPECTROSCOPY|||Y|CHILD|RATER 2|3|Visit_3|40|2|TREATMENT|2020-11-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING|[?]|10^9/L|[?]|1|10^3 CFU/g|SKULL|IPSILATERAL|MIDLINE|LISSAMINE GREEN STAIN||||INDEPENDENT ASSESSOR|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2020-11-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|7|FIFMAXPP|Percent Predicted FIFmax|[?]|PRONE|[?]|mMU/mL|[?]|1|10^3 copies/mL|SKIN OF THE TRUNK|CONTRALATERAL|UPPER EXTENSOR SURFACE|SINGLE-SLICE SPIRAL CT||Y||PARENT|READER 2|4|Visit_4|65|1|TREATMENT|2020-12-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|8|IRV|Inspiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|GPL U|[?]|1|mCi|T5 VERTEBRA|LATERAL|ROSTRAL|NUCLEIC ACID HYBRIDIZATION||||VENDOR|ADJUDICATOR 3|4|Visit_4|65|3|WASHOUT|2020-12-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|9|SALKK|Salazar-Knowles Equation, K|[?]|STANDING, BENT FORWARD|||[?]|1|10^11/L|TOOTH|CONTRALATERAL|MEDIAL|CONTRAST ENHANCED MRI||Y|Y|DOMESTIC PARTNER|ENDOCRINOLOGIST|5|Visit_5|90|6|TREATMENT|2020-12-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|47fad45a-9a4c-47ee-a863-089d979523b5|10|FIF50|Forced Inspiratory Flow at 50%|[?]|LEFT LATERAL DECUBITUS|[?]|ug/L DDU|[?]|1|pL|GREATER CURVATURE OF THE STOMACH|IPSILATERAL|CENTRAL|NUCLEIC ACID BASED METHOD||Y||FRIEND|READER 1|5|Visit_5|90|1|FOLLOW-UP|2020-12-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|mg/L|[?]|1|ug/g/h|URETER|CONTRALATERAL|LOWER FLEXOR SURFACE|IMMUNOASSAY|Y|Y||INTERVIEWER|PATHOLOGIST|1|Visit_1|10|7|WASHOUT|2020-05-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|2|AWWVOL|Airway Wall Volume|[?]|SEMI-RECUMBENT|||[?]|1|ag|LEFT CIRCUMFLEX ARTERY OSTIUM|IPSILATERAL|DORSOLATERAL|AUTOREFRACTION|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|1|Visit_1|10|5|TREATMENT|2020-05-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|3|TSUHYS|Tissue Hysteresivity|[?]|FOWLERS|[?]|cycle/min|[?]|1|log10 copies/mL|IRIS|LATERAL|ANTEROPOSTERIOR|RADIOIMMUNOPRECIPITATION ASSAY||||FAMILY MEMBER|MICROSCOPIST 1|2|Visit_2|25|2|TREATMENT|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|4|ERV|Expiratory Reserve Volume|[?]|SEMI-RECUMBENT|[?]|mAmp|[?]|1|VOXEL|CORPUS UTERI|BILATERAL|TIP|DYNAMIC LIGHT SCATTERING||Y||PARENT|CLINICAL PATHOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|5|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mCi|TIBIA SHAFT|BILATERAL|LOWER FLEXOR SURFACE|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|Y|Y|VENDOR|ADJUDICATOR 2|3|Visit_3|40|2|SCREENING|2020-06-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SUPINE|||[?]|1|10^6 IU|LENS|IPSILATERAL|VENTROLATERAL|DNA MICROARRAY||Y|Y|GUARDIAN|ADJUDICATOR|3|Visit_3|40|5|WASHOUT|2020-06-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-FOWLERS|||[?]|1|10^3 organisms/mL|GASTROINTESTINAL TRACT|RIGHT|POSTERIOR|MICROBIAL CONCENTRATION|||Y|ADJUDICATOR|PHYSIOTHERAPIST|4|Visit_4|65|4|TREATMENT|2020-07-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|8|GAW|Airway Conductance|[?]|SEMI-RECUMBENT|[?]|uL/dose|[?]|1|ppb|EPIGASTRIC REGION|LEFT|INNER|WEBER GREEN STAIN|Y|||GUARDIAN|PATHOLOGIST 2|4|Visit_4|65|7|TREATMENT|2020-07-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|9|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|mU/L|[?]|1|nmol/L/min|HYPOPHARYNX|BILATERAL|ROSTRAL|KLEIHAUER-BETKE||||FAMILY MEMBER|RATER 2|5|Visit_5|90|7|TREATMENT|2020-08-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|RE|317b8b6d-9638-44a3-816f-7f3fca1e01a3|10|EVC|Expiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|dpm/mg|LACRIMAL GLAND|UNILATERAL|UPPER FLEXOR SURFACE|SXA SCAN||Y|Y|INVESTIGATOR|ADJUDICATOR|5|Visit_5|90|4|TREATMENT|2020-08-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|IC|Inspiratory Capacity|[?]|STANDING|[?]|ka_u/dL|[?]|1|dmol|LIVER, CAUDATE LOBE|LEFT|HIND|WRIGHT STAIN|Y|||CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-07-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|2|MALIND|Malignancy Indicator|[?]|FOWLERS|[?]|dpm/mL|[?]|1|10^6 U|HEART|LATERAL|TEMPORAL|CENTRIFUGATION||Y||INTERVIEWER|MICROSCOPIST|1|Visit_1|10|5|WASHOUT|2020-07-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|3|AWVOLPP|Percent Predicted Airway Volume|[?]|STANDING|[?]|mL/g/h|[?]|1|uEq|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|IPSILATERAL|PERIVENTRICULAR|IMMUNODIFFUSION||||DOMESTIC PARTNER|ONCOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-07-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|4|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING, BENT FORWARD|||[?]|1|10^12 IU/L|TRIGEMINAL NERVE|LEFT|MIDLINE|SISH|||Y|CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|2|Visit_2|25|7|WASHOUT|2020-07-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|5|OXYPULSE|Oxygen Pulse|[?]|SITTING|[?]|pmol/10^10 cells|[?]|1|mEq|LEFT MAIN CORONARY ARTERY BODY|UNILATERAL|PERIVENTRICULAR|HIGH RESOLUTION MELT ANALYSIS||Y||ADJUDICATION COMMITTEE|RATER 2|3|Visit_3|40|4|WASHOUT|2020-08-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|mg/m2/min|[?]|1|pmol/10^9 cells|ABDOMINAL WALL|LEFT|APICAL|MAGNETIC RESONANCE ELASTOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|READER|3|Visit_3|40|6|TREATMENT|2020-08-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|BOLUS|[?]|1|Log10 ELISA unit|L4-L5 INTERVERTEBRAL SPACE|IPSILATERAL|HIND|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||STUDY SUBJECT|ADJUDICATOR 1|4|Visit_4|65|1|SCREENING|2020-09-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|8|FIF75|Forced Inspiratory Flow at 75%|[?]|SUPINE|[?]|mEq/dL|[?]|1|10^5/hpf|THORACIC SPINE|UNILATERAL|PROXIMAL|MICROPARTICLE ENZYME IMMUNOASSAY|Y|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-09-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|9|MIP|Maximal Inspiratory Pressure|[?]|SUPINE|[?]|MnFI|[?]|1|WAFER|PULMONARY VALVE, ANTERIOR CUSP|CONTRALATERAL|PERIPHERAL|PUPILLOMETRY||Y||INVESTIGATOR|MICROSCOPIST 1|5|Visit_5|90|3|FOLLOW-UP|2020-09-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|nmol/L/h|[?]|1|uCi|FINGER EXTENSOR MUSCLES|UNILATERAL|HIND|COMPUTERIZED CORNEAL TOPOGRAPHY||Y||ADJUDICATOR|RATER 2|5|Visit_5|90|3|TREATMENT|2020-09-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|1|FEV6PP|Percent Predicted FEV6|[?]|FOWLERS|[?]|umol/day|[?]|1|PACK|OLFACTORY NERVE|LEFT|TIP|PERFUSION MRI||Y||PROXY|PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|2|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|[?]|% INHIBITION|[?]|1|um/s|SKIN OF THE INFRASCAPULAR REGION|LATERAL|PROXIMAL VOLAR|SLIT LAMP||||STUDY SUBJECT|ADJUDICATOR|1|Visit_1|10|3|SCREENING|2021-01-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|3|SRAW|Specific Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|mL/kg/day|[?]|1|mEq/ug|MITRAL VALVE, POSTERIOR ANNULUS|LEFT|HIND|CALCULATION||||DOMESTIC PARTNER|RADIOLOGIST 1|2|Visit_2|25|1|FOLLOW-UP|2021-01-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|UNCONSTRAINED|[?]|SYRINGE|[?]|1|U/m2/h|SKIN OF THE KNEE|IPSILATERAL|SUPERFICIAL|RAJI CELL EIA|Y|Y||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|5|IRV|Inspiratory Reserve Volume|[?]|SLING|||[?]|1|mmAL|METACARPAL BONE 2|LATERAL|ANTEROTEMPORAL|CAPILLARY ELECTROPHORESIS|||Y|INTERVIEWER|ADJUDICATOR 2|3|Visit_3|40|7|SCREENING|2021-02-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|6|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|[?]|mL/m2/min|[?]|1|HOMEOPATHIC DILUTION|AORTIC VALVE, NON-CORONARY CUSP|IPSILATERAL|OUTER|FLUORESCENT IMMUNOASSAY||||FRIEND|PATHOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2021-02-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SUPINE|[?]|ug/L DDU|[?]|1|%(w/v)|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|IPSILATERAL|FRONTAL|FORCED OSCILLATION TECHNIQUE||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|4|Visit_4|65|7|FOLLOW-UP|2021-03-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|8|DLCOHC|HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|cm2|[?]|1|Hz|PITUITARY GLAND|LEFT|UPPER FLEXOR SURFACE|GRAM STAIN||||FRIEND|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2021-03-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|UNCONSTRAINED|||[?]|1|m3|CARPOMETACARPAL JOINT 5|LATERAL|INNER|PERIODIC ACID SCHIFF STAIN|||Y|ADJUDICATOR|CARDIOLOGIST|5|Visit_5|90|7|TREATMENT|2021-03-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|e7cee930-54f6-482e-b782-01aed0f0db06|10|FIVC|Forced Inspiratory Vital Capacity|[?]|SITTING|[?]|BU|[?]|1|mL/cm3/min|WRIST JOINT EXTENSOR TENDONS|LEFT|POSTERIOR|THERMAL IONIZATION MASS SPECTROMETRY||||INTERVIEWER|CARDIOLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|AWVOLPP|Percent Predicted Airway Volume|[?]|SLING|||[?]|1|mm/2h|MAIN BRONCHUS, LEFT|LATERAL|ANTEROTEMPORAL|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|1|Visit_1|10|5|SCREENING|2021-01-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|2|MIPPP|Percent Predicted MIP|[?]|LATERAL DECUBITUS|[?]|10^3 RNA copies/mL|[?]|1|usec|ANKLE MORTISE|IPSILATERAL|DEEP|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||SIGNIFICANT OTHER|DERMATOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2021-01-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|3|GAW|Airway Conductance|[?]|TRENDELENBURG|[?]|Sv|[?]|1|POUCH|HAIR|CONTRALATERAL|VENTROLATERAL|RADIOIMMUNOPRECIPITATION ASSAY||||INTERVIEWER|READER 3|2|Visit_2|25|6|SCREENING|2021-02-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|[?]|Frames/s|[?]|1|EVENTS|CAUDAL VERTEBRA|RIGHT|TEMPORAL|RAJI CELL RIA|Y|||GUARDIAN|ONCOLOGIST|2|Visit_2|25|2|WASHOUT|2021-02-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|UNCONSTRAINED|||[?]|1|gMFI|FEMALE GENITALIA|BILATERAL|VOLAR|CAPILLARY ELECTROPHORESIS|||Y|STUDY SUBJECT|NEUROLOGIST 2|3|Visit_3|40|4|FOLLOW-UP|2021-02-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|g/cage|VEIN|CONTRALATERAL|CAUDAL|BALLPOINT PEN TECHNIQUE|||Y|SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2021-02-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|7|FEV_PEF|FEV at PEF|[?]|SEMI-RECUMBENT|[?]|mmol|[?]|1|Bq/kg|VOMER|IPSILATERAL|UPPER EXTENSOR SURFACE|WHOLE TRANSCRIPTOME SEQUENCING||||SIGNIFICANT OTHER|PATHOLOGIST 2|4|Visit_4|65|2|FOLLOW-UP|2021-03-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|8|FEV1SVC|FEV1/SVC|[?]|STANDING|[?]|in|[?]|1|ug/L DDU|GREAT VESSELS|LEFT|LOWER EXTENSOR SURFACE|IMPEDANCE CONDUCTIVITY||Y||PARENT|UROLOGIST|4|Visit_4|65|5|WASHOUT|2021-03-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|||[?]|1|U|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|CONTRALATERAL|INNER|KINETIC MICROPARTICLE IMMUNOASSAY|||Y|DOMESTIC PARTNER|INTERNIST|5|Visit_5|90|7|TREATMENT|2021-04-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|10|QUASCOMP|Quasi-Static Compliance|[?]|REVERSE TRENDELENBURG|[?]|U/g Hb|[?]|1|damol/L|THORACIC CAVITY|LEFT|POSTERIOR|SPECULAR MICROSCOPY||||ADJUDICATION COMMITTEE|RATER 1|5|Visit_5|90|2|TREATMENT|2021-04-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|1|IRV|Inspiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|pmol/L/h|[?]|1|cmH2O*s2/mL|LIVER, QUADRATE LOBE|CONTRALATERAL|FACIAL|SNELLEN EYE CHART||||PROXY|OTOLARYNGOLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|2|RVPP|Percent Predicted Residual Volume|[?]|PRONE|[?]|dmol|[?]|1|/HPF|FINGER EXTENSOR MUSCLES|RIGHT|INTERMEDIATE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|1|Visit_1|10|3|SCREENING|2020-09-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|3|FIV1PP|Percent Predicted FIV1|[?]|SITTING|[?]|ng|[?]|1|MPL U/mL|DISTAL PHALANX 2 OF THE HAND|RIGHT|UPPER|AGAR PROPORTION||||PROXY|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-10-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|4|SGAW|Specific Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|gpELISA unit/mL|[?]|1|cm H2O|LEFT VENTRICULAR APEX SEGMENT|CONTRALATERAL|LOWER MEDIAL|MICRODENSITOMETRY|Y|||SPOUSE|DERMATOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-10-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|5|SRAW|Specific Airway Resistance|[?]|PRONE|||[?]|1|10^6/L|MITRAL VALVE, POSTERIOR ANNULUS|BILATERAL|LOWER EXTENSOR SURFACE|ELECTRONEUROGRAPHY|||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|3|Visit_3|40|6|TREATMENT|2020-10-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|6|ERV|Expiratory Reserve Volume|[?]|SITTING|||[?]|1|mg/g/min|UTERUS|CONTRALATERAL|DEEP|HEMAGGLUTINATION INHIBITION ASSAY||Y|Y|STUDY SUBJECT|RATER|3|Visit_3|40|5|TREATMENT|2020-10-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|10^6/L|[?]|1|mmAL|ADDUCTOR LONGUS MUSCLE|CONTRALATERAL|ANTEROTEMPORAL|PANENDOSCOPY|Y|Y||FRIEND|ADJUDICATOR 1|4|Visit_4|65|3|FOLLOW-UP|2020-11-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|mL/cm3/min|[?]|1|% INHIBITION|PRECUNEUS|LATERAL|ANTEROMEDIAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-11-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|9|FEV1FVC|FEV1/FVC|[?]|SUPINE|[?]|P|[?]|1|MBq/uL|FOOT DIGIT 4|RIGHT|NASAL|IN SITU HYBRIDIZATION||Y||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|5|Visit_5|90|7|WASHOUT|2020-12-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|f754ae7d-0776-41c0-988c-8cf2879d85da|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-RECUMBENT|||[?]|1|MPL U|VASTUS MEDIALIS MUSCLE|RIGHT|CENTRAL|MASS SPECTROMETRY|||Y|GUARDIAN|READER 2|5|Visit_5|90|2|FOLLOW-UP|2020-12-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|TRENDELENBURG|[?]|mol/mg|[?]|1|mL|MIDDLE PHALANX 5 OF THE HAND|CONTRALATERAL|APICAL|PERCUSSION||||VENDOR|ADJUDICATOR 2|1|Visit_1|10|7|TREATMENT|2020-06-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|TRENDELENBURG|[?]|g/cm2|[?]|1|g/day|FLEXOR DIGITORUM LONGUS MUSCLE|CONTRALATERAL|INFERIOR|SURFACE PLASMON RESONANCE|Y|Y||FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-06-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|3|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|Ci/g|[?]|1|OI50|FINGER FLEXOR MUSCLES|CONTRALATERAL|ANTEROLATERAL|IMPULSE OSCILLOMETRY||||INVESTIGATOR|NEUROLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-07-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|4|IVC|Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|Linear ft*LB|[?]|1|10^3 DNA copies/mL|LIVER FISSURE|LEFT|FACIAL|GC/MS/MS||Y||ADJUDICATOR|MICROSCOPIST 1|2|Visit_2|25|7|SCREENING|2020-07-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|5|ERVPP|Percent Predicted ERV|[?]|UNCONSTRAINED|[?]|cmH2O/mL|[?]|1|TUBE|UTERINE ARTERY|IPSILATERAL|FRONTAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||SPOUSE|READER 2|3|Visit_3|40|2|TREATMENT|2020-07-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|nmol|[?]|1|min*mg/mL|METATARSOPHALANGEAL JOINT 1|LEFT|FACIAL|SLOAN LETTER EYE CHART 1.25%|Y|||INVESTIGATOR|UROLOGIST|3|Visit_3|40|2|TREATMENT|2020-07-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|[?]|um2|[?]|1|NFIU|KIDNEY, UPPER LOBE|LEFT|CAUDAL|TWO-COLOR MICROARRAY||||INTERVIEWER|RATER 2|4|Visit_4|65|6|TREATMENT|2020-08-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|8|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|[?]|g/cm2|[?]|1|Gravitational Unit|EYE, VITREOUS CHAMBER|IPSILATERAL|PROXIMAL VOLAR|AGAR DILUTION||||ADJUDICATION COMMITTEE|PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|9|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|pt_us|[?]|1|10^3 organisms/g|LEFT VENTRICULAR APEX SEGMENT|LATERAL|SUPERFICIAL|ICC||||VENDOR|FORENSIC PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2020-09-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|8a8d8c31-ae36-4a64-90da-ba5eb473e420|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|ngEq/L|[?]|1|uU/L|CEREBRUM|UNILATERAL|INNER|SEQUENCING|Y|||PARENT|READER 1|5|Visit_5|90|2|TREATMENT|2020-09-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-RECUMBENT|||[?]|1|IMPLANT|MALE REPRODUCTIVE SYSTEM|RIGHT|SUPERFICIAL|CONGO RED STAIN||Y|Y|STUDY SUBJECT|RATER 1|1|Visit_1|10|2|TREATMENT|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|[?]|Mile|[?]|1|MESF|PREFRONTAL CORTEX|LEFT|ANTEROPOSTERIOR|TRYPAN BLUE STAIN||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|3|FEF2575|Forced Expiratory Flow 25-75%|[?]|UNCONSTRAINED|[?]|U/m2/day|[?]|1|mg/kg/dose|GASTROINTESTINAL TRACT, UPPER|LEFT|OUTER|IMMUNOBLOT||Y||FRIEND|READER|2|Visit_2|25|4|SCREENING|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|4|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|uIU/dL|[?]|1|g/g|MAIN BRONCHUS, RIGHT|IPSILATERAL|POSTERIOR|RULER MEASUREMENT METHOD||||SIBLING|UROLOGIST|2|Visit_2|25|4|TREATMENT|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|5|MEP|Maximal Expiratory Pressure|[?]|SEMI-FOWLERS|[?]|MHz|[?]|1|nkat|ANTERIOR HORN OF THE LATERAL VENTRICLE|CONTRALATERAL|ANTEROMEDIAL|IMMUNOPRECIPITATION||||GUARDIAN|NEUROLOGIST|3|Visit_3|40|7|WASHOUT|2020-08-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|6|ELSTNCE|Elastance|[?]|REVERSE TRENDELENBURG|[?]|Hz|[?]|1|nmol/L|FAT PAD|BILATERAL|CENTRAL|RAJI CELL RIA|Y|Y||ADJUDICATION COMMITTEE|MICROSCOPIST 2|3|Visit_3|40|4|TREATMENT|2020-08-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|7|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING|||[?]|1|mmAL|HAIR SHAFT|RIGHT|LOWER FLEXOR SURFACE|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||Y|Y|INDEPENDENT ASSESSOR|RATER|4|Visit_4|65|6|WASHOUT|2020-09-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|8|DLCOHC|HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|Ci/uL|[?]|1|JDF Unit|RETINAL ARTERY|IPSILATERAL|DORSOLATERAL|IN SITU HYBRIDIZATION|Y|||HEALTH CARE PROFESSIONAL|DERMATOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|9|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING|||[?]|1|OI50|RECTUS FEMORIS MUSCLE|IPSILATERAL|LOWER MEDIAL|EEG|Y||Y|ADJUDICATION COMMITTEE|CARDIOLOGIST|5|Visit_5|90|5|WASHOUT|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|482e40c9-2908-4269-b93c-61c311e9fde3|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|%|PROXIMAL PHALANX 1 OF THE HAND|CONTRALATERAL|LOWER|COULOMETRIC TITRATION|||Y|INTERVIEWER|ONCOLOGIST|5|Visit_5|90|4|WASHOUT|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|1|FEV1FVC|FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|in|[?]|1|10^3 DNA copies/mL|RETROPHARYNGEAL LYMPH NODE|CONTRALATERAL|PROXIMAL|TRIPLE-PHASE MRI SCAN||||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|1|Visit_1|10|6|TREATMENT|2020-06-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|2|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|mmHg/L/min|[?]|1|TRACE|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|ANTEROTEMPORAL|WRIGHT STAIN||Y||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|WASHOUT|2020-06-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|3|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING|[?]|kIU|[?]|1|INHALATION|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|APICAL|CT SCAN WITHOUT CONTRAST||Y||DOMESTIC PARTNER|ONCOLOGIST 2|2|Visit_2|25|7|SCREENING|2020-07-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SEMI-RECUMBENT|[?]|10^7 PFU|[?]|1|kcal|COSTOCHONDRAL JOINT 7|LATERAL|SUPERIOR|ROMANOWSKY STAIN|Y|||SIGNIFICANT OTHER|NEUROLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-07-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|5|PIF|Peak Inspiratory Flow|[?]|TRENDELENBURG|[?]|L/kg|[?]|1|10^9 organisms/g|GASTRIC CURVATURE LYMPH NODE|BILATERAL|POSTERIOR|ELISPOT||||PARENT|ENDOCRINOLOGIST|3|Visit_3|40|1|WASHOUT|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|6|RV|Residual Volume|[?]|TRENDELENBURG|[?]|uL/mL|[?]|1|mU|FOREARM|CONTRALATERAL|DORSAL|GC/FID||||SPOUSE|NEUROLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|7|FVC|Forced Vital Capacity|[?]|TRENDELENBURG|[?]|MAC50|[?]|1|pmol/L|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|PARIETO-OCCIPITAL|PERIPHERAL ANGIOGRAPHY|Y|||FRIEND|ADJUDICATOR 2|4|Visit_4|65|1|TREATMENT|2020-08-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|8|SAWVOL|Specific Airway Volume|[?]|LATERAL DECUBITUS|||[?]|1|BEAM BREAKS|HEART, RIGHT VENTRICLE|LEFT|TIP|MICROBIAL CULTURE||Y|Y|ADJUDICATOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|7|SCREENING|2020-08-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|fL|[?]|1|PIPE|BRACHIOCEPHALIC ARTERY|IPSILATERAL|INTERMEDIATE|DIRECT SEQUENCING||||PROXY|RADIOLOGIST 2|5|Visit_5|90|3|TREATMENT|2020-09-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|f7cfb281-0556-4316-9373-65edf63c4b23|10|FEV1FVC|FEV1/FVC|[?]|PRONE|[?]|nmol/day|[?]|1|10^6 organisms|CORONARY ARTERY, RIGHT|RIGHT|DISTAL|SPIRAL CT SCAN WITHOUT CONTRAST||||FRIEND|DERMATOLOGIST|5|Visit_5|90|7|TREATMENT|2020-09-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|h*%|[?]|1|LENS|BRAIN VENTRICLE, LATERAL|UNILATERAL|INFERIOR|BIOPSY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|1|Visit_1|10|6|FOLLOW-UP|2021-01-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|2|TSUELAS|Tissue Elastance|[?]|LEFT LATERAL DECUBITUS|||[?]|1|GPS U|SECOND OBTUSE MARGINAL BRANCH ARTERY|LATERAL|LOWER FLEXOR SURFACE|REFRACTOMETRY|||Y|HEALTH CARE PROFESSIONAL|UROLOGIST|1|Visit_1|10|7|TREATMENT|2021-01-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|3|MALEVDES|Malignancy Evidence Description|[?]|PRONE|[?]|mmHg/L/min|[?]|1|ppth|C7 VERTEBRA|RIGHT|OCCIPITAL|ULTRASONOGRAPHIC ELASTOGRAPHY||||ADJUDICATION COMMITTEE|PATHOLOGIST|2|Visit_2|25|7|WASHOUT|2021-01-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|4|IRVPP|Percent Predicted IRV|[?]|STANDING, BENT FORWARD|[?]|s/h|[?]|1|C|ESOPHAGUS, THORACIC|UNILATERAL|SURFACE|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|||PROXY|NEUROLOGIST 1|2|Visit_2|25|5|TREATMENT|2021-01-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|5|FEF50|Forced Expiratory Flow 50%|[?]|STANDING|[?]|IU|[?]|1|U/kg/min|SUPRASPINATUS MUSCLE|CONTRALATERAL|LATERAL|ZIEHL NEELSEN ACID FAST STAIN||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|3|Visit_3|40|5|SCREENING|2021-02-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|6|FRCPP|Percent Predicted FRC|[?]|FOWLERS|[?]|fmol/g|[?]|1|g/cm2|PHARYNGEAL TONSIL|UNILATERAL|VENTRAL|TRIPLE-PHASE SPIRAL CT SCAN||||SIBLING|RATER 1|3|Visit_3|40|5|TREATMENT|2021-02-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|7|MIP|Maximal Inspiratory Pressure|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^7 PFU|TIBIALIS ANTERIOR MUSCLE|CONTRALATERAL|PERIVENTRICULAR|FLUORESCEIN STAIN|||Y|CAREGIVER|READER 1|4|Visit_4|65|2|WASHOUT|2021-03-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|8|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/dL|[?]|1|mL/dose|SUBMENTAL LYMPH NODE|IPSILATERAL|PARIETO-OCCIPITAL|MUGA|Y|||FAMILY MEMBER|RATER|4|Visit_4|65|2|WASHOUT|2021-03-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|9|TLC|Total Lung Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|umol/h/mmol|CEREBRAL VEIN|CONTRALATERAL|BASAL|DOUBLE IMMUNODIFFUSION|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 3|5|Visit_5|90|1|TREATMENT|2021-03-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|10|PLMXRS|Pulmonary Reactance|[?]|REVERSE TRENDELENBURG|||[?]|1|U/kg|AXILLARY ARTERY|LATERAL|CENTRAL|ELASTOGRAPHY|||Y|CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|TREATMENT|2021-03-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|UNCONSTRAINED|[?]|10^6 organisms/mg|[?]|1|CONTAINER|EPIGASTRIC REGION|CONTRALATERAL|LOWER|KNEMOMETRY||||CAREGIVER|MICROSCOPIST|1|Visit_1|10|3|TREATMENT|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|[?]|ECL unit|[?]|1|yd|CARDIAC VALVE|BILATERAL|LATERAL|CALCOFLUOR WHITE STAIN||||DOMESTIC PARTNER|MICROSCOPIST 1|1|Visit_1|10|7|TREATMENT|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|3|SALKA|Salazar-Knowles Equation Parameter A|[?]|UNCONSTRAINED|||[?]|1|pmol/L/h|TRIANGULAR-LUNATE JOINT|IPSILATERAL|FORE|MAGNETIC RESONANCE ANGIOGRAPHY|||Y|SIBLING|NEUROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-09-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|DECUBITUS|||[?]|1|umol/h/mmol|PATELLA|LATERAL|INNER|OBSERVATION|Y|Y|Y|CHILD|RATER|2|Visit_2|25|4|FOLLOW-UP|2020-09-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|5|FIF50|Forced Inspiratory Flow at 50%|[?]|FOWLERS|[?]|pmol/g|[?]|1|mL/kg|HEART, RIGHT ATRIUM|UNILATERAL|ANTERIOR|GIEMSA STAIN|Y|||CHILD|READER 3|3|Visit_3|40|1|SCREENING|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|6|FEV6PP|Percent Predicted FEV6|[?]|LEFT LATERAL DECUBITUS|[?]|g/m2|[?]|1|WAFER|CEPHALIC VEIN|RIGHT|DISTAL|ELECTROMYOGRAPHY||||VENDOR|RATER|3|Visit_3|40|6|SCREENING|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|7|PLMXRS|Pulmonary Reactance|[?]|DECUBITUS|[?]|10^6 RNA copies/mL|[?]|1|g/cage/wk|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|LOWER EXTENSOR SURFACE|PET/CT SCAN WITHOUT CONTRAST||||INDEPENDENT ASSESSOR|RATER 2|4|Visit_4|65|6|FOLLOW-UP|2020-10-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|8|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING|[?]|10^4/L|[?]|1|kPa|FRONTAL SINUS|LATERAL|ANTEROTEMPORAL|MECHANICAL CLOT DETECTION||||SIBLING|RATER 1|4|Visit_4|65|1|WASHOUT|2020-10-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|9|FEV3FVC|FEV3/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|mL/g/min|[?]|1|mg|ESOPHAGUS, MIDDLE THIRD|LEFT|OCCIPITAL|TELLER ACUITY CARDS|Y|||ADJUDICATION COMMITTEE|RADIOLOGIST 2|5|Visit_5|90|6|TREATMENT|2020-11-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|9ed8a578-a82a-423a-81ca-ee87f98d62f7|10|RV|Residual Volume|[?]|STANDING, BENT FORWARD|[?]|mEq/mL|[?]|1|10^5/hpf|CARDIAC VALVE|BILATERAL|CENTRAL|CONTRAST ENHANCED X-RAY||||SIBLING|ONCOLOGIST 1|5|Visit_5|90|5|TREATMENT|2020-11-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING|[?]|umol/L/sec|[?]|1|vg/mL|RADIAL ARTERY|LEFT|DISTAL VOLAR|HANSEL STAIN||||STUDY SUBJECT|ONCOLOGIST 2|1|Visit_1|10|3|SCREENING|2020-10-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|2|FRC|Functional Residual Capacity|[?]|DECUBITUS|[?]|tuberculin unit|[?]|1|LOZENGE|FINGER EXTENSOR TENDONS|LEFT|UPPER EXTENSOR SURFACE|MOUSE PROTECTION ASSAY||||SIBLING|ONCOLOGIST|1|Visit_1|10|1|SCREENING|2020-10-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|3|EVC|Expiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|APPLICATION|[?]|1|APS U|BASAL GANGLIA|RIGHT|MIDLINE|FLAME PHOTOMETRY|Y|||SPOUSE|DERMATOLOGIST|2|Visit_2|25|7|WASHOUT|2020-11-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING, BENT FORWARD|[?]|mgEq|[?]|1|genEq/mL|METACARPOPHALANGEAL JOINT 5|RIGHT|UPPER FLEXOR SURFACE|POLYSOMNOGRAPHY||||CAREGIVER|OTOLARYNGOLOGIST|2|Visit_2|25|4|SCREENING|2020-11-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|5|TSUELAS|Tissue Elastance|[?]|TRENDELENBURG|[?]|ppb|[?]|1|/day|GASTROINTESTINAL TRACT, LOWER, WALL|BILATERAL|TEMPORAL|MRS||||SIGNIFICANT OTHER|READER|3|Visit_3|40|2|TREATMENT|2020-11-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|6|RAW|Airway Resistance|[?]|STANDING|||[?]|1|mol|SPLEEN|RIGHT|PERIVENTRICULAR|REVERSE TRANSCRIPTASE PCR|||Y|INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|SCREENING|2020-11-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|7|SVC|Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|cm2|[?]|1|mL/dL|PULMONARY VALVE, ANTERIOR CUSP|IPSILATERAL|OUTER|HEMAGGLUTINATION ASSAY|Y|Y||GUARDIAN|HEMATOLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|8|INFLTIND|Infiltrates Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|mmAL|[?]|1|10^6 organisms/mL|T10 VERTEBRA|IPSILATERAL|TEMPORAL|ACRIDINE ORANGE STAIN|Y|||FRIEND|FORENSIC PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|9|FIF25|Forced Inspiratory Flow at 25%|[?]|DECUBITUS|||[?]|1|dpm/mg|ANKLE JOINT|LATERAL|INTERMEDIATE|AUTOREFRACTION|Y||Y|CHILD|MICROSCOPIST 3|5|Visit_5|90|1|SCREENING|2021-01-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|2214af46-1072-4328-bf3d-f4fe9cd97d9b|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|[?]|10^6/L|[?]|1|Log10 ELISA unit|TROCHANTER|UNILATERAL|FRONTAL|HPLC-FL||||SIBLING|OPHTHALMOLOGIST|5|Visit_5|90|5|SCREENING|2021-01-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|mL/cage/wk|[?]|1|eq|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|CONTRALATERAL|ROSTRAL|WHOLE TRANSCRIPTOME SEQUENCING||Y||FAMILY MEMBER|RATER 2|1|Visit_1|10|3|SCREENING|2021-01-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|2|TSUELAS|Tissue Elastance|[?]|STANDING|[?]|%(w/w)|[?]|1|U.CARR|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|POSTERIOR|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|1|Visit_1|10|5|FOLLOW-UP|2021-01-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|3|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|mL/kg/h|[?]|1|titer|PARA-AORTIC LYMPH NODE|IPSILATERAL|ANTERIOR|SURFACE PLASMON RESONANCE||||DOMESTIC PARTNER|MICROSCOPIST 1|2|Visit_2|25|2|WASHOUT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|SUPINE|[?]|ug/L/h|[?]|1|DISK|TIBIO-PERONEAL TRUNK|RIGHT|CRANIAL|DIGITAL PCR ARRAY|Y|||FRIEND|PATHOLOGIST 1|2|Visit_2|25|4|WASHOUT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|kat|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|CONTRALATERAL|VOLAR|IODINE STAIN|||Y|PARENT|ONCOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|6|FEV3PP|Percent Predicted FEV3|[?]|UNCONSTRAINED|[?]|GLOBULE|[?]|1|ag|GASTROESOPHAGEAL JUNCTION|UNILATERAL|PERIPHERAL|PULSE OXIMETRY||||PARENT|NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|7|MALIND|Malignancy Indicator|[?]|SEMI-FOWLERS|[?]|GLOBULE|[?]|1|SUPPOSITORY|T6 VERTEBRA|IPSILATERAL|SUPERIOR|HANSEL STAIN|Y|Y||SIBLING|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|[?]|lx|[?]|1|mN|ENDOCARDIUM|UNILATERAL|SUPERFICIAL|OPTICAL MAPPING||Y||INTERVIEWER|UROLOGIST|4|Visit_4|65|6|WASHOUT|2021-03-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|9|FEV1PP|Percent Predicted FEV1|[?]|RIGHT LATERAL DECUBITUS|[?]|U/kg|[?]|1|DNA copies/ug|MALE REPRODUCTIVE SYSTEM|CONTRALATERAL|LATERAL|PET/SPECT SCAN|Y|Y||STUDY SUBJECT|UROLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|7e56eb43-62a6-45ac-9476-1d0655595a04|10|MEP|Maximal Expiratory Pressure|[?]|SITTING|[?]|ukat/L|[?]|1|/HPF|INTERATRIAL SEPTUM|LATERAL|MIDLINE|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|5|Visit_5|90|5|WASHOUT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|ALVVOL|Alveolar Volume|[?]|FOWLERS|[?]|mL/cage|[?]|1|mEq/mL|SEBACEOUS GLAND|CONTRALATERAL|MEDIAL|WEBER GREEN STAIN||||VENDOR|CLINICAL PATHOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-06-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|2|FIF50|Forced Inspiratory Flow at 50%|[?]|TRENDELENBURG|[?]|ks|[?]|1|cmol/L|WRIST JOINT|CONTRALATERAL|PERIPHERAL|ELECTROMYOGRAPHY||||CAREGIVER|NEUROLOGIST 2|1|Visit_1|10|2|WASHOUT|2020-06-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|FOWLERS|[?]|U/dL|[?]|1|nU/cL|ILEUM, TERMINAL|LATERAL|MEDIAL|AUSCULTATION|Y|||FRIEND|INTERNIST|2|Visit_2|25|3|SCREENING|2020-07-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|4|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-RECUMBENT|[?]|fmol/L/sec|[?]|1|log10 CFU/g|CARPOMETACARPAL JOINT 3|CONTRALATERAL|ANTEROMEDIAL|PULMONARY ANGIOGRAPHY||||INDEPENDENT ASSESSOR|RADIOLOGIST 2|2|Visit_2|25|3|FOLLOW-UP|2020-07-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|5|FEV1SVC|FEV1/SVC|[?]|SEMI-FOWLERS|[?]|log EID 50/dose|[?]|1|Sv|SHOULDER|UNILATERAL|LOWER FLEXOR SURFACE|SNP ARRAY||||STUDY SUBJECT|READER 3|3|Visit_3|40|3|SCREENING|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|6|ELSTNCE|Elastance|[?]|SLING|[?]|g/g|[?]|1|ELISA unit/dose|NASOPHARYNX|RIGHT|ANTEROLATERAL|MAGNETIC RESONANCE ENTEROGRAPHY||||VENDOR|ONCOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|7|MEP|Maximal Expiratory Pressure|[?]|SLING|[?]|ug/g/h|[?]|1|CONTAINER|ASCENDING AORTA, AORTIC ROOT|LATERAL|ANTERIOR|MICROPARTICLE ENZYME IMMUNOASSAY||||ADJUDICATOR|RATER 1|4|Visit_4|65|5|TREATMENT|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING, LEGS DEPENDENT|[?]|cd/m2|[?]|1|mg/L|SUBLINGUAL REGION|LATERAL|LOWER MEDIAL|ANTIBIOTIC AGAR SCREEN||||INDEPENDENT ASSESSOR|UROLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|9|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|[?]|pt_br|[?]|1|mJoule/cm2|LACRIMAL BONE|LATERAL|LOWER EXTENSOR SURFACE|HIGH RESOLUTION MELT ANALYSIS|Y|Y||DOMESTIC PARTNER|ADJUDICATOR 2|5|Visit_5|90|4|TREATMENT|2020-09-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|73a8e85a-0b5f-496b-b164-afc4d1f02de2|10|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-RECUMBENT|[?]|Sv|[?]|1|LOZENGE|MALLEUS|RIGHT|ANTEROLATERAL|JAEGER EYE CHART||||GUARDIAN|READER|5|Visit_5|90|2|SCREENING|2020-09-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|1|TVPP|Percent Predicted Tidal Volume|[?]|SEMI-FOWLERS|||[?]|1|mOsm|GASTROCNEMIUS MUSCLE|LATERAL|TEMPORAL|SPECT SCAN|Y|Y|Y|CLINICAL STUDY SPONSOR|PATHOLOGIST 2|1|Visit_1|10|7|SCREENING|2020-05-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SUPINE|[?]|pt_br|[?]|1|mL/kg/min|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LATERAL|HIND|FREEZING POINT DEPRESSION||||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|1|Visit_1|10|1|SCREENING|2020-05-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|3|OXYPULSE|Oxygen Pulse|[?]|PRONE|||[?]|1|GBq/mg|PERIPHERAL NERVE|UNILATERAL|OCCIPITAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y||Y|INVESTIGATOR|ADJUDICATOR 1|2|Visit_2|25|5|WASHOUT|2020-05-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|4|AWVOL|Airway Volume|[?]|SLING|[?]|L/min|[?]|1|U/m2/h|ABDOMINAL REGION|RIGHT|VOLAR|POLYGRAPHY|Y|||PARENT|RADIOLOGIST 2|2|Visit_2|25|7|SCREENING|2020-05-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SLING|[?]|nmol BCE/mmol|[?]|1|genEq/mL|OBTURATOR INTERNUS MUSCLE|CONTRALATERAL|HIND|AGAR DILUTION|Y|||SIBLING|PATHOLOGIST 2|3|Visit_3|40|4|FOLLOW-UP|2020-06-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|6|RRS|Total Respiratory System Resistance|[?]|PRONE|[?]|mL/dL|[?]|1|uEq/L|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|UNILATERAL|DISTAL|CT SCAN WITHOUT CONTRAST||||ADJUDICATOR|READER|3|Visit_3|40|1|WASHOUT|2020-06-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|7|IC|Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mol/mol|STERNEBRA|LEFT|SUPERIOR|ACID FAST STAIN|||Y|GUARDIAN|INTERNIST|4|Visit_4|65|7|WASHOUT|2020-07-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|PFU/dose|[?]|1|U/mmol|LIVER, CAUDATE LOBE|IPSILATERAL|SUBCORTICAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||STUDY SUBJECT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|2|FOLLOW-UP|2020-07-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|9|TLC|Total Lung Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|/2000 RBC|COLON WALL|CONTRALATERAL|LATERAL|MEDIASTINOSCOPY|||Y|STUDY SUBJECT|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2020-07-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|84f74359-c79b-4f1c-8119-a4993b071973|10|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|[?]|nsec|[?]|1|copies/ug|ESOPHAGUS, CERVICAL|BILATERAL|CENTRAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||ADJUDICATOR|CLINICAL PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-07-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|FIO2|Fraction of Inspired Oxygen|[?]|SLING|[?]|kcal|[?]|1|10^11/L|AORTIC VALVE, RIGHT CORONARY CUSP|LATERAL|INFERIOR|CELL OF ORIGIN ASSAY||||ADJUDICATOR|MICROSCOPIST|1|Visit_1|10|4|TREATMENT|2020-11-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|2|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|UNCONSTRAINED|[?]|log10 CFU/g|[?]|1|m2|GASTRIC CARDIA|BILATERAL|LOWER EXTENSOR SURFACE|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|1|Visit_1|10|4|SCREENING|2020-11-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|3|SALKK|Salazar-Knowles Equation, K|[?]|UNCONSTRAINED|[?]|v/v|[?]|1|nmol/L/h|RIB 7|BILATERAL|LOWER EXTENSOR SURFACE|BIOIMPEDANCE SPECTROSCOPY||Y||GUARDIAN|MICROSCOPIST|2|Visit_2|25|2|WASHOUT|2020-11-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|4|FIF50|Forced Inspiratory Flow at 50%|[?]|SLING|[?]|10^9 organisms/mg|[?]|1|DAgU/mL|POSTERIOR POLE OF THE EYE|UNILATERAL|SURFACE|ULTRASONOGRAPHIC ELASTOGRAPHY||||CAREGIVER|READER 1|2|Visit_2|25|3|TREATMENT|2020-11-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|5|MIP|Maximal Inspiratory Pressure|[?]|UNCONSTRAINED|[?]|10^9 CFU|[?]|1|cpm|ILIUM|LEFT|DEEP|WESTERN BLOT||Y||STUDY SUBJECT|ADJUDICATOR 2|3|Visit_3|40|2|FOLLOW-UP|2020-12-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|6|FIV1PP|Percent Predicted FIV1|[?]|SITTING, LEGS DEPENDENT|||[?]|1|U/m2|FLEXOR DIGITORUM PROFUNDUS MUSCLE|CONTRALATERAL|VENTRAL|TRICHROME STAIN|Y||Y|SPOUSE|MICROSCOPIST 1|3|Visit_3|40|5|TREATMENT|2020-12-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|10^9 organisms/mg|[?]|1|anti-Xa IU|POSTERIOR INFERIOR CEREBELLAR ARTERY|RIGHT|MEDIAL|NO INFORMATION|Y|Y||SIGNIFICANT OTHER|RADIOLOGIST 2|4|Visit_4|65|3|WASHOUT|2020-12-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|8|MALIND|Malignancy Indicator|[?]|STANDING|[?]|grain|[?]|1|g/animal/wk|CAPITATE-LUNATE JOINT|UNILATERAL|ANTERIOR|LAPAROSCOPY||||PARENT|READER 1|4|Visit_4|65|1|TREATMENT|2020-12-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|9|IC|Inspiratory Capacity|[?]|SEMI-FOWLERS|[?]|gpELISA unit/mL|[?]|1|IU/mL|THORACIC AORTA|RIGHT|SURFACE|SURFACE PLASMON RESONANCE||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|1|TREATMENT|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|10|EFFVOL|Effusion Volume|[?]|SUPINE|||[?]|1|Ci|FALCIFORM LIGAMENT|UNILATERAL|SUBCORTICAL|CALCOFLUOR WHITE STAIN|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|5|Visit_5|90|2|WASHOUT|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|[?]|/month|[?]|1|mL/mmHg/min/L|URETHRA, ANTERIOR|IPSILATERAL|UPPER FLEXOR SURFACE|ELISA|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|VIRTUAL PIXEL|[?]|1|10^6 DNA copies/mL|RADIUS SHAFT|RIGHT|BASAL|CHROMOGENIC ASSAY|Y|||DOMESTIC PARTNER|MICROSCOPIST 2|1|Visit_1|10|4|TREATMENT|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|3|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|PNU/mL|[?]|1|uV|KIDNEY|LATERAL|ANTEROTEMPORAL|BRDU CELLULAR PROLIFERATION ASSAY||||INVESTIGATOR|DERMATOLOGIST|2|Visit_2|25|1|TREATMENT|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|4|FIF75|Forced Inspiratory Flow at 75%|[?]|DECUBITUS|||[?]|1|GPL U/mL|TYMPANIC MEMBRANE|BILATERAL|OUTER|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y||Y|GUARDIAN|FORENSIC PATHOLOGIST|2|Visit_2|25|3|SCREENING|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|5|MIP|Maximal Inspiratory Pressure|[?]|STANDING|[?]|Absorbance U/min|[?]|1|Frames/s|INSULAR CORTEX|CONTRALATERAL|CRANIAL|CT SCAN||||SIBLING|MICROSCOPIST 2|3|Visit_3|40|7|WASHOUT|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|6|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|mg/animal|UPPER URINARY SYSTEM|LEFT|UPPER EXTENSOR SURFACE|TRICHROME STAIN|||Y|DOMESTIC PARTNER|ADJUDICATOR 2|3|Visit_3|40|2|FOLLOW-UP|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|7|TGV|Thoracic Gas Volume|[?]|SEMI-FOWLERS|[?]|AFU|[?]|1|mg/kg/week|ANASTOMOSIS|RIGHT|SUPERFICIAL|PERCUSSION||Y||DOMESTIC PARTNER|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|RFU|[?]|1|mmol/s|PALM|UNILATERAL|SURFACE|MANUAL CLOT DETECTION||||CAREGIVER|FORENSIC PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|SUPINE|[?]|h*%|[?]|1|/10^3|THORACIC AORTA|RIGHT|DORSOLATERAL|AURAMINE STAIN||Y||INTERVIEWER|PHYSIOTHERAPIST|5|Visit_5|90|6|FOLLOW-UP|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|cd0c969e-61c6-4c65-ac19-4ee247f5009a|10|AWVOLPP|Percent Predicted Airway Volume|[?]|STANDING|||[?]|1|g/animal/day|POPLITEAL ARTERY BELOW KNEE|IPSILATERAL|INNER|HANSEL STAIN|||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|5|Visit_5|90|2|TREATMENT|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|FEV1|Forced Expiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|||[?]|1|PUFF|KNEE JOINT|LATERAL|ANTEROPOSTERIOR|SINGLE-SLICE SPIRAL CT|||Y|PROXY|ADJUDICATOR 1|1|Visit_1|10|5|TREATMENT|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|2|FEV3PP|Percent Predicted FEV3|[?]|SITTING, LEGS DEPENDENT|[?]|10^9/dose|[?]|1|nmol BCE/nmol|PULMONARY VALVE, RIGHT CUSP|CONTRALATERAL|UPPER FLEXOR SURFACE|OPTICAL MAPPING|Y|||PARENT|NEUROLOGIST 2|1|Visit_1|10|5|TREATMENT|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|3|ELSTNCE|Elastance|[?]|FOWLERS|[?]|Newton|[?]|1|hr/day|SUBCARINAL LYMPH NODE|LATERAL|DORSOLATERAL|FUNDUS PHOTOGRAPHY||||INTERVIEWER|CLINICAL PATHOLOGIST|2|Visit_2|25|2|SCREENING|2021-02-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SUPINE|||[?]|1|vg/kg|TRAPEZIUM-TRAPEZOID JOINT|RIGHT|PERIPHERAL|CALCULATION|||Y|NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-28
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|5|DLCOHC|HGB Corrected DLCO|[?]|STANDING|||[?]|1|EIA unit|PECTORALIS MINOR MUSCLE|LATERAL|OUTER|ELECTROGASTROGRAPHY|||Y|ADJUDICATOR|RADIOLOGIST|3|Visit_3|40|2|TREATMENT|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|kg/mol|[?]|1|MPL U|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|OCCIPITAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||||INDEPENDENT ASSESSOR|PATHOLOGIST 2|3|Visit_3|40|1|TREATMENT|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|7|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|uU/dL|[?]|1|s/h|RADIUS SHAFT|BILATERAL|DEEP|PHASE-CONTRAST MRI||Y||PROXY|RADIOLOGIST 1|4|Visit_4|65|2|TREATMENT|2021-03-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|8|AWVOLPP|Percent Predicted Airway Volume|[?]|SEMI-FOWLERS|[?]|U/kg/day|[?]|1|mkat|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|UNILATERAL|FORE|ALCIAN BLUE STAIN||||HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2021-03-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|9|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING|||[?]|1|Enzyme U/g Hb|KIDNEY, LOWER LOBE|LEFT|DISTAL|KINETIC CHROMOGENIC ASSAY|Y||Y|ADJUDICATOR|ENDOCRINOLOGIST|5|Visit_5|90|6|WASHOUT|2021-04-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|RE|1fff484d-0a68-42cd-8eff-bc4fe4da945c|10|MEPPP|Percent Predicted MEP|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/h|[?]|1|10^10/L|ORAL MUCOSA|CONTRALATERAL|PROXIMAL|WHOLE TRANSCRIPTOME SEQUENCING||||FRIEND|CLINICAL PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|[?]|mmol/min/kPa|[?]|1|ug|TOENAIL|RIGHT|PERIVENTRICULAR|CT SCAN||Y||FAMILY MEMBER|NEUROLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|2|INFLTIND|Infiltrates Indicator|[?]|LATERAL DECUBITUS|||[?]|1|genEq/mL|BRAIN STEM|UNILATERAL|SUPERFICIAL|IODINE STAIN||Y|Y|VENDOR|PATHOLOGIST 1|1|Visit_1|10|2|SCREENING|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|3|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|POINT|[?]|1|VOXEL|CARPAL BONE|RIGHT|LATERAL|CLIP|Y|||CAREGIVER|PHYSIOTHERAPIST|2|Visit_2|25|7|TREATMENT|2020-12-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|4|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SLING|[?]|nkat/g Hb|[?]|1|Tesla|DISTAL RADIOULNAR JOINT|LEFT|PARIETO-OCCIPITAL|GC/FID||Y||SPOUSE|HEMATOLOGIST|2|Visit_2|25|3|WASHOUT|2020-12-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-FOWLERS|[?]|dpm/0.5 mL|[?]|1|WEEKS|SUBCUTIS|UNILATERAL|VENTROLATERAL|CONTRAST ENHANCED PET/CT SCAN||Y||STUDY SUBJECT|ENDOCRINOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2021-01-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|6|FEV3PP|Percent Predicted FEV3|[?]|PRONE|[?]|mL/cage/day|[?]|1|mg/animal|SPLEEN, HILUM|IPSILATERAL|OCCIPITAL|ELLA||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|3|Visit_3|40|1|TREATMENT|2021-01-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING|[?]|Pa|[?]|1|mmol/mol|NIPPLE|BILATERAL|OUTER|ELECTROCHEMILUMINESCENCE|Y|||SIGNIFICANT OTHER|CARDIOLOGIST|4|Visit_4|65|2|TREATMENT|2021-01-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|8|FIO2|Fraction of Inspired Oxygen|[?]|FOWLERS|[?]|WAFER|[?]|1|APPLICATION|HEEL OF THE FOOT|RIGHT|UPPER FLEXOR SURFACE|ROMANOWSKY STAIN||||CHILD|PHYSIOTHERAPIST|4|Visit_4|65|5|FOLLOW-UP|2021-01-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|FOWLERS|[?]|mg/kg/day|[?]|1|kBq/uL|LIMB, LOWER|RIGHT|FORE|IHC||||FAMILY MEMBER|CARDIOLOGIST|5|Visit_5|90|3|TREATMENT|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|e2c20e9a-0ac5-4907-96de-472bee70bd79|10|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|RFU|[?]|1|nmol/mL/min|LUNG|CONTRALATERAL|CENTRAL|SPECT/CT SCAN||Y||SPOUSE|NEUROLOGIST 2|5|Visit_5|90|5|TREATMENT|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|FIO2|Fraction of Inspired Oxygen|[?]|DECUBITUS|||[?]|1|Sv|HYOID BONE|LEFT|OUTER|DOPPLER ULTRASOUND|||Y|HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|1|Visit_1|10|6|WASHOUT|2020-06-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|2|MALIND|Malignancy Indicator|[?]|SITTING|[?]|mol/mol|[?]|1|vp/mL|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|LEFT|ANTEROMEDIAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|Y|||CAREGIVER|MICROSCOPIST 3|1|Visit_1|10|3|FOLLOW-UP|2020-06-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|3|TLC|Total Lung Capacity|[?]|LATERAL DECUBITUS|[?]|uCi/kg|[?]|1|U/kg/h|MEDIASTINUM, ANTERIOR|LATERAL|FORE|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||GUARDIAN|UROLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-06-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|4|MEP|Maximal Expiratory Pressure|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uL/mL|CORNEAL EPITHELIUM|CONTRALATERAL|ROSTRAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||Y|FAMILY MEMBER|MICROSCOPIST 1|2|Visit_2|25|4|SCREENING|2020-06-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|SUPINE|||[?]|1|Bq/g|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|FACIAL|CYSTOMETRY|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR|3|Visit_3|40|7|SCREENING|2020-07-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|Newton|[?]|1|10^10/L|HAND DIGIT 1|BILATERAL|MEDIAL|PERIODIC ACID SCHIFF STAIN||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|3|Visit_3|40|5|FOLLOW-UP|2020-07-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|||[?]|1|10^4/L|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|PROXIMAL VOLAR|ELISA|||Y|CAREGIVER|UROLOGIST|4|Visit_4|65|2|WASHOUT|2020-07-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|8|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING|[?]|g/m2/day|[?]|1|dyn|HEART, SEPTUM|UNILATERAL|CENTRAL|TOTAL BODY RADIOGRAPHY||||STUDY SUBJECT|READER 1|4|Visit_4|65|5|TREATMENT|2020-07-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|9|AWWVOL|Airway Wall Volume|[?]|PRONE|||[?]|1|POUCH|C7 VERTEBRA|BILATERAL|SUPERIOR|RIA|||Y|VENDOR|PATHOLOGIST|5|Visit_5|90|6|WASHOUT|2020-08-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|6064ca8c-b723-4d05-914a-bb547d86fcc5|10|VO2|Oxygen Consumption|[?]|STANDING, BENT FORWARD|[?]|umol/mg/min|[?]|1|PATCH|KIDNEY, HILUM|UNILATERAL|INNER|MRI WITHOUT CONTRAST||||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|5|Visit_5|90|5|TREATMENT|2020-08-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|1|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-FOWLERS|[?]|pmol/L|[?]|1|Bq/uL|TRAPEZIUS MUSCLE|BILATERAL|UPPER EXTENSOR SURFACE|WRIGHT STAIN|Y|||NON-HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|1|Visit_1|10|1|FOLLOW-UP|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|2|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|mL/cm3/min|[?]|1|mL/cage|ULNAR NERVE|LATERAL|ROSTRAL|INCISION-INDUCED BLEEDING METHOD||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|1|Visit_1|10|7|TREATMENT|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|3|SALKK|Salazar-Knowles Equation, K|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/mol|[?]|1|JDF Unit|TRICUSPID VALVE, POSTERIOR CUSP|RIGHT|ANTEROPOSTERIOR|HEMAGGLUTINATION ASSAY||||INVESTIGATOR|MICROSCOPIST 1|2|Visit_2|25|4|TREATMENT|2020-11-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|4|IRVPP|Percent Predicted IRV|[?]|REVERSE TRENDELENBURG|||[?]|1|/2000 RBC|WRIST JOINT EXTENSOR TENDONS|CONTRALATERAL|PERIVENTRICULAR|ENDOSCOPY|||Y|FAMILY MEMBER|PATHOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-11-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|5|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|CCID 50/mL|INTERPHALANGEAL JOINT 3|LATERAL|ANTERIOR|MRI|||Y|CAREGIVER|ONCOLOGIST 2|3|Visit_3|40|7|TREATMENT|2020-12-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|6|QUASCOMP|Quasi-Static Compliance|[?]|PRONE|||[?]|1|uL/kg/day|BLADDER, NECK|LATERAL|LATERAL|CALCULATION|Y|Y|Y|INTERVIEWER|UROLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|7|FRCPP|Percent Predicted FRC|[?]|TRENDELENBURG|[?]|mmol/min/kPa|[?]|1|nmol BCE/mmol|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|PERIPHERAL|SPECTROPHOTOMETRY||||INTERVIEWER|MICROSCOPIST 2|4|Visit_4|65|6|SCREENING|2020-12-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|PRONE|||[?]|1|mL/animal/day|ACROMIOCLAVICULAR JOINT|RIGHT|ANTEROPOSTERIOR|FLAME PHOTOMETRY|||Y|SPOUSE|READER 1|4|Visit_4|65|6|WASHOUT|2020-12-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|9|FIF25|Forced Inspiratory Flow at 25%|[?]|LATERAL DECUBITUS|||[?]|1|mmol/g|FOOT PHALANX|LEFT|ANTEROTEMPORAL|DUCTOGRAPHY|Y||Y|GUARDIAN|OPHTHALMOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|8effbbff-acda-4718-89f1-e30a418f6bae|10|DLCOPP|Percent Predicted DLCO|[?]|SUPINE|[?]|fmol/L/sec|[?]|1|Siemens|MEDIASTINUM, MIDDLE|LATERAL|CRANIAL|SINGLE-MOLECULE ARRAY|Y|||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|5|Visit_5|90|5|SCREENING|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|[?]|Sv|[?]|1|scm|FEMORAL ARTERY|BILATERAL|POSTERIOR|AGAR PROPORTION||||INDEPENDENT ASSESSOR|HEMATOLOGIST|1|Visit_1|10|4|TREATMENT|2020-08-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|2|IRVPP|Percent Predicted IRV|[?]|SLING|[?]|F|[?]|1|g/kg|EPIGASTRIC REGION|UNILATERAL|UPPER FLEXOR SURFACE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||SIBLING|HEMATOLOGIST|1|Visit_1|10|6|SCREENING|2020-08-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|3|TSUHYS|Tissue Hysteresivity|[?]|SEMI-FOWLERS|[?]|log10 CCID 50/dose|[?]|1|pm|OPTIC NERVE|CONTRALATERAL|VENTROLATERAL|DOPPLER ULTRASOUND||Y||CLINICAL RESEARCH ASSOCIATE|READER 2|2|Visit_2|25|4|TREATMENT|2020-09-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|4|EFFIND|Effusion Indicator|[?]|LATERAL DECUBITUS|[?]|nmol/L/min|[?]|1|POUCH|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|IPSILATERAL|PARIETO-OCCIPITAL|LYMPHANGIOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-09-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|5|FIF75|Forced Inspiratory Flow at 75%|[?]|LATERAL DECUBITUS|[?]|IU/mL|[?]|1|/kg|LIVER LOBE|CONTRALATERAL|ROSTRAL|COMPUTERIZED CORNEAL TOPOGRAPHY||||SIGNIFICANT OTHER|READER 3|3|Visit_3|40|7|TREATMENT|2020-09-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|6|DLCOPP|Percent Predicted DLCO|[?]|DECUBITUS|[?]|L/h|[?]|1|nkat|METACARPAL BONE 5|BILATERAL|CAUDAL|PHOTOGRAPHY||||VENDOR|NEUROLOGIST 2|3|Visit_3|40|1|WASHOUT|2020-09-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|7|EFFIND|Effusion Indicator|[?]|UNCONSTRAINED|[?]|Ci/L|[?]|1|DIOPTER|SYMPATHETIC GANGLIA|IPSILATERAL|UPPER EXTENSOR SURFACE|IMMUNODIFFUSION||Y||HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|4|Visit_4|65|2|WASHOUT|2020-10-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|8|TV|Tidal Volume|[?]|DECUBITUS|[?]|MASK|[?]|1|JDF Unit|HARD PALATE|LEFT|UPPER|U-HPLC/MS/MS||Y||SIGNIFICANT OTHER|HEMATOLOGIST|4|Visit_4|65|2|SCREENING|2020-10-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|9|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|10^12/L|[?]|1|/100 HPFs|GLOSSOPHARYNGEAL NERVE|UNILATERAL|ANTERIOR|POPULATION SEQUENCING|Y|||ADJUDICATOR|DERMATOLOGIST|5|Visit_5|90|1|SCREENING|2020-11-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|859b16a5-f6a2-40cc-8e01-18c112b1969e|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|[?]|/month|[?]|1|umol/L/sec|OPHTHALMIC ARTERY|CONTRALATERAL|NASAL|IODINE STAIN||||ADJUDICATION COMMITTEE|RATER 2|5|Visit_5|90|5|TREATMENT|2020-11-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|[?]|Bq/kg|[?]|1|log EID 50/dose|PALATE|IPSILATERAL|SUBCORTICAL|FUNCTIONAL MRI|Y|||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SLING|[?]|mPa|[?]|1|IU/day|INTERPHALANGEAL JOINT 5|LATERAL|DORSAL|CONTRAST ENHANCED CT SCAN||||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|1|Visit_1|10|1|TREATMENT|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|3|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mg/g/min|SECOND DIAGONAL BRANCH ARTERY|LATERAL|LATERAL|IN VITRO GENE EXPRESSION ASSAY|||Y|INDEPENDENT ASSESSOR|READER 2|2|Visit_2|25|7|WASHOUT|2020-08-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|4|ALVVOL|Alveolar Volume|[?]|FOWLERS|||[?]|1|BISCUIT|CEREBRAL ARTERY|RIGHT|CENTRAL|CLOT DETECTION|||Y|SIBLING|NEUROLOGIST 2|2|Visit_2|25|3|WASHOUT|2020-08-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|UNCONSTRAINED|[?]|U/kg/h|[?]|1|10^6 organisms/mg|SUPRACLAVICULAR FOSSA|CONTRALATERAL|ANTEROMEDIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y||INVESTIGATOR|PATHOLOGIST 2|3|Visit_3|40|6|WASHOUT|2020-09-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|6|EXPRELTM|Expiration Relaxation Time|[?]|PRONE|[?]|fmol/L/sec|[?]|1|mmol/day|DISTAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|ANTEROPOSTERIOR|SURFACE PLASMON RESONANCE||||GUARDIAN|ADJUDICATOR 3|3|Visit_3|40|2|TREATMENT|2020-09-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|7|SALKK|Salazar-Knowles Equation, K|[?]|STANDING|[?]|RING|[?]|1|Log10 ELISA unit/dose|VASTUS LATERALIS MUSCLE|LEFT|CENTRAL|ERGOSPIROMETRY||||INDEPENDENT ASSESSOR|MICROSCOPIST 1|4|Visit_4|65|7|TREATMENT|2020-10-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|8|FEV_PEF|FEV at PEF|[?]|SITTING|||[?]|1|grain|JUGULAR VEIN|LATERAL|SUPERIOR|PELLI-ROBSON EYE CHART||Y|Y|CAREGIVER|CLINICAL PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-10-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SUPINE|[?]|cmH2O*s2/mL|[?]|1|EIA unit|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|BILATERAL|VENTRAL|IMMUNORADIOMETRIC ASSAY||Y||PROXY|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2020-11-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|36b457ef-4cf6-4043-a836-49368ebf3f1c|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|FOWLERS|[?]|uCi/kg|[?]|1|/10^3|COMMON FEMORAL ARTERY|UNILATERAL|MIDLINE|WEBER GREEN STAIN||||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|5|Visit_5|90|7|TREATMENT|2020-11-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|PHERESIS UNIT|[?]|1|nmol/mol|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|CONTRALATERAL|ROSTRAL|PET/SPECT SCAN||||CLINICAL STUDY SPONSOR|RATER 1|1|Visit_1|10|4|WASHOUT|2020-07-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|2|AWVOL|Airway Volume|[?]|UNCONSTRAINED|[?]|pmol/day|[?]|1|U/m2/day|MESENTERIC ARTERY|CONTRALATERAL|UPPER FLEXOR SURFACE|DOUBLE IMMUNODIFFUSION||Y||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|1|Visit_1|10|1|TREATMENT|2020-07-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|3|FEV3PP|Percent Predicted FEV3|[?]|SLING|[?]|/10^4|[?]|1|km/h|HEART, LEFT VENTRICULAR WALL|CONTRALATERAL|MIDLINE|DYNAMIC LIGHT SCATTERING||Y||SIGNIFICANT OTHER|UROLOGIST|2|Visit_2|25|3|TREATMENT|2020-07-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|4|FEV1FVC|FEV1/FVC|[?]|DECUBITUS|[?]|mN|[?]|1|U/dL|LUNG|IPSILATERAL|VENTROLATERAL|LC-FL|Y|||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-07-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^9/g|TRICUSPID VALVE, POSTERIOR CUSP|CONTRALATERAL|PROXIMAL VOLAR|POTENTIOMETRY|Y||Y|GUARDIAN|UROLOGIST|3|Visit_3|40|5|SCREENING|2020-07-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|6|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|[?]|m/sec|[?]|1|cpm|SCAPHOID-CAPITATE JOINT|BILATERAL|DISTAL|BETA LACTAMASE||Y||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|7|PEF|Peak Expiratory Flow|[?]|SLING|[?]|mEq/day|[?]|1|mAmp|LUNG, RIGHT|CONTRALATERAL|SUBCORTICAL|POPULATION SEQUENCING||||ADJUDICATION COMMITTEE|DERMATOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|8|INFLTIND|Infiltrates Indicator|[?]|REVERSE TRENDELENBURG|[?]|GBq/g|[?]|1|/LPF|TEMPOROMANDIBULAR JOINT|BILATERAL|DORSOLATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY||||FAMILY MEMBER|RATER 1|4|Visit_4|65|6|FOLLOW-UP|2020-08-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|9|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING, LEGS DEPENDENT|[?]|AFU|[?]|1|atm|CORONARY VEIN|UNILATERAL|FRONTAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|||FRIEND|READER|5|Visit_5|90|7|TREATMENT|2020-09-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|31f33e38-bba6-4c8a-b563-14afaabae5d7|10|IVC|Inspiratory Vital Capacity|[?]|SUPINE|[?]|VIRTUAL PIXEL|[?]|1|mL/sec/1.73m2|SPLEEN, HILUM|UNILATERAL|LOWER EXTENSOR SURFACE|COMPLEMENT FIXATION|Y|||CLINICAL RESEARCH ASSOCIATE|RATER 2|5|Visit_5|90|4|WASHOUT|2020-09-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|days/month|[?]|1|CAPLET|THIGH|RIGHT|SUPERIOR|TRIPLE-PHASE SPIRAL CT SCAN||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-07-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|2|MALIND|Malignancy Indicator|[?]|PRONE|||[?]|1|APL U|THORACIC SPINE|BILATERAL|UPPER|FREEZING POINT DEPRESSION||Y|Y|FRIEND|FORENSIC PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-07-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING|[?]|10^9 organisms/mL|[?]|1|PATCH|PALPEBRAL FISSURE|LATERAL|ROSTRAL|ELECTROCHEMILUMINESCENCE|Y|||CHILD|RADIOLOGIST 2|2|Visit_2|25|4|SCREENING|2020-07-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|4|DLCO|Diffusion Capacity of Lung for CO|[?]|SLING|[?]|mMU/mL|[?]|1|MONTHS|GENITALIA|CONTRALATERAL|ANTEROMEDIAL|MANUAL COUNT|Y|||INTERVIEWER|ONCOLOGIST|2|Visit_2|25|5|SCREENING|2020-07-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|5|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|%/s|[?]|1|scm|EXTENSOR DIGITORUM BREVIS MUSCLE|LATERAL|INTERMEDIATE|IMMUNOASSAY||||SIBLING|HEMATOLOGIST|3|Visit_3|40|4|WASHOUT|2020-08-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|ug/L/h|[?]|1|%/min|HAMSTRING MUSCLE|CONTRALATERAL|OCCIPITAL|INDIRECT IMMUNOFLUORESCENCE||||ADJUDICATION COMMITTEE|ADJUDICATOR 3|3|Visit_3|40|1|WASHOUT|2020-08-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|Ci/L|[?]|1|ugEq/L|HAND DIGIT 3|IPSILATERAL|POSTERIOR|IMMUNOFIXATION ELECTROPHORESIS||||STUDY SUBJECT|MICROSCOPIST 2|4|Visit_4|65|1|TREATMENT|2020-09-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|8|EXPRELTM|Expiration Relaxation Time|[?]|UNCONSTRAINED|[?]|m/sec2|[?]|1|deg|FOREARM|UNILATERAL|PROXIMAL VOLAR|SLIT LAMP||||SIGNIFICANT OTHER|INTERNIST|4|Visit_4|65|6|TREATMENT|2020-09-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|9|QUASCOMP|Quasi-Static Compliance|[?]|SLING|[?]|DRUM|[?]|1|L/h|THORACIC CAVITY|BILATERAL|OCCIPITAL|CYSTOSCOPY||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2020-09-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|6794dffe-333b-425b-8883-26f6e5ba0797|10|SVC|Slow Vital Capacity|[?]|FOWLERS|||[?]|1|lx|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|SUPERFICIAL|AUDIOMETRY|||Y|SIGNIFICANT OTHER|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2020-09-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|PEF|Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|ug/L DDU|[?]|1|mg/mol|PARS COMPACTA|CONTRALATERAL|FORE|WESTERN BLOT|Y|||HEALTH CARE PROFESSIONAL|READER 2|1|Visit_1|10|6|TREATMENT|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|2|FIO2|Fraction of Inspired Oxygen|[?]|FOWLERS|[?]|IMPLANT|[?]|1|ug/kg/h|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|LEFT|ANTERIOR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||INTERVIEWER|MICROSCOPIST|1|Visit_1|10|7|TREATMENT|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|3|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|||[?]|1|mg/kg/h|OBTURATOR MUSCLE|RIGHT|POSTERIOR|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|Y|Y|INTERVIEWER|PATHOLOGIST 2|2|Visit_2|25|3|SCREENING|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|4|MEP|Maximal Expiratory Pressure|[?]|DECUBITUS|[?]|U/g Hb|[?]|1|mL|LUNG, LEFT LOWER LOBE|LATERAL|DORSAL|POLYMERASE CHAIN REACTION||||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|2|Visit_2|25|1|WASHOUT|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|5|TLC|Total Lung Capacity|[?]|SITTING|||[?]|1|10^7 CFU|T11 VERTEBRA|IPSILATERAL|UPPER EXTENSOR SURFACE|PHOROPTER|||Y|ADJUDICATION COMMITTEE|CARDIOLOGIST|3|Visit_3|40|6|WASHOUT|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|6|RAWPP|Percent Predicted Airway Resistance|[?]|DECUBITUS|[?]|APL U|[?]|1|mU|MIDDLE PHALANX 4 OF THE HAND|BILATERAL|ANTEROTEMPORAL|CLIP SEQUENCING||||PARENT|ONCOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|7|ERV|Expiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|[?]|Absorbance U/min|[?]|1|cd*s/m2|LEFT ATRIOVENTRICULAR ARTERY|BILATERAL|PARIETO-OCCIPITAL|TEMPLATE INCISION METHOD||||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|8|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|[?]|C|[?]|1|pL|FLEXOR HALLUCIS BREVIS MUSCLE|UNILATERAL|SURFACE|ETDRS EYE CHART||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|4|Visit_4|65|7|WASHOUT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|9|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|||[?]|1|eq|ACROMIOCLAVICULAR JOINT|CONTRALATERAL|SUPERFICIAL|ENDOSCOPY|Y||Y|CHILD|RADIOLOGIST 1|5|Visit_5|90|4|SCREENING|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|10|AWWVOL|Airway Wall Volume|[?]|SUPINE|||[?]|1|cGy|PERIFACIAL LYMPH NODE|CONTRALATERAL|SURFACE|STRESS ECHOCARDIOGRAPHY|Y||Y|CHILD|READER 1|5|Visit_5|90|5|WASHOUT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|45897452-8f5a-458d-9a43-13237460ba48|1|TGV|Thoracic Gas Volume|[?]|STANDING|[?]|days/wk|[?]|1|TUBE|CORONARY VEIN|RIGHT|ANTERIOR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||CAREGIVER|NEUROLOGIST 2|1|Visit_1|10|1|WASHOUT|2020-11-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|45897452-8f5a-458d-9a43-13237460ba48|2|PLMBLFLW|Pulmonary Blood Flow|[?]|UNCONSTRAINED|[?]|m3|[?]|1|mL*cmH2O|SCAPHOID-LUNATE-CAPITATE JOINT|LEFT|MIDLINE|MICROBIAL CULTURE||||STUDY SUBJECT|PATHOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-11-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|45897452-8f5a-458d-9a43-13237460ba48|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|APL U/mL|[?]|1|mm/h|SKIN FOLD|IPSILATERAL|FACIAL|CAPILLARY ELECTROPHORESIS||||FAMILY MEMBER|OTOLARYNGOLOGIST|2|Visit_2|25|6|SCREENING|2020-11-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|45897452-8f5a-458d-9a43-13237460ba48|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SLING|[?]|uL|[?]|1|MET|LEFT MAIN CORONARY ARTERY BODY|UNILATERAL|PARIETO-OCCIPITAL|RULER MEASUREMENT METHOD||||GUARDIAN|RATER 2|2|Visit_2|25|1|SCREENING|2020-11-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|45897452-8f5a-458d-9a43-13237460ba48|5|MEPPP|Percent Predicted MEP|[?]|SEMI-RECUMBENT|[?]|PHERESIS UNIT|[?]|1|10^7 CFU|CORNEA|LATERAL|TEMPORAL|PATHOLOGICAL EVALUATION|Y|||VENDOR|NEUROLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-12-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|45897452-8f5a-458d-9a43-13237460ba48|6|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|[?]|PHERESIS UNIT|[?]|1|10^4 CFU/mL|NERVE|CONTRALATERAL|DISTAL VOLAR|ELECTROPHORESIS||||HEALTH CARE PROFESSIONAL|RATER 1|3|Visit_3|40|3|TREATMENT|2020-12-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|45897452-8f5a-458d-9a43-13237460ba48|7|MEP|Maximal Expiratory Pressure|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^7/L|CORONARY ARTERY, RIGHT|UNILATERAL|BASAL|DIGITAL PCR ARRAY|Y|Y|Y|ADJUDICATION COMMITTEE|INTERNIST|4|Visit_4|65|1|TREATMENT|2021-01-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|45897452-8f5a-458d-9a43-13237460ba48|8|SVC|Slow Vital Capacity|[?]|SUPINE|||[?]|1|nkat|RENAL PELVIS|UNILATERAL|INTERMEDIATE|PERIPHERAL ANGIOGRAPHY|||Y|CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|4|Visit_4|65|5|SCREENING|2021-01-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|45897452-8f5a-458d-9a43-13237460ba48|9|ERVPP|Percent Predicted ERV|[?]|PRONE|||[?]|1|SUPPOSITORY|FIRST RIGHT POSTEROLATERAL ARTERY|RIGHT|PROXIMAL|RIA||Y|Y|NON-HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|5|Visit_5|90|1|SCREENING|2021-01-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|45897452-8f5a-458d-9a43-13237460ba48|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|EID 50/dose|[?]|1|mEq/kg|INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|SUPERFICIAL|AMSLER GRID|Y|||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|7|SCREENING|2021-01-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|1|INFLTIND|Infiltrates Indicator|[?]|TRENDELENBURG|[?]|DDU|[?]|1|10^6/hpf|FEMORAL NECK|IPSILATERAL|ANTERIOR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|||FAMILY MEMBER|ADJUDICATOR 3|1|Visit_1|10|7|WASHOUT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|2|SALKA|Salazar-Knowles Equation Parameter A|[?]|PRONE|[?]|deg|[?]|1|GBq/mg|MEDULLA OBLONGATA|LATERAL|DISTAL|DNA MICROARRAY||Y||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|3|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|mU|[?]|1|Coulomb|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|LEFT|OCCIPITAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||HEALTH CARE PROFESSIONAL|RATER 2|2|Visit_2|25|6|TREATMENT|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|4|PEF|Peak Expiratory Flow|[?]|LATERAL DECUBITUS|[?]|s*kPa|[?]|1|Tesla|OCCIPITAL LYMPH NODE|UNILATERAL|BASAL|INDIA INK STAIN|Y|Y||DOMESTIC PARTNER|ONCOLOGIST|2|Visit_2|25|4|TREATMENT|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|5|FEV3PP|Percent Predicted FEV3|[?]|FOWLERS|[?]|PACKET|[?]|1|L/day|INTERPHALANGEAL JOINT 1 OF THE FOOT|UNILATERAL|FRONTAL|CAPILLARY ELECTROPHORESIS||Y||FRIEND|RADIOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|[?]|mL/100g/min|[?]|1|BAU/mL|PULMONARY VALVE|RIGHT|OCCIPITAL|IMMUNODIFFUSION||Y||PROXY|RADIOLOGIST 2|3|Visit_3|40|1|FOLLOW-UP|2021-01-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|7|RAW|Airway Resistance|[?]|LATERAL DECUBITUS|[?]|uV*sec|[?]|1|Hz|PENIS, BODY|RIGHT|LOWER FLEXOR SURFACE|PALM METHOD||Y||DOMESTIC PARTNER|ENDOCRINOLOGIST|4|Visit_4|65|4|WASHOUT|2021-02-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|[?]|mMU/mL|[?]|1|ks|SKIN OF THE LOWER LIMB|LEFT|BASAL|SPECULAR MICROSCOPY||||NON-HEALTH CARE PROFESSIONAL|RATER 1|4|Visit_4|65|5|TREATMENT|2021-02-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|9|FEV6PP|Percent Predicted FEV6|[?]|SUPINE|[?]|%|[?]|1|TUBE|MALE REPRODUCTIVE SYSTEM|CONTRALATERAL|TIP|TRIPLE-PHASE MRI SCAN|Y|||INVESTIGATOR|NEUROLOGIST|5|Visit_5|90|1|TREATMENT|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|16eb981f-2118-4658-a83f-93d925c410c9|10|FRC|Functional Residual Capacity|[?]|SEMI-RECUMBENT|[?]|msec|[?]|1|ugEq/L|SCAPHOID-RADIUS JOINT|BILATERAL|CENTRAL|PAP STAIN||||CHILD|PATHOLOGIST 1|5|Visit_5|90|3|FOLLOW-UP|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|pL|[?]|1|BLOCKS|BONE|RIGHT|INFERIOR|POLYMERASE CHAIN REACTION||||FRIEND|READER 3|1|Visit_1|10|5|TREATMENT|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|ft|[?]|1|U/dL|CLAVICLE|RIGHT|LOWER FLEXOR SURFACE|SCINTIGRAPHY||||FRIEND|PATHOLOGIST 1|1|Visit_1|10|5|FOLLOW-UP|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING|[?]|AU/mL|[?]|1|MPS U|FOOT DIGIT 1|RIGHT|PARIETO-OCCIPITAL|CLIP||Y||GUARDIAN|ONCOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2021-01-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|4|FIFMAX|Maximum Forced Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|mL/cm3/min|ARM SKIN|LATERAL|FACIAL|IMMUNOCHROMATOGRAPHY||Y|Y|CAREGIVER|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2021-01-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|5|PEFTIME|Peak Expiratory Flow Time|[?]|SUPINE|||[?]|1|deg2|PROXIMAL PHALANX 3 OF THE HAND|RIGHT|FACIAL|PATHOLOGICAL EVALUATION|||Y|INVESTIGATOR|CARDIOLOGIST|3|Visit_3|40|5|SCREENING|2021-02-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|6|DLCOHC|HGB Corrected DLCO|[?]|SEMI-FOWLERS|||[?]|1|BOLUS|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LATERAL|NASAL|DIGITAL PCR ARRAY|||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 2|3|Visit_3|40|1|TREATMENT|2021-02-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|7|AIRTRAP|Air Trapping|[?]|PRONE|[?]|m/sec|[?]|1|U/mL|OPTIC DISC|LATERAL|CAUDAL|TRIPLE-PHASE SPIRAL CT SCAN||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|4|Visit_4|65|1|WASHOUT|2021-03-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|8|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|PFU/animal|[?]|1|PELLET|CHOROID|LEFT|NASAL|FLOCCULATION, CHARCOAL ENHANCED||Y||SIBLING|OPHTHALMOLOGIST|4|Visit_4|65|2|TREATMENT|2021-03-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|9|RAW|Airway Resistance|[?]|DECUBITUS|||[?]|1|mol/mL|CERVICAL LYMPH NODE|IPSILATERAL|FACIAL|NUCLEIC ACID AMPLIFICATION TEST|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|RATER 1|5|Visit_5|90|5|SCREENING|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|10|FEV_PEF|FEV at PEF|[?]|STANDING|[?]|CONTAINER|[?]|1|min/day|EYE, ANTERIOR CHAMBER|RIGHT|MEDIAL|AUSCULTATION||Y||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|5|Visit_5|90|4|SCREENING|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|UNCONSTRAINED|||[?]|1|Antibody Unit|RADIUS-LUNATE JOINT|RIGHT|VOLAR|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|||Y|STUDY SUBJECT|FORENSIC PATHOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|[?]|%(w/v)|[?]|1|mg/dL|MEDIASTINUM, SUPERIOR|IPSILATERAL|OCCIPITAL|QUANTITATIVE ULTRASOUND||||PROXY|NEUROLOGIST 1|1|Visit_1|10|3|TREATMENT|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|g/kg/day|[?]|1|10^3 RNA copies/mL|DIAPHRAGM|RIGHT|LOWER MEDIAL|POTENTIOMETRY||Y||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|4|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|Ci/g|BRACHIAL LYMPH NODE|RIGHT|SUPERFICIAL|LYMPHANGIOGRAPHY|Y||Y|VENDOR|OTOLARYNGOLOGIST|2|Visit_2|25|2|SCREENING|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|5|FEV1REV|FEV1 Reversibility|[?]|LATERAL DECUBITUS|[?]|/cmH2O|[?]|1|mg/L|EPICONDYLE|LEFT|TIP|VENTILATION PERFUSION LUNG SCAN||||CLINICAL RESEARCH ASSOCIATE|READER 1|3|Visit_3|40|1|TREATMENT|2021-02-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|6|TLC|Total Lung Capacity|[?]|SITTING|[?]|yd|[?]|1|atm|ADDUCTOR LONGUS MUSCLE|RIGHT|FACIAL|MASS SPECTROMETRY||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|3|Visit_3|40|5|WASHOUT|2021-02-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|7|MIPPP|Percent Predicted MIP|[?]|PRONE|[?]|10^4/hpf|[?]|1|mEq/day|PROXIMAL PHALANX 2 OF THE HAND|BILATERAL|PERIVENTRICULAR|SPECT/CT SCAN||||INVESTIGATOR|ONCOLOGIST 2|4|Visit_4|65|7|WASHOUT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|8|DLCOPP|Percent Predicted DLCO|[?]|SEMI-FOWLERS|[?]|10^9 organisms/mL|[?]|1|PUFF|EYE, ANTERIOR SEGMENT|CONTRALATERAL|PROXIMAL VOLAR|IMMUNOTURBIDIMETRY|Y|||INVESTIGATOR|MICROSCOPIST 1|4|Visit_4|65|5|TREATMENT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|PIPE|[?]|1|tuberculin unit|SUPRAGLOTTIS|UNILATERAL|INTERMEDIATE|DROPLET DIGITAL PCR||||CLINICAL STUDY SPONSOR|RATER 2|5|Visit_5|90|2|FOLLOW-UP|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|10|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|U/m2/day|[?]|1|/10^5|PRONATOR TERES MUSCLE|RIGHT|ROSTRAL|MULTIPLE BREATH WASHOUT||Y||CHILD|OPTOMETRIST|5|Visit_5|90|3|TREATMENT|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|1|MIPPP|Percent Predicted MIP|[?]|SEMI-RECUMBENT|[?]|ng/L|[?]|1|10^12 IU/L|LARGE INTESTINE|UNILATERAL|VENTROLATERAL|COMPUTERIZED CORNEAL TOPOGRAPHY||Y||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|STANDING|[?]|psi|[?]|1|pptr|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|IPSILATERAL|BASAL|MULTIPLE BREATH WASHOUT|Y|||GUARDIAN|RADIOLOGIST 1|1|Visit_1|10|2|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|STANDING|[?]|PIXEL|[?]|1|ug/kg/day|GASTRIC CARDIA|LATERAL|DISTAL|TRANSMISSION ELECTRON MICROSCOPY|Y|||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|PRONE|[?]|ng/day|[?]|1|MONTHS|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|CENTRAL|VENTILATION PERFUSION LUNG SCAN||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|5|FEV1FVC6|FEV1/FVC6|[?]|STANDING|[?]|PFU|[?]|1|IU/dL|BLOOD|CONTRALATERAL|BASAL|SNP ARRAY||||VENDOR|ENDOCRINOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|6|RAW|Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|mL/dose|[?]|1|ug/g/min|BRAIN STEM|RIGHT|CENTRAL|FARNSWORTH-MUNSELL 100 HUE TEST||||DOMESTIC PARTNER|ADJUDICATOR 1|3|Visit_3|40|6|WASHOUT|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|7|MEPPP|Percent Predicted MEP|[?]|REVERSE TRENDELENBURG|[?]|APPLICATION|[?]|1|mg/g/min|HEART, APEX|BILATERAL|DISTAL|IMMUNOFLUORESCENT STAIN||||PROXY|CLINICAL PATHOLOGIST|4|Visit_4|65|3|WASHOUT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|8|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|DECUBITUS|[?]|mg2/dL2|[?]|1|mph|LUNG, LEFT LOWER LOBE|BILATERAL|CENTRAL|FLAME PHOTOMETRY||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|9|DLCOVA|DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|IU/day|PROXIMAL CIRCUMFLEX ARTERY|IPSILATERAL|DORSAL|IN SITU HYBRIDIZATION|Y||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|5|Visit_5|90|7|TREATMENT|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|874f491c-5d55-4738-86b7-b1200b16d106|10|PNEUMIND|Pneumonia Indicator|[?]|SITTING|[?]|L/day|[?]|1|m/sec2|OLFACTORY BULB|BILATERAL|VENTRAL|FISH||Y||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|1|DLCOHCVA|HGB Corrected DLCO/VA|[?]|PRONE|[?]|uCi/kg|[?]|1|kg/cm2|RIGHT ATRIAL ENDOCARDIUM|IPSILATERAL|SURFACE|IMMUNORADIOMETRIC ASSAY||||DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-06-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|2|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING|[?]|USP U|[?]|1|nmol|DISTAL CIRCUMFLEX ARTERY|RIGHT|CRANIAL|MACRO BROTH DILUTION|Y|||SIBLING|CARDIOLOGIST|1|Visit_1|10|7|SCREENING|2020-06-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|3|TVPP|Percent Predicted Tidal Volume|[?]|SLING|||[?]|1|mg2/dL2|LIVER, LEFT LOBE|IPSILATERAL|UPPER FLEXOR SURFACE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y|Y|Y|CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|6|TREATMENT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|4|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|||[?]|1|oz|GLUTEAL MUSCLE|UNILATERAL|SUPERFICIAL|PH METER MEASUREMENT METHOD|Y||Y|GUARDIAN|INTERNIST|2|Visit_2|25|7|WASHOUT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|5|FEV3FVC|FEV3/FVC|[?]|PRONE|[?]|nCi|[?]|1|mm/sec|MIDDLE PHALANX 3 OF THE HAND|LEFT|ANTEROTEMPORAL|TONOMETRY||Y||STUDY SUBJECT|PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|6|PNEUMIND|Pneumonia Indicator|[?]|UNCONSTRAINED|||[?]|1|ug/m2/day|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|IPSILATERAL|VENTRAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||Y|SPOUSE|ADJUDICATOR|3|Visit_3|40|1|FOLLOW-UP|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|7|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SITTING|||[?]|1|Log10 ELISA unit|MITRAL VALVE, ANTERIOR ANNULUS|CONTRALATERAL|INTERMEDIATE|TWO-COLOR MICROARRAY|||Y|ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|4|Visit_4|65|6|SCREENING|2020-07-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|8|FEF2575|Forced Expiratory Flow 25-75%|[?]|FOWLERS|||[?]|1|DRUM|TONGUE|IPSILATERAL|NASAL|NEURAMINIDASE INHIBITION ASSAY||Y|Y|INDEPENDENT ASSESSOR|PHYSIOTHERAPIST|4|Visit_4|65|5|TREATMENT|2020-07-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|9|ICREV|IC Reversibility|[?]|FOWLERS|[?]|cy/cm|[?]|1|%(v/v)|THORACIC CAVITY|IPSILATERAL|ANTEROMEDIAL|IMMUNODIFFUSION||||VENDOR|READER 1|5|Visit_5|90|2|SCREENING|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|281ccdef-794c-49ad-9616-6f6f68dd4543|10|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SUPINE|[?]|U/kg/min|[?]|1|pkat/L|CEREBRAL HEMISPHERE, LEFT|LATERAL|PROXIMAL|GC/MS-EI||||FRIEND|RADIOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|1|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|||[?]|1|10^7 CFU/mL|PANCREATIC DUCT|CONTRALATERAL|VOLAR|FREEZING POINT DEPRESSION|||Y|SPOUSE|NEUROLOGIST 1|1|Visit_1|10|5|FOLLOW-UP|2020-08-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|2|IC|Inspiratory Capacity|[?]|LATERAL DECUBITUS|[?]|mL/cm H2O|[?]|1|/cmH2O|LIP, LOWER|LEFT|BASAL|NEURAMINIDASE INHIBITION ASSAY||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-08-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|3|IC|Inspiratory Capacity|[?]|DECUBITUS|[?]|Watt|[?]|1|Ci/g|LIVER, LEFT LOBE|CONTRALATERAL|SURFACE|WESTERN BLOT||||SPOUSE|RADIOLOGIST 1|2|Visit_2|25|2|SCREENING|2020-08-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|4|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|dpm/mL|[?]|1|fmol/L/sec|SKIN OF THE BACK|UNILATERAL|APICAL|DC SHEATH FLOW||||VENDOR|PATHOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-08-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|5|RRS|Total Respiratory System Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|Pack Year|[?]|1|mL/cage/day|NASOPHARYNX|LEFT|ANTEROMEDIAL|FLOCCULATION, CHARCOAL ENHANCED|Y|Y||HEALTH CARE PROFESSIONAL|ONCOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-09-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|6|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|[?]|in|[?]|1|mEq/dL|SUPRAPUBIC REGION|LEFT|NASAL|MUGA||||FAMILY MEMBER|OTOLARYNGOLOGIST|3|Visit_3|40|7|TREATMENT|2020-09-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING|[?]|ppth|[?]|1|BAG|BRACHIAL ARTERY|CONTRALATERAL|PERIPHERAL|TARGETED TRANSCRIPTOME SEQUENCING|Y|||VENDOR|ADJUDICATOR 1|4|Visit_4|65|5|WASHOUT|2020-09-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|8|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|umol/dL|[?]|1|IU/g|BONE|IPSILATERAL|CENTRAL|GC/MS||||CAREGIVER|INTERNIST|4|Visit_4|65|6|TREATMENT|2020-09-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|9|PEF|Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|ug/kg/min|[?]|1|min*mg/mL|OLECRANON|CONTRALATERAL|ANTEROTEMPORAL|CYSTOSCOPY||||INVESTIGATOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|WASHOUT|2020-10-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|b1179e10-e8fe-472c-a511-d6d460571857|10|LCI|Lung Clearance Index|[?]|STANDING, BENT FORWARD|[?]|s/h|[?]|1|PACKET|INCISOR|LATERAL|FACIAL|SLIT LAMP||||VENDOR|MICROSCOPIST 3|5|Visit_5|90|5|FOLLOW-UP|2020-10-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|1|MEPPP|Percent Predicted MEP|[?]|REVERSE TRENDELENBURG|[?]|FEU|[?]|1|uSiemens|HAMSTRING MUSCLE|RIGHT|DORSAL|NUCLEIC ACID BASED METHOD||||INTERVIEWER|ONCOLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-09-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|2|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|10^9 CFU/mL|[?]|1|mCi/kg|RECTOSIGMOID JUNCTION|UNILATERAL|BASAL|WHOLE GENOME SEQUENCING||Y||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|4|TREATMENT|2020-09-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|3|DLCOPP|Percent Predicted DLCO|[?]|TRENDELENBURG|[?]|IU/g Hb|[?]|1|TROCHE|PARANASAL SINUS|UNILATERAL|PROXIMAL VOLAR|PERFUSION MRI||||STUDY SUBJECT|ONCOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-09-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|4|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|[?]|CYLINDER|[?]|1|mU|SPINAL CORD|RIGHT|SURFACE|MICROBIAL CULTURE, SOLID||||CLINICAL STUDY SPONSOR|DERMATOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-09-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|5|EFFIND|Effusion Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|Newton|[?]|1|fmol|METATARSOPHALANGEAL JOINT 3|CONTRALATERAL|UPPER EXTENSOR SURFACE|GC/MS||||CAREGIVER|MICROSCOPIST 3|3|Visit_3|40|5|FOLLOW-UP|2020-10-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|6|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|STRIP|[?]|1|log10 PFU|MOTOR CORTEX|LATERAL|UPPER FLEXOR SURFACE|HPLC/IEX|Y|||INDEPENDENT ASSESSOR|HEMATOLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|7|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|uCi/kg|[?]|1|IMPLANT|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|DISTAL VOLAR|ELECTRICAL IMPEDANCE MYOGRAPHY||Y||SIBLING|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2020-11-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|8|MALEVDES|Malignancy Evidence Description|[?]|SITTING|[?]|10^3 RNA copies/mL|[?]|1|grain|COCCYX|CONTRALATERAL|ANTERIOR|CHROMOGENIC ASSAY||||CAREGIVER|PATHOLOGIST 2|4|Visit_4|65|4|WASHOUT|2020-11-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|9|DLCOPP|Percent Predicted DLCO|[?]|SLING|[?]|ms/mmHg|[?]|1|ng/day|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|CENTRAL|INDIA INK STAIN||||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|6362cf42-f286-4151-bdf7-38fcc5639eed|10|DLCOPP|Percent Predicted DLCO|[?]|SEMI-FOWLERS|[?]|SBE/mL|[?]|1|um2|SPLEEN, HILUM|UNILATERAL|SURFACE|REVERSE TRANSCRIPTASE PCR||Y||CAREGIVER|READER 3|5|Visit_5|90|3|SCREENING|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|PRONE|[?]|hPa|[?]|1|Ci/kg|THORACIC SPINE|UNILATERAL|PROXIMAL|RAJI CELL RIA||||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|1|Visit_1|10|5|WASHOUT|2020-11-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|2|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|g/m2/day|[?]|1|mg/L|URETHRAL SPHINCTER|LATERAL|POSTERIOR|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y|||SPOUSE|PHYSIOTHERAPIST|1|Visit_1|10|2|TREATMENT|2020-11-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|3|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|PRONE|[?]|cg|[?]|1|10^7 CFU/mL|GLOMERULUS|RIGHT|SUPERIOR|WRIGHT-GIEMSA STAIN||||STUDY SUBJECT|PATHOLOGIST 2|2|Visit_2|25|2|SCREENING|2020-12-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING|[?]|Gy/h|[?]|1|mEq/L|TRACHEA|CONTRALATERAL|LOWER|ELLA||||SIGNIFICANT OTHER|ONCOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-12-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|5|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|10^9 CFU/g|[?]|1|GPL U|CARDIAC WALL|UNILATERAL|DISTAL VOLAR|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|||FRIEND|RATER 1|3|Visit_3|40|4|TREATMENT|2020-12-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|6|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|[?]|pmol/L/h|[?]|1|DIP|COMMON ILIAC LYMPH NODE|LEFT|PROXIMAL|EEG||||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|3|Visit_3|40|6|SCREENING|2020-12-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|7|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|Henry|[?]|1|VIRTUAL PIXEL|CORPUS LUTEUM|BILATERAL|PARIETO-OCCIPITAL|MICROSCOPY||||PARENT|READER 3|4|Visit_4|65|3|WASHOUT|2021-01-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|8|FEV3FVC|FEV3/FVC|[?]|TRENDELENBURG|[?]|IMPLANT|[?]|1|mL/kg/h|PROXIMAL URETHRA|UNILATERAL|CRANIAL|IMMUNOTURBIDIMETRY||||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2021-01-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|9|RER|Respiratory Exchange Ratio|[?]|FOWLERS|[?]|/MBP|[?]|1|mL/breath|HEEL OF THE HAND|CONTRALATERAL|ANTERIOR|APPLANATION TONOMETRY|Y|||ADJUDICATION COMMITTEE|READER|5|Visit_5|90|5|TREATMENT|2021-02-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|8e28e3ab-0060-43f7-b033-c16bd77c0e29|10|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|mL/m2|[?]|1|Osm|VERTEBRA|BILATERAL|ANTEROTEMPORAL|IN VITRO GENE EXPRESSION ASSAY||||ADJUDICATION COMMITTEE|NEUROLOGIST|5|Visit_5|90|5|SCREENING|2021-02-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING|[?]|uL/kg/day|[?]|1|eq|VASTUS LATERALIS MUSCLE|BILATERAL|MEDIAL|NON-CONTACT SPECULAR MICROSCOPY||||DOMESTIC PARTNER|PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-06-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|2|RELSZCHG|Relative Size Change|[?]|LATERAL DECUBITUS|[?]|Hounsfield Unit|[?]|1|mL/g/day|INTERNAL ILIAC LYMPH NODE|LEFT|FRONTAL|WRIGHT STAIN||Y||FRIEND|MICROSCOPIST 3|1|Visit_1|10|2|TREATMENT|2020-06-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|3|FIF25|Forced Inspiratory Flow at 25%|[?]|UNCONSTRAINED|[?]|/5x10^4 WBC|[?]|1|SUPPOSITORY|GASTROCNEMIUS MUSCLE|BILATERAL|VENTROLATERAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||Y||SIBLING|OPTOMETRIST|2|Visit_2|25|1|TREATMENT|2020-07-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|4|ICREV|IC Reversibility|[?]|SITTING|[?]|U/g/h|[?]|1|Coulomb|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|CONTRALATERAL|FACIAL|FUNDUS PHOTOGRAPHY||||INTERVIEWER|NEUROLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-07-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|5|INERTANC|Inertance|[?]|SEMI-RECUMBENT|||[?]|1|HEP|RIB 3|LEFT|PARIETO-OCCIPITAL|PYROSEQUENCING||Y|Y|INVESTIGATOR|ONCOLOGIST 1|3|Visit_3|40|3|WASHOUT|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|6|RER|Respiratory Exchange Ratio|[?]|SITTING, LEGS DEPENDENT|[?]|uV2|[?]|1|Roentgen|BRACHIOCEPHALIC ARTERY|BILATERAL|FRONTAL|PERFUSION MRI||||CAREGIVER|ENDOCRINOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|PRONE|[?]|cm2|[?]|1|nL|LEFT POSTEROLATERAL DESCENDING ARTERY|BILATERAL|INFERIOR|ULTRASONOGRAPHIC ELASTOGRAPHY||||DOMESTIC PARTNER|MICROSCOPIST 1|4|Visit_4|65|6|WASHOUT|2020-08-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|8|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|mg/kg/h|[?]|1|10^6 IU/mL|CAPITATE-LUNATE JOINT|IPSILATERAL|NASAL|NEXT GENERATION SEQUENCING||||SIBLING|READER 2|4|Visit_4|65|7|WASHOUT|2020-08-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|9|FIV1PP|Percent Predicted FIV1|[?]|SITTING, LEGS DEPENDENT|[?]|V|[?]|1|umol/min|LIVER, LEFT LOBE|RIGHT|DEEP|SINGLE-SLICE SPIRAL CT||||FRIEND|RATER|5|Visit_5|90|6|TREATMENT|2020-09-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|10|RER|Respiratory Exchange Ratio|[?]|FOWLERS|[?]|cal|[?]|1|mg/mL/min|DURAL VENOUS SINUS|LATERAL|OCCIPITAL|HIGH RESOLUTION MELT ANALYSIS||Y||ADJUDICATOR|ONCOLOGIST 2|5|Visit_5|90|7|FOLLOW-UP|2020-09-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|DIP|[?]|1|PIXELS/in|HIPPOCAMPUS|BILATERAL|LOWER EXTENSOR SURFACE|BIOIMPEDANCE SPECTROSCOPY||||CLINICAL RESEARCH ASSOCIATE|RATER 2|1|Visit_1|10|5|TREATMENT|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|2|FVC|Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|MBq|[?]|1|BP|LIMB|BILATERAL|SURFACE|ELASTOGRAPHY||||CAREGIVER|HEMATOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|||[?]|1|WAFER|PROFUNDA FEMORIS VEIN|UNILATERAL|SUBCORTICAL|CLOT DETECTION||Y|Y|CHILD|ADJUDICATOR 1|2|Visit_2|25|7|TREATMENT|2020-07-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|4|IVC|Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|mU/L|[?]|1|U/g/min|PRONATOR TERES MUSCLE|RIGHT|PROXIMAL|DUCTOGRAPHY||Y||FRIEND|MICROSCOPIST 1|2|Visit_2|25|2|FOLLOW-UP|2020-07-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|5|ICREV|IC Reversibility|[?]|REVERSE TRENDELENBURG|[?]|10^3 CFU|[?]|1|Shock Wave|PROXIMAL PHALANX 4 OF THE HAND|RIGHT|LOWER FLEXOR SURFACE|PET SCAN||||DOMESTIC PARTNER|RATER 2|3|Visit_3|40|7|TREATMENT|2020-07-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|6|MIP|Maximal Inspiratory Pressure|[?]|REVERSE TRENDELENBURG|||[?]|1|mL/kg|SCAPHOID BONE|IPSILATERAL|VENTROLATERAL|SPIROMETRY|Y||Y|SIBLING|ONCOLOGIST|3|Visit_3|40|3|TREATMENT|2020-07-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|7|SRAW|Specific Airway Resistance|[?]|TRENDELENBURG|[?]|DAYS|[?]|1|nmol/L/min|BRAIN|CONTRALATERAL|POSTERIOR|MIGET||||FRIEND|RATER 1|4|Visit_4|65|4|TREATMENT|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|RIGHT LATERAL DECUBITUS|[?]|U/kg/min|[?]|1|ug/kg|BODY|CONTRALATERAL|TEMPORAL|BALLPOINT PEN TECHNIQUE|Y|Y||PARENT|READER 1|4|Visit_4|65|6|FOLLOW-UP|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|9|TV|Tidal Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|DNA copies/ug|ISCHIUM|UNILATERAL|ANTERIOR|CONTRAST ENHANCED PET SCAN|Y||Y|ADJUDICATOR|MICROSCOPIST 2|5|Visit_5|90|1|WASHOUT|2020-09-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|10|PEF|Peak Expiratory Flow|[?]|SUPINE|||[?]|1|h/wk|POSTERIOR POLE OF THE EYE|UNILATERAL|OUTER|KINYOUN STAIN|||Y|ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-09-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|43880587-c397-402d-886b-9b666e3fe455|1|INFLTIND|Infiltrates Indicator|[?]|STANDING, BENT FORWARD|[?]|h/wk|[?]|1|10^4 CFU/mL|PINEAL GLAND|LEFT|UPPER FLEXOR SURFACE|ICP-MS|Y|||ADJUDICATOR|PATHOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-07-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|43880587-c397-402d-886b-9b666e3fe455|2|EFFVOL|Effusion Volume|[?]|TRENDELENBURG|[?]|pm|[?]|1|L/h/m2|BREAST|CONTRALATERAL|INNER|DIGITAL PCR ARRAY||||ADJUDICATION COMMITTEE|ADJUDICATOR 2|1|Visit_1|10|5|FOLLOW-UP|2020-07-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|43880587-c397-402d-886b-9b666e3fe455|3|INERTANC|Inertance|[?]|FOWLERS|[?]|10^3 CFU|[?]|1|BAU/mL|ADDUCTOR MAGNUS MUSCLE|RIGHT|LOWER MEDIAL|OPTICAL COHERENCE TOMOGRAPHY||||INTERVIEWER|INTERNIST|2|Visit_2|25|3|SCREENING|2020-08-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|43880587-c397-402d-886b-9b666e3fe455|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|Hz|[?]|1|g/U|ENDOMETRIAL CAVITY|IPSILATERAL|PROXIMAL|KNEMOMETRY||||INVESTIGATOR|OPHTHALMOLOGIST|2|Visit_2|25|3|SCREENING|2020-08-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|43880587-c397-402d-886b-9b666e3fe455|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|UNCONSTRAINED|[?]|TCID 50/dose|[?]|1|ft3|POPLITEAL LYMPH NODE|LEFT|LOWER MEDIAL|DNA MICROARRAY||Y||FAMILY MEMBER|ENDOCRINOLOGIST|3|Visit_3|40|5|WASHOUT|2020-08-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|43880587-c397-402d-886b-9b666e3fe455|6|VO2|Oxygen Consumption|[?]|LATERAL DECUBITUS|[?]|GLOBULE|[?]|1|U/m2/h|ESOPHAGUS, ABDOMINAL|LEFT|OUTER|TRIPLE-PHASE MRI SCAN|Y|||GUARDIAN|ADJUDICATOR 1|3|Visit_3|40|7|WASHOUT|2020-08-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|43880587-c397-402d-886b-9b666e3fe455|7|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|mg/g/min|[?]|1|mg/g/h|EXTRAOCULAR MUSCLE|CONTRALATERAL|SUPERFICIAL|CLIP SEQUENCING|Y|||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-09-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|43880587-c397-402d-886b-9b666e3fe455|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SITTING|[?]|Bq/mL|[?]|1|mL/min/mmHg|EXTERNAL ILIAC LYMPH NODE|LEFT|PERIVENTRICULAR|PET/SPECT SCAN||||FRIEND|OPTOMETRIST|4|Visit_4|65|6|TREATMENT|2020-09-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|43880587-c397-402d-886b-9b666e3fe455|9|LCI|Lung Clearance Index|[?]|FOWLERS|||[?]|1|anti-Xa IU|URACHAL TRACT|LATERAL|UPPER FLEXOR SURFACE|GC/MS|||Y|INDEPENDENT ASSESSOR|ADJUDICATOR 2|5|Visit_5|90|4|TREATMENT|2020-10-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|43880587-c397-402d-886b-9b666e3fe455|10|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|[?]|kg|[?]|1|PFU/animal|CEREBRAL HEMISPHERE, LEFT|CONTRALATERAL|UPPER FLEXOR SURFACE|TOTAL BODY IRRADIATION||||HEALTH CARE PROFESSIONAL|ONCOLOGIST|5|Visit_5|90|2|SCREENING|2020-10-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|1|MEPPP|Percent Predicted MEP|[?]|TRENDELENBURG|[?]|mg/kg/min|[?]|1|copies/mL|AZYGOS VEIN|RIGHT|SUBCORTICAL|DXA SCAN||||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|1|Visit_1|10|4|TREATMENT|2020-05-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|UNCONSTRAINED|[?]|sec|[?]|1|bel|PREPUTIAL GLAND|LEFT|ROSTRAL|MAGNETIC RESONANCE ENTEROGRAPHY||||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-05-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|U/dL|[?]|1|mL/m2/day|FOREHEAD|CONTRALATERAL|LOWER FLEXOR SURFACE|DYNAMIC LIGHT SCATTERING||||INTERVIEWER|CARDIOLOGIST|2|Visit_2|25|2|TREATMENT|2020-05-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SLING|[?]|IU/mL|[?]|1|hPa|GREATER CURVATURE OF THE STOMACH|BILATERAL|LOWER FLEXOR SURFACE|TRIPLE-PHASE SPIRAL CT SCAN||||DOMESTIC PARTNER|MICROSCOPIST|2|Visit_2|25|4|WASHOUT|2020-05-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|STANDING, BENT FORWARD|||[?]|1|in|MOTOR CORTEX|IPSILATERAL|SUBCORTICAL|ANGIOGRAPHY|||Y|SIGNIFICANT OTHER|RATER 1|3|Visit_3|40|4|FOLLOW-UP|2020-06-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|||[?]|1|cup eq|CHEST|RIGHT|INNER|DOUBLE IMMUNODIFFUSION||Y|Y|INTERVIEWER|MICROSCOPIST|3|Visit_3|40|4|WASHOUT|2020-06-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|7|SVC|Slow Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|deg/mm|TONGUE|LEFT|UPPER EXTENSOR SURFACE|CONTRAST ENHANCED PET/CT SCAN||Y|Y|ADJUDICATION COMMITTEE|READER 3|4|Visit_4|65|1|SCREENING|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-20
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|8|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|log10 CCID 50/dose|[?]|1|Ci/mg|HYPOTHALAMUS|LATERAL|DORSAL|CENTRIFUGATION||||CLINICAL STUDY SPONSOR|READER 2|4|Visit_4|65|5|WASHOUT|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-20
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|TRENDELENBURG|||[?]|1|mol/g|ADDUCTOR BREVIS MUSCLE|LEFT|LOWER EXTENSOR SURFACE|TOTAL BODY RADIOGRAPHY|||Y|PROXY|DERMATOLOGIST|5|Visit_5|90|6|WASHOUT|2020-08-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|807f83d2-9364-4ee4-855d-304f3e252555|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|[?]|Shock Wave|[?]|1|mm/h|ISCHIORECTAL FOSSA|LATERAL|LOWER EXTENSOR SURFACE|HEMAGGLUTINATION ASSAY||Y||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-08-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|LOBVOL|Lobar Volume|[?]|TRENDELENBURG|[?]|kcal/day|[?]|1|mol/mL|STERNUM|BILATERAL|UPPER FLEXOR SURFACE|DUKE INCISION METHOD|Y|Y||SIGNIFICANT OTHER|RADIOLOGIST|1|Visit_1|10|7|WASHOUT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|2|MALEVDES|Malignancy Evidence Description|[?]|FOWLERS|||[?]|1|mEq/mL|ARM SKIN|IPSILATERAL|ANTEROLATERAL|SLOAN LETTER EYE CHART 100%|||Y|DOMESTIC PARTNER|ADJUDICATOR 1|1|Visit_1|10|3|TREATMENT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|DECUBITUS|[?]|10^3 CFU|[?]|1|GPL U|MESENTERIC VEIN|LEFT|NASAL|MACRO BROTH DILUTION||||ADJUDICATOR|RATER|2|Visit_2|25|4|FOLLOW-UP|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|4|OXYPULSE|Oxygen Pulse|[?]|LATERAL DECUBITUS|[?]|ELISA unit|[?]|1|g/U|MAMMARY GLAND|UNILATERAL|APICAL|NUCLEIC ACID AMPLIFICATION TEST||||SIBLING|ONCOLOGIST 1|2|Visit_2|25|1|FOLLOW-UP|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|||[?]|1|/mm2|HAND|LEFT|TIP|MICROBIAL CULTURE|||Y|ADJUDICATOR|CARDIOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|days/wk|[?]|1|ug/animal|RETINA|UNILATERAL|MIDLINE|CLINICAL EVALUATION|Y|||INTERVIEWER|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|7|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|[?]|fmol/L|[?]|1|/500 WBC|POPLITEAL ARTERY ABOVE KNEE|CONTRALATERAL|ANTEROMEDIAL|ETDRS EYE CHART||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|4|Visit_4|65|4|SCREENING|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|FOWLERS|||[?]|1|BOWL|VERTEBRA|LEFT|NASAL|PET/MRI SCAN|||Y|FRIEND|RADIOLOGIST 2|4|Visit_4|65|1|SCREENING|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|9|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|[?]|psec|[?]|1|vp/dose|CLAVICLE|UNILATERAL|DISTAL VOLAR|SICKLE CELL SOLUBILITY TEST|Y|||SPOUSE|MICROSCOPIST|5|Visit_5|90|1|SCREENING|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|TRENDELENBURG|[?]|log10 TCID 50/uL|[?]|1|g/g/day|OBTURATOR MUSCLE|RIGHT|UPPER FLEXOR SURFACE|MICROBIAL CULTURE, LIQUID|Y|||FRIEND|CARDIOLOGIST|5|Visit_5|90|2|WASHOUT|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|kV|[?]|1|/4.0 mL|BREAST|CONTRALATERAL|ANTERIOR|CLINICAL EVALUATION||||HEALTH CARE PROFESSIONAL|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-08-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|2|FRC|Functional Residual Capacity|[?]|REVERSE TRENDELENBURG|[?]|U/g|[?]|1|CFU/g|BRAIN, PERIVENTRICULAR REGION|LATERAL|SUBCORTICAL|LAPAROSCOPY||Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|1|Visit_1|10|1|SCREENING|2020-08-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|3|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|FFU|[?]|1|10^6 organisms/mL|HAND DIGIT 3|LEFT|UPPER|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|||SIBLING|CARDIOLOGIST|2|Visit_2|25|6|SCREENING|2020-08-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|4|IRV|Inspiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|vg/mL|[?]|1|/sec|BRONCHUS|LATERAL|UPPER FLEXOR SURFACE|IMMUNOPRECIPITATION|Y|||FRIEND|CARDIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-08-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|5|AIRTRAP|Air Trapping|[?]|SITTING|[?]|GPL U|[?]|1|ks|INTERPHALANGEAL JOINT 4|CONTRALATERAL|SURFACE|PET/MRI SCAN||||VENDOR|MICROSCOPIST|3|Visit_3|40|5|TREATMENT|2020-09-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|6|FEF2575P|Percent Predicted FEF25-75|[?]|LEFT LATERAL DECUBITUS|[?]|SPRAY|[?]|1|U/animal|CARPOMETACARPAL JOINT 2|UNILATERAL|ROSTRAL|NUCLEAR RADIOLOGY||Y||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-09-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|7|MALIND|Malignancy Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|pmol/10^9 cells|[?]|1|APS U|ULNA|BILATERAL|OCCIPITAL|ELLA|Y|Y||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|4|Visit_4|65|5|FOLLOW-UP|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|8|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|10^5/hpf|[?]|1|g/animal/day|PARASYMPATHETIC GANGLIA|LEFT|SUPERIOR|TEMPLATE INCISION METHOD||Y||DOMESTIC PARTNER|ADJUDICATOR|4|Visit_4|65|7|FOLLOW-UP|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|9|ALVVOL|Alveolar Volume|[?]|DECUBITUS|[?]|DPM|[?]|1|IU/kg|AXILLARY LYMPH NODE LEVEL II|RIGHT|VENTRAL|NUCLEIC ACID HYBRIDIZATION|Y|||CLINICAL RESEARCH COORDINATOR|RATER 2|5|Visit_5|90|2|FOLLOW-UP|2020-11-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|81c33633-6ade-45fe-a78e-0e853d8aa9c2|10|FEF50|Forced Expiratory Flow 50%|[?]|SITTING|||[?]|1|cs|PRETRACHEAL LYMPH NODE|IPSILATERAL|SUPERFICIAL|CLIP|||Y|NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-11-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|FRCPP|Percent Predicted FRC|[?]|SEMI-RECUMBENT|[?]|ug/kg/h|[?]|1|10^3 DNA copies/mL|L3 VERTEBRA|LATERAL|PERIPHERAL|GRADIENT DIFFUSION||||STUDY SUBJECT|NEUROLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|2|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|DECUBITUS|||[?]|1|mEq/ug|ANTRUM PYLORI|BILATERAL|CAUDAL|IN VITRO GENE EXPRESSION ASSAY|||Y|DOMESTIC PARTNER|INTERNIST|1|Visit_1|10|3|SCREENING|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|3|MEPPP|Percent Predicted MEP|[?]|UNCONSTRAINED|[?]|cpm|[?]|1|KIT|PHARYNGEAL TONSIL|UNILATERAL|ANTERIOR|LC/MS/MS||||SPOUSE|PATHOLOGIST 2|2|Visit_2|25|1|FOLLOW-UP|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|4|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|APPLICATION|[?]|1|mol/mg|AXILLARY LYMPH NODE LEVEL II|LEFT|SUPERIOR|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|2|Visit_2|25|5|FOLLOW-UP|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|5|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|[?]|EVENTS|[?]|1|CARTRIDGE|INTERPHALANGEAL JOINT 1|UNILATERAL|VOLAR|OSCILLOMETRY||||VENDOR|INTERNIST|3|Visit_3|40|7|TREATMENT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|6|SRAW|Specific Airway Resistance|[?]|FOWLERS|[?]|Absorbance U|[?]|1|DNA copies/ug|POSTERIOR TIBIAL VEIN|LEFT|INFERIOR|IN SITU HYBRIDIZATION||||FAMILY MEMBER|ONCOLOGIST|3|Visit_3|40|7|TREATMENT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|ug/L FEU|[?]|1|g/g|OPPONENS POLLICIS MUSCLE|CONTRALATERAL|SURFACE|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||Y||DOMESTIC PARTNER|INTERNIST|4|Visit_4|65|6|FOLLOW-UP|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|8|FEV6PP|Percent Predicted FEV6|[?]|LATERAL DECUBITUS|||[?]|1|mL/breath|DURAL VENOUS SINUS|RIGHT|MIDLINE|PET/CT SCAN|||Y|ADJUDICATION COMMITTEE|READER|4|Visit_4|65|2|SCREENING|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|9|INFLTIND|Infiltrates Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|MPL U/mL|[?]|1|10^9 CFU/mL|COMMON ILIAC ARTERY|LEFT|LOWER FLEXOR SURFACE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y||INVESTIGATOR|MICROSCOPIST 1|5|Visit_5|90|5|FOLLOW-UP|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|10|FVC|Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mmol/kg|[?]|1|ELISA unit|LIP, UPPER|BILATERAL|INNER|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||STUDY SUBJECT|NEUROLOGIST 2|5|Visit_5|90|4|WASHOUT|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|FEV3PP|Percent Predicted FEV3|[?]|STANDING|[?]|oz eq|[?]|1|Absorbance U|LARGE INTESTINE|BILATERAL|ROSTRAL|EEG||||INTERVIEWER|READER 3|1|Visit_1|10|2|TREATMENT|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|PRONE|[?]|g/cage/wk|[?]|1|ELISA unit/dose|TEMPORAL BONE|UNILATERAL|ANTEROLATERAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|||CAREGIVER|FORENSIC PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|3|FEV1|Forced Expiratory Volume in 1 Second|[?]|SEMI-FOWLERS|[?]|mPa|[?]|1|cmol/L|PERIURETERAL REGION|LATERAL|UPPER EXTENSOR SURFACE|AUDIOMETRY||||SPOUSE|READER 1|2|Visit_2|25|4|SCREENING|2020-09-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|4|DLCOVA|DLCO/VA|[?]|PRONE|[?]|kcal/day|[?]|1|10^9 CFU|PERINEUM|CONTRALATERAL|ANTEROTEMPORAL|HEMAGGLUTINATION ASSAY||||NON-HEALTH CARE PROFESSIONAL|INTERNIST|2|Visit_2|25|6|TREATMENT|2020-09-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|DECUBITUS|[?]|IU/kg/h|[?]|1|pptr|METATARSAL BONE|UNILATERAL|ANTEROMEDIAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||CLINICAL STUDY SPONSOR|RATER|3|Visit_3|40|3|WASHOUT|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|6|FEV1FVC|FEV1/FVC|[?]|LATERAL DECUBITUS|[?]|s^-1(%O2)^-1|[?]|1|APS U|HEART, LEFT ATRIUM|UNILATERAL|VENTRAL|COLORIMETRY||||FRIEND|INTERNIST|3|Visit_3|40|4|TREATMENT|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING|[?]|pmol/dL|[?]|1|aMFI|FEMALE GENITALIA|LATERAL|INTERMEDIATE|ISHIHARA COLOR PLATES|Y|Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|SCREENING|2020-10-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|8|RELSZCHG|Relative Size Change|[?]|DECUBITUS|[?]|MAC50|[?]|1|Hz|DISTAL INTERPHALANGEAL JOINT 4|IPSILATERAL|FACIAL|ELECTRONEUROGRAPHY|Y|||CHILD|RATER 2|4|Visit_4|65|6|FOLLOW-UP|2020-10-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|9|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|g/m2/day|[?]|1|mL/s/m2|MEDULLA OBLONGATA|RIGHT|ANTEROTEMPORAL|REVERSE TRANSCRIPTASE PCR||Y||STUDY SUBJECT|NEUROLOGIST 2|5|Visit_5|90|1|TREATMENT|2020-11-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|10|FIF25|Forced Inspiratory Flow at 25%|[?]|SEMI-FOWLERS|[?]|PHERESIS UNIT|[?]|1|ug|FOOT DIGIT 3|UNILATERAL|PROXIMAL VOLAR|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||FRIEND|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|WASHOUT|2020-11-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|LCI|Lung Clearance Index|[?]|SITTING|[?]|mN|[?]|1|10^6/hpf|CORONARY ARTERY|LEFT|ROSTRAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||FRIEND|UROLOGIST|1|Visit_1|10|1|FOLLOW-UP|2021-01-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|2|FIV1PP|Percent Predicted FIV1|[?]|STANDING|[?]|um/s|[?]|1|U/m2/day|RIB 5|RIGHT|PROXIMAL|DUKE INCISION METHOD|Y|||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|3|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|[?]|ug/m2/day|[?]|1|Bq/ug|PARAPHARYNGEAL LYMPH NODE|LEFT|FACIAL|ELLA||||INVESTIGATOR|CLINICAL PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|4|FEV1FVC|FEV1/FVC|[?]|SLING|||[?]|1|ELISA unit|BRACHIAL PLEXUS|CONTRALATERAL|OCCIPITAL|KARYOTYPING|||Y|CHILD|PATHOLOGIST 1|2|Visit_2|25|1|TREATMENT|2021-02-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|5|AWVOL|Airway Volume|[?]|UNCONSTRAINED|[?]|log10 copies/mL|[?]|1|10^3 organisms|FINGER FLEXOR MUSCLES|LEFT|VENTRAL|BIOPSY||Y||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|3|Visit_3|40|4|FOLLOW-UP|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|SLING|[?]|% INHIBITION|[?]|1|ng/dL|POSTERIOR CERVICAL LYMPH NODE|IPSILATERAL|SUBCORTICAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y||ADJUDICATOR|CARDIOLOGIST|3|Visit_3|40|6|TREATMENT|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|mmol|[?]|1|10^9 CFU|PISIFORM BONE|UNILATERAL|UPPER EXTENSOR SURFACE|HPLC||||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|6|WASHOUT|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|8|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SLING|[?]|FEU|[?]|1|MESF|VASTUS INTERMEDIUS MUSCLE|RIGHT|CENTRAL|LC/MS||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|7|SCREENING|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|9|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|[?]|kBq/uL|[?]|1|kPa/L/sec|NASAL CAVITY|UNILATERAL|DORSAL|DUKE INCISION METHOD||||INDEPENDENT ASSESSOR|UROLOGIST|5|Visit_5|90|2|TREATMENT|2021-04-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|RE|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|LATERAL DECUBITUS|[?]|10^9/dose|[?]|1|10^12/L|PANCREAS, HEAD|CONTRALATERAL|MEDIAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||PARENT|RATER 1|5|Visit_5|90|6|TREATMENT|2021-04-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|1|MIPPP|Percent Predicted MIP|[?]|REVERSE TRENDELENBURG|[?]|10^3 RNA copies/mL|[?]|1|uV2|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|LATERAL|DORSAL|LIGHT SCATTERING SPECTROSCOPY||||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|2|TVPP|Percent Predicted Tidal Volume|[?]|REVERSE TRENDELENBURG|[?]|MBP|[?]|1|10^6 copies/mL|BASILIC VEIN|RIGHT|FACIAL|AUTOMATED COUNT|Y|||CHILD|FORENSIC PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|3|SALKA|Salazar-Knowles Equation Parameter A|[?]|REVERSE TRENDELENBURG|[?]|mg/mL/day|[?]|1|fmol|GENITALIA|CONTRALATERAL|PERIPHERAL|DIFFUSION TENSOR MRI||Y||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-06-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING|[?]|mCi/kg|[?]|1|dpm/mg|EYE BULGE|RIGHT|DEEP|SPECT/CT SCAN||||PROXY|CARDIOLOGIST|2|Visit_2|25|5|SCREENING|2020-06-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|5|EVC|Expiratory Vital Capacity|[?]|SITTING|||[?]|1|MET*min|BILE DUCT|LATERAL|SUPERFICIAL|INTRAVASCULAR ULTRASOUND|||Y|CHILD|FORENSIC PATHOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-06-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|nsec|[?]|1|mg/day|STERNOCLAVICULAR JOINT|UNILATERAL|VENTROLATERAL|QUANTITATIVE COMPUTED TOMOGRAPHY||Y||SIGNIFICANT OTHER|MICROSCOPIST 2|3|Visit_3|40|4|TREATMENT|2020-06-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|/500 WBC|ACROMION|BILATERAL|LOWER|PHASE-CONTRAST MRI|Y||Y|ADJUDICATOR|RADIOLOGIST 1|4|Visit_4|65|4|FOLLOW-UP|2020-07-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|8|ELSTNCE|Elastance|[?]|STANDING|[?]|Rad|[?]|1|10^12 IU/L|INTERPHALANGEAL OF THE FOOT|BILATERAL|ANTEROLATERAL|ELECTROPHORESIS||||DOMESTIC PARTNER|RADIOLOGIST 2|4|Visit_4|65|6|TREATMENT|2020-07-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|9|PEFREV|PEF Reversibility|[?]|SITTING|[?]|ug/cm2|[?]|1|anti-Xa IU|PANCREAS|LATERAL|SURFACE|CLIP||Y||CLINICAL STUDY SPONSOR|CARDIOLOGIST|5|Visit_5|90|7|TREATMENT|2020-08-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|21740641-69bb-49a9-a86d-2444914f6d12|10|FEF2575|Forced Expiratory Flow 25-75%|[?]|DECUBITUS|[?]|mg/mL/min|[?]|1|TABLET|SCAPULA|CONTRALATERAL|VENTROLATERAL|TRIPLE-PHASE SPIRAL CT SCAN||Y||PARENT|RADIOLOGIST|5|Visit_5|90|6|WASHOUT|2020-08-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|PRONE|[?]|Ci/g|[?]|1|mol/mg|MEDIASTINUM|UNILATERAL|VENTROLATERAL|FLAME PHOTOMETRY|Y|Y||SIGNIFICANT OTHER|INTERNIST|1|Visit_1|10|7|WASHOUT|2020-06-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|2|LCI|Lung Clearance Index|[?]|DECUBITUS|[?]|TAMPON|[?]|1|IU/g Hb|METATARSAL BONE|IPSILATERAL|LOWER FLEXOR SURFACE|FLUORESCENT SPOT TEST||||INDEPENDENT ASSESSOR|RADIOLOGIST 1|1|Visit_1|10|4|WASHOUT|2020-06-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|SLING|[?]|m/sec2|[?]|1|LENS|GENITAL TUBERCLE|BILATERAL|CENTRAL|CELLULOSE TAPE||||INTERVIEWER|HEMATOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-07-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|4|IC|Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|Watt|[?]|1|AFU|PULMONARY VALVE|LEFT|MIDLINE|IMMUNOCHROMATOGRAPHY||||SIGNIFICANT OTHER|HEMATOLOGIST|2|Visit_2|25|3|SCREENING|2020-07-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|5|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|FOWLERS|[?]|ug/L FEU|[?]|1|Ci/L|FALCIFORM LIGAMENT|UNILATERAL|TEMPORAL|HIGH RESOLUTION CT||||DOMESTIC PARTNER|RATER 1|3|Visit_3|40|7|TREATMENT|2020-07-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|6|LCI|Lung Clearance Index|[?]|LATERAL DECUBITUS|[?]|eq|[?]|1|mg2/dL2|PULMONARY VALVE, RIGHT CUSP|RIGHT|INNER|SNP ARRAY||Y||FAMILY MEMBER|ADJUDICATOR 2|3|Visit_3|40|1|SCREENING|2020-07-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|cal|HEPATIC LYMPH NODE|UNILATERAL|FORE|CONTRAST ENHANCED PET/CT SCAN|||Y|ADJUDICATION COMMITTEE|PATHOLOGIST 1|4|Visit_4|65|4|SCREENING|2020-08-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|8|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LATERAL DECUBITUS|||[?]|1|CONTAINER|SKULL, BASE|CONTRALATERAL|APICAL|ORCHIDOMETERY|Y||Y|INTERVIEWER|ONCOLOGIST|4|Visit_4|65|6|TREATMENT|2020-08-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|9|PEF|Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|PIXELS/in|[?]|1|CCID 50/mL|L4 VERTEBRA|IPSILATERAL|HIND|REVERSE TRANSCRIPTASE PCR||||STUDY SUBJECT|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2020-09-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|c3984f41-30a0-49a4-a8bd-f36fad4621a8|10|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|||[?]|1|ng/L|FLEXOR DIGITORUM BREVIS MUSCLE|CONTRALATERAL|UPPER EXTENSOR SURFACE|CONTRAST ENHANCED MRI|Y||Y|FAMILY MEMBER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|[?]|MPL U/mL|[?]|1|s*kPa|GLOTTIS|BILATERAL|FACIAL|SNELLEN EYE CHART||||PARENT|CARDIOLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|2|RRS|Total Respiratory System Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Ci/mL|FEMUR|LATERAL|MIDLINE|IN VITRO GENE EXPRESSION ASSAY|||Y|ADJUDICATOR|NEUROLOGIST 2|1|Visit_1|10|5|TREATMENT|2021-01-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|3|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|keV|[?]|1|scm|HIP|RIGHT|INNER|DIRECT SEQUENCING||||FAMILY MEMBER|UROLOGIST|2|Visit_2|25|3|WASHOUT|2021-02-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|4|INTP|Interpretation|[?]|SUPINE|[?]|COAT|[?]|1|days/wk|THYROID GLAND, RIGHT LOBE|IPSILATERAL|ANTEROMEDIAL|CRYOSCOPY|Y|||NON-HEALTH CARE PROFESSIONAL|READER|2|Visit_2|25|1|FOLLOW-UP|2021-02-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|5|ALVVOL|Alveolar Volume|[?]|TRENDELENBURG|[?]|uV*sec|[?]|1|in2|FOOT|CONTRALATERAL|ANTEROTEMPORAL|ULTRASOUND||||SPOUSE|RATER 1|3|Visit_3|40|1|WASHOUT|2021-02-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|6|RAW|Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|U/m2/day|[?]|1|APPLICATION|FEMORAL ARTERY|LATERAL|INFERIOR|CLINICAL EVALUATION||||SIBLING|DERMATOLOGIST|3|Visit_3|40|5|TREATMENT|2021-02-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|7|ELSTNCE|Elastance|[?]|STANDING|[?]|10^9/dose|[?]|1|Enzyme U|LOCUS CERULEUS|RIGHT|ROSTRAL|PAP STAIN||||CHILD|READER 3|4|Visit_4|65|5|SCREENING|2021-03-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|uIU/L|[?]|1|ugEq/L|TARSAL JOINT|LEFT|LOWER|CELLULOSE TAPE|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2021-03-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|DECUBITUS|[?]|mL/sec/1.73m2|[?]|1|MONTHS|CARPOMETACARPAL JOINT|RIGHT|UPPER|APPLANATION TONOMETRY||||FAMILY MEMBER|HEMATOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|10|FEV1PP|Percent Predicted FEV1|[?]|PRONE|[?]|MET*h|[?]|1|mL/g/h|MESENTERIC ARTERY|RIGHT|UPPER FLEXOR SURFACE|WRIGHT-GIEMSA STAIN||||FAMILY MEMBER|ADJUDICATOR 1|5|Visit_5|90|7|TREATMENT|2021-04-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|MET*h|[?]|1|mL|ABDOMINAL CAVITY|LEFT|ANTERIOR|PHOTOMETRY||Y||PROXY|READER 2|1|Visit_1|10|5|FOLLOW-UP|2020-07-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|2|AWVOL|Airway Volume|[?]|LATERAL DECUBITUS|[?]|kcal/day|[?]|1|um/day|INTERVENTRICULAR SEPTUM|LATERAL|INNER|PATHOLOGICAL EVALUATION||||SPOUSE|HEMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-07-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|3|RER|Respiratory Exchange Ratio|[?]|UNCONSTRAINED|[?]|mmol/s|[?]|1|10^3 organisms|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|BILATERAL|SUPERIOR|PHASE-CONTRAST MRI||||SIBLING|PATHOLOGIST 1|2|Visit_2|25|6|FOLLOW-UP|2020-08-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|4|MIP|Maximal Inspiratory Pressure|[?]|LATERAL DECUBITUS|[?]|amol|[?]|1|mV/sec|RIGHT VENTRICULAR ENDOCARDIUM|UNILATERAL|BASAL|HIGH RESOLUTION CT||Y||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|2|Visit_2|25|4|WASHOUT|2020-08-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|LATERAL DECUBITUS|||[?]|1|cpm|WARDS TRIANGLE|RIGHT|MIDLINE|CALCULATION|||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|3|Visit_3|40|4|SCREENING|2020-08-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING|[?]|deg2|[?]|1|Tbsp|ILIAC FOSSA|RIGHT|MEDIAL|POLYSOMNOGRAPHY|Y|||HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|3|Visit_3|40|4|TREATMENT|2020-08-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|7|QUASCOMP|Quasi-Static Compliance|[?]|SUPINE|[?]|SPRAY|[?]|1|IU/mg|PALATE|BILATERAL|VOLAR|LINE PROBE ASSAY||||ADJUDICATOR|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|8|FVC|Forced Vital Capacity|[?]|FOWLERS|[?]|mL/(min*100mL)|[?]|1|uSiemens|ELBOW JOINT|LEFT|VENTRAL|TEMPLATE INCISION METHOD||Y||VENDOR|ADJUDICATOR|4|Visit_4|65|5|WASHOUT|2020-09-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|||[?]|1|%(v/v)|OPTIC NERVE|RIGHT|LOWER|EEG|||Y|VENDOR|OPTOMETRIST|5|Visit_5|90|6|TREATMENT|2020-10-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|0f85b859-187d-4c6b-8873-33c0f18d3e3c|10|FRCPP|Percent Predicted FRC|[?]|TRENDELENBURG|[?]|CFU/g|[?]|1|JAR|ESOPHAGUS, UPPER THIRD|LEFT|DISTAL|ELASTOGRAPHY||Y||PROXY|MICROSCOPIST 1|5|Visit_5|90|6|FOLLOW-UP|2020-10-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SLING|[?]|IU/g Hb|[?]|1|cP|SKIN|CONTRALATERAL|DORSAL|IMMUNODIFFUSION||||ADJUDICATION COMMITTEE|ADJUDICATOR 3|1|Visit_1|10|5|WASHOUT|2020-09-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|TABLET|[?]|1|mL/kg/h|UVEA|RIGHT|CRANIAL|GC/MS-EI||||PARENT|OPHTHALMOLOGIST|1|Visit_1|10|2|WASHOUT|2020-09-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|3|RAWPP|Percent Predicted Airway Resistance|[?]|TRENDELENBURG|[?]|nsec|[?]|1|10^3/hpf|FINGER EXTENSOR MUSCLES|BILATERAL|APICAL|SINGLE-MOLECULE ARRAY||Y||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|2|Visit_2|25|7|SCREENING|2020-10-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|4|MEPPP|Percent Predicted MEP|[?]|LEFT LATERAL DECUBITUS|||[?]|1|DDU|SKIN OF THE ELBOW|LEFT|INNER|MODIFIED ACID FAST STAIN|Y||Y|FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|6|WASHOUT|2020-10-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|IU/L|[?]|1|yd|SEBACEOUS GLAND|BILATERAL|DISTAL|ENDPOINT DILUTION ASSAY||Y||CLINICAL RESEARCH ASSOCIATE|CLINICAL PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-10-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|6|RAW|Airway Resistance|[?]|SEMI-RECUMBENT|||[?]|1|HEP|ANKLE JOINT ANTERIOR FLEXOR TENDONS|IPSILATERAL|FRONTAL|CLAUSS METHOD|Y||Y|SPOUSE|RATER 1|3|Visit_3|40|4|TREATMENT|2020-10-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|7|AWWVOL|Airway Wall Volume|[?]|DECUBITUS|[?]|DDU|[?]|1|Roentgen|COSTOCHONDRAL JOINT 1|LATERAL|VENTRAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|Y|||CLINICAL STUDY SPONSOR|DERMATOLOGIST|4|Visit_4|65|7|SCREENING|2020-11-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-FOWLERS|[?]|CARTRIDGE|[?]|1|TROCHE|GREAT VESSELS|IPSILATERAL|HIND|PHASE-CONTRAST MRI||||CAREGIVER|ADJUDICATOR 1|4|Visit_4|65|7|TREATMENT|2020-11-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|9|PLMBLFLW|Pulmonary Blood Flow|[?]|TRENDELENBURG|[?]|VIRTUAL PIXEL|[?]|1|ELISA unit/mL|SENSORIMOTOR CORTEX|IPSILATERAL|FORE|SPECTROPHOTOMETRY||||ADJUDICATOR|UROLOGIST|5|Visit_5|90|4|SCREENING|2020-12-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|5e383a9d-dc97-4352-8add-d55a1a566b9f|10|QUASCOMP|Quasi-Static Compliance|[?]|DECUBITUS|[?]|ug/m2/day|[?]|1|Ci/ug|MEDIASTINUM, POSTERIOR|LATERAL|POSTERIOR|WHOLE EXOME SEQUENCING||Y||ADJUDICATOR|ONCOLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-12-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|DLCOVA|DLCO/VA|[?]|UNCONSTRAINED|[?]|U/kg|[?]|1|ug/day|RETINAL ARTERY|BILATERAL|FORE|PET/CT SCAN WITHOUT CONTRAST||||INDEPENDENT ASSESSOR|MICROSCOPIST 1|1|Visit_1|10|3|FOLLOW-UP|2020-06-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|min|[?]|1|10^6 organisms/mL|SUPERIOR VENA CAVA|LATERAL|TIP|IMMUNODIFFUSION||Y||INDEPENDENT ASSESSOR|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-06-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|3|PNEUMIND|Pneumonia Indicator|[?]|UNCONSTRAINED|||[?]|1|VIRTUAL PIXEL|PULMONARY VALVE, RIGHT CUSP|LEFT|MEDIAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|||Y|DOMESTIC PARTNER|RATER 2|2|Visit_2|25|5|FOLLOW-UP|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|4|FEV1FVC|FEV1/FVC|[?]|LATERAL DECUBITUS|[?]|vg/dose|[?]|1|hr/day|SKIN OF THE TRUNK|LEFT|POSTERIOR|GC/MS-EI||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 3|2|Visit_2|25|7|SCREENING|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|5|FEV6PP|Percent Predicted FEV6|[?]|SEMI-RECUMBENT|[?]|ka_u/dL|[?]|1|Sv|CARPOMETACARPAL JOINT 4|LEFT|ANTERIOR|FLUORESCENT SPOT TEST||Y||SIGNIFICANT OTHER|MICROSCOPIST 1|3|Visit_3|40|6|FOLLOW-UP|2020-07-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|6|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|/cmH2O|[?]|1|anti-Xa IU/mL|LATERAL THIRD DIAGONAL BRANCH ARTERY|LATERAL|DEEP|CALCOFLUOR WHITE STAIN||||VENDOR|ONCOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-07-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|7|DLCOPP|Percent Predicted DLCO|[?]|SEMI-RECUMBENT|[?]|mEq/g|[?]|1|IU/g|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|RIGHT|UPPER|FUNDUS PHOTOGRAPHY||Y||PROXY|NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|8|FIVC|Forced Inspiratory Vital Capacity|[?]|SLING|[?]|pg/dL|[?]|1|P|POSTERIOR POLE OF THE EYE|CONTRALATERAL|HIND|REBOUND TONOMETRY||||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|9|ICREV|IC Reversibility|[?]|SLING|||[?]|1|mph|FLEXOR DIGITORUM PROFUNDUS MUSCLE|LATERAL|LOWER MEDIAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||Y|CHILD|PATHOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-09-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|3eda746b-fb97-4950-a528-1d4ae5d3653a|10|DLCOHC|HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|mL/s|[?]|1|g/L|TEMPORAL ARTERY|IPSILATERAL|ANTEROLATERAL|FLAME PHOTOMETRY||||ADJUDICATOR|RADIOLOGIST|5|Visit_5|90|6|WASHOUT|2020-09-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|1|EFFIND|Effusion Indicator|[?]|TRENDELENBURG|[?]|dmol|[?]|1|STRIP|SPLENIC ARTERY|CONTRALATERAL|LOWER MEDIAL|DXA SCAN||||SIBLING|UROLOGIST|1|Visit_1|10|1|TREATMENT|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|2|IVCPP|Percent Predicted IVC|[?]|UNCONSTRAINED|[?]|nL|[?]|1|10^4/L|LEFT VENTRICULAR MID INFERIOR SEGMENT|IPSILATERAL|ANTEROMEDIAL|AUDIOMETRY|Y|Y||DOMESTIC PARTNER|RATER 2|1|Visit_1|10|3|TREATMENT|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|3|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|NEEDLE GAUGE|[?]|1|tsp|MEDIASTINUM, MIDDLE|LEFT|PERIVENTRICULAR|HPLC||||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|2|Visit_2|25|3|WASHOUT|2020-11-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|4|PLMXRS|Pulmonary Reactance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|nmol BCE/nmol|SOFT PALATE|LATERAL|INFERIOR|TOTAL BODY IRRADIATION|Y||Y|CHILD|ADJUDICATOR 1|2|Visit_2|25|2|TREATMENT|2020-11-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|5|IVC|Inspiratory Vital Capacity|[?]|SLING|[?]|/min|[?]|1|mmol/min/kPa|L5-S1 INTERVERTEBRAL SPACE|LATERAL|ANTERIOR|IMMUNO-PET SCAN|Y|||CLINICAL RESEARCH COORDINATOR|READER|3|Visit_3|40|7|TREATMENT|2020-12-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-FOWLERS|[?]|ug/dose|[?]|1|mg/mL/min|TARSAL JOINT|IPSILATERAL|DEEP|PET/MRI SCAN||||HEALTH CARE PROFESSIONAL|UROLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-12-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|7|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING|||[?]|1|MONTHS|ADDUCTOR LONGUS MUSCLE|LEFT|CRANIAL|BIOIMPEDANCE SPECTROSCOPY|||Y|FRIEND|ADJUDICATOR 1|4|Visit_4|65|7|WASHOUT|2020-12-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|8|MIP|Maximal Inspiratory Pressure|[?]|UNCONSTRAINED|[?]|SCOOPFUL|[?]|1|ELISA unit/dose|INTERPHALANGEAL JOINT 5 OF THE FOOT|CONTRALATERAL|SUBCORTICAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|||GUARDIAN|READER|4|Visit_4|65|5|FOLLOW-UP|2020-12-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ug/mL/h|ANTERIOR CINGULATE CORTEX|RIGHT|VENTRAL|DIFFUSION WEIGHTED MRI|Y|Y|Y|GUARDIAN|FORENSIC PATHOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|a3b72841-3401-4dcc-9d06-75438b408d0b|10|AWVOLPP|Percent Predicted Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|10^7 CFU/mL|[?]|1|mIU/L|DISTAL PHALANX 4 OF THE HAND|RIGHT|UPPER|CONGO RED STAIN|Y|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|5|Visit_5|90|1|TREATMENT|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|DECUBITUS|[?]|mL/beat|[?]|1|PELLET|PARAPHARYNGEAL LYMPH NODE|UNILATERAL|OUTER|IODINE STAIN|Y|||INVESTIGATOR|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2020-10-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|2|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|||[?]|1|mEq/mmol|CERVICAL LYMPH NODE|UNILATERAL|SUPERIOR|CYSTOMETRY|||Y|STUDY SUBJECT|OPTOMETRIST|1|Visit_1|10|2|TREATMENT|2020-10-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|3|PEFTIME|Peak Expiratory Flow Time|[?]|PRONE|[?]|mg/cm2|[?]|1|mmHg/sec|TROCHLEAR NERVE|LEFT|HIND|FUNCTIONAL MRI|Y|||PROXY|ADJUDICATOR 3|2|Visit_2|25|4|FOLLOW-UP|2020-11-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|4|TLC|Total Lung Capacity|[?]|UNCONSTRAINED|[?]|mCi|[?]|1|U.CARR|SKIN OF THE FOOT|IPSILATERAL|LOWER MEDIAL|GIEMSA STAIN|Y|||FAMILY MEMBER|READER 2|2|Visit_2|25|3|TREATMENT|2020-11-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|5|TSUHYS|Tissue Hysteresivity|[?]|SLING|[?]|% INHIBITION|[?]|1|mL/cage|BASILIC VEIN|UNILATERAL|PROXIMAL VOLAR|WHOLE TRANSCRIPTOME SEQUENCING|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST 2|3|Visit_3|40|5|SCREENING|2020-11-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|6|MIPPP|Percent Predicted MIP|[?]|REVERSE TRENDELENBURG|[?]|g/kg/day|[?]|1|10^6 organisms/g|SKIN AROUND THE MOUTH|RIGHT|SURFACE|WRIGHT STAIN|Y|Y||INDEPENDENT ASSESSOR|PATHOLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-11-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|7|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|nmol BCE/nmol|[?]|1|ng/L|BICEPS BRACHII MUSCLE|CONTRALATERAL|MIDLINE|CLIP||||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|1|TREATMENT|2020-12-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|8|FEV1PP|Percent Predicted FEV1|[?]|REVERSE TRENDELENBURG|||[?]|1|LOZENGE|BLOOD|LEFT|OCCIPITAL|THICK SMEAR|||Y|CLINICAL STUDY SPONSOR|RATER 1|4|Visit_4|65|1|TREATMENT|2020-12-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|LATERAL DECUBITUS|||[?]|1|mL/sec/1.73m2|GRACILIS MUSCLE|IPSILATERAL|TIP|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||Y|ADJUDICATOR|INTERNIST|5|Visit_5|90|2|TREATMENT|2021-01-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|4393406e-bda5-42e4-a752-a8121004b7ef|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|||[?]|1|gMFI|ANAL VERGE|RIGHT|LOWER FLEXOR SURFACE|ULTRASOUND|||Y|SIGNIFICANT OTHER|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2021-01-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|1|SRAW|Specific Airway Resistance|[?]|SEMI-FOWLERS|[?]|h*%|[?]|1|/100 HPFs|PROXIMAL PHALANX 3 OF THE HAND|UNILATERAL|VENTROLATERAL|GC/MS||||CLINICAL STUDY SPONSOR|NEUROLOGIST|1|Visit_1|10|3|WASHOUT|2020-05-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uU/dL|LATERAL THIRD DIAGONAL BRANCH ARTERY|UNILATERAL|VENTROLATERAL|MRI|Y||Y|ADJUDICATOR|ENDOCRINOLOGIST|1|Visit_1|10|5|TREATMENT|2020-05-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|3|ICPP|Percent Predicted Inspiratory Capacity|[?]|SUPINE|[?]|cs|[?]|1|min/day|COLON, LEFT|BILATERAL|UPPER EXTENSOR SURFACE|HEMAGGLUTINATION ASSAY||||FRIEND|OTOLARYNGOLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|4|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|10^7 PFU|[?]|1|vg/kg|SKIN OF THE ELBOW|LATERAL|FRONTAL|SINGLE-MOLECULE ARRAY||||CLINICAL STUDY SPONSOR|ADJUDICATOR 3|2|Visit_2|25|1|SCREENING|2020-06-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|5|FIF75|Forced Inspiratory Flow at 75%|[?]|FOWLERS|[?]|mL/100g/min|[?]|1|L/day|BASILIC VEIN|LEFT|OCCIPITAL|PELLI-ROBSON EYE CHART||||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|3|Visit_3|40|2|WASHOUT|2020-06-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-25
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|6|PNEUMIND|Pneumonia Indicator|[?]|REVERSE TRENDELENBURG|||[?]|1|/500 WBC|THALAMUS|CONTRALATERAL|UPPER|SPECULAR MICROSCOPY|||Y|INVESTIGATOR|INTERNIST|3|Visit_3|40|1|TREATMENT|2020-06-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-25
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|7|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|mL/g/day|[?]|1|DRINK|PROSTATE GLAND, MIDDLE LOBE|IPSILATERAL|BASAL|POPULATION SEQUENCING||Y||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-07-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING|[?]|% INHIBITION|[?]|1|ug/mL/h|ACCESSORY RENAL ARTERY|LATERAL|DISTAL VOLAR|CAPILLARY ELECTROPHORESIS||||PROXY|READER|4|Visit_4|65|7|WASHOUT|2020-07-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|9|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING, BENT FORWARD|[?]|FEU|[?]|1|mmHg/L/min|BODY|IPSILATERAL|CAUDAL|LC/MS/MS||||GUARDIAN|NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|d70f5903-3d94-422b-8f69-212f015b54c9|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|DECUBITUS|[?]|Ci/mL|[?]|1|Roentgen|RETINAL ARTERY|LATERAL|VENTRAL|KNEMOMETRY||||CHILD|MICROSCOPIST|5|Visit_5|90|5|SCREENING|2020-08-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|PEFREV|PEF Reversibility|[?]|SUPINE|[?]|PACKET|[?]|1|APL U/mL|SKIN AROUND THE MOUTH|LEFT|CRANIAL|FORCED OSCILLATION TECHNIQUE||||VENDOR|NEUROLOGIST 1|1|Visit_1|10|5|WASHOUT|2021-01-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|2|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|||[?]|1|L|CARDIAC VALVE|BILATERAL|FORE|RADIAL IMMUNODIFFUSION|Y||Y|INVESTIGATOR|ADJUDICATOR 2|1|Visit_1|10|3|SCREENING|2021-01-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|3|DLCO|Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|g|[?]|1|Ci/L|TESTIS|CONTRALATERAL|ANTEROPOSTERIOR|X-RAY||Y||ADJUDICATION COMMITTEE|HEMATOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2021-01-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|4|FIV1PP|Percent Predicted FIV1|[?]|STANDING, BENT FORWARD|[?]|uIU/L|[?]|1|uOsm|PUTAMEN|IPSILATERAL|INNER|TURBIDIMETRY||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|2|Visit_2|25|6|SCREENING|2021-01-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|5|DLCOVA|DLCO/VA|[?]|SUPINE|[?]|ug/m2/h|[?]|1|dpm/mL|INTERATRIAL SEPTUM|LEFT|OCCIPITAL|DXA SCAN||Y||PARENT|PATHOLOGIST 2|3|Visit_3|40|6|SCREENING|2021-02-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|6|LCI|Lung Clearance Index|[?]|SUPINE|||[?]|1|MET*min|SUPERFICIAL LYMPH NODE|CONTRALATERAL|CENTRAL|INTERRUPTER TECHNIQUE|||Y|ADJUDICATION COMMITTEE|ONCOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2021-02-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|7|FIF50|Forced Inspiratory Flow at 50%|[?]|DECUBITUS|[?]|BU/mL|[?]|1|10^9 organisms|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|UNILATERAL|SUPERIOR|PHOTOGRAPHY|Y|||VENDOR|ENDOCRINOLOGIST|4|Visit_4|65|3|WASHOUT|2021-03-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|8|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|U/10^12 RBC|[?]|1|Enzyme U/g Hb|SALIVARY GLAND, SUBLINGUAL|RIGHT|ANTEROTEMPORAL|NON-CONTACT SPECULAR MICROSCOPY||Y||SIGNIFICANT OTHER|OPHTHALMOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-03-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|9|QUASCOMP|Quasi-Static Compliance|[?]|LATERAL DECUBITUS|[?]|cmHg|[?]|1|NEBULE|OBTURATOR EXTERNUS MUSCLE|UNILATERAL|INFERIOR|SINGLE-MOLECULE ARRAY||||FAMILY MEMBER|CLINICAL PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-03-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|ef772266-faf1-4904-8ac3-19cbc3ea7d36|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|[?]|deg/mm|[?]|1|uU/dL|FIBULA|LEFT|INNER|IMMUNOASSAY||||ADJUDICATOR|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-03-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SUPINE|[?]|GPL U/mL|[?]|1|10^6 U|COMMON FEMORAL ARTERY|BILATERAL|ANTERIOR|REVERSE TRANSCRIPTASE PCR||||PROXY|PATHOLOGIST 2|1|Visit_1|10|3|WASHOUT|2020-07-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SLING|[?]|ECL unit|[?]|1|PACKET|GASTRIC CARDIA|LATERAL|LOWER FLEXOR SURFACE|X-RAY FLUORESCENCE SPECTROMETRY||||VENDOR|ADJUDICATOR 2|1|Visit_1|10|1|WASHOUT|2020-07-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|3|INERTANC|Inertance|[?]|STANDING|[?]|titer|[?]|1|sec|CARDIOVASCULAR SYSTEM|LATERAL|VENTROLATERAL|ELASTOGRAPHY|Y|Y||ADJUDICATOR|DERMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-07-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|FOWLERS|[?]|uCi/L|[?]|1|L|EPITROCHLEAR LYMPH NODE|IPSILATERAL|PERIPHERAL|LAPAROSCOPY||Y||SPOUSE|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-07-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|5|AWVOLPP|Percent Predicted Airway Volume|[?]|STANDING|[?]|DDU|[?]|1|umol/mol|FIBULAR VEIN|CONTRALATERAL|MIDLINE|ECHOCARDIOGRAPHY||||CHILD|CLINICAL PATHOLOGIST|3|Visit_3|40|6|SCREENING|2020-08-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|6|FEV3PP|Percent Predicted FEV3|[?]|RIGHT LATERAL DECUBITUS|[?]|mmHg/L/min|[?]|1|bel|SACRUM|LATERAL|UPPER EXTENSOR SURFACE|MICRO BROTH DILUTION||||FAMILY MEMBER|RADIOLOGIST 2|3|Visit_3|40|4|SCREENING|2020-08-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|7|DLCOVAPP|Percent Predicted DLCO/VA|[?]|STANDING|[?]|STEPS|[?]|1|psec|ANTERIOR CINGULATE GYRUS|BILATERAL|CRANIAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|||SPOUSE|PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-09-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|8|TLC|Total Lung Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|mg/dose|[?]|1|cd|PROXIMAL INTERPHALANGEAL JOINT 5|RIGHT|SUPERFICIAL|IMMUNOCHROMATOGRAPHY||Y||ADJUDICATOR|READER 1|4|Visit_4|65|6|TREATMENT|2020-09-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|9|EVC|Expiratory Vital Capacity|[?]|STANDING|[?]|mg/dL|[?]|1|g/dL|CARPOMETACARPAL JOINT 3|LATERAL|LOWER FLEXOR SURFACE|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||Y||ADJUDICATION COMMITTEE|MICROSCOPIST 2|5|Visit_5|90|7|FOLLOW-UP|2020-10-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|c0f9c36c-1ae5-4f80-b936-0afe3f661746|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING|||[?]|1|10^6 DNA copies/mL|FINGER|BILATERAL|OUTER|SINGLE-MOLECULE ARRAY|||Y|HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|5|Visit_5|90|3|SCREENING|2020-10-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SLING|[?]|cGy|[?]|1|mm2|CERVICAL LYMPH NODE|IPSILATERAL|POSTERIOR|CENTRIFUGATION||||PARENT|FORENSIC PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|2|IVC|Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|g/mol|[?]|1|GLOBULE|XIPHOID PROCESS|IPSILATERAL|TEMPORAL|CT SCAN WITHOUT CONTRAST||Y||NON-HEALTH CARE PROFESSIONAL|RATER|1|Visit_1|10|4|SCREENING|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|3|ERV|Expiratory Reserve Volume|[?]|PRONE|[?]|mol|[?]|1|ug/day|RETROPHARYNGEAL LYMPH NODE|LATERAL|CRANIAL|SXA SCAN|Y|||SIBLING|RATER|2|Visit_2|25|3|WASHOUT|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|4|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|[?]|keV|[?]|1|BAU|LIVER, CAUDATE LOBE|IPSILATERAL|DEEP|FLUORESCENCE ANGIOGRAPHY||||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|5|MEPPP|Percent Predicted MEP|[?]|SEMI-RECUMBENT|[?]|DNA copies/mL|[?]|1|USP U|PATELLA|BILATERAL|INTERMEDIATE|PHASE CONTRAST MICROSCOPY||||CAREGIVER|RATER 1|3|Visit_3|40|2|WASHOUT|2020-12-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|6|QUASCOMP|Quasi-Static Compliance|[?]|LEFT LATERAL DECUBITUS|[?]|mCi/kg|[?]|1|10^4 CFU/mL|FEMORAL NECK|CONTRALATERAL|DISTAL|IMMUNOASSAY||||CLINICAL RESEARCH ASSOCIATE|READER 3|3|Visit_3|40|4|TREATMENT|2020-12-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|7|LCI|Lung Clearance Index|[?]|TRENDELENBURG|[?]|Farad|[?]|1|U/g/min|PERIPHERAL NERVE|LATERAL|INFERIOR|MEDIASTINOSCOPY||||PARENT|RADIOLOGIST 1|4|Visit_4|65|5|FOLLOW-UP|2021-01-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|8|ERV|Expiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|hr/day|[?]|1|mkat|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|LEFT|FACIAL|MALDI||||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|3|WASHOUT|2021-01-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|9|SVC|Slow Vital Capacity|[?]|PRONE|[?]|Pack Year|[?]|1|PFU/animal|COLON, SIGMOID|IPSILATERAL|UPPER EXTENSOR SURFACE|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||SPOUSE|MICROSCOPIST|5|Visit_5|90|7|WASHOUT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|f17b5630-e782-4135-8a50-4a9bb2fe63b1|10|FIV1PP|Percent Predicted FIV1|[?]|SITTING|[?]|/10^3|[?]|1|kN/cm2|COSTOCHONDRAL JOINT 7|RIGHT|ANTEROPOSTERIOR|IMMUNOASSAY||||PROXY|RATER|5|Visit_5|90|5|TREATMENT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|cd/m2|FACE|RIGHT|LOWER|MUGA|||Y|CAREGIVER|OPTOMETRIST|1|Visit_1|10|3|TREATMENT|2021-01-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|2|DLCOHC|HGB Corrected DLCO|[?]|SLING|[?]|mL/min|[?]|1|pkat/L|POSTERIOR CINGULATE CORTEX|BILATERAL|MEDIAL|VIRUS PLAQUE ASSAY||||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|5|TREATMENT|2021-01-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|||[?]|1|nmol|SUPERIOR SAGITTAL SINUS|CONTRALATERAL|PROXIMAL|SNP ARRAY||Y|Y|SIBLING|CARDIOLOGIST|2|Visit_2|25|6|SCREENING|2021-01-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|4|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|L/kg|[?]|1|pg|SECOND RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|VENTROLATERAL|PET/CT SCAN||||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|2|Visit_2|25|7|SCREENING|2021-01-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|5|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|||[?]|1|RNA copies/mL|LUNG, HILUM|BILATERAL|INFERIOR|RADIOIMMUNOPRECIPITATION ASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|3|Visit_3|40|1|TREATMENT|2021-02-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|6|MALEVDES|Malignancy Evidence Description|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Frames/s|FIBULAR VEIN|CONTRALATERAL|FACIAL|PALPATION|||Y|INDEPENDENT ASSESSOR|READER 1|3|Visit_3|40|7|TREATMENT|2021-02-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|7|ICPP|Percent Predicted Inspiratory Capacity|[?]|DECUBITUS|||[?]|1|10^8/L|LATERAL SECOND DIAGONAL BRANCH ARTERY|LATERAL|CENTRAL|NO INFORMATION||Y|Y|CHILD|OTOLARYNGOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|8|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|[?]|nmol BCE/L|[?]|1|cm2|FLEXOR HALLUCIS BREVIS MUSCLE|LATERAL|VOLAR|FLUORESCENT LIFETIME IMAGING MICROSCOPY||Y||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|9|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|[?]|Pa|[?]|1|Bq|ARTERY|CONTRALATERAL|OCCIPITAL|LYMPHANGIOGRAPHY||Y||CAREGIVER|MICROSCOPIST 2|5|Visit_5|90|6|SCREENING|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|8bdb40c9-1e44-45ae-bf08-81ea635fd762|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|psi|[?]|1|pptr|ABDOMINAL REGION|LATERAL|INFERIOR|NON-CONTACT SPECULAR MICROSCOPY||||FAMILY MEMBER|RADIOLOGIST 2|5|Visit_5|90|4|TREATMENT|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|ELSTNCE|Elastance|[?]|STANDING|[?]|MBP|[?]|1|GBq|TEMPORAL ARTERY|LEFT|BASAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|Y||PARENT|PATHOLOGIST 2|1|Visit_1|10|3|TREATMENT|2021-01-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|2|TSUELAS|Tissue Elastance|[?]|RIGHT LATERAL DECUBITUS|[?]|gpELISA unit/mL|[?]|1|Gy|MAXILLA|LEFT|VENTROLATERAL|COULOMETRIC TITRATION||||INVESTIGATOR|PEDIATRIC NEUROLOGIST|1|Visit_1|10|7|SCREENING|2021-01-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SUPINE|[?]|FINGERTIP UNIT|[?]|1|km|SUPERIOR VENA CAVA|CONTRALATERAL|LOWER|TEST STRIP|Y|||VENDOR|PATHOLOGIST|2|Visit_2|25|4|SCREENING|2021-01-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|4|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|||[?]|1|cm/min|SUPERFICIAL LYMPH NODE|LATERAL|CAUDAL|MAMMOGRAPHY|||Y|VENDOR|FORENSIC PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2021-01-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|5|FEV3PP|Percent Predicted FEV3|[?]|FOWLERS|||[?]|1|mm/2h|FEMALE GENITALIA|CONTRALATERAL|CAUDAL|IMMUNOASSAY|||Y|DOMESTIC PARTNER|PATHOLOGIST|3|Visit_3|40|2|TREATMENT|2021-02-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|6|INERTANC|Inertance|[?]|SUPINE|[?]|10^3/L|[?]|1|genEq|MID-CIRCUMFLEX ARTERY|LEFT|DORSAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||||ADJUDICATION COMMITTEE|NEUROLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|||[?]|1|10^6 organisms/mg|CRANIAL NERVE|CONTRALATERAL|OCCIPITAL|TEST STRIP|||Y|SIGNIFICANT OTHER|RATER 1|4|Visit_4|65|1|FOLLOW-UP|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|8|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|||[?]|1|10^4/L|ORBICULARIS OCULI MUSCLE|LATERAL|POSTERIOR|TOTAL BODY RADIOGRAPHY|||Y|FRIEND|CLINICAL PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|9|RV|Residual Volume|[?]|PRONE|[?]|gtt|[?]|1|10^9 organisms/mg|LESSER TROCHANTER|BILATERAL|LOWER|PANENDOSCOPY|Y|Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|10|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|[?]|RATIO|[?]|1|uOsm|FINGER FLEXOR TENDONS|LATERAL|INNER|WHOLE EXOME SEQUENCING|Y|||INTERVIEWER|HEMATOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|296f8314-5a07-47b5-8796-31afe709b379|1|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING, BENT FORWARD|||[?]|1|mg/g/min|FACIAL NERVE|BILATERAL|NASAL|ENDPOINT DILUTION ASSAY|||Y|DOMESTIC PARTNER|INTERNIST|1|Visit_1|10|3|TREATMENT|2020-07-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|296f8314-5a07-47b5-8796-31afe709b379|2|IVCPP|Percent Predicted IVC|[?]|DECUBITUS|[?]|mL/m2|[?]|1|fmol/L|INCISOR|CONTRALATERAL|SUBCORTICAL|OPTICAL COHERENCE TOMOGRAPHY|Y|||PARENT|NEUROLOGIST 1|1|Visit_1|10|2|WASHOUT|2020-07-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|296f8314-5a07-47b5-8796-31afe709b379|3|VO2|Oxygen Consumption|[?]|PRONE|||[?]|1|umol/h/mmol|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|LEFT|INNER|FLUOROSCOPY|||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|2|Visit_2|25|2|WASHOUT|2020-07-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|296f8314-5a07-47b5-8796-31afe709b379|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LATERAL DECUBITUS|[?]|MnFI|[?]|1|Bq/g|EXTRAOCULAR MUSCLE|CONTRALATERAL|OUTER|CYSTOSCOPY||||SIBLING|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|SCREENING|2020-07-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|296f8314-5a07-47b5-8796-31afe709b379|5|EVC|Expiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|ug/g/day|[?]|1|10^12/L|INTERPHALANGEAL JOINT 5 OF THE FOOT|IPSILATERAL|DISTAL|SCANNING ELECTRON MICROSCOPY||Y||DOMESTIC PARTNER|NEUROLOGIST|3|Visit_3|40|1|SCREENING|2020-08-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|296f8314-5a07-47b5-8796-31afe709b379|6|IC|Inspiratory Capacity|[?]|SUPINE|[?]|min|[?]|1|uIU/L|BULBAR CONJUNCTIVA|IPSILATERAL|POSTERIOR|HIGH RESOLUTION MELT ANALYSIS|Y|||VENDOR|CLINICAL PATHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|296f8314-5a07-47b5-8796-31afe709b379|7|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|[?]|BLOCKS|[?]|1|MET*min|RIB 12|RIGHT|LOWER EXTENSOR SURFACE|TOTAL BODY IRRADIATION||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|4|Visit_4|65|5|SCREENING|2020-09-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|296f8314-5a07-47b5-8796-31afe709b379|8|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|beats/min|TUNICA INTIMA|LATERAL|VENTRAL|TONOMETRY|||Y|HEALTH CARE PROFESSIONAL|READER 3|4|Visit_4|65|5|TREATMENT|2020-09-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|296f8314-5a07-47b5-8796-31afe709b379|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SLING|[?]|keV|[?]|1|U/m2|SEMINAL VESICLE|LEFT|TEMPORAL|SLOAN LETTER EYE CHART 2.5%||||DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|TREATMENT|2020-09-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|296f8314-5a07-47b5-8796-31afe709b379|10|IVCPP|Percent Predicted IVC|[?]|SEMI-FOWLERS|[?]|cm|[?]|1|g/cage/day|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|LEFT|VENTRAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y||DOMESTIC PARTNER|PATHOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-09-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|[?]|g/m2|[?]|1|mmol/min/kPa/L|INTERPHALANGEAL JOINT 4|RIGHT|INTERMEDIATE|TRYPAN BLUE STAIN||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|1|Visit_1|10|6|WASHOUT|2020-12-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|2|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|||[?]|1|/500 WBC|SUPERFICIAL FEMORAL ARTERY|CONTRALATERAL|INFERIOR|REFLECTANCE SPECTROSCOPY||Y|Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|1|Visit_1|10|4|WASHOUT|2020-12-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|3|FIF25|Forced Inspiratory Flow at 25%|[?]|REVERSE TRENDELENBURG|[?]|10^6 organisms/mg|[?]|1|GPS U|CALF MUSCULAR VEIN|RIGHT|ROSTRAL|ELECTROPHORESIS||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|2|Visit_2|25|6|TREATMENT|2020-12-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|4|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-RECUMBENT|[?]|fmol/L|[?]|1|log10 CCID 50/dose|JUGULAR VEIN|IPSILATERAL|ANTEROTEMPORAL|CONTRAST ENHANCED CT SCAN||||CLINICAL RESEARCH COORDINATOR|READER 1|2|Visit_2|25|1|FOLLOW-UP|2020-12-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|5|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|||[?]|1|MPL U/mL|INTESTINE|UNILATERAL|CAUDAL|AMSLER GRID|||Y|GUARDIAN|PEDIATRIC NEUROLOGIST|3|Visit_3|40|7|TREATMENT|2021-01-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|SLING|[?]|USP U|[?]|1|ug/mol|CEREBELLUM|RIGHT|ANTEROPOSTERIOR|CAPILLARY ELECTROPHORESIS||Y||FAMILY MEMBER|PHYSIOTHERAPIST|3|Visit_3|40|5|TREATMENT|2021-01-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|7|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|DECUBITUS|[?]|DAgU/mL|[?]|1|/LPF|VASTUS INTERMEDIUS MUSCLE|BILATERAL|PARIETO-OCCIPITAL|ICC||||INDEPENDENT ASSESSOR|NEUROLOGIST|4|Visit_4|65|1|SCREENING|2021-02-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING|[?]|umol/dL|[?]|1|mL/animal/day|RETINAL ARTERY|LATERAL|DORSAL|TONOMETRY|Y|||PROXY|PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2021-02-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|9|MIP|Maximal Inspiratory Pressure|[?]|SLING|[?]|g/m2|[?]|1|TAMPON|HEART, APEX|CONTRALATERAL|INFERIOR|IMPEDANCE CONDUCTIVITY||||GUARDIAN|OPTOMETRIST|5|Visit_5|90|7|TREATMENT|2021-03-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|10|SGAW|Specific Airway Conductance|[?]|SLING|||[?]|1|fmol/g|KIDNEY, UPPER LOBE|RIGHT|HIND|IMMUNODIFFUSION|||Y|CAREGIVER|RADIOLOGIST|5|Visit_5|90|4|SCREENING|2021-03-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|FIF75|Forced Inspiratory Flow at 75%|[?]|REVERSE TRENDELENBURG|[?]|pmol|[?]|1|U/g/day|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|DEEP|INTERRUPTER TECHNIQUE||Y||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|1|Visit_1|10|1|SCREENING|2021-01-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|2|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|[?]|oz|[?]|1|pg|ABDUCTOR DIGITI QUINTI MUSCLE|IPSILATERAL|LATERAL|NO INFORMATION||||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|1|Visit_1|10|4|SCREENING|2021-01-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|3|ERVPP|Percent Predicted ERV|[?]|SEMI-FOWLERS|[?]|mg/kg|[?]|1|mL/min/1.73m2|L5-S1 INTERVERTEBRAL SPACE|IPSILATERAL|INTERMEDIATE|POLYMERASE CHAIN REACTION|Y|Y||INVESTIGATOR|RATER|2|Visit_2|25|1|TREATMENT|2021-02-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|DECUBITUS|[?]|dpm/0.5 mL|[?]|1|Bq/kg|PRECUNEUS|LEFT|SUPERFICIAL|CONTACT SPECULAR MICROSCOPY||||DOMESTIC PARTNER|READER 2|2|Visit_2|25|1|TREATMENT|2021-02-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|5|TV|Tidal Volume|[?]|TRENDELENBURG|[?]|PELLET|[?]|1|CONTAINER|HEAD|CONTRALATERAL|OUTER|COMPUTERIZED CORNEAL TOPOGRAPHY||||INDEPENDENT ASSESSOR|MICROSCOPIST 1|3|Visit_3|40|4|WASHOUT|2021-02-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|6|FIV1|Forced Inspiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|||[?]|1|L/min|SCAPHOID-TRAPEZOID JOINT|RIGHT|LOWER|MIGET|Y||Y|DOMESTIC PARTNER|FORENSIC PATHOLOGIST|3|Visit_3|40|3|WASHOUT|2021-02-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|7|PCF|Peak Cough Flow|[?]|SEMI-FOWLERS|||[?]|1|10^9/L|HAIR FOLLICLE|UNILATERAL|DISTAL|MALDI-TOF|||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|4|Visit_4|65|6|SCREENING|2021-03-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|8|MALIND|Malignancy Indicator|[?]|UNCONSTRAINED|[?]|mm/h|[?]|1|pkat|MITRAL VALVE|UNILATERAL|MEDIAL|CONTRAST ENHANCED PET/CT SCAN||||SPOUSE|PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2021-03-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|9|MALIND|Malignancy Indicator|[?]|SLING|||[?]|1|mg/mol|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|CENTRAL|TRIPLE-PHASE MRI SCAN|||Y|NON-HEALTH CARE PROFESSIONAL|READER 2|5|Visit_5|90|1|TREATMENT|2021-04-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|b06043ae-8251-4df8-ab6d-0ceb269c1a42|10|DLCOPP|Percent Predicted DLCO|[?]|SLING|[?]|NFIU|[?]|1|uCi|L5 VERTEBRA|CONTRALATERAL|DORSOLATERAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||FAMILY MEMBER|RADIOLOGIST|5|Visit_5|90|7|WASHOUT|2021-04-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|/mm|BICEPS FEMORIS MUSCLE|BILATERAL|CENTRAL|OPHTHALMOSCOPY|Y||Y|PROXY|CLINICAL PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-RECUMBENT|||[?]|1|Bq/g|AXILLARY VEIN|CONTRALATERAL|OUTER|POTENTIOMETRY|Y||Y|INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|3|FIFMAXPP|Percent Predicted FIFmax|[?]|RIGHT LATERAL DECUBITUS|[?]|ag|[?]|1|ngEq/L|TIBIA SHAFT|IPSILATERAL|FRONTAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||FRIEND|HEMATOLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|4|FEV3PP|Percent Predicted FEV3|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol BCE/nmol|[?]|1|10^9 organisms/mg|RECTOVAGINAL SPACE|UNILATERAL|VENTROLATERAL|MICROBIAL CULTURE||||CLINICAL STUDY SPONSOR|RATER 1|2|Visit_2|25|7|TREATMENT|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|5|FIV1PP|Percent Predicted FIV1|[?]|SEMI-RECUMBENT|[?]|g|[?]|1|ng/mol|BILE DUCT|LATERAL|ROSTRAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||CHILD|PATHOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|6|FRCPP|Percent Predicted FRC|[?]|SUPINE|||[?]|1|L/min/m2|PRELARYNGEAL LYMPH NODE|LATERAL|PROXIMAL VOLAR|BIOIMPEDANCE SPECTROSCOPY|||Y|CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|3|Visit_3|40|5|WASHOUT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|7|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|mMU/mL|[?]|1|mmHg/sec|TEMPLE|LATERAL|LOWER EXTENSOR SURFACE|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|||DOMESTIC PARTNER|ONCOLOGIST|4|Visit_4|65|1|SCREENING|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|REVERSE TRENDELENBURG|||[?]|1|/mm|CORPUS CALLOSUM|IPSILATERAL|SUBCORTICAL|CONTACT SPECULAR MICROSCOPY|||Y|PARENT|PATHOLOGIST 1|4|Visit_4|65|6|TREATMENT|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|ng/L|[?]|1|mOsm|INSULAR CORTEX|BILATERAL|OCCIPITAL|DIGITAL PCR||||FRIEND|MICROSCOPIST|5|Visit_5|90|4|TREATMENT|2021-01-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|d4fb5b9e-e244-4818-be3d-dbb57faacd43|10|TGV|Thoracic Gas Volume|[?]|TRENDELENBURG|[?]|mol/mL|[?]|1|s^-1(%O2)^-1|BLOOD|CONTRALATERAL|ANTEROLATERAL|ANTIMICROBIAL COMBINATION TESTING|Y|||INVESTIGATOR|CLINICAL PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2021-01-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|UNCONSTRAINED|||[?]|1|CUP|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|LATERAL|UPPER FLEXOR SURFACE|FUNDUS PHOTOGRAPHY|||Y|SIGNIFICANT OTHER|NEUROLOGIST 2|1|Visit_1|10|5|FOLLOW-UP|2020-07-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|2|LOBVOL|Lobar Volume|[?]|TRENDELENBURG|[?]|mmol|[?]|1|nU/cL|LEFT VENTRICULAR EPICARDIUM|CONTRALATERAL|CRANIAL|MULTIPLE BREATH WASHOUT||Y||PARENT|ADJUDICATOR 1|1|Visit_1|10|7|WASHOUT|2020-07-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|STANDING, BENT FORWARD|[?]|10^6 copies/mL|[?]|1|mL/g/day|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|IPSILATERAL|CRANIAL|MIGET||||INTERVIEWER|FORENSIC PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|4|FEV3FVC|FEV3/FVC|[?]|SUPINE|[?]|10^4 CFU|[?]|1|kBq/uL|POSTERIOR TIBIAL ARTERY|LEFT|UPPER|IN VITRO GENE EXPRESSION ASSAY||||VENDOR|NEUROLOGIST 1|2|Visit_2|25|7|FOLLOW-UP|2020-07-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|5|EFFVOL|Effusion Volume|[?]|SLING|||[?]|1|BOLUS|EYE|BILATERAL|INNER|DYNAMIC LIGHT SCATTERING|||Y|CHILD|RADIOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-08-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|6|RVPP|Percent Predicted Residual Volume|[?]|STANDING|||[?]|1|g/L|L4 VERTEBRA|LATERAL|ANTERIOR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y||Y|CHILD|RADIOLOGIST 2|3|Visit_3|40|6|SCREENING|2020-08-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|7|RRS|Total Respiratory System Resistance|[?]|SITTING|[?]|g/animal/day|[?]|1|km/h|L1 VERTEBRA|BILATERAL|PERIPHERAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|||SPOUSE|ONCOLOGIST|4|Visit_4|65|2|SCREENING|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|TABLET|[?]|1|PACKAGE|BICEPS FEMORIS MUSCLE|UNILATERAL|DISTAL|ORCHIDOMETERY||||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|4|Visit_4|65|6|SCREENING|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|9|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mph|[?]|1|Bq/uL|FEMUR|LEFT|OUTER|AGAR DILUTION||||CAREGIVER|PATHOLOGIST 1|5|Visit_5|90|5|WASHOUT|2020-10-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|10|AIRTRAP|Air Trapping|[?]|RIGHT LATERAL DECUBITUS|[?]|V|[?]|1|Absorbance U/min|OROPHARYNX|CONTRALATERAL|VENTRAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||ADJUDICATOR|ENDOCRINOLOGIST|5|Visit_5|90|1|WASHOUT|2020-10-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-RECUMBENT|||[?]|1|mEq/mL|SKIN OF THE CHEST|LEFT|LATERAL|STRESS ECHOCARDIOGRAPHY|||Y|PARENT|READER 2|1|Visit_1|10|5|FOLLOW-UP|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|2|TLC|Total Lung Capacity|[?]|DECUBITUS|[?]|/5x10^4 WBC|[?]|1|mL/day|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|IPSILATERAL|CAUDAL|NUCLEIC ACID AMPLIFICATION TEST|Y|||SPOUSE|RATER 1|1|Visit_1|10|5|FOLLOW-UP|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|nmol/L/min|[?]|1|/7.5 mL|METATARSOPHALANGEAL JOINT 5|IPSILATERAL|OCCIPITAL|SICKLE CELL SOLUBILITY TEST|Y|||INTERVIEWER|NEUROLOGIST|2|Visit_2|25|4|SCREENING|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|4|AWWVOL|Airway Wall Volume|[?]|PRONE|[?]|mL/100g/min|[?]|1|ug/g/day|DIAPHRAGMATIC LYMPH NODE|RIGHT|SUPERIOR|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||SPOUSE|OTOLARYNGOLOGIST|2|Visit_2|25|4|SCREENING|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|5|RVPP|Percent Predicted Residual Volume|[?]|LATERAL DECUBITUS|[?]|10^7/L|[?]|1|10^3 organisms|SACRUM|UNILATERAL|VOLAR|X-RAY||||SIBLING|READER|3|Visit_3|40|6|WASHOUT|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|6|FEV1FVC6|FEV1/FVC6|[?]|RIGHT LATERAL DECUBITUS|[?]|g/day|[?]|1|hr/day|PITUITARY GLAND|UNILATERAL|CENTRAL|IMMUNODIFFUSION|Y|||ADJUDICATOR|ONCOLOGIST 1|3|Visit_3|40|5|TREATMENT|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|7|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|mg2/dL2|[?]|1|cd|OPPONENS POLLICIS MUSCLE|IPSILATERAL|ANTEROMEDIAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|||PROXY|ADJUDICATOR 2|4|Visit_4|65|2|WASHOUT|2021-03-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|8|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|10^6/L|[?]|1|Henry|LATERAL RAMUS INTERMEDIUS ARTERY|LATERAL|BASAL|SNELLEN EYE CHART|Y|||SIBLING|PEDIATRIC NEUROLOGIST|4|Visit_4|65|2|WASHOUT|2021-03-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|ft|SUDORIFEROUS GLAND|LEFT|OUTER|POLYGRAPHY|Y||Y|VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|5|TREATMENT|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|10|PCF|Peak Cough Flow|[?]|SEMI-FOWLERS|[?]|mg/dL|[?]|1|10^6 organisms|RENAL ARTERY|LEFT|OUTER|FLOCCULATION, CHARCOAL ENHANCED||Y||SIGNIFICANT OTHER|MICROSCOPIST|5|Visit_5|90|4|SCREENING|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|1|IRVPP|Percent Predicted IRV|[?]|LATERAL DECUBITUS|[?]|10^12/L|[?]|1|TUBE|MOTOR CORTEX|CONTRALATERAL|CAUDAL|IMMUNOTURBIDIMETRY||||INVESTIGATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|pmol/dL|[?]|1|uSiemens|HUMERUS|UNILATERAL|VENTROLATERAL|INCISION-INDUCED BLEEDING METHOD||Y||CAREGIVER|ONCOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|TRENDELENBURG|[?]|Watt|[?]|1|EVENTS|GASTROINTESTINAL TRACT, UPPER, WALL|LATERAL|SUPERFICIAL|INDIRECT IMMUNOFLUORESCENCE||||CHILD|MICROSCOPIST 1|2|Visit_2|25|1|TREATMENT|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|4|PEF|Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|mg/dose|[?]|1|Absorbance U/mL|SKIN OF THE LOWER LIMB|CONTRALATERAL|CRANIAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||PARENT|MICROSCOPIST 3|2|Visit_2|25|4|SCREENING|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|5|IRV|Inspiratory Reserve Volume|[?]|SEMI-FOWLERS|[?]|g/cage/wk|[?]|1|copies/mL|SPINAL ACCESSORY NERVE|CONTRALATERAL|TIP|ACCELERATOR MASS SPECTROMETRY|Y|||DOMESTIC PARTNER|ONCOLOGIST 2|3|Visit_3|40|1|FOLLOW-UP|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|6|FEV3FVC|FEV3/FVC|[?]|SLING|||[?]|1|log10 TCID 50/mL|RIB 1|IPSILATERAL|ANTEROPOSTERIOR|SMEAR|||Y|ADJUDICATION COMMITTEE|READER|3|Visit_3|40|7|FOLLOW-UP|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|7|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|[?]|mg/kg/week|[?]|1|amol|MALE REPRODUCTIVE SYSTEM|LATERAL|ANTEROLATERAL|FLAME PHOTOMETRY||||SPOUSE|PATHOLOGIST 1|4|Visit_4|65|4|TREATMENT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|8|FEV1REV|FEV1 Reversibility|[?]|REVERSE TRENDELENBURG|[?]|10^9 organisms|[?]|1|TRANSDUCING UNIT/mL|CAUDATE NUCLEUS|CONTRALATERAL|ROSTRAL|SLOAN LETTER EYE CHART 2.5%|Y|||HEALTH CARE PROFESSIONAL|ONCOLOGIST|4|Visit_4|65|2|TREATMENT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|9|PEFTIME|Peak Expiratory Flow Time|[?]|UNCONSTRAINED|[?]|PFU/dose|[?]|1|U/kg/day|FLANK|LEFT|NASAL|LAPAROSCOPY||||ADJUDICATION COMMITTEE|ONCOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|b1215705-4c22-43bd-aa65-58bd8745f081|10|MALIND|Malignancy Indicator|[?]|SITTING|[?]|uL/mL|[?]|1|CYLINDER|GLOTTIS|IPSILATERAL|ANTEROMEDIAL|NUCLEIC ACID AMPLIFICATION TEST|Y|||STUDY SUBJECT|NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|DLCO|Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|mCi|[?]|1|ka_u/dL|RENAL ARTERY|LATERAL|NASAL|TURBIDIMETRY||||CHILD|UROLOGIST|1|Visit_1|10|2|TREATMENT|2020-10-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|2|LCI|Lung Clearance Index|[?]|REVERSE TRENDELENBURG|[?]|10^3 organisms|[?]|1|10^4 CFU/mL|AORTOPULMONARY WINDOW LYMPH NODE|LATERAL|ROSTRAL|REVERSE TRANSCRIPTASE PCR||Y||CHILD|ONCOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-10-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|uL/kg/day|[?]|1|VOXEL|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|TIP|FREEZING POINT DEPRESSION|Y|||SIBLING|UROLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-11-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|4|FVC|Forced Vital Capacity|[?]|SEMI-FOWLERS|[?]|mg/dL|[?]|1|kHz|AORTA|UNILATERAL|LOWER EXTENSOR SURFACE|DIFFUSION TENSOR MRI||||CAREGIVER|READER 3|2|Visit_2|25|2|TREATMENT|2020-11-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|5|FEV1PP|Percent Predicted FEV1|[?]|SUPINE|||[?]|1|10^6 organisms/g|RECTOVAGINAL SPACE|LEFT|LATERAL|HPLC/MS||Y|Y|CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2020-11-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING, BENT FORWARD|||[?]|1|CFU/g|FEMORAL ARTERY|RIGHT|PROXIMAL VOLAR|RADIOGRAPHY||Y|Y|PARENT|FORENSIC PATHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-11-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|7|FEV3PP|Percent Predicted FEV3|[?]|SITTING|[?]|MBq|[?]|1|s^-1(%O2)^-1|HAND DIGIT 5|BILATERAL|DISTAL VOLAR|ORCHIDOMETERY|Y|||ADJUDICATOR|ONCOLOGIST 1|4|Visit_4|65|5|TREATMENT|2020-12-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|8|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LEFT LATERAL DECUBITUS|||[?]|1|g/cage|HUMERAL EPICONDYLE|UNILATERAL|CRANIAL|LINE PROBE ASSAY|||Y|GUARDIAN|ENDOCRINOLOGIST|4|Visit_4|65|2|WASHOUT|2020-12-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|DECUBITUS|[?]|vp/mL|[?]|1|breaths/min|COMMON ILIAC ARTERY|CONTRALATERAL|UPPER FLEXOR SURFACE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|5|Visit_5|90|4|WASHOUT|2021-01-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|b99c6528-af4e-42f5-8d2d-18943b57d55a|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SLING|[?]|mEq/L|[?]|1|mL/cage/wk|SOFT PALATE|RIGHT|LATERAL|BIOPSY|Y|||INDEPENDENT ASSESSOR|ADJUDICATOR 1|5|Visit_5|90|4|WASHOUT|2021-01-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|1|FEF50|Forced Expiratory Flow 50%|[?]|SITTING|||[?]|1|fmol|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|CONTRALATERAL|INFERIOR|ELASTOGRAPHY|||Y|CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|1|Visit_1|10|4|TREATMENT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|log EID 50/dose|SACRAL TUBEROSITY|LEFT|LOWER|IMMUNOFIXATION ELECTROPHORESIS|||Y|PROXY|READER 2|1|Visit_1|10|6|TREATMENT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|3|RRS|Total Respiratory System Resistance|[?]|DECUBITUS|||[?]|1|cd*s/m2|BRACHIAL VEIN|RIGHT|VENTRAL|SPIROMETRY|||Y|PROXY|ONCOLOGIST|2|Visit_2|25|2|TREATMENT|2020-11-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|4|IVC|Inspiratory Vital Capacity|[?]|PRONE|[?]|QUANTITY SUFFICIENT|[?]|1|mmol/s|SHOULDER JOINT TENDONS|UNILATERAL|ANTERIOR|TRYPAN BLUE STAIN||||GUARDIAN|HEMATOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-11-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|mL/kg/day|[?]|1|POINT|SKIN OF THE LOWER LIMB|RIGHT|ANTEROLATERAL|URANYL ACETATE STAIN||Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-12-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|6|RRS|Total Respiratory System Resistance|[?]|STANDING|||[?]|1|mN|EPIGLOTTIS|CONTRALATERAL|LOWER EXTENSOR SURFACE|IN SITU HYBRIDIZATION|||Y|SIGNIFICANT OTHER|OTOLARYNGOLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|7|LOBVOL|Lobar Volume|[?]|DECUBITUS|||[?]|1|10^3 copies/mL|SPLENIC HILAR LYMPH NODE|RIGHT|LATERAL|INTERRUPTER TECHNIQUE|Y||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|4|Visit_4|65|5|TREATMENT|2021-01-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|8|QUASCOMP|Quasi-Static Compliance|[?]|PRONE|[?]|Ci|[?]|1|CAN|SECOND RIGHT POSTEROLATERAL ARTERY|LATERAL|DEEP|PH METER MEASUREMENT METHOD|Y|||FRIEND|ADJUDICATOR 1|4|Visit_4|65|5|TREATMENT|2021-01-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|9|ELSTNCE|Elastance|[?]|SUPINE|[?]|Tesla|[?]|1|/10^5|HEPATIC ARTERY|LATERAL|MIDLINE|DYNAMIC LIGHT SCATTERING|Y|Y||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|5|Visit_5|90|6|TREATMENT|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|6848e438-51ca-4a7d-8f81-26c375969a64|10|DLCOHC|HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|mmHg/sec|[?]|1|%(v/v)|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|UNILATERAL|ANTEROTEMPORAL|ENDOSCOPY||||CLINICAL STUDY SPONSOR|RATER 1|5|Visit_5|90|1|TREATMENT|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|1|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|[?]|g/day|[?]|1|m|BLADDER, FUNDUS|LATERAL|ANTEROMEDIAL|SLOAN LETTER EYE CHART 2.5%||||PROXY|MICROSCOPIST 3|1|Visit_1|10|2|WASHOUT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SUPINE|[?]|BU|[?]|1|CAPFUL|AXILLARY LYMPH NODE LEVEL II|BILATERAL|LOWER FLEXOR SURFACE|GC/FID||||CHILD|FORENSIC PATHOLOGIST|1|Visit_1|10|4|SCREENING|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|3|IVC|Inspiratory Vital Capacity|[?]|SITTING|[?]|uL|[?]|1|GPL U/mL|CORPUS STRIATUM|BILATERAL|PROXIMAL VOLAR|SNELLEN EYE CHART||||CAREGIVER|DERMATOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|4|FRC|Functional Residual Capacity|[?]|FOWLERS|||[?]|1|mg/cm2|RIGHT VENTRICULAR BRANCH|RIGHT|PROXIMAL|SANGER SEQUENCING|||Y|INTERVIEWER|NEUROLOGIST 1|2|Visit_2|25|6|FOLLOW-UP|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|5|AIRTRAP|Air Trapping|[?]|SEMI-FOWLERS|[?]|U/mg|[?]|1|mL/g/h|BILIARY TRACT|LEFT|DISTAL|NUCLEIC ACID AMPLIFICATION TEST||||HEALTH CARE PROFESSIONAL|READER 3|3|Visit_3|40|7|FOLLOW-UP|2020-09-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|6|FIF50|Forced Inspiratory Flow at 50%|[?]|RIGHT LATERAL DECUBITUS|[?]|cup eq|[?]|1|log10 CCID 50/dose|VENA CAVA|IPSILATERAL|PARIETO-OCCIPITAL|IMMUNORADIOMETRIC ASSAY|Y|||VENDOR|OTOLARYNGOLOGIST|3|Visit_3|40|2|TREATMENT|2020-09-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|7|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|anti-Xa IU|[?]|1|Bq/L|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|RIGHT|CAUDAL|GC/MS||||ADJUDICATOR|RATER 2|4|Visit_4|65|5|FOLLOW-UP|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|8|TGV|Thoracic Gas Volume|[?]|STANDING, BENT FORWARD|||[?]|1|/month|SUBGLOTTIS|IPSILATERAL|POSTERIOR|CONTACT SPECULAR MICROSCOPY|Y||Y|DOMESTIC PARTNER|RATER 2|4|Visit_4|65|2|WASHOUT|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|9|SGAW|Specific Airway Conductance|[?]|SEMI-RECUMBENT|[?]|mL/animal/day|[?]|1|Enzyme U/L|LATERAL THIRD DIAGONAL BRANCH ARTERY|UNILATERAL|FRONTAL|MAMMOGRAPHY||||CLINICAL STUDY SPONSOR|READER|5|Visit_5|90|4|WASHOUT|2020-10-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|a6e11c33-7905-42d2-bda9-671d756d4c51|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|REVERSE TRENDELENBURG|[?]|fraction of 1|[?]|1|DIP|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|BILATERAL|VOLAR|MICROBIAL CULTURE, SOLID||||FAMILY MEMBER|NEUROLOGIST 1|5|Visit_5|90|7|WASHOUT|2020-10-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|AWVOLPP|Percent Predicted Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|mOsm|MAMMARY GLAND|UNILATERAL|INTERMEDIATE|PLETHYSMOGRAPHY|Y||Y|CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|1|Visit_1|10|4|SCREENING|2020-11-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|2|TVPP|Percent Predicted Tidal Volume|[?]|DECUBITUS|[?]|F|[?]|1|10^3/hpf|PENIS, GLANS|CONTRALATERAL|PARIETO-OCCIPITAL|ANTIMICROBIAL COMBINATION TESTING|Y|||DOMESTIC PARTNER|READER|1|Visit_1|10|7|SCREENING|2020-11-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|PRONE|||[?]|1|10^6/hpf|METATARSOPHALANGEAL JOINT 2|LEFT|FRONTAL|POLYMERASE CHAIN REACTION|||Y|NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|2|Visit_2|25|7|WASHOUT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|4|ERV|Expiratory Reserve Volume|[?]|SEMI-RECUMBENT|||[?]|1|IMPLANT|INTERPHALANGEAL THUMB JOINT|UNILATERAL|FACIAL|TELLER ACUITY CARDS|||Y|SIGNIFICANT OTHER|OTOLARYNGOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|5|TGV|Thoracic Gas Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|g/dL|MASTOID PROCESS|LATERAL|CRANIAL|SLOAN LETTER EYE CHART 1.25%|||Y|FAMILY MEMBER|PHYSIOTHERAPIST|3|Visit_3|40|4|SCREENING|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|UNCONSTRAINED|[?]|10^6 organisms/mg|[?]|1|MBq|ORAL MUCOSA|LATERAL|ANTEROPOSTERIOR|ISHIHARA COLOR PLATES|Y|Y||SPOUSE|UROLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|DECUBITUS|||[?]|1|SACHET|THYROID GLAND, RIGHT LOBE|IPSILATERAL|INFERIOR|PYROSEQUENCING|||Y|GUARDIAN|READER|4|Visit_4|65|2|SCREENING|2021-01-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|||[?]|1|BE/mL|PORTAL VEIN BIFURCATION|RIGHT|MIDLINE|JAEGER EYE CHART|||Y|SIGNIFICANT OTHER|MICROSCOPIST 1|4|Visit_4|65|5|TREATMENT|2021-01-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|9|PIF|Peak Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mph|DISTAL COMMON BILE DUCT|IPSILATERAL|LOWER FLEXOR SURFACE|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||Y|PROXY|CARDIOLOGIST|5|Visit_5|90|6|WASHOUT|2021-01-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|TRENDELENBURG|[?]|CAN|[?]|1|10^6 organisms/mg|POSTERIOR POLE OF THE EYE|RIGHT|VENTRAL|LC/MS/MS||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|5|Visit_5|90|7|WASHOUT|2021-01-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|FEF50|Forced Expiratory Flow 50%|[?]|FOWLERS|[?]|/ms|[?]|1|APS U|PUTAMEN|CONTRALATERAL|ANTERIOR|PEAK FLOWMETRY||Y||SPOUSE|OTOLARYNGOLOGIST|1|Visit_1|10|3|SCREENING|2020-09-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|2|SRAW|Specific Airway Resistance|[?]|SEMI-RECUMBENT|[?]|MBq|[?]|1|LOZENGE|TARSAL JOINT|LATERAL|MEDIAL|TOTAL BODY IRRADIATION||||FRIEND|PHYSIOTHERAPIST|1|Visit_1|10|5|TREATMENT|2020-09-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|3|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|||[?]|1|POUCH|GASTROINTESTINAL TRACT|RIGHT|POSTERIOR|CAPILLARY ELECTROPHORESIS|||Y|PROXY|INTERNIST|2|Visit_2|25|7|SCREENING|2020-09-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|4|FEV1REV|FEV1 Reversibility|[?]|PRONE|[?]|MBq/uL|[?]|1|IU/mL|SUBCUTIS|IPSILATERAL|FRONTAL|ROMANOWSKY STAIN||||CHILD|READER 1|2|Visit_2|25|5|SCREENING|2020-09-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|UNCONSTRAINED|[?]|10^10/L|[?]|1|10^3 CFU/g|GANGLION|LATERAL|DISTAL VOLAR|BIOPSY||||CLINICAL STUDY SPONSOR|ONCOLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|MPL U|[?]|1|uCi/L|RETINAL PIGMENTED EPITHELIAL LAYER|CONTRALATERAL|OCCIPITAL|MASS SPECTROMETRY||||FAMILY MEMBER|MICROSCOPIST|3|Visit_3|40|4|WASHOUT|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|7|EFFIND|Effusion Indicator|[?]|SITTING|[?]|MET|[?]|1|IU/mmol|UPPER CERVICAL LYMPH NODE|IPSILATERAL|CENTRAL|RAJI CELL RIA||||CLINICAL RESEARCH COORDINATOR|UROLOGIST|4|Visit_4|65|7|TREATMENT|2020-11-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|8|FEV6PP|Percent Predicted FEV6|[?]|LEFT LATERAL DECUBITUS|||[?]|1|GBq|RETINA|UNILATERAL|DISTAL|X-RAY|||Y|HEALTH CARE PROFESSIONAL|UROLOGIST|4|Visit_4|65|4|TREATMENT|2020-11-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|9|SALKA|Salazar-Knowles Equation Parameter A|[?]|SLING|[?]|ng|[?]|1|/10^5|RENAL ARTERY|RIGHT|LATERAL|MICROBIAL CULTURE, LIQUID||||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|3|SCREENING|2020-11-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|8ef37b54-b463-43a4-879f-3ad653c4fef4|10|FEF2575|Forced Expiratory Flow 25-75%|[?]|FOWLERS|[?]|10^9 CFU/g|[?]|1|BOWL|DUODENUM|LATERAL|UPPER|ZIEHL NEELSEN ACID FAST STAIN||||DOMESTIC PARTNER|OTOLARYNGOLOGIST|5|Visit_5|90|1|WASHOUT|2020-11-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|1|ICREV|IC Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/kg/day|[?]|1|mL/cage|FLEXOR CARPI RADIALIS MUSCLE|LATERAL|CRANIAL|MAGNETIC RESONANCE ENTEROGRAPHY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|1|Visit_1|10|5|FOLLOW-UP|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SEMI-FOWLERS|[?]|MBq|[?]|1|Ci/g|SAPHENOUS VEIN|BILATERAL|SUPERFICIAL|RADIOIMMUNOPRECIPITATION ASSAY|Y|||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|3|DLCOPP|Percent Predicted DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|SPRAY|[?]|1|mmol/s|CALF MUSCULAR VEIN|LATERAL|PROXIMAL VOLAR|PAP STAIN||||STUDY SUBJECT|ENDOCRINOLOGIST|2|Visit_2|25|1|SCREENING|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|4|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|[?]|nU/cL|[?]|1|g/animal/wk|PROXIMAL INTERPHALANGEAL JOINT 4|BILATERAL|UPPER|FISH|Y|||INTERVIEWER|ADJUDICATOR|2|Visit_2|25|2|FOLLOW-UP|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|5|TSUHYS|Tissue Hysteresivity|[?]|LATERAL DECUBITUS|[?]|CAPLET|[?]|1|10^6 CFU/mL|ANTECUBITAL FOSSA|UNILATERAL|SURFACE|ANTIBIOTIC AGAR SCREEN||||CAREGIVER|READER 1|3|Visit_3|40|1|WASHOUT|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|6|FEV_PEF|FEV at PEF|[?]|STANDING|[?]|ELISA unit/dose|[?]|1|%(v/v)|METACARPAL 1 BASE|RIGHT|ANTEROLATERAL|DARK FIELD MICROSCOPY||||CAREGIVER|READER 2|3|Visit_3|40|5|SCREENING|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|MASK|[?]|1|%|TRIGEMINAL NERVE|BILATERAL|ANTEROPOSTERIOR|NON-INVASIVE DIELECTRIC SENSING||Y||INDEPENDENT ASSESSOR|READER 1|4|Visit_4|65|5|TREATMENT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|8|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|foz_us|[?]|1|/ms|INTRAHEPATIC BILE DUCT|LEFT|MIDLINE|MODIFIED ACID FAST STAIN||||CHILD|PATHOLOGIST 2|4|Visit_4|65|7|SCREENING|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|9|PCF|Peak Cough Flow|[?]|DECUBITUS|[?]|10^7 CFU|[?]|1|lm|EXTRAOCULAR MUSCLE|BILATERAL|ANTERIOR|CONTRAST ENHANCED PET/CT SCAN|Y|||CHILD|ADJUDICATOR 3|5|Visit_5|90|2|TREATMENT|2020-08-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|cf10035c-4d44-4512-810b-c267d1c8821b|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|[?]|/HPF|[?]|1|cL|RAPHE|LEFT|ROSTRAL|SICKLE CELL SOLUBILITY TEST||||NON-HEALTH CARE PROFESSIONAL|RATER 1|5|Visit_5|90|2|WASHOUT|2020-08-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|FRC|Functional Residual Capacity|[?]|SUPINE|[?]|/ms|[?]|1|EVENTS|ABDOMINAL LYMPH NODE|LATERAL|TEMPORAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||FAMILY MEMBER|RADIOLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-08-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING|[?]|mm/min|[?]|1|cmHg|CERVICAL SPINE|LATERAL|LOWER EXTENSOR SURFACE|HPLC||||FAMILY MEMBER|READER 1|1|Visit_1|10|4|TREATMENT|2020-08-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|3|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|[?]|vp/mL|[?]|1|mL/s|MID-CIRCUMFLEX ARTERY|LATERAL|UPPER EXTENSOR SURFACE|PATHOLOGICAL EVALUATION||||PROXY|ADJUDICATOR 1|2|Visit_2|25|2|TREATMENT|2020-08-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|REVERSE TRENDELENBURG|[?]|10^6 organisms/mg|[?]|1|EVENTS|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|LATERAL|NASAL|ROMANOWSKY STAIN||||CAREGIVER|OPHTHALMOLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-03
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|FOWLERS|[?]|Joule|[?]|1|nU/cL|INTERPHALANGEAL JOINT OF THE HAND|CONTRALATERAL|PERIVENTRICULAR|PULSE OXIMETRY|Y|||FAMILY MEMBER|ADJUDICATOR 3|3|Visit_3|40|7|TREATMENT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|[?]|mmol/min/kPa|[?]|1|nCi|CARPOMETACARPAL JOINT 2|IPSILATERAL|PERIVENTRICULAR|CYSTOMETRY||||SIBLING|ADJUDICATOR 2|3|Visit_3|40|5|WASHOUT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|7|FIF75|Forced Inspiratory Flow at 75%|[?]|TRENDELENBURG|[?]|kcal/day|[?]|1|vg/mL|SCLERA|LATERAL|PROXIMAL VOLAR|IMMUNO-PET SCAN|Y|||CHILD|RADIOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|8|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|Gy|[?]|1|mU|EYE, ANTERIOR CHAMBER|UNILATERAL|SUPERIOR|VIRUS PLAQUE ASSAY||||ADJUDICATION COMMITTEE|CARDIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|9|FVC|Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|v/v|[?]|1|umol/L/h|SUPERFICIAL LYMPH NODE|LEFT|UPPER EXTENSOR SURFACE|HEMAGGLUTINATION INHIBITION ASSAY||||CAREGIVER|READER 1|5|Visit_5|90|3|WASHOUT|2020-10-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|10|ERVPP|Percent Predicted ERV|[?]|DECUBITUS|[?]|HEP|[?]|1|nsec|GLUTEAL MUSCLE|LEFT|HIND|RAJI CELL EIA||||CAREGIVER|PATHOLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2020-10-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|1|MIPPP|Percent Predicted MIP|[?]|DECUBITUS|||[?]|1|g/kg/day|HEART, RIGHT VENTRICULAR FREE WALL|BILATERAL|BASAL|TELLER ACUITY CARDS|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-08-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|2|TV|Tidal Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|ug/L DDU|ABDOMINAL WALL|CONTRALATERAL|FRONTAL|PELLI-ROBSON EYE CHART|||Y|CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-08-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|V|[?]|1|10^3 organisms|JOINT|LATERAL|SUPERIOR|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||INVESTIGATOR|PHYSIOTHERAPIST|2|Visit_2|25|3|WASHOUT|2020-08-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|LEFT LATERAL DECUBITUS|[?]|umol/dL|[?]|1|pmol/L|BLADDER, TRIGONE|LEFT|OCCIPITAL|NUCLEIC ACID BASED METHOD||||SPOUSE|OTOLARYNGOLOGIST|2|Visit_2|25|7|SCREENING|2020-08-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|5|MIP|Maximal Inspiratory Pressure|[?]|SLING|||[?]|1|%(v/v)|ANASTOMOSIS|CONTRALATERAL|CENTRAL|TELLER ACUITY CARDS|||Y|INVESTIGATOR|HEMATOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|6|PCF|Peak Cough Flow|[?]|SEMI-RECUMBENT|[?]|VIRTUAL PIXEL|[?]|1|mPa|HYOID BONE|RIGHT|UPPER EXTENSOR SURFACE|ENZYMATIC COLORIMETRY||||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-09-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|7|FIVC|Forced Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|Bq/L|COSTOCHONDRAL JOINT 7|IPSILATERAL|LATERAL|MOUSE PROTECTION ASSAY|||Y|INVESTIGATOR|RATER|4|Visit_4|65|6|WASHOUT|2020-10-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|8|ERV|Expiratory Reserve Volume|[?]|SEMI-FOWLERS|[?]|U/m2/h|[?]|1|mCi/L|HEART, BASE|RIGHT|NASAL|WHOLE TRANSCRIPTOME SEQUENCING||||SPOUSE|ADJUDICATOR 2|4|Visit_4|65|4|TREATMENT|2020-10-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|9|AWWVOL|Airway Wall Volume|[?]|STANDING|||[?]|1|log10 IU/mL|T5 VERTEBRA|IPSILATERAL|BASAL|EIA|||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 2|5|Visit_5|90|3|TREATMENT|2020-10-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|a1e0035a-3328-4966-8664-82e53a44eb59|10|FEV1FVC|FEV1/FVC|[?]|SLING|[?]|log10 PFU/mL|[?]|1|%/min|GASTROINTESTINAL TRACT, LOWER, WALL|UNILATERAL|PROXIMAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||Y||PARENT|ADJUDICATOR 2|5|Visit_5|90|6|TREATMENT|2020-10-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|1|FEF2575|Forced Expiratory Flow 25-75%|[?]|TRENDELENBURG|[?]|cmH2O*s/mL|[?]|1|mL/cage/wk|SKIN OF THE LIP|LATERAL|ROSTRAL|DYNAMIC CONTRAST ENHANCED MRI||Y||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|SCREENING|2020-11-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|2|FEF50|Forced Expiratory Flow 50%|[?]|TRENDELENBURG|[?]|BU|[?]|1|fmol/L/sec|COLON, RECTOSIGMOID|LATERAL|LOWER EXTENSOR SURFACE|DUCTOGRAPHY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-11-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|3|INERTANC|Inertance|[?]|DECUBITUS|[?]|Gy/h|[?]|1|amu|TUNICA INTIMA|LEFT|VENTRAL|PET/MRI SCAN||||SPOUSE|RATER|2|Visit_2|25|4|TREATMENT|2020-11-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|4|RAW|Airway Resistance|[?]|DECUBITUS|[?]|mAnson U/mL|[?]|1|10^9 organisms|SKIN AROUND THE EYE|IPSILATERAL|ANTERIOR|TELLER ACUITY CARDS||Y||CLINICAL STUDY SPONSOR|RADIOLOGIST|2|Visit_2|25|5|SCREENING|2020-11-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|5|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|ug/m2|[?]|1|uV*sec|LEFT ATRIOVENTRICULAR ARTERY|BILATERAL|ANTERIOR|ENZYMATIC SPECTROPHOTOMETRY||||FRIEND|ONCOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|6|SVC|Slow Vital Capacity|[?]|SLING|[?]|cpm|[?]|1|kBq/uL|TEMPORAL ARTERY|IPSILATERAL|APICAL|PANENDOSCOPY||||PROXY|MICROSCOPIST|3|Visit_3|40|1|TREATMENT|2020-12-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|7|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mg/g/min|[?]|1|MASK|VESTIBULOCOCHLEAR NERVE|LEFT|DORSOLATERAL|GC/MS/MS||Y||PARENT|READER|4|Visit_4|65|2|TREATMENT|2021-01-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|8|LCI|Lung Clearance Index|[?]|SEMI-FOWLERS|||[?]|1|ug/L FEU|WRIST JOINT FLEXOR MUSCLES|LEFT|LOWER MEDIAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||Y|GUARDIAN|ONCOLOGIST 2|4|Visit_4|65|7|TREATMENT|2021-01-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|TRENDELENBURG|[?]|mol/mol|[?]|1|cmH2O*s2/mL|EYE, VITREOUS CHAMBER|UNILATERAL|VOLAR|GRADIENT DIFFUSION||||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|5|Visit_5|90|7|TREATMENT|2021-01-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|771377fd-724f-4056-b2ea-84e1adab1f47|10|QUASCOMP|Quasi-Static Compliance|[?]|SITTING|[?]|log10 CFU/g|[?]|1|mg/m2/min|DIGIT|LATERAL|INFERIOR|BRDU CELLULAR PROLIFERATION ASSAY|Y|||FRIEND|RATER 1|5|Visit_5|90|3|WASHOUT|2021-01-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|kV|[?]|1|Farad|ILEUM|LATERAL|ANTEROTEMPORAL|RAJI CELL RIA||||PROXY|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-08-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SUPINE|[?]|GPS U|[?]|1|10^6 CFU/g|TROCHLEAR NERVE|IPSILATERAL|ANTEROTEMPORAL|MAGNETIC RESONANCE ELASTOGRAPHY||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|1|Visit_1|10|7|SCREENING|2020-08-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|3|IVCPP|Percent Predicted IVC|[?]|FOWLERS|||[?]|1|U/mmol|PROXIMAL INTERPHALANGEAL JOINT 2|UNILATERAL|UPPER EXTENSOR SURFACE|HPLC-FL|||Y|VENDOR|PATHOLOGIST 1|2|Visit_2|25|2|SCREENING|2020-09-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|4|DLCOPP|Percent Predicted DLCO|[?]|LATERAL DECUBITUS|||[?]|1|PA|AXILLARY VEIN|IPSILATERAL|ROSTRAL|SCANNING ELECTRON MICROSCOPY||Y|Y|STUDY SUBJECT|NEUROLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-09-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|5|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SUPINE|[?]|nkat/L|[?]|1|g/cage/day|CENTRAL NERVOUS SYSTEM|UNILATERAL|CENTRAL|TEMPLATE INCISION METHOD|Y|||PROXY|PHYSIOTHERAPIST|3|Visit_3|40|2|SCREENING|2020-09-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|6|PEF|Peak Expiratory Flow|[?]|SUPINE|[?]|um2|[?]|1|Tbsp|OPTIC NERVE|IPSILATERAL|LOWER|RIA||||INDEPENDENT ASSESSOR|RATER 2|3|Visit_3|40|2|SCREENING|2020-09-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|PRONE|||[?]|1|pm|HAIR SHAFT|CONTRALATERAL|APICAL|ANALYTICAL ULTRACENTRIFUGATION|||Y|ADJUDICATION COMMITTEE|INTERNIST|4|Visit_4|65|1|TREATMENT|2020-10-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|8|IRVPP|Percent Predicted IRV|[?]|RIGHT LATERAL DECUBITUS|[?]|msec|[?]|1|s/h|FOOT DIGIT 4|LATERAL|UPPER EXTENSOR SURFACE|SIZE EXCLUSION CHROMATOGRAPHY||||SIGNIFICANT OTHER|PATHOLOGIST|4|Visit_4|65|6|WASHOUT|2020-10-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|9|VO2|Oxygen Consumption|[?]|STANDING|[?]|/LSQN|[?]|1|AgU/mL|PANCREAS, ENDOCRINE|BILATERAL|CENTRAL|RADIATION DOSIMETRY||||INVESTIGATOR|MICROSCOPIST 3|5|Visit_5|90|1|TREATMENT|2020-11-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|10|MALIND|Malignancy Indicator|[?]|SITTING|||[?]|1|% INHIBITION|GASTRIC CURVATURE LYMPH NODE|RIGHT|DEEP|MULTIPLE BREATH WASHOUT|||Y|INTERVIEWER|PATHOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2020-11-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|1|SAWVOL|Specific Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|mL/g/day|[?]|1|SYRINGE|VOMER|LEFT|PROXIMAL VOLAR|RULER MEASUREMENT METHOD||||SIBLING|ENDOCRINOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|2|PEFTIME|Peak Expiratory Flow Time|[?]|LEFT LATERAL DECUBITUS|[?]|SQU/mL|[?]|1|ug/cm2|WRIST JOINT EXTENSOR MUSCLES|LATERAL|DORSOLATERAL|GC/MS-EI||||SIGNIFICANT OTHER|CARDIOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-08-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|3|MALIND|Malignancy Indicator|[?]|SEMI-FOWLERS|[?]|Hz|[?]|1|10^6 CFU/g|RETINAL PIGMENTED EPITHELIAL LAYER|BILATERAL|FORE|CELLULAR PROLIFERATION ASSAY|Y|||INTERVIEWER|PATHOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|4|SRAW|Specific Airway Resistance|[?]|SUPINE|[?]|umol/mol|[?]|1|cL|LARGE INTESTINE|RIGHT|CENTRAL|PUPILLOMETRY|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST|2|Visit_2|25|7|TREATMENT|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|5|RV|Residual Volume|[?]|SEMI-FOWLERS|[?]|10^3 organisms/mL|[?]|1|COAT|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|FORE|SPIRAL CT SCAN WITHOUT CONTRAST|Y|||INDEPENDENT ASSESSOR|RATER 1|3|Visit_3|40|3|TREATMENT|2020-09-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|6|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|||[?]|1|mL/dose|DISTAL INTERPHALANGEAL JOINT 2|LATERAL|ANTEROTEMPORAL|CLOT DETECTION|||Y|FRIEND|PATHOLOGIST|3|Visit_3|40|2|SCREENING|2020-09-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|7|IRV|Inspiratory Reserve Volume|[?]|TRENDELENBURG|||[?]|1|cy/cm|TRICUSPID VALVE, SEPTAL CUSP|UNILATERAL|APICAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|||Y|SPOUSE|FORENSIC PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-10-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|8|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|cL|MYOMETRIUM|LATERAL|INFERIOR|SLIT LAMP PHOTOGRAPHY|||Y|DOMESTIC PARTNER|RADIOLOGIST|4|Visit_4|65|1|TREATMENT|2020-10-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LATERAL DECUBITUS|[?]|TAMPON|[?]|1|mL/g/min|ORBIT|LATERAL|OCCIPITAL|LIGHT SCATTERING SPECTROSCOPY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|5|Visit_5|90|1|SCREENING|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|3aea0861-8f67-4717-93ce-c1e322f151d9|10|MALEVDES|Malignancy Evidence Description|[?]|SEMI-RECUMBENT|||[?]|1|s^-1(%O2)^-1|RIB 10|RIGHT|FORE|HPLC-FL|Y|Y|Y|CLINICAL RESEARCH ASSOCIATE|READER 1|5|Visit_5|90|7|TREATMENT|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|SRAW|Specific Airway Resistance|[?]|STANDING|[?]|10^9 organisms/mg|[?]|1|mg|PARASPINAL REGION|IPSILATERAL|LATERAL|MICRODENSITOMETRY|Y|||CLINICAL STUDY SPONSOR|MICROSCOPIST 3|1|Visit_1|10|1|TREATMENT|2020-10-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|2|RAWPP|Percent Predicted Airway Resistance|[?]|SUPINE|[?]|mg/min|[?]|1|/2500 WBC|RIGHT VENTRICULAR ENDOCARDIUM|LATERAL|UPPER|ORCHIDOMETERY||||INVESTIGATOR|PHYSIOTHERAPIST|1|Visit_1|10|6|SCREENING|2020-10-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|3|SGAW|Specific Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|ng|[?]|1|ug|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|LEFT|VENTROLATERAL|PALM METHOD|Y|Y||INTERVIEWER|RADIOLOGIST 2|2|Visit_2|25|1|WASHOUT|2020-10-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|Gy/h|[?]|1|DNA copies/ug|PALPEBRAL FISSURE|CONTRALATERAL|LOWER FLEXOR SURFACE|KNEMOMETRY|Y|||CHILD|FORENSIC PATHOLOGIST|2|Visit_2|25|1|SCREENING|2020-10-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|5|VO2|Oxygen Consumption|[?]|STANDING|[?]|cP|[?]|1|YEARS|OLFACTORY NERVE|RIGHT|INTERMEDIATE|MIGET||||CAREGIVER|RATER 1|3|Visit_3|40|5|WASHOUT|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|6|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING|[?]|INHALATION|[?]|1|U/dL|RIGHT CORONARY ARTERY OSTIUM|CONTRALATERAL|TEMPORAL|SURFACE PLASMON RESONANCE||||ADJUDICATION COMMITTEE|ONCOLOGIST|3|Visit_3|40|7|WASHOUT|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|7|ERVPP|Percent Predicted ERV|[?]|SEMI-RECUMBENT|[?]|ug/m2|[?]|1|U.CARR|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|IPSILATERAL|ANTEROMEDIAL|MAGNETIC RESONANCE ENTEROGRAPHY||||FRIEND|OPHTHALMOLOGIST|4|Visit_4|65|3|WASHOUT|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|8|SVCPP|Percent Predicted Slow Vital Capacity|[?]|DECUBITUS|[?]|dpm/mg|[?]|1|/LSQN|PUPIL|LATERAL|ANTEROMEDIAL|IMMUNO-PET SCAN||||FRIEND|CARDIOLOGIST|4|Visit_4|65|1|TREATMENT|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|9|ALVVOL|Alveolar Volume|[?]|DECUBITUS|||[?]|1|U/mmol|TRIANGULAR BONE|LEFT|HIND|LASER CAPTURE MICRODISSECTION|Y||Y|PROXY|PATHOLOGIST 1|5|Visit_5|90|3|SCREENING|2020-12-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uL/kg/day|TRAPEZOID-CAPITATE JOINT|LEFT|PROXIMAL VOLAR|TARGETED TRANSCRIPTOME SEQUENCING|Y||Y|PROXY|MICROSCOPIST 3|5|Visit_5|90|4|TREATMENT|2020-12-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|keV|[?]|1|PFU|METACARPAL BONE 2|BILATERAL|ANTEROTEMPORAL|SICKLE CELL SOLUBILITY TEST||||FRIEND|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|2|ERVPP|Percent Predicted ERV|[?]|LATERAL DECUBITUS|[?]|amp|[?]|1|gtt|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|CONTRALATERAL|DORSOLATERAL|PHOTOGRAPHY|Y|||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|3|ERV|Expiratory Reserve Volume|[?]|SUPINE|[?]|Osm|[?]|1|P|RETINAL NERVE FIBER LAYER|CONTRALATERAL|LOWER EXTENSOR SURFACE|STRESS ECHOCARDIOGRAPHY||||SPOUSE|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|4|FEV1FVC|FEV1/FVC|[?]|FOWLERS|[?]|mg/cm2|[?]|1|INHALATION|FUNDUS UTERI|LEFT|ANTEROMEDIAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||VENDOR|PATHOLOGIST 1|2|Visit_2|25|6|TREATMENT|2021-01-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|5|EVC|Expiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/animal|ENDOCARDIUM|BILATERAL|PERIVENTRICULAR|CONTACT SPECULAR MICROSCOPY|||Y|FAMILY MEMBER|RADIOLOGIST 1|3|Visit_3|40|2|TREATMENT|2021-01-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|6|FIV1PP|Percent Predicted FIV1|[?]|UNCONSTRAINED|[?]|/2000 RBC|[?]|1|Absorbance U/min|SEMITENDINOSUS MUSCLE|UNILATERAL|PROXIMAL|AUSCULTATION|Y|Y||INVESTIGATOR|READER 2|3|Visit_3|40|5|TREATMENT|2021-01-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|7|LOBVOLPP|Percent Predicted Lobar Volume|[?]|PRONE|[?]|10^6 organisms/mL|[?]|1|HOURS|PALPEBRAL CONJUNCTIVA|RIGHT|PROXIMAL|BIOIMPEDANCE SPECTROSCOPY||Y||INTERVIEWER|OPTOMETRIST|4|Visit_4|65|2|SCREENING|2021-02-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|UNCONSTRAINED|[?]|mL/animal/day|[?]|1|cmH2O*s2/mL|BRACHIAL ARTERY|LATERAL|LOWER FLEXOR SURFACE|NUCLEIC ACID AMPLIFICATION TEST|Y|Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|4|Visit_4|65|7|TREATMENT|2021-02-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-27
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|9|RAWPP|Percent Predicted Airway Resistance|[?]|DECUBITUS|||[?]|1|APPLICATION|RECTO-UTERINE POUCH|RIGHT|ANTEROTEMPORAL|LISSAMINE GREEN STAIN|||Y|PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|TREATMENT|2021-03-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|10|MEPPP|Percent Predicted MEP|[?]|UNCONSTRAINED|[?]|pg/dL|[?]|1|/day|CORONARY ARTERY, RIGHT|IPSILATERAL|DORSOLATERAL|PLETHYSMOGRAPHY||Y||SIBLING|READER|5|Visit_5|90|5|SCREENING|2021-03-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING, LEGS DEPENDENT|[?]|g/g/day|[?]|1|GBq/g|T7 VERTEBRA|CONTRALATERAL|MEDIAL|OLIGO ACGH||||CLINICAL STUDY SPONSOR|ADJUDICATOR|1|Visit_1|10|4|WASHOUT|2020-09-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|2|ALVVOL|Alveolar Volume|[?]|STANDING|[?]|U/mg|[?]|1|/MBP|ADRENAL GLAND|UNILATERAL|MIDLINE|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||FAMILY MEMBER|UROLOGIST|1|Visit_1|10|7|TREATMENT|2020-09-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|3|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|||[?]|1|GBq/g|LIVER, LEFT LOBE|BILATERAL|SUBCORTICAL|MANUAL CLOT DETECTION|||Y|ADJUDICATOR|MICROSCOPIST|2|Visit_2|25|6|WASHOUT|2020-10-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|4|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|TAMPON|RESPIRATORY SYSTEM|BILATERAL|BASAL|DISK DIFFUSION|||Y|PARENT|NEUROLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-10-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SLING|[?]|DIOPTER|[?]|1|mL/min/1.73m2|BUCCAL MUCOSA|BILATERAL|VOLAR|TEST STRIP||||INVESTIGATOR|RATER|3|Visit_3|40|1|TREATMENT|2020-10-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|6|ERV|Expiratory Reserve Volume|[?]|PRONE|[?]|MPS U|[?]|1|mg/mL/min|FORELIMB|CONTRALATERAL|SUBCORTICAL|PET/MRI SCAN||||CLINICAL RESEARCH ASSOCIATE|INTERNIST|3|Visit_3|40|5|TREATMENT|2020-10-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|GBq|[?]|1|vg/mL|BLADDER WALL|RIGHT|LOWER|MICROARRAY|Y|||DOMESTIC PARTNER|RADIOLOGIST 1|4|Visit_4|65|6|SCREENING|2020-11-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/dL|[?]|1|g/g|PLEURAL CAVITY|BILATERAL|LATERAL|ELISA||Y||CLINICAL STUDY SPONSOR|NEUROLOGIST 1|4|Visit_4|65|7|SCREENING|2020-11-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|9|TLC|Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|EU|[?]|1|kBq|URETHRA, POSTERIOR|RIGHT|PARIETO-OCCIPITAL|TRIPLE-PHASE MRI SCAN|Y|Y||GUARDIAN|PATHOLOGIST 1|5|Visit_5|90|1|TREATMENT|2020-12-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|39f51bd8-5edc-4434-92d4-7d8b683a6c32|10|PLMBLFLW|Pulmonary Blood Flow|[?]|LEFT LATERAL DECUBITUS|[?]|/LSQN|[?]|1|mg/kg/dose|GREATER CURVATURE OF THE STOMACH|UNILATERAL|UPPER FLEXOR SURFACE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y|||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2020-12-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|UNCONSTRAINED|||[?]|1|mg/L|INTRAHEPATIC BILE DUCT|UNILATERAL|INTERMEDIATE|CALIPER MEASUREMENT METHOD|Y||Y|ADJUDICATOR|PHYSIOTHERAPIST|1|Visit_1|10|7|FOLLOW-UP|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|10^6 RNA copies/mL|[?]|1|mU/g|CAROTID ARTERY|BILATERAL|ROSTRAL|EEG|Y|Y||CLINICAL STUDY SPONSOR|OPTOMETRIST|1|Visit_1|10|2|TREATMENT|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING, BENT FORWARD|[?]|SYRINGE|[?]|1|in|LIVER, QUADRATE LOBE|CONTRALATERAL|INTERMEDIATE|CONTRAST ENHANCED SPIRAL CT SCAN||Y||SIBLING|RADIOLOGIST 2|2|Visit_2|25|5|FOLLOW-UP|2021-02-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|4|MEP|Maximal Expiratory Pressure|[?]|REVERSE TRENDELENBURG|[?]|DAgU/mL|[?]|1|KALLIKREIN INHIBITOR UNIT|SUPRATENTORIAL BRAIN|CONTRALATERAL|ROSTRAL|REVERSE TRANSCRIPTASE PCR||||CLINICAL RESEARCH COORDINATOR|RATER 1|2|Visit_2|25|3|TREATMENT|2021-02-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|5|FEV_PEF|FEV at PEF|[?]|LEFT LATERAL DECUBITUS|||[?]|1|PFU/dose|PERIPHERAL NERVE|LEFT|DORSOLATERAL|CLOT DETECTION|||Y|NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|3|Visit_3|40|3|WASHOUT|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|cup eq|[?]|1|kcal|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|LEFT|VOLAR|COULOMETRIC TITRATION||||SPOUSE|ADJUDICATOR 2|3|Visit_3|40|4|WASHOUT|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|[?]|kg/L|[?]|1|oz eq|CORONARY ARTERY|IPSILATERAL|PERIVENTRICULAR|GIEMSA STAIN|Y|Y||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|4|Visit_4|65|6|TREATMENT|2021-03-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|8|PEF|Peak Expiratory Flow|[?]|SITTING|[?]|FIU|[?]|1|Watt|SKIN OF THE BENDING JOINT|LATERAL|SUBCORTICAL|ENDOSCOPY||Y||SIGNIFICANT OTHER|NEUROLOGIST|4|Visit_4|65|6|WASHOUT|2021-03-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|9|IVC|Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|mU/g|[?]|1|Ci|FAT PAD|BILATERAL|TEMPORAL|MANUAL COUNT|Y|||DOMESTIC PARTNER|ADJUDICATOR|5|Visit_5|90|1|WASHOUT|2021-04-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|80565a22-8cec-46a2-abd7-91daf0767035|10|PEFREV|PEF Reversibility|[?]|SITTING|||[?]|1|kcal|POSTEROLATERAL SEGMENTAL ARTERY|UNILATERAL|INNER|DYNAMOMETRY|||Y|SIBLING|MICROSCOPIST 1|5|Visit_5|90|7|TREATMENT|2021-04-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|U/g/day|[?]|1|ppth|PUTAMEN|UNILATERAL|VENTROLATERAL|BIOIMPEDANCE SPECTROSCOPY||Y||CLINICAL STUDY SPONSOR|ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2020-10-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|mEq/g|[?]|1|MPL U|XIPHOID PROCESS|RIGHT|DEEP|ENDPOINT DILUTION ASSAY|Y|Y||CAREGIVER|CLINICAL PATHOLOGIST|1|Visit_1|10|7|SCREENING|2020-10-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mAmp|L2 VERTEBRA|UNILATERAL|APICAL|CARDIAC THERMODILUTION|Y||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|2|Visit_2|25|5|TREATMENT|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|4|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|Log10 ELISA unit|[?]|1|mL/animal/wk|CEREBRAL HEMISPHERE, RIGHT|CONTRALATERAL|PERIPHERAL|MRI||||DOMESTIC PARTNER|NEUROLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|5|PEFREV|PEF Reversibility|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|deg|CEREBRAL HEMISPHERE, RIGHT|UNILATERAL|CAUDAL|FLUORESCENT IMMUNOASSAY|||Y|CHILD|PATHOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|6|MEP|Maximal Expiratory Pressure|[?]|SITTING, LEGS DEPENDENT|[?]|mL/cm3/min|[?]|1|L/s|T1 VERTEBRA|BILATERAL|FACIAL|NEURAMINIDASE INHIBITION ASSAY|Y|||CHILD|MICROSCOPIST 1|3|Visit_3|40|3|TREATMENT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|7|DLCOPP|Percent Predicted DLCO|[?]|DECUBITUS|[?]|mg/L|[?]|1|CAPLET|SEMITENDINOSUS MUSCLE|CONTRALATERAL|ANTEROLATERAL|IN VITRO GENE EXPRESSION ASSAY|Y|||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|4|Visit_4|65|4|TREATMENT|2020-12-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|mL/sec/1.73m2|[?]|1|log10 CFU/g|CENTRAL NERVOUS SYSTEM|BILATERAL|PROXIMAL VOLAR|CHROMOGENIC ASSAY||||INDEPENDENT ASSESSOR|RATER 2|4|Visit_4|65|4|TREATMENT|2020-12-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|9|DLCO|Diffusion Capacity of Lung for CO|[?]|STANDING|[?]|uIU/dL|[?]|1|100 IU/mL|MALE GENITALIA|BILATERAL|FORE|GC/FID||||ADJUDICATOR|PATHOLOGIST 2|5|Visit_5|90|3|TREATMENT|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|585a254e-c36b-44cf-b8a9-335fb98e0fd2|10|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|cP|[?]|1|mL/mmHg|SKIN BETWEEN EYEBROWS|IPSILATERAL|INFERIOR|IMPEDANCE CONDUCTIVITY||Y||CAREGIVER|CLINICAL PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|DAYS|BICEPS FEMORIS MUSCLE|BILATERAL|LATERAL|DXA SCAN|||Y|FRIEND|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|2|IVCPP|Percent Predicted IVC|[?]|TRENDELENBURG|[?]|ms/mmHg|[?]|1|anti-Xa IU|PERIPHERAL NERVE|BILATERAL|LOWER|CARDIAC THERMODILUTION||||INDEPENDENT ASSESSOR|MICROSCOPIST 2|1|Visit_1|10|3|TREATMENT|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING|[?]|lx|[?]|1|10^12 IU/L|PALATINE BONE|UNILATERAL|PROXIMAL|DARK FIELD MICROSCOPY|Y|||FAMILY MEMBER|DERMATOLOGIST|2|Visit_2|25|1|TREATMENT|2020-09-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|4|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|umol/L|[?]|1|nkat/g Hb|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|RIGHT|INFERIOR|HPLC|Y|||VENDOR|MICROSCOPIST 2|2|Visit_2|25|7|TREATMENT|2020-09-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|5|AWWVOL|Airway Wall Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mg2/dL2|PENIS, RADIX|BILATERAL|INFERIOR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||Y|INDEPENDENT ASSESSOR|HEMATOLOGIST|3|Visit_3|40|7|TREATMENT|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|6|FEV3PP|Percent Predicted FEV3|[?]|STANDING|[?]|mg/kg/day|[?]|1|IU/kg/h|OVARIAN FOLLICLE|CONTRALATERAL|SUPERIOR|NEURAMINIDASE INHIBITION ASSAY||||PARENT|NEUROLOGIST 2|3|Visit_3|40|5|WASHOUT|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|7|FIO2|Fraction of Inspired Oxygen|[?]|SLING|[?]|uU/dL|[?]|1|10^6 DNA copies/mL|LIVER, QUADRATE LOBE|LATERAL|SURFACE|ULTRASONOGRAPHIC ELASTOGRAPHY||||VENDOR|OPHTHALMOLOGIST|4|Visit_4|65|7|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|8|TV|Tidal Volume|[?]|SLING|[?]|deg/s|[?]|1|GBq/mg|SCAPULA|CONTRALATERAL|VENTRAL|CRYOSCOPY|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST 2|4|Visit_4|65|7|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|9|IRVPP|Percent Predicted IRV|[?]|FOWLERS|||[?]|1|1/(s*kPa)|METACARPAL BONE|RIGHT|POSTERIOR|IODINE STAIN|Y||Y|CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|5|Visit_5|90|1|TREATMENT|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|9ee3632d-4e99-4a46-b0b9-237467d97ca0|10|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|[?]|mOsm/kg|[?]|1|mL/m2/h|PUTAMEN|BILATERAL|APICAL|PHYSICAL EXAMINATION|Y|||PARENT|ADJUDICATOR 3|5|Visit_5|90|5|TREATMENT|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|FEV1FVC|FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|cd|LEFT CIRCUMFLEX CORONARY ARTERY|LEFT|LOWER MEDIAL|FLUORESCENT SPOT TEST|Y||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST|1|Visit_1|10|4|TREATMENT|2020-06-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|2|AWVOL|Airway Volume|[?]|LATERAL DECUBITUS|[?]|kIU|[?]|1|um2|DIAPHRAGM|RIGHT|OUTER|ANALYTICAL ULTRACENTRIFUGATION||Y||INDEPENDENT ASSESSOR|MICROSCOPIST 1|1|Visit_1|10|4|TREATMENT|2020-06-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING|[?]|g/kg/day|[?]|1|nm|CERVIX UTERI|BILATERAL|ROSTRAL|EPSILOMETER||Y||SPOUSE|DERMATOLOGIST|2|Visit_2|25|2|TREATMENT|2020-07-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SITTING|[?]|PELLET|[?]|1|10^5/L|SUPRASPINATUS MUSCLE|LATERAL|UPPER EXTENSOR SURFACE|LISSAMINE GREEN STAIN||Y||INVESTIGATOR|OPTOMETRIST|2|Visit_2|25|3|TREATMENT|2020-07-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|5|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|[?]|F|[?]|1|mCi|TROCHLEAR NERVE|CONTRALATERAL|ANTEROPOSTERIOR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-07-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|6|MALIND|Malignancy Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|mEq/mmol|[?]|1|psi|TEMPORAL LOBE|CONTRALATERAL|LOWER EXTENSOR SURFACE|POPULATION SEQUENCING||||PROXY|UROLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|7|DLCOVAPP|Percent Predicted DLCO/VA|[?]|PRONE|||[?]|1|mg/mL/min|COMMON ILIAC ARTERY|UNILATERAL|LOWER MEDIAL|RULER MEASUREMENT METHOD|Y||Y|DOMESTIC PARTNER|MICROSCOPIST 1|4|Visit_4|65|3|TREATMENT|2020-08-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|8|ICREV|IC Reversibility|[?]|DECUBITUS|[?]|g/kg|[?]|1|amu|ASCENDING AORTA|LATERAL|DISTAL|ENZYMATIC COLORIMETRY||||PARENT|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2020-08-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|9|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|g/m2/day|[?]|1|mEq/g|TROCHLEAR NERVE|RIGHT|FACIAL|THIN SMEAR||||SPOUSE|RADIOLOGIST 1|5|Visit_5|90|4|TREATMENT|2020-09-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|10|AWVOLPP|Percent Predicted Airway Volume|[?]|PRONE|[?]|DAgU|[?]|1|EU|RADIUS SHAFT|UNILATERAL|LOWER EXTENSOR SURFACE|CRYOSCOPY|Y|||CAREGIVER|ADJUDICATOR 1|5|Visit_5|90|7|TREATMENT|2020-09-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|QUASCOMP|Quasi-Static Compliance|[?]|LEFT LATERAL DECUBITUS|[?]|in2|[?]|1|V/sec|FLEXOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|SUPERIOR|DUCTOGRAPHY||Y||CHILD|CLINICAL PATHOLOGIST|1|Visit_1|10|3|SCREENING|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|VIRTUAL PIXEL|[?]|1|L/kg|ANKLE MORTISE|LATERAL|SUPERFICIAL|HIGH RESOLUTION MELT ANALYSIS||||INTERVIEWER|PATHOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|3|SGAW|Specific Airway Conductance|[?]|SEMI-RECUMBENT|[?]|/5x10^4 WBC|[?]|1|U/dL|SUBTALAR JOINT|IPSILATERAL|UPPER|CHROMOGENIC ASSAY||||SPOUSE|CARDIOLOGIST|2|Visit_2|25|2|TREATMENT|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|4|ERV|Expiratory Reserve Volume|[?]|SEMI-RECUMBENT|[?]|EID 50/mL|[?]|1|10^9 organisms|METACARPAL BONE 1|UNILATERAL|ANTEROMEDIAL|DXA SCAN||Y||HEALTH CARE PROFESSIONAL|READER 2|2|Visit_2|25|1|TREATMENT|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|5|RER|Respiratory Exchange Ratio|[?]|STANDING|[?]|g/g/day|[?]|1|mph|COLON, SIGMOID|UNILATERAL|PROXIMAL VOLAR|FORCED OSCILLATION TECHNIQUE|Y|||INVESTIGATOR|ONCOLOGIST|3|Visit_3|40|3|SCREENING|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|6|MIPPP|Percent Predicted MIP|[?]|SUPINE|||[?]|1|PACKET|INTERPHALANGEAL JOINT 5|BILATERAL|PERIVENTRICULAR|IMMUNOCHROMATOGRAPHY|Y||Y|PARENT|MICROSCOPIST|3|Visit_3|40|6|SCREENING|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|7|QUASCOMP|Quasi-Static Compliance|[?]|STANDING, BENT FORWARD|||[?]|1|pmol/day|SHOULDER JOINT|UNILATERAL|SURFACE|SLOAN LETTER EYE CHART 2.5%|||Y|DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|3|TREATMENT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|8|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|mg/kg|[?]|1|10^6 organisms/mg|PITUITARY GLAND|RIGHT|OUTER|IMMUNORADIOMETRIC ASSAY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|4|Visit_4|65|4|TREATMENT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|9|FEV6PP|Percent Predicted FEV6|[?]|UNCONSTRAINED|[?]|PFU/dose|[?]|1|ppm|FOREBRAIN|BILATERAL|SUPERFICIAL|AUDIOMETRY||||SPOUSE|PATHOLOGIST 2|5|Visit_5|90|1|WASHOUT|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|34b2090b-13ac-4fb2-8d87-eca2839a62f2|10|FRCPP|Percent Predicted FRC|[?]|PRONE|[?]|pg/dL|[?]|1|uCi/kg|MEDIASTINUM, POSTERIOR|LATERAL|DISTAL|MICROBIAL CULTURE, SOLID||||CLINICAL STUDY SPONSOR|MICROSCOPIST|5|Visit_5|90|7|TREATMENT|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|FEV3PP|Percent Predicted FEV3|[?]|STANDING, BENT FORWARD|[?]|anti-Xa IU/mL|[?]|1|AgU/mL|CEREBRUM|IPSILATERAL|LATERAL|INFRARED SPECTROMETRY||Y||FAMILY MEMBER|MICROSCOPIST 1|1|Visit_1|10|3|FOLLOW-UP|2020-07-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|2|FEF2575P|Percent Predicted FEF25-75|[?]|LATERAL DECUBITUS|||[?]|1|U/L|EPITROCHLEAR LYMPH NODE|RIGHT|INNER|IHC|Y|Y|Y|ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|WASHOUT|2020-07-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mL/dose|SPINAL CORD|BILATERAL|LOWER|SINGLE-SLICE SPIRAL CT|||Y|VENDOR|RADIOLOGIST 2|2|Visit_2|25|5|SCREENING|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|4|FRC|Functional Residual Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 DNA copies/mL|[?]|1|fmol|PROFUNDA FEMORIS ARTERY|LEFT|POSTERIOR|FLUORIMETRY||||INDEPENDENT ASSESSOR|UROLOGIST|2|Visit_2|25|7|WASHOUT|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|ug/m2/h|[?]|1|cd/m2|ANKLE MORTISE|BILATERAL|LOWER EXTENSOR SURFACE|CT SCAN WITHOUT CONTRAST||||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|U/kg/h|[?]|1|fmol/L/sec|SCAPULA|LATERAL|VOLAR|FLAME PHOTOMETRY|Y|||ADJUDICATION COMMITTEE|CARDIOLOGIST|3|Visit_3|40|1|TREATMENT|2020-08-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|||[?]|1|BP|THROAT|LEFT|PROXIMAL|POLYSOMNOGRAPHY||Y|Y|PARENT|ONCOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-09-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|8|FVC|Forced Vital Capacity|[?]|FOWLERS|[?]|ug/m2/h|[?]|1|umol/mg/min|PULMONARY VALVE, RIGHT CUSP|UNILATERAL|DORSAL|DIFFUSION WEIGHTED MRI||||FRIEND|PATHOLOGIST|4|Visit_4|65|3|WASHOUT|2020-09-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SLING|[?]|eq|[?]|1|Ejaculate U|PERICARDIAL LYMPH NODE|LATERAL|SUBCORTICAL|TEMPLATE INCISION METHOD||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|5|Visit_5|90|2|WASHOUT|2020-10-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|bfc19b4b-51bb-4056-9195-8bd2db53a497|10|FIF25|Forced Inspiratory Flow at 25%|[?]|REVERSE TRENDELENBURG|||[?]|1|Ci/g|GLENOID FOSSA|UNILATERAL|LOWER|MICRO BROTH DILUTION|Y||Y|SPOUSE|UROLOGIST|5|Visit_5|90|7|TREATMENT|2020-10-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|[?]|10^9/g|[?]|1|ug/animal|ENDOCARDIUM|BILATERAL|CAUDAL|PH METER MEASUREMENT METHOD||Y||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|1|Visit_1|10|6|WASHOUT|2020-09-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|2|PNIF|Peak Nasal Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|Bq/L|[?]|1|mkat|DISTAL INTERPHALANGEAL JOINT 5|IPSILATERAL|SUPERFICIAL|RADIOIMMUNOPRECIPITATION ASSAY||||SIGNIFICANT OTHER|MICROSCOPIST 1|1|Visit_1|10|5|TREATMENT|2020-09-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|3|FEF50|Forced Expiratory Flow 50%|[?]|DECUBITUS|[?]|mmol2/L2|[?]|1|10^3/L|SEMITENDINOSUS MUSCLE|UNILATERAL|SUPERIOR|PHASE-CONTRAST MRI||||GUARDIAN|PHYSIOTHERAPIST|2|Visit_2|25|4|FOLLOW-UP|2020-10-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|4|TGV|Thoracic Gas Volume|[?]|SLING|||[?]|1|uOsm|LEFT VENTRICULAR EPICARDIUM|BILATERAL|OUTER|ACRIDINE ORANGE STAIN||Y|Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-10-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|5|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|fmol/L|SECOND RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|OCCIPITAL|OPTICAL COHERENCE TOMOGRAPHY|||Y|PROXY|UROLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|6|FEV_PEF|FEV at PEF|[?]|SUPINE|||[?]|1|oz|T5 VERTEBRA|LATERAL|INTERMEDIATE|CINEANGIOGRAPHY|||Y|FAMILY MEMBER|NEUROLOGIST 2|3|Visit_3|40|2|TREATMENT|2020-10-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|7|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-FOWLERS|[?]|mL/(min*100mL)|[?]|1|Osm|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|CAUDAL|ENDOSCOPY||||ADJUDICATOR|MICROSCOPIST 1|4|Visit_4|65|2|FOLLOW-UP|2020-11-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SLING|||[?]|1|ng/mol|LIVER, RIGHT LOBE|IPSILATERAL|CAUDAL|ANGIOGRAPHY|||Y|SIGNIFICANT OTHER|READER 3|4|Visit_4|65|3|TREATMENT|2020-11-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|FOWLERS|[?]|mCi/kg|[?]|1|g/dL|EPICONDYLE|IPSILATERAL|SUPERIOR|WRIGHT STAIN||||INVESTIGATOR|READER 1|5|Visit_5|90|7|TREATMENT|2020-12-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING|||[?]|1|10^6 CFU/mL|SIGMOID SINUS|RIGHT|DISTAL VOLAR|FREEZING POINT DEPRESSION|||Y|INTERVIEWER|ADJUDICATOR 1|5|Visit_5|90|1|TREATMENT|2020-12-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|||[?]|1|SQU/mL|PINEAL GLAND|LATERAL|DISTAL|HEMAGGLUTINATION ASSAY|||Y|SIBLING|ENDOCRINOLOGIST|1|Visit_1|10|3|TREATMENT|2020-09-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|2|INTP|Interpretation|[?]|SITTING|||[?]|1|nmol/mol|BILIARY TRACT|IPSILATERAL|FORE|DROPLET DIGITAL PCR|Y||Y|PARENT|CARDIOLOGIST|1|Visit_1|10|7|WASHOUT|2020-09-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|3|DLCOHC|HGB Corrected DLCO|[?]|SLING|[?]|C|[?]|1|ugEq|POPLITEAL FOSSA|IPSILATERAL|SUBCORTICAL|PERIODIC ACID SCHIFF STAIN||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|4|SVC|Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|g/cage|[?]|1|APL U/mL|RECTO-UTERINE POUCH|RIGHT|CENTRAL|CALCULATION|Y|||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SEMI-FOWLERS|[?]|nm|[?]|1|U/mL|MIDDLE EAR|CONTRALATERAL|UPPER FLEXOR SURFACE|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||ADJUDICATION COMMITTEE|NEUROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|6|ALVVOL|Alveolar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mg/dL|[?]|1|ft3|URETERIC ORIFICE|RIGHT|MIDLINE|MICRODENSITOMETRY||||HEALTH CARE PROFESSIONAL|RATER 1|3|Visit_3|40|2|TREATMENT|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|7|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|10^3 copies/mL|[?]|1|pkat|AXILLARY LYMPH NODE|CONTRALATERAL|PERIPHERAL|CONTACT SPECULAR MICROSCOPY|Y|||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|8|EFFVOL|Effusion Volume|[?]|FOWLERS|||[?]|1|pkat|FRONTAL LOBE|BILATERAL|ANTEROMEDIAL|DUKE INCISION METHOD|||Y|CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|9|PIF|Peak Inspiratory Flow|[?]|UNCONSTRAINED|||[?]|1|BAU/mL|L3 VERTEBRA|LATERAL|PROXIMAL|HILLMEN COLOR CHART|Y|Y|Y|CLINICAL RESEARCH ASSOCIATE|UROLOGIST|5|Visit_5|90|6|SCREENING|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|64a70103-14bf-42f4-808b-fbdecec8bd4f|10|PEF|Peak Expiratory Flow|[?]|DECUBITUS|[?]|APL U|[?]|1|MPL U|JOINT|UNILATERAL|LOWER EXTENSOR SURFACE|ICC|Y|||GUARDIAN|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|SCREENING|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|RER|Respiratory Exchange Ratio|[?]|SEMI-FOWLERS|[?]|10^6 copies/mL|[?]|1|MBq/uL|SKIN OF THE INFRASCAPULAR REGION|UNILATERAL|LOWER EXTENSOR SURFACE|MS/MS|Y|||PARENT|RATER|1|Visit_1|10|7|TREATMENT|2021-01-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|2|MIPPP|Percent Predicted MIP|[?]|SLING|[?]|10^4 CFU|[?]|1|ug/L DDU|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|LATERAL|VENTROLATERAL|PLETHYSMOGRAPHY|Y|||INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|5|TREATMENT|2021-01-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|3|RELSZCHG|Relative Size Change|[?]|SLING|[?]|RNA copies/mL|[?]|1|mL/m2/min|FOOT DIGIT 1|UNILATERAL|FACIAL|WESTERGREN||||INVESTIGATOR|ONCOLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-RECUMBENT|[?]|U/mg|[?]|1|log10 CFU/g|SKIN OF THE NECK|LATERAL|APICAL|BIOPSY||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|2|Visit_2|25|4|FOLLOW-UP|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|5|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|mL/h|[?]|1|mV/sec|QUADRICEPS MUSCLE|RIGHT|ANTEROTEMPORAL|KLEIHAUER-BETKE||Y||CLINICAL RESEARCH COORDINATOR|UROLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|||[?]|1|IU/mL|CALCANEUS|LATERAL|ANTEROMEDIAL|TURBIDIMETRY|Y|Y|Y|INTERVIEWER|PATHOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|LEFT LATERAL DECUBITUS|[?]|cm/s|[?]|1|VIAL|SKIN OF THE HAND|UNILATERAL|MIDLINE|WHOLE EXOME SEQUENCING||||VENDOR|MICROSCOPIST 2|4|Visit_4|65|1|TREATMENT|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LEFT LATERAL DECUBITUS|[?]|/100 WBC|[?]|1|mmHg/L/min|LARYNX|UNILATERAL|MEDIAL|IMPULSE OSCILLOMETRY|Y|||FAMILY MEMBER|UROLOGIST|4|Visit_4|65|7|SCREENING|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|ug/min|[?]|1|MET*h|EXTRAHEPATIC BILE DUCT|BILATERAL|UPPER EXTENSOR SURFACE|THIN SMEAR||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|5|Visit_5|90|4|SCREENING|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|00f3949b-b14a-47c5-942c-2ab71e03e40f|10|IRVPP|Percent Predicted IRV|[?]|RIGHT LATERAL DECUBITUS|[?]|MONTHS|[?]|1|g/day|L5 VERTEBRA|IPSILATERAL|DISTAL|NUCLEIC ACID SEQUENCING||||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|5|Visit_5|90|3|SCREENING|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|LOBVOL|Lobar Volume|[?]|TRENDELENBURG|[?]|Arbitrary U|[?]|1|NFIU|ANTERIOR SUPERIOR ILIAC SPINE|UNILATERAL|SUPERIOR|ELECTROMYOGRAPHY||Y||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|2|FIF75|Forced Inspiratory Flow at 75%|[?]|FOWLERS|||[?]|1|YEARS|LUNG, LEFT LOWER LOBE|IPSILATERAL|ANTEROTEMPORAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|GUARDIAN|NEUROLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|3|INERTANC|Inertance|[?]|FOWLERS|[?]|/kg|[?]|1|cmHg|DISTAL COMMON BILE DUCT|CONTRALATERAL|PROXIMAL|NUCLEIC ACID AMPLIFICATION TEST||||PROXY|HEMATOLOGIST|2|Visit_2|25|3|TREATMENT|2021-01-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mg/kg/h|ACUTE MARGINAL ARTERY|LATERAL|NASAL|GC/MS-CI||Y|Y|PARENT|ONCOLOGIST 1|2|Visit_2|25|3|TREATMENT|2021-01-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SLING|[?]|g/day|[?]|1|PFU/animal|SOFT PALATE|IPSILATERAL|DEEP|FLUORESCENT IMMUNOASSAY||Y||SPOUSE|UROLOGIST|3|Visit_3|40|5|FOLLOW-UP|2021-01-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|ug/mL/h|[?]|1|mV2/Hz|MIDBRAIN|IPSILATERAL|UPPER EXTENSOR SURFACE|KARYOTYPING||Y||VENDOR|READER 2|3|Visit_3|40|6|FOLLOW-UP|2021-01-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-23
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|7|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|10^9 CFU/mL|[?]|1|mL/s/m2|AXILLA|LEFT|DISTAL VOLAR|IN SITU HYBRIDIZATION||||VENDOR|ADJUDICATOR 1|4|Visit_4|65|6|FOLLOW-UP|2021-02-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|8|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|log10 PFU/mL|[?]|1|ukat/10^12 RBC|FALCIFORM LIGAMENT|CONTRALATERAL|UPPER EXTENSOR SURFACE|ENZYMATIC ULTRACENTRIFUGATION||Y||GUARDIAN|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2021-02-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|UNCONSTRAINED|[?]|mm3/mm2/year|[?]|1|ug/m2/min|LUNG, LEFT LOWER LOBE|IPSILATERAL|HIND|PATHOLOGICAL EVALUATION|Y|||CAREGIVER|DERMATOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|10|INTP|Interpretation|[?]|TRENDELENBURG|[?]|AFU|[?]|1|APL U/mL|CINGULATE CORTEX|RIGHT|OCCIPITAL|GRAM STAIN||||PROXY|ONCOLOGIST 1|5|Visit_5|90|7|SCREENING|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|TSUHYS|Tissue Hysteresivity|[?]|REVERSE TRENDELENBURG|[?]|ugEq|[?]|1|mL/animal/wk|SPINOUS PROCESS|LATERAL|SURFACE|WHOLE TRANSCRIPTOME SEQUENCING||||STUDY SUBJECT|READER 3|1|Visit_1|10|3|FOLLOW-UP|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|2|MIPPP|Percent Predicted MIP|[?]|SLING|[?]|breaths/min|[?]|1|Siemens|RETROCRURAL LYMPH NODE|LATERAL|LOWER MEDIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||INDEPENDENT ASSESSOR|READER|1|Visit_1|10|5|TREATMENT|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|3|FEV1SVC|FEV1/SVC|[?]|LATERAL DECUBITUS|[?]|U/g|[?]|1|C|LARGE INTESTINE|CONTRALATERAL|APICAL|MRI WITHOUT CONTRAST|Y|||DOMESTIC PARTNER|NEUROLOGIST 2|2|Visit_2|25|4|WASHOUT|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|4|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|APPLICATION|[?]|1|Hounsfield Unit|URINARY SYSTEM|LATERAL|SURFACE|IN VITRO GENE EXPRESSION ASSAY||||STUDY SUBJECT|RADIOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|CUP|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|PROXIMAL VOLAR|IMMUNO-PET SCAN|||Y|SPOUSE|OTOLARYNGOLOGIST|3|Visit_3|40|7|TREATMENT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|6|DLCOPP|Percent Predicted DLCO|[?]|SITTING|||[?]|1|HEP|EAR, OUTER|CONTRALATERAL|PROXIMAL VOLAR|ENZYMATIC ULTRACENTRIFUGATION|Y||Y|FAMILY MEMBER|ONCOLOGIST|3|Visit_3|40|7|WASHOUT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|7|TV|Tidal Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|BE/mL|BACK|RIGHT|ANTEROMEDIAL|MAGNETIC RESONANCE ELASTOGRAPHY|||Y|CLINICAL RESEARCH COORDINATOR|READER 3|4|Visit_4|65|5|TREATMENT|2020-09-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|8|SRAW|Specific Airway Resistance|[?]|FOWLERS|[?]|PNU/mL|[?]|1|10^6 organisms/mg|THYMUS GLAND|CONTRALATERAL|ANTEROMEDIAL|CLIP SEQUENCING||||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-09-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|/500 WBC|[?]|1|anti-Xa IU|PROSTATE GLAND, MIDDLE LOBE|LEFT|TIP|SXA SCAN||||STUDY SUBJECT|PATHOLOGIST 1|5|Visit_5|90|3|SCREENING|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|APL U/mL|[?]|1|10^3 DNA copies/mL|HAND|IPSILATERAL|OUTER|DIRECT SEQUENCING||Y||FAMILY MEMBER|MICROSCOPIST 1|5|Visit_5|90|5|WASHOUT|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|Absorbance U/min|[?]|1|tuberculin unit|METATARSOPHALANGEAL JOINT 4|BILATERAL|LOWER EXTENSOR SURFACE|IRON HEMATOXYLIN STAIN||||HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|2|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING|||[?]|1|SBE/mL|CORONARY ARTERY, RIGHT|UNILATERAL|ANTEROMEDIAL|WHOLE GENOME SEQUENCING|Y|Y|Y|VENDOR|PATHOLOGIST 1|1|Visit_1|10|1|SCREENING|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|3|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|TRENDELENBURG|[?]|nCi|[?]|1|g/animal/day|SKIN OF THE FACE|BILATERAL|ANTEROTEMPORAL|FLUORESCENT ENZYME IMMUNOASSAY||||INVESTIGATOR|INTERNIST|2|Visit_2|25|6|FOLLOW-UP|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|TRENDELENBURG|[?]|ug/m2/day|[?]|1|mEq/ug|FOOT DIGIT 2|LATERAL|DORSOLATERAL|MICROBIAL CONCENTRATION||||ADJUDICATOR|ADJUDICATOR 2|2|Visit_2|25|5|TREATMENT|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|5|DLCOHCVA|HGB Corrected DLCO/VA|[?]|PRONE|[?]|ng/dL|[?]|1|EVENTS|COCCYX|BILATERAL|UPPER EXTENSOR SURFACE|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||CLINICAL STUDY SPONSOR|RADIOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|6|IRV|Inspiratory Reserve Volume|[?]|UNCONSTRAINED|||[?]|1|U/cL|ESOPHAGUS, CERVICAL|LATERAL|TEMPORAL|DXA SCAN|||Y|INTERVIEWER|RADIOLOGIST 2|3|Visit_3|40|5|WASHOUT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|7|RV|Residual Volume|[?]|LATERAL DECUBITUS|||[?]|1|dyn|DISTAL PHALANX 5 OF THE HAND|LATERAL|FORE|TEST STRIP|Y||Y|CAREGIVER|RADIOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-09-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|8|QUASCOMP|Quasi-Static Compliance|[?]|REVERSE TRENDELENBURG|[?]|ug/g/min|[?]|1|10^9 CFU/mL|TEMPORAL BONE|BILATERAL|NASAL|POLYGRAPHY||||INDEPENDENT ASSESSOR|READER 2|4|Visit_4|65|2|TREATMENT|2020-09-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|DECUBITUS|[?]|IU/L|[?]|1|10^6 organisms/mL|BRACHIORADIALIS MUSCLE|RIGHT|ANTEROPOSTERIOR|STRESS ECHOCARDIOGRAPHY||||SIGNIFICANT OTHER|PHYSIOTHERAPIST|5|Visit_5|90|5|WASHOUT|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|44ca1fe6-76d2-4a94-9854-1ddbde638803|10|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|MHz|[?]|1|GPL U/mL|GASTROINTESTINAL TRACT, LOWER|IPSILATERAL|CENTRAL|TRYPAN BLUE STAIN||||INTERVIEWER|RADIOLOGIST 2|5|Visit_5|90|5|FOLLOW-UP|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SLING|[?]|/mm2|[?]|1|PHERESIS UNIT|PANCREAS, TAIL|IPSILATERAL|LOWER FLEXOR SURFACE|ANALYTICAL ULTRACENTRIFUGATION||||SIBLING|RADIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|2|FEV3FVC|FEV3/FVC|[?]|SEMI-RECUMBENT|[?]|mV/sec|[?]|1|L/h|SPINAL ACCESSORY NERVE|RIGHT|FORE|PEAK FLOWMETRY||||SIBLING|MICROSCOPIST 1|1|Visit_1|10|1|FOLLOW-UP|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LATERAL DECUBITUS|||[?]|1|mm2|MITRAL VALVE, POSTERIOR ANNULUS|BILATERAL|NASAL|DOPPLER ULTRASOUND|||Y|NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|IU/L|[?]|1|s*kPa|CECUM|BILATERAL|DORSOLATERAL|NEURAMINIDASE INHIBITION ASSAY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-12-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|5|FEV_PEF|FEV at PEF|[?]|STANDING, BENT FORWARD|||[?]|1|mmol/g|COMMON ILIAC ARTERY|BILATERAL|PERIVENTRICULAR|HPLC-FL|||Y|INTERVIEWER|OPHTHALMOLOGIST|3|Visit_3|40|5|TREATMENT|2021-01-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|6|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|[?]|Hz|[?]|1|MBq/uL|BUCCAL LYMPH NODE|CONTRALATERAL|APICAL|PH METER MEASUREMENT METHOD||||ADJUDICATION COMMITTEE|MICROSCOPIST 3|3|Visit_3|40|1|TREATMENT|2021-01-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|Bq/g|[?]|1|km|OSTIOMEATAL COMPLEX|BILATERAL|VENTRAL|RULER MEASUREMENT METHOD|Y|Y||GUARDIAN|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2021-01-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SUPINE|[?]|kg/cm|[?]|1|U/mL|SKULL|CONTRALATERAL|VENTRAL|LC-FL||||GUARDIAN|READER|4|Visit_4|65|3|TREATMENT|2021-01-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|9|FEV1SVC|FEV1/SVC|[?]|PRONE|[?]|nkat/g Hb|[?]|1|PELLET|MIDDLE PHALANX 2 OF THE HAND|UNILATERAL|APICAL|MYELOPEROXIDASE STAIN||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 2|5|Visit_5|90|7|WASHOUT|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|edc935ed-3b94-43fa-9b7f-facf6eb6780e|10|INFLTIND|Infiltrates Indicator|[?]|STANDING|[?]|mol/mL|[?]|1|IU/kg|ABDOMINAL CAVITY|BILATERAL|INFERIOR|CALIPER MEASUREMENT METHOD||||INDEPENDENT ASSESSOR|ADJUDICATOR 2|5|Visit_5|90|3|TREATMENT|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|OXYPULSE|Oxygen Pulse|[?]|SUPINE|[?]|mL/cm H2O|[?]|1|damol/L|SKIN OF THE UPPER LIMB|LEFT|CENTRAL|QUANTITATIVE CORONARY ANGIOGRAPHY||||PROXY|NEUROLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-06-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|Enzyme U/L|[?]|1|cm/min|BODY OF STOMACH|IPSILATERAL|PROXIMAL VOLAR|PULMONARY ANGIOGRAPHY|Y|||DOMESTIC PARTNER|MICROSCOPIST 1|1|Visit_1|10|3|TREATMENT|2020-06-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|3|DLCOVA|DLCO/VA|[?]|SLING|[?]|HOURS|[?]|1|L/kg|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|POSTERIOR|APPLANATION TONOMETRY||||DOMESTIC PARTNER|READER 1|2|Visit_2|25|3|SCREENING|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|DECUBITUS|[?]|ELISA unit|[?]|1|OD Unit|AORTOCAVAL LYMPH NODE|RIGHT|ROSTRAL|PULMONARY ANGIOGRAPHY|Y|||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|5|MALIND|Malignancy Indicator|[?]|SEMI-RECUMBENT|[?]|mEq/dL|[?]|1|QUANTITY SUFFICIENT|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|VENTROLATERAL|MYELOPEROXIDASE STAIN||||INDEPENDENT ASSESSOR|ONCOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|6|SGAW|Specific Airway Conductance|[?]|REVERSE TRENDELENBURG|[?]|mL/animal|[?]|1|FIU|SCROTUM|RIGHT|ANTEROLATERAL|CHROMATOGRAPHY||||PARENT|MICROSCOPIST 2|3|Visit_3|40|4|SCREENING|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|7|FIV1PP|Percent Predicted FIV1|[?]|SEMI-RECUMBENT|||[?]|1|mAnson U/mL|RECTO-UTERINE POUCH|IPSILATERAL|TEMPORAL|CONTRAST ENHANCED X-RAY||Y|Y|CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|WASHOUT|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|8|FEV1FVC6|FEV1/FVC6|[?]|DECUBITUS|[?]|nmol/day|[?]|1|uSiemens|SUBMANDIBULAR GLAND|IPSILATERAL|PROXIMAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||CLINICAL RESEARCH ASSOCIATE|RATER 2|4|Visit_4|65|7|SCREENING|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|10^4/L|SKIN OF THE BACK|IPSILATERAL|LATERAL|LIQUID SCINTILLATION COUNTING|||Y|VENDOR|RATER|5|Visit_5|90|6|WASHOUT|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|f997ad2a-e9b1-4341-96d5-caef4bcb7196|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|UNCONSTRAINED|[?]|Ci/L|[?]|1|10^8/L|ADDUCTOR POLLICIS MUSCLE|UNILATERAL|LATERAL|FLUORESCENT SPOT TEST||||ADJUDICATOR|OPTOMETRIST|5|Visit_5|90|7|FOLLOW-UP|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|v/v|[?]|1|beats/min|LEFT VENTRICULAR APEX SEGMENT|BILATERAL|INNER|FLUORESCENT ENZYME IMMUNOASSAY|Y|||DOMESTIC PARTNER|OPHTHALMOLOGIST|1|Visit_1|10|7|SCREENING|2020-06-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|2|INERTANC|Inertance|[?]|TRENDELENBURG|[?]|mL/m2/min|[?]|1|FIU|THORACIC ARTERY|IPSILATERAL|HIND|ANTIMICROBIAL COMBINATION TESTING||||ADJUDICATION COMMITTEE|RADIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|3|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|APPLICATION|[?]|1|BU|FEMORAL NECK|IPSILATERAL|VOLAR|NUCLEIC ACID HYBRIDIZATION|Y|Y||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|2|Visit_2|25|4|SCREENING|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SLING|[?]|uSiemens|[?]|1|mg/dose|HEART, BASE|UNILATERAL|VOLAR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||CHILD|UROLOGIST|2|Visit_2|25|4|SCREENING|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|5|MEP|Maximal Expiratory Pressure|[?]|REVERSE TRENDELENBURG|[?]|mL*cmH2O|[?]|1|ug/L DDU|POPLITEAL ARTERY BELOW KNEE|BILATERAL|SURFACE|IMMUNOTURBIDIMETRY|Y|||SPOUSE|RATER|3|Visit_3|40|5|TREATMENT|2020-07-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|6|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|||[?]|1|CUP|CALCANEAL TUBEROSITY|BILATERAL|APICAL|DARK FIELD MICROSCOPY|||Y|GUARDIAN|PATHOLOGIST 1|3|Visit_3|40|7|WASHOUT|2020-07-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|7|TLCPP|Percent Predicted Total Lung Capacity|[?]|LATERAL DECUBITUS|||[?]|1|m/sec2|INTERPHALANGEAL JOINT 4|LEFT|LOWER MEDIAL|AGAR PROPORTION|||Y|ADJUDICATOR|NEUROLOGIST 2|4|Visit_4|65|6|SCREENING|2020-08-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|8|FEV6PP|Percent Predicted FEV6|[?]|DECUBITUS|||[?]|1|ug/L|CENTRAL NERVOUS SYSTEM|LATERAL|PERIPHERAL|ZIEHL NEELSEN ACID FAST STAIN|||Y|HEALTH CARE PROFESSIONAL|READER|4|Visit_4|65|4|SCREENING|2020-08-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|9|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|P|[?]|1|dmol|SUPRARENAL AORTA|LEFT|MIDLINE|SEQUENCING||||ADJUDICATION COMMITTEE|ADJUDICATOR 2|5|Visit_5|90|3|FOLLOW-UP|2020-09-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|5a56874f-10e4-4cd0-842f-19552a04d1bd|10|MALIND|Malignancy Indicator|[?]|TRENDELENBURG|[?]|nkat/g Hb|[?]|1|kat|SUPRARENAL AORTA|IPSILATERAL|PERIVENTRICULAR|MICROARRAY||||STUDY SUBJECT|MICROSCOPIST 2|5|Visit_5|90|7|SCREENING|2020-09-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|mol/mg|[?]|1|m/sec2|BRONCHUS|CONTRALATERAL|ROSTRAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y||FRIEND|ENDOCRINOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-11-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|2|RELSZCHG|Relative Size Change|[?]|SUPINE|[?]|ms/mmHg|[?]|1|PHERESIS UNIT|FASCIA|RIGHT|OCCIPITAL|CONTRAST ENHANCED X-RAY||||SPOUSE|INTERNIST|1|Visit_1|10|2|TREATMENT|2020-11-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|UNCONSTRAINED|[?]|mL/kg/day|[?]|1|/ms|LIP, UPPER|IPSILATERAL|VOLAR|KLEIHAUER-BETKE||||FRIEND|RATER 2|2|Visit_2|25|6|FOLLOW-UP|2020-11-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|4|FRC|Functional Residual Capacity|[?]|SUPINE|[?]|HEP|[?]|1|fraction of 1|EYELID|BILATERAL|CAUDAL|MICRONEUTRALIZATION ASSAY||||CLINICAL STUDY SPONSOR|UROLOGIST|2|Visit_2|25|1|SCREENING|2020-11-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|5|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING|[?]|Bq/mL|[?]|1|10^5/hpf|SKIN OF THE LOWER LIMB|LEFT|SUPERIOR|PANENDOSCOPY|Y|||CLINICAL RESEARCH ASSOCIATE|READER 1|3|Visit_3|40|3|TREATMENT|2020-12-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|6|FVCPP|Percent Predicted Forced Vital Capacity|[?]|FOWLERS|||[?]|1|log10 TCID 50/dose|PERIHILAR LYMPH NODE|RIGHT|POSTERIOR|KINETIC MICROPARTICLE IMMUNOASSAY||Y|Y|FRIEND|DERMATOLOGIST|3|Visit_3|40|1|TREATMENT|2020-12-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|7|SAWVOL|Specific Airway Volume|[?]|SUPINE|[?]|/4.0 mL|[?]|1|KALLIKREIN INHIBITOR UNIT|THORACIC ARTERY|IPSILATERAL|PERIVENTRICULAR|ETDRS EYE CHART|Y|||STUDY SUBJECT|HEMATOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-01-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|[?]|FINGERTIP UNIT|[?]|1|mg/kg/min|ELBOW EXTENSOR MUSCLES|BILATERAL|BASAL|GRADIENT DIFFUSION||||SIBLING|NEUROLOGIST 1|4|Visit_4|65|2|TREATMENT|2021-01-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|umol/h/mmol|[?]|1|PIXEL|T4 VERTEBRA|UNILATERAL|CAUDAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||FAMILY MEMBER|ENDOCRINOLOGIST|5|Visit_5|90|1|SCREENING|2021-01-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|f1d4ebe5-fc72-447b-8872-67e971ff471b|10|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING|[?]|Gauss|[?]|1|U/kg/day|ABDOMINAL SKIN|LATERAL|SUPERIOR|FISH||||STUDY SUBJECT|MICROSCOPIST|5|Visit_5|90|4|TREATMENT|2021-01-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|2a141b73-e336-4701-9067-8d51d532596b|1|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|[?]|mg/dL|[?]|1|TRANSDUCING UNIT/mL|FLEXOR CARPI ULNARIS MUSCLE|BILATERAL|FORE|CRYOSCOPY|Y|Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|1|Visit_1|10|4|SCREENING|2020-06-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|2a141b73-e336-4701-9067-8d51d532596b|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|mL/kg/day|[?]|1|ks|VENA CAVA|UNILATERAL|POSTERIOR|DIGITAL PCR ARRAY||||SPOUSE|RATER 1|1|Visit_1|10|2|FOLLOW-UP|2020-06-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|2a141b73-e336-4701-9067-8d51d532596b|3|FVC|Forced Vital Capacity|[?]|LATERAL DECUBITUS|||[?]|1|kV|MEDIASTINAL LYMPH NODE|BILATERAL|DORSAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y||Y|NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|2|Visit_2|25|1|FOLLOW-UP|2020-06-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|2a141b73-e336-4701-9067-8d51d532596b|4|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|uEq|[?]|1|EVENTS|SPLEEN|BILATERAL|LATERAL|PALPATION|Y|||CLINICAL STUDY SPONSOR|RATER 2|2|Visit_2|25|4|FOLLOW-UP|2020-06-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|2a141b73-e336-4701-9067-8d51d532596b|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|PRONE|[?]|ft|[?]|1|usec|ARM|LATERAL|UPPER|GEL ELECTROPHORESIS|Y|||CAREGIVER|PATHOLOGIST 2|3|Visit_3|40|2|TREATMENT|2020-07-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|2a141b73-e336-4701-9067-8d51d532596b|6|SRAW|Specific Airway Resistance|[?]|UNCONSTRAINED|[?]|uL|[?]|1|days/month|BILE DUCT|LEFT|ANTEROMEDIAL|GC/MS-EI||Y||INTERVIEWER|NEUROLOGIST 2|3|Visit_3|40|2|SCREENING|2020-07-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|2a141b73-e336-4701-9067-8d51d532596b|7|FIF50|Forced Inspiratory Flow at 50%|[?]|TRENDELENBURG|||[?]|1|CAPLET|LYMPH NODE HILUM|LEFT|LOWER MEDIAL|LINE PROBE ASSAY|Y||Y|INVESTIGATOR|OPTOMETRIST|4|Visit_4|65|1|TREATMENT|2020-08-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|2a141b73-e336-4701-9067-8d51d532596b|8|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING|[?]|U.CARR|[?]|1|mkat|METATARSOPHALANGEAL JOINT 3|CONTRALATERAL|CENTRAL|LIGHT MICROSCOPY||Y||DOMESTIC PARTNER|READER 1|4|Visit_4|65|5|TREATMENT|2020-08-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|2a141b73-e336-4701-9067-8d51d532596b|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|OI50|[?]|1|ug/kg|LEFT ATRIOVENTRICULAR ARTERY|LATERAL|FRONTAL|NON-INVASIVE DIELECTRIC SENSING||||INVESTIGATOR|CLINICAL PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-08-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|2a141b73-e336-4701-9067-8d51d532596b|10|EVC|Expiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|SACHET|[?]|1|mL/min/1.73m2|RIB 5|LATERAL|FRONTAL|PHOTOMETRIC CLOT DETECTION||||FAMILY MEMBER|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2020-08-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|1|DLCOHC|HGB Corrected DLCO|[?]|PRONE|[?]|ug/m2/min|[?]|1|mmol/mol|FACIAL NERVE|LATERAL|LATERAL|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|||CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|1|Visit_1|10|6|TREATMENT|2020-11-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|2|EFFIND|Effusion Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|100 IU/mL|[?]|1|kHz|LINGULA OF THE LUNG|RIGHT|VENTRAL|COMPLEMENT FIXATION||||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|1|Visit_1|10|7|TREATMENT|2020-11-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|uEq|[?]|1|kN/cm2|AXIAL SKELETON|LATERAL|DORSAL|EPSILOMETER||Y||ADJUDICATION COMMITTEE|RATER 2|2|Visit_2|25|6|SCREENING|2020-12-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|4|TSUELAS|Tissue Elastance|[?]|LEFT LATERAL DECUBITUS|||[?]|1|P|PROFUNDA FEMORIS ARTERY|CONTRALATERAL|MEDIAL|ENDOSCOPY||Y|Y|SIGNIFICANT OTHER|ADJUDICATOR 1|2|Visit_2|25|2|TREATMENT|2020-12-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|5|DLCOHC|HGB Corrected DLCO|[?]|LATERAL DECUBITUS|[?]|pptr|[?]|1|MESF|CARPOMETACARPAL JOINT 5|RIGHT|CAUDAL|AGAR PROPORTION||||SIBLING|NEUROLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-12-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|6|MIPPP|Percent Predicted MIP|[?]|LATERAL DECUBITUS|[?]|mL/cage/day|[?]|1|mL/m2|RECTOVAGINAL SPACE|LEFT|SURFACE|THERMAL IONIZATION MASS SPECTROMETRY|Y|Y||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|3|Visit_3|40|6|FOLLOW-UP|2020-12-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|7|FIO2|Fraction of Inspired Oxygen|[?]|STANDING|[?]|FIU|[?]|1|GBq|TRANSVERSE TARSAL JOINT|BILATERAL|DORSOLATERAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||FAMILY MEMBER|ONCOLOGIST 2|4|Visit_4|65|1|TREATMENT|2021-01-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|8|SVC|Slow Vital Capacity|[?]|PRONE|[?]|pptr|[?]|1|g/cage/day|BLADDER|UNILATERAL|SUPERIOR|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||SIGNIFICANT OTHER|CARDIOLOGIST|4|Visit_4|65|6|TREATMENT|2021-01-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|9|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|/sec|[?]|1|uIU/L|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|CONTRALATERAL|UPPER FLEXOR SURFACE|SICKLE CELL SOLUBILITY TEST||||SIGNIFICANT OTHER|DERMATOLOGIST|5|Visit_5|90|2|TREATMENT|2021-02-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|4adf9a2c-3c43-4289-8156-1a109791580c|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|vg/mL|METATARSOPHALANGEAL JOINT 2|IPSILATERAL|ANTEROLATERAL|INTERRUPTER TECHNIQUE||Y|Y|INTERVIEWER|PATHOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2021-02-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SUPINE|[?]|Gauss|[?]|1|mg/m2/min|FOREHEAD|LEFT|UPPER|ACCELERATOR MASS SPECTROMETRY||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|1|Visit_1|10|1|WASHOUT|2020-05-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|2|PEF|Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|TRANSDUCING UNIT|JAW|RIGHT|ANTEROTEMPORAL|LC-FL|||Y|SPOUSE|NEUROLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-05-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|3|SGAW|Specific Airway Conductance|[?]|PRONE|[?]|hr/day|[?]|1|aMFI|SUBTALAR JOINT|CONTRALATERAL|ANTEROTEMPORAL|TWO-COLOR MICROARRAY|Y|||CAREGIVER|READER|2|Visit_2|25|7|WASHOUT|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|4|LCI|Lung Clearance Index|[?]|LEFT LATERAL DECUBITUS|[?]|rpm|[?]|1|uCi/kg|MID-CIRCUMFLEX ARTERY|CONTRALATERAL|UPPER|GC/FID||Y||ADJUDICATION COMMITTEE|UROLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|5|ELSTNCE|Elastance|[?]|STANDING, BENT FORWARD|[?]|/2000 RBC|[?]|1|DAgU/mL|SKIN OF THE SOLE|IPSILATERAL|INTERMEDIATE|BIOIMPEDANCE SPECTROSCOPY|Y|||SIGNIFICANT OTHER|ADJUDICATOR 1|3|Visit_3|40|4|TREATMENT|2020-06-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-16
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|UNCONSTRAINED|[?]|mg/kg|[?]|1|mg/mol|GREAT TROCHANTER|CONTRALATERAL|FACIAL|PERIPHERAL ANGIOGRAPHY||Y||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-06-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-16
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|7|INTP|Interpretation|[?]|SITTING|[?]|ug/L|[?]|1|Linear ft*LB|EPIDURAL SPACE|LATERAL|INNER|OLIGO ACGH||Y||INTERVIEWER|RADIOLOGIST 2|4|Visit_4|65|3|SCREENING|2020-07-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|8|TV|Tidal Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|kcal/day|DISTAL COMMON BILE DUCT|BILATERAL|TIP|TRANSCRIPTION-MEDIATED AMPLIFICATION|||Y|DOMESTIC PARTNER|OPTOMETRIST|4|Visit_4|65|4|TREATMENT|2020-07-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|ECL unit|SCAPHOID-CAPITATE JOINT|LATERAL|NASAL|SANGER SEQUENCING|||Y|SPOUSE|READER 3|5|Visit_5|90|2|TREATMENT|2020-08-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|10|FIV1PP|Percent Predicted FIV1|[?]|TRENDELENBURG|||[?]|1|breaths/min|TOOTH|LATERAL|PROXIMAL|POLYGRAPHY||Y|Y|ADJUDICATOR|OPHTHALMOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|QUASCOMP|Quasi-Static Compliance|[?]|SLING|[?]|g/m2/day|[?]|1|mL/s|BRACHIORADIALIS MUSCLE|BILATERAL|HIND|BETA LACTAMASE|Y|||ADJUDICATOR|READER 1|1|Visit_1|10|2|FOLLOW-UP|2020-05-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|2|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|||[?]|1|IU/mg|TOE|CONTRALATERAL|PARIETO-OCCIPITAL|DIRECT SEQUENCING|||Y|GUARDIAN|ONCOLOGIST 2|1|Visit_1|10|3|FOLLOW-UP|2020-05-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|3|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING, BENT FORWARD|||[?]|1|APPLICATION|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|BILATERAL|DORSAL|DROPLET DIGITAL PCR|||Y|FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|3|TREATMENT|2020-06-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|4|IRVPP|Percent Predicted IRV|[?]|STANDING|[?]|kcal|[?]|1|mmHg|BLADDER, FUNDUS|IPSILATERAL|INFERIOR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||INVESTIGATOR|READER 3|2|Visit_2|25|4|TREATMENT|2020-06-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-19
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|5|IVC|Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|mg/kg/h|[?]|1|pkat/L|SCAPULA|CONTRALATERAL|DISTAL VOLAR|IHC|Y|||FRIEND|ADJUDICATOR 3|3|Visit_3|40|4|TREATMENT|2020-06-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|6|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SLING|[?]|U/g/min|[?]|1|Gauss|INTERPHALANGEAL JOINT OF THE HAND|IPSILATERAL|TEMPORAL|CALCOFLUOR WHITE STAIN||||FRIEND|RADIOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-06-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|7|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING, BENT FORWARD|||[?]|1|Arbitrary U|FOOT DIGIT 5|LATERAL|PROXIMAL|NUCLEIC ACID AMPLIFICATION TEST|Y||Y|GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|LATERAL DECUBITUS|[?]|uL|[?]|1|Gy|HIPPOCAMPUS|IPSILATERAL|FRONTAL|TONOMETRY||||SPOUSE|MICROSCOPIST 2|4|Visit_4|65|5|TREATMENT|2020-07-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SITTING|[?]|MET*h|[?]|1|PFU/mL|DISTANT LYMPH NODE|CONTRALATERAL|FORE|TRICHROME STAIN||||FAMILY MEMBER|ADJUDICATOR 1|5|Visit_5|90|4|FOLLOW-UP|2020-08-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|1b2eda86-2d2c-4fdc-a88e-409ea5180603|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING|[?]|ELISA unit/dose|[?]|1|PFU/dose|GONAD|CONTRALATERAL|FACIAL|VIRUS PLAQUE ASSAY||||CAREGIVER|ONCOLOGIST|5|Visit_5|90|6|TREATMENT|2020-08-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|UNCONSTRAINED|[?]|yd|[?]|1|pg/L|CERVIX UTERI|LATERAL|ANTEROTEMPORAL|VENTILATION PERFUSION LUNG SCAN||||PROXY|HEMATOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|2|ALVVOL|Alveolar Volume|[?]|FOWLERS|||[?]|1|mmol/min/kPa|METATARSOPHALANGEAL JOINT|CONTRALATERAL|VOLAR|CALCOFLUOR WHITE STAIN|Y|Y|Y|PARENT|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|4|WASHOUT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|3|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|U/m2|[?]|1|mol/day|GASTRIC CURVATURE LYMPH NODE|RIGHT|VENTROLATERAL|OPHTHALMOSCOPY|Y|||SIGNIFICANT OTHER|RADIOLOGIST 2|2|Visit_2|25|4|FOLLOW-UP|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|4|RRS|Total Respiratory System Resistance|[?]|STANDING, BENT FORWARD|||[?]|1|uCi/L|LUNG|CONTRALATERAL|SUPERFICIAL|MASS SPECTROMETRY|||Y|PARENT|PHYSIOTHERAPIST|2|Visit_2|25|3|WASHOUT|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LATERAL DECUBITUS|[?]|U/10^12 RBC|[?]|1|copies/ug|AXILLARY LYMPH NODE LEVEL III|LEFT|PROXIMAL VOLAR|INCISION-INDUCED BLEEDING METHOD||||CAREGIVER|ONCOLOGIST 2|3|Visit_3|40|3|TREATMENT|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|6|FIF50|Forced Inspiratory Flow at 50%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|DNA copies/mL|HAND DIGIT 5|CONTRALATERAL|ANTEROTEMPORAL|DIFFUSION WEIGHTED MRI|||Y|INTERVIEWER|ADJUDICATOR 1|3|Visit_3|40|5|FOLLOW-UP|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|7|FEV1PP|Percent Predicted FEV1|[?]|SLING|||[?]|1|pg/L|PARATHYROID GLAND|IPSILATERAL|UPPER FLEXOR SURFACE|DIFFUSION WEIGHTED MRI|||Y|PROXY|MICROSCOPIST 1|4|Visit_4|65|1|SCREENING|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|8|FEV6PP|Percent Predicted FEV6|[?]|SEMI-RECUMBENT|||[?]|1|m3|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|UNILATERAL|UPPER|DOUBLE IMMUNODIFFUSION|Y||Y|SIBLING|MICROSCOPIST 2|4|Visit_4|65|2|TREATMENT|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|9|DLCOVA|DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|/4.0 mL|[?]|1|uOsm|ARTERY|BILATERAL|UPPER EXTENSOR SURFACE|TELLER ACUITY CARDS||||SIBLING|READER 3|5|Visit_5|90|3|TREATMENT|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|fc02184a-dfba-4964-be3a-cfa5f5d7200e|10|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|[?]|CIGAR|[?]|1|1/(s*kPa)|GASTROINTESTINAL SYSTEM|RIGHT|CAUDAL|LC/MS/MS||||HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|5|Visit_5|90|2|WASHOUT|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SUPINE|[?]|umol/mg/min|[?]|1|10^6 RNA copies/mL|AXILLA|RIGHT|SUBCORTICAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|||PARENT|READER 1|1|Visit_1|10|5|TREATMENT|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|2|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|[?]|MPL U|[?]|1|%/s|L5 VERTEBRA|IPSILATERAL|DORSAL|RULER MEASUREMENT METHOD||||CLINICAL STUDY SPONSOR|ONCOLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|3|RAW|Airway Resistance|[?]|SLING|[?]|anti-Xa IU/mL|[?]|1|EIA unit|WRIST JOINT|IPSILATERAL|ANTEROMEDIAL|IODINE STAIN||Y||CAREGIVER|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-06-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|4|FEV_PEF|FEV at PEF|[?]|DECUBITUS|[?]|DAgU|[?]|1|WEEKS|PALATE|LEFT|MIDLINE|CISH||Y||FRIEND|RADIOLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-06-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|5|RRS|Total Respiratory System Resistance|[?]|LATERAL DECUBITUS|[?]|ug/m2/min|[?]|1|BLOCKS|BULBAR CONJUNCTIVA|CONTRALATERAL|UPPER EXTENSOR SURFACE|EIA||||STUDY SUBJECT|READER 3|3|Visit_3|40|2|TREATMENT|2020-06-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|6|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING|||[?]|1|10^6 RNA copies/mL|SUPRARENAL AORTA|LATERAL|DORSOLATERAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN|||Y|HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|3|Visit_3|40|3|SCREENING|2020-06-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|7|FIFMAXPP|Percent Predicted FIFmax|[?]|UNCONSTRAINED|[?]|1/(s*kPa)|[?]|1|TRACE|PARANASAL SINUS|LEFT|ANTEROLATERAL|HEMAGGLUTINATION ASSAY||Y||STUDY SUBJECT|PHYSIOTHERAPIST|4|Visit_4|65|1|TREATMENT|2020-07-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|8|EXPRELTM|Expiration Relaxation Time|[?]|SITTING, LEGS DEPENDENT|[?]|U/kg/day|[?]|1|%(w/w)|MIDDLE PHALANX 4 OF THE HAND|BILATERAL|APICAL|LAPAROSCOPY||||CAREGIVER|RATER|4|Visit_4|65|3|SCREENING|2020-07-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|9|SVC|Slow Vital Capacity|[?]|PRONE|||[?]|1|Enzyme U|SKIN BETWEEN EYEBROWS|UNILATERAL|LOWER MEDIAL|DOUBLE IMMUNODIFFUSION|||Y|INVESTIGATOR|ADJUDICATOR 1|5|Visit_5|90|1|SCREENING|2020-08-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|37c59cfa-b952-4d16-a675-5e3b3a2e0288|10|PNEUMIND|Pneumonia Indicator|[?]|SUPINE|||[?]|1|10^6 copies/mL|HAIR ROOT|BILATERAL|UPPER|HPLC/MS|Y|Y|Y|SPOUSE|PATHOLOGIST|5|Visit_5|90|3|WASHOUT|2020-08-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pmol|EPIDURAL SPACE|IPSILATERAL|POSTERIOR|DXA SCAN||Y|Y|FRIEND|PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-12-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|2|IVCPP|Percent Predicted IVC|[?]|DECUBITUS|||[?]|1|/day|L2 VERTEBRA|LATERAL|ANTEROLATERAL|FUNDUS PHOTOGRAPHY|||Y|STUDY SUBJECT|CLINICAL PATHOLOGIST|1|Visit_1|10|2|SCREENING|2020-12-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|3|FIO2|Fraction of Inspired Oxygen|[?]|LATERAL DECUBITUS|[?]|vg/mL|[?]|1|in2|COLON, DESCENDING|IPSILATERAL|CRANIAL|HPLC/MS/MS||||SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|2|TREATMENT|2020-12-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|4|FRC|Functional Residual Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|GBq/mg|CHEST WALL|CONTRALATERAL|ANTEROLATERAL|NUCLEIC ACID SEQUENCING|||Y|PARENT|PATHOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-12-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|5|EVC|Expiratory Vital Capacity|[?]|TRENDELENBURG|[?]|pmol/dL|[?]|1|/day|T12 VERTEBRA|RIGHT|SURFACE|X-RAY||Y||INTERVIEWER|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2021-01-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|6|SALKA|Salazar-Knowles Equation Parameter A|[?]|SEMI-FOWLERS|[?]|10^4/hpf|[?]|1|um/day|CORONARY ARTERY|RIGHT|SUPERIOR|RAJI CELL RIA||||FRIEND|READER 1|3|Visit_3|40|1|TREATMENT|2021-01-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|7|ALVVOL|Alveolar Volume|[?]|LATERAL DECUBITUS|[?]|g/kg/day|[?]|1|m2|ELBOW FLEXOR MUSCLES|CONTRALATERAL|MIDLINE|FLOCCULATION, CHARCOAL ENHANCED|Y|||INTERVIEWER|MICROSCOPIST 3|4|Visit_4|65|4|WASHOUT|2021-01-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|EVENTS|[?]|1|amol|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|SUPERFICIAL|ELECTROCHEMILUMINESCENCE||||SIBLING|INTERNIST|4|Visit_4|65|6|FOLLOW-UP|2021-01-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|9|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|Enzyme U|BONE MARROW|BILATERAL|PERIPHERAL|ANTIMICROBIAL COMBINATION TESTING||Y|Y|GUARDIAN|MICROSCOPIST 3|5|Visit_5|90|2|WASHOUT|2021-02-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|11130b2c-e9fd-4a50-87ee-5dfa19199eba|10|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|[?]|uV|[?]|1|Enzyme U/L|GASTROINTESTINAL TRACT, UPPER, WALL|CONTRALATERAL|OCCIPITAL|NUCLEIC ACID AMPLIFICATION TEST||||STUDY SUBJECT|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2021-02-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|1|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|PRONE|||[?]|1|mm/2h|LATERAL FIRST DIAGONAL BRANCH ARTERY|UNILATERAL|SUBCORTICAL|FUNDUS PHOTOGRAPHY|||Y|ADJUDICATION COMMITTEE|PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|2|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|umol/dL|[?]|1|10^8 PFU|URETHRA, ANTERIOR|BILATERAL|ANTEROMEDIAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y||GUARDIAN|PATHOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-06
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|3|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|[?]|mol/mL|[?]|1|10^9 organisms/mg|SEMINAL VESICLE|BILATERAL|PROXIMAL VOLAR|DC SHEATH FLOW||||SIBLING|INTERNIST|2|Visit_2|25|3|TREATMENT|2020-05-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SUPINE|[?]|10^3 copies/mL|[?]|1|10^6/hpf|THORACIC CAVITY|RIGHT|DISTAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|Y||PARENT|OPTOMETRIST|2|Visit_2|25|5|TREATMENT|2020-05-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|[?]|Ci/kg|[?]|1|U/mg|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|OUTER|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|||CLINICAL STUDY SPONSOR|MICROSCOPIST|3|Visit_3|40|4|TREATMENT|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|6|TSUELAS|Tissue Elastance|[?]|UNCONSTRAINED|[?]|mol/mL|[?]|1|umol/L/sec|KIDNEY, UPPER LOBE|BILATERAL|SUPERIOR|ELISA||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|3|Visit_3|40|3|SCREENING|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-29
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|7|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|10^6 RNA copies/mL|[?]|1|10^10/L|TRIANGULAR-HAMATE JOINT|IPSILATERAL|VENTROLATERAL|LISSAMINE GREEN STAIN||||VENDOR|MICROSCOPIST|4|Visit_4|65|7|WASHOUT|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|TRENDELENBURG|[?]|g/cage/wk|[?]|1|IMPLANT|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|UNILATERAL|INNER|MECHANICAL CLOT DETECTION||Y||CAREGIVER|NEUROLOGIST|4|Visit_4|65|2|SCREENING|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|9|PIF|Peak Inspiratory Flow|[?]|SLING|||[?]|1|kg|ELBOW EXTENSOR MUSCLES|BILATERAL|VENTRAL|ORCHIDOMETERY|Y||Y|VENDOR|MICROSCOPIST 2|5|Visit_5|90|1|TREATMENT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|08e4310f-f868-4858-a321-f33a21a771e8|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SITTING|[?]|ng|[?]|1|10^9 CFU/g|RETINAL ARTERY|CONTRALATERAL|ANTERIOR|LANDOLT RING||||PARENT|ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|1|FEV6PP|Percent Predicted FEV6|[?]|LEFT LATERAL DECUBITUS|||[?]|1|IU/mmol|ENDOCARDIUM|IPSILATERAL|POSTERIOR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||Y|INVESTIGATOR|READER 1|1|Visit_1|10|2|SCREENING|2020-08-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|2|INTP|Interpretation|[?]|TRENDELENBURG|[?]|umol/mg/min|[?]|1|CONTAINER|RIGHT VENTRICULAR ENDOCARDIUM|IPSILATERAL|MEDIAL|FLAME PHOTOMETRY||Y||PROXY|INTERNIST|1|Visit_1|10|7|SCREENING|2020-08-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|3|LOBVOL|Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|IU|[?]|1|APL U/mL|C4 VERTEBRA|UNILATERAL|PERIPHERAL|HPLC-UV|Y|||CHILD|CLINICAL PATHOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-09-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|4|ELSTNCE|Elastance|[?]|STANDING|[?]|mg/min|[?]|1|mL/day|CORPUS LUTEUM|UNILATERAL|ANTEROPOSTERIOR|CONTRAST ENHANCED X-RAY||||CLINICAL STUDY SPONSOR|RADIOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-09-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|5|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|DAgU/mL|[?]|1|cmol/L|FACET JOINT|CONTRALATERAL|VENTROLATERAL|PAP STAIN|Y|Y||ADJUDICATION COMMITTEE|INTERNIST|3|Visit_3|40|7|FOLLOW-UP|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|mU/g|[?]|1|MBq|ILIUM|LEFT|CRANIAL|FLOCCULATION, CHARCOAL ENHANCED|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|3|Visit_3|40|2|TREATMENT|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|7|PLMXRS|Pulmonary Reactance|[?]|SITTING, LEGS DEPENDENT|[?]|mL|[?]|1|WAFER|EPIGLOTTIS|LATERAL|TIP|AUTOMATED COUNT||Y||FRIEND|ONCOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|8|DLCOVA|DLCO/VA|[?]|SEMI-RECUMBENT|||[?]|1|eq|SINUS|LATERAL|CRANIAL|HIGH RESOLUTION MELT ANALYSIS|||Y|DOMESTIC PARTNER|HEMATOLOGIST|4|Visit_4|65|2|WASHOUT|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-RECUMBENT|[?]|%|[?]|1|Hz/s|ADRENAL GLAND|LEFT|HIND|FLUORESCENT SPOT TEST|Y|||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|6|WASHOUT|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|29edf133-8b5b-46d5-bf7a-f75af4658417|10|TVPP|Percent Predicted Tidal Volume|[?]|SITTING, LEGS DEPENDENT|[?]|ug|[?]|1|mL/min/1.73m2|TIBIALIS ANTERIOR MUSCLE|BILATERAL|CRANIAL|SLIT LAMP PHOTOGRAPHY||||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|TREATMENT|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|FEV3PP|Percent Predicted FEV3|[?]|STANDING|[?]|IU/day|[?]|1|BOTTLE|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|RIGHT|UPPER|PALM METHOD|Y|||HEALTH CARE PROFESSIONAL|DERMATOLOGIST|1|Visit_1|10|4|WASHOUT|2020-08-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|2|AWVOL|Airway Volume|[?]|PRONE|[?]|mJoule/cm2|[?]|1|mEq/day|ILIAC LYMPH NODE|UNILATERAL|FRONTAL|DC SHEATH FLOW|Y|||DOMESTIC PARTNER|DERMATOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-08-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|3|SVC|Slow Vital Capacity|[?]|PRONE|[?]|ug|[?]|1|10^6 RNA copies/mL|COCCYGEAL VERTEBRA|LATERAL|PERIVENTRICULAR|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|Y|||SIBLING|ADJUDICATOR 2|2|Visit_2|25|5|TREATMENT|2020-08-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-FOWLERS|||[?]|1|mg/kg/h|ESOPHAGUS, ABDOMINAL|IPSILATERAL|FRONTAL|DISK DIFFUSION||Y|Y|FRIEND|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-08-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|5|RELSZCHG|Relative Size Change|[?]|SLING|[?]|IU|[?]|1|10^9 organisms/mg|MESENTERIC ARTERY|LATERAL|LOWER EXTENSOR SURFACE|ELLA||||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|FOLLOW-UP|2020-09-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|6|FVCPP|Percent Predicted Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|Henry|[?]|1|pmol/g|URETHRA, POSTERIOR|LEFT|PROXIMAL VOLAR|MICRONEUTRALIZATION ASSAY||||ADJUDICATOR|INTERNIST|3|Visit_3|40|6|TREATMENT|2020-09-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|DECUBITUS|||[?]|1|log10 IU/mL|EYE, VITREOUS CHAMBER|BILATERAL|UPPER FLEXOR SURFACE|KLEIHAUER-BETKE||Y|Y|CLINICAL STUDY SPONSOR|READER 3|4|Visit_4|65|7|TREATMENT|2020-10-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|8|DLCO|Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|g/m2/day|[?]|1|ELISA unit/dose|SPLEEN|LEFT|PERIPHERAL|PLETHYSMOGRAPHY||||SIGNIFICANT OTHER|RADIOLOGIST|4|Visit_4|65|7|TREATMENT|2020-10-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|10^6/g|[?]|1|10^8/L|MITRAL VALVE|IPSILATERAL|UPPER FLEXOR SURFACE|IMMUNOCHROMATOGRAPHY||Y||ADJUDICATION COMMITTEE|MICROSCOPIST 1|5|Visit_5|90|2|WASHOUT|2020-10-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|49756233-e18f-4187-8d48-3b6b4fa7e5c2|10|FIF75|Forced Inspiratory Flow at 75%|[?]|DECUBITUS|[?]|g|[?]|1|mg/mol|PRECUNEUS|RIGHT|BASAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|WASHOUT|2020-10-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|TRENDELENBURG|[?]|kg/L|[?]|1|mg/m2/day|OCULOMOTOR NERVE|LEFT|UPPER FLEXOR SURFACE|ANALYTICAL ULTRACENTRIFUGATION||||FRIEND|READER 1|1|Visit_1|10|2|FOLLOW-UP|2020-10-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|2|EXPRELTM|Expiration Relaxation Time|[?]|SUPINE|[?]|oz eq|[?]|1|U/m2|PANCREAS, HEAD|RIGHT|SUBCORTICAL|IN VITRO GENE EXPRESSION ASSAY|Y|||CHILD|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2020-10-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|3|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|[?]|dB|[?]|1|g/m2|CEPHALIC VEIN|CONTRALATERAL|SUPERIOR|SPECULAR MICROSCOPY||||GUARDIAN|PATHOLOGIST 2|2|Visit_2|25|6|SCREENING|2020-10-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|ft|[?]|1|titer|ETHMOID BONE|UNILATERAL|DISTAL VOLAR|HPLC||||CLINICAL RESEARCH COORDINATOR|READER|2|Visit_2|25|7|FOLLOW-UP|2020-10-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|5|FEV6PP|Percent Predicted FEV6|[?]|TRENDELENBURG|[?]|U.CARR|[?]|1|genEq|CORONARY ARTERY|CONTRALATERAL|UPPER EXTENSOR SURFACE|PEAK FLOWMETRY|Y|Y||INVESTIGATOR|NEUROLOGIST 1|3|Visit_3|40|6|SCREENING|2020-11-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|/5x10^4 WBC|[?]|1|nL|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|LOWER FLEXOR SURFACE|WHOLE TRANSCRIPTOME SEQUENCING||Y||CLINICAL RESEARCH COORDINATOR|OTOLARYNGOLOGIST|3|Visit_3|40|2|TREATMENT|2020-11-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|7|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|[?]|cmH2O*s2/mL|[?]|1|pg|URETERIC ORIFICE|LEFT|NASAL|DYNAMIC LIGHT SCATTERING||||CHILD|READER 3|4|Visit_4|65|6|WASHOUT|2020-12-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|8|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|[?]|pmol/day|[?]|1|nmol/mol|FLEXOR DIGITORUM LONGUS MUSCLE|CONTRALATERAL|UPPER EXTENSOR SURFACE|PERIPHERAL ANGIOGRAPHY||||CLINICAL STUDY SPONSOR|UROLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-12-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|9|FIFMAX|Maximum Forced Inspiratory Flow|[?]|TRENDELENBURG|[?]|10^9 CFU/g|[?]|1|mEq/mmol|TRICEPS BRACHII MUSCLE|BILATERAL|LOWER MEDIAL|SLOAN LETTER EYE CHART 2.5%||||SIGNIFICANT OTHER|PATHOLOGIST 1|5|Visit_5|90|1|TREATMENT|2021-01-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|7a046104-7215-4708-9d85-66683ceb8fe8|10|AWVOL|Airway Volume|[?]|STANDING, BENT FORWARD|[?]|mL|[?]|1|cmHg|JAW|CONTRALATERAL|LOWER EXTENSOR SURFACE|MICROSCOPY||Y||CLINICAL RESEARCH ASSOCIATE|UROLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-01-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|vp/mL|[?]|1|log EID 50/dose|WRIST JOINT EXTENSOR MUSCLES|LATERAL|DEEP|CELLULOSE TAPE|Y|Y||STUDY SUBJECT|PATHOLOGIST|1|Visit_1|10|5|SCREENING|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|2|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|||[?]|1|ug/cm2|INTERNAL MAMMARY ARTERY|IPSILATERAL|LOWER FLEXOR SURFACE|RYAN BLUE STAIN|||Y|SIBLING|HEMATOLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SUPINE|||[?]|1|10^12/L|GENITOURINARY SYSTEM|LEFT|DORSAL|TOTAL BODY IRRADIATION||Y|Y|HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|7|SCREENING|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|UNCONSTRAINED|[?]|ug/kg/day|[?]|1|L/h/m2|FRONTAL LOBE|UNILATERAL|ANTEROLATERAL|ELLA||Y||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|2|Visit_2|25|4|WASHOUT|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|||[?]|1|EID 50/mL|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|BILATERAL|OUTER|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y|Y|CHILD|NEUROLOGIST 2|3|Visit_3|40|3|SCREENING|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|6|FEV6PP|Percent Predicted FEV6|[?]|PRONE|[?]|/10^4|[?]|1|FEU|INGUINAL LYMPH NODE|BILATERAL|TIP|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|Y||GUARDIAN|OPTOMETRIST|3|Visit_3|40|2|SCREENING|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|7|AWWVOL|Airway Wall Volume|[?]|SEMI-RECUMBENT|[?]|ug/kg/day|[?]|1|km/h|FOOT DIGIT 3|CONTRALATERAL|TEMPORAL|PHASE-CONTRAST MRI||||SPOUSE|PATHOLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|8|FEV3PP|Percent Predicted FEV3|[?]|SITTING|[?]|10^4/L|[?]|1|mmol|RETINAL PIGMENTED EPITHELIAL LAYER|IPSILATERAL|TEMPORAL|PULSE OXIMETRY||||INTERVIEWER|CLINICAL PATHOLOGIST|4|Visit_4|65|2|SCREENING|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|||[?]|1|s/h|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|PROXIMAL|CONTRAST ENHANCED PET SCAN|||Y|ADJUDICATOR|ADJUDICATOR 1|5|Visit_5|90|5|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|10|ICREV|IC Reversibility|[?]|DECUBITUS|||[?]|1|msec|C4 VERTEBRA|UNILATERAL|NASAL|CLAUSS METHOD|||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|g/g/day|FEMUR|UNILATERAL|SURFACE|TRIPLE-PHASE MRI SCAN|||Y|INVESTIGATOR|READER 3|1|Visit_1|10|5|TREATMENT|2020-05-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|2|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|K|[?]|1|dL|SACRUM|LEFT|ANTERIOR|ICP-MS||Y||GUARDIAN|ONCOLOGIST|1|Visit_1|10|7|WASHOUT|2020-05-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|3|PEF|Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|/min|[?]|1|nmol/day|STERNUM|BILATERAL|SUPERFICIAL|BIOIMPEDANCE SPECTROSCOPY|Y|||ADJUDICATOR|PATHOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-06-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|DECUBITUS|||[?]|1|nmol BCE/mmol|SCLERA|LEFT|LOWER|LIGHT SCATTERING SPECTROSCOPY||Y|Y|GUARDIAN|DERMATOLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|5|DLCO|Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|||[?]|1|10^3 CFU/mL|ILEUM, TERMINAL|IPSILATERAL|SURFACE|DIFFUSION TENSOR MRI||Y|Y|SIGNIFICANT OTHER|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-06-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|6|RV|Residual Volume|[?]|DECUBITUS|[?]|10^6/g|[?]|1|mmol/s|NOSE|LEFT|SURFACE|NUCLEAR RADIOLOGY|Y|||INTERVIEWER|PATHOLOGIST 2|3|Visit_3|40|1|FOLLOW-UP|2020-06-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|7|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-RECUMBENT|[?]|mL/breath|[?]|1|ug/g/h|EARLOBE|LATERAL|FRONTAL|PALPATION||||VENDOR|READER 1|4|Visit_4|65|7|FOLLOW-UP|2020-07-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|8|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|||[?]|1|mU/L|SKIN OF THE HEAD|LEFT|UPPER FLEXOR SURFACE|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|4|Visit_4|65|2|FOLLOW-UP|2020-07-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|9|FIF25|Forced Inspiratory Flow at 25%|[?]|SEMI-FOWLERS|[?]|uCi|[?]|1|ug/day|PERIPANCREATIC LYMPH NODE|CONTRALATERAL|FACIAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|5|Visit_5|90|5|TREATMENT|2020-08-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|bcbe7d50-2ebe-483a-9d71-dce4094f864e|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|||[?]|1|umol/L|L4-L5 INTERVERTEBRAL SPACE|IPSILATERAL|BASAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||Y|FAMILY MEMBER|INTERNIST|5|Visit_5|90|5|TREATMENT|2020-08-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|UNCONSTRAINED|[?]|pg/L|[?]|1|mmol|CORRUGATOR SUPERCILII MUSCLE|CONTRALATERAL|LOWER|PHOTOGRAPHY|Y|Y||SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|5|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|2|FEV6PP|Percent Predicted FEV6|[?]|SITTING, LEGS DEPENDENT|[?]|CCID 50/mL|[?]|1|mEq/mL|PARIETAL LOBE|RIGHT|APICAL|NEURAMINIDASE INHIBITION ASSAY||Y||DOMESTIC PARTNER|NEUROLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|3|ICREV|IC Reversibility|[?]|FOWLERS|[?]|g/U|[?]|1|mEq/mmol|ADDUCTOR LONGUS MUSCLE|LEFT|LOWER EXTENSOR SURFACE|CENTRIFUGATION||||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|2|Visit_2|25|7|TREATMENT|2021-02-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|4|TV|Tidal Volume|[?]|SEMI-RECUMBENT|[?]|10^7 PFU|[?]|1|AU/mL|GUT-ASSOCIATED LYMPHOID TISSUE|LATERAL|CAUDAL|BIOIMPEDANCE SPECTROSCOPY||||INDEPENDENT ASSESSOR|ONCOLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|5|PEFTIME|Peak Expiratory Flow Time|[?]|UNCONSTRAINED|[?]|ms2|[?]|1|foz_br|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|CONTRALATERAL|PROXIMAL|HPLC-FL||Y||FRIEND|MICROSCOPIST 2|3|Visit_3|40|5|SCREENING|2021-02-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-06
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|6|TLC|Total Lung Capacity|[?]|DECUBITUS|[?]|PACKAGE|[?]|1|/2500 WBC|MAIN BRONCHUS, LEFT|LEFT|VENTROLATERAL|WHOLE EXOME SEQUENCING||||NON-HEALTH CARE PROFESSIONAL|RATER 2|3|Visit_3|40|7|WASHOUT|2021-02-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-06
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|7|FEV1SVC|FEV1/SVC|[?]|LATERAL DECUBITUS|[?]|mL/kg|[?]|1|bel|PAROTID GLAND|BILATERAL|PROXIMAL VOLAR|FUNDUS PHOTOGRAPHY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|8|SVC|Slow Vital Capacity|[?]|FOWLERS|[?]|in2|[?]|1|FEU|AMYGDALA|BILATERAL|SURFACE|GC/FID||||DOMESTIC PARTNER|RATER|4|Visit_4|65|6|TREATMENT|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|9|IRVPP|Percent Predicted IRV|[?]|SITTING, LEGS DEPENDENT|[?]|fmol|[?]|1|mEq/day|INTERPHALANGEAL OF THE FOOT|CONTRALATERAL|PERIVENTRICULAR|CONGO RED STAIN||||VENDOR|MICROSCOPIST 1|5|Visit_5|90|6|TREATMENT|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|2550ba24-7bcf-41e2-9eae-536e13d4b345|10|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|||[?]|1|g/cage/wk|PARASYMPATHETIC GANGLIA|BILATERAL|ANTEROLATERAL|ANTIBIOTIC AGAR SCREEN|Y|Y|Y|CLINICAL STUDY SPONSOR|NEUROLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|[?]|/wk|[?]|1|ukat/L|MITRAL VALVE, POSTERIOR ANNULUS|CONTRALATERAL|POSTERIOR|ELECTROGASTROGRAPHY||||SIBLING|CARDIOLOGIST|1|Visit_1|10|1|SCREENING|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|2|DLCOHC|HGB Corrected DLCO|[?]|SEMI-RECUMBENT|||[?]|1|ug/L/h|LIMB|IPSILATERAL|DEEP|CLOT DETECTION|||Y|SIGNIFICANT OTHER|RADIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|3|INFLTIND|Infiltrates Indicator|[?]|DECUBITUS|||[?]|1|PNU/mL|LEFT VENTRICULAR EPICARDIUM|CONTRALATERAL|UPPER FLEXOR SURFACE|QUANTITATIVE COMPUTED TOMOGRAPHY|||Y|ADJUDICATION COMMITTEE|INTERNIST|2|Visit_2|25|5|SCREENING|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|4|ICREV|IC Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|U/g/day|[?]|1|msec|SKIN OF THE INGUINAL REGION|LEFT|PERIVENTRICULAR|REFLECTANCE SPECTROSCOPY|Y|||INTERVIEWER|MICROSCOPIST 1|2|Visit_2|25|2|WASHOUT|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|5|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|m3|[?]|1|mg2/dL2|CORNEA|LATERAL|LOWER|MS/MS|Y|||DOMESTIC PARTNER|READER|3|Visit_3|40|3|FOLLOW-UP|2020-09-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|6|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|mg/animal|[?]|1|mEq/g|ANAL CANAL|IPSILATERAL|DORSOLATERAL|CT SCAN||||GUARDIAN|READER 1|3|Visit_3|40|1|FOLLOW-UP|2020-09-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|7|FEV1PP|Percent Predicted FEV1|[?]|SUPINE|||[?]|1|kat|SUPERIOR SAGITTAL SINUS|BILATERAL|OCCIPITAL|IMMUNOPRECIPITATION|||Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-10-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|8|IRVPP|Percent Predicted IRV|[?]|SITTING, LEGS DEPENDENT|[?]|ug/min|[?]|1|K|SKIN OF THE FOREARM|RIGHT|POSTERIOR|SINGLE-MOLECULE ARRAY||Y||PROXY|OPTOMETRIST|4|Visit_4|65|6|FOLLOW-UP|2020-10-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|9|TSUELAS|Tissue Elastance|[?]|SEMI-RECUMBENT|||[?]|1|mL/mmHg/min/L|WRIST JOINT FLEXOR TENDONS|CONTRALATERAL|PERIPHERAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||Y|CLINICAL STUDY SPONSOR|HEMATOLOGIST|5|Visit_5|90|3|WASHOUT|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|10|ERVPP|Percent Predicted ERV|[?]|DECUBITUS|[?]|/VF|[?]|1|10^3/L|EYE, VITREOUS CHAMBER|RIGHT|LOWER MEDIAL|MICRONEUTRALIZATION ASSAY|Y|||SIGNIFICANT OTHER|DERMATOLOGIST|5|Visit_5|90|7|TREATMENT|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|10^12/L|[?]|1|10^4/hpf|LIGAMENT|LATERAL|DORSAL|TELLER ACUITY CARDS||||VENDOR|RADIOLOGIST 2|1|Visit_1|10|5|TREATMENT|2020-07-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|2|FIVC|Forced Inspiratory Vital Capacity|[?]|TRENDELENBURG|||[?]|1|POUCH|VOCAL CORD|UNILATERAL|FACIAL|LINE PROBE ASSAY||Y|Y|CLINICAL STUDY SPONSOR|CARDIOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-07-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|3|INFLTIND|Infiltrates Indicator|[?]|SEMI-FOWLERS|[?]|VIAL|[?]|1|mL/beat|INTERPHALANGEAL JOINT 1 OF THE FOOT|LEFT|MEDIAL|BIOPSY||Y||HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|4|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SLING|[?]|m/sec|[?]|1|ngEq/L|DISTAL RADIOULNAR JOINT|RIGHT|UPPER|IN SITU HYBRIDIZATION|Y|Y||GUARDIAN|ADJUDICATOR 3|2|Visit_2|25|6|TREATMENT|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|5|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|lm|[?]|1|pg|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|UNILATERAL|ANTEROTEMPORAL|INDIA INK STAIN||||PROXY|READER 2|3|Visit_3|40|6|FOLLOW-UP|2020-08-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|6|AWVOL|Airway Volume|[?]|SUPINE|||[?]|1|mg/kg|BUCCAL MUCOSA|RIGHT|FORE|LISSAMINE GREEN STAIN||Y|Y|DOMESTIC PARTNER|MICROSCOPIST 1|3|Visit_3|40|3|TREATMENT|2020-08-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|PRONE|[?]|mL/m2/h|[?]|1|NEBULE|MUCOSA OF THE LIP|IPSILATERAL|PERIVENTRICULAR|PHOTOGRAPHY|Y|||INTERVIEWER|UROLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|8|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|DAgU/mL|SPLENIC ARTERY|RIGHT|ANTEROTEMPORAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|||Y|NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|SCREENING|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|9|FRC|Functional Residual Capacity|[?]|SEMI-RECUMBENT|[?]|/40 HPFs|[?]|1|pg/L|DENTAL ARCH|CONTRALATERAL|PERIPHERAL|SLOAN LETTER EYE CHART 2.5%||Y||FAMILY MEMBER|ADJUDICATOR 1|5|Visit_5|90|2|SCREENING|2020-10-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|6ec23671-252e-4dc9-b919-88254fce68a5|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|PRONE|[?]|WEEKS|[?]|1|PLUG|CARPOMETACARPAL JOINT 1|BILATERAL|MIDLINE|TOLUIDINE BLUE STAIN||Y||SPOUSE|MICROSCOPIST 3|5|Visit_5|90|3|WASHOUT|2020-10-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|10^6 organisms/mg|[?]|1|mmAL|CORONARY ARTERY|UNILATERAL|ROSTRAL|SIZE EXCLUSION CHROMATOGRAPHY||||FAMILY MEMBER|CLINICAL PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-05-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-10
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|2|ERV|Expiratory Reserve Volume|[?]|DECUBITUS|[?]|nmol/L|[?]|1|Joule|SPLEEN, HILUM|LEFT|INTERMEDIATE|LC-FL||||CAREGIVER|RATER|1|Visit_1|10|5|WASHOUT|2020-05-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-10
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|3|FVC|Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|mAmp|[?]|1|pkat|LIMB|UNILATERAL|PERIVENTRICULAR|U-HPLC/MS/MS||Y||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|2|Visit_2|25|4|TREATMENT|2020-05-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|DECUBITUS|[?]|mL/cm3/min|[?]|1|ohm|DISTAL FEMUR R1|IPSILATERAL|PROXIMAL VOLAR|EPSILOMETER|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|2|Visit_2|25|4|TREATMENT|2020-05-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|BLOCKS|TEMPLE|LEFT|UPPER EXTENSOR SURFACE|DNA MICROARRAY|||Y|GUARDIAN|CLINICAL PATHOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-06-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|6|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|||[?]|1|cg|THYROID GLAND, LEFT LOBE|LEFT|LOWER|GC/MS||Y|Y|GUARDIAN|OPTOMETRIST|3|Visit_3|40|7|TREATMENT|2020-06-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|7|MALIND|Malignancy Indicator|[?]|DECUBITUS|[?]|10^3 DNA copies/mL|[?]|1|IU/mg|AXILLARY LYMPH NODE|IPSILATERAL|PARIETO-OCCIPITAL|MICROBIAL CULTURE, SOLID|Y|||ADJUDICATOR|RATER 2|4|Visit_4|65|3|FOLLOW-UP|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|[?]|lx|[?]|1|umol/h/mmol|LEG SKIN|RIGHT|SUBCORTICAL|LANDOLT RING||||FAMILY MEMBER|HEMATOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|9|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|PRONE|[?]|/LPF|[?]|1|ft3|ORBIT|LATERAL|FACIAL|INFRARED SPECTROMETRY|Y|Y||PROXY|MICROSCOPIST 2|5|Visit_5|90|5|SCREENING|2020-08-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|db59e5e1-ccda-480b-8955-da5157e16c4a|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|TRENDELENBURG|[?]|amol|[?]|1|mL/mmHg|LUNG, RIGHT MIDDLE LOBE|IPSILATERAL|ANTEROPOSTERIOR|ZIEHL NEELSEN ACID FAST STAIN||||STUDY SUBJECT|MICROSCOPIST|5|Visit_5|90|1|FOLLOW-UP|2020-08-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|SRAW|Specific Airway Resistance|[?]|FOWLERS|[?]|nkat|[?]|1|DNA copies/ug|TUNICA INTIMA|IPSILATERAL|PROXIMAL VOLAR|ELECTROCHEMILUMINESCENCE||Y||ADJUDICATION COMMITTEE|RADIOLOGIST 1|1|Visit_1|10|3|SCREENING|2020-09-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|2|AIRTRAP|Air Trapping|[?]|REVERSE TRENDELENBURG|[?]|km|[?]|1|DROP|SKIN BETWEEN EYEBROWS|CONTRALATERAL|DISTAL VOLAR|PET/MRI SCAN||||SIBLING|RATER|1|Visit_1|10|3|TREATMENT|2020-09-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|3|TSUHYS|Tissue Hysteresivity|[?]|SLING|[?]|g/U|[?]|1|DDU|TRICUSPID VALVE|IPSILATERAL|OUTER|MUGA||Y||STUDY SUBJECT|PHYSIOTHERAPIST|2|Visit_2|25|2|TREATMENT|2020-09-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SUPINE|[?]|BAR|[?]|1|ug/dL|PARA-AORTIC LYMPH NODE|IPSILATERAL|PARIETO-OCCIPITAL|SXA SCAN||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|2|Visit_2|25|2|TREATMENT|2020-09-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SLING|[?]|kcal/day|[?]|1|MASK|PERICARDIAL WALL|IPSILATERAL|ANTEROTEMPORAL|MICROBIAL CULTURE, LIQUID|Y|||PROXY|ADJUDICATOR 3|3|Visit_3|40|1|TREATMENT|2020-10-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|FOWLERS|||[?]|1|DRINK|LUNG, LEFT UPPER LOBE|IPSILATERAL|CENTRAL|IMMUNOFIXATION ELECTROPHORESIS|Y||Y|DOMESTIC PARTNER|READER 1|3|Visit_3|40|5|SCREENING|2020-10-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|7|TLC|Total Lung Capacity|[?]|DECUBITUS|||[?]|1|nmol/mol|SCIATIC NERVE|RIGHT|DORSAL|MANUAL CLOT DETECTION|||Y|INTERVIEWER|ENDOCRINOLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SUPINE|[?]|PHERESIS UNIT|[?]|1|WEEKS|AZYGOS VEIN|LEFT|SUPERFICIAL|OPTICAL COHERENCE TOMOGRAPHY||||FAMILY MEMBER|MICROSCOPIST 3|4|Visit_4|65|7|TREATMENT|2020-11-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|OD Unit|[?]|1|%/s|PROSTATE GLAND, MIDDLE LOBE|LEFT|POSTERIOR|CELL BASED BIOASSAY||||SPOUSE|FORENSIC PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2020-12-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|1dce856e-b7cb-4899-b27f-87ab8d918df4|10|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|Bq/kg|[?]|1|10^6 IU|RADIAL ARTERY|UNILATERAL|PROXIMAL VOLAR|ANALYTICAL ULTRACENTRIFUGATION|Y|||ADJUDICATOR|HEMATOLOGIST|5|Visit_5|90|5|WASHOUT|2020-12-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|7449180b-e226-4e97-a059-8760f6523f77|1|FRC|Functional Residual Capacity|[?]|FOWLERS|[?]|Farad|[?]|1|mg/h|INTERPHALANGEAL JOINT OF THE HAND|LATERAL|INFERIOR|DIGITAL PCR||Y||INTERVIEWER|FORENSIC PATHOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-07-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|7449180b-e226-4e97-a059-8760f6523f77|2|SVC|Slow Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|U/g/h|SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|UPPER EXTENSOR SURFACE|SCINTIGRAPHY|||Y|FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-07-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|7449180b-e226-4e97-a059-8760f6523f77|3|INERTANC|Inertance|[?]|STANDING|[?]|F|[?]|1|um/s|ABDOMINAL AORTA|RIGHT|ANTEROMEDIAL|FARR ASSAY||||SIBLING|OTOLARYNGOLOGIST|2|Visit_2|25|4|TREATMENT|2020-07-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|7449180b-e226-4e97-a059-8760f6523f77|4|PEFTIME|Peak Expiratory Flow Time|[?]|DECUBITUS|||[?]|1|/LSQN|MALE REPRODUCTIVE SYSTEM|UNILATERAL|DISTAL|MULTIPLE BREATH WASHOUT|||Y|ADJUDICATOR|ENDOCRINOLOGIST|2|Visit_2|25|5|SCREENING|2020-07-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|7449180b-e226-4e97-a059-8760f6523f77|5|FIFMAXPP|Percent Predicted FIFmax|[?]|DECUBITUS|[?]|dram|[?]|1|10^6 CFU/g|TRANSVERSE TARSAL JOINT|LATERAL|FACIAL|HILLMEN COLOR CHART||||INTERVIEWER|MICROSCOPIST 3|3|Visit_3|40|6|TREATMENT|2020-08-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|7449180b-e226-4e97-a059-8760f6523f77|6|FEF50|Forced Expiratory Flow 50%|[?]|STANDING, BENT FORWARD|[?]|ug/animal|[?]|1|ug/m2|IRIS|LATERAL|LOWER FLEXOR SURFACE|DC SHEATH FLOW||||INVESTIGATOR|OTOLARYNGOLOGIST|3|Visit_3|40|4|WASHOUT|2020-08-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|7449180b-e226-4e97-a059-8760f6523f77|7|DLCOPP|Percent Predicted DLCO|[?]|SEMI-RECUMBENT|[?]|vg/mL|[?]|1|uSiemens|PARAMETRIUM|RIGHT|LOWER FLEXOR SURFACE|ORCHIDOMETERY||||ADJUDICATOR|ONCOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|7449180b-e226-4e97-a059-8760f6523f77|8|IVCPP|Percent Predicted IVC|[?]|SEMI-FOWLERS|||[?]|1|/day|METATARSOPHALANGEAL JOINT 3|UNILATERAL|PERIVENTRICULAR|PERIPHERAL ANGIOGRAPHY|||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|4|Visit_4|65|4|TREATMENT|2020-08-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|7449180b-e226-4e97-a059-8760f6523f77|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|Enzyme U/g Hb|[?]|1|Bq/L|PYLORIC SPHINCTER|LATERAL|APICAL|NEXT GENERATION SEQUENCING||Y||ADJUDICATION COMMITTEE|RATER 1|5|Visit_5|90|3|FOLLOW-UP|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|7449180b-e226-4e97-a059-8760f6523f77|10|RAWPP|Percent Predicted Airway Resistance|[?]|PRONE|[?]|10^9 CFU/g|[?]|1|Tesla|DISTAL PHALANX 4 OF THE HAND|BILATERAL|CENTRAL|ANTIBIOTIC AGAR SCREEN||||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|||[?]|1|RNA copies/mL|DUCTUS ARTERIOSUS|IPSILATERAL|LOWER|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|DOMESTIC PARTNER|RADIOLOGIST|1|Visit_1|10|7|TREATMENT|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|2|IVC|Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|mL/kg/day|[?]|1|TAMPON|RIB 11|LATERAL|DISTAL|LIQUID SCINTILLATION COUNTING||Y||CAREGIVER|READER 3|1|Visit_1|10|7|TREATMENT|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|3|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|[?]|cmH2O*s2/mL|[?]|1|g/kg|AORTIC VALVE, RIGHT CORONARY CUSP|BILATERAL|ANTEROPOSTERIOR|PATHOLOGICAL EVALUATION||||PROXY|ONCOLOGIST 1|2|Visit_2|25|5|FOLLOW-UP|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|4|IVC|Inspiratory Vital Capacity|[?]|TRENDELENBURG|[?]|kg/mol|[?]|1|mmol/day|5TH LUMBAR SPINOUS PROCESS|UNILATERAL|PROXIMAL VOLAR|SMEAR|Y|||HEALTH CARE PROFESSIONAL|RADIOLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|5|TLC|Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|aMFI|[?]|1|nmol|CALCARINE SULCUS|CONTRALATERAL|SUPERFICIAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|SCREENING|2020-07-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|6|VO2|Oxygen Consumption|[?]|SUPINE|||[?]|1|Henry|INTRAHEPATIC LARGE BILE DUCT|LEFT|VENTRAL|SCANNING ELECTRON MICROSCOPY|||Y|CAREGIVER|ONCOLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|7|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|[?]|DNA copies/ug|[?]|1|mmHg/sec|EPICARDIUM|CONTRALATERAL|ANTEROPOSTERIOR|IMMUNE REPERTOIRE DEEP SEQUENCING||||FRIEND|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|SCREENING|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|8|OXYPULSE|Oxygen Pulse|[?]|SITTING, LEGS DEPENDENT|[?]|nmol/mL/min|[?]|1|mol/mol|BRONCHUS|IPSILATERAL|ANTEROLATERAL|WHOLE GENOME SEQUENCING||||CHILD|NEUROLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|9|TLC|Total Lung Capacity|[?]|SUPINE|[?]|nmol BCE/mmol|[?]|1|PLUG|HAIR|UNILATERAL|SUPERFICIAL|PELLI-ROBSON EYE CHART||||CLINICAL RESEARCH COORDINATOR|READER 3|5|Visit_5|90|4|FOLLOW-UP|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|f077c497-b0f0-4a20-b448-608b0cc6ab36|10|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|nsec|[?]|1|log10 PFU/mL|BRACHIAL VEIN|UNILATERAL|UPPER EXTENSOR SURFACE|MAPH||||SPOUSE|CLINICAL PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING|[?]|mL/m2/day|[?]|1|kHz|HEART, RIGHT ATRIUM|UNILATERAL|DEEP|IN SITU HYBRIDIZATION||Y||FRIEND|OPHTHALMOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|2|SALKK|Salazar-Knowles Equation, K|[?]|SUPINE|[?]|/ms|[?]|1|hPa|ACETABULUM|LATERAL|INFERIOR|LEAD CITRATE STAIN|Y|Y||STUDY SUBJECT|DERMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|3|FEV1SVC|FEV1/SVC|[?]|SEMI-FOWLERS|[?]|ECL unit|[?]|1|POUCH|COLON, LEFT|CONTRALATERAL|INTERMEDIATE|IODINE STAIN||||PARENT|OTOLARYNGOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|4|FIF25|Forced Inspiratory Flow at 25%|[?]|PRONE|[?]|mL/min/mmHg|[?]|1|Hz|RECTUS FEMORIS MUSCLE|LATERAL|LOWER EXTENSOR SURFACE|IMMUNE REPERTOIRE DEEP SEQUENCING||||VENDOR|FORENSIC PATHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SUPINE|[?]|mm/sec|[?]|1|10^6 organisms|ATRIOVENTRICULAR VALVE|BILATERAL|TEMPORAL|CONTRAST ENHANCED SPIRAL CT SCAN|Y|||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|3|Visit_3|40|7|TREATMENT|2020-07-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|6|RAW|Airway Resistance|[?]|SLING|||[?]|1|HOMEOPATHIC DILUTION|DISTAL PHALANX 4 OF THE HAND|LATERAL|LOWER|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||Y|CAREGIVER|ADJUDICATOR 1|3|Visit_3|40|5|TREATMENT|2020-07-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING, BENT FORWARD|[?]|mg/kg/week|[?]|1|g/g|CEPHALIC VEIN|LEFT|MEDIAL|BRDU CELLULAR PROLIFERATION ASSAY||||CHILD|PHYSIOTHERAPIST|4|Visit_4|65|7|TREATMENT|2020-08-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|8|SGAW|Specific Airway Conductance|[?]|SITTING, LEGS DEPENDENT|[?]|mol/L|[?]|1|U/L|LUNG, LEFT UPPER LOBE|LEFT|POSTERIOR|HIGH RESOLUTION MELT ANALYSIS||Y||DOMESTIC PARTNER|RATER|4|Visit_4|65|3|TREATMENT|2020-08-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|SUPINE|[?]|kg/cm|[?]|1|ELISA unit/dose|POSTERIOR POLE OF THE EYE|LATERAL|ANTEROMEDIAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||PARENT|OPTOMETRIST|5|Visit_5|90|3|TREATMENT|2020-08-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|SUPINE|[?]|10^6 copies/mL|[?]|1|mAmp|ILIAC LYMPH NODE|IPSILATERAL|SUBCORTICAL|KLEIHAUER-BETKE|Y|||VENDOR|ADJUDICATOR 2|5|Visit_5|90|6|FOLLOW-UP|2020-08-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|SGAW|Specific Airway Conductance|[?]|SEMI-FOWLERS|||[?]|1|msec|ACCESSORY RENAL ARTERY|IPSILATERAL|MEDIAL|CALCULATION|||Y|SPOUSE|RATER 2|1|Visit_1|10|3|TREATMENT|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|2|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^8 PFU|METACARPOPHALANGEAL JOINT 5|LEFT|DORSAL|RULER MEASUREMENT METHOD|||Y|SIGNIFICANT OTHER|READER 1|1|Visit_1|10|7|TREATMENT|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|3|RVPP|Percent Predicted Residual Volume|[?]|REVERSE TRENDELENBURG|[?]|s*kPa|[?]|1|GBq/g|ABDOMINAL WALL|UNILATERAL|ANTEROLATERAL|PET/CT SCAN||Y||INVESTIGATOR|NEUROLOGIST 1|2|Visit_2|25|4|WASHOUT|2021-01-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|4|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|[?]|Gy/min|[?]|1|mmol|OCCIPITAL LYMPH NODE|LEFT|DORSAL|CORONARY ANGIOGRAPHY||||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|2|FOLLOW-UP|2021-01-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-RECUMBENT|[?]|U/L|[?]|1|Sv|TONGUE|RIGHT|LATERAL|GC/FID||Y||CAREGIVER|FORENSIC PATHOLOGIST|3|Visit_3|40|2|WASHOUT|2021-02-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|6|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|cup eq|[?]|1|grain|PLACENTA|LATERAL|ROSTRAL|ENZYMATIC COLORIMETRY||||SPOUSE|NEUROLOGIST 2|3|Visit_3|40|1|TREATMENT|2021-02-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|7|SALKK|Salazar-Knowles Equation, K|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^7 CFU/mL|INFRARENAL AORTA|UNILATERAL|NASAL|FLUORESCEIN STAIN|||Y|SIBLING|MICROSCOPIST|4|Visit_4|65|3|FOLLOW-UP|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|LATERAL DECUBITUS|[?]|ug/m2/h|[?]|1|ft2|URETHRA, PENILE|RIGHT|VENTRAL|FUNDUS PHOTOGRAPHY||||VENDOR|HEMATOLOGIST|4|Visit_4|65|5|SCREENING|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|9|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|oz|PUTAMEN|BILATERAL|NASAL|MASS SPECTROMETRY|||Y|SIGNIFICANT OTHER|READER 2|5|Visit_5|90|3|FOLLOW-UP|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|3f7c46ac-fe30-4ef3-a581-99c064a85efa|10|EVC|Expiratory Vital Capacity|[?]|STANDING|||[?]|1|ELISA unit/mL|ANKLE JOINT ANTERIOR FLEXOR TENDONS|CONTRALATERAL|SUPERIOR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|||Y|CHILD|PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|DLCOHC|HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|||[?]|1|nmol/g|CARPOMETACARPAL JOINT 1|IPSILATERAL|DORSAL|FLOCCULATION, CHARCOAL ENHANCED|||Y|CAREGIVER|OPHTHALMOLOGIST|1|Visit_1|10|2|TREATMENT|2020-09-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LATERAL DECUBITUS|||[?]|1|10^7 TCID 50/dose|WRIST JOINT FLEXOR MUSCLES|BILATERAL|FRONTAL|PET/CT SCAN|||Y|INTERVIEWER|DERMATOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-09-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|3|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|||[?]|1|HEP|CILIARY BODY|RIGHT|ANTEROPOSTERIOR|CLIP SEQUENCING||Y|Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-10-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|4|PEFREV|PEF Reversibility|[?]|STANDING|[?]|10^4/L|[?]|1|uL/kg/day|SKULL|CONTRALATERAL|ANTEROPOSTERIOR|MOUSE PROTECTION ASSAY||||CHILD|ONCOLOGIST 1|2|Visit_2|25|7|SCREENING|2020-10-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|5|OXYPULSE|Oxygen Pulse|[?]|SLING|[?]|Enzyme U/m2|[?]|1|mg/m2/day|OBTURATOR EXTERNUS MUSCLE|LATERAL|DEEP|THICK SMEAR||||FAMILY MEMBER|MICROSCOPIST 3|3|Visit_3|40|2|FOLLOW-UP|2020-10-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|6|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-FOWLERS|[?]|Ci/g|[?]|1|KIT|CAUDAL VERTEBRA|CONTRALATERAL|TEMPORAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||Y||CLINICAL STUDY SPONSOR|INTERNIST|3|Visit_3|40|1|TREATMENT|2020-10-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|7|EFFIND|Effusion Indicator|[?]|SEMI-RECUMBENT|||[?]|1|um/s|ESOPHAGEAL LYMPH NODE|BILATERAL|MEDIAL|CHROMATOGRAPHY|Y||Y|FAMILY MEMBER|HEMATOLOGIST|4|Visit_4|65|5|WASHOUT|2020-11-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|[?]|pg/L|[?]|1|cy/cm|MEDULLA OBLONGATA|IPSILATERAL|ANTEROTEMPORAL|LASER CAPTURE MICRODISSECTION|Y|||CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|9|FEV6PP|Percent Predicted FEV6|[?]|UNCONSTRAINED|[?]|pmol/L/h|[?]|1|U.CARR|PANCREAS, TAIL|LATERAL|APICAL|CHROMOGENIC ASSAY||||FRIEND|UROLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-12-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|8d944400-df75-4ec7-8fb4-239eb0f6de9d|10|FIVC|Forced Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|s^-1(%O2)^-1|[?]|1|Torr|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LATERAL|OCCIPITAL|PALM METHOD||||CLINICAL STUDY SPONSOR|RADIOLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-12-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|1|TV|Tidal Volume|[?]|FOWLERS|[?]|U/mL|[?]|1|CAPLET|MEDIASTINUM, POSTERIOR|UNILATERAL|PERIPHERAL|ETDRS EYE CHART||Y||PARENT|MICROSCOPIST|1|Visit_1|10|2|SCREENING|2020-12-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SUPINE|[?]|mU/L|[?]|1|pmol|KIDNEY, UPPER LOBE|IPSILATERAL|SURFACE|TRICHROME STAIN||||DOMESTIC PARTNER|ADJUDICATOR 1|1|Visit_1|10|1|WASHOUT|2020-12-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|3|PLMXRS|Pulmonary Reactance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Log10 ELISA unit/dose|SKIN OF THE ELBOW|IPSILATERAL|LATERAL|POPULATION SEQUENCING|||Y|SPOUSE|ONCOLOGIST 1|2|Visit_2|25|5|WASHOUT|2021-01-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|4|FEV1FVC6|FEV1/FVC6|[?]|SUPINE|[?]|BU/mL|[?]|1|umol/day|ESOPHAGUS, CERVICAL|UNILATERAL|CAUDAL|HILLMEN COLOR CHART|Y|||STUDY SUBJECT|ADJUDICATOR 2|2|Visit_2|25|3|FOLLOW-UP|2021-01-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|5|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-RECUMBENT|[?]|in2|[?]|1|NFIU|DISTAL INTERPHALANGEAL JOINT 4|LATERAL|SUPERFICIAL|HIGH RESOLUTION CT||Y||INVESTIGATOR|DERMATOLOGIST|3|Visit_3|40|4|SCREENING|2021-01-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|6|AWVOL|Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|ka_u/dL|[?]|1|Ci/g|KIDNEY, MEDULLA|LATERAL|DORSOLATERAL|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||SIGNIFICANT OTHER|NEUROLOGIST 2|3|Visit_3|40|5|WASHOUT|2021-01-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|7|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|[?]|cm2|[?]|1|ukat/10^12 RBC|MEDIASTINAL LYMPH NODE|IPSILATERAL|NASAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||Y||ADJUDICATION COMMITTEE|NEUROLOGIST|4|Visit_4|65|1|TREATMENT|2021-02-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|8|ICREV|IC Reversibility|[?]|PRONE|[?]|10^9/dose|[?]|1|DDU|L1 VERTEBRA|BILATERAL|FACIAL|PHASE CONTRAST MICROSCOPY||Y||PARENT|ONCOLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-02-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|9|DLCOVA|DLCO/VA|[?]|SITTING|[?]|mL/min/1.73m2|[?]|1|L/min/m2|UTERINE ARTERY|RIGHT|ANTEROPOSTERIOR|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|WASHOUT|2021-03-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|7b201f93-bd8c-4507-a7b7-27a02e364647|10|IVC|Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|10^10/L|[?]|1|uV*sec|LINGULA OF THE LUNG|LATERAL|FACIAL|GC/MS/MS||||VENDOR|READER 1|5|Visit_5|90|4|SCREENING|2021-03-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|SAWVOL|Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|cd*s/m2|LIVER, QUADRATE LOBE|BILATERAL|OCCIPITAL|ALCIAN BLUE STAIN||Y|Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|1|Visit_1|10|5|SCREENING|2020-08-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|2|IVC|Inspiratory Vital Capacity|[?]|PRONE|[?]|U/10^12 RBC|[?]|1|mg/animal|SKIN OF THE ELBOW|CONTRALATERAL|INTERMEDIATE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||Y||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|1|Visit_1|10|3|SCREENING|2020-08-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|3|SALKK|Salazar-Knowles Equation, K|[?]|LATERAL DECUBITUS|[?]|uEq/L|[?]|1|mEq/mmol|PENIS, GLANS|BILATERAL|DISTAL VOLAR|PHOTOMETRY|Y|||GUARDIAN|NEUROLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-08-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|4|MIP|Maximal Inspiratory Pressure|[?]|FOWLERS|[?]|tsp|[?]|1|10^9 CFU/mL|PAW|LEFT|DEEP|ORCHIDOMETERY||||INTERVIEWER|PATHOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-08-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|5|FIV1|Forced Inspiratory Volume in 1 Second|[?]|PRONE|||[?]|1|mg/dose|BRACHIALIS MUSCLE|CONTRALATERAL|INFERIOR|ECHOCARDIOGRAPHY||Y|Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|3|Visit_3|40|2|TREATMENT|2020-09-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|6|DLCOHC|HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|g/kg/day|[?]|1|ug/dose|TRICUSPID VALVE ANNULUS|CONTRALATERAL|HIND|OBSERVATION||Y||STUDY SUBJECT|UROLOGIST|3|Visit_3|40|1|SCREENING|2020-09-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|7|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|||[?]|1|U/dL|LUNG, HILUM|CONTRALATERAL|BASAL|REVERSE TRANSCRIPTASE PCR|||Y|CLINICAL RESEARCH ASSOCIATE|READER 1|4|Visit_4|65|4|TREATMENT|2020-09-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|TRENDELENBURG|[?]|SBE/mL|[?]|1|U/mmol|NOSE|LATERAL|SURFACE|WESTERN BLOT||||FAMILY MEMBER|NEUROLOGIST 1|4|Visit_4|65|7|WASHOUT|2020-09-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|9|DLCO|Diffusion Capacity of Lung for CO|[?]|SLING|[?]|ka_u/dL|[?]|1|mg/kg/h|TIBIAL-CRURAL PERIPHERAL ARTERY|LEFT|TIP|POLYGRAPHY||||PROXY|PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-10-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|[?]|PATCH|[?]|1|F|FOOT DIGIT 3|CONTRALATERAL|INNER|IMMUNO-PET SCAN|Y|||PARENT|READER 3|5|Visit_5|90|4|TREATMENT|2020-10-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|1|IVC|Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|mL/m2|[?]|1|umol/min|L4-L5 INTERVERTEBRAL SPACE|UNILATERAL|ANTEROTEMPORAL|LIQUID SCINTILLATION COUNTING||||CHILD|READER 3|1|Visit_1|10|6|SCREENING|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|2|TSUHYS|Tissue Hysteresivity|[?]|DECUBITUS|[?]|PELLET|[?]|1|RFU|RECTO-UTERINE POUCH|RIGHT|LOWER EXTENSOR SURFACE|COLORIMETRY|Y|||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|1|Visit_1|10|2|WASHOUT|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|3|EFFIND|Effusion Indicator|[?]|STANDING, BENT FORWARD|||[?]|1|uCi/L|CARPOMETACARPAL JOINT 2|RIGHT|VENTROLATERAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|2|Visit_2|25|6|WASHOUT|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|4|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|[?]|BOLUS|[?]|1|umol/L|ADDUCTOR LONGUS MUSCLE|LEFT|HIND|POTENTIOMETRY||||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|5|FIFMAXPP|Percent Predicted FIFmax|[?]|LEFT LATERAL DECUBITUS|[?]|10^7 CFU/mL|[?]|1|g/cm2|OCCIPITAL LOBE|RIGHT|SUPERFICIAL|CAPILLARY ELECTROPHORESIS||Y||ADJUDICATION COMMITTEE|READER 2|3|Visit_3|40|7|FOLLOW-UP|2020-09-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|6|FEF2575P|Percent Predicted FEF25-75|[?]|SLING|||[?]|1|Gravitational Unit|GASTROINTESTINAL TRACT, LOWER|CONTRALATERAL|CAUDAL|FLOCCULATION|||Y|PROXY|READER 1|3|Visit_3|40|7|FOLLOW-UP|2020-09-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SUPINE|[?]|MPL U/mL|[?]|1|10^3/hpf|SCAPHOID-LUNATE-CAPITATE JOINT|CONTRALATERAL|UPPER|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||ADJUDICATOR|ADJUDICATOR 3|4|Visit_4|65|3|SCREENING|2020-09-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|pptr|[?]|1|Log10 ELISA unit/dose|THROAT|BILATERAL|FORE|RADIATION DOSIMETRY||Y||STUDY SUBJECT|DERMATOLOGIST|4|Visit_4|65|7|TREATMENT|2020-09-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|9|EVC|Expiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|/500 WBC|[?]|1|U/g|HEPATIC VEIN|IPSILATERAL|MEDIAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|5|TREATMENT|2020-10-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|3611b798-9b3d-4173-b23e-3017939847e0|10|PNEUMIND|Pneumonia Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|mAmp|[?]|1|mmol/min/kPa/L|CEREBELLUM|IPSILATERAL|UPPER EXTENSOR SURFACE|HPLC/MS|Y|||GUARDIAN|ONCOLOGIST|5|Visit_5|90|7|WASHOUT|2020-10-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING|[?]|pg/cell|[?]|1|g/mol|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|RIGHT|FACIAL|ZIEHL NEELSEN ACID FAST STAIN||||INDEPENDENT ASSESSOR|READER 2|1|Visit_1|10|2|TREATMENT|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|2|EFFVOL|Effusion Volume|[?]|TRENDELENBURG|[?]|dyn|[?]|1|% INHIBITION|RESPIRATORY SYSTEM|UNILATERAL|INTERMEDIATE|IMMUNOFLUORESCENT STAIN||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|2|TREATMENT|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|3|EFFIND|Effusion Indicator|[?]|DECUBITUS|[?]|mEq/L|[?]|1|cmH2O*s/mL|BLOOD|UNILATERAL|APICAL|MAGNETIC RESONANCE ENTEROGRAPHY|Y|||DOMESTIC PARTNER|MICROSCOPIST|2|Visit_2|25|6|FOLLOW-UP|2020-07-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|4|INTP|Interpretation|[?]|DECUBITUS|[?]|10^3 CFU/mL|[?]|1|mg/m2/min|ILIUM|LEFT|INTERMEDIATE|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||ADJUDICATOR|ADJUDICATOR 2|2|Visit_2|25|3|TREATMENT|2020-07-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|5|PIF|Peak Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|||[?]|1|% INHIBITION|ACETABULUM|LEFT|LOWER MEDIAL|REFRACTOMETRY|||Y|HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|3|Visit_3|40|7|FOLLOW-UP|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|6|EFFVOL|Effusion Volume|[?]|STANDING|||[?]|1|10^6 organisms/mL|ETHMOID BONE|CONTRALATERAL|HIND|MRS|||Y|STUDY SUBJECT|RADIOLOGIST 1|3|Visit_3|40|3|SCREENING|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|7|OXYPULSE|Oxygen Pulse|[?]|LATERAL DECUBITUS|||[?]|1|nmol/day|NERVE|IPSILATERAL|CAUDAL|DUKE INCISION METHOD|||Y|CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|4|Visit_4|65|3|WASHOUT|2020-08-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|8|RELSZCHG|Relative Size Change|[?]|SEMI-RECUMBENT|[?]|mL/day|[?]|1|mmol/min/kPa/L|CRANIAL NERVE|LEFT|UPPER FLEXOR SURFACE|MICROBIAL CULTURE, LIQUID||||SIBLING|NEUROLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-08-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SLING|[?]|uV|[?]|1|psi|INTERPHALANGEAL JOINT 5 OF THE FOOT|CONTRALATERAL|DISTAL VOLAR|POPULATION SEQUENCING|Y|Y||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|5|Visit_5|90|1|TREATMENT|2020-09-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|f651799b-9723-4c2c-88d1-de2f347e9a69|10|PNEUMIND|Pneumonia Indicator|[?]|STANDING|[?]|ukat/L|[?]|1|BOLUS|OLFACTORY BULB|LEFT|OUTER|PH METER MEASUREMENT METHOD||Y||CHILD|CARDIOLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|[?]|g/cm2|[?]|1|umol/mg/min|SYNOVIAL FLUID|LEFT|OCCIPITAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||CAREGIVER|MICROSCOPIST 1|1|Visit_1|10|1|TREATMENT|2020-10-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|2|OXYPULSE|Oxygen Pulse|[?]|REVERSE TRENDELENBURG|||[?]|1|usec|BLADDER, NECK|LEFT|LOWER|LC-FL|||Y|CHILD|PATHOLOGIST|1|Visit_1|10|1|WASHOUT|2020-10-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|3|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|[?]|vg/mL|[?]|1|ft|SKIN OF THE LOWER LIMB|IPSILATERAL|ROSTRAL|SURFACE PLASMON RESONANCE||Y||CHILD|FORENSIC PATHOLOGIST|2|Visit_2|25|1|SCREENING|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|DAgU|[?]|1|10^6 organisms/mL|CERVIX UTERI|RIGHT|APICAL|GC/MS-CI||||SIBLING|DERMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|5|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING|[?]|mL/kg/day|[?]|1|foz_br|ILIAC FOSSA|CONTRALATERAL|LOWER MEDIAL|HPLC||||FAMILY MEMBER|NEUROLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|FOWLERS|[?]|CONTAINER|[?]|1|CIGAR|POPLITEAL ARTERY BELOW KNEE|BILATERAL|CAUDAL|DYNAMOMETRY||Y||ADJUDICATOR|OPTOMETRIST|3|Visit_3|40|4|TREATMENT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|IU/g Hb|[?]|1|mmol/min/kPa/L|PERIPHERAL NERVE|UNILATERAL|UPPER FLEXOR SURFACE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||PARENT|CARDIOLOGIST|4|Visit_4|65|2|SCREENING|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|8|FIF75|Forced Inspiratory Flow at 75%|[?]|FOWLERS|||[?]|1|GPS U|FUNDUS OF THE STOMACH|LEFT|FACIAL|NO INFORMATION|Y||Y|FAMILY MEMBER|NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|9|MEP|Maximal Expiratory Pressure|[?]|SLING|[?]|mL/sec/1.73m2|[?]|1|DROP|MALE REPRODUCTIVE SYSTEM|UNILATERAL|LOWER FLEXOR SURFACE|MYELOPEROXIDASE STAIN||||FAMILY MEMBER|ADJUDICATOR 3|5|Visit_5|90|7|FOLLOW-UP|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|10|INERTANC|Inertance|[?]|UNCONSTRAINED|[?]|L/kg|[?]|1|umol/dL|MESENTERY|RIGHT|DORSAL|NON-INVASIVE DIELECTRIC SENSING|Y|||SIGNIFICANT OTHER|ONCOLOGIST 1|5|Visit_5|90|5|TREATMENT|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|29b16c31-df0e-493c-a777-46113b904879|1|SGAW|Specific Airway Conductance|[?]|RIGHT LATERAL DECUBITUS|[?]|BLOCKS|[?]|1|U/m2/h|STERNUM|LATERAL|SUPERIOR|CT SCAN WITHOUT CONTRAST|Y|||VENDOR|RADIOLOGIST 2|1|Visit_1|10|1|SCREENING|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|29b16c31-df0e-493c-a777-46113b904879|2|TGV|Thoracic Gas Volume|[?]|REVERSE TRENDELENBURG|[?]|IU|[?]|1|kg/cm|BLOOD|CONTRALATERAL|DISTAL|CAPILLARY ELECTROPHORESIS||||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|5|TREATMENT|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|29b16c31-df0e-493c-a777-46113b904879|3|TSUELAS|Tissue Elastance|[?]|SUPINE|[?]|oz eq|[?]|1|Absorbance U/min|HAND|IPSILATERAL|FORE|ANTIMICROBIAL COMBINATION TESTING||||SIBLING|ENDOCRINOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|29b16c31-df0e-493c-a777-46113b904879|4|TV|Tidal Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|g/L|HEART, ATRIUM|CONTRALATERAL|ROSTRAL|GC/FID|||Y|CLINICAL STUDY SPONSOR|READER|2|Visit_2|25|7|TREATMENT|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|29b16c31-df0e-493c-a777-46113b904879|5|PLMXRS|Pulmonary Reactance|[?]|PRONE|||[?]|1|mL/100g/min|TONGUE|LATERAL|SUPERIOR|IMPEDANCE CONDUCTIVITY||Y|Y|STUDY SUBJECT|DERMATOLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|29b16c31-df0e-493c-a777-46113b904879|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|/100 HPFs|[?]|1|AFU|VERTEBRAL ARTERY|IPSILATERAL|VENTRAL|FLUORESCENT IMMUNOASSAY||Y||CLINICAL RESEARCH COORDINATOR|UROLOGIST|3|Visit_3|40|6|TREATMENT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|29b16c31-df0e-493c-a777-46113b904879|7|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SUPINE|[?]|SPRAY|[?]|1|umol/kg/min|ABDOMINAL LYMPH NODE|BILATERAL|FRONTAL|FUNCTIONAL MRI||||INDEPENDENT ASSESSOR|MICROSCOPIST 2|4|Visit_4|65|5|WASHOUT|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|29b16c31-df0e-493c-a777-46113b904879|8|ICREV|IC Reversibility|[?]|SLING|[?]|uV*sec|[?]|1|SACHET|ANTERIOR HORN OF THE LATERAL VENTRICLE|LATERAL|MEDIAL|IVY INCISION METHOD||||NON-HEALTH CARE PROFESSIONAL|READER 3|4|Visit_4|65|6|WASHOUT|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|29b16c31-df0e-493c-a777-46113b904879|9|TGV|Thoracic Gas Volume|[?]|PRONE|||[?]|1|mg/kg/week|TONSIL|LATERAL|ANTEROTEMPORAL|CONTRAST ENHANCED MRI||Y|Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|5|Visit_5|90|6|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|29b16c31-df0e-493c-a777-46113b904879|10|GAW|Airway Conductance|[?]|DECUBITUS|[?]|Bq/g|[?]|1|ng/mol|HYMENAL RING|CONTRALATERAL|LOWER|TONOMETRY||||DOMESTIC PARTNER|PATHOLOGIST 1|5|Visit_5|90|1|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|[?]|mm/min|[?]|1|GPS U|CHEST WALL|UNILATERAL|LOWER MEDIAL|TOLUIDINE BLUE STAIN||||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|1|Visit_1|10|3|TREATMENT|2020-07-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|2|SALKK|Salazar-Knowles Equation, K|[?]|PRONE|[?]|Hounsfield Unit|[?]|1|mL/dL|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|UNILATERAL|OCCIPITAL|SPIRAL CT SCAN WITHOUT CONTRAST|Y|||SPOUSE|NEUROLOGIST 2|1|Visit_1|10|7|FOLLOW-UP|2020-07-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|3|MIPPP|Percent Predicted MIP|[?]|SLING|[?]|pmol/10^10 cells|[?]|1|VIRTUAL PIXEL|TROCHANTER|LATERAL|UPPER FLEXOR SURFACE|POLYGRAPHY|Y|||SIBLING|ONCOLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|4|OXYPULSE|Oxygen Pulse|[?]|UNCONSTRAINED|||[?]|1|vg/kg|LATISSIMUS DORSI MUSCLE|BILATERAL|MIDLINE|MOUSE PROTECTION ASSAY||Y|Y|SIBLING|PATHOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|5|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|Tbsp|[?]|1|steps/min|ANUS|IPSILATERAL|PROXIMAL VOLAR|PALM METHOD||||STUDY SUBJECT|READER 3|3|Visit_3|40|3|FOLLOW-UP|2020-08-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|6|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|JDF Unit|[?]|1|HEP|MITRAL VALVE ANNULUS|CONTRALATERAL|MIDLINE|AURAMINE STAIN|Y|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|3|Visit_3|40|1|FOLLOW-UP|2020-08-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|7|RELSZCHG|Relative Size Change|[?]|SITTING|[?]|%(w/v)|[?]|1|mU|INSULAR CORTEX|UNILATERAL|CENTRAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||Y||DOMESTIC PARTNER|RADIOLOGIST 2|4|Visit_4|65|4|SCREENING|2020-09-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|8|AWVOL|Airway Volume|[?]|PRONE|||[?]|1|Osm|MAIN BRONCHUS, LEFT|RIGHT|ROSTRAL|FARNSWORTH-MUNSELL 100 HUE TEST|||Y|SIBLING|RATER 2|4|Visit_4|65|2|FOLLOW-UP|2020-09-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING|||[?]|1|mL/min/1.73m2|CARPAL BONE|IPSILATERAL|PROXIMAL|CLIP SEQUENCING|||Y|CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-10-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|10|EVC|Expiratory Vital Capacity|[?]|DECUBITUS|||[?]|1|mkat|SCALP|LEFT|LOWER EXTENSOR SURFACE|CAPILLARY ELECTROPHORESIS|Y||Y|SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|FOLLOW-UP|2020-10-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|118914c8-9f6a-47c8-b427-296a99547756|1|PEFREV|PEF Reversibility|[?]|PRONE|[?]|NFIU|[?]|1|10^3 CFU/mL|SKIN OF THE BUTTOCK|BILATERAL|OUTER|CALCOFLUOR WHITE STAIN||||CLINICAL STUDY SPONSOR|NEUROLOGIST|1|Visit_1|10|5|WASHOUT|2020-10-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|118914c8-9f6a-47c8-b427-296a99547756|2|IC|Inspiratory Capacity|[?]|SEMI-RECUMBENT|[?]|nsec|[?]|1|FIU|CORPUS LUTEUM|IPSILATERAL|MIDLINE|IMMUNE REPERTOIRE DEEP SEQUENCING||||GUARDIAN|NEUROLOGIST 1|1|Visit_1|10|5|FOLLOW-UP|2020-10-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|118914c8-9f6a-47c8-b427-296a99547756|3|SAWVOL|Specific Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|ng|[?]|1|Siemens|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|BILATERAL|ANTEROMEDIAL|FLOCCULATION||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|2|Visit_2|25|3|TREATMENT|2020-11-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|118914c8-9f6a-47c8-b427-296a99547756|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|SITTING|[?]|DAgU|[?]|1|Enzyme U/g Hb|MIDDLE PHALANX 4 OF THE HAND|CONTRALATERAL|INFERIOR|ETDRS EYE CHART|Y|Y||SIGNIFICANT OTHER|CARDIOLOGIST|2|Visit_2|25|4|TREATMENT|2020-11-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|118914c8-9f6a-47c8-b427-296a99547756|5|FVC|Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|L/h|[?]|1|ms2|ANKLE JOINT ANTERIOR FLEXOR TENDONS|RIGHT|LOWER MEDIAL|COMPLEMENT FIXATION||||CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-11-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|118914c8-9f6a-47c8-b427-296a99547756|6|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|[?]|g/g|[?]|1|Ci/uL|CORONARY ARTERY, LEFT|UNILATERAL|ANTEROLATERAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|Y|||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-11-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|118914c8-9f6a-47c8-b427-296a99547756|7|FEV1FVC|FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|MASK|[?]|1|tsp|ESOPHAGUS|LATERAL|APICAL|QUANTITATIVE COMPUTED TOMOGRAPHY||Y||PROXY|ONCOLOGIST 2|4|Visit_4|65|3|FOLLOW-UP|2020-12-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|118914c8-9f6a-47c8-b427-296a99547756|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|UNCONSTRAINED|[?]|BAR|[?]|1|10^8/L|SKIN OF THE SOLE|UNILATERAL|UPPER EXTENSOR SURFACE|WESTERGREN|Y|||SPOUSE|DERMATOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|118914c8-9f6a-47c8-b427-296a99547756|9|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING, LEGS DEPENDENT|[?]|Gy|[?]|1|mg2/dL2|CALF|LATERAL|DORSAL|OPHTHALMOSCOPY||Y||CHILD|ADJUDICATOR|5|Visit_5|90|6|WASHOUT|2021-01-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|118914c8-9f6a-47c8-b427-296a99547756|10|MALIND|Malignancy Indicator|[?]|SLING|[?]|mL/100g/min|[?]|1|PIXELS/cm|DIAPHRAGM|BILATERAL|ANTEROLATERAL|GC/MS||||ADJUDICATOR|RADIOLOGIST|5|Visit_5|90|3|TREATMENT|2021-01-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-RECUMBENT|[?]|U|[?]|1|g/mol|LUMBAR VERTEBRA|BILATERAL|INTERMEDIATE|PERFUSION MRI||||SIBLING|RADIOLOGIST|1|Visit_1|10|2|WASHOUT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|2|DLCOVA|DLCO/VA|[?]|STANDING|[?]|TABLET|[?]|1|g/animal/day|COLON WALL|LEFT|DORSAL|TOLUIDINE BLUE STAIN||Y||STUDY SUBJECT|PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|3|MIPPP|Percent Predicted MIP|[?]|SITTING, LEGS DEPENDENT|[?]|Bq/mg|[?]|1|mL/animal|MOTOR CORTEX|LATERAL|INTERMEDIATE|TEST STRIP|Y|Y||SIBLING|MICROSCOPIST 2|2|Visit_2|25|6|WASHOUT|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|4|SGAW|Specific Airway Conductance|[?]|LATERAL DECUBITUS|||[?]|1|DDU|CARPOMETACARPAL JOINT|LEFT|INTERMEDIATE|IODINE STAIN||Y|Y|ADJUDICATION COMMITTEE|PATHOLOGIST|2|Visit_2|25|5|TREATMENT|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|PRONE|[?]|mol/mol|[?]|1|pg/cell|THORACIC LYMPH NODE|LEFT|DORSAL|AUSCULTATION||||VENDOR|PATHOLOGIST 1|3|Visit_3|40|5|SCREENING|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|6|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|mL/m2/day|[?]|1|/ms|RETROAURICULAR LYMPH NODE|IPSILATERAL|UPPER FLEXOR SURFACE|CT SCAN WITHOUT CONTRAST||Y||PARENT|ONCOLOGIST 2|3|Visit_3|40|1|TREATMENT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|7|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-FOWLERS|[?]|10^4 CFU/mL|[?]|1|WEEKS|RADIUS-LUNATE JOINT|UNILATERAL|SUPERIOR|HEMAGGLUTINATION ASSAY||||GUARDIAN|OPHTHALMOLOGIST|4|Visit_4|65|7|TREATMENT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|8|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|||[?]|1|pL|FACIAL BONE|CONTRALATERAL|FRONTAL|IMMUNOTURBIDIMETRY|Y|Y|Y|SPOUSE|PATHOLOGIST 1|4|Visit_4|65|5|TREATMENT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|FOWLERS|[?]|Linear ft*LB|[?]|1|mmol2/L2|URETER|UNILATERAL|BASAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||Y||INTERVIEWER|OTOLARYNGOLOGIST|5|Visit_5|90|7|SCREENING|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|10|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|Hz/s|[?]|1|ug/kg|THORACIC LYMPH NODE|LATERAL|ANTEROTEMPORAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|deg|[?]|1|mL/cm H2O|LEFT VENTRICULAR EPICARDIUM|BILATERAL|POSTERIOR|CONTRAST ENHANCED PET/CT SCAN||||STUDY SUBJECT|RATER 2|1|Visit_1|10|3|WASHOUT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|2|TSUHYS|Tissue Hysteresivity|[?]|SEMI-RECUMBENT|[?]|mg/kg/week|[?]|1|MET*min|SPLEEN|BILATERAL|BASAL|CONTACT SPECULAR MICROSCOPY|Y|Y||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|3|GAW|Airway Conductance|[?]|SLING|[?]|Enzyme U/L|[?]|1|ng/L|PARASPINAL REGION|CONTRALATERAL|CENTRAL|TURBIDIMETRY||||PARENT|READER 2|2|Visit_2|25|3|FOLLOW-UP|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|4|FEV1FVC6|FEV1/FVC6|[?]|LATERAL DECUBITUS|||[?]|1|MdFI|TOENAIL|IPSILATERAL|APICAL|QUANTITATIVE ULTRASOUND|Y||Y|STUDY SUBJECT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|2|TREATMENT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|5|INFLTIND|Infiltrates Indicator|[?]|PRONE|[?]|10^3 RNA copies/mL|[?]|1|pmol|TEMPORAL BONE|IPSILATERAL|CRANIAL|SPIROMETRY||||GUARDIAN|NEUROLOGIST 1|3|Visit_3|40|1|TREATMENT|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|6|SGAW|Specific Airway Conductance|[?]|DECUBITUS|[?]|log10 PFU|[?]|1|ELISA unit/dose|CHOROID PLEXUS|BILATERAL|TIP|TRANSCRIPTION-MEDIATED AMPLIFICATION||Y||PROXY|PATHOLOGIST 2|3|Visit_3|40|4|TREATMENT|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|7|AIRTRAP|Air Trapping|[?]|SITTING|[?]|mmHg|[?]|1|DAYS|TRICEPS BRACHII MUSCLE|IPSILATERAL|FACIAL|STATIC PERIMETRY||Y||INDEPENDENT ASSESSOR|ADJUDICATOR 1|4|Visit_4|65|5|WASHOUT|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|PRONE|[?]|mL/(min*100mL)|[?]|1|GBq|PARATHYROID GLAND|CONTRALATERAL|PERIVENTRICULAR|HPLC/IEX||||FAMILY MEMBER|RADIOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|UNCONSTRAINED|[?]|mmol/min/kPa|[?]|1|mL/s|LENS|UNILATERAL|INNER|U-HPLC/MS/MS||||PROXY|OPTOMETRIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|RE|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|pkat/L|[?]|1|Ci/ug|SOLE|BILATERAL|VENTRAL|HILLMEN COLOR CHART||||CLINICAL STUDY SPONSOR|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|TRENDELENBURG|||[?]|1|mL/day|LUNG, RIGHT LOWER LOBE|RIGHT|UPPER FLEXOR SURFACE|ENZYMATIC COLORIMETRY|||Y|INTERVIEWER|MICROSCOPIST 1|1|Visit_1|10|6|TREATMENT|2020-07-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|2|SVC|Slow Vital Capacity|[?]|FOWLERS|||[?]|1|mCi/kg|THORACIC LYMPH NODE|UNILATERAL|UPPER EXTENSOR SURFACE|THICK SMEAR|||Y|INDEPENDENT ASSESSOR|PATHOLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-07-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SEMI-FOWLERS|[?]|USP U|[?]|1|log10 CFU/g|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|RIGHT|VENTROLATERAL|CONTACT SPECULAR MICROSCOPY||||FRIEND|PEDIATRIC NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|4|EFFVOL|Effusion Volume|[?]|STANDING, BENT FORWARD|||[?]|1|Arbitrary U|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|RIGHT|TIP|BIOPSY|||Y|CLINICAL RESEARCH COORDINATOR|RATER|2|Visit_2|25|7|TREATMENT|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|5|RRS|Total Respiratory System Resistance|[?]|SLING|[?]|/2000 RBC|[?]|1|copies/uL|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|UNILATERAL|FACIAL|U-HPLC/MS/MS||||PROXY|RADIOLOGIST 2|3|Visit_3|40|7|TREATMENT|2020-08-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|mL/mmHg|[?]|1|cm/min|INGUINAL REGION|BILATERAL|FORE|PHOTOMETRY||||PARENT|RATER 1|3|Visit_3|40|5|TREATMENT|2020-08-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|7|AWWVOL|Airway Wall Volume|[?]|TRENDELENBURG|[?]|10^3 organisms|[?]|1|BOX|LARYNX|LEFT|PROXIMAL|ELECTROCHEMILUMINESCENCE||||INTERVIEWER|ADJUDICATOR 2|4|Visit_4|65|4|SCREENING|2020-08-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|8|RELSZCHG|Relative Size Change|[?]|LATERAL DECUBITUS|[?]|10^6 copies/mL|[?]|1|mm/min|COMMON FEMORAL ARTERY|LEFT|APICAL|HPLC-FL||||PARENT|ADJUDICATOR 3|4|Visit_4|65|1|TREATMENT|2020-08-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|9|AWVOLPP|Percent Predicted Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mmHg/L/min|[?]|1|CAPFUL|TRAPEZIUM-TRAPEZOID JOINT|CONTRALATERAL|APICAL|DISK DIFFUSION||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|1|TREATMENT|2020-09-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|7a5ae465-03b9-4006-a29e-94822ed857aa|10|MALIND|Malignancy Indicator|[?]|SITTING, LEGS DEPENDENT|||[?]|1|m/sec|COLON LYMPH NODE|RIGHT|HIND|VIRUS PLAQUE ASSAY|Y||Y|FAMILY MEMBER|OTOLARYNGOLOGIST|5|Visit_5|90|7|TREATMENT|2020-09-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|PCF|Peak Cough Flow|[?]|LEFT LATERAL DECUBITUS|[?]|m/sec2|[?]|1|mg|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LEFT|OUTER|ETDRS EYE CHART|Y|||PARENT|NEUROLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-09-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|2|FEV1FVC6|FEV1/FVC6|[?]|LATERAL DECUBITUS|[?]|cg|[?]|1|BOWL|MIDDLE PHALANX 4 OF THE HAND|BILATERAL|OCCIPITAL|IHC||||CLINICAL RESEARCH COORDINATOR|OTOLARYNGOLOGIST|1|Visit_1|10|1|TREATMENT|2020-09-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|3|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|DECUBITUS|[?]|/ms|[?]|1|gtt|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL|ANTEROLATERAL|IMMUNO-PET SCAN||||STUDY SUBJECT|PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-10-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|4|PEFTIME|Peak Expiratory Flow Time|[?]|TRENDELENBURG|[?]|mL/dose|[?]|1|MnFI|XIPHOID PROCESS|IPSILATERAL|UPPER FLEXOR SURFACE|HPLC-UV||||NON-HEALTH CARE PROFESSIONAL|READER 3|2|Visit_2|25|3|SCREENING|2020-10-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|pmol|[?]|1|MdFI|MENINGES|IPSILATERAL|SUBCORTICAL|GRADIENT DIFFUSION|Y|||SPOUSE|OPHTHALMOLOGIST|3|Visit_3|40|2|WASHOUT|2020-10-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|||[?]|1|cL|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|PERIVENTRICULAR|FLUORESCENT ENZYME IMMUNOASSAY|||Y|VENDOR|ONCOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-10-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|7|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|FOWLERS|[?]|VOXEL|[?]|1|ohm|LAD SEPTAL PERFORATOR ARTERY|IPSILATERAL|UPPER FLEXOR SURFACE|TRICHROME STAIN|Y|Y||CAREGIVER|RATER 2|4|Visit_4|65|3|FOLLOW-UP|2020-11-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|8|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|[?]|deg/s|[?]|1|DDU|PARALARYNGEAL LYMPH NODE|CONTRALATERAL|HIND|COLORIMETRY||||INVESTIGATOR|MICROSCOPIST 3|4|Visit_4|65|5|TREATMENT|2020-11-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|DECUBITUS|[?]|pmol/day|[?]|1|tuberculin unit|COSTOCHONDRAL JOINT 7|LEFT|ANTEROTEMPORAL|WHOLE TRANSCRIPTOME SEQUENCING||Y||CHILD|ADJUDICATOR|5|Visit_5|90|2|WASHOUT|2020-12-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|10|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|[?]|g/dL|[?]|1|v/v|FINGER EXTENSOR MUSCLES|LEFT|NASAL|REBOUND TONOMETRY||||PROXY|MICROSCOPIST|5|Visit_5|90|5|WASHOUT|2020-12-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/dose|[?]|1|COAT|BICEPS FEMORIS MUSCLE|LEFT|FRONTAL|KLEIHAUER-BETKE||||ADJUDICATOR|READER 3|1|Visit_1|10|3|FOLLOW-UP|2020-11-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|2|IVCPP|Percent Predicted IVC|[?]|SEMI-FOWLERS|[?]|Hounsfield Unit|[?]|1|log10 TCID 50/uL|LUMBAR SPINE|LEFT|MEDIAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|||INDEPENDENT ASSESSOR|OPTOMETRIST|1|Visit_1|10|5|TREATMENT|2020-11-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|3|AWWVOL|Airway Wall Volume|[?]|FOWLERS|[?]|mL*cmH2O|[?]|1|Siemens|TRUNK|UNILATERAL|ROSTRAL|SURFACE PLASMON RESONANCE||||FRIEND|RADIOLOGIST 1|2|Visit_2|25|5|TREATMENT|2020-12-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|[?]|mEq/uL|[?]|1|HEP|INTERPHALANGEAL THUMB JOINT|LEFT|INFERIOR|POLYSOMNOGRAPHY||||PROXY|OPTOMETRIST|2|Visit_2|25|5|TREATMENT|2020-12-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|5|RRS|Total Respiratory System Resistance|[?]|SUPINE|[?]|APS U|[?]|1|vp/mL|REGIONAL LYMPH NODE|BILATERAL|DEEP|REFLECTANCE SPECTROSCOPY||||CHILD|NEUROLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-12-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|6|IRV|Inspiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|Pack Year|PARATRACHEAL LYMPH NODE|IPSILATERAL|MIDLINE|HPLC|Y||Y|CHILD|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-12-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|7|IRV|Inspiratory Reserve Volume|[?]|UNCONSTRAINED|[?]|mg/dose|[?]|1|copies/ug|BLOOD VESSEL|BILATERAL|ANTEROLATERAL|ACRIDINE ORANGE STAIN||||FAMILY MEMBER|NEUROLOGIST|4|Visit_4|65|4|SCREENING|2021-01-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|8|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SUPINE|[?]|ug/g/min|[?]|1|g/g|FACE|LATERAL|LOWER FLEXOR SURFACE|MODIFIED ACID FAST STAIN||||DOMESTIC PARTNER|NEUROLOGIST 1|4|Visit_4|65|3|FOLLOW-UP|2021-01-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|9|PCF|Peak Cough Flow|[?]|SITTING|[?]|ft2|[?]|1|CUP|SKIN BETWEEN EYEBROWS|LEFT|MIDLINE|CARDIAC THERMODILUTION||||SIBLING|RATER 1|5|Visit_5|90|1|TREATMENT|2021-02-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|2e4cd860-734a-40b0-bde5-ca08297415a9|10|PIF|Peak Inspiratory Flow|[?]|TRENDELENBURG|[?]|vg/dose|[?]|1|g|OBTURATOR EXTERNUS MUSCLE|UNILATERAL|INTERMEDIATE|IMMUNOPRECIPITATION|Y|||CAREGIVER|HEMATOLOGIST|5|Visit_5|90|2|TREATMENT|2021-02-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|1|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|[?]|um/day|[?]|1|ug/kg|DISTAL INTERPHALANGEAL JOINT 3|BILATERAL|PARIETO-OCCIPITAL|ANALYTICAL ULTRACENTRIFUGATION||||SPOUSE|UROLOGIST|1|Visit_1|10|3|TREATMENT|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|2|PLMBLFLW|Pulmonary Blood Flow|[?]|REVERSE TRENDELENBURG|[?]|10^6 organisms/mL|[?]|1|dB|ADDUCTOR MAGNUS MUSCLE|UNILATERAL|CENTRAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|1|Visit_1|10|2|FOLLOW-UP|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|3|FVC|Forced Vital Capacity|[?]|SEMI-RECUMBENT|[?]|ng|[?]|1|Farad|RIB 2|CONTRALATERAL|UPPER EXTENSOR SURFACE|ANTIBIOTIC AGAR SCREEN|Y|||INTERVIEWER|ADJUDICATOR 3|2|Visit_2|25|3|TREATMENT|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|4|IVC|Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|MPL U|[?]|1|lx|TROCHANTER|BILATERAL|OCCIPITAL|HPLC-FL||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|2|Visit_2|25|6|SCREENING|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|5|DLCO|Diffusion Capacity of Lung for CO|[?]|SLING|[?]|g/cage/wk|[?]|1|genEq|ESOPHAGUS, ABDOMINAL|IPSILATERAL|UPPER FLEXOR SURFACE|AUDIOMETRY|Y|||VENDOR|RATER 2|3|Visit_3|40|2|TREATMENT|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|6|EXPRELTM|Expiration Relaxation Time|[?]|PRONE|||[?]|1|L/h/m2|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|ROSTRAL|LANDOLT RING|||Y|FAMILY MEMBER|PHYSIOTHERAPIST|3|Visit_3|40|7|TREATMENT|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|7|INERTANC|Inertance|[?]|PRONE|||[?]|1|titer|RAPHE|BILATERAL|ROSTRAL|ALCIAN BLUE STAIN|||Y|PROXY|ADJUDICATOR|4|Visit_4|65|2|FOLLOW-UP|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|8|INFLTIND|Infiltrates Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|kat|[?]|1|10^3 CFU/g|LUNG, LEFT|UNILATERAL|FACIAL|MECHANICAL CLOT DETECTION||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|TREATMENT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|9|VO2|Oxygen Consumption|[?]|SITTING, LEGS DEPENDENT|[?]|uL/dose|[?]|1|10^12/L|TRACHEA|RIGHT|DORSAL|ECHOCARDIOGRAPHY|Y|||INTERVIEWER|ONCOLOGIST|5|Visit_5|90|7|WASHOUT|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|3f1854fb-d14e-4699-888b-d5042fa9327c|10|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|[?]|um/s|[?]|1|DAYS|RIB 12|UNILATERAL|LOWER FLEXOR SURFACE|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||ADJUDICATION COMMITTEE|CARDIOLOGIST|5|Visit_5|90|5|TREATMENT|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|||[?]|1|dB|BLADDER|IPSILATERAL|PROXIMAL|CONTRAST ENHANCED SPIRAL CT SCAN|||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|1|Visit_1|10|5|SCREENING|2020-12-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|2|AWVOL|Airway Volume|[?]|STANDING, BENT FORWARD|[?]|mOsm|[?]|1|Bq|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|RIGHT|MIDLINE|POLYSOMNOGRAPHY||||SIBLING|ONCOLOGIST|1|Visit_1|10|2|WASHOUT|2020-12-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|3|DLCOHC|HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|[?]|mmol/mol|[?]|1|10^6 U|GANGLION|UNILATERAL|SURFACE|POLYGRAPHY||Y||ADJUDICATOR|HEMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|SITTING|||[?]|1|10^6 U|CAUDATE NUCLEUS|IPSILATERAL|LATERAL|PAP STAIN||Y|Y|INTERVIEWER|HEMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|LATERAL DECUBITUS|||[?]|1|BU/mL|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|ANTEROPOSTERIOR|DISK DIFFUSION|||Y|ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2021-01-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|6|SAWVOL|Specific Airway Volume|[?]|FOWLERS|[?]|g/cage/day|[?]|1|kDa|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|RIGHT|DEEP|COLORIMETRY||Y||DOMESTIC PARTNER|NEUROLOGIST|3|Visit_3|40|3|TREATMENT|2021-01-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|7|FEV1FVC|FEV1/FVC|[?]|SITTING|[?]|TRANSDUCING UNIT|[?]|1|kPa|LIVER FISSURE|LEFT|FACIAL|EEG||Y||CLINICAL STUDY SPONSOR|ADJUDICATOR|4|Visit_4|65|7|TREATMENT|2021-02-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|8|FRC|Functional Residual Capacity|[?]|STANDING|[?]|LOZENGE|[?]|1|DIOPTER|EYE, ANTERIOR CHAMBER|IPSILATERAL|ANTERIOR|ORCHIDOMETERY||||INVESTIGATOR|NEUROLOGIST 2|4|Visit_4|65|3|TREATMENT|2021-02-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|9|FIO2|Fraction of Inspired Oxygen|[?]|DECUBITUS|||[?]|1|dram|CARDIOVASCULAR SYSTEM|UNILATERAL|PERIVENTRICULAR|FLUORESCENT MICROSCOPY||Y|Y|CLINICAL STUDY SPONSOR|READER 3|5|Visit_5|90|5|TREATMENT|2021-02-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|f6e37eba-e224-47f3-baa0-59dfdfb47b70|10|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|[?]|RING|[?]|1|DNA copies/ug|INTERPHALANGEAL JOINT 4 OF THE HAND|RIGHT|DEEP|IMMUNOASSAY||||FAMILY MEMBER|NEUROLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-02-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|QUASCOMP|Quasi-Static Compliance|[?]|LEFT LATERAL DECUBITUS|[?]|kg/m2|[?]|1|cy/cm|GLOMERULUS|IPSILATERAL|FRONTAL|SICKLE CELL SOLUBILITY TEST||||ADJUDICATOR|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2020-07-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|BISCUIT|[?]|1|ELISA unit|LACRIMAL GLAND|RIGHT|LOWER MEDIAL|FLUORESCENCE ANGIOGRAPHY||||GUARDIAN|RATER 2|1|Visit_1|10|1|TREATMENT|2020-07-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|3|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|||[?]|1|uL/mL|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|LATERAL|HIND|EEG||Y|Y|PROXY|READER|2|Visit_2|25|1|FOLLOW-UP|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|4|IVCPP|Percent Predicted IVC|[?]|STANDING, BENT FORWARD|[?]|L/kg|[?]|1|mmol2/L2|ENDOMETRIUM|IPSILATERAL|INFERIOR|PERIPHERAL ANGIOGRAPHY|Y|||CHILD|HEMATOLOGIST|2|Visit_2|25|4|SCREENING|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|5|TLC|Total Lung Capacity|[?]|UNCONSTRAINED|[?]|DAgU|[?]|1|Linear ft*LB|CEREBRAL ARTERY|RIGHT|SUPERFICIAL|ELECTROCHEMILUMINESCENCE||||SIBLING|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-08-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|6|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-RECUMBENT|||[?]|1|mL/animal|DISTAL INTERPHALANGEAL JOINT 5|BILATERAL|POSTERIOR|IMMUNODIFFUSION|||Y|CHILD|UROLOGIST|3|Visit_3|40|6|WASHOUT|2020-08-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|DECUBITUS|[?]|nm|[?]|1|10^4/L|HIPPOCAMPUS|LEFT|ANTEROMEDIAL|X-RAY|Y|||ADJUDICATOR|ONCOLOGIST|4|Visit_4|65|7|WASHOUT|2020-09-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LATERAL DECUBITUS|[?]|mEq/L|[?]|1|Roentgen|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|LEFT|OCCIPITAL|FLUORESCENCE ANGIOGRAPHY||||INVESTIGATOR|RATER 1|4|Visit_4|65|7|SCREENING|2020-09-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|9|FEV_PEF|FEV at PEF|[?]|UNCONSTRAINED|[?]|umol/mg/min|[?]|1|WEEKS|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|UNILATERAL|ANTEROLATERAL|PAP STAIN||||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-10-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|8298b45d-16ff-42ef-8404-0f3ce628f9e5|10|ERV|Expiratory Reserve Volume|[?]|SLING|[?]|damol/L|[?]|1|umol|CERVICAL SPINE|RIGHT|SUBCORTICAL|CONFOCAL MICROSCOPY||Y||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|5|Visit_5|90|5|TREATMENT|2020-10-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|mL/animal/wk|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|RIGHT|VENTRAL|TEST STRIP|||Y|FAMILY MEMBER|ONCOLOGIST|1|Visit_1|10|1|WASHOUT|2020-06-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|2|INTP|Interpretation|[?]|STANDING, BENT FORWARD|[?]|cmHg|[?]|1|10^3 DNA copies/mL|FOOT DIGIT 5|BILATERAL|ANTEROMEDIAL|DC SHEATH FLOW||||DOMESTIC PARTNER|PATHOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-06-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|3|PNIF|Peak Nasal Inspiratory Flow|[?]|DECUBITUS|[?]|BAR|[?]|1|DNA copies/ug|INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|PROXIMAL VOLAR|JAFFE REACTION||||FAMILY MEMBER|ADJUDICATOR 1|2|Visit_2|25|3|SCREENING|2020-06-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|4|LCI|Lung Clearance Index|[?]|LEFT LATERAL DECUBITUS|[?]|pm|[?]|1|AgU/mL|PERONEAL ARTERY|BILATERAL|LOWER|ELECTROPHORESIS||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|2|Visit_2|25|7|WASHOUT|2020-06-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|5|VO2|Oxygen Consumption|[?]|UNCONSTRAINED|[?]|cP|[?]|1|DISK|T6 VERTEBRA|LATERAL|LOWER MEDIAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|||CLINICAL STUDY SPONSOR|READER 3|3|Visit_3|40|5|TREATMENT|2020-07-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|6|VO2|Oxygen Consumption|[?]|REVERSE TRENDELENBURG|[?]|10^9/dose|[?]|1|/2500 WBC|SACRAL VERTEBRA|LATERAL|UPPER FLEXOR SURFACE|REBOUND TONOMETRY||||DOMESTIC PARTNER|RADIOLOGIST 2|3|Visit_3|40|3|FOLLOW-UP|2020-07-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|7|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|PELLET|[?]|1|ug/dL|GLENOID FOSSA|LATERAL|ROSTRAL|HPLC/MS||||INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|8|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|SYRINGE|[?]|1|Tbsp|METACARPAL BONE 2|RIGHT|CAUDAL|LC-FL|Y|Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|4|Visit_4|65|4|TREATMENT|2020-08-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|9|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING|||[?]|1|Enzyme U/L|RECTOSIGMOID JUNCTION|LATERAL|VOLAR|ALCIAN BLUE STAIN|||Y|INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|TREATMENT|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|ee5c6623-5cb4-4f18-99b0-6373328abc1d|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|||[?]|1|10^9 organisms/mL|LARGE INTESTINE|IPSILATERAL|MIDLINE|CALCOFLUOR WHITE STAIN|Y||Y|CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|TREATMENT|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|FEF50|Forced Expiratory Flow 50%|[?]|UNCONSTRAINED|[?]|pmol/day|[?]|1|mV2/Hz|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|BILATERAL|OUTER|LISSAMINE GREEN STAIN||Y||SIBLING|PHYSIOTHERAPIST|1|Visit_1|10|1|WASHOUT|2020-06-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|2|PEFTIME|Peak Expiratory Flow Time|[?]|TRENDELENBURG|[?]|Absorbance U|[?]|1|U/kg|SUPERIOR SAGITTAL SINUS|LEFT|LOWER|FLOW MICROSCOPY|Y|Y||ADJUDICATOR|PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-06-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|3|INTP|Interpretation|[?]|LEFT LATERAL DECUBITUS|[?]|nmol/kg/day|[?]|1|log10 TCID 50/uL|COLON, SIGMOID|LEFT|CRANIAL|CYSTOSCOPY||Y||FAMILY MEMBER|RADIOLOGIST 1|2|Visit_2|25|6|SCREENING|2020-07-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|||[?]|1|min|EPIGASTRIC REGION|LATERAL|HIND|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y||Y|FRIEND|RATER 1|2|Visit_2|25|7|TREATMENT|2020-07-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|5|MALIND|Malignancy Indicator|[?]|STANDING, BENT FORWARD|[?]|COAT|[?]|1|10^6 IU|BRACHIOCEPHALIC ARTERY|CONTRALATERAL|SURFACE|INTRAVASCULAR ULTRASOUND||||CLINICAL STUDY SPONSOR|DERMATOLOGIST|3|Visit_3|40|1|WASHOUT|2020-07-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SLING|||[?]|1|10^10/L|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|BILATERAL|ANTEROLATERAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||Y|FRIEND|MICROSCOPIST 3|3|Visit_3|40|4|TREATMENT|2020-07-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|7|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|||[?]|1|RNA copies/mL|T11 VERTEBRA|CONTRALATERAL|ANTEROPOSTERIOR|DXA SCAN|||Y|FRIEND|OPTOMETRIST|4|Visit_4|65|4|FOLLOW-UP|2020-08-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|8|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|PHERESIS UNIT|[?]|1|umol/dL|INTRATHORACIC LYMPH NODE|UNILATERAL|UPPER FLEXOR SURFACE|MICRODENSITOMETRY|Y|||STUDY SUBJECT|RADIOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|SLING|[?]|mg/L FEU|[?]|1|mmol/min/kPa/L|PUPIL|UNILATERAL|ANTERIOR|DYNAMOMETRY||||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|f8d6576b-b300-4c5f-8f5a-6bb35250d576|10|TV|Tidal Volume|[?]|STANDING|||[?]|1|uIU/L|OSTIOMEATAL COMPLEX|UNILATERAL|PARIETO-OCCIPITAL|LASER CAPTURE MICRODISSECTION||Y|Y|CHILD|RATER 1|5|Visit_5|90|3|SCREENING|2020-09-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|FEV1SVC|FEV1/SVC|[?]|DECUBITUS|||[?]|1|GPL U|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|LOWER MEDIAL|CRYOSCOPY|||Y|DOMESTIC PARTNER|RATER|1|Visit_1|10|6|WASHOUT|2020-10-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|2|PEFREV|PEF Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|RNA copies/mL|[?]|1|ms/mmHg|TRICUSPID VALVE ANNULUS|CONTRALATERAL|PERIPHERAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||Y||HEALTH CARE PROFESSIONAL|OPTOMETRIST|1|Visit_1|10|3|WASHOUT|2020-10-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|3|GAW|Airway Conductance|[?]|DECUBITUS|[?]|CIGAR|[?]|1|VIAL|HILAR|UNILATERAL|LOWER|SPECT SCAN||||CLINICAL STUDY SPONSOR|UROLOGIST|2|Visit_2|25|6|WASHOUT|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|4|ALVVOL|Alveolar Volume|[?]|DECUBITUS|[?]|nkat|[?]|1|mEq/kg|CEREBELLUM|IPSILATERAL|LOWER|FARNSWORTH-MUNSELL 100 HUE TEST||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|2|Visit_2|25|2|TREATMENT|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|UNCONSTRAINED|[?]|mL/cm3/min|[?]|1|mL/s/m2|GINGIVAL MUCOSA|UNILATERAL|LOWER|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||CHILD|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|6|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|mL/cage/day|[?]|1|kg/mol|C6 VERTEBRA|UNILATERAL|PROXIMAL VOLAR|SLOAN LETTER EYE CHART 1.25%||Y||FAMILY MEMBER|ADJUDICATOR|3|Visit_3|40|6|FOLLOW-UP|2020-11-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|DECUBITUS|[?]|ELISA unit/dose|[?]|1|APS U|POSTERIOR SUPERIOR ILIAC SPINE|LATERAL|FRONTAL|MACRO BROTH DILUTION||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-12-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|8|FEV1PP|Percent Predicted FEV1|[?]|SEMI-RECUMBENT|[?]|cy/cm|[?]|1|10^3 CFU/mL|EYE, VITREOUS CHAMBER|CONTRALATERAL|ANTEROTEMPORAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|||ADJUDICATION COMMITTEE|INTERNIST|4|Visit_4|65|7|TREATMENT|2020-12-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|9|SRAW|Specific Airway Resistance|[?]|SUPINE|[?]|mm/min|[?]|1|Enzyme U|HAND PHALANX|RIGHT|PERIVENTRICULAR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|||SIGNIFICANT OTHER|ONCOLOGIST|5|Visit_5|90|1|TREATMENT|2021-01-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|8635a6b3-d16e-432c-90bf-53f1494dbe5e|10|FEV1PP|Percent Predicted FEV1|[?]|UNCONSTRAINED|[?]|% INHIBITION|[?]|1|ug/kg|PALPEBRAL FISSURE|RIGHT|OUTER|FISH||||HEALTH CARE PROFESSIONAL|READER 1|5|Visit_5|90|5|TREATMENT|2021-01-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|1|PEFTIME|Peak Expiratory Flow Time|[?]|LEFT LATERAL DECUBITUS|[?]|tuberculin unit|[?]|1|MONTHS|PROXIMAL INTERPHALANGEAL JOINT 4|BILATERAL|APICAL|BIOPSY||||INDEPENDENT ASSESSOR|ONCOLOGIST 2|1|Visit_1|10|5|FOLLOW-UP|2020-06-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|2|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|mg/h|[?]|1|SUPPOSITORY|HEEL OF THE FOOT|LATERAL|TEMPORAL|DIFFUSION WEIGHTED MRI||||INTERVIEWER|INTERNIST|1|Visit_1|10|4|TREATMENT|2020-06-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|3|SVC|Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|10^6/L|[?]|1|U/m2/h|HEART, RIGHT VENTRICLE|LEFT|SUPERIOR|SPECULAR MICROSCOPY|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|2|Visit_2|25|6|WASHOUT|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|4|ERV|Expiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uU/dL|CORONARY ARTERY|IPSILATERAL|UPPER|OPTICAL COHERENCE TOMOGRAPHY|||Y|FRIEND|ADJUDICATOR 2|2|Visit_2|25|6|SCREENING|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|5|FIF25|Forced Inspiratory Flow at 25%|[?]|SLING|||[?]|1|10^9 CFU|HIP ADDUCTORS|IPSILATERAL|HIND|BALLPOINT PEN TECHNIQUE|||Y|INVESTIGATOR|ONCOLOGIST 1|3|Visit_3|40|5|WASHOUT|2020-07-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|6|IVC|Inspiratory Vital Capacity|[?]|SLING|||[?]|1|NEEDLE GAUGE|PULMONARY VALVE, LEFT CUSP|IPSILATERAL|VENTRAL|MIGET||Y|Y|CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-07-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|7|ALVVOL|Alveolar Volume|[?]|SLING|||[?]|1|mL/m2/h|FOREHEAD|CONTRALATERAL|UPPER EXTENSOR SURFACE|WRIGHT STAIN|||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|4|Visit_4|65|4|TREATMENT|2020-08-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|8|RAW|Airway Resistance|[?]|DECUBITUS|[?]|10^7 TCID 50/dose|[?]|1|/mm|PAROTID GLAND LYMPH NODE|RIGHT|PROXIMAL|PH METER MEASUREMENT METHOD||||SPOUSE|NEUROLOGIST 2|4|Visit_4|65|7|TREATMENT|2020-08-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|9|EVC|Expiratory Vital Capacity|[?]|FOWLERS|||[?]|1|CONTAINER|INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL|FORE|FLOW MICROSCOPY|||Y|CHILD|READER 3|5|Visit_5|90|5|FOLLOW-UP|2020-09-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|2cda4297-410a-49e4-949c-deb3dc4c6656|10|FIV1PP|Percent Predicted FIV1|[?]|SITTING|[?]|TABLET|[?]|1|mEq/ug|RIGHT ATRIAL ENDOCARDIUM|RIGHT|INTERMEDIATE|ACID FAST STAIN|Y|||PARENT|HEMATOLOGIST|5|Visit_5|90|5|TREATMENT|2020-09-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|RV|Residual Volume|[?]|LATERAL DECUBITUS|||[?]|1|10^11/L|HEART, RIGHT ATRIUM|BILATERAL|MIDLINE|KNEMOMETRY|||Y|INTERVIEWER|READER 3|1|Visit_1|10|5|WASHOUT|2021-01-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|10^3/hpf|[?]|1|tuberculin unit|OROPHARYNX|LATERAL|PROXIMAL VOLAR|MRS|Y|Y||INTERVIEWER|NEUROLOGIST 1|1|Visit_1|10|5|TREATMENT|2021-01-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|3|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|mL/m2|[?]|1|mU|COCCYX|IPSILATERAL|INFERIOR|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|Y||CAREGIVER|INTERNIST|2|Visit_2|25|1|WASHOUT|2021-02-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-23
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|4|OXYPULSE|Oxygen Pulse|[?]|SEMI-FOWLERS|[?]|MESF|[?]|1|Weber|SKIN OF THE FACE|IPSILATERAL|LOWER FLEXOR SURFACE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||DOMESTIC PARTNER|ADJUDICATOR 2|2|Visit_2|25|6|TREATMENT|2021-02-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-23
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|5|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|[?]|mL/m2|[?]|1|10^9/L|EYELASH|UNILATERAL|UPPER|SINGLE-SLICE SPIRAL CT|Y|||NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2021-02-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|REVERSE TRENDELENBURG|||[?]|1|DAgU/mL|PRELARYNGEAL LYMPH NODE|LATERAL|DORSOLATERAL|SPECTROPHOTOMETRY|||Y|FRIEND|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2021-02-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|7|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|[?]|V/sec|[?]|1|GBq/mg|INTERNAL ILIAC ARTERY|UNILATERAL|DISTAL VOLAR|POLYGRAPHY||||INVESTIGATOR|CARDIOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|8|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-FOWLERS|[?]|kIU|[?]|1|U/mL|POSTEROLATERAL SEGMENTAL ARTERY|RIGHT|LOWER EXTENSOR SURFACE|FLOCCULATION||||SIBLING|PATHOLOGIST 1|4|Visit_4|65|1|FOLLOW-UP|2021-03-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|9|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING|[?]|10^3 RNA copies/mL|[?]|1|ppm|SHIN|BILATERAL|PERIVENTRICULAR|TRYPAN BLUE STAIN||||FAMILY MEMBER|RATER|5|Visit_5|90|3|TREATMENT|2021-04-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|10|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|[?]|vg/kg|[?]|1|cmHg|RESPIRATORY SYSTEM|CONTRALATERAL|DORSOLATERAL|FLUOROSCOPY||||PROXY|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2021-04-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|IC|Inspiratory Capacity|[?]|STANDING|||[?]|1|CIGAR|MALE REPRODUCTIVE SYSTEM|RIGHT|LATERAL|CONTRAST ENHANCED PET SCAN|||Y|SIBLING|RADIOLOGIST 1|1|Visit_1|10|7|SCREENING|2020-05-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|dpm/mg|[?]|1|10^5/L|METACARPOPHALANGEAL JOINT 5|CONTRALATERAL|ROSTRAL|PANENDOSCOPY||||STUDY SUBJECT|ADJUDICATOR 3|1|Visit_1|10|5|SCREENING|2020-05-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|3|LCI|Lung Clearance Index|[?]|UNCONSTRAINED|||[?]|1|umol/L/min|C1 VERTEBRA|IPSILATERAL|HIND|PALPATION|||Y|INTERVIEWER|NEUROLOGIST 1|2|Visit_2|25|3|FOLLOW-UP|2020-06-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|FOWLERS|[?]|cmol/L|[?]|1|IU/mmol|GLENOID FOSSA|LATERAL|MIDLINE|ANGIOGRAPHY||||STUDY SUBJECT|ONCOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-06-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|5|IRV|Inspiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mL/cm3/min|[?]|1|10^6/g|PELVIC BONE|IPSILATERAL|LOWER MEDIAL|PYROSEQUENCING||||SIGNIFICANT OTHER|ONCOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-06-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|6|AWVOLPP|Percent Predicted Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|10^9 organisms|[?]|1|10^9/L|RECTOSIGMOID JUNCTION|RIGHT|PROXIMAL VOLAR|PET SCAN||||PROXY|ADJUDICATOR|3|Visit_3|40|3|SCREENING|2020-06-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|7|INERTANC|Inertance|[?]|RIGHT LATERAL DECUBITUS|[?]|10^8 PFU|[?]|1|mEq/ug|HEAD|IPSILATERAL|DORSOLATERAL|RAJI CELL EIA|Y|Y||CAREGIVER|RADIOLOGIST 2|4|Visit_4|65|7|TREATMENT|2020-07-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|L/kg|[?]|1|dpm/100mg|BICEPS BRACHII MUSCLE|CONTRALATERAL|CENTRAL|LC-FL||||PROXY|NEUROLOGIST 1|4|Visit_4|65|2|SCREENING|2020-07-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|9|ALVVOL|Alveolar Volume|[?]|STANDING, BENT FORWARD|[?]|cpm|[?]|1|10^4/hpf|FEMUR SHAFT|CONTRALATERAL|CRANIAL|PET/CT SCAN||||FRIEND|ADJUDICATOR 1|5|Visit_5|90|2|WASHOUT|2020-08-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|9e82141b-e2b9-42c7-b813-b79bda2bd216|10|SVCPP|Percent Predicted Slow Vital Capacity|[?]|PRONE|[?]|Ci|[?]|1|%(w/v)|PARAPHARYNGEAL LYMPH NODE|LATERAL|SUPERIOR|PET/MRI SCAN||||INTERVIEWER|OTOLARYNGOLOGIST|5|Visit_5|90|3|SCREENING|2020-08-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|1|FIVC|Forced Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|days/month|EAR|BILATERAL|HIND|MASS SPECTROMETRY|||Y|ADJUDICATOR|RADIOLOGIST|1|Visit_1|10|4|TREATMENT|2020-09-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|2|AWWVOL|Airway Wall Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mEq/uL|[?]|1|mEq/mL|FACET JOINT|UNILATERAL|SUPERFICIAL|HILLMEN COLOR CHART||Y||CHILD|READER 2|1|Visit_1|10|7|TREATMENT|2020-09-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|3|IVCPP|Percent Predicted IVC|[?]|SITTING|[?]|ppth|[?]|1|PFU|TIBIAL-CRURAL PERIPHERAL ARTERY|IPSILATERAL|UPPER FLEXOR SURFACE|LAPAROSCOPY|Y|||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|2|Visit_2|25|6|WASHOUT|2020-09-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|4|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|mL/s/m2|[?]|1|BAG|RECTOVAGINAL SPACE|CONTRALATERAL|UPPER FLEXOR SURFACE|KNEMOMETRY||||ADJUDICATOR|RATER 2|2|Visit_2|25|5|TREATMENT|2020-09-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|5|PNEUMIND|Pneumonia Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|breaths/30s|[?]|1|kg|FACIAL NERVE|UNILATERAL|BASAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||FRIEND|READER|3|Visit_3|40|3|SCREENING|2020-10-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|6|MIP|Maximal Inspiratory Pressure|[?]|SUPINE|[?]|fmol/L/sec|[?]|1|L/h|EXTRAHEPATIC BILE DUCT|RIGHT|LOWER MEDIAL|FLUORESCENT MICROSCOPY||||SPOUSE|OPTOMETRIST|3|Visit_3|40|3|WASHOUT|2020-10-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|7|FEF50|Forced Expiratory Flow 50%|[?]|LEFT LATERAL DECUBITUS|[?]|L/min|[?]|1|ug/g/h|SACRAL VERTEBRA|UNILATERAL|FACIAL|WRIGHT STAIN|Y|||PARENT|RATER|4|Visit_4|65|5|SCREENING|2020-11-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|8|QUASCOMP|Quasi-Static Compliance|[?]|UNCONSTRAINED|[?]|ng/L|[?]|1|PA|TROCHANTER|BILATERAL|BASAL|DIRECT SEQUENCING||Y||INTERVIEWER|MICROSCOPIST 3|4|Visit_4|65|4|WASHOUT|2020-11-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|9|PNIF|Peak Nasal Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|10^6 organisms/mg|[?]|1|dram|STOMACH|LATERAL|DEEP|INFRARED SPECTROMETRY|Y|||DOMESTIC PARTNER|RADIOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-12-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|4b432c61-c620-4c5e-8aad-411facc0f4db|10|RV|Residual Volume|[?]|DECUBITUS|[?]|nmol/L/h|[?]|1|mm/2h|ANTERIOR CINGULATE CORTEX|CONTRALATERAL|UPPER FLEXOR SURFACE|GC/FID||||PARENT|READER 1|5|Visit_5|90|5|FOLLOW-UP|2020-12-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|ERV|Expiratory Reserve Volume|[?]|SUPINE|||[?]|1|ug/animal|SCALP|CONTRALATERAL|DORSOLATERAL|MICROBIAL CULTURE||Y|Y|CHILD|READER 2|1|Visit_1|10|5|TREATMENT|2020-12-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|UNCONSTRAINED|[?]|DROP|[?]|1|L/min|PERICARDIAL LYMPH NODE|RIGHT|PERIVENTRICULAR|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||ADJUDICATION COMMITTEE|READER 1|1|Visit_1|10|5|TREATMENT|2020-12-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/L/h|[?]|1|mL/h|CALF|LATERAL|MEDIAL|PET/SPECT SCAN||||DOMESTIC PARTNER|RADIOLOGIST|2|Visit_2|25|4|WASHOUT|2021-01-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|4|TSUHYS|Tissue Hysteresivity|[?]|TRENDELENBURG|[?]|mL|[?]|1|GPL U|VULVA|BILATERAL|ANTEROLATERAL|CONFOCAL MICROSCOPY||||HEALTH CARE PROFESSIONAL|PATHOLOGIST|2|Visit_2|25|1|WASHOUT|2021-01-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|5|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|[?]|mEq/mmol|[?]|1|uV|DISTAL PHALANX 5 OF THE HAND|IPSILATERAL|DORSOLATERAL|FLAME PHOTOMETRY||||FRIEND|READER|3|Visit_3|40|7|SCREENING|2021-01-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|6|RV|Residual Volume|[?]|STANDING|||[?]|1|nmol|COMMON ILIAC ARTERY|IPSILATERAL|LATERAL|GC/MS-CI||Y|Y|GUARDIAN|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-01-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|DECUBITUS|||[?]|1|mg/kg|METACARPAL BONE|CONTRALATERAL|INTERMEDIATE|MICROARRAY|||Y|INTERVIEWER|INTERNIST|4|Visit_4|65|3|SCREENING|2021-02-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|8|LOBVOL|Lobar Volume|[?]|SEMI-FOWLERS|||[?]|1|pm|SPLEEN|RIGHT|SURFACE|TOLUIDINE BLUE STAIN|||Y|ADJUDICATOR|OPHTHALMOLOGIST|4|Visit_4|65|7|TREATMENT|2021-02-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|9|EFFVOL|Effusion Volume|[?]|REVERSE TRENDELENBURG|[?]|mm/2h|[?]|1|ukat/L|CERVICAL VERTEBRA|IPSILATERAL|INTERMEDIATE|SPIRAL CT SCAN WITHOUT CONTRAST|Y|||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|5|Visit_5|90|2|SCREENING|2021-03-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|1a1e6863-26da-4b5d-b82a-5703e3e9056e|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|kPa/L/sec|[?]|1|ug/kg/h|CHIN|CONTRALATERAL|DISTAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|5|Visit_5|90|2|FOLLOW-UP|2021-03-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|TLC|Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|AgU/mL|FIRST OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|PROXIMAL VOLAR|PELLI-ROBSON EYE CHART||Y|Y|CAREGIVER|INTERNIST|1|Visit_1|10|6|SCREENING|2020-05-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|2|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|||[?]|1|SUPPOSITORY|EXTRAOCULAR MUSCLE|IPSILATERAL|SUPERIOR|IMPEDANCE CONDUCTIVITY|Y|Y|Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|1|Visit_1|10|5|WASHOUT|2020-05-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|3|DLCOHC|HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|cm/min|[?]|1|cup eq|RIGHT POSTERIOR DESCENDING ARTERY|LATERAL|UPPER EXTENSOR SURFACE|GC/MS-EI||||VENDOR|MICROSCOPIST 3|2|Visit_2|25|2|TREATMENT|2020-05-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|4|FEV_PEF|FEV at PEF|[?]|SEMI-FOWLERS|[?]|nCi|[?]|1|g/animal/wk|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|IPSILATERAL|SUPERIOR|FLUORESCENCE ANGIOGRAPHY|Y|||SPOUSE|PHYSIOTHERAPIST|2|Visit_2|25|1|SCREENING|2020-05-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|5|FEV1FVC|FEV1/FVC|[?]|SUPINE|[?]|uV|[?]|1|CCID 50/mL|EXTENSOR HALLUCIS BREVIS MUSCLE|LEFT|SUBCORTICAL|FARNSWORTH-MUNSELL 100 HUE TEST||Y||INDEPENDENT ASSESSOR|NEUROLOGIST 2|3|Visit_3|40|7|TREATMENT|2020-06-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|6|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|fmol/g|[?]|1|10^6 CFU/mL|METATARSOPHALANGEAL JOINT 2|RIGHT|DEEP|HIGH RESOLUTION CT|Y|||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-06-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|7|RV|Residual Volume|[?]|SITTING|||[?]|1|GPL U|METACARPOPHALANGEAL JOINT 5|LEFT|ANTEROLATERAL|DOUBLE IMMUNODIFFUSION|||Y|DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|3|TREATMENT|2020-07-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|8|INERTANC|Inertance|[?]|SEMI-RECUMBENT|[?]|%(v/v)|[?]|1|PFU|INTESTINE|CONTRALATERAL|TEMPORAL|SCINTIGRAPHY||||CAREGIVER|MICROSCOPIST 1|4|Visit_4|65|2|TREATMENT|2020-07-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|9|MEPPP|Percent Predicted MEP|[?]|DECUBITUS|[?]|mol/g|[?]|1|Ci/g|COLON, TRANSVERSE|LEFT|LATERAL|BETA LACTAMASE||||FRIEND|RATER 2|5|Visit_5|90|3|FOLLOW-UP|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|8c8053d1-adae-4d45-870e-cf4ad2475c74|10|IVCPP|Percent Predicted IVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|grain|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|BILATERAL|DISTAL|INTERRUPTER TECHNIQUE|||Y|ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|5|Visit_5|90|5|SCREENING|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|1|SAWVOL|Specific Airway Volume|[?]|SITTING|[?]|GPS U|[?]|1|MONTHS|SUBARACHNOID SPACE|CONTRALATERAL|VOLAR|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|5|FOLLOW-UP|2020-11-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-RECUMBENT|[?]|mmol/min/kPa|[?]|1|uU/L|SUPRATENTORIAL BRAIN|CONTRALATERAL|ANTEROTEMPORAL|IMMUNOASSAY||Y||CHILD|ADJUDICATOR 2|1|Visit_1|10|7|TREATMENT|2020-11-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|3|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-FOWLERS|[?]|MET*min|[?]|1|L/kg|HYPOGLOSSAL NERVE|CONTRALATERAL|DORSOLATERAL|PULSE OXIMETRY||||SPOUSE|MICROSCOPIST 1|2|Visit_2|25|5|WASHOUT|2020-12-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|NEBULE|[?]|1|mg/h|HEART, LEFT ATRIUM|LEFT|DISTAL VOLAR|HPLC/MS/MS|Y|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|2|Visit_2|25|2|FOLLOW-UP|2020-12-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|5|RV|Residual Volume|[?]|SITTING, LEGS DEPENDENT|[?]|RFU|[?]|1|ugEq|SUPRACLAVICULAR LYMPH NODE|IPSILATERAL|LOWER FLEXOR SURFACE|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||Y||GUARDIAN|READER 2|3|Visit_3|40|6|TREATMENT|2020-12-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|6|RER|Respiratory Exchange Ratio|[?]|STANDING, BENT FORWARD|[?]|cmol|[?]|1|CFU/mL|ADDUCTOR BREVIS MUSCLE|RIGHT|DISTAL|KLEIHAUER-BETKE||Y||FRIEND|ONCOLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-12-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|7|RAWPP|Percent Predicted Airway Resistance|[?]|FOWLERS|[?]|/40 HPFs|[?]|1|Anson U|TRUNK|UNILATERAL|LATERAL|AUDIOMETRY||||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|8|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING|[?]|SFC/10^6 PBMC|[?]|1|WEEKS|VERTEBRAL ARTERY|LATERAL|POSTERIOR|COULOMETRIC TITRATION|Y|||INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|9|MEP|Maximal Expiratory Pressure|[?]|PRONE|[?]|mL/cage/wk|[?]|1|vp/dose|AXILLARY LYMPH NODE|CONTRALATERAL|SUBCORTICAL|OPTICAL DENSITY MEASUREMENT||||SIBLING|NEUROLOGIST 2|5|Visit_5|90|5|WASHOUT|2021-02-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|c3b911a8-116e-4940-80a2-7128db004f4a|10|RRS|Total Respiratory System Resistance|[?]|DECUBITUS|[?]|MET|[?]|1|foz_br|CORPUS CALLOSUM|LATERAL|DEEP|TOTAL BODY IRRADIATION||||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|5|Visit_5|90|6|WASHOUT|2021-02-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|AWVOLPP|Percent Predicted Airway Volume|[?]|FOWLERS|||[?]|1|L/h|MITRAL VALVE, POSTERIOR CUSP|UNILATERAL|UPPER|IRON HEMATOXYLIN STAIN|||Y|STUDY SUBJECT|ADJUDICATOR|1|Visit_1|10|6|SCREENING|2020-06-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|2|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|[?]|/10^5|[?]|1|mL/s/m2|HUMERUS SHAFT|CONTRALATERAL|LOWER|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|Y||CLINICAL STUDY SPONSOR|INTERNIST|1|Visit_1|10|1|TREATMENT|2020-06-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|3|IC|Inspiratory Capacity|[?]|SEMI-RECUMBENT|[?]|mEq|[?]|1|ng/day|ANASTOMOSIS|BILATERAL|HIND|CLOT DETECTION||||CHILD|OTOLARYNGOLOGIST|2|Visit_2|25|5|SCREENING|2020-06-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|4|RER|Respiratory Exchange Ratio|[?]|REVERSE TRENDELENBURG|[?]|mmol|[?]|1|Enzyme U|ANKLE JOINT ANTERIOR FLEXOR TENDONS|CONTRALATERAL|ANTEROLATERAL|FLUORESCEIN STAIN||Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-06-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|5|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|CFU/mL|[?]|1|F|DISTAL PHALANX 2 OF THE HAND|BILATERAL|MEDIAL|FARR ASSAY||||PARENT|ENDOCRINOLOGIST|3|Visit_3|40|1|SCREENING|2020-07-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|6|TSUELAS|Tissue Elastance|[?]|FOWLERS|[?]|mm|[?]|1|pkat/L|HEART, LEFT ATRIAL APPENDAGE|UNILATERAL|FACIAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||Y||FAMILY MEMBER|NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2020-07-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|7|GAW|Airway Conductance|[?]|SLING|||[?]|1|PELLET|POSTERIOR TIBIAL VEIN|LEFT|PERIVENTRICULAR|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y||Y|FRIEND|MICROSCOPIST|4|Visit_4|65|4|FOLLOW-UP|2020-08-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|8|SGAW|Specific Airway Conductance|[?]|SITTING|[?]|L/L|[?]|1|pg/L|RECTUM|UNILATERAL|ANTEROPOSTERIOR|NEURAMINIDASE INHIBITION ASSAY||||STUDY SUBJECT|ADJUDICATOR 3|4|Visit_4|65|1|TREATMENT|2020-08-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|9|FEV3FVC|FEV3/FVC|[?]|TRENDELENBURG|[?]|CFU/g|[?]|1|/LSQN|INTRATHORACIC LYMPH NODE|LEFT|TIP|INDIRECT IMMUNOFLUORESCENCE||Y||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|5|Visit_5|90|1|SCREENING|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|401d66ba-bc00-4495-ba5d-796068dd1fd6|10|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|grain|[?]|1|mL/s/m2|FOOT DIGIT 4|RIGHT|VOLAR|CYSTOMETRY||||CAREGIVER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|1|DLCOVA|DLCO/VA|[?]|STANDING|[?]|/min|[?]|1|10^9/L|HEART, RIGHT ATRIAL APPENDAGE|BILATERAL|DISTAL VOLAR|OBSERVATION|Y|||PARENT|PATHOLOGIST 2|1|Visit_1|10|5|TREATMENT|2021-01-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|U/10^12 RBC|[?]|1|tsp|TOOTH|LATERAL|LATERAL|MAMMOGRAPHY||||CHILD|RADIOLOGIST 1|1|Visit_1|10|1|TREATMENT|2021-01-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|3|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|||[?]|1|cm|HEEL OF THE FOOT|CONTRALATERAL|UPPER EXTENSOR SURFACE|SCINTIGRAPHY|||Y|CLINICAL STUDY SPONSOR|NEUROLOGIST 1|2|Visit_2|25|6|TREATMENT|2021-02-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|4|RER|Respiratory Exchange Ratio|[?]|SITTING|[?]|10^11/L|[?]|1|Watt|SAPHENOUS VEIN|UNILATERAL|SUPERIOR|IMMUNOCHEMILUMINOMETRIC ASSAY||||SPOUSE|OPHTHALMOLOGIST|2|Visit_2|25|4|WASHOUT|2021-02-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|5|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-FOWLERS|||[?]|1|10^3 organisms/g|NASOPHARYNX|CONTRALATERAL|PERIVENTRICULAR|MS/MS|Y|Y|Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|3|Visit_3|40|5|SCREENING|2021-02-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|6|RVPP|Percent Predicted Residual Volume|[?]|STANDING|[?]|Farad|[?]|1|mL/beat|ANTERIOR TIBIAL VEIN|CONTRALATERAL|UPPER FLEXOR SURFACE|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||Y||CAREGIVER|RADIOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|7|FIVC|Forced Inspiratory Vital Capacity|[?]|FOWLERS|[?]|DAgU/mL|[?]|1|mL/m2/day|SPLENIC ARTERY|LATERAL|LOWER EXTENSOR SURFACE|TONOMETRY|Y|||ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2021-03-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|||[?]|1|Sv|BLADDER, FUNDUS|RIGHT|ANTEROTEMPORAL|POLYSOMNOGRAPHY|||Y|SPOUSE|ONCOLOGIST 2|4|Visit_4|65|2|TREATMENT|2021-03-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|9|FVC|Forced Vital Capacity|[?]|DECUBITUS|[?]|10^9/L|[?]|1|mm/2h|CHOROID PLEXUS|LATERAL|MIDLINE|PULMONARY ANGIOGRAPHY||Y||CAREGIVER|DERMATOLOGIST|5|Visit_5|90|2|SCREENING|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|f8113725-4deb-48a1-876a-ba168a6d2cee|10|IVCPP|Percent Predicted IVC|[?]|UNCONSTRAINED|[?]|DAgU|[?]|1|kV|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|CRANIAL|TRANSTHORACIC ECHOCARDIOGRAPHY||||FAMILY MEMBER|FORENSIC PATHOLOGIST|5|Visit_5|90|1|WASHOUT|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|1|FEF2575P|Percent Predicted FEF25-75|[?]|SLING|[?]|vg/dose|[?]|1|TUBE|BRAIN, THIRD VENTRICLE|IPSILATERAL|UPPER FLEXOR SURFACE|CYSTOSCOPY||||SPOUSE|OPTOMETRIST|1|Visit_1|10|4|TREATMENT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SLING|[?]|mL/m2|[?]|1|mmol/min/kPa/L|PULMONARY VALVE, LEFT CUSP|LEFT|SUPERIOR|JAFFE REACTION|Y|||CAREGIVER|ADJUDICATOR 2|1|Visit_1|10|4|SCREENING|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|3|MALIND|Malignancy Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|Absorbance U|[?]|1|ka_u/dL|HEEL OF THE HAND|IPSILATERAL|PROXIMAL VOLAR|HEMATOXYLIN AND EOSIN STAIN||||FRIEND|INTERNIST|2|Visit_2|25|5|TREATMENT|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|4|QUASCOMP|Quasi-Static Compliance|[?]|FOWLERS|[?]|uL/mL|[?]|1|copies/ug|GRACILIS MUSCLE|UNILATERAL|MIDLINE|DYNAMIC CONTRAST ENHANCED MRI||||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|5|SCREENING|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|5|PLMBLFLW|Pulmonary Blood Flow|[?]|LEFT LATERAL DECUBITUS|[?]|log10 CFU/mL|[?]|1|Ejaculate U|RIB 11|RIGHT|PARIETO-OCCIPITAL|MULTI-SLICE SPIRAL CT||||DOMESTIC PARTNER|ONCOLOGIST 2|3|Visit_3|40|5|TREATMENT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|6|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|copies/ug|[?]|1|10^6 U|AXILLARY VEIN|CONTRALATERAL|ANTEROPOSTERIOR|PH METER MEASUREMENT METHOD||||STUDY SUBJECT|RADIOLOGIST 1|3|Visit_3|40|7|TREATMENT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|7|GAW|Airway Conductance|[?]|LATERAL DECUBITUS|[?]|mm|[?]|1|10^7 CFU/mL|INTERTROCHANTERIC REGION|BILATERAL|ANTEROTEMPORAL|SPIRAL CT SCAN WITHOUT CONTRAST||Y||VENDOR|RADIOLOGIST|4|Visit_4|65|1|TREATMENT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|mL/sec/1.73m2|[?]|1|RATIO|HAND DIGIT 1|UNILATERAL|FRONTAL|CONTRAST ENHANCED PET SCAN||||SIBLING|ENDOCRINOLOGIST|4|Visit_4|65|6|WASHOUT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|IU/day|[?]|1|mL/cm H2O|PRIMARY VISUAL CORTEX|CONTRALATERAL|DORSAL|LEAD CITRATE STAIN||||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|f056c174-b6da-4df6-bf95-2e31911939fb|10|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|Ejaculate U|[?]|1|QUANTITY SUFFICIENT|LOCUS CERULEUS|RIGHT|UPPER FLEXOR SURFACE|FLUORESCENT IMMUNOASSAY|Y|||SPOUSE|FORENSIC PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|PRONE|||[?]|1|Absorbance U|RAPHE|IPSILATERAL|DISTAL|ICC|||Y|FAMILY MEMBER|ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2020-09-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|2|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING, BENT FORWARD|[?]|USP U|[?]|1|kPa|VEIN|IPSILATERAL|INTERMEDIATE|MANUAL CLOT DETECTION||||VENDOR|MICROSCOPIST|1|Visit_1|10|6|TREATMENT|2020-09-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|nmol/L/min|[?]|1|10^3 RNA copies/mL|SKIN OF THE BENDING JOINT|IPSILATERAL|LATERAL|RADIAL IMMUNODIFFUSION||||CLINICAL STUDY SPONSOR|NEUROLOGIST|2|Visit_2|25|7|WASHOUT|2020-10-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|4|FEV6PP|Percent Predicted FEV6|[?]|SITTING, LEGS DEPENDENT|[?]|ug/kg/min|[?]|1|10^6 RNA copies/mL|SHOULDER JOINT TENDONS|LATERAL|MIDLINE|NEPHELOMETRY||||SIBLING|NEUROLOGIST 2|2|Visit_2|25|2|TREATMENT|2020-10-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|5|FIVC|Forced Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|cycle/min|PYLORIC SPHINCTER|CONTRALATERAL|SUPERIOR|LISSAMINE GREEN STAIN|||Y|VENDOR|ONCOLOGIST 1|3|Visit_3|40|7|TREATMENT|2020-10-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|6|RV|Residual Volume|[?]|PRONE|[?]|mol/day|[?]|1|CIGAR|ACHILLES TENDON|CONTRALATERAL|APICAL|DYNAMIC LIGHT SCATTERING|Y|||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-10-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|7|VO2|Oxygen Consumption|[?]|SITTING, LEGS DEPENDENT|[?]|TRANSDUCING UNIT|[?]|1|/7.5 mL|PROSTATE GLAND|BILATERAL|UPPER FLEXOR SURFACE|TOTAL BODY RADIOGRAPHY||||PROXY|RADIOLOGIST 1|4|Visit_4|65|7|SCREENING|2020-11-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|8|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-RECUMBENT|[?]|Ci/L|[?]|1|POINT|UNCINATE PROCESS OF PANCREAS|IPSILATERAL|LOWER EXTENSOR SURFACE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||VENDOR|HEMATOLOGIST|4|Visit_4|65|3|SCREENING|2020-11-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|9|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING|[?]|in2|[?]|1|mg/mol|LEFT VENTRICULAR APICAL LATERAL SEGMENT|LEFT|MIDLINE|CLAUSS METHOD||||FAMILY MEMBER|ADJUDICATOR 2|5|Visit_5|90|1|TREATMENT|2020-12-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|[?]|IU|[?]|1|KIT|LUNG, LEFT LOWER LOBE|CONTRALATERAL|ANTEROTEMPORAL|HPLC||||SIBLING|ADJUDICATOR 1|5|Visit_5|90|5|WASHOUT|2020-12-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|||[?]|1|U/g Hb|FAT PAD|IPSILATERAL|FRONTAL|ELASTOGRAPHY|||Y|CAREGIVER|READER 1|1|Visit_1|10|4|SCREENING|2021-01-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING|[?]|IU/g Hb|[?]|1|JDF Unit|OMENTUM|RIGHT|PROXIMAL|OBSERVATION||Y||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|1|Visit_1|10|1|TREATMENT|2021-01-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|3|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/kg/h|[?]|1|10^9 organisms|CEREBRUM|BILATERAL|VOLAR|AMSLER GRID||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2021-02-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-FOWLERS|[?]|TRANSDUCING UNIT|[?]|1|mL/kg/min|FOOT DIGIT 1|RIGHT|VENTROLATERAL|MICROARRAY||||CHILD|PATHOLOGIST 2|2|Visit_2|25|7|SCREENING|2021-02-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SUPINE|[?]|U/g/min|[?]|1|U/g/h|SKIN OF THE THIGH|RIGHT|LOWER MEDIAL|IMPULSE OSCILLOMETRY||Y||ADJUDICATION COMMITTEE|NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2021-02-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|/cmH2O|[?]|1|titer|COLON, RIGHT|IPSILATERAL|ANTERIOR|KINETIC MICROPARTICLE IMMUNOASSAY|Y|||FRIEND|DERMATOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2021-02-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|7|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-RECUMBENT|||[?]|1|ft2|INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|INFERIOR|CONTRAST ENHANCED CT SCAN|||Y|SIBLING|READER|4|Visit_4|65|5|WASHOUT|2021-03-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|8|TGV|Thoracic Gas Volume|[?]|SLING|[?]|genEq/mL|[?]|1|MET|SUBSCAPULARIS MUSCLE|UNILATERAL|ANTEROLATERAL|QUANTITATIVE ULTRASOUND||||SIBLING|NEUROLOGIST|4|Visit_4|65|4|SCREENING|2021-03-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|9|DLCO|Diffusion Capacity of Lung for CO|[?]|SLING|||[?]|1|10^3 RNA copies/mL|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|BILATERAL|SUBCORTICAL|RYAN BLUE STAIN|||Y|GUARDIAN|FORENSIC PATHOLOGIST|5|Visit_5|90|1|SCREENING|2021-04-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|57b7f30f-5f2a-425d-8bf2-fd5915cac481|10|SGAW|Specific Airway Conductance|[?]|SEMI-RECUMBENT|[?]|uIU/L|[?]|1|fg|T10 VERTEBRA|IPSILATERAL|ANTEROPOSTERIOR|MODIFIED ACID FAST STAIN||||FAMILY MEMBER|ADJUDICATOR 3|5|Visit_5|90|3|SCREENING|2021-04-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|PLMBLFLW|Pulmonary Blood Flow|[?]|PRONE|[?]|V|[?]|1|mCi/L|EAR, INNER|IPSILATERAL|INNER|GC/MS-CI||||SIBLING|PEDIATRIC NEUROLOGIST|1|Visit_1|10|5|WASHOUT|2020-09-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|2|OXYPULSE|Oxygen Pulse|[?]|STANDING|[?]|DISK|[?]|1|kHz|CORNEAL STROMA|CONTRALATERAL|NASAL|PHOTOMETRIC CLOT DETECTION||||INDEPENDENT ASSESSOR|NEUROLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-09-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|3|DLCOHC|HGB Corrected DLCO|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uL/dose|FLEXOR CARPI ULNARIS MUSCLE|LATERAL|BASAL|MASS SPECTROMETRY|Y||Y|PROXY|MICROSCOPIST 2|2|Visit_2|25|2|TREATMENT|2020-09-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|4|MIPPP|Percent Predicted MIP|[?]|SEMI-FOWLERS|[?]|nmol/kg/day|[?]|1|ug/mL/h|MIDDLE PHALANX 2 OF THE HAND|RIGHT|MEDIAL|CALIPER MEASUREMENT METHOD||||CLINICAL STUDY SPONSOR|READER|2|Visit_2|25|1|TREATMENT|2020-09-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|5|PNIF|Peak Nasal Inspiratory Flow|[?]|FOWLERS|[?]|mN|[?]|1|log10 CFU/g|PROCERUS MUSCLE|IPSILATERAL|POSTERIOR|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y|||SIGNIFICANT OTHER|ADJUDICATOR 3|3|Visit_3|40|6|TREATMENT|2020-10-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|6|TSUELAS|Tissue Elastance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|nmol BCE/mmol|ENTORHINAL CORTEX|IPSILATERAL|TIP|SANGER SEQUENCING|Y||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|3|Visit_3|40|6|FOLLOW-UP|2020-10-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|7|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|/4.0 mL|[?]|1|ug/m2/min|CARPOMETACARPAL JOINT 2|LEFT|CRANIAL|CLINICAL EVALUATION||||PROXY|ADJUDICATOR 2|4|Visit_4|65|6|TREATMENT|2020-11-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING, BENT FORWARD|[?]|mph|[?]|1|U/kg/h|DIAPHRAGM|IPSILATERAL|DORSOLATERAL|OBSERVATION||Y||STUDY SUBJECT|PATHOLOGIST 2|4|Visit_4|65|4|WASHOUT|2020-11-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|PRONE|||[?]|1|mm|THORACIC SPINE|CONTRALATERAL|DORSAL|NEXT GENERATION SEQUENCING||Y|Y|SPOUSE|RADIOLOGIST 2|5|Visit_5|90|1|FOLLOW-UP|2020-12-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|02d9a74a-abc8-4b47-a4d4-a196d339f621|10|INTP|Interpretation|[?]|SITTING, LEGS DEPENDENT|[?]|mmol/g|[?]|1|BAU|CAUDAL VERTEBRA|LEFT|ANTEROPOSTERIOR|MICROBIAL CONCENTRATION|Y|||CHILD|INTERNIST|5|Visit_5|90|4|TREATMENT|2020-12-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|[?]|10^10/L|[?]|1|mmHg/L/min|PERICARDIUM|IPSILATERAL|APICAL|MODIFIED ACID FAST STAIN||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|1|Visit_1|10|4|SCREENING|2020-11-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LATERAL DECUBITUS|[?]|BEAM BREAKS|[?]|1|/h|SKIN OF THE ELBOW|IPSILATERAL|UPPER FLEXOR SURFACE|CONTRAST ENHANCED PET/CT SCAN|Y|||CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|1|Visit_1|10|3|TREATMENT|2020-11-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|3|FEV1SVC|FEV1/SVC|[?]|DECUBITUS|[?]|ukat|[?]|1|msec|L5 VERTEBRA|RIGHT|ANTEROMEDIAL|ERGOSPIROMETRY||Y||INVESTIGATOR|HEMATOLOGIST|2|Visit_2|25|4|SCREENING|2020-12-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|4|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|[?]|DRINK|[?]|1|U/kg|LOWER JUGULAR LYMPH NODE|RIGHT|HIND|IMMUNORADIOMETRIC ASSAY||||CHILD|RATER|2|Visit_2|25|4|TREATMENT|2020-12-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-FOWLERS|[?]|% INHIBITION|[?]|1|mg/kg|BICEPS BRACHII MUSCLE|RIGHT|SUPERFICIAL|NEXT GENERATION TARGETED SEQUENCING||||ADJUDICATOR|OTOLARYNGOLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|6|TLC|Total Lung Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|foz_us|[?]|1|10^12 IU/L|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|RIGHT|CRANIAL|HEMAGGLUTINATION INHIBITION ASSAY||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|7|TREATMENT|2020-12-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING|||[?]|1|RATIO|SOFT PALATE|LATERAL|ANTEROTEMPORAL|INDIRECT IMMUNOFLUORESCENCE|||Y|NON-HEALTH CARE PROFESSIONAL|UROLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|8|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|[?]|ug/L FEU|[?]|1|fg|KNEE JOINT|LEFT|ANTERIOR|PH METER MEASUREMENT METHOD||||FRIEND|PATHOLOGIST|4|Visit_4|65|5|SCREENING|2021-01-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|9|FIV1PP|Percent Predicted FIV1|[?]|SEMI-RECUMBENT|||[?]|1|mg/dL|EPICONDYLE|LATERAL|LATERAL|MICRONEUTRALIZATION ASSAY|||Y|PARENT|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|SCREENING|2021-02-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|81480f83-206f-40c0-a5a4-f75b31cda363|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING, BENT FORWARD|[?]|genEq/mL|[?]|1|mg/g/min|BACK|UNILATERAL|ANTEROTEMPORAL|REFLECTANCE SPECTROSCOPY||Y||SIGNIFICANT OTHER|NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2021-02-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|RRS|Total Respiratory System Resistance|[?]|LATERAL DECUBITUS|[?]|mL/dL|[?]|1|ng/day|PHARYNGEAL TONSIL|RIGHT|OCCIPITAL|SLOAN LETTER EYE CHART 100%|Y|Y||ADJUDICATION COMMITTEE|RATER|1|Visit_1|10|3|SCREENING|2020-10-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|2|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-RECUMBENT|[?]|BEAM BREAKS|[?]|1|damol/L|FLOOR OF MOUTH|RIGHT|ANTEROLATERAL|THICK SMEAR||Y||INVESTIGATOR|PATHOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-10-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|3|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LEFT LATERAL DECUBITUS|[?]|pmol/L/h|[?]|1|POINT|BLOOD VESSEL|LATERAL|OCCIPITAL|ACCELERATOR MASS SPECTROMETRY||||PROXY|CARDIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-10-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|g/animal/day|[?]|1|uV2|TRIANGULAR BONE|CONTRALATERAL|VENTROLATERAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||VENDOR|READER 3|2|Visit_2|25|7|WASHOUT|2020-10-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|5|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|UNCONSTRAINED|[?]|mg/L|[?]|1|Log10 ELISA unit|PONS VAROLII|CONTRALATERAL|LOWER|MAMMOGRAPHY||Y||FAMILY MEMBER|HEMATOLOGIST|3|Visit_3|40|5|TREATMENT|2020-11-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|6|TVPP|Percent Predicted Tidal Volume|[?]|LEFT LATERAL DECUBITUS|[?]|%(w/v)|[?]|1|kBq/uL|PRONATOR QUADRATUS MUSCLE|LEFT|SURFACE|VIRUS PLAQUE ASSAY||||SPOUSE|READER 1|3|Visit_3|40|3|WASHOUT|2020-11-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|7|FEV1PP|Percent Predicted FEV1|[?]|STANDING, BENT FORWARD|[?]|10^3 copies/mL|[?]|1|mL/m2/h|MITRAL VALVE, POSTERIOR ANNULUS|UNILATERAL|FORE|IMMUNOBLOT|Y|||FAMILY MEMBER|PATHOLOGIST 1|4|Visit_4|65|3|SCREENING|2020-12-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|8|FEV1REV|FEV1 Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|IU|[?]|1|L/s/kPa|LIVER, RIGHT LOBE|RIGHT|FORE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|||FRIEND|MICROSCOPIST 1|4|Visit_4|65|6|WASHOUT|2020-12-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|9|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|[?]|cmH2O*s2/mL|[?]|1|PACKAGE|ANKLE JOINT|CONTRALATERAL|PERIPHERAL|MALDI-TOF||||INTERVIEWER|PATHOLOGIST 2|5|Visit_5|90|2|TREATMENT|2021-01-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|2b183b69-3ed8-4356-b9e2-0988128de3f2|10|TGV|Thoracic Gas Volume|[?]|SLING|[?]|U/L|[?]|1|mg/animal|PULMONARY TRUNK|IPSILATERAL|LATERAL|MS/MS||||CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|WASHOUT|2021-01-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|||[?]|1|PELLET|KIDNEY|CONTRALATERAL|ANTERIOR|HPLC/IEX||Y|Y|VENDOR|READER 1|1|Visit_1|10|5|SCREENING|2020-06-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|2|MEP|Maximal Expiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|U/m2/min|[?]|1|BP|HAIR SHAFT|LEFT|LATERAL|FARR ASSAY||||HEALTH CARE PROFESSIONAL|READER 3|1|Visit_1|10|5|SCREENING|2020-06-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|3|QUASCOMP|Quasi-Static Compliance|[?]|RIGHT LATERAL DECUBITUS|[?]|g/dL|[?]|1|dram|URINARY SYSTEM|RIGHT|DORSOLATERAL|IODINE STAIN||Y||SPOUSE|RATER 2|2|Visit_2|25|6|TREATMENT|2020-06-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|4|MIP|Maximal Inspiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|kcal/day|[?]|1|U/L|URETHRA, PROSTATIC|UNILATERAL|TEMPORAL|MANUAL CLOT DETECTION|Y|||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|3|WASHOUT|2020-06-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|5|ICPP|Percent Predicted Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|[?]|U/m2/day|[?]|1|mL/kg|NOSTRIL|BILATERAL|SURFACE|U-HPLC/MS/MS||Y||CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|3|Visit_3|40|1|TREATMENT|2020-07-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|6|FVC|Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|aMFI|[?]|1|BOTTLE|EYE|IPSILATERAL|ANTEROLATERAL|INDIRECT IMMUNOFLUORESCENCE||||SPOUSE|ONCOLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-07-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|RIGHT LATERAL DECUBITUS|[?]|RING|[?]|1|uCi/L|RETROPERITONEAL LYMPH NODE|LEFT|FRONTAL|MOUSE PROTECTION ASSAY||Y||STUDY SUBJECT|DERMATOLOGIST|4|Visit_4|65|5|TREATMENT|2020-07-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|8|TGV|Thoracic Gas Volume|[?]|LATERAL DECUBITUS|[?]|uEq/L|[?]|1|psi|CALF|LEFT|POSTERIOR|PATHOLOGICAL EVALUATION||||PROXY|READER 2|4|Visit_4|65|5|TREATMENT|2020-07-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING, BENT FORWARD|[?]|CUP|[?]|1|/10^5|HEART, LEFT ATRIAL APPENDAGE|IPSILATERAL|DISTAL VOLAR|DYNAMIC CONTRAST ENHANCED MRI||Y||FRIEND|OPTOMETRIST|5|Visit_5|90|1|TREATMENT|2020-08-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|6ed8a749-81c0-4998-817d-efc86cfaa091|10|FIF25|Forced Inspiratory Flow at 25%|[?]|PRONE|||[?]|1|cal|FALCIFORM LIGAMENT|BILATERAL|NASAL|IMPULSE OSCILLOMETRY|||Y|PARENT|UROLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|ERVPP|Percent Predicted ERV|[?]|LATERAL DECUBITUS|[?]|steps/min|[?]|1|%(w/v)|FIRST RIGHT POSTEROLATERAL ARTERY|LEFT|ROSTRAL|ACCELERATOR MASS SPECTROMETRY||||FRIEND|OTOLARYNGOLOGIST|1|Visit_1|10|1|TREATMENT|2021-01-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|2|FRC|Functional Residual Capacity|[?]|STANDING|||[?]|1|g/animal/day|SUPERIOR SAGITTAL SINUS|LEFT|PERIVENTRICULAR|OPTICAL MAPPING|Y||Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|1|Visit_1|10|2|SCREENING|2021-01-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|3|FEV_PEF|FEV at PEF|[?]|SEMI-FOWLERS|[?]|U/g/min|[?]|1|mg/L FEU|LUNG, RIGHT LOWER LOBE|UNILATERAL|VENTRAL|HIGH RESOLUTION CT|Y|Y||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2021-02-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|4|FEV1SVC|FEV1/SVC|[?]|SITTING|||[?]|1|%(w/v)|MESENTERIC ARTERY|BILATERAL|VENTROLATERAL|ENDPOINT DILUTION ASSAY||Y|Y|INDEPENDENT ASSESSOR|ADJUDICATOR 3|2|Visit_2|25|3|TREATMENT|2021-02-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|5|ERV|Expiratory Reserve Volume|[?]|SLING|[?]|Mile|[?]|1|ng/dL|VULVA|RIGHT|DISTAL|PALM METHOD|Y|||PARENT|ONCOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2021-02-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|6|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|mEq/L|[?]|1|/10^5|GASTROINTESTINAL TRACT, LOWER|UNILATERAL|INFERIOR|DOPPLER ULTRASOUND||Y||STUDY SUBJECT|READER|3|Visit_3|40|1|SCREENING|2021-02-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|7|DLCO|Diffusion Capacity of Lung for CO|[?]|STANDING|[?]|ug|[?]|1|U/mmol|RECTOSIGMOID JUNCTION|LATERAL|ANTEROMEDIAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||ADJUDICATION COMMITTEE|NEUROLOGIST|4|Visit_4|65|1|FOLLOW-UP|2021-03-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|8|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SITTING|[?]|mg/kg/dose|[?]|1|Absorbance U/min|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|LEFT|VENTRAL|PET/SPECT SCAN||Y||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|4|Visit_4|65|3|TREATMENT|2021-03-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|9|FEV_PEF|FEV at PEF|[?]|SITTING|[?]|ug/g/min|[?]|1|mL/day|PENIS, RADIX|IPSILATERAL|CAUDAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||Y||PROXY|DERMATOLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|10|RELSZCHG|Relative Size Change|[?]|LEFT LATERAL DECUBITUS|[?]|AMPULE|[?]|1|10^6 IU|CARPOMETACARPAL JOINT 5|CONTRALATERAL|UPPER EXTENSOR SURFACE|WRIGHT STAIN||Y||INTERVIEWER|OPHTHALMOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-04-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|1|PCF|Peak Cough Flow|[?]|SEMI-RECUMBENT|[?]|CAPLET|[?]|1|DAYS|RADIAL NERVE|CONTRALATERAL|SUPERIOR|ZIEHL NEELSEN ACID FAST STAIN|Y|Y||PARENT|READER 2|1|Visit_1|10|7|TREATMENT|2020-08-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|2|PLMXRS|Pulmonary Reactance|[?]|PRONE|[?]|mOsm|[?]|1|BISCUIT|PARAMETRIUM|LEFT|ANTERIOR|SMEAR||||VENDOR|ONCOLOGIST|1|Visit_1|10|7|SCREENING|2020-08-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|3|AIRTRAP|Air Trapping|[?]|SITTING, LEGS DEPENDENT|[?]|DIOPTER|[?]|1|U/mL|SUBMENTAL LYMPH NODE|BILATERAL|LOWER FLEXOR SURFACE|PET SCAN||||INVESTIGATOR|RADIOLOGIST|2|Visit_2|25|6|TREATMENT|2020-08-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|FOWLERS|||[?]|1|U/g/h|METATARSOPHALANGEAL JOINT 3|BILATERAL|ANTEROPOSTERIOR|CONTRAST ENHANCED SPIRAL CT SCAN||Y|Y|NON-HEALTH CARE PROFESSIONAL|RATER 1|2|Visit_2|25|1|TREATMENT|2020-08-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|5|FIV1PP|Percent Predicted FIV1|[?]|STANDING, BENT FORWARD|[?]|10^7 TCID 50/dose|[?]|1|MET*h|HAMSTRING MUSCLE|IPSILATERAL|TIP|SPIROMETRY|Y|Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|3|Visit_3|40|2|SCREENING|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|6|GAW|Airway Conductance|[?]|DECUBITUS|[?]|MET|[?]|1|pmol/L/h|UPPER CERVICAL LYMPH NODE|LEFT|FORE|ULTRASONOGRAPHIC ELASTOGRAPHY||||DOMESTIC PARTNER|NEUROLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|7|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-FOWLERS|[?]|1/(s*kPa)|[?]|1|kcal|SUBMANDIBULAR LYMPH NODE|IPSILATERAL|ANTEROLATERAL|RADIOGRAPHY||Y||ADJUDICATION COMMITTEE|OPTOMETRIST|4|Visit_4|65|7|WASHOUT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|8|INERTANC|Inertance|[?]|DECUBITUS|||[?]|1|mL/sec/1.73m2|PHARYNGEAL TONSIL|LEFT|SUPERIOR|BIOIMPEDANCE SPECTROSCOPY|||Y|VENDOR|ONCOLOGIST|4|Visit_4|65|1|TREATMENT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|9|OXYPULSE|Oxygen Pulse|[?]|SITTING, LEGS DEPENDENT|[?]|mCi|[?]|1|mL/day|POPLITEAL LYMPH NODE|IPSILATERAL|CENTRAL|IMMUNOTURBIDIMETRY||||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|7|SCREENING|2020-10-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|e6162980-e240-4924-a13a-dde28b2345cd|10|RV|Residual Volume|[?]|DECUBITUS|[?]|MPL U|[?]|1|Absorbance U|COSTOCHONDRAL JOINT 7|IPSILATERAL|INTERMEDIATE|FLOW CYTOMETRY||||VENDOR|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2020-10-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|GAW|Airway Conductance|[?]|REVERSE TRENDELENBURG|||[?]|1|um|HAND DIGIT 2|IPSILATERAL|APICAL|PET/CT SCAN|||Y|INVESTIGATOR|INTERNIST|1|Visit_1|10|4|TREATMENT|2020-06-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|2|AWVOL|Airway Volume|[?]|SUPINE|[?]|tuberculin unit/mL|[?]|1|10^9/g|URACHAL TRACT|IPSILATERAL|APICAL|PHYSICAL EXAMINATION||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|1|Visit_1|10|4|SCREENING|2020-06-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|3|PLMXRS|Pulmonary Reactance|[?]|RIGHT LATERAL DECUBITUS|[?]|/200 HPFs|[?]|1|s^-1(%O2)^-1|LIVER, LEFT LOBE|IPSILATERAL|VENTRAL|CELL BASED BIOASSAY||Y||INTERVIEWER|UROLOGIST|2|Visit_2|25|6|WASHOUT|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|4|RVPP|Percent Predicted Residual Volume|[?]|STANDING, BENT FORWARD|||[?]|1|hPa|BRACHIAL PLEXUS|LEFT|UPPER|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|Y||Y|ADJUDICATOR|ENDOCRINOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|5|FEF50|Forced Expiratory Flow 50%|[?]|TRENDELENBURG|[?]|Shock Wave|[?]|1|vg/mL|NASOPHARYNX|RIGHT|ANTERIOR|IHC||Y||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-07-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|6|FVC|Forced Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|Tesla|MESENTERY|LATERAL|LOWER FLEXOR SURFACE|FLUORIMETRY|||Y|SIBLING|HEMATOLOGIST|3|Visit_3|40|5|SCREENING|2020-07-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|7|FEV1REV|FEV1 Reversibility|[?]|STANDING|[?]|mg/g/h|[?]|1|MET|FOREBRAIN|BILATERAL|MIDLINE|REVERSE TRANSCRIPTASE PCR||Y||CHILD|RATER 1|4|Visit_4|65|1|SCREENING|2020-08-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|8|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|[?]|Watt|[?]|1|/100 WBC|POSTEROLATERAL SEGMENTAL ARTERY|CONTRALATERAL|FORE|STATIC PERIMETRY|Y|Y||PROXY|MICROSCOPIST|4|Visit_4|65|2|WASHOUT|2020-08-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|9|TSUELAS|Tissue Elastance|[?]|SUPINE|[?]|Bq/mg|[?]|1|PNU/mL|GENITAL TUBERCLE|RIGHT|PERIPHERAL|WHOLE EXOME SEQUENCING||||FAMILY MEMBER|PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|3dc9c666-8be3-4cfa-88d4-b18647e08d00|10|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|deg2|[?]|1|SFC/10^6 PBMC|CILIARY BODY|BILATERAL|FORE|TRIPLE-PHASE MRI SCAN||Y||INTERVIEWER|ONCOLOGIST 2|5|Visit_5|90|6|TREATMENT|2020-09-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|EVC|Expiratory Vital Capacity|[?]|DECUBITUS|||[?]|1|gtt|RECTUS FEMORIS MUSCLE|CONTRALATERAL|VENTROLATERAL|IN SITU HYBRIDIZATION||Y|Y|CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|TREATMENT|2021-01-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|2|TGV|Thoracic Gas Volume|[?]|SLING|[?]|DRINK|[?]|1|ukat/10^12 RBC|FAT PAD|RIGHT|INNER|THIN SMEAR|Y|||VENDOR|NEUROLOGIST 2|1|Visit_1|10|4|TREATMENT|2021-01-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|3|FIF50|Forced Inspiratory Flow at 50%|[?]|FOWLERS|[?]|ug/day|[?]|1|dpm/100mg|FLEXOR HALLUCIS LONGUS MUSCLE|CONTRALATERAL|POSTERIOR|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||PROXY|PATHOLOGIST 1|2|Visit_2|25|5|TREATMENT|2021-02-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|4|AIRTRAP|Air Trapping|[?]|UNCONSTRAINED|[?]|dpm/0.5 mL|[?]|1|mm/min|RECTOVAGINAL SPACE|UNILATERAL|UPPER|SMEAR||||ADJUDICATION COMMITTEE|ONCOLOGIST|2|Visit_2|25|6|WASHOUT|2021-02-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|5|FEV3PP|Percent Predicted FEV3|[?]|LATERAL DECUBITUS|[?]|/10^4|[?]|1|days/wk|ANTERIOR CINGULATE GYRUS|UNILATERAL|INFERIOR|VIRUS PLAQUE ASSAY|Y|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|3|Visit_3|40|4|TREATMENT|2021-02-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|6|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|[?]|mIU/L|[?]|1|pkat|THYMUS GLAND|RIGHT|LATERAL|URANYL ACETATE STAIN||||PROXY|ONCOLOGIST 1|3|Visit_3|40|3|FOLLOW-UP|2021-02-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|[?]|10^12/L|[?]|1|mEq/kg|T12 VERTEBRA|LATERAL|DEEP|DOPPLER ULTRASOUND|Y|||ADJUDICATOR|MICROSCOPIST 1|4|Visit_4|65|6|WASHOUT|2021-03-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|8|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-FOWLERS|[?]|umol/dL|[?]|1|OD Unit|INTERNAL ILIAC LYMPH NODE|RIGHT|FACIAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|||CAREGIVER|PATHOLOGIST 2|4|Visit_4|65|5|WASHOUT|2021-03-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|9|IVCPP|Percent Predicted IVC|[?]|STANDING|[?]|ug/kg|[?]|1|ng/dL|PULMONARY ARTERY BRANCH|IPSILATERAL|OUTER|PET SCAN||||PROXY|PATHOLOGIST 2|5|Visit_5|90|4|TREATMENT|2021-04-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|10|MEPPP|Percent Predicted MEP|[?]|LEFT LATERAL DECUBITUS|[?]|EP U|[?]|1|OI50|DISTAL FEMUR R1|LATERAL|POSTERIOR|PHASE-CONTRAST MRI||||PROXY|CARDIOLOGIST|5|Visit_5|90|1|SCREENING|2021-04-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|FEF2575|Forced Expiratory Flow 25-75%|[?]|SITTING|[?]|CAPSULE|[?]|1|DRUM|MIDBRAIN|BILATERAL|BASAL|HEMAGGLUTINATION INHIBITION ASSAY||||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|1|Visit_1|10|4|FOLLOW-UP|2020-11-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|UNCONSTRAINED|[?]|Ci/L|[?]|1|JDF Unit|PROXIMAL PHALANX 3 OF THE HAND|BILATERAL|INNER|PANENDOSCOPY|Y|Y||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|1|Visit_1|10|4|WASHOUT|2020-11-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|3|TGV|Thoracic Gas Volume|[?]|LEFT LATERAL DECUBITUS|[?]|HOURS|[?]|1|copies/ug|HAND PHALANX|BILATERAL|CAUDAL|POLYMERASE CHAIN REACTION|Y|Y||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|4|ICREV|IC Reversibility|[?]|SEMI-FOWLERS|[?]|GBq|[?]|1|BLOCKS|MITRAL VALVE, POSTERIOR CUSP|UNILATERAL|POSTERIOR|HEMOCYTOMETRY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-12-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|[?]|mm/2h|[?]|1|mL/dL|GREAT SAPHENOUS VEIN|LATERAL|DISTAL|FLUORESCENT SPOT TEST||||PROXY|READER 3|3|Visit_3|40|3|WASHOUT|2020-12-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|UNCONSTRAINED|||[?]|1|Ci/uL|SUBCARINAL LYMPH NODE|LATERAL|SUPERFICIAL|DIFFUSION WEIGHTED MRI|||Y|FRIEND|ENDOCRINOLOGIST|3|Visit_3|40|1|SCREENING|2020-12-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|7|FIV1PP|Percent Predicted FIV1|[?]|LATERAL DECUBITUS|[?]|mm2|[?]|1|GBq/mg|ABDUCTOR DIGITI QUINTI MUSCLE|CONTRALATERAL|LOWER EXTENSOR SURFACE|PHOROPTER|Y|Y||CLINICAL RESEARCH COORDINATOR|RATER 1|4|Visit_4|65|2|TREATMENT|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|8|IRVPP|Percent Predicted IRV|[?]|FOWLERS|[?]|ukat/L|[?]|1|DRINK|NAIL BED|BILATERAL|PERIPHERAL|REFRACTOMETRY|Y|||CAREGIVER|INTERNIST|4|Visit_4|65|4|WASHOUT|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|[?]|g/animal|[?]|1|SQU/mL|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|INNER|COLORIMETRY||||HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|3|SCREENING|2021-02-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-RECUMBENT|[?]|mg/m2/day|[?]|1|g/animal/wk|EPICONDYLE|UNILATERAL|TIP|PH METER MEASUREMENT METHOD||||INVESTIGATOR|CLINICAL PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-02-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|1|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|L/L|[?]|1|dyn|ACCESSORY RENAL ARTERY|LEFT|POSTERIOR|NO INFORMATION||||CAREGIVER|ADJUDICATOR 1|1|Visit_1|10|3|SCREENING|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SITTING, LEGS DEPENDENT|[?]|/2000 RBC|[?]|1|anti-Xa IU/mL|COCCYX|LATERAL|UPPER|WRIGHT STAIN||Y||FAMILY MEMBER|RATER 2|1|Visit_1|10|4|TREATMENT|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|3|AWVOLPP|Percent Predicted Airway Volume|[?]|DECUBITUS|[?]|ng/L|[?]|1|keV|PERIRECTAL LYMPH NODE|RIGHT|OUTER|TARGETED TRANSCRIPTOME SEQUENCING||||VENDOR|ADJUDICATOR 2|2|Visit_2|25|2|WASHOUT|2020-06-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|4|INERTANC|Inertance|[?]|TRENDELENBURG|[?]|BISCUIT|[?]|1|beats/min|VAS DEFERENS|UNILATERAL|VENTROLATERAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||DOMESTIC PARTNER|UROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-06-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|UNCONSTRAINED|[?]|/cmH2O|[?]|1|pmol/10^10 cells|TIBIAL-CRURAL PERIPHERAL ARTERY|LEFT|UPPER|PH METER MEASUREMENT METHOD||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|3|Visit_3|40|5|WASHOUT|2020-06-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|6|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|||[?]|1|mmHg*min/L|PROSTATE GLAND, LATERAL LOBE|LATERAL|FORE|BRDU CELLULAR PROLIFERATION ASSAY|Y||Y|SIGNIFICANT OTHER|RATER 2|3|Visit_3|40|6|WASHOUT|2020-06-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|7|MIPPP|Percent Predicted MIP|[?]|RIGHT LATERAL DECUBITUS|[?]|L/kg|[?]|1|cmHg|UTERINE ARTERY|BILATERAL|SUBCORTICAL|TOTAL BODY RADIOGRAPHY|Y|Y||INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-07-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|8|PLMBLFLW|Pulmonary Blood Flow|[?]|SLING|[?]|DDU|[?]|1|fmol/L|FLANK|LEFT|OUTER|EPSILOMETER||||STUDY SUBJECT|MICROSCOPIST 1|4|Visit_4|65|5|TREATMENT|2020-07-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|9|FIFMAXPP|Percent Predicted FIFmax|[?]|UNCONSTRAINED|[?]|Ci/L|[?]|1|mL/m2/day|HAND DIGIT 3|LEFT|HIND|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|||FAMILY MEMBER|MICROSCOPIST 1|5|Visit_5|90|3|TREATMENT|2020-08-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|2738b933-c71d-4239-a093-6b4aa7cc41df|10|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING, BENT FORWARD|[?]|/mm2|[?]|1|10^6 organisms|HYPOGLOSSAL NERVE|UNILATERAL|MIDLINE|DYNAMIC LIGHT SCATTERING|Y|||STUDY SUBJECT|READER|5|Visit_5|90|4|TREATMENT|2020-08-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|IVC|Inspiratory Vital Capacity|[?]|FOWLERS|[?]|mg/mol|[?]|1|10^6 organisms/mg|SENSORIMOTOR CORTEX|IPSILATERAL|LATERAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||INTERVIEWER|PHYSIOTHERAPIST|1|Visit_1|10|3|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|2|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|UNCONSTRAINED|[?]|ug/h|[?]|1|%(w/w)|CALCANEUS|BILATERAL|PROXIMAL|SINGLE-MOLECULE ARRAY||||CLINICAL RESEARCH ASSOCIATE|RATER|1|Visit_1|10|2|FOLLOW-UP|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|3|RRS|Total Respiratory System Resistance|[?]|SEMI-RECUMBENT|[?]|DNA copies/ug|[?]|1|10^3 CFU|LIVER, RIGHT LOBE|BILATERAL|VENTRAL|MYELOPEROXIDASE STAIN||Y||FAMILY MEMBER|FORENSIC PATHOLOGIST|2|Visit_2|25|1|WASHOUT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|4|FRCPP|Percent Predicted FRC|[?]|UNCONSTRAINED|||[?]|1|m3|CEPHALIC VEIN|RIGHT|LOWER MEDIAL|JAFFE REACTION|Y||Y|PARENT|READER|2|Visit_2|25|1|WASHOUT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|5|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|nmol|[?]|1|AgU/mL|CARDIAC VALVE|UNILATERAL|CENTRAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|Y||FRIEND|MICROSCOPIST 3|3|Visit_3|40|6|SCREENING|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-05
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|TCID 50/dose|[?]|1|ug/dose|ANTERIOR INFERIOR CEREBELLAR ARTERY|LATERAL|BASAL|DC SHEATH FLOW||||DOMESTIC PARTNER|DERMATOLOGIST|3|Visit_3|40|3|WASHOUT|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-05
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|7|DLCOPP|Percent Predicted DLCO|[?]|TRENDELENBURG|||[?]|1|uEq/L|VERTEBRAL COLUMN|LATERAL|DORSAL|CENTRIFUGATION|||Y|PROXY|ADJUDICATOR 3|4|Visit_4|65|7|WASHOUT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|8|RAW|Airway Resistance|[?]|DECUBITUS|[?]|LENS|[?]|1|IU/kg/h|HYMENAL RING|LATERAL|PROXIMAL VOLAR|MALDI-TOF||Y||DOMESTIC PARTNER|UROLOGIST|4|Visit_4|65|6|WASHOUT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|9|DLCOHC|HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|mol/mg|[?]|1|mV*min|HEART, LEFT VENTRICLE|BILATERAL|UPPER FLEXOR SURFACE|POLYMERASE CHAIN REACTION||||INVESTIGATOR|ADJUDICATOR 2|5|Visit_5|90|1|SCREENING|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|68b9ff4e-9694-4545-a752-4d3ac0e89fda|10|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|Pack Year|[?]|1|U/g Hb|DORSAL MOTOR NUCLEUS|RIGHT|UPPER EXTENSOR SURFACE|ULTRASONOGRAPHIC ELASTOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|RATER 1|5|Visit_5|90|5|SCREENING|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|FEV1SVC|FEV1/SVC|[?]|LEFT LATERAL DECUBITUS|[?]|ug/kg/min|[?]|1|ug/dL|SUBARACHNOID SPACE|BILATERAL|APICAL|WHOLE EXOME SEQUENCING|Y|||SPOUSE|ADJUDICATOR 3|1|Visit_1|10|6|TREATMENT|2020-08-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|2|DLCOVA|DLCO/VA|[?]|UNCONSTRAINED|[?]|U|[?]|1|mmHg*min/L|PROXIMAL INTERPHALANGEAL JOINT 5|LATERAL|CRANIAL|KINETIC MICROPARTICLE IMMUNOASSAY||||CLINICAL RESEARCH ASSOCIATE|READER 1|1|Visit_1|10|7|SCREENING|2020-08-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|3|MALEVDES|Malignancy Evidence Description|[?]|LEFT LATERAL DECUBITUS|[?]|U/g/h|[?]|1|mm/h|HIP ADDUCTORS|UNILATERAL|TIP|HEMATOXYLIN AND EOSIN STAIN|Y|||PROXY|RATER 1|2|Visit_2|25|2|TREATMENT|2020-09-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|4|FEV1FVC|FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Ci/ug|TIBIALIS POSTERIOR MUSCLE|BILATERAL|POSTERIOR|ERGOSPIROMETRY|||Y|PARENT|ONCOLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-09-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|SUPINE|[?]|ug/dose|[?]|1|KALLIKREIN INHIBITOR UNIT|HEART, LEFT VENTRICULAR OUTFLOW TRACT|CONTRALATERAL|DORSAL|PET/SPECT SCAN||||INVESTIGATOR|ENDOCRINOLOGIST|3|Visit_3|40|5|TREATMENT|2020-09-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|6|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|||[?]|1|U/mmol|BRACHIAL PLEXUS|UNILATERAL|ROSTRAL|PAP STAIN|Y||Y|CAREGIVER|ONCOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-09-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|7|FEV1REV|FEV1 Reversibility|[?]|DECUBITUS|[?]|g/mol|[?]|1|DAYS|RIB 10|BILATERAL|ROSTRAL|ORCHIDOMETERY||Y||SIGNIFICANT OTHER|ADJUDICATOR 1|4|Visit_4|65|7|SCREENING|2020-10-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|8|IVC|Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|mg2/dL2|[?]|1|beats/min|ANUS|UNILATERAL|CRANIAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||VENDOR|READER|4|Visit_4|65|6|SCREENING|2020-10-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|9|FRCPP|Percent Predicted FRC|[?]|DECUBITUS|||[?]|1|pL|MAXILLA|CONTRALATERAL|FRONTAL|THIN SMEAR|||Y|NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-11-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|0f0ec179-5100-4a3d-9f93-54140aca7d30|10|FEV1FVC6|FEV1/FVC6|[?]|TRENDELENBURG|||[?]|1|/7.5 mL|PANCREAS, TAIL|LATERAL|DISTAL VOLAR|APPLANATION TONOMETRY|Y|Y|Y|GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|6|TREATMENT|2020-11-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING, BENT FORWARD|[?]|/month|[?]|1|NEEDLE GAUGE|SALIVARY GLAND|RIGHT|FRONTAL|ANALYTICAL ULTRACENTRIFUGATION|Y|Y||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|1|Visit_1|10|4|TREATMENT|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|FOWLERS|[?]|RNA copies/mL|[?]|1|min*mg/mL|THIRD RIGHT POSTEROLATERAL ARTERY|RIGHT|PERIVENTRICULAR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||GUARDIAN|ADJUDICATOR 1|1|Visit_1|10|3|FOLLOW-UP|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|Frames/s|ANKLE MORTISE|LATERAL|ANTEROMEDIAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y||Y|GUARDIAN|MICROSCOPIST|2|Visit_2|25|2|TREATMENT|2020-07-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|4|FIFMAX|Maximum Forced Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|ug|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|LEFT|ROSTRAL|IMPULSE OSCILLOMETRY|||Y|PROXY|ADJUDICATOR 2|2|Visit_2|25|1|TREATMENT|2020-07-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|DECUBITUS|||[?]|1|L/s|INTERPHALANGEAL JOINT 2|CONTRALATERAL|POSTERIOR|TELLER ACUITY CARDS|||Y|SPOUSE|OPTOMETRIST|3|Visit_3|40|5|WASHOUT|2020-07-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|6|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|[?]|v/v|[?]|1|ng/L|METATARSOPHALANGEAL JOINT 4|BILATERAL|MIDLINE|FLOCCULATION, CHARCOAL ENHANCED|Y|||PROXY|READER 1|3|Visit_3|40|2|FOLLOW-UP|2020-07-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|7|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|||[?]|1|V/sec|LUMBRICAL MUSCLES OF THE HAND|BILATERAL|LOWER FLEXOR SURFACE|NEXT GENERATION SEQUENCING|||Y|DOMESTIC PARTNER|CLINICAL PATHOLOGIST|4|Visit_4|65|1|SCREENING|2020-08-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|8|INERTANC|Inertance|[?]|RIGHT LATERAL DECUBITUS|[?]|ks|[?]|1|/cmH2O|BICEPS BRACHII MUSCLE|RIGHT|TIP|KINETIC MICROPARTICLE IMMUNOASSAY||||VENDOR|ADJUDICATOR 2|4|Visit_4|65|1|FOLLOW-UP|2020-08-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|9|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|U/animal|NUCHAL LYMPH NODE|LATERAL|LOWER MEDIAL|SNP ARRAY|||Y|CAREGIVER|MICROSCOPIST 2|5|Visit_5|90|4|SCREENING|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|6affe43d-e455-40af-8478-dc38019e89e1|10|EFFIND|Effusion Indicator|[?]|SEMI-RECUMBENT|[?]|mg/kg/day|[?]|1|mL/mmHg/min/L|INSULAR CORTEX|LATERAL|TIP|NON-INVASIVE DIELECTRIC SENSING|Y|||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|6|WASHOUT|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|PEF|Peak Expiratory Flow|[?]|LATERAL DECUBITUS|[?]|Gy/min|[?]|1|/500 WBC|INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|PROXIMAL|HANSEL STAIN||Y||FRIEND|CARDIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|2|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|[?]|/2500 WBC|[?]|1|nU/cL|PROXIMAL PHALANX 4 OF THE HAND|CONTRALATERAL|ANTEROLATERAL|CRYOSCOPY||||VENDOR|UROLOGIST|1|Visit_1|10|6|SCREENING|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|3|IVCPP|Percent Predicted IVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|BAU/mL|METACARPOPHALANGEAL JOINT 2|IPSILATERAL|TEMPORAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|||Y|SPOUSE|PATHOLOGIST|2|Visit_2|25|6|WASHOUT|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|4|FIV1PP|Percent Predicted FIV1|[?]|PRONE|[?]|beats/min|[?]|1|deg/s|SUBCARINAL LYMPH NODE|RIGHT|ANTEROMEDIAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|2|Visit_2|25|4|FOLLOW-UP|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|5|FVC6|Forced Vital Capacity in 6 Seconds|[?]|UNCONSTRAINED|[?]|CIGAR|[?]|1|atm|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|INTERMEDIATE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|3|Visit_3|40|4|WASHOUT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|6|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|||[?]|1|cd|TARSUS BONE|IPSILATERAL|SUBCORTICAL|RADIOGRAPHY|||Y|ADJUDICATION COMMITTEE|RADIOLOGIST 1|3|Visit_3|40|1|WASHOUT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|7|RAW|Airway Resistance|[?]|SEMI-RECUMBENT|[?]|v/v|[?]|1|MPS U|ETHMOID SINUS|LATERAL|ANTEROPOSTERIOR|MICROBIAL CULTURE, SOLID|Y|||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|4|Visit_4|65|2|SCREENING|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|BOX|[?]|1|ug/L|AORTOPULMONARY WINDOW LYMPH NODE|BILATERAL|ANTEROPOSTERIOR|TRANSCRIPTION-MEDIATED AMPLIFICATION||||SIBLING|RADIOLOGIST|4|Visit_4|65|6|WASHOUT|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|9|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|MdFI|[?]|1|TCID 50/dose|FINGER|CONTRALATERAL|SUPERFICIAL|LIQUID SCINTILLATION COUNTING||Y||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|5|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|10|EVC|Expiratory Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|nm|OBTURATOR EXTERNUS MUSCLE|LEFT|POSTERIOR|LIGHT MICROSCOPY|Y||Y|PARENT|OPHTHALMOLOGIST|5|Visit_5|90|1|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING, LEGS DEPENDENT|[?]|copies/ug|[?]|1|10^7 CFU|ULNA SHAFT|BILATERAL|FRONTAL|TRICHROME STAIN||||CAREGIVER|RADIOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-12-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|2|MIPPP|Percent Predicted MIP|[?]|SEMI-FOWLERS|[?]|mol/mol|[?]|1|APL U/mL|PARS COMPACTA|CONTRALATERAL|VENTRAL|WRIGHT STAIN||||SIBLING|READER 2|1|Visit_1|10|7|FOLLOW-UP|2020-12-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|3|MALEVDES|Malignancy Evidence Description|[?]|SITTING|[?]|GLOBULE|[?]|1|MET|THORACIC SPINE|RIGHT|HIND|SIZE EXCLUSION CHROMATOGRAPHY||||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|SCREENING|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|4|EFFIND|Effusion Indicator|[?]|SUPINE|[?]|lm|[?]|1|hPa|TOENAIL|RIGHT|PARIETO-OCCIPITAL|EPSILOMETER|Y|Y||CLINICAL STUDY SPONSOR|NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-09
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-RECUMBENT|||[?]|1|umol/kg/min|PARS COMPACTA|RIGHT|ANTERIOR|PEAK FLOWMETRY|Y||Y|PARENT|HEMATOLOGIST|3|Visit_3|40|2|SCREENING|2021-01-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|DECUBITUS|[?]|scm|[?]|1|PIXEL|MAXILLA|LEFT|INNER|TONOMETRY||||INDEPENDENT ASSESSOR|RATER|3|Visit_3|40|6|TREATMENT|2021-01-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|7|EXPRELTM|Expiration Relaxation Time|[?]|LATERAL DECUBITUS|||[?]|1|hr/day|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LATERAL|PERIVENTRICULAR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|8|SALKK|Salazar-Knowles Equation, K|[?]|STANDING|||[?]|1|ug/min|GLOBUS PALLIDUS|BILATERAL|APICAL|FLUORIMETRY|Y|Y|Y|GUARDIAN|NEUROLOGIST|4|Visit_4|65|7|WASHOUT|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|9|AWWVOL|Airway Wall Volume|[?]|SITTING, LEGS DEPENDENT|[?]|mL/dL|[?]|1|ug/h|PELVIC LYMPH NODE|CONTRALATERAL|LOWER EXTENSOR SURFACE|DC SHEATH FLOW||||CHILD|READER 1|5|Visit_5|90|4|SCREENING|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|e0258c95-7bcc-4b54-895c-f290a1364b5c|10|RER|Respiratory Exchange Ratio|[?]|STANDING|||[?]|1|OI50|POPLITEAL VEIN|RIGHT|PERIPHERAL|MAGNETIC RESONANCE ELASTOGRAPHY|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|6|TREATMENT|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SEMI-FOWLERS|[?]|mg/kg/dose|[?]|1|Absorbance U|LINGULA OF THE LUNG|LATERAL|OUTER|PHOTOMETRY||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|1|Visit_1|10|7|WASHOUT|2021-01-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|PRONE|[?]|fmol/L|[?]|1|gpELISA unit/mL|CELIAC ARTERY|LEFT|FORE|BRDU CELLULAR PROLIFERATION ASSAY|Y|||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2021-01-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|[?]|ug/cm2|[?]|1|log10 TCID 50/dose|COMMON ILIAC LYMPH NODE|UNILATERAL|UPPER FLEXOR SURFACE|CALCULATION||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|2|Visit_2|25|6|TREATMENT|2021-01-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|4|FIF75|Forced Inspiratory Flow at 75%|[?]|FOWLERS|[?]|mV*min|[?]|1|kg/mol|TIBIALIS POSTERIOR MUSCLE|RIGHT|UPPER|ROMANOWSKY STAIN|Y|||FRIEND|ONCOLOGIST|2|Visit_2|25|3|WASHOUT|2021-01-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mkat|OPHTHALMIC ARTERY|BILATERAL|SUPERFICIAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||Y|INTERVIEWER|MICROSCOPIST 3|3|Visit_3|40|5|TREATMENT|2021-02-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|100 IU/mL|[?]|1|DISK|GREAT SAPHENOUS VEIN|RIGHT|CENTRAL|KINETIC MICROPARTICLE IMMUNOASSAY||||SPOUSE|PHYSIOTHERAPIST|3|Visit_3|40|3|TREATMENT|2021-02-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|7|IVCPP|Percent Predicted IVC|[?]|SEMI-FOWLERS|[?]|nmol/L/h|[?]|1|GPL U/mL|TOOTH|IPSILATERAL|UPPER|DNA MICROARRAY||||VENDOR|READER 1|4|Visit_4|65|3|FOLLOW-UP|2021-03-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|8|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|UNCONSTRAINED|[?]|scm|[?]|1|g/m2|DISTAL RIGHT CORONARY ARTERY CONDUIT|BILATERAL|ANTERIOR|HPLC/IEX||||ADJUDICATOR|ONCOLOGIST|4|Visit_4|65|6|TREATMENT|2021-03-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-01
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|9|MIP|Maximal Inspiratory Pressure|[?]|TRENDELENBURG|||[?]|1|PIPE|LYMPH NODE|LATERAL|DEEP|GC/MS-CI|||Y|INDEPENDENT ASSESSOR|RADIOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|7218f9ae-0119-4633-a8d3-7d98b2ae1671|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|SUPINE|[?]|umol/min|[?]|1|STRIP|POPLITEAL ARTERY BELOW KNEE|RIGHT|UPPER EXTENSOR SURFACE|HPLC/IEX|Y|||DOMESTIC PARTNER|RATER 1|5|Visit_5|90|7|TREATMENT|2021-04-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|10^4/L|[?]|1|umol/kg/min|SCROTUM|CONTRALATERAL|SUPERFICIAL|SIZE EXCLUSION CHROMATOGRAPHY||||DOMESTIC PARTNER|INTERNIST|1|Visit_1|10|3|FOLLOW-UP|2020-05-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|2|DLCOHC|HGB Corrected DLCO|[?]|STANDING|[?]|ELISA unit/dose|[?]|1|nmol|ADDUCTOR LONGUS MUSCLE|IPSILATERAL|VOLAR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||VENDOR|CARDIOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-05-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|3|TLC|Total Lung Capacity|[?]|SUPINE|[?]|anti-Xa IU|[?]|1|ug/kg/min|MENINGES|IPSILATERAL|CENTRAL|PHASE-CONTRAST MRI|Y|||FRIEND|MICROSCOPIST 3|2|Visit_2|25|2|WASHOUT|2020-05-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-13
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|4|IVCPP|Percent Predicted IVC|[?]|SITTING|[?]|mEq|[?]|1|TABLET|CORONARY ARTERY, ANTERIOR DESCENDING|LATERAL|DORSAL|KINYOUN STAIN||||ADJUDICATOR|MICROSCOPIST 3|2|Visit_2|25|5|WASHOUT|2020-05-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-13
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|5|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-RECUMBENT|||[?]|1|cmol|VASTUS MEDIALIS MUSCLE|LEFT|LOWER EXTENSOR SURFACE|NON-CONTACT SPECULAR MICROSCOPY|||Y|NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|3|Visit_3|40|2|TREATMENT|2020-06-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|6|AWWVOL|Airway Wall Volume|[?]|SUPINE|||[?]|1|Bq/uL|UVEA|UNILATERAL|CAUDAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y|Y|HEALTH CARE PROFESSIONAL|RATER 2|3|Visit_3|40|5|SCREENING|2020-06-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|7|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|||[?]|1|aMFI|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|RIGHT|LATERAL|CONTRAST ENHANCED PET SCAN|Y||Y|CAREGIVER|RATER 1|4|Visit_4|65|7|TREATMENT|2020-07-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-04
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|8|TLC|Total Lung Capacity|[?]|DECUBITUS|[?]|DPM|[?]|1|ELISA unit/dose|TEMPOROMANDIBULAR JOINT|LATERAL|LATERAL|IMPULSE OSCILLOMETRY||||CHILD|PATHOLOGIST 2|4|Visit_4|65|4|SCREENING|2020-07-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-04
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|9|FVC|Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|Bq/mg|[?]|1|TCID 50/dose|AORTOPULMONARY WINDOW LYMPH NODE|IPSILATERAL|OUTER|SISH||Y||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|5|Visit_5|90|4|TREATMENT|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|f8c938ff-21c8-4d0b-9335-08d2865543ab|10|PIF|Peak Inspiratory Flow|[?]|PRONE|[?]|MdFI|[?]|1|kPa/L/sec|CEPHALIC VEIN|LEFT|DORSOLATERAL|WRIGHT-GIEMSA STAIN||||CHILD|ADJUDICATOR 3|5|Visit_5|90|2|WASHOUT|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|7176f852-7392-4636-800f-3aad48e93065|1|RV|Residual Volume|[?]|UNCONSTRAINED|[?]|Mile|[?]|1|10^6/hpf|HIP JOINT|CONTRALATERAL|UPPER|MAGNETIC RESONANCE ENTEROGRAPHY||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|1|Visit_1|10|2|FOLLOW-UP|2021-01-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|RE|7176f852-7392-4636-800f-3aad48e93065|2|FEV_PEF|FEV at PEF|[?]|REVERSE TRENDELENBURG|[?]|Absorbance U|[?]|1|Henry|SKULL, BASE|BILATERAL|TIP|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|||PROXY|READER 3|1|Visit_1|10|6|TREATMENT|2021-01-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|RE|7176f852-7392-4636-800f-3aad48e93065|3|FEV1FVC6|FEV1/FVC6|[?]|SEMI-FOWLERS|[?]|keV|[?]|1|nmol/L/min|HEAD AND NECK|RIGHT|OUTER|ELISA|Y|||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|2|Visit_2|25|5|TREATMENT|2021-01-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-12
e|RE|7176f852-7392-4636-800f-3aad48e93065|4|IC|Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|cup eq|[?]|1|/100 WBC|MEDIASTINUM, POSTERIOR|LEFT|VOLAR|IMMUNOCHEMILUMINOMETRIC ASSAY||||SIBLING|RATER 2|2|Visit_2|25|1|TREATMENT|2021-01-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-12
e|RE|7176f852-7392-4636-800f-3aad48e93065|5|PEF|Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|log10 IU/mL|[?]|1|Mile|SUPRAGLOTTIS|LEFT|DISTAL|IMMUNOPRECIPITATION||||PROXY|READER 3|3|Visit_3|40|2|TREATMENT|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|7176f852-7392-4636-800f-3aad48e93065|6|FEF50|Forced Expiratory Flow 50%|[?]|PRONE|[?]|Antibody Unit|[?]|1|nmol/L/min|PREFRONTAL CORTEX|RIGHT|UPPER EXTENSOR SURFACE|TARGETED TRANSCRIPTOME SEQUENCING||||PARENT|READER 1|3|Visit_3|40|3|SCREENING|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|7176f852-7392-4636-800f-3aad48e93065|7|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-FOWLERS|[?]|tuberculin unit|[?]|1|umol/mol|RADIUS SHAFT|LATERAL|PERIVENTRICULAR|IMMUNO-PET SCAN||||SIBLING|MICROSCOPIST 1|4|Visit_4|65|2|FOLLOW-UP|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|7176f852-7392-4636-800f-3aad48e93065|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|||[?]|1|U.CARR|PROXIMAL PHALANX 2 OF THE HAND|LATERAL|PROXIMAL|HPLC-FL|Y||Y|FRIEND|OPHTHALMOLOGIST|4|Visit_4|65|4|TREATMENT|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|7176f852-7392-4636-800f-3aad48e93065|9|RV|Residual Volume|[?]|UNCONSTRAINED|[?]|anti-Xa IU/mL|[?]|1|mg/m2/h|VERTEBRAL ARTERY|RIGHT|LOWER|IRON HEMATOXYLIN STAIN||||INTERVIEWER|RADIOLOGIST 2|5|Visit_5|90|4|TREATMENT|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|7176f852-7392-4636-800f-3aad48e93065|10|FEV1FVC6|FEV1/FVC6|[?]|SITTING|[?]|ug/animal|[?]|1|TAMPON|ETHMOID BONE|IPSILATERAL|OUTER|AGAR DILUTION||Y||STUDY SUBJECT|READER 3|5|Visit_5|90|3|FOLLOW-UP|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|QUASCOMP|Quasi-Static Compliance|[?]|RIGHT LATERAL DECUBITUS|[?]|TAMPON|[?]|1|10^9 CFU/mL|COMMON ILIAC LYMPH NODE|RIGHT|CENTRAL|URANYL ACETATE STAIN||Y||GUARDIAN|ADJUDICATOR 2|1|Visit_1|10|5|TREATMENT|2020-10-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LATERAL DECUBITUS|[?]|/month|[?]|1|Ci/L|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|LATERAL|PERIVENTRICULAR|ANALYTICAL ULTRACENTRIFUGATION||||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|1|Visit_1|10|4|SCREENING|2020-10-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|PRONE|[?]|IU|[?]|1|Log10 ELISA unit/dose|TRICUSPID VALVE ANNULUS|LEFT|LOWER MEDIAL|OLIGO ACGH|Y|||PARENT|ONCOLOGIST 1|2|Visit_2|25|5|SCREENING|2020-10-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|4|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|MPS U|[?]|1|10^5/L|GASTROINTESTINAL SYSTEM|LEFT|VENTROLATERAL|BIOIMPEDANCE SPECTROSCOPY||||FAMILY MEMBER|ONCOLOGIST 1|2|Visit_2|25|5|SCREENING|2020-10-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|5|PNIF|Peak Nasal Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|nm|[?]|1|10^12 IU/L|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|BILATERAL|APICAL|OPTICAL COHERENCE TOMOGRAPHY|Y|||CLINICAL STUDY SPONSOR|OPTOMETRIST|3|Visit_3|40|5|FOLLOW-UP|2020-11-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|pmol/dL|[?]|1|10^7 TCID 50/dose|HAND DIGIT 4|IPSILATERAL|SUPERIOR|DYNAMOMETRY||||GUARDIAN|CARDIOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-11-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|FOWLERS|||[?]|1|10^6 CFU/g|SCAPHOID BONE|IPSILATERAL|CENTRAL|CLOT DETECTION|||Y|PROXY|OPHTHALMOLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|8|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|LOZENGE|[?]|1|STEPS|ELBOW EXTENSOR MUSCLES|CONTRALATERAL|DISTAL|INDIRECT IMMUNOFLUORESCENCE|Y|||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|2|SCREENING|2020-12-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|PRONE|[?]|10^5/hpf|[?]|1|psi|PELVIC BONE|LEFT|DORSAL|APPLANATION TONOMETRY||||STUDY SUBJECT|ADJUDICATOR|5|Visit_5|90|4|SCREENING|2020-12-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|10|IC|Inspiratory Capacity|[?]|SLING|||[?]|1|Enzyme U/m2|IRIS|RIGHT|APICAL|SNELLEN EYE CHART|||Y|PARENT|RADIOLOGIST|5|Visit_5|90|7|TREATMENT|2020-12-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|dB|[?]|1|g/cage/wk|CHIN|BILATERAL|DORSAL|POPULATION SEQUENCING||||CAREGIVER|HEMATOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-10-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|2|TLC|Total Lung Capacity|[?]|FOWLERS|[?]|mmol/L|[?]|1|Henry|BRACHIAL ARTERY|RIGHT|LOWER EXTENSOR SURFACE|SPECULAR MICROSCOPY||||SIGNIFICANT OTHER|ADJUDICATOR 1|1|Visit_1|10|1|WASHOUT|2020-10-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|3|RELSZCHG|Relative Size Change|[?]|SEMI-FOWLERS|[?]|um|[?]|1|/100 WBC|COLON|IPSILATERAL|FRONTAL|LIGHT MICROSCOPY||||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|2|Visit_2|25|3|SCREENING|2020-11-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|||[?]|1|10^9 CFU/mL|RIGHT VENTRICULAR BRANCH|UNILATERAL|OCCIPITAL|LC/MS||Y|Y|GUARDIAN|PEDIATRIC NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2020-11-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|5|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-RECUMBENT|[?]|%/s|[?]|1|L/s|CALCARINE SULCUS|IPSILATERAL|DORSOLATERAL|SINGLE-MOLECULE ARRAY||||ADJUDICATOR|UROLOGIST|3|Visit_3|40|2|WASHOUT|2020-11-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|DECUBITUS|||[?]|1|mL/cage|SKIN AROUND THE MOUTH|LEFT|PROXIMAL|TONOMETRY||Y|Y|ADJUDICATOR|MICROSCOPIST 3|3|Visit_3|40|6|SCREENING|2020-11-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|7|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SLING|[?]|min*mg/mL|[?]|1|uOsm|FOREHEAD|CONTRALATERAL|MEDIAL|SLIT LAMP PHOTOGRAPHY||||INTERVIEWER|CLINICAL PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|8|FEV1SVC|FEV1/SVC|[?]|PRONE|[?]|g|[?]|1|mEq/g|TRACHEOBRONCHIAL TREE|RIGHT|TEMPORAL|REBOUND TONOMETRY||||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|4|Visit_4|65|5|WASHOUT|2020-12-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|9|INTP|Interpretation|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ug/cm2|HAIR|CONTRALATERAL|FRONTAL|IMPEDANCE CONDUCTIVITY|||Y|FRIEND|PATHOLOGIST 2|5|Visit_5|90|5|TREATMENT|2021-01-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|69e41d6b-57f7-48b0-be7a-29fca953f8d9|10|FVC|Forced Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|mm/sec|[?]|1|L/min|SKIN OF THE BENDING JOINT|IPSILATERAL|UPPER FLEXOR SURFACE|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|Y|||STUDY SUBJECT|ENDOCRINOLOGIST|5|Visit_5|90|2|TREATMENT|2021-01-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|SAWVOL|Specific Airway Volume|[?]|DECUBITUS|[?]|nmol/L|[?]|1|mg/animal|RIB 10|BILATERAL|SUPERFICIAL|CONTRAST ENHANCED SPIRAL CT SCAN||||STUDY SUBJECT|RATER|1|Visit_1|10|3|TREATMENT|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|2|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|[?]|bel|[?]|1|hr/day|ADDUCTOR LONGUS MUSCLE|IPSILATERAL|ANTEROPOSTERIOR|PHOROPTER||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|TREATMENT|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|3|PEF|Peak Expiratory Flow|[?]|PRONE|||[?]|1|TUBE|UTERUS|LEFT|DISTAL VOLAR|TWO-COLOR MICROARRAY|Y||Y|FRIEND|UROLOGIST|2|Visit_2|25|3|TREATMENT|2020-12-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|4|PLMBLFLW|Pulmonary Blood Flow|[?]|TRENDELENBURG|[?]|10^3 organisms|[?]|1|amu|FOOT DIGIT 2|LEFT|VENTRAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||INDEPENDENT ASSESSOR|CARDIOLOGIST|2|Visit_2|25|3|WASHOUT|2020-12-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|5|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|mV|[?]|1|10^6 CFU/mL|PAW|RIGHT|MEDIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||ADJUDICATOR|ADJUDICATOR 1|3|Visit_3|40|1|FOLLOW-UP|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|6|FEV6PP|Percent Predicted FEV6|[?]|STANDING, BENT FORWARD|[?]|JDF Unit|[?]|1|U/kg|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LEFT|DORSOLATERAL|MICROPARTICLE ENZYME IMMUNOASSAY||||SPOUSE|PEDIATRIC NEUROLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/day|[?]|1|mL/h|TIBIAL-CRURAL PERIPHERAL ARTERY|UNILATERAL|SUPERFICIAL|PERCUSSION||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|4|Visit_4|65|2|FOLLOW-UP|2021-01-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|DECUBITUS|[?]|Log10 ELISA unit/dose|[?]|1|nL|T10 VERTEBRA|CONTRALATERAL|VENTRAL|TELLER ACUITY CARDS||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|6|TREATMENT|2021-01-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|9|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|Linear ft*LB|[?]|1|deg|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|BILATERAL|MIDLINE|RADIOIMMUNOPRECIPITATION ASSAY|Y|||STUDY SUBJECT|MICROSCOPIST|5|Visit_5|90|3|FOLLOW-UP|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|a38eb4fc-2422-4d4a-a435-58ae9bf42589|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|DECUBITUS|[?]|10^9/dose|[?]|1|mol/mg|SKIN OF THE THIGH|IPSILATERAL|TEMPORAL|WHOLE GENOME SEQUENCING||||ADJUDICATION COMMITTEE|MICROSCOPIST 1|5|Visit_5|90|3|FOLLOW-UP|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|DLCOPP|Percent Predicted DLCO|[?]|DECUBITUS|[?]|/ms|[?]|1|uCi|NAVICULAR BONE|RIGHT|SUPERFICIAL|CONFOCAL MICROSCOPY|Y|||ADJUDICATOR|PEDIATRIC NEUROLOGIST|1|Visit_1|10|5|SCREENING|2020-09-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|Gauss|[?]|1|ug/kg|BULBAR CONJUNCTIVA|IPSILATERAL|NASAL|ICP-MS|Y|Y||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|1|Visit_1|10|7|SCREENING|2020-09-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|3|MEPPP|Percent Predicted MEP|[?]|UNCONSTRAINED|[?]|L/s|[?]|1|mL|DISTAL INTERPHALANGEAL JOINT 2|BILATERAL|ANTEROTEMPORAL|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|||ADJUDICATOR|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-10-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|4|LOBVOL|Lobar Volume|[?]|SITTING|[?]|gMFI|[?]|1|/2000 RBC|PERINEUM|LATERAL|LOWER|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-10-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|5|IVC|Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/L/h|[?]|1|pkat/L|THYROID GLAND, LEFT LOBE|LEFT|DISTAL|IMMUNOCHEMILUMINOMETRIC ASSAY||||DOMESTIC PARTNER|OPHTHALMOLOGIST|3|Visit_3|40|5|TREATMENT|2020-10-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|6|RRS|Total Respiratory System Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|/VF|[?]|1|mmol/mol|FACIAL NERVE|LATERAL|OUTER|TRYPAN BLUE STAIN||||INTERVIEWER|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-10-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|7|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|[?]|CARTRIDGE|[?]|1|APS U|COSTAL CARTILAGE|CONTRALATERAL|LOWER|TEST STRIP||||CAREGIVER|OPHTHALMOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-11-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|8|IC|Inspiratory Capacity|[?]|STANDING|[?]|Bq|[?]|1|10^10/L|TRICUSPID VALVE, SEPTAL CUSP|BILATERAL|UPPER EXTENSOR SURFACE|ENZYMATIC ULTRACENTRIFUGATION||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|4|Visit_4|65|2|SCREENING|2020-11-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|nmol/day|[?]|1|IU/dL|MEDIASTINUM, ANTERIOR|BILATERAL|UPPER|CT SCAN||||PROXY|NEUROLOGIST|5|Visit_5|90|4|WASHOUT|2020-12-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|10|SALKK|Salazar-Knowles Equation, K|[?]|SLING|[?]|10^4/L|[?]|1|rpm|FOOT|IPSILATERAL|UPPER FLEXOR SURFACE|PERCUSSION||Y||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2020-12-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SEMI-FOWLERS|||[?]|1|kBq/uL|ABDUCTOR HALLUCIS MUSCLE|IPSILATERAL|INFERIOR|LYMPHANGIOGRAPHY|||Y|FAMILY MEMBER|ADJUDICATOR 1|1|Visit_1|10|3|TREATMENT|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|2|FRC|Functional Residual Capacity|[?]|FOWLERS|[?]|v/v|[?]|1|mg/L FEU|EYE, ANTERIOR CHAMBER|BILATERAL|VENTRAL|SIZE EXCLUSION CHROMATOGRAPHY||Y||FAMILY MEMBER|RADIOLOGIST 1|1|Visit_1|10|7|TREATMENT|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SLING|[?]|oz|[?]|1|%/min|SKIN OF THE CHIN|CONTRALATERAL|TIP|MYELOPEROXIDASE STAIN||||ADJUDICATION COMMITTEE|MICROSCOPIST|2|Visit_2|25|1|FOLLOW-UP|2021-01-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|Gauss|[?]|1|HOMEOPATHIC DILUTION|NOSE|CONTRALATERAL|FACIAL|ROMANOWSKY STAIN||||FAMILY MEMBER|READER|2|Visit_2|25|3|TREATMENT|2021-01-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|5|EFFVOL|Effusion Volume|[?]|SLING|[?]|10^9 organisms|[?]|1|U/kg/min|COLON, RECTOSIGMOID|CONTRALATERAL|LOWER|ELECTRONEUROGRAPHY||Y||NON-HEALTH CARE PROFESSIONAL|READER|3|Visit_3|40|5|TREATMENT|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING|[?]|nmol/mL/min|[?]|1|kg/cm2|PROXIMAL INTERPHALANGEAL JOINT 3|LATERAL|DISTAL VOLAR|CARDIAC THERMODILUTION|Y|||VENDOR|ADJUDICATOR|3|Visit_3|40|2|WASHOUT|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|7|INFLTIND|Infiltrates Indicator|[?]|STANDING, BENT FORWARD|[?]|Frames/s|[?]|1|g/animal|BUCCAL MUCOSA|LATERAL|INFERIOR|GC/FID||||CAREGIVER|MICROSCOPIST 2|4|Visit_4|65|7|WASHOUT|2021-02-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|8|INFLTIND|Infiltrates Indicator|[?]|SUPINE|[?]|m/sec|[?]|1|10^4 CFU/mL|HAIR FOLLICLE|UNILATERAL|CRANIAL|CELL BASED BIOASSAY||||NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|4|Visit_4|65|4|TREATMENT|2021-02-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING|[?]|10^8/L|[?]|1|Ejaculate U|KIDNEY, LOWER LOBE|RIGHT|ANTEROTEMPORAL|MAMMOGRAPHY||||PARENT|ADJUDICATOR 1|5|Visit_5|90|3|SCREENING|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|10|INFLTIND|Infiltrates Indicator|[?]|TRENDELENBURG|||[?]|1|USP U|MIDBRAIN|IPSILATERAL|MIDLINE|THIN SMEAR|||Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|5|Visit_5|90|1|TREATMENT|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|1|DLCOVA|DLCO/VA|[?]|SITTING|||[?]|1|ug|PROXIMAL PHALANX 4 OF THE HAND|IPSILATERAL|UPPER FLEXOR SURFACE|LAPAROSCOPY||Y|Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|1|Visit_1|10|3|SCREENING|2020-05-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|2|VO2|Oxygen Consumption|[?]|SLING|[?]|mL/beat|[?]|1|mg/cm2|PARS COMPACTA|IPSILATERAL|APICAL|TRANSTHORACIC ECHOCARDIOGRAPHY||||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-05-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|3|FEF2575|Forced Expiratory Flow 25-75%|[?]|UNCONSTRAINED|[?]|kN/cm2|[?]|1|10^7 TCID 50/dose|CEREBRAL SUBCORTEX|IPSILATERAL|PERIVENTRICULAR|FARR ASSAY||||STUDY SUBJECT|ADJUDICATOR 1|2|Visit_2|25|4|SCREENING|2020-06-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|4|FIV1PP|Percent Predicted FIV1|[?]|SLING|||[?]|1|nL|PRIMARY VISUAL CORTEX|LEFT|PERIVENTRICULAR|OPTICAL COHERENCE TOMOGRAPHY||Y|Y|SIBLING|DERMATOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-06-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|UNCONSTRAINED|[?]|vp/dose|[?]|1|nmol BCE/L|OVARIAN FOLLICLE|LEFT|APICAL|LANDOLT RING||Y||INDEPENDENT ASSESSOR|UROLOGIST|3|Visit_3|40|7|TREATMENT|2020-06-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SLING|[?]|nkat/L|[?]|1|mL/kg|ILIOTIBIAL BAND|LATERAL|INTERMEDIATE|MAPH||||FAMILY MEMBER|MICROSCOPIST|3|Visit_3|40|4|TREATMENT|2020-06-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|7|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|U/L|[?]|1|mm|PARASYMPATHETIC GANGLIA|LEFT|ANTEROTEMPORAL|SNP ARRAY||||PROXY|HEMATOLOGIST|4|Visit_4|65|6|SCREENING|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|8|RELSZCHG|Relative Size Change|[?]|DECUBITUS|||[?]|1|INHALATION|POPLITEAL LYMPH NODE|LEFT|PARIETO-OCCIPITAL|JAEGER EYE CHART|||Y|HEALTH CARE PROFESSIONAL|RATER 1|4|Visit_4|65|5|TREATMENT|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|9|FEV1REV|FEV1 Reversibility|[?]|REVERSE TRENDELENBURG|[?]|ft|[?]|1|MBq|EXTRAOCULAR MUSCLE|IPSILATERAL|DISTAL VOLAR|MOUSE PROTECTION ASSAY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|5|Visit_5|90|5|TREATMENT|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|dd518f55-0280-445d-a29f-10f09b21fd53|10|EFFIND|Effusion Indicator|[?]|SUPINE|[?]|pmol/L/h|[?]|1|ug/L FEU|SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|INFERIOR|PALPATION||Y||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|5|Visit_5|90|6|WASHOUT|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|1|MEP|Maximal Expiratory Pressure|[?]|PRONE|[?]|kN/cm2|[?]|1|mEq/uL|AORTIC VALVE, LEFT CORONARY CUSP|RIGHT|DORSAL|LASER CAPTURE MICRODISSECTION||||CHILD|NEUROLOGIST 1|1|Visit_1|10|5|SCREENING|2020-06-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|2|MALIND|Malignancy Indicator|[?]|LEFT LATERAL DECUBITUS|||[?]|1|U/cL|SHOULDER|IPSILATERAL|SUPERIOR|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|||Y|SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|SCREENING|2020-06-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|3|AWVOL|Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/mL/h|[?]|1|lx|PROXIMAL INTERPHALANGEAL JOINT 4|RIGHT|TEMPORAL|RAJI CELL RIA||Y||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-07-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|4|MALEVDES|Malignancy Evidence Description|[?]|SLING|[?]|DAgU|[?]|1|FEU|THORACIC ARTERY|LEFT|LOWER MEDIAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||ADJUDICATOR|HEMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-07-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|5|AWVOL|Airway Volume|[?]|SITTING|||[?]|1|EP U|GLUTEAL MUSCLE|BILATERAL|HIND|DUCTOGRAPHY|Y||Y|INVESTIGATOR|RADIOLOGIST 1|3|Visit_3|40|5|SCREENING|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|6|IVCPP|Percent Predicted IVC|[?]|SUPINE|[?]|/wk|[?]|1|10^3 CFU/g|UMBILICUS|LATERAL|ANTERIOR|IMMUNOFLUORESCENT STAIN||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|3|Visit_3|40|2|TREATMENT|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|7|IVC|Inspiratory Vital Capacity|[?]|PRONE|||[?]|1|deg|MEDIAN NERVE|UNILATERAL|CRANIAL|URANYL ACETATE STAIN|||Y|CHILD|RATER 1|4|Visit_4|65|1|FOLLOW-UP|2020-08-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|8|MIP|Maximal Inspiratory Pressure|[?]|SUPINE|||[?]|1|EU|MID-LAD ARTERY|IPSILATERAL|ROSTRAL|HPLC/MS/MS|||Y|CLINICAL STUDY SPONSOR|INTERNIST|4|Visit_4|65|6|TREATMENT|2020-08-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|9|SAWVOL|Specific Airway Volume|[?]|SEMI-RECUMBENT|[?]|mg/kg/min|[?]|1|uV*sec|MALE REPRODUCTIVE SYSTEM|RIGHT|PERIVENTRICULAR|PLETHYSMOGRAPHY|Y|||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|5|Visit_5|90|5|TREATMENT|2020-09-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|49a972da-dfad-438e-b5bc-26ee6b955a59|10|FEV1SVC|FEV1/SVC|[?]|RIGHT LATERAL DECUBITUS|[?]|ECL unit|[?]|1|/LSQN|UNCINATE PROCESS OF PANCREAS|RIGHT|DEEP|SLIT LAMP PHOTOGRAPHY||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|5|Visit_5|90|6|TREATMENT|2020-09-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|1|AWVOLPP|Percent Predicted Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|/10^5|[?]|1|/500 WBC|ELBOW JOINT|LEFT|LOWER MEDIAL|JAEGER EYE CHART|Y|||CLINICAL STUDY SPONSOR|CARDIOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-11-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|2|RV|Residual Volume|[?]|STANDING|||[?]|1|pt_us|LACRIMAL GLAND|CONTRALATERAL|UPPER FLEXOR SURFACE|IMMUNOASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 3|1|Visit_1|10|3|SCREENING|2020-11-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|3|INTP|Interpretation|[?]|SITTING, LEGS DEPENDENT|[?]|/100 HPFs|[?]|1|pg|PERIURETHRAL REGION|UNILATERAL|POSTERIOR|DUKE INCISION METHOD|Y|||FAMILY MEMBER|MICROSCOPIST 2|2|Visit_2|25|2|TREATMENT|2020-12-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|4|RAW|Airway Resistance|[?]|UNCONSTRAINED|[?]|mN|[?]|1|HOURS|RIB 7|UNILATERAL|UPPER FLEXOR SURFACE|MAPH||||ADJUDICATOR|READER 1|2|Visit_2|25|7|TREATMENT|2020-12-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|5|SGAW|Specific Airway Conductance|[?]|PRONE|[?]|SQU/mL|[?]|1|10^9/g|CAUDATE NUCLEUS|LATERAL|PERIPHERAL|ACRIDINE ORANGE STAIN||Y||CLINICAL RESEARCH COORDINATOR|RATER 2|3|Visit_3|40|3|FOLLOW-UP|2020-12-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|6|ICPP|Percent Predicted Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mg/m2/day|SEBACEOUS GLAND|IPSILATERAL|LOWER|BRDU CELLULAR PROLIFERATION ASSAY|Y||Y|CHILD|OPHTHALMOLOGIST|3|Visit_3|40|7|WASHOUT|2020-12-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|7|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|[?]|pg|[?]|1|U/g Hb|CORNEAL EPITHELIUM|LEFT|LOWER EXTENSOR SURFACE|PELLI-ROBSON EYE CHART||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|TREATMENT|2021-01-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|Gauss|[?]|1|mm2|PROFUNDA FEMORIS VEIN|UNILATERAL|POSTERIOR|ENZYMATIC ULTRACENTRIFUGATION||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|4|Visit_4|65|2|TREATMENT|2021-01-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kg/L|MAXILLARY SINUS|IPSILATERAL|PROXIMAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2021-02-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|502a42a7-2ed6-46b9-9b10-728f849334b6|10|FEV1PP|Percent Predicted FEV1|[?]|STANDING|||[?]|1|Bq/mL|ISCHIAL TUBEROSITY|IPSILATERAL|SURFACE|HEMOCYTOMETRY|Y||Y|NON-HEALTH CARE PROFESSIONAL|RATER 1|5|Visit_5|90|4|SCREENING|2021-02-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|[?]|COAT|[?]|1|um/s|FOOT PHALANX|IPSILATERAL|APICAL|ENDOSCOPY||Y||VENDOR|DERMATOLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|2|INERTANC|Inertance|[?]|TRENDELENBURG|[?]|10^12 IU/L|[?]|1|BE/mL|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|UNILATERAL|CRANIAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|||SPOUSE|ADJUDICATOR 1|1|Visit_1|10|5|FOLLOW-UP|2020-10-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|3|FRCPP|Percent Predicted FRC|[?]|UNCONSTRAINED|||[?]|1|lm|METACARPOPHALANGEAL JOINT 3|IPSILATERAL|LOWER MEDIAL|IN SITU HYBRIDIZATION|Y|Y|Y|ADJUDICATION COMMITTEE|ADJUDICATOR 2|2|Visit_2|25|1|TREATMENT|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|4|MIPPP|Percent Predicted MIP|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|cP|PINEAL GLAND|LEFT|OCCIPITAL|MICROPARTICLE ENZYME IMMUNOASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|2|Visit_2|25|5|WASHOUT|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|5|RRS|Total Respiratory System Resistance|[?]|SUPINE|[?]|L|[?]|1|/mm|THALAMUS|CONTRALATERAL|TIP|NUCLEAR RADIOLOGY|Y|Y||SIBLING|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-11-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|6|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SUPINE|||[?]|1|L/s|INTERTROCHANTERIC REGION|IPSILATERAL|LOWER|HPLC-UV|||Y|NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-11-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|7|INTP|Interpretation|[?]|LATERAL DECUBITUS|[?]|genEq|[?]|1|cm2|ESOPHAGUS, UPPER THIRD|LATERAL|LOWER MEDIAL|HPLC/MS|Y|Y||CAREGIVER|ONCOLOGIST 2|4|Visit_4|65|7|WASHOUT|2020-12-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING, BENT FORWARD|[?]|g/day|[?]|1|uEq|GASTRIC CURVATURE LYMPH NODE|CONTRALATERAL|CENTRAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||STUDY SUBJECT|MICROSCOPIST 1|4|Visit_4|65|2|TREATMENT|2020-12-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|STANDING|[?]|mmol/min/kPa|[?]|1|umol/L/sec|RIB 5|CONTRALATERAL|ROSTRAL|HPLC-UV||||PARENT|ONCOLOGIST|5|Visit_5|90|1|TREATMENT|2021-01-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|10|FIF50|Forced Inspiratory Flow at 50%|[?]|SUPINE|||[?]|1|kg/cm2|LUNG, RIGHT MIDDLE LOBE|IPSILATERAL|DORSOLATERAL|MALDI|Y||Y|SPOUSE|READER 3|5|Visit_5|90|2|TREATMENT|2021-01-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|LATERAL DECUBITUS|[?]|L/min/m2|[?]|1|log10 CFU/g|NASAL CAVITY|RIGHT|UPPER|LASER CAPTURE MICRODISSECTION||Y||PROXY|NEUROLOGIST 2|1|Visit_1|10|1|SCREENING|2020-07-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|2|AWVOL|Airway Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|oz|TIBIO-PERONEAL TRUNK|BILATERAL|FRONTAL|WHOLE GENOME SEQUENCING|Y||Y|FAMILY MEMBER|ONCOLOGIST 1|1|Visit_1|10|4|SCREENING|2020-07-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|DECUBITUS|||[?]|1|ugEq/L|OCULOMOTOR NERVE|UNILATERAL|CRANIAL|PERIPHERAL ANGIOGRAPHY|||Y|FAMILY MEMBER|ADJUDICATOR 3|2|Visit_2|25|6|TREATMENT|2020-07-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|4|FIF75|Forced Inspiratory Flow at 75%|[?]|FOWLERS|||[?]|1|g|WRIST JOINT FLEXOR TENDONS|IPSILATERAL|CAUDAL|ICP-MS|||Y|NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-07-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|5|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|L/L|[?]|1|fmol/g|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|BILATERAL|UPPER FLEXOR SURFACE|ELECTRONEUROGRAPHY||||INVESTIGATOR|FORENSIC PATHOLOGIST|3|Visit_3|40|7|SCREENING|2020-08-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|6|RER|Respiratory Exchange Ratio|[?]|DECUBITUS|||[?]|1|100 IU/mL|ESOPHAGUS, LOWER THIRD|UNILATERAL|TEMPORAL|CELLULOSE TAPE|||Y|INVESTIGATOR|ADJUDICATOR 1|3|Visit_3|40|6|TREATMENT|2020-08-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|7|FEV_PEF|FEV at PEF|[?]|STANDING, BENT FORWARD|[?]|DAYS|[?]|1|fg|PALM|CONTRALATERAL|LOWER FLEXOR SURFACE|CONTRAST ENHANCED PET SCAN|Y|Y||FRIEND|READER 2|4|Visit_4|65|3|TREATMENT|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|8|ERV|Expiratory Reserve Volume|[?]|SEMI-FOWLERS|[?]|kIU|[?]|1|h/wk|POSTERIOR TIBIAL VEIN|LATERAL|ANTEROTEMPORAL|RADIOIMMUNOPRECIPITATION ASSAY||Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|4|Visit_4|65|6|TREATMENT|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|9|SALKK|Salazar-Knowles Equation, K|[?]|STANDING, BENT FORWARD|[?]|PHERESIS UNIT|[?]|1|vg/dose|LYMPH NODE|RIGHT|OUTER|SPECT/CT SCAN||||PARENT|ENDOCRINOLOGIST|5|Visit_5|90|4|SCREENING|2020-10-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|40c048ea-d637-426b-8afe-2da3a6961528|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|LEFT LATERAL DECUBITUS|[?]|MPL U|[?]|1|% INHIBITION|VERTEBRAL COLUMN|IPSILATERAL|DORSOLATERAL|LIQUID SCINTILLATION COUNTING||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|5|Visit_5|90|4|WASHOUT|2020-10-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|PCF|Peak Cough Flow|[?]|STANDING|[?]|Enzyme U/m2|[?]|1|/500 WBC|PAROTID GLAND|IPSILATERAL|PERIPHERAL|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||||INTERVIEWER|ADJUDICATOR 1|1|Visit_1|10|6|SCREENING|2021-01-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|PRONE|[?]|ELISA unit/dose|[?]|1|s/h|CUBOID BONE|BILATERAL|DORSAL|SPECT SCAN||||ADJUDICATOR|NEUROLOGIST 2|1|Visit_1|10|5|TREATMENT|2021-01-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|3|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|TRENDELENBURG|[?]|genEq/mL|[?]|1|MET*h|PUBIC BONE|CONTRALATERAL|ANTEROLATERAL|CLOT DETECTION||||CLINICAL RESEARCH COORDINATOR|OTOLARYNGOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2021-01-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|4|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|[?]|PELLET|[?]|1|mJoule/cm2|INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|DORSAL|PELLI-ROBSON EYE CHART||||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|2|Visit_2|25|6|TREATMENT|2021-01-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|5|EVC|Expiratory Vital Capacity|[?]|SLING|[?]|mmHg*min/L|[?]|1|ELISA unit/dose|ARM SKIN|UNILATERAL|TIP|TEST STRIP|Y|Y||PARENT|MICROSCOPIST 2|3|Visit_3|40|3|TREATMENT|2021-02-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|6|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|TRENDELENBURG|[?]|sec|[?]|1|mCi/kg|ABDOMINAL CAVITY|RIGHT|PERIVENTRICULAR|RADIOIMMUNOPRECIPITATION ASSAY|Y|||CLINICAL RESEARCH COORDINATOR|RATER 1|3|Visit_3|40|4|TREATMENT|2021-02-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|7|FEV1SVC|FEV1/SVC|[?]|TRENDELENBURG|||[?]|1|DPM|ABDUCTOR POLLICIS BREVIS MUSCLE|UNILATERAL|DEEP|ELECTROCHEMILUMINESCENCE|Y|Y|Y|SIGNIFICANT OTHER|MICROSCOPIST|4|Visit_4|65|3|SCREENING|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-RECUMBENT|[?]|mL|[?]|1|foz_br|TIBIA|LATERAL|PERIVENTRICULAR|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|4|Visit_4|65|5|FOLLOW-UP|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|9|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|IU|HEART, LEFT ATRIUM|LEFT|PERIVENTRICULAR|INCISION-INDUCED BLEEDING METHOD|||Y|CHILD|READER 2|5|Visit_5|90|2|TREATMENT|2021-03-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|4d03b209-bd53-47f5-8251-f9fb2074bc38|10|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|v/v|[?]|1|log10 CFU/g|SCAPHOID-CAPITATE JOINT|UNILATERAL|ANTEROTEMPORAL|KINETIC MICROPARTICLE IMMUNOASSAY||||SIBLING|CLINICAL PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|1|RELSZCHG|Relative Size Change|[?]|STANDING|[?]|ug/mol|[?]|1|yd|HEART, LEFT VENTRICULAR WALL|LATERAL|HIND|ANALYTICAL ULTRACENTRIFUGATION||||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|WASHOUT|2020-09-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING|||[?]|1|ug/m2|SUBSCAPULARIS MUSCLE|BILATERAL|SURFACE|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y||Y|CHILD|ONCOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-09-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|3|MIP|Maximal Inspiratory Pressure|[?]|UNCONSTRAINED|[?]|psec|[?]|1|mol/mg|ULNAR ARTERY|IPSILATERAL|POSTERIOR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-10-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|4|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|||[?]|1|mL/animal|JAW|RIGHT|INNER|DYNAMOMETRY|Y||Y|STUDY SUBJECT|DERMATOLOGIST|2|Visit_2|25|3|TREATMENT|2020-10-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|5|FIVC|Forced Inspiratory Vital Capacity|[?]|SLING|[?]|mmHg*min/L|[?]|1|RNA copies/mL|ABDOMINAL CAVITY|CONTRALATERAL|PERIVENTRICULAR|MODIFIED ACID FAST STAIN||||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-10-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|6|AWVOLPP|Percent Predicted Airway Volume|[?]|SLING|||[?]|1|10^7 CFU|CELIAC ARTERY|BILATERAL|FACIAL|TRIPLE-PHASE SPIRAL CT SCAN|||Y|INTERVIEWER|ADJUDICATOR 2|3|Visit_3|40|6|TREATMENT|2020-10-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|7|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|mg/min|[?]|1|g/cm2|METACARPOPHALANGEAL JOINT 5|LEFT|LOWER FLEXOR SURFACE|MRI|Y|||NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|4|Visit_4|65|4|TREATMENT|2020-11-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|8|RER|Respiratory Exchange Ratio|[?]|STANDING|[?]|MnFI|[?]|1|mU|PERICARDIAL LYMPH NODE|LEFT|LOWER|SLIT LAMP PHOTOGRAPHY|Y|Y||INVESTIGATOR|RATER 1|4|Visit_4|65|1|WASHOUT|2020-11-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|9|QUASCOMP|Quasi-Static Compliance|[?]|TRENDELENBURG|[?]|OD Unit|[?]|1|fmol/L/sec|SOFT TISSUE|RIGHT|PROXIMAL|OLIGO ACGH||Y||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|5|Visit_5|90|3|TREATMENT|2020-12-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|35f01eda-1acb-4700-8285-c8cd4b69b524|10|GAW|Airway Conductance|[?]|STANDING|[?]|dpm/0.5 mL|[?]|1|nmol/mL/min|SKIN OF THE FINGER|UNILATERAL|HIND|PAP STAIN||Y||CLINICAL STUDY SPONSOR|READER 3|5|Visit_5|90|2|FOLLOW-UP|2020-12-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|||[?]|1|/200 HPFs|HYOID BONE|UNILATERAL|VOLAR|MICROARRAY|||Y|SIGNIFICANT OTHER|ADJUDICATOR 2|1|Visit_1|10|2|FOLLOW-UP|2020-11-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|2|AWVOLPP|Percent Predicted Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|EVENTS|[?]|1|mol/mL|BRACHIALIS MUSCLE|LEFT|CRANIAL|SANGER SEQUENCING||||CLINICAL STUDY SPONSOR|HEMATOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-11-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|SUPINE|[?]|10^3 organisms|[?]|1|mL/kg|ABDUCTOR DIGITI QUINTI MUSCLE|CONTRALATERAL|LATERAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|||HEALTH CARE PROFESSIONAL|READER|2|Visit_2|25|6|TREATMENT|2020-11-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|4|QUASCOMP|Quasi-Static Compliance|[?]|SITTING|[?]|/sec|[?]|1|CCID 50/mL|ANTRUM PYLORI|LEFT|LATERAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|Y||HEALTH CARE PROFESSIONAL|UROLOGIST|2|Visit_2|25|6|TREATMENT|2020-11-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|5|RAWPP|Percent Predicted Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|ukat|[?]|1|g/g|TRICUSPID VALVE, ANTERIOR CUSP|UNILATERAL|LOWER MEDIAL|DIFFUSION WEIGHTED MRI||Y||INTERVIEWER|ADJUDICATOR 3|3|Visit_3|40|3|WASHOUT|2020-12-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|6|INFLTIND|Infiltrates Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|RFU|[?]|1|mEq/day|PENIS, BODY|UNILATERAL|DISTAL|ACRIDINE ORANGE STAIN|Y|||CLINICAL RESEARCH ASSOCIATE|RATER 1|3|Visit_3|40|3|TREATMENT|2020-12-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|7|RAW|Airway Resistance|[?]|SLING|[?]|atm|[?]|1|CAPLET|DISTANT LYMPH NODE|LATERAL|DORSAL|LYMPHANGIOGRAPHY||||PROXY|NEUROLOGIST|4|Visit_4|65|6|TREATMENT|2020-12-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|8|FEV1REV|FEV1 Reversibility|[?]|PRONE|[?]|Watt|[?]|1|mg/animal|BLADDER, FUNDUS|LEFT|APICAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|Y||VENDOR|PATHOLOGIST|4|Visit_4|65|3|WASHOUT|2020-12-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|9|DLCOVA|DLCO/VA|[?]|SUPINE|[?]|mg/kg/h|[?]|1|pmol|LIVER LOBE|BILATERAL|BASAL|MALDI-TOF||||SPOUSE|MICROSCOPIST 2|5|Visit_5|90|2|TREATMENT|2021-01-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|9df97277-7d07-4020-bae0-dfa982f21c8d|10|ERVPP|Percent Predicted ERV|[?]|SUPINE|[?]|g/m2|[?]|1|umol/L/sec|INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|LOWER FLEXOR SURFACE|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|Y|||DOMESTIC PARTNER|READER|5|Visit_5|90|3|TREATMENT|2021-01-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|1|FEV1PP|Percent Predicted FEV1|[?]|SITTING|||[?]|1|Pack Year|PORTACAVAL LYMPH NODE|IPSILATERAL|DORSAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y|Y|PARENT|ONCOLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|2|OXYPULSE|Oxygen Pulse|[?]|SEMI-RECUMBENT|[?]|titer|[?]|1|deg|COLON, RECTOSIGMOID|LEFT|INNER|SICKLE CELL SOLUBILITY TEST||||STUDY SUBJECT|MICROSCOPIST 3|1|Visit_1|10|1|TREATMENT|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|3|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|ug/h|[?]|1|mL/m2/min|URETHRA, ANTERIOR|BILATERAL|VENTROLATERAL|SPIROMETRY||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|2|Visit_2|25|1|TREATMENT|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|4|PEF|Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|dpm/100mg|[?]|1|dB|FOREHEAD|UNILATERAL|INFERIOR|FISH||||GUARDIAN|FORENSIC PATHOLOGIST|2|Visit_2|25|3|SCREENING|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|5|ELSTNCE|Elastance|[?]|SITTING|[?]|mmol/kg|[?]|1|kHz|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|RIGHT|ANTERIOR|FARR ASSAY||||ADJUDICATOR|MICROSCOPIST 2|3|Visit_3|40|3|TREATMENT|2020-11-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|[?]|IU/kg|[?]|1|ug/m2|MEDIAN BASILIC VEIN|BILATERAL|BASAL|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y||INDEPENDENT ASSESSOR|RATER|3|Visit_3|40|6|SCREENING|2020-11-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|7|FEV3PP|Percent Predicted FEV3|[?]|SITTING, LEGS DEPENDENT|[?]|10^3 RNA copies/mL|[?]|1|ft3|CEREBRAL VEIN|CONTRALATERAL|INTERMEDIATE|DISK DIFFUSION||||INVESTIGATOR|READER 2|4|Visit_4|65|1|FOLLOW-UP|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|8|SAWVOL|Specific Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|FINGERTIP UNIT|MEDIASTINUM|BILATERAL|DISTAL VOLAR|FUNCTIONAL MRI|Y||Y|STUDY SUBJECT|MICROSCOPIST 1|4|Visit_4|65|7|TREATMENT|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|9|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|U/10^12 RBC|[?]|1|log EID 50/dose|ISCHIUM|LEFT|TIP|EEG||Y||ADJUDICATOR|RADIOLOGIST 2|5|Visit_5|90|1|WASHOUT|2020-12-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|d1b522d5-557a-4361-a9da-292aa601fbc3|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|TRENDELENBURG|||[?]|1|/day|ABDOMINAL LYMPH NODE|LEFT|SUPERFICIAL|SLIT LAMP PHOTOGRAPHY|||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|5|Visit_5|90|1|TREATMENT|2020-12-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|LATERAL DECUBITUS|[?]|cmHg|[?]|1|ug/m2/h|SUPRATENTORIAL BRAIN|RIGHT|ANTEROPOSTERIOR|IRON HEMATOXYLIN STAIN|Y|||PARENT|UROLOGIST|1|Visit_1|10|6|TREATMENT|2020-07-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|2|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SITTING, LEGS DEPENDENT|[?]|GPL U/mL|[?]|1|ugEq|ENDOCARDIUM|UNILATERAL|PROXIMAL VOLAR|ELECTROGASTROGRAPHY||||PARENT|ONCOLOGIST 2|1|Visit_1|10|1|WASHOUT|2020-07-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|3|SRAW|Specific Airway Resistance|[?]|STANDING|[?]|Newton|[?]|1|mg|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|CONTRALATERAL|PROXIMAL|FLUORIMETRY||Y||NON-HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|1|WASHOUT|2020-08-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|4|RRS|Total Respiratory System Resistance|[?]|LATERAL DECUBITUS|[?]|mL/s/m2|[?]|1|CUP|GREAT VESSELS|RIGHT|MIDLINE|MEDIASTINOSCOPY|Y|||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|2|Visit_2|25|4|SCREENING|2020-08-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|5|AWWVOL|Airway Wall Volume|[?]|LATERAL DECUBITUS|[?]|IU/mL|[?]|1|ppth|LUNG, HILUM|BILATERAL|DISTAL VOLAR|IMMUNE REPERTOIRE DEEP SEQUENCING||||SIBLING|MICROSCOPIST|3|Visit_3|40|1|FOLLOW-UP|2020-08-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|6|SVC|Slow Vital Capacity|[?]|STANDING|[?]|IU/g Hb|[?]|1|SACHET|FEMALE GENITALIA|LEFT|INTERMEDIATE|U-HPLC/MS/MS||||FAMILY MEMBER|DERMATOLOGIST|3|Visit_3|40|1|TREATMENT|2020-08-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|7|GAW|Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|10^9 CFU/g|[?]|1|ug|ORAL CAVITY|UNILATERAL|CAUDAL|PAP STAIN||||SIBLING|INTERNIST|4|Visit_4|65|2|FOLLOW-UP|2020-09-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|8|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|kcal|[?]|1|SUPPOSITORY|AXILLARY LYMPH NODE LEVEL III|LATERAL|VOLAR|HPLC/MS/MS||||CHILD|READER 1|4|Visit_4|65|4|WASHOUT|2020-09-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|9|RER|Respiratory Exchange Ratio|[?]|TRENDELENBURG|||[?]|1|LENS|SKIN OF THE INFRASCAPULAR REGION|UNILATERAL|TEMPORAL|RADIAL IMMUNODIFFUSION||Y|Y|FAMILY MEMBER|MICROSCOPIST|5|Visit_5|90|1|TREATMENT|2020-10-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|10|TSUHYS|Tissue Hysteresivity|[?]|TRENDELENBURG|[?]|ms/mmHg|[?]|1|HOURS|HEART, RIGHT VENTRICULAR WALL|BILATERAL|CRANIAL|CALIPER MEASUREMENT METHOD||Y||FAMILY MEMBER|MICROSCOPIST 2|5|Visit_5|90|5|WASHOUT|2020-10-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|10^6 organisms/g|[?]|1|kg/cm|VENOUS SINUS|RIGHT|PROXIMAL VOLAR|WHOLE TRANSCRIPTOME SEQUENCING||||INVESTIGATOR|PHYSIOTHERAPIST|1|Visit_1|10|6|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|TRENDELENBURG|[?]|Pack Year|[?]|1|PIPE|HEART|IPSILATERAL|FACIAL|DUKE INCISION METHOD||||VENDOR|PATHOLOGIST|1|Visit_1|10|1|SCREENING|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-RECUMBENT|[?]|mJoule/cm2|[?]|1|log10 PFU|ANKLE JOINT|LATERAL|ROSTRAL|IMMUNOFIXATION ELECTROPHORESIS||||DOMESTIC PARTNER|PATHOLOGIST|2|Visit_2|25|6|SCREENING|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|4|SRAW|Specific Airway Resistance|[?]|SUPINE|||[?]|1|HOURS|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|RIGHT|VOLAR|PANENDOSCOPY|Y||Y|INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|4|SCREENING|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|LATERAL DECUBITUS|[?]|cmH2O*s/mL|[?]|1|ug/dL|PROXIMAL PHALANX 1 OF THE HAND|UNILATERAL|INFERIOR|AGAR DILUTION|Y|||NON-HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|1|SCREENING|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|6|FIFMAXPP|Percent Predicted FIFmax|[?]|TRENDELENBURG|[?]|kDa|[?]|1|pkat|SCROTUM|BILATERAL|APICAL|ELECTRICAL IMPEDANCE MYOGRAPHY||||ADJUDICATION COMMITTEE|MICROSCOPIST 2|3|Visit_3|40|7|FOLLOW-UP|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|7|SGAW|Specific Airway Conductance|[?]|DECUBITUS|[?]|mg/kg/min|[?]|1|DRUM|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|BILATERAL|VOLAR|ULTRASONOGRAPHIC ELASTOGRAPHY||Y||PROXY|MICROSCOPIST 2|4|Visit_4|65|7|SCREENING|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|8|PLMXRS|Pulmonary Reactance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|m/sec2|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|POSTERIOR|NUCLEIC ACID AMPLIFICATION TEST|Y||Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|4|Visit_4|65|1|SCREENING|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|9|FIF25|Forced Inspiratory Flow at 25%|[?]|SUPINE|[?]|P|[?]|1|damol/L|GASTROINTESTINAL SYSTEM|UNILATERAL|DISTAL|TRICHROME STAIN||Y||SIBLING|MICROSCOPIST 3|5|Visit_5|90|4|TREATMENT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|da2d0844-3608-4927-9103-cb7c52dd2c96|10|DLCOVA|DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|/10^3|[?]|1|deg|ESOPHAGUS, UPPER THIRD|LATERAL|TEMPORAL|MAGNETIC RESONANCE ENTEROGRAPHY||Y||FRIEND|READER 1|5|Visit_5|90|4|FOLLOW-UP|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|PRONE|||[?]|1|log10 copies/mL|PERIPHERAL NERVE|LATERAL|PERIVENTRICULAR|LAPAROSCOPY|||Y|ADJUDICATOR|PATHOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-12-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|2|FRC|Functional Residual Capacity|[?]|SUPINE|||[?]|1|BU/mL|METACARPAL BONE 3|LEFT|NASAL|SLOAN LETTER EYE CHART 100%||Y|Y|PROXY|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-12-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|pmol|[?]|1|mg/mol|BONE|RIGHT|LOWER FLEXOR SURFACE|TRANSVAGINAL ULTRASOUND||Y||INTERVIEWER|RATER 1|2|Visit_2|25|5|TREATMENT|2020-12-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|4|ALVVOL|Alveolar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ng/dL|BRAIN, PERIVENTRICULAR REGION|CONTRALATERAL|ANTERIOR|HEMAGGLUTINATION ASSAY|Y|Y|Y|VENDOR|READER 1|2|Visit_2|25|2|SCREENING|2020-12-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|5|IC|Inspiratory Capacity|[?]|UNCONSTRAINED|[?]|mL/mmHg|[?]|1|nkat|ABDOMINAL CAVITY|BILATERAL|PARIETO-OCCIPITAL|INTERRUPTER TECHNIQUE|Y|||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|1|WASHOUT|2021-01-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|6|IVC|Inspiratory Vital Capacity|[?]|SLING|[?]|cmol/L|[?]|1|anti-Xa IU/mL|LEFT VENTRICULAR APEX SEGMENT|IPSILATERAL|LATERAL|SLIT LAMP||||DOMESTIC PARTNER|PATHOLOGIST 2|3|Visit_3|40|4|TREATMENT|2021-01-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|7|SVC|Slow Vital Capacity|[?]|DECUBITUS|[?]|g/animal/day|[?]|1|NEBULE|INTERNAL MAMMARY ARTERY|CONTRALATERAL|DEEP|WESTERGREN||||HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-01-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|8|FEV1FVC|FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|KIT|[?]|1|mL/h|ADDUCTOR POLLICIS MUSCLE|CONTRALATERAL|LOWER MEDIAL|TEST STRIP||||CLINICAL STUDY SPONSOR|RADIOLOGIST 2|4|Visit_4|65|3|SCREENING|2021-01-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|9|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-FOWLERS|[?]|kg/cm2|[?]|1|ft2|AXILLARY LYMPH NODE LEVEL II|IPSILATERAL|CAUDAL|HEMOCYTOMETRY||||SPOUSE|ENDOCRINOLOGIST|5|Visit_5|90|7|TREATMENT|2021-02-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|30b6f8a7-4512-462d-a162-45c3dad853e5|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|DECUBITUS|||[?]|1|BAU|JOINT|LATERAL|DORSAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|||Y|VENDOR|RADIOLOGIST 2|5|Visit_5|90|1|FOLLOW-UP|2021-02-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|amp|[?]|1|IU/mg|SKIN OF THE BACK|UNILATERAL|ANTEROMEDIAL|MICROBIAL CONCENTRATION||||SIBLING|READER 1|1|Visit_1|10|2|TREATMENT|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|||[?]|1|Frames/s|PARAPHARYNGEAL LYMPH NODE|IPSILATERAL|LOWER EXTENSOR SURFACE|EEG|||Y|CLINICAL RESEARCH COORDINATOR|RATER 1|1|Visit_1|10|2|FOLLOW-UP|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|3|EVC|Expiratory Vital Capacity|[?]|PRONE|[?]|mm/2h|[?]|1|mL/m2/min|FOREBRAIN|CONTRALATERAL|BASAL|THICK SMEAR||Y||INVESTIGATOR|ADJUDICATOR 1|2|Visit_2|25|7|TREATMENT|2020-11-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|4|FEV1PP|Percent Predicted FEV1|[?]|PRONE|[?]|cmH2O*s2/mL|[?]|1|mMU/mL|PALM|LEFT|DORSAL|MICROBIAL CULTURE, LIQUID||||DOMESTIC PARTNER|ONCOLOGIST|2|Visit_2|25|2|TREATMENT|2020-11-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|||[?]|1|10^9 organisms|PROCERUS MUSCLE|CONTRALATERAL|BASAL|ULTRASONOGRAPHIC ELASTOGRAPHY|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR|3|Visit_3|40|4|TREATMENT|2020-12-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|6|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|PRONE|[?]|mg|[?]|1|umol/min|TUNICA INTIMA|CONTRALATERAL|VENTRAL|PHOTOGRAPHY||||INVESTIGATOR|CLINICAL PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|7|FEV1FVC|FEV1/FVC|[?]|STANDING, BENT FORWARD|[?]|AgU/mL|[?]|1|ugEq/L|INFERIOR PUBIC RAMUS|UNILATERAL|PERIPHERAL|POTENTIOMETRY||||PROXY|RATER 2|4|Visit_4|65|4|TREATMENT|2021-01-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|8|RELSZCHG|Relative Size Change|[?]|SITTING, LEGS DEPENDENT|[?]|ukat/L|[?]|1|usec|METACARPAL BONE 4|RIGHT|MIDLINE|PUPILLOMETRY|Y|||SIBLING|INTERNIST|4|Visit_4|65|2|FOLLOW-UP|2021-01-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|||[?]|1|um2|MESENTERIC ARTERY|LATERAL|LOWER EXTENSOR SURFACE|ULTRASOUND|||Y|PROXY|UROLOGIST|5|Visit_5|90|1|FOLLOW-UP|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|1a3808b9-6004-4133-8f59-49905d04655e|10|RAWPP|Percent Predicted Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|%|[?]|1|g/U|LESSER TROCHANTER|LEFT|PARIETO-OCCIPITAL|PET/SPECT SCAN||||SPOUSE|RADIOLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|mEq/g|[?]|1|U/m2/min|THIRD POSTEROLATERAL DESCENDING ARTERY|LEFT|SUPERFICIAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|1|TREATMENT|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|U/10^12 RBC|[?]|1|%(v/v)|LIVER, CAUDATE LOBE|IPSILATERAL|DEEP|IVY INCISION METHOD|Y|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|1|Visit_1|10|3|FOLLOW-UP|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|3|TLC|Total Lung Capacity|[?]|SLING|[?]|ks|[?]|1|PACKAGE|NASAL SEPTUM|LEFT|LOWER|IVY INCISION METHOD||||FRIEND|UROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|UNCONSTRAINED|[?]|uV|[?]|1|ug/m2/min|AMYGDALA|RIGHT|DEEP|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||||CHILD|CARDIOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|5|FEF2575P|Percent Predicted FEF25-75|[?]|LATERAL DECUBITUS|[?]|NFIU|[?]|1|nmol BCE/nmol|ESOPHAGUS, ABDOMINAL|BILATERAL|UPPER FLEXOR SURFACE|CELLULAR PROLIFERATION ASSAY|Y|||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|TREATMENT|2021-02-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|6|SRAW|Specific Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|10^4 CFU|[?]|1|AU/mL|DISTAL CIRCUMFLEX ARTERY|CONTRALATERAL|APICAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||||SIGNIFICANT OTHER|READER 2|3|Visit_3|40|1|SCREENING|2021-02-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|7|FEV3PP|Percent Predicted FEV3|[?]|UNCONSTRAINED|[?]|log10 CFU/g|[?]|1|log10 IU/mL|NUCLEUS ACCUMBENS|UNILATERAL|TIP|CONTRAST ENHANCED MRI||||CAREGIVER|RADIOLOGIST 2|4|Visit_4|65|2|SCREENING|2021-03-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|8|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|usec|ELBOW FLEXOR MUSCLES|BILATERAL|LOWER EXTENSOR SURFACE|SNELLEN EYE CHART|||Y|INDEPENDENT ASSESSOR|OPHTHALMOLOGIST|4|Visit_4|65|4|SCREENING|2021-03-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|LATERAL DECUBITUS|||[?]|1|mmol/L|PORTAL LYMPH NODE|LATERAL|ANTEROPOSTERIOR|DARK FIELD MICROSCOPY|||Y|FAMILY MEMBER|OPHTHALMOLOGIST|5|Visit_5|90|6|SCREENING|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|5c91894d-c756-4ade-9fc4-2a64d4acc53f|10|PLMBLFLW|Pulmonary Blood Flow|[?]|LEFT LATERAL DECUBITUS|||[?]|1|Ci/g|RENAL ARTERY|LEFT|CRANIAL|FREEZING POINT DEPRESSION|||Y|CLINICAL RESEARCH ASSOCIATE|READER 2|5|Visit_5|90|7|WASHOUT|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|FEF2575P|Percent Predicted FEF25-75|[?]|SUPINE|[?]|mU/g|[?]|1|/cmH2O|LATERAL SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|UPPER|GC/MS-EI||||PARENT|RATER 2|1|Visit_1|10|6|FOLLOW-UP|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|2|AWWVOL|Airway Wall Volume|[?]|LATERAL DECUBITUS|[?]|ugEq/L|[?]|1|cm/min|PREPUTIAL GLAND|IPSILATERAL|INFERIOR|X-RAY FLUORESCENCE SPECTROMETRY|Y|||VENDOR|MICROSCOPIST 1|1|Visit_1|10|7|TREATMENT|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|3|FIV1PP|Percent Predicted FIV1|[?]|FOWLERS|[?]|cP|[?]|1|10^6 organisms/mL|INTERPHALANGEAL THUMB JOINT|IPSILATERAL|VENTROLATERAL|NUCLEIC ACID BASED METHOD||Y||ADJUDICATION COMMITTEE|READER 2|2|Visit_2|25|2|FOLLOW-UP|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|4|SALKK|Salazar-Knowles Equation, K|[?]|SLING|[?]|Tbsp|[?]|1|PFU/mL|FAT PAD|IPSILATERAL|SUBCORTICAL|AUSCULTATION||||INTERVIEWER|PATHOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SUPINE|[?]|U.CARR|[?]|1|g/cage/wk|SKIN OF THE INGUINAL REGION|BILATERAL|DORSOLATERAL|CISH||||PROXY|CARDIOLOGIST|3|Visit_3|40|1|WASHOUT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|6|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-FOWLERS|[?]|uSiemens|[?]|1|/kg|HIP JOINT|CONTRALATERAL|PROXIMAL VOLAR|RAJI CELL EIA|Y|||VENDOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|7|MEP|Maximal Expiratory Pressure|[?]|PRONE|[?]|10^6/L|[?]|1|mg/m2|GLOSSOPHARYNGEAL NERVE|LEFT|PARIETO-OCCIPITAL|POTENTIOMETRY||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-09-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|gMFI|[?]|1|U/L|ORBIT|BILATERAL|NASAL|TOTAL BODY RADIOGRAPHY||||CHILD|ENDOCRINOLOGIST|4|Visit_4|65|2|SCREENING|2020-09-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|9|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|nmol/L/h|[?]|1|IU/day|TESTIS|RIGHT|TIP|RADIOGRAPHY||||SPOUSE|READER 2|5|Visit_5|90|4|WASHOUT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|10|AWWVOL|Airway Wall Volume|[?]|LEFT LATERAL DECUBITUS|[?]|nmol|[?]|1|ms2|SCAPHOID-LUNATE JOINT|UNILATERAL|UPPER EXTENSOR SURFACE|LASER CAPTURE MICRODISSECTION||||INTERVIEWER|OPTOMETRIST|5|Visit_5|90|6|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING|[?]|/LSQN|[?]|1|mPa|CINGULATE CORTEX|BILATERAL|VENTROLATERAL|IMMUNOCHEMILUMINOMETRIC ASSAY||||ADJUDICATOR|RADIOLOGIST 2|1|Visit_1|10|7|SCREENING|2020-09-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|2|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|mAmp|[?]|1|nmol/day|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LEFT|DEEP|JAEGER EYE CHART||Y||CLINICAL STUDY SPONSOR|HEMATOLOGIST|1|Visit_1|10|5|WASHOUT|2020-09-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|3|FIO2|Fraction of Inspired Oxygen|[?]|LEFT LATERAL DECUBITUS|[?]|oz|[?]|1|ohm|HEART, LEFT VENTRICULAR WALL|UNILATERAL|UPPER FLEXOR SURFACE|WRIGHT STAIN||||ADJUDICATION COMMITTEE|ADJUDICATOR|2|Visit_2|25|6|SCREENING|2020-09-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|4|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|[?]|10^6 CFU|[?]|1|um2|ANASTOMOSIS|LATERAL|ANTERIOR|IMMUNORADIOMETRIC ASSAY||Y||DOMESTIC PARTNER|PHYSIOTHERAPIST|2|Visit_2|25|3|TREATMENT|2020-09-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|5|EVC|Expiratory Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|tsp|URETHRA, PROSTATIC|UNILATERAL|INTERMEDIATE|KINYOUN STAIN|||Y|STUDY SUBJECT|NEUROLOGIST 1|3|Visit_3|40|1|FOLLOW-UP|2020-10-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|6|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-FOWLERS|[?]|m3|[?]|1|mEq/L|INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL|ANTEROPOSTERIOR|PERFUSION MRI||||INTERVIEWER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|6|TREATMENT|2020-10-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|7|LOBVOLPP|Percent Predicted Lobar Volume|[?]|PRONE|||[?]|1|GLOBULE|FACIAL BONE|RIGHT|MEDIAL|TOTAL BODY RADIOGRAPHY|Y|Y|Y|PROXY|ENDOCRINOLOGIST|4|Visit_4|65|3|WASHOUT|2020-11-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SLING|[?]|JDF Unit|[?]|1|10^9/dose|ABDUCTOR POLLICIS BREVIS MUSCLE|BILATERAL|DORSOLATERAL|DXA SCAN||||PARENT|OPHTHALMOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-11-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|9|DLCOPP|Percent Predicted DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|mL/m2/h|[?]|1|10^6/hpf|HINDLIMB|LATERAL|PARIETO-OCCIPITAL|CYSTOSCOPY||Y||CAREGIVER|NEUROLOGIST 1|5|Visit_5|90|3|SCREENING|2020-12-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|10|RVPP|Percent Predicted Residual Volume|[?]|SEMI-FOWLERS|||[?]|1|pmol/L|DUODENUM|RIGHT|PROXIMAL|MS/MS|Y|Y|Y|CHILD|ONCOLOGIST|5|Visit_5|90|6|WASHOUT|2020-12-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|PNEUMIND|Pneumonia Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|PFU/animal|[?]|1|uU/dL|RECTOSIGMOID JUNCTION|IPSILATERAL|SUPERIOR|SPIRAL CT||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|1|Visit_1|10|3|WASHOUT|2020-06-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|DECUBITUS|[?]|Torr|[?]|1|nmol|COLON, TRANSVERSE|LATERAL|SUPERIOR|STRESS ECHOCARDIOGRAPHY|Y|||CLINICAL RESEARCH ASSOCIATE|READER 3|1|Visit_1|10|2|FOLLOW-UP|2020-06-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|3|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|TRENDELENBURG|||[?]|1|msec|HEAD|BILATERAL|MEDIAL|IMMUNOPRECIPITATION|Y||Y|CLINICAL STUDY SPONSOR|RADIOLOGIST|2|Visit_2|25|4|SCREENING|2020-06-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|4|PCF|Peak Cough Flow|[?]|SLING|[?]|/wk|[?]|1|ft3|ARTERY|IPSILATERAL|LATERAL|SANGER SEQUENCING||||CLINICAL STUDY SPONSOR|HEMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|5|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|nm|[?]|1|mL/animal/wk|COSTOCHONDRAL JOINT 1|RIGHT|CENTRAL|INDIA INK STAIN|Y|||SIGNIFICANT OTHER|PATHOLOGIST 1|3|Visit_3|40|1|SCREENING|2020-07-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING|||[?]|1|in2|THIRD POSTEROLATERAL DESCENDING ARTERY|BILATERAL|ANTEROPOSTERIOR|DISK DIFFUSION|||Y|GUARDIAN|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|7|ELSTNCE|Elastance|[?]|STANDING, BENT FORWARD|||[?]|1|uL/mL|TRACHEOBRONCHIAL TREE|RIGHT|ANTEROPOSTERIOR|MAGNETIC RESONANCE ENTEROGRAPHY|||Y|FAMILY MEMBER|ADJUDICATOR 2|4|Visit_4|65|1|SCREENING|2020-08-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|8|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|uL|[?]|1|g/animal|GASTROCNEMIUS MUSCLE, LATERAL HEAD|LEFT|ROSTRAL|THICK SMEAR||||CAREGIVER|ADJUDICATOR 3|4|Visit_4|65|2|WASHOUT|2020-08-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|9|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|[?]|Gy/min|[?]|1|um/s|VULVOVAGINAL REGION|UNILATERAL|UPPER EXTENSOR SURFACE|SCINTIGRAPHY|Y|||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|TREATMENT|2020-08-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|10|SAWVOL|Specific Airway Volume|[?]|SLING|[?]|Mile|[?]|1|ms2|EPIGASTRIC REGION|IPSILATERAL|NASAL|CELLULAR PROLIFERATION ASSAY||||CAREGIVER|ONCOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-08-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|1|FEV3FVC|FEV3/FVC|[?]|SITTING|||[?]|1|RNA copies/mL|RADIAL ARTERY|IPSILATERAL|PROXIMAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-06-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|2|FIV1PP|Percent Predicted FIV1|[?]|FOWLERS|||[?]|1|mmol/s|SKIN OF THE BACK|RIGHT|ANTEROLATERAL|DIGITAL PCR|Y||Y|INDEPENDENT ASSESSOR|PATHOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-06-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|3|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING|[?]|umol/L/min|[?]|1|um/day|PALPEBRAL CONJUNCTIVA|RIGHT|POSTERIOR|AGAR DILUTION||||FAMILY MEMBER|READER 3|2|Visit_2|25|2|TREATMENT|2020-07-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uL|CANINE TOOTH|BILATERAL|PROXIMAL VOLAR|WHOLE TRANSCRIPTOME SEQUENCING|Y|Y|Y|INVESTIGATOR|MICROSCOPIST 2|2|Visit_2|25|7|TREATMENT|2020-07-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|5|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|TRENDELENBURG|[?]|ug/mol|[?]|1|Newton|PALATE|LEFT|VENTRAL|HPLC/IEX||||SIBLING|ADJUDICATOR 1|3|Visit_3|40|2|WASHOUT|2020-07-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|6|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|[?]|cmHg|[?]|1|ug/g/min|SUBSCAPULARIS MUSCLE|RIGHT|MIDLINE|MICROBIAL CONCENTRATION|Y|||CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2020-07-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|7|FEF50|Forced Expiratory Flow 50%|[?]|STANDING|[?]|Absorbance U/min|[?]|1|10^6/hpf|L6 VERTEBRA|LEFT|LOWER FLEXOR SURFACE|X-RAY||Y||PARENT|READER 3|4|Visit_4|65|1|FOLLOW-UP|2020-08-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|8|SGAW|Specific Airway Conductance|[?]|SLING|||[?]|1|tuberculin unit|MESENTERIC ARTERY|BILATERAL|MEDIAL|IHC|||Y|FAMILY MEMBER|FORENSIC PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 CFU/mL|[?]|1|mL/100g/min|HYMENAL RING|CONTRALATERAL|DISTAL VOLAR|HPLC-FL|Y|||STUDY SUBJECT|PATHOLOGIST|5|Visit_5|90|1|TREATMENT|2020-09-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|37610314-f803-4ffa-a584-ebfe09267a0d|10|RAW|Airway Resistance|[?]|FOWLERS|[?]|pptr|[?]|1|U/kg|HEART, RIGHT VENTRICLE|IPSILATERAL|LOWER FLEXOR SURFACE|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||ADJUDICATION COMMITTEE|MICROSCOPIST|5|Visit_5|90|7|SCREENING|2020-09-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|PIF|Peak Inspiratory Flow|[?]|SUPINE|[?]|ms2|[?]|1|BAR|CARPOMETACARPAL JOINT 2|UNILATERAL|FRONTAL|URANYL ACETATE STAIN||||GUARDIAN|DERMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|2|FEV6PP|Percent Predicted FEV6|[?]|SEMI-FOWLERS|||[?]|1|nmol/g|THYROID GLAND ISTHMUS|IPSILATERAL|LOWER FLEXOR SURFACE|MODIFIED ACID FAST STAIN|||Y|PROXY|ONCOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING|||[?]|1|MET|RIGHT CORONARY ARTERY OSTIUM|CONTRALATERAL|VENTRAL|DOUBLE IMMUNODIFFUSION||Y|Y|CLINICAL RESEARCH COORDINATOR|READER 2|2|Visit_2|25|4|WASHOUT|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|4|FIO2|Fraction of Inspired Oxygen|[?]|LATERAL DECUBITUS|||[?]|1|kBq|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|RIGHT|DISTAL|POPULATION SEQUENCING|||Y|PROXY|MICROSCOPIST 2|2|Visit_2|25|6|WASHOUT|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|5|FVC|Forced Vital Capacity|[?]|PRONE|[?]|U/animal|[?]|1|EVENTS|VEIN|RIGHT|UPPER|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||INTERVIEWER|ONCOLOGIST 2|3|Visit_3|40|5|SCREENING|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|6|SALKA|Salazar-Knowles Equation Parameter A|[?]|TRENDELENBURG|||[?]|1|aMFI|VERTEBRAL COLUMN|UNILATERAL|LOWER|SANGER SEQUENCING|||Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|7|FEV1PP|Percent Predicted FEV1|[?]|LATERAL DECUBITUS|[?]|days/month|[?]|1|mU/g|TRIGEMINAL NERVE|BILATERAL|FORE|NON-INVASIVE DIELECTRIC SENSING||||FAMILY MEMBER|INTERNIST|4|Visit_4|65|3|TREATMENT|2020-11-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|8|FEV3FVC|FEV3/FVC|[?]|SEMI-RECUMBENT|[?]|h*%|[?]|1|ug/kg/day|L4-L5 INTERVERTEBRAL SPACE|CONTRALATERAL|LOWER|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||INTERVIEWER|DERMATOLOGIST|4|Visit_4|65|2|WASHOUT|2020-11-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING|[?]|dpm/mL|[?]|1|DDU|CARPOMETACARPAL JOINT 4|LEFT|CRANIAL|MICRONEUTRALIZATION ASSAY|Y|||FAMILY MEMBER|READER 3|5|Visit_5|90|6|TREATMENT|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|760ec5ce-3ae7-4268-9f76-b83085ad3754|10|AWVOL|Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|mg/m2/min|[?]|1|log EID 50/dose|SUPERFICIAL FEMORAL ARTERY|RIGHT|VOLAR|DUCTOGRAPHY||||CLINICAL STUDY SPONSOR|RATER 2|5|Visit_5|90|4|WASHOUT|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|ERV|Expiratory Reserve Volume|[?]|SEMI-RECUMBENT|[?]|uL|[?]|1|in2|MEDIAN NERVE|UNILATERAL|SUPERFICIAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||CAREGIVER|MICROSCOPIST 3|1|Visit_1|10|7|TREATMENT|2020-06-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|||[?]|1|Joule|HAIR FOLLICLE|LEFT|TEMPORAL|TRANSMISSION ELECTRON MICROSCOPY|Y||Y|DOMESTIC PARTNER|RADIOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-06-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|3|FIV1PP|Percent Predicted FIV1|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|APL U|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LEFT|LOWER|ICC|Y|Y|Y|VENDOR|FORENSIC PATHOLOGIST|2|Visit_2|25|3|WASHOUT|2020-06-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|4|IC|Inspiratory Capacity|[?]|SUPINE|[?]|U/mg|[?]|1|cal|DISTAL INTERPHALANGEAL JOINT 2|BILATERAL|OUTER|ELECTROPHORESIS||||DOMESTIC PARTNER|CARDIOLOGIST|2|Visit_2|25|6|SCREENING|2020-06-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|TRENDELENBURG|[?]|cm H2O|[?]|1|mg2/dL2|THYROID GLAND ISTHMUS|LEFT|PERIPHERAL|CT SCAN WITHOUT CONTRAST||Y||VENDOR|NEUROLOGIST|3|Visit_3|40|4|WASHOUT|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|6|SALKA|Salazar-Knowles Equation Parameter A|[?]|LEFT LATERAL DECUBITUS|||[?]|1|g/animal/day|VERTEBRAL COLUMN|LEFT|LOWER MEDIAL|OSCILLOMETRY|||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|3|Visit_3|40|2|WASHOUT|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|7|EXPRELTM|Expiration Relaxation Time|[?]|UNCONSTRAINED|||[?]|1|kg/cm|LIVER|RIGHT|FORE|LIGHT MICROSCOPY|||Y|SIGNIFICANT OTHER|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-08-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|8|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LATERAL DECUBITUS|[?]|V/sec|[?]|1|JAR|RECTUS FEMORIS MUSCLE|UNILATERAL|OCCIPITAL|SLOAN LETTER EYE CHART 2.5%||||INTERVIEWER|PHYSIOTHERAPIST|4|Visit_4|65|5|TREATMENT|2020-08-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LATERAL DECUBITUS|[?]|pmol/10^9 cells|[?]|1|ukat|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|NASAL|PUPILLOMETRY||||PROXY|NEUROLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|10|GAW|Airway Conductance|[?]|SUPINE|[?]|dpm/mL|[?]|1|10^4 CFU|LEFT POSTEROLATERAL DESCENDING ARTERY|RIGHT|DISTAL|DYNAMIC LIGHT SCATTERING|Y|||CLINICAL STUDY SPONSOR|RATER 1|5|Visit_5|90|6|SCREENING|2020-09-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|[?]|deg/mm|[?]|1|TRANSDUCING UNIT/mL|PERICARDIAL WALL|LATERAL|SURFACE|DIRECT SEQUENCING||||INDEPENDENT ASSESSOR|OPHTHALMOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2021-01-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|2|QUASCOMP|Quasi-Static Compliance|[?]|SITTING, LEGS DEPENDENT|[?]|Tesla|[?]|1|mL/dose|KNEE JOINT TENDONS|RIGHT|ANTEROLATERAL|ATOMIC ABSORPTION SPECTROMETRY||||PARENT|INTERNIST|1|Visit_1|10|7|TREATMENT|2021-01-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|3|TV|Tidal Volume|[?]|PRONE|[?]|TABLET|[?]|1|fraction of 1|MID-CIRCUMFLEX ARTERY|LATERAL|PERIPHERAL|BALLPOINT PEN TECHNIQUE||Y||SIGNIFICANT OTHER|PATHOLOGIST 1|2|Visit_2|25|5|WASHOUT|2021-02-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|[?]|TRANSDUCING UNIT|[?]|1|Enzyme U/L|RIGHT VENTRICULAR BRANCH|BILATERAL|SURFACE|IMMUNO-PET SCAN||||DOMESTIC PARTNER|ONCOLOGIST|2|Visit_2|25|1|TREATMENT|2021-02-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|5|PEFREV|PEF Reversibility|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mmol/g|HILAR LYMPH NODE|IPSILATERAL|OCCIPITAL|AGAR DILUTION|||Y|GUARDIAN|READER 3|3|Visit_3|40|6|TREATMENT|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|6|IVCPP|Percent Predicted IVC|[?]|SLING|[?]|Ci/ug|[?]|1|SCOOPFUL|BONE|RIGHT|PARIETO-OCCIPITAL|FLUORESCENT MICROSCOPY|Y|Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|3|Visit_3|40|5|TREATMENT|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|10^3 RNA copies/mL|[?]|1|mCi/kg|GLOMERULUS|CONTRALATERAL|LOWER EXTENSOR SURFACE|OBSERVATION|Y|||CLINICAL STUDY SPONSOR|PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|8|DLCOHC|HGB Corrected DLCO|[?]|SITTING|||[?]|1|EU|VAGINAL WALL|IPSILATERAL|TEMPORAL|NO INFORMATION|Y||Y|SIGNIFICANT OTHER|HEMATOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|9|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|[?]|mL/s|[?]|1|uV*sec|TIBIOTARSAL JOINT|BILATERAL|PARIETO-OCCIPITAL|TEST STRIP|Y|Y||INDEPENDENT ASSESSOR|UROLOGIST|5|Visit_5|90|2|TREATMENT|2021-04-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-12
e|RE|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|10|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|nL|PYRAMIDAL TRACTS, INTERNAL CAPSULE|UNILATERAL|ANTERIOR|SEQUENCING|Y||Y|CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|5|SCREENING|2021-04-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-12
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|RV|Residual Volume|[?]|STANDING|[?]|OD Unit|[?]|1|uV|LIP, UPPER|LATERAL|LOWER|LISSAMINE GREEN STAIN|Y|||SPOUSE|OPTOMETRIST|1|Visit_1|10|6|WASHOUT|2020-11-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|2|RAWPP|Percent Predicted Airway Resistance|[?]|SUPINE|[?]|mg/kg/day|[?]|1|mm/sec|ELBOW EXTENSOR MUSCLES|UNILATERAL|UPPER EXTENSOR SURFACE|IODINE STAIN||||SPOUSE|ADJUDICATOR 2|1|Visit_1|10|3|SCREENING|2020-11-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|3|FIF75|Forced Inspiratory Flow at 75%|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/cage/day|[?]|1|/200 HPFs|L5 VERTEBRA|RIGHT|VOLAR|HPLC/MS/MS||||GUARDIAN|CLINICAL PATHOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-11-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|4|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|||[?]|1|GBq/g|SCROTUM|BILATERAL|PROXIMAL|CONTRAST ENHANCED MRI|Y||Y|PARENT|MICROSCOPIST 2|2|Visit_2|25|5|WASHOUT|2020-11-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|5|INERTANC|Inertance|[?]|SEMI-RECUMBENT|[?]|APPLICATION|[?]|1|/sec|EARLOBE|BILATERAL|SUBCORTICAL|COULOMETRIC TITRATION||||SPOUSE|ENDOCRINOLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|6|LOBVOL|Lobar Volume|[?]|SITTING|[?]|MPS U|[?]|1|mkat|DURAL VENOUS SINUS|IPSILATERAL|POSTERIOR|BALLPOINT PEN TECHNIQUE||||GUARDIAN|OPTOMETRIST|3|Visit_3|40|5|SCREENING|2020-12-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|7|TSUHYS|Tissue Hysteresivity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|vp/mL|THYROID GLAND, RIGHT LOBE|UNILATERAL|SUPERFICIAL|PHOTOGRAPHY|Y|Y|Y|STUDY SUBJECT|READER 2|4|Visit_4|65|6|TREATMENT|2021-01-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|8|RRS|Total Respiratory System Resistance|[?]|DECUBITUS|[?]|nmol/kg/day|[?]|1|BAU/mL|FLEXOR CARPI RADIALIS MUSCLE|IPSILATERAL|DEEP|BIOIMPEDANCE SPECTROSCOPY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|4|Visit_4|65|1|FOLLOW-UP|2021-01-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|mg/kg/day|[?]|1|10^6 U|WRIST JOINT EXTENSOR MUSCLES|RIGHT|LOWER|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||INVESTIGATOR|ONCOLOGIST 1|5|Visit_5|90|1|SCREENING|2021-02-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|[?]|mEq|[?]|1|TRANSDUCING UNIT|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|DEEP|IODINE STAIN|Y|||HEALTH CARE PROFESSIONAL|UROLOGIST|5|Visit_5|90|4|TREATMENT|2021-02-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|1|QUASCOMP|Quasi-Static Compliance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|uSiemens|COLON|UNILATERAL|CRANIAL|ELECTROPHORESIS||Y|Y|FAMILY MEMBER|ADJUDICATOR 3|1|Visit_1|10|6|TREATMENT|2020-09-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|2|PNIF|Peak Nasal Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|Torr|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|LATERAL|PARIETO-OCCIPITAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|||Y|PROXY|MICROSCOPIST 2|1|Visit_1|10|5|SCREENING|2020-09-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|L/min/m2|[?]|1|log10 CCID 50/dose|PENIS, BODY|LEFT|DISTAL VOLAR|PELLI-ROBSON EYE CHART||||FAMILY MEMBER|ADJUDICATOR|2|Visit_2|25|2|SCREENING|2020-09-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|SEMI-FOWLERS|||[?]|1|/HPF|LEFT ATRIOVENTRICULAR ARTERY|LEFT|FORE|AGAR PROPORTION||Y|Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 2|2|Visit_2|25|7|TREATMENT|2020-09-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|5|FIFMAX|Maximum Forced Inspiratory Flow|[?]|TRENDELENBURG|[?]|mg/m2/h|[?]|1|kg/cm|PROFUNDA FEMORIS ARTERY|LATERAL|BASAL|PALM METHOD||||STUDY SUBJECT|READER 3|3|Visit_3|40|5|WASHOUT|2020-10-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|6|FIV1PP|Percent Predicted FIV1|[?]|SUPINE|[?]|DRUM|[?]|1|km/h|MAXILLA|CONTRALATERAL|ANTEROMEDIAL|PERIPHERAL ANGIOGRAPHY|Y|||SIGNIFICANT OTHER|NEUROLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-10-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|UNCONSTRAINED|||[?]|1|10^7 PFU|PREPUTIAL GLAND|UNILATERAL|DORSOLATERAL|QUANTITATIVE COMPUTED TOMOGRAPHY||Y|Y|INVESTIGATOR|OPHTHALMOLOGIST|4|Visit_4|65|2|WASHOUT|2020-11-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-RECUMBENT|||[?]|1|U/mg|DISTANT LYMPH NODE|RIGHT|UPPER FLEXOR SURFACE|ANTIMICROBIAL COMBINATION TESTING||Y|Y|ADJUDICATOR|MICROSCOPIST 2|4|Visit_4|65|1|TREATMENT|2020-11-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|9|ERVPP|Percent Predicted ERV|[?]|LATERAL DECUBITUS|[?]|AFU|[?]|1|/100 HPFs|INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|LOWER EXTENSOR SURFACE|DOUBLE IMMUNODIFFUSION|Y|Y||ADJUDICATION COMMITTEE|ONCOLOGIST 2|5|Visit_5|90|3|SCREENING|2020-12-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|d7b41e15-6725-4433-8a35-72629e342b47|10|ERVPP|Percent Predicted ERV|[?]|LATERAL DECUBITUS|||[?]|1|EU|PORTAL LYMPH NODE|LEFT|UPPER|CT SCAN WITHOUT CONTRAST|||Y|STUDY SUBJECT|RATER 2|5|Visit_5|90|3|TREATMENT|2020-12-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|PEFREV|PEF Reversibility|[?]|DECUBITUS|||[?]|1|L/min/m2|PARAMETRIUM|LEFT|VENTROLATERAL|PEAK FLOWMETRY|||Y|SIGNIFICANT OTHER|ONCOLOGIST|1|Visit_1|10|3|TREATMENT|2020-10-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|2|SALKA|Salazar-Knowles Equation Parameter A|[?]|SEMI-RECUMBENT|[?]|mL/g/min|[?]|1|dpm/mg|NAIL BED|IPSILATERAL|ANTEROMEDIAL|OPTICAL DENSITY MEASUREMENT||||ADJUDICATION COMMITTEE|NEUROLOGIST 2|1|Visit_1|10|5|TREATMENT|2020-10-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|3|LCI|Lung Clearance Index|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^9/g|NAIL BED|UNILATERAL|FACIAL|STATIC PERIMETRY|Y||Y|SIBLING|PATHOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|4|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|10^3/hpf|[?]|1|genEq/mL|ESOPHAGUS, THORACIC|LEFT|INNER|PERIODIC ACID SCHIFF STAIN||||PARENT|READER 1|2|Visit_2|25|3|TREATMENT|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|STANDING, BENT FORWARD|[?]|EID 50/dose|[?]|1|amu|METATARSAL BONE|BILATERAL|PROXIMAL VOLAR|BALLPOINT PEN TECHNIQUE||||FRIEND|MICROSCOPIST 3|3|Visit_3|40|2|TREATMENT|2020-11-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|6|EFFVOL|Effusion Volume|[?]|DECUBITUS|||[?]|1|g/m2/day|PRESACRAL LYMPH NODE|CONTRALATERAL|SURFACE|PHYSICAL EXAMINATION|Y|Y|Y|PROXY|ONCOLOGIST 1|3|Visit_3|40|7|WASHOUT|2020-11-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|7|SALKB|Salazar-Knowles Equation Parameter B|[?]|SUPINE|[?]|pmol/L|[?]|1|uCi|SCAPHOID-CAPITATE JOINT|LATERAL|SUPERFICIAL|PH METER MEASUREMENT METHOD||||SPOUSE|CARDIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|8|ICREV|IC Reversibility|[?]|UNCONSTRAINED|[?]|kPa|[?]|1|mL/h|WRIST JOINT EXTENSOR MUSCLES|BILATERAL|NASAL|ETDRS EYE CHART||Y||CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|SCREENING|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|UNCONSTRAINED|[?]|dpm/100mg|[?]|1|CAPSULE|VENOUS SINUS|UNILATERAL|VOLAR|BIOIMPEDANCE SPECTROSCOPY||Y||ADJUDICATION COMMITTEE|UROLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|aeddc1ed-545c-405e-b1f7-08131961f5ff|10|FEF2575|Forced Expiratory Flow 25-75%|[?]|SLING|||[?]|1|mL/animal/wk|DISTAL CIRCUMFLEX ARTERY|IPSILATERAL|PERIPHERAL|PALPATION|||Y|CLINICAL STUDY SPONSOR|PATHOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-01-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|1|SVC|Slow Vital Capacity|[?]|SEMI-FOWLERS|[?]|CUP|[?]|1|10^9 CFU/g|INTRATHORACIC LYMPH NODE|BILATERAL|POSTERIOR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y||FRIEND|READER 3|1|Visit_1|10|2|TREATMENT|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|2|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|||[?]|1|GPS U|FIBULA|BILATERAL|LOWER FLEXOR SURFACE|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|ADJUDICATOR|PATHOLOGIST 1|1|Visit_1|10|7|TREATMENT|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|||[?]|1|YEARS|PALM|UNILATERAL|VENTROLATERAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y||Y|ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|SCREENING|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|4|SVC|Slow Vital Capacity|[?]|TRENDELENBURG|[?]|mg/mL/day|[?]|1|foz_br|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|LATERAL|DISTAL VOLAR|GRADIENT DIFFUSION||||FAMILY MEMBER|READER|2|Visit_2|25|6|TREATMENT|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|5|SRAW|Specific Airway Resistance|[?]|SITTING|||[?]|1|ng/L|POSTERIOR SUPERIOR ILIAC SPINE|UNILATERAL|PROXIMAL|CONGO RED STAIN|||Y|PROXY|NEUROLOGIST 1|3|Visit_3|40|4|TREATMENT|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|6|FIO2|Fraction of Inspired Oxygen|[?]|UNCONSTRAINED|[?]|pmol|[?]|1|MBq|KIDNEY, UPPER LOBE|RIGHT|DISTAL VOLAR|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|Y||GUARDIAN|ADJUDICATOR 3|3|Visit_3|40|3|TREATMENT|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|7|RRS|Total Respiratory System Resistance|[?]|SLING|[?]|gMFI|[?]|1|fL|PERIHILAR LYMPH NODE|CONTRALATERAL|INTERMEDIATE|ANALYTICAL ULTRACENTRIFUGATION||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|4|Visit_4|65|4|WASHOUT|2021-03-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|8|ICREV|IC Reversibility|[?]|PRONE|[?]|CAPLET|[?]|1|mL/min/1.73m2|OROPHARYNX|LATERAL|FRONTAL|TRYPAN BLUE STAIN||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|4|Visit_4|65|5|TREATMENT|2021-03-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|9|FRC|Functional Residual Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|log10 PFU/mL|COMMON ILIAC ARTERY|RIGHT|PERIPHERAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||Y|Y|INTERVIEWER|RATER|5|Visit_5|90|5|TREATMENT|2021-04-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|3effe272-6a68-4163-a4f3-bd269af6061c|10|DLCO|Diffusion Capacity of Lung for CO|[?]|STANDING|[?]|days/wk|[?]|1|anti-Xa IU/mL|LUNG, RIGHT LOWER LOBE|RIGHT|DISTAL VOLAR|CONTRAST ENHANCED CT SCAN|Y|||NON-HEALTH CARE PROFESSIONAL|INTERNIST|5|Visit_5|90|3|TREATMENT|2021-04-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|FIV1PP|Percent Predicted FIV1|[?]|RIGHT LATERAL DECUBITUS|[?]|BAU/mL|[?]|1|mol/g|ETHMOID BONE|CONTRALATERAL|INTERMEDIATE|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||Y||INDEPENDENT ASSESSOR|PATHOLOGIST|1|Visit_1|10|5|SCREENING|2020-09-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|2|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|/sec|[?]|1|mL/m2/h|KIDNEY|RIGHT|UPPER FLEXOR SURFACE|CAPILLARY ELECTROPHORESIS||||GUARDIAN|RADIOLOGIST 1|1|Visit_1|10|3|WASHOUT|2020-09-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|3|AWVOL|Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|GLOBULE|[?]|1|cycle/min|FOOT DIGIT 1|UNILATERAL|LOWER|KINETIC MICROPARTICLE IMMUNOASSAY|Y|Y||ADJUDICATOR|NEUROLOGIST 1|2|Visit_2|25|1|SCREENING|2020-10-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|4|MALEVDES|Malignancy Evidence Description|[?]|RIGHT LATERAL DECUBITUS|[?]|BU|[?]|1|Ejaculate U|FOREBRAIN|RIGHT|PERIPHERAL|RADIATION DOSIMETRY||||PROXY|RATER 2|2|Visit_2|25|1|TREATMENT|2020-10-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|5|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|[?]|hr/day|[?]|1|L/s|PERIRECTAL LYMPH NODE|IPSILATERAL|PERIVENTRICULAR|LIGHT MICROSCOPY||||CHILD|UROLOGIST|3|Visit_3|40|1|TREATMENT|2020-10-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|6|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SUPINE|[?]|mL/kg/min|[?]|1|SFC/10^6 PBMC|THYROID GLAND, LEFT LOBE|LATERAL|PARIETO-OCCIPITAL|DIFFUSION TENSOR MRI||||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|FOLLOW-UP|2020-10-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|PRONE|[?]|mm2|[?]|1|/day|ENDOMETRIUM|UNILATERAL|NASAL|ENDPOINT DILUTION ASSAY||Y||CAREGIVER|RATER|4|Visit_4|65|7|TREATMENT|2020-11-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|8|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|g/kg/day|[?]|1|uCi/L|URETHRA|BILATERAL|VENTROLATERAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||VENDOR|RATER 2|4|Visit_4|65|6|FOLLOW-UP|2020-11-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|9|RELSZCHG|Relative Size Change|[?]|STANDING|[?]|log10 PFU|[?]|1|10^4/hpf|INFERIOR PUBIC RAMUS|UNILATERAL|SURFACE|AGAR PROPORTION||Y||CLINICAL STUDY SPONSOR|RADIOLOGIST|5|Visit_5|90|7|TREATMENT|2020-12-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|8153c765-a92a-4b0f-9ef3-6ca925337f54|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|TRENDELENBURG|||[?]|1|SUPPOSITORY|ANKLE JOINT ANTERIOR FLEXOR TENDONS|IPSILATERAL|SURFACE|TURBIDIMETRY|||Y|ADJUDICATION COMMITTEE|RADIOLOGIST 1|5|Visit_5|90|6|TREATMENT|2020-12-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|DLCOHC|HGB Corrected DLCO|[?]|PRONE|[?]|uU/dL|[?]|1|STEPS|LENS|RIGHT|SURFACE|SINGLE-MOLECULE ARRAY|Y|||GUARDIAN|MICROSCOPIST|1|Visit_1|10|5|FOLLOW-UP|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|2|FEV1FVC6|FEV1/FVC6|[?]|REVERSE TRENDELENBURG|[?]|g|[?]|1|U/g Hb|PARACOLIC GUTTER|CONTRALATERAL|OUTER|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||HEALTH CARE PROFESSIONAL|CARDIOLOGIST|1|Visit_1|10|4|TREATMENT|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|3|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-FOWLERS|[?]|Sv|[?]|1|MPL U|CECUM|LEFT|MEDIAL|REFRACTOMETRY|Y|Y||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|TREATMENT|2020-11-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 RNA copies/mL|[?]|1|nmol/kg/day|PRETRACHEAL LYMPH NODE|RIGHT|PARIETO-OCCIPITAL|SCINTIGRAPHY||Y||HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|2|Visit_2|25|4|SCREENING|2020-11-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|5|TSUELAS|Tissue Elastance|[?]|DECUBITUS|||[?]|1|ug/m2/day|METATARSOPHALANGEAL JOINT 3|UNILATERAL|INNER|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||Y|VENDOR|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-11-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|6|DLCO|Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|mV*min|[?]|1|GPL U/mL|SKIN OF THE LIP|RIGHT|LOWER FLEXOR SURFACE|ANGIOGRAPHY||||STUDY SUBJECT|RADIOLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-11-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING, BENT FORWARD|||[?]|1|/4.0 mL|BLOOD VESSEL|UNILATERAL|CAUDAL|CALIPER MEASUREMENT METHOD|||Y|STUDY SUBJECT|PATHOLOGIST 2|4|Visit_4|65|2|SCREENING|2020-12-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|8|TSUHYS|Tissue Hysteresivity|[?]|FOWLERS|[?]|km/h|[?]|1|EU|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|BILATERAL|ANTEROPOSTERIOR|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y||FAMILY MEMBER|READER 3|4|Visit_4|65|5|SCREENING|2020-12-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|UNCONSTRAINED|[?]|mL/animal|[?]|1|LOZENGE|PELVIC LYMPH NODE|BILATERAL|LOWER|LYMPHANGIOGRAPHY||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2021-01-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|8d27cdcf-768e-4630-95b5-da554f6f3b56|10|TLC|Total Lung Capacity|[?]|PRONE|[?]|mg/cm2|[?]|1|mV/sec|STERNUM|LEFT|OUTER|BRDU CELLULAR PROLIFERATION ASSAY||Y||STUDY SUBJECT|READER|5|Visit_5|90|4|TREATMENT|2021-01-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|1|SALKK|Salazar-Knowles Equation, K|[?]|LATERAL DECUBITUS|[?]|ng/mol|[?]|1|nL|PISIFORM BONE|RIGHT|INFERIOR|PET SCAN||||GUARDIAN|READER 1|1|Visit_1|10|5|FOLLOW-UP|2020-09-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|2|DLCOVA|DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|ugEq|[?]|1|10^3 organisms/mL|PERICARDIUM|LATERAL|SURFACE|EPSILOMETER||||ADJUDICATION COMMITTEE|READER 1|1|Visit_1|10|2|TREATMENT|2020-09-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|Torr|[?]|1|PFU/mL|URETHRA, PENILE|CONTRALATERAL|SUPERFICIAL|SCINTIGRAPHY||Y||CLINICAL STUDY SPONSOR|READER 1|2|Visit_2|25|2|SCREENING|2020-09-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|4|FIV1PP|Percent Predicted FIV1|[?]|SEMI-RECUMBENT|||[?]|1|umol/h/mmol|POSTERIOR TIBIAL VEIN|LATERAL|ANTEROPOSTERIOR|IN VITRO GENE EXPRESSION ASSAY|||Y|SIGNIFICANT OTHER|ADJUDICATOR 1|2|Visit_2|25|7|SCREENING|2020-09-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|5|FEF2575P|Percent Predicted FEF25-75|[?]|FOWLERS|[?]|mmHg/sec|[?]|1|ug/L DDU|PARAPHARYNGEAL LYMPH NODE|UNILATERAL|LOWER|QUANTITATIVE CORONARY ANGIOGRAPHY||Y||PARENT|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2020-10-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-FOWLERS|||[?]|1|ug/dL|INTERPHALANGEAL JOINT 5|LATERAL|ANTEROLATERAL|ZIEHL NEELSEN ACID FAST STAIN|||Y|GUARDIAN|MICROSCOPIST 2|3|Visit_3|40|5|TREATMENT|2020-10-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|7|FEV1FVC|FEV1/FVC|[?]|STANDING, BENT FORWARD|[?]|L|[?]|1|/h|BUCCAL LYMPH NODE|CONTRALATERAL|MEDIAL|NON-INVASIVE DIELECTRIC SENSING|Y|Y||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2020-10-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|8|FIF50|Forced Inspiratory Flow at 50%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|tsp eq|BRAIN VENTRICLE|LATERAL|ANTERIOR|HPLC-UV||Y|Y|ADJUDICATOR|READER 3|4|Visit_4|65|6|FOLLOW-UP|2020-10-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|9|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|mL/100g/min|[?]|1|10^9 organisms|JEJUNUM|LEFT|PROXIMAL|MICROSCOPY||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 2|5|Visit_5|90|4|FOLLOW-UP|2020-11-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|5c2791ff-aaf6-413f-9827-6e97e2273388|10|TLC|Total Lung Capacity|[?]|DECUBITUS|[?]|10^6 IU|[?]|1|psec|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|RIGHT|HIND|HEMOCYTOMETRY||||NON-HEALTH CARE PROFESSIONAL|READER 3|5|Visit_5|90|3|WASHOUT|2020-11-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|1|IVCPP|Percent Predicted IVC|[?]|PRONE|[?]|mg/mol|[?]|1|10^9 CFU/mL|EYE BULGE|LEFT|OCCIPITAL|LC-FL||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-09-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|2|AIRTRAP|Air Trapping|[?]|UNCONSTRAINED|[?]|mg/kg|[?]|1|min*mg/mL|VEIN|LATERAL|UPPER|PERIODIC ACID SCHIFF STAIN||Y||DOMESTIC PARTNER|MICROSCOPIST 2|1|Visit_1|10|3|SCREENING|2020-09-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|3|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|[?]|mPa|[?]|1|% INHIBITION|TUNICA INTIMA|IPSILATERAL|PERIVENTRICULAR|INFRARED SPECTROMETRY||||PARENT|READER 3|2|Visit_2|25|2|WASHOUT|2020-10-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|4|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|[?]|mL/m2/min|[?]|1|mL/breath|SUPERIOR VENA CAVA|CONTRALATERAL|VENTRAL|MASS SPECTROMETRY|Y|Y||FAMILY MEMBER|OTOLARYNGOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-10-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|5|PEF|Peak Expiratory Flow|[?]|LATERAL DECUBITUS|[?]|ugEq|[?]|1|U/kg/h|HEART, LEFT VENTRICULAR OUTFLOW TRACT|LEFT|SURFACE|FLUORESCENCE ANGIOGRAPHY||||INDEPENDENT ASSESSOR|READER 2|3|Visit_3|40|2|TREATMENT|2020-10-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|6|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|||[?]|1|umol/mol|PERIUMBILICAL REGION|CONTRALATERAL|ANTEROLATERAL|AURAMINE STAIN||Y|Y|GUARDIAN|RATER 2|3|Visit_3|40|7|WASHOUT|2020-10-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|7|EVC|Expiratory Vital Capacity|[?]|STANDING|||[?]|1|mL/mmHg|MITRAL VALVE, ANTERIOR CUSP|RIGHT|OCCIPITAL|TWO-COLOR MICROARRAY||Y|Y|ADJUDICATOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-11-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|8|SGAW|Specific Airway Conductance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|log10 copies/mL|COLON, ASCENDING|UNILATERAL|LOWER FLEXOR SURFACE|SINGLE-MOLECULE ARRAY|Y||Y|VENDOR|NEUROLOGIST|4|Visit_4|65|2|SCREENING|2020-11-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|9|RVPP|Percent Predicted Residual Volume|[?]|SITTING|[?]|kBq|[?]|1|Hz|SKIN OF THE BUTTOCK|IPSILATERAL|ANTEROPOSTERIOR|ANALYTICAL ULTRACENTRIFUGATION||||HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|5|Visit_5|90|4|WASHOUT|2020-12-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|b336d8c2-7bca-404e-aea3-5148d559ea99|10|MALEVDES|Malignancy Evidence Description|[?]|SLING|[?]|mL/s|[?]|1|uU/dL|CELIAC LYMPH NODE|CONTRALATERAL|UPPER|ELASTOGRAPHY||||ADJUDICATION COMMITTEE|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2020-12-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING|[?]|pkat/L|[?]|1|pg/dL|SKIN OF THE NECK|RIGHT|SURFACE|PALM METHOD||||CAREGIVER|READER 1|1|Visit_1|10|1|WASHOUT|2020-06-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|2|PIF|Peak Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|GBq/mg|[?]|1|TROCHE|ESOPHAGUS, UPPER THIRD|RIGHT|OUTER|DIFFUSION WEIGHTED MRI||||VENDOR|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-06-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|3|FEV1SVC|FEV1/SVC|[?]|RIGHT LATERAL DECUBITUS|[?]|Ejaculate U|[?]|1|vg/kg|PENIS, GLANS|LEFT|VOLAR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||PROXY|RADIOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|4|DLCOHC|HGB Corrected DLCO|[?]|SEMI-FOWLERS|[?]|OI50|[?]|1|ug/kg/h|ANAL VERGE|BILATERAL|HIND|SPECT/CT SCAN||Y||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|5|RER|Respiratory Exchange Ratio|[?]|STANDING|[?]|PACK|[?]|1|ug/m2|KIDNEY, UPPER LOBE|BILATERAL|LOWER|HEMAGGLUTINATION ASSAY|Y|||FAMILY MEMBER|PHYSIOTHERAPIST|3|Visit_3|40|7|WASHOUT|2020-07-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|6|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|breaths/30s|[?]|1|10^9 organisms/mL|TRAPEZIUM-TRAPEZOID JOINT|RIGHT|SUPERIOR|BRDU CELLULAR PROLIFERATION ASSAY||||SIGNIFICANT OTHER|HEMATOLOGIST|3|Visit_3|40|7|SCREENING|2020-07-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|7|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING|[?]|umol/h/mmol|[?]|1|Gy|EAR, INNER|LEFT|CENTRAL|PET/MRI SCAN|Y|||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|8|TGV|Thoracic Gas Volume|[?]|SUPINE|||[?]|1|10^3 organisms/mL|UPPER RESPIRATORY SYSTEM|RIGHT|ANTEROPOSTERIOR|JAFFE REACTION|Y||Y|FRIEND|FORENSIC PATHOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-08-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|STANDING, BENT FORWARD|[?]|deg/s|[?]|1|kg/cm|LEFT VENTRICULAR EPICARDIUM|IPSILATERAL|SURFACE|CARDIAC THERMODILUTION||||INVESTIGATOR|ONCOLOGIST 1|5|Visit_5|90|2|SCREENING|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|702b2f8f-63b9-44c1-a46d-1a41bc837c32|10|FEV_PEF|FEV at PEF|[?]|FOWLERS|[?]|breaths/min|[?]|1|AU/mL|VULVA|CONTRALATERAL|APICAL|SLOAN LETTER EYE CHART 2.5%||||PARENT|READER 3|5|Visit_5|90|7|TREATMENT|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|1|MALEVDES|Malignancy Evidence Description|[?]|STANDING, BENT FORWARD|||[?]|1|uU/L|T9 VERTEBRA|CONTRALATERAL|DORSAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y||Y|FRIEND|UROLOGIST|1|Visit_1|10|2|WASHOUT|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|2|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|||[?]|1|aMFI|PERIFACIAL LYMPH NODE|IPSILATERAL|NASAL|IN SITU HYBRIDIZATION||Y|Y|INDEPENDENT ASSESSOR|MICROSCOPIST|1|Visit_1|10|7|FOLLOW-UP|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|3|FEV6PP|Percent Predicted FEV6|[?]|SITTING|[?]|FIU|[?]|1|mL/g/h|ENDOMETRIAL CAVITY|BILATERAL|SURFACE|NON-CONTACT SPECULAR MICROSCOPY|Y|||CLINICAL STUDY SPONSOR|RATER 1|2|Visit_2|25|6|TREATMENT|2020-10-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|4|AWVOLPP|Percent Predicted Airway Volume|[?]|SUPINE|[?]|nmol/mol|[?]|1|IU/L|ANTERIOR HORN OF THE LATERAL VENTRICLE|BILATERAL|CENTRAL|FLUOROSCOPY||||CLINICAL STUDY SPONSOR|NEUROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-10-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|5|ALVVOL|Alveolar Volume|[?]|SITTING|[?]|fmol|[?]|1|/cmH2O|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|RIGHT|SUBCORTICAL|PHOTOMETRY||||SIGNIFICANT OTHER|HEMATOLOGIST|3|Visit_3|40|2|WASHOUT|2020-10-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|6|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING|||[?]|1|pmol/dL|KIDNEY, MEDULLA|UNILATERAL|PROXIMAL|ENDOSCOPY|Y||Y|FRIEND|OPHTHALMOLOGIST|3|Visit_3|40|2|TREATMENT|2020-10-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|7|PEF|Peak Expiratory Flow|[?]|FOWLERS|[?]|ug/day|[?]|1|AgU/mL|COLON LYMPH NODE|CONTRALATERAL|ANTEROTEMPORAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||SIBLING|ONCOLOGIST 2|4|Visit_4|65|7|SCREENING|2020-11-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING|[?]|/10^4|[?]|1|mL/animal|VENA CAVA|CONTRALATERAL|ANTERIOR|MRS||||DOMESTIC PARTNER|MICROSCOPIST|4|Visit_4|65|5|FOLLOW-UP|2020-11-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|9|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-FOWLERS|[?]|tuberculin unit/mL|[?]|1|POINT|SEMITENDINOSUS MUSCLE|UNILATERAL|PROXIMAL VOLAR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|||DOMESTIC PARTNER|RADIOLOGIST 1|5|Visit_5|90|3|FOLLOW-UP|2020-12-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|1261eee1-f073-4419-b0b7-28abd0ec1513|10|LCI|Lung Clearance Index|[?]|SUPINE|[?]|hr/day|[?]|1|MONTHS|PECTORALIS MINOR MUSCLE|IPSILATERAL|UPPER EXTENSOR SURFACE|GC/MS||||CHILD|OPTOMETRIST|5|Visit_5|90|4|TREATMENT|2020-12-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|[?]|mg/cm2|[?]|1|mm3/mm2/year|CORNEA|LEFT|LOWER|TEMPLATE INCISION METHOD|Y|Y||DOMESTIC PARTNER|OTOLARYNGOLOGIST|1|Visit_1|10|2|TREATMENT|2020-12-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|2|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|[?]|s^-1(%O2)^-1|[?]|1|VOXEL|OCCIPITAL SCALP|CONTRALATERAL|PROXIMAL|PUPILLOMETRY||||SPOUSE|PATHOLOGIST 1|1|Visit_1|10|1|SCREENING|2020-12-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|3|FIFMAXPP|Percent Predicted FIFmax|[?]|SLING|[?]|mL/cm3/min|[?]|1|10^3 organisms|BLADDER, NECK|LEFT|PARIETO-OCCIPITAL|SLOAN LETTER EYE CHART 1.25%||||GUARDIAN|RATER 2|2|Visit_2|25|6|FOLLOW-UP|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-RECUMBENT|||[?]|1|uEq|HEPATIC ARTERY|UNILATERAL|UPPER|ENDPOINT DILUTION ASSAY|Y||Y|FAMILY MEMBER|READER 1|2|Visit_2|25|6|TREATMENT|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|5|FEV1FVC|FEV1/FVC|[?]|DECUBITUS|[?]|ukat|[?]|1|% INHIBITION|TONGUE|LEFT|NASAL|HPLC|Y|||PROXY|RATER 1|3|Visit_3|40|5|TREATMENT|2021-01-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|6|MIPPP|Percent Predicted MIP|[?]|SUPINE|||[?]|1|kPa/L/sec|FAT PAD|UNILATERAL|CAUDAL|PET/SPECT SCAN|||Y|CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|3|Visit_3|40|4|SCREENING|2021-01-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|7|FIV1PP|Percent Predicted FIV1|[?]|SLING|[?]|DAYS|[?]|1|dpm/mg|HARD PALATE|RIGHT|PROXIMAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|4|Visit_4|65|5|SCREENING|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|8|FIO2|Fraction of Inspired Oxygen|[?]|DECUBITUS|||[?]|1|/LPF|SCAPHOID-LUNATE-CAPITATE JOINT|LEFT|UPPER FLEXOR SURFACE|BIOIMPEDANCE SPECTROSCOPY||Y|Y|STUDY SUBJECT|DERMATOLOGIST|4|Visit_4|65|3|TREATMENT|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|9|IRVPP|Percent Predicted IRV|[?]|FOWLERS|[?]|Enzyme U|[?]|1|Henry|HIP ADDUCTORS|LEFT|LOWER FLEXOR SURFACE|CONGO RED STAIN||Y||CLINICAL RESEARCH COORDINATOR|OTOLARYNGOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|46eefdf3-c314-4e61-963c-ce7f48c636e5|10|ERVPP|Percent Predicted ERV|[?]|LATERAL DECUBITUS|[?]|psi|[?]|1|%(w/w)|LOWER JUGULAR LYMPH NODE|LEFT|SUBCORTICAL|PHASE-CONTRAST MRI||||CHILD|RATER|5|Visit_5|90|2|TREATMENT|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|MALIND|Malignancy Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|uOsm|[?]|1|TROCHE|BONE MARROW|RIGHT|CRANIAL|ETDRS EYE CHART|Y|||CHILD|OTOLARYNGOLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|2|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|[?]|%|[?]|1|days/wk|GREAT SAPHENOUS VEIN|BILATERAL|FORE|PHYSICAL EXAMINATION||||SIGNIFICANT OTHER|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|3|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|[?]|PRESSOR UNITS|[?]|1|PACKET|BRAIN VENTRICLE, LATERAL|LEFT|INTERMEDIATE|ENZYMATIC COLORIMETRY||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|2|Visit_2|25|4|TREATMENT|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|4|ALVVOL|Alveolar Volume|[?]|PRONE|||[?]|1|umol/L/sec|URETER|CONTRALATERAL|INNER|ELECTROPHORESIS|||Y|DOMESTIC PARTNER|ONCOLOGIST 1|2|Visit_2|25|1|TREATMENT|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|mL/cm|[?]|1|GBq/mg|INTERPHALANGEAL JOINT 1|BILATERAL|PARIETO-OCCIPITAL|CLIP SEQUENCING|Y|Y||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|6|PEFREV|PEF Reversibility|[?]|REVERSE TRENDELENBURG|||[?]|1|uU/dL|ILIAC VEIN|RIGHT|VENTROLATERAL|ACID FAST STAIN|||Y|NON-HEALTH CARE PROFESSIONAL|RATER 2|3|Visit_3|40|1|TREATMENT|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|7|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|MONTHS|[?]|1|dpm/mL|ARM|IPSILATERAL|OUTER|SPECT SCAN||||FRIEND|READER 1|4|Visit_4|65|7|TREATMENT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING|[?]|10^6 IU|[?]|1|amol|OLFACTORY BULB|RIGHT|TIP|MAGNETIC RESONANCE ENTEROGRAPHY||||HEALTH CARE PROFESSIONAL|INTERNIST|4|Visit_4|65|1|TREATMENT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|9|MALEVDES|Malignancy Evidence Description|[?]|TRENDELENBURG|||[?]|1|DDU|HAMSTRING MUSCLE|BILATERAL|SURFACE|MICRONEUTRALIZATION ASSAY||Y|Y|VENDOR|READER 3|5|Visit_5|90|1|SCREENING|2021-04-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|f632159b-8c91-4f0d-81cb-e5b9195588c9|10|EFFIND|Effusion Indicator|[?]|PRONE|[?]|pkat/L|[?]|1|ppm|PERONEAL ARTERY|BILATERAL|BASAL|ELECTROMYOGRAPHY||Y||FAMILY MEMBER|PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|1|AWWVOL|Airway Wall Volume|[?]|LATERAL DECUBITUS|[?]|mEq/ug|[?]|1|L/min/m2|HEART|BILATERAL|VOLAR|IMMUNOTURBIDIMETRY||||INTERVIEWER|OPHTHALMOLOGIST|1|Visit_1|10|5|TREATMENT|2020-05-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|TRENDELENBURG|[?]|MPS U|[?]|1|oz|RECTUM|LATERAL|OCCIPITAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||Y||ADJUDICATOR|RATER|1|Visit_1|10|3|TREATMENT|2020-05-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|3|MEP|Maximal Expiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|/cmH2O|[?]|1|MBP|INTERVENTRICULAR SEPTUM|LEFT|TEMPORAL|MULTI-SLICE SPIRAL CT||||CLINICAL STUDY SPONSOR|RATER|2|Visit_2|25|6|TREATMENT|2020-06-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|4|FEV1FVC6|FEV1/FVC6|[?]|SITTING|[?]|EP U|[?]|1|mL/g/day|FOOT|IPSILATERAL|ANTEROMEDIAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||GUARDIAN|INTERNIST|2|Visit_2|25|4|FOLLOW-UP|2020-06-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LATERAL DECUBITUS|||[?]|1|ELISA unit/dose|DISTAL COMMON BILE DUCT|UNILATERAL|DORSOLATERAL|ISHIHARA COLOR PLATES||Y|Y|CLINICAL RESEARCH ASSOCIATE|RATER|3|Visit_3|40|7|TREATMENT|2020-06-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|6|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|[?]|BP|[?]|1|10^9/g|CEREBRUM|UNILATERAL|SUPERIOR|MICROSCOPY||Y||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|WASHOUT|2020-06-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING|[?]|kUSP|[?]|1|s/h|PECTORALIS MAJOR MUSCLE|CONTRALATERAL|INFERIOR|RADIATION DOSIMETRY||Y||HEALTH CARE PROFESSIONAL|MICROSCOPIST|4|Visit_4|65|7|FOLLOW-UP|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|8|AWVOLPP|Percent Predicted Airway Volume|[?]|DECUBITUS|[?]|10^6/L|[?]|1|kN/cm2|LEFT POSTEROLATERAL DESCENDING ARTERY|CONTRALATERAL|PERIPHERAL|MICROBIAL CULTURE, LIQUID||||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|4|Visit_4|65|4|TREATMENT|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|9|LOBVOL|Lobar Volume|[?]|SITTING, LEGS DEPENDENT|[?]|pmol|[?]|1|DAgU/mL|ANASTOMOSIS|BILATERAL|VENTRAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|5|Visit_5|90|6|WASHOUT|2020-08-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|898a9d2f-338b-41bf-8ac0-c4a025481349|10|FRC|Functional Residual Capacity|[?]|FOWLERS|[?]|PACKAGE|[?]|1|/MBP|METACARPOPHALANGEAL JOINT 2|LATERAL|PERIVENTRICULAR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|Y||SIGNIFICANT OTHER|RATER 2|5|Visit_5|90|7|FOLLOW-UP|2020-08-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|1|ERV|Expiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|[?]|nmol/g|[?]|1|COAT|INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|SURFACE|RADIOGRAPHY||||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|2|SCREENING|2020-05-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|TRENDELENBURG|[?]|nmol/kg/day|[?]|1|SPRAY|DISTAL LAD ARTERY|CONTRALATERAL|ANTEROLATERAL|SISH||||FAMILY MEMBER|OTOLARYNGOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|3|PEFTIME|Peak Expiratory Flow Time|[?]|DECUBITUS|[?]|cycle/min|[?]|1|mU/L|URINARY SYSTEM|UNILATERAL|ANTEROTEMPORAL|MICRONEUTRALIZATION ASSAY|Y|||ADJUDICATION COMMITTEE|READER 2|2|Visit_2|25|4|TREATMENT|2020-06-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|4|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Ci/mL|FOREHEAD|RIGHT|DORSAL|PERCUSSION|Y||Y|FRIEND|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-06-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|5|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|ukat/L|[?]|1|dB|EPIGASTRIC LYMPH NODE|UNILATERAL|SUPERIOR|TRANSCRIPTION-MEDIATED AMPLIFICATION||||STUDY SUBJECT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|FOLLOW-UP|2020-06-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|6|TSUELAS|Tissue Elastance|[?]|SITTING, LEGS DEPENDENT|[?]|10^9 organisms/mg|[?]|1|/2000 RBC|NUCHAL LYMPH NODE|CONTRALATERAL|DEEP|DUKE INCISION METHOD||||SIGNIFICANT OTHER|READER 2|3|Visit_3|40|2|TREATMENT|2020-06-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|7|IRVPP|Percent Predicted IRV|[?]|SLING|||[?]|1|nkat/g Hb|DURAL VENOUS SINUS|BILATERAL|SUBCORTICAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||Y|CHILD|RADIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-07-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SLING|[?]|Enzyme U/m2|[?]|1|Joule|HAIR FOLLICLE|RIGHT|DISTAL|SPECT SCAN||Y||ADJUDICATION COMMITTEE|ONCOLOGIST|4|Visit_4|65|6|TREATMENT|2020-07-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|9|AWVOLPP|Percent Predicted Airway Volume|[?]|FOWLERS|[?]|VOXEL|[?]|1|g/animal|C7 VERTEBRA|LEFT|DORSOLATERAL|KLEIHAUER-BETKE||||SIBLING|OTOLARYNGOLOGIST|5|Visit_5|90|4|SCREENING|2020-08-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|db3824aa-375d-4e40-a14b-af0e4460914e|10|DLCOPP|Percent Predicted DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|SUPPOSITORY|[?]|1|Ci|TRACHEOBRONCHIAL TREE|CONTRALATERAL|UPPER EXTENSOR SURFACE|THERMAL IONIZATION MASS SPECTROMETRY|Y|||FRIEND|MICROSCOPIST 3|5|Visit_5|90|5|SCREENING|2020-08-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|mL/min/1.73m2|[?]|1|DNA copies/ug|HAMATE BONE|LATERAL|PROXIMAL VOLAR|HPLC/MS/MS||Y||PROXY|RATER|1|Visit_1|10|6|TREATMENT|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|2|FEV1PP|Percent Predicted FEV1|[?]|SEMI-RECUMBENT|[?]|ng|[?]|1|pmol|LUNG LOBE|BILATERAL|LATERAL|KINETIC CHROMOGENIC ASSAY||Y||FRIEND|NEUROLOGIST 1|1|Visit_1|10|3|TREATMENT|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|3|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|[?]|mg|[?]|1|genEq/mL|METACARPOPHALANGEAL JOINT 4|IPSILATERAL|ANTEROPOSTERIOR|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|||FAMILY MEMBER|RADIOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2021-02-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|DECUBITUS|[?]|pkat/L|[?]|1|cm H2O|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|APICAL|CENTRIFUGATION|Y|||VENDOR|OPTOMETRIST|2|Visit_2|25|6|TREATMENT|2021-02-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|5|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|mV/sec|[?]|1|mV|CAPITATE-HAMATE JOINT|BILATERAL|VOLAR|IMMUNOFLUORESCENT STAIN||||ADJUDICATOR|ONCOLOGIST 2|3|Visit_3|40|3|SCREENING|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|6|FVC|Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq|[?]|1|ukat/10^12 RBC|COLON WALL|LEFT|LATERAL|CELL BASED BIOASSAY|Y|||HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|7|PNIF|Peak Nasal Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|PUFF|[?]|1|FFU|SCAPHOID-LUNATE-CAPITATE JOINT|CONTRALATERAL|BASAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|4|Visit_4|65|5|TREATMENT|2021-03-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|8|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|REVERSE TRENDELENBURG|||[?]|1|Tbsp|LIVER, CAUDATE LOBE|UNILATERAL|PERIVENTRICULAR|IMMUNOPRECIPITATION||Y|Y|SPOUSE|RATER 1|4|Visit_4|65|4|SCREENING|2021-03-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|DECUBITUS|[?]|/2000 RBC|[?]|1|TABLET|ORBICULARIS OCULI MUSCLE|RIGHT|UPPER EXTENSOR SURFACE|CORONARY ANGIOGRAPHY||Y||SPOUSE|OPTOMETRIST|5|Visit_5|90|6|WASHOUT|2021-04-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|0ea6be64-32f8-4e10-b993-687ea200e4e9|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|STANDING, BENT FORWARD|[?]|tuberculin unit/mL|[?]|1|C|CARDIOVASCULAR SYSTEM|LEFT|FACIAL|FLUORESCENCE ANGIOGRAPHY||||SPOUSE|READER 3|5|Visit_5|90|6|WASHOUT|2021-04-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|FEV1|Forced Expiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|tuberculin unit|[?]|1|gtt|FOOT DIGIT 2|LEFT|PERIVENTRICULAR|HIGH RESOLUTION MELT ANALYSIS||||PARENT|MICROSCOPIST 2|1|Visit_1|10|2|FOLLOW-UP|2020-06-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|2|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LEFT LATERAL DECUBITUS|[?]|sec|[?]|1|ug/min|MALE GENITALIA|LATERAL|INTERMEDIATE|COULOMETRIC TITRATION||||PROXY|CLINICAL PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-06-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|AMPULE|[?]|1|mPa|HAND DIGIT 5|UNILATERAL|LOWER EXTENSOR SURFACE|SIZE EXCLUSION CHROMATOGRAPHY||||CLINICAL STUDY SPONSOR|ONCOLOGIST|2|Visit_2|25|1|WASHOUT|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|Ci|[?]|1|uIU/dL|FIBULA SHAFT|RIGHT|UPPER EXTENSOR SURFACE|PERIPHERAL ANGIOGRAPHY||Y||SPOUSE|NEUROLOGIST 1|2|Visit_2|25|5|TREATMENT|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|5|DLCOHCVA|HGB Corrected DLCO/VA|[?]|FOWLERS|[?]|BEAM BREAKS|[?]|1|100 IU/mL|CAPITATE BONE|LATERAL|PARIETO-OCCIPITAL|DXA SCAN||||PROXY|NEUROLOGIST 1|3|Visit_3|40|6|SCREENING|2020-07-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|[?]|AgU/mL|[?]|1|YEARS|BLOOD|RIGHT|SUPERFICIAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||VENDOR|READER|3|Visit_3|40|3|FOLLOW-UP|2020-07-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|7|LCI|Lung Clearance Index|[?]|SLING|[?]|deg|[?]|1|nkat/L|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|BILATERAL|DORSOLATERAL|OPTICAL MAPPING||||FRIEND|READER|4|Visit_4|65|7|TREATMENT|2020-08-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|8|DLCOHC|HGB Corrected DLCO|[?]|FOWLERS|[?]|PLUG|[?]|1|/LPF|OVARY|LEFT|DISTAL VOLAR|TONOMETRY||||INTERVIEWER|CLINICAL PATHOLOGIST|4|Visit_4|65|1|SCREENING|2020-08-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|9|OXYPULSE|Oxygen Pulse|[?]|SITTING, LEGS DEPENDENT|[?]|m3|[?]|1|mOsm/L|SACRAL TUBEROSITY|LATERAL|SUPERIOR|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||SIBLING|READER 2|5|Visit_5|90|6|SCREENING|2020-09-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|18504c4e-41c8-4c1a-a479-d179ccd318e3|10|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/kg/min|SKIN OF THE BUTTOCK|RIGHT|INNER|TRANSVAGINAL ULTRASOUND|||Y|VENDOR|RATER 1|5|Visit_5|90|2|WASHOUT|2020-09-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|1|PLMBLFLW|Pulmonary Blood Flow|[?]|PRONE|[?]|U|[?]|1|mm3/mm2/year|VASTUS MEDIALIS MUSCLE|LATERAL|CRANIAL|CALCULATION|Y|||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|TREATMENT|2020-08-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|2|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|[?]|min/day|[?]|1|mmol/day|HEART, VENTRICULAR WALL|RIGHT|TIP|TRIPLE-PHASE MRI SCAN||Y||PROXY|PATHOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-08-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|[?]|nm|[?]|1|mL/(min*100mL)|ASCENDING AORTA|LATERAL|TIP|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|Y|||ADJUDICATOR|RATER|2|Visit_2|25|5|TREATMENT|2020-09-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|4|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|VOXEL|[?]|1|TRANSDUCING UNIT/mL|CORONARY ARTERY, LEFT|BILATERAL|TIP|FLOW MICROSCOPY||||INDEPENDENT ASSESSOR|ADJUDICATOR 1|2|Visit_2|25|3|SCREENING|2020-09-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|[?]|RING|[?]|1|AU/mL|BICEPS BRACHII MUSCLE|RIGHT|SUPERFICIAL|GRADIENT DIFFUSION||||PARENT|MICROSCOPIST 3|3|Visit_3|40|5|WASHOUT|2020-09-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|DECUBITUS|[?]|GPS U|[?]|1|nmol BCE/mmol|NOSE|IPSILATERAL|BASAL|ELECTROCHEMILUMINESCENCE||Y||INTERVIEWER|ADJUDICATOR 1|3|Visit_3|40|4|TREATMENT|2020-09-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|7|PEF|Peak Expiratory Flow|[?]|SUPINE|||[?]|1|Coulomb|UMBILICAL CORD|UNILATERAL|MEDIAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||Y|ADJUDICATOR|OPTOMETRIST|4|Visit_4|65|7|TREATMENT|2020-10-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|8|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|U/kg/min|[?]|1|10^3/L|TEMPOROMANDIBULAR JOINT|RIGHT|INFERIOR|BIOPSY||||ADJUDICATOR|READER 3|4|Visit_4|65|3|TREATMENT|2020-10-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|9|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING|[?]|DRINK|[?]|1|U/g/min|MESENTERIC LYMPH NODE|LEFT|LOWER EXTENSOR SURFACE|IN VITRO GENE EXPRESSION ASSAY|Y|Y||GUARDIAN|READER 3|5|Visit_5|90|1|SCREENING|2020-11-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|7f211d8a-7478-4082-8d95-4ace9ceee919|10|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|dB|[?]|1|PACK|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|BILATERAL|BASAL|IMMUNOCHROMATOGRAPHY|Y|||INVESTIGATOR|OPTOMETRIST|5|Visit_5|90|1|TREATMENT|2020-11-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING|[?]|mL/m2|[?]|1|U/g Hb|BRONCHUS|BILATERAL|PERIPHERAL|TEST STRIP|Y|||FRIEND|PATHOLOGIST 1|1|Visit_1|10|4|FOLLOW-UP|2020-10-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|U|[?]|1|10^6/g|ESOPHAGUS|UNILATERAL|APICAL|FLAME PHOTOMETRY||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-10-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|3|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|[?]|g/cage/wk|[?]|1|PELLET|OPTIC DISC|UNILATERAL|PERIVENTRICULAR|ERGOSPIROMETRY||||FRIEND|RADIOLOGIST|2|Visit_2|25|6|SCREENING|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|||[?]|1|mmHg*min/L|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LATERAL|MIDLINE|DROPLET DIGITAL PCR|||Y|ADJUDICATOR|ENDOCRINOLOGIST|2|Visit_2|25|5|SCREENING|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|5|PEFTIME|Peak Expiratory Flow Time|[?]|TRENDELENBURG|[?]|10^5/L|[?]|1|Arbitrary U|LATERAL SECOND DIAGONAL BRANCH ARTERY|BILATERAL|INTERMEDIATE|INDIA INK STAIN|Y|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|3|Visit_3|40|4|WASHOUT|2020-11-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING|[?]|Coulomb|[?]|1|%(w/w)|C2 VERTEBRA|LATERAL|ANTEROPOSTERIOR|GC/FID||||FRIEND|FORENSIC PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mm3/mm2/year|[?]|1|Tbsp|SUBMANDIBULAR LYMPH NODE|LEFT|INTERMEDIATE|PATHOLOGICAL EVALUATION|Y|Y||GUARDIAN|MICROSCOPIST 2|4|Visit_4|65|1|SCREENING|2020-12-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|8|EFFIND|Effusion Indicator|[?]|STANDING, BENT FORWARD|[?]|ug/kg/h|[?]|1|BU|AORTIC VALVE, NON-CORONARY CUSP|RIGHT|LOWER EXTENSOR SURFACE|PALPATION|Y|Y||CAREGIVER|MICROSCOPIST 1|4|Visit_4|65|4|TREATMENT|2020-12-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|9|PLMXRS|Pulmonary Reactance|[?]|TRENDELENBURG|[?]|mg/kg/min|[?]|1|HOMEOPATHIC DILUTION|ANAL CANAL|BILATERAL|CAUDAL|SINGLE-MOLECULE ARRAY|Y|||GUARDIAN|OPHTHALMOLOGIST|5|Visit_5|90|4|TREATMENT|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|0739e140-bcac-4df9-9629-bd0748d1fdd6|10|EFFVOL|Effusion Volume|[?]|SITTING|[?]|log EID 50/dose|[?]|1|ft2|LUNATE BONE|CONTRALATERAL|DEEP|NUCLEIC ACID AMPLIFICATION TEST||||INVESTIGATOR|RATER|5|Visit_5|90|2|WASHOUT|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|ERVPP|Percent Predicted ERV|[?]|DECUBITUS|[?]|/4.0 mL|[?]|1|CFU/mL|SKIN OF THE HEAD|UNILATERAL|INFERIOR|PULSE OXIMETRY|Y|||PARENT|PATHOLOGIST 1|1|Visit_1|10|2|WASHOUT|2020-12-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|2|TSUHYS|Tissue Hysteresivity|[?]|LEFT LATERAL DECUBITUS|[?]|10^9/dose|[?]|1|g/kg/day|TRACHEA|IPSILATERAL|VENTROLATERAL|IMMUNORADIOMETRIC ASSAY||||GUARDIAN|RATER 1|1|Visit_1|10|5|WASHOUT|2020-12-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|3|FEV6PP|Percent Predicted FEV6|[?]|SUPINE|[?]|IU/kg|[?]|1|ug/kg/min|THROAT|UNILATERAL|HIND|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||ADJUDICATION COMMITTEE|MICROSCOPIST 1|2|Visit_2|25|3|WASHOUT|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|gtt|[?]|1|10^12/L|AZYGOS VEIN|RIGHT|DISTAL VOLAR|SNP ARRAY||Y||FAMILY MEMBER|CLINICAL PATHOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|5|FIF75|Forced Inspiratory Flow at 75%|[?]|SUPINE|[?]|TRANSDUCING UNIT/mL|[?]|1|mmHg/sec|BILIARY TRACT|BILATERAL|DISTAL|DYNAMIC CONTRAST ENHANCED MRI||||GUARDIAN|CLINICAL PATHOLOGIST|3|Visit_3|40|5|WASHOUT|2021-01-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|6|MEPPP|Percent Predicted MEP|[?]|SITTING|||[?]|1|fmol|RIGHT ATRIAL ENDOCARDIUM|CONTRALATERAL|VOLAR|COLORIMETRY|||Y|CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|SCREENING|2021-01-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|SEMI-RECUMBENT|[?]|mIU/L|[?]|1|WAFER|VOMER|CONTRALATERAL|PERIPHERAL|LASER CAPTURE MICRODISSECTION|Y|||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2021-02-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Gauss|TRAPEZIAL BONE|RIGHT|CENTRAL|LINE PROBE ASSAY|||Y|CLINICAL RESEARCH COORDINATOR|UROLOGIST|4|Visit_4|65|4|SCREENING|2021-02-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|9|TVPP|Percent Predicted Tidal Volume|[?]|SUPINE|[?]|10^4 CFU/mL|[?]|1|Joule|RENAL FOSSA|LEFT|FORE|IMMUNOTURBIDIMETRY||||ADJUDICATOR|INTERNIST|5|Visit_5|90|7|FOLLOW-UP|2021-03-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|10|ERVPP|Percent Predicted ERV|[?]|STANDING|||[?]|1|MASK|SPINAL ACCESSORY NERVE|IPSILATERAL|ANTEROMEDIAL|ACRIDINE ORANGE STAIN|||Y|INTERVIEWER|OPTOMETRIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|[?]|U/mg|[?]|1|/ms|PARALARYNGEAL LYMPH NODE|UNILATERAL|PERIVENTRICULAR|AGAR DILUTION||||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|1|Visit_1|10|4|TREATMENT|2020-05-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|||[?]|1|ug/g/day|CARPOMETACARPAL JOINT 2|UNILATERAL|PARIETO-OCCIPITAL|SLOAN LETTER EYE CHART 2.5%||Y|Y|PROXY|FORENSIC PATHOLOGIST|1|Visit_1|10|2|WASHOUT|2020-05-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|3|INTP|Interpretation|[?]|FOWLERS|[?]|cm/min|[?]|1|ppth|GREAT SAPHENOUS VEIN|CONTRALATERAL|SUPERIOR|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||STUDY SUBJECT|ADJUDICATOR 1|2|Visit_2|25|6|WASHOUT|2020-05-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-16
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|4|TSUELAS|Tissue Elastance|[?]|DECUBITUS|[?]|Enzyme U/L|[?]|1|Log10 ELISA unit|LESSER TROCHANTER|RIGHT|UPPER|RIA||||INVESTIGATOR|PATHOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-05-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-16
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|5|SVC|Slow Vital Capacity|[?]|SLING|[?]|10^6 organisms/g|[?]|1|YEARS|CEREBELLUM|CONTRALATERAL|OUTER|KLEIHAUER-BETKE|Y|||GUARDIAN|ADJUDICATOR|3|Visit_3|40|2|SCREENING|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|6|FIF50|Forced Inspiratory Flow at 50%|[?]|PRONE|[?]|pmol/10^10 cells|[?]|1|10^11/L|LOWER GASTROINTESTINAL TRACT LYMPH NODE|UNILATERAL|ANTEROPOSTERIOR|SPECT/CT SCAN||||ADJUDICATOR|READER|3|Visit_3|40|7|TREATMENT|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|MONTHS|[?]|1|mm2|WRIST JOINT EXTENSOR MUSCLES|CONTRALATERAL|LATERAL|RADIAL IMMUNODIFFUSION|Y|||INVESTIGATOR|READER|4|Visit_4|65|1|TREATMENT|2020-07-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|SUPINE|||[?]|1|10^7 PFU|CRANIAL CAVITY|IPSILATERAL|VENTROLATERAL|PEAK FLOWMETRY|||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|4|Visit_4|65|4|TREATMENT|2020-07-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|9|FIFMAX|Maximum Forced Inspiratory Flow|[?]|UNCONSTRAINED|[?]|mU|[?]|1|cal|TRICUSPID VALVE, SEPTAL CUSP|CONTRALATERAL|PERIVENTRICULAR|POPULATION SEQUENCING||||ADJUDICATOR|ONCOLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|RE|f24b931a-2cdd-4432-a1dd-69c7286f4690|10|LOBVOL|Lobar Volume|[?]|SITTING|[?]|mV*min|[?]|1|PFU|FACET JOINT|CONTRALATERAL|OCCIPITAL|MIGET|Y|||SIBLING|CLINICAL PATHOLOGIST|5|Visit_5|90|2|WASHOUT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|RE|d394120d-7630-4fcf-a336-482599d88296|1|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|[?]|fmol/L|[?]|1|POUCH|ADDUCTOR MAGNUS MUSCLE|BILATERAL|PERIPHERAL|IMMUNORADIOMETRIC ASSAY|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|1|Visit_1|10|4|TREATMENT|2021-01-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|d394120d-7630-4fcf-a336-482599d88296|2|FIO2|Fraction of Inspired Oxygen|[?]|STANDING, BENT FORWARD|[?]|CAPLET|[?]|1|umol/h/mmol|L2-L3 INTERVERTEBRAL SPACE|RIGHT|UPPER EXTENSOR SURFACE|PERIPHERAL ANGIOGRAPHY||||INDEPENDENT ASSESSOR|DERMATOLOGIST|1|Visit_1|10|3|TREATMENT|2021-01-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|d394120d-7630-4fcf-a336-482599d88296|3|RER|Respiratory Exchange Ratio|[?]|PRONE|[?]|umol/kg/min|[?]|1|CFU/g|MIDDLE PHALANX 3 OF THE HAND|UNILATERAL|TEMPORAL|HPLC-UV||||ADJUDICATOR|PHYSIOTHERAPIST|2|Visit_2|25|3|TREATMENT|2021-02-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|d394120d-7630-4fcf-a336-482599d88296|4|FVC|Forced Vital Capacity|[?]|DECUBITUS|[?]|/ms|[?]|1|10^9/g|AORTOPULMONARY WINDOW LYMPH NODE|IPSILATERAL|MIDLINE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||SIBLING|RATER 2|2|Visit_2|25|5|FOLLOW-UP|2021-02-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|d394120d-7630-4fcf-a336-482599d88296|5|MALIND|Malignancy Indicator|[?]|SLING|[?]|nU/cL|[?]|1|pmol/10^10 cells|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|CONTRALATERAL|UPPER|HEMOCYTOMETRY||||CHILD|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-02-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|d394120d-7630-4fcf-a336-482599d88296|6|TLC|Total Lung Capacity|[?]|FOWLERS|||[?]|1|nmol BCE/mmol|HEART, BASE|RIGHT|ANTERIOR|CALCOFLUOR WHITE STAIN|||Y|INDEPENDENT ASSESSOR|RATER 1|3|Visit_3|40|1|WASHOUT|2021-02-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|d394120d-7630-4fcf-a336-482599d88296|7|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|g|[?]|1|ug/L/h|COLON, SPLENIC FLEXURE|BILATERAL|ANTERIOR|ENDPOINT DILUTION ASSAY|Y|||INVESTIGATOR|NEUROLOGIST 2|4|Visit_4|65|1|FOLLOW-UP|2021-03-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|d394120d-7630-4fcf-a336-482599d88296|8|EFFVOL|Effusion Volume|[?]|UNCONSTRAINED|[?]|g/m2/day|[?]|1|ukat/L|GLENOID FOSSA|UNILATERAL|INNER|CONTRAST ENHANCED SPIRAL CT SCAN||||GUARDIAN|MICROSCOPIST 3|4|Visit_4|65|4|WASHOUT|2021-03-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|d394120d-7630-4fcf-a336-482599d88296|9|ICREV|IC Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|mph|[?]|1|Ci/ug|EPIGASTRIC REGION|LEFT|LOWER MEDIAL|TRANSMISSION ELECTRON MICROSCOPY|Y|||CAREGIVER|PATHOLOGIST|5|Visit_5|90|4|SCREENING|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-17
e|RE|d394120d-7630-4fcf-a336-482599d88296|10|MIPPP|Percent Predicted MIP|[?]|DECUBITUS|||[?]|1|MBq/uL|PARALARYNGEAL LYMPH NODE|IPSILATERAL|APICAL|MICROARRAY|||Y|ADJUDICATOR|RATER 2|5|Visit_5|90|7|TREATMENT|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-17
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|PEF|Peak Expiratory Flow|[?]|SLING|[?]|BEAM BREAKS|[?]|1|NEBULE|ANKLE JOINT|IPSILATERAL|LATERAL|MYELOPEROXIDASE STAIN||||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST|1|Visit_1|10|7|TREATMENT|2020-10-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|2|ALVVOL|Alveolar Volume|[?]|UNCONSTRAINED|[?]|Absorbance U/mL|[?]|1|kUSP|AORTIC VALVE ANNULUS|RIGHT|LOWER EXTENSOR SURFACE|MICROBIAL CULTURE||||DOMESTIC PARTNER|MICROSCOPIST|1|Visit_1|10|1|TREATMENT|2020-10-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|3|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-FOWLERS|[?]|PATCH|[?]|1|MHz|TRICUSPID VALVE|RIGHT|OCCIPITAL|CAPILLARY ELECTROPHORESIS||||ADJUDICATION COMMITTEE|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|4|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-FOWLERS|[?]|BAU|[?]|1|10^6 organisms/mL|CORPUS CALLOSUM, GENU|IPSILATERAL|APICAL|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||INVESTIGATOR|READER 1|2|Visit_2|25|5|SCREENING|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|5|PNIF|Peak Nasal Inspiratory Flow|[?]|FOWLERS|||[?]|1|PFU/animal|SACROILIAC JOINT|LEFT|FACIAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|||Y|CHILD|NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|6|FEV1FVC6|FEV1/FVC6|[?]|TRENDELENBURG|[?]|mg/L|[?]|1|Ejaculate U|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL|ANTERIOR|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||INTERVIEWER|MICROSCOPIST 1|3|Visit_3|40|1|TREATMENT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|7|GAW|Airway Conductance|[?]|SEMI-RECUMBENT|[?]|IU/dL|[?]|1|h*%|SUBSTANTIA NIGRA|IPSILATERAL|INNER|POTENTIOMETRY||||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|TREATMENT|2020-12-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|8|FEV6PP|Percent Predicted FEV6|[?]|LATERAL DECUBITUS|||[?]|1|PELLET|FLEXOR DIGITORUM LONGUS MUSCLE|LATERAL|DISTAL VOLAR|TOTAL BODY IRRADIATION||Y|Y|INDEPENDENT ASSESSOR|READER 1|4|Visit_4|65|5|TREATMENT|2020-12-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|kcal|[?]|1|V/sec|C4 VERTEBRA|LATERAL|PARIETO-OCCIPITAL|CAPILLARY ELECTROPHORESIS||||INDEPENDENT ASSESSOR|READER|5|Visit_5|90|6|FOLLOW-UP|2021-01-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|bcda1d95-58ed-4991-9395-0b98efc1d9a1|10|LOBVOL|Lobar Volume|[?]|STANDING|[?]|um|[?]|1|cmol|CHOROID PLEXUS|LEFT|CENTRAL|TRIPLE-PHASE MRI SCAN||||CLINICAL RESEARCH ASSOCIATE|READER 1|5|Visit_5|90|4|TREATMENT|2021-01-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|MIPPP|Percent Predicted MIP|[?]|STANDING|[?]|10^3 CFU|[?]|1|mmol/kg|C2 VERTEBRA|CONTRALATERAL|LOWER EXTENSOR SURFACE|PHASE-CONTRAST MRI|Y|Y||FRIEND|RATER|1|Visit_1|10|5|FOLLOW-UP|2020-08-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|2|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|[?]|GBq/g|[?]|1|cd/m2|GREAT VESSELS|IPSILATERAL|MEDIAL|PET/CT SCAN WITHOUT CONTRAST||||STUDY SUBJECT|ONCOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-08-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|3|FEV1SVC|FEV1/SVC|[?]|REVERSE TRENDELENBURG|[?]|scm|[?]|1|APL U|PARASPINAL REGION|CONTRALATERAL|APICAL|BIOIMPEDANCE SPECTROSCOPY||||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-08-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|4|MALIND|Malignancy Indicator|[?]|SITTING|||[?]|1|IU/kg|ACCESSORY RENAL ARTERY|LEFT|LOWER EXTENSOR SURFACE|X-RAY FLUORESCENCE SPECTROMETRY|||Y|ADJUDICATOR|ADJUDICATOR 3|2|Visit_2|25|5|SCREENING|2020-08-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|5|FEV1SVC|FEV1/SVC|[?]|SEMI-FOWLERS|||[?]|1|pmol/dL|SKIN OF THE THIGH|UNILATERAL|PROXIMAL|AMSLER GRID|||Y|STUDY SUBJECT|MICROSCOPIST 2|3|Visit_3|40|5|SCREENING|2020-09-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|6|FIV1PP|Percent Predicted FIV1|[?]|SEMI-RECUMBENT|[?]|TROCHE|[?]|1|U/kg|FOOT DIGIT 1|CONTRALATERAL|OUTER|SLOAN LETTER EYE CHART 100%||||CAREGIVER|FORENSIC PATHOLOGIST|3|Visit_3|40|6|SCREENING|2020-09-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|7|PEF|Peak Expiratory Flow|[?]|STANDING|[?]|LOZENGE|[?]|1|vg/kg|PRESACRAL SPACE|LATERAL|FORE|ACRIDINE ORANGE STAIN||||SIBLING|MICROSCOPIST 3|4|Visit_4|65|4|TREATMENT|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|8|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|||[?]|1|GLOBULE|ISCHIUM|IPSILATERAL|INNER|SIZE EXCLUSION CHROMATOGRAPHY|||Y|CLINICAL STUDY SPONSOR|CARDIOLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|9|FEV1PP|Percent Predicted FEV1|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|pt_us|RENAL ARTERY|LEFT|SUPERIOR|X-RAY FLUORESCENCE SPECTROMETRY||Y|Y|CAREGIVER|RATER|5|Visit_5|90|1|TREATMENT|2020-11-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|6999bd5c-0790-42b8-a4ff-e538776b0fb0|10|INTP|Interpretation|[?]|RIGHT LATERAL DECUBITUS|[?]|10^6 U|[?]|1|uL/kg/day|TESTIS|RIGHT|OUTER|ORCHIDOMETERY||||CAREGIVER|READER 1|5|Visit_5|90|2|TREATMENT|2020-11-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|OXYPULSE|Oxygen Pulse|[?]|STANDING|[?]|mL/day|[?]|1|s/h|POSTERIOR SUPERIOR ILIAC SPINE|RIGHT|PROXIMAL|PANENDOSCOPY||||VENDOR|RATER 2|1|Visit_1|10|5|TREATMENT|2020-12-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|REVERSE TRENDELENBURG|||[?]|1|kPa/L/sec|CARDIAC VALVE|RIGHT|VOLAR|BIOIMPEDANCE SPECTROSCOPY|Y||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|1|Visit_1|10|4|SCREENING|2020-12-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|PRONE|[?]|DAgU/mL|[?]|1|steps/min|C1 VERTEBRA|BILATERAL|OUTER|PHOROPTER|Y|||SIGNIFICANT OTHER|READER 1|2|Visit_2|25|1|SCREENING|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|mL/s|[?]|1|Ci/mL|URETHRA, PROSTATIC|LATERAL|FRONTAL|CONTRAST ENHANCED PET SCAN||||DOMESTIC PARTNER|NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|PRONE|[?]|kg/L|[?]|1|g/cm2|ADRENAL GLAND|IPSILATERAL|ANTERIOR|MAGNETIC RESONANCE ANGIOGRAPHY||||CHILD|MICROSCOPIST 1|3|Visit_3|40|1|TREATMENT|2021-01-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|6|FEF2575|Forced Expiratory Flow 25-75%|[?]|DECUBITUS|[?]|mL/min/mmHg|[?]|1|FEU|EYE, ANTERIOR SEGMENT|RIGHT|LOWER EXTENSOR SURFACE|KLEIHAUER-BETKE||||PROXY|UROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2021-01-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|7|GAW|Airway Conductance|[?]|PRONE|||[?]|1|cmH2O*s2/mL|BRACHIOCEPHALIC ARTERY|IPSILATERAL|ANTEROPOSTERIOR|QUANTITATIVE ULTRASOUND||Y|Y|SIBLING|MICROSCOPIST 3|4|Visit_4|65|3|FOLLOW-UP|2021-02-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING|[?]|Roentgen|[?]|1|CYLINDER|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|IPSILATERAL|ANTEROMEDIAL|BETA LACTAMASE||Y||INTERVIEWER|ONCOLOGIST 2|4|Visit_4|65|4|WASHOUT|2021-02-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|9|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SUPINE|[?]|fmol|[?]|1|Bq/L|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|ROSTRAL|CELLULAR PROLIFERATION ASSAY|Y|||FAMILY MEMBER|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2021-03-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|10|TSUELAS|Tissue Elastance|[?]|RIGHT LATERAL DECUBITUS|[?]|BAU|[?]|1|mg/g/min|GASTRIC CURVATURE LYMPH NODE|RIGHT|DISTAL|ALCIAN BLUE STAIN||||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|5|Visit_5|90|5|WASHOUT|2021-03-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|1|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-RECUMBENT|[?]|/min|[?]|1|100 IU/mL|RIB 10|UNILATERAL|TIP|WRIGHT-GIEMSA STAIN||||PARENT|MICROSCOPIST 2|1|Visit_1|10|4|TREATMENT|2021-01-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|2|FEV6PP|Percent Predicted FEV6|[?]|LEFT LATERAL DECUBITUS|||[?]|1|U/kg/day|L2 VERTEBRA|IPSILATERAL|DEEP|SCANNING ELECTRON MICROSCOPY|||Y|SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|3|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|mEq/g|[?]|1|Ejaculate U|UPPER URINARY SYSTEM|CONTRALATERAL|VOLAR|QUANTITATIVE ULTRASOUND||||CAREGIVER|ONCOLOGIST|2|Visit_2|25|4|TREATMENT|2021-01-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|4|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|nmol BCE/nmol|[?]|1|nkat/L|CUBOID BONE|BILATERAL|DISTAL VOLAR|PUPILLOMETRY||||CHILD|OPTOMETRIST|2|Visit_2|25|5|WASHOUT|2021-01-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|5|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|h/wk|[?]|1|EU|TOOTH CANAL|LATERAL|SURFACE|POPULATION SEQUENCING||||SPOUSE|RATER 2|3|Visit_3|40|1|SCREENING|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|6|FIFMAXPP|Percent Predicted FIFmax|[?]|RIGHT LATERAL DECUBITUS|[?]|mmHg/L/min|[?]|1|10^7 TCID 50/dose|TRICUSPID VALVE, POSTERIOR ANNULUS|CONTRALATERAL|INTERMEDIATE|GC/MS||||SIGNIFICANT OTHER|READER|3|Visit_3|40|4|FOLLOW-UP|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|7|FIFMAXPP|Percent Predicted FIFmax|[?]|PRONE|||[?]|1|10^9 organisms/g|PELVIC BONE|BILATERAL|SUBCORTICAL|RADIAL IMMUNODIFFUSION||Y|Y|INTERVIEWER|UROLOGIST|4|Visit_4|65|7|TREATMENT|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|8|FIV1PP|Percent Predicted FIV1|[?]|SEMI-FOWLERS|[?]|Torr|[?]|1|pmol/L/h|ANKLE MORTISE|LEFT|HIND|BIOPSY|Y|Y||INTERVIEWER|NEUROLOGIST 1|4|Visit_4|65|6|TREATMENT|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|9|DLCOHC|HGB Corrected DLCO|[?]|SLING|[?]|tsp|[?]|1|lx|ANAL CANAL|RIGHT|FACIAL|IMMUNOFIXATION ELECTROPHORESIS||Y||VENDOR|PATHOLOGIST 1|5|Visit_5|90|2|TREATMENT|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|59b0fee3-2294-448e-9837-38bd6b5c794b|10|PEFTIME|Peak Expiratory Flow Time|[?]|RIGHT LATERAL DECUBITUS|[?]|LB|[?]|1|g/g|ABDUCTOR DIGITI QUINTI MUSCLE|IPSILATERAL|OCCIPITAL|ORCHIDOMETERY||||PARENT|FORENSIC PATHOLOGIST|5|Visit_5|90|5|SCREENING|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|1|FIF25|Forced Inspiratory Flow at 25%|[?]|SLING|||[?]|1|g/day|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|PERIPHERAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||Y|Y|SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|2|SCREENING|2020-12-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|2|INTP|Interpretation|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^3 organisms/mL|MIDDLE EAR|BILATERAL|HIND|CINEANGIOGRAPHY|Y|Y|Y|PARENT|ONCOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|UNCONSTRAINED|[?]|SFC/10^6 PBMC|[?]|1|ECL unit|PROXIMAL INTERPHALANGEAL JOINT 5|IPSILATERAL|VENTROLATERAL|SCINTIGRAPHY||||CAREGIVER|READER 2|2|Visit_2|25|3|TREATMENT|2021-01-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|4|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|mmHg|[?]|1|g/g|INTESTINE|LATERAL|MIDLINE|LC-FL|Y|||SPOUSE|NEUROLOGIST 2|2|Visit_2|25|5|TREATMENT|2021-01-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|5|FEV1FVC6|FEV1/FVC6|[?]|PRONE|||[?]|1|DAgU/mL|RADIAL NERVE|UNILATERAL|SURFACE|INTRAVASCULAR ULTRASOUND|||Y|INVESTIGATOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|3|TREATMENT|2021-01-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|6|FIFMAXPP|Percent Predicted FIFmax|[?]|REVERSE TRENDELENBURG|||[?]|1|pm|THYROID GLAND|BILATERAL|INNER|GC/MS-CI|||Y|VENDOR|PHYSIOTHERAPIST|3|Visit_3|40|7|TREATMENT|2021-01-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|7|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|[?]|Ci/mL|[?]|1|kg|SUBSTANTIA NIGRA|IPSILATERAL|MEDIAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||STUDY SUBJECT|ONCOLOGIST 1|4|Visit_4|65|7|TREATMENT|2021-02-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|8|FEV3FVC|FEV3/FVC|[?]|REVERSE TRENDELENBURG|[?]|10^9 CFU/g|[?]|1|mEq/L|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|LEFT|DISTAL|PALM METHOD|Y|Y||INDEPENDENT ASSESSOR|PHYSIOTHERAPIST|4|Visit_4|65|1|FOLLOW-UP|2021-02-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|9|FIF75|Forced Inspiratory Flow at 75%|[?]|REVERSE TRENDELENBURG|||[?]|1|/4.0 mL|PARS COMPACTA|LEFT|VENTROLATERAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y||Y|CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-03-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|RE|d9bdb1e3-4630-423f-be01-4873bce30422|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|REVERSE TRENDELENBURG|[?]|%(w/w)|[?]|1|DIOPTER|ULNAR NERVE|LATERAL|SURFACE|APPLANATION TONOMETRY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|5|Visit_5|90|5|TREATMENT|2021-03-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|MIP|Maximal Inspiratory Pressure|[?]|SITTING, LEGS DEPENDENT|[?]|ug/L|[?]|1|mL/beat|T8 VERTEBRA|IPSILATERAL|SUPERFICIAL|CLIP|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|1|Visit_1|10|5|TREATMENT|2020-06-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|2|IVC|Inspiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|log10 IU/mL|[?]|1|FIU|PROSTATE GLAND, LATERAL LOBE|LATERAL|CENTRAL|DIGITAL PCR||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|1|Visit_1|10|3|TREATMENT|2020-06-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|3|IVC|Inspiratory Vital Capacity|[?]|FOWLERS|||[?]|1|ug/m2|UPPER RESPIRATORY SYSTEM|UNILATERAL|PROXIMAL VOLAR|HPLC/IEX|Y||Y|INDEPENDENT ASSESSOR|READER|2|Visit_2|25|6|TREATMENT|2020-07-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|4|SVC|Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|CONTAINER|[?]|1|mg/min|ACROMIOCLAVICULAR JOINT|RIGHT|PROXIMAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||INVESTIGATOR|MICROSCOPIST|2|Visit_2|25|7|SCREENING|2020-07-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|5|QUASCOMP|Quasi-Static Compliance|[?]|SUPINE|||[?]|1|amol|LIVER, QUADRATE LOBE|RIGHT|SUPERFICIAL|PANENDOSCOPY|||Y|CLINICAL STUDY SPONSOR|OPTOMETRIST|3|Visit_3|40|3|FOLLOW-UP|2020-07-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|6|FEF2575|Forced Expiratory Flow 25-75%|[?]|FOWLERS|[?]|/HPF|[?]|1|PRESSOR UNITS|PHARYNX|LATERAL|PERIPHERAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||STUDY SUBJECT|NEUROLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-07-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|7|FRCPP|Percent Predicted FRC|[?]|LEFT LATERAL DECUBITUS|[?]|APL U/mL|[?]|1|Bq/L|FEMUR SHAFT|LATERAL|PERIPHERAL|NUCLEIC ACID AMPLIFICATION TEST||||INDEPENDENT ASSESSOR|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-08-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|8|TGV|Thoracic Gas Volume|[?]|SEMI-RECUMBENT|[?]|Gy/min|[?]|1|cm|ILIAC CREST|RIGHT|VOLAR|TRIPLE-PHASE MRI SCAN|Y|||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|9|FEV_PEF|FEV at PEF|[?]|UNCONSTRAINED|[?]|/4.0 mL|[?]|1|kg/m2|SKIN OF THE INFRASCAPULAR REGION|IPSILATERAL|UPPER EXTENSOR SURFACE|ELECTROCHEMILUMINESCENCE||||PARENT|PATHOLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-09-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-RECUMBENT|[?]|/wk|[?]|1|mmol2/L2|HAIR BULB|LATERAL|INNER|IHC|Y|Y||INVESTIGATOR|HEMATOLOGIST|5|Visit_5|90|2|SCREENING|2020-09-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING|[?]|mL*cmH2O|[?]|1|umol/kg/min|METATARSOPHALANGEAL JOINT 3|CONTRALATERAL|ROSTRAL|JAEGER EYE CHART||||DOMESTIC PARTNER|MICROSCOPIST 1|1|Visit_1|10|1|TREATMENT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|UNCONSTRAINED|[?]|ug/L/h|[?]|1|eq|PONS VAROLII|CONTRALATERAL|DORSOLATERAL|SPECT/CT SCAN||||CHILD|NEUROLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|3|FEV6PP|Percent Predicted FEV6|[?]|TRENDELENBURG|[?]|10^6 organisms|[?]|1|MPS U|HAMSTRING MUSCLE|CONTRALATERAL|VENTRAL|SIZE EXCLUSION CHROMATOGRAPHY||||DOMESTIC PARTNER|NEUROLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|4|AWVOL|Airway Volume|[?]|DECUBITUS|[?]|pmol/10^9 cells|[?]|1|mg/m2/day|CORNEAL ENDOTHELIUM|RIGHT|OUTER|CONTRAST ENHANCED PET SCAN||||FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|7|TREATMENT|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|5|IC|Inspiratory Capacity|[?]|SITTING|||[?]|1|BU/mL|SUBMENTAL LYMPH NODE|LATERAL|ANTERIOR|JAEGER EYE CHART|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|6|GAW|Airway Conductance|[?]|LATERAL DECUBITUS|[?]|m/sec|[?]|1|10^3 RNA copies/mL|STERNUM|UNILATERAL|CAUDAL|FLOCCULATION||||CAREGIVER|ADJUDICATOR 3|3|Visit_3|40|1|FOLLOW-UP|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|7|FIV1|Forced Inspiratory Volume in 1 Second|[?]|DECUBITUS|[?]|/200 HPFs|[?]|1|PNU/mL|SKIN OF THE CHIN|RIGHT|MIDLINE|IMMUNOFLUORESCENT STAIN||||PARENT|ADJUDICATOR 1|4|Visit_4|65|6|TREATMENT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|8|RELSZCHG|Relative Size Change|[?]|DECUBITUS|[?]|ks|[?]|1|mCi/kg|ENDOCERVIX|LATERAL|ROSTRAL|STRESS ECHOCARDIOGRAPHY||||ADJUDICATOR|READER 1|4|Visit_4|65|2|SCREENING|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|9|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|[?]|uCi/L|[?]|1|ms2|LIVER FISSURE|LATERAL|UPPER FLEXOR SURFACE|PERIPHERAL ANGIOGRAPHY||||SIBLING|ONCOLOGIST|5|Visit_5|90|6|TREATMENT|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|umol/mol|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|IPSILATERAL|UPPER EXTENSOR SURFACE|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y|Y|INTERVIEWER|ADJUDICATOR 1|5|Visit_5|90|6|SCREENING|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|1|EFFVOL|Effusion Volume|[?]|UNCONSTRAINED|||[?]|1|aMFI|COMMON ILIAC ARTERY|CONTRALATERAL|VOLAR|INDIRECT IMMUNOFLUORESCENCE|||Y|SIGNIFICANT OTHER|ADJUDICATOR 2|1|Visit_1|10|1|TREATMENT|2020-09-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|mol|[?]|1|rpm|DISTAL PHALANX 2 OF THE HAND|UNILATERAL|INNER|CT SCAN||||DOMESTIC PARTNER|NEUROLOGIST|1|Visit_1|10|6|TREATMENT|2020-09-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|3|VO2|Oxygen Consumption|[?]|SITTING, LEGS DEPENDENT|[?]|HEP|[?]|1|10^8/L|T7 VERTEBRA|BILATERAL|VENTRAL|MICROBIAL CULTURE, SOLID||||FAMILY MEMBER|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-09-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|4|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|[?]|mm/2h|[?]|1|BOX|SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|ANTEROLATERAL|SPIRAL CT SCAN WITHOUT CONTRAST||||FRIEND|ADJUDICATOR 1|2|Visit_2|25|3|WASHOUT|2020-09-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|5|FRCPP|Percent Predicted FRC|[?]|UNCONSTRAINED|[?]|Log10 ELISA unit|[?]|1|log10 CFU/mL|LIVER FISSURE|CONTRALATERAL|PROXIMAL VOLAR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|3|Visit_3|40|5|SCREENING|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|6|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|||[?]|1|ka_u/dL|BICEPS BRACHII MUSCLE|BILATERAL|ANTERIOR|MICRONEUTRALIZATION ASSAY|||Y|DOMESTIC PARTNER|NEUROLOGIST 1|3|Visit_3|40|4|SCREENING|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|7|FEV_PEF|FEV at PEF|[?]|LEFT LATERAL DECUBITUS|[?]|umol/L|[?]|1|Shock Wave|PROSTATE GLAND, POSTERIOR LOBE|LATERAL|TIP|IMMUNOFLUORESCENT STAIN||||CAREGIVER|NEUROLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|[?]|in|[?]|1|10^6 organisms/mg|THORACIC VERTEBRA|LEFT|LOWER|MAPH||||FAMILY MEMBER|ADJUDICATOR 1|4|Visit_4|65|1|TREATMENT|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|9|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|mL/m2|[?]|1|U/kg/h|VEIN|RIGHT|ANTEROMEDIAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|Y||GUARDIAN|OPHTHALMOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-11-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|933c3a61-59a0-4cfb-ae17-45bc48229323|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|[?]|log10 copies/mL|[?]|1|U/mmol|PREFRONTAL CORTEX|LATERAL|SUPERFICIAL|IN VITRO GENE EXPRESSION ASSAY|Y|||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|TREATMENT|2020-11-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|PIF|Peak Inspiratory Flow|[?]|SITTING|[?]|nsec|[?]|1|SACHET|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|LATERAL|ANTEROLATERAL|IMPULSE OSCILLOMETRY||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|1|Visit_1|10|6|TREATMENT|2020-10-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|2|INTP|Interpretation|[?]|SITTING|[?]|pmol|[?]|1|uL|CARDIAC WALL|IPSILATERAL|PERIVENTRICULAR|AUTOMATED COUNT|Y|Y||FRIEND|NEUROLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-10-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|3|INERTANC|Inertance|[?]|SEMI-FOWLERS|[?]|mkat|[?]|1|BAR|HIP ADDUCTORS|UNILATERAL|PROXIMAL VOLAR|PERFUSION MRI|Y|||VENDOR|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|SFC/10^6 PBMC|[?]|1|10^9 CFU|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LATERAL|HIND|PET/MRI SCAN||||SPOUSE|ADJUDICATOR 3|2|Visit_2|25|4|TREATMENT|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|5|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|10^9/dose|[?]|1|AFU|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|IPSILATERAL|VENTRAL|INFRARED SPECTROMETRY||||INTERVIEWER|NEUROLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-11-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|6|IVCPP|Percent Predicted IVC|[?]|PRONE|[?]|mCi/kg|[?]|1|mg/L FEU|HAIR BULB|LEFT|APICAL|HEMAGGLUTINATION INHIBITION ASSAY||||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-11-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|7|FIF50|Forced Inspiratory Flow at 50%|[?]|DECUBITUS|[?]|mEq/mmol|[?]|1|10^9 CFU|PERIPHERAL NERVE|IPSILATERAL|PROXIMAL|GC/MS||||ADJUDICATION COMMITTEE|MICROSCOPIST 2|4|Visit_4|65|1|SCREENING|2020-12-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|8|DLCOVAPP|Percent Predicted DLCO/VA|[?]|FOWLERS|[?]|Bq/g|[?]|1|g/dL|HAND DIGIT 5|RIGHT|INTERMEDIATE|RIA||Y||VENDOR|PATHOLOGIST|4|Visit_4|65|4|WASHOUT|2020-12-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|9|AWVOL|Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|pkat|[?]|1|Mile|PAROTID GLAND LYMPH NODE|BILATERAL|DISTAL VOLAR|PALPATION||Y||SPOUSE|ADJUDICATOR 2|5|Visit_5|90|2|FOLLOW-UP|2021-01-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|58d871e3-ef99-48da-ab12-fdfdc2e01da6|10|FIF50|Forced Inspiratory Flow at 50%|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mL/animal|TYMPANIC MEMBRANE|BILATERAL|POSTERIOR|PLETHYSMOGRAPHY|||Y|CAREGIVER|ADJUDICATOR|5|Visit_5|90|1|FOLLOW-UP|2021-01-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|[?]|ug/dose|[?]|1|m|PROXIMAL PHALANX 1 OF THE HAND|LATERAL|VOLAR|SURFACE PLASMON RESONANCE||||DOMESTIC PARTNER|PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-10-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|2|MEP|Maximal Expiratory Pressure|[?]|STANDING|[?]|mmol/s|[?]|1|10^5/L|CARDIAC VALVE|LEFT|MIDLINE|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|1|Visit_1|10|2|TREATMENT|2020-10-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|3|RRS|Total Respiratory System Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|10^9 CFU|[?]|1|mol/L|MIDDLE PHALANX 4 OF THE HAND|CONTRALATERAL|SURFACE|CONTACT SPECULAR MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|2|Visit_2|25|5|TREATMENT|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|4|INFLTIND|Infiltrates Indicator|[?]|SLING|[?]|dyn|[?]|1|psi|CORPUS CALLOSUM|CONTRALATERAL|UPPER|LASER CAPTURE MICRODISSECTION||||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|5|MALIND|Malignancy Indicator|[?]|SITTING|[?]|cm|[?]|1|ug/m2/min|PROSTATE GLAND, MIDDLE LOBE|RIGHT|FACIAL|NEXT GENERATION SEQUENCING||Y||CHILD|DERMATOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|6|LOBVOL|Lobar Volume|[?]|TRENDELENBURG|||[?]|1|fmol/L/sec|CAPITATE-HAMATE JOINT|LEFT|PARIETO-OCCIPITAL|TRANSTHORACIC ECHOCARDIOGRAPHY|Y||Y|SIBLING|RATER 1|3|Visit_3|40|3|TREATMENT|2020-11-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|7|MALIND|Malignancy Indicator|[?]|SUPINE|[?]|U/m2|[?]|1|mU|TRIANGULAR BONE|UNILATERAL|LOWER|TEST STRIP||||CLINICAL RESEARCH COORDINATOR|OPHTHALMOLOGIST|4|Visit_4|65|4|TREATMENT|2020-12-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|ug/kg/day|[?]|1|/HPF|ABDOMINAL WALL|UNILATERAL|MIDLINE|ENZYMATIC ULTRACENTRIFUGATION||||INTERVIEWER|RADIOLOGIST 2|4|Visit_4|65|7|WASHOUT|2020-12-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|9|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|ukat/L|[?]|1|deg2|CORONARY ARTERY, RIGHT|RIGHT|DEEP|NO INFORMATION||||DOMESTIC PARTNER|ADJUDICATOR 2|5|Visit_5|90|7|FOLLOW-UP|2021-01-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|ac66129e-3244-4cd8-a235-43b4bfb7dace|10|AWVOLPP|Percent Predicted Airway Volume|[?]|SUPINE|[?]|Bq/ug|[?]|1|MET*h|ELBOW EXTENSOR MUSCLES|RIGHT|ANTERIOR|HEMAGGLUTINATION INHIBITION ASSAY||||CLINICAL STUDY SPONSOR|RADIOLOGIST|5|Visit_5|90|1|TREATMENT|2021-01-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SLING|[?]|VOXEL|[?]|1|10^6 IU/mL|SUBSTANTIA NIGRA|UNILATERAL|VENTRAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||CAREGIVER|ONCOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|2|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|mg/kg/day|[?]|1|mg/mL/min|COMMON FEMORAL ARTERY|LEFT|OCCIPITAL|ANALYTICAL ULTRACENTRIFUGATION||||HEALTH CARE PROFESSIONAL|READER 1|1|Visit_1|10|3|FOLLOW-UP|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SLING|||[?]|1|U/L|LEFT POSTERIOR DESCENDING ARTERY|CONTRALATERAL|VOLAR|CLOT DETECTION|||Y|FRIEND|RATER 2|2|Visit_2|25|3|TREATMENT|2020-09-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|4|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|10^7 TCID 50/dose|[?]|1|%|CORPUS CALLOSUM|CONTRALATERAL|ANTEROLATERAL|NUCLEIC ACID HYBRIDIZATION||||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|2|Visit_2|25|2|TREATMENT|2020-09-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|5|RER|Respiratory Exchange Ratio|[?]|DECUBITUS|[?]|YEARS|[?]|1|mU|FIBULA SHAFT|CONTRALATERAL|SUPERIOR|PALPATION||Y||STUDY SUBJECT|HEMATOLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|6|FEV3FVC|FEV3/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|psec|[?]|1|mm|SCAPHOID-CAPITATE JOINT|CONTRALATERAL|DORSAL|CONTRAST ENHANCED SPIRAL CT SCAN||||GUARDIAN|NEUROLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|uV2|[?]|1|LB|CEREBRAL SUBCORTEX|RIGHT|FORE|PUPILLOMETRY||||HEALTH CARE PROFESSIONAL|OPTOMETRIST|4|Visit_4|65|5|TREATMENT|2020-10-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|8|FEV1SVC|FEV1/SVC|[?]|LEFT LATERAL DECUBITUS|[?]|gMFI|[?]|1|kBq|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|PROXIMAL VOLAR|FLUORIMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|4|Visit_4|65|7|FOLLOW-UP|2020-10-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|9|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|uIU/dL|[?]|1|pL|SPINAL CORD|IPSILATERAL|PERIVENTRICULAR|IMMUNOASSAY||||SIBLING|CLINICAL PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2020-11-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|10|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/g/day|[?]|1|10^3 RNA copies/mL|LENS|LATERAL|ANTERIOR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||PARENT|RATER 2|5|Visit_5|90|7|SCREENING|2020-11-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|1|ERVPP|Percent Predicted ERV|[?]|SEMI-RECUMBENT|[?]|C|[?]|1|%(w/w)|ANUS|IPSILATERAL|INTERMEDIATE|CLAUSS METHOD||||SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|TREATMENT|2020-10-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|2|EFFVOL|Effusion Volume|[?]|SLING|[?]|mL/sec/1.73m2|[?]|1|nmol/day|CORNEAL EPITHELIUM|LATERAL|INFERIOR|PUPILLOMETRY||Y||SIBLING|RADIOLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|3|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-FOWLERS|[?]|beats/min|[?]|1|g/U|VOMER|LEFT|VOLAR|IODINE STAIN|Y|Y||STUDY SUBJECT|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|4|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|[?]|mL/dL|[?]|1|L/h|SUBCARINAL LYMPH NODE|IPSILATERAL|NASAL|MICROPARTICLE ENZYME IMMUNOASSAY||||STUDY SUBJECT|OPTOMETRIST|2|Visit_2|25|3|SCREENING|2020-11-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|5|EFFVOL|Effusion Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/s/m2|[?]|1|mm/min|AORTOPULMONARY WINDOW LYMPH NODE|BILATERAL|BASAL|ORCHIDOMETERY|Y|||PROXY|ADJUDICATOR 1|3|Visit_3|40|4|FOLLOW-UP|2020-11-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|6|FEF50|Forced Expiratory Flow 50%|[?]|UNCONSTRAINED|||[?]|1|Enzyme U/g Hb|TIBIA|LATERAL|CENTRAL|IN VITRO GENE EXPRESSION ASSAY|||Y|FRIEND|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-11-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|7|SVC|Slow Vital Capacity|[?]|SEMI-FOWLERS|[?]|L/min|[?]|1|U/g|KNEE JOINT|LATERAL|LOWER FLEXOR SURFACE|MULTIPLE BREATH WASHOUT||||ADJUDICATOR|RADIOLOGIST 2|4|Visit_4|65|3|FOLLOW-UP|2020-12-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-RECUMBENT|||[?]|1|mN|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|IPSILATERAL|FRONTAL|NEURAMINIDASE INHIBITION ASSAY|||Y|DOMESTIC PARTNER|INTERNIST|4|Visit_4|65|5|WASHOUT|2020-12-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|9|PIF|Peak Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^6 CFU/mL|SKIN OF THE BUTTOCK|BILATERAL|ANTEROPOSTERIOR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y||Y|SIGNIFICANT OTHER|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2021-01-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|3d59a754-10bb-4847-93ea-433b43265a2f|10|DLCOHC|HGB Corrected DLCO|[?]|STANDING|||[?]|1|MBq/uL|CEREBRAL VEIN|UNILATERAL|PERIPHERAL|PERIODIC ACID SCHIFF STAIN|||Y|PARENT|OPHTHALMOLOGIST|5|Visit_5|90|2|TREATMENT|2021-01-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING|[?]|fmol|[?]|1|ppth|SKIN OF THE THIGH|UNILATERAL|POSTERIOR|WHOLE EXOME SEQUENCING||||FAMILY MEMBER|PATHOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|2|FEV3PP|Percent Predicted FEV3|[?]|SEMI-FOWLERS|[?]|in|[?]|1|cm H2O|LIP|CONTRALATERAL|ANTEROLATERAL|CT SCAN WITHOUT CONTRAST||Y||FRIEND|ADJUDICATOR 1|1|Visit_1|10|7|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ug/m2/h|HEART, LEFT ATRIAL APPENDAGE|BILATERAL|OUTER|ZIEHL NEELSEN ACID FAST STAIN|Y||Y|GUARDIAN|PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|4|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|Ci/ug|UPPER URINARY SYSTEM|CONTRALATERAL|SUPERIOR|ICP-MS|Y|||VENDOR|MICROSCOPIST 2|2|Visit_2|25|4|TREATMENT|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|5|FRC|Functional Residual Capacity|[?]|TRENDELENBURG|[?]|g/m2|[?]|1|log10 TCID 50/mL|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|RIGHT|HIND|POLYGRAPHY|Y|||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|TREATMENT|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|DECUBITUS|[?]|umol|[?]|1|uV2|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|PERIVENTRICULAR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||INVESTIGATOR|HEMATOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|7|PEFREV|PEF Reversibility|[?]|DECUBITUS|[?]|mL/kg/day|[?]|1|10^8/L|CORONARY SINUS|LATERAL|PARIETO-OCCIPITAL|ENZYMATIC COLORIMETRY|Y|||DOMESTIC PARTNER|NEUROLOGIST|4|Visit_4|65|6|TREATMENT|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|||[?]|1|ukat/L|PANCREAS, TAIL|RIGHT|PERIVENTRICULAR|INDIRECT IMMUNOFLUORESCENCE|||Y|CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|4|Visit_4|65|2|SCREENING|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|9|FEV1FVC|FEV1/FVC|[?]|SEMI-FOWLERS|[?]|10^6 IU|[?]|1|10^4/hpf|GASTRIC CURVATURE LYMPH NODE|LEFT|DISTAL|INDIA INK STAIN||||DOMESTIC PARTNER|ONCOLOGIST 2|5|Visit_5|90|5|TREATMENT|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|RE|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|10|FEV_PEF|FEV at PEF|[?]|SITTING|[?]|pmol/10^10 cells|[?]|1|EVENTS|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|UNILATERAL|DISTAL|LINE PROBE ASSAY||Y||CLINICAL STUDY SPONSOR|ONCOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|1|PLMXRS|Pulmonary Reactance|[?]|LATERAL DECUBITUS|[?]|SQU/mL|[?]|1|ugEq|SKIN OF THE ELBOW|RIGHT|TEMPORAL|COULOMETRIC TITRATION|Y|||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-09-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|2|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|[?]|mg/kg/h|[?]|1|in2|FUNDUS OF THE STOMACH|IPSILATERAL|DISTAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-09-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|3|TGV|Thoracic Gas Volume|[?]|STANDING, BENT FORWARD|||[?]|1|/sec|TRICUSPID VALVE ANNULUS|IPSILATERAL|SUPERFICIAL|IMMUNORADIOMETRIC ASSAY||Y|Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST|2|Visit_2|25|5|TREATMENT|2020-09-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|DECUBITUS|[?]|U/g/day|[?]|1|mV2/Hz|THORACIC SPINE|LATERAL|PERIPHERAL|AURAMINE STAIN|Y|Y||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|1|SCREENING|2020-09-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|||[?]|1|cmol/L|FOOT PHALANX|RIGHT|PROXIMAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y|Y|CLINICAL STUDY SPONSOR|UROLOGIST|3|Visit_3|40|7|SCREENING|2020-10-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|6|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SUPINE|[?]|in|[?]|1|ug/g/day|CERVICAL VERTEBRA|RIGHT|ROSTRAL|KARYOTYPING||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|3|Visit_3|40|2|SCREENING|2020-10-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|7|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|/200 HPFs|[?]|1|mEq/mL|MANDIBLE|BILATERAL|PARIETO-OCCIPITAL|CAPILLARY ELECTROPHORESIS||||SIBLING|RATER 1|4|Visit_4|65|6|SCREENING|2020-11-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|8|PLMBLFLW|Pulmonary Blood Flow|[?]|REVERSE TRENDELENBURG|[?]|BU|[?]|1|cy/cm|CHEST|LEFT|VENTROLATERAL|ELECTROPHORESIS||||STUDY SUBJECT|MICROSCOPIST 2|4|Visit_4|65|5|TREATMENT|2020-11-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|9|ERVPP|Percent Predicted ERV|[?]|SITTING|[?]|mOsm/kg|[?]|1|VIRTUAL PIXEL|PANCREAS|RIGHT|POSTERIOR|JAFFE REACTION|Y|Y||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|5|Visit_5|90|3|SCREENING|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|89209495-c485-4eb7-b858-8dc5490d2b64|10|TV|Tidal Volume|[?]|SITTING|[?]|mU/L|[?]|1|PIPE|ANKLE MORTISE|LEFT|POSTERIOR|DIFFUSION TENSOR MRI|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|5|Visit_5|90|5|TREATMENT|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|1|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-FOWLERS|[?]|DRINK|[?]|1|ug/mL/h|EPICONDYLE|LATERAL|MEDIAL|AURAMINE STAIN||||FAMILY MEMBER|ADJUDICATOR 3|1|Visit_1|10|3|WASHOUT|2020-12-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|2|FIO2|Fraction of Inspired Oxygen|[?]|STANDING|[?]|PFU|[?]|1|IU/g|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT|CRANIAL|LIGHT MICROSCOPY||||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|1|Visit_1|10|4|SCREENING|2020-12-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|3|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING, LEGS DEPENDENT|[?]|s^-1(%O2)^-1|[?]|1|IU/mL|ASCENDING AORTA, SINUS OF VALSALVA|RIGHT|PARIETO-OCCIPITAL|ENZYMATIC COLORIMETRY||||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2021-01-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|4|SVC|Slow Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|10^11/L|[?]|1|mL/cm H2O|TRICUSPID VALVE, POSTERIOR ANNULUS|RIGHT|FORE|SCANNING ELECTRON MICROSCOPY|Y|||VENDOR|READER|2|Visit_2|25|2|SCREENING|2021-01-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|5|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|[?]|10^3 organisms|[?]|1|U/kg/min|PHARYNGEAL TONSIL|BILATERAL|LOWER FLEXOR SURFACE|GRADIENT DIFFUSION||Y||FAMILY MEMBER|FORENSIC PATHOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2021-01-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|kDa|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|RIGHT|OCCIPITAL|FLUORESCENT SPOT TEST||Y|Y|VENDOR|RATER 1|3|Visit_3|40|4|WASHOUT|2021-01-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|7|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|||[?]|1|mmol/s|GINGIVA|LEFT|INFERIOR|MULTIPLE BREATH WASHOUT|||Y|STUDY SUBJECT|OTOLARYNGOLOGIST|4|Visit_4|65|2|TREATMENT|2021-02-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|8|IRV|Inspiratory Reserve Volume|[?]|DECUBITUS|||[?]|1|pt_us|GENITOURINARY SYSTEM|RIGHT|DISTAL|IHC|||Y|FAMILY MEMBER|FORENSIC PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|9|AWWVOL|Airway Wall Volume|[?]|SITTING, LEGS DEPENDENT|[?]|cg|[?]|1|log10 TCID 50/mL|INFRATENTORIAL BRAIN|RIGHT|PROXIMAL|NUCLEIC ACID AMPLIFICATION TEST||Y||INDEPENDENT ASSESSOR|ADJUDICATOR 2|5|Visit_5|90|4|TREATMENT|2021-03-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|d80522bb-f146-4270-a6e1-326fde50d9ca|10|IVC|Inspiratory Vital Capacity|[?]|SITTING|||[?]|1|EP U|OCCIPITAL LYMPH NODE|BILATERAL|CAUDAL|CONTRAST ENHANCED X-RAY|||Y|HEALTH CARE PROFESSIONAL|DERMATOLOGIST|5|Visit_5|90|6|TREATMENT|2021-03-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|3982a462-95f6-4e71-93e5-9df777770067|1|ELSTNCE|Elastance|[?]|UNCONSTRAINED|[?]|WAFER|[?]|1|10^10/L|MAMMARY GLAND|UNILATERAL|CRANIAL|RAJI CELL RIA|Y|Y||ADJUDICATION COMMITTEE|READER|1|Visit_1|10|1|WASHOUT|2020-12-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|3982a462-95f6-4e71-93e5-9df777770067|2|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|mL/min/1.73m2|[?]|1|Bq/mg|HEART, RIGHT ATRIAL APPENDAGE|IPSILATERAL|TEMPORAL|CONTRAST ENHANCED X-RAY||||CLINICAL STUDY SPONSOR|RADIOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-12-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|3982a462-95f6-4e71-93e5-9df777770067|3|PCF|Peak Cough Flow|[?]|PRONE|[?]|kg/cm|[?]|1|DROP|VERTEBRAL COLUMN|LEFT|PERIVENTRICULAR|TRANSTHORACIC ECHOCARDIOGRAPHY||||VENDOR|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2021-01-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|3982a462-95f6-4e71-93e5-9df777770067|4|FEF50|Forced Expiratory Flow 50%|[?]|TRENDELENBURG|[?]|HEP|[?]|1|APS U|L1 VERTEBRA|CONTRALATERAL|PERIPHERAL|ICP-MS|Y|||DOMESTIC PARTNER|READER 2|2|Visit_2|25|2|WASHOUT|2021-01-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|3982a462-95f6-4e71-93e5-9df777770067|5|IC|Inspiratory Capacity|[?]|TRENDELENBURG|[?]|%(w/v)|[?]|1|nmol BCE/L|NOSE|IPSILATERAL|SUBCORTICAL|IVY INCISION METHOD|Y|||PROXY|ONCOLOGIST 1|3|Visit_3|40|3|SCREENING|2021-01-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|3982a462-95f6-4e71-93e5-9df777770067|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|STANDING|[?]|BU/mL|[?]|1|beats/min|DISTAL INTERPHALANGEAL JOINT 2|LATERAL|TIP|SICKLE CELL SOLUBILITY TEST||||CHILD|ONCOLOGIST 2|3|Visit_3|40|2|WASHOUT|2021-01-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|3982a462-95f6-4e71-93e5-9df777770067|7|PLMBLFLW|Pulmonary Blood Flow|[?]|FOWLERS|[?]|nkat/g Hb|[?]|1|CYLINDER|SKIN OF THE HAND|UNILATERAL|SURFACE|IMMUNOBLOT||||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|4|Visit_4|65|7|SCREENING|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|3982a462-95f6-4e71-93e5-9df777770067|8|LCI|Lung Clearance Index|[?]|SEMI-RECUMBENT|[?]|Bq/mg|[?]|1|L/s|HARD PALATE|UNILATERAL|INTERMEDIATE|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||||DOMESTIC PARTNER|ENDOCRINOLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|3982a462-95f6-4e71-93e5-9df777770067|9|FEV3FVC|FEV3/FVC|[?]|SEMI-FOWLERS|[?]|/10^4|[?]|1|/40 HPFs|OPPONENS POLLICIS MUSCLE|LATERAL|INNER|PANENDOSCOPY|Y|Y||VENDOR|READER 2|5|Visit_5|90|1|TREATMENT|2021-03-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|3982a462-95f6-4e71-93e5-9df777770067|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|Farad|[?]|1|IU|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|LEFT|NASAL|AUSCULTATION||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-03-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING|[?]|IU/L|[?]|1|uL/dose|SMALL INTESTINE|LEFT|LATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY||||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-11-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|Tbsp|[?]|1|kg/cm|RIGHT VENTRICULAR BRANCH|CONTRALATERAL|ANTEROMEDIAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||Y||PROXY|NEUROLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-11-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|IU/mL|[?]|1|dB|FOOT PHALANX|IPSILATERAL|MIDLINE|IRON HEMATOXYLIN STAIN||||DOMESTIC PARTNER|OPHTHALMOLOGIST|2|Visit_2|25|6|WASHOUT|2020-11-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|4|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|||[?]|1|L/L|THORACIC AORTA|UNILATERAL|ANTERIOR|ACID FAST STAIN|Y||Y|CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-11-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|5|TSUELAS|Tissue Elastance|[?]|SITTING, LEGS DEPENDENT|[?]|umol/L/min|[?]|1|mol/mg|LACRIMAL GLAND|RIGHT|MEDIAL|HPLC-UV||||DOMESTIC PARTNER|MICROSCOPIST|3|Visit_3|40|2|TREATMENT|2020-12-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|6|DLCOPP|Percent Predicted DLCO|[?]|STANDING, BENT FORWARD|||[?]|1|dyn|FALLOPIAN TUBE|CONTRALATERAL|LOWER MEDIAL|DOUBLE IMMUNODIFFUSION|Y||Y|GUARDIAN|READER 2|3|Visit_3|40|1|FOLLOW-UP|2020-12-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|7|EFFVOL|Effusion Volume|[?]|SLING|[?]|Hounsfield Unit|[?]|1|mg/kg/min|RENAL ARTERY|RIGHT|DISTAL VOLAR|CONTRAST ENHANCED PET/CT SCAN||||VENDOR|DERMATOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|Log10 ELISA unit|FEMORAL CONDYLE|LEFT|DEEP|CALCOFLUOR WHITE STAIN|||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST|4|Visit_4|65|6|TREATMENT|2021-01-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|9|FEV_PEF|FEV at PEF|[?]|STANDING|[?]|g/animal/wk|[?]|1|%(w/w)|MESENTERIC LYMPH NODE|BILATERAL|HIND|PHYSICAL EXAMINATION||||CAREGIVER|NEUROLOGIST|5|Visit_5|90|3|WASHOUT|2021-01-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|f3a3a6ca-2344-4cee-a6a5-59beee9304df|10|EXPRELTM|Expiration Relaxation Time|[?]|STANDING, BENT FORWARD|[?]|SCOOPFUL|[?]|1|cpm|PERIURETHRAL REGION|LATERAL|VENTROLATERAL|GC/MS/MS||Y||GUARDIAN|MICROSCOPIST 1|5|Visit_5|90|7|TREATMENT|2021-01-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|GAW|Airway Conductance|[?]|LATERAL DECUBITUS|[?]|pg/cell|[?]|1|mEq/ug|CORONARY ARTERY, ANTERIOR DESCENDING|LEFT|PROXIMAL VOLAR|NON-INVASIVE DIELECTRIC SENSING|Y|||FRIEND|UROLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|2|IRVPP|Percent Predicted IRV|[?]|SUPINE|[?]|amp|[?]|1|Coulomb|METATARSAL BONE|BILATERAL|UPPER|COLORIMETRY||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|1|Visit_1|10|3|SCREENING|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|3|AWWVOL|Airway Wall Volume|[?]|SEMI-RECUMBENT|[?]|10^3 CFU|[?]|1|IU/kg|KNEE JOINT TENDONS|LATERAL|SURFACE|SEQUENCING||Y||PARENT|PEDIATRIC NEUROLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|4|PNIF|Peak Nasal Inspiratory Flow|[?]|SEMI-RECUMBENT|[?]|mL/g/h|[?]|1|TRANSDUCING UNIT/mL|DISTAL RADIOULNAR JOINT|LEFT|VENTRAL|WHOLE TRANSCRIPTOME SEQUENCING||Y||CLINICAL STUDY SPONSOR|UROLOGIST|2|Visit_2|25|6|SCREENING|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|5|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|||[?]|1|mm/sec|PERITONEAL CAVITY|UNILATERAL|FORE|SLOAN LETTER EYE CHART 100%|||Y|SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|3|Visit_3|40|7|WASHOUT|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|/month|[?]|1|nm|CORONARY SINUS|BILATERAL|ANTEROMEDIAL|FLAME PHOTOMETRY||Y||CAREGIVER|MICROSCOPIST 2|3|Visit_3|40|2|TREATMENT|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|7|LOBVOL|Lobar Volume|[?]|PRONE|||[?]|1|mL/dL|THORACIC AORTA|CONTRALATERAL|SUBCORTICAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||Y|GUARDIAN|READER 3|4|Visit_4|65|1|TREATMENT|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|oz|[?]|1|genEq|ANTERIOR TIBIAL VEIN|RIGHT|ANTEROLATERAL|JAEGER EYE CHART||||ADJUDICATOR|READER 2|4|Visit_4|65|1|SCREENING|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|9|SALKK|Salazar-Knowles Equation, K|[?]|PRONE|[?]|DAYS|[?]|1|in|TEMPORAL ARTERY|RIGHT|NASAL|TURBIDIMETRY|Y|||FRIEND|CARDIOLOGIST|5|Visit_5|90|3|WASHOUT|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|175cfd82-a6fe-463b-81e5-07ae9e1253db|10|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|umol/L/sec|[?]|1|MPS U|ANTERIOR CINGULATE CORTEX|RIGHT|TIP|CT SCAN WITHOUT CONTRAST||||INDEPENDENT ASSESSOR|ADJUDICATOR 1|5|Visit_5|90|1|TREATMENT|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|1|SAWVOL|Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|BOWL|[?]|1|10^6 CFU|EPITROCHLEAR LYMPH NODE|RIGHT|LOWER MEDIAL|SEQUENCING||||DOMESTIC PARTNER|PATHOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2021-01-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|2|AWWVOL|Airway Wall Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uCi|ASCENDING AORTA, AORTIC ROOT|IPSILATERAL|DORSOLATERAL|CENTRIFUGATION|Y||Y|SIBLING|MICROSCOPIST|1|Visit_1|10|5|TREATMENT|2021-01-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|3|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING|[?]|uU/L|[?]|1|g/animal/day|CEREBELLUM|LEFT|UPPER EXTENSOR SURFACE|SIZE EXCLUSION CHROMATOGRAPHY||||PARENT|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2021-02-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-21
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|4|IRVPP|Percent Predicted IRV|[?]|SITTING|[?]|/40 HPFs|[?]|1|APL U|ILEUM|UNILATERAL|NASAL|PERIODIC ACID SCHIFF STAIN||Y||INDEPENDENT ASSESSOR|RADIOLOGIST 2|2|Visit_2|25|1|WASHOUT|2021-02-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-21
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|5|PNIF|Peak Nasal Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|GBq/ug|[?]|1|U|CINGULATE CORTEX|RIGHT|DEEP|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|||FRIEND|HEMATOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|6|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|EIA unit|[?]|1|kg|FOREBRAIN|LATERAL|MEDIAL|POLYSOMNOGRAPHY|Y|||SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|SCREENING|2021-02-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|7|FIFMAXPP|Percent Predicted FIFmax|[?]|FOWLERS|[?]|kN/cm2|[?]|1|Rad|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|CONTRALATERAL|DEEP|TURBIDIMETRY||||SPOUSE|RATER|4|Visit_4|65|4|FOLLOW-UP|2021-03-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|TRENDELENBURG|[?]|deg/mm|[?]|1|10^6 organisms/mg|ANTERIOR CINGULATE GYRUS|BILATERAL|FRONTAL|CENTRIFUGATION||||STUDY SUBJECT|OPHTHALMOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-03-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|9|RER|Respiratory Exchange Ratio|[?]|LEFT LATERAL DECUBITUS|[?]|QUANTITY SUFFICIENT|[?]|1|Henry|APPENDICULAR SKELETON|CONTRALATERAL|VENTRAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|Y||GUARDIAN|ONCOLOGIST 1|5|Visit_5|90|1|TREATMENT|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|RE|e19b469c-40d5-4506-8233-a86bebde880d|10|PNEUMIND|Pneumonia Indicator|[?]|SITTING|[?]|U/m2/min|[?]|1|PATCH|PREPUTIAL GLAND|CONTRALATERAL|MIDLINE|LIGHT MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|5|Visit_5|90|1|TREATMENT|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|1|TGV|Thoracic Gas Volume|[?]|STANDING|[?]|mg/kg/day|[?]|1|mL/m2|OSTIOMEATAL COMPLEX|BILATERAL|LOWER EXTENSOR SURFACE|FLUORESCEIN STAIN|Y|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|1|Visit_1|10|4|TREATMENT|2020-12-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|2|SALKA|Salazar-Knowles Equation Parameter A|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Henry|METATARSOPHALANGEAL JOINT 3|BILATERAL|LOWER|PAP STAIN|||Y|FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|4|WASHOUT|2020-12-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|3|IRVPP|Percent Predicted IRV|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/animal|[?]|1|MET|DIAPHRAGMATIC LYMPH NODE|IPSILATERAL|ANTEROTEMPORAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||FRIEND|HEMATOLOGIST|2|Visit_2|25|7|TREATMENT|2021-01-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|mmol/s|[?]|1|mmol/g|FEMORAL HEAD|LATERAL|PROXIMAL|TRICHROME STAIN||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|2|Visit_2|25|1|TREATMENT|2021-01-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|5|FRCPP|Percent Predicted FRC|[?]|SITTING|[?]|nmol BCE/L|[?]|1|KALLIKREIN INHIBITOR UNIT|MIDDLE PHALANX 3 OF THE HAND|BILATERAL|VOLAR|INTERRUPTER TECHNIQUE||||SIBLING|ADJUDICATOR 2|3|Visit_3|40|3|TREATMENT|2021-01-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|6|TV|Tidal Volume|[?]|FOWLERS|[?]|umol/min|[?]|1|DDU|SUPRACLAVICULAR FOSSA|IPSILATERAL|LOWER FLEXOR SURFACE|SLIT LAMP|Y|||PROXY|ADJUDICATOR 2|3|Visit_3|40|3|TREATMENT|2021-01-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|TRANSDUCING UNIT|[?]|1|Enzyme U/L|ILIAC CREST|BILATERAL|DORSOLATERAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|4|Visit_4|65|2|FOLLOW-UP|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|8|OXYPULSE|Oxygen Pulse|[?]|SUPINE|[?]|umol|[?]|1|mg/mL/day|LARYNX|IPSILATERAL|APICAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||Y||ADJUDICATION COMMITTEE|ADJUDICATOR|4|Visit_4|65|1|FOLLOW-UP|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|DECUBITUS|[?]|MBq/uL|[?]|1|mL/dose|PALPEBRAL CONJUNCTIVA|LEFT|POSTERIOR|MAPH||Y||ADJUDICATOR|RATER 2|5|Visit_5|90|7|TREATMENT|2021-03-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|f280a4a5-9826-4d77-adf1-992284cb3314|10|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|||[?]|1|10^3 CFU/g|ABDUCTOR HALLUCIS MUSCLE|RIGHT|APICAL|MODIFIED ACID FAST STAIN|||Y|GUARDIAN|READER 3|5|Visit_5|90|1|WASHOUT|2021-03-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|82840929-7800-4254-b60a-8af4786664f6|1|FIV1PP|Percent Predicted FIV1|[?]|DECUBITUS|[?]|10^12 IU/L|[?]|1|ug/L FEU|RECTOVAGINAL SPACE|RIGHT|ANTEROLATERAL|HPLC||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|1|Visit_1|10|4|WASHOUT|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|82840929-7800-4254-b60a-8af4786664f6|2|FIFMAX|Maximum Forced Inspiratory Flow|[?]|LATERAL DECUBITUS|||[?]|1|mmol/day|COLON LYMPH NODE|RIGHT|ROSTRAL|CLIP SEQUENCING|||Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|1|Visit_1|10|3|TREATMENT|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|82840929-7800-4254-b60a-8af4786664f6|3|FEV1FVC|FEV1/FVC|[?]|FOWLERS|[?]|YEARS|[?]|1|SBE/mL|PANCREAS|UNILATERAL|ANTEROPOSTERIOR|FISH|Y|Y||SIBLING|CLINICAL PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-06-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|82840929-7800-4254-b60a-8af4786664f6|4|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|[?]|nmol/day|[?]|1|min*mg/mL|EYE BULGE|RIGHT|VENTROLATERAL|RYAN BLUE STAIN||||STUDY SUBJECT|PATHOLOGIST 1|2|Visit_2|25|7|FOLLOW-UP|2020-06-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|82840929-7800-4254-b60a-8af4786664f6|5|FIV1|Forced Inspiratory Volume in 1 Second|[?]|UNCONSTRAINED|[?]|IU/g|[?]|1|mol/mg|CERVICAL LYMPH NODE|CONTRALATERAL|MEDIAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y||CLINICAL STUDY SPONSOR|OPTOMETRIST|3|Visit_3|40|2|TREATMENT|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|82840929-7800-4254-b60a-8af4786664f6|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|SITTING|[?]|mL/mmHg|[?]|1|/VF|PALPEBRAL CONJUNCTIVA|CONTRALATERAL|ANTEROTEMPORAL|VENTILATION PERFUSION LUNG SCAN||||VENDOR|DERMATOLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|82840929-7800-4254-b60a-8af4786664f6|7|AWWVOL|Airway Wall Volume|[?]|SEMI-RECUMBENT|[?]|vp/mL|[?]|1|ug/g/day|SUBSTANTIA NIGRA|LATERAL|OCCIPITAL|CELL BASED BIOASSAY||Y||PROXY|READER 1|4|Visit_4|65|3|TREATMENT|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|82840929-7800-4254-b60a-8af4786664f6|8|FRCPP|Percent Predicted FRC|[?]|STANDING, BENT FORWARD|[?]|10^9 CFU|[?]|1|Torr|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LATERAL|SUPERIOR|ELECTRONEUROGRAPHY||||CAREGIVER|PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|82840929-7800-4254-b60a-8af4786664f6|9|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|[?]|/5x10^4 WBC|[?]|1|BOLUS|LACRIMAL GLAND|LEFT|SURFACE|SMEAR|Y|||PROXY|NEUROLOGIST 1|5|Visit_5|90|6|WASHOUT|2020-08-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|82840929-7800-4254-b60a-8af4786664f6|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|UNCONSTRAINED|||[?]|1|Coulomb|L3-L4 INTERVERTEBRAL SPACE|LATERAL|ROSTRAL|FARR ASSAY|Y||Y|INVESTIGATOR|ONCOLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-08-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|umol/mg/min|[?]|1|g/m2/day|CEREBRAL VEIN|IPSILATERAL|LOWER EXTENSOR SURFACE|CLOT DETECTION||Y||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|SCREENING|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|2|FEV1SVC|FEV1/SVC|[?]|UNCONSTRAINED|||[?]|1|nmol BCE/nmol|TYMPANIC MEMBRANE|IPSILATERAL|INTERMEDIATE|NUCLEIC ACID AMPLIFICATION TEST||Y|Y|GUARDIAN|RADIOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|3|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|||[?]|1|10^7 CFU|COSTOCHONDRAL JOINT 7|LEFT|ANTEROPOSTERIOR|CELLULAR PROLIFERATION ASSAY||Y|Y|INTERVIEWER|PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-09-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|4|SAWVOL|Specific Airway Volume|[?]|STANDING|[?]|L/h|[?]|1|mg/L|PALM|CONTRALATERAL|ANTEROTEMPORAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||||INDEPENDENT ASSESSOR|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-09-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|5|FIO2|Fraction of Inspired Oxygen|[?]|DECUBITUS|[?]|JAR|[?]|1|10^3 RNA copies/mL|TRACHEA|LEFT|DISTAL VOLAR|AUTOREFRACTION||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|3|Visit_3|40|2|TREATMENT|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|[?]|BOTTLE|[?]|1|IU/mg|UPPER CERVICAL LYMPH NODE|LEFT|ANTEROLATERAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||||PARENT|RADIOLOGIST 2|3|Visit_3|40|1|SCREENING|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|7|PEFTIME|Peak Expiratory Flow Time|[?]|LATERAL DECUBITUS|[?]|mg/g/min|[?]|1|WEEKS|PECTORALIS MINOR MUSCLE|LEFT|MEDIAL|GC/MS||||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|8|RV|Residual Volume|[?]|UNCONSTRAINED|[?]|10^6 CFU|[?]|1|Pa|TIBIAL-CRURAL PERIPHERAL ARTERY|RIGHT|OUTER|FLUORESCENT MICROSCOPY||||SIBLING|HEMATOLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING|[?]|min|[?]|1|kg|BILE DUCT|UNILATERAL|VENTRAL|KNEMOMETRY|Y|Y||ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|5|Visit_5|90|3|SCREENING|2020-11-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|dae25bdb-38fd-4852-9a9a-7627368e9497|10|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-FOWLERS|[?]|cm H2O|[?]|1|kg|MEDIAN BASILIC VEIN|RIGHT|FORE|ICP-MS||Y||DOMESTIC PARTNER|FORENSIC PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2020-11-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|MALIND|Malignancy Indicator|[?]|LATERAL DECUBITUS|||[?]|1|Ci/mL|ISCHIUM|RIGHT|SURFACE|PET/CT SCAN|||Y|SIGNIFICANT OTHER|ADJUDICATOR 1|1|Visit_1|10|1|TREATMENT|2020-10-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|2|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING|[?]|uIU/dL|[?]|1|uL/dose|OCCIPITAL LYMPH NODE|CONTRALATERAL|POSTERIOR|MICRONEUTRALIZATION ASSAY|Y|Y||NON-HEALTH CARE PROFESSIONAL|READER 1|1|Visit_1|10|7|FOLLOW-UP|2020-10-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|3|LOBVOL|Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|10^9 organisms/g|[?]|1|U/m2|ILIAC CREST|BILATERAL|FACIAL|KNEMOMETRY||||CAREGIVER|ADJUDICATOR 3|2|Visit_2|25|3|TREATMENT|2020-10-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|4|MIPPP|Percent Predicted MIP|[?]|SITTING, LEGS DEPENDENT|[?]|Frames/s|[?]|1|foz_us|FLEXOR POLLICIS LONGUS MUSCLE|UNILATERAL|INFERIOR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y||FRIEND|RADIOLOGIST 1|2|Visit_2|25|4|SCREENING|2020-10-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|5|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pptr|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|RIGHT|POSTERIOR|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y|Y|DOMESTIC PARTNER|PHYSIOTHERAPIST|3|Visit_3|40|4|WASHOUT|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|FOWLERS|[?]|mg/kg/day|[?]|1|kV|LIVER LOBE|IPSILATERAL|PERIVENTRICULAR|PAP STAIN||Y||PARENT|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|7|AIRTRAP|Air Trapping|[?]|SLING|[?]|mmol/day|[?]|1|ELISA unit/mL|DISTAL COMMON BILE DUCT|IPSILATERAL|ANTEROPOSTERIOR|JAEGER EYE CHART||Y||INTERVIEWER|HEMATOLOGIST|4|Visit_4|65|7|WASHOUT|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|8|TV|Tidal Volume|[?]|STANDING|[?]|Ci/g|[?]|1|mEq/L|5TH LUMBAR SPINOUS PROCESS|CONTRALATERAL|TIP|WESTERN BLOT||||GUARDIAN|ADJUDICATOR 1|4|Visit_4|65|5|FOLLOW-UP|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|9|OXYPULSE|Oxygen Pulse|[?]|SITTING|[?]|Pack Year|[?]|1|fL|LEFT MAIN CORONARY ARTERY BODY|BILATERAL|TEMPORAL|DC SHEATH FLOW||Y||GUARDIAN|CLINICAL PATHOLOGIST|5|Visit_5|90|7|WASHOUT|2020-12-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|9e009737-cd77-4b96-a4af-e9731ef7e9d0|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|LATERAL DECUBITUS|[?]|SFC/10^6 PBMC|[?]|1|PFU/dose|THORACIC ARTERY|IPSILATERAL|PERIPHERAL|IMMUNOTURBIDIMETRY||||STUDY SUBJECT|RATER 2|5|Visit_5|90|5|TREATMENT|2020-12-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|Bq/kg|[?]|1|IU/g|T12 VERTEBRA|BILATERAL|PROXIMAL VOLAR|ACRIDINE ORANGE STAIN||Y||SIBLING|INTERNIST|1|Visit_1|10|1|SCREENING|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|2|IVC|Inspiratory Vital Capacity|[?]|TRENDELENBURG|[?]|nmol/kg/day|[?]|1|PIXELS/cm|CORONARY ARTERY, RIGHT|LEFT|ANTEROMEDIAL|FLUORESCENT IMMUNOASSAY||||ADJUDICATION COMMITTEE|PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|3|FIV1PP|Percent Predicted FIV1|[?]|TRENDELENBURG|[?]|U/kg|[?]|1|1/(s*kPa)|CORONARY SINUS|UNILATERAL|PERIVENTRICULAR|CALCOFLUOR WHITE STAIN|Y|Y||DOMESTIC PARTNER|READER 1|2|Visit_2|25|1|TREATMENT|2020-10-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|4|DLCOPP|Percent Predicted DLCO|[?]|SITTING, LEGS DEPENDENT|[?]|mL/cm|[?]|1|PIXELS/in|RIB 11|RIGHT|TIP|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||FRIEND|MICROSCOPIST 3|2|Visit_2|25|2|FOLLOW-UP|2020-10-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|5|INFLTIND|Infiltrates Indicator|[?]|SITTING|||[?]|1|U/mL|PARAPHARYNGEAL LYMPH NODE|UNILATERAL|CRANIAL|ULTRASOUND||Y|Y|PROXY|ONCOLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-11-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|FOWLERS|[?]|L/day|[?]|1|DRINK|DISTAL INTERPHALANGEAL JOINT 3|IPSILATERAL|VENTRAL|ELISA||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|3|Visit_3|40|3|TREATMENT|2020-11-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|||[?]|1|PACKET|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|NASAL|SPECT SCAN||Y|Y|FRIEND|READER 1|4|Visit_4|65|2|SCREENING|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|8|IVC|Inspiratory Vital Capacity|[?]|STANDING|[?]|PNU/mL|[?]|1|dram|CEREBELLUM|BILATERAL|SUBCORTICAL|SPECULAR MICROSCOPY||||VENDOR|ENDOCRINOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|9|MEP|Maximal Expiratory Pressure|[?]|PRONE|[?]|m|[?]|1|Bq|SCAPHOID-CAPITATE JOINT|CONTRALATERAL|BASAL|RADIAL IMMUNODIFFUSION||||SIBLING|RADIOLOGIST|5|Visit_5|90|3|TREATMENT|2021-01-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|e7468d01-71b3-47c4-9715-62fe143364cb|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SLING|||[?]|1|MPS U|ESOPHAGUS, ABDOMINAL|RIGHT|APICAL|INTERRUPTER TECHNIQUE|||Y|ADJUDICATION COMMITTEE|PATHOLOGIST 1|5|Visit_5|90|3|TREATMENT|2021-01-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|FIVC|Forced Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|mg2/dL2|[?]|1|cd*s/m2|HYPOTHALAMUS|BILATERAL|LOWER FLEXOR SURFACE|WEBER GREEN STAIN||Y||CHILD|CLINICAL PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-05-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|2|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|10^6/hpf|[?]|1|/sec|CRANIAL CAVITY|IPSILATERAL|INFERIOR|SPECT/CT SCAN||||VENDOR|READER 3|1|Visit_1|10|5|FOLLOW-UP|2020-05-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|3|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|fraction of 1|[?]|1|uOsm|MUSCULOSKELETAL SYSTEM|BILATERAL|APICAL|IMMUNOPRECIPITATION||||CHILD|READER 1|2|Visit_2|25|7|FOLLOW-UP|2020-06-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|4|INTP|Interpretation|[?]|STANDING|[?]|Mile|[?]|1|/cmH2O|T7 VERTEBRA|IPSILATERAL|FACIAL|ENDOSCOPY||Y||VENDOR|ENDOCRINOLOGIST|2|Visit_2|25|7|WASHOUT|2020-06-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-27
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|5|IRV|Inspiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|ft|[?]|1|g/U|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|BILATERAL|DORSAL|ENZYMATIC COLORIMETRY||Y||HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|3|Visit_3|40|4|WASHOUT|2020-06-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|6|PEFTIME|Peak Expiratory Flow Time|[?]|LATERAL DECUBITUS|||[?]|1|COAT|BUCCAL LYMPH NODE|LATERAL|SUPERFICIAL|CONTRAST ENHANCED SPIRAL CT SCAN||Y|Y|SIGNIFICANT OTHER|OPTOMETRIST|3|Visit_3|40|1|SCREENING|2020-06-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|mV/sec|[?]|1|mL/h|SPLENIC LYMPH NODE|CONTRALATERAL|TEMPORAL|RIA||||SIGNIFICANT OTHER|PATHOLOGIST|4|Visit_4|65|7|SCREENING|2020-07-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|8|FEV1FVC6|FEV1/FVC6|[?]|SLING|[?]|PACKET|[?]|1|pg/L|HYPOGLOSSAL NERVE|RIGHT|ANTEROLATERAL|CALIPER MEASUREMENT METHOD|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR|4|Visit_4|65|4|TREATMENT|2020-07-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|9|FEF2575P|Percent Predicted FEF25-75|[?]|FOWLERS|[?]|cmHg|[?]|1|mV/sec|ANAL VERGE|IPSILATERAL|PARIETO-OCCIPITAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|||ADJUDICATOR|CARDIOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|6a021859-1b18-4eb5-9548-0e32c0c1edf7|10|IVCPP|Percent Predicted IVC|[?]|SUPINE|||[?]|1|AgU/mL|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|ANTEROMEDIAL|FLUOROSCOPY|Y||Y|SIBLING|PATHOLOGIST 1|5|Visit_5|90|4|TREATMENT|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|tsp eq|[?]|1|mg/mL/min|IRIS|CONTRALATERAL|APICAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||SIBLING|RATER 2|1|Visit_1|10|4|WASHOUT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|tuberculin unit/mL|[?]|1|beats/min|KNEE JOINT TENDONS|RIGHT|OUTER|BALLPOINT PEN TECHNIQUE||Y||ADJUDICATOR|HEMATOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|3|AIRTRAP|Air Trapping|[?]|STANDING, BENT FORWARD|[?]|pg/cell|[?]|1|gMFI|FEMORAL CONDYLE|CONTRALATERAL|DISTAL|DC SHEATH FLOW||||FAMILY MEMBER|NEUROLOGIST 1|2|Visit_2|25|5|FOLLOW-UP|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|4|TLC|Total Lung Capacity|[?]|PRONE|[?]|mmAL|[?]|1|mg/kg/week|CARPOMETACARPAL JOINT 3|BILATERAL|APICAL|SICKLE CELL SOLUBILITY TEST||Y||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|5|RV|Residual Volume|[?]|TRENDELENBURG|[?]|MET*min|[?]|1|PFU/dose|HARD PALATE|RIGHT|CENTRAL|CELL OF ORIGIN ASSAY||||FRIEND|RADIOLOGIST 2|3|Visit_3|40|6|FOLLOW-UP|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|6|FEV1SVC|FEV1/SVC|[?]|LEFT LATERAL DECUBITUS|[?]|psi|[?]|1|APL U/mL|GASTROINTESTINAL TRACT|RIGHT|INFERIOR|URANYL ACETATE STAIN||||CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|3|Visit_3|40|2|TREATMENT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SLING|||[?]|1|uU/L|FOOT DIGIT 4|LATERAL|INFERIOR|CLIP|||Y|INVESTIGATOR|PATHOLOGIST 1|4|Visit_4|65|3|FOLLOW-UP|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|8|IC|Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|umol/mg/min|[?]|1|ug/animal|GREAT SAPHENOUS VEIN|LEFT|DEEP|IMMUNOCHROMATOGRAPHY||Y||INTERVIEWER|CLINICAL PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|9|LCI|Lung Clearance Index|[?]|PRONE|[?]|PUFF|[?]|1|grain|ABDOMINAL SKIN|LATERAL|MIDLINE|ELECTROPHORESIS||||DOMESTIC PARTNER|RADIOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|eb409ec5-4c02-41c8-a11f-03d990818c2a|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|SEMI-FOWLERS|[?]|yd|[?]|1|s*kPa|SPLENIC LYMPH NODE|BILATERAL|DORSAL|WEBER GREEN STAIN||||INTERVIEWER|RADIOLOGIST 2|5|Visit_5|90|4|TREATMENT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|FOWLERS|||[?]|1|m/sec2|L1 VERTEBRA|RIGHT|DORSAL|PHOROPTER|||Y|PROXY|OTOLARYNGOLOGIST|1|Visit_1|10|4|TREATMENT|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|2|MIPPP|Percent Predicted MIP|[?]|STANDING, BENT FORWARD|[?]|ukat|[?]|1|pg|PERIHILAR LYMPH NODE|BILATERAL|DORSOLATERAL|LYMPHANGIOGRAPHY|Y|Y||INVESTIGATOR|NEUROLOGIST 1|1|Visit_1|10|2|SCREENING|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|3|MIP|Maximal Inspiratory Pressure|[?]|PRONE|||[?]|1|genEq/mL|NASAL CAVITY|LATERAL|DORSAL|PERIPHERAL ANGIOGRAPHY|||Y|PARENT|READER|2|Visit_2|25|4|SCREENING|2020-11-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|4|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|PRONE|[?]|PACKAGE|[?]|1|SFC/10^6 PBMC|PULMONARY ARTERY BRANCH|CONTRALATERAL|INFERIOR|ENDOSCOPY||||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|2|Visit_2|25|6|FOLLOW-UP|2020-11-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|5|PCF|Peak Cough Flow|[?]|STANDING|[?]|dpm/0.5 mL|[?]|1|Mile|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|LEFT|INTERMEDIATE|GC/MS||Y||CHILD|READER 3|3|Visit_3|40|4|WASHOUT|2020-12-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|PRONE|[?]|IU/mL|[?]|1|ng/dL|BILIARY TRACT|RIGHT|MIDLINE|CONTACT SPECULAR MICROSCOPY||||CHILD|NEUROLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|7|RAWPP|Percent Predicted Airway Resistance|[?]|SLING|[?]|10^7 CFU/mL|[?]|1|IU/dL|PERIURETHRAL REGION|RIGHT|INFERIOR|SEQUENCING||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-12-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|8|SAWVOL|Specific Airway Volume|[?]|SITTING|[?]|umol/day|[?]|1|L/day|CONJUNCTIVA|UNILATERAL|MEDIAL|SXA SCAN||||STUDY SUBJECT|READER 3|4|Visit_4|65|7|TREATMENT|2020-12-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|9|IVCPP|Percent Predicted IVC|[?]|DECUBITUS|[?]|bel|[?]|1|ug/animal|OLFACTORY NERVE|BILATERAL|FRONTAL|GRAM STAIN|Y|Y||DOMESTIC PARTNER|NEUROLOGIST 2|5|Visit_5|90|1|TREATMENT|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|2178f542-809d-4306-84e4-26d3b3b370b0|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LEFT LATERAL DECUBITUS|[?]|Tesla|[?]|1|umol/mg/min|BLOOD VESSEL|CONTRALATERAL|DORSAL|NUCLEIC ACID HYBRIDIZATION||||CLINICAL STUDY SPONSOR|RATER 2|5|Visit_5|90|5|TREATMENT|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|LEFT LATERAL DECUBITUS|[?]|Bq/g|[?]|1|ugEq/L|FINGER FLEXOR TENDONS|IPSILATERAL|SUPERIOR|TRICHROME STAIN||||INVESTIGATOR|MICROSCOPIST 1|1|Visit_1|10|3|TREATMENT|2020-10-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|DECUBITUS|[?]|WAFER|[?]|1|mL/(min*100mL)|SKIN OF THE SOLE|UNILATERAL|INNER|BETA LACTAMASE||||SPOUSE|RADIOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-10-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|3|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|||[?]|1|SACHET|FLEXOR POLLICIS LONGUS MUSCLE|RIGHT|PERIVENTRICULAR|CALCULATION||Y|Y|FAMILY MEMBER|RATER 1|2|Visit_2|25|7|TREATMENT|2020-10-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|4|DLCOPP|Percent Predicted DLCO|[?]|TRENDELENBURG|[?]|10^9 CFU/g|[?]|1|deg|NASAL CAVITY|UNILATERAL|DORSOLATERAL|ELECTROPHORESIS||Y||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-10-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|BOWL|[?]|1|mL|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LEFT|MEDIAL|PYROSEQUENCING||||HEALTH CARE PROFESSIONAL|RATER|3|Visit_3|40|1|TREATMENT|2020-11-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|6|IVC|Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|%(w/v)|LATERAL RAMUS INTERMEDIUS ARTERY|BILATERAL|ANTEROLATERAL|CONGO RED STAIN|Y||Y|NON-HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-11-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|7|TVPP|Percent Predicted Tidal Volume|[?]|SITTING, LEGS DEPENDENT|[?]|WEEKS|[?]|1|kV|PREFRONTAL CORTEX|LATERAL|LOWER EXTENSOR SURFACE|MAMMOGRAPHY||Y||VENDOR|MICROSCOPIST|4|Visit_4|65|4|WASHOUT|2020-11-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|8|PEFREV|PEF Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|genEq|[?]|1|PLUG|ULNAR NERVE|LEFT|CENTRAL|ANGIOGRAPHY|Y|||CAREGIVER|PHYSIOTHERAPIST|4|Visit_4|65|5|TREATMENT|2020-11-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|9|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|BLOCKS|COLON, DESCENDING|UNILATERAL|ANTEROLATERAL|PET/CT SCAN WITHOUT CONTRAST||Y|Y|INVESTIGATOR|ONCOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2020-12-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|da7423fb-461e-43a6-bcb9-aa87051bda0a|10|FEV1FVC|FEV1/FVC|[?]|STANDING|[?]|10^6/hpf|[?]|1|anti-Xa IU|INTRATHORACIC LYMPH NODE|LATERAL|PARIETO-OCCIPITAL|CHROMOGENIC ASSAY|Y|||FAMILY MEMBER|ADJUDICATOR 2|5|Visit_5|90|5|WASHOUT|2020-12-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|1|RAW|Airway Resistance|[?]|FOWLERS|[?]|MAC50|[?]|1|amp|RIGHT VENTRICULAR ENDOCARDIUM|LATERAL|MEDIAL|NEXT GENERATION SEQUENCING|Y|||VENDOR|NEUROLOGIST 1|1|Visit_1|10|1|FOLLOW-UP|2021-01-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|2|SVC|Slow Vital Capacity|[?]|TRENDELENBURG|[?]|Hz|[?]|1|log10 IU/mL|ILIAC CREST|IPSILATERAL|SURFACE|TARGETED TRANSCRIPTOME SEQUENCING||Y||INVESTIGATOR|ONCOLOGIST 1|1|Visit_1|10|1|FOLLOW-UP|2021-01-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|3|MIP|Maximal Inspiratory Pressure|[?]|LATERAL DECUBITUS|[?]|amp|[?]|1|10^9 CFU|KNEE JOINT|LATERAL|ANTEROTEMPORAL|URANYL ACETATE STAIN||||VENDOR|PATHOLOGIST 1|2|Visit_2|25|6|SCREENING|2021-02-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|PRONE|[?]|s*kPa|[?]|1|mL/min/1.73m2|EXTERNAL ILIAC ARTERY|LEFT|UPPER EXTENSOR SURFACE|PERFUSION MRI|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|2|Visit_2|25|3|WASHOUT|2021-02-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|5|SGAW|Specific Airway Conductance|[?]|SLING|[?]|mg/m2/min|[?]|1|g/cage|SKIN OF THE FOOT|LATERAL|ANTEROPOSTERIOR|SMEAR|Y|Y||FRIEND|NEUROLOGIST|3|Visit_3|40|2|SCREENING|2021-03-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|6|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|||[?]|1|kg/L|GREAT TROCHANTER|IPSILATERAL|UPPER|FLAME PHOTOMETRY||Y|Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|3|Visit_3|40|7|FOLLOW-UP|2021-03-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|7|FVC|Forced Vital Capacity|[?]|FOWLERS|||[?]|1|uV|NASAL CAVITY|BILATERAL|DORSAL|FORCED OSCILLATION TECHNIQUE||Y|Y|SIGNIFICANT OTHER|DERMATOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2021-03-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-21
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|8|IRV|Inspiratory Reserve Volume|[?]|STANDING|[?]|kg/cm2|[?]|1|LOZENGE|SKIN BETWEEN EYEBROWS|IPSILATERAL|ANTEROMEDIAL|PET/SPECT SCAN||Y||SPOUSE|READER 3|4|Visit_4|65|7|TREATMENT|2021-03-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-21
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|9|FEV1SVC|FEV1/SVC|[?]|STANDING|[?]|mL/kg/min|[?]|1|U.CARR|LIGAMENT|UNILATERAL|INNER|SEQUENCING||||ADJUDICATOR|INTERNIST|5|Visit_5|90|6|WASHOUT|2021-04-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|40e4c69f-6115-4f0e-8555-45b12b222801|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|REVERSE TRENDELENBURG|[?]|fraction of 1|[?]|1|/ms|PERIUMBILICAL REGION|RIGHT|PERIVENTRICULAR|OBSERVATION|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 3|5|Visit_5|90|4|TREATMENT|2021-04-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|||[?]|1|10^7/L|VAGINA|RIGHT|CAUDAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||Y|CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|1|Visit_1|10|4|TREATMENT|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|2|IRVPP|Percent Predicted IRV|[?]|SEMI-RECUMBENT|[?]|usec|[?]|1|L/min|ESOPHAGUS|CONTRALATERAL|LOWER|DOPPLER ULTRASOUND|Y|||CHILD|RADIOLOGIST 2|1|Visit_1|10|1|WASHOUT|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|TRENDELENBURG|||[?]|1|cm/s|PONS VAROLII|IPSILATERAL|LOWER|ISHIHARA COLOR PLATES|||Y|ADJUDICATOR|DERMATOLOGIST|2|Visit_2|25|1|SCREENING|2020-06-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|4|FEV_PEF|FEV at PEF|[?]|SITTING, LEGS DEPENDENT|[?]|mL/cm|[?]|1|nmol/L|PROSTATE GLAND, LATERAL LOBE|UNILATERAL|SUBCORTICAL|COMPLEMENT FIXATION|Y|Y||CHILD|UROLOGIST|2|Visit_2|25|5|SCREENING|2020-06-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SLING|||[?]|1|MET*h|GREAT VESSELS|UNILATERAL|OUTER|KINETIC MICROPARTICLE IMMUNOASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-06-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|6|SAWVOL|Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|BISCUIT|[?]|1|vp/mL|TRIANGULAR BONE|CONTRALATERAL|DISTAL|MEDIASTINOSCOPY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|3|Visit_3|40|1|WASHOUT|2020-06-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|7|AIRTRAP|Air Trapping|[?]|SITTING, LEGS DEPENDENT|[?]|BOX|[?]|1|ug/g/day|EXTRAOCULAR MUSCLE|LATERAL|SUPERIOR|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||CHILD|MICROSCOPIST 3|4|Visit_4|65|2|SCREENING|2020-07-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|8|ELSTNCE|Elastance|[?]|DECUBITUS|[?]|DNA copies/ug|[?]|1|Tbsp|MID-RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|SURFACE|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||SPOUSE|MICROSCOPIST 1|4|Visit_4|65|2|TREATMENT|2020-07-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|9|PLMXRS|Pulmonary Reactance|[?]|TRENDELENBURG|[?]|IU/L|[?]|1|Roentgen|CHEST WALL|IPSILATERAL|FORE|PULSE OXIMETRY||Y||ADJUDICATION COMMITTEE|ONCOLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|1307d7f6-acb6-4096-a907-08345548a82b|10|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|10^9 CFU/g|[?]|1|mEq/kg|BRAIN VENTRICLE, LATERAL|RIGHT|POSTERIOR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||ADJUDICATOR|RADIOLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-08-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|1|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING, LEGS DEPENDENT|||[?]|1|MET*h|MEDIAN NERVE|UNILATERAL|TIP|MULTIPLE BREATH WASHOUT|Y||Y|HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-05-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|2|ERVPP|Percent Predicted ERV|[?]|TRENDELENBURG|[?]|10^9/g|[?]|1|nmol BCE/L|MESENTERIC LYMPH NODE|LATERAL|VOLAR|CLAUSS METHOD|Y|Y||STUDY SUBJECT|MICROSCOPIST 1|1|Visit_1|10|6|TREATMENT|2020-05-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|3|ICREV|IC Reversibility|[?]|STANDING, BENT FORWARD|||[?]|1|EU|PREAURICULAR LYMPH NODE|BILATERAL|LOWER EXTENSOR SURFACE|FLUORESCENT ENZYME IMMUNOASSAY||Y|Y|STUDY SUBJECT|RATER|2|Visit_2|25|5|TREATMENT|2020-06-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|4|LCI|Lung Clearance Index|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 copies/mL|[?]|1|IU|PELVIC LYMPH NODE|LEFT|SURFACE|IMPEDANCE CONDUCTIVITY||||PARENT|MICROSCOPIST|2|Visit_2|25|3|SCREENING|2020-06-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|mL/dose|[?]|1|uV|COMMON FEMORAL ARTERY|BILATERAL|PERIVENTRICULAR|RIA|Y|||CHILD|ONCOLOGIST 1|3|Visit_3|40|7|WASHOUT|2020-06-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|6|FIF25|Forced Inspiratory Flow at 25%|[?]|LEFT LATERAL DECUBITUS|[?]|CCID 50/mL|[?]|1|kg/m2|JEJUNUM|LATERAL|ANTEROTEMPORAL|MRS|Y|||HEALTH CARE PROFESSIONAL|NEUROLOGIST|3|Visit_3|40|4|TREATMENT|2020-06-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-26
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|STANDING|[?]|TABLET|[?]|1|L/min|ISCHIUM|CONTRALATERAL|UPPER|PULSE OXIMETRY||||HEALTH CARE PROFESSIONAL|READER|4|Visit_4|65|5|TREATMENT|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|8|FRCPP|Percent Predicted FRC|[?]|FOWLERS|[?]|10^3/hpf|[?]|1|pt_br|PANCREAS, BODY|RIGHT|BASAL|ELLA||Y||INDEPENDENT ASSESSOR|PATHOLOGIST|4|Visit_4|65|1|SCREENING|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|9|INERTANC|Inertance|[?]|PRONE|[?]|10^6 organisms/mg|[?]|1|BAU|T2 VERTEBRA|LATERAL|POSTERIOR|LIGHT MICROSCOPY||||NON-HEALTH CARE PROFESSIONAL|RATER 1|5|Visit_5|90|7|WASHOUT|2020-08-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|RE|bac23835-1120-43b2-9d99-694bef97f44b|10|SAWVOL|Specific Airway Volume|[?]|DECUBITUS|||[?]|1|mol/g|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|LEFT|ANTERIOR|IMMUNOTURBIDIMETRY|||Y|INDEPENDENT ASSESSOR|RADIOLOGIST 2|5|Visit_5|90|1|TREATMENT|2020-08-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-30
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|AIRTRAP|Air Trapping|[?]|FOWLERS|||[?]|1|cmH2O/mL|PARIETAL LOBE|LATERAL|APICAL|HANSEL STAIN||Y|Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST|1|Visit_1|10|1|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|2|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|ug/L FEU|[?]|1|mmol/min/kPa|NIPPLE|UNILATERAL|APICAL|TURBIDIMETRY|Y|||FRIEND|PATHOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|3|IC|Inspiratory Capacity|[?]|SEMI-RECUMBENT|[?]|log10 CFU/g|[?]|1|nmol/mol|NERVE|LEFT|FORE|CELL BASED BIOASSAY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|2|Visit_2|25|6|TREATMENT|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|||[?]|1|mCi/L|URETHRA, PENILE|LEFT|INNER|ENDOSCOPY|||Y|CHILD|INTERNIST|2|Visit_2|25|6|TREATMENT|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|5|ELSTNCE|Elastance|[?]|UNCONSTRAINED|[?]|LB|[?]|1|cy/cm|LEFT VENTRICULAR EPICARDIUM|LATERAL|ANTEROTEMPORAL|SXA SCAN||||CLINICAL RESEARCH ASSOCIATE|READER|3|Visit_3|40|3|TREATMENT|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|kN/cm2|[?]|1|mmHg|NASAL BONE|CONTRALATERAL|UPPER FLEXOR SURFACE|DYNAMIC LIGHT SCATTERING||||SIGNIFICANT OTHER|ADJUDICATOR 1|3|Visit_3|40|5|TREATMENT|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|7|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING, BENT FORWARD|[?]|lx|[?]|1|Gauss|SUPRASPINATUS MUSCLE|BILATERAL|SURFACE|PERCUSSION||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|4|Visit_4|65|7|SCREENING|2020-11-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING, BENT FORWARD|||[?]|1|mmol/L|AXILLARY LYMPH NODE LEVEL I|LEFT|DORSOLATERAL|AMSLER GRID|||Y|ADJUDICATION COMMITTEE|OPTOMETRIST|4|Visit_4|65|7|TREATMENT|2020-11-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|9|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING|[?]|Hz|[?]|1|/10^4|PROXIMAL LAD ARTERY|RIGHT|LOWER FLEXOR SURFACE|IRON HEMATOXYLIN STAIN||||INVESTIGATOR|NEUROLOGIST 1|5|Visit_5|90|7|FOLLOW-UP|2020-12-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|10|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|[?]|mg/kg/week|[?]|1|mmol/mol|INTERTROCHANTERIC REGION|IPSILATERAL|VENTRAL|DXA SCAN||||VENDOR|READER 3|5|Visit_5|90|3|WASHOUT|2020-12-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|FIF75|Forced Inspiratory Flow at 75%|[?]|PRONE|[?]|L/min|[?]|1|ug/dL|FEMORAL ARTERY|RIGHT|CRANIAL|MICROARRAY||||CAREGIVER|NEUROLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|||[?]|1|DIP|HILAR|BILATERAL|ROSTRAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|||Y|INVESTIGATOR|RADIOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|3|RAW|Airway Resistance|[?]|UNCONSTRAINED|[?]|mL/animal|[?]|1|BAU|TIBIO-PERONEAL TRUNK|LEFT|VOLAR|FLOW CYTOMETRY||||CHILD|OTOLARYNGOLOGIST|2|Visit_2|25|7|TREATMENT|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|4|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|1/(s*kPa)|[?]|1|MBP|POPLITEAL VEIN|UNILATERAL|UPPER EXTENSOR SURFACE|MICRO BROTH DILUTION||Y||CLINICAL RESEARCH ASSOCIATE|RATER|2|Visit_2|25|1|TREATMENT|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|5|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|10^4/L|[?]|1|DIOPTER|ESOPHAGUS|BILATERAL|FRONTAL|MECHANICAL CLOT DETECTION||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|3|Visit_3|40|7|SCREENING|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|6|IRVPP|Percent Predicted IRV|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^6/Ejaculate U|INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|FORE|RADIOIMMUNOPRECIPITATION ASSAY|||Y|FAMILY MEMBER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|7|IC|Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|[?]|10^3 organisms|[?]|1|MAC50|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|CAUDAL|ERGOSPIROMETRY||||INDEPENDENT ASSESSOR|MICROSCOPIST 2|4|Visit_4|65|4|TREATMENT|2020-11-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|8|DLCOHC|HGB Corrected DLCO|[?]|SEMI-RECUMBENT|[?]|Arbitrary U|[?]|1|ugEq/L|OCCIPITAL LOBE|RIGHT|UPPER EXTENSOR SURFACE|WHOLE EXOME SEQUENCING||Y||INVESTIGATOR|UROLOGIST|4|Visit_4|65|1|WASHOUT|2020-11-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|9|SGAW|Specific Airway Conductance|[?]|RIGHT LATERAL DECUBITUS|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|umol/L/sec|MALLEUS|LATERAL|SUPERFICIAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||INVESTIGATOR|RADIOLOGIST 1|5|Visit_5|90|5|SCREENING|2020-12-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|14cd64f5-f3c8-47a4-b40e-9c5090890870|10|FEV1FVC|FEV1/FVC|[?]|STANDING|[?]|pmol/g|[?]|1|IU/mL|TIBIALIS ANTERIOR MUSCLE|LEFT|BASAL|CALCOFLUOR WHITE STAIN||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|5|Visit_5|90|4|SCREENING|2020-12-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|PEF|Peak Expiratory Flow|[?]|SLING|[?]|mmol|[?]|1|Tbsp|FUNDUS OF THE EYE|UNILATERAL|VENTROLATERAL|CONTRAST ENHANCED CT SCAN|Y|Y||HEALTH CARE PROFESSIONAL|OPTOMETRIST|1|Visit_1|10|6|WASHOUT|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|2|PNIF|Peak Nasal Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|%(w/v)|[?]|1|DIP|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LEFT|UPPER|PET/MRI SCAN|Y|Y||INTERVIEWER|PATHOLOGIST 2|1|Visit_1|10|7|WASHOUT|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|REVERSE TRENDELENBURG|||[?]|1|10^3 DNA copies/mL|METACARPAL BONE 4|CONTRALATERAL|VENTRAL|FLUORIMETRY|||Y|INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|2|SCREENING|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|4|RELSZCHG|Relative Size Change|[?]|SEMI-FOWLERS|[?]|APL U/mL|[?]|1|GBq|SPLEEN, HILUM|UNILATERAL|MEDIAL|MICROBIAL CONCENTRATION||||ADJUDICATOR|PATHOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|s*kPa|[?]|1|Linear ft*LB|METATARSOPHALANGEAL JOINT|BILATERAL|DISTAL|LIGHT MICROSCOPY||Y||STUDY SUBJECT|READER 2|3|Visit_3|40|7|SCREENING|2020-11-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|6|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-FOWLERS|||[?]|1|Siemens|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|BILATERAL|SUPERFICIAL|MICRONEUTRALIZATION ASSAY|Y||Y|SPOUSE|RADIOLOGIST 2|3|Visit_3|40|1|SCREENING|2020-11-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|7|EFFIND|Effusion Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/mL/day|[?]|1|tsp|KIDNEY, LOWER LOBE|CONTRALATERAL|FRONTAL|DNA MICROARRAY|Y|||FRIEND|RADIOLOGIST|4|Visit_4|65|4|SCREENING|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|8|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|||[?]|1|gtt|SARTORIUS MUSCLE|BILATERAL|UPPER|LEAD CITRATE STAIN|Y||Y|SPOUSE|HEMATOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING|[?]|ppm|[?]|1|IU/day|MAIN BRONCHUS, RIGHT|UNILATERAL|UPPER EXTENSOR SURFACE|MOUSE PROTECTION ASSAY||||ADJUDICATOR|HEMATOLOGIST|5|Visit_5|90|7|TREATMENT|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|ca4a06be-5e6a-4220-9854-e5fe02b384af|10|FEV3FVC|FEV3/FVC|[?]|SUPINE|[?]|Pack Year|[?]|1|10^7 CFU|PELVIS|LATERAL|PROXIMAL VOLAR|NEURAMINIDASE INHIBITION ASSAY||||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|5|Visit_5|90|5|FOLLOW-UP|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|1|RVPP|Percent Predicted Residual Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^9/L|EPICARDIUM|CONTRALATERAL|ROSTRAL|LASER CAPTURE MICRODISSECTION|||Y|INDEPENDENT ASSESSOR|READER|1|Visit_1|10|7|TREATMENT|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|2|FVC|Forced Vital Capacity|[?]|UNCONSTRAINED|[?]|mm/2h|[?]|1|cal|LIVER LOBE|BILATERAL|CRANIAL|MS/MS||||FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|1|TREATMENT|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|3|FEV1REV|FEV1 Reversibility|[?]|STANDING|[?]|FIU|[?]|1|pkat|PALPEBRAL CONJUNCTIVA|RIGHT|UPPER|HPLC-UV||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|2|Visit_2|25|5|SCREENING|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|4|IVCPP|Percent Predicted IVC|[?]|SITTING, LEGS DEPENDENT|[?]|ppm|[?]|1|aMFI|EXTENSOR HALLUCIS BREVIS MUSCLE|LATERAL|DORSAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|||INVESTIGATOR|MICROSCOPIST 1|2|Visit_2|25|3|WASHOUT|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|5|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|||[?]|1|cup eq|PULMONARY VALVE, RIGHT CUSP|RIGHT|OCCIPITAL|PULSE OXIMETRY|Y||Y|CAREGIVER|NEUROLOGIST 1|3|Visit_3|40|4|TREATMENT|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-RECUMBENT|[?]|pg/dL|[?]|1|/wk|HEART, RIGHT VENTRICULAR WALL|BILATERAL|DEEP|POTENTIOMETRY||||ADJUDICATOR|RATER 2|3|Visit_3|40|7|FOLLOW-UP|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|7|LOBVOLPP|Percent Predicted Lobar Volume|[?]|DECUBITUS|[?]|EID 50/mL|[?]|1|YEARS|ANTERIOR SUPERIOR ILIAC SPINE|UNILATERAL|MEDIAL|GEL ELECTROPHORESIS||||VENDOR|NEUROLOGIST 1|4|Visit_4|65|4|TREATMENT|2021-03-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|8|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING|||[?]|1|mL/g/min|L1 VERTEBRA|BILATERAL|DEEP|FLOCCULATION|Y||Y|FRIEND|READER|4|Visit_4|65|7|TREATMENT|2021-03-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-FOWLERS|[?]|BOWL|[?]|1|mg/L FEU|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|RIGHT|PERIVENTRICULAR|DARK FIELD MICROSCOPY|Y|||SIBLING|NEUROLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|55504c69-a659-402b-a0cb-95ab4e08c086|10|DLCOVA|DLCO/VA|[?]|STANDING|[?]|ft2|[?]|1|ELISA unit/dose|BLADDER|LEFT|VENTROLATERAL|CONTRAST ENHANCED X-RAY||||FAMILY MEMBER|RATER|5|Visit_5|90|2|TREATMENT|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 organisms/mg|[?]|1|g/dL|RADIUS SHAFT|LATERAL|INTERMEDIATE|ENZYMATIC ULTRACENTRIFUGATION||||HEALTH CARE PROFESSIONAL|PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-11-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|PRONE|[?]|cup eq|[?]|1|10^9 CFU/mL|PERIURETHRAL REGION|LATERAL|DEEP|TELLER ACUITY CARDS|Y|||SPOUSE|PATHOLOGIST|1|Visit_1|10|5|SCREENING|2020-11-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|3|IVC|Inspiratory Vital Capacity|[?]|TRENDELENBURG|||[?]|1|VOXEL|ANTERIOR CINGULATE CORTEX|UNILATERAL|CENTRAL|MICRO BROTH DILUTION|||Y|INVESTIGATOR|UROLOGIST|2|Visit_2|25|2|WASHOUT|2020-12-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SUPINE|[?]|mL/g/day|[?]|1|10^6 organisms/mL|SKIN OF THE NECK|CONTRALATERAL|FACIAL|INCISION-INDUCED BLEEDING METHOD|Y|||SIGNIFICANT OTHER|RATER 2|2|Visit_2|25|2|WASHOUT|2020-12-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING|[?]|amp|[?]|1|ug/dose|T10 VERTEBRA|CONTRALATERAL|SURFACE|ENZYMATIC COLORIMETRY|Y|||PROXY|READER 1|3|Visit_3|40|7|TREATMENT|2020-12-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|6|RV|Residual Volume|[?]|SEMI-FOWLERS|[?]|MESF|[?]|1|mg|SCAPHOID-LUNATE-CAPITATE JOINT|RIGHT|ANTEROMEDIAL|CONFOCAL MICROSCOPY||||CAREGIVER|ADJUDICATOR 2|3|Visit_3|40|7|WASHOUT|2020-12-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|7|PEF|Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|10^6 organisms/mL|[?]|1|10^3/L|GONAD|LATERAL|CENTRAL|COMPLEMENT FIXATION||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|4|Visit_4|65|5|WASHOUT|2021-01-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|8|DLCOVAPP|Percent Predicted DLCO/VA|[?]|STANDING|[?]|uU/dL|[?]|1|uU/dL|SCLERA|IPSILATERAL|ANTERIOR|MIGET||||CHILD|MICROSCOPIST 2|4|Visit_4|65|5|WASHOUT|2021-01-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|9|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SLING|[?]|GBq/g|[?]|1|g/cage/day|ARTERY|CONTRALATERAL|DISTAL|DYNAMIC LIGHT SCATTERING||||GUARDIAN|NEUROLOGIST 1|5|Visit_5|90|2|TREATMENT|2021-02-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|bffa468a-a27b-4e87-a60d-b5787a03c6f6|10|ERV|Expiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|PELLET|FACIAL NERVE|BILATERAL|ANTERIOR|MULTIPLE BREATH WASHOUT|Y||Y|SIGNIFICANT OTHER|INTERNIST|5|Visit_5|90|1|WASHOUT|2021-02-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|||[?]|1|TCID 50/dose|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|CONTRALATERAL|INFERIOR|PHOROPTER|||Y|CAREGIVER|PATHOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-12-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|2|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|[?]|Ejaculate U|[?]|1|ug/animal|EPIDURAL SPACE|LATERAL|DORSOLATERAL|HIGH RESOLUTION MELT ANALYSIS|Y|||FAMILY MEMBER|OPTOMETRIST|1|Visit_1|10|6|TREATMENT|2020-12-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|3|AWWVOL|Airway Wall Volume|[?]|STANDING|[?]|g/cage/day|[?]|1|mmol|WALDEYER'S TONSILLAR RING|LEFT|LOWER EXTENSOR SURFACE|AGAR PROPORTION|Y|Y||CHILD|MICROSCOPIST 3|2|Visit_2|25|4|TREATMENT|2020-12-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|SUPINE|||[?]|1|Enzyme U/g Hb|LUMBAR SPINE|IPSILATERAL|POSTERIOR|PERCUSSION|||Y|CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|2|Visit_2|25|6|WASHOUT|2020-12-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|||[?]|1|/HPF|MESENTERY|CONTRALATERAL|OCCIPITAL|SLOAN LETTER EYE CHART 1.25%||Y|Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|3|Visit_3|40|4|WASHOUT|2021-01-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING, BENT FORWARD|[?]|10^9 organisms/g|[?]|1|log10 CFU/g|OVARIAN FOLLICLE|BILATERAL|TIP|CHROMOGENIC ASSAY||||INDEPENDENT ASSESSOR|MICROSCOPIST 3|3|Visit_3|40|4|TREATMENT|2021-01-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|7|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|kBq|[?]|1|cmH2O*s2/mL|DORSAL MOTOR NUCLEUS|RIGHT|CENTRAL|MAGNETIC RESONANCE ENTEROGRAPHY||||ADJUDICATOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|8|FEV6PP|Percent Predicted FEV6|[?]|SLING|[?]|mm3/mm2/year|[?]|1|kat|SKULL|CONTRALATERAL|LATERAL|CLINICAL EVALUATION||Y||INDEPENDENT ASSESSOR|RATER 1|4|Visit_4|65|5|TREATMENT|2021-02-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|9|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|[?]|APS U|[?]|1|DISK|SENSORIMOTOR CORTEX|LEFT|BASAL|RIA|Y|Y||GUARDIAN|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2021-03-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|2e25aa76-914f-41e3-82ce-7c56ba2f6271|10|FEV_PEF|FEV at PEF|[?]|SEMI-RECUMBENT|[?]|umol/mol|[?]|1|ug/m2/h|FOOT DIGIT 4|LATERAL|FACIAL|BETA LACTAMASE||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|5|Visit_5|90|7|TREATMENT|2021-03-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|1|FEV6PP|Percent Predicted FEV6|[?]|SUPINE|[?]|umol/min|[?]|1|ug/L FEU|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|IPSILATERAL|MEDIAL|MAGNETIC RESONANCE ANGIOGRAPHY||||PROXY|NEUROLOGIST 1|1|Visit_1|10|3|SCREENING|2021-01-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|2|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|[?]|CAN|[?]|1|GBq/ug|SUBCLAVIAN ARTERY|RIGHT|ANTEROPOSTERIOR|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|Y||DOMESTIC PARTNER|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2021-01-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|TRENDELENBURG|||[?]|1|10^9/L|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|RIGHT|PROXIMAL|SNELLEN EYE CHART|Y||Y|ADJUDICATOR|MICROSCOPIST 3|2|Visit_2|25|2|WASHOUT|2021-02-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|4|FEV3FVC|FEV3/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/m2/min|[?]|1|10^6 U|C5 VERTEBRA|CONTRALATERAL|CENTRAL|INTERRUPTER TECHNIQUE||||CLINICAL RESEARCH COORDINATOR|READER 2|2|Visit_2|25|6|TREATMENT|2021-02-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|5|DLCOHC|HGB Corrected DLCO|[?]|SUPINE|[?]|beats/min|[?]|1|/4.0 mL|ESOPHAGUS, UPPER THIRD|LATERAL|OCCIPITAL|MICROSCOPY||||SIGNIFICANT OTHER|ADJUDICATOR 3|3|Visit_3|40|1|TREATMENT|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|6|DLCOVA|DLCO/VA|[?]|FOWLERS|[?]|mIU/L|[?]|1|V|COSTAL CARTILAGE|RIGHT|PROXIMAL|AUTOMATED COUNT||||FAMILY MEMBER|RADIOLOGIST 2|3|Visit_3|40|6|WASHOUT|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|ugEq|[?]|1|BP|HEART, LEFT VENTRICULAR WALL|IPSILATERAL|PROXIMAL VOLAR|KLEIHAUER-BETKE||||INVESTIGATOR|CARDIOLOGIST|4|Visit_4|65|5|TREATMENT|2021-03-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|8|TGV|Thoracic Gas Volume|[?]|SEMI-FOWLERS|[?]|Enzyme U/m2|[?]|1|mg/L FEU|SPLENIC ARTERY|LEFT|CAUDAL|EEG|Y|Y||SIBLING|READER 1|4|Visit_4|65|2|TREATMENT|2021-03-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|9|FEV1FVC6|FEV1/FVC6|[?]|STANDING, BENT FORWARD|[?]|mL/beat|[?]|1|mg/m2/day|TEMPORAL LOBE|IPSILATERAL|PROXIMAL VOLAR|PHASE CONTRAST MICROSCOPY||Y||VENDOR|MICROSCOPIST 1|5|Visit_5|90|2|TREATMENT|2021-04-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|12c24fff-080b-4889-a455-ff55d5c0536c|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|[?]|ag|[?]|1|cy/cm|PERIHILAR LYMPH NODE|UNILATERAL|ANTEROTEMPORAL|HPLC-FL|Y|||SPOUSE|CARDIOLOGIST|5|Visit_5|90|4|TREATMENT|2021-04-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|FVCPP|Percent Predicted Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|LOZENGE|TRAPEZOID-CAPITATE JOINT|UNILATERAL|BASAL|NEXT GENERATION TARGETED SEQUENCING||Y|Y|ADJUDICATION COMMITTEE|INTERNIST|1|Visit_1|10|4|TREATMENT|2021-01-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|FOWLERS|||[?]|1|TRANSDUCING UNIT/mL|ABDOMINAL CAVITY|CONTRALATERAL|SUPERFICIAL|PERFUSION MRI|||Y|STUDY SUBJECT|RATER|1|Visit_1|10|7|FOLLOW-UP|2021-01-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|3|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|uU/dL|[?]|1|P|HIP|CONTRALATERAL|DISTAL|AURAMINE STAIN||Y||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|2|Visit_2|25|7|TREATMENT|2021-02-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|4|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|[?]|mL/cage/wk|[?]|1|MnFI|STERNOCLAVICULAR JOINT|LATERAL|NASAL|GC/FID||Y||FRIEND|ENDOCRINOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2021-02-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|5|INERTANC|Inertance|[?]|SITTING|||[?]|1|U/L|SPLENIC ARTERY|IPSILATERAL|FACIAL|POPULATION SEQUENCING||Y|Y|DOMESTIC PARTNER|MICROSCOPIST 2|3|Visit_3|40|7|WASHOUT|2021-02-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|6|FIF75|Forced Inspiratory Flow at 75%|[?]|SUPINE|[?]|umol|[?]|1|VIRTUAL PIXEL|ALVEOLUS|CONTRALATERAL|OUTER|GC/FID||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|TREATMENT|2021-02-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|7|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|||[?]|1|usec|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|BILATERAL|TEMPORAL|CT SCAN|||Y|VENDOR|READER|4|Visit_4|65|2|FOLLOW-UP|2021-03-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|8|MEPPP|Percent Predicted MEP|[?]|LATERAL DECUBITUS|[?]|g/animal/day|[?]|1|Weber|SECOND RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|ANTERIOR|CELLULAR PROLIFERATION ASSAY||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|4|Visit_4|65|7|FOLLOW-UP|2021-03-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|STANDING|||[?]|1|U.CARR|PINEAL GLAND|BILATERAL|MIDLINE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||Y|Y|SIBLING|RATER|5|Visit_5|90|7|TREATMENT|2021-04-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|aecfe062-4e0d-4c91-8b67-1f304c5765ae|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING|[?]|mV*min|[?]|1|mmol/kg|TRICUSPID VALVE, ANTERIOR CUSP|BILATERAL|ROSTRAL|FLUORESCENT MICROSCOPY||||FAMILY MEMBER|MICROSCOPIST 2|5|Visit_5|90|1|FOLLOW-UP|2021-04-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|UNCONSTRAINED|[?]|umol/L|[?]|1|BOTTLE|AORTIC VALVE, RIGHT CORONARY CUSP|LEFT|INFERIOR|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||INVESTIGATOR|MICROSCOPIST|1|Visit_1|10|6|WASHOUT|2020-11-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|2|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|vg/kg|[?]|1|U/kg/h|ARM SKIN|IPSILATERAL|LATERAL|VIRUS PLAQUE ASSAY||||INDEPENDENT ASSESSOR|ONCOLOGIST|1|Visit_1|10|7|TREATMENT|2020-11-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|3|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|[?]|JDF Unit|[?]|1|umol/min|ILIUM|CONTRALATERAL|LATERAL|PALM METHOD||||PROXY|MICROSCOPIST 1|2|Visit_2|25|4|FOLLOW-UP|2020-12-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|4|FIV1PP|Percent Predicted FIV1|[?]|SUPINE|||[?]|1|nmol/L/h|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|CONTRALATERAL|SURFACE|THERMAL IONIZATION MASS SPECTROMETRY|||Y|GUARDIAN|HEMATOLOGIST|2|Visit_2|25|1|TREATMENT|2020-12-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-FOWLERS|||[?]|1|10^10/L|HEPATIC VEIN|UNILATERAL|LOWER EXTENSOR SURFACE|PALM METHOD|Y||Y|INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|3|Visit_3|40|7|WASHOUT|2020-12-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|TRENDELENBURG|[?]|RNA copies/mL|[?]|1|U/kg/min|COLON, LEFT|LEFT|CENTRAL|INCISION-INDUCED BLEEDING METHOD||||SPOUSE|ADJUDICATOR 1|3|Visit_3|40|2|SCREENING|2020-12-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|7|RELSZCHG|Relative Size Change|[?]|REVERSE TRENDELENBURG|||[?]|1|10^3 organisms/mL|L2 VERTEBRA|LEFT|DORSAL|NUCLEIC ACID SEQUENCING|||Y|FRIEND|FORENSIC PATHOLOGIST|4|Visit_4|65|3|SCREENING|2021-01-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|8|RAW|Airway Resistance|[?]|SEMI-RECUMBENT|[?]|ukat/L|[?]|1|10^5/L|ORBICULARIS OCULI MUSCLE|CONTRALATERAL|PROXIMAL VOLAR|PUPILLOMETRY||||VENDOR|READER|4|Visit_4|65|7|TREATMENT|2021-01-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|FOWLERS|||[?]|1|lm|HAMSTRING MUSCLE|LEFT|PERIPHERAL|INCISION-INDUCED BLEEDING METHOD|Y||Y|INTERVIEWER|ONCOLOGIST|5|Visit_5|90|3|TREATMENT|2021-02-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|05a142dc-a779-44cb-ab2e-f961676a3940|10|VO2|Oxygen Consumption|[?]|RIGHT LATERAL DECUBITUS|[?]|v/v|[?]|1|Bq|SUPRACLAVICULAR FOSSA|LEFT|SUPERIOR|GEL ELECTROPHORESIS||||FAMILY MEMBER|FORENSIC PATHOLOGIST|5|Visit_5|90|1|WASHOUT|2021-02-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|1|PLMBLFLW|Pulmonary Blood Flow|[?]|DECUBITUS|||[?]|1|IU/day|TIBIAL-CRURAL PERIPHERAL ARTERY|LATERAL|LOWER EXTENSOR SURFACE|MICROBIAL CONCENTRATION|||Y|PARENT|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|2|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|PRONE|||[?]|1|PATCH|LUNG, LEFT LOWER LOBE|CONTRALATERAL|SURFACE|OPTICAL MAPPING|Y||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST|1|Visit_1|10|4|SCREENING|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|3|FIVC|Forced Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/cm|[?]|1|Gravitational Unit|PERIPHERAL NERVE|BILATERAL|OUTER|SIZE EXCLUSION CHROMATOGRAPHY||||SPOUSE|ENDOCRINOLOGIST|2|Visit_2|25|6|TREATMENT|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|4|SVC|Slow Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|Absorbance U/mL|PERIUMBILICAL REGION|CONTRALATERAL|BASAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||Y|FAMILY MEMBER|RATER 1|2|Visit_2|25|1|WASHOUT|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|5|EFFVOL|Effusion Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|cmH2O*s/mL|[?]|1|Absorbance U/min|PULMONARY VALVE, RIGHT CUSP|UNILATERAL|MEDIAL|SNP ARRAY|Y|||INTERVIEWER|PHYSIOTHERAPIST|3|Visit_3|40|3|SCREENING|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|6|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|TRENDELENBURG|[?]|lx|[?]|1|Hounsfield Unit|SCAPHOID-TRAPEZOID JOINT|BILATERAL|APICAL|PERCUSSION||||STUDY SUBJECT|UROLOGIST|3|Visit_3|40|6|WASHOUT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|7|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|IMPLANT|[?]|1|g|HILAR|RIGHT|MEDIAL|FREEZING POINT DEPRESSION|Y|||STUDY SUBJECT|RATER 2|4|Visit_4|65|4|WASHOUT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|8|MIP|Maximal Inspiratory Pressure|[?]|LATERAL DECUBITUS|[?]|m|[?]|1|ug/L|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LEFT|POSTERIOR|INDIRECT IMMUNOFLUORESCENCE||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|4|Visit_4|65|4|FOLLOW-UP|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|9|MEP|Maximal Expiratory Pressure|[?]|TRENDELENBURG|||[?]|1|GBq|HAIR|UNILATERAL|FRONTAL|ANTIMICROBIAL COMBINATION TESTING||Y|Y|INDEPENDENT ASSESSOR|NEUROLOGIST 2|5|Visit_5|90|6|TREATMENT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|498524c5-08c4-41a4-af81-876ab2452f64|10|IVCPP|Percent Predicted IVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|AFU|COLON, RIGHT|LATERAL|CAUDAL|INTERRUPTER TECHNIQUE||Y|Y|SPOUSE|MICROSCOPIST 1|5|Visit_5|90|7|FOLLOW-UP|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|1|RER|Respiratory Exchange Ratio|[?]|LEFT LATERAL DECUBITUS|[?]|kDa|[?]|1|s^-1(%O2)^-1|DISTAL FEMUR R1|UNILATERAL|PERIPHERAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y||GUARDIAN|RADIOLOGIST|1|Visit_1|10|2|TREATMENT|2020-11-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|2|IVC|Inspiratory Vital Capacity|[?]|SITTING|||[?]|1|ug/cm2|HAIR SHAFT|LEFT|VOLAR|CALCULATION|||Y|PARENT|UROLOGIST|1|Visit_1|10|3|SCREENING|2020-11-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|3|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LATERAL DECUBITUS|||[?]|1|mV*min|SPLENIC ARTERY|CONTRALATERAL|UPPER EXTENSOR SURFACE|WHOLE EXOME SEQUENCING|||Y|PROXY|ONCOLOGIST 2|2|Visit_2|25|5|WASHOUT|2020-12-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|4|FIF75|Forced Inspiratory Flow at 75%|[?]|SEMI-FOWLERS|[?]|mmHg|[?]|1|BOX|LIVER, CAUDATE LOBE|UNILATERAL|LOWER MEDIAL|TRIPLE-PHASE SPIRAL CT SCAN||||CHILD|ONCOLOGIST 2|2|Visit_2|25|2|TREATMENT|2020-12-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|5|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|/100 HPFs|[?]|1|uEq|EYE, ANTERIOR SEGMENT|IPSILATERAL|NASAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y||INDEPENDENT ASSESSOR|NEUROLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-12-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|||[?]|1|beats/min|TEMPORAL LOBE|RIGHT|POSTERIOR|CISH|||Y|HEALTH CARE PROFESSIONAL|OPTOMETRIST|3|Visit_3|40|6|SCREENING|2020-12-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|7|PNEUMIND|Pneumonia Indicator|[?]|SUPINE|[?]|mV*min|[?]|1|GBq/g|RENAL PELVIS|UNILATERAL|LOWER|ERGOSPIROMETRY||||FRIEND|MICROSCOPIST|4|Visit_4|65|5|TREATMENT|2021-01-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|8|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|log10 IU/mL|[?]|1|vp/mL|HUMERUS|LATERAL|PERIVENTRICULAR|REFRACTOMETRY||||ADJUDICATION COMMITTEE|NEUROLOGIST 1|4|Visit_4|65|1|TREATMENT|2021-01-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|9|FIO2|Fraction of Inspired Oxygen|[?]|UNCONSTRAINED|[?]|10^6/g|[?]|1|MBP|HEAD OF THE HUMERUS|LATERAL|VENTROLATERAL|PALM METHOD||Y||STUDY SUBJECT|NEUROLOGIST 1|5|Visit_5|90|5|SCREENING|2021-02-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|93490930-01cd-470e-81a3-bcd7a140ccc1|10|EFFVOL|Effusion Volume|[?]|TRENDELENBURG|[?]|mL/day|[?]|1|fL|SUPERFICIAL FEMORAL ARTERY|BILATERAL|CRANIAL|HPLC-FL|Y|||VENDOR|RADIOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-02-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|1|SAWVOL|Specific Airway Volume|[?]|PRONE|[?]|umol/h/mmol|[?]|1|10^9 CFU/g|GASTROINTESTINAL TRACT, WALL|LEFT|FORE|FLUOROSCOPY||Y||INTERVIEWER|NEUROLOGIST 2|1|Visit_1|10|3|WASHOUT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|2|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|||[?]|1|nCi|HEART, RIGHT VENTRICLE|LEFT|OUTER|SPECT SCAN|Y||Y|ADJUDICATION COMMITTEE|RADIOLOGIST 2|1|Visit_1|10|2|WASHOUT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|3|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|SPRAY|SUBSCAPULARIS MUSCLE|LATERAL|SUPERIOR|ISHIHARA COLOR PLATES|||Y|INTERVIEWER|ONCOLOGIST 1|2|Visit_2|25|6|WASHOUT|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|4|INFLTIND|Infiltrates Indicator|[?]|FOWLERS|||[?]|1|mmol/L|ACETABULUM|UNILATERAL|UPPER EXTENSOR SURFACE|ENZYMATIC COLORIMETRY||Y|Y|INVESTIGATOR|DERMATOLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|5|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|PRONE|[?]|mL*cmH2O|[?]|1|amol|C6 VERTEBRA|RIGHT|APICAL|POPULATION SEQUENCING||Y||STUDY SUBJECT|FORENSIC PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|6|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|aMFI|GONAD|BILATERAL|INTERMEDIATE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||Y|FRIEND|INTERNIST|3|Visit_3|40|3|TREATMENT|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|7|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SITTING|[?]|ug|[?]|1|mm/sec|SPLENIC VEIN|LATERAL|FRONTAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||STUDY SUBJECT|HEMATOLOGIST|4|Visit_4|65|4|TREATMENT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|STANDING|[?]|mmol/g|[?]|1|mL/mmHg|PARASYMPATHETIC GANGLIA|UNILATERAL|CRANIAL|GC/MS/MS|Y|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|4|Visit_4|65|7|TREATMENT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|9|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-FOWLERS|[?]|g/m2/day|[?]|1|pt_us|KIDNEY, CORTEX|LEFT|SURFACE|STRESS ECHOCARDIOGRAPHY||Y||FRIEND|RATER 1|5|Visit_5|90|7|FOLLOW-UP|2020-08-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|RE|fd588c97-c57f-432f-81a0-a116a017c5dd|10|VO2|Oxygen Consumption|[?]|PRONE|[?]|kg/cm2|[?]|1|U/kg/day|ABDOMINAL SKIN|RIGHT|SUPERFICIAL|IMPULSE OSCILLOMETRY||||CHILD|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-08-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|min|[?]|1|copies/uL|TAIL|CONTRALATERAL|SUPERFICIAL|KLEIHAUER-BETKE||||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|1|Visit_1|10|5|WASHOUT|2020-12-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|UNCONSTRAINED|||[?]|1|mEq/dL|HAND|CONTRALATERAL|OUTER|SISH|||Y|PARENT|PATHOLOGIST|1|Visit_1|10|3|SCREENING|2020-12-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|3|FEV3FVC|FEV3/FVC|[?]|TRENDELENBURG|[?]|10^6 CFU/g|[?]|1|mV|FEMORAL CONDYLE|LATERAL|LATERAL|PALPATION||||SIBLING|OPTOMETRIST|2|Visit_2|25|7|WASHOUT|2021-01-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|4|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mmol/g|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LEFT|ANTEROMEDIAL|ECHOCARDIOGRAPHY|Y||Y|ADJUDICATION COMMITTEE|ONCOLOGIST|2|Visit_2|25|3|WASHOUT|2021-01-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|5|FEV1REV|FEV1 Reversibility|[?]|REVERSE TRENDELENBURG|||[?]|1|min/day|GLOBUS PALLIDUS|UNILATERAL|POSTERIOR|ARTERIAL SPIN LABELING FUNCTIONAL MRI||Y|Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|3|Visit_3|40|4|SCREENING|2021-01-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|6|ERV|Expiratory Reserve Volume|[?]|UNCONSTRAINED|[?]|mU|[?]|1|PACKET|ESOPHAGUS|UNILATERAL|PROXIMAL VOLAR|DIFFUSION WEIGHTED MRI||Y||INDEPENDENT ASSESSOR|OPHTHALMOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2021-01-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|ng/dL|[?]|1|mg/L FEU|LEFT VENTRICULAR APEX SEGMENT|RIGHT|TEMPORAL|PET/SPECT SCAN||||GUARDIAN|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2021-02-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|8|MIPPP|Percent Predicted MIP|[?]|STANDING, BENT FORWARD|[?]|PRESSOR UNITS|[?]|1|mg/dL|BRAIN|BILATERAL|LOWER MEDIAL|ULTRASOUND||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 1|4|Visit_4|65|6|TREATMENT|2021-02-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SUPINE|||[?]|1|um|INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|VOLAR|MALDI|||Y|PARENT|CLINICAL PATHOLOGIST|5|Visit_5|90|5|WASHOUT|2021-03-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|18028efc-33b9-4741-a47a-8fdac0a90e6e|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SUPINE|||[?]|1|nmol/mL/min|URINARY SYSTEM|BILATERAL|LOWER FLEXOR SURFACE|ENZYMATIC SPECTROPHOTOMETRY|||Y|CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|5|Visit_5|90|2|WASHOUT|2021-03-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|FIO2|Fraction of Inspired Oxygen|[?]|REVERSE TRENDELENBURG|[?]|ug/m2/h|[?]|1|/2500 WBC|L2 VERTEBRA|RIGHT|BASAL|RAJI CELL RIA||Y||FRIEND|OPHTHALMOLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|2|RER|Respiratory Exchange Ratio|[?]|RIGHT LATERAL DECUBITUS|[?]|kPa|[?]|1|umol/h/mmol|SEMINAL VESICLE|BILATERAL|POSTERIOR|ATOMIC ABSORPTION SPECTROMETRY|Y|Y||SIGNIFICANT OTHER|ADJUDICATOR 1|1|Visit_1|10|1|TREATMENT|2020-06-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|3|SALKK|Salazar-Knowles Equation, K|[?]|SEMI-RECUMBENT|[?]|MESF|[?]|1|10^9 organisms/g|SEMITENDINOSUS MUSCLE|LEFT|UPPER EXTENSOR SURFACE|LANDOLT RING||||ADJUDICATOR|ADJUDICATOR 2|2|Visit_2|25|1|FOLLOW-UP|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|4|TVPP|Percent Predicted Tidal Volume|[?]|STANDING, BENT FORWARD|[?]|MBq|[?]|1|g/cage/wk|FOREBRAIN|RIGHT|DISTAL VOLAR|SURFACE PLASMON RESONANCE||||INDEPENDENT ASSESSOR|ADJUDICATOR 1|2|Visit_2|25|2|WASHOUT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|5|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|mU|[?]|1|uU/L|LUNG, LEFT LOWER LOBE|UNILATERAL|SUPERIOR|AUSCULTATION||Y||VENDOR|RATER 1|3|Visit_3|40|6|FOLLOW-UP|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|DECUBITUS|[?]|dmol|[?]|1|mmAL|LEFT VENTRICULAR APICAL LATERAL SEGMENT|CONTRALATERAL|UPPER FLEXOR SURFACE|FLUORESCENT SPOT TEST|Y|||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|7|MALIND|Malignancy Indicator|[?]|SLING|[?]|pmol/L|[?]|1|dpm/0.5 mL|OLECRANON|CONTRALATERAL|CAUDAL|ATOMIC ABSORPTION SPECTROMETRY||||CLINICAL RESEARCH ASSOCIATE|RATER 1|4|Visit_4|65|4|WASHOUT|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|UNCONSTRAINED|[?]|mL/s|[?]|1|kV|CORPUS CALLOSUM, GENU|CONTRALATERAL|DORSAL|QUANTITATIVE ULTRASOUND|Y|||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|9|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|umol/L|[?]|1|10^6/Ejaculate U|TRAPEZIUS MUSCLE|RIGHT|PROXIMAL VOLAR|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|Y||INVESTIGATOR|READER 3|5|Visit_5|90|2|WASHOUT|2020-08-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|10|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|[?]|Mile|[?]|1|nmol/L/h|BRACHIAL LYMPH NODE|UNILATERAL|INTERMEDIATE|CHROMATOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|5|Visit_5|90|3|WASHOUT|2020-08-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|GPS U|[?]|1|MAC50|CORONARY ARTERY|BILATERAL|ANTEROPOSTERIOR|MICROBIAL BIOCHEMICAL IDENTIFICATION||||CAREGIVER|RATER 2|1|Visit_1|10|7|SCREENING|2021-01-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|2|AWVOL|Airway Volume|[?]|DECUBITUS|||[?]|1|g/animal/day|PANCREAS, BODY|CONTRALATERAL|ANTERIOR|CONFOCAL MICROSCOPY||Y|Y|CHILD|MICROSCOPIST|1|Visit_1|10|2|TREATMENT|2021-01-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SLING|||[?]|1|pmol/dL|CRANIAL NERVE|RIGHT|SUPERIOR|DIFFUSION TENSOR MRI|||Y|GUARDIAN|MICROSCOPIST 1|2|Visit_2|25|1|FOLLOW-UP|2021-02-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|4|FIVC|Forced Inspiratory Vital Capacity|[?]|PRONE|[?]|10^6 organisms/mL|[?]|1|L/s|DENTAL ARCH|BILATERAL|BASAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|2|Visit_2|25|2|TREATMENT|2021-02-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|5|FRCPP|Percent Predicted FRC|[?]|SUPINE|[?]|kN/cm2|[?]|1|MET|SKIN OF THE BACK|RIGHT|PERIPHERAL|LEAD CITRATE STAIN||||PARENT|OTOLARYNGOLOGIST|3|Visit_3|40|7|SCREENING|2021-02-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-06
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|6|LOBVOL|Lobar Volume|[?]|LATERAL DECUBITUS|[?]|ng/day|[?]|1|kV|COLON LYMPH NODE|RIGHT|INNER|IMPULSE OSCILLOMETRY|Y|||INVESTIGATOR|HEMATOLOGIST|3|Visit_3|40|5|TREATMENT|2021-02-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-06
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|7|GAW|Airway Conductance|[?]|TRENDELENBURG|[?]|umol|[?]|1|mL/s/m2|HEART, RIGHT VENTRICLE|CONTRALATERAL|INFERIOR|MAGNETIC RESONANCE ELASTOGRAPHY||||PARENT|MICROSCOPIST|4|Visit_4|65|3|TREATMENT|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|8|EFFVOL|Effusion Volume|[?]|SITTING|[?]|foz_us|[?]|1|mg/kg/min|MITRAL VALVE, POSTERIOR CUSP|LATERAL|MEDIAL|QUANTITATIVE COMPUTED TOMOGRAPHY||Y||FRIEND|INTERNIST|4|Visit_4|65|3|FOLLOW-UP|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|9|FEV6PP|Percent Predicted FEV6|[?]|SITTING|||[?]|1|mg/m2/day|OPHTHALMIC ARTERY|RIGHT|VOLAR|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||Y|INDEPENDENT ASSESSOR|RADIOLOGIST 1|5|Visit_5|90|7|WASHOUT|2021-04-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|08fccce4-64bf-431e-81b0-a96566e77df6|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SLING|[?]|10^3 DNA copies/mL|[?]|1|DAYS|POPLITEAL FOSSA|LATERAL|DISTAL VOLAR|DOUBLE IMMUNODIFFUSION|Y|||INDEPENDENT ASSESSOR|PATHOLOGIST|5|Visit_5|90|1|SCREENING|2021-04-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|1|QUASCOMP|Quasi-Static Compliance|[?]|FOWLERS|[?]|APL U/mL|[?]|1|mmHg/sec|ACROMION|CONTRALATERAL|PERIPHERAL|PATHOLOGICAL EVALUATION||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|1|Visit_1|10|6|SCREENING|2021-01-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|2|EVC|Expiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|cd*s/m2|[?]|1|ug/kg/min|LEFT CIRCUMFLEX ARTERY OSTIUM|CONTRALATERAL|DORSAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||||FRIEND|FORENSIC PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2021-01-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|3|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|UNCONSTRAINED|||[?]|1|mAmp|ANTERIOR SUPERIOR ILIAC SPINE|RIGHT|DEEP|ARTERIAL SPIN LABELING FUNCTIONAL MRI|||Y|PROXY|NEUROLOGIST 2|2|Visit_2|25|4|TREATMENT|2021-02-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|4|PCF|Peak Cough Flow|[?]|TRENDELENBURG|||[?]|1|KALLIKREIN INHIBITOR UNIT|DISTAL PHALANX 5 OF THE HAND|CONTRALATERAL|PERIVENTRICULAR|FARR ASSAY|Y||Y|ADJUDICATION COMMITTEE|MICROSCOPIST 1|2|Visit_2|25|5|TREATMENT|2021-02-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|5|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SUPINE|[?]|DIOPTER|[?]|1|m/sec|DISTAL PHALANX 5 OF THE HAND|IPSILATERAL|LOWER EXTENSOR SURFACE|MALDI-TOF||||INVESTIGATOR|ONCOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/dL|[?]|1|IU/mL|STERNEBRA|RIGHT|UPPER|CALIPER MEASUREMENT METHOD||||STUDY SUBJECT|OPHTHALMOLOGIST|3|Visit_3|40|6|TREATMENT|2021-02-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|7|FIVC|Forced Inspiratory Vital Capacity|[?]|TRENDELENBURG|[?]|Mile|[?]|1|/h|LACRIMAL GLAND|CONTRALATERAL|LOWER MEDIAL|PUPILLOMETRY|Y|Y||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|4|Visit_4|65|4|TREATMENT|2021-03-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|GBq/mg|[?]|1|Arbitrary U|THIRD POSTEROLATERAL DESCENDING ARTERY|RIGHT|ANTEROTEMPORAL|HANSEL STAIN|Y|||PROXY|PHYSIOTHERAPIST|4|Visit_4|65|1|TREATMENT|2021-03-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|9|INTP|Interpretation|[?]|LATERAL DECUBITUS|[?]|Mile|[?]|1|mmol/min/kPa/L|ILIAC CREST|BILATERAL|PERIPHERAL|DIFFUSION WEIGHTED MRI||||FRIEND|RATER 1|5|Visit_5|90|5|FOLLOW-UP|2021-04-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|0354fab5-5636-4504-8345-af060ad4c90c|10|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|g/dL|[?]|1|10^6 organisms/mL|METATARSOPHALANGEAL JOINT 1|RIGHT|PERIVENTRICULAR|MRI WITHOUT CONTRAST||Y||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-04-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|DECUBITUS|[?]|anti-Xa IU/mL|[?]|1|PELLET|UPPER CERVICAL LYMPH NODE|LATERAL|TIP|ULTRASONOGRAPHIC ELASTOGRAPHY||||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|1|Visit_1|10|6|WASHOUT|2021-01-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING|||[?]|1|U/g/day|SKIN OF THE EAR|UNILATERAL|CAUDAL|CELL BASED BIOASSAY|||Y|GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2021-01-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|3|MALEVDES|Malignancy Evidence Description|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/ug|[?]|1|/10^5|RIB 8|RIGHT|INNER|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||SIBLING|DERMATOLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SUPINE|[?]|CAPSULE|[?]|1|mL/g/day|BICEPS BRACHII MUSCLE|CONTRALATERAL|LOWER MEDIAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|||CHILD|RATER 2|2|Visit_2|25|1|SCREENING|2021-01-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|5|IRVPP|Percent Predicted IRV|[?]|SUPINE|[?]|m/sec2|[?]|1|10^7/L|RETROCRURAL LYMPH NODE|LEFT|LOWER EXTENSOR SURFACE|SINGLE-MOLECULE ARRAY||Y||CHILD|PATHOLOGIST 1|3|Visit_3|40|1|SCREENING|2021-02-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|6|TLC|Total Lung Capacity|[?]|SLING|[?]|Weber|[?]|1|U/kg/day|JAW|LEFT|TEMPORAL|MYELOPEROXIDASE STAIN||||VENDOR|RATER|3|Visit_3|40|2|FOLLOW-UP|2021-02-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|7|AWWVOL|Airway Wall Volume|[?]|SUPINE|[?]|dL|[?]|1|mg/day|SENSORIMOTOR CORTEX|RIGHT|DISTAL|DYNAMOMETRY||||FRIEND|CARDIOLOGIST|4|Visit_4|65|1|TREATMENT|2021-03-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|8|FIFMAX|Maximum Forced Inspiratory Flow|[?]|LATERAL DECUBITUS|||[?]|1|Log10 ELISA unit|EPIGASTRIC REGION|UNILATERAL|UPPER FLEXOR SURFACE|PELLI-ROBSON EYE CHART|||Y|FRIEND|HEMATOLOGIST|4|Visit_4|65|6|TREATMENT|2021-03-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|kBq|[?]|1|pg/L|FRONTAL SINUS|LEFT|CAUDAL|IMMUNOFIXATION ELECTROPHORESIS||Y||DOMESTIC PARTNER|RADIOLOGIST 2|5|Visit_5|90|1|TREATMENT|2021-03-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|f4f1a53a-d621-4f75-b44e-96b959aed03d|10|FEV1SVC|FEV1/SVC|[?]|RIGHT LATERAL DECUBITUS|[?]|GBq/ug|[?]|1|g/animal/wk|SKIN OF THE CHEST|IPSILATERAL|MIDLINE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||Y||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-03-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|[?]|mmol|[?]|1|cs|BACK|BILATERAL|LATERAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|Y||VENDOR|MICROSCOPIST 2|1|Visit_1|10|1|TREATMENT|2020-10-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|2|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|cP|[?]|1|BOWL|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|RIGHT|ANTEROTEMPORAL|TARGETED TRANSCRIPTOME SEQUENCING||||PARENT|OPTOMETRIST|1|Visit_1|10|6|TREATMENT|2020-10-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|3|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|[?]|mm|[?]|1|Roentgen|SPLENIC VEIN|IPSILATERAL|DEEP|AUSCULTATION||Y||INVESTIGATOR|ADJUDICATOR 1|2|Visit_2|25|1|TREATMENT|2020-10-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|4|EFFVOL|Effusion Volume|[?]|DECUBITUS|[?]|MBq/uL|[?]|1|BOTTLE|CORPUS CALLOSUM, GENU|LEFT|APICAL|IMMUNE REPERTOIRE DEEP SEQUENCING||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-10-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|tuberculin unit|[?]|1|/100 WBC|ANAL VERGE|LATERAL|CENTRAL|ACID FAST STAIN|Y|Y||INDEPENDENT ASSESSOR|MICROSCOPIST 3|3|Visit_3|40|7|TREATMENT|2020-10-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|6|ELSTNCE|Elastance|[?]|FOWLERS|||[?]|1|uIU/L|SHIN|LEFT|VENTRAL|CLIP|||Y|FAMILY MEMBER|MICROSCOPIST 3|3|Visit_3|40|6|SCREENING|2020-10-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|7|FIO2|Fraction of Inspired Oxygen|[?]|SUPINE|[?]|dmol|[?]|1|ppth|HEART, LEFT VENTRICULAR OUTFLOW TRACT|UNILATERAL|DORSAL|LAPAROSCOPY|Y|||GUARDIAN|READER 2|4|Visit_4|65|2|TREATMENT|2020-11-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|mU|[?]|1|EP U|FLEXOR DIGITORUM PROFUNDUS MUSCLE|IPSILATERAL|ANTEROMEDIAL|MALDI-TOF||||INVESTIGATOR|RATER|4|Visit_4|65|5|FOLLOW-UP|2020-11-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-10
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|9|OXYPULSE|Oxygen Pulse|[?]|SITTING, LEGS DEPENDENT|[?]|ukat|[?]|1|mol/L|UTERUS|LATERAL|VENTROLATERAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI||Y||ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|5|Visit_5|90|3|TREATMENT|2020-12-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|10|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING|[?]|Log10 ELISA unit/dose|[?]|1|RNA copies/mL|DISTAL CIRCUMFLEX ARTERY|RIGHT|LATERAL|NUCLEIC ACID AMPLIFICATION TEST||||FRIEND|ADJUDICATOR 2|5|Visit_5|90|5|SCREENING|2020-12-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|1|IC|Inspiratory Capacity|[?]|SLING|[?]|CFU/g|[?]|1|mL/sec/1.73m2|BRAIN STEM|RIGHT|ANTEROTEMPORAL|SURFACE PLASMON RESONANCE||||INDEPENDENT ASSESSOR|UROLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|2|ICREV|IC Reversibility|[?]|SITTING|[?]|ug/g/min|[?]|1|POUCH|THORACIC CAVITY|RIGHT|INTERMEDIATE|PERFUSION MRI|Y|Y||FRIEND|OTOLARYNGOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|cd|T11 VERTEBRA|LEFT|OUTER|TRANSTHORACIC ECHOCARDIOGRAPHY|||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST|2|Visit_2|25|4|TREATMENT|2020-08-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|4|DLCO|Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|[?]|min/day|[?]|1|cd|LATERAL FIRST DIAGONAL BRANCH ARTERY|BILATERAL|INTERMEDIATE|ELECTROMYOGRAPHY||Y||STUDY SUBJECT|OPTOMETRIST|2|Visit_2|25|4|TREATMENT|2020-08-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|5|AWVOLPP|Percent Predicted Airway Volume|[?]|UNCONSTRAINED|||[?]|1|10^5/hpf|BILE DUCT|CONTRALATERAL|PARIETO-OCCIPITAL|MYELOPEROXIDASE STAIN|||Y|SIBLING|RATER 1|3|Visit_3|40|6|TREATMENT|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|6|FEV1FVC|FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|Ci|[?]|1|PFU/dose|PARATHYROID GLAND|LEFT|POSTERIOR|INDIA INK STAIN|Y|Y||HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|6|TREATMENT|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|7|FIF75|Forced Inspiratory Flow at 75%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Pack Year|LIVER FISSURE|LEFT|VENTROLATERAL|PERCUSSION|||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST|4|Visit_4|65|3|WASHOUT|2020-09-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|8|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|||[?]|1|Gy/min|TYMPANIC MEMBRANE|LEFT|ANTEROLATERAL|THIN SMEAR|||Y|VENDOR|READER 2|4|Visit_4|65|7|FOLLOW-UP|2020-09-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|9|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|genEq|[?]|1|10^7/L|SCAPHOID-TRAPEZIUM JOINT|BILATERAL|DISTAL|IMPULSE OSCILLOMETRY||||PARENT|ENDOCRINOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|679423a4-92cf-4a93-8277-282f9b43f2ed|10|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING, BENT FORWARD|[?]|mmol/L|[?]|1|nkat/L|ELBOW FLEXOR MUSCLES|CONTRALATERAL|MEDIAL|CONTRAST ENHANCED X-RAY||||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|5|Visit_5|90|6|TREATMENT|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|[?]|psec|[?]|1|cycle/min|ANASTOMOSIS|LATERAL|ANTEROMEDIAL|IMMUNOPRECIPITATION||Y||INVESTIGATOR|READER 2|1|Visit_1|10|4|TREATMENT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|PA|[?]|1|mEq/dL|OLFACTORY BULB|BILATERAL|PERIVENTRICULAR|CENTRIFUGATION||||INTERVIEWER|PATHOLOGIST 1|1|Visit_1|10|2|WASHOUT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|3|FEV3FVC|FEV3/FVC|[?]|STANDING, BENT FORWARD|[?]|MONTHS|[?]|1|mmHg/sec|TONSIL|BILATERAL|FACIAL|SPECTROPHOTOMETRY||||STUDY SUBJECT|ONCOLOGIST 2|2|Visit_2|25|6|FOLLOW-UP|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|[?]|titer|[?]|1|mL/min|MAXILLA|RIGHT|FORE|TOLUIDINE BLUE STAIN||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|5|MEP|Maximal Expiratory Pressure|[?]|SITTING, LEGS DEPENDENT|[?]|Watt|[?]|1|mg/kg/dose|FINGER EXTENSOR TENDONS|LATERAL|SUBCORTICAL|ERGOSPIROMETRY||||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|3|Visit_3|40|1|TREATMENT|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|6|SGAW|Specific Airway Conductance|[?]|SUPINE|||[?]|1|pL|ANASTOMOSIS|BILATERAL|BASAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||Y|VENDOR|READER 3|3|Visit_3|40|4|TREATMENT|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|7|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|DIOPTER|[?]|1|SYRINGE|FACIAL NERVE|LEFT|INFERIOR|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||Y||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|4|TREATMENT|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|||[?]|1|mm/h|SKIN OF THE KNEE|LEFT|CAUDAL|NEXT GENERATION SEQUENCING|||Y|INVESTIGATOR|ONCOLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|9|FRCPP|Percent Predicted FRC|[?]|STANDING|||[?]|1|mg/dL|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|UNILATERAL|VOLAR|HILLMEN COLOR CHART|||Y|INVESTIGATOR|ADJUDICATOR 3|5|Visit_5|90|3|SCREENING|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|fb686cda-337b-46aa-b67b-790414201d9a|10|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|[?]|hr/day|[?]|1|TRACE|TALUS|UNILATERAL|CAUDAL|SICKLE CELL SOLUBILITY TEST||||SIGNIFICANT OTHER|NEUROLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-08-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|[?]|mg/kg/h|[?]|1|kcal|MENINGES|RIGHT|PROXIMAL|ANTIBIOTIC AGAR SCREEN|Y|||INTERVIEWER|RATER 1|1|Visit_1|10|6|TREATMENT|2020-10-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|2|RVPP|Percent Predicted Residual Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|Gy/h|[?]|1|v/v|COLON WALL|LATERAL|LOWER FLEXOR SURFACE|PET/CT SCAN||Y||ADJUDICATOR|OPTOMETRIST|1|Visit_1|10|2|TREATMENT|2020-10-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|3|ICREV|IC Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|fmol|[?]|1|AMPULE|ETHMOID BONE|UNILATERAL|PERIPHERAL|STATIC PERIMETRY||||SPOUSE|RATER 1|2|Visit_2|25|4|SCREENING|2020-10-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|4|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|fL|[?]|1|Ci/g|HEART, RIGHT VENTRICULAR WALL|UNILATERAL|OUTER|ELECTRICAL IMPEDANCE MYOGRAPHY||||ADJUDICATOR|READER 1|2|Visit_2|25|5|TREATMENT|2020-10-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|5|DLCOPP|Percent Predicted DLCO|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^3 organisms/mL|FINGER FLEXOR MUSCLES|UNILATERAL|NASAL|WEBER GREEN STAIN|||Y|SIGNIFICANT OTHER|RADIOLOGIST 2|3|Visit_3|40|6|FOLLOW-UP|2020-11-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|6|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|ugEq/L|[?]|1|umol/kg/min|TRAPEZIUS MUSCLE|LEFT|CENTRAL|DOPPLER ULTRASOUND||||INDEPENDENT ASSESSOR|ADJUDICATOR 2|3|Visit_3|40|2|WASHOUT|2020-11-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING|[?]|steps/min|[?]|1|nCi|T1 VERTEBRA|BILATERAL|LOWER|PANENDOSCOPY||||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|8|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|mL/min/mmHg|[?]|1|nkat|BILIARY TRACT|UNILATERAL|HIND|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|||ADJUDICATION COMMITTEE|ADJUDICATOR 2|4|Visit_4|65|1|TREATMENT|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|9|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-RECUMBENT|[?]|/100 HPFs|[?]|1|mL/cage|OPTIC DISC|BILATERAL|ANTEROTEMPORAL|OLIGO ACGH|Y|||DOMESTIC PARTNER|HEMATOLOGIST|5|Visit_5|90|3|TREATMENT|2020-12-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|10|INFLTIND|Infiltrates Indicator|[?]|REVERSE TRENDELENBURG|[?]|HOMEOPATHIC DILUTION|[?]|1|Bq/L|SKIN OF THE TRUNK|UNILATERAL|FACIAL|SPIROMETRY||Y||PARENT|MICROSCOPIST|5|Visit_5|90|7|SCREENING|2020-12-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|FEF50|Forced Expiratory Flow 50%|[?]|TRENDELENBURG|[?]|uCi/L|[?]|1|ng/day|MALLEUS|BILATERAL|FACIAL|HANSEL STAIN||Y||STUDY SUBJECT|ADJUDICATOR 1|1|Visit_1|10|4|TREATMENT|2020-12-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|2|AWVOLPP|Percent Predicted Airway Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mCi/kg|AXILLARY LYMPH NODE LEVEL III|LEFT|MEDIAL|ANALYTICAL ULTRACENTRIFUGATION|||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST 2|1|Visit_1|10|7|WASHOUT|2020-12-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|3|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|min|[?]|1|10^4/hpf|SKIN OF THE PALM|LEFT|DEEP|PET/MRI SCAN|Y|||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|2|Visit_2|25|3|TREATMENT|2020-12-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|4|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|Ci/ug|[?]|1|mCi/L|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|FACIAL|HPLC-UV||||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-12-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|5|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|mg/kg/day|[?]|1|CIGAR|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|UPPER|ELECTROPHORESIS||Y||NON-HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|6|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|[?]|C|[?]|1|kg/cm2|URETHRA, PROSTATIC|CONTRALATERAL|OCCIPITAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|SLING|||[?]|1|mL/animal|ABDOMINAL WALL|IPSILATERAL|POSTERIOR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y|Y|PROXY|READER 1|4|Visit_4|65|2|SCREENING|2021-01-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|V|[?]|1|Ci/uL|SUPRAGLOTTIS|CONTRALATERAL|CENTRAL|NON-INVASIVE DIELECTRIC SENSING||Y||SPOUSE|READER|4|Visit_4|65|2|TREATMENT|2021-01-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|9|VO2|Oxygen Consumption|[?]|SEMI-RECUMBENT|[?]|pmol|[?]|1|10^3 organisms/mL|THORACIC ARTERY|CONTRALATERAL|LOWER FLEXOR SURFACE|IMMUNO-PET SCAN|Y|||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|5|WASHOUT|2021-02-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|92d7a180-9353-41f8-93e2-ebcee32a1c63|10|DLCOHC|HGB Corrected DLCO|[?]|SITTING|||[?]|1|sec|TEMPOROMANDIBULAR JOINT|LATERAL|INTERMEDIATE|MICROBIAL CULTURE, LIQUID|Y||Y|PROXY|ONCOLOGIST 1|5|Visit_5|90|5|TREATMENT|2021-02-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|PEFREV|PEF Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|mmol|[?]|1|min|HAIR BULB|BILATERAL|VOLAR|HIGH RESOLUTION CT||Y||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|1|Visit_1|10|5|WASHOUT|2020-10-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|2|SVC|Slow Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|um|[?]|1|bel|ADRENAL GLAND|CONTRALATERAL|ANTEROMEDIAL|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|||FRIEND|RADIOLOGIST|1|Visit_1|10|3|SCREENING|2020-10-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|3|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|ug/m2/h|[?]|1|mU|CENTRAL NERVOUS SYSTEM|LATERAL|DISTAL VOLAR|WEBER GREEN STAIN||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|2|Visit_2|25|2|WASHOUT|2020-11-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|4|FIFMAXPP|Percent Predicted FIFmax|[?]|LEFT LATERAL DECUBITUS|[?]|scm|[?]|1|Arbitrary U|EPIGLOTTIS|RIGHT|MEDIAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|||SPOUSE|NEUROLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-11-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|[?]|log10 TCID 50/mL|[?]|1|Log10 ELISA unit/dose|SACRUM|CONTRALATERAL|UPPER EXTENSOR SURFACE|HPLC-FL||Y||CLINICAL STUDY SPONSOR|READER 3|3|Visit_3|40|2|TREATMENT|2020-11-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|6|FIVC|Forced Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|uIU/dL|[?]|1|TCID 50/dose|SUDORIFEROUS GLAND|UNILATERAL|ROSTRAL|PALM METHOD|Y|||INVESTIGATOR|READER 3|3|Visit_3|40|5|WASHOUT|2020-11-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|7|INFLTIND|Infiltrates Indicator|[?]|PRONE|[?]|mL/animal|[?]|1|mL/dL|HEART, RIGHT VENTRICLE|LATERAL|UPPER|WRIGHT STAIN||||VENDOR|CLINICAL PATHOLOGIST|4|Visit_4|65|2|WASHOUT|2020-12-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|8|PEF|Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|Frames/s|[?]|1|g/g|FINGER EXTENSOR MUSCLES|LEFT|MEDIAL|TRIPLE-PHASE MRI SCAN||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|4|Visit_4|65|5|FOLLOW-UP|2020-12-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|9|FIF75|Forced Inspiratory Flow at 75%|[?]|SEMI-FOWLERS|[?]|nmol/L|[?]|1|SYRINGE|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|RIGHT|DORSAL|GC/MS||Y||NON-HEALTH CARE PROFESSIONAL|RATER 2|5|Visit_5|90|7|TREATMENT|2021-01-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|5da18fbc-1274-4cb3-bb6b-b57872b9815b|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|SEMI-RECUMBENT|[?]|Ejaculate U|[?]|1|HEP|TOE|UNILATERAL|DORSOLATERAL|ELISPOT||||CHILD|OPHTHALMOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-01-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|MALIND|Malignancy Indicator|[?]|SITTING|||[?]|1|ug/g/day|VOMER|LATERAL|DISTAL|TELLER ACUITY CARDS|Y||Y|DOMESTIC PARTNER|READER 3|1|Visit_1|10|4|SCREENING|2020-11-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|2|ERV|Expiratory Reserve Volume|[?]|TRENDELENBURG|[?]|m/sec2|[?]|1|in2|CARPOMETACARPAL JOINT 1|LATERAL|INTERMEDIATE|PHOTOMETRY||||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|TREATMENT|2020-11-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|3|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|||[?]|1|CONTAINER|CORONARY ARTERY, ANTERIOR DESCENDING|BILATERAL|TEMPORAL|FISH|||Y|CAREGIVER|NEUROLOGIST 1|2|Visit_2|25|1|FOLLOW-UP|2020-12-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|4|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|[?]|SFC/10^6 PBMC|[?]|1|10^6/hpf|PERICARDIAL CAVITY|LEFT|VENTRAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||SIBLING|RADIOLOGIST|2|Visit_2|25|5|WASHOUT|2020-12-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|HEP|[?]|1|pg/cell|VOCAL CORD|UNILATERAL|VOLAR|STRESS ECHOCARDIOGRAPHY|Y|||CHILD|INTERNIST|3|Visit_3|40|5|WASHOUT|2020-12-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING|[?]|log10 TCID 50/uL|[?]|1|ug/L FEU|RIB|IPSILATERAL|TIP|INCISION-INDUCED BLEEDING METHOD||||SIGNIFICANT OTHER|RADIOLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-12-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|7|IRV|Inspiratory Reserve Volume|[?]|SITTING|||[?]|1|MBP|DUCTUS ARTERIOSUS|IPSILATERAL|FORE|CONFOCAL MICROSCOPY||Y|Y|CLINICAL STUDY SPONSOR|PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2021-01-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|8|IRVPP|Percent Predicted IRV|[?]|STANDING|[?]|U/kg|[?]|1|copies/mL|MEDIAN OR LOWER CERVICAL LYMPH NODE|IPSILATERAL|LOWER EXTENSOR SURFACE|IMMUNOASSAY|Y|||STUDY SUBJECT|RADIOLOGIST 2|4|Visit_4|65|2|TREATMENT|2021-01-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|9|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|||[?]|1|cy/cm|LOCUS CERULEUS|BILATERAL|INNER|HILLMEN COLOR CHART|||Y|INTERVIEWER|ADJUDICATOR 1|5|Visit_5|90|1|SCREENING|2021-02-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|10|LOBVOL|Lobar Volume|[?]|SUPINE|||[?]|1|F|MUCOSA|RIGHT|ANTEROTEMPORAL|TEST STRIP|||Y|CHILD|ONCOLOGIST|5|Visit_5|90|1|SCREENING|2021-02-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|1|MALIND|Malignancy Indicator|[?]|PRONE|[?]|mol/mol|[?]|1|mL/s|PERIRECTAL LYMPH NODE|LATERAL|ANTEROLATERAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||SIGNIFICANT OTHER|PATHOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-07-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|2|ICREV|IC Reversibility|[?]|FOWLERS|||[?]|1|ELISA unit|REGIONAL LYMPH NODE|LEFT|BASAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y|Y|INVESTIGATOR|CARDIOLOGIST|1|Visit_1|10|4|TREATMENT|2020-07-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|3|INERTANC|Inertance|[?]|STANDING, BENT FORWARD|[?]|PFU/animal|[?]|1|PFU|MIDDLE PHALANX 3 OF THE HAND|CONTRALATERAL|CAUDAL|FLUORIMETRY||Y||PROXY|OPTOMETRIST|2|Visit_2|25|2|TREATMENT|2020-08-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|PRONE|||[?]|1|BE/mL|AORTIC VALVE, LEFT CORONARY CUSP|BILATERAL|LATERAL|EIA|Y||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|2|Visit_2|25|4|TREATMENT|2020-08-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|5|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|[?]|mL/m2/min|[?]|1|scm|PULMONARY VALVE, LEFT CUSP|CONTRALATERAL|LOWER MEDIAL|SNP ARRAY||||GUARDIAN|OPTOMETRIST|3|Visit_3|40|2|TREATMENT|2020-08-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|6|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|[?]|10^6 organisms/g|[?]|1|/h|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|MEDIAL|IMMUNOFIXATION ELECTROPHORESIS||||STUDY SUBJECT|DERMATOLOGIST|3|Visit_3|40|6|WASHOUT|2020-08-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|7|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|L/kg|[?]|1|mol/mL|L3 VERTEBRA|CONTRALATERAL|VENTROLATERAL|PUPILLOMETRY||Y||PARENT|FORENSIC PATHOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-09-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|FOWLERS|[?]|ug/kg/day|[?]|1|10^5/L|METACARPOPHALANGEAL JOINT 3|BILATERAL|PROXIMAL VOLAR|ICP-MS||||FAMILY MEMBER|OPTOMETRIST|4|Visit_4|65|2|FOLLOW-UP|2020-09-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|9|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|damol/L|[?]|1|fL|HIP JOINT|LEFT|TIP|FLOCCULATION, CHARCOAL ENHANCED||||FAMILY MEMBER|ADJUDICATOR 2|5|Visit_5|90|2|WASHOUT|2020-10-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|4a195822-d646-4b22-a3b9-f6642442474d|10|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|[?]|cg|[?]|1|STEPS|SEMINAL VESICLE|UNILATERAL|FORE|THIN SMEAR||||DOMESTIC PARTNER|RADIOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-10-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|MIPPP|Percent Predicted MIP|[?]|SITTING, LEGS DEPENDENT|[?]|mL/animal/wk|[?]|1|m|RIGHT ATRIAL ENDOCARDIUM|RIGHT|ANTEROTEMPORAL|NUCLEIC ACID HYBRIDIZATION|Y|||STUDY SUBJECT|CLINICAL PATHOLOGIST|1|Visit_1|10|4|WASHOUT|2020-09-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|ELISA unit/dose|[?]|1|mmHg/L/min|LOCUS CERULEUS|LEFT|VOLAR|TOTAL BODY IRRADIATION||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|1|Visit_1|10|2|WASHOUT|2020-09-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|3|LCI|Lung Clearance Index|[?]|DECUBITUS|[?]|Hz/s|[?]|1|log10 IU/mL|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|RIGHT|PROXIMAL VOLAR|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||VENDOR|PATHOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-09-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|4|LOBVOL|Lobar Volume|[?]|LATERAL DECUBITUS|[?]|h/wk|[?]|1|mL/animal/day|ANKLE JOINT ANTERIOR FLEXOR TENDONS|BILATERAL|DISTAL VOLAR|WHOLE GENOME SEQUENCING||Y||GUARDIAN|PATHOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-09-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|5|PEFREV|PEF Reversibility|[?]|TRENDELENBURG|||[?]|1|msec|ILEUM, TERMINAL|CONTRALATERAL|CAUDAL|ATOMIC ABSORPTION SPECTROMETRY|||Y|ADJUDICATOR|PATHOLOGIST|3|Visit_3|40|1|TREATMENT|2020-10-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING|[?]|ukat/10^12 RBC|[?]|1|g/dL|SUPERFICIAL FEMORAL ARTERY|RIGHT|FORE|POLYGRAPHY|Y|Y||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|3|Visit_3|40|5|TREATMENT|2020-10-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|[?]|PFU/animal|[?]|1|dyn|ULNAR ARTERY|LEFT|SUPERFICIAL|FLOW CYTOMETRY|Y|||CHILD|UROLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-11-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|8|TVPP|Percent Predicted Tidal Volume|[?]|SUPINE|[?]|/HPF|[?]|1|P|MUSCULOSKELETAL SYSTEM|LEFT|VENTRAL|DARK FIELD MICROSCOPY||||CLINICAL STUDY SPONSOR|RATER|4|Visit_4|65|5|FOLLOW-UP|2020-11-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|9|DLCOHCVA|HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|10^9/g|[?]|1|10^4 CFU/mL|EPIGASTRIC LYMPH NODE|UNILATERAL|POSTERIOR|PHYSICAL EXAMINATION|Y|||SPOUSE|MICROSCOPIST 1|5|Visit_5|90|3|SCREENING|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|515808c1-fda7-43bb-91dc-28e2d4e308cd|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|LEFT LATERAL DECUBITUS|[?]|uIU/L|[?]|1|beats/min|AORTIC VALVE, LEFT CORONARY CUSP|LATERAL|ANTEROLATERAL|GC/FID||Y||FAMILY MEMBER|ONCOLOGIST 2|5|Visit_5|90|1|WASHOUT|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|1|MIPPP|Percent Predicted MIP|[?]|SITTING, LEGS DEPENDENT|[?]|U/g/min|[?]|1|ka_u/dL|DIAPHRAGM|BILATERAL|FORE|MICROBIAL CULTURE||Y||STUDY SUBJECT|READER 1|1|Visit_1|10|4|WASHOUT|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|2|OXYPULSE|Oxygen Pulse|[?]|RIGHT LATERAL DECUBITUS|[?]|ng/day|[?]|1|deg/s|HEPATOBILIARY SYSTEM|IPSILATERAL|DISTAL VOLAR|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||FRIEND|ENDOCRINOLOGIST|1|Visit_1|10|7|SCREENING|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|3|RRS|Total Respiratory System Resistance|[?]|STANDING|[?]|DISK|[?]|1|kPa/L/sec|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|UPPER FLEXOR SURFACE|SICKLE CELL SOLUBILITY TEST||Y||GUARDIAN|OPHTHALMOLOGIST|2|Visit_2|25|1|SCREENING|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|4|EFFVOL|Effusion Volume|[?]|SITTING, LEGS DEPENDENT|[?]|10^4 CFU|[?]|1|msec|PARIETAL LOBE|UNILATERAL|TEMPORAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||||PARENT|ADJUDICATOR|2|Visit_2|25|4|WASHOUT|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING|||[?]|1|msec|AORTO-ILIAC PERIPHERAL ARTERY|IPSILATERAL|LOWER FLEXOR SURFACE|MICROBIAL CULTURE, LIQUID|||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 1|3|Visit_3|40|7|FOLLOW-UP|2020-11-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|6|SGAW|Specific Airway Conductance|[?]|TRENDELENBURG|[?]|mL/kg/day|[?]|1|g/cage/day|BASILIC VEIN|LATERAL|DORSOLATERAL|ROMANOWSKY STAIN||||INTERVIEWER|READER 2|3|Visit_3|40|4|TREATMENT|2020-11-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|7|RELSZCHG|Relative Size Change|[?]|SLING|[?]|SPRAY|[?]|1|10^9 organisms/mL|HUMERUS SHAFT|LATERAL|LATERAL|COMPLEMENT FIXATION|Y|Y||INDEPENDENT ASSESSOR|MICROSCOPIST 3|4|Visit_4|65|6|TREATMENT|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|8|TVPP|Percent Predicted Tidal Volume|[?]|FOWLERS|[?]|v/v|[?]|1|umol/L/h|MESENTERIC LYMPH NODE|LEFT|CAUDAL|SURFACE PLASMON RESONANCE||||CLINICAL STUDY SPONSOR|MICROSCOPIST 3|4|Visit_4|65|6|FOLLOW-UP|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|9|PIF|Peak Inspiratory Flow|[?]|SITTING|[?]|uSiemens|[?]|1|10^5/hpf|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|UNILATERAL|PERIVENTRICULAR|INFRARED SPECTROMETRY||||VENDOR|FORENSIC PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-12-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|18461665-388d-403b-90e4-2b42fcb4a01a|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|CCID 50/dose|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|LOWER EXTENSOR SURFACE|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|||Y|INTERVIEWER|MICROSCOPIST|5|Visit_5|90|2|SCREENING|2020-12-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|DLCOPP|Percent Predicted DLCO|[?]|FOWLERS|[?]|Coulomb|[?]|1|amp|T7 VERTEBRA|IPSILATERAL|ANTERIOR|CLINICAL EVALUATION||||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|2|FIV1PP|Percent Predicted FIV1|[?]|STANDING, BENT FORWARD|||[?]|1|mL/cage|MEDIAN NERVE|LATERAL|DEEP|RULER MEASUREMENT METHOD|||Y|CAREGIVER|ADJUDICATOR 2|1|Visit_1|10|4|FOLLOW-UP|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|3|FEV1SVC|FEV1/SVC|[?]|SUPINE|[?]|ng/day|[?]|1|GBq/ug|VESTIBULOCOCHLEAR NERVE|IPSILATERAL|PROXIMAL|SPECULAR MICROSCOPY||||FAMILY MEMBER|ONCOLOGIST 2|2|Visit_2|25|5|SCREENING|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|[?]|DDU|[?]|1|pm|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|BASAL|SCINTIGRAPHY|Y|||PARENT|READER 3|2|Visit_2|25|5|SCREENING|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|5|IVC|Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|g/animal/wk|[?]|1|Shock Wave|URINARY SYSTEM|LEFT|VENTRAL|CONGO RED STAIN||||SIGNIFICANT OTHER|HEMATOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-09-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|6|ERVPP|Percent Predicted ERV|[?]|SUPINE|[?]|Osm|[?]|1|SFC/10^6 PBMC|PORTAL VEIN BIFURCATION|RIGHT|FRONTAL|GC/MS-EI|Y|Y||VENDOR|PATHOLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-09-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|7|FVC|Forced Vital Capacity|[?]|SLING|[?]|cmH2O*s2/mL|[?]|1|10^4/hpf|TRIGEMINAL NERVE|LEFT|UPPER EXTENSOR SURFACE|SPECT/CT SCAN||Y||VENDOR|MICROSCOPIST|4|Visit_4|65|3|FOLLOW-UP|2020-10-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|8|FEV1PP|Percent Predicted FEV1|[?]|STANDING, BENT FORWARD|[?]|mmol|[?]|1|fmol/L/sec|HIP ADDUCTORS|UNILATERAL|INNER|IMMUNOFLUORESCENT STAIN|Y|||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|4|Visit_4|65|1|TREATMENT|2020-10-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|9|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|DECUBITUS|[?]|mm3/mm2/year|[?]|1|IU/L|CLAVICLE|IPSILATERAL|UPPER FLEXOR SURFACE|INFRARED SPECTROMETRY|Y|||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|TREATMENT|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|10|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LATERAL DECUBITUS|[?]|mJoule/cm2|[?]|1|g/day|MID-LAD ARTERY|LATERAL|DEEP|SPIRAL CT SCAN WITHOUT CONTRAST||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|TREATMENT|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|IRV|Inspiratory Reserve Volume|[?]|SEMI-RECUMBENT|||[?]|1|OD Unit|C6 VERTEBRA|LATERAL|HIND|KNEMOMETRY||Y|Y|DOMESTIC PARTNER|ONCOLOGIST 2|1|Visit_1|10|6|WASHOUT|2020-08-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|2|LOBVOL|Lobar Volume|[?]|SLING|||[?]|1|10^3 organisms/g|PULMONARY VALVE, ANTERIOR CUSP|LEFT|DEEP|PHASE-CONTRAST MRI|||Y|SIBLING|MICROSCOPIST 3|1|Visit_1|10|3|TREATMENT|2020-08-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|3|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|ECL unit|[?]|1|yd|MUCOSA OF THE LIP|CONTRALATERAL|SURFACE|TRANSTHORACIC ECHOCARDIOGRAPHY||||ADJUDICATOR|MICROSCOPIST 2|2|Visit_2|25|1|TREATMENT|2020-08-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|4|PIF|Peak Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|/200 HPFs|[?]|1|Osm|AORTIC VALVE|IPSILATERAL|UPPER|QUANTITATIVE COMPUTED TOMOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|2|Visit_2|25|5|FOLLOW-UP|2020-08-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|5|FVC6|Forced Vital Capacity in 6 Seconds|[?]|DECUBITUS|[?]|AMPULE|[?]|1|mm|SCAPHOID-RADIUS JOINT|LATERAL|LOWER|MALDI||||CHILD|DERMATOLOGIST|3|Visit_3|40|1|TREATMENT|2020-09-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|6|RRS|Total Respiratory System Resistance|[?]|PRONE|[?]|FFU|[?]|1|10^6/Ejaculate U|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|CONTRALATERAL|DORSAL|ANGIOGRAPHY||||SIGNIFICANT OTHER|NEUROLOGIST 2|3|Visit_3|40|6|FOLLOW-UP|2020-09-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uEq/L|SUBGLOTTIS|RIGHT|UPPER|CENTRIFUGATION|Y||Y|DOMESTIC PARTNER|MICROSCOPIST 3|4|Visit_4|65|3|SCREENING|2020-10-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|8|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING, BENT FORWARD|[?]|log EID 50/dose|[?]|1|IU/mL|C6 VERTEBRA|UNILATERAL|MIDLINE|MIGET||||SPOUSE|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-10-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|1/(s*kPa)|[?]|1|dpm/0.5 mL|T5 VERTEBRA|CONTRALATERAL|PROXIMAL|HPLC-FL||||FAMILY MEMBER|NEUROLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-10-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|e3ce1661-1b72-4835-88d1-5a6d3655b674|10|ICREV|IC Reversibility|[?]|STANDING|[?]|mL/animal/wk|[?]|1|mol/mol|COMMON FEMORAL VEIN|LEFT|LOWER FLEXOR SURFACE|ANTIMICROBIAL COMBINATION TESTING|Y|||INDEPENDENT ASSESSOR|ADJUDICATOR 1|5|Visit_5|90|5|SCREENING|2020-10-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|FEV1FVC6|FEV1/FVC6|[?]|LEFT LATERAL DECUBITUS|[?]|h/wk|[?]|1|Newton|UPPER URINARY SYSTEM|LATERAL|ROSTRAL|DNA MICROARRAY||||SIGNIFICANT OTHER|MICROSCOPIST 3|1|Visit_1|10|1|TREATMENT|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^6 CFU|HEART, VENTRICLE|CONTRALATERAL|ANTEROLATERAL|SMEAR|Y||Y|INTERVIEWER|ADJUDICATOR 1|1|Visit_1|10|5|SCREENING|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|3|ELSTNCE|Elastance|[?]|FOWLERS|[?]|U/cL|[?]|1|/MBP|PARA-AORTIC LYMPH NODE|BILATERAL|DORSAL|CINEANGIOGRAPHY|Y|Y||FAMILY MEMBER|NEUROLOGIST 2|2|Visit_2|25|2|TREATMENT|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|4|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|BOLUS|[?]|1|keV|TRICUSPID VALVE, ANTERIOR CUSP|UNILATERAL|DISTAL VOLAR|DYNAMOMETRY||Y||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|TREATMENT|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|5|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|||[?]|1|Linear ft*LB|INFRATENTORIAL BRAIN|LEFT|FACIAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y|Y|SIBLING|RATER|3|Visit_3|40|1|FOLLOW-UP|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|6|EFFVOL|Effusion Volume|[?]|PRONE|[?]|HEP|[?]|1|DNA copies/ug|SKIN OF THE SOLE|LEFT|LOWER|SPIRAL CT||Y||SIBLING|READER 2|3|Visit_3|40|1|FOLLOW-UP|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|7|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING, LEGS DEPENDENT|[?]|mEq/kg|[?]|1|U/10^12 RBC|SKIN BETWEEN EYEBROWS|BILATERAL|ANTEROTEMPORAL|PALM METHOD||||INDEPENDENT ASSESSOR|READER 3|4|Visit_4|65|6|WASHOUT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|8|IRV|Inspiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|HOURS|FEMORAL VEIN|BILATERAL|ROSTRAL|DIFFUSION WEIGHTED MRI|Y||Y|ADJUDICATOR|RATER 2|4|Visit_4|65|1|TREATMENT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|9|DLCOHC|HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|/sec|[?]|1|10^3/L|CILIARY BODY|RIGHT|INNER|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y|Y||VENDOR|PATHOLOGIST 2|5|Visit_5|90|3|WASHOUT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|240844e9-3dda-438e-81b2-8f6aa4e0427e|10|LOBVOL|Lobar Volume|[?]|STANDING|[?]|Bq/mL|[?]|1|mU/L|PARA-AORTIC LYMPH NODE|UNILATERAL|LATERAL|RADIAL IMMUNODIFFUSION||||INTERVIEWER|FORENSIC PATHOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|1|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|PFU/animal|[?]|1|ug/kg/day|BICEPS BRACHII MUSCLE|BILATERAL|VOLAR|LISSAMINE GREEN STAIN||||INDEPENDENT ASSESSOR|RATER 2|1|Visit_1|10|2|TREATMENT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|10^3 CFU/mL|[?]|1|CAPFUL|EYE|CONTRALATERAL|LOWER|COMPUTERIZED CORNEAL TOPOGRAPHY||Y||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|1|Visit_1|10|2|WASHOUT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|3|FIFMAXPP|Percent Predicted FIFmax|[?]|SLING|[?]|/VF|[?]|1|10^3 organisms/g|L2 VERTEBRA|UNILATERAL|PARIETO-OCCIPITAL|NEURAMINIDASE INHIBITION ASSAY|Y|||CLINICAL STUDY SPONSOR|RATER 2|2|Visit_2|25|1|TREATMENT|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|UNCONSTRAINED|[?]|nmol BCE/mmol|[?]|1|RFU|MEDIAN BASILIC VEIN|RIGHT|ANTERIOR|POLYSOMNOGRAPHY||||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|FOWLERS|[?]|log10 CCID 50/dose|[?]|1|IMPLANT|PORTACAVAL LYMPH NODE|BILATERAL|TEMPORAL|CLOT DETECTION||||ADJUDICATOR|PATHOLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SLING|||[?]|1|g/day|SKIN OF THE SOLE|LATERAL|ANTEROLATERAL|CYSTOSCOPY||Y|Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|3|Visit_3|40|5|FOLLOW-UP|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|LATERAL DECUBITUS|||[?]|1|cm2|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|CAUDAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|READER 2|4|Visit_4|65|6|TREATMENT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|8|FEV3FVC|FEV3/FVC|[?]|SEMI-RECUMBENT|[?]|ELISA unit/dose|[?]|1|GBq/ug|HIP|BILATERAL|UPPER FLEXOR SURFACE|ENZYMATIC ULTRACENTRIFUGATION||||CLINICAL RESEARCH ASSOCIATE|UROLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|9|SVCPP|Percent Predicted Slow Vital Capacity|[?]|TRENDELENBURG|[?]|cpm|[?]|1|pmol/day|URETHRA, ANTERIOR|RIGHT|NASAL|AUTOMATED COUNT||Y||INVESTIGATOR|CARDIOLOGIST|5|Visit_5|90|2|SCREENING|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|fccf5c5d-deb6-4f13-a485-afcda3556578|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING, BENT FORWARD|[?]|10^7/L|[?]|1|10^4 CFU|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|LATERAL|DISTAL VOLAR|AGAR DILUTION||Y||GUARDIAN|HEMATOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|U|[?]|1|mEq/uL|LEFT POSTERIOR DESCENDING ARTERY|LEFT|DORSAL|MUGA|Y|||FRIEND|DERMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|2|SVC|Slow Vital Capacity|[?]|PRONE|[?]|10^6 organisms/mL|[?]|1|Bq/kg|ANUS|CONTRALATERAL|ANTEROMEDIAL|TEST STRIP||||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|U/cL|[?]|1|mg/m2/day|PULMONARY VALVE, LEFT CUSP|CONTRALATERAL|TIP|JAFFE REACTION|Y|||CHILD|MICROSCOPIST 1|2|Visit_2|25|2|SCREENING|2020-08-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|4|IVCPP|Percent Predicted IVC|[?]|LATERAL DECUBITUS|[?]|Tesla|[?]|1|pmol|PULMONARY ARTERY BRANCH|UNILATERAL|LATERAL|POPULATION SEQUENCING||||ADJUDICATOR|READER 2|2|Visit_2|25|3|TREATMENT|2020-08-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|5|MEPPP|Percent Predicted MEP|[?]|DECUBITUS|||[?]|1|10^11/L|ESOPHAGUS|CONTRALATERAL|ANTEROMEDIAL|PHASE-CONTRAST MRI||Y|Y|INDEPENDENT ASSESSOR|NEUROLOGIST 1|3|Visit_3|40|4|WASHOUT|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|6|OXYPULSE|Oxygen Pulse|[?]|TRENDELENBURG|[?]|CAN|[?]|1|U|RECTUM|BILATERAL|VENTROLATERAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||||SPOUSE|OPHTHALMOLOGIST|3|Visit_3|40|1|TREATMENT|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|7|FIF50|Forced Inspiratory Flow at 50%|[?]|REVERSE TRENDELENBURG|[?]|mL|[?]|1|Ejaculate U|MIDBRAIN|IPSILATERAL|SUPERFICIAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||ADJUDICATION COMMITTEE|HEMATOLOGIST|4|Visit_4|65|6|TREATMENT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|8|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|ug/L|[?]|1|10^11/L|PULMONARY ARTERY BRANCH|LEFT|DORSOLATERAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|Y|Y||INTERVIEWER|READER 3|4|Visit_4|65|1|TREATMENT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SITTING, LEGS DEPENDENT|[?]|IU/mmol|[?]|1|CIGARETTE|COCCYGEAL VERTEBRA|LATERAL|NASAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||FRIEND|ADJUDICATOR 2|5|Visit_5|90|3|SCREENING|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|94620ed0-1ae8-4fa5-a629-9210860b0be9|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|uU/L|[?]|1|vg/dose|FEMORAL NECK|UNILATERAL|PERIPHERAL|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|||GUARDIAN|RADIOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|1|ALVVOL|Alveolar Volume|[?]|SEMI-FOWLERS|[?]|pmol/10^10 cells|[?]|1|mg/min|PERICARDIAL CAVITY|LEFT|CENTRAL|NON-CONTACT SPECULAR MICROSCOPY||||DOMESTIC PARTNER|MICROSCOPIST 3|1|Visit_1|10|1|FOLLOW-UP|2021-01-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|2|RRS|Total Respiratory System Resistance|[?]|DECUBITUS|[?]|uL/mL|[?]|1|pt_us|ETHMOID BONE|LATERAL|ANTERIOR|X-RAY|Y|||SIGNIFICANT OTHER|DERMATOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2021-01-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|3|ERV|Expiratory Reserve Volume|[?]|DECUBITUS|[?]|10^4 CFU/mL|[?]|1|POINT|LIMB, UPPER|BILATERAL|UPPER|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|||INVESTIGATOR|PATHOLOGIST 1|2|Visit_2|25|1|FOLLOW-UP|2021-02-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|4|LCI|Lung Clearance Index|[?]|SEMI-FOWLERS|||[?]|1|mkat|GREAT SAPHENOUS VEIN|BILATERAL|UPPER FLEXOR SURFACE|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2021-02-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|5|TLC|Total Lung Capacity|[?]|TRENDELENBURG|[?]|10^6 organisms/g|[?]|1|mg/h|LIVER LOBE|LATERAL|SUBCORTICAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||VENDOR|PHYSIOTHERAPIST|3|Visit_3|40|7|TREATMENT|2021-02-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|6|FEF2575P|Percent Predicted FEF25-75|[?]|TRENDELENBURG|||[?]|1|cal|ADRENAL GLAND|RIGHT|TEMPORAL|WESTERN BLOT|||Y|SIBLING|READER 1|3|Visit_3|40|6|TREATMENT|2021-02-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|7|RV|Residual Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|/100 WBC|[?]|1|DNA copies/ug|HEART, SEPTUM|RIGHT|SUBCORTICAL|MICRO BROTH DILUTION|Y|||CLINICAL STUDY SPONSOR|RATER 1|4|Visit_4|65|3|SCREENING|2021-03-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|LEFT LATERAL DECUBITUS|[?]|pg/L|[?]|1|FFU|SUPERFICIAL LYMPH NODE|RIGHT|SUBCORTICAL|REFRACTOMETRY|Y|||SPOUSE|OPHTHALMOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2021-03-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-FOWLERS|||[?]|1|mL/min|PROXIMAL INTERPHALANGEAL JOINT 4|CONTRALATERAL|ROSTRAL|CALIPER MEASUREMENT METHOD|||Y|STUDY SUBJECT|READER|5|Visit_5|90|7|WASHOUT|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|9c3b6912-19be-435c-87fc-781a08efb847|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SLING|[?]|uV2|[?]|1|pg/L|RIB 12|LEFT|FORE|PULMONARY ANGIOGRAPHY||||CHILD|MICROSCOPIST|5|Visit_5|90|3|FOLLOW-UP|2021-04-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|1|PEFTIME|Peak Expiratory Flow Time|[?]|SUPINE|[?]|pkat/L|[?]|1|ELISA unit|AORTIC VALVE, NON-CORONARY CUSP|CONTRALATERAL|PROXIMAL|FLOW CYTOMETRY||||HEALTH CARE PROFESSIONAL|UROLOGIST|1|Visit_1|10|6|TREATMENT|2020-08-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|2|DLCO|Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|ag|[?]|1|10^3 copies/mL|RIGHT CORONARY ARTERY OSTIUM|CONTRALATERAL|PROXIMAL VOLAR|ETDRS EYE CHART||||CHILD|READER 3|1|Visit_1|10|3|WASHOUT|2020-08-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|3|INTP|Interpretation|[?]|SEMI-FOWLERS|[?]|pg|[?]|1|mV|ANKLE MORTISE|LEFT|ANTEROTEMPORAL|PUPILLOMETRY||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|2|Visit_2|25|7|TREATMENT|2020-08-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|4|IVCPP|Percent Predicted IVC|[?]|SITTING, LEGS DEPENDENT|[?]|uCi/L|[?]|1|umol/L/min|SKIN OF THE LIP|BILATERAL|LOWER EXTENSOR SURFACE|DUCTOGRAPHY||||CLINICAL STUDY SPONSOR|UROLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-08-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|5|ALVVOL|Alveolar Volume|[?]|SITTING|[?]|ukat/10^12 RBC|[?]|1|breaths/30s|NASAL CAVITY|UNILATERAL|FACIAL|SURFACE PLASMON RESONANCE|Y|||CAREGIVER|MICROSCOPIST 3|3|Visit_3|40|2|WASHOUT|2020-09-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|6|SGAW|Specific Airway Conductance|[?]|LATERAL DECUBITUS|[?]|mL*cmH2O|[?]|1|Torr|RIB 11|BILATERAL|HIND|IVY INCISION METHOD||Y||HEALTH CARE PROFESSIONAL|INTERNIST|3|Visit_3|40|4|WASHOUT|2020-09-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|7|RAWPP|Percent Predicted Airway Resistance|[?]|SUPINE|[?]|Newton|[?]|1|cmH2O*s2/mL|SUBGLOTTIS|CONTRALATERAL|INTERMEDIATE|IMMUNOASSAY||||GUARDIAN|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2020-09-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|8|RV|Residual Volume|[?]|SEMI-RECUMBENT|||[?]|1|vp/dose|LOWER GASTROINTESTINAL TRACT LYMPH NODE|RIGHT|PARIETO-OCCIPITAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|||Y|SPOUSE|PATHOLOGIST 1|4|Visit_4|65|7|WASHOUT|2020-09-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|9|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-RECUMBENT|||[?]|1|BE/mL|PROSTATE GLAND, LATERAL LOBE|LEFT|DISTAL VOLAR|SCANNING ELECTRON MICROSCOPY|Y|Y|Y|CAREGIVER|ONCOLOGIST 2|5|Visit_5|90|3|WASHOUT|2020-10-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|171a6d85-ba2e-45da-b31b-01651b26e890|10|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|DECUBITUS|[?]|g/g/day|[?]|1|log10 TCID 50/mL|NAVICULAR BONE|LEFT|ROSTRAL|EIA||||PARENT|OPTOMETRIST|5|Visit_5|90|7|TREATMENT|2020-10-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|FEV1FVC6|FEV1/FVC6|[?]|LEFT LATERAL DECUBITUS|[?]|nkat/L|[?]|1|uV2|LUNG LOBE|UNILATERAL|INFERIOR|TURBIDIMETRY||Y||SIBLING|CLINICAL PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING|[?]|days/month|[?]|1|pg|SENSORIMOTOR CORTEX|LATERAL|UPPER FLEXOR SURFACE|LINE PROBE ASSAY||||STUDY SUBJECT|ONCOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-12-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|PFU/mL|[?]|1|CAPSULE|FINGER FLEXOR TENDONS|CONTRALATERAL|FACIAL|ELECTROCHEMILUMINESCENCE|Y|Y||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|7|TREATMENT|2020-12-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|4|GAW|Airway Conductance|[?]|SUPINE|[?]|mmol/min/kPa|[?]|1|ELISA unit/dose|EARLOBE|UNILATERAL|ANTEROTEMPORAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||Y||SPOUSE|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-12-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|BU/mL|[?]|1|TUBE|LUNG, RIGHT MIDDLE LOBE|IPSILATERAL|LOWER EXTENSOR SURFACE|LC/MS/MS||||HEALTH CARE PROFESSIONAL|READER 2|3|Visit_3|40|7|FOLLOW-UP|2021-01-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|6|RAWPP|Percent Predicted Airway Resistance|[?]|SLING|[?]|kcal|[?]|1|PELLET|STERNAL MANUBRIUM|LEFT|DISTAL VOLAR|EPSILOMETER||||CLINICAL STUDY SPONSOR|READER 1|3|Visit_3|40|2|FOLLOW-UP|2021-01-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|DECUBITUS|[?]|U/m2|[?]|1|mU|GUT-ASSOCIATED LYMPHOID TISSUE|RIGHT|VOLAR|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||Y||INDEPENDENT ASSESSOR|READER|4|Visit_4|65|6|SCREENING|2021-02-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|8|FRC|Functional Residual Capacity|[?]|SEMI-RECUMBENT|||[?]|1|IU/g Hb|PARATHYROID GLAND|IPSILATERAL|ANTEROLATERAL|AMSLER GRID|Y||Y|FRIEND|RADIOLOGIST 1|4|Visit_4|65|6|WASHOUT|2021-02-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|9|RRS|Total Respiratory System Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|/LSQN|[?]|1|Linear ft*LB|LUNG, LEFT LOWER LOBE|UNILATERAL|LOWER MEDIAL|IMMUNOBLOT||||FRIEND|INTERNIST|5|Visit_5|90|4|TREATMENT|2021-02-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|a8338164-1bb5-4474-9432-4d5a81ab30d8|10|MIPPP|Percent Predicted MIP|[?]|PRONE|||[?]|1|10^5/L|RIB 8|BILATERAL|DORSAL|CYSTOMETRY||Y|Y|NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|5|Visit_5|90|4|SCREENING|2021-02-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|DLCOPP|Percent Predicted DLCO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kBq|SUBSTANTIA NIGRA|LATERAL|ANTEROPOSTERIOR|NEXT GENERATION SEQUENCING|||Y|GUARDIAN|OPHTHALMOLOGIST|1|Visit_1|10|7|SCREENING|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|2|MIP|Maximal Inspiratory Pressure|[?]|PRONE|[?]|DNA copies/ug|[?]|1|10^7 CFU|PANCREATIC DUCT|LEFT|DISTAL|ELECTROPHORESIS||||INVESTIGATOR|MICROSCOPIST 1|1|Visit_1|10|6|TREATMENT|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|3|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|oz eq|[?]|1|ug/g/h|MEDIAL FEMORAL CONDYLE|CONTRALATERAL|BASAL|DUCTOGRAPHY||||SIGNIFICANT OTHER|MICROSCOPIST 2|2|Visit_2|25|3|SCREENING|2020-07-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING|||[?]|1|mL/day|ILEUM LYMPH NODE|CONTRALATERAL|PERIVENTRICULAR|PH METER MEASUREMENT METHOD|||Y|SIGNIFICANT OTHER|DERMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-07-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|5|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|Sv|[?]|1|mL/dL|HYPOGLOSSAL NERVE|BILATERAL|CAUDAL|PET SCAN||||INDEPENDENT ASSESSOR|READER 2|3|Visit_3|40|6|TREATMENT|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|6|ERV|Expiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|[?]|CIGARETTE|[?]|1|mEq/ug|SUDORIFEROUS GLAND|BILATERAL|ANTERIOR|TARGETED TRANSCRIPTOME SEQUENCING||Y||HEALTH CARE PROFESSIONAL|INTERNIST|3|Visit_3|40|1|TREATMENT|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|DECUBITUS|[?]|tsp eq|[?]|1|ppm|RECTO-UTERINE POUCH|IPSILATERAL|BASAL|SPECT/CT SCAN||||INVESTIGATOR|UROLOGIST|4|Visit_4|65|4|SCREENING|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|8|FVC|Forced Vital Capacity|[?]|LATERAL DECUBITUS|||[?]|1|/100 WBC|MAIN BRONCHUS, LEFT|RIGHT|FORE|FLAME PHOTOMETRY|Y||Y|HEALTH CARE PROFESSIONAL|READER 3|4|Visit_4|65|2|TREATMENT|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|vg/mL|METACARPAL BONE|LATERAL|HIND|PLETHYSMOGRAPHY||Y|Y|DOMESTIC PARTNER|READER 2|5|Visit_5|90|3|FOLLOW-UP|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|6d64077e-1f18-4bd6-ba86-53d90121f7a9|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|UNCONSTRAINED|[?]|ug/L FEU|[?]|1|U/kg/day|ANTERIOR TIBIAL ARTERY|UNILATERAL|LOWER EXTENSOR SURFACE|ENZYMATIC SPECTROPHOTOMETRY|Y|||FRIEND|ADJUDICATOR 3|5|Visit_5|90|4|TREATMENT|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|MALIND|Malignancy Indicator|[?]|UNCONSTRAINED|[?]|deg/mm|[?]|1|uEq|HYPOGLOSSAL NERVE|CONTRALATERAL|CAUDAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|||STUDY SUBJECT|ONCOLOGIST 1|1|Visit_1|10|3|FOLLOW-UP|2020-12-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|2|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SLING|[?]|STRIP|[?]|1|cg|L4-L5 INTERVERTEBRAL SPACE|CONTRALATERAL|FACIAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|||ADJUDICATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|7|WASHOUT|2020-12-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|3|TLC|Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|DIOPTER|[?]|1|Tbsp|COMMON FEMORAL ARTERY|IPSILATERAL|PROXIMAL VOLAR|MICROARRAY|Y|||INVESTIGATOR|MICROSCOPIST 2|2|Visit_2|25|2|SCREENING|2021-01-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|4|FEV3PP|Percent Predicted FEV3|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/mmol|[?]|1|fL|HEEL OF THE FOOT|RIGHT|LOWER EXTENSOR SURFACE|MAMMOGRAPHY||Y||INTERVIEWER|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2021-01-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|5|PCF|Peak Cough Flow|[?]|SUPINE|[?]|kg/cm|[?]|1|/40 HPFs|PERONEAL ARTERY|RIGHT|MIDLINE|PHOTOMETRY||||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|7|TREATMENT|2021-01-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|6|PLMBLFLW|Pulmonary Blood Flow|[?]|DECUBITUS|[?]|Tbsp|[?]|1|MPL U/mL|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|CONTRALATERAL|PROXIMAL VOLAR|SPIRAL CT SCAN WITHOUT CONTRAST||||ADJUDICATION COMMITTEE|ADJUDICATOR|3|Visit_3|40|1|SCREENING|2021-01-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|7|FIF25|Forced Inspiratory Flow at 25%|[?]|LATERAL DECUBITUS|[?]|SYRINGE|[?]|1|/10^5|SKIN OF THE BUTTOCK|BILATERAL|ANTEROMEDIAL|COULOMETRIC TITRATION||Y||VENDOR|PHYSIOTHERAPIST|4|Visit_4|65|4|FOLLOW-UP|2021-02-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|TRENDELENBURG|||[?]|1|ms2|PULMONARY VALVE, RIGHT CUSP|LEFT|PROXIMAL VOLAR|FLOW MICROSCOPY|||Y|SIBLING|ONCOLOGIST|4|Visit_4|65|1|SCREENING|2021-02-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|9|INTP|Interpretation|[?]|STANDING|[?]|DISK|[?]|1|log10 TCID 50/uL|COCCYX|BILATERAL|INNER|HEMATOXYLIN AND EOSIN STAIN||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|5|Visit_5|90|3|TREATMENT|2021-03-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|91d08486-3db7-4c71-a63f-fd060f4ae1a4|10|FEV_PEF|FEV at PEF|[?]|STANDING, BENT FORWARD|||[?]|1|10^6 organisms/mL|COCCYX|BILATERAL|OUTER|NEXT GENERATION TARGETED SEQUENCING|||Y|ADJUDICATOR|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2021-03-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|DLCO|Diffusion Capacity of Lung for CO|[?]|SLING|[?]|ug/g/day|[?]|1|%/min|RENAL PELVIS|LEFT|HIND|TRIPLE-PHASE MRI SCAN||||SIBLING|RADIOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-08-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|2|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SLING|[?]|10^9/dose|[?]|1|U/m2/h|EYE|UNILATERAL|DEEP|FLOW CYTOMETRY|Y|||SIGNIFICANT OTHER|NEUROLOGIST|1|Visit_1|10|4|TREATMENT|2020-08-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|3|IRVPP|Percent Predicted IRV|[?]|FOWLERS|||[?]|1|MPL U|HAND DIGIT 4|LATERAL|CENTRAL|INCISION-INDUCED BLEEDING METHOD|||Y|HEALTH CARE PROFESSIONAL|RATER 2|2|Visit_2|25|1|TREATMENT|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|NEEDLE GAUGE|[?]|1|mg/day|PRIMARY VISUAL CORTEX|CONTRALATERAL|PERIVENTRICULAR|PET/CT SCAN||||STUDY SUBJECT|READER|2|Visit_2|25|4|WASHOUT|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|[?]|mL/mmHg|[?]|1|umol/L/h|ACUTE MARGINAL ARTERY|UNILATERAL|ANTEROMEDIAL|OPTICAL MAPPING|Y|||CHILD|PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-09-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|6|PLMXRS|Pulmonary Reactance|[?]|DECUBITUS|[?]|log10 CFU/mL|[?]|1|mL/cm3/min|AORTOPULMONARY WINDOW LYMPH NODE|IPSILATERAL|UPPER|PAP STAIN||||SIGNIFICANT OTHER|PATHOLOGIST 1|3|Visit_3|40|5|WASHOUT|2020-09-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|7|AWVOL|Airway Volume|[?]|STANDING, BENT FORWARD|[?]|amu|[?]|1|% INHIBITION|TRANSVERSE TARSAL JOINT|UNILATERAL|ROSTRAL|SXA SCAN||Y||GUARDIAN|CARDIOLOGIST|4|Visit_4|65|2|TREATMENT|2020-10-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|8|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|[?]|nmol/mol|[?]|1|mmHg|OLFACTORY MUCOSA|UNILATERAL|LATERAL|IMPEDANCE CONDUCTIVITY|Y|||SIBLING|RATER|4|Visit_4|65|4|SCREENING|2020-10-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|9|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|[?]|nmol/g|[?]|1|ng|REGIONAL LYMPH NODE|LEFT|FORE|SLOAN LETTER EYE CHART 1.25%||Y||GUARDIAN|RATER|5|Visit_5|90|5|TREATMENT|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|10|FIFMAXPP|Percent Predicted FIFmax|[?]|SLING|[?]|mg/m2/min|[?]|1|cGy|TIBIO-PERONEAL TRUNK|LATERAL|CRANIAL|SXA SCAN|Y|||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-11-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|DLCOHC|HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|10^6 CFU|[?]|1|nkat/L|LIVER, LEFT LOBE|IPSILATERAL|CENTRAL|INTERRUPTER TECHNIQUE||||INVESTIGATOR|ADJUDICATOR|1|Visit_1|10|7|SCREENING|2021-01-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|2|PNIF|Peak Nasal Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|kcal/day|[?]|1|umol|PARATHYROID GLAND|BILATERAL|INFERIOR|PHOROPTER||||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2021-01-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|3|FIF75|Forced Inspiratory Flow at 75%|[?]|LATERAL DECUBITUS|[?]|h*%|[?]|1|mol/mg|URINARY SYSTEM|LATERAL|LATERAL|HILLMEN COLOR CHART||||CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|4|FOLLOW-UP|2021-01-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-FOWLERS|[?]|cmH2O/mL|[?]|1|mol/mL|PELVIS|UNILATERAL|PERIVENTRICULAR|LC/MS/MS||||CAREGIVER|ONCOLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|5|FIFMAX|Maximum Forced Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|ug/dL|[?]|1|min*mg/mL|ORAL MUCOSA|RIGHT|HIND|OPTICAL COHERENCE TOMOGRAPHY||||CAREGIVER|MICROSCOPIST 2|3|Visit_3|40|4|TREATMENT|2021-02-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|6|FVC|Forced Vital Capacity|[?]|STANDING|[?]|ng/dL|[?]|1|L/day|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|LATERAL|CRANIAL|SLIT LAMP PHOTOGRAPHY|Y|||CAREGIVER|NEUROLOGIST|3|Visit_3|40|7|TREATMENT|2021-02-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|7|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|[?]|log10 CFU/mL|[?]|1|GPL U|VESTIBULOCOCHLEAR NERVE|RIGHT|TIP|IMMUNO-PET SCAN|Y|||CAREGIVER|READER 2|4|Visit_4|65|7|TREATMENT|2021-03-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|||[?]|1|ng/mol|HEART, LEFT VENTRICULAR OUTFLOW TRACT|BILATERAL|PROXIMAL VOLAR|IMMUNOBLOT|||Y|FRIEND|ADJUDICATOR 2|4|Visit_4|65|1|SCREENING|2021-03-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-FOWLERS|[?]|cup eq|[?]|1|POUCH|SUBMANDIBULAR LYMPH NODE|CONTRALATERAL|CRANIAL|WHOLE GENOME SEQUENCING||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|5|Visit_5|90|5|WASHOUT|2021-03-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|10|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|mCi/kg|[?]|1|umol/min|PONS VAROLII|IPSILATERAL|DORSOLATERAL|TEMPLATE INCISION METHOD||||INDEPENDENT ASSESSOR|MICROSCOPIST 3|5|Visit_5|90|1|SCREENING|2021-03-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|1|MIP|Maximal Inspiratory Pressure|[?]|SLING|[?]|amp|[?]|1|steps/min|SPLENIC LYMPH NODE|CONTRALATERAL|DEEP|FLUORESCENT ENZYME IMMUNOASSAY||Y||FRIEND|INTERNIST|1|Visit_1|10|7|TREATMENT|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|2|FEV1REV|FEV1 Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|fmol/g|[?]|1|kg/L|HAND DIGIT 4|LATERAL|UPPER FLEXOR SURFACE|GC/MS/MS|Y|||CAREGIVER|RADIOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|3|PEF|Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|10^3 copies/mL|[?]|1|ukat/L|METACARPAL 1 BASE|LEFT|ANTEROMEDIAL|FLOW MICROSCOPY||Y||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|2|Visit_2|25|5|WASHOUT|2020-09-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|4|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|mL/(min*100mL)|[?]|1|anti-Xa IU/mL|SUPRAGLOTTIS|CONTRALATERAL|VENTRAL|ACCELERATOR MASS SPECTROMETRY||||CLINICAL RESEARCH ASSOCIATE|RATER|2|Visit_2|25|3|TREATMENT|2020-09-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|5|DLCOVA|DLCO/VA|[?]|LATERAL DECUBITUS|[?]|umol/day|[?]|1|mEq/kg|MAIN BRONCHUS, LEFT|LATERAL|PROXIMAL|POTENTIOMETRY||||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|6|EVC|Expiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mg2/dL2|[?]|1|DAYS|PROXIMAL INTERPHALANGEAL JOINT 3|RIGHT|VOLAR|SPECULAR MICROSCOPY||||CHILD|INTERNIST|3|Visit_3|40|4|TREATMENT|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SUPINE|[?]|Bq/mg|[?]|1|mmol/L|GLUTEAL MUSCLE|BILATERAL|OCCIPITAL|CELL BASED BIOASSAY||||FRIEND|NEUROLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|8|IC|Inspiratory Capacity|[?]|DECUBITUS|[?]|PACK|[?]|1|g/g|AORTA|IPSILATERAL|VENTRAL|REFRACTOMETRY||||PARENT|NEUROLOGIST 2|4|Visit_4|65|4|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|STANDING|[?]|PIXEL|[?]|1|dpm/100mg|T9 VERTEBRA|IPSILATERAL|VENTROLATERAL|PERIODIC ACID SCHIFF STAIN||Y||CHILD|RATER|5|Visit_5|90|3|TREATMENT|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|87998e13-813a-464d-935c-d5513cd0db5e|10|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|[?]|TRACE|[?]|1|cmH2O*s2/mL|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|LEFT|CENTRAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|Y||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|5|Visit_5|90|1|WASHOUT|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|[?]|/sec|[?]|1|ms2|PRONATOR TERES MUSCLE|CONTRALATERAL|LOWER FLEXOR SURFACE|PHOTOMETRIC CLOT DETECTION||||HEALTH CARE PROFESSIONAL|RADIOLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|PRONE|[?]|vg/dose|[?]|1|BP|ANAL CANAL|CONTRALATERAL|UPPER|MAGNETIC RESONANCE ENTEROGRAPHY||||SIGNIFICANT OTHER|MICROSCOPIST|1|Visit_1|10|1|TREATMENT|2021-01-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|3|FRC|Functional Residual Capacity|[?]|SITTING|[?]|L/s/kPa|[?]|1|kg/mol|TEMPLE|UNILATERAL|PROXIMAL|NUCLEIC ACID HYBRIDIZATION||||SIBLING|OTOLARYNGOLOGIST|2|Visit_2|25|5|WASHOUT|2021-02-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|4|TSUHYS|Tissue Hysteresivity|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/g/day|[?]|1|log10 TCID 50/dose|POPLITEAL LYMPH NODE|RIGHT|LOWER|OPTICAL MAPPING||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 2|2|Visit_2|25|4|TREATMENT|2021-02-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|5|RVPP|Percent Predicted Residual Volume|[?]|TRENDELENBURG|||[?]|1|10^9 organisms/mg|ASCENDING AORTA, AORTIC ROOT|LATERAL|NASAL|DC SHEATH FLOW||Y|Y|FAMILY MEMBER|READER 2|3|Visit_3|40|4|WASHOUT|2021-02-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|6|SGAW|Specific Airway Conductance|[?]|SEMI-FOWLERS|[?]|ug/L|[?]|1|mL/m2/day|NUCLEUS OF DIAGONAL BAND|LATERAL|INNER|TRANSMISSION ELECTRON MICROSCOPY||||SIBLING|RADIOLOGIST|3|Visit_3|40|7|TREATMENT|2021-02-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|7|EXPRELTM|Expiration Relaxation Time|[?]|TRENDELENBURG|[?]|V/sec|[?]|1|CAPFUL|GASTROINTESTINAL SYSTEM|LEFT|LOWER FLEXOR SURFACE|KINETIC CHROMOGENIC ASSAY||||SIBLING|READER 1|4|Visit_4|65|7|TREATMENT|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|8|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|L/s/kPa|[?]|1|VOXEL|BRONCHUS|CONTRALATERAL|DORSAL|INCISION-INDUCED BLEEDING METHOD||||PARENT|PATHOLOGIST 1|4|Visit_4|65|4|TREATMENT|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|9|AWWVOL|Airway Wall Volume|[?]|SUPINE|[?]|SCOOPFUL|[?]|1|WEEKS|TRAPEZOID BONE|RIGHT|ANTEROMEDIAL|MOUSE PROTECTION ASSAY||||SIGNIFICANT OTHER|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2021-04-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|7812e96e-ea53-4eb0-8160-d4118c567c9d|10|TSUELAS|Tissue Elastance|[?]|UNCONSTRAINED|[?]|uL/mL|[?]|1|usec|LUNG, LEFT|RIGHT|DEEP|AGAR DILUTION|Y|||FRIEND|MICROSCOPIST 2|5|Visit_5|90|1|FOLLOW-UP|2021-04-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|LOBVOL|Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|umol/L/h|[?]|1|kg|PELVIC BONE|CONTRALATERAL|HIND|ACRIDINE ORANGE STAIN||||SPOUSE|FORENSIC PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-11-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|2|FEV3FVC|FEV3/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|mU/L|[?]|1|10^10/L|ADDUCTOR BREVIS MUSCLE|LEFT|ANTEROMEDIAL|OPTICAL MAPPING||Y||VENDOR|ONCOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-11-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|3|PEF|Peak Expiratory Flow|[?]|SUPINE|||[?]|1|cmH2O/mL|FIRST DIAGONAL BRANCH ARTERY|LEFT|MEDIAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|Y|Y|ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|TREATMENT|2020-11-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|4|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|Arbitrary U|[?]|1|mg/L|HILAR LYMPH NODE|BILATERAL|SURFACE|RAJI CELL RIA|Y|||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|2|Visit_2|25|5|FOLLOW-UP|2020-11-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LATERAL DECUBITUS|[?]|nmol BCE/nmol|[?]|1|kg/cm2|PERIURETERAL REGION|LEFT|VENTRAL|SLOAN LETTER EYE CHART 100%|Y|Y||INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|3|Visit_3|40|2|SCREENING|2020-12-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|6|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|mL/cm H2O|[?]|1|mm|BUTTOCK|LATERAL|LATERAL|MEDIASTINOSCOPY|Y|Y||CLINICAL RESEARCH COORDINATOR|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2020-12-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|7|LCI|Lung Clearance Index|[?]|DECUBITUS|[?]|cmH2O*s/mL|[?]|1|PACK|MAIN BRONCHUS, LEFT|CONTRALATERAL|INNER|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y|||CLINICAL RESEARCH COORDINATOR|RATER|4|Visit_4|65|2|WASHOUT|2021-01-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|8|DLCOPP|Percent Predicted DLCO|[?]|SUPINE|||[?]|1|h/wk|TRICUSPID VALVE, POSTERIOR CUSP|LATERAL|PERIVENTRICULAR|RIA|||Y|GUARDIAN|PEDIATRIC NEUROLOGIST|4|Visit_4|65|6|TREATMENT|2021-01-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|L/s|[?]|1|mmol|SCIATIC NERVE|BILATERAL|ANTEROMEDIAL|MECHANICAL CLOT DETECTION||||INDEPENDENT ASSESSOR|PATHOLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-01-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|f9c6c448-0e3d-421f-a63f-be4aeb965256|10|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 IU|[?]|1|Bq/g|LIVER, LEFT LOBE|RIGHT|UPPER EXTENSOR SURFACE|MANUAL COUNT||||STUDY SUBJECT|RADIOLOGIST 2|5|Visit_5|90|1|TREATMENT|2021-01-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|DECUBITUS|||[?]|1|mg/g/h|PROFUNDA FEMORIS ARTERY|LEFT|SUPERFICIAL|FORCED OSCILLATION TECHNIQUE|||Y|SIGNIFICANT OTHER|ADJUDICATOR 2|1|Visit_1|10|2|TREATMENT|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|2|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|PRONE|[?]|U/cL|[?]|1|mph|SKIN OF THE ELBOW|LATERAL|SUPERFICIAL|PUPILLOMETRY||||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|7|TREATMENT|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|3|ELSTNCE|Elastance|[?]|FOWLERS|[?]|GBq/g|[?]|1|10^9 organisms/mg|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|PERIVENTRICULAR|BALLPOINT PEN TECHNIQUE|Y|Y||CLINICAL RESEARCH COORDINATOR|READER 3|2|Visit_2|25|6|TREATMENT|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|4|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|[?]|AgU/mL|[?]|1|NFIU|GENITALIA|UNILATERAL|ANTEROPOSTERIOR|FLUORESCENT SPOT TEST||||SIGNIFICANT OTHER|NEUROLOGIST|2|Visit_2|25|6|WASHOUT|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|5|PEF|Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|AU/mL|[?]|1|Osm|REGIONAL LYMPH NODE|IPSILATERAL|TIP|CYSTOMETRY||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|SCREENING|2021-01-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|6|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SLING|[?]|/200 HPFs|[?]|1|F|L2 VERTEBRA|LEFT|SUBCORTICAL|WHOLE EXOME SEQUENCING||||GUARDIAN|NEUROLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-01-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|7|IRVPP|Percent Predicted IRV|[?]|TRENDELENBURG|[?]|mJoule/cm2|[?]|1|BAU|HAMSTRING MUSCLE|UNILATERAL|DISTAL|HIGH RESOLUTION MELT ANALYSIS||||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2021-02-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LATERAL DECUBITUS|[?]|10^4/L|[?]|1|cmH2O*s/mL|INTERPHALANGEAL JOINT 1|CONTRALATERAL|CENTRAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|||GUARDIAN|MICROSCOPIST 3|4|Visit_4|65|6|TREATMENT|2021-02-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|9|FEV1PP|Percent Predicted FEV1|[?]|SUPINE|||[?]|1|mCi/kg|MEDIASTINUM, SUPERIOR|UNILATERAL|HIND|ANTIBIOTIC AGAR SCREEN|||Y|FRIEND|OPHTHALMOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|e8da815a-b53c-46f4-a546-e8553152719f|10|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|[?]|bel|[?]|1|K|RAMUS INTERMEDIUS ARTERY|LEFT|PERIPHERAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|Y|||FRIEND|PATHOLOGIST 2|5|Visit_5|90|1|WASHOUT|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|LCI|Lung Clearance Index|[?]|STANDING|||[?]|1|/100 WBC|C2 VERTEBRA|LATERAL|LATERAL|NON-INVASIVE DIELECTRIC SENSING||Y|Y|CLINICAL STUDY SPONSOR|READER|1|Visit_1|10|5|TREATMENT|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|2|PEFREV|PEF Reversibility|[?]|REVERSE TRENDELENBURG|[?]|Bq/kg|[?]|1|ug/h|RIB 4|UNILATERAL|LATERAL|ALCIAN BLUE STAIN||Y||PARENT|READER 2|1|Visit_1|10|6|FOLLOW-UP|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|DECUBITUS|[?]|/LPF|[?]|1|cy/cm|BUCCAL LYMPH NODE|RIGHT|CAUDAL|IMMUNE REPERTOIRE DEEP SEQUENCING||||PARENT|ADJUDICATOR 1|2|Visit_2|25|2|SCREENING|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-25
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|4|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|PRONE|||[?]|1|mL/cm3/min|PARATHYROID GLAND|CONTRALATERAL|FRONTAL|QUANTITATIVE ULTRASOUND|Y||Y|SIBLING|OPHTHALMOLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-25
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|[?]|PELLET|[?]|1|cmH2O*s/mL|REGIONAL LYMPH NODE|CONTRALATERAL|VOLAR|WHOLE EXOME SEQUENCING||Y||INDEPENDENT ASSESSOR|NEUROLOGIST 1|3|Visit_3|40|2|FOLLOW-UP|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|6|FEV1FVC|FEV1/FVC|[?]|SITTING|[?]|POINT|[?]|1|mU|PORTA HEPATIS LYMPH NODE|CONTRALATERAL|ANTEROLATERAL|ULTRASOUND||||CLINICAL RESEARCH ASSOCIATE|RATER|3|Visit_3|40|1|TREATMENT|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|7|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|DDU|[?]|1|kPa|NERVE|BILATERAL|VOLAR|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|Y||GUARDIAN|ADJUDICATOR 1|4|Visit_4|65|2|TREATMENT|2021-03-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|8|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|dpm/mg|[?]|1|ug/L|INTERPHALANGEAL JOINT 4 OF THE FOOT|CONTRALATERAL|CAUDAL|THIN SMEAR||Y||CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|4|Visit_4|65|3|TREATMENT|2021-03-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|9|RER|Respiratory Exchange Ratio|[?]|SITTING|[?]|MHz|[?]|1|mL/dL|PARASPINAL REGION|UNILATERAL|ANTEROMEDIAL|NUCLEIC ACID HYBRIDIZATION||||CLINICAL RESEARCH COORDINATOR|RATER 1|5|Visit_5|90|7|FOLLOW-UP|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|701d794b-07b4-4394-a2a4-d31a9f5b743a|10|LCI|Lung Clearance Index|[?]|STANDING|[?]|IMPLANT|[?]|1|tsp|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|BILATERAL|CAUDAL|PLETHYSMOGRAPHY||||CHILD|FORENSIC PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|FEV1FVC|FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|pt_br|[?]|1|10^3/L|BRAIN, THIRD VENTRICLE|BILATERAL|LOWER FLEXOR SURFACE|SINGLE-SLICE SPIRAL CT||||VENDOR|OPTOMETRIST|1|Visit_1|10|5|FOLLOW-UP|2020-12-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|FOWLERS|[?]|Farad|[?]|1|uV*sec|BONE MARROW|BILATERAL|ROSTRAL|DIFFUSION WEIGHTED MRI|Y|Y||ADJUDICATOR|OPTOMETRIST|1|Visit_1|10|2|TREATMENT|2020-12-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|3|ERVPP|Percent Predicted ERV|[?]|SUPINE|[?]|cd/m2|[?]|1|kV|COMMON ILIAC LYMPH NODE|LATERAL|DISTAL VOLAR|MICROPARTICLE ENZYME IMMUNOASSAY||||DOMESTIC PARTNER|RADIOLOGIST 1|2|Visit_2|25|4|SCREENING|2021-01-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|4|AIRTRAP|Air Trapping|[?]|STANDING|[?]|g/mol|[?]|1|SBE/mL|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|LEFT|ANTERIOR|SPIRAL CT||||ADJUDICATION COMMITTEE|READER 2|2|Visit_2|25|5|SCREENING|2021-01-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|[?]|pmol|[?]|1|uEq/L|THIRD POSTEROLATERAL DESCENDING ARTERY|LATERAL|OCCIPITAL|IMMUNOTURBIDIMETRY||||HEALTH CARE PROFESSIONAL|PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|6|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|ng/mol|[?]|1|ft2|ORAL MUCOSA|BILATERAL|INNER|ECHOCARDIOGRAPHY||||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|4|WASHOUT|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|7|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|BU/mL|[?]|1|ppb|AXILLARY ARTERY|IPSILATERAL|APICAL|WRIGHT-GIEMSA STAIN||||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|TREATMENT|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|EID 50/dose|[?]|1|U/g|LEFT VENTRICULAR APICAL LATERAL SEGMENT|LEFT|SUPERIOR|HEMAGGLUTINATION INHIBITION ASSAY||||VENDOR|PHYSIOTHERAPIST|4|Visit_4|65|2|FOLLOW-UP|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|9|TSUELAS|Tissue Elastance|[?]|DECUBITUS|||[?]|1|ELISA unit/dose|SKIN OF THE LIP|LEFT|FORE|TELLER ACUITY CARDS|||Y|SIBLING|CLINICAL PATHOLOGIST|5|Visit_5|90|4|WASHOUT|2021-03-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|vg/kg|[?]|1|EVENTS|INTERPHALANGEAL JOINT 4 OF THE FOOT|IPSILATERAL|VOLAR|FARR ASSAY||Y||INTERVIEWER|ONCOLOGIST 1|5|Visit_5|90|5|TREATMENT|2021-03-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|PCF|Peak Cough Flow|[?]|LATERAL DECUBITUS|||[?]|1|TABLET|CORONARY ARTERY, ANTERIOR DESCENDING|RIGHT|LATERAL|ELECTROCHEMILUMINESCENCE|||Y|CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|4|WASHOUT|2020-08-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|dL|[?]|1|10^3 CFU/mL|KIDNEY, CORTEX|LEFT|ANTEROPOSTERIOR|IMMUNOTURBIDIMETRY||||CLINICAL STUDY SPONSOR|HEMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-08-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|EID 50/mL|[?]|1|IU/mL|FOREHEAD|LEFT|LOWER FLEXOR SURFACE|PULSE OXIMETRY||||FAMILY MEMBER|ENDOCRINOLOGIST|2|Visit_2|25|1|SCREENING|2020-08-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|4|ELSTNCE|Elastance|[?]|LEFT LATERAL DECUBITUS|[?]|mL/mmHg|[?]|1|BOX|EYE BULGE|UNILATERAL|PERIVENTRICULAR|DIFFUSION TENSOR MRI|Y|||NON-HEALTH CARE PROFESSIONAL|INTERNIST|2|Visit_2|25|3|TREATMENT|2020-08-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|5|FEF50|Forced Expiratory Flow 50%|[?]|PRONE|||[?]|1|10^5/hpf|SALIVARY GLAND, SUBLINGUAL|RIGHT|DORSOLATERAL|HEMATOXYLIN AND EOSIN STAIN||Y|Y|GUARDIAN|READER 1|3|Visit_3|40|2|TREATMENT|2020-09-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|6|PCF|Peak Cough Flow|[?]|LATERAL DECUBITUS|[?]|nL|[?]|1|IU/day|POSTERIOR POLE OF THE EYE|LEFT|ANTEROMEDIAL|CALCOFLUOR WHITE STAIN||||DOMESTIC PARTNER|NEUROLOGIST 1|3|Visit_3|40|4|SCREENING|2020-09-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|7|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|RFU|[?]|1|10^3 RNA copies/mL|BRACHIAL ARTERY|LEFT|CENTRAL|MICRONEUTRALIZATION ASSAY||||INDEPENDENT ASSESSOR|OPTOMETRIST|4|Visit_4|65|4|WASHOUT|2020-10-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|8|VO2|Oxygen Consumption|[?]|REVERSE TRENDELENBURG|[?]|Bq/kg|[?]|1|mJoule/cm2|CORNEAL STROMA|LATERAL|PARIETO-OCCIPITAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||ADJUDICATION COMMITTEE|DERMATOLOGIST|4|Visit_4|65|2|TREATMENT|2020-10-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|9|TGV|Thoracic Gas Volume|[?]|SEMI-RECUMBENT|[?]|%|[?]|1|yd|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|UNILATERAL|VENTROLATERAL|CALIPER MEASUREMENT METHOD||Y||VENDOR|HEMATOLOGIST|5|Visit_5|90|4|TREATMENT|2020-10-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|10|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|h*%|[?]|1|Ci/ug|5TH LUMBAR SPINOUS PROCESS|LATERAL|TIP|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||FRIEND|CLINICAL PATHOLOGIST|5|Visit_5|90|7|SCREENING|2020-10-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|FOWLERS|[?]|fmol|[?]|1|Log10 ELISA unit/dose|INTERPHALANGEAL JOINT 4|UNILATERAL|BASAL|MRI WITHOUT CONTRAST||||CAREGIVER|MICROSCOPIST|1|Visit_1|10|2|WASHOUT|2021-01-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|2|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING, BENT FORWARD|||[?]|1|Enzyme U/m2|BODY OF STOMACH|BILATERAL|HIND|CONTRAST ENHANCED CT SCAN|||Y|DOMESTIC PARTNER|OPHTHALMOLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|3|FEV1FVC|FEV1/FVC|[?]|SEMI-FOWLERS|[?]|pg/L|[?]|1|cd/m2|POPLITEAL LYMPH NODE|UNILATERAL|VENTRAL|FISH||||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|2|Visit_2|25|1|SCREENING|2021-01-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|4|SVC|Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|U/m2/day|[?]|1|EP U|ELBOW JOINT|IPSILATERAL|DORSOLATERAL|AGAR DILUTION||Y||CAREGIVER|INTERNIST|2|Visit_2|25|2|TREATMENT|2021-01-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|5|MALIND|Malignancy Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|dpm/mg|ILIAC LYMPH NODE|UNILATERAL|LATERAL|HPLC-UV||Y||CAREGIVER|PATHOLOGIST 1|3|Visit_3|40|3|WASHOUT|2021-02-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|6|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|[?]|IU/g Hb|[?]|1|mL/dose|RAPHE|UNILATERAL|DEEP|FLUORESCENT MICROSCOPY||||FRIEND|CARDIOLOGIST|3|Visit_3|40|6|WASHOUT|2021-02-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|7|TSUELAS|Tissue Elastance|[?]|STANDING|[?]|umol/mg/min|[?]|1|cy/cm|SKIN AROUND THE EYE|LATERAL|PARIETO-OCCIPITAL|MOUSE PROTECTION ASSAY|Y|||INTERVIEWER|RATER 2|4|Visit_4|65|2|WASHOUT|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|UNCONSTRAINED|[?]|PLUG|[?]|1|Ci/L|RADIUS|RIGHT|DORSOLATERAL|GIEMSA STAIN||Y||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|4|Visit_4|65|6|WASHOUT|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SLING|||[?]|1|mg/cm2|PRECUNEUS|CONTRALATERAL|TEMPORAL|TELLER ACUITY CARDS|||Y|NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST|5|Visit_5|90|6|TREATMENT|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|10|FVC|Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|aMFI|[?]|1|cmol|L3 VERTEBRA|CONTRALATERAL|PERIPHERAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||CHILD|NEUROLOGIST 1|5|Visit_5|90|1|TREATMENT|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|LCI|Lung Clearance Index|[?]|SEMI-FOWLERS|[?]|WEEKS|[?]|1|deg|ANUS|LEFT|INFERIOR|IMMUNOFIXATION ELECTROPHORESIS||||ADJUDICATION COMMITTEE|PATHOLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-11-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|2|TGV|Thoracic Gas Volume|[?]|SLING|||[?]|1|fmol|FAT PAD|CONTRALATERAL|ANTEROTEMPORAL|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|DOMESTIC PARTNER|PHYSIOTHERAPIST|1|Visit_1|10|6|TREATMENT|2020-11-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|3|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|||[?]|1|Torr|TRIANGULAR BONE|LEFT|ANTEROPOSTERIOR|QUANTITATIVE ULTRASOUND|||Y|VENDOR|READER|2|Visit_2|25|7|TREATMENT|2020-12-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-FOWLERS|||[?]|1|SCOOPFUL|TRICUSPID VALVE, POSTERIOR ANNULUS|LATERAL|INNER|IMMUNOBLOT|||Y|ADJUDICATOR|FORENSIC PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-12-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|5|TSUELAS|Tissue Elastance|[?]|SITTING, LEGS DEPENDENT|[?]|fraction of 1|[?]|1|ukat/10^12 RBC|LAD SEPTAL PERFORATOR ARTERY|BILATERAL|MEDIAL|NEXT GENERATION SEQUENCING||||FAMILY MEMBER|CLINICAL PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|6|ALVVOL|Alveolar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/g|[?]|1|10^11/L|ULNAR NERVE|LATERAL|BASAL|ELECTROMYOGRAPHY||||INVESTIGATOR|ENDOCRINOLOGIST|3|Visit_3|40|1|TREATMENT|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|7|LCI|Lung Clearance Index|[?]|SITTING, LEGS DEPENDENT|[?]|mmol/min/kPa|[?]|1|ukat|UMBILICUS|CONTRALATERAL|PROXIMAL|SPIROMETRY||Y||INTERVIEWER|PATHOLOGIST 2|4|Visit_4|65|7|WASHOUT|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|8|AWVOL|Airway Volume|[?]|PRONE|[?]|uL|[?]|1|Weber|LIP, LOWER|CONTRALATERAL|INTERMEDIATE|WHOLE TRANSCRIPTOME SEQUENCING||Y||INDEPENDENT ASSESSOR|INTERNIST|4|Visit_4|65|3|WASHOUT|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|9|FEV3PP|Percent Predicted FEV3|[?]|SITTING|[?]|cd*s/m2|[?]|1|mol/mg|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|BILATERAL|SUPERFICIAL|REFLECTANCE SPECTROSCOPY|Y|||PROXY|RADIOLOGIST|5|Visit_5|90|6|TREATMENT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|bb2487c3-cc05-48f8-9031-0e433c07e3d6|10|PEFREV|PEF Reversibility|[?]|LATERAL DECUBITUS|||[?]|1|steps/min|MESENTERY|LATERAL|APICAL|HILLMEN COLOR CHART|||Y|PARENT|RADIOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING, BENT FORWARD|[?]|BU/mL|[?]|1|mL/cm H2O|PARANASAL SINUS|CONTRALATERAL|DISTAL|PHOTOMETRY|Y|||CLINICAL RESEARCH COORDINATOR|READER|1|Visit_1|10|2|FOLLOW-UP|2020-07-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|2|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-RECUMBENT|[?]|foz_us|[?]|1|10^6/L|THYROID GLAND|LATERAL|DORSOLATERAL|DYNAMIC CONTRAST ENHANCED MRI||||PROXY|MICROSCOPIST|1|Visit_1|10|5|TREATMENT|2020-07-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING|[?]|m/sec2|[?]|1|g/mol|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|RIGHT|MIDLINE|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||VENDOR|NEUROLOGIST 1|2|Visit_2|25|4|WASHOUT|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|4|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|[?]|tsp eq|[?]|1|m/sec|RENAL PELVIS|CONTRALATERAL|VOLAR|MICRODENSITOMETRY|Y|||CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|5|FEV3PP|Percent Predicted FEV3|[?]|SITTING, LEGS DEPENDENT|[?]|dyn|[?]|1|L/h/m2|MAXILLA|BILATERAL|UPPER|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||PROXY|NEUROLOGIST|3|Visit_3|40|1|TREATMENT|2020-08-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|6|MALIND|Malignancy Indicator|[?]|REVERSE TRENDELENBURG|||[?]|1|mL/(min*100mL)|SKIN OF THE THIGH|CONTRALATERAL|MEDIAL|MEDIASTINOSCOPY|Y|Y|Y|SIBLING|ENDOCRINOLOGIST|3|Visit_3|40|6|WASHOUT|2020-08-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|TRENDELENBURG|[?]|mCi|[?]|1|mol/L|SCAPHOID-LUNATE-CAPITATE JOINT|UNILATERAL|TIP|KNEMOMETRY|Y|||FRIEND|OPTOMETRIST|4|Visit_4|65|5|TREATMENT|2020-09-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|8|AWVOLPP|Percent Predicted Airway Volume|[?]|FOWLERS|[?]|U/m2/min|[?]|1|mg/L FEU|HEAD|CONTRALATERAL|UPPER FLEXOR SURFACE|ROMANOWSKY STAIN||||CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-09-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|9|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING, BENT FORWARD|[?]|log10 TCID 50/uL|[?]|1|mm/h|MITRAL VALVE|LEFT|SURFACE|IODINE STAIN||||CLINICAL STUDY SPONSOR|UROLOGIST|5|Visit_5|90|1|SCREENING|2020-10-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|2661da18-b539-49d8-ac80-9da03c127d21|10|DLCOHC|HGB Corrected DLCO|[?]|SITTING|||[?]|1|mol|INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|BASAL|CLIP|||Y|SIGNIFICANT OTHER|ENDOCRINOLOGIST|5|Visit_5|90|2|WASHOUT|2020-10-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|1|EXPRELTM|Expiration Relaxation Time|[?]|STANDING|[?]|10^3 DNA copies/mL|[?]|1|uL/kg/day|METATARSOPHALANGEAL JOINT 3|UNILATERAL|MEDIAL|FLAME PHOTOMETRY||Y||CAREGIVER|ADJUDICATOR 3|1|Visit_1|10|5|TREATMENT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|2|DLCOVA|DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|Torr|[?]|1|/kg|PORTAL VEIN|RIGHT|CAUDAL|LANDOLT RING||||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|1|Visit_1|10|6|WASHOUT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|nL|[?]|1|cycle/min|COLON, HEPATIC FLEXURE|BILATERAL|LOWER FLEXOR SURFACE|PHYSICAL EXAMINATION||||STUDY SUBJECT|PATHOLOGIST 1|2|Visit_2|25|2|SCREENING|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|4|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|FOWLERS|[?]|foz_us|[?]|1|U/mL|INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|FACIAL|OPTICAL MAPPING||||ADJUDICATOR|MICROSCOPIST 1|2|Visit_2|25|4|SCREENING|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING|[?]|dram|[?]|1|YEARS|BILIARY TRACT|UNILATERAL|MIDLINE|TWO-COLOR MICROARRAY|Y|Y||CLINICAL STUDY SPONSOR|CARDIOLOGIST|3|Visit_3|40|3|WASHOUT|2020-09-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|6|AIRTRAP|Air Trapping|[?]|STANDING, BENT FORWARD|[?]|cL|[?]|1|ug/L/h|RADIUS-LUNATE JOINT|IPSILATERAL|APICAL|BIOIMPEDANCE SPECTROSCOPY||||VENDOR|ADJUDICATOR|3|Visit_3|40|5|TREATMENT|2020-09-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|7|MEPPP|Percent Predicted MEP|[?]|PRONE|[?]|kPa/L/sec|[?]|1|lx|LUNG, RIGHT LOWER LOBE|UNILATERAL|HIND|VIRUS PLAQUE ASSAY||||FRIEND|OPTOMETRIST|4|Visit_4|65|5|TREATMENT|2020-09-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|PRONE|[?]|10^3/hpf|[?]|1|Gauss|BONE|CONTRALATERAL|INTERMEDIATE|DIGITAL PCR|Y|||GUARDIAN|NEUROLOGIST 2|4|Visit_4|65|2|FOLLOW-UP|2020-09-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|9|SVC|Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|WEEKS|[?]|1|kN/cm2|L1 VERTEBRA|LATERAL|FRONTAL|DIFFUSION TENSOR MRI||||ADJUDICATION COMMITTEE|ONCOLOGIST|5|Visit_5|90|1|WASHOUT|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|f1835786-c567-4235-9bd1-f7ffcec12741|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|/HPF|[?]|1|JDF Unit|SPINAL ACCESSORY NERVE|LATERAL|UPPER EXTENSOR SURFACE|ELECTROMYOGRAPHY||||CHILD|ONCOLOGIST 1|5|Visit_5|90|5|SCREENING|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|ALVVOL|Alveolar Volume|[?]|SLING|[?]|CAN|[?]|1|copies/mL|PATELLA|CONTRALATERAL|ROSTRAL|X-RAY FLUORESCENCE SPECTROMETRY||Y||VENDOR|NEUROLOGIST|1|Visit_1|10|4|SCREENING|2020-07-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|2|RAW|Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|QUANTITY SUFFICIENT|[?]|1|SUPPOSITORY|TROCHLEAR NERVE|LEFT|OUTER|ROMANOWSKY STAIN|Y|Y||STUDY SUBJECT|RADIOLOGIST 2|1|Visit_1|10|7|FOLLOW-UP|2020-07-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|3|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pmol/L/h|METACARPAL BONE 2|RIGHT|MEDIAL|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y||Y|DOMESTIC PARTNER|ONCOLOGIST 2|2|Visit_2|25|4|FOLLOW-UP|2020-07-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/L|[?]|1|ug/kg/h|FEMORAL VEIN|LEFT|PROXIMAL VOLAR|NEXT GENERATION TARGETED SEQUENCING|Y|||ADJUDICATION COMMITTEE|RATER 1|2|Visit_2|25|7|SCREENING|2020-07-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|[?]|cmH2O*s2/mL|[?]|1|KALLIKREIN INHIBITOR UNIT|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|CONTRALATERAL|HIND|PERIPHERAL ANGIOGRAPHY||Y||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2020-08-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|6|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mV2/Hz|GREATER CURVATURE OF THE STOMACH|UNILATERAL|DISTAL VOLAR|MICROBIAL CULTURE, SOLID|Y|Y|Y|PROXY|PATHOLOGIST 2|3|Visit_3|40|7|TREATMENT|2020-08-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SLING|[?]|g|[?]|1|/MBP|PERIURETERAL REGION|LATERAL|MEDIAL|HEMAGGLUTINATION ASSAY||||FRIEND|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|WASHOUT|2020-09-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|mL/g/day|[?]|1|ng/L|FLEXOR HALLUCIS BREVIS MUSCLE|BILATERAL|HIND|ACRIDINE ORANGE STAIN||||SPOUSE|ADJUDICATOR|4|Visit_4|65|2|SCREENING|2020-09-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|Enzyme U|[?]|1|mm/2h|MITRAL VALVE, POSTERIOR CUSP|CONTRALATERAL|VENTRAL|SPIRAL CT|Y|||GUARDIAN|NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|019eb415-1da3-40fa-b4ba-b1f381ec3cac|10|RV|Residual Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|/VF|LOWER JUGULAR LYMPH NODE|BILATERAL|HIND|DARK FIELD MICROSCOPY|||Y|GUARDIAN|READER 3|5|Visit_5|90|4|FOLLOW-UP|2020-09-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|RELSZCHG|Relative Size Change|[?]|STANDING, BENT FORWARD|[?]|OD Unit|[?]|1|um/day|ATRIOVENTRICULAR VALVE|IPSILATERAL|ANTEROPOSTERIOR|TOTAL BODY RADIOGRAPHY||Y||CAREGIVER|INTERNIST|1|Visit_1|10|1|FOLLOW-UP|2020-07-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|2|RER|Respiratory Exchange Ratio|[?]|SLING|[?]|mol/L|[?]|1|% INHIBITION|DISTAL RADIOULNAR JOINT|RIGHT|LOWER MEDIAL|HPLC-FL|Y|||GUARDIAN|ADJUDICATOR 1|1|Visit_1|10|2|SCREENING|2020-07-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|3|TLC|Total Lung Capacity|[?]|PRONE|[?]|mOsm/kg|[?]|1|Ci/kg|PREAURICULAR LYMPH NODE|RIGHT|INNER|SPIROMETRY||||VENDOR|FORENSIC PATHOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-08-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|FOWLERS|[?]|Henry|[?]|1|U|ILIOTIBIAL BAND|LEFT|LOWER|EPSILOMETER||||CAREGIVER|DERMATOLOGIST|2|Visit_2|25|2|TREATMENT|2020-08-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|LATERAL DECUBITUS|[?]|uV|[?]|1|fmol/L|CEREBRAL VEIN|LEFT|HIND|ENDPOINT DILUTION ASSAY||||DOMESTIC PARTNER|ADJUDICATOR 2|3|Visit_3|40|5|SCREENING|2020-08-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|mL/beat|[?]|1|HEP|LOWER JUGULAR LYMPH NODE|RIGHT|TEMPORAL|TRIPLE-PHASE MRI SCAN|Y|||INVESTIGATOR|RADIOLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|7|EVC|Expiratory Vital Capacity|[?]|PRONE|[?]|umol/L/h|[?]|1|psec|PERIHILAR LYMPH NODE|UNILATERAL|LOWER FLEXOR SURFACE|NUCLEIC ACID HYBRIDIZATION|Y|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|4|Visit_4|65|6|TREATMENT|2020-09-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|8|INFLTIND|Infiltrates Indicator|[?]|SITTING|[?]|mL/(min*100mL)|[?]|1|umol/kg/min|UPPER CERVICAL LYMPH NODE|CONTRALATERAL|UPPER FLEXOR SURFACE|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||PROXY|RADIOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-09-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|9|FIF25|Forced Inspiratory Flow at 25%|[?]|SITTING, LEGS DEPENDENT|[?]|10^9/g|[?]|1|10^3 CFU/g|ADDUCTOR POLLICIS MUSCLE|UNILATERAL|FACIAL|MS/MS||Y||INDEPENDENT ASSESSOR|READER|5|Visit_5|90|1|TREATMENT|2020-10-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|2506c6e2-018f-4300-b3b5-44ff8d6e13df|10|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|HOMEOPATHIC DILUTION|[?]|1|U.CARR|INTERNAL MAMMARY LYMPH NODE|UNILATERAL|PERIVENTRICULAR|MUGA||||INDEPENDENT ASSESSOR|NEUROLOGIST|5|Visit_5|90|4|TREATMENT|2020-10-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|[?]|MBP|[?]|1|100 IU/mL|ENTORHINAL CORTEX|LEFT|NASAL|CT SCAN WITHOUT CONTRAST||||VENDOR|FORENSIC PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|2|ICREV|IC Reversibility|[?]|FOWLERS|||[?]|1|Gy|RIB 11|IPSILATERAL|INTERMEDIATE|MICRONEUTRALIZATION ASSAY|Y|Y|Y|CAREGIVER|MICROSCOPIST|1|Visit_1|10|7|SCREENING|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|3|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|[?]|rpm|[?]|1|lx|PERITONEUM|BILATERAL|DISTAL|LC/MS||||INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|Ci/mL|[?]|1|ng/day|CAPITATE BONE|BILATERAL|DISTAL VOLAR|TRANSCRIPTION-MEDIATED AMPLIFICATION||||ADJUDICATION COMMITTEE|ADJUDICATOR 3|2|Visit_2|25|1|WASHOUT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|5|MALEVDES|Malignancy Evidence Description|[?]|SITTING, LEGS DEPENDENT|[?]|Ci|[?]|1|ngEq/L|LIVER, QUADRATE LOBE|IPSILATERAL|PROXIMAL|GC/MS-CI||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|3|Visit_3|40|6|WASHOUT|2020-07-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|6|FEV3FVC|FEV3/FVC|[?]|REVERSE TRENDELENBURG|[?]|/HPF|[?]|1|FEU|FLEXOR POLLICIS LONGUS MUSCLE|LEFT|UPPER|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||||STUDY SUBJECT|NEUROLOGIST|3|Visit_3|40|3|WASHOUT|2020-07-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|7|FVC|Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|mol/L|[?]|1|cP|CHOROID PLEXUS|CONTRALATERAL|UPPER|HEMOCYTOMETRY||||GUARDIAN|INTERNIST|4|Visit_4|65|6|TREATMENT|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|8|RV|Residual Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|TRANSDUCING UNIT|ILEUM|LATERAL|MIDLINE|MALDI|||Y|INTERVIEWER|NEUROLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|9|AWVOL|Airway Volume|[?]|SLING|[?]|lm|[?]|1|APL U|PARACAVAL LYMPH NODE|LEFT|SUPERIOR|IMMUNORADIOMETRIC ASSAY|Y|||STUDY SUBJECT|ONCOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|65c439f8-9658-4ac5-9eae-0837182a90fd|10|EVC|Expiratory Vital Capacity|[?]|STANDING|[?]|U/mL|[?]|1|P|METACARPAL BONE|BILATERAL|INTERMEDIATE|IMMUNORADIOMETRIC ASSAY||||FRIEND|NEUROLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|||[?]|1|pkat|MITRAL VALVE, ANTERIOR CUSP|IPSILATERAL|TIP|IMPULSE OSCILLOMETRY||Y|Y|ADJUDICATION COMMITTEE|NEUROLOGIST|1|Visit_1|10|4|SCREENING|2020-06-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|2|EVC|Expiratory Vital Capacity|[?]|FOWLERS|[?]|cmH2O/mL|[?]|1|cmH2O/mL|PARACAVAL LYMPH NODE|IPSILATERAL|ANTEROMEDIAL|SLIT LAMP PHOTOGRAPHY|Y|Y||VENDOR|ENDOCRINOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|PIPE|[?]|1|mEq/mL|L1 VERTEBRA|CONTRALATERAL|DEEP|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y||INTERVIEWER|RADIOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-06-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|4|FIF25|Forced Inspiratory Flow at 25%|[?]|REVERSE TRENDELENBURG|[?]|U/m2/h|[?]|1|Enzyme U/g Hb|PRESACRAL SPACE|LATERAL|SURFACE|TRANSTHORACIC ECHOCARDIOGRAPHY||||PROXY|NEUROLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-06-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|[?]|g/day|[?]|1|g/L|TOOTH CANAL|RIGHT|DISTAL|TRANSMISSION ELECTRON MICROSCOPY||Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|3|Visit_3|40|1|TREATMENT|2020-07-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|6|PLMXRS|Pulmonary Reactance|[?]|SLING|||[?]|1|oz eq|VOCAL CORD|CONTRALATERAL|MEDIAL|AURAMINE STAIN|||Y|SPOUSE|NEUROLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-07-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|7|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-FOWLERS|||[?]|1|RING|FIBULA SHAFT|CONTRALATERAL|DISTAL|DOUBLE IMMUNODIFFUSION|||Y|INTERVIEWER|HEMATOLOGIST|4|Visit_4|65|1|WASHOUT|2020-08-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|8|FEF2575|Forced Expiratory Flow 25-75%|[?]|UNCONSTRAINED|||[?]|1|NEBULE|AORTA|IPSILATERAL|ANTEROMEDIAL|CHROMOGENIC ASSAY|||Y|PARENT|NEUROLOGIST 1|4|Visit_4|65|7|FOLLOW-UP|2020-08-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|9|FEV1FVC|FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|JAR|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|UNILATERAL|PROXIMAL|ENZYMATIC COLORIMETRY|||Y|SIBLING|READER 2|5|Visit_5|90|5|FOLLOW-UP|2020-08-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|5b73ad4c-bb28-47d1-a2f6-8508444059a5|10|SGAW|Specific Airway Conductance|[?]|SLING|[?]|IU/L|[?]|1|mPa|COLON, SIGMOID|UNILATERAL|CAUDAL|BAC ACGH|Y|||VENDOR|OPTOMETRIST|5|Visit_5|90|2|TREATMENT|2020-08-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|SLING|[?]|mL/min|[?]|1|PIXELS/in|NAIL BED|RIGHT|NASAL|POLYSOMNOGRAPHY||||INVESTIGATOR|ADJUDICATOR 3|1|Visit_1|10|5|SCREENING|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|2|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|IU|[?]|1|uEq/L|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|BILATERAL|INTERMEDIATE|CELLULAR PROLIFERATION ASSAY||||ADJUDICATOR|ONCOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-06-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|3|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|uU/dL|[?]|1|/mm2|HEAD|LEFT|VENTROLATERAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||ADJUDICATION COMMITTEE|UROLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|DECUBITUS|[?]|EU|[?]|1|CFU/mL|T4 VERTEBRA|UNILATERAL|ANTERIOR|CLINICAL EVALUATION||||DOMESTIC PARTNER|MICROSCOPIST|2|Visit_2|25|5|TREATMENT|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|TRENDELENBURG|||[?]|1|cmH2O*s/mL|PENIS, GLANS|BILATERAL|DORSOLATERAL|PALM METHOD|||Y|INVESTIGATOR|PATHOLOGIST 2|3|Visit_3|40|3|TREATMENT|2020-07-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|6|MIPPP|Percent Predicted MIP|[?]|SEMI-RECUMBENT|[?]|ppth|[?]|1|mL/cm3/min|THORACIC LYMPH NODE|CONTRALATERAL|PERIVENTRICULAR|IMMUNOFIXATION ELECTROPHORESIS||||CAREGIVER|READER 1|3|Visit_3|40|5|TREATMENT|2020-07-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-RECUMBENT|[?]|/10^3|[?]|1|BOLUS|OVARY|LATERAL|VOLAR|POLYMERASE CHAIN REACTION||||CLINICAL STUDY SPONSOR|INTERNIST|4|Visit_4|65|3|SCREENING|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|REVERSE TRENDELENBURG|||[?]|1|log10 PFU/mL|FIRST DIAGONAL BRANCH ARTERY|RIGHT|DORSOLATERAL|SXA SCAN|||Y|VENDOR|OPHTHALMOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|AU/mL|[?]|1|grain|PARACOLIC GUTTER|IPSILATERAL|SURFACE|CELL OF ORIGIN ASSAY||||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|TREATMENT|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|16dcaefa-701c-4863-b010-8ac640aeb55a|10|IVC|Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|/10^4|[?]|1|dmol|PHARYNX|CONTRALATERAL|CENTRAL|SINGLE-SLICE SPIRAL CT||||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|U/mL|[?]|1|Frames/s|HEART, APEX|LATERAL|LOWER FLEXOR SURFACE|PHOTOMETRY|Y|||ADJUDICATOR|READER 2|1|Visit_1|10|4|WASHOUT|2020-08-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|2|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|mol/L|[?]|1|U/kg/h|TIBIAL-CRURAL PERIPHERAL ARTERY|CONTRALATERAL|UPPER|REFLECTANCE SPECTROSCOPY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-08-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|3|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|[?]|uCi|[?]|1|10^10/L|BACK|IPSILATERAL|FORE|GRAM STAIN||Y||INTERVIEWER|PHYSIOTHERAPIST|2|Visit_2|25|4|FOLLOW-UP|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|LATERAL DECUBITUS|[?]|mm/sec|[?]|1|g/animal|TRICUSPID VALVE, POSTERIOR ANNULUS|LEFT|DEEP|ORCHIDOMETERY||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|2|Visit_2|25|4|FOLLOW-UP|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|5|AIRTRAP|Air Trapping|[?]|DECUBITUS|[?]|dyn|[?]|1|Tbsp|PARA-AORTIC LYMPH NODE|UNILATERAL|VOLAR|PUPILLOMETRY|Y|||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 2|3|Visit_3|40|7|TREATMENT|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|PFU/dose|SCLERA|CONTRALATERAL|CRANIAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y||Y|CAREGIVER|MICROSCOPIST 2|3|Visit_3|40|4|FOLLOW-UP|2020-09-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|7|EFFIND|Effusion Indicator|[?]|STANDING, BENT FORWARD|[?]|tsp|[?]|1|F|PORTACAVAL LYMPH NODE|IPSILATERAL|INNER|MAGNETIC RESONANCE ELASTOGRAPHY||||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|4|Visit_4|65|3|TREATMENT|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|8|RRS|Total Respiratory System Resistance|[?]|FOWLERS|||[?]|1|Bq/ug|RETROPERITONEAL LYMPH NODE|CONTRALATERAL|FRONTAL|RADIOIMMUNOPRECIPITATION ASSAY|||Y|GUARDIAN|CARDIOLOGIST|4|Visit_4|65|1|TREATMENT|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|cm2|[?]|1|U/m2/day|UPPER URINARY SYSTEM|LEFT|PERIPHERAL|BETA LACTAMASE||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|4c19e870-9195-41d8-9c8a-8a54bb428732|10|MIPPP|Percent Predicted MIP|[?]|LEFT LATERAL DECUBITUS|[?]|Bq|[?]|1|Bq/g|CARPOMETACARPAL JOINT 2|UNILATERAL|TEMPORAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|WASHOUT|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|1|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|UNCONSTRAINED|[?]|tuberculin unit/mL|[?]|1|ft2|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|UNILATERAL|PROXIMAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|4|TREATMENT|2020-12-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING|[?]|mL/m2|[?]|1|deg/s|CARPAL BONE|LEFT|FACIAL|LC/MS/MS|Y|Y||SPOUSE|RATER 1|1|Visit_1|10|7|SCREENING|2020-12-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|3|GAW|Airway Conductance|[?]|TRENDELENBURG|||[?]|1|mmAL|CLITORIS|UNILATERAL|OCCIPITAL|IVY INCISION METHOD|||Y|SPOUSE|MICROSCOPIST 2|2|Visit_2|25|4|TREATMENT|2021-01-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|4|TV|Tidal Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|uOsm|TARSUS BONE|CONTRALATERAL|ANTERIOR|PULMONARY ANGIOGRAPHY|||Y|VENDOR|MICROSCOPIST|2|Visit_2|25|1|SCREENING|2021-01-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|5|IRVPP|Percent Predicted IRV|[?]|DECUBITUS|[?]|g/dL|[?]|1|Ci/ug|RIB 3|RIGHT|FRONTAL|U-HPLC/MS/MS||||INVESTIGATOR|HEMATOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|6|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|deg/s|[?]|1|mm/2h|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|RIGHT|DISTAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|||STUDY SUBJECT|READER 2|3|Visit_3|40|1|FOLLOW-UP|2021-01-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|7|PEF|Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|mL/beat|[?]|1|min*mg/mL|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|UNILATERAL|BASAL|ELISA||||PROXY|HEMATOLOGIST|4|Visit_4|65|2|SCREENING|2021-02-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|8|RAW|Airway Resistance|[?]|PRONE|[?]|s*kPa|[?]|1|keV|PARASPINAL REGION|BILATERAL|MIDLINE|DC SHEATH FLOW||||STUDY SUBJECT|MICROSCOPIST 3|4|Visit_4|65|7|TREATMENT|2021-02-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|TRENDELENBURG|[?]|lm|[?]|1|kg/L|INTERPHALANGEAL JOINT 3|RIGHT|LOWER|ENZYMATIC SPECTROPHOTOMETRY|Y|||STUDY SUBJECT|HEMATOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-03-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|7682184f-0801-4315-9c5f-116f7321a2b0|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|TRENDELENBURG|[?]|pmol/10^9 cells|[?]|1|foz_br|LUNATE BONE|LATERAL|ANTEROMEDIAL|PATHOLOGICAL EVALUATION|Y|Y||INTERVIEWER|PATHOLOGIST 1|5|Visit_5|90|2|SCREENING|2021-03-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|DLCOVA|DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|U/10^12 RBC|[?]|1|pmol|SYMPATHETIC GANGLIA|CONTRALATERAL|LOWER MEDIAL|CRYOSCOPY|Y|||SIGNIFICANT OTHER|MICROSCOPIST 2|1|Visit_1|10|5|TREATMENT|2020-12-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|2|MEP|Maximal Expiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|tuberculin unit/mL|[?]|1|min|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|IPSILATERAL|PROXIMAL VOLAR|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||SPOUSE|PHYSIOTHERAPIST|1|Visit_1|10|3|TREATMENT|2020-12-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|||[?]|1|Joule|ANTERIOR HORN OF THE LATERAL VENTRICLE|LEFT|INTERMEDIATE|TARGETED TRANSCRIPTOME SEQUENCING|||Y|CAREGIVER|PHYSIOTHERAPIST|2|Visit_2|25|5|SCREENING|2020-12-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|4|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|[?]|in|[?]|1|mAnson U/mL|FALCIFORM LIGAMENT|UNILATERAL|LOWER|PET/MRI SCAN|Y|||NON-HEALTH CARE PROFESSIONAL|READER 2|2|Visit_2|25|2|FOLLOW-UP|2020-12-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|5|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|mV|GRACILIS MUSCLE|LEFT|OCCIPITAL|MAGNETIC RESONANCE ELASTOGRAPHY|||Y|SIGNIFICANT OTHER|RADIOLOGIST 1|3|Visit_3|40|4|SCREENING|2021-01-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|6|AWWVOL|Airway Wall Volume|[?]|SLING|||[?]|1|10^3 CFU/mL|FLEXOR DIGITORUM LONGUS MUSCLE|UNILATERAL|DISTAL VOLAR|LEAD CITRATE STAIN|||Y|INVESTIGATOR|OTOLARYNGOLOGIST|3|Visit_3|40|3|TREATMENT|2021-01-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|7|FEV1FVC6|FEV1/FVC6|[?]|TRENDELENBURG|[?]|%/min|[?]|1|/4.0 mL|FOOT DIGIT 4|CONTRALATERAL|INTERMEDIATE|ELASTOGRAPHY||||PROXY|READER 1|4|Visit_4|65|3|TREATMENT|2021-02-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|8|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uU/L|INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|ANTEROMEDIAL|PERCUSSION||Y|Y|ADJUDICATOR|ADJUDICATOR 2|4|Visit_4|65|2|WASHOUT|2021-02-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|9|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|UNCONSTRAINED|[?]|/5x10^4 WBC|[?]|1|kHz|METACARPAL BONE 2|LEFT|MEDIAL|ETDRS EYE CHART||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|5|Visit_5|90|2|TREATMENT|2021-03-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|c40f9cb3-b597-4614-8ba5-d40849030ff9|10|MIPPP|Percent Predicted MIP|[?]|SEMI-FOWLERS|[?]|umol/L|[?]|1|mCi|VOCAL CORD|LEFT|LOWER EXTENSOR SURFACE|HEMATOXYLIN AND EOSIN STAIN||||INVESTIGATOR|RADIOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-03-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|[?]|10^9/L|[?]|1|STEPS|CELIAC LYMPH NODE|IPSILATERAL|FACIAL|INCISION-INDUCED BLEEDING METHOD||Y||SIGNIFICANT OTHER|MICROSCOPIST 1|1|Visit_1|10|2|SCREENING|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|2|LOBVOL|Lobar Volume|[?]|FOWLERS|[?]|RING|[?]|1|/7.5 mL|RIB 7|LATERAL|ROSTRAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||||FAMILY MEMBER|CLINICAL PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|3|FEV1FVC6|FEV1/FVC6|[?]|RIGHT LATERAL DECUBITUS|[?]|HOMEOPATHIC DILUTION|[?]|1|10^6 copies/mL|T9 VERTEBRA|LATERAL|SUBCORTICAL|ACRIDINE ORANGE STAIN||||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|2|Visit_2|25|5|WASHOUT|2020-09-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|4|TLC|Total Lung Capacity|[?]|STANDING|[?]|10^6 IU/mL|[?]|1|ukat/10^12 RBC|DISTANT LYMPH NODE|RIGHT|PERIVENTRICULAR|TRICHROME STAIN|Y|||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-09-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|5|EFFVOL|Effusion Volume|[?]|SITTING|[?]|VIAL|[?]|1|VIAL|THYROID GLAND|RIGHT|LATERAL|GC/MS-EI||Y||FAMILY MEMBER|ONCOLOGIST|3|Visit_3|40|7|TREATMENT|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SLING|[?]|cd*s/m2|[?]|1|Frames/s|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|SUPERFICIAL|MICRODENSITOMETRY||Y||CAREGIVER|READER 2|3|Visit_3|40|5|SCREENING|2020-10-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|7|MALEVDES|Malignancy Evidence Description|[?]|RIGHT LATERAL DECUBITUS|[?]|damol/L|[?]|1|log10 CCID 50/dose|LACRIMAL BONE|IPSILATERAL|PROXIMAL|MODIFIED ACID FAST STAIN||||DOMESTIC PARTNER|OTOLARYNGOLOGIST|4|Visit_4|65|3|SCREENING|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|STANDING|||[?]|1|BAG|SKIN OF THE BACK|UNILATERAL|ROSTRAL|GRADIENT DIFFUSION|||Y|HEALTH CARE PROFESSIONAL|RATER 1|4|Visit_4|65|4|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-03
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|10^4/L|[?]|1|tsp eq|URETER|LEFT|UPPER|TRICHROME STAIN||||DOMESTIC PARTNER|READER 3|5|Visit_5|90|3|TREATMENT|2020-11-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|10|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|Log10 ELISA unit/dose|[?]|1|PUFF|HEART, LEFT VENTRICLE|IPSILATERAL|ROSTRAL|FREEZING POINT DEPRESSION||Y||HEALTH CARE PROFESSIONAL|UROLOGIST|5|Visit_5|90|5|TREATMENT|2020-11-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING|[?]|Hz|[?]|1|CIGARETTE|PERICARDIAL LYMPH NODE|LEFT|APICAL|MRI WITHOUT CONTRAST|Y|||SPOUSE|OPHTHALMOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|2|RELSZCHG|Relative Size Change|[?]|DECUBITUS|[?]|SBE/mL|[?]|1|NEEDLE GAUGE|LENS|LEFT|ANTERIOR|CONTRAST ENHANCED MRI||||INDEPENDENT ASSESSOR|ONCOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|3|AWWVOL|Airway Wall Volume|[?]|UNCONSTRAINED|[?]|min|[?]|1|10^9 CFU/mL|T11 VERTEBRA|RIGHT|DISTAL VOLAR|FREEZING POINT DEPRESSION||Y||SIBLING|PEDIATRIC NEUROLOGIST|2|Visit_2|25|5|WASHOUT|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|4|ICREV|IC Reversibility|[?]|SUPINE|||[?]|1|ug/m2/h|HEPATIC LYMPH NODE|UNILATERAL|LATERAL|FARNSWORTH-MUNSELL 100 HUE TEST|||Y|PROXY|ENDOCRINOLOGIST|2|Visit_2|25|2|SCREENING|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|5|IVC|Inspiratory Vital Capacity|[?]|FOWLERS|[?]|FFU|[?]|1|mg/m2|DISTAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|INTERMEDIATE|CONTRAST ENHANCED X-RAY||||PARENT|PATHOLOGIST 2|3|Visit_3|40|2|WASHOUT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|TRENDELENBURG|[?]|genEq/mL|[?]|1|Gy/min|TRAPEZIUM-TRAPEZOID JOINT|LEFT|LOWER MEDIAL|AUTOMATED COUNT|Y|||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|3|Visit_3|40|5|TREATMENT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|7|FVC|Forced Vital Capacity|[?]|UNCONSTRAINED|[?]|/cmH2O|[?]|1|Anson U|SUBCARINAL LYMPH NODE|LEFT|SURFACE|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||GUARDIAN|RADIOLOGIST 1|4|Visit_4|65|1|TREATMENT|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|8|FIF50|Forced Inspiratory Flow at 50%|[?]|TRENDELENBURG|||[?]|1|mL/sec/1.73m2|THYROID GLAND, RIGHT LOBE|RIGHT|POSTERIOR|MICROBIAL CULTURE|||Y|PARENT|RATER|4|Visit_4|65|1|SCREENING|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|9|TSUHYS|Tissue Hysteresivity|[?]|PRONE|||[?]|1|mm|ANTECUBITAL FOSSA|CONTRALATERAL|ROSTRAL|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|INVESTIGATOR|NEUROLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|c9308aa7-f38f-4b54-a919-d3f893b18cd1|10|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|10^12 IU/L|[?]|1|10^3 RNA copies/mL|BRAIN, PERIVENTRICULAR REGION|IPSILATERAL|PROXIMAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||CAREGIVER|PATHOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|SALKK|Salazar-Knowles Equation, K|[?]|SEMI-FOWLERS|||[?]|1|mg/animal|URINARY SYSTEM|BILATERAL|CAUDAL|CLINICAL EVALUATION||Y|Y|SPOUSE|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2020-08-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|2|FEV_PEF|FEV at PEF|[?]|SITTING, LEGS DEPENDENT|[?]|mL/kg/day|[?]|1|grain|ULNA SHAFT|BILATERAL|INTERMEDIATE|SPIRAL CT||||INTERVIEWER|RADIOLOGIST 2|1|Visit_1|10|5|SCREENING|2020-08-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|L/L|[?]|1|copies/ug|INTERPHALANGEAL JOINT OF THE HAND|LEFT|VENTRAL|SIZE EXCLUSION CHROMATOGRAPHY||||INVESTIGATOR|OTOLARYNGOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-09-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|4|PNIF|Peak Nasal Inspiratory Flow|[?]|SEMI-FOWLERS|||[?]|1|10^6/L|COLON|CONTRALATERAL|PROXIMAL VOLAR|HPLC/IEX|Y|Y|Y|PROXY|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|SCREENING|2020-09-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|PRONE|||[?]|1|PHERESIS UNIT|LEFT VENTRICULAR MID INFERIOR SEGMENT|LEFT|FRONTAL|AGAR PROPORTION|||Y|CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|3|Visit_3|40|1|SCREENING|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|10^9 organisms|[?]|1|mg/min|CAPITATE-HAMATE JOINT|CONTRALATERAL|PERIPHERAL|LC/MS||||STUDY SUBJECT|MICROSCOPIST 3|3|Visit_3|40|2|TREATMENT|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|7|SGAW|Specific Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|umol/kg/min|[?]|1|mEq/day|ILIUM|IPSILATERAL|VOLAR|MAGNETIC RESONANCE ANGIOGRAPHY||||CLINICAL RESEARCH COORDINATOR|RATER 1|4|Visit_4|65|7|TREATMENT|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|8|FEV1REV|FEV1 Reversibility|[?]|REVERSE TRENDELENBURG|||[?]|1|U/kg/min|GASTROCNEMIUS MUSCLE|IPSILATERAL|VENTROLATERAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|4|Visit_4|65|1|TREATMENT|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|||[?]|1|pg/dL|DISTAL PHALANX 2 OF THE HAND|LATERAL|VOLAR|HEMAGGLUTINATION INHIBITION ASSAY|Y||Y|INVESTIGATOR|INTERNIST|5|Visit_5|90|3|FOLLOW-UP|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|10|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|mol/mL|[?]|1|mL/cage/wk|CORONARY SINUS|BILATERAL|BASAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||FAMILY MEMBER|ENDOCRINOLOGIST|5|Visit_5|90|7|TREATMENT|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|PIF|Peak Inspiratory Flow|[?]|SLING|[?]|10^6 DNA copies/mL|[?]|1|GLOBULE|THIRD POSTEROLATERAL DESCENDING ARTERY|CONTRALATERAL|PROXIMAL VOLAR|KINYOUN STAIN||||NON-HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|5|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|2|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|ug/L DDU|SUPRAPUBIC REGION|RIGHT|LOWER FLEXOR SURFACE|CONTRAST ENHANCED X-RAY|||Y|FRIEND|PATHOLOGIST 2|1|Visit_1|10|4|WASHOUT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|3|TV|Tidal Volume|[?]|STANDING|[?]|MASK|[?]|1|PUFF|DORSALIS PEDIS ARTERY|RIGHT|CRANIAL|HPLC/IEX||Y||STUDY SUBJECT|RADIOLOGIST 2|2|Visit_2|25|3|WASHOUT|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|4|FIO2|Fraction of Inspired Oxygen|[?]|DECUBITUS|[?]|kPa|[?]|1|MESF|INFERIOR PUBIC RAMUS|RIGHT|LOWER FLEXOR SURFACE|ANTIBIOTIC AGAR SCREEN||||ADJUDICATOR|MICROSCOPIST 2|2|Visit_2|25|1|SCREENING|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|5|FIF25|Forced Inspiratory Flow at 25%|[?]|DECUBITUS|[?]|g/animal/wk|[?]|1|mEq/mmol|PRESACRAL LYMPH NODE|UNILATERAL|ROSTRAL|MAPH||||VENDOR|OPTOMETRIST|3|Visit_3|40|7|WASHOUT|2021-02-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|6|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|cm/min|[?]|1|mL/mmHg|BRAIN STEM|RIGHT|PERIVENTRICULAR|MEDIASTINOSCOPY||||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|7|TREATMENT|2021-02-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|7|LOBVOL|Lobar Volume|[?]|SLING|[?]|m/sec2|[?]|1|BLOCKS|LEFT VENTRICULAR EPICARDIUM|RIGHT|SUPERIOR|ANTIMICROBIAL COMBINATION TESTING||||FRIEND|OPTOMETRIST|4|Visit_4|65|7|TREATMENT|2021-03-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|8|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|[?]|/mm2|[?]|1|ka_u/dL|FASCIA|UNILATERAL|NASAL|SPECULAR MICROSCOPY||Y||SIBLING|ADJUDICATOR 3|4|Visit_4|65|2|SCREENING|2021-03-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|9|MEP|Maximal Expiratory Pressure|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/s|METATARSOPHALANGEAL JOINT 3|RIGHT|DORSAL|CELL BASED BIOASSAY|||Y|CAREGIVER|PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|3da865e8-9680-4112-b6d3-1f5763cfdaae|10|SGAW|Specific Airway Conductance|[?]|RIGHT LATERAL DECUBITUS|[?]|kg/mol|[?]|1|pg/L|PROXIMAL INTERPHALANGEAL JOINT 2|LATERAL|SUPERFICIAL|DXA SCAN||Y||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|5|Visit_5|90|6|SCREENING|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|IRVPP|Percent Predicted IRV|[?]|SLING|[?]|JDF Unit|[?]|1|mmol/L|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LEFT|PROXIMAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||DOMESTIC PARTNER|HEMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|2|ERV|Expiratory Reserve Volume|[?]|PRONE|[?]|mm/min|[?]|1|Pa|INTERVENTRICULAR SEPTUM|UNILATERAL|UPPER FLEXOR SURFACE|SPIROMETRY|Y|||FAMILY MEMBER|INTERNIST|1|Visit_1|10|3|WASHOUT|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|3|IRV|Inspiratory Reserve Volume|[?]|DECUBITUS|||[?]|1|SFC/10^6 PBMC|BRACHIAL VEIN|UNILATERAL|LATERAL|REVERSE TRANSCRIPTASE PCR|||Y|DOMESTIC PARTNER|OPTOMETRIST|2|Visit_2|25|1|SCREENING|2020-08-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|4|IVC|Inspiratory Vital Capacity|[?]|SLING|[?]|10^11/L|[?]|1|g|HARD PALATE|RIGHT|FACIAL|BIOPSY||Y||CHILD|MICROSCOPIST 3|2|Visit_2|25|3|TREATMENT|2020-08-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|5|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ppth|ABDOMINAL CAVITY|BILATERAL|NASAL|CYSTOMETRY||Y|Y|CAREGIVER|UROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-09-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|6|PEF|Peak Expiratory Flow|[?]|PRONE|[?]|uL/mL|[?]|1|mmHg/sec|FEMORAL CONDYLE|IPSILATERAL|DORSAL|REFLECTANCE SPECTROSCOPY||||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|3|Visit_3|40|5|TREATMENT|2020-09-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|ug/min|[?]|1|cycle/min|ANAL VERGE|BILATERAL|CRANIAL|SLIT LAMP PHOTOGRAPHY|Y|||PROXY|ADJUDICATOR|4|Visit_4|65|3|FOLLOW-UP|2020-10-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|8|EFFVOL|Effusion Volume|[?]|SITTING, LEGS DEPENDENT|[?]|INHALATION|[?]|1|RING|FEMUR|BILATERAL|VENTRAL|CELLULOSE TAPE||||ADJUDICATOR|ONCOLOGIST 1|4|Visit_4|65|5|TREATMENT|2020-10-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|9|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-RECUMBENT|||[?]|1|foz_br|SKIN OF THE LIP|BILATERAL|SUPERFICIAL|CLAUSS METHOD|||Y|CAREGIVER|OPTOMETRIST|5|Visit_5|90|3|TREATMENT|2020-11-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|60afc3a3-56b7-4988-9006-e12f3bc1097c|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-FOWLERS|[?]|uSiemens|[?]|1|mg/kg/min|TRICEPS BRACHII MUSCLE|RIGHT|PROXIMAL VOLAR|PET/SPECT SCAN||||INVESTIGATOR|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2020-11-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|1|AWWVOL|Airway Wall Volume|[?]|SITTING|[?]|BOLUS|[?]|1|DROP|SUBARACHNOID SPACE|RIGHT|SUBCORTICAL|MAMMOGRAPHY||Y||INTERVIEWER|OTOLARYNGOLOGIST|1|Visit_1|10|7|SCREENING|2020-12-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|2|MIPPP|Percent Predicted MIP|[?]|LEFT LATERAL DECUBITUS|[?]|SCOOPFUL|[?]|1|g/day|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|RIGHT|NASAL|IMMUNOCHEMILUMINOMETRIC ASSAY||||SIBLING|READER 2|1|Visit_1|10|1|TREATMENT|2020-12-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|3|RRS|Total Respiratory System Resistance|[?]|SLING|[?]|mMU/mL|[?]|1|cup eq|PRESACRAL SPACE|UNILATERAL|SUPERIOR|ICC|Y|||PROXY|ADJUDICATOR|2|Visit_2|25|7|WASHOUT|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|4|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|um2|[?]|1|MdFI|PANCREAS, TAIL|IPSILATERAL|ANTERIOR|CONGO RED STAIN||||SIGNIFICANT OTHER|DERMATOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|SITTING, LEGS DEPENDENT|||[?]|1|GBq/mg|LUNG, RIGHT MIDDLE LOBE|LATERAL|UPPER EXTENSOR SURFACE|FORCED OSCILLATION TECHNIQUE|||Y|PARENT|RATER 2|3|Visit_3|40|6|TREATMENT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|6|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|nmol|[?]|1|Bq|NUCLEUS ACCUMBENS|UNILATERAL|CENTRAL|CONTRAST ENHANCED MRI||||DOMESTIC PARTNER|ADJUDICATOR|3|Visit_3|40|5|WASHOUT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|7|FIV1PP|Percent Predicted FIV1|[?]|LATERAL DECUBITUS|[?]|10^10/L|[?]|1|uEq/L|L3 VERTEBRA|CONTRALATERAL|VOLAR|ANGIOGRAPHY||||CAREGIVER|ADJUDICATOR 3|4|Visit_4|65|7|FOLLOW-UP|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|8|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|||[?]|1|/MBP|LUMBRICAL MUSCLES OF THE HAND|CONTRALATERAL|SURFACE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||Y|Y|SIGNIFICANT OTHER|ADJUDICATOR|4|Visit_4|65|2|WASHOUT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|9|ICREV|IC Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|Log10 ELISA unit|[?]|1|1/(s*kPa)|COMMON FEMORAL ARTERY|RIGHT|LOWER|SPIRAL CT SCAN WITHOUT CONTRAST||||ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|5|Visit_5|90|2|WASHOUT|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|440119fb-ad46-4348-b236-8e2979c7bf2e|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|Ci|[?]|1|10^7 PFU|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|LATERAL|FORE|HEMOCYTOMETRY|Y|||ADJUDICATOR|RADIOLOGIST 2|5|Visit_5|90|3|TREATMENT|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|UNCONSTRAINED|[?]|TUBE|[?]|1|s*kPa|UTERINE ARTERY|CONTRALATERAL|LOWER EXTENSOR SURFACE|REVERSE TRANSCRIPTASE PCR||||SIBLING|READER 3|1|Visit_1|10|6|TREATMENT|2020-06-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|%/min|[?]|1|mAmp|TEMPLE|IPSILATERAL|VOLAR|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|Y||CAREGIVER|RATER|1|Visit_1|10|3|SCREENING|2020-06-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|3|INERTANC|Inertance|[?]|LEFT LATERAL DECUBITUS|[?]|log10 IU/mL|[?]|1|Absorbance U|XIPHOID PROCESS|CONTRALATERAL|SURFACE|JAEGER EYE CHART||||CAREGIVER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|6|WASHOUT|2020-06-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|4|IRV|Inspiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|PA|[?]|1|kat|FLEXOR HALLUCIS LONGUS MUSCLE|LEFT|LATERAL|MALDI|Y|||INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|7|SCREENING|2020-06-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|5|INERTANC|Inertance|[?]|REVERSE TRENDELENBURG|[?]|nmol/L|[?]|1|BEAM BREAKS|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|VOLAR|EPSILOMETER|Y|Y||DOMESTIC PARTNER|ADJUDICATOR 2|3|Visit_3|40|7|TREATMENT|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|6|MALIND|Malignancy Indicator|[?]|SEMI-FOWLERS|[?]|mMU/mL|[?]|1|10^5/hpf|ABDUCTOR HALLUCIS MUSCLE|UNILATERAL|BASAL|ANGIOGRAPHY||||FRIEND|UROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|7|PEF|Peak Expiratory Flow|[?]|SUPINE|[?]|10^3 organisms/mL|[?]|1|mm/2h|TEMPORAL BONE|LEFT|ANTEROLATERAL|BIOIMPEDANCE SPECTROSCOPY|Y|||FAMILY MEMBER|MICROSCOPIST 2|4|Visit_4|65|3|WASHOUT|2020-08-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|[?]|PATCH|[?]|1|ug/day|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|CONTRALATERAL|LOWER FLEXOR SURFACE|PULSE OXIMETRY|Y|Y||CLINICAL STUDY SPONSOR|RADIOLOGIST|4|Visit_4|65|6|SCREENING|2020-08-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|9|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|[?]|DNA copies/ug|[?]|1|mg/kg|TEMPOROMANDIBULAR JOINT|RIGHT|ANTEROTEMPORAL|AGAR DILUTION||Y||INVESTIGATOR|FORENSIC PATHOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-09-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|af45a9de-c8aa-4602-8e3b-d16998740ebd|10|SAWVOL|Specific Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|umol/mol|[?]|1|mmAL|OCCIPITAL LYMPH NODE|BILATERAL|PROXIMAL VOLAR|GC/MS-EI||Y||INDEPENDENT ASSESSOR|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-09-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|23306866-3fcb-418d-861b-de3bd779260d|1|PLMBLFLW|Pulmonary Blood Flow|[?]|TRENDELENBURG|[?]|ug/L FEU|[?]|1|U/m2/day|HYOID BONE|BILATERAL|UPPER|HIGH RESOLUTION MELT ANALYSIS||Y||INVESTIGATOR|RADIOLOGIST|1|Visit_1|10|7|WASHOUT|2020-07-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|23306866-3fcb-418d-861b-de3bd779260d|2|MALIND|Malignancy Indicator|[?]|REVERSE TRENDELENBURG|[?]|genEq/mL|[?]|1|V|DENTAL ARCH|IPSILATERAL|MIDLINE|OSCILLOMETRY||Y||GUARDIAN|NEUROLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-07-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|23306866-3fcb-418d-861b-de3bd779260d|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|[?]|IU/mmol|[?]|1|mL/min|PERICARDIUM|LEFT|VENTRAL|MRS|Y|Y||CHILD|RADIOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-08-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|23306866-3fcb-418d-861b-de3bd779260d|4|MALEVDES|Malignancy Evidence Description|[?]|FOWLERS|[?]|umol/L/sec|[?]|1|ug/kg|THYROID GLAND, LEFT LOBE|RIGHT|MEDIAL|MODIFIED ACID FAST STAIN||Y||SIBLING|UROLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|23306866-3fcb-418d-861b-de3bd779260d|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|[?]|ug/kg/min|[?]|1|IU/mL|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|RIGHT|TEMPORAL|DOPPLER ULTRASOUND||Y||CLINICAL RESEARCH ASSOCIATE|RATER 1|3|Visit_3|40|5|WASHOUT|2020-08-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|23306866-3fcb-418d-861b-de3bd779260d|6|TSUHYS|Tissue Hysteresivity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mmol/min/kPa/L|VOCAL CORD|LEFT|PARIETO-OCCIPITAL|SURFACE PLASMON RESONANCE|Y||Y|SIBLING|FORENSIC PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-08-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|23306866-3fcb-418d-861b-de3bd779260d|7|MALEVDES|Malignancy Evidence Description|[?]|PRONE|[?]|mol/mol|[?]|1|min/day|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|CONTRALATERAL|MIDLINE|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|2|FOLLOW-UP|2020-09-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|23306866-3fcb-418d-861b-de3bd779260d|8|FEF2575|Forced Expiratory Flow 25-75%|[?]|PRONE|[?]|mg/kg/week|[?]|1|CYLINDER|TARSUS BONE|IPSILATERAL|ANTEROMEDIAL|HPLC/IEX||||INTERVIEWER|READER 2|4|Visit_4|65|7|TREATMENT|2020-09-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|23306866-3fcb-418d-861b-de3bd779260d|9|SVC|Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|ug/L DDU|[?]|1|s^-1(%O2)^-1|ACCESSORY RENAL ARTERY|IPSILATERAL|CAUDAL|PET/CT SCAN||||FAMILY MEMBER|CARDIOLOGIST|5|Visit_5|90|3|WASHOUT|2020-10-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|23306866-3fcb-418d-861b-de3bd779260d|10|MEP|Maximal Expiratory Pressure|[?]|SITTING|[?]|SCOOPFUL|[?]|1|log10 PFU/mL|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|BILATERAL|CRANIAL|CT SCAN WITHOUT CONTRAST||Y||ADJUDICATION COMMITTEE|ADJUDICATOR|5|Visit_5|90|6|SCREENING|2020-10-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|LCI|Lung Clearance Index|[?]|UNCONSTRAINED|||[?]|1|/10^3|C2 VERTEBRA|LEFT|SUBCORTICAL|MAMMOGRAPHY|||Y|ADJUDICATION COMMITTEE|PATHOLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|2|DLCOVA|DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|DAYS|[?]|1|mAnson U/mL|HEART, LEFT ATRIAL APPENDAGE|LEFT|CENTRAL|PATHOLOGICAL EVALUATION||Y||FAMILY MEMBER|OTOLARYNGOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SLING|||[?]|1|cmol/L|OMENTUM|LATERAL|FORE|CONTRAST ENHANCED MRI|||Y|PARENT|RATER|2|Visit_2|25|6|SCREENING|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|4|FIF25|Forced Inspiratory Flow at 25%|[?]|SITTING|[?]|EID 50/mL|[?]|1|U/cL|HEART, LEFT VENTRICLE|LATERAL|LOWER FLEXOR SURFACE|KNEMOMETRY||||PROXY|PATHOLOGIST|2|Visit_2|25|7|SCREENING|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|5|IC|Inspiratory Capacity|[?]|SUPINE|||[?]|1|atm|PARIETAL LOBE|LEFT|FRONTAL|ELECTRONEUROGRAPHY|Y||Y|SIGNIFICANT OTHER|RADIOLOGIST 1|3|Visit_3|40|6|SCREENING|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|6|DLCOVA|DLCO/VA|[?]|SITTING|[?]|cycle/min|[?]|1|mL/min/mmHg|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT|UPPER FLEXOR SURFACE|DROPLET DIGITAL PCR|Y|||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|3|Visit_3|40|6|SCREENING|2020-09-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|7|EFFVOL|Effusion Volume|[?]|SITTING|[?]|nmol|[?]|1|10^9 organisms/mL|SEMITENDINOSUS MUSCLE|UNILATERAL|ANTERIOR|BRDU CELLULAR PROLIFERATION ASSAY||||VENDOR|HEMATOLOGIST|4|Visit_4|65|1|TREATMENT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|8|INFLTIND|Infiltrates Indicator|[?]|STANDING, BENT FORWARD|[?]|mm/sec|[?]|1|mL/cage/day|C1 VERTEBRA|LEFT|LOWER MEDIAL|WRIGHT STAIN||||ADJUDICATION COMMITTEE|RADIOLOGIST|4|Visit_4|65|1|WASHOUT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|9|DLCO|Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|rpm|[?]|1|pt_us|CARPOMETACARPAL JOINT|UNILATERAL|CRANIAL|KNEMOMETRY||||FRIEND|ADJUDICATOR 2|5|Visit_5|90|7|TREATMENT|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|144d2eb9-d79a-4a61-91f5-6a807832d8ca|10|FIF75|Forced Inspiratory Flow at 75%|[?]|TRENDELENBURG|[?]|mg/m2|[?]|1|pt_us|NASAL SEPTUM|LATERAL|FRONTAL|HPLC/IEX|Y|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|5|Visit_5|90|6|TREATMENT|2020-10-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|1|PEF|Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|MASK|[?]|1|Gravitational Unit|FOOT DIGIT 3|LEFT|DISTAL VOLAR|WRIGHT-GIEMSA STAIN||Y||ADJUDICATION COMMITTEE|MICROSCOPIST|1|Visit_1|10|3|TREATMENT|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|2|SGAW|Specific Airway Conductance|[?]|FOWLERS|[?]|mL/m2/day|[?]|1|cy/cm|BICEPS FEMORIS MUSCLE|UNILATERAL|MEDIAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y||VENDOR|MICROSCOPIST 2|1|Visit_1|10|7|FOLLOW-UP|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|3|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|breaths/min|[?]|1|m2|LOCUS CERULEUS|UNILATERAL|CENTRAL|MASS SPECTROMETRY||||CLINICAL RESEARCH ASSOCIATE|READER 3|2|Visit_2|25|5|FOLLOW-UP|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-RECUMBENT|[?]|fmol/g|[?]|1|h*%|CARPOMETACARPAL JOINT 4|LATERAL|DEEP|OBSERVATION||||INTERVIEWER|UROLOGIST|2|Visit_2|25|1|TREATMENT|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|5|SRAW|Specific Airway Resistance|[?]|SLING|[?]|STRIP|[?]|1|PACKET|INTERPHALANGEAL JOINT 1|CONTRALATERAL|LATERAL|CENTRIFUGATION||||SIGNIFICANT OTHER|READER 1|3|Visit_3|40|1|WASHOUT|2020-12-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|6|EFFVOL|Effusion Volume|[?]|SITTING|||[?]|1|mg/kg/min|INGUINAL REGION|LEFT|VENTRAL|BALLPOINT PEN TECHNIQUE|||Y|STUDY SUBJECT|INTERNIST|3|Visit_3|40|4|TREATMENT|2020-12-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|7|IRVPP|Percent Predicted IRV|[?]|LEFT LATERAL DECUBITUS|[?]|ng|[?]|1|RNA copies/mL|SKIN OF THE INGUINAL REGION|RIGHT|VOLAR|FLUORESCEIN STAIN||Y||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|8|ELSTNCE|Elastance|[?]|REVERSE TRENDELENBURG|||[?]|1|dpm/0.5 mL|ANTRUM PYLORI|BILATERAL|UPPER EXTENSOR SURFACE|ETDRS EYE CHART|Y||Y|GUARDIAN|NEUROLOGIST 2|4|Visit_4|65|3|WASHOUT|2021-01-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|9|FIV1PP|Percent Predicted FIV1|[?]|SUPINE|[?]|mg/m2|[?]|1|JAR|PROXIMAL PHALANX 5 OF THE HAND|CONTRALATERAL|APICAL|X-RAY FLUORESCENCE SPECTROMETRY||||INTERVIEWER|UROLOGIST|5|Visit_5|90|7|TREATMENT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|92855d33-eee6-449f-a9e6-c06a1532571f|10|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|[?]|kHz|[?]|1|min*mg/mL|LUMBRICAL MUSCLES OF THE HAND|LATERAL|ANTEROLATERAL|OPTICAL COHERENCE TOMOGRAPHY|Y|||GUARDIAN|ADJUDICATOR 3|5|Visit_5|90|2|TREATMENT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|MEP|Maximal Expiratory Pressure|[?]|REVERSE TRENDELENBURG|[?]|10^3 organisms/mL|[?]|1|EVENTS|OROPHARYNX|BILATERAL|CAUDAL|ANALYTICAL ULTRACENTRIFUGATION|Y|||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 2|1|Visit_1|10|2|TREATMENT|2021-01-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|2|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|[?]|10^6 copies/mL|[?]|1|umol/dL|HAIR BULB|LEFT|PARIETO-OCCIPITAL|SEQUENCING||||FRIEND|RADIOLOGIST|1|Visit_1|10|1|TREATMENT|2021-01-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-19
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|3|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|FOWLERS|[?]|HOMEOPATHIC DILUTION|[?]|1|kBq|HEART, ATRIUM|RIGHT|TEMPORAL|MAMMOGRAPHY||||FAMILY MEMBER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-28
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|4|RAWPP|Percent Predicted Airway Resistance|[?]|UNCONSTRAINED|[?]|CFU/mL|[?]|1|dmol|SUBSTANTIA NIGRA|IPSILATERAL|FRONTAL|INDIRECT IMMUNOFLUORESCENCE||||ADJUDICATION COMMITTEE|MICROSCOPIST 2|2|Visit_2|25|2|SCREENING|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-28
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|5|EFFVOL|Effusion Volume|[?]|SEMI-RECUMBENT|[?]|cs|[?]|1|mL/day|EPIGASTRIC REGION|BILATERAL|LOWER FLEXOR SURFACE|FLUORESCENCE ANGIOGRAPHY||||GUARDIAN|ADJUDICATOR|3|Visit_3|40|7|TREATMENT|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|6|SAWVOL|Specific Airway Volume|[?]|FOWLERS|[?]|10^6 IU|[?]|1|nmol/kg/day|SKULL|BILATERAL|DORSAL|BIOIMPEDANCE SPECTROSCOPY||||PROXY|OPTOMETRIST|3|Visit_3|40|5|TREATMENT|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|7|SVC|Slow Vital Capacity|[?]|PRONE|[?]|g/animal|[?]|1|BAG|GENITALIA|BILATERAL|TEMPORAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||INVESTIGATOR|RADIOLOGIST 1|4|Visit_4|65|2|WASHOUT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|8|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|TRENDELENBURG|||[?]|1|dmol|FORELIMB|RIGHT|UPPER|DYNAMOMETRY|||Y|DOMESTIC PARTNER|ENDOCRINOLOGIST|4|Visit_4|65|2|TREATMENT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|9|IRVPP|Percent Predicted IRV|[?]|SITTING, LEGS DEPENDENT|[?]|10^6/hpf|[?]|1|mg|CAPITATE-HAMATE JOINT|LATERAL|LOWER MEDIAL|GC/MS-CI||||GUARDIAN|RATER 2|5|Visit_5|90|2|TREATMENT|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|10|FIFMAXPP|Percent Predicted FIFmax|[?]|LEFT LATERAL DECUBITUS|[?]|Pack Year|[?]|1|/500 WBC|DISTAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|PROXIMAL|CONFOCAL MICROSCOPY||||ADJUDICATOR|RADIOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|PIPE|[?]|1|mMU/mL|GASTROESOPHAGEAL JUNCTION|LATERAL|LOWER MEDIAL|FLOW CYTOMETRY||||INDEPENDENT ASSESSOR|NEUROLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-10-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|[?]|10^7 CFU|[?]|1|lx|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|LATERAL|PROXIMAL VOLAR|MICROSCOPY||||PARENT|NEUROLOGIST 1|1|Visit_1|10|4|FOLLOW-UP|2020-10-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|3|OXYPULSE|Oxygen Pulse|[?]|SEMI-FOWLERS|[?]|CONTAINER|[?]|1|Ci/L|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|LATERAL|SUBCORTICAL|TRIPLE-PHASE MRI SCAN||||SIBLING|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|Anson U|[?]|1|pmol/10^10 cells|BRAIN, PERIVENTRICULAR REGION|LATERAL|TEMPORAL|GRADIENT DIFFUSION||Y||PARENT|MICROSCOPIST 1|2|Visit_2|25|2|TREATMENT|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|5|IC|Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|INHALATION|[?]|1|g/m2/day|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|UNILATERAL|CRANIAL|OPTICAL MAPPING||||SIBLING|NEUROLOGIST|3|Visit_3|40|4|WASHOUT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|6|OXYPULSE|Oxygen Pulse|[?]|LATERAL DECUBITUS|[?]|RATIO|[?]|1|mV/sec|PARA-AORTIC LYMPH NODE|RIGHT|SUPERIOR|CHROMOGENIC ASSAY||||PROXY|ONCOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|ukat/10^12 RBC|[?]|1|Weber|CARPOMETACARPAL JOINT 3|RIGHT|LOWER|TRANSMISSION ELECTRON MICROSCOPY||||HEALTH CARE PROFESSIONAL|READER 3|4|Visit_4|65|3|SCREENING|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|8|FIF75|Forced Inspiratory Flow at 75%|[?]|PRONE|[?]|ugEq|[?]|1|uCi/L|LYMPH NODE|BILATERAL|APICAL|EEG||||HEALTH CARE PROFESSIONAL|CARDIOLOGIST|4|Visit_4|65|2|WASHOUT|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|9|TSUELAS|Tissue Elastance|[?]|SITTING|[?]|Ci/uL|[?]|1|JDF Unit|COLON, LEFT|UNILATERAL|DEEP|ENZYMATIC ULTRACENTRIFUGATION||||INVESTIGATOR|READER 3|5|Visit_5|90|7|TREATMENT|2021-01-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|40cb9bc3-abec-4158-bdee-becdeceba727|10|FEV1FVC|FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|IU/day|ADDUCTOR BREVIS MUSCLE|LEFT|ANTEROTEMPORAL|GC/MS|||Y|PROXY|READER|5|Visit_5|90|1|SCREENING|2021-01-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|um|[?]|1|EU|DISTAL FEMUR R1|BILATERAL|DISTAL VOLAR|OPTICAL COHERENCE TOMOGRAPHY||||FRIEND|READER|1|Visit_1|10|7|TREATMENT|2020-10-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|2|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|[?]|um/s|[?]|1|cs|TOOTH|LEFT|TEMPORAL|KNEMOMETRY||||FRIEND|READER|1|Visit_1|10|3|WASHOUT|2020-10-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|3|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|mL/min/1.73m2|[?]|1|U/m2|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|UNILATERAL|FORE|ACCELERATOR MASS SPECTROMETRY||||FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|6|TREATMENT|2020-11-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|4|RER|Respiratory Exchange Ratio|[?]|STANDING|||[?]|1|10^7 CFU/mL|SUPRAPUBIC REGION|RIGHT|ANTEROTEMPORAL|MICROBIAL BIOCHEMICAL IDENTIFICATION|||Y|FRIEND|OTOLARYNGOLOGIST|2|Visit_2|25|4|TREATMENT|2020-11-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|5|SVCPP|Percent Predicted Slow Vital Capacity|[?]|LATERAL DECUBITUS|[?]|Roentgen|[?]|1|%/min|T12 VERTEBRA|LATERAL|VENTRAL|DOPPLER ULTRASOUND||Y||CHILD|READER|3|Visit_3|40|6|TREATMENT|2020-11-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|FOWLERS|[?]|PHERESIS UNIT|[?]|1|mL/s|RETINA|LATERAL|INFERIOR|SNP ARRAY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|3|Visit_3|40|2|SCREENING|2020-11-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|DECUBITUS|[?]|ELISA unit|[?]|1|Ci/mL|INTERPHALANGEAL JOINT 3|BILATERAL|ANTEROPOSTERIOR|IN SITU HYBRIDIZATION||Y||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-12-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|8|FIF50|Forced Inspiratory Flow at 50%|[?]|LEFT LATERAL DECUBITUS|[?]|10^7/L|[?]|1|GLOBULE|INTERPHALANGEAL JOINT 3|CONTRALATERAL|BASAL|GC/MS|Y|||FRIEND|NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-12-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|9|EFFIND|Effusion Indicator|[?]|STANDING|[?]|km|[?]|1|10^6/hpf|INTERPHALANGEAL JOINT 5|UNILATERAL|ANTEROTEMPORAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||Y||PROXY|MICROSCOPIST 1|5|Visit_5|90|1|WASHOUT|2021-01-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|||[?]|1|pg/dL|GLOMERULUS|CONTRALATERAL|SURFACE|ANTIBIOTIC AGAR SCREEN|Y||Y|FAMILY MEMBER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|WASHOUT|2021-01-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|1|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|mol/mg|[?]|1|cup eq|HAND DIGIT 4|LATERAL|SUBCORTICAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y||FAMILY MEMBER|OPTOMETRIST|1|Visit_1|10|6|FOLLOW-UP|2020-09-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|2|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|kg/L|[?]|1|Tesla|DORSAL MOTOR NUCLEUS|UNILATERAL|SUPERFICIAL|SLIT LAMP PHOTOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|7|WASHOUT|2020-09-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|TRENDELENBURG|[?]|Farad|[?]|1|dyn|SECOND DIAGONAL BRANCH ARTERY|BILATERAL|DISTAL|MULTI-SLICE SPIRAL CT|Y|||GUARDIAN|NEUROLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-09-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|FOWLERS|||[?]|1|/2000 RBC|MEDIAL FEMORAL CONDYLE|IPSILATERAL|PROXIMAL|NUCLEIC ACID SEQUENCING||Y|Y|DOMESTIC PARTNER|ONCOLOGIST 1|2|Visit_2|25|5|WASHOUT|2020-09-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|5|FEV1REV|FEV1 Reversibility|[?]|SITTING|||[?]|1|vg/kg|TRICUSPID VALVE, POSTERIOR CUSP|LATERAL|ANTEROPOSTERIOR|FLOW CYTOMETRY|||Y|FRIEND|UROLOGIST|3|Visit_3|40|6|TREATMENT|2020-10-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|6|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|BAU|[?]|1|kcal|COLON|BILATERAL|CENTRAL|BAC ACGH||Y||CHILD|READER 3|3|Visit_3|40|4|SCREENING|2020-10-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|7|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|mV/sec|[?]|1|HOURS|C7 VERTEBRA|IPSILATERAL|VENTRAL|SPIRAL CT||Y||ADJUDICATION COMMITTEE|UROLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|8|ELSTNCE|Elastance|[?]|SLING|||[?]|1|10^6 organisms/g|SPLEEN, HILUM|IPSILATERAL|CENTRAL|DIGITAL PCR ARRAY|||Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|4|Visit_4|65|7|SCREENING|2020-10-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|9|RAW|Airway Resistance|[?]|SITTING|[?]|/LPF|[?]|1|TCID 50/dose|ORAL MUCOSA|CONTRALATERAL|TEMPORAL|SPIRAL CT SCAN WITHOUT CONTRAST||||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2020-11-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|616b284a-3fed-4009-bafe-7da10acd537e|10|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|g/m2/day|[?]|1|v/v|DISTAL COMMON BILE DUCT|BILATERAL|HIND|OPTICAL DENSITY MEASUREMENT||||CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|SCREENING|2020-11-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|1|MALEVDES|Malignancy Evidence Description|[?]|UNCONSTRAINED|||[?]|1|um/day|CELIAC ARTERY|RIGHT|BASAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||Y|Y|INDEPENDENT ASSESSOR|MICROSCOPIST 3|1|Visit_1|10|2|FOLLOW-UP|2020-10-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|2|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|/day|[?]|1|mL/kg|METACARPAL 1 BASE|LATERAL|SUPERIOR|CORONARY ANGIOGRAPHY||||CAREGIVER|READER 3|1|Visit_1|10|4|WASHOUT|2020-10-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|3|PEF|Peak Expiratory Flow|[?]|FOWLERS|[?]|kg/mol|[?]|1|psec|HEPATIC LYMPH NODE|CONTRALATERAL|CAUDAL|CINEANGIOGRAPHY||||PARENT|ADJUDICATOR 1|2|Visit_2|25|2|SCREENING|2020-10-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|4|VO2|Oxygen Consumption|[?]|SEMI-FOWLERS|[?]|SYRINGE|[?]|1|CARTRIDGE|SOFT PALATE|LATERAL|BASAL|LISSAMINE GREEN STAIN|Y|||SIBLING|MICROSCOPIST|2|Visit_2|25|7|TREATMENT|2020-10-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|5|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-RECUMBENT|||[?]|1|U/kg/day|RAMUS INTERMEDIUS ARTERY|LATERAL|MIDLINE|SURFACE PLASMON RESONANCE|||Y|FAMILY MEMBER|NEUROLOGIST 2|3|Visit_3|40|2|TREATMENT|2020-11-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|6|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|Ci/L|[?]|1|mL/kg/h|HUMERAL EPICONDYLE|RIGHT|DORSAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|3|Visit_3|40|7|TREATMENT|2020-11-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|7|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|[?]|EID 50/mL|[?]|1|pmol/L/h|HEART, LEFT VENTRICLE|LATERAL|LOWER EXTENSOR SURFACE|TEMPLATE INCISION METHOD||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-11-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|8|TSUHYS|Tissue Hysteresivity|[?]|FOWLERS|[?]|10^6 CFU|[?]|1|ug/kg/h|EXTENSOR DIGITORUM BREVIS MUSCLE|LEFT|OUTER|NUCLEIC ACID SEQUENCING||||FAMILY MEMBER|READER 1|4|Visit_4|65|1|WASHOUT|2020-11-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|9|FEV3PP|Percent Predicted FEV3|[?]|FOWLERS|[?]|LB|[?]|1|/sec|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|PERIPHERAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||Y||HEALTH CARE PROFESSIONAL|READER 2|5|Visit_5|90|7|FOLLOW-UP|2020-12-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|d39b53da-187f-4da6-9614-2bd301e9ad05|10|VO2|Oxygen Consumption|[?]|DECUBITUS|[?]|g/cm2|[?]|1|L/h|MEDIASTINUM, ANTERIOR|RIGHT|UPPER|LIQUID SCINTILLATION COUNTING||||CHILD|MICROSCOPIST|5|Visit_5|90|3|FOLLOW-UP|2020-12-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|PEFTIME|Peak Expiratory Flow Time|[?]|LATERAL DECUBITUS|[?]|U/g/min|[?]|1|Henry|SKIN OF THE KNEE|UNILATERAL|DISTAL VOLAR|TOTAL BODY IRRADIATION||Y||CHILD|OPTOMETRIST|1|Visit_1|10|5|WASHOUT|2020-12-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|2|TV|Tidal Volume|[?]|UNCONSTRAINED|||[?]|1|g/kg|DISTAL PHALANX 2 OF THE HAND|UNILATERAL|TIP|TRIPLE-PHASE MRI SCAN|||Y|HEALTH CARE PROFESSIONAL|RADIOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-12-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|3|AWVOL|Airway Volume|[?]|FOWLERS|[?]|uSiemens|[?]|1|POINT|LEFT ATRIOVENTRICULAR ARTERY|LATERAL|INNER|RADIATION DOSIMETRY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|2|Visit_2|25|4|WASHOUT|2020-12-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|4|FIF50|Forced Inspiratory Flow at 50%|[?]|DECUBITUS|||[?]|1|mL/s|MEDIASTINUM, ANTERIOR|RIGHT|ANTEROMEDIAL|MALDI|Y|Y|Y|FAMILY MEMBER|NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2020-12-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|5|IVC|Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|10^7/L|T5 VERTEBRA|CONTRALATERAL|ROSTRAL|FLAME PHOTOMETRY|Y|Y|Y|FRIEND|OPHTHALMOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2021-01-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|PIXEL|[?]|1|MET|OLFACTORY BULB|UNILATERAL|ANTEROMEDIAL|BIOPSY|Y|Y||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-01-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|7|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|cm2|[?]|1|mL/s|SCALP|IPSILATERAL|ANTEROTEMPORAL|LYMPHANGIOGRAPHY|Y|Y||PROXY|FORENSIC PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-01-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|8|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mg|SKIN OF THE BACK|UNILATERAL|NASAL|HILLMEN COLOR CHART|||Y|INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|mL/m2/day|[?]|1|ag|TAIL|CONTRALATERAL|UPPER FLEXOR SURFACE|CONTRAST ENHANCED X-RAY|Y|||CLINICAL STUDY SPONSOR|RATER|5|Visit_5|90|3|FOLLOW-UP|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|10|FIO2|Fraction of Inspired Oxygen|[?]|SITTING, LEGS DEPENDENT|[?]|m/sec2|[?]|1|L/L|FIBULA|LEFT|NASAL|LC/MS/MS||Y||STUDY SUBJECT|READER 1|5|Visit_5|90|1|FOLLOW-UP|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|1|EFFIND|Effusion Indicator|[?]|LATERAL DECUBITUS|[?]|PHERESIS UNIT|[?]|1|bel|FLEXOR HALLUCIS BREVIS MUSCLE|LEFT|VOLAR|IMPEDANCE CONDUCTIVITY|Y|||STUDY SUBJECT|READER 3|1|Visit_1|10|6|TREATMENT|2020-11-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|2|AWVOLPP|Percent Predicted Airway Volume|[?]|PRONE|||[?]|1|kHz|ANASTOMOSIS|IPSILATERAL|UPPER FLEXOR SURFACE|CLIP SEQUENCING|||Y|INVESTIGATOR|RADIOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-11-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|3|IC|Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|cL|SUPERFICIAL LYMPH NODE|BILATERAL|SURFACE|X-RAY|Y||Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|2|Visit_2|25|6|TREATMENT|2020-12-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|4|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|LENS|[?]|1|BU/mL|HEART, VENTRICULAR WALL|LEFT|INTERMEDIATE|NEPHELOMETRY||Y||CAREGIVER|RATER|2|Visit_2|25|2|TREATMENT|2020-12-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|5|FIF50|Forced Inspiratory Flow at 50%|[?]|DECUBITUS|[?]|mL/h|[?]|1|pmol|ASCENDING AORTA, SINUS OF VALSALVA|LATERAL|APICAL|MAGNETIC RESONANCE ENTEROGRAPHY||||CHILD|FORENSIC PATHOLOGIST|3|Visit_3|40|3|WASHOUT|2020-12-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SLING|[?]|mL/m2/h|[?]|1|DRUM|FEMORAL NECK|BILATERAL|SUPERFICIAL|PHASE CONTRAST MICROSCOPY||||STUDY SUBJECT|ONCOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-12-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|7|FEF50|Forced Expiratory Flow 50%|[?]|REVERSE TRENDELENBURG|[?]|MBP|[?]|1|mL/min|TRIANGULAR BONE|CONTRALATERAL|LOWER FLEXOR SURFACE|DUKE INCISION METHOD|Y|Y||SIGNIFICANT OTHER|NEUROLOGIST|4|Visit_4|65|1|SCREENING|2021-01-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|8|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|ug/dose|[?]|1|mEq/g|EPITROCHLEAR LYMPH NODE|CONTRALATERAL|DORSOLATERAL|INTRAVASCULAR ULTRASOUND||||CHILD|PATHOLOGIST 1|4|Visit_4|65|1|FOLLOW-UP|2021-01-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|TRENDELENBURG|[?]|STEPS|[?]|1|scm|FIRST RIGHT POSTEROLATERAL ARTERY|LEFT|FRONTAL|PULSE OXIMETRY|Y|||ADJUDICATOR|RADIOLOGIST 1|5|Visit_5|90|6|WASHOUT|2021-02-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|e51cf168-af89-44d9-9e56-14785071f6b0|10|PLMBLFLW|Pulmonary Blood Flow|[?]|LATERAL DECUBITUS|[?]|KIT|[?]|1|U/kg|POSTERIOR CERVICAL LYMPH NODE|LATERAL|LATERAL|DXA SCAN|Y|||CLINICAL RESEARCH ASSOCIATE|READER 3|5|Visit_5|90|7|FOLLOW-UP|2021-02-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|SRAW|Specific Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|mMU/mL|[?]|1|mm3/mm2/year|ANTERIOR TIBIAL ARTERY|UNILATERAL|CENTRAL|CT SCAN WITHOUT CONTRAST||||HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|5|FOLLOW-UP|2020-06-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|2|FEF50|Forced Expiratory Flow 50%|[?]|LATERAL DECUBITUS|[?]|mV|[?]|1|ukat/10^12 RBC|AXILLARY LYMPH NODE|BILATERAL|HIND|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y||ADJUDICATOR|MICROSCOPIST 1|1|Visit_1|10|7|TREATMENT|2020-06-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|3|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|10^7 CFU/mL|[?]|1|10^6 CFU|KIDNEY, UPPER LOBE|BILATERAL|PARIETO-OCCIPITAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y||DOMESTIC PARTNER|READER 1|2|Visit_2|25|1|FOLLOW-UP|2020-06-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|4|PEFTIME|Peak Expiratory Flow Time|[?]|FOWLERS|[?]|dL|[?]|1|P|FRONTAL SINUS|LEFT|INFERIOR|OSCILLOMETRY||||INDEPENDENT ASSESSOR|NEUROLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-06-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|5|FEV1SVC|FEV1/SVC|[?]|UNCONSTRAINED|[?]|kBq/uL|[?]|1|ukat/L|URETHRA, PROSTATIC|UNILATERAL|LOWER EXTENSOR SURFACE|CLINICAL EVALUATION||||ADJUDICATION COMMITTEE|OPTOMETRIST|3|Visit_3|40|2|TREATMENT|2020-07-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|6|TVPP|Percent Predicted Tidal Volume|[?]|FOWLERS|[?]|PFU|[?]|1|10^3 copies/mL|RAPHE|BILATERAL|PERIPHERAL|GIEMSA STAIN||||INTERVIEWER|RATER 1|3|Visit_3|40|3|SCREENING|2020-07-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|7|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|||[?]|1|ug/m2/h|TIBIOTARSAL JOINT|RIGHT|DISTAL VOLAR|MACRO BROTH DILUTION|||Y|SPOUSE|OTOLARYNGOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-08-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|8|FRCPP|Percent Predicted FRC|[?]|SITTING|[?]|mmHg/sec|[?]|1|PFU|GASTROINTESTINAL TRACT, LOWER, WALL|CONTRALATERAL|APICAL|NEXT GENERATION SEQUENCING||Y||CLINICAL STUDY SPONSOR|INTERNIST|4|Visit_4|65|5|TREATMENT|2020-08-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|9|FEV1PP|Percent Predicted FEV1|[?]|SEMI-RECUMBENT|[?]|cmol|[?]|1|DAgU|PULMONARY ARTERY BRANCH|UNILATERAL|LOWER|SNP ARRAY|Y|||SIGNIFICANT OTHER|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-09-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|8416f8c6-d0e4-43fc-9a66-6a916e853e87|10|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING|||[?]|1|BAR|SKIN OF THE PALM|UNILATERAL|PERIPHERAL|RYAN BLUE STAIN|||Y|NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-09-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|1|FEV1REV|FEV1 Reversibility|[?]|SLING|[?]|mm3/mm2/year|[?]|1|IU/dL|RENAL PELVIS|LATERAL|VOLAR|NON-CONTACT SPECULAR MICROSCOPY|Y|||CLINICAL RESEARCH ASSOCIATE|RATER|1|Visit_1|10|7|FOLLOW-UP|2020-10-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|2|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-FOWLERS|||[?]|1|cd|HAIR FOLLICLE|RIGHT|PROXIMAL VOLAR|REFLECTANCE SPECTROSCOPY||Y|Y|GUARDIAN|READER 3|1|Visit_1|10|3|TREATMENT|2020-10-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|3|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|[?]|SCOOPFUL|[?]|1|umol/min|PROXIMAL INTERPHALANGEAL JOINT 4|IPSILATERAL|DISTAL|PET SCAN||||HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|4|SGAW|Specific Airway Conductance|[?]|SEMI-FOWLERS|[?]|pt_us|[?]|1|Newton|MID-LAD ARTERY|CONTRALATERAL|BASAL|AUTOREFRACTION|Y|Y||INDEPENDENT ASSESSOR|RATER 1|2|Visit_2|25|2|SCREENING|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|5|EFFVOL|Effusion Volume|[?]|LEFT LATERAL DECUBITUS|[?]|dmol|[?]|1|WEEKS|GREAT TROCHANTER|UNILATERAL|ANTEROTEMPORAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|Y||STUDY SUBJECT|PATHOLOGIST 2|3|Visit_3|40|7|TREATMENT|2020-11-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|6|PIF|Peak Inspiratory Flow|[?]|UNCONSTRAINED|[?]|dL|[?]|1|L/min/m2|PANCREAS, ENDOCRINE|LEFT|VOLAR|NUCLEIC ACID AMPLIFICATION TEST||||ADJUDICATION COMMITTEE|NEUROLOGIST 1|3|Visit_3|40|4|SCREENING|2020-11-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|7|SVC|Slow Vital Capacity|[?]|LATERAL DECUBITUS|||[?]|1|m|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|UNILATERAL|UPPER|CAPILLARY ELECTROPHORESIS||Y|Y|CLINICAL RESEARCH ASSOCIATE|READER|4|Visit_4|65|2|FOLLOW-UP|2020-12-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING|||[?]|1|10^9 CFU|INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|CENTRAL|RAJI CELL RIA|||Y|INVESTIGATOR|OTOLARYNGOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-12-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|9|MIP|Maximal Inspiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|U/dL|[?]|1|log10 TCID 50/dose|FUNDUS OF THE STOMACH|RIGHT|DORSAL|NUCLEIC ACID AMPLIFICATION TEST||Y||NON-HEALTH CARE PROFESSIONAL|RATER 1|5|Visit_5|90|1|WASHOUT|2021-01-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|a110e924-90a1-4e84-b47a-410f800fa201|10|QUASCOMP|Quasi-Static Compliance|[?]|UNCONSTRAINED|||[?]|1|VIRTUAL PIXEL|ILEUM|UNILATERAL|LOWER EXTENSOR SURFACE|RYAN BLUE STAIN|||Y|INVESTIGATOR|RADIOLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-01-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|QUASCOMP|Quasi-Static Compliance|[?]|REVERSE TRENDELENBURG|[?]|nU/cL|[?]|1|POUCH|CHEEK|CONTRALATERAL|ROSTRAL|APPLANATION TONOMETRY||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-08-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|2|FEV_PEF|FEV at PEF|[?]|FOWLERS|[?]|fL|[?]|1|CUP|PANCREAS, HEAD|CONTRALATERAL|MEDIAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||DOMESTIC PARTNER|PATHOLOGIST 1|1|Visit_1|10|6|WASHOUT|2020-08-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|3|ICPP|Percent Predicted Inspiratory Capacity|[?]|TRENDELENBURG|||[?]|1|cGy|THORAX|BILATERAL|FACIAL|LYMPHANGIOGRAPHY|||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|2|Visit_2|25|1|TREATMENT|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|4|QUASCOMP|Quasi-Static Compliance|[?]|PRONE|||[?]|1|hPa|GLOTTIS|LEFT|ANTEROMEDIAL|CYSTOSCOPY||Y|Y|INVESTIGATOR|PATHOLOGIST 2|2|Visit_2|25|1|FOLLOW-UP|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|5|INFLTIND|Infiltrates Indicator|[?]|TRENDELENBURG|[?]|V/sec|[?]|1|BE/mL|CANINE TOOTH|UNILATERAL|UPPER FLEXOR SURFACE|KINYOUN STAIN||||STUDY SUBJECT|MICROSCOPIST 3|3|Visit_3|40|3|TREATMENT|2020-09-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|6|RELSZCHG|Relative Size Change|[?]|LEFT LATERAL DECUBITUS|[?]|L/min|[?]|1|EIA unit|INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|MEDIAL|ELISPOT||Y||ADJUDICATION COMMITTEE|RATER|3|Visit_3|40|3|WASHOUT|2020-09-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|LEFT LATERAL DECUBITUS|[?]|mmHg/L/min|[?]|1|mL/min|CAUDATE NUCLEUS|UNILATERAL|UPPER FLEXOR SURFACE|MICROSCOPY|Y|||STUDY SUBJECT|ADJUDICATOR 2|4|Visit_4|65|3|TREATMENT|2020-10-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|8|IVCPP|Percent Predicted IVC|[?]|TRENDELENBURG|||[?]|1|L/min/m2|REGIONAL LYMPH NODE|LEFT|INFERIOR|X-RAY FLUORESCENCE SPECTROMETRY|||Y|CAREGIVER|CARDIOLOGIST|4|Visit_4|65|4|WASHOUT|2020-10-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|9|TVPP|Percent Predicted Tidal Volume|[?]|SUPINE|||[?]|1|kN/cm2|FOOT DIGIT 3|LATERAL|ANTEROMEDIAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|Y|Y|SIGNIFICANT OTHER|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|40681cb8-5d49-4e1d-b893-f5fad62a0885|10|PEF|Peak Expiratory Flow|[?]|SITTING|||[?]|1|mL/m2/day|CAPITATE-LUNATE JOINT|LATERAL|VENTROLATERAL|FISH|||Y|CHILD|RADIOLOGIST 2|5|Visit_5|90|4|WASHOUT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|IVCPP|Percent Predicted IVC|[?]|SEMI-RECUMBENT|[?]|cP|[?]|1|/day|TESTIS|LATERAL|INFERIOR|TWO-COLOR MICROARRAY||||INVESTIGATOR|CARDIOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|2|IVC|Inspiratory Vital Capacity|[?]|SUPINE|[?]|mmol/kg|[?]|1|mL/cage/wk|LIP, UPPER|BILATERAL|ANTEROLATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|Y||CLINICAL STUDY SPONSOR|READER|1|Visit_1|10|7|WASHOUT|2020-12-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING|[?]|gMFI|[?]|1|um2|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LEFT|DORSOLATERAL|PHOTOMETRY||Y||GUARDIAN|OTOLARYNGOLOGIST|2|Visit_2|25|7|TREATMENT|2021-01-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|4|MEP|Maximal Expiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|mol|[?]|1|mg/m2/h|COLON, LEFT|CONTRALATERAL|LOWER EXTENSOR SURFACE|DYNAMOMETRY||Y||CLINICAL RESEARCH ASSOCIATE|UROLOGIST|2|Visit_2|25|4|WASHOUT|2021-01-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|5|SRAW|Specific Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|tsp|[?]|1|mL/dose|UMBILICUS|BILATERAL|VOLAR|SPECTROPHOTOMETRY||||SIBLING|ADJUDICATOR 3|3|Visit_3|40|6|SCREENING|2021-01-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|%/s|[?]|1|U/g/day|LIMB, UPPER|LEFT|INTERMEDIATE|BIOPSY|Y|Y||INVESTIGATOR|READER 1|3|Visit_3|40|2|SCREENING|2021-01-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|7|FEV1REV|FEV1 Reversibility|[?]|PRONE|||[?]|1|mL/day|THIRD RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|ANTERIOR|CLIP SEQUENCING|Y||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 2|4|Visit_4|65|6|TREATMENT|2021-02-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|8|FVC|Forced Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|ug/kg/day|[?]|1|kg/mol|METACARPAL 1 BASE|CONTRALATERAL|MEDIAL|MAGNETIC RESONANCE ENTEROGRAPHY|Y|||PARENT|OTOLARYNGOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2021-02-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|9|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/mL/min|[?]|1|log10 copies/mL|THORACIC ARTERY|LATERAL|SUPERFICIAL|AUSCULTATION||Y||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|1|WASHOUT|2021-03-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|REVERSE TRENDELENBURG|[?]|mmol/min/kPa/L|[?]|1|titer|THORACIC ARTERY|LATERAL|MEDIAL|MICROBIAL CULTURE, LIQUID||Y||INDEPENDENT ASSESSOR|READER 3|5|Visit_5|90|5|TREATMENT|2021-03-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SLING|||[?]|1|IU/kg|FEMORO-POPLITEAL PERIPHERAL ARTERY|UNILATERAL|UPPER FLEXOR SURFACE|MICRO BROTH DILUTION|||Y|CHILD|OPTOMETRIST|1|Visit_1|10|7|TREATMENT|2020-09-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|nmol|[?]|1|mPa|FLEXOR POLLICIS LONGUS MUSCLE|RIGHT|PERIVENTRICULAR|SISH||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|1|Visit_1|10|3|SCREENING|2020-09-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|3|SRAW|Specific Airway Resistance|[?]|DECUBITUS|[?]|mL/cm|[?]|1|umol/kg/min|TRAPEZIUM-TRAPEZOID JOINT|LATERAL|POSTERIOR|LASER CAPTURE MICRODISSECTION||||ADJUDICATION COMMITTEE|MICROSCOPIST|2|Visit_2|25|4|WASHOUT|2020-09-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|4|TLC|Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|DISK|[?]|1|mEq/g|CEPHALIC VEIN|LEFT|FRONTAL|MS/MS|Y|Y||PROXY|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-09-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|5|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SLING|[?]|foz_us|[?]|1|ug/m2/h|BRAIN, PERIVENTRICULAR REGION|UNILATERAL|INFERIOR|BRDU CELLULAR PROLIFERATION ASSAY||Y||ADJUDICATOR|RADIOLOGIST 2|3|Visit_3|40|6|FOLLOW-UP|2020-10-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|6|MIP|Maximal Inspiratory Pressure|[?]|SUPINE|||[?]|1|/HPF|THALAMUS|UNILATERAL|LOWER|LIGHT MICROSCOPY|Y||Y|NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|LEFT LATERAL DECUBITUS|||[?]|1|m2|METATARSOPHALANGEAL JOINT|CONTRALATERAL|SUPERIOR|APPLANATION TONOMETRY|Y||Y|SIBLING|RADIOLOGIST 2|4|Visit_4|65|6|WASHOUT|2020-11-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|8|RELSZCHG|Relative Size Change|[?]|DECUBITUS|||[?]|1|dB|HIPPOCAMPUS|LATERAL|PARIETO-OCCIPITAL|FARR ASSAY|||Y|SIBLING|MICROSCOPIST 2|4|Visit_4|65|5|WASHOUT|2020-11-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|PIPE|[?]|1|/sec|METATARSAL BONE|LEFT|OUTER|ENZYMATIC COLORIMETRY||Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|5|Visit_5|90|3|WASHOUT|2020-11-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|96e65c5c-723c-42d9-8e88-0bcb600e9f88|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SLING|[?]|CYLINDER|[?]|1|pkat/L|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|DISTAL VOLAR|ORCHIDOMETERY||||SIGNIFICANT OTHER|RATER 1|5|Visit_5|90|7|FOLLOW-UP|2020-11-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SLING|[?]|sec|[?]|1|mL/sec/1.73m2|PULMONARY VALVE, ANTERIOR CUSP|LEFT|PERIPHERAL|CALCOFLUOR WHITE STAIN||||CHILD|ADJUDICATOR 3|1|Visit_1|10|4|FOLLOW-UP|2020-07-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|2|ICPP|Percent Predicted Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/sec/1.73m2|[?]|1|ug/L FEU|CAPITATE-HAMATE JOINT|LATERAL|LATERAL|TRIPLE-PHASE SPIRAL CT SCAN||||DOMESTIC PARTNER|READER 1|1|Visit_1|10|6|TREATMENT|2020-07-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|||[?]|1|mg/kg/dose|ESOPHAGUS, LOWER THIRD|LEFT|ANTEROPOSTERIOR|CONTRAST ENHANCED PET SCAN|||Y|GUARDIAN|MICROSCOPIST|2|Visit_2|25|4|FOLLOW-UP|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING|[?]|/kg|[?]|1|mg/kg|NUCHAL LYMPH NODE|CONTRALATERAL|VENTROLATERAL|ELISPOT||||VENDOR|READER 2|2|Visit_2|25|3|WASHOUT|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|FFU|[?]|1|GPL U|INTERATRIAL SEPTUM|CONTRALATERAL|DISTAL|FLUORESCENT ENZYME IMMUNOASSAY|Y|Y||PARENT|PHYSIOTHERAPIST|3|Visit_3|40|1|FOLLOW-UP|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|6|FEV1FVC|FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ELISA unit/mL|FEMORAL CONDYLE|LATERAL|PROXIMAL VOLAR|STATIC PERIMETRY|||Y|SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|7|FOLLOW-UP|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|7|SVC|Slow Vital Capacity|[?]|TRENDELENBURG|[?]|g/m2|[?]|1|K|PROXIMAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|LOWER|HEMOCYTOMETRY|Y|||SIGNIFICANT OTHER|MICROSCOPIST 3|4|Visit_4|65|3|FOLLOW-UP|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|8|PIF|Peak Inspiratory Flow|[?]|SITTING|[?]|JAR|[?]|1|cm2|TROCHLEAR NERVE|CONTRALATERAL|LOWER EXTENSOR SURFACE|MULTI-SLICE SPIRAL CT||||FRIEND|OPTOMETRIST|4|Visit_4|65|6|SCREENING|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|SLING|[?]|deg2|[?]|1|deg|FRONTAL LOBE|UNILATERAL|ANTEROMEDIAL|TONOMETRY||||VENDOR|ONCOLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|10|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|g/g|[?]|1|/10^4|EYE, VITREOUS CHAMBER|RIGHT|LOWER EXTENSOR SURFACE|PERIODIC ACID SCHIFF STAIN||Y||INVESTIGATOR|NEUROLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-09-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|[?]|Mile|[?]|1|mgEq|SKIN OF THE TRUNK|RIGHT|LOWER|FUNCTIONAL MRI||||INVESTIGATOR|UROLOGIST|1|Visit_1|10|6|WASHOUT|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|2|FEV3PP|Percent Predicted FEV3|[?]|SEMI-RECUMBENT|[?]|CIGAR|[?]|1|mL/beat|COLON WALL|IPSILATERAL|LOWER FLEXOR SURFACE|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||PROXY|PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|3|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|nL|[?]|1|ECL unit|LEFT VENTRICULAR APICAL LATERAL SEGMENT|CONTRALATERAL|DISTAL VOLAR|ANTIMICROBIAL COMBINATION TESTING||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|5|TREATMENT|2020-06-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|4|TSUHYS|Tissue Hysteresivity|[?]|LATERAL DECUBITUS|[?]|MESF|[?]|1|10^4/L|LIGAMENT|BILATERAL|PERIPHERAL|IMMUNOCHROMATOGRAPHY||||SIBLING|MICROSCOPIST 2|2|Visit_2|25|2|TREATMENT|2020-06-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|5|PNEUMIND|Pneumonia Indicator|[?]|SEMI-RECUMBENT|[?]|IU/mL|[?]|1|kat|KIDNEY, UPPER LOBE|LEFT|PROXIMAL VOLAR|MRS||||SIBLING|CARDIOLOGIST|3|Visit_3|40|4|SCREENING|2020-06-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|/200 HPFs|[?]|1|10^6 copies/mL|MEDIAN BASILIC VEIN|LEFT|TEMPORAL|NUCLEIC ACID HYBRIDIZATION|Y|||HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|3|Visit_3|40|5|FOLLOW-UP|2020-06-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|ug/g/min|[?]|1|%(w/w)|MIDDLE EAR|IPSILATERAL|POSTERIOR|HEMAGGLUTINATION ASSAY||Y||CAREGIVER|ONCOLOGIST 1|4|Visit_4|65|2|WASHOUT|2020-07-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|8|FEV1|Forced Expiratory Volume in 1 Second|[?]|FOWLERS|||[?]|1|10^6/hpf|RADIUS SHAFT|LEFT|LOWER EXTENSOR SURFACE|RULER MEASUREMENT METHOD|||Y|CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|4|Visit_4|65|2|TREATMENT|2020-07-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-27
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|9|AIRTRAP|Air Trapping|[?]|SLING|[?]|mL/g/min|[?]|1|MPS U|TRICEPS BRACHII MUSCLE|CONTRALATERAL|SUBCORTICAL|ENDOSCOPY||||STUDY SUBJECT|ADJUDICATOR 3|5|Visit_5|90|5|TREATMENT|2020-08-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|RE|f81742a2-5250-43d7-a6e2-8fcb1625a114|10|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING|||[?]|1|mL/100g/min|PARIETAL LOBE|RIGHT|DORSAL|ENZYMATIC SPECTROPHOTOMETRY|||Y|CLINICAL RESEARCH COORDINATOR|UROLOGIST|5|Visit_5|90|5|WASHOUT|2020-08-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|UNCONSTRAINED|[?]|nmol BCE/nmol|[?]|1|/ms|UMBILICUS|BILATERAL|MIDLINE|CLIP|Y|Y||HEALTH CARE PROFESSIONAL|NEUROLOGIST|1|Visit_1|10|4|SCREENING|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|2|ERVPP|Percent Predicted ERV|[?]|SUPINE|||[?]|1|mg/mL/day|TRACHEA|CONTRALATERAL|PARIETO-OCCIPITAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y|Y|SPOUSE|READER|1|Visit_1|10|7|TREATMENT|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|V|[?]|1|CAPFUL|FRONTAL SINUS|LEFT|PROXIMAL|ELECTROMYOGRAPHY||Y||VENDOR|NEUROLOGIST 2|2|Visit_2|25|7|SCREENING|2020-07-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING|[?]|hPa|[?]|1|CFU/mL|WRIST JOINT|RIGHT|CRANIAL|DYNAMIC CONTRAST ENHANCED MRI||Y||PROXY|MICROSCOPIST 2|2|Visit_2|25|1|FOLLOW-UP|2020-07-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|5|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Siemens|SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|PROXIMAL VOLAR|TRANSMISSION ELECTRON MICROSCOPY||Y|Y|HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|7|TREATMENT|2020-07-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|||[?]|1|mg/kg|BRAIN VENTRICLE, LATERAL|UNILATERAL|TIP|KLEIHAUER-BETKE||Y|Y|INTERVIEWER|CARDIOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-07-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|7|FEV1SVC|FEV1/SVC|[?]|SITTING, LEGS DEPENDENT|[?]|STRIP|[?]|1|Siemens|CORNEAL ENDOTHELIUM|BILATERAL|ANTEROMEDIAL|DIGITAL PCR||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|4|Visit_4|65|2|WASHOUT|2020-08-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|8|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|[?]|mol/mL|[?]|1|uIU/dL|FOOT DIGIT 1|CONTRALATERAL|PROXIMAL|CONTRAST ENHANCED CT SCAN|Y|Y||FRIEND|ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2020-08-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|9|INERTANC|Inertance|[?]|SITTING, LEGS DEPENDENT|[?]|/VF|[?]|1|Hz/s|SPLENIC HILAR LYMPH NODE|RIGHT|INNER|CELLULOSE TAPE|Y|||INVESTIGATOR|NEUROLOGIST 2|5|Visit_5|90|3|WASHOUT|2020-09-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|c6bad1d0-3514-4f98-b229-d093a94dfbc4|10|FEV3FVC|FEV3/FVC|[?]|SUPINE|[?]|v/v|[?]|1|PACKAGE|FALCIFORM LIGAMENT|IPSILATERAL|ANTEROTEMPORAL|ICC||||FRIEND|READER 2|5|Visit_5|90|3|WASHOUT|2020-09-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|1|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mm/2h|[?]|1|/10^5|DIAPHRAGM|LEFT|APICAL|PERFUSION MRI||Y||FRIEND|ADJUDICATOR 2|1|Visit_1|10|3|TREATMENT|2020-06-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|2|ICPP|Percent Predicted Inspiratory Capacity|[?]|DECUBITUS|[?]|dram|[?]|1|10^12 IU/L|PERONEAL ARTERY|LEFT|ANTEROTEMPORAL|RAJI CELL EIA||||CHILD|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-06-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|3|ICREV|IC Reversibility|[?]|STANDING|[?]|dpm/0.5 mL|[?]|1|mL/min/1.73m2|URETER|UNILATERAL|DEEP|AUTOMATED COUNT||||INVESTIGATOR|RADIOLOGIST 1|2|Visit_2|25|7|SCREENING|2020-07-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|4|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|||[?]|1|s*kPa|ULNA SHAFT|RIGHT|SUPERIOR|REFLECTANCE SPECTROSCOPY|||Y|CHILD|RATER 2|2|Visit_2|25|5|WASHOUT|2020-07-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|5|PCF|Peak Cough Flow|[?]|SLING|[?]|ug/g/min|[?]|1|log EID 50/dose|FASCIA|LATERAL|VENTRAL|SPIROMETRY||||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|6|IC|Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|/LPF|[?]|1|L/h/m2|ANKLE JOINT|RIGHT|ANTEROLATERAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|||PARENT|READER 2|3|Visit_3|40|7|TREATMENT|2020-07-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|7|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|PRONE|||[?]|1|U/g|BLADDER|IPSILATERAL|ROSTRAL|IMMUNOCHROMATOGRAPHY||Y|Y|SPOUSE|FORENSIC PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|8|INTP|Interpretation|[?]|LEFT LATERAL DECUBITUS|[?]|DROP|[?]|1|mg/mL/day|SCAPHOID BONE|BILATERAL|INFERIOR|ISHIHARA COLOR PLATES|Y|Y||STUDY SUBJECT|RADIOLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|DECUBITUS|[?]|dpm/mg|[?]|1|umol/kg/min|VOMER|CONTRALATERAL|SUPERFICIAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||||ADJUDICATOR|UROLOGIST|5|Visit_5|90|5|TREATMENT|2020-09-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|RE|84d68bcc-dc7a-4366-9630-40ce8885351d|10|PLMXRS|Pulmonary Reactance|[?]|SITTING, LEGS DEPENDENT|[?]|rpm|[?]|1|g/L|EPICONDYLE|LATERAL|FORE|MRS||Y||INVESTIGATOR|READER 3|5|Visit_5|90|3|TREATMENT|2020-09-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|||[?]|1|PFU/dose|SCAPHOID-RADIUS JOINT|CONTRALATERAL|VENTROLATERAL|GEL ELECTROPHORESIS||Y|Y|GUARDIAN|CLINICAL PATHOLOGIST|1|Visit_1|10|6|SCREENING|2021-01-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|2|DLCOHC|HGB Corrected DLCO|[?]|PRONE|[?]|ng/day|[?]|1|K|OPTIC NERVE|BILATERAL|MEDIAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||PARENT|ADJUDICATOR 3|1|Visit_1|10|7|WASHOUT|2021-01-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|3|IVCPP|Percent Predicted IVC|[?]|SUPINE|||[?]|1|kcal/day|SKULL|BILATERAL|OUTER|FLUORESCEIN STAIN|||Y|ADJUDICATION COMMITTEE|READER|2|Visit_2|25|3|SCREENING|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|4|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|Hounsfield Unit|[?]|1|umol/dL|MOTOR CORTEX|CONTRALATERAL|SURFACE|MICRODENSITOMETRY|Y|||CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|2|Visit_2|25|1|WASHOUT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|UNCONSTRAINED|[?]|pm|[?]|1|U/L|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|VENTROLATERAL|FLOCCULATION, CHARCOAL ENHANCED|Y|||SIGNIFICANT OTHER|READER|3|Visit_3|40|7|TREATMENT|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|6|PEFREV|PEF Reversibility|[?]|REVERSE TRENDELENBURG|[?]|pg/dL|[?]|1|mPa|HINDLIMB|UNILATERAL|VENTRAL|MAPH||||INTERVIEWER|MICROSCOPIST 1|3|Visit_3|40|5|FOLLOW-UP|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|7|VO2|Oxygen Consumption|[?]|SITTING, LEGS DEPENDENT|[?]|mEq/ug|[?]|1|mL/cage|LOWER GASTROINTESTINAL TRACT LYMPH NODE|LEFT|UPPER EXTENSOR SURFACE|THERMAL IONIZATION MASS SPECTROMETRY||Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|8|FEV6PP|Percent Predicted FEV6|[?]|DECUBITUS|||[?]|1|nmol/day|BRACHIORADIALIS MUSCLE|UNILATERAL|TEMPORAL|JAEGER EYE CHART||Y|Y|CAREGIVER|PHYSIOTHERAPIST|4|Visit_4|65|3|FOLLOW-UP|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|9|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|log10 CFU/mL|[?]|1|mU/L|PANCREAS, ENDOCRINE|LEFT|LOWER EXTENSOR SURFACE|PHOTOMETRIC CLOT DETECTION||||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|5|Visit_5|90|6|WASHOUT|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|517f3930-5202-4e0a-b3e1-85ed4bd7e117|10|MALIND|Malignancy Indicator|[?]|LEFT LATERAL DECUBITUS|||[?]|1|SUPPOSITORY|T7 VERTEBRA|UNILATERAL|DORSOLATERAL|MICROSCOPY|||Y|INVESTIGATOR|MICROSCOPIST|5|Visit_5|90|2|WASHOUT|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|ALVVOL|Alveolar Volume|[?]|STANDING|[?]|/LSQN|[?]|1|m3|HEART, RIGHT VENTRICULAR FREE WALL|IPSILATERAL|ANTEROLATERAL|NEXT GENERATION SEQUENCING||||SIGNIFICANT OTHER|PHYSIOTHERAPIST|1|Visit_1|10|7|WASHOUT|2020-12-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|TRENDELENBURG|[?]|log10 TCID 50/uL|[?]|1|CUP|AORTOCAVAL LYMPH NODE|IPSILATERAL|BASAL|ACCELERATOR MASS SPECTROMETRY||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2020-12-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|3|FIF25|Forced Inspiratory Flow at 25%|[?]|SEMI-FOWLERS|||[?]|1|deg2|DISTAL COMMON BILE DUCT|UNILATERAL|FACIAL|ATOMIC ABSORPTION SPECTROMETRY||Y|Y|HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|1|SCREENING|2021-01-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|TRENDELENBURG|[?]|BOWL|[?]|1|mL/(min*100mL)|METACARPAL BONE 3|LATERAL|ANTERIOR|HPLC|Y|||SPOUSE|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2021-01-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|5|ICREV|IC Reversibility|[?]|SITTING, LEGS DEPENDENT|||[?]|1|100 IU/mL|CEREBRAL HEMISPHERE, LEFT|IPSILATERAL|ANTERIOR|DISK DIFFUSION|Y||Y|FAMILY MEMBER|ADJUDICATOR 2|3|Visit_3|40|3|FOLLOW-UP|2021-01-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|6|ERVPP|Percent Predicted ERV|[?]|UNCONSTRAINED|[?]|10^7/L|[?]|1|MAC50|HIP|IPSILATERAL|FORE|MAGNETIC RESONANCE ELASTOGRAPHY||||STUDY SUBJECT|PATHOLOGIST 1|3|Visit_3|40|2|TREATMENT|2021-01-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|7|SGAW|Specific Airway Conductance|[?]|SEMI-FOWLERS|[?]|10^4/hpf|[?]|1|GBq/ug|PULMONARY VALVE, ANTERIOR CUSP|IPSILATERAL|ANTEROLATERAL|OSCILLOMETRY|Y|||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|4|Visit_4|65|7|WASHOUT|2021-02-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|8|RELSZCHG|Relative Size Change|[?]|LATERAL DECUBITUS|[?]|dL|[?]|1|IU|RADIAL ARTERY|IPSILATERAL|PERIPHERAL|ORCHIDOMETERY||||SPOUSE|RADIOLOGIST 1|4|Visit_4|65|7|WASHOUT|2021-02-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|9|LOBVOL|Lobar Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|/10^4|CHEST WALL|RIGHT|DEEP|APPLANATION TONOMETRY|Y|Y|Y|ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|TREATMENT|2021-03-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|edd73650-27bb-474f-bab7-d2c3d57b2dc4|10|IC|Inspiratory Capacity|[?]|LATERAL DECUBITUS|[?]|v/v|[?]|1|10^3 DNA copies/mL|CEREBRAL SUBCORTEX|BILATERAL|INTERMEDIATE|TOTAL BODY IRRADIATION|Y|||ADJUDICATION COMMITTEE|RATER 2|5|Visit_5|90|3|TREATMENT|2021-03-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|98737dfa-0058-4420-a515-38526f01f90d|1|IC|Inspiratory Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|psec|VENOUS SINUS|BILATERAL|NASAL|LC/MS/MS||Y|Y|GUARDIAN|PHYSIOTHERAPIST|1|Visit_1|10|1|TREATMENT|2020-09-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|98737dfa-0058-4420-a515-38526f01f90d|2|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING|[?]|GPS U|[?]|1|EU|ANKLE MORTISE|CONTRALATERAL|ANTEROMEDIAL|LIGHT SCATTERING SPECTROSCOPY|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|1|Visit_1|10|2|TREATMENT|2020-09-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|98737dfa-0058-4420-a515-38526f01f90d|3|FEV3PP|Percent Predicted FEV3|[?]|TRENDELENBURG|||[?]|1|g/cm2|EXTERNAL ILIAC ARTERY|LATERAL|LOWER|MANUAL COUNT|Y||Y|SIBLING|READER|2|Visit_2|25|4|SCREENING|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|98737dfa-0058-4420-a515-38526f01f90d|4|FVC|Forced Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|P|LUMBAR REGION|BILATERAL|DISTAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||Y|Y|CLINICAL STUDY SPONSOR|RATER|2|Visit_2|25|4|TREATMENT|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|98737dfa-0058-4420-a515-38526f01f90d|5|EFFIND|Effusion Indicator|[?]|FOWLERS|||[?]|1|g/animal/wk|CALCANEUS|CONTRALATERAL|UPPER|INFRARED SPECTROMETRY|||Y|NON-HEALTH CARE PROFESSIONAL|INTERNIST|3|Visit_3|40|6|TREATMENT|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|98737dfa-0058-4420-a515-38526f01f90d|6|PNIF|Peak Nasal Inspiratory Flow|[?]|UNCONSTRAINED|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|CCID 50/mL|FEMORAL VEIN|UNILATERAL|SUPERIOR|ICC||||SPOUSE|NEUROLOGIST 1|3|Visit_3|40|7|TREATMENT|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|98737dfa-0058-4420-a515-38526f01f90d|7|FIVC|Forced Inspiratory Vital Capacity|[?]|FOWLERS|[?]|nmol BCE/nmol|[?]|1|mmol/kg|T5 VERTEBRA|CONTRALATERAL|PERIVENTRICULAR|SNELLEN EYE CHART||||SPOUSE|MICROSCOPIST 3|4|Visit_4|65|4|SCREENING|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|98737dfa-0058-4420-a515-38526f01f90d|8|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|Gravitational Unit|[?]|1|Gauss|HAIR|IPSILATERAL|INFERIOR|OSCILLOMETRY||Y||PROXY|NEUROLOGIST|4|Visit_4|65|6|WASHOUT|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|98737dfa-0058-4420-a515-38526f01f90d|9|FEV1SVC|FEV1/SVC|[?]|FOWLERS|[?]|U/g|[?]|1|in2|DISTAL INTERPHALANGEAL JOINT 2|UNILATERAL|FRONTAL|CYSTOMETRY||||HEALTH CARE PROFESSIONAL|READER|5|Visit_5|90|1|WASHOUT|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|98737dfa-0058-4420-a515-38526f01f90d|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING|[?]|/100 HPFs|[?]|1|KIT|URETHRA|IPSILATERAL|CENTRAL|RAJI CELL EIA||||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|5|Visit_5|90|7|SCREENING|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|MEP|Maximal Expiratory Pressure|[?]|TRENDELENBURG|[?]|/mm|[?]|1|ug/kg/day|PREPUTIAL GLAND|LEFT|SUPERFICIAL|TRANSMISSION ELECTRON MICROSCOPY||||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|2|GAW|Airway Conductance|[?]|SEMI-RECUMBENT|[?]|BAR|[?]|1|pkat|SKIN BETWEEN EYEBROWS|CONTRALATERAL|NASAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y||ADJUDICATION COMMITTEE|RADIOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|3|RV|Residual Volume|[?]|DECUBITUS|||[?]|1|PACK|OVARIAN FOLLICLE|LEFT|DEEP|ENDOSCOPY|Y||Y|SIGNIFICANT OTHER|UROLOGIST|2|Visit_2|25|3|TREATMENT|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|4|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING|[?]|nmol/kg/day|[?]|1|ukat/10^12 RBC|ETHMOID SINUS|UNILATERAL|SUPERIOR|FLUORESCENCE ANGIOGRAPHY||||FRIEND|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|5|FEV6PP|Percent Predicted FEV6|[?]|LEFT LATERAL DECUBITUS|[?]|10^6/g|[?]|1|kcal/day|T11 VERTEBRA|RIGHT|ANTEROMEDIAL|INCISION-INDUCED BLEEDING METHOD||Y||DOMESTIC PARTNER|RATER 2|3|Visit_3|40|7|WASHOUT|2020-11-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|6|RELSZCHG|Relative Size Change|[?]|DECUBITUS|[?]|lm|[?]|1|uU/dL|GENITAL TUBERCLE|UNILATERAL|POSTERIOR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||||HEALTH CARE PROFESSIONAL|MICROSCOPIST|3|Visit_3|40|1|SCREENING|2020-11-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|7|TSUELAS|Tissue Elastance|[?]|DECUBITUS|[?]|cmH2O*s/mL|[?]|1|COAT|URETHRA, ANTERIOR|UNILATERAL|UPPER FLEXOR SURFACE|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y||VENDOR|PHYSIOTHERAPIST|4|Visit_4|65|1|FOLLOW-UP|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|8|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|amp|[?]|1|DRUM|RIB 4|RIGHT|LOWER FLEXOR SURFACE|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||CHILD|READER 3|4|Visit_4|65|4|TREATMENT|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|9|INERTANC|Inertance|[?]|SEMI-RECUMBENT|[?]|Ci/uL|[?]|1|TABLET|BLADDER, TRIGONE|LATERAL|CENTRAL|LAPAROSCOPY||Y||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|e713c631-cdd8-428f-a3a6-0195f6fb80b4|10|TGV|Thoracic Gas Volume|[?]|TRENDELENBURG|[?]|U/g|[?]|1|mU/L|T7 VERTEBRA|CONTRALATERAL|LOWER FLEXOR SURFACE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||INTERVIEWER|RADIOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|||[?]|1|vg/dose|DISTAL COMMON BILE DUCT|IPSILATERAL|LOWER FLEXOR SURFACE|RAJI CELL RIA|Y||Y|PARENT|CARDIOLOGIST|1|Visit_1|10|2|TREATMENT|2020-09-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|2|DLCOPP|Percent Predicted DLCO|[?]|SLING|[?]|grain|[?]|1|mg/kg/min|HEART, RIGHT ATRIAL APPENDAGE|LATERAL|SURFACE|PERIODIC ACID SCHIFF STAIN||Y||GUARDIAN|PATHOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-09-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|pmol/g|[?]|1|10^8/L|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|PROXIMAL VOLAR|GIEMSA STAIN||||PROXY|RATER 1|2|Visit_2|25|3|WASHOUT|2020-10-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|4|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-FOWLERS|[?]|cm H2O|[?]|1|mL*cmH2O|AXILLARY VEIN|CONTRALATERAL|MEDIAL|MRI||||SIBLING|HEMATOLOGIST|2|Visit_2|25|2|TREATMENT|2020-10-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|5|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SLING|[?]|ukat/10^12 RBC|[?]|1|cmHg|FLEXOR CARPI RADIALIS MUSCLE|LEFT|NASAL|KLEIHAUER-BETKE||Y||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-10-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|6|VO2|Oxygen Consumption|[?]|FOWLERS|||[?]|1|pmol/L/h|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|PROXIMAL VOLAR|WHOLE EXOME SEQUENCING|||Y|NON-HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|2|WASHOUT|2020-10-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-RECUMBENT|||[?]|1|mL/(min*100mL)|ELBOW EXTENSOR MUSCLES|UNILATERAL|DISTAL|ELISPOT||Y|Y|DOMESTIC PARTNER|FORENSIC PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-11-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|8|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|g/m2/day|[?]|1|cd*s/m2|DUCTUS ARTERIOSUS|IPSILATERAL|INNER|TOTAL BODY IRRADIATION||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|4|Visit_4|65|7|FOLLOW-UP|2020-11-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|9|FEV1PP|Percent Predicted FEV1|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^6/g|RIB 5|UNILATERAL|NASAL|CHROMOGENIC ASSAY|||Y|SIBLING|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2020-12-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|a3964bed-1273-4bce-bbb4-b8d768b30aa3|10|FEV6PP|Percent Predicted FEV6|[?]|TRENDELENBURG|[?]|U/animal|[?]|1|10^9 CFU|LEFT CIRCUMFLEX CORONARY ARTERY|CONTRALATERAL|LOWER MEDIAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|5|Visit_5|90|2|WASHOUT|2020-12-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|PRONE|[?]|BAU/mL|[?]|1|SUPPOSITORY|QUADRICEPS MUSCLE|IPSILATERAL|INTERMEDIATE|MALDI||||SIGNIFICANT OTHER|DERMATOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-12-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|2|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|km/h|[?]|1|PFU/dose|ASCENDING AORTA, SINUS OF VALSALVA|LATERAL|MIDLINE|NO INFORMATION||||VENDOR|PHYSIOTHERAPIST|1|Visit_1|10|3|TREATMENT|2020-12-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|3|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/day|[?]|1|PFU/mL|ANASTOMOSIS|UNILATERAL|DISTAL VOLAR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||INTERVIEWER|MICROSCOPIST 1|2|Visit_2|25|4|SCREENING|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|4|AWVOLPP|Percent Predicted Airway Volume|[?]|LATERAL DECUBITUS|[?]|C|[?]|1|10^6 copies/mL|BICEPS BRACHII MUSCLE|LEFT|LATERAL|SINGLE-MOLECULE ARRAY||||PROXY|CLINICAL PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|5|FIV1PP|Percent Predicted FIV1|[?]|LEFT LATERAL DECUBITUS|[?]|g/g/day|[?]|1|m2|HEPATIC ARTERY|CONTRALATERAL|POSTERIOR|MICRO BROTH DILUTION||||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST|3|Visit_3|40|6|SCREENING|2021-01-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|6|FEV3PP|Percent Predicted FEV3|[?]|SITTING, LEGS DEPENDENT|[?]|10^3 CFU/mL|[?]|1|deg/s|ELBOW JOINT|RIGHT|MEDIAL|TRANSMISSION ELECTRON MICROSCOPY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|3|Visit_3|40|2|TREATMENT|2021-01-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-15
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|7|IVCPP|Percent Predicted IVC|[?]|SLING|||[?]|1|/100 WBC|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|LATERAL|DORSAL|EIA|||Y|CLINICAL STUDY SPONSOR|RADIOLOGIST 2|4|Visit_4|65|3|FOLLOW-UP|2021-02-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|8|ELSTNCE|Elastance|[?]|STANDING, BENT FORWARD|[?]|YEARS|[?]|1|BLOCKS|ISCHIORECTAL FOSSA|BILATERAL|SUPERFICIAL|RAJI CELL RIA||||INVESTIGATOR|NEUROLOGIST|4|Visit_4|65|4|WASHOUT|2021-02-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|kBq|[?]|1|mg/kg/dose|TRIANGULAR-HAMATE JOINT|IPSILATERAL|INTERMEDIATE|NUCLEIC ACID HYBRIDIZATION||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|TREATMENT|2021-03-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING, BENT FORWARD|||[?]|1|/200 HPFs|FUNDUS OF THE STOMACH|RIGHT|PARIETO-OCCIPITAL|HEMATOXYLIN AND EOSIN STAIN|||Y|CHILD|CARDIOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|INTP|Interpretation|[?]|SUPINE|||[?]|1|L/s/kPa|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|BILATERAL|FACIAL|RADIAL IMMUNODIFFUSION|Y|Y|Y|CLINICAL RESEARCH ASSOCIATE|RATER 1|1|Visit_1|10|3|FOLLOW-UP|2020-06-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|2|FEV1FVC|FEV1/FVC|[?]|REVERSE TRENDELENBURG|||[?]|1|CFU/g|MAMMARY GLAND|UNILATERAL|TIP|PHASE-CONTRAST MRI|Y||Y|FAMILY MEMBER|NEUROLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|3|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|UNCONSTRAINED|||[?]|1|cGy|PHARYNGEAL TONSIL|LATERAL|MIDLINE|FLOCCULATION|||Y|CLINICAL RESEARCH ASSOCIATE|READER|2|Visit_2|25|1|TREATMENT|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|4|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LATERAL DECUBITUS|||[?]|1|U/cL|EPIGLOTTIS|LEFT|UPPER FLEXOR SURFACE|KINETIC CHROMOGENIC ASSAY|||Y|PROXY|ADJUDICATOR 3|2|Visit_2|25|3|TREATMENT|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-01
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|5|FIF75|Forced Inspiratory Flow at 75%|[?]|FOWLERS|[?]|Ci/uL|[?]|1|pg|SKIN OF THE FOREARM|IPSILATERAL|FACIAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|3|Visit_3|40|6|SCREENING|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|6|TVPP|Percent Predicted Tidal Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|ms/mmHg|INFRARENAL AORTA|BILATERAL|PROXIMAL VOLAR|MOUSE PROTECTION ASSAY|||Y|CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|3|Visit_3|40|3|FOLLOW-UP|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|7|RV|Residual Volume|[?]|STANDING|[?]|uIU/L|[?]|1|PHERESIS UNIT|EAR, INNER|BILATERAL|BASAL|AURAMINE STAIN||||ADJUDICATOR|PATHOLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|8|IRVPP|Percent Predicted IRV|[?]|SITTING, LEGS DEPENDENT|[?]|10^12 IU/L|[?]|1|CARTRIDGE|DISTAL INTERPHALANGEAL JOINT 3|LEFT|UPPER FLEXOR SURFACE|HPLC/MS/MS||||GUARDIAN|ADJUDICATOR 1|4|Visit_4|65|2|SCREENING|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|9|PNEUMIND|Pneumonia Indicator|[?]|SITTING|[?]|mmHg/L/min|[?]|1|mL/m2/min|PERIPHERAL NERVE|UNILATERAL|UPPER|SLOAN LETTER EYE CHART 100%||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|10|FEV_PEF|FEV at PEF|[?]|FOWLERS|[?]|ug/kg/min|[?]|1|copies/uL|MIDDLE PHALANX 4 OF THE HAND|UNILATERAL|VENTROLATERAL|NUCLEIC ACID BASED METHOD||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|5|Visit_5|90|6|WASHOUT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|EFFVOL|Effusion Volume|[?]|SEMI-RECUMBENT|[?]|SYRINGE|[?]|1|dram|CHOROID|CONTRALATERAL|INTERMEDIATE|RIA|Y|||PARENT|PHYSIOTHERAPIST|1|Visit_1|10|5|TREATMENT|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|2|ICPP|Percent Predicted Inspiratory Capacity|[?]|UNCONSTRAINED|[?]|deg/mm|[?]|1|BAU|CINGULATE CORTEX|UNILATERAL|FACIAL|MRS||||SPOUSE|ADJUDICATOR 1|1|Visit_1|10|4|WASHOUT|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|3|ICREV|IC Reversibility|[?]|SEMI-FOWLERS|[?]|IU/dL|[?]|1|m/sec|POPLITEAL ARTERY ABOVE KNEE|RIGHT|LATERAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-06-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|4|ERVPP|Percent Predicted ERV|[?]|SEMI-RECUMBENT|[?]|mmHg|[?]|1|V|GLUTEUS MAXIMUS|UNILATERAL|DORSOLATERAL|GC/MS/MS||||DOMESTIC PARTNER|MICROSCOPIST 2|2|Visit_2|25|6|TREATMENT|2020-06-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|5|IVC|Inspiratory Vital Capacity|[?]|SLING|[?]|MPL U|[?]|1|mg/g/h|ANTERIOR CINGULATE GYRUS|BILATERAL|PERIPHERAL|LASER CAPTURE MICRODISSECTION||Y||CLINICAL STUDY SPONSOR|OPTOMETRIST|3|Visit_3|40|6|TREATMENT|2020-06-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|6|RV|Residual Volume|[?]|SEMI-RECUMBENT|[?]|kBq|[?]|1|10^6 IU/mL|ABDOMINAL LYMPH NODE|LEFT|LOWER EXTENSOR SURFACE|HPLC/MS/MS||||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-06-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|7|ICPP|Percent Predicted Inspiratory Capacity|[?]|SUPINE|[?]|vg/mL|[?]|1|Absorbance U/mL|TRICEPS BRACHII MUSCLE|CONTRALATERAL|PERIVENTRICULAR|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y|Y||CLINICAL RESEARCH ASSOCIATE|READER 3|4|Visit_4|65|3|TREATMENT|2020-07-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|8|SAWVOL|Specific Airway Volume|[?]|UNCONSTRAINED|[?]|log10 CFU/mL|[?]|1|/200 HPFs|AXILLARY LYMPH NODE LEVEL I|IPSILATERAL|MIDLINE|CONTRAST ENHANCED SPIRAL CT SCAN|Y|||ADJUDICATION COMMITTEE|RATER 2|4|Visit_4|65|3|TREATMENT|2020-07-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|9|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/kg/day|[?]|1|LOZENGE|HIP|CONTRALATERAL|ANTEROMEDIAL|PLETHYSMOGRAPHY||||INTERVIEWER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|TREATMENT|2020-08-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|597ff319-c16e-4aae-a7d9-ed2bc25684dc|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|[?]|L/s/kPa|[?]|1|tuberculin unit/mL|POSTERIOR CINGULATE CORTEX|UNILATERAL|CENTRAL|JAEGER EYE CHART||Y||PARENT|RATER|5|Visit_5|90|4|FOLLOW-UP|2020-08-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|||[?]|1|WAFER|HEPATIC VEIN|BILATERAL|INFERIOR|MAGNETIC RESONANCE ENTEROGRAPHY|||Y|GUARDIAN|UROLOGIST|1|Visit_1|10|4|WASHOUT|2020-11-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SITTING|[?]|Pack Year|[?]|1|mg/dL|COLON, RIGHT|RIGHT|BASAL|TONOMETRY||||GUARDIAN|OPHTHALMOLOGIST|1|Visit_1|10|1|WASHOUT|2020-11-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|3|FRCPP|Percent Predicted FRC|[?]|TRENDELENBURG|[?]|U.CARR|[?]|1|ft3|CEREBRAL HEMISPHERE, LEFT|BILATERAL|FRONTAL|FREEZING POINT DEPRESSION||||CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|2|Visit_2|25|4|TREATMENT|2020-11-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING|||[?]|1|genEq|L2 VERTEBRA|RIGHT|OCCIPITAL|MRI WITHOUT CONTRAST|Y||Y|SIGNIFICANT OTHER|READER 1|2|Visit_2|25|2|WASHOUT|2020-11-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|5|QUASCOMP|Quasi-Static Compliance|[?]|SLING|||[?]|1|/10^5|SARTORIUS MUSCLE|LEFT|LATERAL|GC/MS-CI|Y||Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|3|Visit_3|40|4|FOLLOW-UP|2020-12-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SUPINE|[?]|psec|[?]|1|U/mg|MASTOID PROCESS|BILATERAL|PARIETO-OCCIPITAL|WEBER GREEN STAIN||||INVESTIGATOR|CLINICAL PATHOLOGIST|3|Visit_3|40|1|TREATMENT|2020-12-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|7|RELSZCHG|Relative Size Change|[?]|UNCONSTRAINED|[?]|hr/day|[?]|1|IU/kg/h|C2 VERTEBRA|CONTRALATERAL|INTERMEDIATE|DROPLET DIGITAL PCR||||CHILD|CARDIOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-01-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|8|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SUPINE|[?]|g/animal/day|[?]|1|/LPF|LARYNX|CONTRALATERAL|LOWER FLEXOR SURFACE|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||PROXY|FORENSIC PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2021-01-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|9|AWWVOL|Airway Wall Volume|[?]|SEMI-RECUMBENT|[?]|PELLET|[?]|1|ms2|PARASYMPATHETIC GANGLIA|LATERAL|LATERAL|TARGETED TRANSCRIPTOME SEQUENCING||||CHILD|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|7d845e3e-8bd1-4647-a3e8-352a52b585cb|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|DECUBITUS|||[?]|1|cd*s/m2|MESENTERIC ARTERY|BILATERAL|VENTRAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|||Y|ADJUDICATION COMMITTEE|RADIOLOGIST 2|5|Visit_5|90|1|SCREENING|2021-01-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|1|LCI|Lung Clearance Index|[?]|SLING|[?]|TABLET|[?]|1|mg/animal|CAPITATE-HAMATE JOINT|RIGHT|SUPERIOR|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|1|Visit_1|10|6|WASHOUT|2020-12-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|2|TLC|Total Lung Capacity|[?]|PRONE|[?]|mg/L FEU|[?]|1|kHz|FIBULA|CONTRALATERAL|ANTEROPOSTERIOR|ELECTROCHEMILUMINESCENCE||||SPOUSE|MICROSCOPIST 1|1|Visit_1|10|7|SCREENING|2020-12-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|||[?]|1|kcal|ABDOMINAL REGION|LATERAL|LOWER FLEXOR SURFACE|MS/MS||Y|Y|ADJUDICATION COMMITTEE|RADIOLOGIST|2|Visit_2|25|4|TREATMENT|2020-12-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|4|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-FOWLERS|||[?]|1|Gy/min|PERIURETERAL REGION|LEFT|ANTEROPOSTERIOR|RADIATION DOSIMETRY|||Y|INTERVIEWER|RADIOLOGIST 1|2|Visit_2|25|2|SCREENING|2020-12-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|DECUBITUS|[?]|10^9 CFU/g|[?]|1|Hounsfield Unit|PENIS, RADIX|BILATERAL|NASAL|COMPUTERIZED CORNEAL TOPOGRAPHY||||HEALTH CARE PROFESSIONAL|CARDIOLOGIST|3|Visit_3|40|4|TREATMENT|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|6|MIPPP|Percent Predicted MIP|[?]|SEMI-RECUMBENT|[?]|mL/g/min|[?]|1|Bq/mL|MUSCLE|LEFT|FRONTAL|ZIEHL NEELSEN ACID FAST STAIN||Y||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|WASHOUT|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|7|EXPRELTM|Expiration Relaxation Time|[?]|STANDING|[?]|hr/day|[?]|1|Ci/kg|SKIN OF THE UPPER LIMB|IPSILATERAL|FACIAL|LASER CAPTURE MICRODISSECTION||||INVESTIGATOR|MICROSCOPIST 3|4|Visit_4|65|4|TREATMENT|2021-02-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|8|FRC|Functional Residual Capacity|[?]|SLING|[?]|fmol|[?]|1|/cmH2O|IRIS|RIGHT|DEEP|FLUORESCENT ENZYME IMMUNOASSAY|Y|||SIBLING|RADIOLOGIST 2|4|Visit_4|65|6|SCREENING|2021-02-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|9|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|||[?]|1|ug/m2/min|TRAPEZIUS MUSCLE|UNILATERAL|FORE|ICP-MS|||Y|NON-HEALTH CARE PROFESSIONAL|RATER 1|5|Visit_5|90|1|TREATMENT|2021-03-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|7e9f4283-f90b-4f74-939c-b42648e8373c|10|DLCO|Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|||[?]|1|KIT|MANDIBLE|CONTRALATERAL|VENTROLATERAL|IMMUNODIFFUSION|||Y|CHILD|RATER|5|Visit_5|90|6|FOLLOW-UP|2021-03-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|STRIP|[?]|1|mL/m2/day|EAR|LATERAL|ANTEROPOSTERIOR|SANGER SEQUENCING||||SPOUSE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|2|MALEVDES|Malignancy Evidence Description|[?]|SITTING|[?]|10^6 DNA copies/mL|[?]|1|nmol/g|STERNUM|UNILATERAL|BASAL|ANGIOGRAPHY|Y|||FRIEND|NEUROLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-10-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/m2|LATERAL THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL|LOWER EXTENSOR SURFACE|DARK FIELD MICROSCOPY||Y|Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2020-11-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING|[?]|pt_br|[?]|1|U/g/h|ILEUM|UNILATERAL|LOWER FLEXOR SURFACE|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y||ADJUDICATOR|OTOLARYNGOLOGIST|2|Visit_2|25|6|TREATMENT|2020-11-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|5|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|vp/dose|[?]|1|mg/g/min|EPIDURAL SPACE|LATERAL|PARIETO-OCCIPITAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|3|Visit_3|40|5|FOLLOW-UP|2020-11-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|6|EFFVOL|Effusion Volume|[?]|DECUBITUS|[?]|ug/kg|[?]|1|BU/mL|METACARPAL BONE 5|IPSILATERAL|INFERIOR|LINE PROBE ASSAY||||SPOUSE|READER 1|3|Visit_3|40|5|TREATMENT|2020-11-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|7|MIPPP|Percent Predicted MIP|[?]|SLING|[?]|ng/L|[?]|1|HEP|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|VENTROLATERAL|PERIODIC ACID SCHIFF STAIN||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|4|Visit_4|65|6|FOLLOW-UP|2020-12-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|8|IC|Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|/2500 WBC|[?]|1|pmol/10^10 cells|LUNG, HILUM|UNILATERAL|UPPER FLEXOR SURFACE|ELECTROGASTROGRAPHY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|4|Visit_4|65|1|FOLLOW-UP|2020-12-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|9|INTP|Interpretation|[?]|LATERAL DECUBITUS|[?]|IU/L|[?]|1|fmol|C4 VERTEBRA|RIGHT|PROXIMAL|CELLULAR PROLIFERATION ASSAY|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST 2|5|Visit_5|90|3|FOLLOW-UP|2021-01-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|20a637e6-83d2-4a86-9ecc-8ddb0523997f|10|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING, BENT FORWARD|||[?]|1|SUPPOSITORY|PERIUMBILICAL REGION|CONTRALATERAL|VOLAR|RULER MEASUREMENT METHOD|||Y|PARENT|READER 1|5|Visit_5|90|1|TREATMENT|2021-01-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|PNIF|Peak Nasal Inspiratory Flow|[?]|TRENDELENBURG|[?]|STEPS|[?]|1|10^6 organisms/mL|KIDNEY|IPSILATERAL|CRANIAL|LASER CAPTURE MICRODISSECTION|Y|||PROXY|RADIOLOGIST|1|Visit_1|10|4|TREATMENT|2020-05-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|2|PEF|Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|uL/dose|[?]|1|10^7 TCID 50/dose|SUPRAGLOTTIS|UNILATERAL|UPPER EXTENSOR SURFACE|MAGNETIC RESONANCE ENTEROGRAPHY||||DOMESTIC PARTNER|FORENSIC PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-05-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|3|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|um/s|PROSTATE GLAND|LEFT|MEDIAL|HEMATOXYLIN AND EOSIN STAIN|Y||Y|SPOUSE|MICROSCOPIST 3|2|Visit_2|25|1|FOLLOW-UP|2020-05-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|4|EFFIND|Effusion Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|/5x10^4 WBC|[?]|1|ug/kg/min|THORAX|RIGHT|INFERIOR|SICKLE CELL SOLUBILITY TEST||||FRIEND|CLINICAL PATHOLOGIST|2|Visit_2|25|4|SCREENING|2020-05-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|5|TSUHYS|Tissue Hysteresivity|[?]|SEMI-FOWLERS|[?]|PELLET|[?]|1|deg/mm|CEREBRAL ARTERY|IPSILATERAL|ANTERIOR|CHROMOGENIC ASSAY||||STUDY SUBJECT|READER 1|3|Visit_3|40|1|TREATMENT|2020-06-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|6|RELSZCHG|Relative Size Change|[?]|PRONE|||[?]|1|mg/kg/week|OMENTUM|LEFT|VOLAR|ENZYMATIC SPECTROPHOTOMETRY||Y|Y|PARENT|READER 3|3|Visit_3|40|3|TREATMENT|2020-06-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|7|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|FOWLERS|[?]|Log10 ELISA unit|[?]|1|cg|MEDIASTINAL LYMPH NODE|UNILATERAL|NASAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||ADJUDICATION COMMITTEE|MICROSCOPIST 3|4|Visit_4|65|7|TREATMENT|2020-07-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|8|TGV|Thoracic Gas Volume|[?]|SITTING|||[?]|1|SFC/10^6 PBMC|CORPUS LUTEUM|BILATERAL|ANTERIOR|SPIRAL CT|||Y|INTERVIEWER|MICROSCOPIST 3|4|Visit_4|65|6|TREATMENT|2020-07-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|9|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SUPINE|[?]|mPa|[?]|1|mmol/mol|DISTANT LYMPH NODE|UNILATERAL|CRANIAL|PALM METHOD||Y||SIBLING|MICROSCOPIST 2|5|Visit_5|90|3|TREATMENT|2020-08-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|10|FEV1FVC6|FEV1/FVC6|[?]|STANDING|[?]|10^6/hpf|[?]|1|mL/animal/day|VULVA|BILATERAL|VENTROLATERAL|TARGETED TRANSCRIPTOME SEQUENCING|Y|||GUARDIAN|CLINICAL PATHOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-08-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|1|MEPPP|Percent Predicted MEP|[?]|SLING|||[?]|1|MdFI|THROAT|LEFT|HIND|CONGO RED STAIN|||Y|GUARDIAN|ADJUDICATOR 3|1|Visit_1|10|3|FOLLOW-UP|2020-08-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-FOWLERS|[?]|U/10^12 RBC|[?]|1|kcal|TRAPEZIUS MUSCLE|IPSILATERAL|UPPER|LASER CAPTURE MICRODISSECTION||||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|TREATMENT|2020-08-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|3|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SLING|[?]|BAU/mL|[?]|1|BAU|SCAPHOID BONE|RIGHT|ROSTRAL|IMMUNORADIOMETRIC ASSAY||||SPOUSE|RADIOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-09-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|4|FIF75|Forced Inspiratory Flow at 75%|[?]|REVERSE TRENDELENBURG|[?]|BE/mL|[?]|1|psec|EYE, ANTERIOR CHAMBER|UNILATERAL|PERIPHERAL|SXA SCAN||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-09-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|5|SRAW|Specific Airway Resistance|[?]|STANDING|||[?]|1|mL|SUBMANDIBULAR LYMPH NODE|LATERAL|SURFACE|MICROBIAL BIOCHEMICAL IDENTIFICATION|||Y|ADJUDICATION COMMITTEE|ONCOLOGIST 2|3|Visit_3|40|6|FOLLOW-UP|2020-09-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|6|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|MHz|[?]|1|ng/dL|TOOTH CANAL|LATERAL|DORSAL|OPTICAL COHERENCE TOMOGRAPHY|Y|Y||GUARDIAN|ADJUDICATOR 3|3|Visit_3|40|1|WASHOUT|2020-09-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|7|FEV3FVC|FEV3/FVC|[?]|SITTING|[?]|nmol/kg/day|[?]|1|kIU|TRACHEA|RIGHT|INNER|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 2|4|Visit_4|65|2|TREATMENT|2020-10-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|8|INFLTIND|Infiltrates Indicator|[?]|DECUBITUS|[?]|mL/s/m2|[?]|1|uSiemens|ADDUCTOR BREVIS MUSCLE|IPSILATERAL|DISTAL|FLOW CYTOMETRY||||CAREGIVER|ADJUDICATOR 1|4|Visit_4|65|4|TREATMENT|2020-10-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|9|RAW|Airway Resistance|[?]|SITTING|[?]|mmHg*min/L|[?]|1|fmol/L|LENS|UNILATERAL|DORSAL|IMMUNOPRECIPITATION||||ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|5|Visit_5|90|7|SCREENING|2020-11-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|595aa95c-4378-47c1-96e9-5512d08fb653|10|FEV6PP|Percent Predicted FEV6|[?]|TRENDELENBURG|||[?]|1|10^3/hpf|PARS COMPACTA|UNILATERAL|APICAL|CINEANGIOGRAPHY||Y|Y|GUARDIAN|RADIOLOGIST 1|5|Visit_5|90|1|TREATMENT|2020-11-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|1|FVC|Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|U/g/day|[?]|1|ECL unit|CORRUGATOR SUPERCILII MUSCLE|CONTRALATERAL|LOWER EXTENSOR SURFACE|PH METER MEASUREMENT METHOD||||INVESTIGATOR|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-12-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|2|MALEVDES|Malignancy Evidence Description|[?]|UNCONSTRAINED|[?]|SFC/10^6 PBMC|[?]|1|ug/m2/h|TALUS|UNILATERAL|PARIETO-OCCIPITAL|HIGH RESOLUTION MELT ANALYSIS|Y|||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|FOLLOW-UP|2020-12-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|3|FEF50|Forced Expiratory Flow 50%|[?]|LEFT LATERAL DECUBITUS|[?]|U/kg/min|[?]|1|uU/dL|ARM|BILATERAL|INTERMEDIATE|MEDIASTINOSCOPY||Y||PROXY|NEUROLOGIST 2|2|Visit_2|25|4|FOLLOW-UP|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|TRENDELENBURG|||[?]|1|SCOOPFUL|T7 VERTEBRA|LEFT|MIDLINE|OBSERVATION|Y|Y|Y|SIBLING|READER 2|2|Visit_2|25|5|WASHOUT|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|DECUBITUS|||[?]|1|mm2|SCAPHOID-CAPITATE JOINT|LATERAL|DORSOLATERAL|POTENTIOMETRY|Y||Y|CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|3|Visit_3|40|5|TREATMENT|2021-01-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|6|DLCO|Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|[?]|mL/dL|[?]|1|mEq/uL|BUCCAL MUCOSA|LEFT|UPPER|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|||PARENT|INTERNIST|3|Visit_3|40|2|WASHOUT|2021-01-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|7|IVCPP|Percent Predicted IVC|[?]|SUPINE|[?]|pkat/L|[?]|1|GPS U|LUNG LOBE|LATERAL|ANTERIOR|IMMUNOCHEMILUMINOMETRIC ASSAY||||CAREGIVER|PATHOLOGIST 1|4|Visit_4|65|7|TREATMENT|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|8|SVCPP|Percent Predicted Slow Vital Capacity|[?]|DECUBITUS|[?]|APL U|[?]|1|AgU/mL|PARALARYNGEAL LYMPH NODE|LATERAL|FACIAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||Y||GUARDIAN|ADJUDICATOR 1|4|Visit_4|65|7|SCREENING|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|9|FVC|Forced Vital Capacity|[?]|SITTING|[?]|nsec|[?]|1|IU|HYPOTHALAMUS|LATERAL|FORE|CELLULAR PROLIFERATION ASSAY||||DOMESTIC PARTNER|PATHOLOGIST 2|5|Visit_5|90|6|TREATMENT|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|b528dc24-e791-41b1-95b3-fc0be18da47f|10|FEF2575|Forced Expiratory Flow 25-75%|[?]|LATERAL DECUBITUS|||[?]|1|TROCHE|INTERVENTRICULAR SEPTUM|BILATERAL|LOWER MEDIAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|5|Visit_5|90|3|WASHOUT|2021-03-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LATERAL DECUBITUS|[?]|dram|[?]|1|JDF Unit|TARSUS BONE|LATERAL|SURFACE|ELISPOT||||SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|2|AIRTRAP|Air Trapping|[?]|REVERSE TRENDELENBURG|[?]|mAnson U/mL|[?]|1|fL|ABDOMINAL AORTA|RIGHT|SUPERIOR|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y||CHILD|NEUROLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|3|TSUELAS|Tissue Elastance|[?]|PRONE|||[?]|1|AFU|TRICUSPID VALVE, SEPTAL CUSP|CONTRALATERAL|UPPER FLEXOR SURFACE|RAJI CELL EIA|||Y|CLINICAL STUDY SPONSOR|INTERNIST|2|Visit_2|25|7|TREATMENT|2020-06-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|4|INERTANC|Inertance|[?]|SLING|[?]|GBq/mg|[?]|1|MAC50|LUNG, LEFT UPPER LOBE|LEFT|ANTEROMEDIAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y||CAREGIVER|RADIOLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-06-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|5|FIO2|Fraction of Inspired Oxygen|[?]|LATERAL DECUBITUS|[?]|fg|[?]|1|/5x10^4 WBC|SUPRASPINATUS MUSCLE|LATERAL|SUPERFICIAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||STUDY SUBJECT|PATHOLOGIST 1|3|Visit_3|40|4|WASHOUT|2020-06-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|6|IRVPP|Percent Predicted IRV|[?]|STANDING|[?]|K|[?]|1|L|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|TIP|IHC||||NON-HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|3|Visit_3|40|5|FOLLOW-UP|2020-06-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|7|SALKB|Salazar-Knowles Equation Parameter B|[?]|PRONE|||[?]|1|km|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|CONTRALATERAL|VOLAR|SXA SCAN|||Y|CAREGIVER|READER 3|4|Visit_4|65|6|TREATMENT|2020-07-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|8|RAW|Airway Resistance|[?]|SUPINE|[?]|mL/m2|[?]|1|ug/g/min|PISIFORM BONE|LATERAL|INFERIOR|DIRECT SEQUENCING|Y|||ADJUDICATION COMMITTEE|ADJUDICATOR 1|4|Visit_4|65|4|SCREENING|2020-07-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|9|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|Hounsfield Unit|TRICEPS BRACHII MUSCLE|UNILATERAL|HIND|DYNAMIC LIGHT SCATTERING|||Y|INTERVIEWER|RATER 2|5|Visit_5|90|1|WASHOUT|2020-08-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|7a43c892-0e7f-4f33-9130-e175e475531f|10|AWWVOL|Airway Wall Volume|[?]|LATERAL DECUBITUS|[?]|genEq/mL|[?]|1|Farad|TRIGEMINAL NERVE|BILATERAL|TEMPORAL|ENZYMATIC ULTRACENTRIFUGATION||||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|ELSTNCE|Elastance|[?]|FOWLERS|||[?]|1|Rad|ACETABULUM|RIGHT|CRANIAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y||Y|PARENT|ONCOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|TUBE|[?]|1|K|MIDDLE PHALANX 5 OF THE HAND|LEFT|UPPER EXTENSOR SURFACE|MICRODENSITOMETRY||||CLINICAL RESEARCH ASSOCIATE|RATER|1|Visit_1|10|6|WASHOUT|2020-12-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|3|FRC|Functional Residual Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|g/day|VASTUS LATERALIS MUSCLE|BILATERAL|PROXIMAL|BALLPOINT PEN TECHNIQUE|Y|Y|Y|NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|2|Visit_2|25|5|WASHOUT|2020-12-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|4|EFFVOL|Effusion Volume|[?]|UNCONSTRAINED|[?]|L/day|[?]|1|V|SACRAL VERTEBRA|BILATERAL|ROSTRAL|WRIGHT STAIN||||STUDY SUBJECT|ADJUDICATOR 3|2|Visit_2|25|3|TREATMENT|2020-12-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|5|SVC|Slow Vital Capacity|[?]|LATERAL DECUBITUS|[?]|K|[?]|1|COAT|PORTAL LYMPH NODE|IPSILATERAL|POSTERIOR|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||FAMILY MEMBER|INTERNIST|3|Visit_3|40|7|TREATMENT|2021-01-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|6|INTP|Interpretation|[?]|STANDING, BENT FORWARD|[?]|mL/cage/wk|[?]|1|STRIP|MOTOR CORTEX|UNILATERAL|LOWER MEDIAL|FLUORESCENCE ANGIOGRAPHY||Y||VENDOR|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-01-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|7|FIF50|Forced Inspiratory Flow at 50%|[?]|DECUBITUS|[?]|mU|[?]|1|pt_us|ESOPHAGUS, MIDDLE THIRD|LATERAL|UPPER EXTENSOR SURFACE|MS/MS|Y|||FRIEND|CARDIOLOGIST|4|Visit_4|65|3|TREATMENT|2021-02-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|8|IVCPP|Percent Predicted IVC|[?]|SITTING|[?]|CAPSULE|[?]|1|GPL U/mL|SCLERA|LEFT|INFERIOR|MICRODENSITOMETRY||||PROXY|NEUROLOGIST 2|4|Visit_4|65|1|FOLLOW-UP|2021-02-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|9|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|[?]|cm2|[?]|1|ug/dL|T2 VERTEBRA|UNILATERAL|DISTAL|SPECT SCAN||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|5|Visit_5|90|5|FOLLOW-UP|2021-02-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|10|TGV|Thoracic Gas Volume|[?]|SUPINE|[?]|10^9 CFU/g|[?]|1|dpm/100mg|THIRD POSTEROLATERAL DESCENDING ARTERY|LEFT|MEDIAL|MANUAL COUNT|Y|||NON-HEALTH CARE PROFESSIONAL|INTERNIST|5|Visit_5|90|6|FOLLOW-UP|2021-02-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING|[?]|mmAL|[?]|1|VIRTUAL PIXEL|RADIUS|LEFT|UPPER|TRIPLE-PHASE SPIRAL CT SCAN|Y|Y||FRIEND|ENDOCRINOLOGIST|1|Visit_1|10|6|SCREENING|2020-08-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|2|DLCO|Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|10^3 CFU/g|POPLITEAL ARTERY ABOVE KNEE|LATERAL|LOWER MEDIAL|PERIODIC ACID SCHIFF STAIN||Y||CHILD|RATER|1|Visit_1|10|6|TREATMENT|2020-08-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|3|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|10^6 organisms|[?]|1|USP U|SECOND RIGHT POSTEROLATERAL ARTERY|RIGHT|CAUDAL|TRANSMISSION ELECTRON MICROSCOPY||Y||DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|7|TREATMENT|2020-09-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|STANDING|[?]|mCi/kg|[?]|1|V|TRICUSPID VALVE, POSTERIOR ANNULUS|LATERAL|UPPER FLEXOR SURFACE|INCISION-INDUCED BLEEDING METHOD||Y||PARENT|PATHOLOGIST|2|Visit_2|25|5|TREATMENT|2020-09-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|5|TLC|Total Lung Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|scm|[?]|1|ugEq/L|DISTAL PHALANX 3 OF THE HAND|CONTRALATERAL|ANTEROTEMPORAL|WESTERGREN||Y||ADJUDICATION COMMITTEE|RADIOLOGIST 1|3|Visit_3|40|3|WASHOUT|2020-09-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|6|MEPPP|Percent Predicted MEP|[?]|SEMI-FOWLERS|[?]|mg/m2/h|[?]|1|nkat|CANINE TOOTH|LATERAL|PERIVENTRICULAR|BETA LACTAMASE||Y||INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|FOLLOW-UP|2020-09-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|7|PIF|Peak Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|APPLICATION|[?]|1|U.CARR|PANCREAS, TAIL|IPSILATERAL|INFERIOR|MUGA||||VENDOR|NEUROLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-10-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|PRONE|[?]|mol|[?]|1|100 IU/mL|LATERAL SECOND DIAGONAL BRANCH ARTERY|RIGHT|INFERIOR|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||GUARDIAN|PATHOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-10-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|9|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kcal|FOREHEAD|IPSILATERAL|PROXIMAL|MAGNETIC RESONANCE ELASTOGRAPHY|||Y|INTERVIEWER|ADJUDICATOR|5|Visit_5|90|3|WASHOUT|2020-11-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|bde9096e-9ab9-45fe-8e96-1ec9762824a0|10|EFFVOL|Effusion Volume|[?]|PRONE|[?]|ngEq/L|[?]|1|cmH2O*s2/mL|TRIANGULAR-HAMATE JOINT|RIGHT|LATERAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||||ADJUDICATOR|ONCOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-11-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SEMI-RECUMBENT|[?]|/LSQN|[?]|1|TRANSDUCING UNIT/mL|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|INTERMEDIATE|DUCTOGRAPHY|Y|||SIBLING|MICROSCOPIST|1|Visit_1|10|6|SCREENING|2020-06-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|2|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|||[?]|1|g/cm2|METATARSOPHALANGEAL JOINT 4|LEFT|DISTAL VOLAR|THIN SMEAR|Y|Y|Y|DOMESTIC PARTNER|ONCOLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-06-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|3|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|||[?]|1|ft3|PYLORIC SPHINCTER|LEFT|OUTER|OPTICAL COHERENCE TOMOGRAPHY|||Y|FAMILY MEMBER|READER 1|2|Visit_2|25|7|TREATMENT|2020-07-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|4|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|nmol/g|HUMERAL EPICONDYLE|LEFT|ANTEROMEDIAL|ENZYMATIC ULTRACENTRIFUGATION||Y|Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|2|Visit_2|25|2|WASHOUT|2020-07-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|5|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-FOWLERS|[?]|ug/mL/h|[?]|1|DRINK|TENTORIUM CEREBELLI|UNILATERAL|PERIVENTRICULAR|COULOMETRIC TITRATION||||SIBLING|NEUROLOGIST|3|Visit_3|40|3|SCREENING|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|6|FVCPP|Percent Predicted Forced Vital Capacity|[?]|DECUBITUS|[?]|U/mg|[?]|1|10^3 RNA copies/mL|VULVOVAGINAL REGION|LEFT|DEEP|SLOAN LETTER EYE CHART 2.5%||||CAREGIVER|PHYSIOTHERAPIST|3|Visit_3|40|7|SCREENING|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SUPINE|[?]|mg/m2|[?]|1|ngEq/L|URETHRA, PENILE|UNILATERAL|OCCIPITAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|FOWLERS|[?]|MPL U/mL|[?]|1|kg/cm|CAROTID ARTERY|UNILATERAL|VOLAR|MICRO BROTH DILUTION||Y||PARENT|FORENSIC PATHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|9|INTP|Interpretation|[?]|LATERAL DECUBITUS|[?]|JAR|[?]|1|cy/cm|PANCREAS, EXOCRINE|IPSILATERAL|DEEP|IMMUNE REPERTOIRE DEEP SEQUENCING||Y||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|5|Visit_5|90|4|TREATMENT|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|ea7907aa-811e-48ec-9fc6-ab8affde8913|10|LCI|Lung Clearance Index|[?]|LEFT LATERAL DECUBITUS|[?]|TCID 50/dose|[?]|1|10^4 CFU|MASTOID PROCESS|CONTRALATERAL|PERIPHERAL|PANENDOSCOPY||||ADJUDICATION COMMITTEE|NEUROLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|PRONE|[?]|mg/g/h|[?]|1|ug/kg/min|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|LATERAL|OCCIPITAL|SPIRAL CT SCAN WITHOUT CONTRAST||||CAREGIVER|PHYSIOTHERAPIST|1|Visit_1|10|2|TREATMENT|2020-08-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|2|TSUHYS|Tissue Hysteresivity|[?]|STANDING|||[?]|1|BAU|SUPERIOR VENA CAVA|LEFT|UPPER|PEAK FLOWMETRY|||Y|SPOUSE|CARDIOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-08-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|3|RER|Respiratory Exchange Ratio|[?]|SEMI-RECUMBENT|||[?]|1|Frames/s|QUADRICEPS MUSCLE|LATERAL|DORSOLATERAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|||Y|VENDOR|NEUROLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-09-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|4|RV|Residual Volume|[?]|SITTING|[?]|BAR|[?]|1|vp/dose|FACIAL NERVE|CONTRALATERAL|INTERMEDIATE|DXA SCAN|Y|||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|2|Visit_2|25|1|FOLLOW-UP|2020-09-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|5|TSUELAS|Tissue Elastance|[?]|UNCONSTRAINED|[?]|/5x10^4 WBC|[?]|1|10^4/L|SINUS|LATERAL|HIND|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|||SIBLING|ONCOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-09-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|6|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING, BENT FORWARD|[?]|Gy|[?]|1|ECL unit|FACET JOINT|BILATERAL|DISTAL|DUCTOGRAPHY||Y||DOMESTIC PARTNER|UROLOGIST|3|Visit_3|40|1|TREATMENT|2020-09-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|7|PCF|Peak Cough Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|uOsm|POPLITEAL ARTERY ABOVE KNEE|LEFT|PARIETO-OCCIPITAL|IMMUNORADIOMETRIC ASSAY|||Y|STUDY SUBJECT|ONCOLOGIST|4|Visit_4|65|7|TREATMENT|2020-10-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|8|PLMXRS|Pulmonary Reactance|[?]|SEMI-RECUMBENT|[?]|atm|[?]|1|Bq|SKIN OF THE SOLE|IPSILATERAL|LOWER|CALCOFLUOR WHITE STAIN||||FRIEND|NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2020-10-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|9|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING, BENT FORWARD|[?]|10^9/L|[?]|1|uIU/dL|ABDOMINAL LYMPH NODE|LATERAL|DORSOLATERAL|DOUBLE IMMUNODIFFUSION||||INTERVIEWER|RADIOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-11-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|3aa9935c-943d-406a-bb6e-fc067fa8a487|10|MIPPP|Percent Predicted MIP|[?]|LATERAL DECUBITUS|[?]|10^12 IU/L|[?]|1|L/min|ADDUCTOR POLLICIS MUSCLE|IPSILATERAL|NASAL|PLETHYSMOGRAPHY||||FRIEND|OPHTHALMOLOGIST|5|Visit_5|90|3|TREATMENT|2020-11-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING, BENT FORWARD|[?]|umol/dL|[?]|1|Ci|SCAPHOID-RADIUS JOINT|IPSILATERAL|LOWER MEDIAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-12-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|2|SAWVOL|Specific Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|gMFI|[?]|1|mm/2h|THORACIC LYMPH NODE|CONTRALATERAL|BASAL|IMPEDANCE CONDUCTIVITY||||CLINICAL RESEARCH COORDINATOR|UROLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|3|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|[?]|ELISA unit|[?]|1|mg/day|VASTUS INTERMEDIUS MUSCLE|LATERAL|MEDIAL|TWO-COLOR MICROARRAY||Y||CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|3|SCREENING|2020-12-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-RECUMBENT|[?]|EIA unit|[?]|1|U/g/day|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|CONTRALATERAL|PARIETO-OCCIPITAL|SPECT SCAN||||DOMESTIC PARTNER|OPTOMETRIST|2|Visit_2|25|6|TREATMENT|2020-12-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|DECUBITUS|[?]|ug/dose|[?]|1|ELISA unit/mL|EPIDURAL SPACE|RIGHT|ANTEROMEDIAL|QUANTITATIVE CORONARY ANGIOGRAPHY||||PROXY|READER 1|3|Visit_3|40|3|SCREENING|2020-12-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|6|FIV1|Forced Inspiratory Volume in 1 Second|[?]|UNCONSTRAINED|[?]|mg/kg/day|[?]|1|cmH2O/mL|HAIR ROOT|LATERAL|ROSTRAL|BETA LACTAMASE|Y|||GUARDIAN|READER 1|3|Visit_3|40|2|SCREENING|2020-12-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|||[?]|1|mmHg/L/min|PROXIMAL LAD ARTERY|LEFT|SURFACE|ICP-MS|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2021-01-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|8|GAW|Airway Conductance|[?]|UNCONSTRAINED|[?]|KIT|[?]|1|ukat/10^12 RBC|SHOULDER JOINT|LEFT|LOWER EXTENSOR SURFACE|CALCOFLUOR WHITE STAIN|Y|||SPOUSE|PEDIATRIC NEUROLOGIST|4|Visit_4|65|1|TREATMENT|2021-01-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|9|DLCOVA|DLCO/VA|[?]|SEMI-FOWLERS|[?]|genEq/mL|[?]|1|um2|RIGHT VENTRICULAR ENDOCARDIUM|IPSILATERAL|LOWER|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||CAREGIVER|NEUROLOGIST 2|5|Visit_5|90|2|SCREENING|2021-02-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|0cac2007-ca12-45ba-9b1c-70f753232f05|10|FIFMAXPP|Percent Predicted FIFmax|[?]|FOWLERS|[?]|g/day|[?]|1|g/animal/wk|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|LOWER|DOUBLE IMMUNODIFFUSION||||PROXY|INTERNIST|5|Visit_5|90|6|FOLLOW-UP|2021-02-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|1|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|[?]|mkat|[?]|1|mL/cm3/min|TIBIALIS POSTERIOR MUSCLE|LATERAL|ANTERIOR|GRADIENT DIFFUSION|Y|||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-07-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|2|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|||[?]|1|SYRINGE|MITRAL VALVE ANNULUS|IPSILATERAL|ROSTRAL|SNP ARRAY|||Y|INDEPENDENT ASSESSOR|ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2020-07-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|3|EFFVOL|Effusion Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|kDa|AXILLARY LYMPH NODE LEVEL III|RIGHT|SURFACE|OPHTHALMOSCOPY|Y||Y|CLINICAL RESEARCH ASSOCIATE|READER|2|Visit_2|25|5|TREATMENT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|4|SGAW|Specific Airway Conductance|[?]|TRENDELENBURG|[?]|mL/min/1.73m2|[?]|1|kg/cm|LIVER FISSURE|RIGHT|TEMPORAL|MAMMOGRAPHY||||INTERVIEWER|OPTOMETRIST|2|Visit_2|25|2|TREATMENT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|5|DLCOHCVA|HGB Corrected DLCO/VA|[?]|TRENDELENBURG|[?]|BLOCKS|[?]|1|U/mg|VOMER|BILATERAL|MIDLINE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||HEALTH CARE PROFESSIONAL|ADJUDICATOR|3|Visit_3|40|5|SCREENING|2020-08-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|TRENDELENBURG|[?]|U/dL|[?]|1|Roentgen|MID-JUGULAR LYMPH NODE|CONTRALATERAL|TEMPORAL|SPECT/CT SCAN||||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|1|FOLLOW-UP|2020-08-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|LATERAL DECUBITUS|[?]|IU/g Hb|[?]|1|L/L|CALCANEUS|BILATERAL|UPPER EXTENSOR SURFACE|GC/MS||||FAMILY MEMBER|ONCOLOGIST 1|4|Visit_4|65|2|WASHOUT|2020-08-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|8|ALVVOL|Alveolar Volume|[?]|SLING|[?]|mV*min|[?]|1|INHALATION|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|RIGHT|LOWER MEDIAL|ENZYMATIC ULTRACENTRIFUGATION||||CLINICAL RESEARCH ASSOCIATE|READER 1|4|Visit_4|65|5|TREATMENT|2020-08-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|9|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING|[?]|FEU|[?]|1|cL|TRIGEMINAL NERVE|BILATERAL|CRANIAL|DYNAMIC CONTRAST ENHANCED MRI||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2020-09-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|2339e91a-b93e-426f-9b60-3d3b6969268d|10|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|[?]|STEPS|[?]|1|mL/(min*100mL)|HINDLIMB|CONTRALATERAL|OUTER|REFLECTANCE SPECTROSCOPY|Y|||PARENT|MICROSCOPIST 2|5|Visit_5|90|3|TREATMENT|2020-09-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|1|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|nmol/mL/min|[?]|1|Farad|ULNA SHAFT|UNILATERAL|DORSAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|WASHOUT|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|2|ERVPP|Percent Predicted ERV|[?]|STANDING|[?]|amu|[?]|1|AMPULE|SMALL INTESTINE|BILATERAL|ANTERIOR|EEG|Y|||HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|3|FIVC|Forced Inspiratory Vital Capacity|[?]|FOWLERS|[?]|oz eq|[?]|1|pkat/L|HAIR SHAFT|UNILATERAL|OUTER|DYNAMIC CONTRAST ENHANCED MRI||||CLINICAL RESEARCH COORDINATOR|INTERNIST|2|Visit_2|25|6|WASHOUT|2020-11-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|4|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|ukat/10^12 RBC|[?]|1|fL|CEPHALIC VEIN|RIGHT|CRANIAL|ELECTROPHORESIS||||CAREGIVER|ONCOLOGIST 2|2|Visit_2|25|7|FOLLOW-UP|2020-11-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|5|INERTANC|Inertance|[?]|REVERSE TRENDELENBURG|||[?]|1|log10 PFU|LOWER JUGULAR LYMPH NODE|IPSILATERAL|MIDLINE|RYAN BLUE STAIN|Y||Y|CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|6|AIRTRAP|Air Trapping|[?]|SLING|[?]|mL/m2/h|[?]|1|mL/m2/day|SPLENIC LYMPH NODE|LEFT|FRONTAL|HIGH RESOLUTION MELT ANALYSIS||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|3|Visit_3|40|2|TREATMENT|2020-11-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|7|PEFTIME|Peak Expiratory Flow Time|[?]|SUPINE|[?]|copies/ug|[?]|1|umol/L/min|HEART|CONTRALATERAL|UPPER|SLIT LAMP PHOTOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2020-12-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|8|MALIND|Malignancy Indicator|[?]|UNCONSTRAINED|[?]|IU/day|[?]|1|Torr|GLOBUS PALLIDUS|CONTRALATERAL|LOWER EXTENSOR SURFACE|ISHIHARA COLOR PLATES||||ADJUDICATION COMMITTEE|PATHOLOGIST|4|Visit_4|65|7|WASHOUT|2020-12-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|9|RER|Respiratory Exchange Ratio|[?]|LEFT LATERAL DECUBITUS|[?]|PHERESIS UNIT|[?]|1|JDF Unit|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|PROXIMAL|CONTRAST ENHANCED PET SCAN||||FAMILY MEMBER|ONCOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-01-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|0d09e35b-e864-4492-a341-21c71d92b551|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SLING|[?]|SFC/10^6 PBMC|[?]|1|L/h/m2|C3 VERTEBRA|IPSILATERAL|LOWER MEDIAL|AUSCULTATION||||CHILD|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-01-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|ELSTNCE|Elastance|[?]|SLING|[?]|VIAL|[?]|1|/ms|PARA-AORTIC LYMPH NODE|IPSILATERAL|PERIVENTRICULAR|GC/FID||Y||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|2|FIFMAX|Maximum Forced Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|mEq/L|[?]|1|DRINK|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|LEFT|PROXIMAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|||SIGNIFICANT OTHER|ONCOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-06-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|3|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|[?]|U/dL|[?]|1|mEq/g|SKIN OF THE NECK|LEFT|APICAL|MAGNETIC RESONANCE ENTEROGRAPHY||Y||CHILD|ADJUDICATOR 1|2|Visit_2|25|7|FOLLOW-UP|2020-06-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|10^6 DNA copies/mL|[?]|1|MnFI|POPLITEAL LYMPH NODE|LATERAL|ANTEROTEMPORAL|PH METER MEASUREMENT METHOD|Y|||INVESTIGATOR|PATHOLOGIST 2|2|Visit_2|25|2|TREATMENT|2020-06-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|5|FIF50|Forced Inspiratory Flow at 50%|[?]|UNCONSTRAINED|[?]|dpm/mL|[?]|1|ug/L|POSTERIOR TIBIAL ARTERY|LEFT|PERIVENTRICULAR|RADIOGRAPHY||||SIGNIFICANT OTHER|ADJUDICATOR 1|3|Visit_3|40|5|SCREENING|2020-07-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|6|FEF2575P|Percent Predicted FEF25-75|[?]|UNCONSTRAINED|||[?]|1|ug/day|THORACIC VERTEBRA|LEFT|OCCIPITAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y||Y|CHILD|READER 1|3|Visit_3|40|7|TREATMENT|2020-07-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|[?]|mg/m2/day|[?]|1|mmol/L|HEART, RIGHT VENTRICULAR FREE WALL|LATERAL|MEDIAL|CALIPER MEASUREMENT METHOD||Y||CAREGIVER|CLINICAL PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|8|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|||[?]|1|umol/h/mmol|DISTAL RADIOULNAR JOINT|UNILATERAL|PERIVENTRICULAR|WHOLE GENOME SEQUENCING|||Y|SPOUSE|OPHTHALMOLOGIST|4|Visit_4|65|1|SCREENING|2020-07-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|9|IRV|Inspiratory Reserve Volume|[?]|TRENDELENBURG|[?]|%/min|[?]|1|mgEq|THROAT|LEFT|LOWER|ELECTROCHEMILUMINESCENCE||Y||SIGNIFICANT OTHER|READER 1|5|Visit_5|90|4|WASHOUT|2020-08-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|10|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|mg/day|[?]|1|cmHg|EYELID|RIGHT|PARIETO-OCCIPITAL|APPLANATION TONOMETRY||||HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|2|FOLLOW-UP|2020-08-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|RAW|Airway Resistance|[?]|UNCONSTRAINED|[?]|U/g/h|[?]|1|g/animal/wk|SUPRAGLOTTIS|RIGHT|SUPERFICIAL|MUGA|Y|||ADJUDICATOR|RADIOLOGIST 1|1|Visit_1|10|3|TREATMENT|2021-01-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|2|OXYPULSE|Oxygen Pulse|[?]|STANDING|[?]|CCID 50/mL|[?]|1|log10 CFU/mL|CELIAC LYMPH NODE|LATERAL|PROXIMAL|IMMUNORADIOMETRIC ASSAY||||STUDY SUBJECT|RATER 2|1|Visit_1|10|1|TREATMENT|2021-01-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|3|RVPP|Percent Predicted Residual Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|v/v|CORONARY ARTERY, ANTERIOR DESCENDING|LEFT|APICAL|FISH|||Y|STUDY SUBJECT|NEUROLOGIST|2|Visit_2|25|4|WASHOUT|2021-01-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SITTING|[?]|nmol/day|[?]|1|titer|DISTAL INTERPHALANGEAL JOINT 3|LEFT|NASAL|SINGLE-MOLECULE ARRAY|Y|Y||GUARDIAN|MICROSCOPIST 2|2|Visit_2|25|4|SCREENING|2021-01-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|5|IVC|Inspiratory Vital Capacity|[?]|TRENDELENBURG|[?]|PA|[?]|1|10^6 copies/mL|PROXIMAL CIRCUMFLEX ARTERY|UNILATERAL|CENTRAL|SURFACE PLASMON RESONANCE|Y|||CAREGIVER|OTOLARYNGOLOGIST|3|Visit_3|40|6|WASHOUT|2021-02-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|pkat|[?]|1|10^7 CFU/mL|EYELASH|BILATERAL|MIDLINE|LANDOLT RING|Y|Y||SPOUSE|HEMATOLOGIST|3|Visit_3|40|6|WASHOUT|2021-02-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|7|AWVOL|Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|log10 TCID 50/mL|[?]|1|Ci/ug|RIB 9|CONTRALATERAL|POSTERIOR|DIRECT SEQUENCING||||SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2021-02-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|8|RAW|Airway Resistance|[?]|SLING|[?]|dB|[?]|1|mIU/L|TEMPORAL BONE|LATERAL|ANTEROPOSTERIOR|PET SCAN||||ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-02-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|9|IRVPP|Percent Predicted IRV|[?]|TRENDELENBURG|[?]|mL/m2/day|[?]|1|mmHg/L/min|WALDEYER'S TONSILLAR RING|LATERAL|OUTER|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||PROXY|MICROSCOPIST 3|5|Visit_5|90|7|TREATMENT|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|0a5b1036-cd00-4221-b218-ee2664e5a43e|10|PNEUMIND|Pneumonia Indicator|[?]|DECUBITUS|||[?]|1|U/10^12 RBC|PANCREAS, TAIL|IPSILATERAL|PERIPHERAL|PATHOLOGICAL EVALUATION|Y|Y|Y|INVESTIGATOR|PHYSIOTHERAPIST|5|Visit_5|90|3|WASHOUT|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|IRVPP|Percent Predicted IRV|[?]|SLING|||[?]|1|usec|PERIURETERAL REGION|CONTRALATERAL|SURFACE|TRYPAN BLUE STAIN||Y|Y|INTERVIEWER|READER 3|1|Visit_1|10|1|TREATMENT|2020-09-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|2|SALKK|Salazar-Knowles Equation, K|[?]|SEMI-FOWLERS|[?]|P|[?]|1|mol|MASTOID PROCESS|IPSILATERAL|PARIETO-OCCIPITAL|TURBIDIMETRY||||ADJUDICATOR|MICROSCOPIST 3|1|Visit_1|10|2|WASHOUT|2020-09-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|3|MALEVDES|Malignancy Evidence Description|[?]|SEMI-FOWLERS|[?]|PACK|[?]|1|TRANSDUCING UNIT|ABDOMINAL CAVITY|LATERAL|HIND|IMMUNOBLOT||||ADJUDICATOR|ENDOCRINOLOGIST|2|Visit_2|25|3|TREATMENT|2020-10-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|/month|[?]|1|STEPS|METATARSAL BONE|CONTRALATERAL|UPPER EXTENSOR SURFACE|NUCLEIC ACID AMPLIFICATION TEST|Y|Y||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|2|Visit_2|25|2|FOLLOW-UP|2020-10-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|5|SAWVOL|Specific Airway Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|m|OVARIAN FOLLICLE|RIGHT|UPPER|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|||Y|PARENT|ENDOCRINOLOGIST|3|Visit_3|40|5|TREATMENT|2020-10-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|6|IRV|Inspiratory Reserve Volume|[?]|SEMI-FOWLERS|||[?]|1|nmol/mol|EPIDURAL SPACE|CONTRALATERAL|VOLAR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|Y|Y|ADJUDICATOR|NEUROLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-10-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|7|MEP|Maximal Expiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|pptr|[?]|1|mL/beat|INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|POSTERIOR|TRYPAN BLUE STAIN||||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SLING|[?]|Weber|[?]|1|s*kPa|CARDIAC WALL|LATERAL|CRANIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||FRIEND|RADIOLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|% INHIBITION|[?]|1|U/m2/day|MITRAL VALVE, POSTERIOR CUSP|LATERAL|HIND|AMSLER GRID|Y|Y||INVESTIGATOR|NEUROLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-12-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|a4f74465-7abc-4cc2-a0be-25d1c802af8c|10|MIPPP|Percent Predicted MIP|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|PACK|RIB 6|UNILATERAL|DISTAL VOLAR|CORONARY ANGIOGRAPHY|||Y|INVESTIGATOR|MICROSCOPIST|5|Visit_5|90|4|SCREENING|2020-12-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|VO2|Oxygen Consumption|[?]|STANDING, BENT FORWARD|||[?]|1|mEq/mL|OCCIPITAL LOBE|LEFT|OCCIPITAL|LIGHT SCATTERING SPECTROSCOPY|||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|1|Visit_1|10|1|TREATMENT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|2|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|UNCONSTRAINED|[?]|Arbitrary U|[?]|1|pmol/day|HAIR ROOT|LATERAL|ANTEROMEDIAL|PALPATION|Y|||GUARDIAN|RADIOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|3|FEV1REV|FEV1 Reversibility|[?]|UNCONSTRAINED|||[?]|1|Enzyme U/L|CALF MUSCULAR VEIN|RIGHT|DORSAL|NUCLEAR RADIOLOGY|Y||Y|ADJUDICATOR|ADJUDICATOR 1|2|Visit_2|25|2|TREATMENT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING|[?]|mg/mol|[?]|1|mg/mol|LEFT VENTRICULAR APICAL LATERAL SEGMENT|LATERAL|DISTAL|OPTICAL MAPPING||||CHILD|MICROSCOPIST 1|2|Visit_2|25|6|WASHOUT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|5|MIPPP|Percent Predicted MIP|[?]|PRONE|||[?]|1|mAmp|SKIN OF THE LOWER LIMB|UNILATERAL|ANTERIOR|CYSTOMETRY|||Y|SIBLING|OPTOMETRIST|3|Visit_3|40|1|SCREENING|2020-12-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|6|FIV1PP|Percent Predicted FIV1|[?]|SUPINE|||[?]|1|DPM|MIDDLE PHALANX 5 OF THE HAND|CONTRALATERAL|APICAL|NO INFORMATION|||Y|INTERVIEWER|DERMATOLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|DECUBITUS|||[?]|1|g/animal/day|SUBCLAVIAN ARTERY|IPSILATERAL|OCCIPITAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||Y|PROXY|OPTOMETRIST|4|Visit_4|65|3|TREATMENT|2021-01-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|8|LCI|Lung Clearance Index|[?]|DECUBITUS|||[?]|1|mgEq|LIMB, UPPER|UNILATERAL|PARIETO-OCCIPITAL|HIGH RESOLUTION CT|||Y|VENDOR|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2021-01-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|9|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING, LEGS DEPENDENT|[?]|AMPULE|[?]|1|umol/h/mmol|PERICARDIAL CAVITY|IPSILATERAL|DISTAL|REVERSE TRANSCRIPTASE PCR||||ADJUDICATION COMMITTEE|NEUROLOGIST 2|5|Visit_5|90|3|TREATMENT|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|10|TLC|Total Lung Capacity|[?]|UNCONSTRAINED|[?]|mL/cm|[?]|1|ug/g/h|HAMATE BONE|RIGHT|DISTAL VOLAR|CYSTOSCOPY||||SIGNIFICANT OTHER|MICROSCOPIST|5|Visit_5|90|1|TREATMENT|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|1|FEV3PP|Percent Predicted FEV3|[?]|STANDING, BENT FORWARD|[?]|NEEDLE GAUGE|[?]|1|10^4/hpf|KIDNEY, UPPER LOBE|BILATERAL|PERIVENTRICULAR|POPULATION SEQUENCING|Y|||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|1|Visit_1|10|4|WASHOUT|2020-09-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|2|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|||[?]|1|10^6/L|HEART, ATRIUM|BILATERAL|SUBCORTICAL|EEG|||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST|1|Visit_1|10|5|FOLLOW-UP|2020-09-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LATERAL DECUBITUS|[?]|BU|[?]|1|10^6 organisms/mg|MEDIAL FEMORAL CONDYLE|IPSILATERAL|OUTER|AUDIOMETRY||Y||PARENT|READER 3|2|Visit_2|25|2|WASHOUT|2020-09-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|TRENDELENBURG|[?]|10^6 CFU/g|[?]|1|mg/dL|SECOND DIAGONAL BRANCH ARTERY|IPSILATERAL|ANTERIOR|SNP ARRAY||||SIBLING|ONCOLOGIST|2|Visit_2|25|6|SCREENING|2020-09-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|5|LOBVOL|Lobar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|pg|[?]|1|pmol/10^10 cells|SKIN OF THE INFRASCAPULAR REGION|UNILATERAL|CENTRAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||Y||DOMESTIC PARTNER|MICROSCOPIST 1|3|Visit_3|40|1|TREATMENT|2020-10-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|6|FEV1REV|FEV1 Reversibility|[?]|LATERAL DECUBITUS|[?]|MPS U|[?]|1|mph|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LEFT|APICAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y||INTERVIEWER|FORENSIC PATHOLOGIST|3|Visit_3|40|3|SCREENING|2020-10-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|7|SALKK|Salazar-Knowles Equation, K|[?]|SEMI-RECUMBENT|||[?]|1|%(v/v)|ANTERIOR CINGULATE CORTEX|UNILATERAL|INNER|FLAME PHOTOMETRY||Y|Y|FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|TREATMENT|2020-11-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|TRENDELENBURG|[?]|CUP|[?]|1|m/sec|ANTERIOR TIBIAL VEIN|LEFT|PARIETO-OCCIPITAL|EPSILOMETER||||GUARDIAN|FORENSIC PATHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-11-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|9|INERTANC|Inertance|[?]|LEFT LATERAL DECUBITUS|[?]|Ci/ug|[?]|1|/2500 WBC|ANKLE MORTISE|UNILATERAL|FACIAL|ELISPOT||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|5|Visit_5|90|4|WASHOUT|2020-12-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|e7262592-01e8-4cb3-b967-ec1037505e81|10|TGV|Thoracic Gas Volume|[?]|SITTING|[?]|Joule|[?]|1|kPa|GREAT SAPHENOUS VEIN|BILATERAL|VOLAR|RIA||||PARENT|READER|5|Visit_5|90|5|TREATMENT|2020-12-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|bf150829-1b25-418a-9bc6-61716984387c|1|FRC|Functional Residual Capacity|[?]|SUPINE|||[?]|1|ug/mol|VESTIBULOCOCHLEAR NERVE|LATERAL|DEEP|EEG|||Y|CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|1|Visit_1|10|7|SCREENING|2020-06-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|bf150829-1b25-418a-9bc6-61716984387c|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|min*mg/mL|[?]|1|Log10 ELISA unit|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|RIGHT|UPPER FLEXOR SURFACE|STRESS ECHOCARDIOGRAPHY|Y|Y||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|3|SCREENING|2020-06-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|bf150829-1b25-418a-9bc6-61716984387c|3|EVC|Expiratory Vital Capacity|[?]|STANDING|[?]|BEAM BREAKS|[?]|1|mL/s/m2|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|RIGHT|FACIAL|KNEMOMETRY||||INDEPENDENT ASSESSOR|NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|bf150829-1b25-418a-9bc6-61716984387c|4|VO2|Oxygen Consumption|[?]|STANDING|[?]|cmH2O*s2/mL|[?]|1|QUANTITY SUFFICIENT|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|RIGHT|DISTAL VOLAR|GC/MS||||HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|5|FOLLOW-UP|2020-06-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|bf150829-1b25-418a-9bc6-61716984387c|5|FEV1SVC|FEV1/SVC|[?]|STANDING|[?]|%(w/w)|[?]|1|PRESSOR UNITS|FLEXOR POLLICIS LONGUS MUSCLE|LEFT|LOWER|BRDU CELLULAR PROLIFERATION ASSAY||||CAREGIVER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|bf150829-1b25-418a-9bc6-61716984387c|6|FEV1SVC|FEV1/SVC|[?]|FOWLERS|||[?]|1|pmol/10^10 cells|EYELID|UNILATERAL|UPPER EXTENSOR SURFACE|APPLANATION TONOMETRY|Y|Y|Y|STUDY SUBJECT|NEUROLOGIST 1|3|Visit_3|40|3|SCREENING|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|bf150829-1b25-418a-9bc6-61716984387c|7|FIF75|Forced Inspiratory Flow at 75%|[?]|STANDING, BENT FORWARD|[?]|BLOCKS|[?]|1|cd*s/m2|GLOBUS PALLIDUS|CONTRALATERAL|OUTER|STRESS ECHOCARDIOGRAPHY||||CLINICAL RESEARCH COORDINATOR|OPHTHALMOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-08-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|bf150829-1b25-418a-9bc6-61716984387c|8|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|||[?]|1|/kg|HAIR|UNILATERAL|DORSOLATERAL|GC/FID|||Y|FAMILY MEMBER|ONCOLOGIST 1|4|Visit_4|65|2|FOLLOW-UP|2020-08-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|bf150829-1b25-418a-9bc6-61716984387c|9|FEV3PP|Percent Predicted FEV3|[?]|SITTING|||[?]|1|PFU|CORNEAL EPITHELIUM|BILATERAL|LOWER MEDIAL|ELISPOT|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|5|Visit_5|90|6|SCREENING|2020-09-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|bf150829-1b25-418a-9bc6-61716984387c|10|MEP|Maximal Expiratory Pressure|[?]|SLING|||[?]|1|ukat/L|FOOT DIGIT 3|RIGHT|SURFACE|ELISA||Y|Y|HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|5|Visit_5|90|4|SCREENING|2020-09-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|RVPP|Percent Predicted Residual Volume|[?]|REVERSE TRENDELENBURG|[?]|STEPS|[?]|1|mL/min/1.73m2|MID-JUGULAR LYMPH NODE|RIGHT|LOWER MEDIAL|PET/CT SCAN WITHOUT CONTRAST|Y|||GUARDIAN|ENDOCRINOLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|Torr|[?]|1|mm|AXILLARY LYMPH NODE LEVEL III|IPSILATERAL|POSTERIOR|PH METER MEASUREMENT METHOD||Y||GUARDIAN|MICROSCOPIST 2|1|Visit_1|10|7|TREATMENT|2020-09-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|MdFI|[?]|1|yd|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|BASAL|IMMUNOASSAY||Y||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|2|Visit_2|25|5|WASHOUT|2020-09-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|4|RELSZCHG|Relative Size Change|[?]|UNCONSTRAINED|||[?]|1|nmol/day|EXTENSOR HALLUCIS BREVIS MUSCLE|LEFT|FRONTAL|INDIRECT IMMUNOFLUORESCENCE||Y|Y|INVESTIGATOR|MICROSCOPIST|2|Visit_2|25|7|SCREENING|2020-09-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|5|LOBVOL|Lobar Volume|[?]|SEMI-FOWLERS|[?]|log10 CFU/mL|[?]|1|mmol/min/kPa|MOTOR CORTEX|IPSILATERAL|ANTEROTEMPORAL|SCANNING ELECTRON MICROSCOPY|Y|||GUARDIAN|RADIOLOGIST 2|3|Visit_3|40|2|WASHOUT|2020-10-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|6|ICREV|IC Reversibility|[?]|STANDING, BENT FORWARD|[?]|ug/g/h|[?]|1|Gy/h|ESOPHAGEAL LYMPH NODE|BILATERAL|UPPER|IMMUNORADIOMETRIC ASSAY|Y|||VENDOR|INTERNIST|3|Visit_3|40|6|WASHOUT|2020-10-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|7|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING|[?]|PIPE|[?]|1|mN|EXTRAHEPATIC BILE DUCT|BILATERAL|ANTERIOR|CONTACT SPECULAR MICROSCOPY||||SIGNIFICANT OTHER|ENDOCRINOLOGIST|4|Visit_4|65|5|WASHOUT|2020-10-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|8|FEV1PP|Percent Predicted FEV1|[?]|LATERAL DECUBITUS|||[?]|1|gMFI|VERTEBRAL ARTERY|UNILATERAL|BASAL|TRANSTHORACIC ECHOCARDIOGRAPHY|||Y|NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|4|Visit_4|65|6|SCREENING|2020-10-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|9|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|||[?]|1|cg|ANTERIOR TIBIAL VEIN|CONTRALATERAL|DORSOLATERAL|IMPEDANCE CONDUCTIVITY|||Y|FRIEND|READER 3|5|Visit_5|90|6|TREATMENT|2020-11-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|5c1cc260-97a0-493c-bc11-57f31ffd7455|10|RAWPP|Percent Predicted Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|pmol/L|[?]|1|Ci/L|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|UNILATERAL|DISTAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-11-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|ELSTNCE|Elastance|[?]|RIGHT LATERAL DECUBITUS|[?]|INHALATION|[?]|1|mmHg|PROSTATE GLAND, MIDDLE LOBE|IPSILATERAL|PERIPHERAL|BRDU CELLULAR PROLIFERATION ASSAY||||SIBLING|RADIOLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-07-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|TRENDELENBURG|[?]|L/day|[?]|1|cmH2O*s2/mL|INTERTROCHANTERIC REGION|LEFT|UPPER FLEXOR SURFACE|NUCLEIC ACID BASED METHOD||Y||INDEPENDENT ASSESSOR|RATER 2|1|Visit_1|10|7|SCREENING|2020-07-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|3|MEPPP|Percent Predicted MEP|[?]|UNCONSTRAINED|||[?]|1|GBq/mg|CERVICAL VERTEBRA|LATERAL|DORSAL|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|ADJUDICATOR|READER 1|2|Visit_2|25|2|TREATMENT|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|4|FRC|Functional Residual Capacity|[?]|SEMI-RECUMBENT|||[?]|1|pm|SUPRASPINATUS MUSCLE|LEFT|ANTEROLATERAL|TELLER ACUITY CARDS||Y|Y|CLINICAL STUDY SPONSOR|NEUROLOGIST 2|2|Visit_2|25|1|SCREENING|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|5|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|log EID 50/dose|[?]|1|10^6 organisms/g|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|LEFT|VOLAR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||CLINICAL STUDY SPONSOR|READER 1|3|Visit_3|40|6|TREATMENT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|6|FEV1REV|FEV1 Reversibility|[?]|FOWLERS|||[?]|1|CFU/g|MENINGES|RIGHT|INNER|MICROARRAY||Y|Y|FRIEND|PATHOLOGIST 2|3|Visit_3|40|1|WASHOUT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|7|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|uL/mL|[?]|1|kPa/L/sec|AXILLARY LYMPH NODE LEVEL II|BILATERAL|ANTEROMEDIAL|GC/MS-CI||||INTERVIEWER|PHYSIOTHERAPIST|4|Visit_4|65|5|FOLLOW-UP|2020-09-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|8|ERV|Expiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|MBP|[?]|1|psec|INTERNAL ILIAC LYMPH NODE|CONTRALATERAL|UPPER FLEXOR SURFACE|FLUORESCENCE ANGIOGRAPHY|Y|Y||CLINICAL RESEARCH COORDINATOR|INTERNIST|4|Visit_4|65|5|FOLLOW-UP|2020-09-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|9|DLCO|Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|||[?]|1|10^3 CFU|TRANSVERSE TARSAL JOINT|CONTRALATERAL|ANTERIOR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|5|Visit_5|90|5|WASHOUT|2020-10-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|cca2835b-ca8d-4db6-89b4-9f2855968a8a|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|TRENDELENBURG|[?]|kg/cm2|[?]|1|Ci|T11 VERTEBRA|BILATERAL|UPPER|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||||FAMILY MEMBER|MICROSCOPIST|5|Visit_5|90|4|TREATMENT|2020-10-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SLING|||[?]|1|kBq/uL|TRAPEZIUS MUSCLE|IPSILATERAL|SUPERFICIAL|NEPHELOMETRY|Y||Y|NON-HEALTH CARE PROFESSIONAL|READER|1|Visit_1|10|5|WASHOUT|2020-10-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|[?]|DNA copies/ug|[?]|1|U/cL|CARDIAC VALVE|UNILATERAL|DISTAL VOLAR|HILLMEN COLOR CHART||||GUARDIAN|INTERNIST|1|Visit_1|10|6|TREATMENT|2020-10-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|3|INERTANC|Inertance|[?]|UNCONSTRAINED|[?]|PIXELS/cm|[?]|1|uV2|SOFT TISSUE|IPSILATERAL|FACIAL|MAGNETIC RESONANCE ELASTOGRAPHY||||CAREGIVER|READER 1|2|Visit_2|25|2|TREATMENT|2020-10-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|4|INERTANC|Inertance|[?]|DECUBITUS|||[?]|1|10^3 RNA copies/mL|PARS COMPACTA|LEFT|OUTER|CONFOCAL MICROSCOPY|||Y|VENDOR|ADJUDICATOR 1|2|Visit_2|25|3|WASHOUT|2020-10-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|5|FIFMAXPP|Percent Predicted FIFmax|[?]|LATERAL DECUBITUS|||[?]|1|GBq/mg|THYROID GLAND, RIGHT LOBE|UNILATERAL|LATERAL|DYNAMIC LIGHT SCATTERING|||Y|PROXY|OPTOMETRIST|3|Visit_3|40|6|TREATMENT|2020-11-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|6|ELSTNCE|Elastance|[?]|LATERAL DECUBITUS|||[?]|1|10^5/hpf|MIDDLE PHALANX 3 OF THE HAND|UNILATERAL|VENTRAL|MECHANICAL CLOT DETECTION||Y|Y|INDEPENDENT ASSESSOR|RADIOLOGIST|3|Visit_3|40|3|WASHOUT|2020-11-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|7|EVC|Expiratory Vital Capacity|[?]|SITTING|[?]|10^3/L|[?]|1|mU/g|PANCREAS|BILATERAL|CAUDAL|ATOMIC ABSORPTION SPECTROMETRY||||SIBLING|FORENSIC PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|8|DLCOHCVA|HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|mAnson U/mL|[?]|1|mL/dL|L2-L3 INTERVERTEBRAL SPACE|LEFT|POSTERIOR|LIQUID SCINTILLATION COUNTING||||FAMILY MEMBER|FORENSIC PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-12-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|9|ELSTNCE|Elastance|[?]|TRENDELENBURG|[?]|log10 TCID 50/dose|[?]|1|RATIO|LATERAL THIRD DIAGONAL BRANCH ARTERY|BILATERAL|LOWER|CLIP||||SIBLING|READER 2|5|Visit_5|90|7|WASHOUT|2020-12-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING|[?]|Hz|[?]|1|mL/h|BRAIN|LEFT|FACIAL|AURAMINE STAIN||||SPOUSE|CARDIOLOGIST|5|Visit_5|90|3|TREATMENT|2020-12-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|INTP|Interpretation|[?]|PRONE|[?]|DRUM|[?]|1|MBq/uL|PERICARDIAL LYMPH NODE|LATERAL|APICAL|INTRAVASCULAR ULTRASOUND|Y|||STUDY SUBJECT|ENDOCRINOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|2|OXYPULSE|Oxygen Pulse|[?]|SEMI-FOWLERS|[?]|HOURS|[?]|1|Gravitational Unit|JEJUNUM|LEFT|ANTEROPOSTERIOR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|||CHILD|RADIOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|[?]|KIT|[?]|1|deg/mm|HILAR|LATERAL|ANTEROLATERAL|CINEANGIOGRAPHY||Y||INTERVIEWER|INTERNIST|2|Visit_2|25|4|TREATMENT|2020-05-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|4|IC|Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|10^5/L|[?]|1|mg/L FEU|RIB 3|RIGHT|ANTERIOR|AUTOMATED COUNT|Y|Y||INDEPENDENT ASSESSOR|PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-05-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|SUPINE|||[?]|1|/VF|TRIANGULAR-HAMATE JOINT|BILATERAL|TIP|JAFFE REACTION|Y|Y|Y|ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2020-06-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|6|TGV|Thoracic Gas Volume|[?]|STANDING, BENT FORWARD|[?]|pg/cell|[?]|1|BOX|HEPATOBILIARY SYSTEM|UNILATERAL|INFERIOR|PEAK FLOWMETRY||Y||INTERVIEWER|RATER|3|Visit_3|40|6|WASHOUT|2020-06-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|7|INFLTIND|Infiltrates Indicator|[?]|STANDING, BENT FORWARD|[?]|pm|[?]|1|kcal/day|PAROTID GLAND|BILATERAL|UPPER FLEXOR SURFACE|VIRUS PLAQUE ASSAY||||INVESTIGATOR|FORENSIC PATHOLOGIST|4|Visit_4|65|6|SCREENING|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|g/animal/wk|CEPHALIC VEIN|BILATERAL|UPPER EXTENSOR SURFACE|PEAK FLOWMETRY|Y||Y|PARENT|ONCOLOGIST|4|Visit_4|65|1|TREATMENT|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|9|TVPP|Percent Predicted Tidal Volume|[?]|DECUBITUS|||[?]|1|/LPF|SAPHENOUS VEIN|LATERAL|ANTEROTEMPORAL|PLETHYSMOGRAPHY|||Y|SIBLING|READER 3|5|Visit_5|90|7|TREATMENT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|74cd0a4f-f9fe-4df9-93b8-7832512d0828|10|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING|[?]|ft2|[?]|1|ng/day|EYELASH|UNILATERAL|ANTEROLATERAL|HEMAGGLUTINATION ASSAY||||PROXY|ONCOLOGIST|5|Visit_5|90|1|WASHOUT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|1|FRCPP|Percent Predicted FRC|[?]|SITTING, LEGS DEPENDENT|[?]|GPL U/mL|[?]|1|10^6 IU/mL|C5 VERTEBRA|LEFT|PROXIMAL VOLAR|REFLECTANCE SPECTROSCOPY||Y||INDEPENDENT ASSESSOR|MICROSCOPIST 3|1|Visit_1|10|1|TREATMENT|2020-06-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|2|IVCPP|Percent Predicted IVC|[?]|SEMI-FOWLERS|[?]|mg/L|[?]|1|K|PORTAL VEIN BIFURCATION|LEFT|UPPER|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|3|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pkat/L|SMALL SAPHENOUS VEIN|IPSILATERAL|UPPER FLEXOR SURFACE|VIRUS PLAQUE ASSAY||Y|Y|PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|5|FOLLOW-UP|2020-07-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|cycle/min|[?]|1|mOsm|TRIGEMINAL NERVE|LEFT|FRONTAL|IN VITRO GENE EXPRESSION ASSAY|Y|||CAREGIVER|RADIOLOGIST|2|Visit_2|25|1|TREATMENT|2020-07-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|5|RELSZCHG|Relative Size Change|[?]|UNCONSTRAINED|||[?]|1|10^6 IU/mL|RENAL ARTERY|BILATERAL|DISTAL|PULMONARY ANGIOGRAPHY|Y||Y|GUARDIAN|ADJUDICATOR 2|3|Visit_3|40|3|TREATMENT|2020-07-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|6|FIF25|Forced Inspiratory Flow at 25%|[?]|SUPINE|||[?]|1|rpm|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|BILATERAL|DISTAL|AUTOMATED COUNT|Y||Y|CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-07-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|7|ALVVOL|Alveolar Volume|[?]|LATERAL DECUBITUS|||[?]|1|/LPF|UVEA|BILATERAL|VENTROLATERAL|PHOROPTER|||Y|SIGNIFICANT OTHER|ONCOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|8|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|||[?]|1|mm/h|RETROPERITONEUM|RIGHT|INNER|TURBIDIMETRY||Y|Y|SIBLING|MICROSCOPIST|4|Visit_4|65|4|TREATMENT|2020-08-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|9|FRCPP|Percent Predicted FRC|[?]|STANDING|[?]|/LPF|[?]|1|mgEq|CECUM|CONTRALATERAL|INNER|FORCED OSCILLATION TECHNIQUE||||INDEPENDENT ASSESSOR|ONCOLOGIST 1|5|Visit_5|90|6|FOLLOW-UP|2020-09-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|09238251-feaf-45a9-b295-dfed9a75fbb2|10|MEP|Maximal Expiratory Pressure|[?]|SITTING, LEGS DEPENDENT|[?]|PIPE|[?]|1|GPL U/mL|ANTERIOR TIBIAL VEIN|IPSILATERAL|PROXIMAL VOLAR|SPIROMETRY||||CHILD|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2020-09-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|1|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mg2/dL2|FALCIFORM LIGAMENT|RIGHT|TIP|GC/MS|||Y|SPOUSE|DERMATOLOGIST|1|Visit_1|10|6|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|2|EXPRELTM|Expiration Relaxation Time|[?]|SITTING|[?]|umol/min|[?]|1|lm|L1 VERTEBRA|IPSILATERAL|INNER|RIA||Y||INDEPENDENT ASSESSOR|RATER 2|1|Visit_1|10|4|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|3|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|hr/day|[?]|1|mg/h|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LEFT|INNER|POTENTIOMETRY||||SPOUSE|PATHOLOGIST 1|2|Visit_2|25|2|WASHOUT|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|4|PEFTIME|Peak Expiratory Flow Time|[?]|LEFT LATERAL DECUBITUS|[?]|/10^4|[?]|1|mmol/L|CORPUS UTERI|UNILATERAL|ANTEROPOSTERIOR|DROPLET DIGITAL PCR|Y|||DOMESTIC PARTNER|READER 1|2|Visit_2|25|4|SCREENING|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|5|IC|Inspiratory Capacity|[?]|SLING|[?]|uU/dL|[?]|1|uCi/kg|CINGULATE CORTEX|RIGHT|BASAL|PULSE OXIMETRY||||FAMILY MEMBER|RADIOLOGIST 1|3|Visit_3|40|4|SCREENING|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|DECUBITUS|||[?]|1|cal|LUMBRICAL MUSCLES OF THE HAND|RIGHT|OCCIPITAL|FUNCTIONAL MRI|Y||Y|CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|3|Visit_3|40|4|SCREENING|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|7|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|Bq|[?]|1|hr/day|GASTROINTESTINAL SYSTEM|LEFT|TIP|HIGH RESOLUTION MELT ANALYSIS||||PARENT|FORENSIC PATHOLOGIST|4|Visit_4|65|7|SCREENING|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|8|EFFIND|Effusion Indicator|[?]|STANDING, BENT FORWARD|[?]|GBq/mg|[?]|1|TCID 50/dose|COLON, RIGHT|UNILATERAL|SUPERIOR|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|kg|SUPERFICIAL FEMORAL ARTERY|RIGHT|LOWER|NO INFORMATION||Y|Y|STUDY SUBJECT|ENDOCRINOLOGIST|5|Visit_5|90|4|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|3e896568-85dc-4a14-ba41-eb3575940a9d|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|Gy/h|[?]|1|fraction of 1|POPLITEAL ARTERY ABOVE KNEE|LEFT|FRONTAL|FLOCCULATION, CHARCOAL ENHANCED|Y|Y||CAREGIVER|CLINICAL PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|||[?]|1|pmol|CAUDATE NUCLEUS|LATERAL|LOWER MEDIAL|MANUAL CLOT DETECTION|||Y|GUARDIAN|MICROSCOPIST|1|Visit_1|10|2|TREATMENT|2020-10-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|2|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|psi|[?]|1|umol/L/h|GLOSSOPHARYNGEAL NERVE|LEFT|BASAL|SURFACE PLASMON RESONANCE||||PROXY|READER 2|1|Visit_1|10|6|FOLLOW-UP|2020-10-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|3|QUASCOMP|Quasi-Static Compliance|[?]|SITTING|||[?]|1|IU/g Hb|TALUS|LATERAL|ANTEROMEDIAL|MULTI-SLICE SPIRAL CT|||Y|SIBLING|ENDOCRINOLOGIST|2|Visit_2|25|1|SCREENING|2020-11-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|4|MIP|Maximal Inspiratory Pressure|[?]|PRONE|[?]|fraction of 1|[?]|1|MHz|PHARYNX|CONTRALATERAL|CENTRAL|CLIP||Y||PROXY|RADIOLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-11-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|ukat|[?]|1|RNA copies/mL|MENINGES|BILATERAL|DEEP|FLOCCULATION||||PROXY|RATER|3|Visit_3|40|6|TREATMENT|2020-11-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|6|MALIND|Malignancy Indicator|[?]|REVERSE TRENDELENBURG|[?]|min*mg/mL|[?]|1|/ms|GREAT SAPHENOUS VEIN|UNILATERAL|MIDLINE|PATHOLOGICAL EVALUATION|Y|||DOMESTIC PARTNER|PHYSIOTHERAPIST|3|Visit_3|40|2|TREATMENT|2020-11-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|7|PNEUMIND|Pneumonia Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol BCE/L|[?]|1|uU/L|PRESACRAL LYMPH NODE|CONTRALATERAL|SUPERFICIAL|WHOLE TRANSCRIPTOME SEQUENCING|Y|Y||ADJUDICATION COMMITTEE|READER 2|4|Visit_4|65|2|TREATMENT|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|10^3/L|[?]|1|ug/m2|INFRARENAL AORTA|LATERAL|FACIAL|LIQUID SCINTILLATION COUNTING||||PROXY|NEUROLOGIST 2|4|Visit_4|65|7|FOLLOW-UP|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|9|FIFMAX|Maximum Forced Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|U/m2/h|[?]|1|kBq/uL|DISTAL INTERPHALANGEAL JOINT 4|CONTRALATERAL|TIP|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|||PROXY|ADJUDICATOR 1|5|Visit_5|90|4|WASHOUT|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|10|FEF2575|Forced Expiratory Flow 25-75%|[?]|UNCONSTRAINED|[?]|g/U|[?]|1|L/s|AORTIC VALVE, NON-CORONARY CUSP|BILATERAL|MIDLINE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||Y||SPOUSE|MICROSCOPIST 2|5|Visit_5|90|3|TREATMENT|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|1|PLMBLFLW|Pulmonary Blood Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|SCOOPFUL|BRAIN, THIRD VENTRICLE|UNILATERAL|SURFACE|POLYSOMNOGRAPHY|||Y|SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|SCREENING|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|2|AWVOL|Airway Volume|[?]|SEMI-FOWLERS|[?]|OI50|[?]|1|BU/mL|LEFT POSTEROLATERAL DESCENDING ARTERY|UNILATERAL|VENTRAL|RADIATION DOSIMETRY||Y||ADJUDICATION COMMITTEE|ONCOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|3|RAWPP|Percent Predicted Airway Resistance|[?]|PRONE|||[?]|1|pg/cell|AORTA|CONTRALATERAL|PROXIMAL VOLAR|OBSERVATION|||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|2|Visit_2|25|5|WASHOUT|2020-12-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|4|LOBVOL|Lobar Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|/500 WBC|MAIN BRONCHUS, LEFT|UNILATERAL|FRONTAL|FLUORESCENT SPOT TEST|Y||Y|CHILD|ENDOCRINOLOGIST|2|Visit_2|25|6|SCREENING|2020-12-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|5|PCF|Peak Cough Flow|[?]|SEMI-FOWLERS|[?]|mol/mg|[?]|1|U/kg/h|INTERPHALANGEAL JOINT 2 OF THE FOOT|CONTRALATERAL|UPPER EXTENSOR SURFACE|IVY INCISION METHOD||||CHILD|RATER 1|3|Visit_3|40|1|TREATMENT|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|6|AIRTRAP|Air Trapping|[?]|STANDING, BENT FORWARD|[?]|FINGERTIP UNIT|[?]|1|PIXELS/in|BRAIN|LEFT|CAUDAL|TWO-COLOR MICROARRAY||Y||ADJUDICATOR|CARDIOLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|NEEDLE GAUGE|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|IPSILATERAL|MIDLINE|X-RAY FLUORESCENCE SPECTROMETRY|||Y|PARENT|DERMATOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2021-01-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|DECUBITUS|||[?]|1|ug/kg/min|URETER|IPSILATERAL|PERIPHERAL|MANUAL COUNT||Y|Y|FRIEND|PHYSIOTHERAPIST|4|Visit_4|65|1|TREATMENT|2021-01-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|9|FRC|Functional Residual Capacity|[?]|SEMI-RECUMBENT|[?]|amol|[?]|1|ug/L/h|PECTORALIS MAJOR MUSCLE|LATERAL|CAUDAL|EIA|Y|||FRIEND|DERMATOLOGIST|5|Visit_5|90|6|TREATMENT|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|725c5a91-72b0-4b2c-a51a-d1006303373e|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|TRENDELENBURG|[?]|in|[?]|1|mmol/min/kPa|MEDIAL FEMORAL CONDYLE|BILATERAL|TIP|CHROMATOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|5|Visit_5|90|1|TREATMENT|2021-02-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SUPINE|||[?]|1|Log10 ELISA unit|SOLEUS MUSCLE|BILATERAL|ROSTRAL|MICRO BROTH DILUTION|||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 2|1|Visit_1|10|2|TREATMENT|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|2|TSUHYS|Tissue Hysteresivity|[?]|SEMI-FOWLERS|[?]|U/m2/min|[?]|1|GBq/ug|PUPIL|IPSILATERAL|LOWER|ATOMIC ABSORPTION SPECTROMETRY||||CAREGIVER|MICROSCOPIST|1|Visit_1|10|7|SCREENING|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|3|FIO2|Fraction of Inspired Oxygen|[?]|REVERSE TRENDELENBURG|[?]|ug/L/h|[?]|1|ug/L|RECTUS FEMORIS MUSCLE|RIGHT|ANTEROLATERAL|CENTRIFUGATION||||CAREGIVER|PATHOLOGIST 1|2|Visit_2|25|6|WASHOUT|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|4|ALVVOL|Alveolar Volume|[?]|STANDING, BENT FORWARD|[?]|RING|[?]|1|10^3/hpf|CERVICAL LYMPH NODE|BILATERAL|DEEP|GEL ELECTROPHORESIS|Y|||ADJUDICATION COMMITTEE|ADJUDICATOR 2|2|Visit_2|25|4|WASHOUT|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|5|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING|[?]|usec|[?]|1|MET*h|EXTERNAL ILIAC LYMPH NODE|IPSILATERAL|DEEP|SMEAR|Y|||PROXY|ADJUDICATOR 2|3|Visit_3|40|4|TREATMENT|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|RIGHT LATERAL DECUBITUS|[?]|F|[?]|1|mAnson U/mL|COLON, RECTOSIGMOID|CONTRALATERAL|INNER|EIA|Y|Y||CHILD|NEUROLOGIST 1|3|Visit_3|40|6|WASHOUT|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|7|FIV1PP|Percent Predicted FIV1|[?]|PRONE|[?]|10^8/L|[?]|1|STEPS|EPITROCHLEAR LYMPH NODE|BILATERAL|ANTEROMEDIAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|8|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|uV2|[?]|1|BE/mL|INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|APICAL|ELLA|Y|||CHILD|RADIOLOGIST 2|4|Visit_4|65|3|TREATMENT|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|9|FIF25|Forced Inspiratory Flow at 25%|[?]|TRENDELENBURG|[?]|F|[?]|1|mmHg/L/min|HEART, SEPTUM|IPSILATERAL|DISTAL VOLAR|REFRACTOMETRY||||INTERVIEWER|RATER 2|5|Visit_5|90|1|TREATMENT|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|5bf5b31d-a59d-46b7-8f8f-97919d449565|10|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|[?]|Ci/ug|[?]|1|mL/100g/min|OROPHARYNX|LEFT|LOWER MEDIAL|OLIGO ACGH||||PROXY|MICROSCOPIST 2|5|Visit_5|90|1|WASHOUT|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|[?]|umol/L|[?]|1|uV|LEFT VENTRICULAR EPICARDIUM|LATERAL|INFERIOR|CORONARY ANGIOGRAPHY||||INTERVIEWER|FORENSIC PATHOLOGIST|1|Visit_1|10|3|SCREENING|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|FOWLERS|[?]|BAU|[?]|1|ukat/10^12 RBC|ULNAR ARTERY|BILATERAL|ANTEROMEDIAL|MRS||||CLINICAL STUDY SPONSOR|UROLOGIST|1|Visit_1|10|7|WASHOUT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|3|TVPP|Percent Predicted Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/s/m2|[?]|1|mL/s|CORONARY SINUS|LEFT|INFERIOR|LEAD CITRATE STAIN|Y|||CAREGIVER|NEUROLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|SUPINE|||[?]|1|10^4 CFU/mL|PANCREAS, BODY|LATERAL|ANTEROMEDIAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||Y|INVESTIGATOR|CARDIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|5|ALVVOL|Alveolar Volume|[?]|SLING|[?]|Bq/L|[?]|1|dpm/0.5 mL|BRACHIAL VEIN|CONTRALATERAL|INTERMEDIATE|CORONARY ANGIOGRAPHY|Y|||PROXY|PATHOLOGIST 1|3|Visit_3|40|1|SCREENING|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|6|RELSZCHG|Relative Size Change|[?]|SUPINE|[?]|Bq/uL|[?]|1|mL/(min*100mL)|EPIGLOTTIS|UNILATERAL|FORE|PET/CT SCAN|Y|||CHILD|RADIOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|7|FRCPP|Percent Predicted FRC|[?]|PRONE|[?]|v/v|[?]|1|days/wk|MIDDLE PHALANX 4 OF THE HAND|RIGHT|ANTEROLATERAL|SPECT SCAN||||CLINICAL RESEARCH COORDINATOR|READER 3|4|Visit_4|65|1|TREATMENT|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|STANDING|[?]|10^6/Ejaculate U|[?]|1|Ci/mg|GANGLION|UNILATERAL|FACIAL|NUCLEIC ACID SEQUENCING||Y||SIGNIFICANT OTHER|PHYSIOTHERAPIST|4|Visit_4|65|5|TREATMENT|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|9|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|U/g/h|[?]|1|Ci/mg|HUMERAL EPICONDYLE|UNILATERAL|INNER|HPLC/IEX||Y||SIBLING|NEUROLOGIST|5|Visit_5|90|2|SCREENING|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|7fc35880-1672-4e64-ba3b-aa3f1e42764b|10|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SLING|[?]|ms/mmHg|[?]|1|uCi|COLON WALL|RIGHT|CENTRAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||PROXY|READER 2|5|Visit_5|90|1|WASHOUT|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|DIP|SKIN OF THE HEAD|LATERAL|SUBCORTICAL|PET/MRI SCAN|||Y|CLINICAL STUDY SPONSOR|NEUROLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-10-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|2|RAW|Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|PNU/mL|[?]|1|mV*min|EAR, OUTER|LATERAL|INNER|PYROSEQUENCING||Y||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|1|Visit_1|10|2|WASHOUT|2020-10-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|3|FIF50|Forced Inspiratory Flow at 50%|[?]|TRENDELENBURG|[?]|mol/L|[?]|1|PRESSOR UNITS|HYPOGLOSSAL NERVE|LATERAL|HIND|SCINTIGRAPHY||Y||INVESTIGATOR|OPHTHALMOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-10-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|PNU/mL|[?]|1|USP U|AORTIC VALVE, NON-CORONARY CUSP|LEFT|SUPERFICIAL|THERMAL IONIZATION MASS SPECTROMETRY||||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|TREATMENT|2020-10-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SITTING|[?]|/MBP|[?]|1|mEq/mmol|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|CONTRALATERAL|SUPERIOR|TRANSVAGINAL ULTRASOUND|Y|Y||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-11-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|6|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|[?]|AU/mL|[?]|1|ELISA unit/dose|SUPRAGLOTTIS|IPSILATERAL|APICAL|FLUORESCENT ENZYME IMMUNOASSAY|Y|||PARENT|INTERNIST|3|Visit_3|40|1|TREATMENT|2020-11-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|7|RER|Respiratory Exchange Ratio|[?]|STANDING|[?]|log10 TCID 50/mL|[?]|1|10^9/g|WRIST JOINT EXTENSOR MUSCLES|IPSILATERAL|ANTEROMEDIAL|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|READER|4|Visit_4|65|7|TREATMENT|2020-12-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LATERAL DECUBITUS|[?]|Ci/uL|[?]|1|hr/day|L4 VERTEBRA|BILATERAL|PARIETO-OCCIPITAL|PHOTOGRAPHY||Y||ADJUDICATOR|READER 2|4|Visit_4|65|1|SCREENING|2020-12-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|9|FEV_PEF|FEV at PEF|[?]|STANDING|[?]|BE/mL|[?]|1|MPL U/mL|EPIGASTRIC LYMPH NODE|BILATERAL|PARIETO-OCCIPITAL|ACID FAST STAIN||||SPOUSE|ADJUDICATOR 3|5|Visit_5|90|1|TREATMENT|2021-01-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|10|LCI|Lung Clearance Index|[?]|SEMI-RECUMBENT|[?]|DISK|[?]|1|in|CARPOMETACARPAL JOINT 4|IPSILATERAL|ANTEROMEDIAL|COMPLEMENT FIXATION|Y|||SIGNIFICANT OTHER|ADJUDICATOR 3|5|Visit_5|90|5|TREATMENT|2021-01-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|REVERSE TRENDELENBURG|[?]|mg/min|[?]|1|Tbsp|POSTERIOR TIBIAL VEIN|CONTRALATERAL|CRANIAL|SCINTIGRAPHY|Y|Y||SIBLING|READER|1|Visit_1|10|2|SCREENING|2021-01-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|2|ELSTNCE|Elastance|[?]|LEFT LATERAL DECUBITUS|[?]|GBq|[?]|1|10^3 CFU|CORONARY ARTERY, RIGHT|LATERAL|INFERIOR|ENDPOINT DILUTION ASSAY||||GUARDIAN|PATHOLOGIST 1|1|Visit_1|10|7|SCREENING|2021-01-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|3|FIF25|Forced Inspiratory Flow at 25%|[?]|TRENDELENBURG|[?]|umol/kg/min|[?]|1|KALLIKREIN INHIBITOR UNIT|ANTERIOR CINGULATE CORTEX|LEFT|FRONTAL|LISSAMINE GREEN STAIN||||SIGNIFICANT OTHER|ENDOCRINOLOGIST|2|Visit_2|25|7|TREATMENT|2021-01-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-FOWLERS|[?]|cmol/L|[?]|1|10^6 CFU|OVARIAN FOLLICLE|LEFT|BASAL|SLOAN LETTER EYE CHART 2.5%||||SIBLING|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2021-01-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|5|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|[?]|Hz|[?]|1|Hz/s|INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|DEEP|HANSEL STAIN||||CHILD|OTOLARYNGOLOGIST|3|Visit_3|40|1|WASHOUT|2021-02-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|6|IC|Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|cm H2O|[?]|1|QUANTITY SUFFICIENT|PAROTID GLAND|BILATERAL|SUPERIOR|IMMUNOCHROMATOGRAPHY||Y||FRIEND|READER 3|3|Visit_3|40|2|FOLLOW-UP|2021-02-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|[?]|kDa|[?]|1|h*%|HAND DIGIT 1|CONTRALATERAL|SURFACE|MICROSCOPY||Y||PARENT|NEUROLOGIST|4|Visit_4|65|2|SCREENING|2021-02-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|8|MEPPP|Percent Predicted MEP|[?]|SEMI-FOWLERS|[?]|fmol/L/sec|[?]|1|mIU/L|GLOMERULUS|LATERAL|PROXIMAL VOLAR|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||GUARDIAN|MICROSCOPIST 1|4|Visit_4|65|6|TREATMENT|2021-02-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|PRONE|||[?]|1|usec|COMMON ILIAC LYMPH NODE|BILATERAL|CRANIAL|ELECTRICAL IMPEDANCE MYOGRAPHY|||Y|VENDOR|ADJUDICATOR|5|Visit_5|90|1|FOLLOW-UP|2021-03-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|f8878ffd-67af-414c-b346-596dbec640cf|10|SVC|Slow Vital Capacity|[?]|PRONE|[?]|SPRAY|[?]|1|/10^4|FOOT DIGIT 2|LATERAL|TIP|CLIP||||FRIEND|READER 2|5|Visit_5|90|1|FOLLOW-UP|2021-03-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|cm|[?]|1|mg/kg|BRAIN, PERIVENTRICULAR REGION|BILATERAL|PERIPHERAL|INTRAVASCULAR ULTRASOUND||||SIBLING|ONCOLOGIST 2|1|Visit_1|10|3|FOLLOW-UP|2020-05-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-08
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|2|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|kg/L|[?]|1|nU/cL|MITRAL VALVE, POSTERIOR ANNULUS|LEFT|ROSTRAL|MICRODENSITOMETRY|Y|Y||STUDY SUBJECT|OPTOMETRIST|1|Visit_1|10|6|WASHOUT|2020-05-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-08
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|3|TLC|Total Lung Capacity|[?]|SEMI-FOWLERS|[?]|10^6/g|[?]|1|genEq/mL|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|UNILATERAL|ANTEROPOSTERIOR|ELECTROCHEMILUMINESCENCE|Y|||CAREGIVER|RADIOLOGIST|2|Visit_2|25|2|WASHOUT|2020-05-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|4|FRC|Functional Residual Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|EID 50/dose|[?]|1|10^9 organisms/mg|SKIN OF THE TRUNK|UNILATERAL|ANTEROPOSTERIOR|WHOLE EXOME SEQUENCING|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 3|2|Visit_2|25|6|TREATMENT|2020-05-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|PFU/dose|[?]|1|mPa|RETROPERITONEAL LYMPH NODE|LATERAL|VENTRAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y||PROXY|READER 1|3|Visit_3|40|3|TREATMENT|2020-06-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|6|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|[?]|DNA copies/ug|[?]|1|P|THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|INNER|ALCIAN BLUE STAIN||||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|1|TREATMENT|2020-06-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|7|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|[?]|Osm|[?]|1|nmol BCE/mmol|FINGER EXTENSOR TENDONS|LATERAL|UPPER FLEXOR SURFACE|STATIC PERIMETRY|Y|Y||FRIEND|ADJUDICATOR 1|4|Visit_4|65|3|TREATMENT|2020-07-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|kIU|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|UNILATERAL|FACIAL|JAFFE REACTION|||Y|NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-07-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|9|ELSTNCE|Elastance|[?]|TRENDELENBURG|||[?]|1|cup eq|SPLEEN|LATERAL|DEEP|PEAK FLOWMETRY|Y||Y|PARENT|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|d8212248-cd8c-4404-8ad8-2c89c05bee9e|10|ERVPP|Percent Predicted ERV|[?]|SEMI-RECUMBENT|[?]|mg/cm2|[?]|1|MPS U|PROXIMAL URETHRA|BILATERAL|SUPERFICIAL|CAPILLARY ELECTROPHORESIS||||VENDOR|NEUROLOGIST 2|5|Visit_5|90|1|FOLLOW-UP|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|PNEUMIND|Pneumonia Indicator|[?]|PRONE|||[?]|1|mL/animal/day|PELVIS|RIGHT|CRANIAL|DARK FIELD MICROSCOPY||Y|Y|HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|7|SCREENING|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SLING|[?]|mg/m2/h|[?]|1|ug|PROXIMAL CIRCUMFLEX ARTERY|BILATERAL|LOWER MEDIAL|COULOMETRIC TITRATION||||SIBLING|RADIOLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|3|FIO2|Fraction of Inspired Oxygen|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/kg/h|OLFACTORY BULB|IPSILATERAL|PERIVENTRICULAR|DIFFUSION TENSOR MRI|||Y|CAREGIVER|READER 3|2|Visit_2|25|1|FOLLOW-UP|2020-07-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|4|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|[?]|/mm2|[?]|1|TRANSDUCING UNIT|TYMPANIC MEMBRANE|RIGHT|LOWER|MODIFIED ACID FAST STAIN|Y|Y||GUARDIAN|PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|5|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-RECUMBENT|[?]|Joule|[?]|1|cpm|CHEST WALL|CONTRALATERAL|NASAL|PHASE-CONTRAST MRI|Y|||INTERVIEWER|NEUROLOGIST 1|3|Visit_3|40|4|WASHOUT|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|6|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|||[?]|1|CAPFUL|POSTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|UPPER EXTENSOR SURFACE|CONTRAST ENHANCED MRI|||Y|CLINICAL RESEARCH COORDINATOR|RATER 2|3|Visit_3|40|1|TREATMENT|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|7|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|[?]|mL/m2/min|[?]|1|g/U|HEART, LEFT VENTRICLE|UNILATERAL|POSTERIOR|ACCELERATOR MASS SPECTROMETRY||||ADJUDICATOR|READER 3|4|Visit_4|65|6|TREATMENT|2020-08-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|8|FEV1FVC|FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|10^7/L|[?]|1|nmol/mol|SARTORIUS MUSCLE|IPSILATERAL|HIND|RADIOGRAPHY||||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|9|ICREV|IC Reversibility|[?]|SITTING|||[?]|1|%|DISTAL COMMON BILE DUCT|UNILATERAL|VENTRAL|CISH|||Y|INTERVIEWER|RATER|5|Visit_5|90|2|TREATMENT|2020-09-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|10|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|||[?]|1|MPS U|STERNAL MANUBRIUM|IPSILATERAL|PERIVENTRICULAR|DISK DIFFUSION||Y|Y|INVESTIGATOR|READER 2|5|Visit_5|90|5|TREATMENT|2020-09-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|kcal/day|[?]|1|CUP|EYE, VITREOUS CHAMBER|LEFT|SUPERIOR|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||ADJUDICATOR|ENDOCRINOLOGIST|1|Visit_1|10|7|TREATMENT|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|UNCONSTRAINED|[?]|%/min|[?]|1|mL/breath|LARYNX|CONTRALATERAL|DORSOLATERAL|DYNAMIC LIGHT SCATTERING||||DOMESTIC PARTNER|MICROSCOPIST|1|Visit_1|10|5|WASHOUT|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|3|RAWPP|Percent Predicted Airway Resistance|[?]|DECUBITUS|[?]|tsp|[?]|1|C|FLEXOR DIGITORUM PROFUNDUS MUSCLE|BILATERAL|UPPER|TWO-COLOR MICROARRAY|Y|||PARENT|RATER 1|2|Visit_2|25|6|WASHOUT|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-FOWLERS|[?]|g/U|[?]|1|MET*min|FOREARM|CONTRALATERAL|VENTROLATERAL|ELECTRONEUROGRAPHY|Y|||FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|5|SCREENING|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|5|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|Ci|[?]|1|uSiemens|LENS|LEFT|VOLAR|KNEMOMETRY||||SIBLING|ONCOLOGIST 2|3|Visit_3|40|3|FOLLOW-UP|2021-02-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|6|FEV1PP|Percent Predicted FEV1|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ug/dose|PAROTID GLAND|LEFT|APICAL|CRYOSCOPY|||Y|PARENT|ONCOLOGIST 1|3|Visit_3|40|5|TREATMENT|2021-02-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|7|MIP|Maximal Inspiratory Pressure|[?]|DECUBITUS|[?]|copies/mL|[?]|1|log EID 50/dose|TRICUSPID VALVE, POSTERIOR ANNULUS|UNILATERAL|ANTEROTEMPORAL|LIGHT SCATTERING SPECTROSCOPY||||PARENT|MICROSCOPIST 1|4|Visit_4|65|5|WASHOUT|2021-03-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|8|TSUELAS|Tissue Elastance|[?]|TRENDELENBURG|[?]|mol|[?]|1|SQU/mL|TRICUSPID VALVE|IPSILATERAL|ANTEROMEDIAL|MICROARRAY||||INDEPENDENT ASSESSOR|OPTOMETRIST|4|Visit_4|65|3|SCREENING|2021-03-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|9|FEV1FVC6|FEV1/FVC6|[?]|LEFT LATERAL DECUBITUS|[?]|kcal/day|[?]|1|nm|LEFT CIRCUMFLEX ARTERY OSTIUM|CONTRALATERAL|PARIETO-OCCIPITAL|FORCED OSCILLATION TECHNIQUE|Y|Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|SCREENING|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|b832144e-88c4-4ad6-b173-abac7802a36c|10|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|[?]|/4.0 mL|[?]|1|mg/dose|STOMACH|UNILATERAL|UPPER|NEPHELOMETRY||Y||ADJUDICATOR|OPHTHALMOLOGIST|5|Visit_5|90|3|TREATMENT|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|1|DLCOHC|HGB Corrected DLCO|[?]|DECUBITUS|[?]|mL/cm|[?]|1|mg/day|GREAT VESSELS|CONTRALATERAL|CRANIAL|FLOCCULATION|Y|||PARENT|MICROSCOPIST 3|1|Visit_1|10|5|SCREENING|2020-05-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING|||[?]|1|mkat|SKIN OF THE NECK|CONTRALATERAL|PROXIMAL|CALCOFLUOR WHITE STAIN||Y|Y|SIBLING|ADJUDICATOR 2|1|Visit_1|10|3|TREATMENT|2020-05-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|3|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|||[?]|1|mg/kg/day|AXIAL SKELETON|LATERAL|VOLAR|PANENDOSCOPY|||Y|INTERVIEWER|RATER|2|Visit_2|25|2|SCREENING|2020-06-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|4|MEPPP|Percent Predicted MEP|[?]|TRENDELENBURG|[?]|mV*min|[?]|1|APS U|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|CAUDAL|SURFACE PLASMON RESONANCE|Y|||ADJUDICATOR|ONCOLOGIST 1|2|Visit_2|25|3|WASHOUT|2020-06-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|TRENDELENBURG|||[?]|1|10^9 CFU/mL|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|IPSILATERAL|CRANIAL|WRIGHT STAIN|Y||Y|FRIEND|OTOLARYNGOLOGIST|3|Visit_3|40|7|SCREENING|2020-06-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|6|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|Sv|[?]|1|nmol/mL/min|LIMB, LOWER|LATERAL|FACIAL|CONTRAST ENHANCED CT SCAN||||ADJUDICATION COMMITTEE|RATER|3|Visit_3|40|1|SCREENING|2020-06-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|7|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|REVERSE TRENDELENBURG|||[?]|1|/mm|INTRAHEPATIC LARGE BILE DUCT|CONTRALATERAL|PERIPHERAL|MODIFIED ACID FAST STAIN|||Y|CLINICAL RESEARCH ASSOCIATE|READER 3|4|Visit_4|65|4|WASHOUT|2020-07-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|8|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|U/animal|[?]|1|pptr|REGIONAL LYMPH NODE|UNILATERAL|MEDIAL|DUCTOGRAPHY||Y||VENDOR|HEMATOLOGIST|4|Visit_4|65|1|WASHOUT|2020-07-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|9|ICREV|IC Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|SYRINGE|[?]|1|TRANSDUCING UNIT|PERONEAL ARTERY|RIGHT|OCCIPITAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|||HEALTH CARE PROFESSIONAL|PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-08-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|6acacd87-c487-401c-8888-76ccf97b640d|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|[?]|L/s/kPa|[?]|1|PFU/animal|PAROTID GLAND|LATERAL|DORSAL|SPECT/CT SCAN||Y||CAREGIVER|RATER|5|Visit_5|90|1|TREATMENT|2020-08-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|INTP|Interpretation|[?]|STANDING|[?]|ft3|[?]|1|mg/dL|PERIUMBILICAL REGION|LEFT|FRONTAL|INFRARED SPECTROMETRY||||FAMILY MEMBER|PHYSIOTHERAPIST|1|Visit_1|10|2|FOLLOW-UP|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING, BENT FORWARD|[?]|mmol/g|[?]|1|uL/kg/day|SKIN OF THE LIP|BILATERAL|ROSTRAL|CELLULAR PROLIFERATION ASSAY||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|1|Visit_1|10|1|FOLLOW-UP|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|3|PEF|Peak Expiratory Flow|[?]|SEMI-RECUMBENT|||[?]|1|/40 HPFs|COLON, SIGMOID|RIGHT|NASAL|TARGETED GENOME SEQUENCING|Y||Y|SIGNIFICANT OTHER|CARDIOLOGIST|2|Visit_2|25|3|SCREENING|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|4|VO2|Oxygen Consumption|[?]|UNCONSTRAINED|[?]|OI50|[?]|1|COAT|FINGER EXTENSOR TENDONS|RIGHT|INNER|COMPLEMENT FIXATION||||FRIEND|ONCOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|5|RER|Respiratory Exchange Ratio|[?]|RIGHT LATERAL DECUBITUS|[?]|ng|[?]|1|lx|SUPERIOR SAGITTAL SINUS|UNILATERAL|UPPER|INCISION-INDUCED BLEEDING METHOD||||DOMESTIC PARTNER|PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-08-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SLING|[?]|GPS U|[?]|1|FINGERTIP UNIT|COLON, DESCENDING|CONTRALATERAL|UPPER FLEXOR SURFACE|TOLUIDINE BLUE STAIN||||VENDOR|ADJUDICATOR 1|3|Visit_3|40|4|SCREENING|2020-08-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|STANDING|[?]|10^12/L|[?]|1|LOZENGE|OBTURATOR MUSCLE|LEFT|NASAL|FLOCCULATION, CHARCOAL ENHANCED||||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2020-09-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|8|DLCOHC|HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|mCi|[?]|1|FEU|TEMPLE|UNILATERAL|APICAL|DIRECT SEQUENCING|Y|Y||SIBLING|ADJUDICATOR 2|4|Visit_4|65|6|SCREENING|2020-09-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|9|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|[?]|FIU|[?]|1|umol/L/h|DISTAL PHALANX 4 OF THE HAND|RIGHT|SURFACE|CARDIAC THERMODILUTION||||ADJUDICATION COMMITTEE|OPTOMETRIST|5|Visit_5|90|3|TREATMENT|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|PRONE|[?]|IU/mg|[?]|1|mol|TRUNK|LATERAL|MIDLINE|BETA LACTAMASE||Y||CAREGIVER|READER 2|5|Visit_5|90|5|WASHOUT|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|[?]|ug/m2/h|[?]|1|10^6 organisms/g|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|RIGHT|ANTEROPOSTERIOR|TARGETED TRANSCRIPTOME SEQUENCING||Y||SPOUSE|RATER 1|1|Visit_1|10|7|TREATMENT|2021-01-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|2|FEV3PP|Percent Predicted FEV3|[?]|TRENDELENBURG|[?]|10^5/hpf|[?]|1|cm/min|SKIN OF THE FINGER|CONTRALATERAL|CENTRAL|RYAN BLUE STAIN||||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|1|Visit_1|10|1|WASHOUT|2021-01-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|3|PEF|Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|||[?]|1|%(w/w)|TROCHANTER|LATERAL|FORE|JAFFE REACTION|Y|Y|Y|INDEPENDENT ASSESSOR|NEUROLOGIST 2|2|Visit_2|25|5|TREATMENT|2021-01-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|4|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|DECUBITUS|[?]|lm|[?]|1|PFU/dose|PARS COMPACTA|BILATERAL|ANTEROPOSTERIOR|SPECULAR MICROSCOPY||Y||FRIEND|RATER 1|2|Visit_2|25|4|TREATMENT|2021-01-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|5|FEV1PP|Percent Predicted FEV1|[?]|RIGHT LATERAL DECUBITUS|[?]|Ci|[?]|1|Absorbance U/mL|ILEUM LYMPH NODE|LATERAL|LOWER FLEXOR SURFACE|GC/MS||||FRIEND|ONCOLOGIST 1|3|Visit_3|40|3|TREATMENT|2021-02-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|6|IVCPP|Percent Predicted IVC|[?]|UNCONSTRAINED|||[?]|1|cP|SCAPHOID BONE|CONTRALATERAL|HIND|FLOCCULATION, CHARCOAL ENHANCED||Y|Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|3|Visit_3|40|1|WASHOUT|2021-02-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|7|TV|Tidal Volume|[?]|LATERAL DECUBITUS|[?]|IU/mg|[?]|1|ELISA unit/dose|FEMALE REPRODUCTIVE SYSTEM|CONTRALATERAL|CENTRAL|PULSE OXIMETRY||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|4|Visit_4|65|7|WASHOUT|2021-02-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|TRENDELENBURG|||[?]|1|ukat|TRAPEZOID-CAPITATE JOINT|LATERAL|DISTAL|STRESS ECHOCARDIOGRAPHY|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 3|4|Visit_4|65|3|TREATMENT|2021-02-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|9|ALVVOL|Alveolar Volume|[?]|SEMI-FOWLERS|[?]|uCi/kg|[?]|1|DROP|FUNDUS OF THE EYE|IPSILATERAL|LOWER FLEXOR SURFACE|FLUORESCENT IMMUNOASSAY||||INTERVIEWER|READER 1|5|Visit_5|90|7|SCREENING|2021-03-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|73988e01-56c0-4b31-84e2-c23ce0bac5ac|10|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|REVERSE TRENDELENBURG|||[?]|1|PATCH|C2 VERTEBRA|CONTRALATERAL|ANTERIOR|JAEGER EYE CHART|||Y|STUDY SUBJECT|OPTOMETRIST|5|Visit_5|90|3|FOLLOW-UP|2021-03-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|1|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING|||[?]|1|P|COSTAL CARTILAGE|IPSILATERAL|INTERMEDIATE|ENZYMATIC COLORIMETRY|||Y|SPOUSE|MICROSCOPIST|1|Visit_1|10|7|TREATMENT|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-08
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|2|TLC|Total Lung Capacity|[?]|TRENDELENBURG|[?]|RFU|[?]|1|/min|ILEUM|RIGHT|INNER|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-08
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SLING|[?]|g/cage|[?]|1|L/h|OMENTUM|RIGHT|PERIVENTRICULAR|AUSCULTATION||||HEALTH CARE PROFESSIONAL|ONCOLOGIST|2|Visit_2|25|7|WASHOUT|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|4|FVC|Forced Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|g/mol|SUBCUTIS|UNILATERAL|SUPERIOR|SIZE EXCLUSION CHROMATOGRAPHY||Y|Y|FRIEND|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|WASHOUT|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|5|FVC|Forced Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|10^3 organisms/g|TEMPOROMANDIBULAR JOINT|CONTRALATERAL|LOWER MEDIAL|CONTRAST ENHANCED X-RAY||Y|Y|SIBLING|READER 2|3|Visit_3|40|5|SCREENING|2020-06-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|BLOCKS|[?]|1|ug/animal|TRUNK|UNILATERAL|FORE|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|2|TREATMENT|2020-06-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|7|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|GBq/mg|[?]|1|PIXELS/cm|FAT PAD|IPSILATERAL|DISTAL|CHROMATOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|READER 3|4|Visit_4|65|3|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-11
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|DECUBITUS|[?]|mL/min/mmHg|[?]|1|mmol|C1 VERTEBRA|LATERAL|DISTAL|RAJI CELL RIA||||FRIEND|ONCOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-11
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|9|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|[?]|mL/cage|[?]|1|10^10/L|KIDNEY|CONTRALATERAL|SUBCORTICAL|CONFOCAL MICROSCOPY||||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|0670f6a3-18c9-4027-91c1-56f5555589a8|10|FEV1FVC6|FEV1/FVC6|[?]|DECUBITUS|[?]|tuberculin unit|[?]|1|/min|GRACILIS MUSCLE|LATERAL|SURFACE|CT SCAN||||FRIEND|NEUROLOGIST 2|5|Visit_5|90|7|FOLLOW-UP|2020-08-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|1|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING|[?]|BOWL|[?]|1|h*%|FOOT PHALANX|LATERAL|FACIAL|DYNAMOMETRY|Y|||STUDY SUBJECT|PHYSIOTHERAPIST|1|Visit_1|10|7|WASHOUT|2020-08-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|2|DLCOHCVA|HGB Corrected DLCO/VA|[?]|FOWLERS|||[?]|1|ug/animal|INGUINAL REGION|CONTRALATERAL|DEEP|TONOMETRY||Y|Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|1|Visit_1|10|6|FOLLOW-UP|2020-08-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|3|AWWVOL|Airway Wall Volume|[?]|PRONE|[?]|atm|[?]|1|10^9 organisms/mL|BRACHIAL VEIN|IPSILATERAL|DORSOLATERAL|GC/MS-CI||Y||INTERVIEWER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|WASHOUT|2020-08-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|cd/m2|[?]|1|MdFI|AORTIC VALVE, NON-CORONARY CUSP|RIGHT|DORSOLATERAL|LIGHT MICROSCOPY||Y||CHILD|OTOLARYNGOLOGIST|2|Visit_2|25|7|TREATMENT|2020-08-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|5|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|V/sec|[?]|1|cal|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|PERIPHERAL|NUCLEIC ACID BASED METHOD||||FAMILY MEMBER|RADIOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-09-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|6|QUASCOMP|Quasi-Static Compliance|[?]|DECUBITUS|||[?]|1|mL/s/m2|INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|LOWER FLEXOR SURFACE|MAPH|||Y|INVESTIGATOR|PATHOLOGIST 1|3|Visit_3|40|3|WASHOUT|2020-09-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|7|FEF50|Forced Expiratory Flow 50%|[?]|STANDING|||[?]|1|10^6/g|HEAD|LATERAL|UPPER EXTENSOR SURFACE|NEURAMINIDASE INHIBITION ASSAY|Y|Y|Y|ADJUDICATOR|MICROSCOPIST 1|4|Visit_4|65|6|WASHOUT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|8|IRV|Inspiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|[?]|SQU/mL|[?]|1|10^7 TCID 50/dose|CARPOMETACARPAL JOINT 2|RIGHT|LOWER EXTENSOR SURFACE|CLOT DETECTION||||INTERVIEWER|PATHOLOGIST 1|4|Visit_4|65|6|FOLLOW-UP|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|9|PEF|Peak Expiratory Flow|[?]|LATERAL DECUBITUS|[?]|ug/m2/day|[?]|1|ppb|DISTANT LYMPH NODE|IPSILATERAL|PROXIMAL VOLAR|THICK SMEAR||||SIGNIFICANT OTHER|RADIOLOGIST|5|Visit_5|90|6|SCREENING|2020-10-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|59179734-8784-4a88-aa6b-51b6082ffc1b|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|[?]|ug/m2/min|[?]|1|mL/day|CANINE TOOTH|IPSILATERAL|ANTEROMEDIAL|STRESS ECHOCARDIOGRAPHY|Y|||INVESTIGATOR|RATER 1|5|Visit_5|90|1|WASHOUT|2020-10-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|LATERAL DECUBITUS|[?]|NEEDLE GAUGE|[?]|1|uL/dose|THALAMUS|IPSILATERAL|UPPER EXTENSOR SURFACE|RULER MEASUREMENT METHOD||||CAREGIVER|READER 1|1|Visit_1|10|1|SCREENING|2020-08-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|2|SVC|Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|AMPULE|[?]|1|PUFF|RETROPHARYNGEAL LYMPH NODE|UNILATERAL|SURFACE|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||Y||DOMESTIC PARTNER|READER|1|Visit_1|10|7|SCREENING|2020-08-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|3|AIRTRAP|Air Trapping|[?]|UNCONSTRAINED|[?]|mIU/L|[?]|1|FEU|AORTO-ILIAC PERIPHERAL ARTERY|IPSILATERAL|PROXIMAL VOLAR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|||SIBLING|ENDOCRINOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-09-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|4|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|||[?]|1|TRANSDUCING UNIT/mL|PORTAL VEIN|LEFT|LOWER FLEXOR SURFACE|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y||Y|GUARDIAN|READER|2|Visit_2|25|3|TREATMENT|2020-09-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|REVERSE TRENDELENBURG|||[?]|1|um/day|DIAPHRAGM|LATERAL|INTERMEDIATE|MYELOPEROXIDASE STAIN|||Y|VENDOR|HEMATOLOGIST|3|Visit_3|40|5|TREATMENT|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|6|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|cup eq|[?]|1|mL/s|LIMB|CONTRALATERAL|MIDLINE|REFRACTOMETRY||||ADJUDICATOR|ONCOLOGIST 2|3|Visit_3|40|1|WASHOUT|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|7|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LATERAL DECUBITUS|[?]|m2|[?]|1|%/s|DIAPHRAGM|BILATERAL|OUTER|TONOMETRY||Y||VENDOR|NEUROLOGIST 2|4|Visit_4|65|4|TREATMENT|2020-10-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|8|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|10^4/hpf|[?]|1|uCi|NAIL|RIGHT|SUPERFICIAL|ELECTROMYOGRAPHY|Y|||INVESTIGATOR|READER 3|4|Visit_4|65|6|WASHOUT|2020-10-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING, BENT FORWARD|[?]|ug/kg|[?]|1|WEEKS|FINGERNAIL|LEFT|CRANIAL|GC/MS-EI||||PROXY|RADIOLOGIST 2|5|Visit_5|90|6|TREATMENT|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|10|AWWVOL|Airway Wall Volume|[?]|SEMI-FOWLERS|[?]|kg/mol|[?]|1|PELLET|SKIN OF THE AXILLA|RIGHT|MIDLINE|POLYGRAPHY|Y|||SPOUSE|ADJUDICATOR 3|5|Visit_5|90|6|SCREENING|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|dyn|[?]|1|ng/dL|THROAT|CONTRALATERAL|FORE|CHROMOGENIC ASSAY||Y||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|1|Visit_1|10|2|TREATMENT|2020-09-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|2|IRVPP|Percent Predicted IRV|[?]|SITTING|[?]|kPa|[?]|1|m|MIDDLE PHALANX 2 OF THE HAND|LATERAL|ANTEROMEDIAL|LIGHT MICROSCOPY||||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-09-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|3|AWVOL|Airway Volume|[?]|STANDING|[?]|mph|[?]|1|mL*cmH2O|MAIN BRONCHUS, LEFT|LEFT|PERIVENTRICULAR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y||NON-HEALTH CARE PROFESSIONAL|READER 1|2|Visit_2|25|3|TREATMENT|2020-10-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|4|FEV1SVC|FEV1/SVC|[?]|FOWLERS|[?]|nL|[?]|1|cm/s|PROCERUS MUSCLE|UNILATERAL|LOWER MEDIAL|SPECT/CT SCAN||||INTERVIEWER|RADIOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-10-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|5|INFLTIND|Infiltrates Indicator|[?]|SLING|||[?]|1|mg/dose|PROXIMAL CIRCUMFLEX ARTERY|IPSILATERAL|VOLAR|PATHOLOGICAL EVALUATION|Y|Y|Y|SPOUSE|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-10-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|6|MEP|Maximal Expiratory Pressure|[?]|SUPINE|[?]|kBq/uL|[?]|1|mEq/L|ANASTOMOSIS|BILATERAL|PROXIMAL VOLAR|AGAR DILUTION||||INDEPENDENT ASSESSOR|READER 1|3|Visit_3|40|7|WASHOUT|2020-10-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING|[?]|mL/animal/day|[?]|1|ukat|MALE GENITALIA|BILATERAL|ANTERIOR|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-11-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|PRONE|[?]|IU/dL|[?]|1|10^3 CFU/g|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|UNILATERAL|SUPERFICIAL|OPHTHALMOSCOPY||||PARENT|RATER|4|Visit_4|65|3|TREATMENT|2020-11-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|9|ALVVOL|Alveolar Volume|[?]|SLING|[?]|/sec|[?]|1|L/day|HAND DIGIT 3|UNILATERAL|VENTROLATERAL|URANYL ACETATE STAIN||Y||INVESTIGATOR|READER 1|5|Visit_5|90|2|TREATMENT|2020-12-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|01c642f8-48ef-4375-aa2b-d0940b74e580|10|FIV1PP|Percent Predicted FIV1|[?]|LEFT LATERAL DECUBITUS|[?]|cpm|[?]|1|ug/g/h|SKIN OF THE ELBOW|BILATERAL|SURFACE|MS/MS|Y|Y||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|5|Visit_5|90|3|TREATMENT|2020-12-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|1|RELSZCHG|Relative Size Change|[?]|SUPINE|[?]|VOXEL|[?]|1|YEARS|ESOPHAGUS, CERVICAL|CONTRALATERAL|SURFACE|GIEMSA STAIN||||ADJUDICATION COMMITTEE|RATER|1|Visit_1|10|2|TREATMENT|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|2|SVC|Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|ugEq|[?]|1|gMFI|PALPEBRAL FISSURE|IPSILATERAL|LOWER FLEXOR SURFACE|CONGO RED STAIN|Y|||CHILD|OPHTHALMOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|3|LCI|Lung Clearance Index|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/min/1.73m2|CEREBRAL SUBCORTEX|LATERAL|POSTERIOR|ENDOSCOPY|||Y|CAREGIVER|MICROSCOPIST 3|2|Visit_2|25|7|TREATMENT|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|4|VO2|Oxygen Consumption|[?]|SEMI-FOWLERS|[?]|mL/h|[?]|1|IU/mg|STRIATUM|LEFT|ANTEROPOSTERIOR|VENTILATION PERFUSION LUNG SCAN||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|2|Visit_2|25|6|FOLLOW-UP|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|5|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|[?]|Roentgen|[?]|1|mg/kg/dose|SCAPHOID-RADIUS JOINT|IPSILATERAL|DISTAL VOLAR|MAGNETIC RESONANCE ENTEROGRAPHY||Y||STUDY SUBJECT|NEUROLOGIST 1|3|Visit_3|40|3|WASHOUT|2020-08-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|UNCONSTRAINED|[?]|10^7 CFU/mL|[?]|1|IU/mg|DISTAL PHALANX 5 OF THE HAND|LEFT|APICAL|DIRECT SEQUENCING||||DOMESTIC PARTNER|ENDOCRINOLOGIST|3|Visit_3|40|5|SCREENING|2020-08-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|7|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-FOWLERS|||[?]|1|10^4/L|SUBLINGUAL REGION|UNILATERAL|SURFACE|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||Y|DOMESTIC PARTNER|RATER 1|4|Visit_4|65|2|WASHOUT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|8|SAWVOL|Specific Airway Volume|[?]|SITTING|||[?]|1|foz_us|HEPATOBILIARY SYSTEM|IPSILATERAL|OCCIPITAL|PAP STAIN|||Y|ADJUDICATOR|RATER 1|4|Visit_4|65|2|SCREENING|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|9|PEFREV|PEF Reversibility|[?]|UNCONSTRAINED|[?]|mph|[?]|1|ug/g/min|URETHRAL SPHINCTER|BILATERAL|PERIPHERAL|MRI||||CAREGIVER|READER 1|5|Visit_5|90|4|SCREENING|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|c0e7028c-6f5c-410a-afde-e56af2177983|10|INTP|Interpretation|[?]|STANDING|[?]|DAYS|[?]|1|mL/dose|METATARSOPHALANGEAL JOINT|BILATERAL|LOWER|CELLULAR PROLIFERATION ASSAY|Y|Y||ADJUDICATION COMMITTEE|PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|1|SVC|Slow Vital Capacity|[?]|TRENDELENBURG|[?]|L/min/m2|[?]|1|ELISA unit/dose|DURAL VENOUS SINUS|UNILATERAL|PERIVENTRICULAR|WESTERN BLOT|Y|||CLINICAL STUDY SPONSOR|RATER 1|1|Visit_1|10|1|WASHOUT|2020-08-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|2|INERTANC|Inertance|[?]|SLING|[?]|Enzyme U/L|[?]|1|COAT|MEDIASTINUM, POSTERIOR|CONTRALATERAL|PERIPHERAL|DIFFUSION WEIGHTED MRI||Y||CHILD|PHYSIOTHERAPIST|1|Visit_1|10|7|SCREENING|2020-08-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|3|ICREV|IC Reversibility|[?]|LATERAL DECUBITUS|[?]|nmol/L/min|[?]|1|uU/dL|HAMSTRING MUSCLE|LATERAL|LOWER FLEXOR SURFACE|HEMAGGLUTINATION INHIBITION ASSAY|Y|Y||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|2|Visit_2|25|1|SCREENING|2020-08-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|4|TLC|Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|%(w/w)|[?]|1|Mile|BRACHIORADIALIS MUSCLE|UNILATERAL|PERIPHERAL|PEAK FLOWMETRY||Y||GUARDIAN|ONCOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-08-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|5|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|10^9 CFU/mL|[?]|1|umol/L/min|EXTENSOR DIGITORUM BREVIS MUSCLE|LATERAL|SUPERIOR|PEAK FLOWMETRY|Y|||INTERVIEWER|OTOLARYNGOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|6|INTP|Interpretation|[?]|PRONE|[?]|JDF Unit|[?]|1|g/animal|MITRAL VALVE, POSTERIOR ANNULUS|CONTRALATERAL|BASAL|FLOW CYTOMETRY||Y||GUARDIAN|RADIOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|7|MIP|Maximal Inspiratory Pressure|[?]|UNCONSTRAINED|[?]|CFU/mL|[?]|1|Shock Wave|HIP|BILATERAL|ANTEROMEDIAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|3|TREATMENT|2020-10-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|8|RRS|Total Respiratory System Resistance|[?]|LATERAL DECUBITUS|[?]|uL/kg/day|[?]|1|FFU|VASTUS MEDIALIS MUSCLE|IPSILATERAL|ANTERIOR|REFRACTOMETRY||Y||SIGNIFICANT OTHER|ONCOLOGIST 2|4|Visit_4|65|3|FOLLOW-UP|2020-10-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|DECUBITUS|[?]|ug/min|[?]|1|10^3 organisms|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LEFT|SURFACE|MANUAL COUNT||Y||PROXY|ADJUDICATOR 1|5|Visit_5|90|2|WASHOUT|2020-10-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|eba928ed-9434-4e75-b49d-169298f966e1|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|/4.0 mL|[?]|1|CCID 50/dose|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|IPSILATERAL|FACIAL|FLAME PHOTOMETRY||||SIBLING|HEMATOLOGIST|5|Visit_5|90|2|TREATMENT|2020-10-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|1|FEV3FVC|FEV3/FVC|[?]|TRENDELENBURG|[?]|Ci/kg|[?]|1|U/mL|SPLENIC VEIN|RIGHT|VENTROLATERAL|LINE PROBE ASSAY||||SPOUSE|RATER 1|1|Visit_1|10|5|SCREENING|2020-07-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|2|INTP|Interpretation|[?]|DECUBITUS|[?]|g/kg/day|[?]|1|10^6/L|COCCYGEAL VERTEBRA|BILATERAL|VOLAR|FARR ASSAY|Y|||PARENT|NEUROLOGIST|1|Visit_1|10|1|TREATMENT|2020-07-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|3|FEV3PP|Percent Predicted FEV3|[?]|SEMI-FOWLERS|[?]|10^6 CFU/g|[?]|1|IU/mg|PHARYNGEAL TONSIL|UNILATERAL|FACIAL|ENZYMATIC ULTRACENTRIFUGATION|Y|||SIGNIFICANT OTHER|ADJUDICATOR 1|2|Visit_2|25|4|TREATMENT|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SUPINE|[?]|Ci/L|[?]|1|mg/m2/h|URINARY SYSTEM|LEFT|FORE|RADIOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|2|Visit_2|25|7|WASHOUT|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|/500 WBC|[?]|1|mAmp|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|INTERMEDIATE|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|3|Visit_3|40|3|FOLLOW-UP|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|6|FEV1REV|FEV1 Reversibility|[?]|LATERAL DECUBITUS|[?]|U/kg|[?]|1|Pa|STERNUM|BILATERAL|UPPER FLEXOR SURFACE|NUCLEIC ACID HYBRIDIZATION|Y|||STUDY SUBJECT|RADIOLOGIST 2|3|Visit_3|40|4|WASHOUT|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SLING|||[?]|1|IU/g Hb|GENITOURINARY SYSTEM|LATERAL|SUPERIOR|KNEMOMETRY|||Y|PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|SCREENING|2020-09-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SUPINE|[?]|mL/kg/day|[?]|1|10^3/hpf|ETHMOID BONE|BILATERAL|CRANIAL|TRANSVAGINAL ULTRASOUND||||PARENT|NEUROLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-09-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|mL/min|[?]|1|mL/h|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|IPSILATERAL|VENTROLATERAL|FLOW CYTOMETRY||||SIBLING|READER|5|Visit_5|90|7|TREATMENT|2020-09-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|4772aa80-2097-4867-a549-b6f9b140f141|10|LOBVOL|Lobar Volume|[?]|DECUBITUS|[?]|IU/g Hb|[?]|1|m/sec|FRONTAL LOBE|CONTRALATERAL|INNER|CONTACT SPECULAR MICROSCOPY||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|5|Visit_5|90|3|TREATMENT|2020-09-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING, BENT FORWARD|[?]|Ci/uL|[?]|1|um|SKIN OF THE CHIN|BILATERAL|SURFACE|SICKLE CELL SOLUBILITY TEST||Y||FRIEND|RATER 2|1|Visit_1|10|7|SCREENING|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|2|IVCPP|Percent Predicted IVC|[?]|STANDING|||[?]|1|10^12 IU/L|SOFT TISSUE|RIGHT|SURFACE|CYSTOSCOPY|||Y|ADJUDICATION COMMITTEE|PATHOLOGIST 2|1|Visit_1|10|7|SCREENING|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING, BENT FORWARD|[?]|cm|[?]|1|m/sec2|EPIGASTRIC REGION|UNILATERAL|DISTAL|IMMUNORADIOMETRIC ASSAY||||GUARDIAN|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|4|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LEFT LATERAL DECUBITUS|||[?]|1|pptr|MUCOSA|UNILATERAL|FRONTAL|VIRUS PLAQUE ASSAY|||Y|CLINICAL STUDY SPONSOR|RADIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|5|DLCOVA|DLCO/VA|[?]|LATERAL DECUBITUS|[?]|vg/kg|[?]|1|100 IU/mL|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LATERAL|VENTRAL|CHROMOGENIC ASSAY||||GUARDIAN|NEUROLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|6|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|EID 50/dose|[?]|1|mg/m2/min|TRAPEZIAL BONE|IPSILATERAL|PARIETO-OCCIPITAL|SLOAN LETTER EYE CHART 1.25%||||CLINICAL RESEARCH COORDINATOR|RATER|3|Visit_3|40|3|FOLLOW-UP|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|7|TVPP|Percent Predicted Tidal Volume|[?]|LEFT LATERAL DECUBITUS|[?]|10^7 TCID 50/dose|[?]|1|log10 PFU/mL|FOOT DIGIT 4|LATERAL|PARIETO-OCCIPITAL|INDIA INK STAIN||Y||INVESTIGATOR|PATHOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|8|FEV3FVC|FEV3/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|GLOBULE|[?]|1|DIOPTER|LEFT ATRIOVENTRICULAR ARTERY|BILATERAL|BASAL|PANENDOSCOPY||||INTERVIEWER|RATER 1|4|Visit_4|65|2|SCREENING|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|9|FEF50|Forced Expiratory Flow 50%|[?]|DECUBITUS|[?]|10^6 organisms|[?]|1|mg/m2|SUBARACHNOID SPACE|UNILATERAL|PROXIMAL|GIEMSA STAIN|Y|||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|7|SCREENING|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|10|ERV|Expiratory Reserve Volume|[?]|DECUBITUS|[?]|gtt|[?]|1|OI50|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|UNILATERAL|HIND|PANENDOSCOPY||||FRIEND|MICROSCOPIST|5|Visit_5|90|5|SCREENING|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|pg/cell|[?]|1|Ci/mL|DIGIT|CONTRALATERAL|BASAL|RIA||||ADJUDICATOR|UROLOGIST|1|Visit_1|10|3|SCREENING|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|2|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|m/sec|[?]|1|dpm/mg|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|BILATERAL|SUPERIOR|INDIA INK STAIN||Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|1|Visit_1|10|4|TREATMENT|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|3|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING|[?]|Absorbance U/min|[?]|1|10^3/L|LUNG LOBE|LATERAL|CAUDAL|CELL OF ORIGIN ASSAY||||FRIEND|PATHOLOGIST 2|2|Visit_2|25|1|TREATMENT|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|UNCONSTRAINED|||[?]|1|dpm/mg|ANTERIOR CINGULATE GYRUS|UNILATERAL|OCCIPITAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|||Y|PROXY|MICROSCOPIST 2|2|Visit_2|25|7|TREATMENT|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mCi|[?]|1|ukat|POSTERIOR CERVICAL LYMPH NODE|CONTRALATERAL|OCCIPITAL|NEPHELOMETRY||||STUDY SUBJECT|READER 2|3|Visit_3|40|1|TREATMENT|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|6|IVC|Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|CAPSULE|PREPUTIAL GLAND|BILATERAL|UPPER FLEXOR SURFACE|ACID FAST STAIN||Y|Y|SIGNIFICANT OTHER|RATER|3|Visit_3|40|2|TREATMENT|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|PRONE|[?]|DPM|[?]|1|U/m2/min|INFERIOR VENA CAVA|UNILATERAL|ANTERIOR|LIGHT MICROSCOPY|Y|||SPOUSE|UROLOGIST|4|Visit_4|65|1|TREATMENT|2021-02-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|8|FRC|Functional Residual Capacity|[?]|REVERSE TRENDELENBURG|[?]|IU/day|[?]|1|ug/L|CECUM|BILATERAL|ANTEROMEDIAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||FAMILY MEMBER|MICROSCOPIST|4|Visit_4|65|6|SCREENING|2021-02-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|9|AWVOLPP|Percent Predicted Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|ug/m2|[?]|1|mL*cmH2O|GLOTTIS|LEFT|FACIAL|CONTRAST ENHANCED X-RAY||Y||CAREGIVER|INTERNIST|5|Visit_5|90|7|TREATMENT|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|4d8dd0d0-407d-4374-8345-c11f30603273|10|FRC|Functional Residual Capacity|[?]|DECUBITUS|[?]|ppm|[?]|1|m/sec|RETROPHARYNGEAL LYMPH NODE|UNILATERAL|ANTERIOR|WESTERN BLOT|Y|||CHILD|READER|5|Visit_5|90|7|WASHOUT|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|1|EVC|Expiratory Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|10^8 PFU|ANTERIOR HORN OF THE LATERAL VENTRICLE|CONTRALATERAL|DISTAL VOLAR|MYELOPEROXIDASE STAIN|Y||Y|SIBLING|RATER|1|Visit_1|10|6|TREATMENT|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|2|FEF50|Forced Expiratory Flow 50%|[?]|DECUBITUS|[?]|PRESSOR UNITS|[?]|1|10^4/L|ABDOMINAL CAVITY|LEFT|VENTRAL|POTENTIOMETRY||||DOMESTIC PARTNER|HEMATOLOGIST|1|Visit_1|10|2|SCREENING|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|DECUBITUS|[?]|ngEq/L|[?]|1|g/cm2|TAIL|BILATERAL|OCCIPITAL|DNA MICROARRAY||Y||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|4|RAW|Airway Resistance|[?]|PRONE|[?]|hPa|[?]|1|/40 HPFs|EPICONDYLE|RIGHT|POSTERIOR|CINEANGIOGRAPHY||||DOMESTIC PARTNER|NEUROLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|5|FEV6PP|Percent Predicted FEV6|[?]|SITTING|[?]|BOTTLE|[?]|1|cP|RETINA|UNILATERAL|VENTRAL|CONTRAST ENHANCED CT SCAN||Y||STUDY SUBJECT|OPHTHALMOLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|6|EFFVOL|Effusion Volume|[?]|SITTING|||[?]|1|ECL unit|ANTECUBITAL FOSSA|RIGHT|CAUDAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||Y|Y|VENDOR|CARDIOLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SLING|[?]|TROCHE|[?]|1|10^9/dose|PONS VAROLII|RIGHT|UPPER EXTENSOR SURFACE|CONTACT SPECULAR MICROSCOPY||Y||SPOUSE|RADIOLOGIST|4|Visit_4|65|4|SCREENING|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|8|SALKK|Salazar-Knowles Equation, K|[?]|SLING|[?]|Gy|[?]|1|mL/min/mmHg|METATARSOPHALANGEAL JOINT 1|RIGHT|LATERAL|SPIRAL CT||||PROXY|NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|9|FEV_PEF|FEV at PEF|[?]|DECUBITUS|||[?]|1|umol/dL|METACARPAL BONE 3|LATERAL|ANTEROLATERAL|SCINTIGRAPHY|||Y|INVESTIGATOR|ADJUDICATOR 3|5|Visit_5|90|1|TREATMENT|2020-08-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|6996077b-556a-47b9-bbff-20c1b4df35ea|10|FEV6PP|Percent Predicted FEV6|[?]|FOWLERS|[?]|ug/L DDU|[?]|1|IU/mg|L3 VERTEBRA|RIGHT|CENTRAL|TOLUIDINE BLUE STAIN||Y||SIGNIFICANT OTHER|INTERNIST|5|Visit_5|90|6|SCREENING|2020-08-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|FIVC|Forced Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|Enzyme U/g Hb|[?]|1|log10 CCID 50/dose|DISTAL FEMUR R1|LEFT|INTERMEDIATE|FARR ASSAY||Y||CHILD|RATER 1|1|Visit_1|10|1|WASHOUT|2020-10-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|2|TSUHYS|Tissue Hysteresivity|[?]|REVERSE TRENDELENBURG|[?]|PIXELS/in|[?]|1|BOX|UMBILICUS|UNILATERAL|DEEP|PYROSEQUENCING||||INTERVIEWER|PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|3|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SLING|[?]|mm|[?]|1|mmHg/L/min|FEMORAL CONDYLE|UNILATERAL|PARIETO-OCCIPITAL|BETA LACTAMASE||||VENDOR|PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-11-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|4|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-RECUMBENT|||[?]|1|mL/min/mmHg|COLON WALL|CONTRALATERAL|CAUDAL|AUTOREFRACTION|||Y|HEALTH CARE PROFESSIONAL|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|5|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|dB|[?]|1|U|BRAIN STEM|CONTRALATERAL|TIP|TRANSCRIPTION-MEDIATED AMPLIFICATION||||ADJUDICATOR|DERMATOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|6|RAWPP|Percent Predicted Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mL/m2/min|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|CRANIAL|AMSLER GRID|Y||Y|INTERVIEWER|DERMATOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|UNCONSTRAINED|||[?]|1|HOMEOPATHIC DILUTION|TARSAL JOINT|IPSILATERAL|DISTAL VOLAR|CT SCAN WITHOUT CONTRAST|||Y|ADJUDICATION COMMITTEE|RATER 1|4|Visit_4|65|7|TREATMENT|2020-12-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|8|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|[?]|BAG|[?]|1|ug/mol|HYPOTHALAMUS|BILATERAL|NASAL|AGAR PROPORTION|Y|||INTERVIEWER|ONCOLOGIST|4|Visit_4|65|7|SCREENING|2020-12-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|9|AIRTRAP|Air Trapping|[?]|LATERAL DECUBITUS|[?]|vg/dose|[?]|1|ugEq/L|C7 VERTEBRA|BILATERAL|FORE|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||INDEPENDENT ASSESSOR|ONCOLOGIST 2|5|Visit_5|90|5|TREATMENT|2021-01-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|d79d31c5-d51a-46a7-b22c-20d6d483f46e|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/mol|[?]|1|um/s|TIBIA|RIGHT|UPPER EXTENSOR SURFACE|FREEZING POINT DEPRESSION||||INVESTIGATOR|ENDOCRINOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-01-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|738d539e-a810-4207-8904-fc6a5d055424|1|ERVPP|Percent Predicted ERV|[?]|STANDING, BENT FORWARD|[?]|mL/cm3/min|[?]|1|ug/L|T8 VERTEBRA|BILATERAL|FACIAL|MS/MS||||INTERVIEWER|FORENSIC PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2021-01-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|738d539e-a810-4207-8904-fc6a5d055424|2|FEV1REV|FEV1 Reversibility|[?]|SLING|[?]|dpm/mg|[?]|1|PACKET|CORNEAL STROMA|LEFT|PARIETO-OCCIPITAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||CAREGIVER|ADJUDICATOR 2|1|Visit_1|10|3|SCREENING|2021-01-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|738d539e-a810-4207-8904-fc6a5d055424|3|SGAW|Specific Airway Conductance|[?]|REVERSE TRENDELENBURG|[?]|mL/m2/min|[?]|1|nmol/L/h|EYELID|CONTRALATERAL|ANTERIOR|CORONARY ANGIOGRAPHY|Y|||SIGNIFICANT OTHER|UROLOGIST|2|Visit_2|25|6|SCREENING|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|738d539e-a810-4207-8904-fc6a5d055424|4|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|UNCONSTRAINED|[?]|CAPSULE|[?]|1|Ci/ug|DENTAL ARCH|UNILATERAL|LOWER|SPIRAL CT SCAN WITHOUT CONTRAST||||DOMESTIC PARTNER|READER 2|2|Visit_2|25|3|SCREENING|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|738d539e-a810-4207-8904-fc6a5d055424|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|[?]|log10 copies/mL|[?]|1|PATCH|MESENTERIC ARTERY|IPSILATERAL|POSTERIOR|OPHTHALMOSCOPY||||STUDY SUBJECT|PHYSIOTHERAPIST|3|Visit_3|40|6|SCREENING|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|738d539e-a810-4207-8904-fc6a5d055424|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|PRONE|||[?]|1|Ci/mL|LIGAMENT|LATERAL|ANTEROLATERAL|FLOCCULATION|||Y|SPOUSE|PATHOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|738d539e-a810-4207-8904-fc6a5d055424|7|RER|Respiratory Exchange Ratio|[?]|LATERAL DECUBITUS|[?]|mL/animal/day|[?]|1|mmol2/L2|RIB 3|LATERAL|ANTEROPOSTERIOR|LANDOLT RING|Y|||PARENT|READER 3|4|Visit_4|65|3|TREATMENT|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|738d539e-a810-4207-8904-fc6a5d055424|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|LATERAL DECUBITUS|[?]|ukat/10^12 RBC|[?]|1|umol/day|PROXIMAL LAD ARTERY|UNILATERAL|VENTRAL|ISHIHARA COLOR PLATES||||SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|3|SCREENING|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|738d539e-a810-4207-8904-fc6a5d055424|9|TGV|Thoracic Gas Volume|[?]|STANDING, BENT FORWARD|[?]|mL/cage/day|[?]|1|mL/cm3/min|GASTROCNEMIUS MUSCLE, LATERAL HEAD|LEFT|ANTEROMEDIAL|REVERSE TRANSCRIPTASE PCR||||CAREGIVER|READER 3|5|Visit_5|90|4|TREATMENT|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|738d539e-a810-4207-8904-fc6a5d055424|10|PCF|Peak Cough Flow|[?]|SITTING|[?]|EP U|[?]|1|tuberculin unit/mL|ILEUM WALL|IPSILATERAL|BASAL|FLUORESCENT MICROSCOPY||||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|SCREENING|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-FOWLERS|[?]|10^3 organisms/mL|[?]|1|GBq/mg|RECTOSIGMOID JUNCTION|UNILATERAL|SUPERIOR|MICROPARTICLE ENZYME IMMUNOASSAY||||FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-08-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|g/cage/day|[?]|1|U/m2/day|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|UNILATERAL|DISTAL|CALCOFLUOR WHITE STAIN||||FRIEND|ADJUDICATOR|1|Visit_1|10|1|SCREENING|2020-08-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|3|QUASCOMP|Quasi-Static Compliance|[?]|REVERSE TRENDELENBURG|||[?]|1|RNA copies/mL|PANCREAS, HEAD|LEFT|ANTERIOR|NUCLEIC ACID SEQUENCING|||Y|ADJUDICATOR|HEMATOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-08-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|4|MEP|Maximal Expiratory Pressure|[?]|SEMI-FOWLERS|[?]|deg|[?]|1|uCi/kg|SUPERIOR PUBIC RAMUS|LEFT|DORSOLATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY||Y||STUDY SUBJECT|RADIOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-08-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|5|FEF50|Forced Expiratory Flow 50%|[?]|DECUBITUS|[?]|vg/kg|[?]|1|dyn|CERVICAL VERTEBRA|LEFT|NASAL|PHYSICAL EXAMINATION||||DOMESTIC PARTNER|PHYSIOTHERAPIST|3|Visit_3|40|1|TREATMENT|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|6|LOBVOL|Lobar Volume|[?]|TRENDELENBURG|[?]|mCi/kg|[?]|1|g/kg/day|NUCLEUS OF DIAGONAL BAND|LEFT|MEDIAL|THERMAL IONIZATION MASS SPECTROMETRY|Y|||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|7|TV|Tidal Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^9/dose|MEDIAN NERVE|BILATERAL|ANTEROTEMPORAL|AUTOREFRACTION|||Y|FRIEND|ONCOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|8|FEV3FVC|FEV3/FVC|[?]|SEMI-RECUMBENT|||[?]|1|in|SUPRACLAVICULAR FOSSA|BILATERAL|UPPER|RAJI CELL RIA|||Y|INTERVIEWER|PHYSIOTHERAPIST|4|Visit_4|65|6|TREATMENT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|9|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|[?]|Farad|[?]|1|keV|LEFT MAIN CORONARY ARTERY BODY|LATERAL|CENTRAL|PALM METHOD||||SIGNIFICANT OTHER|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2020-10-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|10|FVC|Forced Vital Capacity|[?]|STANDING|[?]|uCi/kg|[?]|1|mL/breath|HEEL OF THE FOOT|BILATERAL|POSTERIOR|CYSTOMETRY||||HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|7|TREATMENT|2020-10-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|1|EFFIND|Effusion Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|/100 HPFs|[?]|1|pkat|STERNEBRA|UNILATERAL|LOWER FLEXOR SURFACE|CARDIAC THERMODILUTION||||CLINICAL STUDY SPONSOR|RATER 1|1|Visit_1|10|4|TREATMENT|2020-11-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|2|FEV_PEF|FEV at PEF|[?]|SEMI-RECUMBENT|[?]|mmol/min/kPa|[?]|1|pmol/L/h|RENAL FOSSA|LEFT|HIND|ENZYMATIC COLORIMETRY||Y||PARENT|ADJUDICATOR 3|1|Visit_1|10|5|TREATMENT|2020-11-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|TRENDELENBURG|||[?]|1|TCID 50/dose|ILIAC FOSSA|RIGHT|TEMPORAL|PALPATION|Y||Y|INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|5|TREATMENT|2020-12-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|4|DLCOHC|HGB Corrected DLCO|[?]|FOWLERS|[?]|nmol/L|[?]|1|mmHg|SECOND DIAGONAL BRANCH ARTERY|IPSILATERAL|VOLAR|SNP ARRAY||Y||SIGNIFICANT OTHER|RATER 1|2|Visit_2|25|1|TREATMENT|2020-12-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|5|AIRTRAP|Air Trapping|[?]|DECUBITUS|[?]|IU/mL|[?]|1|EU|LEFT VENTRICULAR EPICARDIUM|LATERAL|SUPERFICIAL|BRDU CELLULAR PROLIFERATION ASSAY|Y|||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|4|TREATMENT|2020-12-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|6|RELSZCHG|Relative Size Change|[?]|TRENDELENBURG|[?]|100 IU/mL|[?]|1|V|TENTORIUM CEREBELLI|LATERAL|UPPER|IHC||||INDEPENDENT ASSESSOR|MICROSCOPIST|3|Visit_3|40|5|TREATMENT|2020-12-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|7|GAW|Airway Conductance|[?]|LATERAL DECUBITUS|[?]|pmol/g|[?]|1|mmol/L|BLADDER, TRIGONE|RIGHT|VENTRAL|NUCLEIC ACID HYBRIDIZATION|Y|Y||ADJUDICATOR|CARDIOLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|8|PNEUMIND|Pneumonia Indicator|[?]|SLING|||[?]|1|BOWL|MITRAL VALVE ANNULUS|LATERAL|FORE|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|||Y|CHILD|PEDIATRIC NEUROLOGIST|4|Visit_4|65|6|TREATMENT|2021-01-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|9|SGAW|Specific Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|10^6 DNA copies/mL|[?]|1|GPS U|HAND|BILATERAL|ANTEROPOSTERIOR|IMMUNODIFFUSION||||ADJUDICATOR|READER 2|5|Visit_5|90|4|WASHOUT|2021-02-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|20841d37-0444-4d1d-b934-1e805cdacdaf|10|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|mg/mol|[?]|1|CONTAINER|MITRAL VALVE, POSTERIOR ANNULUS|CONTRALATERAL|FACIAL|CELL OF ORIGIN ASSAY||||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|5|Visit_5|90|5|SCREENING|2021-02-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|FEV1FVC6|FEV1/FVC6|[?]|SLING|[?]|10^6 IU|[?]|1|/ms|LUNG, RIGHT|RIGHT|DISTAL|NUCLEIC ACID HYBRIDIZATION||Y||CHILD|ENDOCRINOLOGIST|1|Visit_1|10|7|TREATMENT|2020-11-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|2|MIP|Maximal Inspiratory Pressure|[?]|REVERSE TRENDELENBURG|[?]|pmol/10^10 cells|[?]|1|s/h|PROXIMAL LAD ARTERY|LATERAL|DORSAL|FLAME PHOTOMETRY||||INVESTIGATOR|READER 2|1|Visit_1|10|3|SCREENING|2020-11-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|3|RER|Respiratory Exchange Ratio|[?]|SEMI-FOWLERS|||[?]|1|FIU|URETERIC ORIFICE|CONTRALATERAL|NASAL|MICROARRAY|Y||Y|SIGNIFICANT OTHER|INTERNIST|2|Visit_2|25|6|SCREENING|2020-11-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|4|MALIND|Malignancy Indicator|[?]|LATERAL DECUBITUS|[?]|Ci/ug|[?]|1|mmol/min/kPa/L|SKIN OF THE BENDING JOINT|RIGHT|ROSTRAL|CRYOSCOPY||||INVESTIGATOR|ADJUDICATOR 2|2|Visit_2|25|2|FOLLOW-UP|2020-11-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|5|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|g/day|[?]|1|IU/mmol|PERINEUM|IPSILATERAL|CAUDAL|CELLULOSE TAPE||||SIBLING|ONCOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-12-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|6|FEV3PP|Percent Predicted FEV3|[?]|SEMI-RECUMBENT|[?]|mL/100g/min|[?]|1|mL/breath|THYROID GLAND, LEFT LOBE|RIGHT|FRONTAL|CLINICAL EVALUATION||Y||STUDY SUBJECT|NEUROLOGIST 2|3|Visit_3|40|4|WASHOUT|2020-12-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|7|INTP|Interpretation|[?]|LATERAL DECUBITUS|||[?]|1|uV*sec|TYMPANIC MEMBRANE|IPSILATERAL|BASAL|MAGNETIC RESONANCE ANGIOGRAPHY|||Y|CHILD|CLINICAL PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|LEFT LATERAL DECUBITUS|[?]|pmol/10^10 cells|[?]|1|cy/cm|CALF MUSCULAR VEIN|LATERAL|INTERMEDIATE|ICC||Y||FRIEND|NEUROLOGIST|4|Visit_4|65|1|TREATMENT|2020-12-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|9|TLC|Total Lung Capacity|[?]|LATERAL DECUBITUS|[?]|uIU/dL|[?]|1|foz_br|PROXIMAL PHALANX 4 OF THE HAND|LATERAL|INNER|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|1|WASHOUT|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|10|PLMXRS|Pulmonary Reactance|[?]|TRENDELENBURG|[?]|pm|[?]|1|Ci/kg|CELIAC ARTERY|LEFT|DORSAL|SPIRAL CT||Y||PROXY|OTOLARYNGOLOGIST|5|Visit_5|90|7|WASHOUT|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|FRC|Functional Residual Capacity|[?]|SUPINE|||[?]|1|ks|MEDULLA OBLONGATA|BILATERAL|PERIPHERAL|SPIRAL CT SCAN WITHOUT CONTRAST|||Y|PROXY|CARDIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|2|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|cmol|[?]|1|ug/m2/h|ANTERIOR CINGULATE CORTEX|IPSILATERAL|ANTEROTEMPORAL|REFLECTANCE SPECTROSCOPY||||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|3|FEF50|Forced Expiratory Flow 50%|[?]|REVERSE TRENDELENBURG|||[?]|1|10^9 CFU|ESOPHAGUS, UPPER THIRD|RIGHT|LOWER FLEXOR SURFACE|TRICHROME STAIN|||Y|HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|3|TREATMENT|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|4|FEF50|Forced Expiratory Flow 50%|[?]|RIGHT LATERAL DECUBITUS|[?]|PA|[?]|1|g/cm2|LEFT CIRCUMFLEX ARTERY OSTIUM|BILATERAL|OUTER|ELASTOGRAPHY|Y|Y||NON-HEALTH CARE PROFESSIONAL|INTERNIST|2|Visit_2|25|7|SCREENING|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|5|ICREV|IC Reversibility|[?]|UNCONSTRAINED|[?]|mmHg/L/min|[?]|1|VOXEL|RIGHT POSTERIOR DESCENDING ARTERY|IPSILATERAL|LOWER EXTENSOR SURFACE|TELLER ACUITY CARDS||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|10^3 CFU/mL|[?]|1|10^8/L|HEEL OF THE HAND|RIGHT|TEMPORAL|WHOLE TRANSCRIPTOME SEQUENCING||||CHILD|NEUROLOGIST 1|3|Visit_3|40|3|SCREENING|2020-09-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|7|FRC|Functional Residual Capacity|[?]|LATERAL DECUBITUS|[?]|Enzyme U/m2|[?]|1|mL/cage|CORONARY ARTERY, LEFT|CONTRALATERAL|LATERAL|FORCED OSCILLATION TECHNIQUE||Y||PROXY|INTERNIST|4|Visit_4|65|3|FOLLOW-UP|2020-10-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|8|MIPPP|Percent Predicted MIP|[?]|REVERSE TRENDELENBURG|[?]|cmH2O*s2/mL|[?]|1|g/mol|POSTERIOR SUPERIOR ILIAC SPINE|LEFT|UPPER FLEXOR SURFACE|JAFFE REACTION|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|4|Visit_4|65|1|TREATMENT|2020-10-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|9|ALVVOL|Alveolar Volume|[?]|PRONE|||[?]|1|10^12 IU/L|SUPERIOR PUBIC RAMUS|UNILATERAL|POSTERIOR|IN VITRO GENE EXPRESSION ASSAY|||Y|CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|TREATMENT|2020-10-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|d74682f1-824e-449d-bdf1-db517d8fdf2e|10|MALEVDES|Malignancy Evidence Description|[?]|STANDING, BENT FORWARD|[?]|mL/mmHg|[?]|1|Ci/mg|GASTROINTESTINAL SYSTEM|LATERAL|FRONTAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||INTERVIEWER|DERMATOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-10-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|mEq/dL|[?]|1|10^5/L|HYPOTHALAMUS|RIGHT|TEMPORAL|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 3|1|Visit_1|10|4|TREATMENT|2020-12-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|2|FEV1REV|FEV1 Reversibility|[?]|STANDING|||[?]|1|hr/day|SKIN FOLD|CONTRALATERAL|DISTAL VOLAR|HPLC-FL|Y||Y|PARENT|CLINICAL PATHOLOGIST|1|Visit_1|10|6|WASHOUT|2020-12-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|3|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|cup eq|[?]|1|beats/min|INTERVENTRICULAR SEPTUM|BILATERAL|INTERMEDIATE|ETDRS EYE CHART||||INTERVIEWER|FORENSIC PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-12-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|4|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|||[?]|1|10^9 CFU/g|INCISOR|BILATERAL|APICAL|SANGER SEQUENCING|||Y|PARENT|PHYSIOTHERAPIST|2|Visit_2|25|5|TREATMENT|2020-12-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|5|INTP|Interpretation|[?]|SLING|[?]|%(w/w)|[?]|1|SUPPOSITORY|SUPRACLAVICULAR FOSSA|CONTRALATERAL|UPPER|GC/MS-CI|Y|||SIBLING|PHYSIOTHERAPIST|3|Visit_3|40|2|SCREENING|2021-01-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING|[?]|v/v|[?]|1|pmol/10^9 cells|MITRAL VALVE, ANTERIOR CUSP|BILATERAL|DISTAL|REFLECTANCE SPECTROSCOPY|Y|||INTERVIEWER|ONCOLOGIST 1|3|Visit_3|40|4|FOLLOW-UP|2021-01-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|7|SAWVOL|Specific Airway Volume|[?]|SUPINE|[?]|RATIO|[?]|1|PFU/mL|TRACHEOBRONCHIAL TREE|BILATERAL|PROXIMAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|FOLLOW-UP|2021-01-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|8|MIP|Maximal Inspiratory Pressure|[?]|PRONE|||[?]|1|mL/m2/day|LIP, UPPER|RIGHT|VENTRAL|HANSEL STAIN|||Y|VENDOR|DERMATOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|9|PLMXRS|Pulmonary Reactance|[?]|SITTING|[?]|dB|[?]|1|10^9/dose|GONAD|CONTRALATERAL|HIND|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|5|Visit_5|90|2|TREATMENT|2021-02-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|10|FRCPP|Percent Predicted FRC|[?]|TRENDELENBURG|[?]|km/h|[?]|1|uL/kg/day|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|CONTRALATERAL|HIND|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||FRIEND|OPTOMETRIST|5|Visit_5|90|6|TREATMENT|2021-02-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|IRVPP|Percent Predicted IRV|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uU/L|SUPRAPUBIC REGION|LATERAL|POSTERIOR|TARGETED TRANSCRIPTOME SEQUENCING|||Y|SIBLING|RATER|1|Visit_1|10|2|WASHOUT|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|2|SAWVOL|Specific Airway Volume|[?]|PRONE|||[?]|1|mg2/dL2|PERINEUM|LEFT|ANTEROTEMPORAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||Y|Y|SIBLING|NEUROLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|3|FIF50|Forced Inspiratory Flow at 50%|[?]|PRONE|[?]|msec|[?]|1|uU/L|PALATINE BONE|BILATERAL|LOWER MEDIAL|CELLULAR PROLIFERATION ASSAY||||SIGNIFICANT OTHER|PATHOLOGIST 1|2|Visit_2|25|7|FOLLOW-UP|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|4|MIPPP|Percent Predicted MIP|[?]|TRENDELENBURG|[?]|GPL U/mL|[?]|1|ugEq|CEREBRAL VEIN|BILATERAL|TEMPORAL|INDIRECT IMMUNOFLUORESCENCE||||DOMESTIC PARTNER|MICROSCOPIST 1|2|Visit_2|25|3|FOLLOW-UP|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|5|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|[?]|U/kg/h|[?]|1|DDU|POSTERIOR CERVICAL LYMPH NODE|LATERAL|SUPERIOR|NON-CONTACT SPECULAR MICROSCOPY||||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING|[?]|nmol/mol|[?]|1|ppb|ANTECUBITAL FOSSA|LEFT|FRONTAL|ICC||Y||INDEPENDENT ASSESSOR|UROLOGIST|3|Visit_3|40|1|TREATMENT|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|7|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-RECUMBENT|[?]|umol/kg/min|[?]|1|DNA copies/ug|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|IPSILATERAL|POSTERIOR|POTENTIOMETRY||||GUARDIAN|READER 2|4|Visit_4|65|2|TREATMENT|2020-08-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|8|AWVOL|Airway Volume|[?]|SUPINE|||[?]|1|SACHET|GENITAL TUBERCLE|RIGHT|LOWER MEDIAL|IMMUNOFIXATION ELECTROPHORESIS|||Y|FRIEND|RATER 1|4|Visit_4|65|5|FOLLOW-UP|2020-08-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|9|IVCPP|Percent Predicted IVC|[?]|LATERAL DECUBITUS|[?]|U/cL|[?]|1|Log10 ELISA unit/dose|ASCENDING AORTA, AORTIC ROOT|BILATERAL|DISTAL|PET/CT SCAN WITHOUT CONTRAST||||SIGNIFICANT OTHER|READER 1|5|Visit_5|90|3|TREATMENT|2020-09-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|10|ICREV|IC Reversibility|[?]|PRONE|[?]|mL/animal/day|[?]|1|L/h/m2|GLOMERULUS|IPSILATERAL|LOWER MEDIAL|MODIFIED ACID FAST STAIN|Y|||ADJUDICATION COMMITTEE|RADIOLOGIST 1|5|Visit_5|90|2|TREATMENT|2020-09-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|PIF|Peak Inspiratory Flow|[?]|TRENDELENBURG|[?]|mL/kg|[?]|1|BAR|FASCIA|LEFT|CRANIAL|FLUORESCENT MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|1|Visit_1|10|5|FOLLOW-UP|2020-11-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|2|FEV1PP|Percent Predicted FEV1|[?]|UNCONSTRAINED|[?]|ms/mmHg|[?]|1|SUPPOSITORY|FLEXOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|PERIVENTRICULAR|DYNAMIC LIGHT SCATTERING||Y||CLINICAL RESEARCH COORDINATOR|INTERNIST|1|Visit_1|10|3|FOLLOW-UP|2020-11-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SITTING, LEGS DEPENDENT|[?]|mL/100g/min|[?]|1|lx|CEREBRAL HEMISPHERE, LEFT|RIGHT|PROXIMAL|GC/MS-CI||||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|2|Visit_2|25|7|WASHOUT|2020-12-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|4|IVC|Inspiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|Ci/uL|[?]|1|/5x10^4 WBC|CHEST WALL|IPSILATERAL|CENTRAL|DROPLET DIGITAL PCR|Y|Y||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-12-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING, BENT FORWARD|[?]|g/m2/day|[?]|1|mg/mL/min|NASOPHARYNX|LATERAL|CENTRAL|MASS SPECTROMETRY||||CAREGIVER|PHYSIOTHERAPIST|3|Visit_3|40|5|SCREENING|2020-12-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|6|ICREV|IC Reversibility|[?]|UNCONSTRAINED|[?]|mmol/kg|[?]|1|TAMPON|FOOT DIGIT 5|LEFT|UPPER EXTENSOR SURFACE|CELLULOSE TAPE|Y|||PROXY|PEDIATRIC NEUROLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|7|PCF|Peak Cough Flow|[?]|SEMI-RECUMBENT|[?]|cmH2O*s2/mL|[?]|1|kg|HEART, RIGHT ATRIAL APPENDAGE|IPSILATERAL|TEMPORAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|Y||FRIEND|CLINICAL PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2021-01-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING, LEGS DEPENDENT|[?]|vg/mL|[?]|1|SACHET|SCAPULA|IPSILATERAL|SUBCORTICAL|DROPLET DIGITAL PCR||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|4|Visit_4|65|1|WASHOUT|2021-01-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|9|EVC|Expiratory Vital Capacity|[?]|SUPINE|[?]|mEq/mmol|[?]|1|U/g Hb|PROXIMAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|MEDIAL|TOTAL BODY RADIOGRAPHY||Y||PROXY|RATER 1|5|Visit_5|90|2|TREATMENT|2021-02-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|RE|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|mg/cm2|[?]|1|DNA copies/mL|SUBMANDIBULAR LYMPH NODE|IPSILATERAL|PERIPHERAL|DYNAMOMETRY||||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|5|Visit_5|90|5|TREATMENT|2021-02-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-RECUMBENT|[?]|GBq/ug|[?]|1|uU/L|FLEXOR DIGITORUM LONGUS MUSCLE|LATERAL|CAUDAL|JAEGER EYE CHART||||STUDY SUBJECT|HEMATOLOGIST|1|Visit_1|10|1|TREATMENT|2020-10-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|2|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SUPINE|||[?]|1|CFU/mL|HINDLIMB|CONTRALATERAL|LOWER|IMPULSE OSCILLOMETRY|||Y|SIBLING|RATER|1|Visit_1|10|1|WASHOUT|2020-10-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|3|RER|Respiratory Exchange Ratio|[?]|FOWLERS|[?]|kg/L|[?]|1|POINT|MEDIASTINAL LYMPH NODE|RIGHT|INFERIOR|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||STUDY SUBJECT|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-11-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|4|ICREV|IC Reversibility|[?]|SEMI-RECUMBENT|||[?]|1|nCi|KNEE JOINT|BILATERAL|UPPER FLEXOR SURFACE|DIGITAL PCR|Y||Y|INTERVIEWER|RATER|2|Visit_2|25|5|SCREENING|2020-11-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|5|FEV1SVC|FEV1/SVC|[?]|TRENDELENBURG|||[?]|1|uV|LIVER LOBE|RIGHT|ANTEROPOSTERIOR|VENTILATION PERFUSION LUNG SCAN|Y||Y|FAMILY MEMBER|CARDIOLOGIST|3|Visit_3|40|3|TREATMENT|2020-11-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|6|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|copies/mL|[?]|1|PA|ESOPHAGUS, THORACIC|LATERAL|SUPERIOR|PUPILLOMETRY||||ADJUDICATOR|OPTOMETRIST|3|Visit_3|40|3|TREATMENT|2020-11-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|BOLUS|[?]|1|CAPFUL|PULMONARY VALVE, ANTERIOR CUSP|BILATERAL|ANTERIOR|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|Y||CLINICAL STUDY SPONSOR|ADJUDICATOR|4|Visit_4|65|3|WASHOUT|2020-12-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|8|PEFTIME|Peak Expiratory Flow Time|[?]|DECUBITUS|[?]|uL|[?]|1|in2|METACARPOPHALANGEAL JOINT 5|RIGHT|VENTROLATERAL|ACID FAST STAIN|Y|||SIBLING|MICROSCOPIST 2|4|Visit_4|65|1|TREATMENT|2020-12-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|9|FEV3PP|Percent Predicted FEV3|[?]|UNCONSTRAINED|[?]|ug/dose|[?]|1|mL/dose|HAND DIGIT 2|IPSILATERAL|LOWER MEDIAL|DROPLET DIGITAL PCR|Y|||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|5|Visit_5|90|1|SCREENING|2021-01-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|10|TSUHYS|Tissue Hysteresivity|[?]|SITTING, LEGS DEPENDENT|[?]|kg|[?]|1|10^9 organisms|RIB 7|RIGHT|PERIPHERAL|LC/MS|Y|||CLINICAL RESEARCH ASSOCIATE|RATER 2|5|Visit_5|90|3|TREATMENT|2021-01-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|PLMXRS|Pulmonary Reactance|[?]|LEFT LATERAL DECUBITUS|[?]|ng/day|[?]|1|pL|SKIN OF THE INFRASCAPULAR REGION|BILATERAL|OUTER|FUNDUS PHOTOGRAPHY||||INVESTIGATOR|OPTOMETRIST|1|Visit_1|10|3|TREATMENT|2020-12-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|kg/L|[?]|1|10^9 organisms/mg|CARPOMETACARPAL JOINT 2|LEFT|NASAL|RADIAL IMMUNODIFFUSION||||SIGNIFICANT OTHER|ONCOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-12-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|3|FIO2|Fraction of Inspired Oxygen|[?]|SITTING, LEGS DEPENDENT|[?]|MONTHS|[?]|1|cP|VOMER|LATERAL|DISTAL|BAC ACGH|Y|||SIGNIFICANT OTHER|MICROSCOPIST|2|Visit_2|25|7|FOLLOW-UP|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|4|TLC|Total Lung Capacity|[?]|LATERAL DECUBITUS|[?]|QUANTITY SUFFICIENT|[?]|1|RATIO|VULVA|UNILATERAL|LOWER FLEXOR SURFACE|FREEZING POINT DEPRESSION||||PARENT|ADJUDICATOR 3|2|Visit_2|25|4|TREATMENT|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|5|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|[?]|/40 HPFs|[?]|1|CCID 50/dose|SUPERIOR VENA CAVA|BILATERAL|INNER|IRON HEMATOXYLIN STAIN|Y|||INDEPENDENT ASSESSOR|ADJUDICATOR 2|3|Visit_3|40|3|SCREENING|2021-01-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|6|ALVVOL|Alveolar Volume|[?]|FOWLERS|[?]|Mile|[?]|1|pmol/g|FIRST OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|DISTAL VOLAR|CYSTOMETRY||||CHILD|CLINICAL PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2021-01-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|7|FEF50|Forced Expiratory Flow 50%|[?]|REVERSE TRENDELENBURG|[?]|U/cL|[?]|1|SFC/10^6 PBMC|OCCIPITAL LOBE|CONTRALATERAL|UPPER EXTENSOR SURFACE|ISHIHARA COLOR PLATES||||INVESTIGATOR|NEUROLOGIST 1|4|Visit_4|65|1|SCREENING|2021-02-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|8|IRVPP|Percent Predicted IRV|[?]|SEMI-FOWLERS|[?]|mL/min/mmHg|[?]|1|fmol/g|OBTURATOR EXTERNUS MUSCLE|LEFT|FACIAL|WRIGHT-GIEMSA STAIN||||INTERVIEWER|RATER 2|4|Visit_4|65|5|TREATMENT|2021-02-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|9|AWVOLPP|Percent Predicted Airway Volume|[?]|DECUBITUS|[?]|10^6/L|[?]|1|Ci/ug|POPLITEAL LYMPH NODE|IPSILATERAL|SURFACE|WRIGHT-GIEMSA STAIN||||SIBLING|READER 1|5|Visit_5|90|6|FOLLOW-UP|2021-03-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|b5644705-65e9-4d9b-9f5c-f8f62d26e257|10|MEPPP|Percent Predicted MEP|[?]|SUPINE|[?]|Osm|[?]|1|GLOBULE|LEFT ATRIOVENTRICULAR ARTERY|RIGHT|APICAL|TRIPLE-PHASE MRI SCAN||||STUDY SUBJECT|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2021-03-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING|[?]|ugEq|[?]|1|kcal|KIDNEY, HILUM|RIGHT|PROXIMAL VOLAR|TARGETED TRANSCRIPTOME SEQUENCING||Y||STUDY SUBJECT|MICROSCOPIST 2|1|Visit_1|10|1|SCREENING|2020-05-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|2|IVC|Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|10^3 RNA copies/mL|[?]|1|POUCH|LYMPH NODE HILUM|BILATERAL|VENTRAL|HIGH RESOLUTION MELT ANALYSIS||||CLINICAL RESEARCH COORDINATOR|RATER|1|Visit_1|10|5|TREATMENT|2020-05-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|3|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SUPINE|[?]|cmHg|[?]|1|oz|CUBOID BONE|RIGHT|DORSOLATERAL|PALPATION||||SPOUSE|ONCOLOGIST 1|2|Visit_2|25|6|FOLLOW-UP|2020-05-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|4|FEV_PEF|FEV at PEF|[?]|SUPINE|[?]|Farad|[?]|1|kHz|LIVER LOBE|BILATERAL|DEEP|LC/MS/MS|Y|||VENDOR|NEUROLOGIST 2|2|Visit_2|25|5|FOLLOW-UP|2020-05-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|5|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|min*mg/mL|[?]|1|cm|FORELIMB|CONTRALATERAL|FACIAL|PHOTOGRAPHY|Y|Y||INDEPENDENT ASSESSOR|NEUROLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-06-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|6|VO2|Oxygen Consumption|[?]|SITTING, LEGS DEPENDENT|[?]|Weber|[?]|1|mL/dose|MEDIASTINUM, ANTERIOR|IPSILATERAL|ANTEROMEDIAL|ERGOSPIROMETRY||Y||FAMILY MEMBER|ADJUDICATOR 1|3|Visit_3|40|5|SCREENING|2020-06-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-06
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|7|TV|Tidal Volume|[?]|REVERSE TRENDELENBURG|[?]|MET|[?]|1|STEPS|STERNUM|CONTRALATERAL|SURFACE|BETA LACTAMASE||||DOMESTIC PARTNER|OPTOMETRIST|4|Visit_4|65|6|TREATMENT|2020-07-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|8|RV|Residual Volume|[?]|PRONE|[?]|mmol/L|[?]|1|GBq/mg|ISCHIORECTAL FOSSA|CONTRALATERAL|POSTERIOR|NUCLEIC ACID AMPLIFICATION TEST||Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|4|Visit_4|65|6|TREATMENT|2020-07-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|9|FIVC|Forced Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|mg/kg|NERVE|RIGHT|UPPER|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||Y|Y|CAREGIVER|CARDIOLOGIST|5|Visit_5|90|5|WASHOUT|2020-08-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|RE|ec82f59b-197a-4ccc-b5e5-d91627a86a27|10|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/dL|[?]|1|NEBULE|CELIAC LYMPH NODE|BILATERAL|ROSTRAL|IN VITRO GENE EXPRESSION ASSAY||||FAMILY MEMBER|READER 3|5|Visit_5|90|3|TREATMENT|2020-08-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|STANDING, BENT FORWARD|[?]|ug/kg/min|[?]|1|Bq/mL|THALAMUS|RIGHT|OUTER|KNEMOMETRY||||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|1|Visit_1|10|2|WASHOUT|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|2|EVC|Expiratory Vital Capacity|[?]|SITTING|[?]|fmol/L/sec|[?]|1|10^6 CFU/mL|OVARIAN FOLLICLE|UNILATERAL|LATERAL|X-RAY FLUORESCENCE SPECTROMETRY||||PARENT|PHYSIOTHERAPIST|1|Visit_1|10|4|SCREENING|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|3|EVC|Expiratory Vital Capacity|[?]|SUPINE|[?]|g/L|[?]|1|10^11/L|HAND DIGIT 5|LEFT|DORSOLATERAL|PHYSICAL EXAMINATION||||GUARDIAN|OPHTHALMOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|4|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|[?]|usec|[?]|1|dpm/mg|PERONEAL ARTERY|LATERAL|PERIPHERAL|MICROPARTICLE ENZYME IMMUNOASSAY|Y|||CAREGIVER|RADIOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|5|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING, BENT FORWARD|[?]|U.CARR|[?]|1|mg/L FEU|LEFT CIRCUMFLEX ARTERY OSTIUM|LEFT|DISTAL VOLAR|CHROMOGENIC ASSAY||||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|1|WASHOUT|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|6|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-RECUMBENT|[?]|umol/day|[?]|1|/MBP|PARAMETRIUM|BILATERAL|DISTAL VOLAR|INDIRECT IMMUNOFLUORESCENCE|Y|||CLINICAL STUDY SPONSOR|HEMATOLOGIST|3|Visit_3|40|2|TREATMENT|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|7|SRAW|Specific Airway Resistance|[?]|SEMI-RECUMBENT|[?]|lx|[?]|1|Absorbance U|LUMBAR SPINE|RIGHT|PROXIMAL VOLAR|PATHOLOGICAL EVALUATION||||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|Frames/s|[?]|1|kN/cm2|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|OCCIPITAL|HPLC-FL||||VENDOR|RADIOLOGIST 2|4|Visit_4|65|1|TREATMENT|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|9|FEF50|Forced Expiratory Flow 50%|[?]|STANDING|[?]|IU/L|[?]|1|TUBE|HEART, LEFT ATRIUM|IPSILATERAL|DORSAL|OPTICAL MAPPING||Y||SIBLING|MICROSCOPIST 3|5|Visit_5|90|1|WASHOUT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|527fd604-110f-47b1-bd8b-b1de2f5b0d29|10|INTP|Interpretation|[?]|PRONE|||[?]|1|mL*cmH2O|SKIN AROUND THE MOUTH|LATERAL|MEDIAL|CONTRAST ENHANCED X-RAY|||Y|INVESTIGATOR|ONCOLOGIST|5|Visit_5|90|1|WASHOUT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|||[?]|1|mOsm/kg|LIVER, QUADRATE LOBE|LATERAL|PARIETO-OCCIPITAL|DYNAMIC CONTRAST ENHANCED MRI|||Y|FRIEND|OTOLARYNGOLOGIST|1|Visit_1|10|1|TREATMENT|2020-10-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SLING|||[?]|1|mg/kg/h|DISTAL RIGHT CORONARY ARTERY CONDUIT|LATERAL|DORSOLATERAL|POPULATION SEQUENCING||Y|Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|1|Visit_1|10|7|TREATMENT|2020-10-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|3|FIO2|Fraction of Inspired Oxygen|[?]|RIGHT LATERAL DECUBITUS|[?]|g|[?]|1|IU/kg|INTERPHALANGEAL JOINT 5|UNILATERAL|SURFACE|APPLANATION TONOMETRY||||FAMILY MEMBER|ENDOCRINOLOGIST|2|Visit_2|25|5|TREATMENT|2020-11-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|4|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING|[?]|fmol/L/sec|[?]|1|DRUM|NIPPLE|CONTRALATERAL|UPPER|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||PROXY|UROLOGIST|2|Visit_2|25|6|TREATMENT|2020-11-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|FFU|[?]|1|pg/L|HEAD|LEFT|SUPERIOR|DIFFUSION TENSOR MRI||Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|3|Visit_3|40|2|FOLLOW-UP|2020-11-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|6|PCF|Peak Cough Flow|[?]|SEMI-RECUMBENT|[?]|TRACE|[?]|1|PACKAGE|CHEST WALL|RIGHT|SURFACE|SISH||||SPOUSE|NEUROLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-11-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|||[?]|1|V|HEPATIC VEIN|LATERAL|ANTEROPOSTERIOR|PH METER MEASUREMENT METHOD|Y||Y|ADJUDICATION COMMITTEE|MICROSCOPIST 1|4|Visit_4|65|4|TREATMENT|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|DECUBITUS|[?]|PA|[?]|1|BAU|WRIST JOINT FLEXOR MUSCLES|LATERAL|LOWER FLEXOR SURFACE|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|||GUARDIAN|ONCOLOGIST|4|Visit_4|65|7|SCREENING|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|9|PCF|Peak Cough Flow|[?]|STANDING|[?]|ug/kg|[?]|1|umol/L/min|GENITAL TUBERCLE|IPSILATERAL|LOWER FLEXOR SURFACE|PET SCAN||Y||CLINICAL RESEARCH ASSOCIATE|INTERNIST|5|Visit_5|90|3|SCREENING|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|1e1de453-920a-4132-b2f7-6335ee81ec83|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mL/kg/min|EPIDURAL SPACE|LATERAL|ANTEROTEMPORAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|Y|Y|SIGNIFICANT OTHER|RATER|5|Visit_5|90|2|TREATMENT|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|INERTANC|Inertance|[?]|PRONE|[?]|umol/L/sec|[?]|1|cmH2O/mL|OCCIPITAL SCALP|LATERAL|NASAL|SINGLE-MOLECULE ARRAY||||SIBLING|CLINICAL PATHOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-06-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|FOWLERS|[?]|log10 copies/mL|[?]|1|%(w/v)|HAIR|LATERAL|PROXIMAL VOLAR|IMMUNOCHEMILUMINOMETRIC ASSAY||||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|4|TREATMENT|2020-06-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|[?]|log10 PFU/mL|[?]|1|kN/cm2|BRAIN, THIRD VENTRICLE|BILATERAL|FACIAL|SINGLE-SLICE SPIRAL CT||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|2|Visit_2|25|3|WASHOUT|2020-07-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|4|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|/100 HPFs|[?]|1|umol/L/min|URETHRA, ANTERIOR|CONTRALATERAL|UPPER FLEXOR SURFACE|DIFFUSION TENSOR MRI||||CHILD|PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-07-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|5|FIFMAXPP|Percent Predicted FIFmax|[?]|TRENDELENBURG|[?]|ug/g/min|[?]|1|um/day|NERVE|LEFT|TEMPORAL|FLUORESCENT ENZYME IMMUNOASSAY||||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|6|RAW|Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|10^10/L|[?]|1|log EID 50/dose|PERICARDIAL WALL|CONTRALATERAL|UPPER EXTENSOR SURFACE|THIN SMEAR||Y||INVESTIGATOR|RATER|3|Visit_3|40|5|SCREENING|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|7|TLCPP|Percent Predicted Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mL/kg/h|AORTIC VALVE, RIGHT CORONARY CUSP|CONTRALATERAL|DORSAL|IMMUNOPRECIPITATION|||Y|FAMILY MEMBER|ONCOLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|8|AWVOL|Airway Volume|[?]|STANDING, BENT FORWARD|[?]|JDF Unit|[?]|1|10^3 DNA copies/mL|GLOBUS PALLIDUS|UNILATERAL|PARIETO-OCCIPITAL|URANYL ACETATE STAIN|Y|||VENDOR|MICROSCOPIST 3|4|Visit_4|65|3|TREATMENT|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|9|SAWVOL|Specific Airway Volume|[?]|SUPINE|[?]|Bq/mg|[?]|1|Ci/uL|HAMSTRING MUSCLE|LATERAL|UPPER EXTENSOR SURFACE|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||PROXY|ADJUDICATOR 1|5|Visit_5|90|1|TREATMENT|2020-09-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|e553ad8e-96f4-4cb0-a005-51e9b64513b7|10|TGV|Thoracic Gas Volume|[?]|LATERAL DECUBITUS|||[?]|1|NFIU|COLON, HEPATIC FLEXURE|UNILATERAL|POSTERIOR|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|||Y|INDEPENDENT ASSESSOR|RADIOLOGIST|5|Visit_5|90|5|TREATMENT|2020-09-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|PCF|Peak Cough Flow|[?]|PRONE|[?]|km|[?]|1|nmol BCE/mmol|AXILLARY ARTERY|LATERAL|SURFACE|HEMOCYTOMETRY||||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|1|Visit_1|10|3|WASHOUT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|2|ELSTNCE|Elastance|[?]|TRENDELENBURG|[?]|ohm|[?]|1|Shock Wave|CILIARY BODY|RIGHT|INTERMEDIATE|LANDOLT RING|Y|Y||SIBLING|ADJUDICATOR 3|1|Visit_1|10|5|FOLLOW-UP|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|3|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|U/g/min|[?]|1|uCi/kg|RENAL PELVIS|RIGHT|CENTRAL|STATIC PERIMETRY||Y||HEALTH CARE PROFESSIONAL|NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|UNCONSTRAINED|[?]|deg/s|[?]|1|nmol|SCAPHOID-TRAPEZOID JOINT|LATERAL|ANTEROPOSTERIOR|REFRACTOMETRY||||STUDY SUBJECT|HEMATOLOGIST|2|Visit_2|25|7|WASHOUT|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|5|FEV3PP|Percent Predicted FEV3|[?]|STANDING, BENT FORWARD|[?]|Pa|[?]|1|/HPF|CORONARY ARTERY, ANTERIOR DESCENDING|BILATERAL|DORSAL|CONTRAST ENHANCED CT SCAN||Y||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|[?]|umol/L/sec|[?]|1|10^4/L|DISTAL LAD ARTERY|IPSILATERAL|FACIAL|PHASE CONTRAST MICROSCOPY||||STUDY SUBJECT|RATER 2|3|Visit_3|40|1|SCREENING|2021-01-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|7|VO2|Oxygen Consumption|[?]|SITTING|[?]|IMPLANT|[?]|1|10^12/L|EPITROCHLEAR LYMPH NODE|CONTRALATERAL|APICAL|EEG|Y|||SIGNIFICANT OTHER|RATER 2|4|Visit_4|65|7|SCREENING|2021-02-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|8|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|||[?]|1|ug/L FEU|ESOPHAGUS, ABDOMINAL|UNILATERAL|CAUDAL|KINETIC CHROMOGENIC ASSAY|||Y|STUDY SUBJECT|PATHOLOGIST 2|4|Visit_4|65|7|FOLLOW-UP|2021-02-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|9|ERV|Expiratory Reserve Volume|[?]|STANDING|[?]|m2|[?]|1|mm2|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|BILATERAL|FACIAL|GC/MS/MS||||SPOUSE|INTERNIST|5|Visit_5|90|4|TREATMENT|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|10|INFLTIND|Infiltrates Indicator|[?]|STANDING, BENT FORWARD|[?]|hPa|[?]|1|/LPF|RECTOVAGINAL SPACE|CONTRALATERAL|UPPER EXTENSOR SURFACE|ACRIDINE ORANGE STAIN||||STUDY SUBJECT|ONCOLOGIST 2|5|Visit_5|90|6|TREATMENT|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|PLMXRS|Pulmonary Reactance|[?]|SLING|||[?]|1|ohm|CARPOMETACARPAL JOINT 4|IPSILATERAL|FACIAL|LANDOLT RING|||Y|SIGNIFICANT OTHER|ENDOCRINOLOGIST|1|Visit_1|10|4|TREATMENT|2020-06-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|10^7 CFU|RIB 7|BILATERAL|INNER|LAPAROSCOPY|||Y|INDEPENDENT ASSESSOR|ONCOLOGIST 2|1|Visit_1|10|5|TREATMENT|2020-06-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|3|TSUHYS|Tissue Hysteresivity|[?]|SUPINE|[?]|deg/mm|[?]|1|/min|INTERPHALANGEAL JOINT 5|UNILATERAL|ANTEROPOSTERIOR|PLAQUE REDUCTION NEUTRALIZATION ASSAY||Y||ADJUDICATOR|MICROSCOPIST|2|Visit_2|25|1|SCREENING|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|STANDING|||[?]|1|gtt|CORONARY VEIN|LEFT|ANTERIOR|DIGITAL PCR|Y||Y|SPOUSE|READER 3|2|Visit_2|25|1|TREATMENT|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|5|FIF25|Forced Inspiratory Flow at 25%|[?]|PRONE|[?]|scm|[?]|1|nmol/L|PERINEUM|UNILATERAL|INFERIOR|MIGET||||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|3|Visit_3|40|5|WASHOUT|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|6|INERTANC|Inertance|[?]|STANDING, BENT FORWARD|[?]|10^3 organisms/mL|[?]|1|ug/h|METACARPOPHALANGEAL JOINT 1|LEFT|BASAL|OSCILLOMETRY||||PARENT|MICROSCOPIST|3|Visit_3|40|6|TREATMENT|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|7|QUASCOMP|Quasi-Static Compliance|[?]|REVERSE TRENDELENBURG|||[?]|1|ug/m2/h|PRELARYNGEAL LYMPH NODE|RIGHT|DORSOLATERAL|PERFUSION MRI|||Y|NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|8|MIP|Maximal Inspiratory Pressure|[?]|REVERSE TRENDELENBURG|[?]|USP U|[?]|1|OD Unit|TOOTH|UNILATERAL|UPPER|HEMAGGLUTINATION ASSAY||Y||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|9|INTP|Interpretation|[?]|LATERAL DECUBITUS|[?]|Joule|[?]|1|mOsm/kg|MIDDLE PHALANX 2 OF THE HAND|BILATERAL|LOWER|TELLER ACUITY CARDS||||INDEPENDENT ASSESSOR|HEMATOLOGIST|5|Visit_5|90|4|TREATMENT|2020-08-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|10|SVC|Slow Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|mg/m2/min|PERITONEUM|BILATERAL|ANTEROMEDIAL|FLUORESCENCE ANGIOGRAPHY|||Y|PROXY|ONCOLOGIST 2|5|Visit_5|90|5|FOLLOW-UP|2020-08-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|SAWVOL|Specific Airway Volume|[?]|FOWLERS|[?]|pL|[?]|1|GBq/ug|AXILLARY ARTERY|BILATERAL|PROXIMAL VOLAR|LEAD CITRATE STAIN||||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-10-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|2|SGAW|Specific Airway Conductance|[?]|STANDING|||[?]|1|ug/L DDU|OCCIPITAL LOBE|IPSILATERAL|MIDLINE|NON-CONTACT SPECULAR MICROSCOPY|||Y|SPOUSE|DERMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-10-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|3|INTP|Interpretation|[?]|SITTING|[?]|kBq/uL|[?]|1|COAT|SUPRACLAVICULAR FOSSA|CONTRALATERAL|PROXIMAL|CORONARY ANGIOGRAPHY|Y|Y||FRIEND|ADJUDICATOR 2|2|Visit_2|25|5|SCREENING|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|4|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|[?]|MET*min|[?]|1|hr/day|FLEXOR POLLICIS LONGUS MUSCLE|UNILATERAL|ANTEROPOSTERIOR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST|2|Visit_2|25|7|TREATMENT|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|PRONE|[?]|Enzyme U/m2|[?]|1|cg|NIPPLE|IPSILATERAL|HIND|KNEMOMETRY||||FAMILY MEMBER|ONCOLOGIST 1|3|Visit_3|40|4|FOLLOW-UP|2020-11-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|CAPSULE|[?]|1|10^6 RNA copies/mL|MENINGES|UNILATERAL|CENTRAL|ETDRS EYE CHART||Y||FRIEND|RATER 2|3|Visit_3|40|7|SCREENING|2020-11-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|7|SVCPP|Percent Predicted Slow Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|IU/mmol|[?]|1|amp|ANTRUM PYLORI|RIGHT|LOWER EXTENSOR SURFACE|ANALYTICAL ULTRACENTRIFUGATION||Y||PROXY|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|8|EVC|Expiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|log10 CCID 50/dose|[?]|1|mmol/kg|RADIAL ARTERY|RIGHT|PROXIMAL|OBSERVATION|Y|||DOMESTIC PARTNER|MICROSCOPIST|4|Visit_4|65|6|WASHOUT|2020-12-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|9|FIVC|Forced Inspiratory Vital Capacity|[?]|FOWLERS|[?]|mg/kg/h|[?]|1|cmHg|LUNG LOBE|CONTRALATERAL|BASAL|X-RAY||Y||FRIEND|READER 2|5|Visit_5|90|2|TREATMENT|2021-01-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|10|FEV1FVC6|FEV1/FVC6|[?]|LATERAL DECUBITUS|[?]|PIPE|[?]|1|TUBE|PRIMARY VISUAL CORTEX|CONTRALATERAL|LOWER FLEXOR SURFACE|PUPILLOMETRY||Y||FRIEND|MICROSCOPIST 1|5|Visit_5|90|3|TREATMENT|2021-01-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|FOWLERS|||[?]|1|Watt|EYE, ANTERIOR SEGMENT|BILATERAL|BASAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|Y|Y|CAREGIVER|PATHOLOGIST 2|1|Visit_1|10|1|SCREENING|2020-12-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|2|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|[?]|mL/min/mmHg|[?]|1|Enzyme U/m2|AXILLARY LYMPH NODE LEVEL II|CONTRALATERAL|ANTEROPOSTERIOR|TEST STRIP|Y|||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|2|SCREENING|2020-12-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|3|FIVC|Forced Inspiratory Vital Capacity|[?]|PRONE|[?]|log10 CFU/mL|[?]|1|kBq/uL|DISTAL INTERPHALANGEAL JOINT 3|BILATERAL|VENTROLATERAL|POLYSOMNOGRAPHY||||SPOUSE|ONCOLOGIST 1|2|Visit_2|25|6|TREATMENT|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|4|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|mL/min|[?]|1|g/g|TOENAIL|RIGHT|ANTEROMEDIAL|IMMUNOCHEMILUMINOMETRIC ASSAY||||SIBLING|RADIOLOGIST 2|2|Visit_2|25|3|TREATMENT|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|5|FEV3PP|Percent Predicted FEV3|[?]|TRENDELENBURG|[?]|Pack Year|[?]|1|ug/L|SKIN OF THE EAR|UNILATERAL|SUPERIOR|GIEMSA STAIN||||INVESTIGATOR|READER 1|3|Visit_3|40|3|WASHOUT|2021-01-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|6|GAW|Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|mol/L|[?]|1|10^6 IU|OLFACTORY NERVE|LEFT|INFERIOR|DIFFUSION WEIGHTED MRI||||ADJUDICATION COMMITTEE|ONCOLOGIST|3|Visit_3|40|2|TREATMENT|2021-01-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|7|EFFIND|Effusion Indicator|[?]|SITTING|||[?]|1|mm/min|BLADDER, FUNDUS|LEFT|SUPERFICIAL|WHOLE EXOME SEQUENCING|||Y|GUARDIAN|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2021-02-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|8|INERTANC|Inertance|[?]|SITTING|[?]|m3|[?]|1|cs|SKIN OF THE BACK|IPSILATERAL|SUPERFICIAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||ADJUDICATION COMMITTEE|CARDIOLOGIST|4|Visit_4|65|2|WASHOUT|2021-02-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|9|TSUELAS|Tissue Elastance|[?]|FOWLERS|[?]|BAG|[?]|1|10^6 U|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|RIGHT|APICAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||HEALTH CARE PROFESSIONAL|READER 3|5|Visit_5|90|1|TREATMENT|2021-03-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|10|ICREV|IC Reversibility|[?]|SEMI-FOWLERS|[?]|/200 HPFs|[?]|1|IU/mmol|ABDUCTOR HALLUCIS MUSCLE|RIGHT|PARIETO-OCCIPITAL|RIA||||PROXY|NEUROLOGIST 2|5|Visit_5|90|3|WASHOUT|2021-03-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|UNCONSTRAINED|||[?]|1|IU/g|HYMENAL RING|BILATERAL|DISTAL|CELL OF ORIGIN ASSAY|||Y|CHILD|ADJUDICATOR 3|1|Visit_1|10|5|WASHOUT|2020-10-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|2|AWWVOL|Airway Wall Volume|[?]|SITTING|[?]|ug/m2/min|[?]|1|mph|DENTAL ARCH|LATERAL|VENTROLATERAL|PERFUSION MRI||||DOMESTIC PARTNER|NEUROLOGIST 2|1|Visit_1|10|3|SCREENING|2020-10-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SUPINE|[?]|FIU|[?]|1|ug|AXIAL SKELETON|IPSILATERAL|ANTEROLATERAL|SIZE EXCLUSION CHROMATOGRAPHY|Y|Y||ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mmol/mol|[?]|1|mMU/mL|FEMORAL VEIN|CONTRALATERAL|UPPER EXTENSOR SURFACE|MICRO BROTH DILUTION||Y||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|2|Visit_2|25|4|WASHOUT|2020-11-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|FOWLERS|||[?]|1|FIU|FEMORAL CONDYLE|LATERAL|LOWER|THIN SMEAR|Y|Y|Y|HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|6|RELSZCHG|Relative Size Change|[?]|LEFT LATERAL DECUBITUS|[?]|ukat|[?]|1|mkat|CEREBRAL SUBCORTEX|LEFT|LOWER EXTENSOR SURFACE|GRADIENT DIFFUSION||||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-11-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|7|INFLTIND|Infiltrates Indicator|[?]|REVERSE TRENDELENBURG|[?]|mg/cm2|[?]|1|PIXEL|INTERPHALANGEAL JOINT 1|LEFT|TEMPORAL|MICROBIAL CULTURE, SOLID||||CLINICAL RESEARCH COORDINATOR|RATER 2|4|Visit_4|65|3|SCREENING|2020-12-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SUPINE|[?]|/10^4|[?]|1|mg/g/min|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|CONTRALATERAL|SUPERIOR|LIQUID SCINTILLATION COUNTING||||INTERVIEWER|RATER 2|4|Visit_4|65|3|FOLLOW-UP|2020-12-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|9|PIF|Peak Inspiratory Flow|[?]|PRONE|[?]|APL U/mL|[?]|1|genEq/mL|TONSIL|IPSILATERAL|POSTERIOR|POPULATION SEQUENCING||||FRIEND|OTOLARYNGOLOGIST|5|Visit_5|90|1|SCREENING|2021-01-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|ad04ec90-9fd5-49f2-ae23-264273eb0a24|10|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING, LEGS DEPENDENT|||[?]|1|nkat/L|GLOSSOPHARYNGEAL NERVE|UNILATERAL|SUPERIOR|CONTRAST ENHANCED X-RAY|||Y|PROXY|UROLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|1|DLCOHCVA|HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|copies/ug|[?]|1|nkat|CEREBRAL CORTEX|LEFT|LOWER EXTENSOR SURFACE|MULTIPLE BREATH WASHOUT|Y|Y||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|2|FRCPP|Percent Predicted FRC|[?]|SITTING|[?]|PIXEL|[?]|1|mL/min/1.73m2|MUCOSA|LEFT|INNER|TRICHROME STAIN||||FRIEND|OPTOMETRIST|1|Visit_1|10|2|SCREENING|2021-01-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|SLING|||[?]|1|cm2|ILIAC VEIN|BILATERAL|NASAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y|Y|ADJUDICATION COMMITTEE|ONCOLOGIST 2|2|Visit_2|25|3|WASHOUT|2021-02-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-20
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|4|EXPRELTM|Expiration Relaxation Time|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol BCE/mmol|[?]|1|vg/kg|DISTAL LAD ARTERY|IPSILATERAL|FACIAL|PHASE CONTRAST MICROSCOPY||||INDEPENDENT ASSESSOR|NEUROLOGIST 1|2|Visit_2|25|3|SCREENING|2021-02-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-20
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|5|RAWPP|Percent Predicted Airway Resistance|[?]|LATERAL DECUBITUS|[?]|ngEq/L|[?]|1|mCi/L|INTERPHALANGEAL JOINT 5 OF THE FOOT|CONTRALATERAL|DISTAL|DUKE INCISION METHOD|Y|||DOMESTIC PARTNER|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-26
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|6|DLCOPP|Percent Predicted DLCO|[?]|PRONE|||[?]|1|breaths/30s|TIBIA|LEFT|UPPER|INCISION-INDUCED BLEEDING METHOD|||Y|ADJUDICATOR|ADJUDICATOR 2|3|Visit_3|40|7|WASHOUT|2021-02-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-26
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|7|EVC|Expiratory Vital Capacity|[?]|DECUBITUS|[?]|umol/L/min|[?]|1|uCi|SUPRACLAVICULAR LYMPH NODE|CONTRALATERAL|NASAL|GIEMSA STAIN||||CAREGIVER|ADJUDICATOR 3|4|Visit_4|65|7|TREATMENT|2021-03-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|8|FEV1REV|FEV1 Reversibility|[?]|SUPINE|[?]|PFU/dose|[?]|1|cm|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|FRONTAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||Y||FAMILY MEMBER|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|9|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|usec|[?]|1|CCID 50/dose|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|FORE|CLAUSS METHOD||||VENDOR|CLINICAL PATHOLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|a1d203ef-7ee1-4373-988a-370532bae2b1|10|TSUHYS|Tissue Hysteresivity|[?]|SLING|[?]|dpm/100mg|[?]|1|/day|SUBMANDIBULAR GLAND|RIGHT|NASAL|KINETIC MICROPARTICLE IMMUNOASSAY||Y||GUARDIAN|RADIOLOGIST 1|5|Visit_5|90|3|SCREENING|2021-04-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|1|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|10^3 CFU|[?]|1|nkat/L|AXILLARY LYMPH NODE|CONTRALATERAL|OUTER|POLYSOMNOGRAPHY||Y||SIBLING|INTERNIST|1|Visit_1|10|6|TREATMENT|2020-06-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|2|MIP|Maximal Inspiratory Pressure|[?]|SLING|[?]|nCi|[?]|1|cmH2O*s/mL|TEMPOROMANDIBULAR JOINT|LEFT|MIDLINE|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-06-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|3|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|10^6/g|LIVER|UNILATERAL|DORSAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||Y|CAREGIVER|MICROSCOPIST 3|2|Visit_2|25|4|SCREENING|2020-07-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|4|EFFIND|Effusion Indicator|[?]|SEMI-RECUMBENT|[?]|EID 50/mL|[?]|1|mOsm/kg|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|IPSILATERAL|UPPER EXTENSOR SURFACE|IMMUNOASSAY||||VENDOR|READER 1|2|Visit_2|25|4|WASHOUT|2020-07-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SUPINE|[?]|bel|[?]|1|DNA copies/mL|SUPRARENAL AORTA|LATERAL|LOWER EXTENSOR SURFACE|FLUORESCENT MICROSCOPY|Y|||ADJUDICATOR|CARDIOLOGIST|3|Visit_3|40|1|SCREENING|2020-07-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|6|FIV1|Forced Inspiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|10^7 CFU|[?]|1|g/cage/day|OROPHARYNX|LATERAL|DORSOLATERAL|LIGHT MICROSCOPY||||CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|7|ELSTNCE|Elastance|[?]|LEFT LATERAL DECUBITUS|[?]|mEq/g|[?]|1|mV2/Hz|GUT-ASSOCIATED LYMPHOID TISSUE|IPSILATERAL|PROXIMAL VOLAR|CONTRAST ENHANCED PET SCAN||||INDEPENDENT ASSESSOR|HEMATOLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|8|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|[?]|sec|[?]|1|g/day|KIDNEY, CORTEX|RIGHT|VENTRAL|ACCELERATOR MASS SPECTROMETRY||||CAREGIVER|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|9|FEV1FVC6|FEV1/FVC6|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/g|[?]|1|mL/dL|TALUS|UNILATERAL|SUPERIOR|TELLER ACUITY CARDS|Y|Y||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|4389d158-cb51-4779-b19a-f38dbef0806a|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|DECUBITUS|[?]|U/10^12 RBC|[?]|1|nmol|MENINGES|BILATERAL|TIP|FARR ASSAY|Y|||SPOUSE|HEMATOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|DECUBITUS|[?]|uV2|[?]|1|g/cage/wk|LARGE INTESTINE|UNILATERAL|UPPER FLEXOR SURFACE|CT SCAN WITHOUT CONTRAST|Y|||PROXY|DERMATOLOGIST|1|Visit_1|10|1|TREATMENT|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|2|TSUHYS|Tissue Hysteresivity|[?]|SEMI-FOWLERS|[?]|Absorbance U/mL|[?]|1|umol/h/mmol|INCUS|LATERAL|ANTERIOR|MICRO BROTH DILUTION||||VENDOR|CARDIOLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|3|FIF75|Forced Inspiratory Flow at 75%|[?]|REVERSE TRENDELENBURG|[?]|/4.0 mL|[?]|1|deg|FACIAL NERVE|IPSILATERAL|PERIVENTRICULAR|PET/MRI SCAN||||PROXY|ONCOLOGIST|2|Visit_2|25|3|SCREENING|2021-02-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|4|SGAW|Specific Airway Conductance|[?]|PRONE|[?]|grain|[?]|1|10^5/L|VAGINA|BILATERAL|UPPER EXTENSOR SURFACE|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||INDEPENDENT ASSESSOR|PATHOLOGIST|2|Visit_2|25|5|WASHOUT|2021-02-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|5|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-RECUMBENT|[?]|mg/kg/h|[?]|1|VOXEL|COSTOCHONDRAL JOINT 1|LATERAL|UPPER EXTENSOR SURFACE|LANDOLT RING||Y||PROXY|ENDOCRINOLOGIST|3|Visit_3|40|4|SCREENING|2021-02-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|6|PEFREV|PEF Reversibility|[?]|REVERSE TRENDELENBURG|||[?]|1|Ci/mL|CONJUNCTIVA|LEFT|DISTAL VOLAR|NO INFORMATION|Y||Y|DOMESTIC PARTNER|CLINICAL PATHOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2021-02-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|7|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|[?]|/wk|[?]|1|kDa|AORTA|UNILATERAL|POSTERIOR|WHOLE GENOME SEQUENCING||||CLINICAL RESEARCH COORDINATOR|READER 1|4|Visit_4|65|4|TREATMENT|2021-03-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|8|MIPPP|Percent Predicted MIP|[?]|FOWLERS|[?]|scm|[?]|1|uIU/L|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|CONTRALATERAL|LOWER EXTENSOR SURFACE|TEST STRIP||||CLINICAL RESEARCH ASSOCIATE|CLINICAL PATHOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2021-03-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|9|FIF75|Forced Inspiratory Flow at 75%|[?]|SEMI-RECUMBENT|[?]|pmol/day|[?]|1|pm|TRAPEZIUS MUSCLE|RIGHT|VENTROLATERAL|EEG||||GUARDIAN|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|3a973b7a-3583-4383-b59e-3dab51b511bd|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|/100 HPFs|[?]|1|nL|NUCLEUS ACCUMBENS|BILATERAL|POSTERIOR|ACRIDINE ORANGE STAIN||||DOMESTIC PARTNER|READER 3|5|Visit_5|90|3|FOLLOW-UP|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|1|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|[?]|log10 copies/mL|[?]|1|/mm|MESENTERIC VEIN|LEFT|NASAL|MACRO BROTH DILUTION||Y||INDEPENDENT ASSESSOR|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-09-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|2|FEV1PP|Percent Predicted FEV1|[?]|FOWLERS|[?]|TRANSDUCING UNIT/mL|[?]|1|10^3 CFU/g|JEJUNUM|RIGHT|SUBCORTICAL|IMMUNORADIOMETRIC ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|RATER|1|Visit_1|10|7|FOLLOW-UP|2020-09-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|3|TGV|Thoracic Gas Volume|[?]|LATERAL DECUBITUS|[?]|%(w/w)|[?]|1|Bq/L|LEFT MAIN CORONARY ARTERY BODY|UNILATERAL|APICAL|VENTILATION PERFUSION LUNG SCAN||Y||SIGNIFICANT OTHER|ONCOLOGIST 1|2|Visit_2|25|3|FOLLOW-UP|2020-10-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|CCID 50/mL|[?]|1|mN|SACRUM|CONTRALATERAL|CAUDAL|ORCHIDOMETERY||||INDEPENDENT ASSESSOR|INTERNIST|2|Visit_2|25|6|FOLLOW-UP|2020-10-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|5|INTP|Interpretation|[?]|PRONE|[?]|ug/L/h|[?]|1|dB|HILAR LYMPH NODE|LATERAL|ANTEROTEMPORAL|TRANSMISSION ELECTRON MICROSCOPY||||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|2|TREATMENT|2020-10-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|6|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|||[?]|1|mgEq|PERIFACIAL LYMPH NODE|IPSILATERAL|BASAL|MAGNETIC RESONANCE ENTEROGRAPHY|Y||Y|CHILD|OPTOMETRIST|3|Visit_3|40|7|TREATMENT|2020-10-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|7|AIRTRAP|Air Trapping|[?]|SUPINE|[?]|U/g Hb|[?]|1|PA|EPIGASTRIC LYMPH NODE|CONTRALATERAL|NASAL|NUCLEIC ACID HYBRIDIZATION||||VENDOR|READER|4|Visit_4|65|2|SCREENING|2020-11-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|8|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/beat|FASCIA|LATERAL|FRONTAL|REBOUND TONOMETRY|||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|4|Visit_4|65|5|WASHOUT|2020-11-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|9|FIVC|Forced Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|SACHET|[?]|1|rpm|ORBIT|LEFT|ANTERIOR|CT SCAN||Y||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|5|Visit_5|90|5|FOLLOW-UP|2020-12-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|d283591c-2085-459e-94f2-d3eb6b81aea7|10|RELSZCHG|Relative Size Change|[?]|STANDING|[?]|dL|[?]|1|/h|BLADDER|LATERAL|FORE|FARR ASSAY||||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|FOLLOW-UP|2020-12-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-FOWLERS|[?]|km/h|[?]|1|mmol/min/kPa/L|URINARY SYSTEM|BILATERAL|NASAL|MUGA||Y||NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|1|Visit_1|10|5|TREATMENT|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|UNCONSTRAINED|[?]|kUSP|[?]|1|U/g Hb|ACHILLES TENDON|LEFT|INNER|AUDIOMETRY||Y||SIBLING|READER 2|1|Visit_1|10|6|FOLLOW-UP|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|3|DLCOVA|DLCO/VA|[?]|LATERAL DECUBITUS|[?]|mmol/mol|[?]|1|damol/L|PROXIMAL PHALANX 1 OF THE HAND|CONTRALATERAL|BASAL|LIQUID SCINTILLATION COUNTING|Y|||CAREGIVER|ENDOCRINOLOGIST|2|Visit_2|25|6|TREATMENT|2020-10-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|4|FEV1PP|Percent Predicted FEV1|[?]|FOWLERS|[?]|ug/m2/min|[?]|1|kUSP|ASCENDING AORTA, SINOTUBULAR JUNCTION|LATERAL|UPPER|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||INDEPENDENT ASSESSOR|PATHOLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-10-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Hounsfield Unit|MAMMARY GLAND|LEFT|LOWER|CT SCAN WITHOUT CONTRAST|||Y|HEALTH CARE PROFESSIONAL|INTERNIST|3|Visit_3|40|1|SCREENING|2020-10-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|6|EXPRELTM|Expiration Relaxation Time|[?]|SITTING, LEGS DEPENDENT|[?]|mL/sec/1.73m2|[?]|1|Joule|SARTORIUS MUSCLE|UNILATERAL|UPPER EXTENSOR SURFACE|NUCLEAR RADIOLOGY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|7|TREATMENT|2020-10-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|7|DLCOHC|HGB Corrected DLCO|[?]|SLING|||[?]|1|mEq/kg|HUMERAL EPICONDYLE|LATERAL|NASAL|WRIGHT STAIN|||Y|INDEPENDENT ASSESSOR|HEMATOLOGIST|4|Visit_4|65|3|SCREENING|2020-11-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|mg/m2/day|[?]|1|10^6/g|AXIAL SKELETON|IPSILATERAL|INFERIOR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||CHILD|ADJUDICATOR 3|4|Visit_4|65|5|FOLLOW-UP|2020-11-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|9|TLC|Total Lung Capacity|[?]|TRENDELENBURG|[?]|/MBP|[?]|1|m|REGIONAL LYMPH NODE|LATERAL|POSTERIOR|KNEMOMETRY||||CHILD|READER 3|5|Visit_5|90|5|WASHOUT|2020-12-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|da31f695-9f6a-46b2-8002-5c1c21b55cf3|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SUPINE|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|mg/day|FEMORAL HEAD|LEFT|INNER|PET/MRI SCAN||||STUDY SUBJECT|PATHOLOGIST|5|Visit_5|90|7|WASHOUT|2020-12-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|TV|Tidal Volume|[?]|PRONE|[?]|PA|[?]|1|mol/g|HAIR FOLLICLE|RIGHT|VOLAR|DIFFUSION TENSOR MRI||||INVESTIGATOR|CLINICAL PATHOLOGIST|1|Visit_1|10|1|WASHOUT|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING|[?]|STEPS|[?]|1|vg/dose|BLADDER WALL|RIGHT|DISTAL VOLAR|SMEAR||Y||INVESTIGATOR|MICROSCOPIST|1|Visit_1|10|6|TREATMENT|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SUPINE|[?]|mg/cm2|[?]|1|tsp eq|ANKLE JOINT ANTERIOR FLEXOR TENDONS|BILATERAL|DISTAL|TRANSMISSION ELECTRON MICROSCOPY||||SIBLING|DERMATOLOGIST|2|Visit_2|25|6|WASHOUT|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|4|FEF2575P|Percent Predicted FEF25-75|[?]|LATERAL DECUBITUS|[?]|V/sec|[?]|1|mmol|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|INFERIOR|PHASE CONTRAST MICROSCOPY||||GUARDIAN|MICROSCOPIST 3|2|Visit_2|25|4|WASHOUT|2021-01-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|pL|[?]|1|cm|GASTROINTESTINAL TRACT|CONTRALATERAL|POSTERIOR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||INVESTIGATOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|6|TREATMENT|2021-01-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|6|AWWVOL|Airway Wall Volume|[?]|DECUBITUS|[?]|dpm/mL|[?]|1|mmol/min/kPa|SKIN AROUND THE MOUTH|UNILATERAL|NASAL|CT SCAN|Y|||INDEPENDENT ASSESSOR|ONCOLOGIST 2|3|Visit_3|40|5|FOLLOW-UP|2021-01-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|7|PEF|Peak Expiratory Flow|[?]|LATERAL DECUBITUS|[?]|U/g Hb|[?]|1|U/m2/h|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LATERAL|LOWER EXTENSOR SURFACE|HPLC-UV||||ADJUDICATION COMMITTEE|UROLOGIST|4|Visit_4|65|7|TREATMENT|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|8|PEFREV|PEF Reversibility|[?]|STANDING|[?]|pmol/day|[?]|1|kHz|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|BILATERAL|SUPERFICIAL|GEL ELECTROPHORESIS||Y||INVESTIGATOR|MICROSCOPIST 2|4|Visit_4|65|6|SCREENING|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|uEq|[?]|1|umol|LESSER TROCHANTER|LEFT|LATERAL|KNEMOMETRY||Y||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-03-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|RE|4cd63e56-3d93-403a-8011-3b4fcf26e445|10|DLCOVA|DLCO/VA|[?]|STANDING, BENT FORWARD|[?]|mg/kg/dose|[?]|1|AU/mL|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|UNILATERAL|MEDIAL|FORCED OSCILLATION TECHNIQUE||||PARENT|NEUROLOGIST 2|5|Visit_5|90|1|WASHOUT|2021-03-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|SGAW|Specific Airway Conductance|[?]|SUPINE|[?]|umol/mol|[?]|1|10^8/L|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|BILATERAL|SUPERIOR|RYAN BLUE STAIN||Y||INVESTIGATOR|ADJUDICATOR 1|1|Visit_1|10|6|WASHOUT|2020-05-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|2|DLCOHCVA|HGB Corrected DLCO/VA|[?]|DECUBITUS|[?]|SACHET|[?]|1|nmol/mol|SKULL|UNILATERAL|ANTEROMEDIAL|THICK SMEAR||||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|1|Visit_1|10|4|TREATMENT|2020-05-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|3|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/breath|[?]|1|mph|LIVER, LEFT LOBE|LATERAL|DORSAL|CRYOSCOPY||Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|4|DLCOPP|Percent Predicted DLCO|[?]|SITTING|[?]|kIU|[?]|1|pmol/10^10 cells|TRAPEZIUM-TRAPEZOID JOINT|BILATERAL|SUPERIOR|CYSTOSCOPY||Y||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|TREATMENT|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|5|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|mL/m2/day|[?]|1|Rad|TIBIOTARSAL JOINT|IPSILATERAL|OCCIPITAL|U-HPLC/MS/MS||||ADJUDICATION COMMITTEE|ADJUDICATOR 2|3|Visit_3|40|1|TREATMENT|2020-06-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|6|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|Tbsp|[?]|1|nL|OROPHARYNX|UNILATERAL|DORSAL|SINGLE-SLICE SPIRAL CT||||INDEPENDENT ASSESSOR|OPHTHALMOLOGIST|3|Visit_3|40|3|TREATMENT|2020-06-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|10^6 CFU/g|[?]|1|nCi|SUDORIFEROUS GLAND|CONTRALATERAL|ANTEROLATERAL|CENTRIFUGATION||||SIGNIFICANT OTHER|CARDIOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-07-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|vg/mL|INTERPHALANGEAL JOINT 3|LEFT|CAUDAL|CYSTOSCOPY||Y|Y|FRIEND|ADJUDICATOR|4|Visit_4|65|4|WASHOUT|2020-07-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|9|FEV1PP|Percent Predicted FEV1|[?]|SITTING|[?]|days/month|[?]|1|mL/min|PANCREAS|IPSILATERAL|PROXIMAL VOLAR|LC-FL||||CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING|[?]|tuberculin unit|[?]|1|ugEq/L|POPLITEAL ARTERY ABOVE KNEE|LEFT|UPPER FLEXOR SURFACE|IVY INCISION METHOD|Y|||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-08-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|MBq/uL|[?]|1|/HPF|AORTOPULMONARY WINDOW LYMPH NODE|LATERAL|PROXIMAL VOLAR|SURFACE PLASMON RESONANCE||Y||ADJUDICATION COMMITTEE|RADIOLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-08-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|2|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|Gy/min|[?]|1|10^3/hpf|STERNEBRA|LATERAL|UPPER EXTENSOR SURFACE|PERCUSSION||||CLINICAL STUDY SPONSOR|CARDIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-08-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|3|ELSTNCE|Elastance|[?]|STANDING, BENT FORWARD|[?]|%(w/w)|[?]|1|days/month|BRAIN VENTRICLE, LATERAL|IPSILATERAL|POSTERIOR|MICRO BROTH DILUTION||||DOMESTIC PARTNER|MICROSCOPIST|2|Visit_2|25|5|WASHOUT|2020-08-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|4|LOBVOL|Lobar Volume|[?]|DECUBITUS|||[?]|1|U/m2/day|ISCHIUM|LEFT|PERIVENTRICULAR|SISH|Y||Y|NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|2|Visit_2|25|6|FOLLOW-UP|2020-08-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|5|FEV1SVC|FEV1/SVC|[?]|FOWLERS|||[?]|1|mL/cm H2O|CARDIOVASCULAR SYSTEM|UNILATERAL|MEDIAL|X-RAY FLUORESCENCE SPECTROMETRY|||Y|SIBLING|ONCOLOGIST|3|Visit_3|40|2|TREATMENT|2020-09-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|6|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|TRENDELENBURG|[?]|umol/L/sec|[?]|1|g/L|MAXILLARY SINUS|BILATERAL|VOLAR|SPECT SCAN|Y|||NON-HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|5|WASHOUT|2020-09-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|7|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-RECUMBENT|[?]|STEPS|[?]|1|mmHg/L/min|TRAPEZOID BONE|BILATERAL|PROXIMAL|PUPILLOMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|FOLLOW-UP|2020-10-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|8|TGV|Thoracic Gas Volume|[?]|TRENDELENBURG|[?]|PRESSOR UNITS|[?]|1|Gy/min|ESOPHAGUS, UPPER THIRD|BILATERAL|DISTAL VOLAR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||||CAREGIVER|FORENSIC PATHOLOGIST|4|Visit_4|65|3|WASHOUT|2020-10-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|9|MALIND|Malignancy Indicator|[?]|SEMI-FOWLERS|[?]|DIP|[?]|1|Ci/mg|T1 VERTEBRA|IPSILATERAL|ANTEROLATERAL|SLOAN LETTER EYE CHART 100%||||PARENT|ONCOLOGIST 2|5|Visit_5|90|1|WASHOUT|2020-10-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|f31bab3b-3624-44a5-a62f-f8cf9055eec4|10|FEV1PP|Percent Predicted FEV1|[?]|STANDING|||[?]|1|TABLET|ANAL CANAL|CONTRALATERAL|UPPER FLEXOR SURFACE|PHOTOMETRY|||Y|GUARDIAN|UROLOGIST|5|Visit_5|90|3|TREATMENT|2020-10-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|RV|Residual Volume|[?]|STANDING|[?]|mL/cm H2O|[?]|1|10^6/Ejaculate U|TONGUE|LEFT|ANTEROLATERAL|DARK FIELD MICROSCOPY||||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-06-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|2|SVC|Slow Vital Capacity|[?]|SUPINE|[?]|dL|[?]|1|umol/L/h|SPLENIC ARTERY|CONTRALATERAL|TIP|EPSILOMETER|Y|Y||NON-HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|3|TREATMENT|2020-06-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|3|INTP|Interpretation|[?]|LATERAL DECUBITUS|[?]|ms/mmHg|[?]|1|Ci/mL|LIMB, LOWER|LATERAL|DEEP|CYSTOMETRY||Y||CHILD|UROLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|||[?]|1|KIT|KNEE JOINT|UNILATERAL|INFERIOR|QUANTITATIVE ULTRASOUND|||Y|DOMESTIC PARTNER|READER|2|Visit_2|25|1|WASHOUT|2020-07-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING, BENT FORWARD|||[?]|1|L/h/m2|COLON, RIGHT|RIGHT|FACIAL|ANGIOGRAPHY|Y||Y|HEALTH CARE PROFESSIONAL|READER|3|Visit_3|40|2|FOLLOW-UP|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|TRENDELENBURG|||[?]|1|ug/kg/min|MITRAL VALVE, ANTERIOR ANNULUS|RIGHT|UPPER EXTENSOR SURFACE|TRIPLE-PHASE SPIRAL CT SCAN|Y||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|3|Visit_3|40|4|SCREENING|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|7|IVCPP|Percent Predicted IVC|[?]|SITTING, LEGS DEPENDENT|[?]|%(v/v)|[?]|1|10^6 DNA copies/mL|ILEUM, TERMINAL|RIGHT|LOWER FLEXOR SURFACE|EIA||Y||INDEPENDENT ASSESSOR|MICROSCOPIST 1|4|Visit_4|65|4|WASHOUT|2020-08-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|8|RRS|Total Respiratory System Resistance|[?]|SLING|||[?]|1|mg/kg/week|BLADDER, TRIGONE|UNILATERAL|LATERAL|AGAR DILUTION|||Y|SIBLING|READER 2|4|Visit_4|65|7|TREATMENT|2020-08-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|9|IVCPP|Percent Predicted IVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mV/sec|AXILLARY ARTERY|BILATERAL|HIND|MALDI-TOF||Y|Y|CHILD|INTERNIST|5|Visit_5|90|3|TREATMENT|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|0b5675aa-4ec0-4548-9a0b-a13f8de89883|10|MEP|Maximal Expiratory Pressure|[?]|LATERAL DECUBITUS|[?]|DPM|[?]|1|DNA copies/mL|HUMERAL EPICONDYLE|CONTRALATERAL|VOLAR|PET/SPECT SCAN||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|5|Visit_5|90|6|TREATMENT|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|MONTHS|[?]|1|mOsm/L|HEART, BASE|IPSILATERAL|SUPERIOR|IMMUNOCHEMILUMINOMETRIC ASSAY||Y||FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|4|WASHOUT|2021-01-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mEq/kg|[?]|1|GPL U/mL|AXILLARY LYMPH NODE LEVEL I|LATERAL|APICAL|PHYSICAL EXAMINATION||||CLINICAL RESEARCH COORDINATOR|READER 2|1|Visit_1|10|5|TREATMENT|2021-01-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|3|AWVOLPP|Percent Predicted Airway Volume|[?]|DECUBITUS|[?]|kIU|[?]|1|/200 HPFs|ILEUM LYMPH NODE|BILATERAL|LOWER MEDIAL|PYROSEQUENCING||||FAMILY MEMBER|FORENSIC PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2021-02-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|4|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-FOWLERS|[?]|PATCH|[?]|1|mg/kg/day|DISTAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|FRONTAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y||CLINICAL STUDY SPONSOR|READER|2|Visit_2|25|5|WASHOUT|2021-02-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|5|PEFTIME|Peak Expiratory Flow Time|[?]|REVERSE TRENDELENBURG|[?]|umol/L/min|[?]|1|mg/m2/min|DISTAL LAD ARTERY|RIGHT|SURFACE|POLYGRAPHY|Y|||CAREGIVER|NEUROLOGIST 1|3|Visit_3|40|6|WASHOUT|2021-02-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|6|PLMBLFLW|Pulmonary Blood Flow|[?]|REVERSE TRENDELENBURG|[?]|Ci/ug|[?]|1|PIXELS/cm|ISCHIAL TUBEROSITY|LATERAL|BASAL|INDIA INK STAIN||||PARENT|ENDOCRINOLOGIST|3|Visit_3|40|4|SCREENING|2021-02-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|7|EFFVOL|Effusion Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/day|[?]|1|MdFI|RECTO-UTERINE POUCH|BILATERAL|ANTEROLATERAL|ELECTRONEUROGRAPHY|Y|||CHILD|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|8|ICREV|IC Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/L/h|[?]|1|genEq/mL|EYE, VITREOUS CHAMBER|LEFT|POSTERIOR|ELECTRICAL IMPEDANCE MYOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|4|Visit_4|65|2|TREATMENT|2021-03-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|PRONE|[?]|ppb|[?]|1|log10 TCID 50/mL|RIB 4|CONTRALATERAL|FACIAL|MULTIPLE BREATH WASHOUT||||FAMILY MEMBER|UROLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-04-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|9bdf9856-3b2a-43db-b369-3e13868ef413|10|FIFMAX|Maximum Forced Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|Mile|[?]|1|fg|LIVER FISSURE|LEFT|DISTAL|FLOW MICROSCOPY|Y|Y||CHILD|NEUROLOGIST 1|5|Visit_5|90|4|SCREENING|2021-04-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|PLMBLFLW|Pulmonary Blood Flow|[?]|DECUBITUS|||[?]|1|Antibody Unit|CARPOMETACARPAL JOINT 4|RIGHT|PROXIMAL VOLAR|ELECTROGASTROGRAPHY||Y|Y|CAREGIVER|ADJUDICATOR 3|1|Visit_1|10|5|TREATMENT|2020-12-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|2|SVC|Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|mmHg|[?]|1|U/10^12 RBC|THYROID GLAND|IPSILATERAL|MEDIAL|DISK DIFFUSION||Y||INTERVIEWER|RATER|1|Visit_1|10|5|TREATMENT|2020-12-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol BCE/L|[?]|1|ppb|PULMONARY TRUNK|CONTRALATERAL|ANTERIOR|CONTRAST ENHANCED PET SCAN||||CAREGIVER|READER 1|2|Visit_2|25|5|WASHOUT|2021-01-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|4|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|gpELISA unit/mL|[?]|1|mEq/L|FLEXOR CARPI ULNARIS MUSCLE|BILATERAL|POSTERIOR|ARTERIAL SPIN LABELING FUNCTIONAL MRI|Y|Y||FRIEND|NEUROLOGIST 1|2|Visit_2|25|6|TREATMENT|2021-01-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|5|ICREV|IC Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|ug/L FEU|[?]|1|mg/kg/dose|SMALL SAPHENOUS VEIN|LATERAL|UPPER FLEXOR SURFACE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||PROXY|INTERNIST|3|Visit_3|40|3|FOLLOW-UP|2021-01-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|6|FRCPP|Percent Predicted FRC|[?]|LEFT LATERAL DECUBITUS|[?]|mg/dose|[?]|1|lm|ACROMIOCLAVICULAR JOINT|UNILATERAL|VENTRAL|TURBIDIMETRY||||CLINICAL STUDY SPONSOR|CARDIOLOGIST|3|Visit_3|40|7|TREATMENT|2021-01-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|7|FRCPP|Percent Predicted FRC|[?]|SEMI-FOWLERS|||[?]|1|APS U|TIBIOTARSAL JOINT|UNILATERAL|DISTAL|CONFOCAL MICROSCOPY||Y|Y|INDEPENDENT ASSESSOR|NEUROLOGIST 2|4|Visit_4|65|3|TREATMENT|2021-02-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-FOWLERS|[?]|IU/L|[?]|1|nmol/L/h|HAIR SHAFT|CONTRALATERAL|APICAL|ELECTROMYOGRAPHY||||DOMESTIC PARTNER|RADIOLOGIST 2|4|Visit_4|65|6|WASHOUT|2021-02-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|9|MEPPP|Percent Predicted MEP|[?]|SUPINE|[?]|g/animal/day|[?]|1|nmol/L/h|ILIAC VEIN|IPSILATERAL|PROXIMAL|CLIP||||VENDOR|ONCOLOGIST 2|5|Visit_5|90|1|TREATMENT|2021-03-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|5cc53922-60c0-4bce-8d4a-bc59e9203d63|10|PNIF|Peak Nasal Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|usec|[?]|1|BISCUIT|HIP JOINT|UNILATERAL|ANTEROMEDIAL|AUTOREFRACTION|Y|||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|5|TREATMENT|2021-03-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|PEF|Peak Expiratory Flow|[?]|FOWLERS|[?]|10^3/hpf|[?]|1|% INHIBITION|SPHENOID SINUS|CONTRALATERAL|POSTERIOR|SPECULAR MICROSCOPY||||CHILD|ONCOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|2|SGAW|Specific Airway Conductance|[?]|SEMI-RECUMBENT|[?]|keV|[?]|1|DNA copies/ug|SKIN OF THE AXILLA|UNILATERAL|DISTAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||SPOUSE|ONCOLOGIST 1|1|Visit_1|10|4|FOLLOW-UP|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|PRONE|[?]|INHALATION|[?]|1|%|ENDOMETRIUM|RIGHT|ANTERIOR|SLIT LAMP PHOTOGRAPHY||||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|2|Visit_2|25|4|WASHOUT|2021-01-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|4|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|[?]|PLUG|[?]|1|MBP|VERTEBRA|CONTRALATERAL|DISTAL VOLAR|WEBER GREEN STAIN||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|2|Visit_2|25|5|TREATMENT|2021-01-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|[?]|steps/min|[?]|1|Ci/ug|INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|DISTAL|MUGA|Y|Y||STUDY SUBJECT|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|6|TV|Tidal Volume|[?]|SITTING, LEGS DEPENDENT|[?]|vg/mL|[?]|1|10^3 organisms/mL|GLENOID FOSSA|UNILATERAL|SUPERIOR|ENDOSCOPY||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|3|Visit_3|40|2|WASHOUT|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|REVERSE TRENDELENBURG|[?]|ug/dose|[?]|1|mV*min|LATERAL SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|SUPERIOR|SPECT/CT SCAN||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|4|Visit_4|65|5|SCREENING|2021-02-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|8|OXYPULSE|Oxygen Pulse|[?]|LATERAL DECUBITUS|||[?]|1|IU/g|FLEXOR DIGITORUM LONGUS MUSCLE|IPSILATERAL|CENTRAL|LISSAMINE GREEN STAIN|Y||Y|PROXY|MICROSCOPIST 3|4|Visit_4|65|4|WASHOUT|2021-02-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|APS U|[?]|1|L/min|T9 VERTEBRA|IPSILATERAL|BASAL|PALM METHOD|Y|Y||PARENT|FORENSIC PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING|[?]|kg/mol|[?]|1|Hz|TONSIL|BILATERAL|LOWER|THIN SMEAR||Y||HEALTH CARE PROFESSIONAL|READER|5|Visit_5|90|7|SCREENING|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|066281d3-27b8-439f-8340-f59115f646ef|1|FEV1FVC|FEV1/FVC|[?]|FOWLERS|||[?]|1|TCID 50/dose|TRAPEZOID BONE|CONTRALATERAL|FORE|SURFACE PLASMON RESONANCE|Y|Y|Y|DOMESTIC PARTNER|PATHOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-10-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|066281d3-27b8-439f-8340-f59115f646ef|2|TSUELAS|Tissue Elastance|[?]|PRONE|[?]|pm|[?]|1|mL/day|PERIRECTAL LYMPH NODE|CONTRALATERAL|SURFACE|PHASE CONTRAST MICROSCOPY||Y||SIBLING|READER 1|1|Visit_1|10|2|TREATMENT|2020-10-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|066281d3-27b8-439f-8340-f59115f646ef|3|FEV3PP|Percent Predicted FEV3|[?]|LATERAL DECUBITUS|[?]|%(w/w)|[?]|1|Bq/g|BLOOD VESSEL|BILATERAL|ANTEROPOSTERIOR|SEQUENCING||||CLINICAL STUDY SPONSOR|READER|2|Visit_2|25|3|FOLLOW-UP|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|066281d3-27b8-439f-8340-f59115f646ef|4|SGAW|Specific Airway Conductance|[?]|FOWLERS|[?]|/h|[?]|1|dB|MITRAL VALVE|LEFT|PROXIMAL VOLAR|DYNAMIC CONTRAST ENHANCED MRI||Y||CHILD|DERMATOLOGIST|2|Visit_2|25|2|SCREENING|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|066281d3-27b8-439f-8340-f59115f646ef|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|LATERAL DECUBITUS|||[?]|1|10^9/L|FLEXOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|UPPER FLEXOR SURFACE|IHC|Y||Y|GUARDIAN|ONCOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|066281d3-27b8-439f-8340-f59115f646ef|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LATERAL DECUBITUS|[?]|ng|[?]|1|Weber|HIPPOCAMPUS|BILATERAL|CENTRAL|IMPEDANCE CONDUCTIVITY||Y||SPOUSE|CLINICAL PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|066281d3-27b8-439f-8340-f59115f646ef|7|INFLTIND|Infiltrates Indicator|[?]|SITTING|[?]|cd*s/m2|[?]|1|/4.0 mL|PARIETAL LOBE|UNILATERAL|LOWER MEDIAL|GIEMSA STAIN|Y|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|4|Visit_4|65|5|TREATMENT|2020-12-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|066281d3-27b8-439f-8340-f59115f646ef|8|DLCOPP|Percent Predicted DLCO|[?]|STANDING, BENT FORWARD|[?]|beats/min|[?]|1|ELISA unit/mL|ILEUM|LEFT|FRONTAL|ACCELERATOR MASS SPECTROMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|INTERNIST|4|Visit_4|65|6|TREATMENT|2020-12-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|066281d3-27b8-439f-8340-f59115f646ef|9|ELSTNCE|Elastance|[?]|SEMI-FOWLERS|[?]|MET*min|[?]|1|ELISA unit|FIRST OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|PROXIMAL|REBOUND TONOMETRY|Y|||SIBLING|RADIOLOGIST|5|Visit_5|90|6|SCREENING|2021-01-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|066281d3-27b8-439f-8340-f59115f646ef|10|EFFVOL|Effusion Volume|[?]|FOWLERS|[?]|AgU/mL|[?]|1|ug/m2/h|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|ANTEROLATERAL|FLOCCULATION||||INTERVIEWER|RATER|5|Visit_5|90|2|SCREENING|2021-01-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|1|TSUHYS|Tissue Hysteresivity|[?]|SUPINE|[?]|pmol|[?]|1|PIXELS/in|WRIST JOINT FLEXOR TENDONS|UNILATERAL|CENTRAL|FLUORESCEIN STAIN||Y||INTERVIEWER|ONCOLOGIST 1|1|Visit_1|10|5|TREATMENT|2021-01-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|2|AWVOLPP|Percent Predicted Airway Volume|[?]|FOWLERS|[?]|mAmp|[?]|1|100 IU/mL|FOREHEAD|LEFT|PERIVENTRICULAR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||Y||INDEPENDENT ASSESSOR|NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|3|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-FOWLERS|[?]|Absorbance U/mL|[?]|1|10^6 copies/mL|NASAL CAVITY|LATERAL|DISTAL VOLAR|NUCLEIC ACID AMPLIFICATION TEST||Y||STUDY SUBJECT|RATER 1|2|Visit_2|25|1|TREATMENT|2021-02-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|4|MIP|Maximal Inspiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|mg/L FEU|[?]|1|LOZENGE|SUBLINGUAL REGION|RIGHT|DEEP|CONTRAST ENHANCED CT SCAN|Y|||PARENT|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2021-02-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|5|RRS|Total Respiratory System Resistance|[?]|PRONE|[?]|Linear ft*LB|[?]|1|10^9 CFU|SEMITENDINOSUS MUSCLE|IPSILATERAL|LOWER FLEXOR SURFACE|BRDU CELLULAR PROLIFERATION ASSAY||Y||FAMILY MEMBER|FORENSIC PATHOLOGIST|3|Visit_3|40|7|SCREENING|2021-02-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|6|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SLING|[?]|/month|[?]|1|SACHET|ILEUM LYMPH NODE|BILATERAL|PERIVENTRICULAR|LASER CAPTURE MICRODISSECTION||||DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|7|SCREENING|2021-02-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|7|PNEUMIND|Pneumonia Indicator|[?]|STANDING|[?]|scm|[?]|1|nmol/L/h|INTERPHALANGEAL THUMB JOINT|CONTRALATERAL|PROXIMAL VOLAR|POTENTIOMETRY||Y||STUDY SUBJECT|ONCOLOGIST 2|4|Visit_4|65|3|TREATMENT|2021-03-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|8|ERVPP|Percent Predicted ERV|[?]|LEFT LATERAL DECUBITUS|[?]|uL|[?]|1|U/g/h|LEFT VENTRICULAR EPICARDIUM|UNILATERAL|PARIETO-OCCIPITAL|RULER MEASUREMENT METHOD||Y||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|4|Visit_4|65|4|TREATMENT|2021-03-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING|[?]|kUSP|[?]|1|mg/animal|HYOID BONE|BILATERAL|DEEP|ROMANOWSKY STAIN||Y||CHILD|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|TREATMENT|2021-04-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|RE|d23cc47e-da96-4042-a69f-60097beaef0e|10|SVC|Slow Vital Capacity|[?]|PRONE|[?]|PUFF|[?]|1|mg/day|ESOPHAGUS, ABDOMINAL|UNILATERAL|ANTEROMEDIAL|CARDIAC THERMODILUTION||Y||INTERVIEWER|ONCOLOGIST 1|5|Visit_5|90|3|FOLLOW-UP|2021-04-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-12
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Torr|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|IPSILATERAL|UPPER|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y|Y|ADJUDICATION COMMITTEE|ONCOLOGIST 2|1|Visit_1|10|6|WASHOUT|2021-01-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|2|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|Bq/ug|[?]|1|mmHg|SKIN OF THE AXILLA|UNILATERAL|VENTROLATERAL|PULMONARY ANGIOGRAPHY||Y||STUDY SUBJECT|HEMATOLOGIST|1|Visit_1|10|5|WASHOUT|2021-01-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|3|PNEUMIND|Pneumonia Indicator|[?]|UNCONSTRAINED|||[?]|1|mEq/dL|CORONARY SINUS|RIGHT|TEMPORAL|URANYL ACETATE STAIN||Y|Y|VENDOR|READER 3|2|Visit_2|25|6|TREATMENT|2021-01-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|4|TVPP|Percent Predicted Tidal Volume|[?]|REVERSE TRENDELENBURG|[?]|uSiemens|[?]|1|ug/L|GASTROINTESTINAL TRACT, UPPER, WALL|LEFT|LATERAL|ATOMIC ABSORPTION SPECTROMETRY||||FAMILY MEMBER|READER 2|2|Visit_2|25|3|WASHOUT|2021-01-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|5|TSUHYS|Tissue Hysteresivity|[?]|SLING|[?]|cL|[?]|1|pmol/L|AXIAL SKELETON|CONTRALATERAL|FRONTAL|OSCILLOMETRY||Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|3|Visit_3|40|7|SCREENING|2021-02-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|6|ELSTNCE|Elastance|[?]|UNCONSTRAINED|[?]|kcal/day|[?]|1|mg/cm2|PROXIMAL INTERPHALANGEAL JOINT 3|LATERAL|TEMPORAL|SINGLE-SLICE SPIRAL CT||Y||SPOUSE|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2021-02-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-24
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING|||[?]|1|mCi|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|BILATERAL|INTERMEDIATE|WHOLE EXOME SEQUENCING||Y|Y|ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|4|Visit_4|65|3|SCREENING|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|8|INTP|Interpretation|[?]|UNCONSTRAINED|[?]|Enzyme U/m2|[?]|1|mL/mmHg/min/L|ULNA|LEFT|DISTAL|FLUORIMETRY||||PROXY|ONCOLOGIST 2|4|Visit_4|65|4|TREATMENT|2021-02-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|9|INTP|Interpretation|[?]|UNCONSTRAINED|[?]|nmol/mol|[?]|1|g/animal|PAW|BILATERAL|OCCIPITAL|ALCIAN BLUE STAIN||||CAREGIVER|PATHOLOGIST|5|Visit_5|90|6|SCREENING|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|b896c679-87d0-4e29-ad27-3944cf09b3ec|10|SVC|Slow Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|ms/mmHg|MESENTERIC VEIN|LATERAL|LOWER FLEXOR SURFACE|CT SCAN WITHOUT CONTRAST||Y|Y|SIGNIFICANT OTHER|NEUROLOGIST 1|5|Visit_5|90|5|SCREENING|2021-03-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|1|FIF25|Forced Inspiratory Flow at 25%|[?]|SEMI-FOWLERS|[?]|min*mg/mL|[?]|1|mg/L|GASTROCNEMIUS MUSCLE|CONTRALATERAL|MIDLINE|MUGA|Y|||HEALTH CARE PROFESSIONAL|RATER|1|Visit_1|10|7|TREATMENT|2020-07-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|2|SRAW|Specific Airway Resistance|[?]|TRENDELENBURG|[?]|nmol BCE/L|[?]|1|Joule|PARASYMPATHETIC GANGLIA|RIGHT|INTERMEDIATE|PHASE CONTRAST MICROSCOPY||||PARENT|INTERNIST|1|Visit_1|10|1|WASHOUT|2020-07-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|3|ELSTNCE|Elastance|[?]|SEMI-RECUMBENT|[?]|MASK|[?]|1|Bq/kg|LARYNX|RIGHT|HIND|MODIFIED ACID FAST STAIN||||CAREGIVER|CARDIOLOGIST|2|Visit_2|25|2|TREATMENT|2020-08-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|4|EFFIND|Effusion Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|TROCHE|[?]|1|fmol/L|VASTUS LATERALIS MUSCLE|LATERAL|PERIPHERAL|HPLC||||GUARDIAN|MICROSCOPIST|2|Visit_2|25|5|FOLLOW-UP|2020-08-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|5|FEV3FVC|FEV3/FVC|[?]|STANDING|||[?]|1|FEU|MAIN BRONCHUS, LEFT|CONTRALATERAL|UPPER EXTENSOR SURFACE|BALLPOINT PEN TECHNIQUE|||Y|ADJUDICATION COMMITTEE|READER 2|3|Visit_3|40|1|TREATMENT|2020-08-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|TAMPON|[?]|1|mEq/kg|INTESTINE|LATERAL|DEEP|MICRODENSITOMETRY||||SIBLING|INTERNIST|3|Visit_3|40|2|TREATMENT|2020-08-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|7|IC|Inspiratory Capacity|[?]|LATERAL DECUBITUS|[?]|GBq/mg|[?]|1|cg|PLACENTA|LEFT|VOLAR|PULSE OXIMETRY||||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|4|Visit_4|65|6|SCREENING|2020-09-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|8|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|[?]|L/s|[?]|1|vp/mL|FACIAL BONE|LATERAL|HIND|MODIFIED ACID FAST STAIN||||GUARDIAN|ONCOLOGIST|4|Visit_4|65|1|SCREENING|2020-09-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|TRENDELENBURG|[?]|dmol|[?]|1|GLOBULE|PORTAL VEIN BIFURCATION|BILATERAL|BASAL|GC/MS/MS||||PARENT|READER 2|5|Visit_5|90|4|FOLLOW-UP|2020-10-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|6d0ec221-6eb6-4fed-806e-2bc700968333|10|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|uL/mL|[?]|1|uIU/L|GASTROINTESTINAL TRACT, LOWER|CONTRALATERAL|PROXIMAL|RYAN BLUE STAIN||||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|5|Visit_5|90|1|TREATMENT|2020-10-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|[?]|DAgU/mL|[?]|1|mm/min|TRAPEZIAL BONE|RIGHT|DISTAL VOLAR|WESTERN BLOT||Y||SPOUSE|MICROSCOPIST 1|1|Visit_1|10|2|TREATMENT|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|2|FEV1FVC6|FEV1/FVC6|[?]|SITTING|||[?]|1|IU/dL|PUBIC BONE|LEFT|INFERIOR|HEMOCYTOMETRY|Y||Y|CAREGIVER|OTOLARYNGOLOGIST|1|Visit_1|10|4|TREATMENT|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|3|IVCPP|Percent Predicted IVC|[?]|DECUBITUS|[?]|kUSP|[?]|1|log10 TCID 50/dose|EXTRAOCULAR MUSCLE|RIGHT|UPPER EXTENSOR SURFACE|SPECT/CT SCAN|Y|Y||SPOUSE|ENDOCRINOLOGIST|2|Visit_2|25|5|TREATMENT|2020-10-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|DECUBITUS|[?]|uV2|[?]|1|nkat/g Hb|SUPERIOR VENA CAVA|UNILATERAL|FORE|LIGHT MICROSCOPY|Y|||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|3|FOLLOW-UP|2020-10-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|PFU|ASCENDING AORTA, AORTIC ROOT|BILATERAL|TIP|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y||Y|FRIEND|READER 1|3|Visit_3|40|3|TREATMENT|2020-11-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|6|SVC|Slow Vital Capacity|[?]|SITTING|[?]|P|[?]|1|mJoule/cm2|OCULOMOTOR NERVE|UNILATERAL|SUBCORTICAL|ULTRASOUND|Y|||SIGNIFICANT OTHER|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2020-11-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|7|INFLTIND|Infiltrates Indicator|[?]|TRENDELENBURG|[?]|%/min|[?]|1|P|VERTEBRAL ARTERY|BILATERAL|SURFACE|FLOW MICROSCOPY|Y|||PROXY|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|8|TLC|Total Lung Capacity|[?]|STANDING|[?]|mL/cage/day|[?]|1|amp|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|PERIVENTRICULAR|ELECTROPHORESIS||||CLINICAL STUDY SPONSOR|READER 1|4|Visit_4|65|5|FOLLOW-UP|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|||[?]|1|mEq/uL|GASTROCNEMIUS MUSCLE, LATERAL HEAD|RIGHT|VENTRAL|AUTOMATED COUNT||Y|Y|CLINICAL STUDY SPONSOR|HEMATOLOGIST|5|Visit_5|90|1|TREATMENT|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|10|PLMXRS|Pulmonary Reactance|[?]|SLING|[?]|U/g Hb|[?]|1|CFU/g|TRICUSPID VALVE, ANTERIOR CUSP|LEFT|FRONTAL|FLUORESCENCE ANGIOGRAPHY||Y||FAMILY MEMBER|ENDOCRINOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|log10 copies/mL|[?]|1|10^7 CFU|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LEFT|PERIVENTRICULAR|MS/MS||||GUARDIAN|MICROSCOPIST 3|1|Visit_1|10|7|TREATMENT|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|2|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|[?]|PIXEL|[?]|1|mmol2/L2|HEART, LEFT ATRIUM|BILATERAL|VENTRAL|PUPILLOMETRY|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|1|Visit_1|10|6|WASHOUT|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|3|PLMBLFLW|Pulmonary Blood Flow|[?]|REVERSE TRENDELENBURG|[?]|mmol/L|[?]|1|% INHIBITION|PRELARYNGEAL LYMPH NODE|LATERAL|UPPER EXTENSOR SURFACE|WRIGHT STAIN||Y||FRIEND|RADIOLOGIST 1|2|Visit_2|25|3|WASHOUT|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|4|MIPPP|Percent Predicted MIP|[?]|STANDING|[?]|L/h/m2|[?]|1|log10 CCID 50/dose|APPENDICULAR SKELETON|UNILATERAL|FRONTAL|PULMONARY ANGIOGRAPHY||Y||DOMESTIC PARTNER|ENDOCRINOLOGIST|2|Visit_2|25|5|TREATMENT|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|FOWLERS|[?]|nmol BCE/mmol|[?]|1|ug|CRANIAL CAVITY|IPSILATERAL|VENTRAL|WESTERN BLOT||||PROXY|NEUROLOGIST|3|Visit_3|40|7|WASHOUT|2021-02-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|6|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|10^12/L|[?]|1|cycle/min|MIDDLE PHALANX 4 OF THE HAND|UNILATERAL|NASAL|ENZYMATIC COLORIMETRY||||SIGNIFICANT OTHER|OPTOMETRIST|3|Visit_3|40|5|SCREENING|2021-02-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|7|TGV|Thoracic Gas Volume|[?]|STANDING|[?]|Gy|[?]|1|DAgU/mL|LIMB, LOWER|IPSILATERAL|ANTEROPOSTERIOR|HILLMEN COLOR CHART|Y|Y||INDEPENDENT ASSESSOR|PATHOLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|8|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|/500 WBC|[?]|1|MESF|BODY OF STOMACH|LEFT|INFERIOR|CINEANGIOGRAPHY||||SIGNIFICANT OTHER|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|9|DLCOVA|DLCO/VA|[?]|LATERAL DECUBITUS|[?]|MPS U|[?]|1|vg/dose|T5 VERTEBRA|CONTRALATERAL|INTERMEDIATE|ULTRASOUND|Y|Y||DOMESTIC PARTNER|OPTOMETRIST|5|Visit_5|90|7|WASHOUT|2021-03-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|15e5e7ca-b832-450c-a20c-b21585086328|10|QUASCOMP|Quasi-Static Compliance|[?]|STANDING|||[?]|1|g/mol|FIBULAR VEIN|LEFT|ANTEROTEMPORAL|INDIA INK STAIN||Y|Y|VENDOR|DERMATOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|RER|Respiratory Exchange Ratio|[?]|SITTING, LEGS DEPENDENT|[?]|nsec|[?]|1|mmHg|HEART, LEFT VENTRICLE|CONTRALATERAL|LOWER|MACRO BROTH DILUTION||Y||PROXY|ONCOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-10-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|2|SALKB|Salazar-Knowles Equation Parameter B|[?]|LATERAL DECUBITUS|[?]|kg/cm2|[?]|1|cmH2O/mL|INTERTROCHANTERIC REGION|LATERAL|LOWER EXTENSOR SURFACE|OPTICAL COHERENCE TOMOGRAPHY||Y||SIGNIFICANT OTHER|RATER 2|1|Visit_1|10|3|SCREENING|2020-10-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|[?]|BAU/mL|[?]|1|g|LUMBAR REGION|BILATERAL|OCCIPITAL|TOLUIDINE BLUE STAIN||||INDEPENDENT ASSESSOR|NEUROLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-10-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|4|TLC|Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|tuberculin unit/mL|[?]|1|mol/mg|ASCENDING AORTA|IPSILATERAL|SURFACE|CINEANGIOGRAPHY||||GUARDIAN|ONCOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-10-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|5|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|[?]|IU/mL|[?]|1|fraction of 1|GALLBLADDER|BILATERAL|LOWER FLEXOR SURFACE|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||SPOUSE|ONCOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-11-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING|[?]|ng/mol|[?]|1|g/cm2|OBTURATOR MUSCLE|CONTRALATERAL|MIDLINE|FLUORESCENT MICROSCOPY||Y||DOMESTIC PARTNER|ADJUDICATOR 1|3|Visit_3|40|2|SCREENING|2020-11-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|7|PNIF|Peak Nasal Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|dpm/100mg|RIGHT CORONARY ARTERY OSTIUM|RIGHT|PROXIMAL VOLAR|HPLC-FL|Y||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2020-12-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|8|EFFVOL|Effusion Volume|[?]|SEMI-RECUMBENT|[?]|Bq|[?]|1|uCi/kg|LEFT CIRCUMFLEX ARTERY OSTIUM|IPSILATERAL|UPPER EXTENSOR SURFACE|POLYGRAPHY|Y|Y||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|4|Visit_4|65|4|TREATMENT|2020-12-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|9|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|Enzyme U/g Hb|[?]|1|MHz|EAR, OUTER|UNILATERAL|PARIETO-OCCIPITAL|FLUORESCENCE ANGIOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2021-01-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|b46ff3a2-f257-4803-8064-e29bd1114bfc|10|IVC|Inspiratory Vital Capacity|[?]|SLING|||[?]|1|PIPE|MESENTERIC LYMPH NODE|CONTRALATERAL|INNER|CORONARY ANGIOGRAPHY|Y||Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|5|Visit_5|90|1|TREATMENT|2021-01-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|FRC|Functional Residual Capacity|[?]|DECUBITUS|[?]|mg/mL/min|[?]|1|dpm/mL|SKIN|LEFT|LATERAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y||PARENT|NEUROLOGIST 2|1|Visit_1|10|7|WASHOUT|2020-12-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|2|LCI|Lung Clearance Index|[?]|LATERAL DECUBITUS|[?]|SYRINGE|[?]|1|kV|THIGH|LATERAL|CRANIAL|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|||SIGNIFICANT OTHER|HEMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|3|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|AMPULE|[?]|1|uL/dose|MESENTERIC LYMPH NODE|CONTRALATERAL|ANTEROMEDIAL|MALDI-TOF||||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|2|Visit_2|25|1|SCREENING|2020-12-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|4|MEP|Maximal Expiratory Pressure|[?]|PRONE|||[?]|1|ug/kg/h|RETINAL ARTERY|RIGHT|DEEP|THIN SMEAR|||Y|PARENT|MICROSCOPIST|2|Visit_2|25|5|TREATMENT|2020-12-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|5|RAWPP|Percent Predicted Airway Resistance|[?]|SLING|[?]|oz|[?]|1|AgU/mL|INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|FORE|FREEZING POINT DEPRESSION||||FRIEND|OPTOMETRIST|3|Visit_3|40|3|TREATMENT|2021-01-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/m2|[?]|1|Tesla|PORTACAVAL LYMPH NODE|UNILATERAL|SUPERFICIAL|FLUORESCEIN STAIN|Y|||FAMILY MEMBER|RADIOLOGIST 1|3|Visit_3|40|1|TREATMENT|2021-01-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SUPINE|[?]|10^9 organisms/mL|[?]|1|kDa|DUCTUS ARTERIOSUS|BILATERAL|BASAL|IMMUNODIFFUSION|Y|Y||HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|4|Visit_4|65|4|WASHOUT|2021-01-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|8|EVC|Expiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|umol/L/h|[?]|1|10^9 CFU/mL|T7 VERTEBRA|IPSILATERAL|INNER|RAJI CELL EIA||||DOMESTIC PARTNER|READER 2|4|Visit_4|65|2|TREATMENT|2021-01-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|9|OXYPULSE|Oxygen Pulse|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|nmol/mol|SMALL INTESTINE|BILATERAL|FRONTAL|WHOLE EXOME SEQUENCING||Y|Y|GUARDIAN|READER 2|5|Visit_5|90|5|TREATMENT|2021-02-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|10|IC|Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|Ci/ug|[?]|1|RING|GASTROINTESTINAL TRACT, UPPER|IPSILATERAL|ANTEROMEDIAL|CT SCAN WITHOUT CONTRAST||||INVESTIGATOR|READER 3|5|Visit_5|90|4|FOLLOW-UP|2021-02-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|mL/animal|[?]|1|10^4 CFU|TRICUSPID VALVE ANNULUS|IPSILATERAL|DORSAL|NUCLEAR RADIOLOGY||Y||CHILD|MICROSCOPIST 1|1|Visit_1|10|1|WASHOUT|2020-10-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|U/m2/min|[?]|1|tsp|RETINAL PIGMENTED EPITHELIAL LAYER|IPSILATERAL|INFERIOR|TRIPLE-PHASE SPIRAL CT SCAN|Y|||NON-HEALTH CARE PROFESSIONAL|READER 3|1|Visit_1|10|2|TREATMENT|2020-10-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|3|TGV|Thoracic Gas Volume|[?]|SEMI-RECUMBENT|[?]|nmol/L|[?]|1|g/cage/day|PARA-AORTIC LYMPH NODE|BILATERAL|CENTRAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|Y||FRIEND|UROLOGIST|2|Visit_2|25|4|TREATMENT|2020-10-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|4|RRS|Total Respiratory System Resistance|[?]|SITTING|[?]|LENS|[?]|1|TRANSDUCING UNIT/mL|GREAT SAPHENOUS VEIN|LEFT|SUPERFICIAL|EPSILOMETER|Y|||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|2|Visit_2|25|1|TREATMENT|2020-10-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|5|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-FOWLERS|||[?]|1|mg/g/h|RIB 8|CONTRALATERAL|LATERAL|VIRUS PLAQUE ASSAY|Y|Y|Y|CAREGIVER|ADJUDICATOR 3|3|Visit_3|40|5|TREATMENT|2020-11-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|6|INERTANC|Inertance|[?]|TRENDELENBURG|||[?]|1|kg|HYPOPHARYNX|BILATERAL|DORSAL|MAGNETIC RESONANCE ELASTOGRAPHY|||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 3|3|Visit_3|40|4|TREATMENT|2020-11-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|kg/mol|[?]|1|pmol|TALUS|LATERAL|UPPER EXTENSOR SURFACE|CAPILLARY ELECTROPHORESIS||||GUARDIAN|UROLOGIST|4|Visit_4|65|5|TREATMENT|2020-11-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|PRONE|[?]|TCID 50/dose|[?]|1|dL|PERITONEUM|RIGHT|PERIVENTRICULAR|HEMAGGLUTINATION INHIBITION ASSAY||Y||INVESTIGATOR|PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|||[?]|1|PACKET|FALLOPIAN TUBE|IPSILATERAL|LOWER EXTENSOR SURFACE|URANYL ACETATE STAIN|||Y|SIGNIFICANT OTHER|RATER 1|5|Visit_5|90|7|TREATMENT|2020-12-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|a5c667d1-d2ac-49f7-ad44-bf9a44762025|10|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|CFU/g|[?]|1|mL/kg/day|EXTENSOR DIGITORUM BREVIS MUSCLE|CONTRALATERAL|VENTRAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||Y||DOMESTIC PARTNER|READER 2|5|Visit_5|90|7|SCREENING|2020-12-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|1|IVC|Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|Ci/uL|[?]|1|NEEDLE GAUGE|HEART, LEFT VENTRICLE|UNILATERAL|LOWER EXTENSOR SURFACE|MACRO BROTH DILUTION||||PROXY|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2021-01-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|2|FEV3PP|Percent Predicted FEV3|[?]|LATERAL DECUBITUS|||[?]|1|h*%|RECTOSIGMOID JUNCTION|UNILATERAL|FRONTAL|TRANSMISSION ELECTRON MICROSCOPY|Y||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST|1|Visit_1|10|7|WASHOUT|2021-01-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|3|FVC|Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|IU/L|[?]|1|nmol/mL/min|CARDIAC VALVE|LEFT|DORSOLATERAL|CT SCAN||Y||PROXY|DERMATOLOGIST|2|Visit_2|25|3|SCREENING|2021-02-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|4|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|cm2|[?]|1|BLOCKS|COLON, ASCENDING|LEFT|SUBCORTICAL|HPLC-UV|Y|||CLINICAL RESEARCH COORDINATOR|INTERNIST|2|Visit_2|25|7|WASHOUT|2021-02-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|pm|[?]|1|L/s|CALF MUSCULAR VEIN|UNILATERAL|NASAL|ELECTROMYOGRAPHY||Y||PARENT|OPHTHALMOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|6|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|10^3 organisms/mL|[?]|1|ft2|VOMER|RIGHT|CAUDAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|||FRIEND|PATHOLOGIST 2|3|Visit_3|40|5|WASHOUT|2021-02-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|7|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|FOWLERS|[?]|min*mg/mL|[?]|1|nm|RIB 4|BILATERAL|DEEP|TRIPLE-PHASE SPIRAL CT SCAN||||VENDOR|READER 3|4|Visit_4|65|4|WASHOUT|2021-03-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|8|GAW|Airway Conductance|[?]|PRONE|[?]|tsp eq|[?]|1|10^3 copies/mL|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|CONTRALATERAL|FORE|LINE PROBE ASSAY||Y||ADJUDICATOR|FORENSIC PATHOLOGIST|4|Visit_4|65|5|SCREENING|2021-03-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|9|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|TRENDELENBURG|[?]|mmHg/sec|[?]|1|EIA unit|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|DORSOLATERAL|LAPAROSCOPY||||CAREGIVER|UROLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|944a2627-13f1-4ecf-9545-8819a1327138|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|PRONE|||[?]|1|/cmH2O|METACARPAL BONE 2|CONTRALATERAL|UPPER|BIOIMPEDANCE SPECTROSCOPY|||Y|SIBLING|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2021-04-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|1|GAW|Airway Conductance|[?]|SLING|||[?]|1|cm/s|BASILIC VEIN|LEFT|OCCIPITAL|MAMMOGRAPHY|Y||Y|ADJUDICATOR|ONCOLOGIST 1|1|Visit_1|10|2|FOLLOW-UP|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|2|ICREV|IC Reversibility|[?]|PRONE|||[?]|1|Farad|HILAR LYMPH NODE|LATERAL|INNER|IMMUNOFIXATION ELECTROPHORESIS|||Y|GUARDIAN|RADIOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-07
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|SUPINE|[?]|anti-Xa IU/mL|[?]|1|cmol/L|MITRAL VALVE ANNULUS|RIGHT|PROXIMAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||CAREGIVER|MICROSCOPIST|2|Visit_2|25|2|WASHOUT|2020-06-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|log10 TCID 50/mL|[?]|1|mV2/Hz|SPLENIC HILAR LYMPH NODE|UNILATERAL|INFERIOR|THERMAL IONIZATION MASS SPECTROMETRY||||STUDY SUBJECT|ADJUDICATOR 2|2|Visit_2|25|3|FOLLOW-UP|2020-06-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|5|RAW|Airway Resistance|[?]|DECUBITUS|||[?]|1|ug/L|AXILLARY LYMPH NODE LEVEL III|CONTRALATERAL|LATERAL|IMMUNORADIOMETRIC ASSAY||Y|Y|PARENT|RATER 2|3|Visit_3|40|7|TREATMENT|2020-07-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|6|FIV1PP|Percent Predicted FIV1|[?]|UNCONSTRAINED|[?]|CARTRIDGE|[?]|1|MPL U/mL|VASTUS LATERALIS MUSCLE|BILATERAL|APICAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y||INTERVIEWER|CARDIOLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|LATERAL DECUBITUS|||[?]|1|nkat|HAND|CONTRALATERAL|ROSTRAL|KINETIC CHROMOGENIC ASSAY|||Y|ADJUDICATION COMMITTEE|MICROSCOPIST|4|Visit_4|65|4|FOLLOW-UP|2020-07-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING|||[?]|1|mL/h|DISTAL INTERPHALANGEAL JOINT 4|BILATERAL|UPPER|FLUORESCEIN STAIN|Y||Y|GUARDIAN|MICROSCOPIST 3|4|Visit_4|65|7|TREATMENT|2020-07-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|9|FIFMAX|Maximum Forced Inspiratory Flow|[?]|TRENDELENBURG|[?]|CCID 50/mL|[?]|1|QUANTITY SUFFICIENT|SMALL INTESTINE|RIGHT|MEDIAL|NO INFORMATION||||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-08-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|7902955a-6336-45e5-a15d-7c368a28ac4f|10|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING, LEGS DEPENDENT|[?]|mg/kg|[?]|1|Ci/mL|HAMSTRING MUSCLE|BILATERAL|BASAL|PH METER MEASUREMENT METHOD||||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|WASHOUT|2020-08-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|AIRTRAP|Air Trapping|[?]|DECUBITUS|||[?]|1|ug/dose|TARSUS BONE|BILATERAL|SUPERFICIAL|TELLER ACUITY CARDS|Y|Y|Y|HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING|[?]|IU/mL|[?]|1|DRINK|OLFACTORY BULB|IPSILATERAL|LOWER FLEXOR SURFACE|IMPEDANCE CONDUCTIVITY||Y||STUDY SUBJECT|ADJUDICATOR 1|1|Visit_1|10|6|WASHOUT|2020-12-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|[?]|10^6 IU|[?]|1|Gy/h|LOWER RESPIRATORY SYSTEM|CONTRALATERAL|VENTROLATERAL|PALPATION|Y|||INVESTIGATOR|PATHOLOGIST 1|2|Visit_2|25|5|FOLLOW-UP|2021-01-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|4|PNIF|Peak Nasal Inspiratory Flow|[?]|FOWLERS|[?]|mCi/L|[?]|1|ug/m2/day|SOFT PALATE|CONTRALATERAL|DORSAL|MALDI|Y|||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|2|Visit_2|25|5|TREATMENT|2021-01-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|5|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|NEEDLE GAUGE|[?]|1|DISK|AXILLA|UNILATERAL|HIND|URANYL ACETATE STAIN|Y|||ADJUDICATOR|INTERNIST|3|Visit_3|40|5|TREATMENT|2021-01-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|6|PEF|Peak Expiratory Flow|[?]|SUPINE|[?]|SUPPOSITORY|[?]|1|g/cm2|RENAL PELVIS|IPSILATERAL|CRANIAL|IHC||||INVESTIGATOR|OPHTHALMOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2021-01-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|7|FIF75|Forced Inspiratory Flow at 75%|[?]|LATERAL DECUBITUS|[?]|log10 CCID 50/dose|[?]|1|U/mmol|CORONARY ARTERY|CONTRALATERAL|SURFACE|CHROMATOGRAPHY||||PROXY|READER|4|Visit_4|65|7|WASHOUT|2021-02-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING, BENT FORWARD|[?]|L/h|[?]|1|aMFI|CEREBRAL SUBCORTEX|UNILATERAL|BASAL|APPLANATION TONOMETRY||||STUDY SUBJECT|FORENSIC PATHOLOGIST|4|Visit_4|65|7|SCREENING|2021-02-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|9|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|[?]|mg/mL/day|[?]|1|L/s/kPa|LUNG, RIGHT UPPER LOBE|BILATERAL|CRANIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||STUDY SUBJECT|NEUROLOGIST 2|5|Visit_5|90|4|SCREENING|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|10|EXPRELTM|Expiration Relaxation Time|[?]|RIGHT LATERAL DECUBITUS|[?]|CIGARETTE|[?]|1|dmol|UVEA|LEFT|DORSAL|DUKE INCISION METHOD|Y|||FRIEND|RADIOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|1|SAWVOL|Specific Airway Volume|[?]|SEMI-RECUMBENT|[?]|ohm|[?]|1|ug/L FEU|THYROID GLAND, LEFT LOBE|UNILATERAL|CENTRAL|BIOIMPEDANCE SPECTROSCOPY||Y||SIBLING|ONCOLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-09-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|UNCONSTRAINED|||[?]|1|mm/sec|DISTAL LAD ARTERY|RIGHT|OCCIPITAL|MANUAL COUNT|||Y|INVESTIGATOR|DERMATOLOGIST|1|Visit_1|10|4|SCREENING|2020-09-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|3|IRV|Inspiratory Reserve Volume|[?]|FOWLERS|||[?]|1|ug/min|POPLITEAL VEIN|IPSILATERAL|ANTEROLATERAL|MS/MS||Y|Y|PROXY|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2020-09-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|4|ALVVOL|Alveolar Volume|[?]|STANDING, BENT FORWARD|[?]|atm|[?]|1|MASK|KIDNEY, LOWER LOBE|CONTRALATERAL|PROXIMAL|ENZYMATIC SPECTROPHOTOMETRY|Y|||CHILD|PATHOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-09-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|5|IRV|Inspiratory Reserve Volume|[?]|UNCONSTRAINED|||[?]|1|mEq/L|ESOPHAGEAL LYMPH NODE|RIGHT|TIP|CHROMATOGRAPHY||Y|Y|FRIEND|READER 3|3|Visit_3|40|2|WASHOUT|2020-10-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|6|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|||[?]|1|BU/mL|INFRACLAVICULAR LYMPH NODE|CONTRALATERAL|TEMPORAL|DYNAMOMETRY|||Y|CLINICAL RESEARCH COORDINATOR|UROLOGIST|3|Visit_3|40|2|TREATMENT|2020-10-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|7|IVC|Inspiratory Vital Capacity|[?]|SUPINE|||[?]|1|in2|AORTIC VALVE|BILATERAL|PERIPHERAL|MICROARRAY|||Y|CLINICAL RESEARCH COORDINATOR|RATER 2|4|Visit_4|65|1|WASHOUT|2020-11-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|8|FIF50|Forced Inspiratory Flow at 50%|[?]|FOWLERS|||[?]|1|kg/cm2|STERNAL MANUBRIUM|RIGHT|ANTERIOR|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y||Y|SIGNIFICANT OTHER|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2020-11-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|9|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|U/cL|[?]|1|10^9 organisms/g|HAIR BULB|LEFT|SUBCORTICAL|PERIPHERAL ANGIOGRAPHY||||SIBLING|ADJUDICATOR 1|5|Visit_5|90|7|SCREENING|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|6071d81f-2f38-414f-90ca-4ad80c971054|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|DECUBITUS|[?]|titer|[?]|1|BAU|OLECRANON|CONTRALATERAL|SUPERFICIAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||CLINICAL RESEARCH ASSOCIATE|RATER 2|5|Visit_5|90|4|TREATMENT|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|[?]|psi|[?]|1|PHERESIS UNIT|RADIUS|IPSILATERAL|LOWER EXTENSOR SURFACE|INCISION-INDUCED BLEEDING METHOD||Y||VENDOR|READER|1|Visit_1|10|4|TREATMENT|2020-09-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|2|EFFIND|Effusion Indicator|[?]|SUPINE|[?]|mg/kg/day|[?]|1|DNA copies/ug|L2-L3 INTERVERTEBRAL SPACE|CONTRALATERAL|FACIAL|NON-INVASIVE DIELECTRIC SENSING||||ADJUDICATOR|ONCOLOGIST|1|Visit_1|10|2|WASHOUT|2020-09-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|3|EFFVOL|Effusion Volume|[?]|PRONE|[?]|V|[?]|1|Enzyme U/L|REGIONAL LYMPH NODE|LEFT|OUTER|NUCLEIC ACID HYBRIDIZATION||||INTERVIEWER|CLINICAL PATHOLOGIST|2|Visit_2|25|7|WASHOUT|2020-10-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SLING|[?]|EID 50/dose|[?]|1|cy/cm|METACARPOPHALANGEAL JOINT 3|IPSILATERAL|UPPER EXTENSOR SURFACE|SLOAN LETTER EYE CHART 100%|Y|||DOMESTIC PARTNER|ONCOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-10-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|5|EFFIND|Effusion Indicator|[?]|SLING|[?]|U/mg|[?]|1|10^6 organisms/mL|PROXIMAL PHALANX 3 OF THE HAND|UNILATERAL|UPPER EXTENSOR SURFACE|CLAUSS METHOD||||ADJUDICATION COMMITTEE|RADIOLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-10-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|6|MEP|Maximal Expiratory Pressure|[?]|SEMI-RECUMBENT|[?]|MET|[?]|1|SPRAY|GASTROCNEMIUS MUSCLE|IPSILATERAL|PERIVENTRICULAR|CONTRAST ENHANCED SPIRAL CT SCAN|Y|||INVESTIGATOR|READER 1|3|Visit_3|40|1|WASHOUT|2020-10-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|7|RAWPP|Percent Predicted Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|ks|[?]|1|ka_u/dL|PROXIMAL CIRCUMFLEX ARTERY|IPSILATERAL|SUPERIOR|SPECTROPHOTOMETRY||||FRIEND|READER 3|4|Visit_4|65|6|TREATMENT|2020-11-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|8|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|Ci|[?]|1|mEq/dL|RENAL PELVIS|LATERAL|APICAL|APPLANATION TONOMETRY||||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|TREATMENT|2020-11-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|9|PNIF|Peak Nasal Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|ppb|[?]|1|Bq|LEFT VENTRICULAR APEX SEGMENT|IPSILATERAL|BASAL|ELLA|Y|Y||VENDOR|NEUROLOGIST 1|5|Visit_5|90|4|SCREENING|2020-12-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|10|FEV1PP|Percent Predicted FEV1|[?]|LEFT LATERAL DECUBITUS|[?]|%|[?]|1|PFU/dose|OSTIOMEATAL COMPLEX|UNILATERAL|OUTER|HPLC/MS|Y|Y||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|5|Visit_5|90|4|WASHOUT|2020-12-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|mEq/L|[?]|1|Hz|INTERPHALANGEAL JOINT 5|LEFT|PERIVENTRICULAR|RADIAL IMMUNODIFFUSION||||INTERVIEWER|ADJUDICATOR 2|1|Visit_1|10|6|SCREENING|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|2|FEV1FVC|FEV1/FVC|[?]|SLING|[?]|lx|[?]|1|/LSQN|C6 VERTEBRA|CONTRALATERAL|LOWER FLEXOR SURFACE|ENZYMATIC SPECTROPHOTOMETRY||||FRIEND|DERMATOLOGIST|1|Visit_1|10|4|TREATMENT|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|3|TV|Tidal Volume|[?]|LATERAL DECUBITUS|[?]|BAU/mL|[?]|1|breaths/30s|TIBIALIS POSTERIOR MUSCLE|IPSILATERAL|DISTAL VOLAR|GEL ELECTROPHORESIS||||PARENT|FORENSIC PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|||[?]|1|VIAL|INTESTINE|CONTRALATERAL|HIND|MOUSE PROTECTION ASSAY|||Y|FRIEND|OPHTHALMOLOGIST|2|Visit_2|25|6|TREATMENT|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|5|EFFVOL|Effusion Volume|[?]|FOWLERS|[?]|amu|[?]|1|QUANTITY SUFFICIENT|EYE|UNILATERAL|MIDLINE|MIGET|Y|||SIGNIFICANT OTHER|READER 2|3|Visit_3|40|3|TREATMENT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|6|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|||[?]|1|mm|SCAPHOID-LUNATE-CAPITATE JOINT|BILATERAL|OUTER|ATOMIC ABSORPTION SPECTROMETRY|||Y|CHILD|READER 3|3|Visit_3|40|2|FOLLOW-UP|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|7|DLCOVA|DLCO/VA|[?]|SITTING|[?]|10^3 CFU/mL|[?]|1|anti-Xa IU|AXILLARY ARTERY|LEFT|TEMPORAL|CYSTOSCOPY||||ADJUDICATION COMMITTEE|PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|8|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|STANDING|||[?]|1|10^6 RNA copies/mL|CEREBRAL CORTEX|CONTRALATERAL|OCCIPITAL|AUTOREFRACTION|||Y|CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|||[?]|1|10^3 copies/mL|SUBCLAVIAN VEIN|LATERAL|UPPER|KINETIC MICROPARTICLE IMMUNOASSAY|||Y|INDEPENDENT ASSESSOR|NEUROLOGIST|5|Visit_5|90|1|SCREENING|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|a046d48d-b1fa-4d46-902e-3984aed00ec7|10|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|[?]|um/s|[?]|1|POINT|CLAVICLE|CONTRALATERAL|ANTEROLATERAL|MANUAL COUNT||Y||ADJUDICATOR|PATHOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|1|FEV6PP|Percent Predicted FEV6|[?]|STANDING|[?]|mmol2/L2|[?]|1|Tesla|THYROID GLAND ISTHMUS|BILATERAL|VENTROLATERAL|PERFUSION MRI|Y|||CLINICAL STUDY SPONSOR|READER|1|Visit_1|10|1|SCREENING|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|2|SGAW|Specific Airway Conductance|[?]|SUPINE|||[?]|1|ppb|FLEXOR CARPI ULNARIS MUSCLE|BILATERAL|SUPERFICIAL|FLUORIMETRY||Y|Y|PARENT|DERMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|3|PEFREV|PEF Reversibility|[?]|DECUBITUS|||[?]|1|kUSP|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|UNILATERAL|DISTAL VOLAR|RULER MEASUREMENT METHOD|Y||Y|VENDOR|NEUROLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|4|OXYPULSE|Oxygen Pulse|[?]|STANDING|[?]|U/L|[?]|1|P|TYMPANIC MEMBRANE|RIGHT|VENTROLATERAL|FLUORESCENCE ANGIOGRAPHY|Y|Y||ADJUDICATOR|READER 3|2|Visit_2|25|6|TREATMENT|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|5|MALIND|Malignancy Indicator|[?]|REVERSE TRENDELENBURG|[?]|SFC/10^6 PBMC|[?]|1|Gy/h|LIMB|CONTRALATERAL|APICAL|ROMANOWSKY STAIN||Y||PROXY|ONCOLOGIST|3|Visit_3|40|5|WASHOUT|2021-01-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|6|PIF|Peak Inspiratory Flow|[?]|TRENDELENBURG|||[?]|1|mL/kg/min|EYE BULGE|LEFT|ANTEROTEMPORAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|Y|Y|INDEPENDENT ASSESSOR|RADIOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|7|FEF2575P|Percent Predicted FEF25-75|[?]|LEFT LATERAL DECUBITUS|||[?]|1|Bq/mL|TRICEPS BRACHII MUSCLE|LATERAL|FRONTAL|NUCLEIC ACID BASED METHOD||Y|Y|CHILD|MICROSCOPIST|4|Visit_4|65|6|FOLLOW-UP|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|8|PCF|Peak Cough Flow|[?]|SITTING, LEGS DEPENDENT|[?]|OD Unit|[?]|1|cmol/L|THORACIC AORTA|BILATERAL|NASAL|SLOAN LETTER EYE CHART 2.5%||||CAREGIVER|NEUROLOGIST 1|4|Visit_4|65|3|SCREENING|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|9|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|[?]|PA|[?]|1|U/animal|FLEXOR HALLUCIS LONGUS MUSCLE|LEFT|DORSOLATERAL|DIFFUSION TENSOR MRI||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|5|Visit_5|90|5|WASHOUT|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|8b60e1b0-2cd9-419d-b345-9006af042932|10|ELSTNCE|Elastance|[?]|RIGHT LATERAL DECUBITUS|[?]|SACHET|[?]|1|m2|TRUNK|UNILATERAL|SUPERFICIAL|IMMUNO-PET SCAN||||DOMESTIC PARTNER|RADIOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|[?]|ng|[?]|1|mU/L|AZYGOS VEIN|BILATERAL|DISTAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||PROXY|RADIOLOGIST|1|Visit_1|10|1|TREATMENT|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|2|FIF75|Forced Inspiratory Flow at 75%|[?]|SITTING, LEGS DEPENDENT|[?]|Hz|[?]|1|mm/h|ENTORHINAL CORTEX|LEFT|MIDLINE|ULTRASOUND||Y||PARENT|MICROSCOPIST|1|Visit_1|10|6|TREATMENT|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|3|MIP|Maximal Inspiratory Pressure|[?]|DECUBITUS|[?]|cup eq|[?]|1|L|HEART, SEPTUM|LATERAL|INFERIOR|TEST STRIP||Y||NON-HEALTH CARE PROFESSIONAL|RATER 2|2|Visit_2|25|7|FOLLOW-UP|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|4|FIV1|Forced Inspiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|/sec|[?]|1|IU/g Hb|VULVOVAGINAL REGION|CONTRALATERAL|BASAL|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|Y||STUDY SUBJECT|RATER 2|2|Visit_2|25|4|TREATMENT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SLING|[?]|kcal/day|[?]|1|g/g|AXILLARY LYMPH NODE LEVEL I|LEFT|HIND|NUCLEIC ACID BASED METHOD||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|3|Visit_3|40|7|TREATMENT|2021-02-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|6|ERV|Expiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|[?]|fmol|[?]|1|mg/dL|LENS|UNILATERAL|ROSTRAL|SLOAN LETTER EYE CHART 2.5%|Y|Y||CAREGIVER|ONCOLOGIST 2|3|Visit_3|40|3|TREATMENT|2021-02-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|7|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|GPL U/mL|[?]|1|/h|LIVER, CAUDATE LOBE|BILATERAL|CENTRAL|GEL ELECTROPHORESIS||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|4|Visit_4|65|5|TREATMENT|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-05
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|8|IRVPP|Percent Predicted IRV|[?]|FOWLERS|[?]|DAgU/mL|[?]|1|FINGERTIP UNIT|NASAL SEPTUM|UNILATERAL|DEEP|PANENDOSCOPY|Y|||DOMESTIC PARTNER|RADIOLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-05
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|9|IRVPP|Percent Predicted IRV|[?]|LEFT LATERAL DECUBITUS|[?]|U/kg/h|[?]|1|DNA copies/mL|CINGULATE CORTEX|LATERAL|SUPERFICIAL|NUCLEIC ACID BASED METHOD||||PARENT|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|712029bc-471a-4e3d-9123-e38b3c38bc6c|10|FEV1REV|FEV1 Reversibility|[?]|STANDING|[?]|RING|[?]|1|/2500 WBC|HUMERAL EPICONDYLE|CONTRALATERAL|BASAL|CYSTOSCOPY||||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|5|Visit_5|90|2|WASHOUT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|1|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|Coulomb|PROSTATE GLAND, POSTERIOR LOBE|BILATERAL|LATERAL|FUNDUS PHOTOGRAPHY|Y||Y|SIGNIFICANT OTHER|NEUROLOGIST 1|1|Visit_1|10|7|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|2|OXYPULSE|Oxygen Pulse|[?]|SUPINE|||[?]|1|mg/kg/day|METATARSOPHALANGEAL JOINT|BILATERAL|FORE|PLAQUE REDUCTION NEUTRALIZATION ASSAY|||Y|CHILD|RATER|1|Visit_1|10|2|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|3|ALVVOL|Alveolar Volume|[?]|STANDING|||[?]|1|CCID 50/dose|TOOTH|BILATERAL|CAUDAL|DARK FIELD MICROSCOPY|||Y|DOMESTIC PARTNER|ENDOCRINOLOGIST|2|Visit_2|25|6|SCREENING|2021-02-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|4|FIO2|Fraction of Inspired Oxygen|[?]|REVERSE TRENDELENBURG|[?]|SCOOPFUL|[?]|1|ks|EPIGLOTTIS|LATERAL|PERIVENTRICULAR|ACID FAST STAIN||||CAREGIVER|RADIOLOGIST 1|2|Visit_2|25|7|SCREENING|2021-02-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|5|TSUHYS|Tissue Hysteresivity|[?]|FOWLERS|[?]|uV|[?]|1|MET*h|QUADRICEPS MUSCLE|UNILATERAL|INTERMEDIATE|STATIC PERIMETRY||Y||SIBLING|RATER|3|Visit_3|40|5|FOLLOW-UP|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|6|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|||[?]|1|Log10 ELISA unit|SPLENIC LYMPH NODE|LEFT|INTERMEDIATE|TARGETED GENOME SEQUENCING||Y|Y|CAREGIVER|READER 1|3|Visit_3|40|2|SCREENING|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|REVERSE TRENDELENBURG|[?]|PIXELS/cm|[?]|1|umol/mol|VENA CAVA|UNILATERAL|INNER|KNEMOMETRY|Y|||GUARDIAN|RATER 1|4|Visit_4|65|5|TREATMENT|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|8|PEF|Peak Expiratory Flow|[?]|DECUBITUS|[?]|IU|[?]|1|PFU/mL|INSULAR CORTEX|RIGHT|DISTAL VOLAR|MEDIASTINOSCOPY||Y||CHILD|RATER 1|4|Visit_4|65|2|FOLLOW-UP|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/mL|[?]|1|APPLICATION|POSTERIOR CINGULATE CORTEX|BILATERAL|PERIVENTRICULAR|FLUORESCENT ENZYME IMMUNOASSAY|Y|||PARENT|OTOLARYNGOLOGIST|5|Visit_5|90|5|SCREENING|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|92c0183d-5704-45ad-9aec-e24bc5777b80|10|FRC|Functional Residual Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|C|[?]|1|K|EXTENSOR HALLUCIS BREVIS MUSCLE|UNILATERAL|PERIPHERAL|HPLC/MS/MS||||FRIEND|MICROSCOPIST 2|5|Visit_5|90|3|SCREENING|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|1|IVC|Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|ng/mol|[?]|1|h/wk|CEREBRAL CORTEX|UNILATERAL|SURFACE|ANTIBIOTIC AGAR SCREEN|Y|||CHILD|PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|2|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SUPINE|||[?]|1|Enzyme U|ASCENDING AORTA, AORTIC ROOT|BILATERAL|CRANIAL|FLUORESCENT ENZYME IMMUNOASSAY|||Y|CHILD|ENDOCRINOLOGIST|1|Visit_1|10|2|TREATMENT|2020-10-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|3|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|h*%|[?]|1|ug/kg/h|SKIN FOLD|BILATERAL|SURFACE|MRI||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|2|Visit_2|25|6|SCREENING|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|4|RER|Respiratory Exchange Ratio|[?]|SUPINE|||[?]|1|umol/h/mmol|C1 VERTEBRA|RIGHT|MIDLINE|HEMATOXYLIN AND EOSIN STAIN||Y|Y|CHILD|FORENSIC PATHOLOGIST|2|Visit_2|25|7|WASHOUT|2020-11-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|5|FEV_PEF|FEV at PEF|[?]|SITTING|[?]|cup eq|[?]|1|nmol/mol|T6 VERTEBRA|CONTRALATERAL|PARIETO-OCCIPITAL|HEMATOXYLIN AND EOSIN STAIN||||SIBLING|PATHOLOGIST 2|3|Visit_3|40|7|TREATMENT|2020-11-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|6|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|mAnson U/mL|[?]|1|fmol/L|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT|TEMPORAL|WEBER GREEN STAIN||||HEALTH CARE PROFESSIONAL|PATHOLOGIST|3|Visit_3|40|2|WASHOUT|2020-11-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|7|EVC|Expiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|ohm|[?]|1|L/h/m2|TIBIAL-CRURAL PERIPHERAL ARTERY|LEFT|LOWER FLEXOR SURFACE|ENZYMATIC COLORIMETRY|Y|Y||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-12-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|8|TVPP|Percent Predicted Tidal Volume|[?]|FOWLERS|[?]|cm/min|[?]|1|L/h/m2|AXILLARY LYMPH NODE|IPSILATERAL|ANTEROPOSTERIOR|IMMUNOPRECIPITATION||||FAMILY MEMBER|PHYSIOTHERAPIST|4|Visit_4|65|6|WASHOUT|2020-12-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|9|FIV1PP|Percent Predicted FIV1|[?]|LEFT LATERAL DECUBITUS|[?]|cs|[?]|1|uCi/L|INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|UPPER FLEXOR SURFACE|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||CLINICAL STUDY SPONSOR|UROLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|52ce3b1f-9500-4323-861d-73c8b96f59de|10|ERV|Expiratory Reserve Volume|[?]|SITTING|[?]|Ci/kg|[?]|1|MnFI|EXTRAHEPATIC BILE DUCT|UNILATERAL|HIND|OPHTHALMOSCOPY||||HEALTH CARE PROFESSIONAL|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-01-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|DECUBITUS|[?]|DAgU/mL|[?]|1|VIRTUAL PIXEL|HIPPOCAMPUS|CONTRALATERAL|SUBCORTICAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||||ADJUDICATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|2|RAWPP|Percent Predicted Airway Resistance|[?]|TRENDELENBURG|[?]|mL/kg/min|[?]|1|mL/s|HAIR SHAFT|UNILATERAL|UPPER FLEXOR SURFACE|NUCLEAR RADIOLOGY||||INDEPENDENT ASSESSOR|READER|1|Visit_1|10|2|TREATMENT|2020-11-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|3|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING, LEGS DEPENDENT|[?]|EVENTS|[?]|1|ppm|PERIUMBILICAL REGION|RIGHT|LATERAL|LEAD CITRATE STAIN||||CHILD|RADIOLOGIST 1|2|Visit_2|25|3|WASHOUT|2020-12-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|4|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|pt_us|[?]|1|Bq/L|FLEXOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|OCCIPITAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||INTERVIEWER|PATHOLOGIST|2|Visit_2|25|2|WASHOUT|2020-12-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|5|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|[?]|pg/dL|[?]|1|cmol/L|PARASYMPATHETIC GANGLIA|LATERAL|PROXIMAL|CLINICAL EVALUATION||Y||FRIEND|MICROSCOPIST 1|3|Visit_3|40|7|WASHOUT|2020-12-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|6|IC|Inspiratory Capacity|[?]|DECUBITUS|[?]|g/animal|[?]|1|mEq/mL|EAR|BILATERAL|UPPER EXTENSOR SURFACE|SISH||||ADJUDICATION COMMITTEE|ONCOLOGIST|3|Visit_3|40|2|SCREENING|2020-12-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|7|RER|Respiratory Exchange Ratio|[?]|STANDING|[?]|cd|[?]|1|AMPULE|ENDOCARDIUM|IPSILATERAL|SUPERIOR|MYELOPEROXIDASE STAIN|Y|||FAMILY MEMBER|RATER 1|4|Visit_4|65|3|TREATMENT|2021-01-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|8|PCF|Peak Cough Flow|[?]|UNCONSTRAINED|[?]|uV2|[?]|1|10^6/hpf|AXILLARY ARTERY|RIGHT|SUPERIOR|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||SIBLING|CARDIOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|9|OXYPULSE|Oxygen Pulse|[?]|LEFT LATERAL DECUBITUS|[?]|Enzyme U/m2|[?]|1|Linear ft*LB|OVARIAN FOLLICLE|LATERAL|LOWER EXTENSOR SURFACE|MAMMOGRAPHY|Y|||INTERVIEWER|INTERNIST|5|Visit_5|90|7|TREATMENT|2021-02-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|3655d198-2e7e-419e-8337-d7eea7d795ca|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|mIU/L|[?]|1|hr/day|FRONTAL LOBE|LEFT|APICAL|AGAR DILUTION||||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|SCREENING|2021-02-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|1|FEV3FVC|FEV3/FVC|[?]|SUPINE|[?]|cmHg|[?]|1|mOsm/kg|INTERNAL MAMMARY ARTERY|LATERAL|MEDIAL|CAPILLARY ELECTROPHORESIS||||HEALTH CARE PROFESSIONAL|UROLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|[?]|mmol2/L2|[?]|1|mIU/L|MUSCULOSKELETAL SYSTEM|RIGHT|VOLAR|HPLC||||INVESTIGATOR|READER 2|1|Visit_1|10|3|TREATMENT|2020-09-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|UNCONSTRAINED|[?]|RNA copies/mL|[?]|1|/ms|EPIGLOTTIS|BILATERAL|INTERMEDIATE|HEMAGGLUTINATION INHIBITION ASSAY||||ADJUDICATOR|NEUROLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-09-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|4|AWWVOL|Airway Wall Volume|[?]|LEFT LATERAL DECUBITUS|[?]|10^4 CFU|[?]|1|1/(s*kPa)|EXTERNAL ILIAC ARTERY|LATERAL|UPPER FLEXOR SURFACE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|||ADJUDICATOR|READER 3|2|Visit_2|25|5|FOLLOW-UP|2020-09-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|5|FIFMAXPP|Percent Predicted FIFmax|[?]|DECUBITUS|||[?]|1|ug/L DDU|LUMBAR VERTEBRA|LATERAL|INFERIOR|COULOMETRIC TITRATION|Y|Y|Y|VENDOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SLING|[?]|GBq/mg|[?]|1|PFU|VERTEBRAL ARTERY|RIGHT|TEMPORAL|APPLANATION TONOMETRY||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-10-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|7|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|FOWLERS|[?]|10^6 organisms/mL|[?]|1|mCi/L|TAIL|CONTRALATERAL|ANTEROMEDIAL|IMMUNOFLUORESCENT STAIN||||ADJUDICATION COMMITTEE|DERMATOLOGIST|4|Visit_4|65|6|WASHOUT|2020-11-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|8|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|[?]|mg/day|[?]|1|rpm|HILAR|IPSILATERAL|ANTEROLATERAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|4|Visit_4|65|4|TREATMENT|2020-11-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|9|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|[?]|mmol/mol|[?]|1|10^9 organisms/mg|SPLENIC LYMPH NODE|RIGHT|UPPER|FLUORESCENCE ANGIOGRAPHY|Y|||SIGNIFICANT OTHER|ADJUDICATOR 2|5|Visit_5|90|2|TREATMENT|2020-11-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|d47da6bf-8abf-4b62-8bb8-797155981158|10|TVPP|Percent Predicted Tidal Volume|[?]|DECUBITUS|[?]|% INHIBITION|[?]|1|10^4 CFU|VOMER|BILATERAL|CENTRAL|BETA LACTAMASE||Y||VENDOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|SCREENING|2020-11-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|TRENDELENBURG|[?]|dL|[?]|1|U/kg/min|EYELASH|LATERAL|UPPER|TELLER ACUITY CARDS||||CHILD|ONCOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-08-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-RECUMBENT|||[?]|1|10^5/L|RADIUS-LUNATE JOINT|IPSILATERAL|INTERMEDIATE|GRAM STAIN||Y|Y|SIBLING|RATER 1|1|Visit_1|10|4|TREATMENT|2020-08-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|3|FEV3FVC|FEV3/FVC|[?]|DECUBITUS|[?]|uCi/L|[?]|1|CCID 50/mL|EARLOBE|LEFT|BASAL|MALDI-TOF||||VENDOR|DERMATOLOGIST|2|Visit_2|25|7|WASHOUT|2020-08-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|DNA copies/ug|[?]|1|Watt|FOREHEAD|IPSILATERAL|VENTROLATERAL|CONTRAST ENHANCED PET SCAN|Y|||CHILD|UROLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-08-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|5|FEV1FVC|FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|OD Unit|[?]|1|BOWL|FACIAL BONE|IPSILATERAL|CENTRAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||||CLINICAL STUDY SPONSOR|READER|3|Visit_3|40|2|TREATMENT|2020-09-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|6|INFLTIND|Infiltrates Indicator|[?]|FOWLERS|||[?]|1|Henry|SKIN OF THE INFRASCAPULAR REGION|IPSILATERAL|INFERIOR|GC/MS||Y|Y|INVESTIGATOR|RATER 1|3|Visit_3|40|2|SCREENING|2020-09-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|7|FEV1SVC|FEV1/SVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^9 CFU/g|PARACOLIC GUTTER|RIGHT|SUPERFICIAL|ULTRASONOGRAPHIC ELASTOGRAPHY|||Y|ADJUDICATOR|READER|4|Visit_4|65|5|TREATMENT|2020-10-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|8|VO2|Oxygen Consumption|[?]|PRONE|[?]|ft|[?]|1|10^3 organisms/g|LEPTOMENINGES|RIGHT|VENTROLATERAL|PET/CT SCAN WITHOUT CONTRAST||Y||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|1|TREATMENT|2020-10-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|9|VO2|Oxygen Consumption|[?]|RIGHT LATERAL DECUBITUS|[?]|ng/dL|[?]|1|Bq/kg|PECTORALIS MINOR MUSCLE|UNILATERAL|ANTERIOR|TRANSVAGINAL ULTRASOUND||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|5|Visit_5|90|5|FOLLOW-UP|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|25e81c81-8c23-4c9e-be79-35247384dd1f|10|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|cP|[?]|1|DDU|EYE, ANTERIOR CHAMBER|LEFT|DORSOLATERAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||PARENT|PEDIATRIC NEUROLOGIST|5|Visit_5|90|4|TREATMENT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LATERAL DECUBITUS|[?]|PLUG|[?]|1|ft3|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|UNILATERAL|PARIETO-OCCIPITAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||Y||SPOUSE|FORENSIC PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-07-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|2|RRS|Total Respiratory System Resistance|[?]|UNCONSTRAINED|[?]|GBq/mg|[?]|1|mph|SKIN OF THE CHIN|IPSILATERAL|PERIPHERAL|PALM METHOD||||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|TREATMENT|2020-07-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|3|DLCOVA|DLCO/VA|[?]|UNCONSTRAINED|[?]|MET*h|[?]|1|log10 TCID 50/uL|MIDDLE PHALANX 4 OF THE HAND|LATERAL|SUBCORTICAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||Y||CLINICAL RESEARCH COORDINATOR|READER 2|2|Visit_2|25|6|TREATMENT|2020-08-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|4|SALKK|Salazar-Knowles Equation, K|[?]|SEMI-FOWLERS|[?]|APPLICATION|[?]|1|cd/m2|TRACHEOBRONCHIAL TREE|UNILATERAL|SUPERFICIAL|CONTRAST ENHANCED MRI|Y|||SIBLING|READER 2|2|Visit_2|25|7|TREATMENT|2020-08-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|5|MIPPP|Percent Predicted MIP|[?]|FOWLERS|[?]|g/animal|[?]|1|dL|METACARPAL BONE 4|IPSILATERAL|DISTAL|PERCUSSION||Y||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-08-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|6|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|||[?]|1|/200 HPFs|TRICUSPID VALVE ANNULUS|RIGHT|ANTEROPOSTERIOR|INDIA INK STAIN|||Y|CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|3|Visit_3|40|3|TREATMENT|2020-08-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|DECUBITUS|[?]|GBq/g|[?]|1|mg/kg/h|SKIN OF THE FOOT|LATERAL|UPPER EXTENSOR SURFACE|IODINE STAIN||Y||STUDY SUBJECT|INTERNIST|4|Visit_4|65|1|TREATMENT|2020-09-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|8|INTP|Interpretation|[?]|RIGHT LATERAL DECUBITUS|[?]|/month|[?]|1|BOLUS|CORONARY VEIN|LATERAL|CRANIAL|DOUBLE IMMUNODIFFUSION||||CAREGIVER|NEUROLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-09-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|9|PLMXRS|Pulmonary Reactance|[?]|DECUBITUS|[?]|mg/dose|[?]|1|log10 CCID 50/dose|DUODENUM|IPSILATERAL|NASAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||VENDOR|OTOLARYNGOLOGIST|5|Visit_5|90|7|TREATMENT|2020-10-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING|[?]|TCID 50/dose|[?]|1|cm H2O|COLON, DESCENDING|IPSILATERAL|UPPER FLEXOR SURFACE|AMSLER GRID||||INVESTIGATOR|MICROSCOPIST 3|5|Visit_5|90|1|WASHOUT|2020-10-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|MEPPP|Percent Predicted MEP|[?]|SEMI-RECUMBENT|||[?]|1|kN/cm2|GLOMERULUS|CONTRALATERAL|ANTEROPOSTERIOR|COULOMETRIC TITRATION|||Y|SIGNIFICANT OTHER|ENDOCRINOLOGIST|1|Visit_1|10|7|WASHOUT|2020-11-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|2|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|DRINK|[?]|1|CAN|COMMON FEMORAL VEIN|LEFT|TEMPORAL|LEAD CITRATE STAIN||||ADJUDICATION COMMITTEE|PATHOLOGIST|1|Visit_1|10|6|WASHOUT|2020-11-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|3|IVCPP|Percent Predicted IVC|[?]|REVERSE TRENDELENBURG|[?]|umol/dL|[?]|1|mOsm/L|DISTAL PHALANX 4 OF THE HAND|IPSILATERAL|DISTAL|EIA||||STUDY SUBJECT|RATER 2|2|Visit_2|25|5|TREATMENT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|4|GAW|Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|10^6 copies/mL|[?]|1|mPa|HEART, VENTRICLE|RIGHT|INNER|GC/MS||Y||CAREGIVER|MICROSCOPIST 2|2|Visit_2|25|7|TREATMENT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|5|ALVVOL|Alveolar Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|10^9 CFU|AXILLARY VEIN|CONTRALATERAL|ANTERIOR|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||Y|CAREGIVER|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|6|SALKA|Salazar-Knowles Equation Parameter A|[?]|REVERSE TRENDELENBURG|[?]|IU/g Hb|[?]|1|log10 PFU/mL|CORNEA|IPSILATERAL|DISTAL|MICRO BROTH DILUTION|Y|||CHILD|READER 1|3|Visit_3|40|3|SCREENING|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|7|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|ngEq/L|[?]|1|nmol/L/min|PULMONARY VALVE|IPSILATERAL|FRONTAL|FLUORESCENT ENZYME IMMUNOASSAY||||SIBLING|ADJUDICATOR 1|4|Visit_4|65|6|TREATMENT|2021-01-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|8|ICREV|IC Reversibility|[?]|STANDING, BENT FORWARD|[?]|gtt|[?]|1|MAC50|SKIN OF THE ELBOW|CONTRALATERAL|DISTAL VOLAR|OPTICAL COHERENCE TOMOGRAPHY||Y||INVESTIGATOR|ONCOLOGIST 1|4|Visit_4|65|2|SCREENING|2021-01-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|9|RAWPP|Percent Predicted Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^3 CFU/mL|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|UNILATERAL|CAUDAL|TEMPLATE INCISION METHOD|Y||Y|SIBLING|READER|5|Visit_5|90|1|FOLLOW-UP|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|10|RAW|Airway Resistance|[?]|SEMI-RECUMBENT|[?]|umol/kg/min|[?]|1|gpELISA unit/mL|PARALARYNGEAL LYMPH NODE|LATERAL|LOWER FLEXOR SURFACE|RYAN BLUE STAIN||||PARENT|PHYSIOTHERAPIST|5|Visit_5|90|7|TREATMENT|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|1|IVCPP|Percent Predicted IVC|[?]|DECUBITUS|[?]|mL/cm H2O|[?]|1|10^9/g|MIDDLE PHALANX 5 OF THE HAND|IPSILATERAL|SUPERIOR|CARDIAC THERMODILUTION||Y||CHILD|ADJUDICATOR 2|1|Visit_1|10|7|FOLLOW-UP|2020-11-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|2|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|[?]|ukat/L|[?]|1|ELISA unit/mL|LINGULA OF THE LUNG|LEFT|SUPERIOR|IN SITU HYBRIDIZATION||||SPOUSE|PATHOLOGIST 2|1|Visit_1|10|2|FOLLOW-UP|2020-11-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|3|EVC|Expiratory Vital Capacity|[?]|DECUBITUS|[?]|10^3 copies/mL|[?]|1|TROCHE|ILEUM|LATERAL|UPPER EXTENSOR SURFACE|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|||VENDOR|RADIOLOGIST 2|2|Visit_2|25|4|SCREENING|2020-12-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|4|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|||[?]|1|%/min|FALLOPIAN TUBE|RIGHT|ROSTRAL|CONGO RED STAIN|Y||Y|ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|2|Visit_2|25|4|TREATMENT|2020-12-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|5|MALIND|Malignancy Indicator|[?]|UNCONSTRAINED|||[?]|1|mmHg*min/L|SUBCLAVIAN ARTERY|LATERAL|ANTEROLATERAL|MYELOPEROXIDASE STAIN|Y||Y|SIBLING|READER 2|3|Visit_3|40|4|TREATMENT|2020-12-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|6|IC|Inspiratory Capacity|[?]|TRENDELENBURG|[?]|10^6 organisms/mL|[?]|1|IU/mL|SKIN OF THE FINGER|BILATERAL|SUBCORTICAL|X-RAY|Y|||CAREGIVER|PATHOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-12-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|7|AWWVOL|Airway Wall Volume|[?]|SEMI-RECUMBENT|[?]|ug/day|[?]|1|pg/dL|FUNDUS OF THE STOMACH|BILATERAL|PERIPHERAL|DIFFUSION TENSOR MRI||Y||CLINICAL RESEARCH ASSOCIATE|READER|4|Visit_4|65|6|TREATMENT|2021-01-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|8|TSUELAS|Tissue Elastance|[?]|DECUBITUS|[?]|mg/mL/day|[?]|1|LENS|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL|INTERMEDIATE|CINEANGIOGRAPHY|Y|||DOMESTIC PARTNER|ADJUDICATOR 2|4|Visit_4|65|5|FOLLOW-UP|2021-01-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|9|FIVC|Forced Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|Joule|[?]|1|/200 HPFs|SCAPHOID-LUNATE-CAPITATE JOINT|RIGHT|DORSOLATERAL|PHOTOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|5|Visit_5|90|3|TREATMENT|2021-02-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|5ba70148-c29b-47af-9280-10d1a942380a|10|RER|Respiratory Exchange Ratio|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^3 DNA copies/mL|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|RIGHT|DISTAL|CELLULAR PROLIFERATION ASSAY|||Y|CLINICAL RESEARCH COORDINATOR|RATER 2|5|Visit_5|90|2|TREATMENT|2021-02-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|EFFVOL|Effusion Volume|[?]|SUPINE|[?]|EU|[?]|1|Ci/ug|ASCENDING AORTA|LATERAL|DISTAL|KINETIC MICROPARTICLE IMMUNOASSAY||||DOMESTIC PARTNER|RADIOLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|2|PEFREV|PEF Reversibility|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^7/L|PELVIC BONE|IPSILATERAL|FRONTAL|CRYOSCOPY|Y||Y|ADJUDICATION COMMITTEE|NEUROLOGIST 2|1|Visit_1|10|7|WASHOUT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|REVERSE TRENDELENBURG|||[?]|1|ug/L/h|COLON, SPLENIC FLEXURE|LEFT|OUTER|THIN SMEAR||Y|Y|SIBLING|ADJUDICATOR 2|2|Visit_2|25|4|WASHOUT|2020-06-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|4|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|[?]|PFU/mL|[?]|1|Ci/ug|SKIN OF THE BENDING JOINT|BILATERAL|LOWER|MICROBIAL CONCENTRATION|Y|||FAMILY MEMBER|PHYSIOTHERAPIST|2|Visit_2|25|1|WASHOUT|2020-06-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|5|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|mL/m2/h|[?]|1|10^6 organisms|PARACOLIC GUTTER|LATERAL|ANTERIOR|QUANTITATIVE ULTRASOUND||||NON-HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2020-06-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|6|EFFIND|Effusion Indicator|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mmol/s|SKIN OF THE CHEST|CONTRALATERAL|VENTROLATERAL|ACID FAST STAIN|Y||Y|DOMESTIC PARTNER|READER 2|3|Visit_3|40|6|TREATMENT|2020-06-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|Ci/L|[?]|1|min*mg/mL|BRACHIOCEPHALIC ARTERY|IPSILATERAL|PROXIMAL VOLAR|CENTRIFUGATION||||SIBLING|READER 3|4|Visit_4|65|2|TREATMENT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|8|DLCO|Diffusion Capacity of Lung for CO|[?]|PRONE|||[?]|1|10^6 CFU|METATARSOPHALANGEAL JOINT 1|IPSILATERAL|INNER|MANUAL COUNT||Y|Y|INDEPENDENT ASSESSOR|CARDIOLOGIST|4|Visit_4|65|3|SCREENING|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|9|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|[?]|cg|[?]|1|uCi/L|PROXIMAL INTERPHALANGEAL JOINT 4|UNILATERAL|FACIAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||PROXY|RATER 2|5|Visit_5|90|4|SCREENING|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|10|RV|Residual Volume|[?]|SUPINE|[?]|L/day|[?]|1|Ejaculate U|SEMITENDINOSUS MUSCLE|IPSILATERAL|VOLAR|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||Y||ADJUDICATOR|ONCOLOGIST|5|Visit_5|90|2|WASHOUT|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|DECUBITUS|[?]|days/wk|[?]|1|cmol|CLITORIS|IPSILATERAL|LOWER MEDIAL|IMMUNO-PET SCAN||Y||SPOUSE|OPTOMETRIST|1|Visit_1|10|5|FOLLOW-UP|2020-06-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|[?]|BAR|[?]|1|/7.5 mL|PELVIC LYMPH NODE|CONTRALATERAL|DEEP|IRON HEMATOXYLIN STAIN||||ADJUDICATOR|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-06-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|3|EXPRELTM|Expiration Relaxation Time|[?]|SLING|[?]|vp/mL|[?]|1|ng/mol|BILIARY TRACT|IPSILATERAL|LOWER|FLUORESCEIN STAIN||Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-07-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-FOWLERS|[?]|10^6 CFU|[?]|1|U/g|ABDOMINAL CAVITY|CONTRALATERAL|BASAL|DIGITAL PCR||||FAMILY MEMBER|READER 1|2|Visit_2|25|7|TREATMENT|2020-07-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|5|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING|[?]|EID 50/mL|[?]|1|10^6 CFU|COLON LYMPH NODE|CONTRALATERAL|POSTERIOR|FLUORESCENCE ANGIOGRAPHY|Y|||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|6|ICPP|Percent Predicted Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|[?]|Gy/min|[?]|1|mCi/L|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|DORSAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||SPOUSE|PATHOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-07-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|7|FIV1|Forced Inspiratory Volume in 1 Second|[?]|UNCONSTRAINED|||[?]|1|10^6/hpf|FIBULAR VEIN|IPSILATERAL|DISTAL VOLAR|SICKLE CELL SOLUBILITY TEST|Y||Y|VENDOR|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|8|OXYPULSE|Oxygen Pulse|[?]|LATERAL DECUBITUS|[?]|kBq/uL|[?]|1|VIRTUAL PIXEL|MUSCULOSKELETAL SYSTEM|UNILATERAL|UPPER|MAGNETIC RESONANCE ANGIOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|READER|4|Visit_4|65|5|WASHOUT|2020-08-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|9|FIO2|Fraction of Inspired Oxygen|[?]|SITTING, LEGS DEPENDENT|[?]|ft3|[?]|1|ag|SUPRAGLOTTIS|IPSILATERAL|LOWER EXTENSOR SURFACE|DROPLET DIGITAL PCR||||CHILD|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-09-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|2d8f8b1e-7914-400b-afc5-8dc23a626d76|10|ALVVOL|Alveolar Volume|[?]|STANDING|[?]|Absorbance U/min|[?]|1|MONTHS|ETHMOID BONE|IPSILATERAL|DISTAL VOLAR|SLIT LAMP PHOTOGRAPHY|Y|Y||PARENT|OTOLARYNGOLOGIST|5|Visit_5|90|1|WASHOUT|2020-09-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|DECUBITUS|[?]|mEq/mL|[?]|1|BAU|EAR, INNER|UNILATERAL|VOLAR|GEL ELECTROPHORESIS||||INDEPENDENT ASSESSOR|INTERNIST|1|Visit_1|10|5|WASHOUT|2020-08-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|2|SVC|Slow Vital Capacity|[?]|TRENDELENBURG|[?]|vp/dose|[?]|1|10^6/hpf|LEFT CIRCUMFLEX CORONARY ARTERY|RIGHT|PROXIMAL VOLAR|OPTICAL MAPPING||||INVESTIGATOR|ENDOCRINOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|3|FIO2|Fraction of Inspired Oxygen|[?]|PRONE|[?]|U/L|[?]|1|mmAL|ILEUM, TERMINAL|IPSILATERAL|VENTROLATERAL|CONGO RED STAIN||||INDEPENDENT ASSESSOR|ONCOLOGIST|2|Visit_2|25|1|WASHOUT|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|4|RAW|Airway Resistance|[?]|PRONE|||[?]|1|uOsm|PANCREAS, HEAD|IPSILATERAL|UPPER EXTENSOR SURFACE|TRIPLE-PHASE MRI SCAN||Y|Y|CLINICAL RESEARCH COORDINATOR|OTOLARYNGOLOGIST|2|Visit_2|25|4|SCREENING|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|5|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|mEq/day|[?]|1|U/mL|POPLITEAL ARTERY ABOVE KNEE|LATERAL|PROXIMAL VOLAR|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||SPOUSE|PEDIATRIC NEUROLOGIST|3|Visit_3|40|3|WASHOUT|2020-09-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|6|IVC|Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/min/mmHg|[?]|1|TRACE|GENITALIA|UNILATERAL|LOWER EXTENSOR SURFACE|CONTRAST ENHANCED PET/CT SCAN||Y||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-09-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|7|SVC|Slow Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|grain|INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|DORSAL|MRI WITHOUT CONTRAST||Y|Y|GUARDIAN|INTERNIST|4|Visit_4|65|4|FOLLOW-UP|2020-10-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-RECUMBENT|[?]|mOsm|[?]|1|ug/L/h|DISTAL PHALANX 2 OF THE HAND|UNILATERAL|APICAL|POPULATION SEQUENCING||||INDEPENDENT ASSESSOR|RADIOLOGIST|4|Visit_4|65|6|SCREENING|2020-10-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|[?]|uL/mL|[?]|1|Log10 ELISA unit/dose|ACHILLES TENDON|IPSILATERAL|OCCIPITAL|DYNAMOMETRY|Y|||STUDY SUBJECT|INTERNIST|5|Visit_5|90|2|TREATMENT|2020-11-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|10|PEFREV|PEF Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|10^8/L|[?]|1|days/month|SKIN OF THE UPPER LIMB|LATERAL|INNER|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|||PARENT|RADIOLOGIST 1|5|Visit_5|90|1|FOLLOW-UP|2020-11-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LATERAL DECUBITUS|[?]|PFU/dose|[?]|1|10^6 organisms/mL|GENITAL TUBERCLE|IPSILATERAL|CENTRAL|BALLPOINT PEN TECHNIQUE||||FAMILY MEMBER|MICROSCOPIST 2|1|Visit_1|10|2|TREATMENT|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|2|IRV|Inspiratory Reserve Volume|[?]|SEMI-RECUMBENT|||[?]|1|Frames/s|METACARPOPHALANGEAL JOINT 3|CONTRALATERAL|ANTERIOR|DIFFUSION TENSOR MRI||Y|Y|FAMILY MEMBER|UROLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|3|TGV|Thoracic Gas Volume|[?]|SLING|[?]|aMFI|[?]|1|mEq/ug|PECTORALIS MAJOR MUSCLE|LATERAL|SUPERFICIAL|PERIODIC ACID SCHIFF STAIN|Y|||ADJUDICATOR|ADJUDICATOR 3|2|Visit_2|25|5|TREATMENT|2020-08-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/mol|[?]|1|mkat|THIRD RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|VENTRAL|CELL OF ORIGIN ASSAY||Y||CAREGIVER|PATHOLOGIST 2|2|Visit_2|25|7|SCREENING|2020-08-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|5|AWWVOL|Airway Wall Volume|[?]|UNCONSTRAINED|[?]|ug/mol|[?]|1|SACHET|PALPEBRAL FISSURE|UNILATERAL|PROXIMAL|DIRECT SEQUENCING|Y|||INTERVIEWER|DERMATOLOGIST|3|Visit_3|40|3|WASHOUT|2020-09-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|[?]|U/mL|[?]|1|%/min|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|BILATERAL|PROXIMAL VOLAR|MAMMOGRAPHY|Y|||CLINICAL STUDY SPONSOR|CARDIOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|PRONE|||[?]|1|10^9 CFU/g|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LEFT|INTERMEDIATE|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|Y|Y|CAREGIVER|OPTOMETRIST|4|Visit_4|65|1|FOLLOW-UP|2020-10-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|8|FEV_PEF|FEV at PEF|[?]|SITTING|[?]|g/cage/wk|[?]|1|VIRTUAL PIXEL|DUODENUM|RIGHT|APICAL|IMMUNOFLUORESCENT STAIN||||GUARDIAN|OTOLARYNGOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-10-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING|[?]|mL/s/m2|[?]|1|U/m2/h|PARATRACHEAL LYMPH NODE|LATERAL|LOWER FLEXOR SURFACE|DIGITAL PCR|Y|||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|a73142e4-e34b-4144-b95f-7a5562574c1b|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|cycle/min|[?]|1|dram|SCALP|IPSILATERAL|SUPERFICIAL|MECHANICAL CLOT DETECTION|Y|||SIGNIFICANT OTHER|CARDIOLOGIST|5|Visit_5|90|6|TREATMENT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|EFFVOL|Effusion Volume|[?]|SEMI-FOWLERS|[?]|/min|[?]|1|copies/mL|T9 VERTEBRA|UNILATERAL|SURFACE|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||PROXY|ADJUDICATOR|1|Visit_1|10|4|WASHOUT|2020-06-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|2|FIF25|Forced Inspiratory Flow at 25%|[?]|UNCONSTRAINED|[?]|dmol|[?]|1|kDa|CRANIAL NERVE|CONTRALATERAL|APICAL|TRIPLE-PHASE MRI SCAN|Y|Y||INTERVIEWER|NEUROLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-06-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|3|ALVVOL|Alveolar Volume|[?]|DECUBITUS|[?]|1/(s*kPa)|[?]|1|pg/cell|SUPRARENAL AORTA|BILATERAL|VENTRAL|KARYOTYPING||||SPOUSE|ADJUDICATOR 1|2|Visit_2|25|6|TREATMENT|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|4|AIRTRAP|Air Trapping|[?]|DECUBITUS|||[?]|1|beats/min|BUTTOCK|RIGHT|UPPER FLEXOR SURFACE|FLUORESCENT LIFETIME IMAGING MICROSCOPY||Y|Y|PARENT|CARDIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|5|PEF|Peak Expiratory Flow|[?]|STANDING|[?]|ft2|[?]|1|kBq|RETROPERITONEUM|BILATERAL|DEEP|WESTERN BLOT|Y|||INTERVIEWER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|7|SCREENING|2020-07-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|6|FRC|Functional Residual Capacity|[?]|LATERAL DECUBITUS|||[?]|1|10^6 IU/mL|RIB 7|IPSILATERAL|INTERMEDIATE|RULER MEASUREMENT METHOD|||Y|SPOUSE|RADIOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|7|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|U|[?]|1|DNA copies/mL|NUCLEUS ACCUMBENS|LATERAL|OUTER|ELECTRONEUROGRAPHY|Y|||CAREGIVER|MICROSCOPIST 3|4|Visit_4|65|4|FOLLOW-UP|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|8|LOBVOL|Lobar Volume|[?]|UNCONSTRAINED|[?]|umol/mol|[?]|1|K|THIRD POSTEROLATERAL DESCENDING ARTERY|LATERAL|OUTER|WESTERN BLOT||||CHILD|READER|4|Visit_4|65|5|SCREENING|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|9|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|ug/L/h|[?]|1|mL/h|CERVIX UTERI|CONTRALATERAL|CRANIAL|IMMUNOTURBIDIMETRY|Y|||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2020-08-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|10|FEV3FVC|FEV3/FVC|[?]|SLING|||[?]|1|U/g/h|DORSAL MOTOR NUCLEUS|LEFT|PROXIMAL VOLAR|SINGLE-MOLECULE ARRAY|||Y|CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|5|Visit_5|90|3|SCREENING|2020-08-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|mL/animal/wk|[?]|1|mL/sec/1.73m2|ESOPHAGUS|LEFT|SUPERFICIAL|ELECTRICAL IMPEDANCE MYOGRAPHY||||FRIEND|RADIOLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|2|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING|[?]|Weber|[?]|1|mL/m2|VASTUS MEDIALIS MUSCLE|BILATERAL|OCCIPITAL|JAFFE REACTION||Y||ADJUDICATION COMMITTEE|NEUROLOGIST|1|Visit_1|10|6|WASHOUT|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|3|FIF75|Forced Inspiratory Flow at 75%|[?]|SUPINE|||[?]|1|breaths/30s|EPIDIDYMIS|LATERAL|ANTEROTEMPORAL|PERIODIC ACID SCHIFF STAIN|||Y|SIBLING|MICROSCOPIST 3|2|Visit_2|25|5|TREATMENT|2020-06-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|4|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|[?]|10^6 CFU|[?]|1|mPa|SUPERIOR VENA CAVA|CONTRALATERAL|FRONTAL|REVERSE TRANSCRIPTASE PCR||||CAREGIVER|UROLOGIST|2|Visit_2|25|6|WASHOUT|2020-06-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|5|AWVOLPP|Percent Predicted Airway Volume|[?]|FOWLERS|[?]|Pack Year|[?]|1|atm|POPLITEAL ARTERY BELOW KNEE|LATERAL|BASAL|ELISA||||FRIEND|ONCOLOGIST 2|3|Visit_3|40|2|WASHOUT|2020-06-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|6|VO2|Oxygen Consumption|[?]|SITTING, LEGS DEPENDENT|[?]|breaths/30s|[?]|1|/min|CEREBRAL VEIN|LEFT|LOWER MEDIAL|MANUAL CLOT DETECTION||Y||STUDY SUBJECT|MICROSCOPIST 2|3|Visit_3|40|6|TREATMENT|2020-06-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-24
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|7|ERV|Expiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|[?]|Sv|[?]|1|nL|C2 VERTEBRA|LEFT|OUTER|ETDRS EYE CHART||||GUARDIAN|OTOLARYNGOLOGIST|4|Visit_4|65|5|TREATMENT|2020-07-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|8|FVC|Forced Vital Capacity|[?]|FOWLERS|[?]|mL/breath|[?]|1|tsp eq|ILEUM, TERMINAL|CONTRALATERAL|ANTEROLATERAL|LINE PROBE ASSAY||||SIGNIFICANT OTHER|UROLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-07-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|steps/min|[?]|1|LB|EPIGASTRIC LYMPH NODE|IPSILATERAL|SUBCORTICAL|NEXT GENERATION SEQUENCING|Y|Y||FRIEND|OTOLARYNGOLOGIST|5|Visit_5|90|7|SCREENING|2020-08-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|0f682806-b63c-4c3f-9fda-1e59befbd3a3|10|ICREV|IC Reversibility|[?]|LATERAL DECUBITUS|[?]|Bq/uL|[?]|1|ug/cm2|AXILLARY LYMPH NODE LEVEL III|LEFT|CRANIAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||Y||INTERVIEWER|MICROSCOPIST 1|5|Visit_5|90|5|TREATMENT|2020-08-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|1|FEV1FVC6|FEV1/FVC6|[?]|LATERAL DECUBITUS|[?]|oz|[?]|1|mL/animal/wk|THALAMUS|UNILATERAL|TIP|IMMUNO-PET SCAN|Y|||CLINICAL STUDY SPONSOR|NEUROLOGIST 1|1|Visit_1|10|6|SCREENING|2020-09-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|2|TVPP|Percent Predicted Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|bel|[?]|1|mg/kg|COLON LYMPH NODE|CONTRALATERAL|CRANIAL|MICROPARTICLE ENZYME IMMUNOASSAY||||GUARDIAN|MICROSCOPIST|1|Visit_1|10|6|WASHOUT|2020-09-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|3|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING, BENT FORWARD|[?]|foz_us|[?]|1|m/sec2|PORTAL LYMPH NODE|CONTRALATERAL|MEDIAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|TREATMENT|2020-10-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|LEFT LATERAL DECUBITUS|||[?]|1|RNA copies/mL|EPITROCHLEAR LYMPH NODE|UNILATERAL|DISTAL VOLAR|CRYOSCOPY|||Y|CLINICAL RESEARCH COORDINATOR|READER 3|2|Visit_2|25|5|WASHOUT|2020-10-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|5|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING, LEGS DEPENDENT|[?]|pmol/L/h|[?]|1|MBq/uL|FLEXOR CARPI RADIALIS MUSCLE|CONTRALATERAL|POSTERIOR|EIA|Y|||CHILD|ONCOLOGIST|3|Visit_3|40|1|TREATMENT|2020-10-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|6|AWVOLPP|Percent Predicted Airway Volume|[?]|SEMI-RECUMBENT|||[?]|1|mOsm/L|LUNG, LEFT LOWER LOBE|IPSILATERAL|UPPER EXTENSOR SURFACE|X-RAY|||Y|SIBLING|READER 2|3|Visit_3|40|2|TREATMENT|2020-10-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|7|MIPPP|Percent Predicted MIP|[?]|LATERAL DECUBITUS|||[?]|1|ECL unit|WALDEYER'S TONSILLAR RING|IPSILATERAL|LOWER FLEXOR SURFACE|BALLPOINT PEN TECHNIQUE|||Y|ADJUDICATOR|MICROSCOPIST 3|4|Visit_4|65|6|TREATMENT|2020-11-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING|[?]|mL/cage/wk|[?]|1|mMU/mL|CORONARY VEIN|BILATERAL|DEEP|HEMAGGLUTINATION ASSAY||Y||GUARDIAN|ONCOLOGIST|4|Visit_4|65|1|TREATMENT|2020-11-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|9|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|[?]|10^9/g|[?]|1|Coulomb|LOWER GASTROINTESTINAL TRACT LYMPH NODE|RIGHT|SUBCORTICAL|HPLC||Y||SIBLING|MICROSCOPIST|5|Visit_5|90|6|WASHOUT|2020-12-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|1d8aba56-f62e-4116-b447-899dedd3d4df|10|ELSTNCE|Elastance|[?]|SLING|[?]|ug/L/h|[?]|1|L/day|CAPITATE BONE|LEFT|PERIVENTRICULAR|ELISPOT||||CAREGIVER|ADJUDICATOR|5|Visit_5|90|5|SCREENING|2020-12-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|MEP|Maximal Expiratory Pressure|[?]|RIGHT LATERAL DECUBITUS|[?]|GBq/g|[?]|1|umol/dL|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|CONTRALATERAL|DISTAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|||CAREGIVER|READER 3|1|Visit_1|10|3|TREATMENT|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-RECUMBENT|||[?]|1|titer|ULNAR ARTERY|RIGHT|MIDLINE|IHC|||Y|PROXY|MICROSCOPIST 2|1|Visit_1|10|5|TREATMENT|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|3|RAW|Airway Resistance|[?]|PRONE|[?]|PA|[?]|1|U/cL|ORBIT|RIGHT|OCCIPITAL|CAPILLARY ELECTROPHORESIS||||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|2|Visit_2|25|1|TREATMENT|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|4|SAWVOL|Specific Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|LOZENGE|[?]|1|g/m2/day|QUADRICEPS MUSCLE|RIGHT|PERIPHERAL|POLYSOMNOGRAPHY||||FAMILY MEMBER|READER 1|2|Visit_2|25|7|WASHOUT|2020-08-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|5|EXPRELTM|Expiration Relaxation Time|[?]|REVERSE TRENDELENBURG|||[?]|1|mg/m2/h|INTERATRIAL SEPTUM|CONTRALATERAL|NASAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|||Y|PROXY|NEUROLOGIST|3|Visit_3|40|2|WASHOUT|2020-09-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|Pack Year|[?]|1|IU/mmol|RESPIRATORY SYSTEM|UNILATERAL|APICAL|REBOUND TONOMETRY||||INTERVIEWER|ENDOCRINOLOGIST|3|Visit_3|40|5|TREATMENT|2020-09-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|uV2|[?]|1|mL/cage/day|HAND DIGIT 3|BILATERAL|VOLAR|BAC ACGH||||STUDY SUBJECT|CLINICAL PATHOLOGIST|4|Visit_4|65|6|WASHOUT|2020-10-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|8|DLCOVAPP|Percent Predicted DLCO/VA|[?]|DECUBITUS|[?]|cmol/L|[?]|1|pmol/L/h|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|UNILATERAL|POSTERIOR|MANUAL CLOT DETECTION|Y|||DOMESTIC PARTNER|MICROSCOPIST 3|4|Visit_4|65|1|FOLLOW-UP|2020-10-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|copies/mL|[?]|1|VIRTUAL PIXEL|LINGULA OF THE LUNG|UNILATERAL|ANTERIOR|DC SHEATH FLOW||||INTERVIEWER|READER 2|5|Visit_5|90|6|WASHOUT|2020-11-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|10|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING, BENT FORWARD|[?]|10^6/Ejaculate U|[?]|1|nmol BCE/L|FINGER FLEXOR TENDONS|CONTRALATERAL|MIDLINE|PET/CT SCAN WITHOUT CONTRAST||||DOMESTIC PARTNER|RADIOLOGIST 2|5|Visit_5|90|1|TREATMENT|2020-11-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|PEFTIME|Peak Expiratory Flow Time|[?]|REVERSE TRENDELENBURG|[?]|mL/min/mmHg|[?]|1|AMPULE|BRACHIAL ARTERY|LATERAL|INNER|KARYOTYPING||||ADJUDICATOR|NEUROLOGIST 2|1|Visit_1|10|5|FOLLOW-UP|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|2|ALVVOL|Alveolar Volume|[?]|SITTING, LEGS DEPENDENT|[?]|Roentgen|[?]|1|POINT|RIGHT ATRIAL ENDOCARDIUM|LATERAL|LOWER FLEXOR SURFACE|TOLUIDINE BLUE STAIN||Y||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|3|MEP|Maximal Expiratory Pressure|[?]|TRENDELENBURG|||[?]|1|/10^4|MID-RIGHT CORONARY ARTERY CONDUIT|LEFT|APICAL|PERFUSION MRI|||Y|VENDOR|CLINICAL PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|UNCONSTRAINED|||[?]|1|BOWL|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|INNER|REFRACTOMETRY|Y||Y|INTERVIEWER|OPTOMETRIST|2|Visit_2|25|2|FOLLOW-UP|2020-06-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mL*cmH2O|[?]|1|g/animal|CORPUS STRIATUM|CONTRALATERAL|SUPERIOR|GRAM STAIN||Y||SIBLING|READER|3|Visit_3|40|5|SCREENING|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|6|MEPPP|Percent Predicted MEP|[?]|FOWLERS|[?]|mIU/L|[?]|1|dpm/mg|L3-L4 INTERVERTEBRAL SPACE|UNILATERAL|UPPER FLEXOR SURFACE|ELECTROCHEMILUMINESCENCE|Y|||CLINICAL RESEARCH ASSOCIATE|RATER|3|Visit_3|40|7|FOLLOW-UP|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|7|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING|[?]|U/kg/min|[?]|1|/sec|LOWER JUGULAR LYMPH NODE|CONTRALATERAL|TEMPORAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|4|Visit_4|65|3|WASHOUT|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|8|RAW|Airway Resistance|[?]|FOWLERS|||[?]|1|kg/cm2|EAR, INNER|LATERAL|POSTERIOR|MS/MS|Y||Y|INTERVIEWER|RATER 2|4|Visit_4|65|7|TREATMENT|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|9|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|[?]|Henry|[?]|1|min/day|RETROPERITONEUM|IPSILATERAL|LOWER FLEXOR SURFACE|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||CAREGIVER|NEUROLOGIST 1|5|Visit_5|90|5|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|383d3f30-14b7-48c3-b1a8-0f481ef37a50|10|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|[?]|mL/dL|[?]|1|Absorbance U|WRIST JOINT|BILATERAL|PERIPHERAL|ANGIOGRAPHY|Y|||PARENT|READER 2|5|Visit_5|90|6|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|1|TLC|Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|U/m2/h|TIBIALIS POSTERIOR MUSCLE|RIGHT|LOWER FLEXOR SURFACE|HEMAGGLUTINATION INHIBITION ASSAY|Y||Y|INTERVIEWER|FORENSIC PATHOLOGIST|1|Visit_1|10|3|WASHOUT|2020-10-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|2|ICREV|IC Reversibility|[?]|SLING|[?]|BLOCKS|[?]|1|/VF|VEIN|CONTRALATERAL|SURFACE|QUANTITATIVE COMPUTED TOMOGRAPHY||||INVESTIGATOR|RATER|1|Visit_1|10|6|TREATMENT|2020-10-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|3|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|||[?]|1|mL/m2|C7 VERTEBRA|BILATERAL|LOWER MEDIAL|DYNAMOMETRY|||Y|FRIEND|RATER|2|Visit_2|25|2|TREATMENT|2020-11-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|4|FIV1PP|Percent Predicted FIV1|[?]|SITTING|[?]|Tbsp|[?]|1|umol/h/mmol|SCAPHOID-TRAPEZOID JOINT|LATERAL|INNER|GC/MS/MS|Y|||STUDY SUBJECT|CARDIOLOGIST|2|Visit_2|25|4|TREATMENT|2020-11-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|PRONE|[?]|mmol/mol|[?]|1|kg/cm2|RIGHT CORONARY ARTERY OSTIUM|RIGHT|PERIPHERAL|DIGITAL PCR|Y|||CLINICAL RESEARCH COORDINATOR|INTERNIST|3|Visit_3|40|2|FOLLOW-UP|2020-11-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|6|IC|Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|mL/m2|[?]|1|Bq/mL|URETHRA, POSTERIOR|IPSILATERAL|INNER|CONTACT SPECULAR MICROSCOPY||||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|SCREENING|2020-11-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|7|MEPPP|Percent Predicted MEP|[?]|UNCONSTRAINED|[?]|log10 PFU/mL|[?]|1|cmHg|DISTAL PHALANX 2 OF THE HAND|UNILATERAL|POSTERIOR|NON-CONTACT SPECULAR MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|8|FEV6PP|Percent Predicted FEV6|[?]|RIGHT LATERAL DECUBITUS|[?]|Coulomb|[?]|1|nmol/kg/day|OPPONENS POLLICIS MUSCLE|RIGHT|LOWER MEDIAL|MANUAL COUNT|Y|||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|4|Visit_4|65|2|TREATMENT|2020-12-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|9|TVPP|Percent Predicted Tidal Volume|[?]|FOWLERS|[?]|USP U|[?]|1|Log10 ELISA unit/dose|ANKLE JOINT|BILATERAL|ANTEROTEMPORAL|GIEMSA STAIN||Y||ADJUDICATOR|RADIOLOGIST 2|5|Visit_5|90|1|SCREENING|2021-01-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|b4f81b74-fee9-4544-9404-206d931ed8e5|10|PCF|Peak Cough Flow|[?]|UNCONSTRAINED|[?]|10^3 copies/mL|[?]|1|LOZENGE|ACCESSORY RENAL ARTERY|RIGHT|FORE|OPTICAL DENSITY MEASUREMENT||Y||CHILD|MICROSCOPIST 2|5|Visit_5|90|1|TREATMENT|2021-01-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|1|FEV_PEF|FEV at PEF|[?]|SEMI-FOWLERS|[?]|U/m2/min|[?]|1|ug/m2/day|ESOPHAGUS, CERVICAL|CONTRALATERAL|FRONTAL|PYROSEQUENCING||Y||CHILD|NEUROLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|2|INERTANC|Inertance|[?]|SLING|[?]|K|[?]|1|CUP|ABDOMINAL AORTA|LATERAL|ANTERIOR|AUSCULTATION|Y|||PROXY|OPHTHALMOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-06-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|3|EXPRELTM|Expiration Relaxation Time|[?]|LATERAL DECUBITUS|||[?]|1|IU/kg|TONSIL|IPSILATERAL|TEMPORAL|SICKLE CELL SOLUBILITY TEST|||Y|SIGNIFICANT OTHER|UROLOGIST|2|Visit_2|25|7|SCREENING|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|4|SGAW|Specific Airway Conductance|[?]|SEMI-FOWLERS|[?]|/min|[?]|1|ug/m2/min|HAIR FOLLICLE|RIGHT|VENTRAL|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|2|Visit_2|25|3|TREATMENT|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-RECUMBENT|[?]|copies/ug|[?]|1|uIU/L|LATERAL THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL|ROSTRAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|6|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING, BENT FORWARD|[?]|mEq/g|[?]|1|kPa|MID-RIGHT CORONARY ARTERY CONDUIT|IPSILATERAL|PARIETO-OCCIPITAL|GC/MS||||SIGNIFICANT OTHER|UROLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|7|DLCOPP|Percent Predicted DLCO|[?]|TRENDELENBURG|[?]|/min|[?]|1|10^3 CFU|INTERNAL ILIAC ARTERY|UNILATERAL|FORE|MANUAL COUNT||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|[?]|DRINK|[?]|1|mL/cage|OLFACTORY NERVE|LATERAL|CRANIAL|NUCLEIC ACID HYBRIDIZATION||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|4|Visit_4|65|4|WASHOUT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|9|FEV1REV|FEV1 Reversibility|[?]|STANDING|[?]|uL|[?]|1|ug|CLITORIS|LATERAL|LOWER|INTERRUPTER TECHNIQUE||||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|5|Visit_5|90|2|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|9e69b457-20db-45e5-a535-0cd8ac102fea|10|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|[?]|mm|[?]|1|g/mol|ADDUCTOR MAGNUS MUSCLE|UNILATERAL|PROXIMAL|ANGIOGRAPHY|Y|Y||CLINICAL RESEARCH COORDINATOR|UROLOGIST|5|Visit_5|90|4|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|FIF25|Forced Inspiratory Flow at 25%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Ci/ug|INTERATRIAL SEPTUM|IPSILATERAL|TEMPORAL|DC SHEATH FLOW|||Y|FAMILY MEMBER|CLINICAL PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-09-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|2|MALIND|Malignancy Indicator|[?]|STANDING|[?]|mL/100g/min|[?]|1|mL/animal/wk|METACARPOPHALANGEAL JOINT 3|IPSILATERAL|NASAL|ICC||||DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|TREATMENT|2020-09-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|3|ICREV|IC Reversibility|[?]|STANDING|||[?]|1|mJoule/cm2|SUPERIOR SAGITTAL SINUS|LEFT|PROXIMAL|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|SPOUSE|CLINICAL PATHOLOGIST|2|Visit_2|25|6|WASHOUT|2020-10-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|4|PLMBLFLW|Pulmonary Blood Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|g/animal/day|ABDOMINAL SKIN|LEFT|SUBCORTICAL|DXA SCAN||Y|Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|2|Visit_2|25|7|TREATMENT|2020-10-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|5|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|kg/L|[?]|1|10^7/L|ESOPHAGUS, MIDDLE THIRD|BILATERAL|SUPERIOR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|WASHOUT|2020-10-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|6|SALKA|Salazar-Knowles Equation Parameter A|[?]|SUPINE|||[?]|1|USP U|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|MEDIAL|FARR ASSAY|||Y|ADJUDICATOR|MICROSCOPIST 3|3|Visit_3|40|6|WASHOUT|2020-10-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|7|FIF75|Forced Inspiratory Flow at 75%|[?]|STANDING|[?]|mL/m2/min|[?]|1|PATCH|FINGER EXTENSOR MUSCLES|CONTRALATERAL|TIP|MECHANICAL CLOT DETECTION|Y|||STUDY SUBJECT|PHYSIOTHERAPIST|4|Visit_4|65|4|SCREENING|2020-11-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|8|AIRTRAP|Air Trapping|[?]|SUPINE|||[?]|1|10^6/Ejaculate U|ANTERIOR SUPERIOR ILIAC SPINE|CONTRALATERAL|DISTAL VOLAR|FUNDUS PHOTOGRAPHY|||Y|ADJUDICATOR|RADIOLOGIST|4|Visit_4|65|5|TREATMENT|2020-11-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|9|FRCPP|Percent Predicted FRC|[?]|TRENDELENBURG|||[?]|1|10^6 RNA copies/mL|RENAL PELVIS|UNILATERAL|LOWER FLEXOR SURFACE|IN VITRO GENE EXPRESSION ASSAY|||Y|FAMILY MEMBER|DERMATOLOGIST|5|Visit_5|90|1|TREATMENT|2020-12-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|14211798-ddf6-47c8-bd9d-056d95bad8ff|10|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-FOWLERS|[?]|breaths/30s|[?]|1|CIGARETTE|BODY|LATERAL|UPPER|PULSE OXIMETRY|Y|||SIBLING|ADJUDICATOR 3|5|Visit_5|90|2|TREATMENT|2020-12-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|1|IVC|Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|mg/mol|[?]|1|psec|OLFACTORY BULB|CONTRALATERAL|CRANIAL|MANUAL CLOT DETECTION||||INDEPENDENT ASSESSOR|ONCOLOGIST 1|1|Visit_1|10|2|SCREENING|2020-06-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|2|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Absorbance U|AORTIC ARCH|UNILATERAL|ANTEROMEDIAL|REBOUND TONOMETRY|Y||Y|FAMILY MEMBER|INTERNIST|1|Visit_1|10|7|WASHOUT|2020-06-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|3|RAWPP|Percent Predicted Airway Resistance|[?]|LATERAL DECUBITUS|[?]|BOX|[?]|1|U/m2/min|FINGER|LEFT|LOWER FLEXOR SURFACE|FARNSWORTH-MUNSELL 100 HUE TEST||||GUARDIAN|MICROSCOPIST 1|2|Visit_2|25|5|WASHOUT|2020-06-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|4|TV|Tidal Volume|[?]|SEMI-RECUMBENT|[?]|BOLUS|[?]|1|mg/kg/day|MESENTERIC VEIN|RIGHT|SUPERIOR|KINETIC CHROMOGENIC ASSAY||||CLINICAL RESEARCH COORDINATOR|RATER 2|2|Visit_2|25|1|FOLLOW-UP|2020-06-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|5|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|[?]|PFU|[?]|1|IU|APPENDICEAL TIP|BILATERAL|LATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY||||PARENT|READER|3|Visit_3|40|2|SCREENING|2020-07-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|6|ERV|Expiratory Reserve Volume|[?]|PRONE|[?]|min/day|[?]|1|uL/dose|SEMITENDINOSUS MUSCLE|CONTRALATERAL|UPPER FLEXOR SURFACE|POLYSOMNOGRAPHY|Y|||CAREGIVER|ONCOLOGIST 2|3|Visit_3|40|6|WASHOUT|2020-07-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-09
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|7|IVC|Inspiratory Vital Capacity|[?]|SUPINE|[?]|MONTHS|[?]|1|mL/g/h|CORPUS CALLOSUM, BODY|BILATERAL|POSTERIOR|CONFOCAL MICROSCOPY||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|4|Visit_4|65|5|FOLLOW-UP|2020-08-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|8|TSUELAS|Tissue Elastance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|vp/dose|COLON, TRANSVERSE|UNILATERAL|POSTERIOR|CONTRAST ENHANCED X-RAY|Y||Y|INVESTIGATOR|ENDOCRINOLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|FOWLERS|||[?]|1|U/kg|EYE, ANTERIOR CHAMBER|BILATERAL|LATERAL|DROPLET DIGITAL PCR||Y|Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2020-08-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|63f3194e-9b88-491a-9a68-19109ed86e2b|10|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-FOWLERS|||[?]|1|g/m2/day|PARAMETRIUM|LATERAL|INFERIOR|PHASE-CONTRAST MRI|||Y|CLINICAL STUDY SPONSOR|UROLOGIST|5|Visit_5|90|5|WASHOUT|2020-08-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|1|EXPRELTM|Expiration Relaxation Time|[?]|TRENDELENBURG|[?]|oz eq|[?]|1|kV|TROCHANTER|RIGHT|PROXIMAL VOLAR|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-09-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|2|RRS|Total Respiratory System Resistance|[?]|UNCONSTRAINED|[?]|HOMEOPATHIC DILUTION|[?]|1|10^12 IU/L|FUNDUS UTERI|UNILATERAL|PARIETO-OCCIPITAL|LC-FL||Y||INVESTIGATOR|READER 1|1|Visit_1|10|1|SCREENING|2020-09-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|3|FIV1|Forced Inspiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kcal/day|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|BILATERAL|UPPER EXTENSOR SURFACE|NEURAMINIDASE INHIBITION ASSAY|||Y|PROXY|PATHOLOGIST|2|Visit_2|25|6|SCREENING|2020-10-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|4|RAWPP|Percent Predicted Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|ug/L/h|[?]|1|Ci/ug|SKIN OF THE TRUNK|LEFT|BASAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||INVESTIGATOR|READER 3|2|Visit_2|25|4|TREATMENT|2020-10-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|5|IRVPP|Percent Predicted IRV|[?]|REVERSE TRENDELENBURG|[?]|L/min|[?]|1|pmol|SUPERIOR VENA CAVA|RIGHT|FORE|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|||DOMESTIC PARTNER|ENDOCRINOLOGIST|3|Visit_3|40|7|TREATMENT|2020-10-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|6|FIF25|Forced Inspiratory Flow at 25%|[?]|LEFT LATERAL DECUBITUS|[?]|in|[?]|1|umol/L/h|AXILLARY LYMPH NODE LEVEL I|CONTRALATERAL|POSTERIOR|SIZE EXCLUSION CHROMATOGRAPHY||||PROXY|MICROSCOPIST 2|3|Visit_3|40|3|TREATMENT|2020-10-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|7|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|DROP|GINGIVA|RIGHT|DISTAL VOLAR|ECHOCARDIOGRAPHY|||Y|SIBLING|UROLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|8|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|dpm/0.5 mL|[?]|1|days/wk|ENDOCERVIX|CONTRALATERAL|FRONTAL|AGAR PROPORTION||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|SCREENING|2020-11-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|9|RAWPP|Percent Predicted Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|L/s|SCIATIC NERVE|LATERAL|VENTROLATERAL|ACCELERATOR MASS SPECTROMETRY|||Y|INDEPENDENT ASSESSOR|PATHOLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-12-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|b6208258-d7c2-4dde-addf-4677946ab165|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|uU/L|[?]|1|QUANTITY SUFFICIENT|TEMPORAL LOBE|IPSILATERAL|PROXIMAL|CISH||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-12-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|OXYPULSE|Oxygen Pulse|[?]|SLING|[?]|g/animal/wk|[?]|1|/200 HPFs|CEREBELLUM|BILATERAL|HIND|CONTRAST ENHANCED X-RAY|Y|||INTERVIEWER|RATER|1|Visit_1|10|1|WASHOUT|2021-01-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|2|RV|Residual Volume|[?]|SLING|[?]|um2|[?]|1|ug/animal|URACHAL TRACT|RIGHT|LOWER|TRIPLE-PHASE SPIRAL CT SCAN||||PROXY|ADJUDICATOR|1|Visit_1|10|3|FOLLOW-UP|2021-01-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|3|FIF50|Forced Inspiratory Flow at 50%|[?]|DECUBITUS|||[?]|1|AMPULE|ANKLE MORTISE|CONTRALATERAL|TIP|ULTRASONOGRAPHIC ELASTOGRAPHY|||Y|STUDY SUBJECT|HEMATOLOGIST|2|Visit_2|25|2|TREATMENT|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-23
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|4|TVPP|Percent Predicted Tidal Volume|[?]|STANDING|[?]|nsec|[?]|1|mL/s|INTERATRIAL SEPTUM|IPSILATERAL|ANTEROPOSTERIOR|SPIRAL CT SCAN WITHOUT CONTRAST|Y|||INVESTIGATOR|NEUROLOGIST 1|2|Visit_2|25|3|TREATMENT|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-23
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|ms2|[?]|1|10^6/hpf|FEMUR|RIGHT|INNER|MULTI-SLICE SPIRAL CT|Y|||CAREGIVER|RADIOLOGIST 2|3|Visit_3|40|7|WASHOUT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|6|TLC|Total Lung Capacity|[?]|FOWLERS|[?]|10^3/L|[?]|1|log10 CFU/g|HEART, BASE|IPSILATERAL|VENTRAL|BRDU CELLULAR PROLIFERATION ASSAY||||NON-HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|3|Visit_3|40|2|FOLLOW-UP|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|7|FEV1FVC|FEV1/FVC|[?]|STANDING, BENT FORWARD|[?]|FFU|[?]|1|mU|GLUTEAL MUSCLE|LEFT|DISTAL|CYSTOMETRY|Y|||VENDOR|ADJUDICATOR 2|4|Visit_4|65|2|SCREENING|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-24
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING|[?]|uL/kg/day|[?]|1|umol/L/min|SUPERIOR SAGITTAL SINUS|RIGHT|LOWER|TEST STRIP|Y|||SPOUSE|INTERNIST|4|Visit_4|65|2|TREATMENT|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-24
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|9|FEF50|Forced Expiratory Flow 50%|[?]|SUPINE|[?]|APL U/mL|[?]|1|mL/animal/wk|LEFT MAIN CORONARY ARTERY BODY|IPSILATERAL|PROXIMAL|SMEAR|Y|||INTERVIEWER|MICROSCOPIST 3|5|Visit_5|90|7|TREATMENT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|a669a7b9-2034-4bca-aa80-0371c5fb46d3|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-FOWLERS|[?]|10^4 CFU|[?]|1|BU|FLEXOR DIGITORUM BREVIS MUSCLE|UNILATERAL|ANTEROPOSTERIOR|INCISION-INDUCED BLEEDING METHOD||||INTERVIEWER|MICROSCOPIST 2|5|Visit_5|90|6|TREATMENT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|SUPINE|[?]|KIT|[?]|1|Coulomb|TESTIS|LATERAL|LOWER|ECHOCARDIOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-07-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|2|INTP|Interpretation|[?]|SEMI-RECUMBENT|[?]|nmol/L/min|[?]|1|U/m2/min|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|CONTRALATERAL|LOWER EXTENSOR SURFACE|GC/MS-EI||||SIGNIFICANT OTHER|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-07-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|3|IC|Inspiratory Capacity|[?]|SLING|||[?]|1|log10 TCID 50/mL|LYMPH NODE HILUM|BILATERAL|LOWER|MS/MS|||Y|VENDOR|CLINICAL PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|4|FRC|Functional Residual Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|U/g|[?]|1|mol|JAW|IPSILATERAL|BASAL|HANSEL STAIN||Y||FRIEND|UROLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-08-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|5|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|[?]|Ejaculate U|[?]|1|mL/beat|BLADDER WALL|RIGHT|INNER|ELECTROPHORESIS|Y|||SIGNIFICANT OTHER|HEMATOLOGIST|3|Visit_3|40|3|SCREENING|2020-08-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LATERAL DECUBITUS|||[?]|1|anti-Xa IU|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|BILATERAL|UPPER FLEXOR SURFACE|MYELOPEROXIDASE STAIN||Y|Y|ADJUDICATION COMMITTEE|NEUROLOGIST|3|Visit_3|40|6|TREATMENT|2020-08-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|7|FEV1PP|Percent Predicted FEV1|[?]|STANDING|[?]|mL/m2/h|[?]|1|10^7 CFU|IRIS|RIGHT|INFERIOR|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||SPOUSE|MICROSCOPIST 2|4|Visit_4|65|7|TREATMENT|2020-09-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|8|MALIND|Malignancy Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/kg/day|[?]|1|RATIO|LATISSIMUS DORSI MUSCLE|UNILATERAL|UPPER EXTENSOR SURFACE|INTRAVASCULAR ULTRASOUND||||DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2020-09-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|9|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING, BENT FORWARD|||[?]|1|STRIP|HEART, LEFT ATRIAL APPENDAGE|BILATERAL|CRANIAL|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y||Y|CAREGIVER|OTOLARYNGOLOGIST|5|Visit_5|90|1|SCREENING|2020-10-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|e148c13d-ee41-4503-a7e5-397dd6155f04|10|ELSTNCE|Elastance|[?]|DECUBITUS|[?]|mmol|[?]|1|ug/g/min|GLENOID FOSSA|UNILATERAL|DISTAL VOLAR|X-RAY||||STUDY SUBJECT|RATER 1|5|Visit_5|90|3|SCREENING|2020-10-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|815de94a-f259-41ee-8951-8df150184a25|1|INTP|Interpretation|[?]|SEMI-FOWLERS|[?]|Gauss|[?]|1|/VF|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|UNILATERAL|CRANIAL|TOTAL BODY RADIOGRAPHY|Y|Y||SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|7|WASHOUT|2020-07-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|815de94a-f259-41ee-8951-8df150184a25|2|EFFVOL|Effusion Volume|[?]|SUPINE|||[?]|1|BE/mL|SECOND OBTUSE MARGINAL BRANCH ARTERY|LEFT|OUTER|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y||Y|CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-07-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|815de94a-f259-41ee-8951-8df150184a25|3|ERV|Expiratory Reserve Volume|[?]|SEMI-RECUMBENT|[?]|uSiemens|[?]|1|mm|COCCYX|BILATERAL|PROXIMAL|IMMUNOPRECIPITATION||||CLINICAL STUDY SPONSOR|HEMATOLOGIST|2|Visit_2|25|6|WASHOUT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|815de94a-f259-41ee-8951-8df150184a25|4|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pm|APPENDIX|BILATERAL|INTERMEDIATE|DARK FIELD MICROSCOPY|Y||Y|GUARDIAN|DERMATOLOGIST|2|Visit_2|25|1|WASHOUT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|815de94a-f259-41ee-8951-8df150184a25|5|FIV1PP|Percent Predicted FIV1|[?]|STANDING, BENT FORWARD|[?]|10^7/L|[?]|1|ug/L|FEMORAL LYMPH NODE|UNILATERAL|HIND|IMMUNOTURBIDIMETRY||||PROXY|ADJUDICATOR 1|3|Visit_3|40|4|TREATMENT|2020-08-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|815de94a-f259-41ee-8951-8df150184a25|6|INERTANC|Inertance|[?]|SEMI-RECUMBENT|[?]|mL*cmH2O|[?]|1|DIP|NASOPHARYNX|BILATERAL|INFERIOR|SPIRAL CT SCAN WITHOUT CONTRAST|Y|||SPOUSE|CARDIOLOGIST|3|Visit_3|40|4|TREATMENT|2020-08-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|815de94a-f259-41ee-8951-8df150184a25|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|PRONE|||[?]|1|SYRINGE|SKIN OF THE CHIN|LATERAL|HIND|AUDIOMETRY||Y|Y|INVESTIGATOR|CARDIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-08-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|815de94a-f259-41ee-8951-8df150184a25|8|TSUHYS|Tissue Hysteresivity|[?]|REVERSE TRENDELENBURG|[?]|mmHg/L/min|[?]|1|MET*h|BUCCAL LYMPH NODE|RIGHT|DISTAL|IMMUNOPRECIPITATION||||SIGNIFICANT OTHER|READER 2|4|Visit_4|65|6|WASHOUT|2020-08-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|815de94a-f259-41ee-8951-8df150184a25|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|SLING|[?]|fraction of 1|[?]|1|mmol/kg|COLON|LATERAL|SUPERIOR|PHASE-CONTRAST MRI||||PARENT|RATER 1|5|Visit_5|90|5|TREATMENT|2020-09-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|815de94a-f259-41ee-8951-8df150184a25|10|FRCPP|Percent Predicted FRC|[?]|FOWLERS|[?]|Hz|[?]|1|uL/mL|ILIOTIBIAL BAND|IPSILATERAL|INTERMEDIATE|PERFUSION MRI||||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|4|TREATMENT|2020-09-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|10^6 organisms/g|[?]|1|mg/kg/week|SKIN OF THE NECK|UNILATERAL|UPPER FLEXOR SURFACE|FREEZING POINT DEPRESSION|Y|||SIGNIFICANT OTHER|ONCOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-05-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-10
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|2|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|[?]|L/L|[?]|1|mg/dose|FIBULAR VEIN|LATERAL|LOWER EXTENSOR SURFACE|KINETIC CHROMOGENIC ASSAY||||INTERVIEWER|READER|1|Visit_1|10|3|FOLLOW-UP|2020-05-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-10
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|3|AWVOL|Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|MPL U/mL|[?]|1|mIU/L|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|DORSOLATERAL|PALPATION|Y|||ADJUDICATION COMMITTEE|ADJUDICATOR 1|2|Visit_2|25|5|TREATMENT|2020-05-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|4|QUASCOMP|Quasi-Static Compliance|[?]|LEFT LATERAL DECUBITUS|[?]|dmol|[?]|1|/VF|RETINAL NERVE FIBER LAYER|CONTRALATERAL|FRONTAL|ELECTROPHORESIS||Y||FAMILY MEMBER|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-05-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|LATERAL DECUBITUS|[?]|min*mg/mL|[?]|1|min/day|GALLBLADDER|CONTRALATERAL|VOLAR|SPIROMETRY||||SIBLING|MICROSCOPIST 3|3|Visit_3|40|3|TREATMENT|2020-06-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-10
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|6|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|nU/cL|[?]|1|IU/dL|ULNA SHAFT|IPSILATERAL|MIDLINE|SCINTIGRAPHY|Y|||VENDOR|MICROSCOPIST 3|3|Visit_3|40|2|FOLLOW-UP|2020-06-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-10
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|7|TLCPP|Percent Predicted Total Lung Capacity|[?]|SLING|[?]|g|[?]|1|ug/dL|SYMPATHETIC GANGLIA|CONTRALATERAL|ANTERIOR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|||SIBLING|NEUROLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-07-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-08
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING, BENT FORWARD|[?]|psi|[?]|1|PFU|PROXIMAL INTERPHALANGEAL JOINT 5|RIGHT|SURFACE|REFRACTOMETRY||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|TREATMENT|2020-07-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-08
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|9|FEV1SVC|FEV1/SVC|[?]|TRENDELENBURG|||[?]|1|/LSQN|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|TIP|CLIP SEQUENCING|Y||Y|FAMILY MEMBER|MICROSCOPIST 1|5|Visit_5|90|5|TREATMENT|2020-08-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|RE|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|10|FEV3FVC|FEV3/FVC|[?]|STANDING, BENT FORWARD|[?]|mg/g/min|[?]|1|CFU/mL|IRIS|RIGHT|ANTEROLATERAL|OPTICAL DENSITY MEASUREMENT|Y|||SPOUSE|ADJUDICATOR|5|Visit_5|90|2|FOLLOW-UP|2020-08-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-03
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|PEFREV|PEF Reversibility|[?]|PRONE|[?]|TROCHE|[?]|1|ug/h|ORAL MUCOSA|RIGHT|INTERMEDIATE|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||Y||INTERVIEWER|PATHOLOGIST 2|1|Visit_1|10|1|TREATMENT|2021-01-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|2|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|||[?]|1|log10 TCID 50/uL|EXTRAOCULAR MUSCLE|UNILATERAL|DISTAL VOLAR|U-HPLC/MS/MS|||Y|CLINICAL STUDY SPONSOR|ONCOLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|3|IRV|Inspiratory Reserve Volume|[?]|SLING|[?]|dL|[?]|1|mg/m2/min|C5 VERTEBRA|CONTRALATERAL|SUBCORTICAL|OPHTHALMOSCOPY|Y|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|2|Visit_2|25|2|WASHOUT|2021-02-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-19
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|4|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|dL|[?]|1|Bq/uL|PERIANAL REGION|UNILATERAL|APICAL|NUCLEIC ACID AMPLIFICATION TEST||||STUDY SUBJECT|NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2021-02-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-19
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|5|LCI|Lung Clearance Index|[?]|DECUBITUS|[?]|L/h|[?]|1|EID 50/mL|MEDIAN OR LOWER CERVICAL LYMPH NODE|RIGHT|PROXIMAL|TARGETED GENOME SEQUENCING|Y|||GUARDIAN|READER|3|Visit_3|40|2|TREATMENT|2021-02-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|6|AWVOL|Airway Volume|[?]|FOWLERS|[?]|/mm2|[?]|1|ug/animal|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|BILATERAL|HIND|ELISA||||FRIEND|ONCOLOGIST 1|3|Visit_3|40|5|TREATMENT|2021-02-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|7|VO2|Oxygen Consumption|[?]|STANDING|[?]|% INHIBITION|[?]|1|10^6 DNA copies/mL|APPENDIX|LATERAL|CRANIAL|TRYPAN BLUE STAIN||||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|4|Visit_4|65|2|WASHOUT|2021-03-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|8|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-FOWLERS|[?]|ug/m2/day|[?]|1|U/mmol|SKIN OF THE EAR|RIGHT|DORSOLATERAL|OPHTHALMOSCOPY||||SIGNIFICANT OTHER|ADJUDICATOR 3|4|Visit_4|65|2|WASHOUT|2021-03-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LATERAL DECUBITUS|[?]|ppth|[?]|1|mol/g|DISTAL EXTRAHEPATIC BILE DUCT REGION|RIGHT|OUTER|HPLC/MS||Y||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING|[?]|mPa|[?]|1|vg/dose|SUBLINGUAL REGION|BILATERAL|SUPERFICIAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y|Y||FAMILY MEMBER|OTOLARYNGOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|1|IVC|Inspiratory Vital Capacity|[?]|SITTING|[?]|umol/mg/min|[?]|1|10^3 RNA copies/mL|SKIN FOLD|UNILATERAL|VENTRAL|ALCIAN BLUE STAIN||||SIBLING|RADIOLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-09-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|2|FEV3PP|Percent Predicted FEV3|[?]|SEMI-RECUMBENT|||[?]|1|umol|ACCESSORY RENAL ARTERY|BILATERAL|CAUDAL|FLUORESCENT ENZYME IMMUNOASSAY||Y|Y|CLINICAL STUDY SPONSOR|PATHOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-09-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|3|DLCO|Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|[?]|%/min|[?]|1|pg/cell|BRACHIOCEPHALIC ARTERY|UNILATERAL|TEMPORAL|LANDOLT RING||||INTERVIEWER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2020-10-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|DECUBITUS|||[?]|1|mEq/day|PHARYNX|RIGHT|NASAL|HPLC/MS/MS|Y||Y|CHILD|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-10-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|5|TVPP|Percent Predicted Tidal Volume|[?]|LEFT LATERAL DECUBITUS|[?]|10^9 CFU/mL|[?]|1|deg/mm|OVARY|CONTRALATERAL|PERIVENTRICULAR|AUTOREFRACTION|Y|||PROXY|ADJUDICATOR 3|3|Visit_3|40|5|TREATMENT|2020-10-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|6|PCF|Peak Cough Flow|[?]|SITTING, LEGS DEPENDENT|[?]|h/wk|[?]|1|Hz/s|PUPIL|RIGHT|VENTROLATERAL|HEMATOXYLIN AND EOSIN STAIN||Y||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|3|Visit_3|40|7|WASHOUT|2020-10-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|7|FEV3FVC|FEV3/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|log10 TCID 50/mL|[?]|1|steps/min|FACIAL BONE|CONTRALATERAL|OCCIPITAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||PARENT|PATHOLOGIST 1|4|Visit_4|65|6|WASHOUT|2020-11-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|8|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING|||[?]|1|Pack Year|METATARSAL BONE|UNILATERAL|PERIPHERAL|LC/MS/MS|||Y|ADJUDICATION COMMITTEE|UROLOGIST|4|Visit_4|65|4|TREATMENT|2020-11-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|[?]|10^6 organisms|[?]|1|g/cm2|INFERIOR VENA CAVA|IPSILATERAL|VENTRAL|RAJI CELL RIA||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|5|Visit_5|90|4|FOLLOW-UP|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|a616ef00-05d6-459a-8474-06ab3eb493b1|10|AWVOLPP|Percent Predicted Airway Volume|[?]|UNCONSTRAINED|[?]|V|[?]|1|mL/kg/h|LINGULA OF THE LUNG|BILATERAL|INTERMEDIATE|THIN SMEAR||Y||GUARDIAN|NEUROLOGIST|5|Visit_5|90|2|WASHOUT|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|10^6/Ejaculate U|PALPEBRAL CONJUNCTIVA|UNILATERAL|PARIETO-OCCIPITAL|MANUAL COUNT|||Y|ADJUDICATOR|OTOLARYNGOLOGIST|1|Visit_1|10|3|TREATMENT|2020-08-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|2|VO2|Oxygen Consumption|[?]|LATERAL DECUBITUS|||[?]|1|TUBE|PLEURA|RIGHT|INNER|WRIGHT STAIN|Y||Y|FAMILY MEMBER|UROLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|3|IVC|Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|bel|[?]|1|g/animal/wk|INTERPHALANGEAL JOINT 4|CONTRALATERAL|APICAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||VENDOR|OPTOMETRIST|2|Visit_2|25|2|TREATMENT|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|4|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|[?]|Bq/kg|[?]|1|ug/animal|MALE GENITALIA|RIGHT|NASAL|TOLUIDINE BLUE STAIN||||SIBLING|ONCOLOGIST|2|Visit_2|25|3|TREATMENT|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|5|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|||[?]|1|mg/m2/min|NOSE|LEFT|ANTERIOR|CALCULATION||Y|Y|PARENT|HEMATOLOGIST|3|Visit_3|40|2|TREATMENT|2020-09-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|s*kPa|[?]|1|mN|CORNEAL STROMA|LATERAL|LOWER EXTENSOR SURFACE|IMMUNOPRECIPITATION||||PROXY|MICROSCOPIST 1|3|Visit_3|40|3|TREATMENT|2020-09-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|7|PLMXRS|Pulmonary Reactance|[?]|SITTING, LEGS DEPENDENT|[?]|PIXEL|[?]|1|mg/mol|THIGH|BILATERAL|LOWER EXTENSOR SURFACE|MULTIPLE BREATH WASHOUT|Y|||INTERVIEWER|RADIOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-10-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|SUPINE|||[?]|1|mg/g/h|VERTEBRAL COLUMN|RIGHT|VENTRAL|IRON HEMATOXYLIN STAIN|||Y|DOMESTIC PARTNER|READER 2|4|Visit_4|65|5|TREATMENT|2020-10-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|/min|[?]|1|log10 CCID 50/dose|FLEXOR CARPI ULNARIS MUSCLE|CONTRALATERAL|DISTAL VOLAR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y||INVESTIGATOR|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2020-11-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|10|LOBVOLPP|Percent Predicted Lobar Volume|[?]|PRONE|[?]|10^6/L|[?]|1|10^7 CFU|MEDIAN NERVE|RIGHT|UPPER|CONTRAST ENHANCED PET SCAN||Y||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2020-11-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|IRVPP|Percent Predicted IRV|[?]|SITTING|||[?]|1|msec|OCCIPITAL LOBE|RIGHT|CAUDAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y||Y|HEALTH CARE PROFESSIONAL|UROLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-10-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|2|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|[?]|Ci/g|[?]|1|L/h/m2|GASTROINTESTINAL TRACT, LOWER, WALL|CONTRALATERAL|VENTRAL|IMMUNOPRECIPITATION||||SIGNIFICANT OTHER|NEUROLOGIST 1|1|Visit_1|10|1|SCREENING|2020-10-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|3|RELSZCHG|Relative Size Change|[?]|SEMI-FOWLERS|[?]|mmAL|[?]|1|LOZENGE|SEBACEOUS GLAND|LEFT|CENTRAL|FUNDUS PHOTOGRAPHY||Y||INTERVIEWER|FORENSIC PATHOLOGIST|2|Visit_2|25|7|SCREENING|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING|[?]|gtt|[?]|1|log10 CCID 50/dose|SPLEEN|IPSILATERAL|CRANIAL|NUCLEIC ACID HYBRIDIZATION||||DOMESTIC PARTNER|ADJUDICATOR 3|2|Visit_2|25|5|SCREENING|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|5|FIVC|Forced Inspiratory Vital Capacity|[?]|SUPINE|||[?]|1|mL/s/m2|SUPERIOR PUBIC RAMUS|CONTRALATERAL|HIND|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||Y|CHILD|PATHOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|6|LCI|Lung Clearance Index|[?]|DECUBITUS|||[?]|1|10^5/hpf|GASTROESOPHAGEAL JUNCTION|LATERAL|LOWER MEDIAL|ENZYMATIC ULTRACENTRIFUGATION|||Y|SIGNIFICANT OTHER|RATER 2|3|Visit_3|40|3|TREATMENT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|7|FEF50|Forced Expiratory Flow 50%|[?]|SUPINE|[?]|vg/dose|[?]|1|log10 PFU|VAGUS NERVE|IPSILATERAL|ANTEROTEMPORAL|DOPPLER ULTRASOUND||||SIBLING|MICROSCOPIST|4|Visit_4|65|6|TREATMENT|2020-12-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|8|EXPRELTM|Expiration Relaxation Time|[?]|STANDING, BENT FORWARD|[?]|10^7 PFU|[?]|1|IU/mg|ADDUCTOR BREVIS MUSCLE|LEFT|LOWER FLEXOR SURFACE|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||DOMESTIC PARTNER|NEUROLOGIST 1|4|Visit_4|65|5|WASHOUT|2020-12-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|9|PNEUMIND|Pneumonia Indicator|[?]|SEMI-RECUMBENT|[?]|fraction of 1|[?]|1|pmol/L|BONE MARROW|UNILATERAL|DORSOLATERAL|NUCLEIC ACID AMPLIFICATION TEST|Y|||INDEPENDENT ASSESSOR|NEUROLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|10|RRS|Total Respiratory System Resistance|[?]|SEMI-FOWLERS|[?]|OI50|[?]|1|mg/kg/day|VOMER|UNILATERAL|VENTROLATERAL|QUANTITATIVE CORONARY ANGIOGRAPHY||||FAMILY MEMBER|OTOLARYNGOLOGIST|5|Visit_5|90|6|TREATMENT|2021-01-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|DLCOVA|DLCO/VA|[?]|SEMI-FOWLERS|[?]|NFIU|[?]|1|mL/kg|COLON, SIGMOID|BILATERAL|PERIPHERAL|THERMAL IONIZATION MASS SPECTROMETRY||||INVESTIGATOR|READER 2|1|Visit_1|10|5|TREATMENT|2020-07-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|2|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|mol/g|[?]|1|Ejaculate U|TIBIALIS POSTERIOR MUSCLE|CONTRALATERAL|OUTER|URANYL ACETATE STAIN||||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|1|Visit_1|10|1|SCREENING|2020-07-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|3|SALKK|Salazar-Knowles Equation, K|[?]|SITTING|[?]|IU/g Hb|[?]|1|umol/L/sec|COMMON FEMORAL VEIN|UNILATERAL|PARIETO-OCCIPITAL|NEXT GENERATION SEQUENCING||||FAMILY MEMBER|INTERNIST|2|Visit_2|25|6|FOLLOW-UP|2020-07-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|4|ALVVOL|Alveolar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|deg/mm|[?]|1|mmol/min/kPa|RETROPHARYNGEAL LYMPH NODE|LATERAL|PROXIMAL VOLAR|AMSLER GRID||||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|5|RAW|Airway Resistance|[?]|SITTING|[?]|U/m2/h|[?]|1|10^9/g|ABDOMINAL AORTA|UNILATERAL|INTERMEDIATE|CLIP SEQUENCING||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|3|Visit_3|40|4|SCREENING|2020-08-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING|[?]|SYRINGE|[?]|1|nmol BCE/mmol|METACARPOPHALANGEAL JOINT 1|LATERAL|ANTERIOR|MANUAL COUNT||||PARENT|ONCOLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-08-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|7|RV|Residual Volume|[?]|LATERAL DECUBITUS|[?]|ug/m2|[?]|1|pptr|HEPATIC VEIN|LEFT|LOWER FLEXOR SURFACE|HEMAGGLUTINATION ASSAY|Y|||HEALTH CARE PROFESSIONAL|READER 1|4|Visit_4|65|4|FOLLOW-UP|2020-08-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|8|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|[?]|ug/m2/h|[?]|1|10^3 CFU|CEREBRAL VEIN|UNILATERAL|HIND|PHOTOMETRY|Y|||INDEPENDENT ASSESSOR|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-08-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|9|VO2|Oxygen Consumption|[?]|UNCONSTRAINED|[?]|kat|[?]|1|Antibody Unit|DISTAL COMMON BILE DUCT|LATERAL|BASAL|PULMONARY ANGIOGRAPHY||||ADJUDICATOR|NEUROLOGIST 2|5|Visit_5|90|3|TREATMENT|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|10|FEV1SVC|FEV1/SVC|[?]|SLING|[?]|mOsm/L|[?]|1|mm/min|LOWER GASTROINTESTINAL TRACT LYMPH NODE|LATERAL|DISTAL VOLAR|BRDU CELLULAR PROLIFERATION ASSAY||||PARENT|RADIOLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|1|VO2|Oxygen Consumption|[?]|FOWLERS|[?]|pL|[?]|1|cup eq|LINGULA OF THE LUNG|IPSILATERAL|LOWER MEDIAL|ULTRASONOGRAPHIC ELASTOGRAPHY||||FAMILY MEMBER|HEMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-05-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|2|TSUHYS|Tissue Hysteresivity|[?]|SITTING, LEGS DEPENDENT|[?]|RATIO|[?]|1|Torr|RECTUM|UNILATERAL|TIP|HEMAGGLUTINATION ASSAY||||CAREGIVER|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-05-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|3|VO2|Oxygen Consumption|[?]|SLING|[?]|DIOPTER|[?]|1|nmol/mL/min|CRANIAL CAVITY|BILATERAL|UPPER FLEXOR SURFACE|OPTICAL DENSITY MEASUREMENT||Y||INDEPENDENT ASSESSOR|MICROSCOPIST 1|2|Visit_2|25|6|TREATMENT|2020-06-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|10^8/L|[?]|1|mg|NASOPHARYNX|IPSILATERAL|ANTEROTEMPORAL|CONTRAST ENHANCED X-RAY|Y|Y||ADJUDICATOR|ENDOCRINOLOGIST|2|Visit_2|25|1|WASHOUT|2020-06-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-02
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|5|MALIND|Malignancy Indicator|[?]|SEMI-RECUMBENT|||[?]|1|MET*min|VENA CAVA|UNILATERAL|ANTEROTEMPORAL|DUCTOGRAPHY|||Y|FRIEND|CARDIOLOGIST|3|Visit_3|40|4|TREATMENT|2020-06-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|6|FEV1FVC|FEV1/FVC|[?]|DECUBITUS|[?]|Bq/L|[?]|1|Frames/s|LESSER TROCHANTER|CONTRALATERAL|ANTERIOR|MICRODENSITOMETRY||||VENDOR|ADJUDICATOR 2|3|Visit_3|40|2|WASHOUT|2020-06-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|7|INERTANC|Inertance|[?]|SLING|||[?]|1|ug/g/h|ANAL CANAL|IPSILATERAL|DEEP|DYNAMOMETRY|Y||Y|CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|4|Visit_4|65|2|TREATMENT|2020-07-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-RECUMBENT|||[?]|1|mg/kg/dose|T4 VERTEBRA|UNILATERAL|UPPER|HPLC/MS|||Y|PROXY|UROLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|9|ELSTNCE|Elastance|[?]|LATERAL DECUBITUS|[?]|ukat/10^12 RBC|[?]|1|cmH2O*s2/mL|RIB 5|UNILATERAL|UPPER EXTENSOR SURFACE|PELLI-ROBSON EYE CHART||||ADJUDICATOR|MICROSCOPIST 3|5|Visit_5|90|6|TREATMENT|2020-08-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|2014bcd0-1430-4096-87f5-650a01dae626|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|FOWLERS|[?]|vg/mL|[?]|1|umol|FIBULA|BILATERAL|APICAL|OPTICAL COHERENCE TOMOGRAPHY||||FRIEND|RADIOLOGIST|5|Visit_5|90|7|WASHOUT|2020-08-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|1|PCF|Peak Cough Flow|[?]|UNCONSTRAINED|[?]|pL|[?]|1|psi|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|CONTRALATERAL|DORSOLATERAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y||INTERVIEWER|RATER 1|1|Visit_1|10|6|SCREENING|2020-11-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|2|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|REVERSE TRENDELENBURG|||[?]|1|ECL unit|LIP, LOWER|LEFT|FORE|TEST STRIP||Y|Y|ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|5|TREATMENT|2020-11-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|3|FEV1PP|Percent Predicted FEV1|[?]|SITTING, LEGS DEPENDENT|[?]|GBq/ug|[?]|1|kg|SKIN OF THE BACK|UNILATERAL|DORSOLATERAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||ADJUDICATOR|HEMATOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-11-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|4|FEV1FVC6|FEV1/FVC6|[?]|LATERAL DECUBITUS|[?]|log10 PFU|[?]|1|NEEDLE GAUGE|ABDOMINAL WALL|UNILATERAL|SUPERFICIAL|FARNSWORTH-MUNSELL 100 HUE TEST||||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|2|SCREENING|2020-11-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|5|MIPPP|Percent Predicted MIP|[?]|SEMI-RECUMBENT|||[?]|1|Siemens|T11 VERTEBRA|RIGHT|TEMPORAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y||Y|PROXY|READER|3|Visit_3|40|4|WASHOUT|2020-12-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|6|VO2|Oxygen Consumption|[?]|LATERAL DECUBITUS|[?]|IU/mmol|[?]|1|copies/ug|CORNEAL STROMA|CONTRALATERAL|UPPER FLEXOR SURFACE|ULTRASONOGRAPHIC ELASTOGRAPHY||||VENDOR|NEUROLOGIST 1|3|Visit_3|40|6|FOLLOW-UP|2020-12-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|mAmp|[?]|1|m2|FEMORAL CONDYLE|UNILATERAL|PERIPHERAL|NEURAMINIDASE INHIBITION ASSAY||||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|4|Visit_4|65|2|TREATMENT|2021-01-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|8|EVC|Expiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|SQU/mL|[?]|1|AgU/mL|TRUNK|CONTRALATERAL|CAUDAL|DYNAMIC LIGHT SCATTERING|Y|||PROXY|ADJUDICATOR 2|4|Visit_4|65|7|FOLLOW-UP|2021-01-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|mmol/min/kPa|[?]|1|PIXEL|CORONARY SINUS|CONTRALATERAL|INFERIOR|IMMUNOPRECIPITATION|Y|||INVESTIGATOR|CARDIOLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|e043f1b3-6b65-45c0-bdae-eb783406c263|10|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|||[?]|1|mL*cmH2O|HAND|LEFT|TIP|CONTRAST ENHANCED X-RAY|||Y|CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2021-01-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|1|TSUELAS|Tissue Elastance|[?]|SEMI-RECUMBENT|[?]|gMFI|[?]|1|pkat|LEFT MAIN CORONARY ARTERY OSTIUM|LATERAL|POSTERIOR|IMPULSE OSCILLOMETRY||||INVESTIGATOR|READER 3|1|Visit_1|10|6|TREATMENT|2020-07-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|2|RAWPP|Percent Predicted Airway Resistance|[?]|FOWLERS|||[?]|1|/sec|TESTIS|UNILATERAL|INFERIOR|NEXT GENERATION TARGETED SEQUENCING|||Y|CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|4|TREATMENT|2020-07-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|3|FEF50|Forced Expiratory Flow 50%|[?]|TRENDELENBURG|[?]|10^9 organisms/mg|[?]|1|Ci/uL|CELIAC LYMPH NODE|CONTRALATERAL|CENTRAL|GC/FID||Y||SIGNIFICANT OTHER|ADJUDICATOR 3|2|Visit_2|25|6|SCREENING|2020-08-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|4|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|DISK|[?]|1|GBq/mg|BACK|RIGHT|DISTAL VOLAR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||SPOUSE|RADIOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-08-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|5|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-RECUMBENT|[?]|ug/m2|[?]|1|EVENTS|TEMPLE|BILATERAL|LOWER MEDIAL|NEXT GENERATION TARGETED SEQUENCING||||SIGNIFICANT OTHER|RATER 1|3|Visit_3|40|1|SCREENING|2020-08-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|MnFI|[?]|1|HOMEOPATHIC DILUTION|AXILLA|LEFT|VENTROLATERAL|ELLA|Y|Y||GUARDIAN|ADJUDICATOR 2|3|Visit_3|40|2|SCREENING|2020-08-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|7|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|IU/day|[?]|1|PA|NASAL BONE|UNILATERAL|APICAL|CONTRAST ENHANCED CT SCAN|Y|Y||INTERVIEWER|OTOLARYNGOLOGIST|4|Visit_4|65|2|TREATMENT|2020-09-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|8|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING, LEGS DEPENDENT|[?]|pg/cell|[?]|1|umol/min|DISTAL INTERPHALANGEAL JOINT 5|UNILATERAL|HIND|THERMAL IONIZATION MASS SPECTROMETRY||||SIGNIFICANT OTHER|ADJUDICATOR 1|4|Visit_4|65|2|WASHOUT|2020-09-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|9|FIF75|Forced Inspiratory Flow at 75%|[?]|STANDING, BENT FORWARD|[?]|Ci/kg|[?]|1|g/cm2|INTERNAL ILIAC LYMPH NODE|IPSILATERAL|MEDIAL|GC/MS-CI||||INVESTIGATOR|OTOLARYNGOLOGIST|5|Visit_5|90|4|TREATMENT|2020-10-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|45623c39-86de-4b2f-bf2d-998d0e941e92|10|PLMXRS|Pulmonary Reactance|[?]|REVERSE TRENDELENBURG|[?]|pmol/g|[?]|1|10^5/L|VULVA|LATERAL|PARIETO-OCCIPITAL|OLIGO ACGH||||CHILD|ONCOLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-10-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-FOWLERS|[?]|PFU|[?]|1|10^6 organisms/g|CERVICAL LYMPH NODE|IPSILATERAL|DORSOLATERAL|SISH||||FRIEND|MICROSCOPIST|1|Visit_1|10|6|WASHOUT|2020-10-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|vg/kg|[?]|1|10^3 CFU/g|RECTOSIGMOID JUNCTION|CONTRALATERAL|CENTRAL|IMMUNOASSAY||||PROXY|INTERNIST|1|Visit_1|10|1|TREATMENT|2020-10-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|3|MALIND|Malignancy Indicator|[?]|SLING|||[?]|1|ug|TOOTH|IPSILATERAL|DORSOLATERAL|ENZYMATIC COLORIMETRY|Y||Y|VENDOR|MICROSCOPIST 3|2|Visit_2|25|4|SCREENING|2020-11-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|4|EFFIND|Effusion Indicator|[?]|LATERAL DECUBITUS|||[?]|1|POUCH|SOLEUS MUSCLE|UNILATERAL|PARIETO-OCCIPITAL|SEQUENCING|||Y|SIGNIFICANT OTHER|DERMATOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-11-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|5|PEF|Peak Expiratory Flow|[?]|STANDING|[?]|Gy|[?]|1|/4.0 mL|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|IPSILATERAL|TEMPORAL|REFRACTOMETRY|Y|||PROXY|ONCOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-11-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|6|PNIF|Peak Nasal Inspiratory Flow|[?]|SUPINE|[?]|CYLINDER|[?]|1|ka_u/dL|LEFT ATRIOVENTRICULAR ARTERY|IPSILATERAL|LOWER FLEXOR SURFACE|MIGET||Y||FRIEND|RATER 1|3|Visit_3|40|6|SCREENING|2020-11-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|7|VO2|Oxygen Consumption|[?]|SUPINE|||[?]|1|/VF|EPIGLOTTIS|IPSILATERAL|UPPER EXTENSOR SURFACE|MAGNETIC RESONANCE ELASTOGRAPHY|Y||Y|STUDY SUBJECT|READER|4|Visit_4|65|7|TREATMENT|2020-12-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|IMPLANT|[?]|1|hr/day|URINARY SYSTEM|BILATERAL|LATERAL|RAJI CELL RIA||Y||INTERVIEWER|MICROSCOPIST 1|4|Visit_4|65|1|TREATMENT|2020-12-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|9|MEP|Maximal Expiratory Pressure|[?]|SEMI-FOWLERS|||[?]|1|L/min/m2|EXTERNAL ILIAC ARTERY|LEFT|INFERIOR|ACCELERATOR MASS SPECTROMETRY|||Y|PARENT|RADIOLOGIST|5|Visit_5|90|1|TREATMENT|2021-01-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|DECUBITUS|||[?]|1|PFU/mL|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|PROXIMAL VOLAR|SINGLE-MOLECULE ARRAY|Y||Y|CHILD|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2021-01-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|IRVPP|Percent Predicted IRV|[?]|FOWLERS|||[?]|1|U/kg/h|LOWER RESPIRATORY SYSTEM|UNILATERAL|TIP|ICP-MS|Y||Y|VENDOR|RADIOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-09-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|||[?]|1|ng/L|GLENOID FOSSA|LATERAL|DISTAL|RADIAL IMMUNODIFFUSION|||Y|HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-09-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|3|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|[?]|CAN|[?]|1|uU/dL|BODY|RIGHT|DEEP|AGAR PROPORTION||||STUDY SUBJECT|RADIOLOGIST|2|Visit_2|25|7|TREATMENT|2020-09-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|DECUBITUS|[?]|PATCH|[?]|1|Ci/L|EYELID|CONTRALATERAL|SUPERFICIAL|MICROBIAL CULTURE||||NON-HEALTH CARE PROFESSIONAL|RATER 1|2|Visit_2|25|2|TREATMENT|2020-09-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|5|RRS|Total Respiratory System Resistance|[?]|DECUBITUS|[?]|uU/dL|[?]|1|Roentgen|GASTROCNEMIUS MUSCLE|UNILATERAL|ROSTRAL|MAMMOGRAPHY||||SIGNIFICANT OTHER|ONCOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-10-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|6|IC|Inspiratory Capacity|[?]|SUPINE|[?]|VOXEL|[?]|1|10^9 CFU/g|PRELARYNGEAL LYMPH NODE|BILATERAL|DORSOLATERAL|ANALYTICAL ULTRACENTRIFUGATION||||CAREGIVER|RATER 1|3|Visit_3|40|3|FOLLOW-UP|2020-10-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|7|FEV_PEF|FEV at PEF|[?]|PRONE|||[?]|1|Gy|ARTERY|RIGHT|CENTRAL|NON-INVASIVE DIELECTRIC SENSING||Y|Y|INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-10-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|8|IRV|Inspiratory Reserve Volume|[?]|SITTING|||[?]|1|mL/g/day|EYELID|LATERAL|MEDIAL|REFLECTANCE SPECTROSCOPY|||Y|SIGNIFICANT OTHER|INTERNIST|4|Visit_4|65|2|TREATMENT|2020-10-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|9|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|Newton|[?]|1|mL/m2/day|MEDIASTINUM, SUPERIOR|UNILATERAL|ROSTRAL|CYSTOSCOPY||||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|5|Visit_5|90|1|WASHOUT|2020-11-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|e5a105f7-38ac-4f19-aace-4149ed9b1100|10|QUASCOMP|Quasi-Static Compliance|[?]|STANDING, BENT FORWARD|[?]|ug/m2|[?]|1|DROP|MID-JUGULAR LYMPH NODE|LATERAL|DISTAL VOLAR|SNELLEN EYE CHART||||INVESTIGATOR|ADJUDICATOR|5|Visit_5|90|2|SCREENING|2020-11-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|FRCPP|Percent Predicted FRC|[?]|STANDING|[?]|VIRTUAL PIXEL|[?]|1|log10 CFU/mL|BODY|CONTRALATERAL|OCCIPITAL|MICROSCOPY||||INDEPENDENT ASSESSOR|RATER 2|1|Visit_1|10|2|SCREENING|2021-01-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SLING|||[?]|1|g/cage|MAMMARY GLAND|IPSILATERAL|ANTEROLATERAL|DXA SCAN|||Y|INVESTIGATOR|NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|nmol/g|[?]|1|ug/kg/day|SEBACEOUS GLAND|LATERAL|TEMPORAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|Y||SPOUSE|MICROSCOPIST 3|2|Visit_2|25|6|TREATMENT|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|4|TLC|Total Lung Capacity|[?]|STANDING, BENT FORWARD|[?]|ug/kg|[?]|1|g/animal/day|BILIARY TRACT|LATERAL|VENTRAL|MICRO BROTH DILUTION|Y|||FRIEND|READER 3|2|Visit_2|25|1|FOLLOW-UP|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|||[?]|1|sec|COSTOCHONDRAL JOINT 1|RIGHT|ANTEROPOSTERIOR|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||Y|Y|CAREGIVER|OTOLARYNGOLOGIST|3|Visit_3|40|3|TREATMENT|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|6|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|mU|[?]|1|ft3|SCAPULA|IPSILATERAL|DISTAL|ELECTROCHEMILUMINESCENCE||Y||STUDY SUBJECT|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|7|FEF2575P|Percent Predicted FEF25-75|[?]|SUPINE|[?]|ug/h|[?]|1|Bq/g|BRACHIOCEPHALIC ARTERY|IPSILATERAL|LATERAL|OPTICAL DENSITY MEASUREMENT||Y||INDEPENDENT ASSESSOR|RADIOLOGIST|4|Visit_4|65|7|TREATMENT|2021-03-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING, BENT FORWARD|[?]|genEq/mL|[?]|1|DAYS|MIDDLE PHALANX 5 OF THE HAND|LEFT|PARIETO-OCCIPITAL|SLIT LAMP PHOTOGRAPHY||||ADJUDICATOR|ONCOLOGIST 1|4|Visit_4|65|3|TREATMENT|2021-03-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|9|QUASCOMP|Quasi-Static Compliance|[?]|LATERAL DECUBITUS|[?]|MAC50|[?]|1|10^3 CFU|FEMORAL HEAD|LATERAL|LOWER FLEXOR SURFACE|SLIT LAMP||Y||ADJUDICATION COMMITTEE|RATER 2|5|Visit_5|90|5|TREATMENT|2021-04-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|c568ab93-8e7f-4e4e-9685-f0c13f293606|10|PEFTIME|Peak Expiratory Flow Time|[?]|PRONE|[?]|10^12/L|[?]|1|ug/dose|INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT|HIND|ELECTRONEUROGRAPHY||Y||INDEPENDENT ASSESSOR|OPTOMETRIST|5|Visit_5|90|3|FOLLOW-UP|2021-04-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING|[?]|g/kg|[?]|1|mg/m2/min|MEDIASTINUM, POSTERIOR|UNILATERAL|ANTEROPOSTERIOR|IRON HEMATOXYLIN STAIN||||INVESTIGATOR|READER 3|1|Visit_1|10|6|WASHOUT|2020-09-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|2|MALIND|Malignancy Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|10^11/L|[?]|1|ugEq|JOINT|CONTRALATERAL|NASAL|BRDU CELLULAR PROLIFERATION ASSAY||Y||PARENT|ADJUDICATOR|1|Visit_1|10|7|FOLLOW-UP|2020-09-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|[?]|P|[?]|1|DPM|MEDIASTINAL LYMPH NODE|BILATERAL|ANTERIOR|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|2|Visit_2|25|4|TREATMENT|2020-10-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|FOWLERS|[?]|uL|[?]|1|10^9 organisms/mL|GALLBLADDER|IPSILATERAL|SURFACE|HEMATOXYLIN AND EOSIN STAIN||||CLINICAL RESEARCH ASSOCIATE|READER 1|2|Visit_2|25|4|TREATMENT|2020-10-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|5|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|[?]|kN/cm2|[?]|1|in2|PERIURETHRAL REGION|IPSILATERAL|VOLAR|AMSLER GRID||||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|3|Visit_3|40|7|TREATMENT|2020-10-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|FOWLERS|[?]|mol/mg|[?]|1|10^3 CFU|PARAPHARYNGEAL LYMPH NODE|LATERAL|TEMPORAL|SNP ARRAY||||SIBLING|ADJUDICATOR|3|Visit_3|40|6|TREATMENT|2020-10-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|7|VO2|Oxygen Consumption|[?]|TRENDELENBURG|[?]|U/g/h|[?]|1|PIXELS/cm|INTERNAL ILIAC LYMPH NODE|LATERAL|UPPER|TEST STRIP||||PARENT|PHYSIOTHERAPIST|4|Visit_4|65|3|FOLLOW-UP|2020-11-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|tuberculin unit|[?]|1|mg/kg/h|VERTEBRAL COLUMN|RIGHT|VOLAR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||CLINICAL STUDY SPONSOR|ONCOLOGIST|4|Visit_4|65|2|TREATMENT|2020-11-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|9|MIP|Maximal Inspiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|U/cL|[?]|1|mL*cmH2O|PULMONARY VALVE, RIGHT CUSP|LATERAL|PERIPHERAL|NUCLEAR RADIOLOGY||||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|2|WASHOUT|2020-12-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|bccd8af0-2ecf-4091-92e4-681597b57ca4|10|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|||[?]|1|10^3 CFU/g|SKIN OF THE INFRASCAPULAR REGION|LATERAL|INNER|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y|Y|CLINICAL STUDY SPONSOR|NEUROLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-12-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|UNCONSTRAINED|[?]|DRINK|[?]|1|COAT|L6 VERTEBRA|IPSILATERAL|LOWER EXTENSOR SURFACE|ELECTROGASTROGRAPHY||||ADJUDICATOR|NEUROLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|2|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-FOWLERS|||[?]|1|m/sec2|SUPRARENAL AORTA|BILATERAL|VENTROLATERAL|LYMPHANGIOGRAPHY||Y|Y|CHILD|DERMATOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|3|ELSTNCE|Elastance|[?]|SITTING|[?]|s*kPa|[?]|1|kBq/uL|NECK|LATERAL|TIP|KINYOUN STAIN||||CLINICAL STUDY SPONSOR|READER 1|2|Visit_2|25|7|TREATMENT|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|4|MALEVDES|Malignancy Evidence Description|[?]|PRONE|[?]|%/s|[?]|1|mL/kg/min|FOOT DIGIT 4|BILATERAL|UPPER EXTENSOR SURFACE|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||GUARDIAN|MICROSCOPIST|2|Visit_2|25|4|SCREENING|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|5|VO2|Oxygen Consumption|[?]|SLING|[?]|days/wk|[?]|1|h*%|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|CONTRALATERAL|FACIAL|GC/MS-CI||||SIGNIFICANT OTHER|MICROSCOPIST 2|3|Visit_3|40|6|TREATMENT|2020-09-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|6|DLCOVA|DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|/wk|LINGULA OF THE LUNG|RIGHT|LATERAL|PELLI-ROBSON EYE CHART||Y|Y|DOMESTIC PARTNER|RADIOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-09-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|7|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|[?]|Ejaculate U|[?]|1|/month|CEREBRAL SUBCORTEX|RIGHT|FORE|DIGITAL PCR ARRAY||||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|4|Visit_4|65|6|FOLLOW-UP|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|8|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-FOWLERS|[?]|U/L|[?]|1|MONTHS|GINGIVAL MUCOSA|IPSILATERAL|LOWER MEDIAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||Y||SIGNIFICANT OTHER|PATHOLOGIST 2|4|Visit_4|65|5|TREATMENT|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|9|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|[?]|Ci/mg|[?]|1|fraction of 1|LUMBAR REGION|RIGHT|VENTROLATERAL|MAMMOGRAPHY||||SPOUSE|ONCOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2020-10-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|RE|bf069a02-03a6-4013-b16d-d7c954a6cc3d|10|RRS|Total Respiratory System Resistance|[?]|PRONE|||[?]|1|min|FLEXOR POLLICIS LONGUS MUSCLE|LEFT|FRONTAL|URANYL ACETATE STAIN|||Y|SIBLING|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|TREATMENT|2020-10-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|[?]|mmol/g|[?]|1|NFIU|TRAPEZOID BONE|UNILATERAL|PERIPHERAL|QUANTITATIVE ULTRASOUND||||HEALTH CARE PROFESSIONAL|READER 3|1|Visit_1|10|6|TREATMENT|2020-10-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|2|IVC|Inspiratory Vital Capacity|[?]|PRONE|[?]|ug/g/day|[?]|1|g/g/day|GUT-ASSOCIATED LYMPHOID TISSUE|BILATERAL|PERIVENTRICULAR|WRIGHT-GIEMSA STAIN|Y|||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-10-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|3|RRS|Total Respiratory System Resistance|[?]|UNCONSTRAINED|[?]|Pa|[?]|1|U/m2/h|GINGIVA|UNILATERAL|MIDLINE|SLOAN LETTER EYE CHART 1.25%||||SIBLING|ONCOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-10-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|4|SVC|Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|TCID 50/dose|ASCENDING AORTA, AORTIC ROOT|RIGHT|NASAL|SPECT SCAN|||Y|DOMESTIC PARTNER|ONCOLOGIST|2|Visit_2|25|4|TREATMENT|2020-10-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|5|AWWVOL|Airway Wall Volume|[?]|SEMI-FOWLERS|[?]|mL/kg/min|[?]|1|ft2|GLOBUS PALLIDUS|UNILATERAL|CRANIAL|TRIPLE-PHASE SPIRAL CT SCAN||||SIGNIFICANT OTHER|ADJUDICATOR 3|3|Visit_3|40|2|TREATMENT|2020-11-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|6|FRCPP|Percent Predicted FRC|[?]|FOWLERS|[?]|MET*h|[?]|1|mV*min|UVEA|BILATERAL|UPPER FLEXOR SURFACE|WHOLE EXOME SEQUENCING||||INDEPENDENT ASSESSOR|HEMATOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-11-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|7|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|MHz|[?]|1|Coulomb|LUNG, RIGHT, INFERIOR LOBE, LATERAL BASAL SEGMENT|BILATERAL|DORSOLATERAL|CALCOFLUOR WHITE STAIN||||CAREGIVER|NEUROLOGIST|4|Visit_4|65|5|WASHOUT|2020-12-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|8|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|10^4 CFU|[?]|1|mL/cage/wk|POPLITEAL FOSSA|CONTRALATERAL|DORSOLATERAL|MRS|Y|||SIBLING|RADIOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|9|GAW|Airway Conductance|[?]|TRENDELENBURG|[?]|TUBE|[?]|1|ng/day|HEART, RIGHT ATRIAL APPENDAGE|LATERAL|TEMPORAL|CELL OF ORIGIN ASSAY||Y||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|c40fc52b-2668-4fab-b051-5b258da72f2c|10|FIO2|Fraction of Inspired Oxygen|[?]|REVERSE TRENDELENBURG|[?]|fL|[?]|1|NFIU|GALLBLADDER|RIGHT|FRONTAL|COMPLEMENT FIXATION||Y||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|5|Visit_5|90|1|TREATMENT|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|||[?]|1|log10 IU/mL|PERITONEAL CAVITY|LEFT|OCCIPITAL|CLIP|||Y|SIGNIFICANT OTHER|OPTOMETRIST|1|Visit_1|10|4|TREATMENT|2020-07-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|2|FEV1FVC6|FEV1/FVC6|[?]|SUPINE|[?]|10^9 CFU/mL|[?]|1|KIT|ANTERIOR TIBIAL ARTERY|BILATERAL|OUTER|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y||CHILD|RADIOLOGIST|1|Visit_1|10|7|TREATMENT|2020-07-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|3|IVC|Inspiratory Vital Capacity|[?]|SUPINE|[?]|INHALATION|[?]|1|Bq/ug|SCAPHOID BONE|CONTRALATERAL|ANTERIOR|ORCHIDOMETERY||||SIBLING|ADJUDICATOR 2|2|Visit_2|25|6|TREATMENT|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|4|ERVPP|Percent Predicted ERV|[?]|LEFT LATERAL DECUBITUS|[?]|ugEq/L|[?]|1|um/day|NASOPHARYNX|BILATERAL|POSTERIOR|MICROBIAL CULTURE, SOLID||||VENDOR|NEUROLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|5|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|ug/cm2|[?]|1|fmol|TRICUSPID VALVE|BILATERAL|LATERAL|PANENDOSCOPY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|3|Visit_3|40|4|TREATMENT|2020-08-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|6|OXYPULSE|Oxygen Pulse|[?]|REVERSE TRENDELENBURG|[?]|gtt|[?]|1|CUP|CARPOMETACARPAL JOINT 1|LATERAL|LOWER MEDIAL|LAPAROSCOPY|Y|Y||INDEPENDENT ASSESSOR|NEUROLOGIST 2|3|Visit_3|40|2|TREATMENT|2020-08-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|7|AWVOL|Airway Volume|[?]|FOWLERS|||[?]|1|umol/L/sec|SCAPHOID-TRAPEZOID JOINT|LEFT|APICAL|DUCTOGRAPHY|||Y|FAMILY MEMBER|CLINICAL PATHOLOGIST|4|Visit_4|65|5|WASHOUT|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|8|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mmol/min/kPa|[?]|1|10^3 RNA copies/mL|PALPEBRAL CONJUNCTIVA|CONTRALATERAL|LOWER EXTENSOR SURFACE|ELECTROMYOGRAPHY|Y|Y||PARENT|DERMATOLOGIST|4|Visit_4|65|5|TREATMENT|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|9|FIF50|Forced Inspiratory Flow at 50%|[?]|UNCONSTRAINED|||[?]|1|mL/sec/1.73m2|FRONTAL LOBE|UNILATERAL|VENTRAL|FLUORESCENT SPOT TEST|Y||Y|DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-10-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|d7c792d8-fc98-41ab-8a9e-59de1e186a06|10|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING|||[?]|1|nmol/L/h|TIBIA SHAFT|LEFT|PARIETO-OCCIPITAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||Y|Y|SPOUSE|ADJUDICATOR 3|5|Visit_5|90|2|SCREENING|2020-10-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|1|VO2|Oxygen Consumption|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|um2|COLON, LEFT|BILATERAL|LOWER MEDIAL|BIOIMPEDANCE SPECTROSCOPY|||Y|NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-10-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|2|TGV|Thoracic Gas Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|DAgU/mL|[?]|1|MdFI|HEEL OF THE FOOT|CONTRALATERAL|VENTRAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|Y||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-10-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|3|PEFTIME|Peak Expiratory Flow Time|[?]|LEFT LATERAL DECUBITUS|[?]|pL|[?]|1|10^9/L|UNCINATE PROCESS OF PANCREAS|LATERAL|LOWER FLEXOR SURFACE|NEPHELOMETRY||||INVESTIGATOR|READER 1|2|Visit_2|25|4|FOLLOW-UP|2020-11-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|4|FRCPP|Percent Predicted FRC|[?]|FOWLERS|[?]|ugEq|[?]|1|pmol/10^10 cells|INFRACLAVICULAR LYMPH NODE|LATERAL|UPPER FLEXOR SURFACE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||Y||STUDY SUBJECT|INTERNIST|2|Visit_2|25|1|TREATMENT|2020-11-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|5|SAWVOL|Specific Airway Volume|[?]|STANDING, BENT FORWARD|||[?]|1|mg2/dL2|SHOULDER JOINT|BILATERAL|TEMPORAL|THIN SMEAR|Y||Y|ADJUDICATION COMMITTEE|NEUROLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|6|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|[?]|mJoule/cm2|[?]|1|EU|FLEXOR DIGITORUM PROFUNDUS MUSCLE|IPSILATERAL|POSTERIOR|GIEMSA STAIN||||DOMESTIC PARTNER|NEUROLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-11-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|7|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|[?]|tuberculin unit|[?]|1|/VF|ABDUCENS NERVE|LATERAL|FORE|QUANTITATIVE ULTRASOUND||||SIBLING|PEDIATRIC NEUROLOGIST|4|Visit_4|65|7|TREATMENT|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|8|TSUHYS|Tissue Hysteresivity|[?]|PRONE|[?]|Gravitational Unit|[?]|1|Absorbance U/mL|CORONARY VEIN|LATERAL|DISTAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||FAMILY MEMBER|ADJUDICATOR 2|4|Visit_4|65|6|TREATMENT|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|9|ALVVOL|Alveolar Volume|[?]|SLING|[?]|ug/day|[?]|1|nmol BCE/L|COLON, DESCENDING|IPSILATERAL|FRONTAL|IN VITRO GENE EXPRESSION ASSAY||||SIGNIFICANT OTHER|PATHOLOGIST 2|5|Visit_5|90|2|WASHOUT|2021-01-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|f7773659-f207-4b29-8389-3aa766a6337a|10|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|mgEq|[?]|1|/10^4|GENITAL TUBERCLE|LEFT|INNER|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||SIBLING|OPTOMETRIST|5|Visit_5|90|3|TREATMENT|2021-01-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|AWVOLPP|Percent Predicted Airway Volume|[?]|SEMI-FOWLERS|[?]|nmol/L/h|[?]|1|APS U|HAND DIGIT 2|IPSILATERAL|FACIAL|MAPH|Y|||FAMILY MEMBER|CARDIOLOGIST|1|Visit_1|10|1|TREATMENT|2021-01-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|2|FVC|Forced Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|cup eq|[?]|1|SBE/mL|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|IPSILATERAL|PERIVENTRICULAR|LIGHT SCATTERING SPECTROSCOPY||||PARENT|PATHOLOGIST 1|1|Visit_1|10|7|SCREENING|2021-01-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|3|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-FOWLERS|[?]|mL/beat|[?]|1|Rad|NERVE|LEFT|LOWER|TELLER ACUITY CARDS||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|6|SCREENING|2021-01-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|4|IC|Inspiratory Capacity|[?]|DECUBITUS|[?]|mV/sec|[?]|1|10^5/hpf|ENTORHINAL CORTEX|LEFT|LOWER FLEXOR SURFACE|PERFUSION MRI||||GUARDIAN|NEUROLOGIST 1|2|Visit_2|25|7|FOLLOW-UP|2021-01-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|5|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|[?]|mg/kg/min|[?]|1|mL/dL|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|BILATERAL|DORSAL|AUTOMATED COUNT||||FRIEND|NEUROLOGIST 1|3|Visit_3|40|2|TREATMENT|2021-02-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|UNCONSTRAINED|[?]|min*mg/mL|[?]|1|ug/m2/h|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|PERIPHERAL|DIFFUSION TENSOR MRI||Y||SPOUSE|RATER 1|3|Visit_3|40|6|TREATMENT|2021-02-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|REVERSE TRENDELENBURG|[?]|dpm/mL|[?]|1|Hounsfield Unit|LIVER|IPSILATERAL|FRONTAL|PHASE-CONTRAST MRI||Y||ADJUDICATOR|NEUROLOGIST 2|4|Visit_4|65|2|FOLLOW-UP|2021-03-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|8|SAWVOL|Specific Airway Volume|[?]|UNCONSTRAINED|[?]|10^3 CFU/mL|[?]|1|TABLET|LATERAL THIRD DIAGONAL BRANCH ARTERY|LATERAL|LOWER|POLYGRAPHY||Y||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-03-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-15
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|9|SVC|Slow Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|cm/min|[?]|1|mL/100g/min|MID-LAD ARTERY|LEFT|INNER|KNEMOMETRY||Y||INTERVIEWER|RADIOLOGIST 1|5|Visit_5|90|7|TREATMENT|2021-03-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|10|SRAW|Specific Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|VIAL|[?]|1|uV|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|UNILATERAL|CAUDAL|IVY INCISION METHOD||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|WASHOUT|2021-03-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|cmHg|GASTRIC CURVATURE LYMPH NODE|BILATERAL|SUPERFICIAL|HPLC/MS/MS|||Y|INVESTIGATOR|NEUROLOGIST 1|1|Visit_1|10|3|WASHOUT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|BOX|[?]|1|Ci/mL|INSULAR CORTEX|IPSILATERAL|SURFACE|SICKLE CELL SOLUBILITY TEST||Y||PROXY|UROLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|3|IVC|Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|MdFI|[?]|1|APPLICATION|MEDIAN NERVE|LEFT|OUTER|TRANSMISSION ELECTRON MICROSCOPY|Y|||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|3|WASHOUT|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-12
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|4|IC|Inspiratory Capacity|[?]|SITTING|[?]|%(w/w)|[?]|1|mmHg/sec|MASTOID PROCESS|UNILATERAL|PARIETO-OCCIPITAL|CT SCAN WITHOUT CONTRAST||||ADJUDICATOR|OPTOMETRIST|2|Visit_2|25|5|TREATMENT|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-12
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|5|TLC|Total Lung Capacity|[?]|STANDING|[?]|nmol/L/min|[?]|1|ukat/L|INTERPHALANGEAL JOINT 2|LATERAL|SUBCORTICAL|ULTRASOUND||||FAMILY MEMBER|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2021-02-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING|||[?]|1|ug/m2/day|OLECRANON|UNILATERAL|SUBCORTICAL|MICROBIAL CONCENTRATION|||Y|CHILD|OPHTHALMOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-22
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|7|DLCOVAPP|Percent Predicted DLCO/VA|[?]|STANDING|||[?]|1|MPS U|INCISOR|UNILATERAL|INTERMEDIATE|CONFOCAL MICROSCOPY|||Y|STUDY SUBJECT|OTOLARYNGOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|UNCONSTRAINED|[?]|mU|[?]|1|cd/m2|SKIN OF THE HEAD|CONTRALATERAL|DORSOLATERAL|TRYPAN BLUE STAIN||Y||SIGNIFICANT OTHER|RATER|4|Visit_4|65|7|FOLLOW-UP|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|9|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-FOWLERS|[?]|10^6/hpf|[?]|1|nmol|ILIAC CREST|LEFT|UPPER|MIGET|Y|||FRIEND|ADJUDICATOR 2|5|Visit_5|90|6|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|Farad|[?]|1|IU/dL|PROFUNDA FEMORIS VEIN|LEFT|OCCIPITAL|LC/MS/MS||||CAREGIVER|PATHOLOGIST 2|5|Visit_5|90|2|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|10^9 CFU/mL|[?]|1|mmol/g|FEMALE GENITALIA|LEFT|ANTERIOR|RADIATION DOSIMETRY||||SIBLING|ONCOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-06-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|2|DLCOPP|Percent Predicted DLCO|[?]|UNCONSTRAINED|[?]|mol|[?]|1|Enzyme U/L|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|RIGHT|PROXIMAL VOLAR|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||PROXY|MICROSCOPIST 3|1|Visit_1|10|1|WASHOUT|2020-06-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|3|FEV1PP|Percent Predicted FEV1|[?]|STANDING|[?]|Gravitational Unit|[?]|1|mL/animal/wk|INTESTINE|UNILATERAL|LOWER MEDIAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y||FRIEND|NEUROLOGIST 2|2|Visit_2|25|5|WASHOUT|2020-07-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|4|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|||[?]|1|g/dL|SKIN OF THE BACK|RIGHT|LOWER|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|||Y|HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-07-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-22
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|5|LCI|Lung Clearance Index|[?]|UNCONSTRAINED|[?]|cycle/min|[?]|1|sec|LEFT POSTERIOR DESCENDING ARTERY|BILATERAL|TIP|AGAR DILUTION||||SIBLING|ONCOLOGIST 1|3|Visit_3|40|3|FOLLOW-UP|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|6|PEF|Peak Expiratory Flow|[?]|DECUBITUS|[?]|BAG|[?]|1|IU/kg|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|CONTRALATERAL|MEDIAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 2|3|Visit_3|40|6|FOLLOW-UP|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|7|SGAW|Specific Airway Conductance|[?]|STANDING|[?]|Bq/L|[?]|1|BOTTLE|KIDNEY|BILATERAL|INFERIOR|TRYPAN BLUE STAIN|Y|||GUARDIAN|FORENSIC PATHOLOGIST|4|Visit_4|65|2|SCREENING|2020-08-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|8|FEV_PEF|FEV at PEF|[?]|SITTING|[?]|umol/mg/min|[?]|1|mL/(min*100mL)|OPTIC NERVE|LATERAL|ROSTRAL|PANENDOSCOPY||Y||CAREGIVER|RATER 1|4|Visit_4|65|6|TREATMENT|2020-08-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|9|SALKK|Salazar-Knowles Equation, K|[?]|STANDING, BENT FORWARD|||[?]|1|ug/g/h|RETINAL NERVE FIBER LAYER|BILATERAL|UPPER FLEXOR SURFACE|HEMOCYTOMETRY|Y||Y|SIGNIFICANT OTHER|RADIOLOGIST|5|Visit_5|90|4|TREATMENT|2020-09-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|700049a2-ef66-466b-b1d8-f0800bcfde43|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|[?]|ug/g/day|[?]|1|um/s|ARM|LEFT|PERIPHERAL|POPULATION SEQUENCING|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 2|5|Visit_5|90|6|TREATMENT|2020-09-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|1|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|10^6/hpf|[?]|1|Pack Year|MEDIASTINAL LYMPH NODE|LATERAL|NASAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-11-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|2|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|||[?]|1|grain|TEMPOROMANDIBULAR JOINT|CONTRALATERAL|LOWER MEDIAL|FUNDUS PHOTOGRAPHY|Y||Y|FAMILY MEMBER|ADJUDICATOR 1|1|Visit_1|10|2|TREATMENT|2020-11-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|3|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|vg/mL|[?]|1|ms2|INFERIOR PUBIC RAMUS|BILATERAL|TIP|IMMUNOTURBIDIMETRY||Y||INTERVIEWER|ONCOLOGIST 1|2|Visit_2|25|7|SCREENING|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|4|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING|[?]|Joule|[?]|1|kUSP|DISTANT LYMPH NODE|RIGHT|VOLAR|THIN SMEAR|Y|||STUDY SUBJECT|MICROSCOPIST 1|2|Visit_2|25|5|TREATMENT|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-17
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|5|ERVPP|Percent Predicted ERV|[?]|DECUBITUS|[?]|MBP|[?]|1|ELISA unit/mL|SCAPHOID-RADIUS JOINT|RIGHT|INNER|DYNAMIC LIGHT SCATTERING|Y|Y||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-12-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|6|MIPPP|Percent Predicted MIP|[?]|SUPINE|||[?]|1|CCID 50/mL|BRACHIAL PLEXUS|LATERAL|SUPERFICIAL|AGAR DILUTION|||Y|HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|WASHOUT|2020-12-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|7|SRAW|Specific Airway Resistance|[?]|STANDING|[?]|nmol/kg/day|[?]|1|TAMPON|ANAL CANAL|LEFT|UPPER FLEXOR SURFACE|FLOCCULATION, CHARCOAL ENHANCED||||CHILD|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|2|TREATMENT|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|8|RELSZCHG|Relative Size Change|[?]|SLING|[?]|10^3 CFU/g|[?]|1|v/v|SUPERFICIAL FEMORAL ARTERY|IPSILATERAL|SUPERIOR|PET/CT SCAN||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|4|Visit_4|65|4|TREATMENT|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|9|IRV|Inspiratory Reserve Volume|[?]|SEMI-RECUMBENT|[?]|/2000 RBC|[?]|1|Roentgen|THYROID GLAND ISTHMUS|LATERAL|ROSTRAL|FLUOROSCOPY||Y||NON-HEALTH CARE PROFESSIONAL|READER 3|5|Visit_5|90|5|TREATMENT|2021-02-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|00d906a6-2d14-4199-aff9-524388c5117f|10|PLMBLFLW|Pulmonary Blood Flow|[?]|LEFT LATERAL DECUBITUS|[?]|IU/g Hb|[?]|1|mmHg/L/min|FEMALE GENITALIA|UNILATERAL|LOWER|COLORIMETRY||||GUARDIAN|INTERNIST|5|Visit_5|90|2|TREATMENT|2021-02-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|1|ALVVOL|Alveolar Volume|[?]|STANDING|[?]|ng|[?]|1|C|HYPOGLOSSAL NERVE|CONTRALATERAL|ANTEROTEMPORAL|DYNAMIC CONTRAST ENHANCED MRI||||PROXY|RATER 2|1|Visit_1|10|6|TREATMENT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|2|EFFIND|Effusion Indicator|[?]|FOWLERS|[?]|kg/L|[?]|1|DIOPTER|ABDUCTOR HALLUCIS MUSCLE|CONTRALATERAL|ANTERIOR|JAEGER EYE CHART||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|2|SCREENING|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|3|RV|Residual Volume|[?]|SLING|[?]|%|[?]|1|/40 HPFs|INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|ANTEROTEMPORAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||ADJUDICATOR|RADIOLOGIST 1|2|Visit_2|25|4|FOLLOW-UP|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|4|RAW|Airway Resistance|[?]|SUPINE|[?]|mEq/dL|[?]|1|cL|RADIUS|CONTRALATERAL|LOWER EXTENSOR SURFACE|MAGNETIC RESONANCE ENTEROGRAPHY|Y|||FRIEND|OPHTHALMOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|5|ICREV|IC Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|mmol/min/kPa|[?]|1|10^9 organisms/mL|INTRAHEPATIC LARGE BILE DUCT|LEFT|LOWER FLEXOR SURFACE|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||FAMILY MEMBER|PATHOLOGIST 1|3|Visit_3|40|3|FOLLOW-UP|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|10^9 organisms|[?]|1|10^9 CFU/mL|VOMER|RIGHT|CENTRAL|BAC ACGH||||CLINICAL STUDY SPONSOR|HEMATOLOGIST|3|Visit_3|40|4|TREATMENT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|7|SAWVOL|Specific Airway Volume|[?]|PRONE|[?]|g/animal/day|[?]|1|Sv|INTERPHALANGEAL JOINT 1|LATERAL|PERIVENTRICULAR|PLETHYSMOGRAPHY||||GUARDIAN|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-02-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|8|IRVPP|Percent Predicted IRV|[?]|TRENDELENBURG|[?]|cy/cm|[?]|1|Pa|FLEXOR CARPI ULNARIS MUSCLE|CONTRALATERAL|PERIPHERAL|IVY INCISION METHOD||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 3|4|Visit_4|65|5|SCREENING|2021-02-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|9|PLMBLFLW|Pulmonary Blood Flow|[?]|SLING|||[?]|1|10^8 PFU|SUPRACLAVICULAR LYMPH NODE|RIGHT|HIND|KNEMOMETRY|||Y|INVESTIGATOR|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|2fcc5910-bce0-4510-b17e-3925850d6d32|10|ERVPP|Percent Predicted ERV|[?]|SLING|[?]|U/g|[?]|1|SUPPOSITORY|MASTOID PROCESS|RIGHT|ANTEROMEDIAL|WHOLE GENOME SEQUENCING||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|5|Visit_5|90|4|TREATMENT|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-27
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|[?]|Ci/uL|[?]|1|RNA copies/mL|ORBIT|CONTRALATERAL|PROXIMAL VOLAR|ISHIHARA COLOR PLATES||||INVESTIGATOR|READER 2|1|Visit_1|10|2|SCREENING|2020-08-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|2|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|REVERSE TRENDELENBURG|||[?]|1|mg2/dL2|ESOPHAGUS, CERVICAL|CONTRALATERAL|POSTERIOR|SANGER SEQUENCING|Y||Y|GUARDIAN|READER|1|Visit_1|10|4|TREATMENT|2020-08-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|3|AWVOL|Airway Volume|[?]|TRENDELENBURG|[?]|MET|[?]|1|/100 WBC|BLOOD|LATERAL|FORE|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|4|FEV6PP|Percent Predicted FEV6|[?]|SLING|[?]|mL/kg/day|[?]|1|Tbsp|BLOOD|LATERAL|ANTERIOR|SICKLE CELL SOLUBILITY TEST|Y|||CLINICAL STUDY SPONSOR|MICROSCOPIST|2|Visit_2|25|2|TREATMENT|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|10^6 organisms|[?]|1|mPa|PISIFORM BONE|IPSILATERAL|HIND|RADIOIMMUNOPRECIPITATION ASSAY||||FAMILY MEMBER|UROLOGIST|3|Visit_3|40|2|TREATMENT|2020-09-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|g/m2/day|[?]|1|mU/L|GASTROINTESTINAL TRACT, UPPER|LEFT|NASAL|PERIODIC ACID SCHIFF STAIN||||HEALTH CARE PROFESSIONAL|PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-09-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|7|RVPP|Percent Predicted Residual Volume|[?]|SEMI-RECUMBENT|[?]|10^6 organisms/g|[?]|1|ug/m2|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|UNILATERAL|SURFACE|DROPLET DIGITAL PCR|Y|||SPOUSE|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|8|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|||[?]|1|/7.5 mL|METACARPAL BONE 2|UNILATERAL|PARIETO-OCCIPITAL|AUTOMATED COUNT|Y||Y|CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|9|VO2|Oxygen Consumption|[?]|PRONE|[?]|mmAL|[?]|1|mCi/L|PROXIMAL INTERPHALANGEAL JOINT 4|UNILATERAL|ANTEROPOSTERIOR|OBSERVATION||Y||CLINICAL STUDY SPONSOR|RATER 2|5|Visit_5|90|5|SCREENING|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|10|DLCOVA|DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|BAU|[?]|1|ug/m2/day|PATELLA|LEFT|CAUDAL|GEL ELECTROPHORESIS||||PARENT|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|TGV|Thoracic Gas Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|DISK|[?]|1|SUPPOSITORY|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|CONTRALATERAL|INTERMEDIATE|ELASTOGRAPHY||||SPOUSE|ADJUDICATOR 3|1|Visit_1|10|6|SCREENING|2020-07-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|2|MIPPP|Percent Predicted MIP|[?]|STANDING, BENT FORWARD|||[?]|1|L/kg|INTERPHALANGEAL JOINT 2|UNILATERAL|PERIVENTRICULAR|INDIA INK STAIN|||Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|1|Visit_1|10|5|SCREENING|2020-07-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|SPRAY|[?]|1|uL|PERIFACIAL LYMPH NODE|RIGHT|HIND|TWO-COLOR MICROARRAY||||FAMILY MEMBER|OTOLARYNGOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SUPINE|[?]|mmHg*min/L|[?]|1|genEq/mL|SIGMOID SINUS|UNILATERAL|UPPER|QUANTITATIVE ULTRASOUND||||INTERVIEWER|NEUROLOGIST 1|2|Visit_2|25|5|WASHOUT|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|PRONE|[?]|cP|[?]|1|SBE/mL|BRACHIAL VEIN|RIGHT|CAUDAL|DIRECT SEQUENCING||||SPOUSE|OPHTHALMOLOGIST|3|Visit_3|40|1|WASHOUT|2020-08-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-FOWLERS|||[?]|1|U/10^12 RBC|EPICARDIUM|UNILATERAL|DISTAL|IMPULSE OSCILLOMETRY|||Y|HEALTH CARE PROFESSIONAL|READER 2|3|Visit_3|40|3|TREATMENT|2020-08-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|7|MEP|Maximal Expiratory Pressure|[?]|DECUBITUS|[?]|g/mol|[?]|1|Rad|THALAMUS|RIGHT|ANTERIOR|RADIOGRAPHY||||VENDOR|OPTOMETRIST|4|Visit_4|65|3|TREATMENT|2020-09-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|8|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|mm2|[?]|1|LENS|CAPITATE-HAMATE JOINT|LEFT|DORSOLATERAL|IMMUNOFLUORESCENT STAIN||||INDEPENDENT ASSESSOR|UROLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|INHALATION|[?]|1|10^6 organisms/mg|HAIR FOLLICLE|IPSILATERAL|INFERIOR|WHOLE GENOME SEQUENCING||||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|TREATMENT|2020-10-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|10|ALVVOL|Alveolar Volume|[?]|SEMI-RECUMBENT|[?]|copies/mL|[?]|1|10^3 copies/mL|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|BILATERAL|BASAL|ENDPOINT DILUTION ASSAY|Y|||INTERVIEWER|READER 1|5|Visit_5|90|5|SCREENING|2020-10-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SLING|[?]|mAnson U/mL|[?]|1|mg/kg/dose|LUNG, RIGHT UPPER LOBE|LEFT|SUPERIOR|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-10-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|2|DLCO|Diffusion Capacity of Lung for CO|[?]|DECUBITUS|[?]|cpm|[?]|1|cup eq|EPIGASTRIC LYMPH NODE|LEFT|TEMPORAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||CAREGIVER|RADIOLOGIST 1|1|Visit_1|10|3|WASHOUT|2020-10-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|||[?]|1|nL|CORONARY VEIN|BILATERAL|INNER|PET/CT SCAN|Y||Y|SPOUSE|PHYSIOTHERAPIST|2|Visit_2|25|2|TREATMENT|2020-11-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|4|FEV6PP|Percent Predicted FEV6|[?]|PRONE|||[?]|1|Arbitrary U|POPLITEAL VEIN|UNILATERAL|MEDIAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|||Y|CLINICAL RESEARCH ASSOCIATE|READER|2|Visit_2|25|3|SCREENING|2020-11-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|5|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|10^12/L|[?]|1|10^7/L|RETROPERITONEUM|IPSILATERAL|LOWER|WRIGHT STAIN||||VENDOR|NEUROLOGIST 1|3|Visit_3|40|4|SCREENING|2020-11-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|SFC/10^6 PBMC|[?]|1|tuberculin unit|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|CONTRALATERAL|LOWER FLEXOR SURFACE|PHOTOMETRY||||PARENT|OTOLARYNGOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|7|FIV1PP|Percent Predicted FIV1|[?]|TRENDELENBURG|[?]|umol/min|[?]|1|aMFI|NIPPLE|IPSILATERAL|INTERMEDIATE|MANUAL CLOT DETECTION||||GUARDIAN|FORENSIC PATHOLOGIST|4|Visit_4|65|5|WASHOUT|2020-12-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|8|RV|Residual Volume|[?]|SITTING, LEGS DEPENDENT|[?]|QUANTITY SUFFICIENT|[?]|1|10^9 CFU/mL|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|LEFT|MEDIAL|MANUAL COUNT||||FRIEND|RADIOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-12-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|9|MEP|Maximal Expiratory Pressure|[?]|SITTING|[?]|nmol/L|[?]|1|BEAM BREAKS|LUNATE BONE|LEFT|ANTEROMEDIAL|OPTICAL MAPPING||||GUARDIAN|RATER 2|5|Visit_5|90|6|TREATMENT|2021-01-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|10|LCI|Lung Clearance Index|[?]|TRENDELENBURG|||[?]|1|10^6/Ejaculate U|CANINE TOOTH|BILATERAL|PERIPHERAL|POTENTIOMETRY|Y|Y|Y|CLINICAL STUDY SPONSOR|RADIOLOGIST|5|Visit_5|90|6|WASHOUT|2021-01-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|ff163542-abec-4260-b257-f15a11e580ee|1|IC|Inspiratory Capacity|[?]|SITTING|[?]|mEq/uL|[?]|1|mmol/day|OCULOMOTOR NERVE|BILATERAL|LOWER|MRI||||SPOUSE|UROLOGIST|1|Visit_1|10|4|TREATMENT|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|ff163542-abec-4260-b257-f15a11e580ee|2|PNEUMIND|Pneumonia Indicator|[?]|UNCONSTRAINED|||[?]|1|HEP|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|IPSILATERAL|HIND|POPULATION SEQUENCING|||Y|SPOUSE|ADJUDICATOR 2|1|Visit_1|10|1|SCREENING|2020-08-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|ff163542-abec-4260-b257-f15a11e580ee|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|FOWLERS|||[?]|1|cd|LIGAMENT|RIGHT|DORSAL|AURAMINE STAIN|||Y|ADJUDICATOR|RATER 1|2|Visit_2|25|2|TREATMENT|2020-08-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|ff163542-abec-4260-b257-f15a11e580ee|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|hr/day|[?]|1|gtt|PERIPHERAL NERVE|LEFT|CRANIAL|IODINE STAIN||||DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2020-08-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|ff163542-abec-4260-b257-f15a11e580ee|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING|||[?]|1|U/g/h|OBTURATOR MUSCLE|LATERAL|FORE|ELECTRONEUROGRAPHY|||Y|SPOUSE|INTERNIST|3|Visit_3|40|2|TREATMENT|2020-09-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|ff163542-abec-4260-b257-f15a11e580ee|6|ICPP|Percent Predicted Inspiratory Capacity|[?]|DECUBITUS|[?]|Torr|[?]|1|%/min|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|LATERAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|||ADJUDICATOR|MICROSCOPIST 1|3|Visit_3|40|7|WASHOUT|2020-09-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|ff163542-abec-4260-b257-f15a11e580ee|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|PRONE|||[?]|1|PACK|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|DISTAL VOLAR|SIZE EXCLUSION CHROMATOGRAPHY|||Y|HEALTH CARE PROFESSIONAL|PATHOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-10-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|ff163542-abec-4260-b257-f15a11e580ee|8|EXPRELTM|Expiration Relaxation Time|[?]|STANDING|[?]|P|[?]|1|U/kg/day|STERNAL MANUBRIUM|BILATERAL|FRONTAL|MALDI|Y|||PROXY|FORENSIC PATHOLOGIST|4|Visit_4|65|7|WASHOUT|2020-10-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|ff163542-abec-4260-b257-f15a11e580ee|9|FEF50|Forced Expiratory Flow 50%|[?]|REVERSE TRENDELENBURG|[?]|cGy|[?]|1|10^6/L|ILEUM LYMPH NODE|LATERAL|SUPERIOR|ANGIOGRAPHY|Y|||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|5|Visit_5|90|3|TREATMENT|2020-11-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|ff163542-abec-4260-b257-f15a11e580ee|10|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/kg/week|[?]|1|IU/g|LIVER FISSURE|IPSILATERAL|MIDLINE|NO INFORMATION||||FAMILY MEMBER|RATER|5|Visit_5|90|7|TREATMENT|2020-11-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|FEV6PP|Percent Predicted FEV6|[?]|FOWLERS|[?]|mmol/s|[?]|1|10^3/hpf|INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|PROXIMAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|Y|||PARENT|MICROSCOPIST|1|Visit_1|10|7|TREATMENT|2020-08-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|2|FIF75|Forced Inspiratory Flow at 75%|[?]|DECUBITUS|[?]|pkat|[?]|1|vg/dose|PENIS, RADIX|IPSILATERAL|INNER|DUCTOGRAPHY|Y|||INTERVIEWER|ADJUDICATOR 3|1|Visit_1|10|7|TREATMENT|2020-08-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|3|TVPP|Percent Predicted Tidal Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mg/m2/h|HILAR LYMPH NODE|BILATERAL|ANTEROLATERAL|HANSEL STAIN||Y|Y|PROXY|ONCOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-08-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|Enzyme U/L|[?]|1|nmol/mol|SCROTUM|IPSILATERAL|SUBCORTICAL|GIEMSA STAIN|Y|||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|2|Visit_2|25|2|SCREENING|2020-08-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|5|PCF|Peak Cough Flow|[?]|SEMI-FOWLERS|[?]|mg/kg/min|[?]|1|msec|PANCREAS, BODY|IPSILATERAL|VENTROLATERAL|POTENTIOMETRY||||ADJUDICATOR|MICROSCOPIST 3|3|Visit_3|40|3|SCREENING|2020-09-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|6|MEPPP|Percent Predicted MEP|[?]|STANDING, BENT FORWARD|||[?]|1|mU/g|METATARSOPHALANGEAL JOINT 1|CONTRALATERAL|DEEP|HPLC/MS|||Y|INDEPENDENT ASSESSOR|RATER 2|3|Visit_3|40|5|SCREENING|2020-09-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|7|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING, BENT FORWARD|[?]|umol/dL|[?]|1|ug/cm2|CEREBRAL SUBCORTEX|LEFT|MEDIAL|IMMUNE REPERTOIRE DEEP SEQUENCING||||CAREGIVER|DERMATOLOGIST|4|Visit_4|65|2|SCREENING|2020-09-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|8|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|mg/dose|[?]|1|pmol/L/h|ENDOCARDIUM|UNILATERAL|OUTER|EEG||||ADJUDICATION COMMITTEE|ADJUDICATOR 3|4|Visit_4|65|3|WASHOUT|2020-09-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|ug/kg/day|[?]|1|Ci/mL|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|CONTRALATERAL|DISTAL VOLAR|TRANSVAGINAL ULTRASOUND|Y|||PARENT|READER 2|5|Visit_5|90|6|SCREENING|2020-10-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|bb73f732-a52f-4013-9ae6-60ff23b9c224|10|AWVOLPP|Percent Predicted Airway Volume|[?]|TRENDELENBURG|[?]|km|[?]|1|PNU/mL|ABDUCTOR POLLICIS BREVIS MUSCLE|RIGHT|UPPER FLEXOR SURFACE|RAJI CELL RIA||Y||INVESTIGATOR|NEUROLOGIST 2|5|Visit_5|90|3|SCREENING|2020-10-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|FRCPP|Percent Predicted FRC|[?]|PRONE|[?]|vg/kg|[?]|1|mCi|SUPERFICIAL FEMORAL ARTERY|UNILATERAL|CRANIAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||ADJUDICATION COMMITTEE|ONCOLOGIST 1|1|Visit_1|10|7|FOLLOW-UP|2020-07-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|2|FEF50|Forced Expiratory Flow 50%|[?]|UNCONSTRAINED|||[?]|1|gpELISA unit/mL|CINGULATE CORTEX|IPSILATERAL|OCCIPITAL|NEPHELOMETRY|||Y|ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-07-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|3|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|FEU|[?]|1|TRACE|MUSCULOSKELETAL SYSTEM|BILATERAL|VENTROLATERAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||ADJUDICATION COMMITTEE|READER 2|2|Visit_2|25|1|WASHOUT|2020-08-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|4|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|[?]|mL/mmHg|[?]|1|U/m2|HEART, BASE|LATERAL|LOWER EXTENSOR SURFACE|FLAME PHOTOMETRY||||ADJUDICATION COMMITTEE|RADIOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-08-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|5|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|CIGARETTE|PULMONARY VALVE, RIGHT CUSP|LATERAL|ANTERIOR|ELECTROPHORESIS|||Y|FRIEND|NEUROLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-08-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LATERAL DECUBITUS|[?]|VIRTUAL PIXEL|[?]|1|JAR|PECTORALIS MINOR MUSCLE|LATERAL|VENTROLATERAL|MICROBIAL CONCENTRATION||||DOMESTIC PARTNER|RADIOLOGIST 2|3|Visit_3|40|5|FOLLOW-UP|2020-08-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|DIOPTER|[?]|1|COAT|VERTEBRA|RIGHT|VENTROLATERAL|MODIFIED ACID FAST STAIN||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-09-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|8|FEV6PP|Percent Predicted FEV6|[?]|FOWLERS|[?]|/40 HPFs|[?]|1|U/m2/min|ORBIT|LEFT|POSTERIOR|RAJI CELL EIA||Y||STUDY SUBJECT|PHYSIOTHERAPIST|4|Visit_4|65|3|TREATMENT|2020-09-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|9|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|||[?]|1|kBq|DIAPHRAGM|UNILATERAL|SUBCORTICAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|||Y|CHILD|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2020-10-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|10|AWWVOL|Airway Wall Volume|[?]|STANDING|[?]|kcal|[?]|1|deg2|OLECRANON|LATERAL|PARIETO-OCCIPITAL|DARK FIELD MICROSCOPY||||INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-10-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-FOWLERS|||[?]|1|K|ESOPHAGUS, THORACIC|LEFT|ANTEROTEMPORAL|ANGIOGRAPHY|||Y|HEALTH CARE PROFESSIONAL|READER 2|1|Visit_1|10|6|TREATMENT|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|2|EVC|Expiratory Vital Capacity|[?]|SLING|[?]|umol/mg/min|[?]|1|oz eq|OBTURATOR EXTERNUS MUSCLE|CONTRALATERAL|UPPER|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|||CLINICAL RESEARCH ASSOCIATE|READER 1|1|Visit_1|10|3|WASHOUT|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|3|MEPPP|Percent Predicted MEP|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|pm|EPITROCHLEAR LYMPH NODE|CONTRALATERAL|VOLAR|IMMUNORADIOMETRIC ASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|2|Visit_2|25|6|TREATMENT|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|||[?]|1|U/mg|BUCCAL MUCOSA|LEFT|DORSOLATERAL|POLYMERASE CHAIN REACTION|||Y|CAREGIVER|ONCOLOGIST|2|Visit_2|25|6|TREATMENT|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-07
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|5|FEV6PP|Percent Predicted FEV6|[?]|RIGHT LATERAL DECUBITUS|[?]|RNA copies/mL|[?]|1|mCi/L|SUBCUTIS|UNILATERAL|LOWER MEDIAL|SMEAR||||VENDOR|NEUROLOGIST|3|Visit_3|40|4|FOLLOW-UP|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|6|RAWPP|Percent Predicted Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/kg/min|[?]|1|vg/mL|THYROID GLAND, RIGHT LOBE|LEFT|PERIVENTRICULAR|HEMAGGLUTINATION INHIBITION ASSAY||||STUDY SUBJECT|ENDOCRINOLOGIST|3|Visit_3|40|7|WASHOUT|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-20
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|7|LOBVOLPP|Percent Predicted Lobar Volume|[?]|PRONE|[?]|U/mmol|[?]|1|VIRTUAL PIXEL|ILIAC CREST|RIGHT|CAUDAL|GC/MS-EI|Y|Y||PROXY|OPTOMETRIST|4|Visit_4|65|1|WASHOUT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-RECUMBENT|[?]|pt_br|[?]|1|mmHg*min/L|SCAPHOID-LUNATE JOINT|LATERAL|VENTRAL|NUCLEIC ACID HYBRIDIZATION||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|9|EFFVOL|Effusion Volume|[?]|TRENDELENBURG|[?]|mAmp|[?]|1|IU/mmol|INTRAHEPATIC LARGE BILE DUCT|RIGHT|SURFACE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-05
e|RE|8e056558-ffd2-4c43-bbfa-40914b38af34|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|um|SKIN OF THE INFRASCAPULAR REGION|LATERAL|HIND|CHROMOGENIC ASSAY||Y|Y|CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|5|Visit_5|90|7|SCREENING|2021-04-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-05
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|ERV|Expiratory Reserve Volume|[?]|SITTING|[?]|IU/kg|[?]|1|Rad|RIB 3|BILATERAL|DORSAL|PLETHYSMOGRAPHY||||INTERVIEWER|RATER 1|1|Visit_1|10|3|SCREENING|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|2|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|[?]|log10 TCID 50/dose|[?]|1|L/min/m2|INTERPHALANGEAL JOINT 3|LATERAL|VOLAR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y||FAMILY MEMBER|CLINICAL PATHOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|3|SAWVOL|Specific Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|g/U|INTERPHALANGEAL JOINT 2|UNILATERAL|SUPERFICIAL|REFRACTOMETRY||Y|Y|CLINICAL RESEARCH COORDINATOR|RATER 2|2|Visit_2|25|1|FOLLOW-UP|2020-06-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|uSiemens|PARATRACHEAL LYMPH NODE|LEFT|PERIPHERAL|IMMUNOFIXATION ELECTROPHORESIS|Y||Y|ADJUDICATION COMMITTEE|READER 3|2|Visit_2|25|2|WASHOUT|2020-06-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-28
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|LATERAL DECUBITUS|[?]|uV2|[?]|1|uL/dose|SYNOVIAL FLUID|LATERAL|TEMPORAL|LC/MS|Y|||HEALTH CARE PROFESSIONAL|READER|3|Visit_3|40|6|SCREENING|2020-06-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|6|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING, BENT FORWARD|[?]|ELISA unit/mL|[?]|1|10^6 CFU/mL|SPLENIC LYMPH NODE|LATERAL|TEMPORAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|3|Visit_3|40|6|TREATMENT|2020-06-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|7|MEPPP|Percent Predicted MEP|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/kg/h|[?]|1|amol|MUSCULOSKELETAL SYSTEM|IPSILATERAL|VENTROLATERAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||Y||SPOUSE|RATER 1|4|Visit_4|65|5|TREATMENT|2020-07-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|8|INERTANC|Inertance|[?]|LEFT LATERAL DECUBITUS|||[?]|1|Ci/g|HEART, APEX|RIGHT|UPPER|IN SITU HYBRIDIZATION|||Y|HEALTH CARE PROFESSIONAL|READER 1|4|Visit_4|65|6|TREATMENT|2020-07-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-26
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|9|FIFMAXPP|Percent Predicted FIFmax|[?]|TRENDELENBURG|||[?]|1|in|NUCLEUS OF DIAGONAL BAND|RIGHT|SUPERFICIAL|HEMOCYTOMETRY|||Y|FRIEND|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|6|TREATMENT|2020-08-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|10|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|fraction of 1|[?]|1|cGy|BRACHIAL ARTERY|BILATERAL|VOLAR|ETDRS EYE CHART||||GUARDIAN|RADIOLOGIST 1|5|Visit_5|90|6|FOLLOW-UP|2020-08-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|cm H2O|[?]|1|POUCH|GRACILIS MUSCLE|UNILATERAL|POSTERIOR|RYAN BLUE STAIN|Y|Y||FRIEND|READER 2|1|Visit_1|10|3|TREATMENT|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|2|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|||[?]|1|mEq/uL|UPPER CERVICAL LYMPH NODE|CONTRALATERAL|ANTEROPOSTERIOR|AGAR PROPORTION|Y||Y|CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|2|FOLLOW-UP|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|3|IC|Inspiratory Capacity|[?]|PRONE|[?]|tuberculin unit/mL|[?]|1|cmol/L|HILAR|LEFT|SUPERFICIAL|ENZYMATIC SPECTROPHOTOMETRY||Y||FRIEND|READER 1|2|Visit_2|25|1|TREATMENT|2020-09-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|UNCONSTRAINED|||[?]|1|mg2/dL2|LESSER TROCHANTER|LATERAL|LOWER|FISH||Y|Y|SIBLING|MICROSCOPIST 2|2|Visit_2|25|2|TREATMENT|2020-09-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|5|FIF25|Forced Inspiratory Flow at 25%|[?]|SLING|[?]|pptr|[?]|1|MBq|ATRIOVENTRICULAR VALVE|CONTRALATERAL|OCCIPITAL|KINYOUN STAIN||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|6|IVCPP|Percent Predicted IVC|[?]|TRENDELENBURG|||[?]|1|s^-1(%O2)^-1|FASCIA|UNILATERAL|ANTEROTEMPORAL|SPIROMETRY|||Y|DOMESTIC PARTNER|FORENSIC PATHOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|7|RRS|Total Respiratory System Resistance|[?]|SITTING|[?]|IU/kg|[?]|1|PFU/animal|RAPHE|IPSILATERAL|FORE|CELLULOSE TAPE||Y||ADJUDICATION COMMITTEE|ONCOLOGIST 1|4|Visit_4|65|2|SCREENING|2020-10-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|PRONE|||[?]|1|mJoule/cm2|INFRACLAVICULAR LYMPH NODE|UNILATERAL|MIDLINE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y|Y|SIGNIFICANT OTHER|READER|4|Visit_4|65|5|SCREENING|2020-10-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|9|RAWPP|Percent Predicted Airway Resistance|[?]|SLING|[?]|/200 HPFs|[?]|1|MdFI|ESOPHAGUS, CERVICAL|BILATERAL|UPPER|IMMUNOASSAY||||INVESTIGATOR|MICROSCOPIST 3|5|Visit_5|90|6|SCREENING|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|624c1353-347a-417d-9aab-7f1e7077ba7f|10|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SUPINE|[?]|DISK|[?]|1|10^3/L|MYOMETRIUM|RIGHT|UPPER FLEXOR SURFACE|HIGH RESOLUTION MELT ANALYSIS||Y||CAREGIVER|OPHTHALMOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|TSUELAS|Tissue Elastance|[?]|DECUBITUS|||[?]|1|VOXEL|EPIDURAL SPACE|IPSILATERAL|OCCIPITAL|DISK DIFFUSION|||Y|CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|1|Visit_1|10|7|TREATMENT|2020-08-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|DECUBITUS|[?]|SBE/mL|[?]|1|pmol/g|LIVER, CAUDATE LOBE|LATERAL|LOWER EXTENSOR SURFACE|PET/CT SCAN|Y|Y||FAMILY MEMBER|RADIOLOGIST 1|1|Visit_1|10|3|WASHOUT|2020-08-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|3|TLC|Total Lung Capacity|[?]|UNCONSTRAINED|[?]|foz_br|[?]|1|BOLUS|KNEE JOINT TENDONS|RIGHT|SURFACE|TEMPLATE INCISION METHOD||||PROXY|NEUROLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-08-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|4|AWVOLPP|Percent Predicted Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mU|[?]|1|mg/m2|LINGULA OF THE LUNG|LEFT|OCCIPITAL|DIGITAL PCR||||SPOUSE|OTOLARYNGOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-08-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|5|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|||[?]|1|nmol/g|PRONATOR QUADRATUS MUSCLE|CONTRALATERAL|UPPER FLEXOR SURFACE|PET/MRI SCAN|||Y|INDEPENDENT ASSESSOR|HEMATOLOGIST|3|Visit_3|40|6|TREATMENT|2020-09-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|DECUBITUS|||[?]|1|% INHIBITION|TEMPOROMANDIBULAR JOINT|LATERAL|MIDLINE|THERMAL IONIZATION MASS SPECTROMETRY|||Y|SIBLING|MICROSCOPIST 2|3|Visit_3|40|7|TREATMENT|2020-09-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|7|PIF|Peak Inspiratory Flow|[?]|PRONE|[?]|10^5/hpf|[?]|1|DNA copies/mL|EPIDURAL SPACE|LATERAL|FACIAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|||PROXY|ENDOCRINOLOGIST|4|Visit_4|65|2|WASHOUT|2020-09-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|8|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|PHERESIS UNIT|[?]|1|K|AORTOCAVAL LYMPH NODE|RIGHT|DEEP|FLUORIMETRY|Y|||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|4|Visit_4|65|6|WASHOUT|2020-09-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|9|FIFMAXPP|Percent Predicted FIFmax|[?]|FOWLERS|[?]|anti-Xa IU|[?]|1|ug/L FEU|ANTERIOR HORN OF THE LATERAL VENTRICLE|LEFT|CAUDAL|FLUORESCENT ENZYME IMMUNOASSAY|Y|Y||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2020-10-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|ef1cddb8-f4ce-45c4-8671-32fe95f00993|10|SALKK|Salazar-Knowles Equation, K|[?]|SITTING|[?]|10^9 CFU/mL|[?]|1|10^7 CFU/mL|SENSORIMOTOR CORTEX|RIGHT|SUBCORTICAL|DIFFUSION TENSOR MRI||||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|TREATMENT|2020-10-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|1|FIV1PP|Percent Predicted FIV1|[?]|DECUBITUS|[?]|ug/m2/day|[?]|1|Bq/mg|EYELID|RIGHT|HIND|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||Y||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-06-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|2|ERVPP|Percent Predicted ERV|[?]|UNCONSTRAINED|||[?]|1|uV2|ISCHIAL TUBEROSITY|LEFT|INNER|KNEMOMETRY|||Y|CLINICAL STUDY SPONSOR|RATER 2|1|Visit_1|10|6|FOLLOW-UP|2020-06-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|3|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|TRENDELENBURG|[?]|Log10 ELISA unit|[?]|1|mg/mol|DUCTUS ARTERIOSUS|IPSILATERAL|MEDIAL|ANALYTICAL ULTRACENTRIFUGATION||Y||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|2|Visit_2|25|2|WASHOUT|2020-07-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|10^8/L|[?]|1|mL*cmH2O|DISTAL LAD ARTERY|CONTRALATERAL|ANTEROLATERAL|ELISA||||CHILD|RADIOLOGIST 2|2|Visit_2|25|7|SCREENING|2020-07-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|5|DLCOVA|DLCO/VA|[?]|PRONE|||[?]|1|/100 HPFs|SUPRAGLOTTIS|CONTRALATERAL|VENTROLATERAL|HIGH RESOLUTION MELT ANALYSIS|Y||Y|DOMESTIC PARTNER|ADJUDICATOR 2|3|Visit_3|40|6|SCREENING|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|6|ELSTNCE|Elastance|[?]|SITTING|[?]|USP U|[?]|1|mL/cm H2O|LIVER, CAUDATE LOBE|IPSILATERAL|OUTER|RIA||||SIBLING|READER 2|3|Visit_3|40|2|FOLLOW-UP|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|7|ICREV|IC Reversibility|[?]|SITTING|||[?]|1|10^3 organisms/g|ASCENDING AORTA|RIGHT|DISTAL|ELECTROPHORESIS||Y|Y|INDEPENDENT ASSESSOR|PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|8|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|[?]|kBq/uL|[?]|1|BE/mL|HILAR|CONTRALATERAL|FACIAL|MICROBIAL CULTURE, LIQUID|Y|||ADJUDICATION COMMITTEE|ADJUDICATOR 1|4|Visit_4|65|1|TREATMENT|2020-08-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|9|OXYPULSE|Oxygen Pulse|[?]|SLING|[?]|APPLICATION|[?]|1|mg2/dL2|FINGER|LEFT|ANTEROMEDIAL|ACID FAST STAIN||Y||ADJUDICATOR|READER 2|5|Visit_5|90|3|SCREENING|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|da6294b5-de91-4bf7-b160-55d22fefcb07|10|MALIND|Malignancy Indicator|[?]|DECUBITUS|[?]|IU/g|[?]|1|genEq/mL|PREFRONTAL CORTEX|UNILATERAL|ANTEROLATERAL|DIFFUSION TENSOR MRI|Y|||SIGNIFICANT OTHER|ADJUDICATOR 1|5|Visit_5|90|1|TREATMENT|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|mL/cage|EPIGLOTTIS|RIGHT|LOWER FLEXOR SURFACE|TELLER ACUITY CARDS|Y|Y|Y|CLINICAL RESEARCH ASSOCIATE|CLINICAL PATHOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|2|PEFREV|PEF Reversibility|[?]|PRONE|||[?]|1|umol/mol|PORTA HEPATIS LYMPH NODE|LEFT|DEEP|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||Y|CHILD|NEUROLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|3|AWVOLPP|Percent Predicted Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mg/m2/min|[?]|1|mL/100g/min|PARACOLIC GUTTER|IPSILATERAL|CAUDAL|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||CLINICAL STUDY SPONSOR|MICROSCOPIST 3|2|Visit_2|25|4|WASHOUT|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|4|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|FOWLERS|[?]|U/m2|[?]|1|kcal/day|THORACIC VERTEBRA|RIGHT|OUTER|QUANTITATIVE ULTRASOUND|Y|||VENDOR|READER 3|2|Visit_2|25|3|TREATMENT|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|SLING|[?]|L/h|[?]|1|mEq/ug|BUCCAL LYMPH NODE|BILATERAL|ROSTRAL|THERMAL IONIZATION MASS SPECTROMETRY||||FAMILY MEMBER|READER 3|3|Visit_3|40|2|TREATMENT|2020-11-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|6|FIF50|Forced Inspiratory Flow at 50%|[?]|LATERAL DECUBITUS|[?]|vg/kg|[?]|1|CARTRIDGE|THORACIC AORTA|IPSILATERAL|SURFACE|DC SHEATH FLOW||Y||ADJUDICATION COMMITTEE|ADJUDICATOR 3|3|Visit_3|40|4|SCREENING|2020-11-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|TRENDELENBURG|[?]|uCi/L|[?]|1|Ci/uL|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LEFT|OUTER|ISHIHARA COLOR PLATES||||CHILD|NEUROLOGIST 2|4|Visit_4|65|2|FOLLOW-UP|2020-12-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|PRONE|[?]|ft|[?]|1|uU/dL|FEMALE GENITALIA|CONTRALATERAL|FORE|IMMUNORADIOMETRIC ASSAY||Y||VENDOR|NEUROLOGIST 1|4|Visit_4|65|5|WASHOUT|2020-12-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|9|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|||[?]|1|IU/kg|INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|SUBCORTICAL|TEST STRIP|||Y|CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|c01c16d4-7a37-421d-9191-1874eba6a1e3|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|mL/kg/day|[?]|1|YEARS|TRAPEZIUM-TRAPEZOID JOINT|UNILATERAL|PROXIMAL|SLOAN LETTER EYE CHART 100%||||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|5|Visit_5|90|4|SCREENING|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|[?]|PIXELS/in|[?]|1|g/kg/day|CERVIX UTERI|UNILATERAL|MIDLINE|ELASTOGRAPHY||||DOMESTIC PARTNER|RATER 2|1|Visit_1|10|7|WASHOUT|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|2|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|g/kg|[?]|1|pm|EXTERNAL ILIAC LYMPH NODE|IPSILATERAL|FACIAL|HEMAGGLUTINATION INHIBITION ASSAY||||INTERVIEWER|ADJUDICATOR|1|Visit_1|10|3|SCREENING|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|3|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|U/m2/day|HEART, APEX|RIGHT|OCCIPITAL|PERFUSION MRI|||Y|PARENT|RATER 1|2|Visit_2|25|5|FOLLOW-UP|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|4|AWVOLPP|Percent Predicted Airway Volume|[?]|TRENDELENBURG|[?]|pg/L|[?]|1|log10 PFU|PLEURAL CAVITY|BILATERAL|ROSTRAL|HPLC/MS||Y||HEALTH CARE PROFESSIONAL|INTERNIST|2|Visit_2|25|4|TREATMENT|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|5|QUASCOMP|Quasi-Static Compliance|[?]|TRENDELENBURG|[?]|vg/mL|[?]|1|ug/day|COLON, RECTOSIGMOID|LATERAL|LOWER EXTENSOR SURFACE|OPTICAL MAPPING||||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|3|Visit_3|40|3|TREATMENT|2020-07-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|6|SALKK|Salazar-Knowles Equation, K|[?]|SUPINE|[?]|10^6/Ejaculate U|[?]|1|Mile|SENSORIMOTOR CORTEX|CONTRALATERAL|ANTEROMEDIAL|SINGLE-MOLECULE ARRAY|Y|||INTERVIEWER|ENDOCRINOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|TRENDELENBURG|[?]|mL|[?]|1|MAC50|CALCARINE SULCUS|CONTRALATERAL|CAUDAL|TRIPLE-PHASE SPIRAL CT SCAN||||ADJUDICATION COMMITTEE|MICROSCOPIST 2|4|Visit_4|65|4|TREATMENT|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|8|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|ug/g/day|[?]|1|DISK|GALLBLADDER|LATERAL|VENTRAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|Y||INDEPENDENT ASSESSOR|PATHOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|9|FEV1FVC|FEV1/FVC|[?]|SITTING|[?]|g/m2|[?]|1|CYLINDER|TROCHLEAR NERVE|IPSILATERAL|SUPERFICIAL|IMMUNOFLUORESCENT STAIN||Y||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|6036407d-5ac8-400d-91f7-afd63f3cab88|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|UNCONSTRAINED|||[?]|1|mg/kg/h|METACARPOPHALANGEAL JOINT 1|LATERAL|PERIVENTRICULAR|TOLUIDINE BLUE STAIN||Y|Y|FRIEND|CLINICAL PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|1|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|tuberculin unit|[?]|1|mL*cmH2O|RECTUS FEMORIS MUSCLE|RIGHT|PERIVENTRICULAR|ICC|Y|||DOMESTIC PARTNER|MICROSCOPIST 1|1|Visit_1|10|3|TREATMENT|2020-12-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|2|EVC|Expiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|Pa|[?]|1|g/g|LYMPH NODE|RIGHT|DORSAL|SPIROMETRY|Y|Y||INTERVIEWER|PATHOLOGIST 2|1|Visit_1|10|2|FOLLOW-UP|2020-12-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|3|FEV3FVC|FEV3/FVC|[?]|SEMI-RECUMBENT|[?]|usec|[?]|1|U/m2/day|HEART, LEFT ATRIUM|UNILATERAL|PERIVENTRICULAR|CONGO RED STAIN||||FAMILY MEMBER|ONCOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|SLING|[?]|min*mg/mL|[?]|1|%/s|EPIDIDYMIS|BILATERAL|INTERMEDIATE|FORCED OSCILLATION TECHNIQUE||Y||GUARDIAN|RATER|2|Visit_2|25|3|WASHOUT|2020-12-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|5|TLC|Total Lung Capacity|[?]|SUPINE|[?]|10^6 RNA copies/mL|[?]|1|BLOCKS|GASTROCNEMIUS MUSCLE, LATERAL HEAD|IPSILATERAL|ROSTRAL|THICK SMEAR||||CHILD|MICROSCOPIST 2|3|Visit_3|40|5|SCREENING|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LEFT LATERAL DECUBITUS|||[?]|1|mol/day|FINGER FLEXOR TENDONS|IPSILATERAL|BASAL|IMMUNORADIOMETRIC ASSAY|||Y|SIGNIFICANT OTHER|READER|3|Visit_3|40|2|WASHOUT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|7|QUASCOMP|Quasi-Static Compliance|[?]|DECUBITUS|||[?]|1|PACK|NUCLEUS OF DIAGONAL BAND|LATERAL|MIDLINE|IHC|Y||Y|INTERVIEWER|MICROSCOPIST 3|4|Visit_4|65|2|WASHOUT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|gtt|[?]|1|mL/100g/min|TRUNK|RIGHT|LATERAL|APPLANATION TONOMETRY||||SIGNIFICANT OTHER|HEMATOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|9|IVCPP|Percent Predicted IVC|[?]|RIGHT LATERAL DECUBITUS|[?]|Gauss|[?]|1|tuberculin unit/mL|PARACAVAL LYMPH NODE|LEFT|DORSOLATERAL|LC/MS||||PARENT|READER 2|5|Visit_5|90|7|WASHOUT|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|69cf0c4b-13f6-4955-8046-72a333059d6e|10|FEF50|Forced Expiratory Flow 50%|[?]|STANDING, BENT FORWARD|[?]|pkat|[?]|1|mL/(min*100mL)|THIGH|CONTRALATERAL|NASAL|PERIPHERAL ANGIOGRAPHY||||ADJUDICATION COMMITTEE|HEMATOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|1|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|umol/day|[?]|1|mm3/mm2/year|URETHRAL SPHINCTER|LATERAL|VENTROLATERAL|FLUORESCENT SPOT TEST||||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|1|Visit_1|10|2|TREATMENT|2020-07-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|2|RVPP|Percent Predicted Residual Volume|[?]|SEMI-FOWLERS|[?]|tuberculin unit|[?]|1|ug/day|FEMORAL LYMPH NODE|RIGHT|TEMPORAL|SPIRAL CT SCAN WITHOUT CONTRAST||||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-07-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING|[?]|IU/g Hb|[?]|1|Bq/kg|INTRATHORACIC LYMPH NODE|LATERAL|MIDLINE|COMPLEMENT FIXATION|Y|||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|7|WASHOUT|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|4|SVC|Slow Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|mL/cage|CILIARY BODY|RIGHT|CENTRAL|ELECTROMYOGRAPHY|||Y|DOMESTIC PARTNER|ENDOCRINOLOGIST|2|Visit_2|25|7|WASHOUT|2020-07-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|5|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|U|[?]|1|fmol/L|INTERPHALANGEAL JOINT 4|IPSILATERAL|PERIPHERAL|MANUAL CLOT DETECTION||||FAMILY MEMBER|PHYSIOTHERAPIST|3|Visit_3|40|3|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|6|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|[?]|aMFI|[?]|1|amol|DISTANT LYMPH NODE|RIGHT|FACIAL|ACRIDINE ORANGE STAIN|Y|Y||SIGNIFICANT OTHER|NEUROLOGIST 1|3|Visit_3|40|4|FOLLOW-UP|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/min|[?]|1|U/m2/h|METACARPOPHALANGEAL JOINT 1|UNILATERAL|LOWER FLEXOR SURFACE|GC/MS-CI|Y|||INDEPENDENT ASSESSOR|NEUROLOGIST|4|Visit_4|65|7|WASHOUT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|8|PEFREV|PEF Reversibility|[?]|LATERAL DECUBITUS|||[?]|1|AgU/mL|T7 VERTEBRA|CONTRALATERAL|VENTRAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|||Y|CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|9|IVCPP|Percent Predicted IVC|[?]|SITTING, LEGS DEPENDENT|[?]|fraction of 1|[?]|1|% INHIBITION|PERIURETERAL REGION|LEFT|CAUDAL|SLIT LAMP PHOTOGRAPHY|Y|||SIBLING|READER 3|5|Visit_5|90|6|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|19829028-595c-4811-90e3-0ca696a04ba3|10|IVCPP|Percent Predicted IVC|[?]|FOWLERS|[?]|mL/mmHg/min/L|[?]|1|RATIO|FINGERNAIL|LATERAL|DEEP|MASS SPECTROMETRY||||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|TV|Tidal Volume|[?]|STANDING, BENT FORWARD|[?]|10^4/L|[?]|1|ELISA unit/dose|TEMPORAL LOBE|RIGHT|SUBCORTICAL|CENTRIFUGATION||Y||SIBLING|OPTOMETRIST|1|Visit_1|10|5|TREATMENT|2020-09-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|2|PEF|Peak Expiratory Flow|[?]|STANDING|[?]|mN|[?]|1|10^12/L|GANGLION|UNILATERAL|LOWER EXTENSOR SURFACE|MANUAL COUNT||Y||INDEPENDENT ASSESSOR|READER 2|1|Visit_1|10|6|WASHOUT|2020-09-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING, BENT FORWARD|||[?]|1|/mm2|PORTACAVAL LYMPH NODE|IPSILATERAL|VENTROLATERAL|AMSLER GRID|||Y|FRIEND|PHYSIOTHERAPIST|2|Visit_2|25|5|SCREENING|2020-09-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|cal|[?]|1|keV|SUPERIOR SAGITTAL SINUS|BILATERAL|BASAL|SINGLE-MOLECULE ARRAY|Y|Y||CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|2|Visit_2|25|5|SCREENING|2020-09-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|5|IVC|Inspiratory Vital Capacity|[?]|SUPINE|[?]|mL/breath|[?]|1|mL/animal|ESOPHAGEAL LYMPH NODE|IPSILATERAL|LOWER FLEXOR SURFACE|SIZE EXCLUSION CHROMATOGRAPHY||||FRIEND|ENDOCRINOLOGIST|3|Visit_3|40|7|TREATMENT|2020-10-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|6|RV|Residual Volume|[?]|UNCONSTRAINED|[?]|mL/(min*100mL)|[?]|1|kPa|AORTOPULMONARY WINDOW LYMPH NODE|LATERAL|DORSAL|IMMUNODIFFUSION||||INTERVIEWER|MICROSCOPIST 3|3|Visit_3|40|5|TREATMENT|2020-10-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|7|FVC|Forced Vital Capacity|[?]|TRENDELENBURG|[?]|PIXELS/in|[?]|1|BE/mL|INCISOR|IPSILATERAL|LOWER EXTENSOR SURFACE|HIGH RESOLUTION MELT ANALYSIS||Y||CHILD|PATHOLOGIST 2|4|Visit_4|65|4|TREATMENT|2020-10-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|8|QUASCOMP|Quasi-Static Compliance|[?]|SITTING|[?]|10^4/hpf|[?]|1|Hz/s|FEMORAL HEAD|LEFT|VENTRAL|LIGHT MICROSCOPY|Y|||FRIEND|RATER|4|Visit_4|65|2|TREATMENT|2020-10-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|FOWLERS|[?]|ng/dL|[?]|1|tuberculin unit/mL|INTERNAL ILIAC LYMPH NODE|CONTRALATERAL|DORSOLATERAL|TOTAL BODY RADIOGRAPHY||||CAREGIVER|READER 3|5|Visit_5|90|6|TREATMENT|2020-11-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|562a8182-8e9b-4a68-9b95-bc52df58ed46|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|PRONE|[?]|mEq/mL|[?]|1|TAMPON|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|LEFT|OUTER|MICROBIAL CULTURE|Y|||CLINICAL RESEARCH COORDINATOR|RATER|5|Visit_5|90|6|TREATMENT|2020-11-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|10^7 PFU|[?]|1|mmol/g|PALPEBRAL FISSURE|RIGHT|VENTROLATERAL|MECHANICAL CLOT DETECTION|Y|||FRIEND|ADJUDICATOR 1|1|Visit_1|10|1|SCREENING|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|2|FEV1FVC|FEV1/FVC|[?]|STANDING|||[?]|1|nmol/kg/day|GASTRIC CURVATURE LYMPH NODE|IPSILATERAL|LOWER EXTENSOR SURFACE|BIOPSY|Y||Y|DOMESTIC PARTNER|ADJUDICATOR 1|1|Visit_1|10|6|TREATMENT|2021-01-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|3|LCI|Lung Clearance Index|[?]|SLING|[?]|MBq/uL|[?]|1|ug/kg/min|ILIUM|LEFT|SUPERFICIAL|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|||INDEPENDENT ASSESSOR|INTERNIST|2|Visit_2|25|2|TREATMENT|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|4|LCI|Lung Clearance Index|[?]|PRONE|[?]|keV|[?]|1|dpm/mL|LIVER|BILATERAL|MEDIAL|DARK FIELD MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|CLINICAL PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|5|SVC|Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|mL/s|[?]|1|umol/L/min|SUPRACLAVICULAR FOSSA|CONTRALATERAL|NASAL|FLUORESCENT ENZYME IMMUNOASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|WASHOUT|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|6|MIP|Maximal Inspiratory Pressure|[?]|LATERAL DECUBITUS|||[?]|1|Gy|TEMPLE|LEFT|VOLAR|IMMUNOCHEMILUMINOMETRIC ASSAY|Y||Y|CLINICAL STUDY SPONSOR|READER|3|Visit_3|40|3|TREATMENT|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|7|DLCOHC|HGB Corrected DLCO|[?]|STANDING|[?]|MPL U|[?]|1|g/kg|MESENTERIC LYMPH NODE|IPSILATERAL|PERIVENTRICULAR|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|4|Visit_4|65|3|TREATMENT|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|8|AWVOL|Airway Volume|[?]|TRENDELENBURG|[?]|ug/L DDU|[?]|1|Log10 ELISA unit|PERICARDIUM|IPSILATERAL|ANTERIOR|IMMUNOPRECIPITATION||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|4|Visit_4|65|3|WASHOUT|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-05
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|9|FEV6PP|Percent Predicted FEV6|[?]|SLING|[?]|kg/mol|[?]|1|cGy|TARSAL JOINT|RIGHT|LOWER|BRDU CELLULAR PROLIFERATION ASSAY||||CLINICAL RESEARCH COORDINATOR|INTERNIST|5|Visit_5|90|6|FOLLOW-UP|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|RE|b29e6912-42f4-471b-ad90-1ec446f89ac0|10|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|UNCONSTRAINED|||[?]|1|L/h/m2|MUSCLE|LATERAL|DORSOLATERAL|RADIOIMMUNOPRECIPITATION ASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2021-04-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-15
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|EFFIND|Effusion Indicator|[?]|SEMI-FOWLERS|||[?]|1|FINGERTIP UNIT|PINEAL GLAND|RIGHT|OUTER|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y||Y|CLINICAL STUDY SPONSOR|RATER 2|1|Visit_1|10|5|SCREENING|2020-06-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LATERAL DECUBITUS|[?]|USP U|[?]|1|deg|TOOTH CANAL|UNILATERAL|DORSAL|ZIEHL NEELSEN ACID FAST STAIN||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|1|Visit_1|10|7|SCREENING|2020-06-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|3|INERTANC|Inertance|[?]|STANDING|[?]|pptr|[?]|1|/4.0 mL|RETROPHARYNGEAL LYMPH NODE|IPSILATERAL|ANTEROMEDIAL|CORONARY ANGIOGRAPHY||||INVESTIGATOR|ONCOLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|4|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|MET*min|[?]|1|mL/m2|TRIGEMINAL NERVE|LEFT|MIDLINE|RADIATION DOSIMETRY||||ADJUDICATOR|ENDOCRINOLOGIST|2|Visit_2|25|7|SCREENING|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-19
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|5|SRAW|Specific Airway Resistance|[?]|SUPINE|[?]|keV|[?]|1|%|GALLBLADDER|LEFT|SUBCORTICAL|ENZYMATIC ULTRACENTRIFUGATION||||PARENT|READER|3|Visit_3|40|3|FOLLOW-UP|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|6|AWVOL|Airway Volume|[?]|STANDING|||[?]|1|Bq/mL|ADDUCTOR MAGNUS MUSCLE|CONTRALATERAL|VENTROLATERAL|ANTIMICROBIAL COMBINATION TESTING|||Y|NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|3|Visit_3|40|2|TREATMENT|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|7|FRC|Functional Residual Capacity|[?]|SUPINE|[?]|deg|[?]|1|Ci/ug|SKIN OF THE HEAD|BILATERAL|VENTROLATERAL|POLYGRAPHY||||SPOUSE|PATHOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|8|RELSZCHG|Relative Size Change|[?]|SEMI-RECUMBENT|[?]|ngEq/L|[?]|1|KALLIKREIN INHIBITOR UNIT|HINDLIMB|UNILATERAL|CENTRAL|POTENTIOMETRY||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|4|Visit_4|65|1|TREATMENT|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|9|FEV1PP|Percent Predicted FEV1|[?]|REVERSE TRENDELENBURG|[?]|SYRINGE|[?]|1|/VF|T6 VERTEBRA|LEFT|MIDLINE|ELECTRICAL IMPEDANCE MYOGRAPHY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|5|Visit_5|90|6|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING, BENT FORWARD|[?]|VIAL|[?]|1|uV|FOOT DIGIT 1|BILATERAL|BASAL|PHOTOGRAPHY||||PARENT|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|1|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|PRESSOR UNITS|[?]|1|/min|TRIANGULAR-HAMATE JOINT|IPSILATERAL|HIND|CALCOFLUOR WHITE STAIN||||GUARDIAN|MICROSCOPIST 3|1|Visit_1|10|6|TREATMENT|2020-12-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|2|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING, BENT FORWARD|||[?]|1|kat|THORACIC ARTERY|UNILATERAL|ANTEROMEDIAL|PHOTOGRAPHY|||Y|FRIEND|RATER|1|Visit_1|10|6|FOLLOW-UP|2020-12-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|PIPE|[?]|1|Enzyme U/m2|LEFT CIRCUMFLEX ARTERY OSTIUM|RIGHT|ANTEROMEDIAL|MICROPARTICLE ENZYME IMMUNOASSAY||||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|2|Visit_2|25|2|TREATMENT|2021-01-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|4|FEV3PP|Percent Predicted FEV3|[?]|SEMI-FOWLERS|[?]|PUFF|[?]|1|MBq/uL|RETINAL PIGMENTED EPITHELIAL LAYER|LATERAL|MIDLINE|TARGETED TRANSCRIPTOME SEQUENCING||||VENDOR|MICROSCOPIST 1|2|Visit_2|25|4|SCREENING|2021-01-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|5|AWVOL|Airway Volume|[?]|SLING|[?]|g/L|[?]|1|mL/m2|THYROID GLAND, LEFT LOBE|IPSILATERAL|FACIAL|COLORIMETRY||Y||INTERVIEWER|PHYSIOTHERAPIST|3|Visit_3|40|4|SCREENING|2021-01-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|6|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-FOWLERS|[?]|ELISA unit/mL|[?]|1|/cmH2O|CHOROID PLEXUS|IPSILATERAL|SUPERFICIAL|HPLC||||CLINICAL RESEARCH ASSOCIATE|INTERNIST|3|Visit_3|40|6|TREATMENT|2021-01-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|7|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SEMI-FOWLERS|[?]|Hz/s|[?]|1|LENS|RIB 3|RIGHT|PROXIMAL VOLAR|NEPHELOMETRY||||CAREGIVER|RADIOLOGIST 2|4|Visit_4|65|4|FOLLOW-UP|2021-02-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|TRENDELENBURG|[?]|OD Unit|[?]|1|ELISA unit/mL|ESOPHAGEAL LYMPH NODE|UNILATERAL|MEDIAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||STUDY SUBJECT|READER 2|4|Visit_4|65|6|TREATMENT|2021-02-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING|[?]|10^6 organisms|[?]|1|Bq/kg|COLON, RIGHT|RIGHT|LOWER EXTENSOR SURFACE|PALM METHOD|Y|||INVESTIGATOR|UROLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|396295ba-9f4c-4689-88c2-f80cb28b567a|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 organisms/mL|[?]|1|scm|UTERINE ARTERY|CONTRALATERAL|BASAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|||STUDY SUBJECT|OPTOMETRIST|5|Visit_5|90|4|TREATMENT|2021-03-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|PRONE|[?]|m2|[?]|1|Watt|RIB 8|RIGHT|BASAL|CHROMATOGRAPHY||||GUARDIAN|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|WASHOUT|2020-08-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|2|TSUELAS|Tissue Elastance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mL/dL|NASOPHARYNX|CONTRALATERAL|MIDLINE|STRESS ECHOCARDIOGRAPHY|||Y|DOMESTIC PARTNER|READER 3|1|Visit_1|10|6|TREATMENT|2020-08-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|3|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|IU/g Hb|[?]|1|BEAM BREAKS|ASCENDING AORTA, SINOTUBULAR JUNCTION|UNILATERAL|DEEP|RADIOIMMUNOPRECIPITATION ASSAY|Y|||SIBLING|MICROSCOPIST 2|2|Visit_2|25|2|FOLLOW-UP|2020-09-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|4|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|||[?]|1|in2|INTERPHALANGEAL JOINT 4 OF THE HAND|IPSILATERAL|PERIVENTRICULAR|SPIRAL CT SCAN WITHOUT CONTRAST|Y|Y|Y|VENDOR|MICROSCOPIST 2|2|Visit_2|25|3|TREATMENT|2020-09-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|5|DLCO|Diffusion Capacity of Lung for CO|[?]|DECUBITUS|[?]|ug/m2/min|[?]|1|Gy/min|AXILLARY LYMPH NODE LEVEL III|BILATERAL|ANTEROLATERAL|FLUORESCENT ENZYME IMMUNOASSAY||||SPOUSE|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2020-09-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|10^6 copies/mL|[?]|1|ug/min|PATELLA|IPSILATERAL|MIDLINE|CELL BASED BIOASSAY||||NON-HEALTH CARE PROFESSIONAL|READER 3|3|Visit_3|40|7|TREATMENT|2020-09-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|7|SALKB|Salazar-Knowles Equation Parameter B|[?]|UNCONSTRAINED|[?]|Joule|[?]|1|10^8 PFU|RIGHT CORONARY ARTERY OSTIUM|LATERAL|OCCIPITAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||Y||HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|4|Visit_4|65|6|TREATMENT|2020-10-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|8|FIFMAXPP|Percent Predicted FIFmax|[?]|SLING|||[?]|1|Enzyme U/m2|ULNA|LATERAL|LOWER EXTENSOR SURFACE|IN SITU HYBRIDIZATION|||Y|ADJUDICATION COMMITTEE|DERMATOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-10-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|9|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|REVERSE TRENDELENBURG|[?]|10^9/g|[?]|1|/2500 WBC|TRAPEZOID BONE|UNILATERAL|ANTERIOR|MAPH||||CAREGIVER|UROLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-11-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|56072c44-67c3-4c93-8db7-2d1570b2bbbc|10|GAW|Airway Conductance|[?]|SLING|[?]|BU/mL|[?]|1|Gy|SPINAL ACCESSORY NERVE|BILATERAL|LOWER FLEXOR SURFACE|SEQUENCING||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|5|Visit_5|90|4|WASHOUT|2020-11-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LATERAL DECUBITUS|[?]|Ci/uL|[?]|1|ug/min|CILIARY BODY|IPSILATERAL|UPPER FLEXOR SURFACE|NUCLEIC ACID HYBRIDIZATION|Y|||STUDY SUBJECT|READER 3|1|Visit_1|10|6|SCREENING|2020-07-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|2|DLCO|Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|[?]|U/10^12 RBC|[?]|1|umol/L/h|ABDOMINAL SKIN|IPSILATERAL|UPPER FLEXOR SURFACE|SLIT LAMP PHOTOGRAPHY||||FAMILY MEMBER|PHYSIOTHERAPIST|1|Visit_1|10|7|TREATMENT|2020-07-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|3|FEV1REV|FEV1 Reversibility|[?]|REVERSE TRENDELENBURG|[?]|Enzyme U/m2|[?]|1|/day|FLEXOR DIGITORUM LONGUS MUSCLE|IPSILATERAL|UPPER|GC/MS-EI|Y|||INDEPENDENT ASSESSOR|RATER 1|2|Visit_2|25|4|TREATMENT|2020-07-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|4|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|TAMPON|[?]|1|L/day|EPICONDYLE|IPSILATERAL|CENTRAL|CLIP||||GUARDIAN|ADJUDICATOR 2|2|Visit_2|25|3|WASHOUT|2020-07-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|5|AWVOLPP|Percent Predicted Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|MHz|[?]|1|HEP|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|UNILATERAL|SUPERFICIAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||FRIEND|MICROSCOPIST|3|Visit_3|40|7|WASHOUT|2020-07-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|6|INFLTIND|Infiltrates Indicator|[?]|SEMI-RECUMBENT|||[?]|1|pmol/g|BACK|LATERAL|DORSOLATERAL|RADIATION DOSIMETRY|||Y|DOMESTIC PARTNER|RATER 2|3|Visit_3|40|1|TREATMENT|2020-07-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|7|DLCOVA|DLCO/VA|[?]|STANDING|[?]|umol/mol|[?]|1|mL/m2/day|POSTERIOR CINGULATE CORTEX|IPSILATERAL|PERIPHERAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||ADJUDICATION COMMITTEE|MICROSCOPIST|4|Visit_4|65|1|TREATMENT|2020-08-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|8|FEV3FVC|FEV3/FVC|[?]|PRONE|||[?]|1|IU/kg|CORONARY ARTERY, ANTERIOR DESCENDING|LEFT|PERIPHERAL|CELL BASED BIOASSAY||Y|Y|CAREGIVER|RATER|4|Visit_4|65|6|TREATMENT|2020-08-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|9|MALEVDES|Malignancy Evidence Description|[?]|STANDING|[?]|keV|[?]|1|g/kg|PUBIC BONE|LATERAL|TIP|PEAK FLOWMETRY||||PARENT|ADJUDICATOR 3|5|Visit_5|90|1|TREATMENT|2020-09-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|55b23180-01f2-498e-a0af-cb9cd7d81750|10|INFLTIND|Infiltrates Indicator|[?]|SEMI-RECUMBENT|||[?]|1|/200 HPFs|TRIANGULAR-HAMATE JOINT|CONTRALATERAL|SURFACE|IMMUNE REPERTOIRE DEEP SEQUENCING||Y|Y|CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|5|Visit_5|90|4|TREATMENT|2020-09-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-14
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|MAC50|COLON, RECTOSIGMOID|LATERAL|MIDLINE|NON-CONTACT SPECULAR MICROSCOPY||Y|Y|ADJUDICATION COMMITTEE|RADIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-11-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|2|ERVPP|Percent Predicted ERV|[?]|SUPINE|[?]|cal|[?]|1|FIU|ESOPHAGUS, THORACIC|BILATERAL|INFERIOR|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|6|TREATMENT|2020-11-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|3|EFFIND|Effusion Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|1/(s*kPa)|[?]|1|umol/min|CINGULATE CORTEX|RIGHT|INTERMEDIATE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|2|Visit_2|25|2|WASHOUT|2020-11-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SEMI-FOWLERS|[?]|copies/mL|[?]|1|ng|DORSALIS PEDIS ARTERY|CONTRALATERAL|UPPER|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y|Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|2|Visit_2|25|6|TREATMENT|2020-11-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|5|FEV1REV|FEV1 Reversibility|[?]|UNCONSTRAINED|[?]|EU|[?]|1|Ci/uL|HAND PHALANX|IPSILATERAL|LOWER MEDIAL|EEG||||CLINICAL STUDY SPONSOR|READER 3|3|Visit_3|40|1|WASHOUT|2020-12-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/kg/dose|[?]|1|pmol/10^9 cells|TIBIALIS POSTERIOR MUSCLE|BILATERAL|PERIPHERAL|REBOUND TONOMETRY|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|3|Visit_3|40|6|TREATMENT|2020-12-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-11
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-RECUMBENT|||[?]|1|DISK|INCISOR|UNILATERAL|ANTEROTEMPORAL|IODINE STAIN||Y|Y|SIGNIFICANT OTHER|RADIOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2021-01-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|8|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|[?]|cd/m2|[?]|1|log10 CCID 50/dose|FASCIA|IPSILATERAL|POSTERIOR|MRS||||FRIEND|DERMATOLOGIST|4|Visit_4|65|7|SCREENING|2021-01-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|9|TGV|Thoracic Gas Volume|[?]|SEMI-FOWLERS|[?]|mL/m2/h|[?]|1|TRANSDUCING UNIT/mL|ANAL VERGE|BILATERAL|OCCIPITAL|POTENTIOMETRY||Y||CHILD|NEUROLOGIST 2|5|Visit_5|90|4|TREATMENT|2021-01-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|10|MIP|Maximal Inspiratory Pressure|[?]|STANDING|[?]|bel|[?]|1|mol/L|ANASTOMOSIS|LEFT|LOWER FLEXOR SURFACE|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||CLINICAL RESEARCH ASSOCIATE|READER 3|5|Visit_5|90|5|TREATMENT|2021-01-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|[?]|umol/L/sec|[?]|1|10^6 IU|PARASPINAL REGION|CONTRALATERAL|FACIAL|THIN SMEAR|Y|||INDEPENDENT ASSESSOR|UROLOGIST|1|Visit_1|10|7|TREATMENT|2020-11-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|2|FVC6|Forced Vital Capacity in 6 Seconds|[?]|UNCONSTRAINED|[?]|nkat|[?]|1|SYRINGE|KIDNEY|IPSILATERAL|LOWER MEDIAL|INTRAVASCULAR ULTRASOUND|Y|Y||ADJUDICATOR|HEMATOLOGIST|1|Visit_1|10|6|TREATMENT|2020-11-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|3|PCF|Peak Cough Flow|[?]|LEFT LATERAL DECUBITUS|[?]|TUBE|[?]|1|mV/sec|LOWER JUGULAR LYMPH NODE|RIGHT|ANTERIOR|INDIRECT IMMUNOFLUORESCENCE||||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|4|FIO2|Fraction of Inspired Oxygen|[?]|STANDING, BENT FORWARD|||[?]|1|CIGAR|FEMORAL VEIN|RIGHT|APICAL|POLYMERASE CHAIN REACTION|||Y|HEALTH CARE PROFESSIONAL|READER 3|2|Visit_2|25|1|TREATMENT|2020-11-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING|[?]|mg/cm2|[?]|1|K|XIPHOID PROCESS|LEFT|ANTEROLATERAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|3|Visit_3|40|6|FOLLOW-UP|2020-12-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|6|FEF2575P|Percent Predicted FEF25-75|[?]|RIGHT LATERAL DECUBITUS|[?]|% INHIBITION|[?]|1|Bq/ug|FINGER EXTENSOR MUSCLES|LATERAL|SUPERFICIAL|ENZYMATIC SPECTROPHOTOMETRY||Y||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-12-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|||[?]|1|dpm/100mg|CONJUNCTIVA|LEFT|PROXIMAL VOLAR|ISHIHARA COLOR PLATES|||Y|PARENT|DERMATOLOGIST|4|Visit_4|65|1|TREATMENT|2021-01-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|8|PLMBLFLW|Pulmonary Blood Flow|[?]|UNCONSTRAINED|[?]|U/m2/min|[?]|1|RING|DISTANT LYMPH NODE|RIGHT|SUPERIOR|ENZYMATIC SPECTROPHOTOMETRY||||ADJUDICATOR|ONCOLOGIST|4|Visit_4|65|7|SCREENING|2021-01-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|9|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|PRONE|[?]|BAU/mL|[?]|1|mg/m2/day|BONE|BILATERAL|VENTROLATERAL|ELASTOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|5|Visit_5|90|2|WASHOUT|2021-02-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|940e4aef-5648-46b3-9c3e-7c40f7930030|10|AWVOLPP|Percent Predicted Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|umol/mg/min|[?]|1|L/L|WRIST JOINT FLEXOR MUSCLES|LATERAL|PERIPHERAL|COMPLEMENT FIXATION||||SPOUSE|ENDOCRINOLOGIST|5|Visit_5|90|2|TREATMENT|2021-02-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|FOWLERS|[?]|pL|[?]|1|ug/animal|RETROPERITONEUM|RIGHT|PERIPHERAL|AGAR PROPORTION||Y||INVESTIGATOR|RADIOLOGIST 1|1|Visit_1|10|2|WASHOUT|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|2|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|ugEq/L|[?]|1|umol/L/sec|CEREBRUM|LATERAL|ANTERIOR|WESTERN BLOT||||VENDOR|RADIOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|PLUG|[?]|1|ug/kg|ESOPHAGUS, UPPER THIRD|RIGHT|BASAL|KARYOTYPING||Y||STUDY SUBJECT|ADJUDICATOR 1|2|Visit_2|25|3|TREATMENT|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|4|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|[?]|oz eq|[?]|1|/mm|FALLOPIAN TUBE|LEFT|VENTRAL|ELECTROGASTROGRAPHY||Y||CLINICAL RESEARCH ASSOCIATE|RATER 1|2|Visit_2|25|1|TREATMENT|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|5|FVC|Forced Vital Capacity|[?]|DECUBITUS|||[?]|1|in2|SKIN OF THE FINGER|UNILATERAL|LOWER EXTENSOR SURFACE|SLOAN LETTER EYE CHART 2.5%||Y|Y|GUARDIAN|RATER 1|3|Visit_3|40|1|FOLLOW-UP|2020-07-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|6|INERTANC|Inertance|[?]|SLING|[?]|ngEq/L|[?]|1|um|INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|SUPERFICIAL|AURAMINE STAIN||Y||GUARDIAN|INTERNIST|3|Visit_3|40|3|FOLLOW-UP|2020-07-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING|[?]|10^3/L|[?]|1|Siemens|COLON, ASCENDING|IPSILATERAL|PROXIMAL VOLAR|HPLC-FL||Y||SIBLING|MICROSCOPIST 2|4|Visit_4|65|3|WASHOUT|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|8|DLCOVA|DLCO/VA|[?]|DECUBITUS|||[?]|1|STRIP|URACHAL TRACT|UNILATERAL|VENTRAL|LEAD CITRATE STAIN|Y||Y|CAREGIVER|OTOLARYNGOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|9|GAW|Airway Conductance|[?]|SITTING, LEGS DEPENDENT|[?]|kcal/day|[?]|1|ug/L FEU|RIB 1|BILATERAL|OCCIPITAL|TRANSMISSION ELECTRON MICROSCOPY|Y|||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|e4bece1e-6672-4b55-824f-56aa923e60f9|10|SAWVOL|Specific Airway Volume|[?]|FOWLERS|[?]|kBq/uL|[?]|1|Torr|SPLENIC LYMPH NODE|CONTRALATERAL|BASAL|EEG|Y|||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|12e607da-f53c-4078-9742-23a111db6f54|1|IC|Inspiratory Capacity|[?]|SEMI-RECUMBENT|[?]|EU|[?]|1|mg/kg/day|COMMON ILIAC LYMPH NODE|BILATERAL|PROXIMAL VOLAR|LANDOLT RING||||DOMESTIC PARTNER|ADJUDICATOR 1|1|Visit_1|10|6|SCREENING|2020-10-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|12e607da-f53c-4078-9742-23a111db6f54|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|GPS U|[?]|1|kN/cm2|INTERNAL ILIAC ARTERY|LEFT|BASAL|BRDU CELLULAR PROLIFERATION ASSAY|Y|Y||PARENT|NEUROLOGIST|1|Visit_1|10|6|WASHOUT|2020-10-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|12e607da-f53c-4078-9742-23a111db6f54|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|DAgU/mL|[?]|1|uV*sec|FLEXOR DIGITORUM BREVIS MUSCLE|UNILATERAL|BASAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||||PROXY|READER|2|Visit_2|25|7|TREATMENT|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|12e607da-f53c-4078-9742-23a111db6f54|4|TSUELAS|Tissue Elastance|[?]|STANDING|[?]|tsp|[?]|1|IU/kg/h|PELVIC BONE|LATERAL|POSTERIOR|SINGLE-MOLECULE ARRAY|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|2|Visit_2|25|3|SCREENING|2020-10-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|12e607da-f53c-4078-9742-23a111db6f54|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SITTING|||[?]|1|mg/min|HIP|LEFT|CENTRAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y||Y|FAMILY MEMBER|UROLOGIST|3|Visit_3|40|3|WASHOUT|2020-11-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|12e607da-f53c-4078-9742-23a111db6f54|6|INTP|Interpretation|[?]|STANDING, BENT FORWARD|||[?]|1|mEq/kg|SCAPHOID-RADIUS JOINT|RIGHT|DORSAL|ERGOSPIROMETRY|||Y|ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-11-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|12e607da-f53c-4078-9742-23a111db6f54|7|FEV3FVC|FEV3/FVC|[?]|TRENDELENBURG|[?]|DRINK|[?]|1|mL/sec/1.73m2|LYMPH NODE HILUM|LATERAL|LOWER FLEXOR SURFACE|CONTACT SPECULAR MICROSCOPY||||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|4|Visit_4|65|6|TREATMENT|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|12e607da-f53c-4078-9742-23a111db6f54|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|/ms|SCAPHOID BONE|RIGHT|UPPER FLEXOR SURFACE|LISSAMINE GREEN STAIN||Y|Y|CAREGIVER|RATER 1|4|Visit_4|65|7|SCREENING|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|12e607da-f53c-4078-9742-23a111db6f54|9|DLCOPP|Percent Predicted DLCO|[?]|LATERAL DECUBITUS|[?]|Osm|[?]|1|QUANTITY SUFFICIENT|THALAMUS|CONTRALATERAL|ANTEROPOSTERIOR|CT SCAN WITHOUT CONTRAST||||INTERVIEWER|READER 2|5|Visit_5|90|1|WASHOUT|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|12e607da-f53c-4078-9742-23a111db6f54|10|DLCOPP|Percent Predicted DLCO|[?]|UNCONSTRAINED|[?]|mL/day|[?]|1|SACHET|FIBULA|LEFT|HIND|CT SCAN||||SIBLING|ONCOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-12-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SUPINE|[?]|GBq/mg|[?]|1|L/day|BILIARY TRACT|LEFT|DISTAL VOLAR|AUTOREFRACTION||||PARENT|NEUROLOGIST 2|1|Visit_1|10|3|WASHOUT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|2|PLMBLFLW|Pulmonary Blood Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|STEPS|ABDOMINAL REGION|RIGHT|ANTEROLATERAL|IMMUNOASSAY|||Y|FRIEND|MICROSCOPIST|1|Visit_1|10|1|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|FOWLERS|[?]|cm H2O|[?]|1|BAU/mL|PARANASAL SINUS|LATERAL|ANTEROPOSTERIOR|LC-FL||Y||STUDY SUBJECT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|7|WASHOUT|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|4|FVC|Forced Vital Capacity|[?]|TRENDELENBURG|||[?]|1|U/kg|PULMONARY VALVE|RIGHT|SUPERFICIAL|OPTICAL COHERENCE TOMOGRAPHY||Y|Y|SIBLING|PATHOLOGIST 2|2|Visit_2|25|7|TREATMENT|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|[?]|mL/cage|[?]|1|uCi/kg|LEFT MAIN CORONARY ARTERY BIFURCATION|UNILATERAL|ANTEROTEMPORAL|POPULATION SEQUENCING||||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|TREATMENT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|mV|[?]|1|cd|PERIPANCREATIC LYMPH NODE|UNILATERAL|UPPER|GC/MS/MS||||CAREGIVER|CLINICAL PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|LENS|[?]|1|cmH2O*s/mL|MEDIASTINAL LYMPH NODE|RIGHT|LATERAL|LIGHT SCATTERING SPECTROSCOPY||Y||CLINICAL STUDY SPONSOR|READER 1|4|Visit_4|65|6|WASHOUT|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|8|TLC|Total Lung Capacity|[?]|UNCONSTRAINED|[?]|m/sec2|[?]|1|PFU/dose|OBTURATOR EXTERNUS MUSCLE|LEFT|PARIETO-OCCIPITAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|Y|||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|4|Visit_4|65|1|SCREENING|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|9|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|Hz/s|[?]|1|CIGARETTE|L4-L5 INTERVERTEBRAL SPACE|CONTRALATERAL|PROXIMAL VOLAR|HPLC/MS||Y||CLINICAL STUDY SPONSOR|DERMATOLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|10|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|log10 PFU/mL|[?]|1|mm/h|HEART, RIGHT ATRIUM|RIGHT|ANTEROLATERAL|MANUAL COUNT|Y|Y||SIBLING|READER|5|Visit_5|90|1|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|||[?]|1|nmol/g|MEDIASTINUM, ANTERIOR|CONTRALATERAL|TEMPORAL|LISSAMINE GREEN STAIN|||Y|INDEPENDENT ASSESSOR|PATHOLOGIST 1|1|Visit_1|10|5|FOLLOW-UP|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING|[?]|ug/min|[?]|1|log10 TCID 50/uL|CONJUNCTIVA|LATERAL|VENTROLATERAL|TEMPLATE INCISION METHOD||Y||HEALTH CARE PROFESSIONAL|RATER 1|1|Visit_1|10|5|FOLLOW-UP|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|3|SGAW|Specific Airway Conductance|[?]|STANDING|[?]|kBq|[?]|1|LB|OBTURATOR MUSCLE|LEFT|ANTERIOR|MICRO BROTH DILUTION|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST 1|2|Visit_2|25|7|SCREENING|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|4|MEPPP|Percent Predicted MEP|[?]|STANDING, BENT FORWARD|[?]|cy/cm|[?]|1|10^8/L|PROXIMAL PHALANX 2 OF THE HAND|BILATERAL|LOWER MEDIAL|CLOT DETECTION|Y|||ADJUDICATOR|MICROSCOPIST 3|2|Visit_2|25|1|WASHOUT|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|5|IC|Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|dmol|PERIURETHRAL REGION|LEFT|PROXIMAL|MACRO BROTH DILUTION|||Y|NON-HEALTH CARE PROFESSIONAL|READER 3|3|Visit_3|40|2|TREATMENT|2020-08-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING|||[?]|1|nkat|PUTAMEN|UNILATERAL|LOWER MEDIAL|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|||Y|ADJUDICATION COMMITTEE|READER 3|3|Visit_3|40|5|SCREENING|2020-08-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|7|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|[?]|U/g|[?]|1|days/wk|ACROMIOCLAVICULAR JOINT|CONTRALATERAL|ROSTRAL|ACCELERATOR MASS SPECTROMETRY||||PROXY|PATHOLOGIST|4|Visit_4|65|5|WASHOUT|2020-09-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|8|EVC|Expiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|Roentgen|[?]|1|SYRINGE|HUMERUS SHAFT|LEFT|CENTRAL|MALDI-TOF||Y||GUARDIAN|ADJUDICATOR 1|4|Visit_4|65|2|SCREENING|2020-09-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|9|FEV1REV|FEV1 Reversibility|[?]|SLING|[?]|Bq/mL|[?]|1|mL/dL|HUMERUS|UNILATERAL|HIND|CINEANGIOGRAPHY||Y||ADJUDICATOR|DERMATOLOGIST|5|Visit_5|90|7|SCREENING|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|10|IRV|Inspiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|EID 50/dose|[?]|1|DAgU|MAMMARY GLAND|CONTRALATERAL|ANTERIOR|ROMANOWSKY STAIN||||PROXY|INTERNIST|5|Visit_5|90|7|TREATMENT|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|1|MEP|Maximal Expiratory Pressure|[?]|STANDING, BENT FORWARD|||[?]|1|ug/g/day|CARPOMETACARPAL JOINT 2|UNILATERAL|ANTEROMEDIAL|MEDIASTINOSCOPY||Y|Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|1|Visit_1|10|4|TREATMENT|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|2|FEV1REV|FEV1 Reversibility|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/100g/min|PROXIMAL INTERPHALANGEAL JOINT 4|UNILATERAL|UPPER|TRIPLE-PHASE MRI SCAN||Y|Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|1|Visit_1|10|7|TREATMENT|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|3|PNEUMIND|Pneumonia Indicator|[?]|SUPINE|[?]|IU/mmol|[?]|1|ECL unit|DISTAL INTERPHALANGEAL JOINT 5|UNILATERAL|BASAL|ELECTROGASTROGRAPHY||||INTERVIEWER|ONCOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|4|TGV|Thoracic Gas Volume|[?]|TRENDELENBURG|[?]|vg/dose|[?]|1|PUFF|BRACHIAL LYMPH NODE|RIGHT|ANTEROMEDIAL|NO INFORMATION||||STUDY SUBJECT|ADJUDICATOR 3|2|Visit_2|25|3|TREATMENT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|5|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|ug/kg/min|[?]|1|IU/g|ANTERIOR HORN OF THE LATERAL VENTRICLE|BILATERAL|LOWER|BALLPOINT PEN TECHNIQUE||Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|3|Visit_3|40|6|WASHOUT|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|6|ALVVOL|Alveolar Volume|[?]|UNCONSTRAINED|[?]|Sv|[?]|1|10^7 CFU|EXTRAOCULAR MUSCLE|LATERAL|DISTAL|LANDOLT RING||||PROXY|READER 1|3|Visit_3|40|3|WASHOUT|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|FOWLERS|[?]|rpm|[?]|1|EU|SALIVARY GLAND|LEFT|LOWER EXTENSOR SURFACE|KLEIHAUER-BETKE||Y||DOMESTIC PARTNER|ADJUDICATOR 3|4|Visit_4|65|5|FOLLOW-UP|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|8|PNIF|Peak Nasal Inspiratory Flow|[?]|FOWLERS|[?]|TRANSDUCING UNIT/mL|[?]|1|Sv|URETHRA|LEFT|MIDLINE|ETDRS EYE CHART||||CAREGIVER|INTERNIST|4|Visit_4|65|3|WASHOUT|2020-07-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|9|PNEUMIND|Pneumonia Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|cm/s|[?]|1|kPa|PALATINE BONE|CONTRALATERAL|ANTEROLATERAL|ELISPOT|Y|||GUARDIAN|NEUROLOGIST 1|5|Visit_5|90|6|TREATMENT|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|3260122d-3bf4-45ff-a026-2379158721d0|10|OXYPULSE|Oxygen Pulse|[?]|PRONE|[?]|APL U/mL|[?]|1|mg/m2/day|TRICUSPID VALVE|BILATERAL|FRONTAL|WHOLE TRANSCRIPTOME SEQUENCING||||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|7|TREATMENT|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-FOWLERS|[?]|SQU/mL|[?]|1|dyn|CARDIOVASCULAR SYSTEM|CONTRALATERAL|ANTEROLATERAL|TOTAL BODY IRRADIATION||||PARENT|PEDIATRIC NEUROLOGIST|1|Visit_1|10|4|SCREENING|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|2|TGV|Thoracic Gas Volume|[?]|SITTING|[?]|nkat/g Hb|[?]|1|mL/animal|COLON, TRANSVERSE|RIGHT|UPPER FLEXOR SURFACE|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||ADJUDICATOR|MICROSCOPIST|1|Visit_1|10|6|SCREENING|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|3|EFFVOL|Effusion Volume|[?]|UNCONSTRAINED|||[?]|1|dyn|PROXIMAL INTERPHALANGEAL JOINT 4|LATERAL|PERIVENTRICULAR|MICRODENSITOMETRY|||Y|GUARDIAN|ADJUDICATOR 2|2|Visit_2|25|1|TREATMENT|2020-11-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|4|AWVOL|Airway Volume|[?]|SITTING|[?]|mg/kg|[?]|1|cm|CARPOMETACARPAL JOINT|CONTRALATERAL|INFERIOR|HPLC/MS|Y|Y||INDEPENDENT ASSESSOR|ADJUDICATOR 3|2|Visit_2|25|4|TREATMENT|2020-11-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|5|ERVPP|Percent Predicted ERV|[?]|TRENDELENBURG|[?]|10^5/hpf|[?]|1|TAMPON|POSTERIOR TIBIAL ARTERY|BILATERAL|APICAL|RADIAL IMMUNODIFFUSION||||GUARDIAN|NEUROLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-12-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|6|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING, LEGS DEPENDENT|[?]|mL/mmHg/min/L|[?]|1|g/cage/wk|DIAPHRAGM|UNILATERAL|SUPERIOR|ELECTRONEUROGRAPHY||||SIGNIFICANT OTHER|RATER 1|3|Visit_3|40|3|FOLLOW-UP|2020-12-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|7|MEPPP|Percent Predicted MEP|[?]|DECUBITUS|||[?]|1|nkat|LACRIMAL GLAND|CONTRALATERAL|HIND|CLAUSS METHOD|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|4|Visit_4|65|6|WASHOUT|2020-12-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|8|DLCO|Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|atm|[?]|1|um/day|KNEE JOINT TENDONS|IPSILATERAL|INNER|KINETIC CHROMOGENIC ASSAY||||FRIEND|MICROSCOPIST|4|Visit_4|65|7|TREATMENT|2020-12-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|SLING|[?]|ohm|[?]|1|C|SCALP|LEFT|PERIVENTRICULAR|PERCUSSION||||ADJUDICATION COMMITTEE|NEUROLOGIST 1|5|Visit_5|90|6|WASHOUT|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|05eb4e29-887e-4cdb-8854-49939a8a13d1|10|INERTANC|Inertance|[?]|UNCONSTRAINED|[?]|ug/kg/min|[?]|1|mg/kg/h|LENS|CONTRALATERAL|DISTAL VOLAR|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||SIBLING|RATER|5|Visit_5|90|4|TREATMENT|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-08
e|RE|c8390c70-766d-4252-9356-39591651bcdf|1|ERVPP|Percent Predicted ERV|[?]|SLING|[?]|ppm|[?]|1|mV*min|ESOPHAGUS, THORACIC|LEFT|PERIPHERAL|RAJI CELL EIA||||SPOUSE|MICROSCOPIST 2|1|Visit_1|10|7|TREATMENT|2020-08-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|c8390c70-766d-4252-9356-39591651bcdf|2|RRS|Total Respiratory System Resistance|[?]|SEMI-FOWLERS|[?]|uV|[?]|1|dyn|SKIN OF THE LOWER LIMB|CONTRALATERAL|INNER|GC/MS-EI||||FAMILY MEMBER|RATER|1|Visit_1|10|7|TREATMENT|2020-08-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|c8390c70-766d-4252-9356-39591651bcdf|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|||[?]|1|PIXELS/in|ENDOCERVIX|CONTRALATERAL|ANTEROTEMPORAL|KINYOUN STAIN||Y|Y|NON-HEALTH CARE PROFESSIONAL|READER|2|Visit_2|25|7|SCREENING|2020-08-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|c8390c70-766d-4252-9356-39591651bcdf|4|RELSZCHG|Relative Size Change|[?]|STANDING|[?]|mg/animal|[?]|1|mm|PERIPANCREATIC LYMPH NODE|LEFT|OCCIPITAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|2|Visit_2|25|3|SCREENING|2020-08-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|c8390c70-766d-4252-9356-39591651bcdf|5|DLCOHC|HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|cmH2O*s2/mL|[?]|1|mN|COLON, ASCENDING|RIGHT|VENTROLATERAL|TONOMETRY|Y|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|c8390c70-766d-4252-9356-39591651bcdf|6|PIF|Peak Inspiratory Flow|[?]|STANDING|[?]|genEq/mL|[?]|1|cm H2O|INSULAR CORTEX|IPSILATERAL|ANTEROPOSTERIOR|DIGITAL PCR|Y|||STUDY SUBJECT|RATER 2|3|Visit_3|40|5|FOLLOW-UP|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|c8390c70-766d-4252-9356-39591651bcdf|7|INTP|Interpretation|[?]|DECUBITUS|[?]|mL/min/1.73m2|[?]|1|L/h|ILIUM|BILATERAL|VENTRAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||GUARDIAN|ADJUDICATOR 3|4|Visit_4|65|7|FOLLOW-UP|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|c8390c70-766d-4252-9356-39591651bcdf|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|[?]|mg/L FEU|[?]|1|keV|ACETABULUM|BILATERAL|SUPERFICIAL|BRDU CELLULAR PROLIFERATION ASSAY|Y|||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|4|Visit_4|65|6|WASHOUT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|c8390c70-766d-4252-9356-39591651bcdf|9|SRAW|Specific Airway Resistance|[?]|STANDING|||[?]|1|BOTTLE|TYMPANIC MEMBRANE|RIGHT|ANTEROPOSTERIOR|REBOUND TONOMETRY|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 2|5|Visit_5|90|4|TREATMENT|2020-10-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|c8390c70-766d-4252-9356-39591651bcdf|10|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|||[?]|1|10^10/L|AORTIC VALVE|IPSILATERAL|PERIPHERAL|MICROBIAL CULTURE, SOLID|||Y|SPOUSE|UROLOGIST|5|Visit_5|90|7|SCREENING|2020-10-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|a40bf877-c070-40b3-89df-d566b942246e|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-FOWLERS|[?]|mmol/min/kPa/L|[?]|1|nkat|INFERIOR VENA CAVA|LATERAL|HIND|AUSCULTATION||||PROXY|MICROSCOPIST 2|1|Visit_1|10|4|FOLLOW-UP|2020-06-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|a40bf877-c070-40b3-89df-d566b942246e|2|IRVPP|Percent Predicted IRV|[?]|SEMI-RECUMBENT|[?]|10^6 CFU/mL|[?]|1|umol/mg/min|LUNG, RIGHT|RIGHT|FRONTAL|ATOMIC ABSORPTION SPECTROMETRY|Y|Y||SIBLING|ADJUDICATOR 1|1|Visit_1|10|1|TREATMENT|2020-06-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|a40bf877-c070-40b3-89df-d566b942246e|3|IC|Inspiratory Capacity|[?]|TRENDELENBURG|[?]|mCi/kg|[?]|1|L|COLON|RIGHT|OUTER|VENTILATION PERFUSION LUNG SCAN||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|2|Visit_2|25|4|TREATMENT|2020-07-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|a40bf877-c070-40b3-89df-d566b942246e|4|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|||[?]|1|DNA copies/mL|CARPOMETACARPAL JOINT 1|IPSILATERAL|DISTAL|CRYOSCOPY||Y|Y|NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|2|Visit_2|25|2|WASHOUT|2020-07-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|a40bf877-c070-40b3-89df-d566b942246e|5|ELSTNCE|Elastance|[?]|UNCONSTRAINED|[?]|ngEq/L|[?]|1|AFU|MANDIBLE|RIGHT|FORE|MACRO BROTH DILUTION||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|3|Visit_3|40|5|SCREENING|2020-07-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|a40bf877-c070-40b3-89df-d566b942246e|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|||[?]|1|nmol BCE/nmol|LUNG, LEFT|BILATERAL|MEDIAL|FLUORESCENCE ANGIOGRAPHY|||Y|INVESTIGATOR|DERMATOLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|a40bf877-c070-40b3-89df-d566b942246e|7|SVC|Slow Vital Capacity|[?]|DECUBITUS|[?]|deg/mm|[?]|1|/day|METACARPOPHALANGEAL JOINT 4|BILATERAL|BASAL|IMMUNOFLUORESCENT STAIN||||SIBLING|PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|a40bf877-c070-40b3-89df-d566b942246e|8|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|||[?]|1|TUBE|PARACOLIC GUTTER|RIGHT|TEMPORAL|PET/CT SCAN WITHOUT CONTRAST|||Y|INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|a40bf877-c070-40b3-89df-d566b942246e|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|[?]|mmAL|[?]|1|Newton|COMMON FEMORAL VEIN|LATERAL|TEMPORAL|NUCLEIC ACID HYBRIDIZATION||||STUDY SUBJECT|HEMATOLOGIST|5|Visit_5|90|2|WASHOUT|2020-09-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|a40bf877-c070-40b3-89df-d566b942246e|10|LOBVOL|Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|10^6 organisms/mL|[?]|1|vg/dose|ABDOMINAL AORTA|UNILATERAL|FRONTAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|||INTERVIEWER|ADJUDICATOR 1|5|Visit_5|90|5|SCREENING|2020-09-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|IRVPP|Percent Predicted IRV|[?]|STANDING, BENT FORWARD|[?]|10^7/L|[?]|1|/LSQN|AXILLARY LYMPH NODE LEVEL II|RIGHT|INFERIOR|LEAD CITRATE STAIN|Y|||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|1|Visit_1|10|2|WASHOUT|2021-01-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|2|PEF|Peak Expiratory Flow|[?]|FOWLERS|[?]|WEEKS|[?]|1|dpm/0.5 mL|RECTO-UTERINE POUCH|RIGHT|VOLAR|ELECTROMYOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|1|Visit_1|10|3|TREATMENT|2021-01-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|3|AWVOL|Airway Volume|[?]|PRONE|||[?]|1|ng/day|ENDOMETRIAL CAVITY|BILATERAL|PERIVENTRICULAR|ANALYTICAL ULTRACENTRIFUGATION|Y|Y|Y|ADJUDICATOR|PATHOLOGIST 2|2|Visit_2|25|6|FOLLOW-UP|2021-01-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|SACHET|[?]|1|mL/g/min|LEFT VENTRICULAR EPICARDIUM|LATERAL|SUBCORTICAL|IODINE STAIN|Y|||SIGNIFICANT OTHER|PHYSIOTHERAPIST|2|Visit_2|25|2|WASHOUT|2021-01-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|5|AWVOL|Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|V|SPLEEN|RIGHT|VENTROLATERAL|TRIPLE-PHASE MRI SCAN|||Y|FAMILY MEMBER|READER 1|3|Visit_3|40|6|SCREENING|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|Ci/uL|[?]|1|U/kg/min|THYROID GLAND|LEFT|LOWER|BAC ACGH||||INTERVIEWER|ONCOLOGIST 1|3|Visit_3|40|1|FOLLOW-UP|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|7|AIRTRAP|Air Trapping|[?]|DECUBITUS|[?]|/MBP|[?]|1|10^6 DNA copies/mL|SHIN|IPSILATERAL|DISTAL VOLAR|MOUSE PROTECTION ASSAY||Y||DOMESTIC PARTNER|RATER 2|4|Visit_4|65|3|WASHOUT|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|8|ALVVOL|Alveolar Volume|[?]|SUPINE|||[?]|1|ng/L|KIDNEY|LATERAL|LATERAL|DC SHEATH FLOW|||Y|FRIEND|ADJUDICATOR 2|4|Visit_4|65|2|TREATMENT|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|PRONE|[?]|/500 WBC|[?]|1|cm2|ASCENDING AORTA|UNILATERAL|LOWER EXTENSOR SURFACE|HPLC/IEX||||PROXY|CARDIOLOGIST|5|Visit_5|90|1|TREATMENT|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|RE|e9633621-3d08-4b47-b394-5bd3fa47c07f|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mg/m2/day|[?]|1|ug/m2/min|ANTRUM PYLORI|CONTRALATERAL|TEMPORAL|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|||PARENT|ONCOLOGIST|5|Visit_5|90|7|SCREENING|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|DECUBITUS|[?]|pt_br|[?]|1|10^3 DNA copies/mL|DISTAL COMMON BILE DUCT|UNILATERAL|SURFACE|PUPILLOMETRY||||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|1|Visit_1|10|4|TREATMENT|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|2|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|mL/m2/day|[?]|1|mm3/mm2/year|PROXIMAL PHALANX 5 OF THE HAND|LEFT|PERIPHERAL|X-RAY|Y|||FAMILY MEMBER|MICROSCOPIST 1|1|Visit_1|10|2|TREATMENT|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|3|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-FOWLERS|||[?]|1|100 IU/mL|HARD PALATE|IPSILATERAL|DORSOLATERAL|FREEZING POINT DEPRESSION|Y|Y|Y|CHILD|FORENSIC PATHOLOGIST|2|Visit_2|25|4|WASHOUT|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|4|DLCOPP|Percent Predicted DLCO|[?]|LATERAL DECUBITUS|||[?]|1|mg/kg/day|LYMPH NODE HILUM|RIGHT|SURFACE|DYNAMIC LIGHT SCATTERING|||Y|INVESTIGATOR|OPHTHALMOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|[?]|/LPF|[?]|1|kg/m2|COMMON FEMORAL VEIN|BILATERAL|ANTEROPOSTERIOR|MIGET|Y|||PARENT|ONCOLOGIST 2|3|Visit_3|40|2|SCREENING|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|6|FEV1FVC6|FEV1/FVC6|[?]|PRONE|||[?]|1|kg/L|CUBOID BONE|LATERAL|LATERAL|MAPH||Y|Y|FRIEND|ADJUDICATOR 2|3|Visit_3|40|2|WASHOUT|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|7|FVC|Forced Vital Capacity|[?]|UNCONSTRAINED|[?]|umol/day|[?]|1|mg/kg/dose|EPIDIDYMIS|RIGHT|LOWER|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|8|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|||[?]|1|POUCH|C6 VERTEBRA|LATERAL|UPPER|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|||Y|CAREGIVER|READER|4|Visit_4|65|6|SCREENING|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|9|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|pg/cell|[?]|1|mJoule/cm2|SUPERIOR VENA CAVA|RIGHT|LOWER FLEXOR SURFACE|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|||PARENT|PHYSIOTHERAPIST|5|Visit_5|90|2|TREATMENT|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|10|LCI|Lung Clearance Index|[?]|STANDING, BENT FORWARD|[?]|mL/cage|[?]|1|U/kg|ESOPHAGEAL LYMPH NODE|RIGHT|OUTER|DISK DIFFUSION||Y||CHILD|ONCOLOGIST|5|Visit_5|90|1|SCREENING|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|IU/L|TRICUSPID VALVE, ANTERIOR CUSP|LATERAL|NASAL|RADIATION DOSIMETRY|||Y|PROXY|MICROSCOPIST 3|1|Visit_1|10|5|SCREENING|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|2|PEF|Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|U/mmol|[?]|1|BOLUS|CHOROID|IPSILATERAL|NASAL|ISHIHARA COLOR PLATES||||CHILD|MICROSCOPIST 3|1|Visit_1|10|6|WASHOUT|2020-07-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|3|RAW|Airway Resistance|[?]|LEFT LATERAL DECUBITUS|||[?]|1|kV|PERIPANCREATIC LYMPH NODE|CONTRALATERAL|MIDLINE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|||Y|GUARDIAN|NEUROLOGIST 1|2|Visit_2|25|5|WASHOUT|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|anti-Xa IU|[?]|1|umol/mg/min|PROXIMAL PHALANX 1 OF THE HAND|RIGHT|DEEP|CT SCAN WITHOUT CONTRAST||||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-07-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SLING|[?]|Bq/uL|[?]|1|ft2|ABDOMINAL AORTA|LEFT|SUPERIOR|PERIPHERAL ANGIOGRAPHY||||ADJUDICATION COMMITTEE|UROLOGIST|3|Visit_3|40|6|SCREENING|2020-08-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|6|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING|||[?]|1|mL/min/1.73m2|COLON, LEFT|RIGHT|FACIAL|DIFFUSION TENSOR MRI|||Y|FAMILY MEMBER|RADIOLOGIST 2|3|Visit_3|40|3|FOLLOW-UP|2020-08-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|7|ERVPP|Percent Predicted ERV|[?]|TRENDELENBURG|||[?]|1|mJoule/cm2|PROSTATE GLAND|UNILATERAL|ROSTRAL|ENDOSCOPY|||Y|PARENT|FORENSIC PATHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-09-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|8|RELSZCHG|Relative Size Change|[?]|SITTING|[?]|SUPPOSITORY|[?]|1|fL|GENITOURINARY SYSTEM|LATERAL|APICAL|TRIPLE-PHASE SPIRAL CT SCAN|Y|||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|4|Visit_4|65|6|TREATMENT|2020-09-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|9|PIF|Peak Inspiratory Flow|[?]|SLING|[?]|cg|[?]|1|deg/s|URETER|IPSILATERAL|PARIETO-OCCIPITAL|HPLC/IEX||||GUARDIAN|MICROSCOPIST 2|5|Visit_5|90|4|SCREENING|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|10|FIF75|Forced Inspiratory Flow at 75%|[?]|LEFT LATERAL DECUBITUS|[?]|mmol|[?]|1|BP|CEREBELLUM|CONTRALATERAL|ANTERIOR|GRAM STAIN||Y||HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|5|Visit_5|90|2|SCREENING|2020-10-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|1|RRS|Total Respiratory System Resistance|[?]|SEMI-FOWLERS|[?]|IU/dL|[?]|1|mg/m2/min|ETHMOID SINUS|RIGHT|LOWER FLEXOR SURFACE|RIA||||INDEPENDENT ASSESSOR|RADIOLOGIST|1|Visit_1|10|2|SCREENING|2020-10-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|2|AWVOL|Airway Volume|[?]|SEMI-FOWLERS|[?]|mmol/min/kPa/L|[?]|1|pkat/L|THYROID GLAND|RIGHT|VENTRAL|KINETIC MICROPARTICLE IMMUNOASSAY||||HEALTH CARE PROFESSIONAL|READER|1|Visit_1|10|2|TREATMENT|2020-10-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|3|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|mL/100g/min|[?]|1|mg/kg/week|TRUNK|BILATERAL|INNER|TOTAL BODY RADIOGRAPHY||Y||ADJUDICATOR|PHYSIOTHERAPIST|2|Visit_2|25|5|SCREENING|2020-10-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|mL*cmH2O|[?]|1|GPL U/mL|MAXILLA|IPSILATERAL|OUTER|ENZYMATIC ULTRACENTRIFUGATION|Y|Y||FAMILY MEMBER|RADIOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-10-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-25
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|5|PEF|Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|SFC/10^6 PBMC|[?]|1|mU/L|FACE|UNILATERAL|ANTEROMEDIAL|IMMUNOFIXATION ELECTROPHORESIS||Y||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|3|Visit_3|40|2|WASHOUT|2020-11-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|6|FIF75|Forced Inspiratory Flow at 75%|[?]|LATERAL DECUBITUS|||[?]|1|10^9 CFU/g|MAXILLA|CONTRALATERAL|UPPER EXTENSOR SURFACE|PHYSICAL EXAMINATION||Y|Y|INTERVIEWER|OPTOMETRIST|3|Visit_3|40|1|TREATMENT|2020-11-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|UNCONSTRAINED|||[?]|1|10^9 organisms/g|CLAVICLE|UNILATERAL|ANTEROLATERAL|LEAD CITRATE STAIN|||Y|NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-11-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|8|TV|Tidal Volume|[?]|SITTING|||[?]|1|cm|JEJUNUM|RIGHT|HIND|FLUORESCEIN STAIN|||Y|ADJUDICATION COMMITTEE|PATHOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-11-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|9|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING|[?]|mm/min|[?]|1|mEq/ug|BACK|RIGHT|LOWER EXTENSOR SURFACE|MRS|Y|Y||INVESTIGATOR|HEMATOLOGIST|5|Visit_5|90|2|TREATMENT|2020-12-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|63f43990-e56e-440c-a445-76e7d114cf26|10|RV|Residual Volume|[?]|SEMI-RECUMBENT|[?]|WEEKS|[?]|1|log10 TCID 50/mL|SUBSCAPULARIS MUSCLE|CONTRALATERAL|CRANIAL|PAP STAIN|Y|||CHILD|ADJUDICATOR 2|5|Visit_5|90|4|SCREENING|2020-12-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-RECUMBENT|[?]|umol/mol|[?]|1|PRESSOR UNITS|ULNA SHAFT|LATERAL|BASAL|HPLC/IEX||||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|4|TREATMENT|2020-10-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|2|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|uCi|[?]|1|yd|T2 VERTEBRA|IPSILATERAL|INNER|WRIGHT STAIN|Y|||GUARDIAN|RATER 2|1|Visit_1|10|7|WASHOUT|2020-10-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|3|FEF50|Forced Expiratory Flow 50%|[?]|TRENDELENBURG|[?]|MPL U|[?]|1|mL/kg|THIRD RIGHT POSTEROLATERAL ARTERY|UNILATERAL|SUPERIOR|MICROBIAL CULTURE, LIQUID|Y|Y||ADJUDICATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2020-11-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|FOWLERS|[?]|IU/g|[?]|1|vp/dose|MEDIASTINUM, ANTERIOR|LEFT|ANTEROMEDIAL|PATHOLOGICAL EVALUATION||||PROXY|ONCOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-11-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|5|TLC|Total Lung Capacity|[?]|SUPINE|[?]|Ci/g|[?]|1|mL/kg/min|SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|TIP|GC/MS-EI|Y|||GUARDIAN|UROLOGIST|3|Visit_3|40|7|WASHOUT|2020-11-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|6|FVC|Forced Vital Capacity|[?]|UNCONSTRAINED|[?]|mL/(min*100mL)|[?]|1|in|RENAL ARTERY|IPSILATERAL|PERIPHERAL|SPECULAR MICROSCOPY||||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|3|Visit_3|40|1|TREATMENT|2020-11-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|7|MALEVDES|Malignancy Evidence Description|[?]|STANDING|[?]|10^9 CFU|[?]|1|AFU|PUTAMEN|BILATERAL|VOLAR|ECHOCARDIOGRAPHY||||DOMESTIC PARTNER|OPTOMETRIST|4|Visit_4|65|2|SCREENING|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|8|EFFVOL|Effusion Volume|[?]|SEMI-RECUMBENT|[?]|dpm/mL|[?]|1|POUCH|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|RIGHT|FACIAL|OPTICAL COHERENCE TOMOGRAPHY||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|4|Visit_4|65|1|SCREENING|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|9|FIV1PP|Percent Predicted FIV1|[?]|STANDING, BENT FORWARD|[?]|DAgU/mL|[?]|1|cy/cm|LOWER RESPIRATORY SYSTEM|IPSILATERAL|SUPERIOR|TRIPLE-PHASE SPIRAL CT SCAN|Y|||GUARDIAN|ONCOLOGIST 1|5|Visit_5|90|5|FOLLOW-UP|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|380c89f4-2650-4a54-92f5-5e1278b9a91e|10|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|g/g|[?]|1|days/wk|PLEURAL CAVITY|CONTRALATERAL|MEDIAL|WRIGHT STAIN||||VENDOR|NEUROLOGIST 2|5|Visit_5|90|2|TREATMENT|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LATERAL DECUBITUS|||[?]|1|SYRINGE|HILAR|UNILATERAL|LOWER|CLIP||Y|Y|FRIEND|FORENSIC PATHOLOGIST|1|Visit_1|10|2|SCREENING|2020-12-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|2|AWVOL|Airway Volume|[?]|SUPINE|[?]|Hz|[?]|1|PIXEL|MIDDLE PHALANX 5 OF THE HAND|UNILATERAL|HIND|HILLMEN COLOR CHART|Y|||NON-HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|5|FOLLOW-UP|2020-12-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|3|RER|Respiratory Exchange Ratio|[?]|SEMI-RECUMBENT|[?]|mL/sec/1.73m2|[?]|1|mL/min/1.73m2|PERIPHERAL NERVE|LATERAL|APICAL|ORCHIDOMETERY|Y|||FAMILY MEMBER|ADJUDICATOR 3|2|Visit_2|25|5|SCREENING|2020-12-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|foz_br|[?]|1|sec|SECOND DIAGONAL BRANCH ARTERY|RIGHT|ANTEROPOSTERIOR|LYMPHANGIOGRAPHY||||SIBLING|READER 1|2|Visit_2|25|2|TREATMENT|2020-12-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|5|PEF|Peak Expiratory Flow|[?]|PRONE|[?]|mm3/mm2/year|[?]|1|MET*min|LEFT POSTEROLATERAL DESCENDING ARTERY|RIGHT|APICAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|Y||CAREGIVER|READER 1|3|Visit_3|40|5|TREATMENT|2021-01-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|6|AWVOL|Airway Volume|[?]|SLING|[?]|vp/dose|[?]|1|dL|SACRUM|BILATERAL|DISTAL VOLAR|IODINE STAIN||Y||SPOUSE|ONCOLOGIST 1|3|Visit_3|40|7|TREATMENT|2021-01-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SLING|[?]|CAPLET|[?]|1|WEEKS|SKIN OF THE CHIN|UNILATERAL|VOLAR|FLOCCULATION||||NON-HEALTH CARE PROFESSIONAL|INTERNIST|4|Visit_4|65|3|TREATMENT|2021-01-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|8|ICREV|IC Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|mPa|[?]|1|kBq|SKIN OF THE BUTTOCK|BILATERAL|UPPER EXTENSOR SURFACE|WESTERGREN|Y|||SIBLING|MICROSCOPIST 2|4|Visit_4|65|7|TREATMENT|2021-01-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|9|MALIND|Malignancy Indicator|[?]|FOWLERS|||[?]|1|Rad|TRACHEOBRONCHIAL TREE|RIGHT|PERIPHERAL|MICROSCOPY|Y||Y|CAREGIVER|OTOLARYNGOLOGIST|5|Visit_5|90|6|TREATMENT|2021-02-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|84c1f5f4-6415-49d8-b854-22e7529d65b6|10|FIF25|Forced Inspiratory Flow at 25%|[?]|LATERAL DECUBITUS|||[?]|1|pptr|L4-L5 INTERVERTEBRAL SPACE|IPSILATERAL|CENTRAL|CONTRAST ENHANCED CT SCAN|||Y|INVESTIGATOR|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2021-02-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|[?]|cP|[?]|1|1/(s*kPa)|TROCHLEAR NERVE|UNILATERAL|DISTAL VOLAR|FUNCTIONAL MRI||||ADJUDICATOR|READER|1|Visit_1|10|1|SCREENING|2020-05-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-08
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|2|MALEVDES|Malignancy Evidence Description|[?]|LEFT LATERAL DECUBITUS|||[?]|1|BOLUS|T5 VERTEBRA|CONTRALATERAL|BASAL|PHOTOMETRIC CLOT DETECTION|Y|Y|Y|ADJUDICATOR|RADIOLOGIST 2|1|Visit_1|10|7|FOLLOW-UP|2020-05-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-08
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|mg/mL/day|[?]|1|10^7/L|PULMONARY VALVE, ANTERIOR CUSP|UNILATERAL|SURFACE|DXA SCAN||||DOMESTIC PARTNER|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2020-05-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|STANDING, BENT FORWARD|[?]|CUP|[?]|1|DIP|KIDNEY, LOWER LOBE|IPSILATERAL|OUTER|SEQUENCING||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 3|2|Visit_2|25|2|TREATMENT|2020-05-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|5|LOBVOL|Lobar Volume|[?]|SLING|[?]|10^7 PFU|[?]|1|mL/cage/wk|PENIS, RADIX|LATERAL|CENTRAL|NEPHELOMETRY|Y|||INVESTIGATOR|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2020-06-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|6|DLCO|Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|lx|[?]|1|steps/min|TEMPOROMANDIBULAR JOINT|RIGHT|CAUDAL|POTENTIOMETRY||||SPOUSE|ONCOLOGIST|3|Visit_3|40|1|SCREENING|2020-06-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|PRONE|[?]|10^3 CFU|[?]|1|mg/dL|VASTUS INTERMEDIUS MUSCLE|LEFT|ANTEROTEMPORAL|PHOTOMETRY||Y||STUDY SUBJECT|MICROSCOPIST 3|4|Visit_4|65|3|FOLLOW-UP|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SITTING|[?]|L/min|[?]|1|g/dL|VAGINA|RIGHT|FACIAL|MEDIASTINOSCOPY||||CAREGIVER|READER|4|Visit_4|65|1|TREATMENT|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|9|RELSZCHG|Relative Size Change|[?]|SITTING, LEGS DEPENDENT|[?]|CARTRIDGE|[?]|1|PACKAGE|PANCREAS, TAIL|BILATERAL|DEEP|MULTIPLEXED BEAD BASED IMMUNOASSAY||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|RE|77c26a0c-0c84-44d7-8351-a50f3236e59a|10|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|[?]|L/kg|[?]|1|10^3 DNA copies/mL|TRIANGULAR-HAMATE JOINT|IPSILATERAL|VENTROLATERAL|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||SIBLING|READER 1|5|Visit_5|90|3|TREATMENT|2020-08-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|1|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|nmol BCE/L|[?]|1|amp|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|BILATERAL|PROXIMAL|JAEGER EYE CHART|Y|||ADJUDICATION COMMITTEE|MICROSCOPIST 3|1|Visit_1|10|6|TREATMENT|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|2|RER|Respiratory Exchange Ratio|[?]|UNCONSTRAINED|[?]|DAgU|[?]|1|kBq|PANCREAS, HEAD|IPSILATERAL|SUPERIOR|ULTRASOUND||||FRIEND|READER 3|1|Visit_1|10|3|SCREENING|2020-08-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|3|FIF75|Forced Inspiratory Flow at 75%|[?]|SITTING, LEGS DEPENDENT|[?]|BOX|[?]|1|SBE/mL|KIDNEY, LOWER LOBE|UNILATERAL|LOWER|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|||SIBLING|RADIOLOGIST|2|Visit_2|25|4|SCREENING|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|4|ALVVOL|Alveolar Volume|[?]|SITTING, LEGS DEPENDENT|[?]|10^3/L|[?]|1|10^3/hpf|METACARPAL BONE 5|CONTRALATERAL|OCCIPITAL|DISK DIFFUSION||||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|5|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING|[?]|10^9 CFU/g|[?]|1|Osm|L4 VERTEBRA|CONTRALATERAL|CENTRAL|TRIPLE-PHASE MRI SCAN||||CHILD|OTOLARYNGOLOGIST|3|Visit_3|40|5|SCREENING|2020-09-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|PUFF|[?]|1|mEq/dL|PARANASAL SINUS|LEFT|MEDIAL|LEAD CITRATE STAIN||||INTERVIEWER|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-09-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|7|IRV|Inspiratory Reserve Volume|[?]|TRENDELENBURG|[?]|10^3 organisms/g|[?]|1|pmol/day|ANTRUM PYLORI|LATERAL|SUPERFICIAL|DC SHEATH FLOW||||GUARDIAN|DERMATOLOGIST|4|Visit_4|65|3|WASHOUT|2020-09-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|8|SALKK|Salazar-Knowles Equation, K|[?]|STANDING, BENT FORWARD|[?]|10^11/L|[?]|1|PFU/mL|DISTAL INTERPHALANGEAL JOINT 2|CONTRALATERAL|ANTERIOR|PERFUSION MRI|Y|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|4|Visit_4|65|6|FOLLOW-UP|2020-09-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|9|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|mL/g/day|OCULOMOTOR NERVE|IPSILATERAL|DORSAL|CAPILLARY ELECTROPHORESIS|||Y|ADJUDICATOR|PATHOLOGIST 1|5|Visit_5|90|6|WASHOUT|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|a201c78a-e826-4f42-a997-7c6a019e2c91|10|VO2|Oxygen Consumption|[?]|SUPINE|[?]|mL/100g/min|[?]|1|damol/L|FIBULAR VEIN|BILATERAL|LOWER FLEXOR SURFACE|DOPPLER ULTRASOUND||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|||[?]|1|anti-Xa IU|DISTAL PHALANX 3 OF THE HAND|IPSILATERAL|CAUDAL|NUCLEAR RADIOLOGY||Y|Y|CHILD|READER 2|1|Visit_1|10|4|TREATMENT|2020-09-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|2|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|TRENDELENBURG|||[?]|1|U/g/h|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|LATERAL|ACID FAST STAIN|Y|Y|Y|DOMESTIC PARTNER|RADIOLOGIST 1|1|Visit_1|10|7|WASHOUT|2020-09-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|3|PIF|Peak Inspiratory Flow|[?]|SLING|[?]|amp|[?]|1|10^6 IU/mL|LEFT ATRIOVENTRICULAR ARTERY|RIGHT|PERIVENTRICULAR|TARGETED GENOME SEQUENCING||||FAMILY MEMBER|READER 2|2|Visit_2|25|6|SCREENING|2020-09-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|4|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|[?]|nmol BCE/nmol|[?]|1|mL/min/mmHg|METATARSAL BONE|LEFT|FORE|PEAK FLOWMETRY||||INVESTIGATOR|READER 1|2|Visit_2|25|7|SCREENING|2020-09-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|5|VO2|Oxygen Consumption|[?]|TRENDELENBURG|||[?]|1|mMU/mL|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|UNILATERAL|UPPER EXTENSOR SURFACE|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y||Y|INVESTIGATOR|CARDIOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|6|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|[?]|TRANSDUCING UNIT/mL|[?]|1|Ci/kg|HAIR SHAFT|BILATERAL|CRANIAL|TARGETED GENOME SEQUENCING||||ADJUDICATOR|READER|3|Visit_3|40|2|SCREENING|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|FOWLERS|||[?]|1|OI50|BILE DUCT|UNILATERAL|ANTEROPOSTERIOR|REVERSE TRANSCRIPTASE PCR|||Y|DOMESTIC PARTNER|ADJUDICATOR 3|4|Visit_4|65|4|FOLLOW-UP|2020-11-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|8|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|beats/min|[?]|1|MBP|COLON|UNILATERAL|CRANIAL|PHASE-CONTRAST MRI||||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|4|Visit_4|65|4|SCREENING|2020-11-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|9|FEV3PP|Percent Predicted FEV3|[?]|DECUBITUS|[?]|mL/cm H2O|[?]|1|sec|EPIDURAL SPACE|UNILATERAL|PARIETO-OCCIPITAL|SCANNING ELECTRON MICROSCOPY|Y|||VENDOR|ADJUDICATOR 3|5|Visit_5|90|1|TREATMENT|2020-11-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|c41880bd-1e29-4961-b74d-bb0d979ab00f|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|uIU/dL|[?]|1|foz_us|PERIFACIAL LYMPH NODE|BILATERAL|UPPER EXTENSOR SURFACE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y||STUDY SUBJECT|RADIOLOGIST 2|5|Visit_5|90|7|FOLLOW-UP|2020-11-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|1|TLC|Total Lung Capacity|[?]|FOWLERS|[?]|/LPF|[?]|1|mL/dose|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LEFT|ROSTRAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-10-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|2|SGAW|Specific Airway Conductance|[?]|FOWLERS|[?]|pmol/day|[?]|1|U/m2|BRACHIORADIALIS MUSCLE|BILATERAL|BASAL|PERIPHERAL ANGIOGRAPHY||||SIGNIFICANT OTHER|READER 3|1|Visit_1|10|3|WASHOUT|2020-10-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|10^12/L|[?]|1|genEq/mL|PARAPHARYNGEAL LYMPH NODE|UNILATERAL|OUTER|WRIGHT-GIEMSA STAIN||Y||CLINICAL RESEARCH ASSOCIATE|UROLOGIST|2|Visit_2|25|2|TREATMENT|2020-11-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|4|MALIND|Malignancy Indicator|[?]|REVERSE TRENDELENBURG|[?]|L/h/m2|[?]|1|mg|INTERPHALANGEAL OF THE FOOT|LATERAL|UPPER EXTENSOR SURFACE|SINGLE-MOLECULE ARRAY|Y|||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|WASHOUT|2020-11-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|5|FEV3FVC|FEV3/FVC|[?]|DECUBITUS|||[?]|1|10^8/L|PRIMARY VISUAL CORTEX|LEFT|MEDIAL|FREEZING POINT DEPRESSION|Y||Y|SIBLING|NEUROLOGIST 2|3|Visit_3|40|6|WASHOUT|2020-11-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|||[?]|1|psi|GENITOURINARY SYSTEM|BILATERAL|LOWER EXTENSOR SURFACE|AUSCULTATION||Y|Y|NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2020-11-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|7|FIVC|Forced Inspiratory Vital Capacity|[?]|SUPINE|||[?]|1|oz|MIDDLE PHALANX 2 OF THE HAND|BILATERAL|OUTER|FLOCCULATION|||Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|4|Visit_4|65|7|FOLLOW-UP|2020-12-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|8|ICREV|IC Reversibility|[?]|SITTING|[?]|/10^3|[?]|1|uEq|ASCENDING AORTA|BILATERAL|VENTRAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||VENDOR|DERMATOLOGIST|4|Visit_4|65|2|TREATMENT|2020-12-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|9|EVC|Expiratory Vital Capacity|[?]|STANDING|[?]|mV2/Hz|[?]|1|BEAM BREAKS|SUPRAPUBIC REGION|CONTRALATERAL|ROSTRAL|POLYSOMNOGRAPHY||Y||PROXY|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2021-01-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|7de60015-fa9d-4a39-bd19-51c718a624e6|10|INFLTIND|Infiltrates Indicator|[?]|FOWLERS|[?]|ft3|[?]|1|mL/cm H2O|T11 VERTEBRA|IPSILATERAL|LOWER FLEXOR SURFACE|ICC||||CLINICAL RESEARCH COORDINATOR|RATER|5|Visit_5|90|4|TREATMENT|2021-01-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|34d03f58-155a-4908-bba3-aa979be84610|1|EFFIND|Effusion Indicator|[?]|DECUBITUS|[?]|pm|[?]|1|IU/mg|GLOMERULUS|IPSILATERAL|PROXIMAL VOLAR|INDIA INK STAIN||Y||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|1|Visit_1|10|7|WASHOUT|2020-06-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|34d03f58-155a-4908-bba3-aa979be84610|2|PEF|Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|/kg|[?]|1|breaths/min|TRICEPS BRACHII MUSCLE|UNILATERAL|UPPER|IVY INCISION METHOD||Y||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-06-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|34d03f58-155a-4908-bba3-aa979be84610|3|AWWVOL|Airway Wall Volume|[?]|UNCONSTRAINED|[?]|dyn|[?]|1|ka_u/dL|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|RIGHT|PERIPHERAL|MULTIPLE BREATH WASHOUT||||ADJUDICATION COMMITTEE|RATER|2|Visit_2|25|5|WASHOUT|2020-07-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|34d03f58-155a-4908-bba3-aa979be84610|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|[?]|Ci|[?]|1|/10^5|LIMB|BILATERAL|INFERIOR|MASS SPECTROMETRY|Y|||INTERVIEWER|READER 1|2|Visit_2|25|4|SCREENING|2020-07-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|34d03f58-155a-4908-bba3-aa979be84610|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|STANDING|[?]|mg/g/min|[?]|1|mL/h|BUCCAL LYMPH NODE|IPSILATERAL|PARIETO-OCCIPITAL|MICROBIAL CULTURE, LIQUID||||PROXY|MICROSCOPIST 3|3|Visit_3|40|6|TREATMENT|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|34d03f58-155a-4908-bba3-aa979be84610|6|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|||[?]|1|Gy/min|SCROTUM|BILATERAL|NASAL|ELISA|||Y|INVESTIGATOR|NEUROLOGIST 2|3|Visit_3|40|7|FOLLOW-UP|2020-07-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|34d03f58-155a-4908-bba3-aa979be84610|7|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|mm/h|[?]|1|h*%|SCROTUM|IPSILATERAL|DEEP|INCISION-INDUCED BLEEDING METHOD||||GUARDIAN|READER 3|4|Visit_4|65|5|SCREENING|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|34d03f58-155a-4908-bba3-aa979be84610|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING|||[?]|1|ppm|TAIL|CONTRALATERAL|ANTEROTEMPORAL|ELLA|||Y|NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|4|Visit_4|65|6|TREATMENT|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|34d03f58-155a-4908-bba3-aa979be84610|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|[?]|MnFI|[?]|1|10^6 organisms/g|DORSALIS PEDIS ARTERY|IPSILATERAL|NASAL|FLUORIMETRY||||GUARDIAN|ONCOLOGIST|5|Visit_5|90|4|TREATMENT|2020-09-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|34d03f58-155a-4908-bba3-aa979be84610|10|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|pmol/L/h|[?]|1|nm|RENAL PELVIS|CONTRALATERAL|ANTEROTEMPORAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||FRIEND|ONCOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-09-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|/month|[?]|1|IU/day|MEDULLA OBLONGATA|LATERAL|FORE|SPIRAL CT SCAN WITHOUT CONTRAST||||FRIEND|PHYSIOTHERAPIST|1|Visit_1|10|5|SCREENING|2020-08-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|2|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|mg/m2/h|[?]|1|10^6 CFU/mL|MAIN BRONCHUS, LEFT|RIGHT|DORSAL|MALDI||||SPOUSE|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-08-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|3|EFFVOL|Effusion Volume|[?]|STANDING|[?]|mmol/s|[?]|1|10^3/L|ESOPHAGUS|BILATERAL|DEEP|FLUORESCENCE ANGIOGRAPHY||||VENDOR|READER 3|2|Visit_2|25|5|TREATMENT|2020-09-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|4|FEV1PP|Percent Predicted FEV1|[?]|LATERAL DECUBITUS|[?]|g/dL|[?]|1|nkat/g Hb|ELBOW FLEXOR MUSCLES|BILATERAL|TIP|TARGETED GENOME SEQUENCING||||INTERVIEWER|PATHOLOGIST|2|Visit_2|25|5|SCREENING|2020-09-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|5|ALVVOL|Alveolar Volume|[?]|PRONE|[?]|mmHg*min/L|[?]|1|cal|FOREBRAIN|UNILATERAL|DISTAL|SCANNING ELECTRON MICROSCOPY|Y|Y||CHILD|OPHTHALMOLOGIST|3|Visit_3|40|7|SCREENING|2020-09-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|6|MEP|Maximal Expiratory Pressure|[?]|SUPINE|[?]|L/h|[?]|1|U/kg/h|FEMORAL ARTERY|LEFT|UPPER EXTENSOR SURFACE|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||GUARDIAN|OPHTHALMOLOGIST|3|Visit_3|40|7|TREATMENT|2020-09-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|7|AWVOL|Airway Volume|[?]|SLING|||[?]|1|mAmp|ISCHIORECTAL FOSSA|LATERAL|DORSOLATERAL|GC/MS-CI|||Y|NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|4|Visit_4|65|1|TREATMENT|2020-10-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|8|SALKK|Salazar-Knowles Equation, K|[?]|SLING|[?]|ug/dose|[?]|1|kHz|SUBSCAPULARIS MUSCLE|UNILATERAL|VENTRAL|ISHIHARA COLOR PLATES||Y||CLINICAL RESEARCH COORDINATOR|RATER 1|4|Visit_4|65|6|WASHOUT|2020-10-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|9|PEF|Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|pkat|[?]|1|kg/m2|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|CONTRALATERAL|VOLAR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|5|Visit_5|90|4|SCREENING|2020-11-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|3818424f-cbc9-4e79-94b8-7edbc706bdbc|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Linear ft*LB|HARD PALATE|UNILATERAL|DEEP|ENZYMATIC COLORIMETRY||Y|Y|NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|5|Visit_5|90|5|TREATMENT|2020-11-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|1|RELSZCHG|Relative Size Change|[?]|DECUBITUS|[?]|mOsm/L|[?]|1|BAU/mL|SPINAL ACCESSORY NERVE|LATERAL|ANTEROPOSTERIOR|LEAD CITRATE STAIN||||INDEPENDENT ASSESSOR|ONCOLOGIST 1|1|Visit_1|10|5|FOLLOW-UP|2020-09-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|umol/day|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|LATERAL|SUBCORTICAL|PHOTOMETRIC CLOT DETECTION|||Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|1|Visit_1|10|6|WASHOUT|2020-09-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|3|ICPP|Percent Predicted Inspiratory Capacity|[?]|FOWLERS|[?]|Ci/mg|[?]|1|FFU|AORTIC VALVE ANNULUS|CONTRALATERAL|FRONTAL|WHOLE GENOME SEQUENCING||Y||PROXY|ONCOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-09-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING, BENT FORWARD|[?]|F|[?]|1|pmol/g|STERNOCLAVICULAR JOINT|LEFT|DEEP|LIGHT MICROSCOPY||||PROXY|NEUROLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-09-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|5|MALEVDES|Malignancy Evidence Description|[?]|STANDING, BENT FORWARD|||[?]|1|U.CARR|PREPUTIAL GLAND|RIGHT|UPPER FLEXOR SURFACE|DYNAMOMETRY|||Y|GUARDIAN|READER|3|Visit_3|40|1|TREATMENT|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|6|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|mg/kg/dose|[?]|1|/LSQN|L5-S1 INTERVERTEBRAL SPACE|CONTRALATERAL|PERIVENTRICULAR|ELECTRICAL IMPEDANCE MYOGRAPHY||||CAREGIVER|FORENSIC PATHOLOGIST|3|Visit_3|40|5|SCREENING|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|7|INTP|Interpretation|[?]|SITTING, LEGS DEPENDENT|[?]|BLOCKS|[?]|1|mV2/Hz|METACARPAL BONE 2|UNILATERAL|MIDLINE|MICRONEUTRALIZATION ASSAY||||CAREGIVER|MICROSCOPIST 3|4|Visit_4|65|6|SCREENING|2020-11-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|8|RER|Respiratory Exchange Ratio|[?]|SUPINE|[?]|nmol BCE/nmol|[?]|1|mmHg/sec|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|LATERAL|DORSAL|KARYOTYPING||Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-11-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|9|OXYPULSE|Oxygen Pulse|[?]|STANDING, BENT FORWARD|||[?]|1|CAPSULE|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|CONTRALATERAL|LATERAL|IMMUNO-PET SCAN|Y||Y|FAMILY MEMBER|OPTOMETRIST|5|Visit_5|90|7|FOLLOW-UP|2020-11-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|4191788e-b2dc-4885-87d8-da9feb6deea5|10|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|||[?]|1|/wk|BLADDER, NECK|UNILATERAL|SURFACE|CT SCAN WITHOUT CONTRAST||Y|Y|CAREGIVER|MICROSCOPIST|5|Visit_5|90|3|SCREENING|2020-11-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|PRONE|[?]|g/cage/day|[?]|1|mL/mmHg|BRACHIAL PLEXUS|UNILATERAL|LOWER|LISSAMINE GREEN STAIN|Y|Y||GUARDIAN|MICROSCOPIST 1|1|Visit_1|10|4|SCREENING|2020-12-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|2|ERVPP|Percent Predicted ERV|[?]|FOWLERS|[?]|umol/L/h|[?]|1|mg/kg/dose|FRONTAL SINUS|IPSILATERAL|OUTER|ELISPOT||Y||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|WASHOUT|2020-12-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|STEPS|[?]|1|10^12 IU/L|ETHMOID SINUS|BILATERAL|SURFACE|SURFACE PLASMON RESONANCE||Y||INVESTIGATOR|MICROSCOPIST 1|2|Visit_2|25|3|TREATMENT|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SEMI-FOWLERS|||[?]|1|uCi/kg|LATERAL HUMERAL EPICONDYLE|UNILATERAL|BASAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y||Y|GUARDIAN|RADIOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|5|FEV6PP|Percent Predicted FEV6|[?]|SUPINE|[?]|U/m2|[?]|1|msec|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|UNILATERAL|OCCIPITAL|ELECTROMYOGRAPHY||Y||SIBLING|MICROSCOPIST 3|3|Visit_3|40|4|TREATMENT|2021-01-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|6|PEF|Peak Expiratory Flow|[?]|PRONE|||[?]|1|log10 TCID 50/uL|BILIARY TRACT|IPSILATERAL|TIP|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||Y|VENDOR|READER|3|Visit_3|40|5|TREATMENT|2021-01-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|7|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|10^7 TCID 50/dose|[?]|1|10^6 organisms/mg|CORONARY ARTERY, ANTERIOR DESCENDING|BILATERAL|HIND|CELL BASED BIOASSAY||Y||INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|SCREENING|2021-02-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|FOWLERS|[?]|ug/dose|[?]|1|mMU/mL|ADRENAL GLAND|RIGHT|UPPER EXTENSOR SURFACE|IRON HEMATOXYLIN STAIN||||SIGNIFICANT OTHER|RATER 1|4|Visit_4|65|4|TREATMENT|2021-02-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|9|RER|Respiratory Exchange Ratio|[?]|FOWLERS|||[?]|1|mm/2h|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|OCCIPITAL|MUGA|||Y|INVESTIGATOR|ADJUDICATOR|5|Visit_5|90|1|WASHOUT|2021-03-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|8572a9c4-eb87-4745-81b9-8316bc8de69e|10|FEV_PEF|FEV at PEF|[?]|SEMI-FOWLERS|[?]|mEq/mL|[?]|1|mm/h|ASCENDING AORTA, SINUS OF VALSALVA|BILATERAL|SUBCORTICAL|ENZYMATIC SPECTROPHOTOMETRY|Y|||DOMESTIC PARTNER|READER 3|5|Visit_5|90|1|TREATMENT|2021-03-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|Bq/ug|[?]|1|Bq/kg|THIGH|RIGHT|POSTERIOR|MAGNETIC RESONANCE ELASTOGRAPHY||||STUDY SUBJECT|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-11-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|2|FIF75|Forced Inspiratory Flow at 75%|[?]|SUPINE|[?]|mmHg/sec|[?]|1|%|PERICARDIAL WALL|RIGHT|CRANIAL|ELECTROMYOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|1|Visit_1|10|3|FOLLOW-UP|2020-11-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|3|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING|[?]|CCID 50/dose|[?]|1|s/h|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|DEEP|HPLC/IEX||||INVESTIGATOR|MICROSCOPIST 1|2|Visit_2|25|1|TREATMENT|2020-12-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|4|FEV3PP|Percent Predicted FEV3|[?]|SEMI-RECUMBENT|[?]|mg/mol|[?]|1|CONTAINER|CELIAC LYMPH NODE|RIGHT|DISTAL|HPLC-UV||||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|2|Visit_2|25|4|SCREENING|2020-12-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|5|FIO2|Fraction of Inspired Oxygen|[?]|SLING|[?]|MBq|[?]|1|cmol|LARGE INTESTINE|LATERAL|FORE|SPECT/CT SCAN||||ADJUDICATOR|UROLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|mL/dL|GREATER CURVATURE OF THE STOMACH|BILATERAL|DORSOLATERAL|POPULATION SEQUENCING|||Y|STUDY SUBJECT|ENDOCRINOLOGIST|3|Visit_3|40|5|WASHOUT|2020-12-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|7|RVPP|Percent Predicted Residual Volume|[?]|STANDING, BENT FORWARD|[?]|10^8 PFU|[?]|1|/2500 WBC|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|DORSOLATERAL|WHOLE GENOME SEQUENCING||||DOMESTIC PARTNER|ONCOLOGIST|4|Visit_4|65|2|SCREENING|2021-01-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|8|RER|Respiratory Exchange Ratio|[?]|SUPINE|[?]|mg/kg/min|[?]|1|kg/cm2|EPITROCHLEAR LYMPH NODE|IPSILATERAL|PERIVENTRICULAR|BIOPSY||Y||CLINICAL STUDY SPONSOR|NEUROLOGIST|4|Visit_4|65|6|TREATMENT|2021-01-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|JAR|[?]|1|mL/s|SKIN AROUND THE EYE|CONTRALATERAL|DEEP|TRYPAN BLUE STAIN||||FRIEND|MICROSCOPIST|5|Visit_5|90|2|WASHOUT|2021-02-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|10|FIFMAXPP|Percent Predicted FIFmax|[?]|PRONE|||[?]|1|PIPE|T1 VERTEBRA|UNILATERAL|LOWER FLEXOR SURFACE|PULMONARY ANGIOGRAPHY|Y||Y|INVESTIGATOR|PATHOLOGIST 2|5|Visit_5|90|2|TREATMENT|2021-02-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|ug/mol|[?]|1|1/(s*kPa)|ESOPHAGUS, UPPER THIRD|LATERAL|FRONTAL|IODINE STAIN||Y||VENDOR|READER 2|1|Visit_1|10|1|TREATMENT|2020-08-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|2|RER|Respiratory Exchange Ratio|[?]|DECUBITUS|[?]|umol/L|[?]|1|Enzyme U|EPIDURAL SPACE|LATERAL|LATERAL|MAMMOGRAPHY||||INTERVIEWER|OTOLARYNGOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|3|SAWVOL|Specific Airway Volume|[?]|SEMI-FOWLERS|[?]|Arbitrary U|[?]|1|ms/mmHg|GREATER CURVATURE OF THE STOMACH|IPSILATERAL|UPPER|SICKLE CELL SOLUBILITY TEST||Y||FRIEND|PATHOLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-09-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|4|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|[?]|Ci/mg|[?]|1|10^7 CFU|ASCENDING AORTA, SINUS OF VALSALVA|LEFT|DEEP|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||INVESTIGATOR|PATHOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-09-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|5|RRS|Total Respiratory System Resistance|[?]|STANDING|||[?]|1|kIU|COMMON ILIAC ARTERY|CONTRALATERAL|PARIETO-OCCIPITAL|ERGOSPIROMETRY||Y|Y|SPOUSE|MICROSCOPIST 1|3|Visit_3|40|4|TREATMENT|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|6|AWVOL|Airway Volume|[?]|SUPINE|||[?]|1|mMU/mL|CORPUS CALLOSUM, GENU|UNILATERAL|TIP|JAFFE REACTION|||Y|DOMESTIC PARTNER|RATER|3|Visit_3|40|5|WASHOUT|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|7|RAW|Airway Resistance|[?]|SEMI-RECUMBENT|[?]|um/day|[?]|1|IU/g|SCIATIC NERVE|RIGHT|PROXIMAL VOLAR|MICRO BROTH DILUTION||||FRIEND|READER 1|4|Visit_4|65|7|WASHOUT|2020-10-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|8|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|g/cage/wk|[?]|1|mg/L|LEG|CONTRALATERAL|CAUDAL|SNELLEN EYE CHART||Y||FAMILY MEMBER|RATER 2|4|Visit_4|65|1|FOLLOW-UP|2020-10-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|9|SVC|Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|EID 50/mL|[?]|1|nmol/L|INTERNAL MAMMARY LYMPH NODE|LEFT|OUTER|INTRAVASCULAR ULTRASOUND||||GUARDIAN|DERMATOLOGIST|5|Visit_5|90|2|TREATMENT|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|3eceae61-a4a0-49fd-964b-9f142e0da067|10|IRV|Inspiratory Reserve Volume|[?]|TRENDELENBURG|[?]|SACHET|[?]|1|FFU|CEREBRAL CORTEX|IPSILATERAL|INTERMEDIATE|SLOAN LETTER EYE CHART 2.5%||||CHILD|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|WASHOUT|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|PEF|Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|mL/dose|[?]|1|mL/animal/wk|URETHRA, PROSTATIC|LEFT|LOWER FLEXOR SURFACE|MICRODENSITOMETRY||||ADJUDICATION COMMITTEE|PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-05-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|2|ICREV|IC Reversibility|[?]|TRENDELENBURG|||[?]|1|/10^4|BILE DUCT|LEFT|SUPERFICIAL|RADIOIMMUNOPRECIPITATION ASSAY|Y||Y|INDEPENDENT ASSESSOR|READER|1|Visit_1|10|2|TREATMENT|2020-05-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|3|RAW|Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|ng|[?]|1|Antibody Unit|PERIHILAR LYMPH NODE|BILATERAL|FACIAL|NEXT GENERATION TARGETED SEQUENCING|Y|||ADJUDICATOR|ADJUDICATOR 2|2|Visit_2|25|4|TREATMENT|2020-06-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|4|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING, BENT FORWARD|||[?]|1|ugEq|DELTOID MUSCLE|LEFT|ROSTRAL|SPIRAL CT|||Y|SPOUSE|RADIOLOGIST 1|2|Visit_2|25|1|FOLLOW-UP|2020-06-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|5|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|||[?]|1|10^11/L|CARDIAC VALVE|LEFT|LOWER EXTENSOR SURFACE|STATIC PERIMETRY||Y|Y|HEALTH CARE PROFESSIONAL|READER|3|Visit_3|40|2|TREATMENT|2020-06-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|FOWLERS|[?]|s*kPa|[?]|1|/h|CORNEAL ENDOTHELIUM|BILATERAL|PARIETO-OCCIPITAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||INVESTIGATOR|ENDOCRINOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-06-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|7|LOBVOL|Lobar Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|PHERESIS UNIT|WRIST JOINT FLEXOR TENDONS|RIGHT|DORSAL|FLUORESCENT MICROSCOPY||Y|Y|SIGNIFICANT OTHER|READER 3|4|Visit_4|65|4|TREATMENT|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|8|RELSZCHG|Relative Size Change|[?]|PRONE|[?]|uCi/L|[?]|1|Newton|TRICUSPID VALVE, POSTERIOR ANNULUS|UNILATERAL|CAUDAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|4|Visit_4|65|4|SCREENING|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING, BENT FORWARD|[?]|ugEq/L|[?]|1|10^11/L|UVEA|UNILATERAL|DISTAL|SPIROMETRY||Y||INVESTIGATOR|OPHTHALMOLOGIST|5|Visit_5|90|5|TREATMENT|2020-08-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|fe7ad71c-601d-4909-b56a-401c9a10f00c|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|STANDING|[?]|m/sec2|[?]|1|K|OPTIC DISC|BILATERAL|OUTER|DIRECT SEQUENCING||||CHILD|READER 2|5|Visit_5|90|4|WASHOUT|2020-08-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|TRENDELENBURG|[?]|10^5/L|[?]|1|U/kg/h|HEEL OF THE FOOT|BILATERAL|ROSTRAL|TOTAL BODY IRRADIATION||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|1|Visit_1|10|6|FOLLOW-UP|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|DECUBITUS|[?]|10^6 DNA copies/mL|[?]|1|NFIU|T2 VERTEBRA|RIGHT|DEEP|WHOLE TRANSCRIPTOME SEQUENCING||||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|1|Visit_1|10|2|SCREENING|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|3|SALKK|Salazar-Knowles Equation, K|[?]|SLING|[?]|mmHg|[?]|1|mmol/min/kPa/L|FORELIMB|LATERAL|ANTEROTEMPORAL|SPIROMETRY|Y|||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|4|LCI|Lung Clearance Index|[?]|UNCONSTRAINED|[?]|fmol|[?]|1|pm|CALCANEAL TUBEROSITY|LATERAL|CRANIAL|OBSERVATION|Y|Y||ADJUDICATOR|MICROSCOPIST 3|2|Visit_2|25|5|WASHOUT|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|5|RAWPP|Percent Predicted Airway Resistance|[?]|SLING|||[?]|1|pg/cell|SCAPHOID-CAPITATE JOINT|BILATERAL|FACIAL|CONTACT SPECULAR MICROSCOPY||Y|Y|FRIEND|ADJUDICATOR 2|3|Visit_3|40|5|TREATMENT|2020-08-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-FOWLERS|||[?]|1|BISCUIT|HEPATIC LYMPH NODE|CONTRALATERAL|CRANIAL|IMMUNOTURBIDIMETRY|||Y|GUARDIAN|PHYSIOTHERAPIST|3|Visit_3|40|1|SCREENING|2020-08-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|umol|[?]|1|TAMPON|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|LEFT|APICAL|MS/MS||||ADJUDICATION COMMITTEE|ONCOLOGIST 1|4|Visit_4|65|1|TREATMENT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|ECL unit|[?]|1|TUBE|PANCREATIC DUCT|UNILATERAL|LOWER|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||INVESTIGATOR|CLINICAL PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|9|EFFIND|Effusion Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|genEq/mL|[?]|1|ug/m2/day|SKIN OF THE CHIN|CONTRALATERAL|BASAL|THIN SMEAR|Y|||FRIEND|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|cc52d895-5819-46c0-b8e6-b948f1cd2408|10|AWVOLPP|Percent Predicted Airway Volume|[?]|FOWLERS|[?]|10^9/L|[?]|1|CARTRIDGE|COLON, SIGMOID|LATERAL|SURFACE|ENDPOINT DILUTION ASSAY||Y||VENDOR|NEUROLOGIST|5|Visit_5|90|5|TREATMENT|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|TAMPON|[?]|1|mL/cage|SECOND RIGHT POSTEROLATERAL ARTERY|LATERAL|UPPER EXTENSOR SURFACE|STRESS ECHOCARDIOGRAPHY|Y|Y||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|1|Visit_1|10|2|SCREENING|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|SITTING|[?]|PIPE|[?]|1|ug/L/h|GUT-ASSOCIATED LYMPHOID TISSUE|LATERAL|UPPER|PHOTOMETRIC CLOT DETECTION|Y|||PARENT|ONCOLOGIST|1|Visit_1|10|4|WASHOUT|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-01
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|3|SALKK|Salazar-Knowles Equation, K|[?]|REVERSE TRENDELENBURG|||[?]|1|cP|TONGUE|RIGHT|ANTEROMEDIAL|CONTRAST ENHANCED CT SCAN|Y||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|2|Visit_2|25|2|WASHOUT|2021-02-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|4|PNEUMIND|Pneumonia Indicator|[?]|DECUBITUS|||[?]|1|s^-1(%O2)^-1|TUNICA INTIMA|BILATERAL|DORSOLATERAL|SLOAN LETTER EYE CHART 1.25%|||Y|SIBLING|MICROSCOPIST 3|2|Visit_2|25|5|FOLLOW-UP|2021-02-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|5|MALIND|Malignancy Indicator|[?]|STANDING, BENT FORWARD|[?]|ag|[?]|1|mN|HYPOPHARYNX|LATERAL|VENTROLATERAL|FISH||||INVESTIGATOR|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-02
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|6|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|[?]|MET*h|[?]|1|kg|SKIN OF THE PALM|LATERAL|DISTAL|FLUORIMETRY|Y|||CLINICAL RESEARCH ASSOCIATE|READER 2|3|Visit_3|40|6|TREATMENT|2021-02-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-02
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|7|AWWVOL|Airway Wall Volume|[?]|DECUBITUS|[?]|cm H2O|[?]|1|DAgU/mL|CAPITATE BONE|LATERAL|FORE|HIGH RESOLUTION CT|Y|Y||ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|4|Visit_4|65|3|TREATMENT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|ug/day|THORACIC LYMPH NODE|LEFT|ANTEROPOSTERIOR|PET/CT SCAN|||Y|CHILD|ONCOLOGIST|4|Visit_4|65|6|TREATMENT|2021-03-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|UNCONSTRAINED|[?]|ug/min|[?]|1|mL/animal|AORTIC VALVE, LEFT CORONARY CUSP|BILATERAL|MEDIAL|MICRONEUTRALIZATION ASSAY||||CAREGIVER|ADJUDICATOR 3|5|Visit_5|90|5|FOLLOW-UP|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|10|QUASCOMP|Quasi-Static Compliance|[?]|SITTING|[?]|mIU/L|[?]|1|mmol/day|SAPHENOUS VEIN|LEFT|VOLAR|HANSEL STAIN||||STUDY SUBJECT|MICROSCOPIST|5|Visit_5|90|1|TREATMENT|2021-04-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|1409edea-a372-4938-889b-df6ee93b8543|1|PCF|Peak Cough Flow|[?]|PRONE|[?]|ng/mol|[?]|1|g/cage/wk|FOOT DIGIT 4|RIGHT|MIDLINE|DROPLET DIGITAL PCR||||GUARDIAN|OPTOMETRIST|1|Visit_1|10|3|WASHOUT|2020-08-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|1409edea-a372-4938-889b-df6ee93b8543|2|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SUPINE|[?]|POUCH|[?]|1|mg/kg/dose|HEART, VENTRICLE|IPSILATERAL|PERIVENTRICULAR|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||VENDOR|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-08-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|1409edea-a372-4938-889b-df6ee93b8543|3|ERV|Expiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|[?]|ugEq/L|[?]|1|MET|THROAT|LATERAL|CAUDAL|MRI WITHOUT CONTRAST||||CHILD|OPTOMETRIST|2|Visit_2|25|7|TREATMENT|2020-09-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|1409edea-a372-4938-889b-df6ee93b8543|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|FOWLERS|[?]|U/10^12 RBC|[?]|1|mL/g/day|EYE BULGE|LEFT|INTERMEDIATE|PAP STAIN||||FAMILY MEMBER|PATHOLOGIST 1|2|Visit_2|25|7|SCREENING|2020-09-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|1409edea-a372-4938-889b-df6ee93b8543|5|IVC|Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|umol/L/sec|[?]|1|mol/day|TIBIO-PERONEAL TRUNK|IPSILATERAL|CAUDAL|PHASE CONTRAST MICROSCOPY||||ADJUDICATION COMMITTEE|READER 3|3|Visit_3|40|4|TREATMENT|2020-09-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|1409edea-a372-4938-889b-df6ee93b8543|6|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|[?]|mg/dL|[?]|1|fmol/L/sec|PROXIMAL INTERPHALANGEAL JOINT 3|CONTRALATERAL|ANTEROTEMPORAL|REVERSE TRANSCRIPTASE PCR||Y||FRIEND|RATER|3|Visit_3|40|5|TREATMENT|2020-09-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-17
e|RE|1409edea-a372-4938-889b-df6ee93b8543|7|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|[?]|s*kPa|[?]|1|pmol/dL|JOINT|LATERAL|ROSTRAL|DISK DIFFUSION||||CHILD|ADJUDICATOR 1|4|Visit_4|65|1|WASHOUT|2020-10-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|1409edea-a372-4938-889b-df6ee93b8543|8|FIFMAXPP|Percent Predicted FIFmax|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|MPL U/mL|DISTAL FEMUR R1|LATERAL|PROXIMAL|CHROMOGENIC ASSAY|||Y|INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|TREATMENT|2020-10-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-14
e|RE|1409edea-a372-4938-889b-df6ee93b8543|9|MEP|Maximal Expiratory Pressure|[?]|TRENDELENBURG|||[?]|1|L/L|FOREHEAD|RIGHT|SUBCORTICAL|PERFUSION MRI|Y|Y|Y|HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|TREATMENT|2020-11-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|1409edea-a372-4938-889b-df6ee93b8543|10|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|[?]|h*%|[?]|1|cm/s|LEFT VENTRICULAR APEX SEGMENT|UNILATERAL|BASAL|QUANTITATIVE CORONARY ANGIOGRAPHY||Y||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|5|Visit_5|90|6|SCREENING|2020-11-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING, BENT FORWARD|[?]|nmol/L/h|[?]|1|10^3 copies/mL|PULMONARY VALVE|BILATERAL|DISTAL VOLAR|DROPLET DIGITAL PCR|Y|Y||CAREGIVER|READER 2|1|Visit_1|10|3|TREATMENT|2020-09-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|2|RAW|Airway Resistance|[?]|SLING|[?]|s^-1(%O2)^-1|[?]|1|BP|ETHMOID BONE|IPSILATERAL|LOWER|EEG||||SIBLING|NEUROLOGIST|1|Visit_1|10|6|SCREENING|2020-09-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|3|AIRTRAP|Air Trapping|[?]|PRONE|[?]|g/animal/day|[?]|1|mmHg/L/min|FUNDUS UTERI|RIGHT|MIDLINE|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||SPOUSE|READER 2|2|Visit_2|25|7|WASHOUT|2020-09-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|4|EFFVOL|Effusion Volume|[?]|SITTING, LEGS DEPENDENT|[?]|nmol BCE/L|[?]|1|BU|HUMERAL EPICONDYLE|LEFT|DEEP|GC/FID||||SIGNIFICANT OTHER|ONCOLOGIST|2|Visit_2|25|1|WASHOUT|2020-09-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|5|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|||[?]|1|ng/dL|POPLITEAL FOSSA|UNILATERAL|ANTEROLATERAL|WHOLE TRANSCRIPTOME SEQUENCING||Y|Y|HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-10-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|6|FVC|Forced Vital Capacity|[?]|SEMI-RECUMBENT|[?]|ug/L/h|[?]|1|Absorbance U/min|HEART, RIGHT VENTRICULAR WALL|LEFT|CENTRAL|SMEAR||||STUDY SUBJECT|PATHOLOGIST 1|3|Visit_3|40|1|WASHOUT|2020-10-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|7|FEV_PEF|FEV at PEF|[?]|SEMI-FOWLERS|[?]|DAgU|[?]|1|mOsm|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|UNILATERAL|DISTAL|TONOMETRY|Y|||GUARDIAN|ADJUDICATOR 1|4|Visit_4|65|3|SCREENING|2020-10-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|8|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|MET*h|[?]|1|uOsm|TIBIA SHAFT|CONTRALATERAL|UPPER FLEXOR SURFACE|APPLANATION TONOMETRY||||FAMILY MEMBER|ONCOLOGIST|4|Visit_4|65|2|SCREENING|2020-10-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|9|FEV6PP|Percent Predicted FEV6|[?]|TRENDELENBURG|[?]|Arbitrary U|[?]|1|TABLET|LESSER TROCHANTER|IPSILATERAL|CRANIAL|MAGNETIC RESONANCE ENTEROGRAPHY|Y|||INVESTIGATOR|ADJUDICATOR 3|5|Visit_5|90|5|TREATMENT|2020-11-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|3dc16ad2-d49d-4fad-9823-d0197fb57a42|10|PEFTIME|Peak Expiratory Flow Time|[?]|TRENDELENBURG|||[?]|1|dpm/mL|REGIONAL LYMPH NODE|UNILATERAL|VENTROLATERAL|PET SCAN|||Y|SIGNIFICANT OTHER|NEUROLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-11-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|7c244128-0508-422f-88ba-ecce68cec054|1|RVPP|Percent Predicted Residual Volume|[?]|STANDING, BENT FORWARD|[?]|/4.0 mL|[?]|1|kN/cm2|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|TIP|EPSILOMETER||Y||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|7|WASHOUT|2020-08-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|7c244128-0508-422f-88ba-ecce68cec054|2|FVC|Forced Vital Capacity|[?]|SUPINE|[?]|mEq/L|[?]|1|SQU/mL|VOCAL CORD|BILATERAL|CAUDAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y|||DOMESTIC PARTNER|UROLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-08-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|7c244128-0508-422f-88ba-ecce68cec054|3|EVC|Expiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|YEARS|[?]|1|SACHET|PROSTATE GLAND, POSTERIOR LOBE|UNILATERAL|ANTEROLATERAL|IMPEDANCE CONDUCTIVITY||Y||INDEPENDENT ASSESSOR|ADJUDICATOR 2|2|Visit_2|25|5|WASHOUT|2020-08-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|7c244128-0508-422f-88ba-ecce68cec054|4|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|FFU|[?]|1|gtt|DORSALIS PEDIS ARTERY|UNILATERAL|ANTEROTEMPORAL|SPIRAL CT||Y||VENDOR|MICROSCOPIST 2|2|Visit_2|25|2|SCREENING|2020-08-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|7c244128-0508-422f-88ba-ecce68cec054|5|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|[?]|Coulomb|[?]|1|ug/m2|SCLERA|RIGHT|VENTROLATERAL|PHASE-CONTRAST MRI||Y||PARENT|RATER|3|Visit_3|40|6|TREATMENT|2020-09-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|7c244128-0508-422f-88ba-ecce68cec054|6|AWWVOL|Airway Wall Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mL*cmH2O|[?]|1|foz_us|SPLEEN|RIGHT|SUPERIOR|ANALYTICAL ULTRACENTRIFUGATION||||FAMILY MEMBER|RATER|3|Visit_3|40|7|TREATMENT|2020-09-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|7c244128-0508-422f-88ba-ecce68cec054|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING|[?]|umol/L/h|[?]|1|PLUG|APPENDICEAL TIP|LEFT|LOWER MEDIAL|AGAR DILUTION||||INTERVIEWER|CLINICAL PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-09-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|7c244128-0508-422f-88ba-ecce68cec054|8|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|deg|[?]|1|umol/L/h|ANAL VERGE|LEFT|TEMPORAL|PANENDOSCOPY|Y|||FAMILY MEMBER|READER 3|4|Visit_4|65|2|SCREENING|2020-09-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|7c244128-0508-422f-88ba-ecce68cec054|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|DECUBITUS|[?]|%/s|[?]|1|Log10 ELISA unit/dose|LEFT VENTRICULAR MID INFERIOR SEGMENT|LEFT|CENTRAL|FLOCCULATION||||STUDY SUBJECT|RATER 2|5|Visit_5|90|6|FOLLOW-UP|2020-10-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|7c244128-0508-422f-88ba-ecce68cec054|10|FEV1FVC|FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|cup eq|[?]|1|U/g|SCROTUM|UNILATERAL|INTERMEDIATE|EEG|Y|||CHILD|FORENSIC PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2020-10-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-26
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|||[?]|1|PFU/animal|BACK|LEFT|LOWER FLEXOR SURFACE|FLOCCULATION, CHARCOAL ENHANCED|Y||Y|DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|SCREENING|2020-12-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|2|FEV1FVC6|FEV1/FVC6|[?]|STANDING, BENT FORWARD|[?]|U/m2/day|[?]|1|ug/L FEU|COLON, RIGHT|LATERAL|DEEP|TRANSTHORACIC ECHOCARDIOGRAPHY||Y||PROXY|READER|1|Visit_1|10|1|TREATMENT|2020-12-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|||[?]|1|ukat/L|GASTRIC CARDIA|LEFT|DORSAL|NON-INVASIVE DIELECTRIC SENSING|Y||Y|SIGNIFICANT OTHER|ENDOCRINOLOGIST|2|Visit_2|25|5|WASHOUT|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|4|INTP|Interpretation|[?]|STANDING|[?]|10^9/g|[?]|1|%/min|FEMALE GENITALIA|IPSILATERAL|BASAL|IMMUNOBLOT|Y|||CAREGIVER|OTOLARYNGOLOGIST|2|Visit_2|25|2|WASHOUT|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|5|AIRTRAP|Air Trapping|[?]|DECUBITUS|[?]|umol/kg/min|[?]|1|oz eq|COMMON ILIAC LYMPH NODE|BILATERAL|CENTRAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|Y|||NON-HEALTH CARE PROFESSIONAL|READER 2|3|Visit_3|40|5|TREATMENT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|6|IC|Inspiratory Capacity|[?]|DECUBITUS|[?]|TCID 50/dose|[?]|1|GPL U/mL|PORTACAVAL LYMPH NODE|UNILATERAL|ANTEROMEDIAL|MYELOPEROXIDASE STAIN||||VENDOR|CARDIOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|7|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|%(w/w)|[?]|1|mL/m2/h|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|TEMPORAL|HPLC|Y|Y||ADJUDICATOR|OPHTHALMOLOGIST|4|Visit_4|65|2|TREATMENT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|[?]|U/kg|[?]|1|mL/m2/min|OPTIC DISC|LEFT|CENTRAL|CLINICAL EVALUATION||Y||FRIEND|OPHTHALMOLOGIST|4|Visit_4|65|1|TREATMENT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|9|TSUHYS|Tissue Hysteresivity|[?]|LATERAL DECUBITUS|[?]|um2|[?]|1|uCi/L|AXILLARY VEIN|CONTRALATERAL|ANTEROPOSTERIOR|PEAK FLOWMETRY||||VENDOR|READER|5|Visit_5|90|5|TREATMENT|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|247814c7-9fb3-43f2-9e0a-db70b27b3d95|10|FEV1REV|FEV1 Reversibility|[?]|FOWLERS|||[?]|1|SQU/mL|PRIMARY VISUAL CORTEX|LEFT|ANTEROLATERAL|GC/MS-EI|Y||Y|SIGNIFICANT OTHER|NEUROLOGIST 2|5|Visit_5|90|5|TREATMENT|2021-03-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|AIRTRAP|Air Trapping|[?]|RIGHT LATERAL DECUBITUS|[?]|usec|[?]|1|uIU/L|BRACHIALIS MUSCLE|LATERAL|PERIPHERAL|HPLC/MS||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-08-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|2|LOBVOL|Lobar Volume|[?]|SEMI-RECUMBENT|||[?]|1|/wk|SCAPHOID BONE|LATERAL|SURFACE|REVERSE TRANSCRIPTASE PCR||Y|Y|VENDOR|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-08-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|3|IVC|Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|BAU/mL|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|IPSILATERAL|OCCIPITAL|RADIOGRAPHY||Y|Y|INDEPENDENT ASSESSOR|NEUROLOGIST 2|2|Visit_2|25|7|WASHOUT|2020-08-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|keV|[?]|1|cycle/min|SKIN AROUND THE EYE|CONTRALATERAL|VENTRAL|MICROSCOPY||||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|2|Visit_2|25|1|WASHOUT|2020-08-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|5|FVC|Forced Vital Capacity|[?]|FOWLERS|||[?]|1|cm/min|GENITALIA|LATERAL|ROSTRAL|RADIOIMMUNOPRECIPITATION ASSAY|Y||Y|ADJUDICATOR|READER 3|3|Visit_3|40|7|TREATMENT|2020-09-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|6|RAW|Airway Resistance|[?]|FOWLERS|||[?]|1|ft3|URETHRAL SPHINCTER|IPSILATERAL|VENTRAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|||Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|3|Visit_3|40|5|WASHOUT|2020-09-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|||[?]|1|IU/kg|ILEUM WALL|LEFT|DEEP|ANALYTICAL ULTRACENTRIFUGATION||Y|Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|4|Visit_4|65|7|FOLLOW-UP|2020-10-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|8|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|mg/kg/min|[?]|1|Coulomb|TOE|BILATERAL|DISTAL VOLAR|MICRONEUTRALIZATION ASSAY|Y|||FAMILY MEMBER|RADIOLOGIST|4|Visit_4|65|3|SCREENING|2020-10-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|9|IVC|Inspiratory Vital Capacity|[?]|SLING|[?]|TRANSDUCING UNIT|[?]|1|cmol/L|TROCHLEAR NERVE|CONTRALATERAL|ANTEROMEDIAL|MAPH||Y||PARENT|OPHTHALMOLOGIST|5|Visit_5|90|4|TREATMENT|2020-10-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|e870fe2f-b08c-41d9-a672-07da09fe2b99|10|PLMXRS|Pulmonary Reactance|[?]|SLING|[?]|ft|[?]|1|ug/m2/h|COLON, DESCENDING|RIGHT|MIDLINE|FISH||||SIBLING|RATER|5|Visit_5|90|6|FOLLOW-UP|2020-10-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|TLCPP|Percent Predicted Total Lung Capacity|[?]|FOWLERS|[?]|deg2|[?]|1|10^3 organisms/g|OPTIC DISC|LATERAL|BASAL|HPLC/MS/MS||||INTERVIEWER|RATER 2|1|Visit_1|10|1|WASHOUT|2020-07-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|2|FIFMAX|Maximum Forced Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|pkat/L|[?]|1|Hz|SUBCARINAL LYMPH NODE|LEFT|ANTEROLATERAL|NUCLEIC ACID BASED METHOD||||FAMILY MEMBER|MICROSCOPIST 1|1|Visit_1|10|3|SCREENING|2020-07-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mm2|LIGAMENT|BILATERAL|SUPERIOR|ATOMIC ABSORPTION SPECTROMETRY|Y||Y|VENDOR|CARDIOLOGIST|2|Visit_2|25|6|TREATMENT|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|||[?]|1|10^4/hpf|FACET JOINT|RIGHT|BASAL|GC/MS/MS|Y||Y|PARENT|ONCOLOGIST 2|2|Visit_2|25|2|SCREENING|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|[?]|PUFF|[?]|1|mg/h|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|INTERMEDIATE|HPLC||||PARENT|UROLOGIST|3|Visit_3|40|6|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|Gy/min|[?]|1|mEq/L|NUCLEUS ACCUMBENS|RIGHT|FACIAL|LC/MS||||HEALTH CARE PROFESSIONAL|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|7|PCF|Peak Cough Flow|[?]|STANDING|||[?]|1|10^6 organisms/g|LIVER, LEFT LOBE|BILATERAL|FACIAL|FLOCCULATION|||Y|SIGNIFICANT OTHER|READER|4|Visit_4|65|1|WASHOUT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|8|IVC|Inspiratory Vital Capacity|[?]|STANDING|[?]|IU/L|[?]|1|/100 WBC|EAR|IPSILATERAL|PERIVENTRICULAR|ETDRS EYE CHART||Y||CHILD|READER 1|4|Visit_4|65|5|FOLLOW-UP|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|9|SAWVOL|Specific Airway Volume|[?]|DECUBITUS|||[?]|1|cm/min|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL|POSTERIOR|CELLULAR PROLIFERATION ASSAY|Y||Y|ADJUDICATOR|READER 3|5|Visit_5|90|7|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|32979638-fb88-4cbb-a110-a4d2016e9bc5|10|ICREV|IC Reversibility|[?]|LATERAL DECUBITUS|||[?]|1|mg/cm2|HAIR FOLLICLE|LATERAL|PERIPHERAL|CHROMATOGRAPHY|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|FIF50|Forced Inspiratory Flow at 50%|[?]|UNCONSTRAINED|||[?]|1|ug/L|EXTRAOCULAR MUSCLE|UNILATERAL|INNER|ZIEHL NEELSEN ACID FAST STAIN|Y|Y|Y|SIBLING|OPTOMETRIST|1|Visit_1|10|1|TREATMENT|2020-11-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|2|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-RECUMBENT|||[?]|1|umol/mol|HAND|IPSILATERAL|UPPER FLEXOR SURFACE|DYNAMIC CONTRAST ENHANCED MRI|||Y|CAREGIVER|MICROSCOPIST|1|Visit_1|10|3|TREATMENT|2020-11-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|3|ALVVOL|Alveolar Volume|[?]|DECUBITUS|[?]|m2|[?]|1|mL/(min*100mL)|AORTIC VALVE|RIGHT|SURFACE|KINETIC MICROPARTICLE IMMUNOASSAY|Y|Y||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|2|Visit_2|25|2|SCREENING|2020-11-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|4|RRS|Total Respiratory System Resistance|[?]|STANDING|[?]|mL/m2/h|[?]|1|MdFI|FINGER|RIGHT|PERIVENTRICULAR|CALIPER MEASUREMENT METHOD||Y||PROXY|RADIOLOGIST 2|2|Visit_2|25|6|SCREENING|2020-11-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|5|RVPP|Percent Predicted Residual Volume|[?]|STANDING|[?]|10^9/dose|[?]|1|uIU/L|CORONARY ARTERY, LEFT|LEFT|SURFACE|SLIT LAMP|Y|||VENDOR|ONCOLOGIST|3|Visit_3|40|4|WASHOUT|2020-12-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|6|SALKA|Salazar-Knowles Equation Parameter A|[?]|PRONE|||[?]|1|ft2|T10 VERTEBRA|LATERAL|ROSTRAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|||Y|INTERVIEWER|CLINICAL PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|BEAM BREAKS|[?]|1|GPS U|OCCIPITAL LYMPH NODE|IPSILATERAL|TIP|CONTRAST ENHANCED SPIRAL CT SCAN||||CLINICAL RESEARCH COORDINATOR|READER 1|4|Visit_4|65|4|WASHOUT|2021-01-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|8|LCI|Lung Clearance Index|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/beat|THORAX|UNILATERAL|TIP|ULTRASOUND|||Y|CHILD|READER 2|4|Visit_4|65|1|TREATMENT|2021-01-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SEMI-RECUMBENT|[?]|MASK|[?]|1|pm|TIBIAL-CRURAL PERIPHERAL ARTERY|UNILATERAL|DISTAL|MULTI-SLICE SPIRAL CT|Y|||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-02-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|39b8db88-810b-4402-9ca3-c2bab1939c1c|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING|||[?]|1|kN/cm2|KIDNEY, CORTEX|UNILATERAL|PERIPHERAL|MODIFIED ACID FAST STAIN|Y||Y|CLINICAL STUDY SPONSOR|READER 2|5|Visit_5|90|5|FOLLOW-UP|2021-02-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|TLC|Total Lung Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|TROCHE|PERITONEAL CAVITY|CONTRALATERAL|BASAL|NEURAMINIDASE INHIBITION ASSAY|||Y|SPOUSE|ADJUDICATOR 3|1|Visit_1|10|6|TREATMENT|2020-07-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|2|PEFREV|PEF Reversibility|[?]|SUPINE|||[?]|1|10^6 CFU|INTERNAL ILIAC ARTERY|LATERAL|DORSAL|MALDI-TOF||Y|Y|CHILD|ADJUDICATOR|1|Visit_1|10|2|FOLLOW-UP|2020-07-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|3|VO2|Oxygen Consumption|[?]|PRONE|[?]|RATIO|[?]|1|ug/m2/h|BRACHIAL ARTERY|LEFT|FORE|X-RAY FLUORESCENCE SPECTROMETRY||Y||SPOUSE|RATER|2|Visit_2|25|4|TREATMENT|2020-08-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-RECUMBENT|[?]|Antibody Unit|[?]|1|nmol/kg/day|CORONARY ARTERY, LEFT|UNILATERAL|LATERAL|CLINICAL EVALUATION||||INDEPENDENT ASSESSOR|ADJUDICATOR 1|2|Visit_2|25|4|TREATMENT|2020-08-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|5|IVCPP|Percent Predicted IVC|[?]|REVERSE TRENDELENBURG|||[?]|1|PNU/mL|GASTROINTESTINAL TRACT, UPPER, WALL|CONTRALATERAL|ANTERIOR|MANUAL COUNT|Y||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 1|3|Visit_3|40|1|WASHOUT|2020-08-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|6|DLCOPP|Percent Predicted DLCO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|lm|GASTROINTESTINAL TRACT, WALL|IPSILATERAL|INTERMEDIATE|FLUORESCENT MICROSCOPY|||Y|CAREGIVER|NEUROLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-08-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|7|OXYPULSE|Oxygen Pulse|[?]|SITTING|[?]|mmol/day|[?]|1|mU/g|HUMERUS|RIGHT|POSTERIOR|CLOT DETECTION|Y|||CHILD|PATHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-09-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|8|TVPP|Percent Predicted Tidal Volume|[?]|SITTING, LEGS DEPENDENT|[?]|Hounsfield Unit|[?]|1|mV*min|SUBSTANTIA NIGRA|LEFT|PERIVENTRICULAR|CONFOCAL MICROSCOPY|Y|||CLINICAL STUDY SPONSOR|CARDIOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-09-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|9|RVPP|Percent Predicted Residual Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|g/cm2|BILIARY TRACT|RIGHT|TIP|HPLC-UV|||Y|CHILD|ENDOCRINOLOGIST|5|Visit_5|90|7|WASHOUT|2020-10-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|10|RELSZCHG|Relative Size Change|[?]|SITTING|[?]|m/sec2|[?]|1|uCi/kg|LIVER LOBE|LATERAL|CRANIAL|ACRIDINE ORANGE STAIN||||CAREGIVER|ONCOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-10-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|ICREV|IC Reversibility|[?]|REVERSE TRENDELENBURG|||[?]|1|10^3 RNA copies/mL|SCALP|LATERAL|SURFACE|POLYGRAPHY|Y||Y|ADJUDICATOR|ADJUDICATOR 1|1|Visit_1|10|5|SCREENING|2020-11-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|2|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|g/day|MAIN BRONCHUS, RIGHT|LEFT|ROSTRAL|CHROMATOGRAPHY|||Y|INTERVIEWER|ADJUDICATOR 1|1|Visit_1|10|7|WASHOUT|2020-11-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|3|EVC|Expiratory Vital Capacity|[?]|SITTING|[?]|pmol/10^9 cells|[?]|1|Bq/kg|EPIDIDYMIS|IPSILATERAL|SURFACE|NEXT GENERATION SEQUENCING||||PARENT|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|4|OXYPULSE|Oxygen Pulse|[?]|SITTING, LEGS DEPENDENT|[?]|/cmH2O|[?]|1|kPa|LUNG, RIGHT MIDDLE LOBE|BILATERAL|TIP|IMMUNOPRECIPITATION||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|2|Visit_2|25|4|WASHOUT|2020-11-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|5|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|pkat|[?]|1|kHz|FINGERNAIL|UNILATERAL|DORSAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y||SIBLING|DERMATOLOGIST|3|Visit_3|40|6|WASHOUT|2020-12-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|6|DLCOVA|DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|ug/min|[?]|1|mg/mL/day|HEPATIC ARTERY|BILATERAL|FACIAL|SPIRAL CT SCAN WITHOUT CONTRAST||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|3|WASHOUT|2020-12-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|7|FRCPP|Percent Predicted FRC|[?]|FOWLERS|||[?]|1|mm3/mm2/year|RIGHT VENTRICULAR BRANCH|BILATERAL|MEDIAL|BRDU CELLULAR PROLIFERATION ASSAY|||Y|CHILD|ONCOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-12-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|8|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|TRENDELENBURG|[?]|U/kg/day|[?]|1|IU/mL|HEART, RIGHT VENTRICULAR WALL|LEFT|VENTROLATERAL|IMMUNOCHEMILUMINOMETRIC ASSAY||||CHILD|ONCOLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-12-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|LOZENGE|[?]|1|10^8 PFU|WRIST JOINT|CONTRALATERAL|CRANIAL|CISH||||ADJUDICATOR|HEMATOLOGIST|5|Visit_5|90|3|TREATMENT|2021-01-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|bca1f50d-04e6-46f5-afb3-e48aaea1069d|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|PRONE|||[?]|1|ug/m2|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|DEEP|LAPAROSCOPY|Y||Y|CAREGIVER|PATHOLOGIST 1|5|Visit_5|90|5|TREATMENT|2021-01-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|Gy/h|[?]|1|MHz|PENIS, GLANS|IPSILATERAL|SUPERIOR|MAPH|Y|||GUARDIAN|PATHOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-05-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|[?]|mJoule/cm2|[?]|1|Enzyme U/g Hb|AORTIC ARCH|LEFT|POSTERIOR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||PARENT|INTERNIST|1|Visit_1|10|6|FOLLOW-UP|2020-05-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|3|FIO2|Fraction of Inspired Oxygen|[?]|STANDING, BENT FORWARD|[?]|/4.0 mL|[?]|1|SPRAY|SIGMOID SINUS|LATERAL|ANTERIOR|SNP ARRAY||||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|4|TSUHYS|Tissue Hysteresivity|[?]|RIGHT LATERAL DECUBITUS|[?]|cmH2O*s2/mL|[?]|1|10^6 CFU/g|C6 VERTEBRA|CONTRALATERAL|PERIVENTRICULAR|DNA MICROARRAY||||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|WASHOUT|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|5|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|mol/L|[?]|1|log10 TCID 50/dose|SCAPHOID-LUNATE JOINT|IPSILATERAL|ANTEROTEMPORAL|POLYSOMNOGRAPHY|Y|||GUARDIAN|RADIOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-06-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|6|IC|Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|mL/s|EPIGASTRIC REGION|CONTRALATERAL|INTERMEDIATE|COMPLEMENT FIXATION||Y|Y|CHILD|RATER|3|Visit_3|40|5|TREATMENT|2020-06-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SEMI-FOWLERS|[?]|/VF|[?]|1|DISK|ELBOW FLEXOR MUSCLES|RIGHT|LOWER|INCISION-INDUCED BLEEDING METHOD||Y||SIBLING|READER|4|Visit_4|65|4|TREATMENT|2020-07-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|||[?]|1|m|PAROTID GLAND LYMPH NODE|BILATERAL|DORSAL|HPLC/MS/MS|||Y|INDEPENDENT ASSESSOR|HEMATOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|9|IC|Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|km/h|[?]|1|IU/g|GASTROINTESTINAL TRACT, LOWER|CONTRALATERAL|DISTAL VOLAR|HILLMEN COLOR CHART||Y||CAREGIVER|NEUROLOGIST|5|Visit_5|90|7|TREATMENT|2020-08-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|RE|6bddadef-13fb-4fab-b281-aa33aa97aa8f|10|PIF|Peak Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|yd|[?]|1|mol/mg|PARASYMPATHETIC GANGLIA|LATERAL|SURFACE|WHOLE TRANSCRIPTOME SEQUENCING||Y||CLINICAL RESEARCH ASSOCIATE|RATER 2|5|Visit_5|90|4|TREATMENT|2020-08-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SEMI-FOWLERS|||[?]|1|L|SKULL, BASE|BILATERAL|UPPER EXTENSOR SURFACE|NEURAMINIDASE INHIBITION ASSAY||Y|Y|CLINICAL RESEARCH COORDINATOR|RATER 2|1|Visit_1|10|4|TREATMENT|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|2|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING, BENT FORWARD|[?]|CAN|[?]|1|mol/mL|MEDIASTINUM, POSTERIOR|UNILATERAL|FACIAL|PATHOLOGICAL EVALUATION||||CAREGIVER|MICROSCOPIST 3|1|Visit_1|10|1|FOLLOW-UP|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|in|[?]|1|sec|XIPHOID PROCESS|BILATERAL|MIDLINE|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||GUARDIAN|ADJUDICATOR 3|2|Visit_2|25|5|FOLLOW-UP|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|4|PNIF|Peak Nasal Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|mU|[?]|1|/sec|UPPER CERVICAL LYMPH NODE|LATERAL|VENTRAL|MIGET||Y||SPOUSE|NEUROLOGIST 2|2|Visit_2|25|5|WASHOUT|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SUPINE|[?]|mg/m2/min|[?]|1|JDF Unit|RIB 1|CONTRALATERAL|POSTERIOR|JAEGER EYE CHART||||NON-HEALTH CARE PROFESSIONAL|READER|3|Visit_3|40|5|TREATMENT|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|DECUBITUS|[?]|TRACE|[?]|1|IU|TUNICA INTIMA|RIGHT|MIDLINE|MODIFIED ACID FAST STAIN||||HEALTH CARE PROFESSIONAL|RATER 2|3|Visit_3|40|7|TREATMENT|2020-07-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|7|QUASCOMP|Quasi-Static Compliance|[?]|LATERAL DECUBITUS|[?]|sec|[?]|1|mmol/mol|SHOULDER JOINT|BILATERAL|UPPER EXTENSOR SURFACE|SLOAN LETTER EYE CHART 2.5%|Y|||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|4|Visit_4|65|6|TREATMENT|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|8|ERV|Expiratory Reserve Volume|[?]|DECUBITUS|||[?]|1|P|NASAL SEPTUM|UNILATERAL|SUBCORTICAL|FLOW MICROSCOPY|||Y|FRIEND|NEUROLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|9|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SUPINE|[?]|Gravitational Unit|[?]|1|Bq/ug|PUTAMEN|RIGHT|SUPERIOR|POLYGRAPHY||Y||FRIEND|UROLOGIST|5|Visit_5|90|1|TREATMENT|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|6edb7414-d8f4-44da-8483-504b93a7e705|10|FEV_PEF|FEV at PEF|[?]|DECUBITUS|||[?]|1|nm|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|LEFT|DORSAL|GC/MS-CI|Y|Y|Y|VENDOR|RADIOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|EFFIND|Effusion Indicator|[?]|TRENDELENBURG|[?]|mCi|[?]|1|L/h/m2|VASTUS MEDIALIS MUSCLE|CONTRALATERAL|SUBCORTICAL|NUCLEIC ACID AMPLIFICATION TEST||||FAMILY MEMBER|ENDOCRINOLOGIST|1|Visit_1|10|2|TREATMENT|2020-05-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|2|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|DECUBITUS|||[?]|1|mIU/L|PANCREAS, TAIL|LATERAL|ANTEROMEDIAL|ELISA||Y|Y|NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|10^3 CFU/mL|[?]|1|Mile|SUBARACHNOID SPACE|CONTRALATERAL|MEDIAL|CONGO RED STAIN||||SIGNIFICANT OTHER|OPHTHALMOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-05-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|4|OXYPULSE|Oxygen Pulse|[?]|SITTING, LEGS DEPENDENT|[?]|g/animal|[?]|1|kcal|SALIVARY GLAND|RIGHT|OCCIPITAL|MICROARRAY||||INVESTIGATOR|OPHTHALMOLOGIST|2|Visit_2|25|5|TREATMENT|2020-05-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|5|PEF|Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|PFU/dose|PROXIMAL PHALANX 1 OF THE HAND|RIGHT|VENTRAL|KINETIC CHROMOGENIC ASSAY|||Y|ADJUDICATOR|RATER 2|3|Visit_3|40|5|SCREENING|2020-06-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|[?]|Arbitrary U|[?]|1|nmol/day|SCAPHOID-TRAPEZOID JOINT|IPSILATERAL|DEEP|SPIROMETRY||||CLINICAL STUDY SPONSOR|RATER 2|3|Visit_3|40|1|SCREENING|2020-06-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-28
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|7|EXPRELTM|Expiration Relaxation Time|[?]|STANDING|[?]|IU/g Hb|[?]|1|ug/g/min|METACARPAL 1 BASE|RIGHT|VENTROLATERAL|MICRO BROTH DILUTION||Y||SIGNIFICANT OTHER|RADIOLOGIST 2|4|Visit_4|65|4|WASHOUT|2020-07-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|8|LOBVOL|Lobar Volume|[?]|SEMI-FOWLERS|[?]|mm/min|[?]|1|mg/dose|CORNEAL ENDOTHELIUM|UNILATERAL|NASAL|DROPLET DIGITAL PCR||||GUARDIAN|INTERNIST|4|Visit_4|65|4|SCREENING|2020-07-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|9|EFFVOL|Effusion Volume|[?]|SUPINE|[?]|DIOPTER|[?]|1|L|BODY|LATERAL|POSTERIOR|CAPILLARY ELECTROPHORESIS||||SIBLING|CARDIOLOGIST|5|Visit_5|90|1|WASHOUT|2020-08-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|Gauss|[?]|1|mL/cage/wk|GENITOURINARY SYSTEM|BILATERAL|NASAL|IVY INCISION METHOD||Y||STUDY SUBJECT|CARDIOLOGIST|5|Visit_5|90|7|TREATMENT|2020-08-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|PEFREV|PEF Reversibility|[?]|PRONE|||[?]|1|copies/mL|INTERPHALANGEAL JOINT 5 OF THE FOOT|IPSILATERAL|ANTEROLATERAL|CELLULAR PROLIFERATION ASSAY|Y||Y|GUARDIAN|READER 2|1|Visit_1|10|5|FOLLOW-UP|2020-05-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-17
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|10^6/hpf|[?]|1|U/kg|KIDNEY, MEDULLA|LATERAL|LOWER EXTENSOR SURFACE|ROMANOWSKY STAIN|Y|||CHILD|RATER 1|1|Visit_1|10|5|TREATMENT|2020-05-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-17
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|3|AIRTRAP|Air Trapping|[?]|LATERAL DECUBITUS|[?]|SACHET|[?]|1|/500 WBC|FLEXOR DIGITORUM BREVIS MUSCLE|CONTRALATERAL|INTERMEDIATE|HPLC-FL||Y||INTERVIEWER|READER 3|2|Visit_2|25|4|TREATMENT|2020-06-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-12
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|BOTTLE|[?]|1|mg2/dL2|SOFT TISSUE|IPSILATERAL|APICAL|MAGNETIC RESONANCE ENTEROGRAPHY||||FRIEND|RATER 2|2|Visit_2|25|3|TREATMENT|2020-06-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-12
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|5|INTP|Interpretation|[?]|UNCONSTRAINED|[?]|CUP|[?]|1|Joule|PERICARDIAL CAVITY|LATERAL|PERIVENTRICULAR|MICROBIAL CULTURE||||HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|7|TREATMENT|2020-06-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|AgU/mL|KNEE JOINT|RIGHT|SUBCORTICAL|MOUSE PROTECTION ASSAY|||Y|INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|3|Visit_3|40|5|TREATMENT|2020-06-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|7|INTP|Interpretation|[?]|PRONE|[?]|10^9/dose|[?]|1|m3|DISTAL EXTRAHEPATIC BILE DUCT REGION|RIGHT|BASAL|PET/CT SCAN||||INTERVIEWER|RADIOLOGIST 1|4|Visit_4|65|6|FOLLOW-UP|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|8|AIRTRAP|Air Trapping|[?]|REVERSE TRENDELENBURG|[?]|EID 50/mL|[?]|1|Ci/mL|RETROAURICULAR LYMPH NODE|RIGHT|LOWER MEDIAL|QUANTITATIVE ULTRASOUND||||DOMESTIC PARTNER|RADIOLOGIST|4|Visit_4|65|1|TREATMENT|2020-07-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-11
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|UNCONSTRAINED|[?]|10^3 CFU|[?]|1|WAFER|URETHRA, PROSTATIC|UNILATERAL|ROSTRAL|ERGOSPIROMETRY||Y||SIGNIFICANT OTHER|PATHOLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|10|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-RECUMBENT|[?]|IU/L|[?]|1|nsec|RIB 6|CONTRALATERAL|INNER|MYELOPEROXIDASE STAIN||Y||INVESTIGATOR|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2020-08-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|1|GAW|Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|Ci/mg|[?]|1|mL/100g/min|INTERPHALANGEAL JOINT 1 OF THE FOOT|RIGHT|ANTEROLATERAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||||PARENT|OPHTHALMOLOGIST|1|Visit_1|10|3|TREATMENT|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|2|TSUHYS|Tissue Hysteresivity|[?]|TRENDELENBURG|[?]|vp/mL|[?]|1|mV|L5 VERTEBRA|CONTRALATERAL|UPPER|CLIP||Y||INTERVIEWER|INTERNIST|1|Visit_1|10|6|SCREENING|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|3|AWVOLPP|Percent Predicted Airway Volume|[?]|SUPINE|[?]|usec|[?]|1|sec|DISTAL INTERPHALANGEAL JOINT 2|RIGHT|LOWER FLEXOR SURFACE|RADIATION DOSIMETRY||||PROXY|OPTOMETRIST|2|Visit_2|25|3|TREATMENT|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|DECUBITUS|[?]|cmol|[?]|1|mAnson U/mL|CEREBRAL VEIN|IPSILATERAL|TIP|CARDIAC THERMODILUTION|Y|||ADJUDICATOR|NEUROLOGIST 1|2|Visit_2|25|3|TREATMENT|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|5|IRVPP|Percent Predicted IRV|[?]|REVERSE TRENDELENBURG|[?]|msec|[?]|1|usec|DISTAL INTERPHALANGEAL JOINT 4|UNILATERAL|ANTEROLATERAL|ELASTOGRAPHY||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|3|Visit_3|40|6|SCREENING|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|6|RER|Respiratory Exchange Ratio|[?]|TRENDELENBURG|[?]|ng/L|[?]|1|PIXELS/cm|SUPERIOR VENA CAVA|UNILATERAL|ANTEROPOSTERIOR|FORCED OSCILLATION TECHNIQUE||||GUARDIAN|CLINICAL PATHOLOGIST|3|Visit_3|40|2|WASHOUT|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|7|PLMXRS|Pulmonary Reactance|[?]|LATERAL DECUBITUS|[?]|um|[?]|1|/HPF|TIBIAL-CRURAL PERIPHERAL ARTERY|LATERAL|ANTEROMEDIAL|DXA SCAN||||CAREGIVER|READER 3|4|Visit_4|65|7|WASHOUT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|8|EXPRELTM|Expiration Relaxation Time|[?]|UNCONSTRAINED|[?]|LOZENGE|[?]|1|mL/animal/wk|STRIATUM|UNILATERAL|PERIVENTRICULAR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||SIGNIFICANT OTHER|NEUROLOGIST 1|4|Visit_4|65|1|TREATMENT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|Enzyme U/L|[?]|1|umol/day|NOSE|LATERAL|ANTEROPOSTERIOR|PHOTOMETRY||||FAMILY MEMBER|HEMATOLOGIST|5|Visit_5|90|4|SCREENING|2021-04-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|47d55e87-e559-424d-a6ad-d533a0d77f39|10|DLCOVA|DLCO/VA|[?]|DECUBITUS|[?]|PRESSOR UNITS|[?]|1|pkat|SPLENIC VEIN|RIGHT|APICAL|GC/MS|Y|Y||STUDY SUBJECT|MICROSCOPIST 2|5|Visit_5|90|3|SCREENING|2021-04-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|1|ERV|Expiratory Reserve Volume|[?]|STANDING|[?]|dpm/100mg|[?]|1|Bq/mL|GASTROINTESTINAL TRACT, LOWER|UNILATERAL|UPPER EXTENSOR SURFACE|GC/FID||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-12-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|2|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|[?]|MBq|[?]|1|mAmp|ENDOMETRIAL CAVITY|CONTRALATERAL|ANTEROMEDIAL|DIFFUSION WEIGHTED MRI|Y|||INDEPENDENT ASSESSOR|OPTOMETRIST|1|Visit_1|10|1|TREATMENT|2020-12-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|3|FIF75|Forced Inspiratory Flow at 75%|[?]|STANDING, BENT FORWARD|[?]|WEEKS|[?]|1|COAT|PRETRACHEAL LYMPH NODE|LEFT|LOWER MEDIAL|TRIPLE-PHASE MRI SCAN|Y|||FRIEND|INTERNIST|2|Visit_2|25|6|SCREENING|2021-01-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|SLING|[?]|WAFER|[?]|1|um|INTESTINE|BILATERAL|UPPER|FLOW MICROSCOPY||||CAREGIVER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2021-01-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|5|FEV1SVC|FEV1/SVC|[?]|FOWLERS|[?]|CAPFUL|[?]|1|GBq/mg|AORTOPULMONARY WINDOW LYMPH NODE|BILATERAL|SUPERFICIAL|RADIOGRAPHY||||ADJUDICATOR|MICROSCOPIST 1|3|Visit_3|40|5|FOLLOW-UP|2021-01-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|6|MIP|Maximal Inspiratory Pressure|[?]|DECUBITUS|[?]|cycle/min|[?]|1|uV2|COLON, DESCENDING|UNILATERAL|UPPER|ELECTROPHORESIS||||VENDOR|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2021-01-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|UNCONSTRAINED|[?]|mmHg*min/L|[?]|1|BLOCKS|HEAD OF THE HUMERUS|LATERAL|DORSOLATERAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|4|Visit_4|65|4|TREATMENT|2021-02-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|8|FEV6PP|Percent Predicted FEV6|[?]|SLING|||[?]|1|atm|BLADDER|RIGHT|FRONTAL|FLUORESCENT ENZYME IMMUNOASSAY|||Y|ADJUDICATOR|OTOLARYNGOLOGIST|4|Visit_4|65|6|WASHOUT|2021-02-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|9|IRVPP|Percent Predicted IRV|[?]|DECUBITUS|||[?]|1|mV|SPLENIC HILAR LYMPH NODE|RIGHT|PERIPHERAL|PET/CT SCAN WITHOUT CONTRAST|Y||Y|ADJUDICATION COMMITTEE|NEUROLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-03-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|f89c08df-2e24-4c97-a451-1980cecebf14|10|FIO2|Fraction of Inspired Oxygen|[?]|SITTING, LEGS DEPENDENT|||[?]|1|DNA copies/ug|SPLENIC HILAR LYMPH NODE|BILATERAL|CENTRAL|ACRIDINE ORANGE STAIN|Y||Y|PARENT|OPTOMETRIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|1|MEP|Maximal Expiratory Pressure|[?]|SEMI-FOWLERS|[?]|mPa|[?]|1|DROP|SACRUM|LATERAL|INNER|WESTERN BLOT||||VENDOR|NEUROLOGIST 1|1|Visit_1|10|5|SCREENING|2021-01-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|2|IVCPP|Percent Predicted IVC|[?]|STANDING|[?]|foz_us|[?]|1|nmol BCE/mmol|PRESACRAL LYMPH NODE|LEFT|DORSOLATERAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y||FRIEND|PATHOLOGIST 1|1|Visit_1|10|3|FOLLOW-UP|2021-01-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|3|FEV1FVC6|FEV1/FVC6|[?]|SUPINE|||[?]|1|cpm|CAPITATE-LUNATE JOINT|CONTRALATERAL|TIP|NUCLEIC ACID SEQUENCING|||Y|INTERVIEWER|READER|2|Visit_2|25|2|TREATMENT|2021-02-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|4|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|mL/m2/h|[?]|1|copies/uL|FOREHEAD|BILATERAL|ANTEROMEDIAL|IHC||||CLINICAL STUDY SPONSOR|CARDIOLOGIST|2|Visit_2|25|4|WASHOUT|2021-02-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING|[?]|min|[?]|1|cm/min|OLFACTORY MUCOSA|CONTRALATERAL|INFERIOR|AURAMINE STAIN||||FAMILY MEMBER|RATER 1|3|Visit_3|40|4|TREATMENT|2021-02-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|6|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-RECUMBENT|||[?]|1|RFU|SMALL SAPHENOUS VEIN|LATERAL|UPPER|GEL ELECTROPHORESIS|||Y|VENDOR|RADIOLOGIST 2|3|Visit_3|40|7|SCREENING|2021-02-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|m3|[?]|1|g|THIRD DIAGONAL BRANCH ARTERY|BILATERAL|VOLAR|ROMANOWSKY STAIN||||VENDOR|ADJUDICATOR 1|4|Visit_4|65|4|TREATMENT|2021-03-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|8|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^6 organisms/mg|CLAW|RIGHT|FRONTAL|FLAME PHOTOMETRY|||Y|PARENT|MICROSCOPIST|4|Visit_4|65|6|TREATMENT|2021-03-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|9|ELSTNCE|Elastance|[?]|SEMI-RECUMBENT|[?]|Mile|[?]|1|FINGERTIP UNIT|BUCCAL MUCOSA|CONTRALATERAL|INNER|HEMOCYTOMETRY|Y|||PARENT|RATER|5|Visit_5|90|3|TREATMENT|2021-04-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|dbb225ed-e322-4946-a60a-0fafd7e22953|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|[?]|tsp eq|[?]|1|sec|BRAIN VENTRICLE, LATERAL|LATERAL|TEMPORAL|NEXT GENERATION TARGETED SEQUENCING||||SIBLING|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2021-04-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|1|EVC|Expiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|CCID 50/dose|[?]|1|10^12 IU/L|LEFT VENTRICULAR APICAL LATERAL SEGMENT|RIGHT|FACIAL|ELECTROCHEMILUMINESCENCE|Y|||FAMILY MEMBER|OPTOMETRIST|1|Visit_1|10|6|WASHOUT|2020-12-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING, BENT FORWARD|||[?]|1|BAR|TRAPEZIUM-TRAPEZOID JOINT|RIGHT|FRONTAL|COLORIMETRY|Y||Y|HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|1|Visit_1|10|2|SCREENING|2020-12-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|STANDING|[?]|TUBE|[?]|1|pg/L|LESSER TROCHANTER|RIGHT|TEMPORAL|GRADIENT DIFFUSION||||SPOUSE|OPTOMETRIST|2|Visit_2|25|7|TREATMENT|2021-01-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|4|IRV|Inspiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|GBq/mg|[?]|1|Henry|GENITOURINARY SYSTEM|LEFT|OCCIPITAL|CLINICAL EVALUATION|Y|||ADJUDICATION COMMITTEE|RADIOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2021-01-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|5|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|[?]|min/day|[?]|1|mIU/L|LOWER GASTROINTESTINAL TRACT LYMPH NODE|LEFT|DEEP|MAPH||Y||SIBLING|READER 1|3|Visit_3|40|7|TREATMENT|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|6|EXPRELTM|Expiration Relaxation Time|[?]|SUPINE|||[?]|1|JAR|CARDIAC WALL|IPSILATERAL|LATERAL|PHYSICAL EXAMINATION||Y|Y|CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|3|Visit_3|40|3|SCREENING|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|7|FIV1|Forced Inspiratory Volume in 1 Second|[?]|PRONE|[?]|g/g|[?]|1|ug/L/h|LIGAMENT|RIGHT|INFERIOR|SNP ARRAY||||FRIEND|PHYSIOTHERAPIST|4|Visit_4|65|6|FOLLOW-UP|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|8|EXPRELTM|Expiration Relaxation Time|[?]|UNCONSTRAINED|[?]|tuberculin unit/mL|[?]|1|%(w/v)|THORAX|BILATERAL|ROSTRAL|MAGNETIC RESONANCE ENTEROGRAPHY||||SIGNIFICANT OTHER|ADJUDICATOR 1|4|Visit_4|65|7|FOLLOW-UP|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-18
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|9|IC|Inspiratory Capacity|[?]|SEMI-FOWLERS|[?]|Antibody Unit|[?]|1|pg/dL|PINEAL GLAND|CONTRALATERAL|MEDIAL|ELISPOT||Y||INVESTIGATOR|PATHOLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2021-03-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|95e61698-43f7-4cc5-aafa-06dac7870743|10|FIF50|Forced Inspiratory Flow at 50%|[?]|SUPINE|[?]|10^4/hpf|[?]|1|CONTAINER|SCIATIC NERVE|RIGHT|VENTROLATERAL|QUANTITATIVE ULTRASOUND|Y|||DOMESTIC PARTNER|ENDOCRINOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-RECUMBENT|[?]|psi|[?]|1|10^9 organisms/mL|MITRAL VALVE|LATERAL|VOLAR|VENTILATION PERFUSION LUNG SCAN|Y|Y||CAREGIVER|DERMATOLOGIST|1|Visit_1|10|4|WASHOUT|2020-09-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|2|IVCPP|Percent Predicted IVC|[?]|PRONE|[?]|cP|[?]|1|10^6 CFU/g|FEMALE REPRODUCTIVE SYSTEM|CONTRALATERAL|PARIETO-OCCIPITAL|FORCED OSCILLATION TECHNIQUE||||FAMILY MEMBER|RATER|1|Visit_1|10|3|TREATMENT|2020-09-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|3|DLCO|Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|[?]|LOZENGE|[?]|1|100 IU/mL|OLECRANON|UNILATERAL|ANTERIOR|CT SCAN||Y||INDEPENDENT ASSESSOR|RADIOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-09-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SLING|[?]|s*kPa|[?]|1|mm/2h|LATERAL SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|VOLAR|PAP STAIN||Y||ADJUDICATION COMMITTEE|UROLOGIST|2|Visit_2|25|3|WASHOUT|2020-09-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|kg/cm|[?]|1|ug/dL|LEFT VENTRICULAR APEX SEGMENT|BILATERAL|SUPERFICIAL|NON-INVASIVE DIELECTRIC SENSING||Y||INVESTIGATOR|ADJUDICATOR 3|3|Visit_3|40|6|WASHOUT|2020-10-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|6|PNEUMIND|Pneumonia Indicator|[?]|SEMI-FOWLERS|[?]|MBq/uL|[?]|1|IU/dL|LUNG|CONTRALATERAL|CAUDAL|DC SHEATH FLOW|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST|3|Visit_3|40|5|TREATMENT|2020-10-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|7|RER|Respiratory Exchange Ratio|[?]|STANDING|[?]|log10 copies/mL|[?]|1|mmol/L|SUPRACLAVICULAR FOSSA|LEFT|PARIETO-OCCIPITAL|IMMUNOFLUORESCENT STAIN|Y|||INTERVIEWER|ADJUDICATOR 2|4|Visit_4|65|6|TREATMENT|2020-11-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|8|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-FOWLERS|[?]|mg/animal|[?]|1|nkat/g Hb|MALE GENITALIA|IPSILATERAL|LOWER MEDIAL|PHOROPTER||Y||SPOUSE|RADIOLOGIST 1|4|Visit_4|65|7|WASHOUT|2020-11-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|9|MEP|Maximal Expiratory Pressure|[?]|SITTING|[?]|damol/L|[?]|1|10^6 CFU|PARATHYROID GLAND|LEFT|CENTRAL|INDIRECT IMMUNOFLUORESCENCE||||INDEPENDENT ASSESSOR|HEMATOLOGIST|5|Visit_5|90|2|TREATMENT|2020-12-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|151308c7-03aa-4a0b-b13f-9838edb218ef|10|PCF|Peak Cough Flow|[?]|STANDING|[?]|ug/min|[?]|1|mCi/L|GASTROESOPHAGEAL JUNCTION|IPSILATERAL|PROXIMAL|THICK SMEAR|Y|||DOMESTIC PARTNER|MICROSCOPIST|5|Visit_5|90|5|WASHOUT|2020-12-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|UNCONSTRAINED|[?]|kUSP|[?]|1|umol/day|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LEFT|SUPERFICIAL|CELL OF ORIGIN ASSAY||||CHILD|CLINICAL PATHOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-06-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|2|AWVOLPP|Percent Predicted Airway Volume|[?]|DECUBITUS|[?]|CAN|[?]|1|m3|BONE MARROW|LEFT|DORSOLATERAL|INTERRUPTER TECHNIQUE||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|1|Visit_1|10|5|FOLLOW-UP|2020-06-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|3|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|[?]|mol/mg|[?]|1|cm2|SKIN OF THE ELBOW|RIGHT|DISTAL VOLAR|LEAD CITRATE STAIN||||VENDOR|NEUROLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|10^6 copies/mL|[?]|1|mg/kg/h|LIP|LEFT|FORE|MULTIPLE BREATH WASHOUT||||CHILD|NEUROLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-06-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|5|PLMXRS|Pulmonary Reactance|[?]|PRONE|||[?]|1|cm2|POSTERIOR CERVICAL LYMPH NODE|LEFT|MEDIAL|LEAD CITRATE STAIN||Y|Y|INVESTIGATOR|READER 2|3|Visit_3|40|1|TREATMENT|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|6|LOBVOL|Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|kg/cm2|[?]|1|g/animal|THYROID GLAND|LATERAL|MIDLINE|WHOLE EXOME SEQUENCING||||SPOUSE|PEDIATRIC NEUROLOGIST|3|Visit_3|40|4|WASHOUT|2020-07-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-10
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|[?]|gMFI|[?]|1|mol/g|SUBSTANTIA NIGRA|UNILATERAL|LOWER FLEXOR SURFACE|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||FAMILY MEMBER|READER 2|4|Visit_4|65|1|WASHOUT|2020-08-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|8|TLC|Total Lung Capacity|[?]|SUPINE|[?]|ngEq/L|[?]|1|g/kg|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|LATERAL|FACIAL|PYROSEQUENCING||||INTERVIEWER|NEUROLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|9|VO2|Oxygen Consumption|[?]|TRENDELENBURG|[?]|10^5/hpf|[?]|1|nmol BCE/L|INFRACLAVICULAR LYMPH NODE|RIGHT|SUPERIOR|RIA|Y|||PARENT|FORENSIC PATHOLOGIST|5|Visit_5|90|5|WASHOUT|2020-09-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|10|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|[?]|msec|[?]|1|ug/kg/h|SPINAL ACCESSORY NERVE|RIGHT|PERIVENTRICULAR|JAFFE REACTION||||ADJUDICATION COMMITTEE|PATHOLOGIST|5|Visit_5|90|7|WASHOUT|2020-09-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|1|FEV1FVC6|FEV1/FVC6|[?]|REVERSE TRENDELENBURG|[?]|mg/L FEU|[?]|1|Frames/s|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|LATERAL|LATERAL|CELL OF ORIGIN ASSAY||||STUDY SUBJECT|NEUROLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-10-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|log10 TCID 50/dose|[?]|1|mL/min/1.73m2|SKIN OF THE FOOT|LATERAL|SURFACE|TEMPLATE INCISION METHOD||||ADJUDICATOR|ONCOLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|3|RAW|Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|/mm2|[?]|1|%/s|METACARPAL BONE 5|RIGHT|TIP|PET/CT SCAN||||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|SCREENING|2020-11-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|4|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|log10 CCID 50/dose|PERIPANCREATIC LYMPH NODE|LEFT|ANTEROTEMPORAL|MICROBIAL CULTURE, LIQUID|||Y|PROXY|NEUROLOGIST 1|2|Visit_2|25|7|FOLLOW-UP|2020-11-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|BAG|[?]|1|ELISA unit/dose|LUNG, RIGHT UPPER LOBE|RIGHT|LOWER FLEXOR SURFACE|GC/MS-EI||Y||SIGNIFICANT OTHER|NEUROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-11-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-FOWLERS|[?]|INHALATION|[?]|1|g/kg/day|THYMUS GLAND|LATERAL|NASAL|THIN SMEAR||||ADJUDICATOR|PATHOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-11-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|7|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Roentgen|WRIST JOINT FLEXOR TENDONS|CONTRALATERAL|TEMPORAL|STRESS ECHOCARDIOGRAPHY|||Y|NON-HEALTH CARE PROFESSIONAL|READER 1|4|Visit_4|65|5|TREATMENT|2020-12-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|8|FEV1PP|Percent Predicted FEV1|[?]|FOWLERS|[?]|BLOCKS|[?]|1|g/kg/day|MAXILLARY SINUS|UNILATERAL|LATERAL|CLOT DETECTION|Y|||SIBLING|FORENSIC PATHOLOGIST|4|Visit_4|65|2|SCREENING|2020-12-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|9|IRV|Inspiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mIU/L|[?]|1|TRANSDUCING UNIT|ESOPHAGUS, ABDOMINAL|CONTRALATERAL|ROSTRAL|MUGA|Y|||FRIEND|PATHOLOGIST|5|Visit_5|90|2|WASHOUT|2021-01-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|23605586-1b30-4f05-bb15-417dd3a79994|10|FEV1SVC|FEV1/SVC|[?]|REVERSE TRENDELENBURG|[?]|DIP|[?]|1|mOsm|SINUS|UNILATERAL|PERIVENTRICULAR|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||SIGNIFICANT OTHER|DERMATOLOGIST|5|Visit_5|90|2|TREATMENT|2021-01-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|Sv|[?]|1|ug/mol|BUCCAL MUCOSA|BILATERAL|DEEP|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||Y||SIGNIFICANT OTHER|PATHOLOGIST|1|Visit_1|10|5|SCREENING|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|2|FIF75|Forced Inspiratory Flow at 75%|[?]|FOWLERS|[?]|uU/dL|[?]|1|Gy/h|THORACIC AORTA|LATERAL|DORSOLATERAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|||HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|6|SCREENING|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|3|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-FOWLERS|[?]|WAFER|[?]|1|mg/m2/min|CEREBRAL VEIN|BILATERAL|PERIPHERAL|CELL OF ORIGIN ASSAY|Y|Y||STUDY SUBJECT|OTOLARYNGOLOGIST|2|Visit_2|25|6|WASHOUT|2020-09-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|4|PEFTIME|Peak Expiratory Flow Time|[?]|SUPINE|[?]|psec|[?]|1|km/h|CHEST WALL|CONTRALATERAL|LOWER|SURFACE PLASMON RESONANCE|Y|||INVESTIGATOR|ADJUDICATOR 2|2|Visit_2|25|5|TREATMENT|2020-09-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|5|SVC|Slow Vital Capacity|[?]|LATERAL DECUBITUS|[?]|g/kg/day|[?]|1|POUCH|COLON, SIGMOID|BILATERAL|LATERAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||SPOUSE|READER 1|3|Visit_3|40|6|TREATMENT|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|6|LCI|Lung Clearance Index|[?]|STANDING, BENT FORWARD|[?]|kPa|[?]|1|kg|AXILLARY LYMPH NODE LEVEL II|LATERAL|VENTROLATERAL|CALCULATION|Y|||FRIEND|ENDOCRINOLOGIST|3|Visit_3|40|1|TREATMENT|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|7|EFFIND|Effusion Indicator|[?]|TRENDELENBURG|[?]|nkat/L|[?]|1|pptr|BACK|UNILATERAL|MIDLINE|SANGER SEQUENCING|Y|||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-10-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|8|SVC|Slow Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|fL|[?]|1|MBq/uL|TUNICA INTIMA|IPSILATERAL|PROXIMAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|||CHILD|ENDOCRINOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-10-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|9|OXYPULSE|Oxygen Pulse|[?]|STANDING, BENT FORWARD|[?]|uU/dL|[?]|1|tuberculin unit/mL|METATARSOPHALANGEAL JOINT 4|IPSILATERAL|DISTAL VOLAR|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|Y||INVESTIGATOR|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|57d15ac0-06a6-40e0-9201-4d947651c9b0|10|TGV|Thoracic Gas Volume|[?]|SUPINE|[?]|U.CARR|[?]|1|mmHg/sec|MAIN BRONCHUS, RIGHT|UNILATERAL|SURFACE|IMMUNODIFFUSION||Y||CAREGIVER|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|STANDING|[?]|mkat|[?]|1|10^6 CFU/g|SPLENIC ARTERY|BILATERAL|MEDIAL|VENTILATION PERFUSION LUNG SCAN||||HEALTH CARE PROFESSIONAL|MICROSCOPIST|1|Visit_1|10|2|TREATMENT|2020-08-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|2|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|[?]|g/cage/wk|[?]|1|CIGARETTE|FACE|CONTRALATERAL|DISTAL|SPECULAR MICROSCOPY||||ADJUDICATOR|CARDIOLOGIST|1|Visit_1|10|3|TREATMENT|2020-08-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|3|FEF50|Forced Expiratory Flow 50%|[?]|STANDING|[?]|mV/sec|[?]|1|mL/cage|SEMINAL VESICLE|IPSILATERAL|VENTROLATERAL|IMMUNOASSAY||Y||CAREGIVER|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-08-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|PRONE|[?]|nkat/g Hb|[?]|1|mol/day|PRESACRAL SPACE|IPSILATERAL|DORSOLATERAL|HEMATOXYLIN AND EOSIN STAIN||Y||INDEPENDENT ASSESSOR|RATER|2|Visit_2|25|3|TREATMENT|2020-08-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING, BENT FORWARD|||[?]|1|U/dL|PARAVERTEBRAL GANGLIA|UNILATERAL|PERIPHERAL|THERMAL IONIZATION MASS SPECTROMETRY||Y|Y|GUARDIAN|DERMATOLOGIST|3|Visit_3|40|6|WASHOUT|2020-09-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|6|ICREV|IC Reversibility|[?]|PRONE|[?]|U/cL|[?]|1|LOZENGE|FACIAL NERVE|UNILATERAL|DEEP|PERIPHERAL ANGIOGRAPHY||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|SCREENING|2020-09-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|7|DLCOPP|Percent Predicted DLCO|[?]|REVERSE TRENDELENBURG|[?]|BOTTLE|[?]|1|APL U|INGUINAL REGION|LATERAL|BASAL|SLOAN LETTER EYE CHART 100%||||SIGNIFICANT OTHER|PATHOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-10-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|8|FEV6PP|Percent Predicted FEV6|[?]|SEMI-FOWLERS|||[?]|1|INHALATION|JOINT|CONTRALATERAL|ANTEROMEDIAL|SLIT LAMP|||Y|SIGNIFICANT OTHER|READER 3|4|Visit_4|65|6|SCREENING|2020-10-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|9|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING|[?]|cmH2O*s/mL|[?]|1|TCID 50/dose|TOOTH CANAL|RIGHT|MEDIAL|MICRO BROTH DILUTION||||CLINICAL STUDY SPONSOR|DERMATOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-10-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|10|PCF|Peak Cough Flow|[?]|SITTING|[?]|/4.0 mL|[?]|1|mmHg|T4 VERTEBRA|BILATERAL|POSTERIOR|PHASE-CONTRAST MRI|Y|Y||FRIEND|PATHOLOGIST|5|Visit_5|90|1|WASHOUT|2020-10-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|FOWLERS|[?]|NFIU|[?]|1|mL/m2/day|PERITONEAL CAVITY|IPSILATERAL|CENTRAL|MAPH||||PARENT|PEDIATRIC NEUROLOGIST|1|Visit_1|10|5|TREATMENT|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|2|INTP|Interpretation|[?]|SEMI-RECUMBENT|[?]|uU/L|[?]|1|10^9 CFU/mL|BUCCAL MUCOSA|RIGHT|PERIPHERAL|ANTIMICROBIAL COMBINATION TESTING||||FRIEND|UROLOGIST|1|Visit_1|10|6|SCREENING|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|3|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|nL|[?]|1|LOZENGE|SPINAL ACCESSORY NERVE|RIGHT|NASAL|SLOAN LETTER EYE CHART 1.25%||||CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|2|Visit_2|25|7|WASHOUT|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|4|FIV1PP|Percent Predicted FIV1|[?]|LEFT LATERAL DECUBITUS|[?]|MET|[?]|1|Gy/min|INTERATRIAL SEPTUM|UNILATERAL|PROXIMAL|GRADIENT DIFFUSION||||FAMILY MEMBER|ONCOLOGIST|2|Visit_2|25|1|WASHOUT|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|5|FIF50|Forced Inspiratory Flow at 50%|[?]|LATERAL DECUBITUS|[?]|nmol/L/h|[?]|1|mmol/kg|MID-JUGULAR LYMPH NODE|UNILATERAL|INTERMEDIATE|COULOMETRIC TITRATION||||GUARDIAN|HEMATOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|6|FRCPP|Percent Predicted FRC|[?]|STANDING, BENT FORWARD|[?]|nCi|[?]|1|dpm/0.5 mL|SUBLINGUAL REGION|IPSILATERAL|PERIVENTRICULAR|HEMOCYTOMETRY|Y|||SIBLING|PEDIATRIC NEUROLOGIST|3|Visit_3|40|1|TREATMENT|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|7|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING|||[?]|1|BISCUIT|PELVIS|LATERAL|SURFACE|ELECTROGASTROGRAPHY||Y|Y|PROXY|ENDOCRINOLOGIST|4|Visit_4|65|2|WASHOUT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SLING|[?]|dL|[?]|1|nmol|BRAIN VENTRICLE, LATERAL|RIGHT|SUPERFICIAL|IODINE STAIN|Y|||VENDOR|RADIOLOGIST 2|4|Visit_4|65|5|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|9|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|EIA unit|[?]|1|EID 50/dose|PUBIC BONE|IPSILATERAL|TEMPORAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|TREATMENT|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|10|FEV_PEF|FEV at PEF|[?]|SLING|||[?]|1|nmol/mol|SUBARACHNOID SPACE|IPSILATERAL|VENTROLATERAL|PEAK FLOWMETRY|||Y|INTERVIEWER|RATER 1|5|Visit_5|90|1|WASHOUT|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|DIP|[?]|1|mmol/L|INCUS|RIGHT|VOLAR|CLIP SEQUENCING||||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-12-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|2|RV|Residual Volume|[?]|LATERAL DECUBITUS|||[?]|1|PRESSOR UNITS|OBTURATOR INTERNUS MUSCLE|CONTRALATERAL|VENTRAL|INTERRUPTER TECHNIQUE|||Y|INTERVIEWER|ONCOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-12-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|3|PEFTIME|Peak Expiratory Flow Time|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/mL/h|[?]|1|U.CARR|PARANASAL SINUS|IPSILATERAL|DORSOLATERAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||Y||CLINICAL STUDY SPONSOR|OPTOMETRIST|2|Visit_2|25|6|SCREENING|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mJoule/cm2|ARM SKIN|BILATERAL|SUBCORTICAL|MASS SPECTROMETRY|||Y|NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|6|TREATMENT|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|5|MALIND|Malignancy Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|g/U|[?]|1|Gauss|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|BILATERAL|CENTRAL|SICKLE CELL SOLUBILITY TEST||Y||DOMESTIC PARTNER|INTERNIST|3|Visit_3|40|3|TREATMENT|2021-01-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|6|EVC|Expiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|ngEq/L|[?]|1|mm/sec|NOSE|UNILATERAL|FRONTAL|URANYL ACETATE STAIN|Y|||CAREGIVER|MICROSCOPIST 2|3|Visit_3|40|2|TREATMENT|2021-01-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|7|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|Ci/L|RAPHE|RIGHT|UPPER FLEXOR SURFACE|NEPHELOMETRY|Y||Y|PROXY|READER 2|4|Visit_4|65|2|TREATMENT|2021-02-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|Enzyme U|[?]|1|LB|ADDUCTOR LONGUS MUSCLE|BILATERAL|INTERMEDIATE|ELECTROPHORESIS||||SPOUSE|MICROSCOPIST 3|4|Visit_4|65|5|WASHOUT|2021-02-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|9|EFFVOL|Effusion Volume|[?]|SITTING|||[?]|1|g/day|AXILLARY VEIN|LEFT|LOWER MEDIAL|LAPAROSCOPY|Y||Y|SIGNIFICANT OTHER|MICROSCOPIST 1|5|Visit_5|90|7|SCREENING|2021-03-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|10|ERVPP|Percent Predicted ERV|[?]|TRENDELENBURG|[?]|dpm/100mg|[?]|1|PRESSOR UNITS|TIBIALIS POSTERIOR MUSCLE|IPSILATERAL|OCCIPITAL|IMMUNODIFFUSION||||INTERVIEWER|DERMATOLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|DLCOPP|Percent Predicted DLCO|[?]|STANDING, BENT FORWARD|[?]|mg/kg/dose|[?]|1|10^3 DNA copies/mL|SHOULDER JOINT TENDONS|LEFT|LOWER|GC/MS-CI|Y|||CHILD|READER 3|1|Visit_1|10|1|FOLLOW-UP|2020-07-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|2|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|[?]|COAT|[?]|1|nmol/L/h|DORSAL MOTOR NUCLEUS|CONTRALATERAL|APICAL|HIGH RESOLUTION CT||Y||DOMESTIC PARTNER|CARDIOLOGIST|1|Visit_1|10|4|WASHOUT|2020-07-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SUPINE|[?]|EP U|[?]|1|mm/min|BRACHIAL VEIN|RIGHT|LATERAL|DYNAMOMETRY||||INVESTIGATOR|MICROSCOPIST 3|2|Visit_2|25|6|TREATMENT|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|4|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|damol/L|[?]|1|10^8/L|CERVICAL SPINE|LEFT|PERIPHERAL|PANENDOSCOPY||Y||INVESTIGATOR|ONCOLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|5|EVC|Expiratory Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|AU/mL|INFERIOR PUBIC RAMUS|BILATERAL|FRONTAL|DIGITAL PCR ARRAY|||Y|INDEPENDENT ASSESSOR|RATER 2|3|Visit_3|40|6|TREATMENT|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|6|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|ppm|[?]|1|DNA copies/mL|THORAX|IPSILATERAL|PROXIMAL|CLAUSS METHOD|Y|||CLINICAL STUDY SPONSOR|RATER|3|Visit_3|40|3|FOLLOW-UP|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|7|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|[?]|Bq/kg|[?]|1|RING|PROXIMAL PHALANX 4 OF THE HAND|CONTRALATERAL|LATERAL|IMMUNOFLUORESCENT STAIN|Y|||ADJUDICATOR|CLINICAL PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|8|AWVOLPP|Percent Predicted Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|nmol/L/h|[?]|1|Pack Year|PUTAMEN|UNILATERAL|FACIAL|ACRIDINE ORANGE STAIN||||VENDOR|RATER 2|4|Visit_4|65|2|SCREENING|2020-08-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|9|EXPRELTM|Expiration Relaxation Time|[?]|RIGHT LATERAL DECUBITUS|[?]|Log10 ELISA unit/dose|[?]|1|Bq/kg|L1 VERTEBRA|RIGHT|PERIVENTRICULAR|CYSTOSCOPY||||CHILD|MICROSCOPIST|5|Visit_5|90|4|FOLLOW-UP|2020-09-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|TRENDELENBURG|[?]|mm/min|[?]|1|10^5/L|ISCHIORECTAL FOSSA|LATERAL|INFERIOR|DXA SCAN||||CHILD|ADJUDICATOR 1|5|Visit_5|90|5|WASHOUT|2020-09-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|81f62132-123e-4888-abbe-8e289599e965|1|TGV|Thoracic Gas Volume|[?]|SUPINE|[?]|cm/min|[?]|1|F|RIGHT VENTRICULAR ENDOCARDIUM|RIGHT|CRANIAL|CYSTOMETRY||||SIGNIFICANT OTHER|PATHOLOGIST|1|Visit_1|10|6|SCREENING|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|81f62132-123e-4888-abbe-8e289599e965|2|MEPPP|Percent Predicted MEP|[?]|LATERAL DECUBITUS|[?]|10^4/hpf|[?]|1|ng|RETINAL NERVE FIBER LAYER|LEFT|INTERMEDIATE|RADIATION DOSIMETRY|Y|||FAMILY MEMBER|OTOLARYNGOLOGIST|1|Visit_1|10|2|SCREENING|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|81f62132-123e-4888-abbe-8e289599e965|3|ALVVOL|Alveolar Volume|[?]|SLING|||[?]|1|km/h|SUBGLOTTIS|CONTRALATERAL|DORSOLATERAL|TRANSVAGINAL ULTRASOUND||Y|Y|STUDY SUBJECT|UROLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-12-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|81f62132-123e-4888-abbe-8e289599e965|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|||[?]|1|GPL U|VOMER|RIGHT|VENTROLATERAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-12-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|81f62132-123e-4888-abbe-8e289599e965|5|MEP|Maximal Expiratory Pressure|[?]|LATERAL DECUBITUS|[?]|IU/day|[?]|1|GBq/ug|RAPHE|RIGHT|CAUDAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|3|Visit_3|40|4|SCREENING|2021-01-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|81f62132-123e-4888-abbe-8e289599e965|6|RVPP|Percent Predicted Residual Volume|[?]|SUPINE|[?]|mL/day|[?]|1|U/mmol|SHIN|BILATERAL|BASAL|NEXT GENERATION TARGETED SEQUENCING||||VENDOR|ONCOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2021-01-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|81f62132-123e-4888-abbe-8e289599e965|7|LCI|Lung Clearance Index|[?]|TRENDELENBURG|[?]|ng|[?]|1|mL/breath|MITRAL VALVE|UNILATERAL|UPPER|CISH||Y||ADJUDICATION COMMITTEE|ADJUDICATOR 2|4|Visit_4|65|1|FOLLOW-UP|2021-01-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|81f62132-123e-4888-abbe-8e289599e965|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|10^5/L|[?]|1|/LSQN|EAR|RIGHT|CENTRAL|IMMUNOFLUORESCENT STAIN||Y||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2021-01-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|81f62132-123e-4888-abbe-8e289599e965|9|LOBVOL|Lobar Volume|[?]|TRENDELENBURG|[?]|copies/ug|[?]|1|cmol/L|OBTURATOR INTERNUS MUSCLE|LEFT|FRONTAL|POLYGRAPHY||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|5|Visit_5|90|2|WASHOUT|2021-02-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|81f62132-123e-4888-abbe-8e289599e965|10|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|CONTAINER|[?]|1|ug/dose|LIVER, LEFT LOBE|LEFT|CENTRAL|ENZYMATIC ULTRACENTRIFUGATION||||STUDY SUBJECT|ONCOLOGIST 2|5|Visit_5|90|6|TREATMENT|2021-02-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|mL/min/mmHg|[?]|1|IU/dL|AXILLA|BILATERAL|SURFACE|DIRECT SEQUENCING||||PROXY|ADJUDICATOR 2|1|Visit_1|10|5|WASHOUT|2020-05-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|2|AWVOL|Airway Volume|[?]|SITTING|[?]|U/mmol|[?]|1|IU/mL|NUCLEUS OF DIAGONAL BAND|BILATERAL|HIND|IMMUNO-PET SCAN||Y||STUDY SUBJECT|PATHOLOGIST 1|1|Visit_1|10|6|WASHOUT|2020-05-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|3|FEV1|Forced Expiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/h|[?]|1|L/h|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|CONTRALATERAL|SUBCORTICAL|NON-INVASIVE DIELECTRIC SENSING|Y|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|2|Visit_2|25|5|WASHOUT|2020-05-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|4|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING, BENT FORWARD|[?]|Mile|[?]|1|ugEq/L|NUCLEUS ACCUMBENS|BILATERAL|ANTEROLATERAL|PULSE OXIMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|2|Visit_2|25|3|FOLLOW-UP|2020-05-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|DECUBITUS|[?]|fmol/L/sec|[?]|1|g/kg|GREAT VESSELS|CONTRALATERAL|SUPERIOR|GC/MS||||PROXY|READER|3|Visit_3|40|6|TREATMENT|2020-06-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|6|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SITTING, LEGS DEPENDENT|[?]|uSiemens|[?]|1|g/m2/day|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|SUPERFICIAL|TEMPLATE INCISION METHOD||||VENDOR|ADJUDICATOR 2|3|Visit_3|40|5|TREATMENT|2020-06-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|LATERAL DECUBITUS|||[?]|1|Bq/g|PROXIMAL CIRCUMFLEX ARTERY|CONTRALATERAL|LOWER FLEXOR SURFACE|STATIC PERIMETRY|||Y|STUDY SUBJECT|PATHOLOGIST|4|Visit_4|65|7|WASHOUT|2020-07-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|8|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|[?]|Gy/min|[?]|1|mL/animal|KIDNEY, MEDULLA|LEFT|TEMPORAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|4|Visit_4|65|1|TREATMENT|2020-07-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING, BENT FORWARD|||[?]|1|ag|FEMORAL VEIN|UNILATERAL|PARIETO-OCCIPITAL|PEAK FLOWMETRY||Y|Y|GUARDIAN|ADJUDICATOR 2|5|Visit_5|90|3|WASHOUT|2020-08-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|10|FVC|Forced Vital Capacity|[?]|DECUBITUS|[?]|/7.5 mL|[?]|1|mEq/ug|CAUDATE NUCLEUS|UNILATERAL|VENTRAL|MUGA||||SPOUSE|READER 2|5|Visit_5|90|2|SCREENING|2020-08-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|||[?]|1|kg/cm2|GASTRIC CURVATURE LYMPH NODE|LATERAL|OUTER|PHOTOMETRY|||Y|SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|4|FOLLOW-UP|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|DECUBITUS|[?]|TRANSDUCING UNIT/mL|[?]|1|mg/kg/min|AORTOCAVAL LYMPH NODE|LATERAL|UPPER EXTENSOR SURFACE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|7|SCREENING|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|3|QUASCOMP|Quasi-Static Compliance|[?]|SITTING, LEGS DEPENDENT|[?]|mg/L FEU|[?]|1|RATIO|SUBCLAVIAN VEIN|RIGHT|CAUDAL|ENDPOINT DILUTION ASSAY||||CAREGIVER|PATHOLOGIST 1|2|Visit_2|25|6|FOLLOW-UP|2020-06-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|4|RELSZCHG|Relative Size Change|[?]|SUPINE|||[?]|1|Enzyme U/L|FOOT DIGIT 1|RIGHT|DEEP|MALDI-TOF|||Y|ADJUDICATION COMMITTEE|MICROSCOPIST 3|2|Visit_2|25|2|SCREENING|2020-06-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|5|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|||[?]|1|um2|POPLITEAL FOSSA|RIGHT|INTERMEDIATE|MUGA|||Y|SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|2|WASHOUT|2020-06-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|6|ERVPP|Percent Predicted ERV|[?]|SITTING, LEGS DEPENDENT|[?]|g/cm2|[?]|1|mg/dL|T1 VERTEBRA|UNILATERAL|PROXIMAL VOLAR|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||SIBLING|ONCOLOGIST|3|Visit_3|40|1|TREATMENT|2020-06-16|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|7|AWWVOL|Airway Wall Volume|[?]|SITTING|[?]|nU/cL|[?]|1|L/min|MEDIASTINUM|CONTRALATERAL|HIND|BALLPOINT PEN TECHNIQUE||||PARENT|CLINICAL PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|8|PLMBLFLW|Pulmonary Blood Flow|[?]|LEFT LATERAL DECUBITUS|[?]|DISK|[?]|1|10^6 organisms/mL|LATERAL THIRD DIAGONAL BRANCH ARTERY|CONTRALATERAL|SUPERFICIAL|MUGA||||PARENT|RATER|4|Visit_4|65|7|SCREENING|2020-07-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|9|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|[?]|L/h|[?]|1|CAN|MAIN BRONCHUS, LEFT|BILATERAL|TIP|OSCILLOMETRY||Y||CLINICAL STUDY SPONSOR|RATER 2|5|Visit_5|90|6|FOLLOW-UP|2020-08-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|49282406-97ec-4108-adf9-e01c18ce59c6|10|FIF25|Forced Inspiratory Flow at 25%|[?]|UNCONSTRAINED|||[?]|1|RING|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|CONTRALATERAL|ANTEROLATERAL|LANDOLT RING|||Y|GUARDIAN|OPHTHALMOLOGIST|5|Visit_5|90|3|WASHOUT|2020-08-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|1|INTP|Interpretation|[?]|FOWLERS|[?]|mg/L FEU|[?]|1|LOZENGE|POSTERIOR INFERIOR CEREBELLAR ARTERY|RIGHT|HIND|HIGH LEVEL AMINOGLYCOSIDE SCREEN|Y|Y||SIBLING|MICROSCOPIST 3|1|Visit_1|10|7|TREATMENT|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|2|FIO2|Fraction of Inspired Oxygen|[?]|LEFT LATERAL DECUBITUS|[?]|IU/mL|[?]|1|ukat/L|RENAL ARTERY|RIGHT|PROXIMAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||ADJUDICATOR|READER 2|1|Visit_1|10|2|SCREENING|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|3|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING, BENT FORWARD|[?]|uU/dL|[?]|1|s/h|PERINEUM|UNILATERAL|ANTEROPOSTERIOR|MEDIASTINOSCOPY||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|4|ERVPP|Percent Predicted ERV|[?]|TRENDELENBURG|[?]|GPS U|[?]|1|vp/mL|CORNEA|IPSILATERAL|PERIPHERAL|PUPILLOMETRY||Y||INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|5|ICREV|IC Reversibility|[?]|SLING|||[?]|1|10^6/Ejaculate U|LOWER GASTROINTESTINAL TRACT LYMPH NODE|LEFT|POSTERIOR|AUSCULTATION||Y|Y|INTERVIEWER|MICROSCOPIST 2|3|Visit_3|40|5|SCREENING|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|6|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|[?]|JAR|[?]|1|Sv|LATERAL FIRST DIAGONAL BRANCH ARTERY|LEFT|OCCIPITAL|FLUORIMETRY|Y|Y||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|3|Visit_3|40|3|TREATMENT|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|7|PLMXRS|Pulmonary Reactance|[?]|TRENDELENBURG|[?]|Ci/uL|[?]|1|log10 copies/mL|URINARY SYSTEM|IPSILATERAL|DORSOLATERAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|Y|Y||ADJUDICATION COMMITTEE|UROLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|8|INFLTIND|Infiltrates Indicator|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|amol|METACARPAL BONE 1|LEFT|TEMPORAL|COLORIMETRY|||Y|FRIEND|UROLOGIST|4|Visit_4|65|6|WASHOUT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|9|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SUPINE|[?]|QUANTITY SUFFICIENT|[?]|1|ppm|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|LATERAL|MAGNETIC RESONANCE ENTEROGRAPHY||||HEALTH CARE PROFESSIONAL|READER 1|5|Visit_5|90|1|TREATMENT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|310936c8-7d24-4eea-9892-1cd8bb675421|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-FOWLERS|||[?]|1|pmol/dL|HEAD OF THE HUMERUS|LATERAL|SURFACE|MICROBIAL CULTURE|Y||Y|CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|1|ERVPP|Percent Predicted ERV|[?]|FOWLERS|||[?]|1|gtt|COLON LYMPH NODE|LEFT|LOWER FLEXOR SURFACE|PHASE-CONTRAST MRI|||Y|INTERVIEWER|READER 3|1|Visit_1|10|3|TREATMENT|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|2|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|kBq|[?]|1|mEq/L|LEFT POSTEROLATERAL DESCENDING ARTERY|UNILATERAL|INNER|AUSCULTATION||||GUARDIAN|ENDOCRINOLOGIST|1|Visit_1|10|4|WASHOUT|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|3|PNEUMIND|Pneumonia Indicator|[?]|SUPINE|[?]|/min|[?]|1|mOsm/L|RIB 9|RIGHT|INNER|COULOMETRIC TITRATION|Y|||PARENT|PATHOLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-06-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|[?]|ng|[?]|1|10^6 CFU/g|HEART, APEX|LEFT|ANTEROMEDIAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y|Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|2|Visit_2|25|1|WASHOUT|2020-06-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|5|TV|Tidal Volume|[?]|STANDING|||[?]|1|Log10 ELISA unit|CORNEAL STROMA|LEFT|ANTEROPOSTERIOR|MICROPARTICLE ENZYME IMMUNOASSAY|||Y|INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|6|IRV|Inspiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|10^3 organisms|[?]|1|10^3 CFU/g|EYELASH|LEFT|DEEP|DIFFUSION TENSOR MRI|Y|||PROXY|ONCOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-07-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|7|FIF25|Forced Inspiratory Flow at 25%|[?]|SITTING|||[?]|1|/7.5 mL|COCCYX|RIGHT|SUBCORTICAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||Y|FRIEND|OPHTHALMOLOGIST|4|Visit_4|65|1|TREATMENT|2020-07-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|8|FIV1PP|Percent Predicted FIV1|[?]|SITTING, LEGS DEPENDENT|[?]|mL/s|[?]|1|/4.0 mL|HEART, APEX|IPSILATERAL|UPPER|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-07-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|9|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|[?]|L/min/m2|[?]|1|pmol/L/h|HUMERAL EPICONDYLE|LATERAL|DISTAL VOLAR|INTRAVASCULAR ULTRASOUND||||VENDOR|READER 2|5|Visit_5|90|7|TREATMENT|2020-08-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|034e303b-5675-4188-bcea-fc2e53b155d6|10|PNEUMIND|Pneumonia Indicator|[?]|SEMI-FOWLERS|||[?]|1|mL*cmH2O|GUT-ASSOCIATED LYMPHOID TISSUE|LEFT|ROSTRAL|SPECULAR MICROSCOPY|||Y|CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|5|Visit_5|90|1|TREATMENT|2020-08-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|ukat/L|[?]|1|Hz/s|LIVER, CAUDATE LOBE|LEFT|LATERAL|VIRUS PLAQUE ASSAY||||FAMILY MEMBER|OTOLARYNGOLOGIST|1|Visit_1|10|7|TREATMENT|2020-07-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SITTING|[?]|ppth|[?]|1|atm|WRIST JOINT FLEXOR TENDONS|LEFT|ANTEROPOSTERIOR|AGAR PROPORTION||||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-07-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|3|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|[?]|TCID 50/dose|[?]|1|pg|ABDOMINAL WALL|LEFT|ROSTRAL|FLUORESCEIN STAIN|Y|||CLINICAL RESEARCH COORDINATOR|READER|2|Visit_2|25|6|TREATMENT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|cm2|[?]|1|deg/mm|TONGUE|IPSILATERAL|PROXIMAL|DARK FIELD MICROSCOPY||||SPOUSE|RADIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|5|GAW|Airway Conductance|[?]|SLING|[?]|/min|[?]|1|SACHET|FIRST RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|POSTERIOR|PALPATION|Y|||CHILD|ADJUDICATOR 2|3|Visit_3|40|5|TREATMENT|2020-08-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|6|IRV|Inspiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|[?]|NEBULE|[?]|1|100 IU/mL|SARTORIUS MUSCLE|UNILATERAL|MIDLINE|INTRAVASCULAR ULTRASOUND||Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|3|Visit_3|40|3|TREATMENT|2020-08-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-FOWLERS|||[?]|1|CAPSULE|UNCINATE PROCESS OF PANCREAS|CONTRALATERAL|ANTEROMEDIAL|MICRONEUTRALIZATION ASSAY||Y|Y|ADJUDICATION COMMITTEE|MICROSCOPIST|4|Visit_4|65|6|SCREENING|2020-08-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|TRENDELENBURG|[?]|mL/mmHg/min/L|[?]|1|APL U|FINGER FLEXOR TENDONS|BILATERAL|DORSAL|PET/MRI SCAN||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|4|Visit_4|65|2|TREATMENT|2020-08-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|9|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|mEq/dL|[?]|1|ug/h|THIRD POSTEROLATERAL DESCENDING ARTERY|UNILATERAL|ANTEROMEDIAL|KINYOUN STAIN||||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|10|RVPP|Percent Predicted Residual Volume|[?]|LEFT LATERAL DECUBITUS|[?]|PLUG|[?]|1|kPa/L/sec|5TH LUMBAR SPINOUS PROCESS|CONTRALATERAL|VOLAR|SINGLE-MOLECULE ARRAY||||DOMESTIC PARTNER|CARDIOLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|mm/2h|[?]|1|sec|METATARSOPHALANGEAL JOINT|LEFT|NASAL|CARDIAC THERMODILUTION||Y||SIBLING|OPHTHALMOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-07-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|2|DLCOHC|HGB Corrected DLCO|[?]|FOWLERS|||[?]|1|10^6/L|CEREBRAL HEMISPHERE, LEFT|UNILATERAL|CAUDAL|ELECTRONEUROGRAPHY||Y|Y|DOMESTIC PARTNER|PATHOLOGIST 2|1|Visit_1|10|4|SCREENING|2020-07-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|3|DLCOHC|HGB Corrected DLCO|[?]|SUPINE|[?]|mg/mL/min|[?]|1|eq|LOWER GASTROINTESTINAL TRACT LYMPH NODE|CONTRALATERAL|LOWER|RADIAL IMMUNODIFFUSION||Y||CAREGIVER|PATHOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|4|EXPRELTM|Expiration Relaxation Time|[?]|REVERSE TRENDELENBURG|||[?]|1|BAU/mL|ASCENDING AORTA|UNILATERAL|OUTER|ALCIAN BLUE STAIN|Y||Y|VENDOR|OPTOMETRIST|2|Visit_2|25|7|TREATMENT|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|FOWLERS|[?]|10^5/L|[?]|1|tuberculin unit/mL|INTRAHEPATIC LARGE BILE DUCT|LEFT|VENTRAL|PEAK FLOWMETRY||Y||ADJUDICATOR|ADJUDICATOR 2|3|Visit_3|40|3|TREATMENT|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|6|RVPP|Percent Predicted Residual Volume|[?]|SEMI-RECUMBENT|[?]|LOZENGE|[?]|1|MET*h|EPIGASTRIC LYMPH NODE|CONTRALATERAL|PERIPHERAL|IMMUNOFIXATION ELECTROPHORESIS||||VENDOR|PHYSIOTHERAPIST|3|Visit_3|40|1|SCREENING|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SUPINE|||[?]|1|uL/kg/day|COLON, SIGMOID|LEFT|APICAL|AGAR PROPORTION||Y|Y|PROXY|MICROSCOPIST 1|4|Visit_4|65|3|TREATMENT|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|PRONE|[?]|min/day|[?]|1|DAgU|RIB|LEFT|FORE|MANUAL CLOT DETECTION||||HEALTH CARE PROFESSIONAL|UROLOGIST|4|Visit_4|65|2|TREATMENT|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|DAgU/mL|URETHRAL SPHINCTER|BILATERAL|DEEP|HILLMEN COLOR CHART|||Y|INTERVIEWER|UROLOGIST|5|Visit_5|90|1|TREATMENT|2020-09-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|c912affb-cbc2-4919-81b4-ecaa03908261|10|FIV1PP|Percent Predicted FIV1|[?]|SLING|||[?]|1|vg/dose|MEDIAN NERVE|IPSILATERAL|ROSTRAL|MIGET|Y||Y|PARENT|ONCOLOGIST|5|Visit_5|90|5|TREATMENT|2020-09-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|REVERSE TRENDELENBURG|[?]|g/cm2|[?]|1|mL/breath|GREAT VESSELS|BILATERAL|SUPERIOR|OBSERVATION||Y||SIBLING|ONCOLOGIST|1|Visit_1|10|2|SCREENING|2020-07-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|2|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|[?]|mL/100g/min|[?]|1|Coulomb|RETROCRURAL LYMPH NODE|RIGHT|BASAL|CYSTOMETRY|Y|||ADJUDICATOR|ONCOLOGIST|1|Visit_1|10|5|WASHOUT|2020-07-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|3|FVC|Forced Vital Capacity|[?]|SITTING|[?]|10^3 copies/mL|[?]|1|mL/animal/day|ABDOMINAL CAVITY|IPSILATERAL|UPPER|MALDI|Y|Y||FAMILY MEMBER|ADJUDICATOR 1|2|Visit_2|25|7|SCREENING|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|4|PEFTIME|Peak Expiratory Flow Time|[?]|REVERSE TRENDELENBURG|||[?]|1|mg/cm2|SECOND DIAGONAL BRANCH ARTERY|CONTRALATERAL|LOWER|DISK DIFFUSION|Y||Y|ADJUDICATION COMMITTEE|RADIOLOGIST 2|2|Visit_2|25|5|SCREENING|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|5|QUASCOMP|Quasi-Static Compliance|[?]|PRONE|[?]|g/kg/day|[?]|1|RATIO|ADDUCTOR LONGUS MUSCLE|LEFT|LOWER FLEXOR SURFACE|CALCOFLUOR WHITE STAIN|Y|Y||INTERVIEWER|ENDOCRINOLOGIST|3|Visit_3|40|7|WASHOUT|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|BISCUIT|[?]|1|Bq/kg|INTRATHORACIC LYMPH NODE|IPSILATERAL|ANTEROTEMPORAL|TRICHROME STAIN||||CLINICAL RESEARCH ASSOCIATE|READER 1|3|Visit_3|40|6|FOLLOW-UP|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|7|IVCPP|Percent Predicted IVC|[?]|SITTING|[?]|APL U|[?]|1|mm/min|MEDIAN OR LOWER CERVICAL LYMPH NODE|IPSILATERAL|PROXIMAL|ALCIAN BLUE STAIN||Y||FRIEND|MICROSCOPIST 1|4|Visit_4|65|6|TREATMENT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|8|PEFREV|PEF Reversibility|[?]|DECUBITUS|[?]|TCID 50/dose|[?]|1|psec|TYMPANIC MEMBRANE|LATERAL|DISTAL|SCINTIGRAPHY||||GUARDIAN|READER 3|4|Visit_4|65|1|WASHOUT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|9|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING, BENT FORWARD|[?]|PIXEL|[?]|1|g/m2|PATELLA|LATERAL|MEDIAL|MOUSE PROTECTION ASSAY|Y|Y||ADJUDICATOR|PHYSIOTHERAPIST|5|Visit_5|90|5|WASHOUT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|5af817f0-5dfb-4046-ac7c-4bae16a90036|10|ERVPP|Percent Predicted ERV|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^4 CFU/mL|CARDIOVASCULAR SYSTEM|LEFT|SURFACE|BAC ACGH|||Y|PARENT|PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|FOWLERS|[?]|pmol/10^10 cells|[?]|1|10^6 RNA copies/mL|RIB|LEFT|ANTEROMEDIAL|PERIPHERAL ANGIOGRAPHY||||ADJUDICATOR|MICROSCOPIST 3|1|Visit_1|10|4|FOLLOW-UP|2020-06-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|2|SRAW|Specific Airway Resistance|[?]|STANDING, BENT FORWARD|||[?]|1|mg/kg/min|CAPITATE BONE|RIGHT|PARIETO-OCCIPITAL|NEXT GENERATION TARGETED SEQUENCING|Y|Y|Y|INVESTIGATOR|RADIOLOGIST 2|1|Visit_1|10|1|SCREENING|2020-06-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|[?]|umol/L/sec|[?]|1|MET*h|SKIN OF THE TRUNK|IPSILATERAL|NASAL|CYSTOMETRY||Y||CLINICAL RESEARCH COORDINATOR|READER 3|2|Visit_2|25|5|SCREENING|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|TRENDELENBURG|[?]|Anson U|[?]|1|mL/kg|STERNOCLAVICULAR JOINT|LATERAL|SUPERIOR|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||CLINICAL RESEARCH COORDINATOR|RATER 2|2|Visit_2|25|5|TREATMENT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|5|PNEUMIND|Pneumonia Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|pg/L|[?]|1|gpELISA unit/mL|WALDEYER'S TONSILLAR RING|UNILATERAL|CENTRAL|ACID FAST STAIN||||STUDY SUBJECT|MICROSCOPIST 2|3|Visit_3|40|6|TREATMENT|2020-07-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|6|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|Joule|[?]|1|APL U|GINGIVAL MUCOSA|RIGHT|VOLAR|ANTIBIOTIC AGAR SCREEN||Y||FAMILY MEMBER|RADIOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|7|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING, BENT FORWARD|[?]|KIT|[?]|1|PFU/animal|MESENTERIC ARTERY|IPSILATERAL|FRONTAL|MIGET||||FRIEND|NEUROLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|8|FEV1FVC|FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|PIPE|[?]|1|kPa/L/sec|THYROID GLAND, LEFT LOBE|IPSILATERAL|OCCIPITAL|PUPILLOMETRY|Y|||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|9|PEF|Peak Expiratory Flow|[?]|DECUBITUS|[?]|oz eq|[?]|1|dpm/mL|ALVEOLUS|BILATERAL|LATERAL|OPHTHALMOSCOPY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|5|Visit_5|90|6|FOLLOW-UP|2020-08-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|dcefd656-a59a-4b71-9260-efcbcecd2132|10|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|[?]|MET*h|[?]|1|cm H2O|AORTIC ARCH|LEFT|DORSOLATERAL|RADIOGRAPHY||||GUARDIAN|CLINICAL PATHOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-08-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|FEV1FVC|FEV1/FVC|[?]|UNCONSTRAINED|[?]|1/(s*kPa)|[?]|1|Gy/h|LYMPH NODE|UNILATERAL|ANTEROTEMPORAL|FLUORESCENT IMMUNOASSAY||||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|TREATMENT|2020-12-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|SLING|||[?]|1|rpm|PENIS, GLANS|LATERAL|DISTAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y||Y|ADJUDICATION COMMITTEE|HEMATOLOGIST|1|Visit_1|10|5|WASHOUT|2020-12-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|3|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|[?]|Bq/mL|[?]|1|FFU|URETERIC ORIFICE|RIGHT|LOWER FLEXOR SURFACE|MRI||||FAMILY MEMBER|RADIOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2021-01-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LATERAL DECUBITUS|[?]|mg/L FEU|[?]|1|g/U|MEDIASTINUM, SUPERIOR|BILATERAL|PERIPHERAL|IMMUNO-PET SCAN|Y|||DOMESTIC PARTNER|PATHOLOGIST 2|2|Visit_2|25|5|SCREENING|2021-01-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|5|ICPP|Percent Predicted Inspiratory Capacity|[?]|SEMI-FOWLERS|[?]|kUSP|[?]|1|g/day|AORTOCAVAL LYMPH NODE|UNILATERAL|PERIPHERAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|||SPOUSE|RATER 2|3|Visit_3|40|6|WASHOUT|2021-01-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|||[?]|1|10^6 DNA copies/mL|MEDIAN NERVE|CONTRALATERAL|OUTER|AUTOREFRACTION|||Y|GUARDIAN|HEMATOLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|7|ALVVOL|Alveolar Volume|[?]|SLING|[?]|mL/(min*100mL)|[?]|1|/100 HPFs|THIRD RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|SUPERFICIAL|NEPHELOMETRY||||STUDY SUBJECT|ENDOCRINOLOGIST|4|Visit_4|65|6|TREATMENT|2021-02-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|8|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-RECUMBENT|[?]|mg/kg/day|[?]|1|OD Unit|LEFT CIRCUMFLEX ARTERY OSTIUM|BILATERAL|BASAL|TONOMETRY||||INDEPENDENT ASSESSOR|PHYSIOTHERAPIST|4|Visit_4|65|1|FOLLOW-UP|2021-02-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|9|IRV|Inspiratory Reserve Volume|[?]|SLING|||[?]|1|ug/day|REGIONAL LYMPH NODE|LEFT|POSTERIOR|VIRUS PLAQUE ASSAY|Y||Y|SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|TREATMENT|2021-03-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|641c8067-941a-4f1a-a7b1-4eea0242f1d7|10|EVC|Expiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|Linear ft*LB|[?]|1|uCi/L|TENTORIUM CEREBELLI|LATERAL|ANTEROLATERAL|BRDU CELLULAR PROLIFERATION ASSAY||||ADJUDICATION COMMITTEE|READER|5|Visit_5|90|1|TREATMENT|2021-03-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|FIO2|Fraction of Inspired Oxygen|[?]|SITTING, LEGS DEPENDENT|[?]|m/sec2|[?]|1|Henry|TRUNK|RIGHT|PARIETO-OCCIPITAL|MALDI||Y||PROXY|ONCOLOGIST|1|Visit_1|10|3|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|2|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|log10 PFU|[?]|1|yd|NIPPLE|BILATERAL|LOWER MEDIAL|THIN SMEAR||||FAMILY MEMBER|NEUROLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|3|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|BLOCKS|[?]|1|cmol|GONAD|BILATERAL|PERIVENTRICULAR|PULSE OXIMETRY|Y|||ADJUDICATION COMMITTEE|UROLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|4|PLMXRS|Pulmonary Reactance|[?]|PRONE|||[?]|1|mL/m2/min|HYOID BONE|BILATERAL|DISTAL VOLAR|HPLC-FL||Y|Y|STUDY SUBJECT|ADJUDICATOR 2|2|Visit_2|25|3|FOLLOW-UP|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|5|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|log10 CFU/mL|[?]|1|mg|GLOTTIS|RIGHT|INTERMEDIATE|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|||CAREGIVER|NEUROLOGIST 2|3|Visit_3|40|4|WASHOUT|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|GPL U|[?]|1|mL/beat|SKIN OF THE UPPER LIMB|CONTRALATERAL|SURFACE|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|||FRIEND|RADIOLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING|||[?]|1|uEq/L|CORPUS CALLOSUM, BODY|CONTRALATERAL|LOWER MEDIAL|FLUORESCENCE ANGIOGRAPHY|||Y|SIBLING|OPHTHALMOLOGIST|4|Visit_4|65|4|WASHOUT|2020-11-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|8|ALVVOL|Alveolar Volume|[?]|STANDING, BENT FORWARD|[?]|grain|[?]|1|%(w/v)|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|BASAL|CAPILLARY ELECTROPHORESIS||||STUDY SUBJECT|NEUROLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-11-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-FOWLERS|[?]|V/sec|[?]|1|ugEq|PULMONARY VALVE, RIGHT CUSP|LATERAL|OCCIPITAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||INTERVIEWER|CARDIOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|10|FEV_PEF|FEV at PEF|[?]|UNCONSTRAINED|[?]|Watt|[?]|1|mmol/g|LUMBAR SPINE|LATERAL|SURFACE|SCANNING ELECTRON MICROSCOPY||Y||SIGNIFICANT OTHER|ADJUDICATOR 2|5|Visit_5|90|1|TREATMENT|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING|[?]|EVENTS|[?]|1|ft3|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|CONTRALATERAL|MIDLINE|PHASE-CONTRAST MRI||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|1|Visit_1|10|7|TREATMENT|2020-10-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|2|TV|Tidal Volume|[?]|REVERSE TRENDELENBURG|[?]|mL|[?]|1|L/h/m2|ENDOCERVIX|BILATERAL|CENTRAL|REBOUND TONOMETRY||Y||STUDY SUBJECT|ENDOCRINOLOGIST|1|Visit_1|10|2|WASHOUT|2020-10-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|3|FRC|Functional Residual Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|umol/mol|MID-JUGULAR LYMPH NODE|LATERAL|ANTEROMEDIAL|SNP ARRAY|||Y|STUDY SUBJECT|MICROSCOPIST 2|2|Visit_2|25|7|TREATMENT|2020-11-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|4|AWWVOL|Airway Wall Volume|[?]|SITTING|[?]|mg/L FEU|[?]|1|msec|METACARPOPHALANGEAL JOINT 5|IPSILATERAL|VOLAR|SNP ARRAY|Y|||GUARDIAN|NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2020-11-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|5|PCF|Peak Cough Flow|[?]|TRENDELENBURG|||[?]|1|FEU|JEJUNUM|IPSILATERAL|NASAL|INFRARED SPECTROMETRY|||Y|PROXY|MICROSCOPIST 3|3|Visit_3|40|1|TREATMENT|2020-11-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|6|EVC|Expiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|10^6 CFU/g|[?]|1|pL|LEFT VENTRICULAR APICAL LATERAL SEGMENT|RIGHT|OCCIPITAL|CORONARY ANGIOGRAPHY||||FRIEND|MICROSCOPIST 3|3|Visit_3|40|2|SCREENING|2020-11-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|7|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SLING|||[?]|1|g/mol|MITRAL VALVE ANNULUS|BILATERAL|SURFACE|CONTACT SPECULAR MICROSCOPY||Y|Y|VENDOR|READER|4|Visit_4|65|1|FOLLOW-UP|2020-12-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SEMI-FOWLERS|||[?]|1|umol/min|TYMPANIC MEMBRANE|LEFT|LOWER MEDIAL|PUPILLOMETRY|||Y|SPOUSE|ENDOCRINOLOGIST|4|Visit_4|65|3|WASHOUT|2020-12-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|9|RER|Respiratory Exchange Ratio|[?]|REVERSE TRENDELENBURG|||[?]|1|pm|TEMPORAL BONE|UNILATERAL|ANTEROLATERAL|SPECTROPHOTOMETRY||Y|Y|CLINICAL STUDY SPONSOR|READER 2|5|Visit_5|90|5|TREATMENT|2021-01-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|10|RAW|Airway Resistance|[?]|SUPINE|||[?]|1|Gy/min|INTERPHALANGEAL JOINT 3|UNILATERAL|ANTERIOR|OLIGO ACGH|||Y|PARENT|RADIOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-01-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|1|DLCOPP|Percent Predicted DLCO|[?]|PRONE|[?]|P|[?]|1|g/g/day|SCLERA|RIGHT|CAUDAL|ORCHIDOMETERY||||INVESTIGATOR|HEMATOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|2|TLC|Total Lung Capacity|[?]|UNCONSTRAINED|[?]|L/h/m2|[?]|1|in|BONE MARROW|LATERAL|UPPER EXTENSOR SURFACE|CONGO RED STAIN||||ADJUDICATOR|MICROSCOPIST|1|Visit_1|10|3|TREATMENT|2020-12-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|DECUBITUS|[?]|Ejaculate U|[?]|1|PUFF|SPLENIC LYMPH NODE|LEFT|DORSAL|ROMANOWSKY STAIN||||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-12-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|4|INFLTIND|Infiltrates Indicator|[?]|SITTING|||[?]|1|mL/m2|STRIATUM|IPSILATERAL|TEMPORAL|U-HPLC/MS/MS|Y|Y|Y|GUARDIAN|OPTOMETRIST|2|Visit_2|25|1|TREATMENT|2020-12-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|5|TSUELAS|Tissue Elastance|[?]|SUPINE|[?]|ug/kg/min|[?]|1|CARTRIDGE|VENA CAVA|CONTRALATERAL|CENTRAL|OSCILLOMETRY|Y|||ADJUDICATOR|MICROSCOPIST 1|3|Visit_3|40|6|FOLLOW-UP|2021-01-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|6|ICREV|IC Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|/wk|[?]|1|mOsm/L|SECOND RIGHT POSTEROLATERAL ARTERY|LEFT|DORSAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||SPOUSE|CARDIOLOGIST|3|Visit_3|40|1|WASHOUT|2021-01-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|7|ELSTNCE|Elastance|[?]|SEMI-RECUMBENT|||[?]|1|mL/mmHg|PALPEBRAL FISSURE|LEFT|MEDIAL|IMMUNOBLOT||Y|Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST|4|Visit_4|65|3|SCREENING|2021-01-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|8|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-FOWLERS|||[?]|1|PFU|GASTROINTESTINAL TRACT|CONTRALATERAL|SUPERIOR|OLIGO ACGH|||Y|SIBLING|OPTOMETRIST|4|Visit_4|65|5|TREATMENT|2021-01-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|9|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING|||[?]|1|nmol/L|EXTENSOR HALLUCIS BREVIS MUSCLE|RIGHT|ROSTRAL|QUANTITATIVE CORONARY ANGIOGRAPHY|||Y|CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2021-02-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|46304edd-0b05-4819-8fcb-35cf9c02764d|10|IRVPP|Percent Predicted IRV|[?]|SLING|||[?]|1|mL/animal|WALDEYER'S TONSILLAR RING|RIGHT|LATERAL|TEMPLATE INCISION METHOD|||Y|ADJUDICATION COMMITTEE|MICROSCOPIST 2|5|Visit_5|90|4|SCREENING|2021-02-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|ELSTNCE|Elastance|[?]|SEMI-FOWLERS|[?]|mg/mol|[?]|1|damol/L|NAIL BED|IPSILATERAL|MIDLINE|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||Y||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|1|Visit_1|10|4|WASHOUT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|2|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|[?]|mmol/kg|[?]|1|mol/g|RADIUS|LATERAL|OUTER|FARNSWORTH-MUNSELL 100 HUE TEST||||INTERVIEWER|FORENSIC PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|3|TSUELAS|Tissue Elastance|[?]|DECUBITUS|[?]|Siemens|[?]|1|HEP|LYMPH NODE HILUM|LATERAL|LOWER|CLIP||||INVESTIGATOR|ADJUDICATOR 3|2|Visit_2|25|5|WASHOUT|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|4|QUASCOMP|Quasi-Static Compliance|[?]|STANDING, BENT FORWARD|[?]|Anson U|[?]|1|MPL U/mL|VESTIBULOCOCHLEAR NERVE|LEFT|INTERMEDIATE|PERIPHERAL ANGIOGRAPHY||Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|2|Visit_2|25|5|TREATMENT|2020-06-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|TRENDELENBURG|[?]|LENS|[?]|1|U/g/min|TENTORIUM CEREBELLI|LATERAL|APICAL|REBOUND TONOMETRY||Y||PARENT|CLINICAL PATHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|6|SRAW|Specific Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|mmHg/L/min|[?]|1|WEEKS|DISTAL RADIOULNAR JOINT|LEFT|PROXIMAL VOLAR|WRIGHT-GIEMSA STAIN||Y||FRIEND|ONCOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-06-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|7|DLCOHC|HGB Corrected DLCO|[?]|SEMI-FOWLERS|[?]|Hz|[?]|1|10^6 CFU|HUMERUS|LATERAL|OUTER|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||PARENT|HEMATOLOGIST|4|Visit_4|65|1|SCREENING|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|8|MALIND|Malignancy Indicator|[?]|SUPINE|[?]|COAT|[?]|1|um|TARSUS BONE|RIGHT|HIND|SANGER SEQUENCING|Y|||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|4|Visit_4|65|6|TREATMENT|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|9|SVCPP|Percent Predicted Slow Vital Capacity|[?]|TRENDELENBURG|[?]|/MBP|[?]|1|nmol/L|ARTERY|LATERAL|SUPERIOR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|3fd6dab2-b35f-4cc5-88dd-b507583d9539|10|SAWVOL|Specific Airway Volume|[?]|UNCONSTRAINED|[?]|Anson U|[?]|1|10^10/L|TRAPEZIUS MUSCLE|IPSILATERAL|ANTEROMEDIAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|||VENDOR|ONCOLOGIST|5|Visit_5|90|2|SCREENING|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|1|FEV1FVC6|FEV1/FVC6|[?]|STANDING|[?]|mPa|[?]|1|m/sec|CARDIAC WALL|CONTRALATERAL|MEDIAL|IMMUNORADIOMETRIC ASSAY||Y||CHILD|OPHTHALMOLOGIST|1|Visit_1|10|3|TREATMENT|2020-10-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|FOWLERS|[?]|10^3 DNA copies/mL|[?]|1|s^-1(%O2)^-1|SUBGLOTTIS|RIGHT|PERIVENTRICULAR|MAGNETIC RESONANCE ELASTOGRAPHY||||PARENT|MICROSCOPIST 1|1|Visit_1|10|6|SCREENING|2020-10-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|3|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|nsec|BUCCAL MUCOSA|RIGHT|CENTRAL|TWO-COLOR MICROARRAY|||Y|GUARDIAN|READER|2|Visit_2|25|3|FOLLOW-UP|2020-10-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|4|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SITTING|[?]|DRUM|[?]|1|uIU/dL|FIRST OBTUSE MARGINAL BRANCH ARTERY|RIGHT|SURFACE|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||SIBLING|RADIOLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-10-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|5|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SLING|[?]|ppth|[?]|1|ohm|CEREBRAL CORTEX|LATERAL|OCCIPITAL|HEMOCYTOMETRY||||GUARDIAN|CLINICAL PATHOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-11-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|6|PEF|Peak Expiratory Flow|[?]|FOWLERS|[?]|TCID 50/dose|[?]|1|ft2|FINGER FLEXOR TENDONS|IPSILATERAL|INNER|FARR ASSAY||Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 2|3|Visit_3|40|2|TREATMENT|2020-11-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|7|LOBVOL|Lobar Volume|[?]|FOWLERS|[?]|Gy/min|[?]|1|MBP|METACARPAL BONE 3|IPSILATERAL|ANTEROMEDIAL|EEG||||INTERVIEWER|ONCOLOGIST 1|4|Visit_4|65|3|SCREENING|2020-12-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|8|FEV3FVC|FEV3/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|nL|[?]|1|ft|OBTURATOR MUSCLE|CONTRALATERAL|FRONTAL|PHOTOMETRIC CLOT DETECTION||Y||INTERVIEWER|PATHOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-12-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|9|TLC|Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uL/mL|INTERVENTRICULAR SEPTUM|CONTRALATERAL|DEEP|SMEAR||Y|Y|PARENT|PATHOLOGIST 2|5|Visit_5|90|2|TREATMENT|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|daa3b89e-637a-43de-86c1-d0db93f00430|10|FEV1PP|Percent Predicted FEV1|[?]|STANDING, BENT FORWARD|[?]|g/cage/day|[?]|1|L/L|LUMBRICAL MUSCLES OF THE HAND|CONTRALATERAL|LOWER|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||INVESTIGATOR|CARDIOLOGIST|5|Visit_5|90|4|TREATMENT|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|FIF50|Forced Inspiratory Flow at 50%|[?]|LEFT LATERAL DECUBITUS|||[?]|1|dyn|PERIFACIAL LYMPH NODE|IPSILATERAL|INFERIOR|CONTACT SPECULAR MICROSCOPY|||Y|CLINICAL STUDY SPONSOR|INTERNIST|1|Visit_1|10|5|WASHOUT|2020-07-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|FOWLERS|[?]|CIGARETTE|[?]|1|mOsm/L|CAPITATE-LUNATE JOINT|RIGHT|CENTRAL|DNA MICROARRAY|Y|||INVESTIGATOR|READER 2|1|Visit_1|10|5|TREATMENT|2020-07-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|copies/ug|SKIN OF THE HAND|UNILATERAL|DISTAL|WESTERN BLOT|||Y|VENDOR|PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-07-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|4|TSUHYS|Tissue Hysteresivity|[?]|SEMI-RECUMBENT|||[?]|1|Torr|INTESTINE|CONTRALATERAL|PARIETO-OCCIPITAL|X-RAY|||Y|PARENT|CLINICAL PATHOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-07-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|5|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|[?]|pg/cell|[?]|1|U/m2/h|FLEXOR POLLICIS LONGUS MUSCLE|CONTRALATERAL|OCCIPITAL|NUCLEIC ACID SEQUENCING||||SIGNIFICANT OTHER|UROLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-08-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|6|EVC|Expiratory Vital Capacity|[?]|STANDING|||[?]|1|/10^5|BILIARY TRACT|CONTRALATERAL|BASAL|SURFACE PLASMON RESONANCE|Y||Y|PROXY|NEUROLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-08-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|7|FEV_PEF|FEV at PEF|[?]|SEMI-RECUMBENT|[?]|nkat|[?]|1|breaths/30s|NECK|UNILATERAL|VENTROLATERAL|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|||VENDOR|MICROSCOPIST 2|4|Visit_4|65|5|TREATMENT|2020-08-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|8|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|mol/day|[?]|1|10^6 DNA copies/mL|ISCHIUM|UNILATERAL|APICAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||SIBLING|ONCOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-08-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|9|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|[?]|/h|[?]|1|mmol/day|ANASTOMOSIS|LATERAL|LATERAL|MECHANICAL CLOT DETECTION||||STUDY SUBJECT|OTOLARYNGOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|uV|[?]|1|uCi|TRAPEZOID-CAPITATE JOINT|LEFT|ANTEROLATERAL|LC-FL||||ADJUDICATOR|PATHOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SUPINE|||[?]|1|nmol/g|CARDIAC WALL|UNILATERAL|PERIVENTRICULAR|SINGLE-MOLECULE ARRAY||Y|Y|SIGNIFICANT OTHER|ADJUDICATOR 2|1|Visit_1|10|2|WASHOUT|2020-08-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|2|RELSZCHG|Relative Size Change|[?]|SUPINE|||[?]|1|mmHg*min/L|ENDOMETRIUM|CONTRALATERAL|DISTAL VOLAR|ELLA|||Y|CHILD|PATHOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-08-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|3|PLMXRS|Pulmonary Reactance|[?]|SLING|[?]|10^9/dose|[?]|1|mL/s/m2|PLEURAL CAVITY|IPSILATERAL|PARIETO-OCCIPITAL|DROPLET DIGITAL PCR||||INDEPENDENT ASSESSOR|READER 3|2|Visit_2|25|4|TREATMENT|2020-08-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|4|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|ug/L|[?]|1|10^9/dose|T6 VERTEBRA|UNILATERAL|VENTRAL|IMPEDANCE CONDUCTIVITY||||FAMILY MEMBER|RADIOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-08-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SUPINE|[?]|mL/day|[?]|1|kPa/L/sec|VAGINAL WALL|LEFT|UPPER|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|Y||INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-FOWLERS|[?]|IU/day|[?]|1|PIXELS/in|SINUS|BILATERAL|MEDIAL|IMMUNOFIXATION ELECTROPHORESIS||Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|3|Visit_3|40|1|TREATMENT|2020-09-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|REVERSE TRENDELENBURG|[?]|L/min/m2|[?]|1|LB|COMMON ILIAC LYMPH NODE|BILATERAL|CENTRAL|ELASTOGRAPHY||||PROXY|RADIOLOGIST 1|4|Visit_4|65|5|TREATMENT|2020-10-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|8|TVPP|Percent Predicted Tidal Volume|[?]|SITTING|||[?]|1|mL/animal|MEDIAN NERVE|IPSILATERAL|SUPERIOR|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y||Y|GUARDIAN|READER|4|Visit_4|65|4|FOLLOW-UP|2020-10-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|9|TSUELAS|Tissue Elastance|[?]|SITTING|[?]|titer|[?]|1|psec|CAPITATE BONE|UNILATERAL|PROXIMAL VOLAR|SNP ARRAY||||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|5|Visit_5|90|1|FOLLOW-UP|2020-11-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|c22014f2-2d7b-4897-8ad5-e46785e51837|10|AWVOLPP|Percent Predicted Airway Volume|[?]|FOWLERS|[?]|U/dL|[?]|1|PFU/mL|ACHILLES TENDON|UNILATERAL|FORE|MS/MS||||SIBLING|HEMATOLOGIST|5|Visit_5|90|5|SCREENING|2020-11-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|IC|Inspiratory Capacity|[?]|STANDING|[?]|BU/mL|[?]|1|/200 HPFs|WALDEYER'S TONSILLAR RING|LATERAL|LOWER FLEXOR SURFACE|PELLI-ROBSON EYE CHART|Y|Y||CHILD|READER 1|1|Visit_1|10|7|WASHOUT|2020-10-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|[?]|amu|[?]|1|EID 50/mL|PALATINE BONE|CONTRALATERAL|OUTER|FLOW MICROSCOPY||||CLINICAL RESEARCH COORDINATOR|INTERNIST|1|Visit_1|10|4|TREATMENT|2020-10-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|3|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|||[?]|1|cal|COLON, RIGHT|RIGHT|DORSOLATERAL|CAPILLARY ELECTROPHORESIS|Y||Y|INTERVIEWER|READER 3|2|Visit_2|25|5|FOLLOW-UP|2020-10-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|4|RER|Respiratory Exchange Ratio|[?]|SLING|[?]|BE/mL|[?]|1|breaths/30s|SENSORIMOTOR CORTEX|LEFT|CENTRAL|MALDI||||VENDOR|ONCOLOGIST|2|Visit_2|25|3|WASHOUT|2020-10-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|5|ERVPP|Percent Predicted ERV|[?]|SITTING, LEGS DEPENDENT|[?]|IU/mL|[?]|1|kV|HEAD AND NECK|UNILATERAL|ROSTRAL|WESTERN BLOT|Y|||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|6|FEF2575P|Percent Predicted FEF25-75|[?]|FOWLERS|[?]|ug/g/day|[?]|1|Osm|FEMUR SHAFT|LATERAL|DORSAL|X-RAY|Y|Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-11-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|7|MEP|Maximal Expiratory Pressure|[?]|LEFT LATERAL DECUBITUS|||[?]|1|gMFI|HEART, VENTRICLE|IPSILATERAL|INFERIOR|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|Y|Y|CLINICAL STUDY SPONSOR|RATER 2|4|Visit_4|65|4|FOLLOW-UP|2020-12-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|PFU/dose|[?]|1|10^6/hpf|LEFT VENTRICULAR MID INFERIOR SEGMENT|RIGHT|LOWER|CONTRAST ENHANCED CT SCAN|Y|||CLINICAL RESEARCH COORDINATOR|RATER|4|Visit_4|65|2|FOLLOW-UP|2020-12-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|9|LCI|Lung Clearance Index|[?]|REVERSE TRENDELENBURG|||[?]|1|/LPF|THORACIC LYMPH NODE|RIGHT|CAUDAL|IMMUNOFLUORESCENT STAIN||Y|Y|INTERVIEWER|READER 1|5|Visit_5|90|5|SCREENING|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|987102b2-fe2f-4d72-b8dc-14a71bf034b5|10|ELSTNCE|Elastance|[?]|PRONE|||[?]|1|V|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|ANTEROPOSTERIOR|FLUORESCEIN STAIN||Y|Y|SIBLING|MICROSCOPIST|5|Visit_5|90|4|SCREENING|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|1|FEV1FVC6|FEV1/FVC6|[?]|SLING|[?]|kat|[?]|1|ug/day|PULMONARY VALVE, ANTERIOR CUSP|BILATERAL|SUPERFICIAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|1|Visit_1|10|7|TREATMENT|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|2|FIO2|Fraction of Inspired Oxygen|[?]|UNCONSTRAINED|||[?]|1|kg/m2|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LATERAL|FORE|SISH|Y||Y|FRIEND|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|WASHOUT|2021-01-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|3|EXPRELTM|Expiration Relaxation Time|[?]|STANDING, BENT FORWARD|[?]|pmol/10^10 cells|[?]|1|/500 WBC|SCIATIC NERVE|CONTRALATERAL|INNER|MICROBIAL CULTURE||Y||CHILD|OPHTHALMOLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-13
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|4|PNIF|Peak Nasal Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|SUPPOSITORY|[?]|1|mL/g/day|RIB 10|BILATERAL|OUTER|ERGOSPIROMETRY||||PROXY|MICROSCOPIST 3|2|Visit_2|25|1|WASHOUT|2021-02-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-13
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|5|RVPP|Percent Predicted Residual Volume|[?]|SITTING|||[?]|1|U/m2/h|VULVOVAGINAL REGION|LEFT|SUBCORTICAL|BALLPOINT PEN TECHNIQUE|||Y|CHILD|NEUROLOGIST|3|Visit_3|40|2|SCREENING|2021-02-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|6|FEV_PEF|FEV at PEF|[?]|SITTING, LEGS DEPENDENT|[?]|Ci/mL|[?]|1|pmol/dL|PULMONARY VALVE, RIGHT CUSP|UNILATERAL|PERIPHERAL|PET/CT SCAN|Y|||INVESTIGATOR|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2021-02-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-04
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|7|FEV1SVC|FEV1/SVC|[?]|SLING|[?]|bel|[?]|1|g/cage|COLON, SPLENIC FLEXURE|LEFT|APICAL|REVERSE TRANSCRIPTASE PCR||||CHILD|FORENSIC PATHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-03-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|8|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING, BENT FORWARD|||[?]|1|LENS|TEMPOROMANDIBULAR JOINT|IPSILATERAL|DISTAL|FLUORESCENT ENZYME IMMUNOASSAY|Y||Y|CAREGIVER|ADJUDICATOR 2|4|Visit_4|65|7|TREATMENT|2021-03-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|9|SVC|Slow Vital Capacity|[?]|DECUBITUS|[?]|um|[?]|1|cycle/min|CILIARY BODY|UNILATERAL|SUPERIOR|CONGO RED STAIN||||STUDY SUBJECT|RADIOLOGIST 1|5|Visit_5|90|6|WASHOUT|2021-04-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|24ce0c77-1921-4b87-91da-3627e2afd399|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|TRENDELENBURG|[?]|nmol/g|[?]|1|mL/g/min|ANAL CANAL|LEFT|ANTEROPOSTERIOR|FLOCCULATION|Y|||CLINICAL STUDY SPONSOR|DERMATOLOGIST|5|Visit_5|90|2|SCREENING|2021-04-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|PCF|Peak Cough Flow|[?]|TRENDELENBURG|[?]|CUP|[?]|1|BOLUS|SKIN FOLD|LATERAL|DORSOLATERAL|MEDIASTINOSCOPY||Y||STUDY SUBJECT|ENDOCRINOLOGIST|1|Visit_1|10|7|TREATMENT|2020-08-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|2|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-RECUMBENT|[?]|tuberculin unit|[?]|1|QUANTITY SUFFICIENT|ADDUCTOR POLLICIS MUSCLE|LATERAL|FACIAL|HPLC/MS/MS||||FRIEND|ADJUDICATOR 2|1|Visit_1|10|3|TREATMENT|2020-08-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|PRONE|||[?]|1|U/cL|MEDULLA OBLONGATA|LATERAL|FRONTAL|TEST STRIP|||Y|SPOUSE|PHYSIOTHERAPIST|2|Visit_2|25|2|TREATMENT|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|4|PEF|Peak Expiratory Flow|[?]|SITTING|||[?]|1|U/mL|ABDUCTOR DIGITI QUINTI MUSCLE|BILATERAL|UPPER|TOTAL BODY IRRADIATION|||Y|PARENT|NEUROLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|5|RELSZCHG|Relative Size Change|[?]|SUPINE|[?]|sec|[?]|1|DNA copies/ug|ILEUM LYMPH NODE|CONTRALATERAL|LOWER EXTENSOR SURFACE|RIA|Y|||SPOUSE|ADJUDICATOR 3|3|Visit_3|40|7|TREATMENT|2020-09-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|TRENDELENBURG|[?]|APPLICATION|[?]|1|U|5TH LUMBAR SPINOUS PROCESS|BILATERAL|PROXIMAL VOLAR|MOUSE PROTECTION ASSAY||||CHILD|RADIOLOGIST 2|3|Visit_3|40|7|WASHOUT|2020-09-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|7|FEV3FVC|FEV3/FVC|[?]|DECUBITUS|[?]|10^6 IU/mL|[?]|1|mEq/g|LUMBRICAL MUSCLES OF THE HAND|CONTRALATERAL|SUPERFICIAL|LIGHT SCATTERING SPECTROSCOPY||||HEALTH CARE PROFESSIONAL|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-10-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|8|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|deg|[?]|1|ug/m2|MESENTERIC ARTERY|RIGHT|CAUDAL|X-RAY||Y||PARENT|RATER 2|4|Visit_4|65|4|WASHOUT|2020-10-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|9|FVC|Forced Vital Capacity|[?]|PRONE|[?]|kg/mol|[?]|1|GBq/ug|SKIN OF THE FINGER|LEFT|ROSTRAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y||FRIEND|PATHOLOGIST 1|5|Visit_5|90|3|SCREENING|2020-11-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|10|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|IU/g|[?]|1|PACKET|FLANK|LATERAL|SUBCORTICAL|INCISION-INDUCED BLEEDING METHOD||||ADJUDICATION COMMITTEE|ADJUDICATOR 2|5|Visit_5|90|7|TREATMENT|2020-11-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|/10^5|FEMORAL CONDYLE|IPSILATERAL|DORSOLATERAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y||Y|GUARDIAN|ONCOLOGIST|1|Visit_1|10|2|TREATMENT|2020-12-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|2|TLC|Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|Tbsp|[?]|1|uOsm|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|UNILATERAL|CRANIAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||||FAMILY MEMBER|ADJUDICATOR 1|1|Visit_1|10|5|TREATMENT|2020-12-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|3|TVPP|Percent Predicted Tidal Volume|[?]|SITTING|||[?]|1|uL/mL|TIBIALIS ANTERIOR MUSCLE|UNILATERAL|OUTER|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|||Y|ADJUDICATOR|RADIOLOGIST|2|Visit_2|25|6|TREATMENT|2021-01-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|4|FEV1REV|FEV1 Reversibility|[?]|SITTING|[?]|tsp|[?]|1|10^9 CFU/mL|PROXIMAL URETHRA|LATERAL|VENTRAL|IMPULSE OSCILLOMETRY||||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|5|TREATMENT|2021-01-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING, BENT FORWARD|||[?]|1|BE/mL|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|UNILATERAL|VENTRAL|OSCILLOMETRY||Y|Y|NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|3|Visit_3|40|1|TREATMENT|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|6|SGAW|Specific Airway Conductance|[?]|SITTING, LEGS DEPENDENT|[?]|10^9/dose|[?]|1|ng/dL|GREAT VESSELS|LEFT|DORSOLATERAL|NON-INVASIVE DIELECTRIC SENSING||Y||SPOUSE|MICROSCOPIST|3|Visit_3|40|3|TREATMENT|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|SUPINE|[?]|umol/min|[?]|1|log10 CCID 50/dose|MITRAL VALVE, POSTERIOR CUSP|CONTRALATERAL|NASAL|FLOW MICROSCOPY||Y||CHILD|HEMATOLOGIST|4|Visit_4|65|7|TREATMENT|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|8|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|ng/L|[?]|1|10^9/dose|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|LATERAL|CAUDAL|WHOLE GENOME SEQUENCING||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|4|Visit_4|65|2|FOLLOW-UP|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|9|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-RECUMBENT|||[?]|1|TAMPON|OROPHARYNX|CONTRALATERAL|INFERIOR|MALDI-TOF|||Y|GUARDIAN|OPHTHALMOLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|f4b83a72-7cde-4e02-8883-05e789c617a8|10|AIRTRAP|Air Trapping|[?]|SUPINE|[?]|10^6 U|[?]|1|mL/dose|ILIAC FOSSA|CONTRALATERAL|ANTEROTEMPORAL|STATIC PERIMETRY||||GUARDIAN|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|WASHOUT|2021-03-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|UNCONSTRAINED|[?]|hr/day|[?]|1|ELISA unit/dose|FEMORAL VEIN|CONTRALATERAL|MIDLINE|RULER MEASUREMENT METHOD|Y|||VENDOR|READER 2|1|Visit_1|10|7|WASHOUT|2021-01-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|2|FRC|Functional Residual Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uL|SKIN OF THE FINGER|LEFT|LOWER FLEXOR SURFACE|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|Y||Y|PROXY|RATER 1|1|Visit_1|10|1|TREATMENT|2021-01-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|3|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|steps/min|[?]|1|10^9 organisms/g|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|LATERAL|OCCIPITAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||FAMILY MEMBER|PATHOLOGIST 2|2|Visit_2|25|4|SCREENING|2021-01-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|4|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|||[?]|1|10^3 RNA copies/mL|L4 VERTEBRA|CONTRALATERAL|MIDLINE|CYSTOSCOPY|Y||Y|INVESTIGATOR|RATER 1|2|Visit_2|25|1|WASHOUT|2021-01-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|5|MALEVDES|Malignancy Evidence Description|[?]|FOWLERS|[?]|tuberculin unit/mL|[?]|1|g|INFRATENTORIAL BRAIN|IPSILATERAL|DEEP|ACCELERATOR MASS SPECTROMETRY||||INVESTIGATOR|READER 1|3|Visit_3|40|7|WASHOUT|2021-02-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|PRONE|[?]|Frames/s|[?]|1|mEq/kg|HARD PALATE|LATERAL|UPPER EXTENSOR SURFACE|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2021-02-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|7|IRVPP|Percent Predicted IRV|[?]|LEFT LATERAL DECUBITUS|[?]|MESF|[?]|1|BAG|PARANASAL SINUS|LEFT|UPPER FLEXOR SURFACE|INTERRUPTER TECHNIQUE||||ADJUDICATION COMMITTEE|RATER 2|4|Visit_4|65|4|TREATMENT|2021-03-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|8|SALKK|Salazar-Knowles Equation, K|[?]|DECUBITUS|||[?]|1|scm|LUNG, HILUM|LATERAL|DEEP|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||Y|CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-24
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|UNCONSTRAINED|||[?]|1|dram|DUCTUS ARTERIOSUS|LEFT|PERIVENTRICULAR|MICROBIAL CULTURE, SOLID|||Y|STUDY SUBJECT|MICROSCOPIST 1|5|Visit_5|90|7|WASHOUT|2021-03-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|c4087538-422a-4bcf-af25-ed4aab36ed4b|10|RVPP|Percent Predicted Residual Volume|[?]|LATERAL DECUBITUS|||[?]|1|mL/cage/wk|LACRIMAL GLAND|RIGHT|FACIAL|DIGITAL PCR|||Y|CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2021-03-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|FIV1PP|Percent Predicted FIV1|[?]|SLING|||[?]|1|tsp eq|METACARPOPHALANGEAL JOINT 4|IPSILATERAL|OCCIPITAL|TEMPLATE INCISION METHOD|Y|Y|Y|INTERVIEWER|RADIOLOGIST 2|1|Visit_1|10|5|SCREENING|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|2|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|CYLINDER|PARS COMPACTA|IPSILATERAL|LOWER|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||Y|CAREGIVER|RADIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|3|AWVOLPP|Percent Predicted Airway Volume|[?]|TRENDELENBURG|||[?]|1|mL/dose|LIMB, UPPER|IPSILATERAL|MEDIAL|DOPPLER ULTRASOUND|Y||Y|FAMILY MEMBER|RADIOLOGIST 1|2|Visit_2|25|4|SCREENING|2020-11-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|4|INERTANC|Inertance|[?]|SEMI-RECUMBENT|[?]|g/g/day|[?]|1|IU/kg/h|ILIAC LYMPH NODE|UNILATERAL|PARIETO-OCCIPITAL|STATIC PERIMETRY||Y||STUDY SUBJECT|FORENSIC PATHOLOGIST|2|Visit_2|25|2|WASHOUT|2020-11-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|5|SAWVOL|Specific Airway Volume|[?]|SITTING|[?]|ng|[?]|1|ug/L|TROCHANTER|CONTRALATERAL|LOWER|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||PROXY|ONCOLOGIST 2|3|Visit_3|40|2|WASHOUT|2020-12-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|ug/g/day|[?]|1|/10^3|ULNA SHAFT|IPSILATERAL|PROXIMAL VOLAR|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|1|TREATMENT|2020-12-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|7|IVC|Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/mol|[?]|1|L/day|ANAL VERGE|UNILATERAL|SURFACE|ROMANOWSKY STAIN|Y|||GUARDIAN|ONCOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-12-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|8|FRC|Functional Residual Capacity|[?]|LATERAL DECUBITUS|[?]|umol/min|[?]|1|mL/min/mmHg|GLOMERULUS|IPSILATERAL|BASAL|DYNAMIC LIGHT SCATTERING||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|4|Visit_4|65|3|FOLLOW-UP|2020-12-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-01
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|9|FIV1|Forced Inspiratory Volume in 1 Second|[?]|PRONE|[?]|L/h|[?]|1|mL/s|INTRAHEPATIC LARGE BILE DUCT|CONTRALATERAL|FACIAL|AUSCULTATION|Y|Y||PROXY|MICROSCOPIST 1|5|Visit_5|90|1|SCREENING|2021-01-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|947aefaf-20c7-47fc-ac56-140f9b6f38f3|10|TSUHYS|Tissue Hysteresivity|[?]|SUPINE|[?]|CAPSULE|[?]|1|KALLIKREIN INHIBITOR UNIT|PULMONARY VALVE, RIGHT CUSP|UNILATERAL|TEMPORAL|HPLC-FL||||INTERVIEWER|OTOLARYNGOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-01-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|DLCOVA|DLCO/VA|[?]|DECUBITUS|[?]|/LSQN|[?]|1|KIT|BASAL GANGLIA|UNILATERAL|NASAL|FLUORESCEIN STAIN||||CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|7|SCREENING|2020-08-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|2|RAW|Airway Resistance|[?]|SEMI-FOWLERS|[?]|PUFF|[?]|1|mmHg|METATARSOPHALANGEAL JOINT 2|LATERAL|SUPERFICIAL|QUANTITATIVE COMPUTED TOMOGRAPHY||Y||SPOUSE|PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|3|FRC|Functional Residual Capacity|[?]|SEMI-RECUMBENT|[?]|Tbsp|[?]|1|Coulomb|FOOT DIGIT 1|BILATERAL|CENTRAL|IMMUNO-PET SCAN|Y|Y||DOMESTIC PARTNER|MICROSCOPIST|2|Visit_2|25|4|SCREENING|2020-08-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|4|MIP|Maximal Inspiratory Pressure|[?]|TRENDELENBURG|[?]|mol/g|[?]|1|GPL U/mL|ABDUCTOR HALLUCIS MUSCLE|BILATERAL|DORSAL|DIRECT SEQUENCING|Y|||PROXY|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|WASHOUT|2020-08-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-FOWLERS|[?]|Gy/h|[?]|1|ELISA unit|TIBIALIS ANTERIOR MUSCLE|LEFT|LOWER|MICROBIAL CULTURE||||FAMILY MEMBER|ONCOLOGIST|3|Visit_3|40|4|TREATMENT|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|REVERSE TRENDELENBURG|[?]|mOsm/L|[?]|1|/LSQN|SPHENOID SINUS|CONTRALATERAL|FACIAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||SIBLING|HEMATOLOGIST|3|Visit_3|40|2|WASHOUT|2020-09-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|7|IRVPP|Percent Predicted IRV|[?]|PRONE|[?]|v/v|[?]|1|RNA copies/mL|INTERPHALANGEAL JOINT 1|UNILATERAL|FRONTAL|HILLMEN COLOR CHART||||CHILD|HEMATOLOGIST|4|Visit_4|65|7|TREATMENT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|8|FEF50|Forced Expiratory Flow 50%|[?]|TRENDELENBURG|[?]|BOX|[?]|1|mL/cage/wk|LINGULA OF THE LUNG|UNILATERAL|LOWER MEDIAL|DC SHEATH FLOW||Y||VENDOR|OPHTHALMOLOGIST|4|Visit_4|65|3|WASHOUT|2020-10-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|9|AIRTRAP|Air Trapping|[?]|FOWLERS|[?]|/LPF|[?]|1|BOTTLE|AORTOCAVAL LYMPH NODE|LEFT|FORE|MECHANICAL CLOT DETECTION|Y|Y||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|5|Visit_5|90|5|WASHOUT|2020-10-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|3a0c00eb-5614-4053-844d-6bdb71efb1cd|10|QUASCOMP|Quasi-Static Compliance|[?]|STANDING, BENT FORWARD|[?]|100 IU/mL|[?]|1|vp/mL|VASTUS MEDIALIS MUSCLE|CONTRALATERAL|SUPERFICIAL|ENDPOINT DILUTION ASSAY||||FRIEND|READER|5|Visit_5|90|5|FOLLOW-UP|2020-10-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|ALVVOL|Alveolar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|Farad|[?]|1|OI50|LUNG, HILUM|BILATERAL|APICAL|LC/MS||Y||CAREGIVER|MICROSCOPIST 2|1|Visit_1|10|3|SCREENING|2020-10-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|2|MALEVDES|Malignancy Evidence Description|[?]|STANDING|||[?]|1|U.CARR|PROFUNDA FEMORIS ARTERY|LEFT|NASAL|DOPPLER ULTRASOUND|||Y|ADJUDICATION COMMITTEE|READER 2|1|Visit_1|10|2|FOLLOW-UP|2020-10-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|3|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|PRONE|[?]|gpELISA unit/mL|[?]|1|10^3 CFU/g|CARDIOVASCULAR SYSTEM|LEFT|INNER|LASER CAPTURE MICRODISSECTION||||ADJUDICATION COMMITTEE|NEUROLOGIST|2|Visit_2|25|5|TREATMENT|2020-10-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|4|FEV3PP|Percent Predicted FEV3|[?]|SLING|[?]|ng|[?]|1|KALLIKREIN INHIBITOR UNIT|FINGERNAIL|BILATERAL|DEEP|ULTRASOUND||Y||FAMILY MEMBER|CARDIOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-10-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|5|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SEMI-RECUMBENT|[?]|10^6 CFU|[?]|1|U/10^12 RBC|FRONTAL SINUS|UNILATERAL|LOWER MEDIAL|FARR ASSAY|Y|||CAREGIVER|RADIOLOGIST|3|Visit_3|40|3|SCREENING|2020-11-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-FOWLERS|[?]|PIXEL|[?]|1|genEq/mL|ILIAC VEIN|LATERAL|MEDIAL|ENDOSCOPY|Y|||ADJUDICATOR|ADJUDICATOR 3|3|Visit_3|40|3|TREATMENT|2020-11-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|DECUBITUS|||[?]|1|/kg|SCROTUM|RIGHT|BASAL|FREEZING POINT DEPRESSION|||Y|SPOUSE|OPTOMETRIST|4|Visit_4|65|5|SCREENING|2020-12-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|8|TVPP|Percent Predicted Tidal Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|min|LIVER, LEFT LOBE|CONTRALATERAL|APICAL|HPLC-UV||Y|Y|INVESTIGATOR|MICROSCOPIST|4|Visit_4|65|3|FOLLOW-UP|2020-12-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|9|LOBVOL|Lobar Volume|[?]|SUPINE|[?]|mL/animal|[?]|1|VOXEL|CHEST|LATERAL|TEMPORAL|MECHANICAL CLOT DETECTION||Y||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|dc3ce247-24dd-4255-85a8-ec7a58d30c86|10|FIO2|Fraction of Inspired Oxygen|[?]|STANDING, BENT FORWARD|[?]|MET*min|[?]|1|/mm2|PANCREATIC DUCT|LEFT|LOWER EXTENSOR SURFACE|AGAR DILUTION||||SIGNIFICANT OTHER|RADIOLOGIST|5|Visit_5|90|2|TREATMENT|2020-12-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|PNU/mL|[?]|1|cycle/min|GASTRIC CARDIA|LATERAL|PROXIMAL VOLAR|BRDU CELLULAR PROLIFERATION ASSAY||||FAMILY MEMBER|CARDIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-07-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|2|DLCOVA|DLCO/VA|[?]|SUPINE|||[?]|1|log10 CCID 50/dose|ABDUCENS NERVE|BILATERAL|VENTROLATERAL|FLOCCULATION||Y|Y|GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-07-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|3|LCI|Lung Clearance Index|[?]|SITTING|[?]|%/s|[?]|1|m/sec|LIVER LOBE|LATERAL|POSTERIOR|CONTRAST ENHANCED PET/CT SCAN|Y|Y||FAMILY MEMBER|RADIOLOGIST 2|2|Visit_2|25|6|WASHOUT|2020-07-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|4|MEPPP|Percent Predicted MEP|[?]|SEMI-RECUMBENT|[?]|ug/mol|[?]|1|ppb|OBTURATOR EXTERNUS MUSCLE|RIGHT|INNER|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|Y||DOMESTIC PARTNER|HEMATOLOGIST|2|Visit_2|25|2|SCREENING|2020-07-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|5|TVPP|Percent Predicted Tidal Volume|[?]|SUPINE|[?]|dmol|[?]|1|nmol/day|CALCARINE SULCUS|BILATERAL|PERIVENTRICULAR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||CLINICAL RESEARCH COORDINATOR|UROLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-08-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|6|DLCOPP|Percent Predicted DLCO|[?]|SUPINE|[?]|ug/m2/min|[?]|1|uSiemens|PREPUTIAL GLAND|LEFT|TIP|ELLA|Y|||INDEPENDENT ASSESSOR|OPTOMETRIST|3|Visit_3|40|2|TREATMENT|2020-08-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|7|RVPP|Percent Predicted Residual Volume|[?]|SITTING|[?]|/min|[?]|1|fL|SECOND RIGHT POSTEROLATERAL ARTERY|IPSILATERAL|ANTEROLATERAL|ECHOCARDIOGRAPHY||||DOMESTIC PARTNER|RATER 2|4|Visit_4|65|1|TREATMENT|2020-08-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING|[?]|cGy|[?]|1|ug/dose|BLADDER, TRIGONE|CONTRALATERAL|VOLAR|TONOMETRY||||SPOUSE|PATHOLOGIST 2|4|Visit_4|65|6|TREATMENT|2020-08-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|9|FEV6PP|Percent Predicted FEV6|[?]|FOWLERS|[?]|mCi/L|[?]|1|mL/day|WRIST JOINT FLEXOR TENDONS|BILATERAL|FORE|MAGNETIC RESONANCE ANGIOGRAPHY|Y|||CAREGIVER|INTERNIST|5|Visit_5|90|1|FOLLOW-UP|2020-09-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|61c19f94-bdfc-456d-ba7a-c9097ca1c645|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|FOWLERS|[?]|ug/kg/h|[?]|1|mL/animal/wk|TRANSVERSE TARSAL JOINT|LEFT|LOWER FLEXOR SURFACE|SPECT SCAN||||FAMILY MEMBER|ONCOLOGIST 2|5|Visit_5|90|7|FOLLOW-UP|2020-09-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^3/L|FACET JOINT|CONTRALATERAL|ANTEROPOSTERIOR|MICROBIAL BIOCHEMICAL IDENTIFICATION|||Y|STUDY SUBJECT|ONCOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-09-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|2|PNIF|Peak Nasal Inspiratory Flow|[?]|SUPINE|[?]|mL/mmHg|[?]|1|mph|LUNG, RIGHT MIDDLE LOBE|BILATERAL|LOWER|PEAK FLOWMETRY||Y||INVESTIGATOR|ONCOLOGIST|1|Visit_1|10|6|TREATMENT|2020-09-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|3|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|nU/cL|[?]|1|DDU|DISTAL INTERPHALANGEAL JOINT 2|BILATERAL|ANTEROLATERAL|PHYSICAL EXAMINATION||||PARENT|ENDOCRINOLOGIST|2|Visit_2|25|3|TREATMENT|2020-10-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|4|ERVPP|Percent Predicted ERV|[?]|SITTING|[?]|% INHIBITION|[?]|1|mg/kg|GLOTTIS|BILATERAL|FORE|THIN SMEAR||||SIBLING|ONCOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-10-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-25
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|5|SALKK|Salazar-Knowles Equation, K|[?]|SITTING, LEGS DEPENDENT|||[?]|1|cpm|INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|PERIPHERAL|GC/FID|Y|Y|Y|FRIEND|HEMATOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-10-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SITTING, LEGS DEPENDENT|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|IU/kg|FIRST DIAGONAL BRANCH ARTERY|LEFT|TEMPORAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|Y||CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|6|SCREENING|2020-10-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|7|QUASCOMP|Quasi-Static Compliance|[?]|SITTING|[?]|Enzyme U/m2|[?]|1|IU/day|GRACILIS MUSCLE|CONTRALATERAL|APICAL|FLUORESCENT MICROSCOPY||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 1|4|Visit_4|65|5|FOLLOW-UP|2020-11-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|8|PEFREV|PEF Reversibility|[?]|STANDING, BENT FORWARD|||[?]|1|Absorbance U|ESOPHAGUS, UPPER THIRD|LEFT|PROXIMAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y||Y|ADJUDICATION COMMITTEE|CARDIOLOGIST|4|Visit_4|65|3|WASHOUT|2020-11-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|9|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING|[?]|mL/kg|[?]|1|ug/m2/min|ARM|LATERAL|CENTRAL|ENZYMATIC SPECTROPHOTOMETRY||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|5|Visit_5|90|1|TREATMENT|2020-12-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|1e577f2d-2c45-477d-b74f-af24b81d6d20|10|TSUELAS|Tissue Elastance|[?]|FOWLERS|[?]|fraction of 1|[?]|1|gtt|FOOT PHALANX|LEFT|CAUDAL|HIGH RESOLUTION MELT ANALYSIS|Y|||FAMILY MEMBER|ADJUDICATOR 1|5|Visit_5|90|3|TREATMENT|2020-12-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING|[?]|mL/cm3/min|[?]|1|uEq/L|CHIN|CONTRALATERAL|APICAL|ELLA||||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|2|TREATMENT|2020-10-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|[?]|ug/mL/h|[?]|1|mL/animal|INTERPHALANGEAL JOINT 4|BILATERAL|HIND|WHOLE TRANSCRIPTOME SEQUENCING|Y|||FRIEND|PEDIATRIC NEUROLOGIST|1|Visit_1|10|6|SCREENING|2020-10-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|3|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|MPL U|[?]|1|km/h|UVEA|BILATERAL|VOLAR|MICROARRAY||Y||INVESTIGATOR|MICROSCOPIST|2|Visit_2|25|5|WASHOUT|2020-11-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|4|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|||[?]|1|IU/g Hb|MUSCULOSKELETAL SYSTEM|UNILATERAL|VOLAR|SNELLEN EYE CHART|||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|2|Visit_2|25|7|FOLLOW-UP|2020-11-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|PLUG|URACHAL TRACT|CONTRALATERAL|CENTRAL|CELLULOSE TAPE|Y||Y|ADJUDICATOR|MICROSCOPIST 3|3|Visit_3|40|5|FOLLOW-UP|2020-11-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|6|EFFIND|Effusion Indicator|[?]|SITTING|[?]|10^3 CFU/mL|[?]|1|/500 WBC|RECTO-UTERINE POUCH|BILATERAL|VENTROLATERAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||||NON-HEALTH CARE PROFESSIONAL|RATER 2|3|Visit_3|40|1|TREATMENT|2020-11-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|7|ERVPP|Percent Predicted ERV|[?]|SEMI-RECUMBENT|[?]|10^12/L|[?]|1|/MBP|CELIAC LYMPH NODE|BILATERAL|CAUDAL|RAJI CELL EIA|Y|Y||FRIEND|INTERNIST|4|Visit_4|65|7|WASHOUT|2020-12-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|8|AWWVOL|Airway Wall Volume|[?]|STANDING|[?]|mEq/kg|[?]|1|/LPF|MUCOSA OF THE LIP|IPSILATERAL|DORSAL|MUGA||Y||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|SCREENING|2020-12-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|9|AIRTRAP|Air Trapping|[?]|PRONE|[?]|QUANTITY SUFFICIENT|[?]|1|U/kg|GASTROINTESTINAL TRACT, LOWER|CONTRALATERAL|ANTEROLATERAL|ENDOSCOPY||Y||GUARDIAN|CARDIOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-01-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|f845101e-c057-4f84-94b3-6043afb42ac7|10|INFLTIND|Infiltrates Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|DISK|[?]|1|m|BILIARY TRACT|BILATERAL|MIDLINE|RAJI CELL RIA||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2021-01-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|1|INERTANC|Inertance|[?]|LATERAL DECUBITUS|[?]|nCi|[?]|1|/min|MEDIAN NERVE|CONTRALATERAL|TIP|PERIODIC ACID SCHIFF STAIN|Y|||SPOUSE|CLINICAL PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|2|SALKA|Salazar-Knowles Equation Parameter A|[?]|SUPINE|[?]|mEq/uL|[?]|1|anti-Xa IU|BILE DUCT|LEFT|DEEP|RADIOGRAPHY||Y||CLINICAL RESEARCH COORDINATOR|READER 2|1|Visit_1|10|7|TREATMENT|2020-12-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|3|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LEFT LATERAL DECUBITUS|[?]|mm/min|[?]|1|/h|RETINA|LATERAL|SUPERIOR|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||ADJUDICATION COMMITTEE|ADJUDICATOR 1|2|Visit_2|25|2|FOLLOW-UP|2021-01-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|UNCONSTRAINED|[?]|amu|[?]|1|dpm/mg|ENDOCARDIUM|LATERAL|OUTER|MULTI-SLICE SPIRAL CT||Y||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|2|Visit_2|25|5|SCREENING|2021-01-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|[?]|mU/g|[?]|1|Sv|ESOPHAGEAL LYMPH NODE|LEFT|LOWER EXTENSOR SURFACE|MYELOPEROXIDASE STAIN||Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|3|Visit_3|40|1|SCREENING|2021-01-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|6|PEFREV|PEF Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/kg/day|[?]|1|TAMPON|URETHRA, PENILE|RIGHT|UPPER EXTENSOR SURFACE|PELLI-ROBSON EYE CHART||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|1|FOLLOW-UP|2021-01-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|7|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SUPINE|[?]|scm|[?]|1|/2000 RBC|CHEST|BILATERAL|OCCIPITAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||CHILD|READER|4|Visit_4|65|1|TREATMENT|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|8|EXPRELTM|Expiration Relaxation Time|[?]|REVERSE TRENDELENBURG|[?]|PIPE|[?]|1|mol/mg|JOINT|RIGHT|INNER|SPECT SCAN|Y|||FRIEND|NEUROLOGIST 2|4|Visit_4|65|6|FOLLOW-UP|2021-02-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|9|SALKB|Salazar-Knowles Equation Parameter B|[?]|DECUBITUS|||[?]|1|genEq/mL|OCCIPITAL LOBE|CONTRALATERAL|MIDLINE|DOUBLE IMMUNODIFFUSION|||Y|ADJUDICATOR|MICROSCOPIST|5|Visit_5|90|4|FOLLOW-UP|2021-03-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|4ddb2076-6837-4028-81bc-3e8057475977|10|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|||[?]|1|dpm/0.5 mL|BUCCAL LYMPH NODE|CONTRALATERAL|DORSAL|AUTOREFRACTION|||Y|INVESTIGATOR|RATER 2|5|Visit_5|90|5|SCREENING|2021-03-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|[?]|ug/h|[?]|1|Frames/s|METATARSOPHALANGEAL JOINT 2|CONTRALATERAL|UPPER|DARK FIELD MICROSCOPY|Y|||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|1|Visit_1|10|3|WASHOUT|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|2|FIF25|Forced Inspiratory Flow at 25%|[?]|LATERAL DECUBITUS|[?]|10^6 CFU|[?]|1|kUSP|NASAL CAVITY|IPSILATERAL|INTERMEDIATE|MYELOPEROXIDASE STAIN||||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|3|FRCPP|Percent Predicted FRC|[?]|DECUBITUS|[?]|pmol|[?]|1|10^12/L|FLEXOR DIGITORUM PROFUNDUS MUSCLE|CONTRALATERAL|ANTEROLATERAL|SNELLEN EYE CHART|Y|||SPOUSE|MICROSCOPIST 2|2|Visit_2|25|1|WASHOUT|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|4|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-FOWLERS|||[?]|1|g/animal|BLADDER, FUNDUS|LATERAL|LATERAL|QUANTITATIVE COMPUTED TOMOGRAPHY|||Y|SIGNIFICANT OTHER|HEMATOLOGIST|2|Visit_2|25|4|TREATMENT|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|5|AWVOLPP|Percent Predicted Airway Volume|[?]|STANDING|[?]|BLOCKS|[?]|1|ug/m2/day|FALCIFORM LIGAMENT|UNILATERAL|TEMPORAL|PHOROPTER|Y|||SIBLING|NEUROLOGIST 1|3|Visit_3|40|2|TREATMENT|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|6|QUASCOMP|Quasi-Static Compliance|[?]|STANDING|[?]|kIU|[?]|1|dpm/mL|BLADDER, DOME|BILATERAL|ANTEROPOSTERIOR|DYNAMOMETRY|Y|Y||STUDY SUBJECT|HEMATOLOGIST|3|Visit_3|40|1|SCREENING|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|7|EVC|Expiratory Vital Capacity|[?]|TRENDELENBURG|[?]|FINGERTIP UNIT|[?]|1|umol/mol|PENIS, GLANS|LEFT|LOWER FLEXOR SURFACE|PALPATION||||PARENT|ONCOLOGIST 2|4|Visit_4|65|5|FOLLOW-UP|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|8|IVC|Inspiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|PFU|[?]|1|TUBE|GREAT TROCHANTER|LATERAL|NASAL|PET/MRI SCAN||Y||FAMILY MEMBER|CLINICAL PATHOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|9|PEFREV|PEF Reversibility|[?]|PRONE|[?]|ug/kg/day|[?]|1|DISK|SCAPHOID-TRAPEZOID JOINT|BILATERAL|NASAL|MECHANICAL CLOT DETECTION||||PROXY|RATER|5|Visit_5|90|5|TREATMENT|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|c165c69c-2ab2-495c-a190-e32d1204bc4e|10|FIFMAXPP|Percent Predicted FIFmax|[?]|PRONE|[?]|damol/L|[?]|1|DPM|SPLENIC VEIN|RIGHT|DISTAL VOLAR|CONTRAST ENHANCED PET/CT SCAN||||INVESTIGATOR|OPTOMETRIST|5|Visit_5|90|3|FOLLOW-UP|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|FIF25|Forced Inspiratory Flow at 25%|[?]|SLING|||[?]|1|lx|TEMPORAL BONE|IPSILATERAL|CRANIAL|MICRONEUTRALIZATION ASSAY|Y|Y|Y|INVESTIGATOR|MICROSCOPIST 2|1|Visit_1|10|5|TREATMENT|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|UNCONSTRAINED|[?]|mL/cm3/min|[?]|1|uL/mL|INTERPHALANGEAL JOINT 5|UNILATERAL|OCCIPITAL|PATHOLOGICAL EVALUATION||||INVESTIGATOR|OTOLARYNGOLOGIST|1|Visit_1|10|4|TREATMENT|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-14
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|3|FIF75|Forced Inspiratory Flow at 75%|[?]|SITTING|[?]|bel|[?]|1|L/s|SACROILIAC JOINT|CONTRALATERAL|PERIPHERAL|PULMONARY ANGIOGRAPHY||||CLINICAL STUDY SPONSOR|READER|2|Visit_2|25|2|SCREENING|2021-01-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SITTING|||[?]|1|Ci/mL|ABDOMINAL AORTA|BILATERAL|DISTAL VOLAR|HEMATOXYLIN AND EOSIN STAIN|Y||Y|HEALTH CARE PROFESSIONAL|READER 2|2|Visit_2|25|1|TREATMENT|2021-01-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-31
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|5|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|mIU/L|[?]|1|/MBP|PROSTATE GLAND, LATERAL LOBE|UNILATERAL|OCCIPITAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2021-01-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|APL U|[?]|1|IU/day|SPHENOID SINUS|UNILATERAL|MIDLINE|AUSCULTATION||||VENDOR|ADJUDICATOR 1|3|Visit_3|40|2|WASHOUT|2021-01-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|7|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|[?]|L/kg|[?]|1|msec|INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|BASAL|SPECT SCAN||||PROXY|CARDIOLOGIST|4|Visit_4|65|6|SCREENING|2021-02-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|8|DLCOPP|Percent Predicted DLCO|[?]|PRONE|[?]|BU|[?]|1|mmAL|SECOND OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|ROSTRAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION|Y|||INVESTIGATOR|RATER 2|4|Visit_4|65|3|FOLLOW-UP|2021-02-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|9|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|v/v|[?]|1|mL/animal/day|HYPOPHARYNX|IPSILATERAL|LOWER FLEXOR SURFACE|MICRONEUTRALIZATION ASSAY||||DOMESTIC PARTNER|NEUROLOGIST 1|5|Visit_5|90|3|TREATMENT|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|10|INERTANC|Inertance|[?]|SLING|||[?]|1|U/L|HEART, LEFT ATRIUM|LEFT|SUBCORTICAL|KARYOTYPING|Y||Y|PROXY|RADIOLOGIST|5|Visit_5|90|2|SCREENING|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|1|FEV1SVC|FEV1/SVC|[?]|SEMI-RECUMBENT|[?]|ft|[?]|1|mmol/g|CAUDAL VERTEBRA|BILATERAL|PARIETO-OCCIPITAL|PYROSEQUENCING||||DOMESTIC PARTNER|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-06-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|2|SRAW|Specific Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/dL|[?]|1|mol|THIRD RIGHT POSTEROLATERAL ARTERY|RIGHT|OCCIPITAL|PHASE CONTRAST MICROSCOPY|Y|||INDEPENDENT ASSESSOR|READER|1|Visit_1|10|5|TREATMENT|2020-06-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|3|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|[?]|ug/L|[?]|1|gtt|INTERNAL ILIAC LYMPH NODE|LEFT|SURFACE|FUNCTIONAL MRI||||VENDOR|NEUROLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|4|RRS|Total Respiratory System Resistance|[?]|PRONE|[?]|uL/mL|[?]|1|mmol/mol|GLOBUS PALLIDUS|UNILATERAL|PROXIMAL|PALM METHOD||||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|5|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|DNA copies/ug|[?]|1|/kg|TIBIALIS POSTERIOR MUSCLE|LATERAL|DORSOLATERAL|FORCED OSCILLATION TECHNIQUE|Y|||GUARDIAN|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2020-07-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|||[?]|1|MHz|TRIANGULAR-HAMATE JOINT|UNILATERAL|INFERIOR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|PROXY|ONCOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-07-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SUPINE|[?]|SFC/10^6 PBMC|[?]|1|min|RECTO-UTERINE POUCH|RIGHT|DORSOLATERAL|SCANNING ELECTRON MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|4|Visit_4|65|6|TREATMENT|2020-08-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|8|FIO2|Fraction of Inspired Oxygen|[?]|FOWLERS|[?]|Siemens|[?]|1|10^3/hpf|GREAT SAPHENOUS VEIN|IPSILATERAL|PROXIMAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||PARENT|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-08-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|9|SRAW|Specific Airway Resistance|[?]|SEMI-RECUMBENT|||[?]|1|mL/m2/day|DISTAL PHALANX 3 OF THE HAND|LEFT|ANTEROPOSTERIOR|JAEGER EYE CHART||Y|Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-09-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|RE|024a9f6d-4ff1-4673-8617-3790f831fce7|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|UNCONSTRAINED|||[?]|1|ag|LIP, UPPER|CONTRALATERAL|LOWER|ELECTROGASTROGRAPHY|||Y|INTERVIEWER|ONCOLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-09-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-RECUMBENT|[?]|CFU/g|[?]|1|mg/L FEU|ABDUCTOR POLLICIS BREVIS MUSCLE|LEFT|PROXIMAL VOLAR|FUNCTIONAL MRI||||PARENT|RATER 1|1|Visit_1|10|6|TREATMENT|2020-11-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|2|OXYPULSE|Oxygen Pulse|[?]|UNCONSTRAINED|[?]|mL/min/mmHg|[?]|1|Arbitrary U|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|IPSILATERAL|VOLAR|CLIP SEQUENCING||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|1|Visit_1|10|1|FOLLOW-UP|2020-11-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-11
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|3|IVC|Inspiratory Vital Capacity|[?]|SUPINE|||[?]|1|mg/g/min|ABDOMINAL CAVITY|CONTRALATERAL|VOLAR|EEG||Y|Y|FRIEND|ONCOLOGIST|2|Visit_2|25|6|SCREENING|2020-12-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|4|RV|Residual Volume|[?]|PRONE|||[?]|1|ukat/L|RETINAL PIGMENTED EPITHELIAL LAYER|CONTRALATERAL|SUPERIOR|IMMUNOCHROMATOGRAPHY|||Y|NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|5|SCREENING|2020-12-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|tsp eq|[?]|1|ELISA unit/mL|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|LOWER EXTENSOR SURFACE|FARR ASSAY||Y||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|3|Visit_3|40|7|FOLLOW-UP|2020-12-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|6|SGAW|Specific Airway Conductance|[?]|REVERSE TRENDELENBURG|[?]|mg/m2/h|[?]|1|cGy|ILIAC LYMPH NODE|LEFT|INNER|SIZE EXCLUSION CHROMATOGRAPHY||||CAREGIVER|RADIOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-12-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|7|ELSTNCE|Elastance|[?]|FOWLERS|||[?]|1|msec|UMBILICUS|BILATERAL|SUPERFICIAL|CONFOCAL MICROSCOPY|||Y|GUARDIAN|RADIOLOGIST|4|Visit_4|65|1|WASHOUT|2021-01-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|8|DLCOHCVA|HGB Corrected DLCO/VA|[?]|PRONE|[?]|mol/mol|[?]|1|MAC50|PROFUNDA FEMORIS VEIN|CONTRALATERAL|ANTEROTEMPORAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||SPOUSE|READER 2|4|Visit_4|65|2|TREATMENT|2021-01-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|9|SALKB|Salazar-Knowles Equation Parameter B|[?]|DECUBITUS|[?]|MET*h|[?]|1|Hz|MEDIAN OR LOWER CERVICAL LYMPH NODE|CONTRALATERAL|VOLAR|NEURAMINIDASE INHIBITION ASSAY||||CLINICAL STUDY SPONSOR|READER 3|5|Visit_5|90|4|TREATMENT|2021-02-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|40936fc6-251d-4a17-ae9d-3bd1150f8d20|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|BOWL|[?]|1|/month|CHEST WALL|LEFT|ANTERIOR|TEMPLATE INCISION METHOD||||SPOUSE|OTOLARYNGOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2021-02-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|FEV3FVC|FEV3/FVC|[?]|DECUBITUS|||[?]|1|POUCH|RESPIRATORY SYSTEM|IPSILATERAL|INTERMEDIATE|RADIATION DOSIMETRY|Y|Y|Y|ADJUDICATION COMMITTEE|HEMATOLOGIST|1|Visit_1|10|4|WASHOUT|2020-11-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LATERAL DECUBITUS|[?]|Gy/min|[?]|1|APPLICATION|DISTAL COMMON BILE DUCT|UNILATERAL|LATERAL|MRS||||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-11-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|3|ELSTNCE|Elastance|[?]|REVERSE TRENDELENBURG|||[?]|1|EP U|VOCAL CORD|CONTRALATERAL|OUTER|REFLECTANCE SPECTROSCOPY|||Y|SIGNIFICANT OTHER|RADIOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-11-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|4|INTP|Interpretation|[?]|REVERSE TRENDELENBURG|[?]|U/g Hb|[?]|1|10^6 IU|PYRAMIDAL TRACTS, INTERNAL CAPSULE|LEFT|FACIAL|PHOROPTER|Y|Y||PROXY|NEUROLOGIST|2|Visit_2|25|2|TREATMENT|2020-11-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|5|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|||[?]|1|mol/g|LIMB|RIGHT|CRANIAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y|Y|CHILD|PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|6|INFLTIND|Infiltrates Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|mEq/kg|[?]|1|FINGERTIP UNIT|EAR, INNER|CONTRALATERAL|PERIPHERAL|AGAR PROPORTION|Y|Y||CHILD|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|4|SCREENING|2020-12-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|7|RV|Residual Volume|[?]|SUPINE|[?]|mL/dose|[?]|1|log10 CFU/g|METATARSOPHALANGEAL JOINT 4|LATERAL|MIDLINE|SPECT SCAN|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-01-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|8|INTP|Interpretation|[?]|SITTING, LEGS DEPENDENT|||[?]|1|SFC/10^6 PBMC|KIDNEY, MEDULLA|UNILATERAL|DISTAL VOLAR|IRON HEMATOXYLIN STAIN|||Y|ADJUDICATOR|MICROSCOPIST 2|4|Visit_4|65|2|FOLLOW-UP|2021-01-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|9|EVC|Expiratory Vital Capacity|[?]|SLING|[?]|C|[?]|1|U/mg|LUNATE BONE|BILATERAL|DISTAL|MUGA||Y||STUDY SUBJECT|ADJUDICATOR|5|Visit_5|90|7|FOLLOW-UP|2021-01-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|17b9fa7a-f15d-423a-9671-99cd0cbbd362|10|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|DECUBITUS|[?]|U/L|[?]|1|10^7 PFU|INTRAHEPATIC LARGE BILE DUCT|CONTRALATERAL|MEDIAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|TREATMENT|2021-01-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|1|EFFVOL|Effusion Volume|[?]|SUPINE|[?]|U/animal|[?]|1|uCi/L|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LEFT|BASAL|PALPATION||||SIGNIFICANT OTHER|READER 2|1|Visit_1|10|3|TREATMENT|2020-10-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|AU/mL|[?]|1|BEAM BREAKS|MALLEUS|LEFT|CENTRAL|NEXT GENERATION TARGETED SEQUENCING|Y|||DOMESTIC PARTNER|CARDIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-10-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|3|RRS|Total Respiratory System Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|pm|[?]|1|ug/mol|COSTAL CARTILAGE|UNILATERAL|DORSOLATERAL|HEMATOXYLIN AND EOSIN STAIN||||STUDY SUBJECT|PHYSIOTHERAPIST|2|Visit_2|25|1|TREATMENT|2020-11-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|DECUBITUS|[?]|10^12 IU/L|[?]|1|m2|POSTERIOR CINGULATE CORTEX|UNILATERAL|CENTRAL|PERFUSION MRI|Y|Y||ADJUDICATOR|PATHOLOGIST 2|2|Visit_2|25|7|SCREENING|2020-11-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|5|PLMXRS|Pulmonary Reactance|[?]|SUPINE|[?]|Bq/mL|[?]|1|mU|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|LATERAL|FORE|CALCULATION||Y||STUDY SUBJECT|DERMATOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-11-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SLING|[?]|mol/mol|[?]|1|nU/cL|PERIANAL REGION|UNILATERAL|ANTEROLATERAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||||CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|4|WASHOUT|2020-11-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|7|FEV1SVC|FEV1/SVC|[?]|REVERSE TRENDELENBURG|[?]|BU|[?]|1|CIGARETTE|INFERIOR VENA CAVA|IPSILATERAL|PROXIMAL|MULTIPLE BREATH WASHOUT||||CLINICAL STUDY SPONSOR|READER|4|Visit_4|65|6|TREATMENT|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|8|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|[?]|Tbsp|[?]|1|10^12/L|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|CONTRALATERAL|CAUDAL|DNA MICROARRAY||||STUDY SUBJECT|HEMATOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-12-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|9|INTP|Interpretation|[?]|SITTING, LEGS DEPENDENT|[?]|10^12/L|[?]|1|10^6 organisms/g|PORTA HEPATIS LYMPH NODE|CONTRALATERAL|LOWER|FLUORESCENT SPOT TEST||||SIBLING|PATHOLOGIST 2|5|Visit_5|90|4|TREATMENT|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|95c4465b-162a-433d-83c9-6d67dd729c9e|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|mol/mol|[?]|1|tuberculin unit|SUPRASPINATUS MUSCLE|IPSILATERAL|SUBCORTICAL|FUNCTIONAL MRI||||INTERVIEWER|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2021-01-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-27
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|10^9/L|[?]|1|10^7 CFU/mL|GENITAL TUBERCLE|UNILATERAL|VENTRAL|NEXT GENERATION SEQUENCING||||SIGNIFICANT OTHER|PATHOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-06-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING|[?]|/min|[?]|1|breaths/30s|BRAIN, THIRD VENTRICLE|LEFT|UPPER|ENZYMATIC SPECTROPHOTOMETRY||Y||PARENT|CLINICAL PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|3|TVPP|Percent Predicted Tidal Volume|[?]|SEMI-RECUMBENT|[?]|ug/h|[?]|1|DAgU/mL|PELVIC LYMPH NODE|CONTRALATERAL|PERIPHERAL|HEMAGGLUTINATION INHIBITION ASSAY||||ADJUDICATION COMMITTEE|RADIOLOGIST 2|2|Visit_2|25|4|SCREENING|2020-07-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|4|TVPP|Percent Predicted Tidal Volume|[?]|SUPINE|[?]|HEP|[?]|1|ug/g/min|CALCANEUS|LEFT|SUPERIOR|AUTOMATED COUNT|Y|||GUARDIAN|FORENSIC PATHOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-07-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|5|RVPP|Percent Predicted Residual Volume|[?]|SLING|[?]|ug/day|[?]|1|10^9/g|CEREBRAL SUBCORTEX|BILATERAL|NASAL|POTENTIOMETRY||||SPOUSE|ENDOCRINOLOGIST|3|Visit_3|40|6|TREATMENT|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|6|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|[?]|umol/L/sec|[?]|1|TRANSDUCING UNIT|THORACIC AORTA|LEFT|ANTEROMEDIAL|MASS SPECTROMETRY||Y||INTERVIEWER|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|7|RELSZCHG|Relative Size Change|[?]|TRENDELENBURG|[?]|GLOBULE|[?]|1|VIAL|SACRAL VERTEBRA|LEFT|POSTERIOR|TELLER ACUITY CARDS|Y|||PROXY|CARDIOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|8|TSUELAS|Tissue Elastance|[?]|FOWLERS|[?]|mL/dose|[?]|1|Bq/kg|FLEXOR HALLUCIS LONGUS MUSCLE|RIGHT|UPPER EXTENSOR SURFACE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||INVESTIGATOR|DERMATOLOGIST|4|Visit_4|65|4|WASHOUT|2020-08-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|9|PIF|Peak Inspiratory Flow|[?]|FOWLERS|[?]|ug/mol|[?]|1|copies/uL|LEFT MAIN CORONARY ARTERY BIFURCATION|RIGHT|PROXIMAL VOLAR|OLIGO ACGH||||GUARDIAN|OPHTHALMOLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|10|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|[?]|g|[?]|1|mEq/day|CEPHALIC VEIN|UNILATERAL|FACIAL|DC SHEATH FLOW||Y||CHILD|UROLOGIST|5|Visit_5|90|7|SCREENING|2020-09-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|1|FVC|Forced Vital Capacity|[?]|SUPINE|[?]|SPRAY|[?]|1|L/h|BASILIC VEIN|RIGHT|SUPERIOR|WHOLE TRANSCRIPTOME SEQUENCING||||GUARDIAN|ADJUDICATOR 3|1|Visit_1|10|2|TREATMENT|2020-06-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|2|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|[?]|10^7 PFU|[?]|1|MdFI|MEDIASTINUM, POSTERIOR|RIGHT|DISTAL|SPECT SCAN||||SPOUSE|MICROSCOPIST 1|1|Visit_1|10|1|SCREENING|2020-06-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|3|LCI|Lung Clearance Index|[?]|DECUBITUS|[?]|cs|[?]|1|10^6 copies/mL|SCAPHOID BONE|IPSILATERAL|TEMPORAL|KLEIHAUER-BETKE|Y|||SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|SCREENING|2020-06-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|4|RRS|Total Respiratory System Resistance|[?]|SEMI-FOWLERS|[?]|SQU/mL|[?]|1|kBq|SCAPHOID-TRAPEZIUM JOINT|RIGHT|TEMPORAL|IMMUNOFIXATION ELECTROPHORESIS||||CLINICAL RESEARCH COORDINATOR|READER 3|2|Visit_2|25|4|FOLLOW-UP|2020-06-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|5|FRC|Functional Residual Capacity|[?]|TRENDELENBURG|[?]|mL/day|[?]|1|eq|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|UNILATERAL|VOLAR|X-RAY FLUORESCENCE SPECTROMETRY||||ADJUDICATOR|OTOLARYNGOLOGIST|3|Visit_3|40|4|SCREENING|2020-07-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|6|GAW|Airway Conductance|[?]|SEMI-FOWLERS|||[?]|1|HOMEOPATHIC DILUTION|PELVIC LYMPH NODE|IPSILATERAL|DORSOLATERAL|TOTAL BODY IRRADIATION|||Y|HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|TREATMENT|2020-07-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|7|EFFIND|Effusion Indicator|[?]|DECUBITUS|[?]|%(v/v)|[?]|1|NEBULE|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|IPSILATERAL|FACIAL|ELECTRICAL IMPEDANCE MYOGRAPHY||||FRIEND|PHYSIOTHERAPIST|4|Visit_4|65|7|TREATMENT|2020-08-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|8|MEP|Maximal Expiratory Pressure|[?]|DECUBITUS|||[?]|1|F|LACRIMAL GLAND|RIGHT|POSTERIOR|HEMATOXYLIN AND EOSIN STAIN|||Y|VENDOR|ENDOCRINOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|9|MALIND|Malignancy Indicator|[?]|DECUBITUS|[?]|/kg|[?]|1|ng/mol|HYMENAL RING|CONTRALATERAL|HIND|CELLULOSE TAPE||||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2020-08-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|beb6b1ab-1264-456a-bf2b-81e28493301d|10|MALIND|Malignancy Indicator|[?]|TRENDELENBURG|||[?]|1|V/sec|INTRATHORACIC LYMPH NODE|RIGHT|LATERAL|IMMUNOASSAY|||Y|FAMILY MEMBER|MICROSCOPIST 3|5|Visit_5|90|2|WASHOUT|2020-08-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|1|DLCOVA|DLCO/VA|[?]|STANDING|||[?]|1|hr/day|CLITORIS|BILATERAL|VENTRAL|TONOMETRY|||Y|SIBLING|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-12-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|2|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-RECUMBENT|||[?]|1|ppm|SPLENIC LYMPH NODE|CONTRALATERAL|SUPERFICIAL|PUPILLOMETRY|||Y|VENDOR|OPTOMETRIST|1|Visit_1|10|3|TREATMENT|2020-12-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|TRENDELENBURG|||[?]|1|Joule|BRAIN, THIRD VENTRICLE|RIGHT|LOWER FLEXOR SURFACE|IN VITRO GENE EXPRESSION ASSAY|||Y|INTERVIEWER|READER|2|Visit_2|25|2|TREATMENT|2020-12-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|4|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|mEq/kg|[?]|1|V/sec|LEPTOMENINGES|RIGHT|FRONTAL|ELASTOGRAPHY|Y|Y||CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|2|Visit_2|25|4|FOLLOW-UP|2020-12-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|DECUBITUS|[?]|cm H2O|[?]|1|DDU|FOOT DIGIT 4|LATERAL|SUPERIOR|PHOTOMETRIC CLOT DETECTION||Y||ADJUDICATION COMMITTEE|OPTOMETRIST|3|Visit_3|40|4|TREATMENT|2021-01-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|6|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SLING|[?]|g/cage|[?]|1|U/g/min|MAXILLA|CONTRALATERAL|LOWER EXTENSOR SURFACE|NUCLEIC ACID AMPLIFICATION TEST|Y|||STUDY SUBJECT|ADJUDICATOR 2|3|Visit_3|40|5|SCREENING|2021-01-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|7|RELSZCHG|Relative Size Change|[?]|DECUBITUS|[?]|ug/animal|[?]|1|V|CEREBRUM|IPSILATERAL|LOWER EXTENSOR SURFACE|MICROBIAL CULTURE||||HEALTH CARE PROFESSIONAL|NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|8|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-FOWLERS|[?]|Absorbance U/mL|[?]|1|amu|RETINAL PIGMENTED EPITHELIAL LAYER|RIGHT|BASAL|FLUORESCEIN STAIN||||PROXY|RADIOLOGIST 1|4|Visit_4|65|5|TREATMENT|2021-01-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|9|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING|[?]|10^8 PFU|[?]|1|mV|BLADDER, NECK|LEFT|SUBCORTICAL|SPECTROPHOTOMETRY||||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2021-02-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|4292c06d-044e-4dff-aea0-830178a6e220|10|AWWVOL|Airway Wall Volume|[?]|SLING|||[?]|1|Farad|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|IPSILATERAL|SUPERIOR|IMPULSE OSCILLOMETRY|||Y|VENDOR|CLINICAL PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2021-02-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|1|TVPP|Percent Predicted Tidal Volume|[?]|SUPINE|[?]|log10 TCID 50/uL|[?]|1|g/kg|TRICUSPID VALVE ANNULUS|CONTRALATERAL|APICAL|MANUAL COUNT|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|1|Visit_1|10|4|FOLLOW-UP|2020-08-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|2|EFFIND|Effusion Indicator|[?]|STANDING|[?]|nmol BCE/L|[?]|1|umol/L/min|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LATERAL|LOWER MEDIAL|SPECULAR MICROSCOPY||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|1|Visit_1|10|6|TREATMENT|2020-08-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|3|FEV1FVC6|FEV1/FVC6|[?]|SEMI-RECUMBENT|[?]|JAR|[?]|1|PFU/dose|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|BILATERAL|DORSOLATERAL|MICROBIAL CULTURE, SOLID||||STUDY SUBJECT|INTERNIST|2|Visit_2|25|1|SCREENING|2020-09-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|4|IRV|Inspiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|[?]|U/g|[?]|1|PELLET|PERITONEAL CAVITY|LEFT|ROSTRAL|IMMUNODIFFUSION||Y||ADJUDICATION COMMITTEE|ONCOLOGIST|2|Visit_2|25|5|TREATMENT|2020-09-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|5|MEP|Maximal Expiratory Pressure|[?]|SITTING|||[?]|1|g/L|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|UNILATERAL|INTERMEDIATE|SEQUENCING|Y||Y|SIBLING|PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SUPINE|[?]|/ms|[?]|1|pmol/day|SUBLINGUAL REGION|BILATERAL|SURFACE|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||INDEPENDENT ASSESSOR|RADIOLOGIST 2|3|Visit_3|40|2|WASHOUT|2020-09-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|7|SRAW|Specific Airway Resistance|[?]|UNCONSTRAINED|||[?]|1|pg/L|L1 VERTEBRA|CONTRALATERAL|FORE|LEAD CITRATE STAIN|||Y|SPOUSE|CARDIOLOGIST|4|Visit_4|65|5|TREATMENT|2020-10-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|8|DLCOPP|Percent Predicted DLCO|[?]|UNCONSTRAINED|||[?]|1|g/kg|PULMONARY VALVE, LEFT CUSP|CONTRALATERAL|PROXIMAL|CRYOSCOPY|Y||Y|HEALTH CARE PROFESSIONAL|READER|4|Visit_4|65|7|WASHOUT|2020-10-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|9|TSUELAS|Tissue Elastance|[?]|PRONE|[?]|ohm|[?]|1|SACHET|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|LEFT|BASAL|PERIPHERAL ANGIOGRAPHY|Y|Y||SIBLING|ADJUDICATOR 1|5|Visit_5|90|3|TREATMENT|2020-11-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|050c12d2-cf9f-402b-9332-d6a9771ed115|10|TVPP|Percent Predicted Tidal Volume|[?]|LEFT LATERAL DECUBITUS|[?]|/VF|[?]|1|mmHg/sec|PISIFORM BONE|BILATERAL|FORE|PLAQUE REDUCTION NEUTRALIZATION ASSAY|Y|Y||PROXY|PATHOLOGIST 2|5|Visit_5|90|4|FOLLOW-UP|2020-11-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|1|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|[?]|10^6/g|[?]|1|nsec|COLON, RIGHT|IPSILATERAL|DISTAL VOLAR|VIRUS PLAQUE ASSAY||Y||SPOUSE|RADIOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-10-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|2|TLC|Total Lung Capacity|[?]|TRENDELENBURG|[?]|mgEq|[?]|1|Weber|PATELLA|UNILATERAL|LOWER|CONTRAST ENHANCED X-RAY||||FAMILY MEMBER|FORENSIC PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-10-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|3|TV|Tidal Volume|[?]|SUPINE|[?]|AFU|[?]|1|mL/100g/min|KNEE JOINT|LEFT|FRONTAL|ROMANOWSKY STAIN|Y|||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|4|IC|Inspiratory Capacity|[?]|PRONE|||[?]|1|uSiemens|INTERPHALANGEAL THUMB JOINT|IPSILATERAL|DORSAL|TEST STRIP|Y||Y|PARENT|RATER|2|Visit_2|25|6|SCREENING|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|ks|[?]|1|MdFI|PROCERUS MUSCLE|CONTRALATERAL|PROXIMAL|LIQUID SCINTILLATION COUNTING||||SPOUSE|PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|6|SRAW|Specific Airway Resistance|[?]|FOWLERS|[?]|nkat/L|[?]|1|g/U|DISTAL INTERPHALANGEAL JOINT 5|IPSILATERAL|LOWER|FREEZING POINT DEPRESSION||||CLINICAL STUDY SPONSOR|MICROSCOPIST 3|3|Visit_3|40|4|SCREENING|2020-11-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|7|EFFIND|Effusion Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|mL/cage/wk|[?]|1|Bq/mL|SUPERFICIAL LYMPH NODE|CONTRALATERAL|TIP|STATIC PERIMETRY||||PROXY|RATER 1|4|Visit_4|65|7|TREATMENT|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|8|INFLTIND|Infiltrates Indicator|[?]|DECUBITUS|[?]|BAR|[?]|1|nmol/mol|BLADDER, NECK|IPSILATERAL|UPPER FLEXOR SURFACE|FLUORESCENCE ANGIOGRAPHY|Y|||PROXY|PATHOLOGIST|4|Visit_4|65|1|SCREENING|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-19
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|9|RV|Residual Volume|[?]|STANDING|||[?]|1|Anson U|RIB 1|CONTRALATERAL|UPPER FLEXOR SURFACE|URANYL ACETATE STAIN|||Y|SIGNIFICANT OTHER|ADJUDICATOR|5|Visit_5|90|5|FOLLOW-UP|2021-01-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|2f1073e4-607f-423f-a5de-f531b828e2d3|10|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|mmol/L|[?]|1|/LSQN|SCAPHOID-LUNATE JOINT|LATERAL|ANTEROPOSTERIOR|PUPILLOMETRY||||FRIEND|NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2021-01-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|df466903-3212-4e73-bff0-a183447c7408|1|MEP|Maximal Expiratory Pressure|[?]|LEFT LATERAL DECUBITUS|||[?]|1|umol/h/mmol|PERIANAL REGION|CONTRALATERAL|PERIVENTRICULAR|CRYOSCOPY|||Y|CHILD|ADJUDICATOR 1|1|Visit_1|10|7|WASHOUT|2020-11-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|RE|df466903-3212-4e73-bff0-a183447c7408|2|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING|[?]|mL/cm H2O|[?]|1|Watt|ANAL VERGE|BILATERAL|MIDLINE|RYAN BLUE STAIN|Y|||INVESTIGATOR|RADIOLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-11-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|RE|df466903-3212-4e73-bff0-a183447c7408|3|TV|Tidal Volume|[?]|PRONE|[?]|mEq/kg|[?]|1|cmH2O*s2/mL|TRAPEZIUM-TRAPEZOID JOINT|RIGHT|POSTERIOR|PHOTOGRAPHY||||SIGNIFICANT OTHER|RATER 1|2|Visit_2|25|5|SCREENING|2020-11-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|df466903-3212-4e73-bff0-a183447c7408|4|AWVOLPP|Percent Predicted Airway Volume|[?]|SEMI-RECUMBENT|[?]|Arbitrary U|[?]|1|lx|PRECUNEUS|IPSILATERAL|FRONTAL|KLEIHAUER-BETKE||||VENDOR|HEMATOLOGIST|2|Visit_2|25|1|TREATMENT|2020-11-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-31
e|RE|df466903-3212-4e73-bff0-a183447c7408|5|SAWVOL|Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|aMFI|[?]|1|g/animal/day|NAIL|RIGHT|UPPER EXTENSOR SURFACE|ENZYMATIC ULTRACENTRIFUGATION||||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|WASHOUT|2020-12-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|df466903-3212-4e73-bff0-a183447c7408|6|VO2|Oxygen Consumption|[?]|STANDING|||[?]|1|Newton|GASTROESOPHAGEAL JUNCTION|BILATERAL|FACIAL|CONTRAST ENHANCED MRI|Y||Y|CAREGIVER|CLINICAL PATHOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-12-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|df466903-3212-4e73-bff0-a183447c7408|7|EFFIND|Effusion Indicator|[?]|REVERSE TRENDELENBURG|[?]|pmol/L|[?]|1|/100 WBC|FUNDUS OF THE EYE|LATERAL|MEDIAL|REVERSE TRANSCRIPTASE PCR|Y|||INVESTIGATOR|NEUROLOGIST 2|4|Visit_4|65|4|SCREENING|2020-12-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|df466903-3212-4e73-bff0-a183447c7408|8|FRC|Functional Residual Capacity|[?]|DECUBITUS|[?]|mEq/day|[?]|1|CARTRIDGE|OBTURATOR EXTERNUS MUSCLE|RIGHT|PROXIMAL|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|||CAREGIVER|UROLOGIST|4|Visit_4|65|7|TREATMENT|2020-12-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|df466903-3212-4e73-bff0-a183447c7408|9|LOBVOL|Lobar Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|ukat|C4 VERTEBRA|CONTRALATERAL|INFERIOR|PELLI-ROBSON EYE CHART|||Y|CHILD|OTOLARYNGOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|df466903-3212-4e73-bff0-a183447c7408|10|ALVVOL|Alveolar Volume|[?]|SLING|[?]|mmHg/sec|[?]|1|in|URETHRA, PROSTATIC|LEFT|DISTAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||INVESTIGATOR|READER|5|Visit_5|90|5|SCREENING|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|MALIND|Malignancy Indicator|[?]|STANDING, BENT FORWARD|[?]|MET*min|[?]|1|CAPLET|DIAPHRAGMATIC LYMPH NODE|LATERAL|HIND|WRIGHT-GIEMSA STAIN||||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-07-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|2|FEV3PP|Percent Predicted FEV3|[?]|STANDING, BENT FORWARD|[?]|PELLET|[?]|1|U/mg|KIDNEY, MEDULLA|LEFT|LOWER MEDIAL|ATOMIC ABSORPTION SPECTROMETRY||||SIGNIFICANT OTHER|RATER|1|Visit_1|10|4|TREATMENT|2020-07-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|3|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|[?]|mol/L|[?]|1|JAR|DISTAL INTERPHALANGEAL JOINT 4|LEFT|MEDIAL|SPIRAL CT||||STUDY SUBJECT|ADJUDICATOR 1|2|Visit_2|25|5|WASHOUT|2020-07-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|4|MALEVDES|Malignancy Evidence Description|[?]|RIGHT LATERAL DECUBITUS|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|g/day|PENIS, GLANS|RIGHT|MEDIAL|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|||CAREGIVER|OPHTHALMOLOGIST|2|Visit_2|25|5|SCREENING|2020-07-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|5|MALEVDES|Malignancy Evidence Description|[?]|STANDING|||[?]|1|mg/dL|INFRARENAL AORTA|CONTRALATERAL|SUPERFICIAL|VIRUS PLAQUE ASSAY|||Y|ADJUDICATOR|FORENSIC PATHOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-08-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|[?]|gtt|[?]|1|g/g|ESOPHAGUS, LOWER THIRD|RIGHT|LATERAL|TONOMETRY||||DOMESTIC PARTNER|ADJUDICATOR 2|3|Visit_3|40|1|TREATMENT|2020-08-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|7|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|||[?]|1|mL/dose|BRACHIAL VEIN|BILATERAL|ROSTRAL|MACRO BROTH DILUTION|||Y|STUDY SUBJECT|UROLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|8|FIFMAXPP|Percent Predicted FIFmax|[?]|FOWLERS|[?]|kIU|[?]|1|cd|TRUNK|UNILATERAL|LOWER FLEXOR SURFACE|QUANTITATIVE COMPUTED TOMOGRAPHY|Y|||INTERVIEWER|PATHOLOGIST 1|4|Visit_4|65|1|SCREENING|2020-09-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|9|FIF25|Forced Inspiratory Flow at 25%|[?]|LEFT LATERAL DECUBITUS|[?]|KIT|[?]|1|U/L|FEMORAL HEAD|UNILATERAL|INFERIOR|LEAD CITRATE STAIN||||INDEPENDENT ASSESSOR|READER|5|Visit_5|90|3|FOLLOW-UP|2020-10-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|10|PIF|Peak Inspiratory Flow|[?]|SITTING|||[?]|1|V|MEDIASTINUM, ANTERIOR|BILATERAL|SURFACE|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y|Y|GUARDIAN|HEMATOLOGIST|5|Visit_5|90|6|WASHOUT|2020-10-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|LCI|Lung Clearance Index|[?]|SEMI-FOWLERS|[?]|mL/cm H2O|[?]|1|mg/m2/day|TIBIAL-CRURAL PERIPHERAL ARTERY|BILATERAL|TIP|AUTOREFRACTION|Y|Y||PARENT|RATER|1|Visit_1|10|2|FOLLOW-UP|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|2|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|[?]|IU/kg|[?]|1|g/animal|STERNOCLAVICULAR JOINT|BILATERAL|INTERMEDIATE|LEAD CITRATE STAIN||||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-13
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|EID 50/mL|[?]|1|IMPLANT|AORTIC ARCH|LATERAL|DEEP|CISH||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|6|FOLLOW-UP|2020-08-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|4|MALIND|Malignancy Indicator|[?]|TRENDELENBURG|[?]|cd*s/m2|[?]|1|ug/mol|BRAIN, PERIVENTRICULAR REGION|LEFT|DORSAL|NUCLEIC ACID HYBRIDIZATION|Y|||SPOUSE|CARDIOLOGIST|2|Visit_2|25|2|TREATMENT|2020-08-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|5|OXYPULSE|Oxygen Pulse|[?]|SEMI-FOWLERS|[?]|EP U|[?]|1|fmol/L|CAROTID ARTERY|RIGHT|MIDLINE|ETDRS EYE CHART||||FAMILY MEMBER|OPHTHALMOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|6|MIPPP|Percent Predicted MIP|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/min|[?]|1|ug/cm2|NASOPHARYNX|IPSILATERAL|ANTEROPOSTERIOR|PHOROPTER||Y||INDEPENDENT ASSESSOR|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-08-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|7|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|UNCONSTRAINED|[?]|ngEq/L|[?]|1|10^6/g|ABDUCENS NERVE|IPSILATERAL|PERIVENTRICULAR|TARGETED GENOME SEQUENCING||||ADJUDICATOR|RADIOLOGIST 2|4|Visit_4|65|4|FOLLOW-UP|2020-09-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|8|PCF|Peak Cough Flow|[?]|LEFT LATERAL DECUBITUS|[?]|tuberculin unit|[?]|1|pg/cell|HEPATIC ARTERY|LEFT|CRANIAL|AUSCULTATION||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|4|Visit_4|65|4|FOLLOW-UP|2020-09-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|U/kg/min|CEPHALIC VEIN|IPSILATERAL|INNER|PATHOLOGICAL EVALUATION|||Y|CHILD|ADJUDICATOR 1|5|Visit_5|90|6|WASHOUT|2020-10-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|c37df2f6-be8a-4709-b97d-061ab9754e0d|10|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|JAR|[?]|1|PNU/mL|ANTRUM PYLORI|IPSILATERAL|LOWER EXTENSOR SURFACE|ELLA||||STUDY SUBJECT|MICROSCOPIST 1|5|Visit_5|90|3|TREATMENT|2020-10-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|TGV|Thoracic Gas Volume|[?]|STANDING|[?]|cGy|[?]|1|%|STERNUM|UNILATERAL|PARIETO-OCCIPITAL|ICP-MS||Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-05-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|2|FVC|Forced Vital Capacity|[?]|SEMI-RECUMBENT|[?]|/4.0 mL|[?]|1|copies/uL|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|LEFT|POSTERIOR|VENTILATION PERFUSION LUNG SCAN|Y|||CLINICAL RESEARCH COORDINATOR|RATER 2|1|Visit_1|10|4|WASHOUT|2020-05-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|3|AWWVOL|Airway Wall Volume|[?]|FOWLERS|[?]|AU/mL|[?]|1|g/L|BICEPS FEMORIS MUSCLE|RIGHT|VENTROLATERAL|NEXT GENERATION TARGETED SEQUENCING|Y|||ADJUDICATOR|READER 1|2|Visit_2|25|3|FOLLOW-UP|2020-05-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|4|FEV1SVC|FEV1/SVC|[?]|TRENDELENBURG|[?]|RNA copies/mL|[?]|1|BEAM BREAKS|CARPOMETACARPAL JOINT 3|LEFT|DEEP|AUSCULTATION||||CAREGIVER|RATER|2|Visit_2|25|2|WASHOUT|2020-05-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|5|FEV6PP|Percent Predicted FEV6|[?]|SEMI-FOWLERS|||[?]|1|mg/mol|JEJUNUM|LEFT|LATERAL|RADIAL IMMUNODIFFUSION|Y|Y|Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|3|Visit_3|40|1|TREATMENT|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|uEq|[?]|1|g/day|SKIN AROUND THE MOUTH|RIGHT|FRONTAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||PROXY|ONCOLOGIST|3|Visit_3|40|3|WASHOUT|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|7|ICREV|IC Reversibility|[?]|REVERSE TRENDELENBURG|||[?]|1|g/g/day|GINGIVAL MUCOSA|UNILATERAL|SUPERIOR|HPLC|||Y|GUARDIAN|PATHOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|8|MALEVDES|Malignancy Evidence Description|[?]|SLING|[?]|F|[?]|1|STRIP|CARDIOVASCULAR SYSTEM|UNILATERAL|LOWER FLEXOR SURFACE|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|||CLINICAL STUDY SPONSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|4|SCREENING|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|9|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|[?]|10^3 organisms/mL|[?]|1|cs|EXTENSOR DIGITORUM BREVIS MUSCLE|CONTRALATERAL|PARIETO-OCCIPITAL|ULTRASOUND|Y|||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-18
e|RE|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|10|RRS|Total Respiratory System Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|Enzyme U/g Hb|[?]|1|MPL U/mL|URETHRA, ANTERIOR|UNILATERAL|INFERIOR|U-HPLC/MS/MS||||SPOUSE|HEMATOLOGIST|5|Visit_5|90|5|TREATMENT|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-18
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|1|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|tsp|[?]|1|MONTHS|PARATRACHEAL LYMPH NODE|LATERAL|INNER|SNELLEN EYE CHART||Y||INDEPENDENT ASSESSOR|UROLOGIST|1|Visit_1|10|3|SCREENING|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|2|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|||[?]|1|GPL U/mL|AORTOCAVAL LYMPH NODE|BILATERAL|ROSTRAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||Y|ADJUDICATOR|OTOLARYNGOLOGIST|1|Visit_1|10|5|SCREENING|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|Bq/kg|[?]|1|ug/L|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|UNILATERAL|BASAL|PELLI-ROBSON EYE CHART||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|7|FOLLOW-UP|2021-01-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|4|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING|[?]|mCi/kg|[?]|1|min|RETINA|UNILATERAL|MIDLINE|HEMAGGLUTINATION INHIBITION ASSAY|Y|||INDEPENDENT ASSESSOR|NEUROLOGIST 2|2|Visit_2|25|5|SCREENING|2021-01-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|5|FIFMAX|Maximum Forced Inspiratory Flow|[?]|PRONE|[?]|fmol|[?]|1|PFU/animal|PERITONEUM|LEFT|UPPER EXTENSOR SURFACE|IN SITU HYBRIDIZATION|Y|||SIBLING|READER 2|3|Visit_3|40|6|WASHOUT|2021-02-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|6|FEV1FVC|FEV1/FVC|[?]|SLING|[?]|IU/L|[?]|1|g/cage/day|TIBIA SHAFT|LEFT|PROXIMAL|OPHTHALMOSCOPY||||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|3|Visit_3|40|3|SCREENING|2021-02-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|7|SVC|Slow Vital Capacity|[?]|FOWLERS|||[?]|1|vg/mL|ANKLE MORTISE|LATERAL|DORSOLATERAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y||Y|CHILD|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|UNCONSTRAINED|[?]|/VF|[?]|1|Hz|BILE DUCT|RIGHT|INNER|ANTIMICROBIAL COMBINATION TESTING|Y|Y||SIBLING|RADIOLOGIST 2|4|Visit_4|65|1|TREATMENT|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|SLING|[?]|mCi/kg|[?]|1|NEEDLE GAUGE|METACARPAL 1 BASE|BILATERAL|PROXIMAL VOLAR|HILLMEN COLOR CHART||Y||INDEPENDENT ASSESSOR|ADJUDICATOR 3|5|Visit_5|90|1|SCREENING|2021-03-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|cec9e0ce-4d09-470c-9c26-df661d316a69|10|ERV|Expiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|[?]|APL U/mL|[?]|1|Ci/ug|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|BASAL|POLYGRAPHY||||CHILD|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|TREATMENT|2021-03-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|||[?]|1|MASK|PONS VAROLII|BILATERAL|ANTEROPOSTERIOR|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||Y|CHILD|READER 3|1|Visit_1|10|7|WASHOUT|2021-01-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|2|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|dpm/100mg|[?]|1|ECL unit|SEMINAL VESICLE|UNILATERAL|VENTRAL|ECHOCARDIOGRAPHY||||ADJUDICATOR|ONCOLOGIST 1|1|Visit_1|10|1|SCREENING|2021-01-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|UNCONSTRAINED|[?]|g/cm2|[?]|1|mV*min|ILEUM|LEFT|SUBCORTICAL|SINGLE-MOLECULE ARRAY||||FRIEND|NEUROLOGIST 1|2|Visit_2|25|2|TREATMENT|2021-02-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|4|RVPP|Percent Predicted Residual Volume|[?]|LEFT LATERAL DECUBITUS|[?]|MBq/uL|[?]|1|IU/mg|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|RIGHT|UPPER|ELLA||||FRIEND|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|5|TREATMENT|2021-02-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|5|EVC|Expiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|mPa|[?]|1|mL/s/m2|POPLITEAL ARTERY ABOVE KNEE|LATERAL|MIDLINE|SPECT SCAN||||HEALTH CARE PROFESSIONAL|READER 2|3|Visit_3|40|5|TREATMENT|2021-02-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|6|AWVOL|Airway Volume|[?]|STANDING|[?]|mg/m2|[?]|1|DRUM|GASTROCNEMIUS MUSCLE|RIGHT|FORE|HIGH RESOLUTION CT||||HEALTH CARE PROFESSIONAL|READER 3|3|Visit_3|40|6|TREATMENT|2021-02-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|7|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|[?]|10^9 organisms/g|[?]|1|km/h|DIAPHRAGMATIC LYMPH NODE|LEFT|BASAL|LIGHT MICROSCOPY||||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2021-03-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|PRONE|[?]|10^4/L|[?]|1|aMFI|ACCESSORY RENAL ARTERY|LATERAL|DEEP|PHOROPTER||||SIGNIFICANT OTHER|NEUROLOGIST 1|4|Visit_4|65|4|WASHOUT|2021-03-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|9|EFFIND|Effusion Indicator|[?]|LATERAL DECUBITUS|[?]|PFU/animal|[?]|1|umol/L/h|CARDIAC WALL|BILATERAL|PERIPHERAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|READER 2|5|Visit_5|90|7|FOLLOW-UP|2021-04-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|b98b4e19-51ac-40cc-80d5-cb6d8000c112|10|PEF|Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|IU/day|[?]|1|Ci/kg|LIVER LOBE|BILATERAL|HIND|IODINE STAIN||||ADJUDICATION COMMITTEE|ONCOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2021-04-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|U/mg|[?]|1|umol/mol|ANTERIOR INFERIOR CEREBELLAR ARTERY|LATERAL|ANTERIOR|DARK FIELD MICROSCOPY||||FAMILY MEMBER|NEUROLOGIST|1|Visit_1|10|6|TREATMENT|2020-07-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|2|QUASCOMP|Quasi-Static Compliance|[?]|FOWLERS|[?]|g/cage/wk|[?]|1|PIXELS/in|ANTERIOR INFERIOR CEREBELLAR ARTERY|RIGHT|CENTRAL|LASER CAPTURE MICRODISSECTION|Y|Y||PARENT|MICROSCOPIST|1|Visit_1|10|2|TREATMENT|2020-07-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|uV*sec|[?]|1|U/cL|HILAR|BILATERAL|DORSAL|SICKLE CELL SOLUBILITY TEST|Y|Y||INTERVIEWER|READER 2|2|Visit_2|25|4|TREATMENT|2020-07-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|4|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|[?]|TRANSDUCING UNIT|[?]|1|cmH2O*s2/mL|DUCTUS ARTERIOSUS|UNILATERAL|ROSTRAL|OLIGO ACGH|Y|||CAREGIVER|MICROSCOPIST|2|Visit_2|25|3|TREATMENT|2020-07-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|5|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|FOWLERS|||[?]|1|gpELISA unit/mL|GLENOID FOSSA|BILATERAL|ANTERIOR|MEDIASTINOSCOPY|||Y|VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|2|TREATMENT|2020-08-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|6|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|[?]|fg|[?]|1|HOURS|LEFT CIRCUMFLEX CORONARY ARTERY|CONTRALATERAL|FRONTAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|||SIBLING|READER|3|Visit_3|40|2|TREATMENT|2020-08-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|7|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|||[?]|1|mL/g/min|SUBMENTAL LYMPH NODE|UNILATERAL|PROXIMAL|FLUORIMETRY|||Y|SPOUSE|RADIOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|8|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|[?]|mEq/kg|[?]|1|MHz|MIDDLE PHALANX 5 OF THE HAND|LEFT|INFERIOR|THICK SMEAR||Y||SIGNIFICANT OTHER|ENDOCRINOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-08-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|9|PNEUMIND|Pneumonia Indicator|[?]|SLING|[?]|DRUM|[?]|1|um/day|LEFT VENTRICULAR MID ANTERIOR SEGMENT|IPSILATERAL|LOWER EXTENSOR SURFACE|SIZE EXCLUSION CHROMATOGRAPHY||Y||VENDOR|NEUROLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|RE|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|10|IRVPP|Percent Predicted IRV|[?]|LEFT LATERAL DECUBITUS|[?]|10^4 CFU|[?]|1|tuberculin unit/mL|THYMUS GLAND|CONTRALATERAL|APICAL|ELASTOGRAPHY|Y|Y||ADJUDICATION COMMITTEE|PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-09-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-30
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|MESF|[?]|1|breaths/30s|CLITORIS|IPSILATERAL|HIND|HPLC-UV||Y||CAREGIVER|PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-07-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|2|PNEUMIND|Pneumonia Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 organisms/g|[?]|1|m|PORTA HEPATIS LYMPH NODE|LATERAL|SUBCORTICAL|TRICHROME STAIN||Y||ADJUDICATOR|UROLOGIST|1|Visit_1|10|5|TREATMENT|2020-07-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|3|SVC|Slow Vital Capacity|[?]|STANDING|||[?]|1|10^9/L|TRICUSPID VALVE, SEPTAL CUSP|IPSILATERAL|ROSTRAL|ELECTROCHEMILUMINESCENCE||Y|Y|FAMILY MEMBER|PATHOLOGIST|2|Visit_2|25|5|SCREENING|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|4|FEV3PP|Percent Predicted FEV3|[?]|PRONE|[?]|mEq/mmol|[?]|1|pkat|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|IPSILATERAL|DISTAL VOLAR|KINETIC CHROMOGENIC ASSAY||||FRIEND|RADIOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-07-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|5|FEV3FVC|FEV3/FVC|[?]|SITTING|[?]|U/kg/day|[?]|1|10^3/L|GASTRIC CARDIA|UNILATERAL|LOWER EXTENSOR SURFACE|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||SIBLING|RATER 2|3|Visit_3|40|2|FOLLOW-UP|2020-08-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|PRONE|[?]|ugEq|[?]|1|mL/100g/min|AORTO-ILIAC PERIPHERAL ARTERY|IPSILATERAL|DORSOLATERAL|ANTIBIOTIC AGAR SCREEN||||GUARDIAN|READER|3|Visit_3|40|5|TREATMENT|2020-08-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|7|MEP|Maximal Expiratory Pressure|[?]|SLING|||[?]|1|10^7/L|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|LATERAL|ANTERIOR|PERIODIC ACID SCHIFF STAIN||Y|Y|STUDY SUBJECT|HEMATOLOGIST|4|Visit_4|65|2|TREATMENT|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|8|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|[?]|U/g/min|[?]|1|steps/min|METATARSOPHALANGEAL JOINT 5|RIGHT|ANTEROTEMPORAL|PULMONARY ANGIOGRAPHY|Y|||INTERVIEWER|MICROSCOPIST 2|4|Visit_4|65|6|TREATMENT|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|9|EFFVOL|Effusion Volume|[?]|SEMI-FOWLERS|[?]|10^5/L|[?]|1|ug/g/h|FIBULAR VEIN|BILATERAL|LOWER MEDIAL|IN VITRO GENE EXPRESSION ASSAY|Y|Y||CLINICAL STUDY SPONSOR|ADJUDICATOR|5|Visit_5|90|7|SCREENING|2020-09-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|4bc30b18-c8d8-41a3-91d5-33b8b064087b|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|ugEq|[?]|1|BU/mL|VENA CAVA|IPSILATERAL|OUTER|TURBIDIMETRY||||INTERVIEWER|READER 2|5|Visit_5|90|6|TREATMENT|2020-09-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|1|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|||[?]|1|breaths/30s|THORACIC LYMPH NODE|RIGHT|VENTROLATERAL|TOTAL BODY IRRADIATION|Y||Y|ADJUDICATOR|READER 2|1|Visit_1|10|6|TREATMENT|2020-11-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|2|RV|Residual Volume|[?]|PRONE|[?]|/10^4|[?]|1|mmHg*min/L|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|CONTRALATERAL|INNER|ENZYMATIC COLORIMETRY||||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|7|TREATMENT|2020-11-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|3|FEV1SVC|FEV1/SVC|[?]|LEFT LATERAL DECUBITUS|[?]|mmol|[?]|1|kV|PENIS, GLANS|LATERAL|TEMPORAL|ELLA||||SIBLING|MICROSCOPIST 2|2|Visit_2|25|4|FOLLOW-UP|2020-12-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|Tbsp|[?]|1|uIU/dL|INTERPHALANGEAL THUMB JOINT|BILATERAL|TEMPORAL|ANTIBIOTIC AGAR SCREEN|Y|||GUARDIAN|RATER 2|2|Visit_2|25|3|TREATMENT|2020-12-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|5|INTP|Interpretation|[?]|UNCONSTRAINED|[?]|Anson U|[?]|1|mL/beat|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LEFT|UPPER|TRANSTHORACIC ECHOCARDIOGRAPHY||||INVESTIGATOR|OTOLARYNGOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-12-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|6|IVC|Inspiratory Vital Capacity|[?]|SUPINE|[?]|SACHET|[?]|1|mAnson U/mL|LEPTOMENINGES|LATERAL|LOWER FLEXOR SURFACE|KINETIC CHROMOGENIC ASSAY||Y||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|3|Visit_3|40|7|WASHOUT|2020-12-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|7|IVC|Inspiratory Vital Capacity|[?]|SITTING|[?]|mg/mol|[?]|1|10^9 organisms/g|URETHRAL SPHINCTER|LEFT|DORSAL|INTRAVASCULAR ULTRASOUND|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|4|Visit_4|65|4|TREATMENT|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|8|VO2|Oxygen Consumption|[?]|SEMI-RECUMBENT|||[?]|1|BAG|ENTORHINAL CORTEX|BILATERAL|ROSTRAL|WHOLE TRANSCRIPTOME SEQUENCING||Y|Y|FAMILY MEMBER|ENDOCRINOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|9|IRV|Inspiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|[?]|SBE/mL|[?]|1|mEq/uL|ILIUM|UNILATERAL|CENTRAL|FLUORESCENT IMMUNOASSAY||Y||CLINICAL RESEARCH ASSOCIATE|UROLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-02-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|7ff27a70-0472-4cc1-b057-6b161ab29568|10|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|Hz/s|[?]|1|ug/g/day|PARIETAL LOBE|BILATERAL|PERIPHERAL|PYROSEQUENCING||||INVESTIGATOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|TREATMENT|2021-02-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|1|FIF50|Forced Inspiratory Flow at 50%|[?]|LATERAL DECUBITUS|[?]|mV*min|[?]|1|/100 HPFs|HYPOGLOSSAL NERVE|IPSILATERAL|MIDLINE|FLAME PHOTOMETRY||||INTERVIEWER|DERMATOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-06-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|2|ALVVOL|Alveolar Volume|[?]|REVERSE TRENDELENBURG|[?]|gMFI|[?]|1|anti-Xa IU/mL|TRAPEZOID-CAPITATE JOINT|RIGHT|UPPER|LEAD CITRATE STAIN||||CHILD|RATER 2|1|Visit_1|10|3|FOLLOW-UP|2020-06-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|STANDING|[?]|MET|[?]|1|fg|HYPOGLOSSAL NERVE|LATERAL|PROXIMAL VOLAR|PANENDOSCOPY||||INTERVIEWER|RATER 2|2|Visit_2|25|6|SCREENING|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|Hz|[?]|1|genEq/mL|SKIN OF THE CHIN|RIGHT|DISTAL|NEXT GENERATION SEQUENCING||Y||INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|5|PNEUMIND|Pneumonia Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|log EID 50/dose|[?]|1|fg|SUPRACLAVICULAR LYMPH NODE|RIGHT|TEMPORAL|JAEGER EYE CHART|Y|||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|6|PCF|Peak Cough Flow|[?]|REVERSE TRENDELENBURG|[?]|/VF|[?]|1|mg/m2/day|NAVICULAR BONE|LATERAL|OUTER|PATHOLOGICAL EVALUATION||Y||HEALTH CARE PROFESSIONAL|RATER 1|3|Visit_3|40|1|SCREENING|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|7|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING, LEGS DEPENDENT|||[?]|1|in|SACRAL VERTEBRA|LATERAL|INTERMEDIATE|DOUBLE IMMUNODIFFUSION|||Y|CHILD|ADJUDICATOR|4|Visit_4|65|4|WASHOUT|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|STANDING, BENT FORWARD|[?]|HEP|[?]|1|pm|OCCIPITAL SCALP|BILATERAL|POSTERIOR|NO INFORMATION|Y|||PARENT|PATHOLOGIST 1|4|Visit_4|65|5|SCREENING|2020-08-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-29
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|9|FEV1SVC|FEV1/SVC|[?]|SUPINE|[?]|CFU/g|[?]|1|mL/min|DIGIT|CONTRALATERAL|CRANIAL|FUNDUS PHOTOGRAPHY||||PROXY|INTERNIST|5|Visit_5|90|5|TREATMENT|2020-09-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|40529b01-9a80-4ada-a8df-96eec0e65043|10|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|/mm|LIP|UNILATERAL|LOWER EXTENSOR SURFACE|MECHANICAL CLOT DETECTION|||Y|CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-FOWLERS|[?]|SQU/mL|[?]|1|cd/m2|FEMORAL CONDYLE|LEFT|CAUDAL|PULSE OXIMETRY||||ADJUDICATION COMMITTEE|INTERNIST|1|Visit_1|10|3|TREATMENT|2020-12-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LATERAL DECUBITUS|[?]|mL/cage|[?]|1|Ejaculate U|BUTTOCK|UNILATERAL|LOWER FLEXOR SURFACE|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|1|Visit_1|10|5|TREATMENT|2020-12-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|3|FIV1PP|Percent Predicted FIV1|[?]|PRONE|[?]|NEBULE|[?]|1|MHz|DISTANT LYMPH NODE|LATERAL|MIDLINE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||FRIEND|OPHTHALMOLOGIST|2|Visit_2|25|5|TREATMENT|2020-12-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|4|FEV3FVC|FEV3/FVC|[?]|REVERSE TRENDELENBURG|[?]|uV2|[?]|1|fraction of 1|GASTROINTESTINAL TRACT, LOWER, WALL|LEFT|VENTRAL|TONOMETRY||||ADJUDICATION COMMITTEE|ADJUDICATOR|2|Visit_2|25|4|SCREENING|2020-12-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|5|FEF50|Forced Expiratory Flow 50%|[?]|DECUBITUS|||[?]|1|PFU/animal|PERIPHERAL NERVE|IPSILATERAL|PERIPHERAL|AUTOMATED COUNT|||Y|NON-HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|3|Visit_3|40|2|TREATMENT|2021-01-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|6|FVC|Forced Vital Capacity|[?]|FOWLERS|[?]|U/mmol|[?]|1|genEq/mL|BRACHIAL VEIN|LEFT|CAUDAL|NUCLEAR RADIOLOGY||||CHILD|PHYSIOTHERAPIST|3|Visit_3|40|6|FOLLOW-UP|2021-01-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|7|FIV1PP|Percent Predicted FIV1|[?]|SEMI-FOWLERS|[?]|cycle/min|[?]|1|HOURS|TALUS|LATERAL|PROXIMAL VOLAR|PERFUSION MRI||Y||HEALTH CARE PROFESSIONAL|ONCOLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|8|PLMBLFLW|Pulmonary Blood Flow|[?]|TRENDELENBURG|[?]|mmol/min/kPa/L|[?]|1|pL|GLOBUS PALLIDUS|LATERAL|NASAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|4|Visit_4|65|5|FOLLOW-UP|2021-01-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|9|TSUELAS|Tissue Elastance|[?]|STANDING|[?]|GPL U|[?]|1|/cmH2O|NASOPHARYNX|RIGHT|ANTEROLATERAL|RIA||Y||CLINICAL STUDY SPONSOR|READER 2|5|Visit_5|90|4|TREATMENT|2021-02-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|f3e22efc-0948-4c6e-9173-8e284d342d33|10|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|/4.0 mL|[?]|1|BLOCKS|SCAPHOID-TRAPEZOID JOINT|BILATERAL|LOWER MEDIAL|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|||FRIEND|RATER 2|5|Visit_5|90|7|FOLLOW-UP|2021-02-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|g/m2|[?]|1|10^3 CFU/g|LESSER TROCHANTER|BILATERAL|ANTEROTEMPORAL|MECHANICAL CLOT DETECTION||Y||INTERVIEWER|CARDIOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|2|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|[?]|gMFI|[?]|1|mg/min|SUPRACLAVICULAR LYMPH NODE|RIGHT|DORSOLATERAL|BALLPOINT PEN TECHNIQUE|Y|||CAREGIVER|MICROSCOPIST 1|1|Visit_1|10|3|WASHOUT|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|3|IRVPP|Percent Predicted IRV|[?]|PRONE|[?]|Sv|[?]|1|tuberculin unit/mL|HUMERAL EPICONDYLE|UNILATERAL|DEEP|SPECT/CT SCAN||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|2|Visit_2|25|6|TREATMENT|2020-10-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|4|IVCPP|Percent Predicted IVC|[?]|SLING|||[?]|1|EID 50/dose|PRONATOR QUADRATUS MUSCLE|CONTRALATERAL|UPPER EXTENSOR SURFACE|NEPHELOMETRY||Y|Y|SPOUSE|RATER 1|2|Visit_2|25|1|FOLLOW-UP|2020-10-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|5|INTP|Interpretation|[?]|STANDING|[?]|Ci/kg|[?]|1|IMPLANT|HAMSTRING MUSCLE|RIGHT|SURFACE|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||INVESTIGATOR|CLINICAL PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-10-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|[?]|log10 TCID 50/mL|[?]|1|dmol|POSTERIOR TIBIAL ARTERY|BILATERAL|LATERAL|HPLC/MS|Y|||SPOUSE|RATER|3|Visit_3|40|6|WASHOUT|2020-10-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-07
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|7|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|vp/mL|[?]|1|Ci/uL|JEJUNUM|LATERAL|HIND|JAEGER EYE CHART||||VENDOR|RADIOLOGIST 1|4|Visit_4|65|2|SCREENING|2020-11-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|8|FEV1FVC6|FEV1/FVC6|[?]|DECUBITUS|[?]|NEEDLE GAUGE|[?]|1|Absorbance U|PULMONARY VALVE|IPSILATERAL|ANTEROMEDIAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||SIBLING|READER 2|4|Visit_4|65|3|TREATMENT|2020-11-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|9|FEV1FVC|FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|BAU|[?]|1|umol/mg/min|METACARPOPHALANGEAL JOINT 1|IPSILATERAL|SURFACE|DC SHEATH FLOW||||VENDOR|CLINICAL PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2020-12-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|919eb5b4-a3df-41c6-86f7-c78501bb4335|10|MEPPP|Percent Predicted MEP|[?]|SLING|[?]|mg|[?]|1|pmol/L|RIB 6|UNILATERAL|MEDIAL|CT SCAN WITHOUT CONTRAST||||FAMILY MEMBER|OPHTHALMOLOGIST|5|Visit_5|90|6|TREATMENT|2020-12-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|1|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|PIPE|[?]|1|Sv|PERIPHERAL NERVE|BILATERAL|INTERMEDIATE|FREEZING POINT DEPRESSION||||STUDY SUBJECT|RATER|1|Visit_1|10|3|WASHOUT|2020-07-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|2|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|GPS U|[?]|1|EVENTS|AORTOCAVAL LYMPH NODE|BILATERAL|ANTEROMEDIAL|POLYMERASE CHAIN REACTION||Y||ADJUDICATOR|MICROSCOPIST|1|Visit_1|10|2|TREATMENT|2020-07-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|3|IVCPP|Percent Predicted IVC|[?]|SEMI-RECUMBENT|[?]|mg/kg|[?]|1|amol|ABDOMINAL AORTA|UNILATERAL|CAUDAL|TRANSMISSION ELECTRON MICROSCOPY||Y||FAMILY MEMBER|ADJUDICATOR 3|2|Visit_2|25|6|TREATMENT|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|g|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|CONTRALATERAL|CENTRAL|ETDRS EYE CHART|||Y|DOMESTIC PARTNER|PHYSIOTHERAPIST|2|Visit_2|25|5|WASHOUT|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|5|RAW|Airway Resistance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pmol/day|NUCHAL LYMPH NODE|IPSILATERAL|CENTRAL|CONTRAST ENHANCED X-RAY|||Y|FAMILY MEMBER|PATHOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-08-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|6|MALIND|Malignancy Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/L/min|[?]|1|FEU|HAND|BILATERAL|ANTEROLATERAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|||PROXY|FORENSIC PATHOLOGIST|3|Visit_3|40|3|WASHOUT|2020-08-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|7|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|days/wk|[?]|1|CAPLET|FUNDUS OF THE STOMACH|IPSILATERAL|INFERIOR|BIOIMPEDANCE SPECTROSCOPY||||INVESTIGATOR|PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-09-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|LEFT LATERAL DECUBITUS|[?]|mL/cage/day|[?]|1|uCi/kg|ILEUM|UNILATERAL|SUBCORTICAL|PAP STAIN|Y|||VENDOR|READER|4|Visit_4|65|4|TREATMENT|2020-09-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|YEARS|[?]|1|kg/m2|BUTTOCK|IPSILATERAL|SUPERFICIAL|CARDIAC THERMODILUTION|Y|||PROXY|NEUROLOGIST 2|5|Visit_5|90|1|WASHOUT|2020-10-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|f918d6e0-6fc2-4303-b323-521c5d531773|10|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|[?]|U/dL|[?]|1|mol/g|CORNEAL STROMA|UNILATERAL|PARIETO-OCCIPITAL|TARGETED TRANSCRIPTOME SEQUENCING||Y||ADJUDICATION COMMITTEE|ADJUDICATOR|5|Visit_5|90|1|SCREENING|2020-10-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|[?]|mmHg/L/min|[?]|1|mCi/kg|PYLORIC SPHINCTER|IPSILATERAL|CAUDAL|EEG||||PROXY|RADIOLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-11-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|2|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|CONTAINER|[?]|1|mL/kg|HAMATE BONE|RIGHT|FORE|HPLC/MS/MS||||CHILD|ADJUDICATOR 1|1|Visit_1|10|3|SCREENING|2020-11-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|3|INTP|Interpretation|[?]|REVERSE TRENDELENBURG|[?]|nmol BCE/mmol|[?]|1|mL*cmH2O|FINGER FLEXOR TENDONS|CONTRALATERAL|PERIPHERAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|2|Visit_2|25|5|TREATMENT|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|4|OXYPULSE|Oxygen Pulse|[?]|TRENDELENBURG|[?]|uU/L|[?]|1|cycle/min|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|UNILATERAL|SUPERFICIAL|SPIRAL CT||||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|2|Visit_2|25|1|SCREENING|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|5|FEV1REV|FEV1 Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|10^9 organisms|[?]|1|ng/day|SKIN OF THE CHIN|LEFT|INTERMEDIATE|DIGITAL PCR||||SIBLING|NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2020-12-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|SITTING, LEGS DEPENDENT|[?]|min*mg/mL|[?]|1|PACKAGE|PARA-AORTIC LYMPH NODE|IPSILATERAL|ANTEROPOSTERIOR|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|||SPOUSE|PHYSIOTHERAPIST|3|Visit_3|40|1|TREATMENT|2020-12-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|7|EXPRELTM|Expiration Relaxation Time|[?]|REVERSE TRENDELENBURG|[?]|CAPFUL|[?]|1|PACKET|THYMUS GLAND|RIGHT|MEDIAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||Y||GUARDIAN|MICROSCOPIST|4|Visit_4|65|5|TREATMENT|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|8|PCF|Peak Cough Flow|[?]|FOWLERS|[?]|Siemens|[?]|1|mJoule/cm2|MOTOR CORTEX|CONTRALATERAL|CAUDAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||Y||PARENT|ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|9|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|RATIO|[?]|1|gpELISA unit/mL|PROXIMAL CIRCUMFLEX ARTERY|UNILATERAL|LOWER MEDIAL|FLUORESCENT MICROSCOPY||Y||INTERVIEWER|MICROSCOPIST|5|Visit_5|90|3|WASHOUT|2021-02-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|10|FIF75|Forced Inspiratory Flow at 75%|[?]|TRENDELENBURG|[?]|oz eq|[?]|1|U/kg/h|OLFACTORY MUCOSA|RIGHT|SUPERFICIAL|SPECT/CT SCAN||||ADJUDICATION COMMITTEE|HEMATOLOGIST|5|Visit_5|90|2|WASHOUT|2021-02-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|EXPRELTM|Expiration Relaxation Time|[?]|SITTING|[?]|BOX|[?]|1|mL/breath|ILEUM LYMPH NODE|LEFT|VENTRAL|AUTOMATED COUNT||||HEALTH CARE PROFESSIONAL|READER 3|1|Visit_1|10|2|SCREENING|2020-06-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|2|FIFMAXPP|Percent Predicted FIFmax|[?]|PRONE|[?]|mU/g|[?]|1|U/g/h|CORNEAL EPITHELIUM|LEFT|ANTEROTEMPORAL|PERFUSION MRI||||PARENT|RATER 2|1|Visit_1|10|5|TREATMENT|2020-06-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|3|FIO2|Fraction of Inspired Oxygen|[?]|LEFT LATERAL DECUBITUS|[?]|cycle/min|[?]|1|/4.0 mL|ACCESSORY RENAL ARTERY|LATERAL|VENTRAL|PANENDOSCOPY||Y||CLINICAL STUDY SPONSOR|NEUROLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-07-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|4|FEV1FVC6|FEV1/FVC6|[?]|SITTING|[?]|BOX|[?]|1|PELLET|RESPIRATORY SYSTEM|RIGHT|PARIETO-OCCIPITAL|DIRECT SEQUENCING||||VENDOR|RADIOLOGIST|2|Visit_2|25|4|WASHOUT|2020-07-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|5|PEFTIME|Peak Expiratory Flow Time|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/g/min|[?]|1|BE/mL|MESENTERY|IPSILATERAL|MIDLINE|MRI WITHOUT CONTRAST||||CHILD|ONCOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-07-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|6|PCF|Peak Cough Flow|[?]|SLING|[?]|mL/m2/day|[?]|1|SQU/mL|SACRAL VERTEBRA|RIGHT|LOWER EXTENSOR SURFACE|MULTI-SLICE SPIRAL CT||||VENDOR|ADJUDICATOR|3|Visit_3|40|6|FOLLOW-UP|2020-07-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|7|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|TRENDELENBURG|[?]|ug/m2/day|[?]|1|g/dL|COLON, RECTOSIGMOID|CONTRALATERAL|VENTRAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||VENDOR|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|/VF|[?]|1|ug/L/h|T5 VERTEBRA|UNILATERAL|ANTEROTEMPORAL|POPULATION SEQUENCING||||ADJUDICATION COMMITTEE|RADIOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-17
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-RECUMBENT|||[?]|1|g/cage/day|GASTRIC CARDIA|RIGHT|CRANIAL|FLUORESCENT SPOT TEST|Y||Y|INVESTIGATOR|READER|5|Visit_5|90|1|TREATMENT|2020-09-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|4b1e011f-a16d-4ff6-902d-451d5d13ee97|10|AWWVOL|Airway Wall Volume|[?]|DECUBITUS|||[?]|1|Mile|NOSTRIL|BILATERAL|HIND|TRANSMISSION ELECTRON MICROSCOPY||Y|Y|GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-RECUMBENT|[?]|HEP|[?]|1|ukat/L|THALAMUS|BILATERAL|ROSTRAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||DOMESTIC PARTNER|NEUROLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|2|GAW|Airway Conductance|[?]|FOWLERS|[?]|10^6/g|[?]|1|10^6 organisms|PORTAL LYMPH NODE|UNILATERAL|SUPERFICIAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y||PARENT|NEUROLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|3|FVC6|Forced Vital Capacity in 6 Seconds|[?]|FOWLERS|[?]|mL/(min*100mL)|[?]|1|10^6/g|ABDOMINAL WALL|UNILATERAL|DORSAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||VENDOR|READER 3|2|Visit_2|25|2|FOLLOW-UP|2020-08-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|4|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|ELISA unit|[?]|1|U/kg|POSTEROLATERAL SEGMENTAL ARTERY|BILATERAL|VENTRAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y||PROXY|PHYSIOTHERAPIST|2|Visit_2|25|1|WASHOUT|2020-08-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|5|INERTANC|Inertance|[?]|DECUBITUS|||[?]|1|mL/kg|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|CONTRALATERAL|INTERMEDIATE|NO INFORMATION||Y|Y|HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|3|Visit_3|40|5|SCREENING|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|SUPINE|[?]|days/wk|[?]|1|GPL U|L4 VERTEBRA|CONTRALATERAL|PROXIMAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||CLINICAL STUDY SPONSOR|READER 1|3|Visit_3|40|4|TREATMENT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|7|AWVOL|Airway Volume|[?]|FOWLERS|||[?]|1|mmHg|HEART|CONTRALATERAL|ROSTRAL|RADIOGRAPHY|||Y|SIGNIFICANT OTHER|RADIOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-09-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|8|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LATERAL DECUBITUS|||[?]|1|gMFI|SCAPHOID-RADIUS JOINT|LATERAL|ANTEROTEMPORAL|TRANSVAGINAL ULTRASOUND|||Y|SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|1|TREATMENT|2020-09-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|mg/kg/week|[?]|1|uEq/L|SUDORIFEROUS GLAND|LEFT|ANTEROLATERAL|FREEZING POINT DEPRESSION|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST 2|5|Visit_5|90|3|WASHOUT|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|10|TGV|Thoracic Gas Volume|[?]|PRONE|[?]|DROP|[?]|1|F|INFERIOR PUBIC RAMUS|IPSILATERAL|OUTER|CALIPER MEASUREMENT METHOD||||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|um|[?]|1|10^4 CFU|JAW|LATERAL|APICAL|DIGITAL PCR||||STUDY SUBJECT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|7|TREATMENT|2020-11-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|UNCONSTRAINED|||[?]|1|mol/day|TRIGEMINAL NERVE|IPSILATERAL|PROXIMAL|HILLMEN COLOR CHART|||Y|STUDY SUBJECT|RADIOLOGIST 2|1|Visit_1|10|3|SCREENING|2020-11-27|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|3|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|||[?]|1|SFC/10^6 PBMC|HAIR|RIGHT|ROSTRAL|THIN SMEAR|||Y|ADJUDICATOR|NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2020-12-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|4|PCF|Peak Cough Flow|[?]|FOWLERS|[?]|10^3 organisms|[?]|1|AU/mL|BRAIN VENTRICLE, LATERAL|RIGHT|ANTEROMEDIAL|SPECTROPHOTOMETRY||Y||ADJUDICATOR|PHYSIOTHERAPIST|2|Visit_2|25|5|SCREENING|2020-12-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|5|FIV1PP|Percent Predicted FIV1|[?]|RIGHT LATERAL DECUBITUS|[?]|10^3/L|[?]|1|g/animal/wk|GASTROESOPHAGEAL JUNCTION|BILATERAL|SUBCORTICAL|HPLC-FL||||FRIEND|CARDIOLOGIST|3|Visit_3|40|7|TREATMENT|2020-12-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|6|MEP|Maximal Expiratory Pressure|[?]|REVERSE TRENDELENBURG|||[?]|1|ms/mmHg|MITRAL VALVE, ANTERIOR ANNULUS|CONTRALATERAL|MEDIAL|CALCULATION|||Y|CAREGIVER|ONCOLOGIST|3|Visit_3|40|2|SCREENING|2020-12-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|umol|[?]|1|/LSQN|BLADDER, TRIGONE|CONTRALATERAL|UPPER EXTENSOR SURFACE|CONGO RED STAIN||Y||INDEPENDENT ASSESSOR|INTERNIST|4|Visit_4|65|3|SCREENING|2021-01-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|8|RAWPP|Percent Predicted Airway Resistance|[?]|LEFT LATERAL DECUBITUS|||[?]|1|CARTRIDGE|BRACHIOCEPHALIC ARTERY|LEFT|ANTEROTEMPORAL|CINEANGIOGRAPHY|Y||Y|FAMILY MEMBER|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2021-01-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|9|AIRTRAP|Air Trapping|[?]|SUPINE|[?]|EP U|[?]|1|Osm|TROCHANTER|IPSILATERAL|SUBCORTICAL|ELISA|Y|||CHILD|READER|5|Visit_5|90|5|TREATMENT|2021-02-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|10|IRV|Inspiratory Reserve Volume|[?]|UNCONSTRAINED|[?]|pg/dL|[?]|1|Ci/mL|FOOT|BILATERAL|FRONTAL|RULER MEASUREMENT METHOD||Y||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|5|Visit_5|90|4|TREATMENT|2021-02-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|MEPPP|Percent Predicted MEP|[?]|SUPINE|||[?]|1|mmHg/sec|EYE|BILATERAL|NASAL|ENDPOINT DILUTION ASSAY|||Y|FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|2|INFLTIND|Infiltrates Indicator|[?]|SITTING|[?]|tsp|[?]|1|10^4/L|SHIN|UNILATERAL|LOWER FLEXOR SURFACE|SMEAR||Y||FRIEND|NEUROLOGIST 1|1|Visit_1|10|1|WASHOUT|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|3|SALKK|Salazar-Knowles Equation, K|[?]|REVERSE TRENDELENBURG|[?]|/kg|[?]|1|RATIO|SKIN OF THE LIP|CONTRALATERAL|NASAL|MACRO BROTH DILUTION||||ADJUDICATOR|NEUROLOGIST|2|Visit_2|25|5|WASHOUT|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|[?]|L/h/m2|[?]|1|Ci/g|PERIHILAR LYMPH NODE|LEFT|DISTAL|PHOTOMETRIC CLOT DETECTION||||STUDY SUBJECT|MICROSCOPIST 1|2|Visit_2|25|2|SCREENING|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|5|FIV1PP|Percent Predicted FIV1|[?]|DECUBITUS|||[?]|1|AFU|GALLBLADDER|BILATERAL|DISTAL VOLAR|LANDOLT RING|||Y|GUARDIAN|INTERNIST|3|Visit_3|40|3|TREATMENT|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|6|RV|Residual Volume|[?]|PRONE|[?]|vg/mL|[?]|1|mAmp|BASAL GANGLIA|LATERAL|VENTRAL|TEMPLATE INCISION METHOD||Y||FAMILY MEMBER|ENDOCRINOLOGIST|3|Visit_3|40|5|TREATMENT|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|7|EFFVOL|Effusion Volume|[?]|STANDING, BENT FORWARD|[?]|genEq|[?]|1|BLOCKS|METATARSOPHALANGEAL JOINT 3|IPSILATERAL|DORSOLATERAL|MAPH||||FRIEND|READER 2|4|Visit_4|65|2|TREATMENT|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|8|SALKK|Salazar-Knowles Equation, K|[?]|STANDING|[?]|mg/dL|[?]|1|damol/L|HEAD AND NECK|BILATERAL|OUTER|DOUBLE IMMUNODIFFUSION||||STUDY SUBJECT|RATER|4|Visit_4|65|5|WASHOUT|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|9|FRC|Functional Residual Capacity|[?]|PRONE|[?]|ukat/10^12 RBC|[?]|1|nmol|EAR, INNER|LATERAL|HIND|BIOPSY||Y||ADJUDICATOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|WASHOUT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|10|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|||[?]|1|10^6 CFU/g|KIDNEY, MEDULLA|LATERAL|UPPER FLEXOR SURFACE|INTERRUPTER TECHNIQUE|||Y|STUDY SUBJECT|HEMATOLOGIST|5|Visit_5|90|4|TREATMENT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|FOWLERS|[?]|PELLET|[?]|1|gMFI|EYE, ANTERIOR CHAMBER|UNILATERAL|VENTROLATERAL|PHOTOMETRY||Y||ADJUDICATION COMMITTEE|HEMATOLOGIST|1|Visit_1|10|5|WASHOUT|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|2|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|REVERSE TRENDELENBURG|[?]|mmol/day|[?]|1|mmHg*min/L|CEREBRAL SUBCORTEX|RIGHT|INFERIOR|ACCELERATOR MASS SPECTROMETRY||Y||ADJUDICATOR|RATER 2|1|Visit_1|10|1|WASHOUT|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|3|LOBVOL|Lobar Volume|[?]|SEMI-FOWLERS|[?]|copies/uL|[?]|1|10^3/hpf|PRESACRAL LYMPH NODE|LATERAL|INFERIOR|WESTERN BLOT||Y||PROXY|ENDOCRINOLOGIST|2|Visit_2|25|7|WASHOUT|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|4|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|[?]|Ci/mg|[?]|1|cL|LIGAMENT|LATERAL|UPPER FLEXOR SURFACE|OPTICAL MAPPING|Y|||CLINICAL RESEARCH ASSOCIATE|READER 2|2|Visit_2|25|7|SCREENING|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|IU/dL|[?]|1|10^11/L|THORACIC SPINE|UNILATERAL|ANTEROTEMPORAL|SLIT LAMP PHOTOGRAPHY||||ADJUDICATION COMMITTEE|READER 2|3|Visit_3|40|4|TREATMENT|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|6|FVC|Forced Vital Capacity|[?]|SLING|[?]|/sec|[?]|1|amu|SUPRACLAVICULAR FOSSA|UNILATERAL|APICAL|AURAMINE STAIN||||PROXY|PATHOLOGIST 2|3|Visit_3|40|5|SCREENING|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|7|ERVPP|Percent Predicted ERV|[?]|LATERAL DECUBITUS|[?]|mg/mL/min|[?]|1|10^6 IU/mL|TOE|RIGHT|SUPERIOR|SPIRAL CT SCAN WITHOUT CONTRAST||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|WASHOUT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SITTING|[?]|mmol/day|[?]|1|nL|ENDOMETRIUM|BILATERAL|TIP|NEXT GENERATION SEQUENCING||Y||CAREGIVER|READER|4|Visit_4|65|3|WASHOUT|2020-08-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|9|FIF75|Forced Inspiratory Flow at 75%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Bq/L|ILIUM|UNILATERAL|UPPER|ZIEHL NEELSEN ACID FAST STAIN|||Y|PROXY|CARDIOLOGIST|5|Visit_5|90|2|WASHOUT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|10|FIF50|Forced Inspiratory Flow at 50%|[?]|TRENDELENBURG|[?]|V/sec|[?]|1|CAPLET|SKULL|UNILATERAL|SUBCORTICAL|HANSEL STAIN||Y||PROXY|FORENSIC PATHOLOGIST|5|Visit_5|90|1|WASHOUT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|SALKK|Salazar-Knowles Equation, K|[?]|SITTING|[?]|/10^3|[?]|1|mol/mg|GASTROINTESTINAL SYSTEM|BILATERAL|ANTEROPOSTERIOR|SPECTROPHOTOMETRY||Y||VENDOR|DERMATOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-12-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|2|IVCPP|Percent Predicted IVC|[?]|REVERSE TRENDELENBURG|[?]|dB|[?]|1|SCOOPFUL|CEREBRAL SUBCORTEX|LEFT|PARIETO-OCCIPITAL|ENZYMATIC COLORIMETRY||Y||STUDY SUBJECT|PATHOLOGIST|1|Visit_1|10|3|WASHOUT|2020-12-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|3|EFFVOL|Effusion Volume|[?]|REVERSE TRENDELENBURG|[?]|nL|[?]|1|pm|MITRAL VALVE, ANTERIOR CUSP|BILATERAL|TIP|ULTRASONOGRAPHIC ELASTOGRAPHY||||HEALTH CARE PROFESSIONAL|OPTOMETRIST|2|Visit_2|25|1|TREATMENT|2020-12-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|4|FIFMAX|Maximum Forced Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|ppb|[?]|1|10^7/L|PULMONARY VALVE|BILATERAL|FORE|AGAR DILUTION||||INVESTIGATOR|OTOLARYNGOLOGIST|2|Visit_2|25|7|WASHOUT|2020-12-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|5|ICPP|Percent Predicted Inspiratory Capacity|[?]|TRENDELENBURG|[?]|vg/dose|[?]|1|nmol BCE/L|INTRAHEPATIC LARGE BILE DUCT|LEFT|DISTAL VOLAR|STATIC PERIMETRY||||INTERVIEWER|ADJUDICATOR 1|3|Visit_3|40|1|TREATMENT|2021-01-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|6|LOBVOL|Lobar Volume|[?]|DECUBITUS|[?]|cm H2O|[?]|1|cal|PALPEBRAL CONJUNCTIVA|IPSILATERAL|FRONTAL|MICROBIAL CULTURE, LIQUID|Y|||INVESTIGATOR|RATER|3|Visit_3|40|7|TREATMENT|2021-01-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|7|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|[?]|m/sec2|[?]|1|DPM|HAND DIGIT 3|BILATERAL|FORE|VIRUS PLAQUE ASSAY|Y|||CAREGIVER|READER 1|4|Visit_4|65|2|FOLLOW-UP|2021-02-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|8|INFLTIND|Infiltrates Indicator|[?]|SITTING|[?]|g/L|[?]|1|mEq/ug|METACARPAL BONE 3|BILATERAL|INTERMEDIATE|EPSILOMETER||||CHILD|NEUROLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-02-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|9|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|/2500 WBC|[?]|1|bel|TEMPOROMANDIBULAR JOINT|RIGHT|DORSAL|ERGOSPIROMETRY||||INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|TREATMENT|2021-03-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|7f1e0661-ebbd-4abd-9031-cb6b424977e2|10|RELSZCHG|Relative Size Change|[?]|LATERAL DECUBITUS|[?]|/sec|[?]|1|mL/cm H2O|HAIR|LEFT|UPPER|MUGA||||STUDY SUBJECT|MICROSCOPIST 1|5|Visit_5|90|4|TREATMENT|2021-03-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|PRONE|[?]|L/day|[?]|1|Enzyme U/g Hb|INTERPHALANGEAL OF THE FOOT|LATERAL|ANTEROPOSTERIOR|MULTI-SLICE SPIRAL CT||||CHILD|ADJUDICATOR 3|1|Visit_1|10|6|TREATMENT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|2|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|g|[?]|1|10^9 organisms/g|GASTROINTESTINAL TRACT, LOWER|LEFT|UPPER EXTENSOR SURFACE|MACRO BROTH DILUTION||||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|3|PEFTIME|Peak Expiratory Flow Time|[?]|LATERAL DECUBITUS|[?]|dpm/mg|[?]|1|kg/m2|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|IPSILATERAL|UPPER|ENZYMATIC ULTRACENTRIFUGATION|Y|||SIGNIFICANT OTHER|ONCOLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|4|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|COAT|[?]|1|SBE/mL|COCCYGEAL VERTEBRA|RIGHT|OUTER|MS/MS||||CHILD|FORENSIC PATHOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LEFT LATERAL DECUBITUS|||[?]|1|umol/L|RIB 5|LEFT|DORSAL|OPTICAL DENSITY MEASUREMENT|||Y|GUARDIAN|INTERNIST|3|Visit_3|40|2|TREATMENT|2020-06-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-23
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|6|IC|Inspiratory Capacity|[?]|SUPINE|||[?]|1|Pa|UPPER URINARY SYSTEM|LEFT|DISTAL VOLAR|MALDI||Y|Y|ADJUDICATOR|OPTOMETRIST|3|Visit_3|40|1|TREATMENT|2020-06-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-23
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|7|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|PRONE|[?]|vp/dose|[?]|1|HOURS|CONJUNCTIVA|CONTRALATERAL|OCCIPITAL|SPECT/CT SCAN|Y|||INDEPENDENT ASSESSOR|CARDIOLOGIST|4|Visit_4|65|5|WASHOUT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|8|FEV1REV|FEV1 Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|/mm2|[?]|1|min*mg/mL|DISTAL COMMON BILE DUCT|BILATERAL|ANTERIOR|COMPLEMENT FIXATION||||ADJUDICATION COMMITTEE|RADIOLOGIST|4|Visit_4|65|4|WASHOUT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|9|MALEVDES|Malignancy Evidence Description|[?]|STANDING, BENT FORWARD|||[?]|1|cm|MITRAL VALVE ANNULUS|IPSILATERAL|DEEP|HPLC|||Y|INVESTIGATOR|RATER 2|5|Visit_5|90|2|TREATMENT|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|324a2c67-4802-4806-aff2-04fb9c7394d4|10|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING|[?]|fraction of 1|[?]|1|CCID 50/dose|EPIGASTRIC LYMPH NODE|LEFT|FACIAL|DOPPLER ULTRASOUND||Y||SPOUSE|ADJUDICATOR|5|Visit_5|90|2|SCREENING|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|TGV|Thoracic Gas Volume|[?]|SLING|[?]|U/kg/min|[?]|1|cGy|ESOPHAGUS, ABDOMINAL|IPSILATERAL|UPPER|SPECTROPHOTOMETRY||||ADJUDICATION COMMITTEE|READER 3|1|Visit_1|10|7|FOLLOW-UP|2020-12-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|2|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|||[?]|1|pmol/L|HEART, LEFT ATRIAL APPENDAGE|BILATERAL|PARIETO-OCCIPITAL|CONTACT SPECULAR MICROSCOPY||Y|Y|INDEPENDENT ASSESSOR|ADJUDICATOR 1|1|Visit_1|10|5|FOLLOW-UP|2020-12-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-20
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|3|FIV1PP|Percent Predicted FIV1|[?]|SLING|[?]|TUBE|[?]|1|nmol/L/h|GENITAL TUBERCLE|CONTRALATERAL|ANTEROTEMPORAL|GC/FID|Y|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|2|Visit_2|25|4|FOLLOW-UP|2021-01-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|4|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|||[?]|1|GLOBULE|PRIMARY VISUAL CORTEX|BILATERAL|SUBCORTICAL|GC/MS-CI|||Y|SPOUSE|ADJUDICATOR 1|2|Visit_2|25|6|TREATMENT|2021-01-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|5|RELSZCHG|Relative Size Change|[?]|REVERSE TRENDELENBURG|[?]|DAYS|[?]|1|m|SKIN OF THE THIGH|UNILATERAL|ANTERIOR|ISHIHARA COLOR PLATES||||FAMILY MEMBER|OPTOMETRIST|3|Visit_3|40|5|TREATMENT|2021-01-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|6|SGAW|Specific Airway Conductance|[?]|TRENDELENBURG|[?]|10^8 PFU|[?]|1|PACK|ENDOCARDIUM|LEFT|UPPER|U-HPLC/MS/MS||||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|3|Visit_3|40|1|TREATMENT|2021-01-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|7|RAW|Airway Resistance|[?]|LATERAL DECUBITUS|[?]|GPL U/mL|[?]|1|msec|DISTAL INTERPHALANGEAL JOINT 4|LEFT|PERIVENTRICULAR|SLOAN LETTER EYE CHART 2.5%||||DOMESTIC PARTNER|NEUROLOGIST 1|4|Visit_4|65|1|TREATMENT|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|8|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|TRENDELENBURG|[?]|CUP|[?]|1|Gy|CORNEAL ENDOTHELIUM|BILATERAL|MIDLINE|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||SPOUSE|ADJUDICATOR|4|Visit_4|65|7|SCREENING|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-22
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|9|RER|Respiratory Exchange Ratio|[?]|REVERSE TRENDELENBURG|[?]|km|[?]|1|10^6 organisms|CORONARY ARTERY|IPSILATERAL|ANTEROLATERAL|ECHOCARDIOGRAPHY||Y||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|SCREENING|2021-03-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|10|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|[?]|Enzyme U/g Hb|[?]|1|mV*min|BRACHIALIS MUSCLE|LEFT|DORSOLATERAL|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|5|Visit_5|90|7|WASHOUT|2021-03-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|PEFTIME|Peak Expiratory Flow Time|[?]|FOWLERS|[?]|U/kg|[?]|1|cy/cm|FUNDUS OF THE STOMACH|BILATERAL|LOWER EXTENSOR SURFACE|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|1|Visit_1|10|2|TREATMENT|2020-08-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|2|GAW|Airway Conductance|[?]|DECUBITUS|||[?]|1|PFU|INCUS|UNILATERAL|OCCIPITAL|WEBER GREEN STAIN|Y|Y|Y|CHILD|NEUROLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-08-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|3|QUASCOMP|Quasi-Static Compliance|[?]|FOWLERS|[?]|10^3 CFU/mL|[?]|1|10^12/L|SOFT PALATE|UNILATERAL|POSTERIOR|DYNAMIC LIGHT SCATTERING|Y|||ADJUDICATOR|CLINICAL PATHOLOGIST|2|Visit_2|25|2|WASHOUT|2020-09-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|4|RVPP|Percent Predicted Residual Volume|[?]|SEMI-FOWLERS|[?]|cmH2O*s2/mL|[?]|1|Log10 ELISA unit/dose|DISTAL LAD ARTERY|CONTRALATERAL|PROXIMAL VOLAR|IMPULSE OSCILLOMETRY||||CHILD|RADIOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-09-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|5|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|HOMEOPATHIC DILUTION|[?]|1|%|PERIANAL REGION|LATERAL|INNER|OPTICAL MAPPING||||VENDOR|CARDIOLOGIST|3|Visit_3|40|7|TREATMENT|2020-09-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|PIPE|[?]|1|AFU|LYMPH NODE HILUM|CONTRALATERAL|CAUDAL|CELL BASED BIOASSAY|Y|Y||ADJUDICATION COMMITTEE|OPTOMETRIST|3|Visit_3|40|4|TREATMENT|2020-09-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|mL/kg/min|[?]|1|10^6/g|CHEST WALL|CONTRALATERAL|CENTRAL|PAP STAIN||||SPOUSE|READER 1|4|Visit_4|65|6|TREATMENT|2020-10-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|8|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|g/day|[?]|1|mL/cm|SKULL, BASE|CONTRALATERAL|NASAL|KLEIHAUER-BETKE||||FAMILY MEMBER|ADJUDICATOR 2|4|Visit_4|65|5|TREATMENT|2020-10-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|9|LCI|Lung Clearance Index|[?]|SITTING, LEGS DEPENDENT|||[?]|1|HOURS|BUTTOCK|BILATERAL|CRANIAL|GRADIENT DIFFUSION|||Y|CAREGIVER|ENDOCRINOLOGIST|5|Visit_5|90|7|WASHOUT|2020-11-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|10^5/L|[?]|1|HOURS|FASCIA|IPSILATERAL|INNER|IMMUNOCHROMATOGRAPHY|Y|||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|7|TREATMENT|2020-11-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|||[?]|1|ug/g/h|STOMACH|RIGHT|INTERMEDIATE|ENDOSCOPY|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-12-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|2|ICREV|IC Reversibility|[?]|PRONE|[?]|BOTTLE|[?]|1|LB|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|BILATERAL|FACIAL|FLAME PHOTOMETRY||||ADJUDICATOR|ADJUDICATOR 1|1|Visit_1|10|7|TREATMENT|2020-12-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|3|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|[?]|CCID 50/mL|[?]|1|USP U|SUPERIOR VENA CAVA|IPSILATERAL|ANTEROTEMPORAL|NEXT GENERATION TARGETED SEQUENCING||Y||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|2|Visit_2|25|5|TREATMENT|2020-12-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|UNCONSTRAINED|||[?]|1|U/animal|WARDS TRIANGLE|LATERAL|DISTAL VOLAR|FARNSWORTH-MUNSELL 100 HUE TEST|||Y|PARENT|PHYSIOTHERAPIST|2|Visit_2|25|5|TREATMENT|2020-12-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|5|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|||[?]|1|dL|INFRACLAVICULAR LYMPH NODE|LEFT|INNER|MECHANICAL CLOT DETECTION|||Y|CAREGIVER|ONCOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-12-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|6|SVC|Slow Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|copies/uL|CORPUS LUTEUM|BILATERAL|CENTRAL|CLIP||Y|Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2020-12-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|7|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|||[?]|1|Antibody Unit|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|DISTAL VOLAR|INFRARED SPECTROMETRY|Y||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|4|Visit_4|65|3|TREATMENT|2021-01-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|8|ICREV|IC Reversibility|[?]|FOWLERS|[?]|OD Unit|[?]|1|nsec|FEMALE GENITALIA|IPSILATERAL|DISTAL|PLETHYSMOGRAPHY||Y||SPOUSE|RADIOLOGIST 2|4|Visit_4|65|1|TREATMENT|2021-01-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|9|FEV1FVC|FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|/2500 WBC|[?]|1|BLOCKS|PERIHILAR LYMPH NODE|LEFT|PROXIMAL VOLAR|MICROBIAL BIOCHEMICAL IDENTIFICATION||Y||PARENT|CARDIOLOGIST|5|Visit_5|90|1|TREATMENT|2021-02-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|911dc297-91cb-42b1-8a26-18f6c83c32a6|10|RRS|Total Respiratory System Resistance|[?]|DECUBITUS|[?]|L/kg|[?]|1|ug/min|EPITROCHLEAR LYMPH NODE|UNILATERAL|DORSAL|TARGETED TRANSCRIPTOME SEQUENCING||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|5|Visit_5|90|4|FOLLOW-UP|2021-02-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|ERV|Expiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|km|FEMORAL CONDYLE|UNILATERAL|CENTRAL|WRIGHT STAIN|||Y|CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-11-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|2|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|[?]|mm/min|[?]|1|foz_us|BRAIN STEM|LEFT|INTERMEDIATE|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||SIBLING|ENDOCRINOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-11-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|3|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|/mm2|[?]|1|ng/L|EYE|BILATERAL|INNER|ANALYTICAL ULTRACENTRIFUGATION||||STUDY SUBJECT|PHYSIOTHERAPIST|2|Visit_2|25|1|WASHOUT|2020-12-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|4|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-FOWLERS|[?]|mmol/day|[?]|1|min|ILIAC FOSSA|LEFT|HIND|DIGITAL PCR|Y|||DOMESTIC PARTNER|PATHOLOGIST 1|2|Visit_2|25|2|FOLLOW-UP|2020-12-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|5|AWWVOL|Airway Wall Volume|[?]|SITTING|[?]|log10 CCID 50/dose|[?]|1|mCi/kg|OPTIC NERVE|RIGHT|ANTERIOR|OPTICAL MAPPING|Y|||DOMESTIC PARTNER|UROLOGIST|3|Visit_3|40|6|WASHOUT|2020-12-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|6|LCI|Lung Clearance Index|[?]|RIGHT LATERAL DECUBITUS|[?]|vp/dose|[?]|1|/LSQN|PROFUNDA FEMORIS VEIN|LEFT|LATERAL|MOUSE PROTECTION ASSAY|Y|||GUARDIAN|OPTOMETRIST|3|Visit_3|40|3|TREATMENT|2020-12-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|7|IRVPP|Percent Predicted IRV|[?]|SUPINE|[?]|IU/g Hb|[?]|1|mL/cage|AXIAL SKELETON|LEFT|OUTER|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|1|TREATMENT|2021-01-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|8|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SITTING, LEGS DEPENDENT|||[?]|1|s^-1(%O2)^-1|EXTENSOR HALLUCIS BREVIS MUSCLE|IPSILATERAL|PERIVENTRICULAR|LC/MS/MS|||Y|GUARDIAN|OTOLARYNGOLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|9|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|foz_us|[?]|1|um/day|ESOPHAGEAL LYMPH NODE|BILATERAL|SUPERIOR|LANDOLT RING|Y|||INVESTIGATOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|SCREENING|2021-02-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|/kg|[?]|1|ug/kg/day|RECTOVAGINAL SPACE|UNILATERAL|PROXIMAL|PHYSICAL EXAMINATION|Y|Y||GUARDIAN|ONCOLOGIST|5|Visit_5|90|1|TREATMENT|2021-02-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-14
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|/10^4|[?]|1|MPL U/mL|BILE DUCT|LATERAL|ANTEROTEMPORAL|BETA LACTAMASE||||GUARDIAN|PATHOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-08-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|||[?]|1|CAPLET|LUNG, LEFT LOWER LOBE|RIGHT|TEMPORAL|PALPATION|Y|Y|Y|CHILD|ADJUDICATOR 1|1|Visit_1|10|5|SCREENING|2020-08-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|3|FIF50|Forced Inspiratory Flow at 50%|[?]|LEFT LATERAL DECUBITUS|[?]|HEP|[?]|1|V|AZYGOS VEIN|LEFT|TIP|QUANTITATIVE PERIPHERAL ANGIOGRAPHY|Y|||PARENT|RATER|2|Visit_2|25|7|TREATMENT|2020-08-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SUPINE|||[?]|1|umol/L/min|GREAT SAPHENOUS VEIN|CONTRALATERAL|MEDIAL|KLEIHAUER-BETKE|||Y|GUARDIAN|NEUROLOGIST 2|2|Visit_2|25|6|FOLLOW-UP|2020-08-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|PRONE|[?]|10^4/hpf|[?]|1|mL/day|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|LEFT|ANTERIOR|CONFOCAL MICROSCOPY|Y|||ADJUDICATOR|READER 2|3|Visit_3|40|3|SCREENING|2020-09-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|6|OXYPULSE|Oxygen Pulse|[?]|SLING|[?]|DAgU|[?]|1|anti-Xa IU/mL|SKIN OF THE INGUINAL REGION|IPSILATERAL|ANTEROPOSTERIOR|SIZE EXCLUSION CHROMATOGRAPHY||||STUDY SUBJECT|ADJUDICATOR 3|3|Visit_3|40|4|TREATMENT|2020-09-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|7|FEV3FVC|FEV3/FVC|[?]|SITTING|[?]|10^12 IU/L|[?]|1|mEq/ug|BRAIN, THIRD VENTRICLE|CONTRALATERAL|ANTEROMEDIAL|PYROSEQUENCING||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|4|Visit_4|65|3|WASHOUT|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|8|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-FOWLERS|[?]|cmHg|[?]|1|cmH2O*s2/mL|LEFT VENTRICULAR MID ANTERIOR SEGMENT|BILATERAL|INFERIOR|MICROBIAL CONCENTRATION||||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|SCREENING|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|bel|[?]|1|Ci|NIPPLE|BILATERAL|PARIETO-OCCIPITAL|CONTACT SPECULAR MICROSCOPY||Y||ADJUDICATOR|NEUROLOGIST 2|5|Visit_5|90|1|WASHOUT|2020-11-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|9bfcd733-2233-4e54-a6cd-641a59fc8a01|10|IRV|Inspiratory Reserve Volume|[?]|STANDING|[?]|PFU/animal|[?]|1|yd|UTERUS|CONTRALATERAL|CRANIAL|CT SCAN||Y||CLINICAL RESEARCH COORDINATOR|RATER|5|Visit_5|90|1|TREATMENT|2020-11-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|1|ALVVOL|Alveolar Volume|[?]|STANDING|[?]|L/h/m2|[?]|1|pmol/10^10 cells|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|RIGHT|DISTAL VOLAR|MODIFIED ACID FAST STAIN|Y|Y||DOMESTIC PARTNER|ADJUDICATOR 1|1|Visit_1|10|4|FOLLOW-UP|2020-09-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|2|ALVVOL|Alveolar Volume|[?]|DECUBITUS|[?]|SACHET|[?]|1|COAT|DORSALIS PEDIS ARTERY|LEFT|MEDIAL|FLOCCULATION||||INVESTIGATOR|ADJUDICATOR 2|1|Visit_1|10|1|TREATMENT|2020-09-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|3|RAWPP|Percent Predicted Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|mL/s/m2|[?]|1|C|PRELARYNGEAL LYMPH NODE|UNILATERAL|ANTEROPOSTERIOR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||Y||DOMESTIC PARTNER|MICROSCOPIST 2|2|Visit_2|25|4|TREATMENT|2020-09-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|4|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|cmol|[?]|1|Enzyme U/m2|TIBIA|UNILATERAL|LOWER EXTENSOR SURFACE|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||PARENT|OTOLARYNGOLOGIST|2|Visit_2|25|2|TREATMENT|2020-09-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|5|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|PRONE|[?]|10^9/g|[?]|1|mL/min/1.73m2|AORTIC VALVE|IPSILATERAL|NASAL|LIGHT SCATTERING SPECTROSCOPY||||SIGNIFICANT OTHER|PATHOLOGIST 2|3|Visit_3|40|1|FOLLOW-UP|2020-10-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|6|OXYPULSE|Oxygen Pulse|[?]|STANDING, BENT FORWARD|[?]|mL/sec/1.73m2|[?]|1|mg/g/min|SKIN OF THE FACE|LEFT|HIND|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|||SIBLING|NEUROLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-10-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|7|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|fL|[?]|1|DRUM|GENITALIA|BILATERAL|OUTER|RIA||||ADJUDICATION COMMITTEE|NEUROLOGIST|4|Visit_4|65|1|WASHOUT|2020-10-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|8|ICREV|IC Reversibility|[?]|STANDING|[?]|USP U|[?]|1|umol/L/min|LOCUS CERULEUS|UNILATERAL|ANTEROMEDIAL|WEBER GREEN STAIN|Y|||GUARDIAN|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|9|IVCPP|Percent Predicted IVC|[?]|STANDING|[?]|RNA copies/mL|[?]|1|Frames/s|LIVER, RIGHT LOBE|BILATERAL|OCCIPITAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR|5|Visit_5|90|7|WASHOUT|2020-11-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|7eb97152-173c-4923-8604-5dad3140cc25|10|FEV1FVC6|FEV1/FVC6|[?]|RIGHT LATERAL DECUBITUS|[?]|LOZENGE|[?]|1|/4.0 mL|BLADDER, DOME|RIGHT|CRANIAL|POTENTIOMETRY||||FAMILY MEMBER|READER 3|5|Visit_5|90|4|FOLLOW-UP|2020-11-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|RRS|Total Respiratory System Resistance|[?]|SLING|||[?]|1|pg/cell|PELVIS|BILATERAL|ANTEROTEMPORAL|GRADIENT DIFFUSION|||Y|INVESTIGATOR|RADIOLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SLING|[?]|mL/animal/day|[?]|1|NEBULE|CORPUS STRIATUM|BILATERAL|ANTEROLATERAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||SIBLING|ENDOCRINOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|3|FEV1FVC6|FEV1/FVC6|[?]|REVERSE TRENDELENBURG|||[?]|1|PFU/mL|SACRUM|IPSILATERAL|CRANIAL|TRANSTHORACIC ECHOCARDIOGRAPHY||Y|Y|HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|4|MEPPP|Percent Predicted MEP|[?]|REVERSE TRENDELENBURG|[?]|umol/mol|[?]|1|PUFF|STERNOCLAVICULAR JOINT|LATERAL|ANTEROPOSTERIOR|STATIC PERIMETRY|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|5|IVC|Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mMU/mL|GLENOID FOSSA|LATERAL|SURFACE|POLYGRAPHY|Y||Y|PARENT|ADJUDICATOR 2|3|Visit_3|40|6|FOLLOW-UP|2020-09-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|6|FEV3FVC|FEV3/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|CUP|[?]|1|FINGERTIP UNIT|LEFT VENTRICULAR MID INFERIOR SEGMENT|LATERAL|FACIAL|RADIAL IMMUNODIFFUSION|Y|Y||SPOUSE|PEDIATRIC NEUROLOGIST|3|Visit_3|40|6|WASHOUT|2020-09-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING|[?]|min|[?]|1|ohm|TUNICA INTIMA|CONTRALATERAL|APICAL|ELISPOT|Y|||SPOUSE|PHYSIOTHERAPIST|4|Visit_4|65|7|FOLLOW-UP|2020-10-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|PRONE|||[?]|1|CFU/g|MEDIASTINAL LYMPH NODE|UNILATERAL|LOWER MEDIAL|DARK FIELD MICROSCOPY||Y|Y|PARENT|PATHOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-10-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|9|RAW|Airway Resistance|[?]|STANDING|[?]|10^8/L|[?]|1|/mm2|LIGAMENT|CONTRALATERAL|LOWER MEDIAL|TOLUIDINE BLUE STAIN||Y||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|0b2104d0-e1e3-4516-8c4b-de5d42f82784|10|INFLTIND|Infiltrates Indicator|[?]|SITTING|[?]|umol/mol|[?]|1|mmAL|HYPOPHARYNX|LEFT|SUPERFICIAL|TRIPLE-PHASE MRI SCAN|Y|||INTERVIEWER|PATHOLOGIST 1|5|Visit_5|90|6|TREATMENT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|HEP|[?]|1|nkat/g Hb|FALCIFORM LIGAMENT|CONTRALATERAL|LOWER|ANALYTICAL ULTRACENTRIFUGATION||||FAMILY MEMBER|PATHOLOGIST 1|1|Visit_1|10|3|SCREENING|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|2|EFFVOL|Effusion Volume|[?]|REVERSE TRENDELENBURG|[?]|dpm/mL|[?]|1|U/kg/min|T1 VERTEBRA|RIGHT|OUTER|SPIRAL CT||Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|Enzyme U/m2|[?]|1|ks|UMBILICAL CORD|LEFT|UPPER FLEXOR SURFACE|TRIPLE-PHASE SPIRAL CT SCAN||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|2|Visit_2|25|7|SCREENING|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|4|FEV3PP|Percent Predicted FEV3|[?]|FOWLERS|[?]|mmol/mol|[?]|1|nL|HEART, LEFT VENTRICULAR WALL|UNILATERAL|FORE|SPECTROPHOTOMETRY|Y|||INDEPENDENT ASSESSOR|ADJUDICATOR|2|Visit_2|25|4|SCREENING|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LATERAL DECUBITUS|[?]|YEARS|[?]|1|ng/L|FIBULA|CONTRALATERAL|INNER|HPLC/MS||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|3|FOLLOW-UP|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|6|IRVPP|Percent Predicted IRV|[?]|SUPINE|[?]|copies/ug|[?]|1|ng/day|MAIN BRONCHUS, LEFT|UNILATERAL|FRONTAL|LIGHT MICROSCOPY||Y||GUARDIAN|HEMATOLOGIST|3|Visit_3|40|4|TREATMENT|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|||[?]|1|cmH2O*s/mL|HAIR BULB|UNILATERAL|LOWER|THERMAL IONIZATION MASS SPECTROMETRY||Y|Y|SPOUSE|ONCOLOGIST 2|4|Visit_4|65|4|WASHOUT|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|8|DLCOPP|Percent Predicted DLCO|[?]|SITTING|[?]|10^6 organisms/mg|[?]|1|/200 HPFs|KIDNEY, LOWER LOBE|CONTRALATERAL|VOLAR|RADIOGRAPHY||||CHILD|FORENSIC PATHOLOGIST|4|Visit_4|65|4|WASHOUT|2020-07-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|REVERSE TRENDELENBURG|[?]|U/animal|[?]|1|gtt|ARM|CONTRALATERAL|APICAL|PERIPHERAL ANGIOGRAPHY||||INDEPENDENT ASSESSOR|RATER 2|5|Visit_5|90|5|TREATMENT|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|96f68979-6869-403b-a8bd-78c8f965f98a|10|ICREV|IC Reversibility|[?]|SITTING, LEGS DEPENDENT|||[?]|1|cGy|ABDOMINAL REGION|RIGHT|LOWER MEDIAL|MICROBIAL CULTURE, LIQUID|Y||Y|INVESTIGATOR|UROLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|AIRTRAP|Air Trapping|[?]|SEMI-FOWLERS|||[?]|1|g/kg|MALE GENITALIA|LATERAL|SUPERFICIAL|PHOTOGRAPHY|Y||Y|FAMILY MEMBER|NEUROLOGIST|1|Visit_1|10|7|WASHOUT|2020-10-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|2|SALKB|Salazar-Knowles Equation Parameter B|[?]|REVERSE TRENDELENBURG|||[?]|1|/wk|WARDS TRIANGLE|UNILATERAL|LOWER FLEXOR SURFACE|JAFFE REACTION|||Y|INVESTIGATOR|READER 2|1|Visit_1|10|5|WASHOUT|2020-10-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|3|FRC|Functional Residual Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/mmHg|HYMENAL RING|UNILATERAL|VOLAR|REFRACTOMETRY|||Y|DOMESTIC PARTNER|NEUROLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-10-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|REVERSE TRENDELENBURG|[?]|genEq/mL|[?]|1|10^4 CFU/mL|OSTIOMEATAL COMPLEX|UNILATERAL|LOWER FLEXOR SURFACE|RAJI CELL RIA||Y||SIGNIFICANT OTHER|RATER|2|Visit_2|25|2|TREATMENT|2020-10-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|5|FRCPP|Percent Predicted FRC|[?]|DECUBITUS|[?]|Hz|[?]|1|umol/h/mmol|SACRAL VERTEBRA|UNILATERAL|TEMPORAL|RADIOGRAPHY||||SIGNIFICANT OTHER|PHYSIOTHERAPIST|3|Visit_3|40|2|TREATMENT|2020-11-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|/4.0 mL|[?]|1|cycle/min|OPPONENS POLLICIS MUSCLE|LATERAL|DISTAL|TARGETED GENOME SEQUENCING|Y|||HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-11-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|7|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|FOWLERS|||[?]|1|AgU/mL|RECTUS FEMORIS MUSCLE|LEFT|PARIETO-OCCIPITAL|EEG|Y||Y|SIBLING|ONCOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-12-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|TRENDELENBURG|[?]|AgU/mL|[?]|1|mL/100g/min|SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|ROSTRAL|HPLC-UV||||CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|9|ICREV|IC Reversibility|[?]|UNCONSTRAINED|[?]|10^6/hpf|[?]|1|POUCH|SPINOUS PROCESS|BILATERAL|PROXIMAL VOLAR|ULTRASOUND||||FAMILY MEMBER|PATHOLOGIST 2|5|Visit_5|90|3|SCREENING|2021-01-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|e0f67610-b86a-4f5a-88eb-905b1e0aa609|10|INFLTIND|Infiltrates Indicator|[?]|FOWLERS|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|SFC/10^6 PBMC|SKIN OF THE INFRASCAPULAR REGION|BILATERAL|UPPER|SPIROMETRY||||CAREGIVER|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2021-01-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SUPINE|[?]|mEq/ug|[?]|1|mol/L|INSULAR CORTEX|CONTRALATERAL|SUPERIOR|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|1|Visit_1|10|6|WASHOUT|2020-09-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|2|INFLTIND|Infiltrates Indicator|[?]|SEMI-FOWLERS|[?]|mU|[?]|1|ft3|ENDOCERVIX|CONTRALATERAL|SUPERFICIAL|NON-INVASIVE DIELECTRIC SENSING||||CLINICAL STUDY SPONSOR|CARDIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-09-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|breaths/30s|[?]|1|psec|ARTERY|RIGHT|INNER|INTERRUPTER TECHNIQUE|Y|||FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|1|TREATMENT|2020-10-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|4|AWWVOL|Airway Wall Volume|[?]|REVERSE TRENDELENBURG|[?]|nCi|[?]|1|g/cm2|L4 VERTEBRA|LEFT|MIDLINE|LAPAROSCOPY||||CHILD|PATHOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-10-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|5|SRAW|Specific Airway Resistance|[?]|DECUBITUS|[?]|Bq/L|[?]|1|fmol/g|CEREBRAL SUBCORTEX|RIGHT|FACIAL|VIRUS PLAQUE ASSAY||||GUARDIAN|PATHOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-10-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|6|FEF50|Forced Expiratory Flow 50%|[?]|SLING|[?]|amol|[?]|1|PATCH|CORONARY ARTERY, ANTERIOR DESCENDING|RIGHT|VENTROLATERAL|GC/MS/MS||Y||PARENT|OPHTHALMOLOGIST|3|Visit_3|40|5|SCREENING|2020-10-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|7|MALEVDES|Malignancy Evidence Description|[?]|PRONE|[?]|kg/mol|[?]|1|MHz|MITRAL VALVE, ANTERIOR ANNULUS|LEFT|PROXIMAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||SPOUSE|ADJUDICATOR|4|Visit_4|65|6|FOLLOW-UP|2020-11-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|8|TGV|Thoracic Gas Volume|[?]|SEMI-FOWLERS|[?]|ug/h|[?]|1|psec|MUCOSA OF THE LIP|LEFT|ANTEROLATERAL|PERIODIC ACID SCHIFF STAIN||||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2020-11-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|9|RELSZCHG|Relative Size Change|[?]|SEMI-FOWLERS|[?]|U/cL|[?]|1|%/min|NAIL|LATERAL|MIDLINE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|Y||CAREGIVER|CARDIOLOGIST|5|Visit_5|90|1|SCREENING|2020-12-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|d62dc655-8865-4592-af0b-744524d9a24c|10|DLCOPP|Percent Predicted DLCO|[?]|STANDING|[?]|PRESSOR UNITS|[?]|1|SACHET|ESOPHAGEAL LYMPH NODE|UNILATERAL|SUBCORTICAL|IMMUNOBLOT||Y||NON-HEALTH CARE PROFESSIONAL|RATER 2|5|Visit_5|90|6|SCREENING|2020-12-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|QUASCOMP|Quasi-Static Compliance|[?]|REVERSE TRENDELENBURG|[?]|TRANSDUCING UNIT|[?]|1|Ci/ug|SACRAL TUBEROSITY|LATERAL|DISTAL VOLAR|PERIPHERAL ANGIOGRAPHY|Y|||INTERVIEWER|INTERNIST|1|Visit_1|10|5|FOLLOW-UP|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|2|FRCPP|Percent Predicted FRC|[?]|SITTING|[?]|10^3 copies/mL|[?]|1|mph|THALAMUS|LEFT|NASAL|CONGO RED STAIN||||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|3|FIV1PP|Percent Predicted FIV1|[?]|FOWLERS|[?]|ug/g/day|[?]|1|10^6 CFU/mL|INTERPHALANGEAL JOINT 1|LATERAL|DISTAL|BRDU CELLULAR PROLIFERATION ASSAY||||CLINICAL RESEARCH ASSOCIATE|READER 1|2|Visit_2|25|4|TREATMENT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|4|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|fmol/g|[?]|1|P|CEPHALIC VEIN|CONTRALATERAL|PERIPHERAL|SIZE EXCLUSION CHROMATOGRAPHY|Y|||GUARDIAN|MICROSCOPIST|2|Visit_2|25|3|TREATMENT|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|5|RRS|Total Respiratory System Resistance|[?]|SEMI-RECUMBENT|[?]|U.CARR|[?]|1|PACKET|JEJUNUM|BILATERAL|LATERAL|MAGNETIC RESONANCE ELASTOGRAPHY||||PROXY|RATER 1|3|Visit_3|40|3|FOLLOW-UP|2021-02-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|6|FIV1PP|Percent Predicted FIV1|[?]|SEMI-FOWLERS|[?]|vg/dose|[?]|1|log EID 50/dose|VAGINA|LATERAL|LATERAL|CINEANGIOGRAPHY||||CHILD|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2021-02-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|7|PLMBLFLW|Pulmonary Blood Flow|[?]|STANDING|||[?]|1|10^7 CFU|TRUNK|LATERAL|ANTEROMEDIAL|CHROMATOGRAPHY|||Y|FRIEND|PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|8|RV|Residual Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mg/mL/day|[?]|1|mg/kg/week|FEMUR|UNILATERAL|INFERIOR|CELL BASED BIOASSAY||||STUDY SUBJECT|READER 2|4|Visit_4|65|4|FOLLOW-UP|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|9|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|INHALATION|[?]|1|K|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL|SURFACE|SIZE EXCLUSION CHROMATOGRAPHY||||CHILD|ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|SACHET|[?]|1|AMPULE|CEREBRAL HEMISPHERE, RIGHT|BILATERAL|TEMPORAL|CELLULOSE TAPE|Y|||VENDOR|MICROSCOPIST 3|5|Visit_5|90|5|TREATMENT|2021-03-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|1|IRV|Inspiratory Reserve Volume|[?]|FOWLERS|[?]|log EID 50/dose|[?]|1|10^9 CFU/mL|HYOID BONE|LEFT|LOWER EXTENSOR SURFACE|ANGIOGRAPHY|Y|Y||SIGNIFICANT OTHER|ADJUDICATOR 1|1|Visit_1|10|6|WASHOUT|2020-12-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|2|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|[?]|hr/day|[?]|1|Enzyme U/g Hb|SHOULDER JOINT|CONTRALATERAL|SURFACE|DIGITAL PCR||||FRIEND|NEUROLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-12-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING|[?]|CUP|[?]|1|TABLET|MUSCULOSKELETAL SYSTEM|IPSILATERAL|NASAL|FLOCCULATION||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|2|Visit_2|25|1|TREATMENT|2021-01-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|4|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|||[?]|1|nmol/L/h|LEG SKIN|CONTRALATERAL|DORSAL|HPLC-UV|||Y|VENDOR|MICROSCOPIST 2|2|Visit_2|25|5|WASHOUT|2021-01-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|5|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|CAPSULE|[?]|1|PFU/mL|HILAR LYMPH NODE|LEFT|FORE|CONTACT SPECULAR MICROSCOPY||Y||ADJUDICATOR|ADJUDICATOR 2|3|Visit_3|40|5|TREATMENT|2021-01-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|6|SALKK|Salazar-Knowles Equation, K|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/mol|[?]|1|Antibody Unit|KIDNEY, LOWER LOBE|BILATERAL|FRONTAL|PET SCAN||Y||PARENT|PATHOLOGIST|3|Visit_3|40|1|SCREENING|2021-01-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-22
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|7|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|pmol/g|[?]|1|mL/100g/min|HEART, APEX|LEFT|UPPER FLEXOR SURFACE|ELASTOGRAPHY||Y||SIGNIFICANT OTHER|OPHTHALMOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-02-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|8|FIVC|Forced Inspiratory Vital Capacity|[?]|FOWLERS|||[?]|1|100 IU/mL|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|BILATERAL|BASAL|INTERRUPTER TECHNIQUE|Y||Y|VENDOR|RADIOLOGIST 1|4|Visit_4|65|4|TREATMENT|2021-02-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SLING|[?]|kg/mol|[?]|1|cm H2O|INCISOR|CONTRALATERAL|OCCIPITAL|ISHIHARA COLOR PLATES|Y|||DOMESTIC PARTNER|CARDIOLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|8005bd56-3bd6-477a-a466-b9a3bd189770|10|IVC|Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|TRANSDUCING UNIT/mL|[?]|1|log10 TCID 50/uL|CORPUS CALLOSUM, SPLENIUM|UNILATERAL|DEEP|FLUORIMETRY||||ADJUDICATION COMMITTEE|ADJUDICATOR 2|5|Visit_5|90|2|TREATMENT|2021-03-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|078ea33d-4114-4320-9116-740b8385a94e|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|grain|[?]|1|LOZENGE|FINGERNAIL|IPSILATERAL|SUBCORTICAL|DXA SCAN||||PARENT|INTERNIST|1|Visit_1|10|7|WASHOUT|2020-07-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|078ea33d-4114-4320-9116-740b8385a94e|2|FIF75|Forced Inspiratory Flow at 75%|[?]|SITTING, LEGS DEPENDENT|[?]|CAPSULE|[?]|1|RFU|KIDNEY, HILUM|LATERAL|HIND|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||STUDY SUBJECT|MICROSCOPIST 3|1|Visit_1|10|1|WASHOUT|2020-07-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|078ea33d-4114-4320-9116-740b8385a94e|3|OXYPULSE|Oxygen Pulse|[?]|RIGHT LATERAL DECUBITUS|[?]|USP U|[?]|1|/month|HAND PHALANX|CONTRALATERAL|UPPER EXTENSOR SURFACE|CLIP||Y||STUDY SUBJECT|RATER|2|Visit_2|25|4|TREATMENT|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|078ea33d-4114-4320-9116-740b8385a94e|4|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|||[?]|1|IU/dL|COLON, ASCENDING|CONTRALATERAL|ANTEROMEDIAL|THERMAL IONIZATION MASS SPECTROMETRY|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|2|Visit_2|25|2|TREATMENT|2020-08-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|078ea33d-4114-4320-9116-740b8385a94e|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|DECUBITUS|[?]|ug/kg/h|[?]|1|umol/min|PERICARDIAL WALL|LEFT|MEDIAL|FLUORESCENCE ANGIOGRAPHY|Y|Y||SIGNIFICANT OTHER|RATER|3|Visit_3|40|4|TREATMENT|2020-08-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|078ea33d-4114-4320-9116-740b8385a94e|6|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|||[?]|1|HOMEOPATHIC DILUTION|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|CONTRALATERAL|ROSTRAL|TRYPAN BLUE STAIN|||Y|FRIEND|MICROSCOPIST 1|3|Visit_3|40|1|SCREENING|2020-08-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|078ea33d-4114-4320-9116-740b8385a94e|7|MEPPP|Percent Predicted MEP|[?]|LEFT LATERAL DECUBITUS|[?]|ukat|[?]|1|mL/cage/wk|PERIANAL REGION|IPSILATERAL|PROXIMAL|LIGHT SCATTERING SPECTROSCOPY||||ADJUDICATOR|CARDIOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|078ea33d-4114-4320-9116-740b8385a94e|8|QUASCOMP|Quasi-Static Compliance|[?]|SITTING, LEGS DEPENDENT|[?]|MONTHS|[?]|1|min*mg/mL|FALLOPIAN TUBE|UNILATERAL|DISTAL|ANALYTICAL ULTRACENTRIFUGATION||Y||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|FOLLOW-UP|2020-09-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|078ea33d-4114-4320-9116-740b8385a94e|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|TRENDELENBURG|[?]|uIU/L|[?]|1|mL/kg/h|FLEXOR CARPI ULNARIS MUSCLE|LATERAL|FRONTAL|HPLC/MS/MS||||NON-HEALTH CARE PROFESSIONAL|RATER 1|5|Visit_5|90|7|FOLLOW-UP|2020-10-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|078ea33d-4114-4320-9116-740b8385a94e|10|FEV1REV|FEV1 Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|BOX|[?]|1|PATCH|PUTAMEN|CONTRALATERAL|UPPER EXTENSOR SURFACE|APPLANATION TONOMETRY||||CLINICAL RESEARCH ASSOCIATE|RATER|5|Visit_5|90|2|TREATMENT|2020-10-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|UNCONSTRAINED|||[?]|1|g/cage/wk|SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|DISTAL|MICROBIAL CULTURE, LIQUID|||Y|CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|1|Visit_1|10|7|TREATMENT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|2|INTP|Interpretation|[?]|STANDING, BENT FORWARD|[?]|g/g/day|[?]|1|uOsm|DISTAL LAD ARTERY|IPSILATERAL|CAUDAL|IN SITU HYBRIDIZATION||||GUARDIAN|MICROSCOPIST 2|1|Visit_1|10|4|TREATMENT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|3|DLCOVA|DLCO/VA|[?]|DECUBITUS|||[?]|1|CCID 50/mL|TRAPEZIUM-TRAPEZOID JOINT|LEFT|INFERIOR|MOUSE PROTECTION ASSAY||Y|Y|FAMILY MEMBER|PATHOLOGIST 1|2|Visit_2|25|4|SCREENING|2020-06-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|UNCONSTRAINED|[?]|nmol/L/h|[?]|1|mmol/g|TARSAL JOINT|UNILATERAL|FRONTAL|PET/CT SCAN||Y||ADJUDICATION COMMITTEE|OPTOMETRIST|2|Visit_2|25|6|FOLLOW-UP|2020-06-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|5|RER|Respiratory Exchange Ratio|[?]|SEMI-FOWLERS|[?]|10^3 copies/mL|[?]|1|Antibody Unit|PROCERUS MUSCLE|LEFT|VENTROLATERAL|NUCLEIC ACID BASED METHOD|Y|Y||STUDY SUBJECT|MICROSCOPIST|3|Visit_3|40|4|TREATMENT|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|RIGHT LATERAL DECUBITUS|[?]|log10 PFU/mL|[?]|1|L/s/kPa|LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY|LEFT|SUPERIOR|POTENTIOMETRY||||DOMESTIC PARTNER|ONCOLOGIST|3|Visit_3|40|6|WASHOUT|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|7|ERVPP|Percent Predicted ERV|[?]|SUPINE|[?]|mmol/L|[?]|1|ppb|CARPOMETACARPAL JOINT|BILATERAL|APICAL|ICC|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST 2|4|Visit_4|65|2|FOLLOW-UP|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|8|IVCPP|Percent Predicted IVC|[?]|UNCONSTRAINED|||[?]|1|s/h|BONE MARROW|BILATERAL|INTERMEDIATE|IMMUNOCHROMATOGRAPHY|||Y|NON-HEALTH CARE PROFESSIONAL|RATER 1|4|Visit_4|65|6|TREATMENT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|9|MIP|Maximal Inspiratory Pressure|[?]|SUPINE|[?]|HEP|[?]|1|cL|THIRD OBTUSE MARGINAL BRANCH ARTERY|UNILATERAL|FORE|PLETHYSMOGRAPHY|Y|||CHILD|ADJUDICATOR 1|5|Visit_5|90|5|FOLLOW-UP|2020-08-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|RE|1ca91975-9a42-4f4d-9c55-53f7561d82fa|10|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|[?]|BLOCKS|[?]|1|mmol/min/kPa|HARD PALATE|RIGHT|SUBCORTICAL|CONTACT SPECULAR MICROSCOPY||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|5|Visit_5|90|7|SCREENING|2020-08-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|1|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|ng|SUBARACHNOID SPACE|UNILATERAL|DISTAL VOLAR|ERGOSPIROMETRY|Y||Y|VENDOR|FORENSIC PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-06-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SUPINE|||[?]|1|amol|L3 VERTEBRA|LEFT|VENTROLATERAL|INDIRECT IMMUNOFLUORESCENCE|||Y|CHILD|ADJUDICATOR 3|1|Visit_1|10|1|WASHOUT|2020-06-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-02
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|3|EVC|Expiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|Torr|[?]|1|BAR|MEDIASTINUM, POSTERIOR|UNILATERAL|BASAL|IVY INCISION METHOD||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-06-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|||[?]|1|Bq|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|CONTRALATERAL|ANTEROTEMPORAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|||Y|DOMESTIC PARTNER|NEUROLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-06-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|5|IVC|Inspiratory Vital Capacity|[?]|PRONE|[?]|CAN|[?]|1|BAU/mL|PROXIMAL CIRCUMFLEX ARTERY|BILATERAL|ANTEROPOSTERIOR|CT SCAN||||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|mg/dL|[?]|1|Newton|HAIR|LATERAL|ANTERIOR|CINEANGIOGRAPHY||Y||VENDOR|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|7|FIO2|Fraction of Inspired Oxygen|[?]|FOWLERS|||[?]|1|mV*min|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|CONTRALATERAL|CENTRAL|FLUORESCENCE ANGIOGRAPHY|||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|8|LOBVOL|Lobar Volume|[?]|UNCONSTRAINED|[?]|mCi|[?]|1|umol/L/sec|SEBACEOUS GLAND|UNILATERAL|UPPER FLEXOR SURFACE|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||FRIEND|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|9|DLCO|Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|||[?]|1|PFU/mL|HEART, LEFT ATRIUM|LATERAL|POSTERIOR|TELLER ACUITY CARDS|||Y|CHILD|CARDIOLOGIST|5|Visit_5|90|4|TREATMENT|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|c5f292ad-1729-402b-820f-83ecd29ba00d|10|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|mL*cmH2O|[?]|1|uIU/L|FINGER EXTENSOR TENDONS|LEFT|SUBCORTICAL|DYNAMIC LIGHT SCATTERING|Y|||SIBLING|PHYSIOTHERAPIST|5|Visit_5|90|1|TREATMENT|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|FIO2|Fraction of Inspired Oxygen|[?]|LEFT LATERAL DECUBITUS|[?]|L/day|[?]|1|U/m2/min|TRAPEZIUS MUSCLE|CONTRALATERAL|ROSTRAL|FUNDUS PHOTOGRAPHY||Y||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|1|Visit_1|10|4|SCREENING|2020-06-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING|[?]|/VF|[?]|1|10^9 organisms|LIP, LOWER|LEFT|PROXIMAL VOLAR|PAP STAIN||Y||HEALTH CARE PROFESSIONAL|RATER|1|Visit_1|10|3|TREATMENT|2020-06-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-18
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|3|MIPPP|Percent Predicted MIP|[?]|STANDING|[?]|mg/kg/week|[?]|1|oz eq|FLEXOR CARPI RADIALIS MUSCLE|LATERAL|VOLAR|MICROARRAY||Y||PROXY|ADJUDICATOR 1|2|Visit_2|25|2|TREATMENT|2020-07-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|4|TV|Tidal Volume|[?]|SEMI-FOWLERS|[?]|Hz|[?]|1|ug/mL/h|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|RIGHT|VENTROLATERAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||GUARDIAN|ONCOLOGIST|2|Visit_2|25|1|TREATMENT|2020-07-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|5|MALIND|Malignancy Indicator|[?]|DECUBITUS|[?]|kUSP|[?]|1|usec|INTERNAL MAMMARY ARTERY|CONTRALATERAL|CRANIAL|ELECTROPHORESIS|Y|||SIGNIFICANT OTHER|READER 2|3|Visit_3|40|5|SCREENING|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|6|EFFVOL|Effusion Volume|[?]|SITTING, LEGS DEPENDENT|[?]|lm|[?]|1|/40 HPFs|ADDUCTOR LONGUS MUSCLE|RIGHT|OCCIPITAL|MICROBIAL CULTURE, LIQUID||||PROXY|MICROSCOPIST 1|3|Visit_3|40|5|TREATMENT|2020-07-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|7|PCF|Peak Cough Flow|[?]|LATERAL DECUBITUS|||[?]|1|g/g/day|RIB 4|IPSILATERAL|ANTERIOR|MAPH|||Y|NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|4|Visit_4|65|4|WASHOUT|2020-08-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|8|FEV1FVC|FEV1/FVC|[?]|SITTING|[?]|DRINK|[?]|1|eq|METACARPAL BONE|LEFT|OUTER|PERCUSSION||||SIGNIFICANT OTHER|MICROSCOPIST 2|4|Visit_4|65|3|FOLLOW-UP|2020-08-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|atm|[?]|1|mL/dL|PHARYNGEAL TONSIL|UNILATERAL|ANTEROLATERAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||FRIEND|RATER|5|Visit_5|90|7|TREATMENT|2020-09-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|a746aefb-16c8-43db-a0c4-8e9a4efdb244|10|FEV1REV|FEV1 Reversibility|[?]|UNCONSTRAINED|[?]|CCID 50/dose|[?]|1|Enzyme U/m2|POPLITEAL FOSSA|LEFT|PERIVENTRICULAR|TRICHROME STAIN||||CAREGIVER|OPHTHALMOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|FEV3PP|Percent Predicted FEV3|[?]|STANDING|[?]|MESF|[?]|1|AFU|SKIN OF THE FOREARM|CONTRALATERAL|LOWER EXTENSOR SURFACE|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||PARENT|ENDOCRINOLOGIST|1|Visit_1|10|4|TREATMENT|2020-09-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|2|FIF75|Forced Inspiratory Flow at 75%|[?]|PRONE|||[?]|1|10^7 TCID 50/dose|EPICARDIUM|RIGHT|ANTEROLATERAL|LC/MS/MS|||Y|ADJUDICATOR|READER 3|1|Visit_1|10|2|SCREENING|2020-09-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|3|MEPPP|Percent Predicted MEP|[?]|PRONE|[?]|mL/cm H2O|[?]|1|mmol2/L2|BLADDER WALL|CONTRALATERAL|TIP|PUPILLOMETRY||||PARENT|READER|2|Visit_2|25|3|WASHOUT|2020-10-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|4|IVC|Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|10^6 CFU/g|[?]|1|PFU/dose|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|CONTRALATERAL|PERIPHERAL|MODIFIED ACID FAST STAIN||||PROXY|MICROSCOPIST 2|2|Visit_2|25|4|TREATMENT|2020-10-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|5|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|g/day|[?]|1|mg/dose|ASCENDING AORTA|LATERAL|DORSOLATERAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||PARENT|DERMATOLOGIST|3|Visit_3|40|1|TREATMENT|2020-10-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|pg|[?]|1|Torr|CORPUS UTERI|RIGHT|PARIETO-OCCIPITAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y|Y||PROXY|MICROSCOPIST|3|Visit_3|40|7|WASHOUT|2020-10-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|7|DLCOPP|Percent Predicted DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|mL/kg/day|[?]|1|pmol/g|ESOPHAGUS, MIDDLE THIRD|IPSILATERAL|DORSAL|CONTRAST ENHANCED CT SCAN||||SIGNIFICANT OTHER|READER 2|4|Visit_4|65|2|FOLLOW-UP|2020-11-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|8|DLCO|Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|[?]|kg/mol|[?]|1|10^6 RNA copies/mL|TOENAIL|UNILATERAL|VOLAR|PERIODIC ACID SCHIFF STAIN||||FRIEND|PATHOLOGIST|4|Visit_4|65|2|SCREENING|2020-11-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|9|FRCPP|Percent Predicted FRC|[?]|FOWLERS|[?]|mL/kg|[?]|1|ug/g/day|DISTAL INTERPHALANGEAL JOINT 4|LATERAL|PERIPHERAL|FLUORIMETRY||||CAREGIVER|UROLOGIST|5|Visit_5|90|2|TREATMENT|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|7f95b9c0-3b77-4c60-8890-ecc955f97122|10|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|pg/L|[?]|1|CFU/mL|PARACAVAL LYMPH NODE|UNILATERAL|ANTEROMEDIAL|MASS SPECTROMETRY||||CHILD|MICROSCOPIST 1|5|Visit_5|90|5|TREATMENT|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|PEFTIME|Peak Expiratory Flow Time|[?]|TRENDELENBURG|[?]|cm/min|[?]|1|10^9/g|RIGHT ATRIAL ENDOCARDIUM|CONTRALATERAL|POSTERIOR|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||INVESTIGATOR|ONCOLOGIST|1|Visit_1|10|6|WASHOUT|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|2|TVPP|Percent Predicted Tidal Volume|[?]|SLING|[?]|mL/s/m2|[?]|1|nmol BCE/L|PERICARDIAL LYMPH NODE|LEFT|NASAL|PULMONARY ANGIOGRAPHY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|1|Visit_1|10|7|FOLLOW-UP|2020-10-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|3|EFFIND|Effusion Indicator|[?]|STANDING|[?]|mU/L|[?]|1|TRANSDUCING UNIT|C3 VERTEBRA|RIGHT|VENTRAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|||INVESTIGATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2020-10-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|umol/kg/min|[?]|1|Farad|WARDS TRIANGLE|UNILATERAL|TIP|FLOCCULATION, CHARCOAL ENHANCED||Y||CHILD|ONCOLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-10-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|DECUBITUS|[?]|mN|[?]|1|L/min/m2|PARAVERTEBRAL GANGLIA|IPSILATERAL|VENTRAL|OPTICAL COHERENCE TOMOGRAPHY||Y||CHILD|FORENSIC PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|6|AIRTRAP|Air Trapping|[?]|RIGHT LATERAL DECUBITUS|[?]|usec|[?]|1|Hz/s|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|UNILATERAL|SURFACE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y||CAREGIVER|NEUROLOGIST 2|3|Visit_3|40|6|WASHOUT|2020-11-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|7|FEV1FVC6|FEV1/FVC6|[?]|STANDING, BENT FORWARD|||[?]|1|%(w/v)|BODY|UNILATERAL|TIP|CINEANGIOGRAPHY|||Y|CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|8|FRCPP|Percent Predicted FRC|[?]|SITTING, LEGS DEPENDENT|[?]|L/s|[?]|1|mL*cmH2O|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|LEFT|FRONTAL|QUANTITATIVE ULTRASOUND||||CHILD|NEUROLOGIST 1|4|Visit_4|65|4|SCREENING|2020-11-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SLING|[?]|anti-Xa IU/mL|[?]|1|ng/L|ILEUM WALL|CONTRALATERAL|INNER|MANUAL COUNT||||PARENT|OPHTHALMOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-12-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|2be43c56-83f3-4148-9cb1-97c6d191d20e|10|AIRTRAP|Air Trapping|[?]|PRONE|||[?]|1|mmHg|SUPRAGLOTTIS|RIGHT|POSTERIOR|TWO-COLOR MICROARRAY||Y|Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|5|Visit_5|90|3|SCREENING|2020-12-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|1|TV|Tidal Volume|[?]|SITTING|[?]|10^3 organisms/mL|[?]|1|BAG|HEPATIC VEIN|UNILATERAL|NASAL|GIEMSA STAIN||||INTERVIEWER|RADIOLOGIST 2|1|Visit_1|10|4|SCREENING|2020-07-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|dpm/100mg|[?]|1|ppth|ANAL VERGE|UNILATERAL|OCCIPITAL|INDIA INK STAIN|Y|||DOMESTIC PARTNER|ONCOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-07-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING|||[?]|1|PACKET|RIB 11|LEFT|ANTEROLATERAL|SPECULAR MICROSCOPY|Y||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|2|Visit_2|25|2|TREATMENT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|REVERSE TRENDELENBURG|||[?]|1|Ci/mL|LEFT POSTEROLATERAL DESCENDING ARTERY|UNILATERAL|INNER|PET/CT SCAN WITHOUT CONTRAST|Y|Y|Y|FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|1|WASHOUT|2020-07-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|5|PIF|Peak Inspiratory Flow|[?]|FOWLERS|[?]|Coulomb|[?]|1|pm|PRELARYNGEAL LYMPH NODE|LEFT|SUPERFICIAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||GUARDIAN|RADIOLOGIST|3|Visit_3|40|6|TREATMENT|2020-08-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|6|IVC|Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|foz_us|[?]|1|Bq/mg|PRELARYNGEAL LYMPH NODE|BILATERAL|ANTEROLATERAL|MICROBIAL CONCENTRATION||Y||INTERVIEWER|READER|3|Visit_3|40|1|TREATMENT|2020-08-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|7|FIV1PP|Percent Predicted FIV1|[?]|FOWLERS|[?]|10^3 CFU/g|[?]|1|ppth|VASTUS LATERALIS MUSCLE|BILATERAL|LATERAL|PULSE OXIMETRY||||PROXY|INTERNIST|4|Visit_4|65|2|TREATMENT|2020-08-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|8|IVCPP|Percent Predicted IVC|[?]|TRENDELENBURG|[?]|BOTTLE|[?]|1|10^9 organisms|L2 VERTEBRA|BILATERAL|CRANIAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||VENDOR|MICROSCOPIST 3|4|Visit_4|65|4|TREATMENT|2020-08-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|9|FEV_PEF|FEV at PEF|[?]|STANDING, BENT FORWARD|[?]|kPa/L/sec|[?]|1|kBq/uL|RIB 9|UNILATERAL|INFERIOR|CELLULAR PROLIFERATION ASSAY||||INVESTIGATOR|PATHOLOGIST 1|5|Visit_5|90|4|TREATMENT|2020-09-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|e27e0325-5fbe-46c0-8264-982d83124203|10|INTP|Interpretation|[?]|SEMI-RECUMBENT|[?]|log10 copies/mL|[?]|1|Absorbance U|COLON, SIGMOID|BILATERAL|OUTER|TEST STRIP||Y||ADJUDICATION COMMITTEE|INTERNIST|5|Visit_5|90|2|SCREENING|2020-09-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|IVCPP|Percent Predicted IVC|[?]|LEFT LATERAL DECUBITUS|[?]|pmol/10^10 cells|[?]|1|cm/min|ESOPHAGUS, MIDDLE THIRD|UNILATERAL|LOWER MEDIAL|VENTILATION PERFUSION LUNG SCAN|Y|Y||INVESTIGATOR|READER 2|1|Visit_1|10|2|TREATMENT|2020-12-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|[?]|10^6 U|[?]|1|fmol|CARDIAC VALVE|LATERAL|VENTROLATERAL|NEXT GENERATION TARGETED SEQUENCING||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|1|Visit_1|10|1|SCREENING|2020-12-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|3|VO2|Oxygen Consumption|[?]|SEMI-RECUMBENT|[?]|mL/kg/day|[?]|1|mEq/dL|GLOSSOPHARYNGEAL NERVE|LATERAL|OCCIPITAL|PHYSICAL EXAMINATION||||DOMESTIC PARTNER|RATER 2|2|Visit_2|25|5|WASHOUT|2021-01-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|4|FEV3PP|Percent Predicted FEV3|[?]|LEFT LATERAL DECUBITUS|[?]|nmol/day|[?]|1|TRACE|INFRACLAVICULAR LYMPH NODE|BILATERAL|ANTEROTEMPORAL|AUTOREFRACTION||Y||FAMILY MEMBER|OTOLARYNGOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2021-01-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|LATERAL DECUBITUS|[?]|MPL U/mL|[?]|1|WEEKS|CERVICAL SPINE|LEFT|ANTEROTEMPORAL|RYAN BLUE STAIN|Y|Y||STUDY SUBJECT|NEUROLOGIST 1|3|Visit_3|40|2|TREATMENT|2021-01-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|6|DLCOVA|DLCO/VA|[?]|STANDING, BENT FORWARD|||[?]|1|dram|INTERPHALANGEAL JOINT OF THE HAND|BILATERAL|POSTERIOR|POLYGRAPHY|||Y|FRIEND|FORENSIC PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2021-01-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|7|IRVPP|Percent Predicted IRV|[?]|STANDING, BENT FORWARD|[?]|kHz|[?]|1|LB|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|RIGHT|DEEP|INFRARED SPECTROMETRY||Y||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|4|Visit_4|65|6|SCREENING|2021-02-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|8|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SLING|[?]|mL/m2/min|[?]|1|P|RETROAURICULAR LYMPH NODE|LEFT|LATERAL|X-RAY FLUORESCENCE SPECTROMETRY||||PARENT|ONCOLOGIST|4|Visit_4|65|6|TREATMENT|2021-02-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|9|SGAW|Specific Airway Conductance|[?]|SITTING|[?]|nmol/kg/day|[?]|1|%|L2 VERTEBRA|RIGHT|PARIETO-OCCIPITAL|THIN SMEAR||||VENDOR|CARDIOLOGIST|5|Visit_5|90|6|SCREENING|2021-03-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|10|FEF50|Forced Expiratory Flow 50%|[?]|SITTING|||[?]|1|/100 WBC|EXTENSOR HALLUCIS BREVIS MUSCLE|LATERAL|FORE|ROMANOWSKY STAIN|||Y|ADJUDICATOR|ADJUDICATOR 1|5|Visit_5|90|4|TREATMENT|2021-03-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-14
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|1|AWVOLPP|Percent Predicted Airway Volume|[?]|LATERAL DECUBITUS|||[?]|1|fmol/g|PAW|LEFT|SUPERFICIAL|CONGO RED STAIN|||Y|SPOUSE|RADIOLOGIST 2|1|Visit_1|10|4|SCREENING|2020-11-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|2|FIFMAXPP|Percent Predicted FIFmax|[?]|REVERSE TRENDELENBURG|[?]|10^9/g|[?]|1|mg/kg/h|MEDIAN BASILIC VEIN|RIGHT|LATERAL|FLUORESCENT MICROSCOPY|Y|||CHILD|READER 3|1|Visit_1|10|1|TREATMENT|2020-11-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|3|PEF|Peak Expiratory Flow|[?]|SITTING|[?]|fraction of 1|[?]|1|%/min|T2 VERTEBRA|UNILATERAL|LOWER EXTENSOR SURFACE|DOPPLER ULTRASOUND||||VENDOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-12-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|4|DLCOVA|DLCO/VA|[?]|LATERAL DECUBITUS|[?]|umol/L|[?]|1|g/g|L2 VERTEBRA|CONTRALATERAL|FACIAL|ACCELERATOR MASS SPECTROMETRY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-12-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|||[?]|1|g/m2|GASTROINTESTINAL TRACT, UPPER|UNILATERAL|LATERAL|CYSTOMETRY|Y||Y|PROXY|READER|3|Visit_3|40|7|TREATMENT|2020-12-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|6|FEV1FVC|FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|m2|[?]|1|dpm/mL|HILAR LYMPH NODE|UNILATERAL|PARIETO-OCCIPITAL|PERCUSSION||Y||SIBLING|READER 3|3|Visit_3|40|1|SCREENING|2020-12-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|STANDING, BENT FORWARD|[?]|CCID 50/dose|[?]|1|log10 copies/mL|PROXIMAL INTERPHALANGEAL JOINT 4|LATERAL|SUBCORTICAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y||GUARDIAN|RATER 1|4|Visit_4|65|1|TREATMENT|2021-01-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|8|LOBVOL|Lobar Volume|[?]|PRONE|[?]|mol/mol|[?]|1|Gy/h|L5-S1 INTERVERTEBRAL SPACE|RIGHT|ANTEROMEDIAL|TRYPAN BLUE STAIN||||CHILD|RADIOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|9|SRAW|Specific Airway Resistance|[?]|FOWLERS|[?]|mol/mL|[?]|1|dpm/0.5 mL|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|IPSILATERAL|LOWER FLEXOR SURFACE|IN VITRO GENE EXPRESSION ASSAY|Y|||FRIEND|ADJUDICATOR 1|5|Visit_5|90|5|FOLLOW-UP|2021-02-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|29e08650-9eae-461f-981e-f2a20d8d4492|10|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-FOWLERS|[?]|PUFF|[?]|1|BAG|METACARPAL BONE 3|RIGHT|SUPERFICIAL|CONTRAST ENHANCED X-RAY||Y||DOMESTIC PARTNER|READER|5|Visit_5|90|1|TREATMENT|2021-02-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|ERVPP|Percent Predicted ERV|[?]|UNCONSTRAINED|[?]|uCi/kg|[?]|1|umol|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|UNILATERAL|VENTROLATERAL|NON-CONTACT SPECULAR MICROSCOPY||||VENDOR|ADJUDICATOR 1|1|Visit_1|10|1|TREATMENT|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|2|FEV6PP|Percent Predicted FEV6|[?]|LATERAL DECUBITUS|[?]|/h|[?]|1|h*%|AXILLARY LYMPH NODE LEVEL III|UNILATERAL|CENTRAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||INTERVIEWER|ADJUDICATOR 1|1|Visit_1|10|5|SCREENING|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|3|AWVOL|Airway Volume|[?]|DECUBITUS|[?]|pptr|[?]|1|MPS U|TRICUSPID VALVE, POSTERIOR CUSP|BILATERAL|ROSTRAL|WESTERGREN||||STUDY SUBJECT|CARDIOLOGIST|2|Visit_2|25|5|SCREENING|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|PRONE|[?]|ft|[?]|1|Log10 ELISA unit|LEFT POSTEROLATERAL DESCENDING ARTERY|BILATERAL|NASAL|TRIPLE-PHASE MRI SCAN||||SPOUSE|ADJUDICATOR 3|2|Visit_2|25|4|WASHOUT|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|5|TV|Tidal Volume|[?]|SLING|[?]|mg/dose|[?]|1|10^6 organisms/mL|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|IPSILATERAL|ANTEROTEMPORAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|Y||SPOUSE|READER 1|3|Visit_3|40|3|FOLLOW-UP|2020-10-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|6|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mL/mmHg|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LATERAL|LOWER|MUGA||Y|Y|SIBLING|MICROSCOPIST|3|Visit_3|40|1|FOLLOW-UP|2020-10-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|7|MEPPP|Percent Predicted MEP|[?]|DECUBITUS|||[?]|1|log10 TCID 50/uL|TIBIOTARSAL JOINT|UNILATERAL|CRANIAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|||Y|GUARDIAN|MICROSCOPIST|4|Visit_4|65|1|TREATMENT|2020-10-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|8|MIPPP|Percent Predicted MIP|[?]|STANDING, BENT FORWARD|||[?]|1|10^6 IU|OVARY|IPSILATERAL|HIND|FLUORESCEIN STAIN|Y||Y|HEALTH CARE PROFESSIONAL|RADIOLOGIST|4|Visit_4|65|2|TREATMENT|2020-10-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|9|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|[?]|ug/kg/min|[?]|1|BOX|INTRAHEPATIC BILE DUCT|IPSILATERAL|APICAL|LIGHT MICROSCOPY||Y||CLINICAL RESEARCH COORDINATOR|READER 3|5|Visit_5|90|6|TREATMENT|2020-11-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|2b944a62-10bc-475e-a90d-da3f07a2c4df|10|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|[?]|nmol/L/min|[?]|1|/sec|TRICUSPID VALVE, ANTERIOR CUSP|UNILATERAL|DISTAL VOLAR|AGAR PROPORTION||||DOMESTIC PARTNER|PATHOLOGIST|5|Visit_5|90|5|WASHOUT|2020-11-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-05
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING|||[?]|1|log10 TCID 50/uL|BLADDER|LEFT|UPPER|FLOW CYTOMETRY|||Y|SIBLING|RADIOLOGIST 2|1|Visit_1|10|1|WASHOUT|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|PRONE|[?]|cd*s/m2|[?]|1|s/h|PANCREAS, HEAD|RIGHT|BASAL|FORCED OSCILLATION TECHNIQUE||||STUDY SUBJECT|CLINICAL PATHOLOGIST|1|Visit_1|10|2|SCREENING|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|3|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|[?]|Shock Wave|[?]|1|VIAL|ENDOMETRIUM|LEFT|LOWER FLEXOR SURFACE|GC/MS-CI||Y||SIBLING|READER 1|2|Visit_2|25|1|FOLLOW-UP|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|4|FEV1REV|FEV1 Reversibility|[?]|FOWLERS|||[?]|1|cup eq|HEART, VENTRICULAR WALL|LATERAL|ANTEROLATERAL|SANGER SEQUENCING|Y||Y|INTERVIEWER|MICROSCOPIST 2|2|Visit_2|25|5|SCREENING|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|5|PCF|Peak Cough Flow|[?]|UNCONSTRAINED|[?]|mL/day|[?]|1|K|COMMON ILIAC ARTERY|CONTRALATERAL|UPPER FLEXOR SURFACE|POTENTIOMETRY||Y||DOMESTIC PARTNER|MICROSCOPIST 2|3|Visit_3|40|4|WASHOUT|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|6|PCF|Peak Cough Flow|[?]|FOWLERS|[?]|s*kPa|[?]|1|GBq/ug|FLEXOR DIGITORUM LONGUS MUSCLE|UNILATERAL|FRONTAL|PALM METHOD||||PARENT|RATER 1|3|Visit_3|40|3|TREATMENT|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|7|SALKK|Salazar-Knowles Equation, K|[?]|SLING|[?]|m|[?]|1|/mm2|NAIL BED|UNILATERAL|SUBCORTICAL|FLUORESCENT SPOT TEST||||INDEPENDENT ASSESSOR|READER 2|4|Visit_4|65|2|TREATMENT|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|8|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|[?]|mV2/Hz|[?]|1|%|L3-L4 INTERVERTEBRAL SPACE|UNILATERAL|CRANIAL|MAGNETIC RESONANCE ENTEROGRAPHY||||FAMILY MEMBER|NEUROLOGIST 2|4|Visit_4|65|3|SCREENING|2020-11-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|9|INERTANC|Inertance|[?]|SEMI-FOWLERS|[?]|nmol/L/min|[?]|1|km|LIVER, QUADRATE LOBE|UNILATERAL|FRONTAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|5|Visit_5|90|6|FOLLOW-UP|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|10|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ft2|SARTORIUS MUSCLE|BILATERAL|DISTAL|GEL ELECTROPHORESIS|||Y|CLINICAL RESEARCH COORDINATOR|READER 1|5|Visit_5|90|2|TREATMENT|2020-11-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|U/g/min|[?]|1|mg/m2/min|CORNEAL EPITHELIUM|IPSILATERAL|VENTRAL|MAGNETIC RESONANCE ELASTOGRAPHY||||ADJUDICATION COMMITTEE|MICROSCOPIST 2|1|Visit_1|10|1|WASHOUT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|2|EXPRELTM|Expiration Relaxation Time|[?]|SUPINE|[?]|lm|[?]|1|mph|NAVICULAR BONE|BILATERAL|SUPERFICIAL|POLYGRAPHY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|1|Visit_1|10|7|WASHOUT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|3|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Pack Year|TRAPEZIAL BONE|LEFT|POSTERIOR|SNELLEN EYE CHART|||Y|SIBLING|ADJUDICATOR 3|2|Visit_2|25|2|TREATMENT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|4|INFLTIND|Infiltrates Indicator|[?]|SEMI-RECUMBENT|[?]|cup eq|[?]|1|mL/m2/h|RIB 1|UNILATERAL|LOWER|FLOCCULATION||||FAMILY MEMBER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|5|EFFVOL|Effusion Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|g/dL|[?]|1|USP U|INTERNAL MAMMARY ARTERY|RIGHT|LOWER MEDIAL|AGAR PROPORTION||||ADJUDICATION COMMITTEE|OPTOMETRIST|3|Visit_3|40|2|TREATMENT|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|6|FEV1REV|FEV1 Reversibility|[?]|SEMI-FOWLERS|[?]|CAN|[?]|1|RNA copies/mL|THORACIC SPINE|IPSILATERAL|LOWER EXTENSOR SURFACE|POPULATION SEQUENCING||||SIGNIFICANT OTHER|OPHTHALMOLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|7|INTP|Interpretation|[?]|SITTING, LEGS DEPENDENT|[?]|mL/day|[?]|1|kUSP|TEMPORAL BONE|LEFT|INNER|IODINE STAIN||||PROXY|MICROSCOPIST 1|4|Visit_4|65|6|FOLLOW-UP|2021-01-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|MBq|[?]|1|g/kg|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|ANTEROTEMPORAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||SIBLING|UROLOGIST|4|Visit_4|65|1|SCREENING|2021-01-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|steps/min|PANCREAS, ENDOCRINE|CONTRALATERAL|OCCIPITAL|PULSE OXIMETRY|Y||Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|5|Visit_5|90|5|FOLLOW-UP|2021-01-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|8aa77db3-b078-4073-a7f3-9b9a7fb14570|10|LCI|Lung Clearance Index|[?]|PRONE|[?]|mL/kg/min|[?]|1|10^6 U|RETROAURICULAR LYMPH NODE|LATERAL|BASAL|IHC|Y|||GUARDIAN|CARDIOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-01-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|1|PNEUMIND|Pneumonia Indicator|[?]|SLING|||[?]|1|min|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|CONTRALATERAL|PARIETO-OCCIPITAL|SLOAN LETTER EYE CHART 100%|Y|Y|Y|SIGNIFICANT OTHER|ONCOLOGIST|1|Visit_1|10|4|TREATMENT|2020-05-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|2|FIFMAXPP|Percent Predicted FIFmax|[?]|REVERSE TRENDELENBURG|||[?]|1|10^6/hpf|LUNG, LEFT UPPER LOBE|RIGHT|ROSTRAL|MAMMOGRAPHY|Y|Y|Y|FRIEND|ADJUDICATOR 2|1|Visit_1|10|5|SCREENING|2020-05-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|3|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-RECUMBENT|[?]|mmHg/sec|[?]|1|/MBP|INTERPHALANGEAL JOINT 1 OF THE FOOT|LEFT|NASAL|INFRARED SPECTROMETRY||Y||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|7|TREATMENT|2020-06-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-FOWLERS|[?]|mm|[?]|1|rpm|LUMBAR VERTEBRA|LEFT|FORE|MANUAL COUNT||||STUDY SUBJECT|ONCOLOGIST 2|2|Visit_2|25|2|FOLLOW-UP|2020-06-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|5|PIF|Peak Inspiratory Flow|[?]|UNCONSTRAINED|[?]|Farad|[?]|1|mmol/min/kPa|BRAIN|LATERAL|PROXIMAL VOLAR|AURAMINE STAIN||||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-06-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LEFT LATERAL DECUBITUS|[?]|BEAM BREAKS|[?]|1|mU/L|INFERIOR PUBIC RAMUS|CONTRALATERAL|TEMPORAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||Y||SIBLING|RADIOLOGIST 1|3|Visit_3|40|1|WASHOUT|2020-06-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SITTING|[?]|mg/kg/dose|[?]|1|ohm|DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND|LEFT|CAUDAL|SINGLE-SLICE SPIRAL CT||Y||VENDOR|PATHOLOGIST 2|4|Visit_4|65|5|FOLLOW-UP|2020-07-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|8|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|[?]|Hz/s|[?]|1|ug/L/h|LUNG, RIGHT MIDDLE LOBE|LATERAL|DORSOLATERAL|TARGETED GENOME SEQUENCING||||GUARDIAN|INTERNIST|4|Visit_4|65|6|TREATMENT|2020-07-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|pmol/day|[?]|1|uV|MEDIAN NERVE|BILATERAL|ANTERIOR|PELLI-ROBSON EYE CHART||||CHILD|MICROSCOPIST 1|5|Visit_5|90|7|TREATMENT|2020-08-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|1fce031b-680b-414f-9b74-d6383e10091d|10|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING, LEGS DEPENDENT|||[?]|1|/5x10^4 WBC|DISTAL INTERPHALANGEAL JOINT 2|LATERAL|APICAL|PHOROPTER|||Y|FRIEND|MICROSCOPIST|5|Visit_5|90|7|TREATMENT|2020-08-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|[?]|/10^4|[?]|1|10^6 DNA copies/mL|GLENOID FOSSA|CONTRALATERAL|DORSAL|MICROBIAL CULTURE, SOLID||Y||SIGNIFICANT OTHER|RATER|1|Visit_1|10|4|TREATMENT|2020-12-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|2|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|DECUBITUS|[?]|log10 TCID 50/dose|[?]|1|CFU/g|PELVIC BONE|CONTRALATERAL|POSTERIOR|IRON HEMATOXYLIN STAIN||||ADJUDICATION COMMITTEE|READER 1|1|Visit_1|10|6|TREATMENT|2020-12-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|3|INTP|Interpretation|[?]|STANDING, BENT FORWARD|[?]|cmol|[?]|1|DISK|PARAVERTEBRAL GANGLIA|RIGHT|DORSAL|LC-FL||||INTERVIEWER|OTOLARYNGOLOGIST|2|Visit_2|25|1|SCREENING|2021-01-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|4|INTP|Interpretation|[?]|DECUBITUS|[?]|%/s|[?]|1|IU/day|PRESACRAL SPACE|LEFT|LOWER|POLYGRAPHY||||VENDOR|RATER|2|Visit_2|25|1|SCREENING|2021-01-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|5|RELSZCHG|Relative Size Change|[?]|TRENDELENBURG|[?]|IU/L|[?]|1|/200 HPFs|BILE DUCT|IPSILATERAL|LOWER FLEXOR SURFACE|FLOW MICROSCOPY||||SIBLING|ADJUDICATOR 3|3|Visit_3|40|4|SCREENING|2021-01-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|6|INFLTIND|Infiltrates Indicator|[?]|DECUBITUS|[?]|mEq/day|[?]|1|dram|LARGE INTESTINE|LATERAL|VENTROLATERAL|INFRARED SPECTROMETRY||||PROXY|MICROSCOPIST 1|3|Visit_3|40|3|TREATMENT|2021-01-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|7|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|[?]|Hounsfield Unit|[?]|1|ug/kg/h|PROSTATE GLAND, MIDDLE LOBE|IPSILATERAL|DEEP|MUGA||Y||CAREGIVER|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2021-02-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|8|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|mL/cm H2O|[?]|1|10^6 organisms|TRIGEMINAL NERVE|UNILATERAL|FORE|TRIPLE-PHASE MRI SCAN||||VENDOR|MICROSCOPIST 2|4|Visit_4|65|4|TREATMENT|2021-02-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|9|EVC|Expiratory Vital Capacity|[?]|SUPINE|||[?]|1|cs|GASTROINTESTINAL TRACT, LOWER|LEFT|UPPER EXTENSOR SURFACE|BIOIMPEDANCE SPECTROSCOPY|||Y|GUARDIAN|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2021-03-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|dcc67696-e91a-4cef-81dd-f2d2711363ae|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|TRENDELENBURG|[?]|Absorbance U|[?]|1|IU/day|POPLITEAL ARTERY ABOVE KNEE|RIGHT|VENTRAL|PHOROPTER||||PARENT|MICROSCOPIST 3|5|Visit_5|90|1|SCREENING|2021-03-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|1|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|nmol/mL/min|[?]|1|ug/kg/h|FALCIFORM LIGAMENT|RIGHT|DISTAL VOLAR|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||FAMILY MEMBER|ONCOLOGIST|1|Visit_1|10|2|WASHOUT|2020-06-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|ppb|[?]|1|PACK|FLOOR OF MOUTH|LATERAL|DEEP|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||||SIGNIFICANT OTHER|NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|3|AIRTRAP|Air Trapping|[?]|FOWLERS|[?]|TUBE|[?]|1|10^7 TCID 50/dose|ILIOPSOAS MUSCLE|CONTRALATERAL|INFERIOR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||ADJUDICATOR|MICROSCOPIST 3|2|Visit_2|25|2|TREATMENT|2020-06-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|TRENDELENBURG|||[?]|1|mEq/day|OLECRANON|IPSILATERAL|DORSOLATERAL|DARK FIELD MICROSCOPY|||Y|SPOUSE|DERMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-06-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SLING|[?]|/kg|[?]|1|IU/g Hb|HARD PALATE|LEFT|MEDIAL|FLOCCULATION|Y|Y||ADJUDICATOR|PATHOLOGIST 2|3|Visit_3|40|1|FOLLOW-UP|2020-07-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|6|FRC|Functional Residual Capacity|[?]|SLING|||[?]|1|DRINK|STERNAL MANUBRIUM|LATERAL|UPPER|PET/CT SCAN WITHOUT CONTRAST||Y|Y|VENDOR|OPTOMETRIST|3|Visit_3|40|7|WASHOUT|2020-07-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|PRONE|[?]|U/m2/day|[?]|1|/h|SECOND OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|LOWER MEDIAL|IMMUNOPRECIPITATION||||HEALTH CARE PROFESSIONAL|RATER|4|Visit_4|65|7|SCREENING|2020-07-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|8|FVC|Forced Vital Capacity|[?]|SITTING|||[?]|1|pg|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|LEFT|CAUDAL|SEQUENCING|||Y|SIBLING|ENDOCRINOLOGIST|4|Visit_4|65|7|TREATMENT|2020-07-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|9|IRV|Inspiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mEq/L|[?]|1|uU/dL|KIDNEY, UPPER LOBE|IPSILATERAL|LOWER EXTENSOR SURFACE|KARYOTYPING|Y|Y||INTERVIEWER|READER 1|5|Visit_5|90|1|SCREENING|2020-08-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|91e83d7a-186a-4fed-8750-af796d77d356|10|VO2|Oxygen Consumption|[?]|SEMI-FOWLERS|[?]|10^3 RNA copies/mL|[?]|1|MdFI|MITRAL VALVE ANNULUS|UNILATERAL|VOLAR|APPLANATION TONOMETRY|Y|||GUARDIAN|ADJUDICATOR 1|5|Visit_5|90|1|SCREENING|2020-08-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|INERTANC|Inertance|[?]|STANDING, BENT FORWARD|[?]|CARTRIDGE|[?]|1|STEPS|MITRAL VALVE, POSTERIOR ANNULUS|CONTRALATERAL|LATERAL|SIZE EXCLUSION CHROMATOGRAPHY|Y|||FRIEND|RATER 1|1|Visit_1|10|2|TREATMENT|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|2|FIF25|Forced Inspiratory Flow at 25%|[?]|LATERAL DECUBITUS|[?]|mg/kg/week|[?]|1|mL/s|VAGUS NERVE|RIGHT|FACIAL|MICRODENSITOMETRY||||ADJUDICATOR|PHYSIOTHERAPIST|1|Visit_1|10|3|FOLLOW-UP|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|3|FEV6PP|Percent Predicted FEV6|[?]|LEFT LATERAL DECUBITUS|[?]|APL U/mL|[?]|1|MASK|FALLOPIAN TUBE|IPSILATERAL|INNER|SPECT/CT SCAN|Y|||SPOUSE|ONCOLOGIST 1|2|Visit_2|25|4|FOLLOW-UP|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|POUCH|DUODENUM|LATERAL|PARIETO-OCCIPITAL|CISH|Y|Y|Y|INTERVIEWER|READER 3|2|Visit_2|25|3|SCREENING|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|5|FEF50|Forced Expiratory Flow 50%|[?]|SUPINE|[?]|BLOCKS|[?]|1|msec|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|LEFT|LOWER FLEXOR SURFACE|GC/MS-CI|Y|||HEALTH CARE PROFESSIONAL|DERMATOLOGIST|3|Visit_3|40|5|WASHOUT|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|6|PNEUMIND|Pneumonia Indicator|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|KIT|VAS DEFERENS|UNILATERAL|BASAL|CENTRIFUGATION|Y||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|3|Visit_3|40|6|SCREENING|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|copies/mL|GASTROINTESTINAL TRACT, LOWER|UNILATERAL|ANTERIOR|SMEAR||Y|Y|CAREGIVER|READER|4|Visit_4|65|1|SCREENING|2020-07-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|8|PNEUMIND|Pneumonia Indicator|[?]|PRONE|[?]|nmol/L/min|[?]|1|NEEDLE GAUGE|POSTEROLATERAL SEGMENTAL ARTERY|RIGHT|CRANIAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|4|Visit_4|65|5|WASHOUT|2020-07-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|9|RELSZCHG|Relative Size Change|[?]|SLING|[?]|kUSP|[?]|1|copies/mL|ABDOMINAL LYMPH NODE|IPSILATERAL|ANTEROPOSTERIOR|HPLC/IEX|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|5|Visit_5|90|5|TREATMENT|2020-08-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-06
e|RE|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|10|SALKK|Salazar-Knowles Equation, K|[?]|UNCONSTRAINED|[?]|log10 PFU|[?]|1|U.CARR|RIGHT CORONARY ARTERY OSTIUM|CONTRALATERAL|LATERAL|ELISPOT||||ADJUDICATOR|HEMATOLOGIST|5|Visit_5|90|3|WASHOUT|2020-08-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-06
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|1|AWWVOL|Airway Wall Volume|[?]|SITTING|[?]|deg/mm|[?]|1|L/s/kPa|EPIDURAL SPACE|CONTRALATERAL|ANTERIOR|CONTRAST ENHANCED X-RAY||Y||SIGNIFICANT OTHER|PATHOLOGIST 2|1|Visit_1|10|4|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|mol|[?]|1|Farad|ILIAC VEIN|IPSILATERAL|DISTAL VOLAR|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|||ADJUDICATION COMMITTEE|RADIOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|3|IRVPP|Percent Predicted IRV|[?]|SEMI-FOWLERS|||[?]|1|mL/dL|FOOT DIGIT 5|LEFT|ANTEROMEDIAL|NO INFORMATION|Y|Y|Y|DOMESTIC PARTNER|NEUROLOGIST 2|2|Visit_2|25|7|FOLLOW-UP|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|4|EFFVOL|Effusion Volume|[?]|STANDING, BENT FORWARD|||[?]|1|BP|TRICUSPID VALVE ANNULUS|RIGHT|INNER|TONOMETRY|||Y|INDEPENDENT ASSESSOR|PATHOLOGIST|2|Visit_2|25|3|SCREENING|2021-01-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|PRONE|[?]|umol/L/sec|[?]|1|CIGARETTE|CARPOMETACARPAL JOINT 2|IPSILATERAL|DISTAL VOLAR|ELECTRONEUROGRAPHY||||CLINICAL RESEARCH COORDINATOR|READER 3|3|Visit_3|40|7|TREATMENT|2021-02-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|6|IVCPP|Percent Predicted IVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|/100 HPFs|PREAURICULAR LYMPH NODE|CONTRALATERAL|ROSTRAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||Y|Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|3|Visit_3|40|4|FOLLOW-UP|2021-02-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|7|EVC|Expiratory Vital Capacity|[?]|SITTING|||[?]|1|mg/day|BREAST|BILATERAL|DISTAL|FLUORESCENT IMMUNOASSAY|||Y|ADJUDICATOR|CARDIOLOGIST|4|Visit_4|65|4|TREATMENT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|8|AWVOL|Airway Volume|[?]|SLING|[?]|/10^3|[?]|1|lx|ABDOMINAL REGION|UNILATERAL|PERIPHERAL|TRANSTHORACIC ECHOCARDIOGRAPHY||||CAREGIVER|ONCOLOGIST 2|4|Visit_4|65|5|TREATMENT|2021-03-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|9|SGAW|Specific Airway Conductance|[?]|RIGHT LATERAL DECUBITUS|[?]|msec|[?]|1|uL/dose|LEFT VENTRICULAR EPICARDIUM|LATERAL|INTERMEDIATE|GC/FID||Y||CAREGIVER|RATER|5|Visit_5|90|2|TREATMENT|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|0145dfac-a107-4368-b358-bcd136e1ecb3|10|LOBVOL|Lobar Volume|[?]|STANDING|||[?]|1|/wk|SKIN OF THE AXILLA|LEFT|OUTER|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|||Y|INVESTIGATOR|MICROSCOPIST|5|Visit_5|90|5|FOLLOW-UP|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING|[?]|g/m2|[?]|1|breaths/30s|SINUS|LATERAL|TIP|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||SIGNIFICANT OTHER|READER 3|1|Visit_1|10|7|SCREENING|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|2|SVC|Slow Vital Capacity|[?]|DECUBITUS|||[?]|1|QUANTITY SUFFICIENT|BLADDER WALL|CONTRALATERAL|LOWER MEDIAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||Y|Y|CHILD|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|3|FIVC|Forced Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kg/cm|INSULAR CORTEX|RIGHT|MEDIAL|GC/FID|||Y|CAREGIVER|ADJUDICATOR 3|2|Visit_2|25|4|TREATMENT|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|4|TGV|Thoracic Gas Volume|[?]|SLING|[?]|sec|[?]|1|SYRINGE|METACARPOPHALANGEAL JOINT 1|CONTRALATERAL|FORE|CONTRAST ENHANCED X-RAY||||PROXY|RADIOLOGIST 2|2|Visit_2|25|6|FOLLOW-UP|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|5|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|[?]|mAmp|[?]|1|mL/s/m2|INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL|LOWER MEDIAL|CLINICAL EVALUATION||||FRIEND|ONCOLOGIST 1|3|Visit_3|40|7|WASHOUT|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|6|SVC|Slow Vital Capacity|[?]|DECUBITUS|[?]|cm H2O|[?]|1|nmol BCE/nmol|SKIN OF THE CHIN|UNILATERAL|DEEP|AUDIOMETRY||Y||SIBLING|READER|3|Visit_3|40|4|TREATMENT|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|7|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|[?]|SPRAY|[?]|1|ug/dose|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|CONTRALATERAL|FORE|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||SIGNIFICANT OTHER|ONCOLOGIST 2|4|Visit_4|65|7|TREATMENT|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING, BENT FORWARD|[?]|INHALATION|[?]|1|mg|COLON, HEPATIC FLEXURE|IPSILATERAL|BASAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||VENDOR|ONCOLOGIST 2|4|Visit_4|65|7|WASHOUT|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|9|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|[?]|copies/ug|[?]|1|SCOOPFUL|CORONARY ARTERY, ANTERIOR DESCENDING|BILATERAL|DORSAL|IHC||||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|5|Visit_5|90|7|TREATMENT|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|UNCONSTRAINED|[?]|umol/h/mmol|[?]|1|IU|L3 VERTEBRA|RIGHT|DORSOLATERAL|OBSERVATION||||PROXY|RADIOLOGIST 2|5|Visit_5|90|3|TREATMENT|2021-03-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-03
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|TSUHYS|Tissue Hysteresivity|[?]|FOWLERS|||[?]|1|CCID 50/dose|FEMUR|UNILATERAL|ANTEROMEDIAL|VENTILATION PERFUSION LUNG SCAN||Y|Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-11-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|2|IC|Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|[?]|ug/g/day|[?]|1|/10^4|MAIN BRONCHUS, RIGHT|LATERAL|VENTRAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||ADJUDICATION COMMITTEE|NEUROLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-11-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|3|SALKK|Salazar-Knowles Equation, K|[?]|PRONE|||[?]|1|DAYS|EYELID|LATERAL|CENTRAL|URANYL ACETATE STAIN|||Y|VENDOR|MICROSCOPIST 2|2|Visit_2|25|2|FOLLOW-UP|2020-12-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|4|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|PRONE|[?]|LB|[?]|1|10^3 DNA copies/mL|MUCOSA OF THE LIP|CONTRALATERAL|MIDLINE|X-RAY FLUORESCENCE SPECTROMETRY|Y|||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-12-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|5|MEPPP|Percent Predicted MEP|[?]|SUPINE|[?]|nmol BCE/nmol|[?]|1|CIGAR|FEMORAL HEAD|LEFT|VENTROLATERAL|REFLECTANCE SPECTROSCOPY||Y||SIBLING|PATHOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-12-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|6|GAW|Airway Conductance|[?]|STANDING, BENT FORWARD|||[?]|1|mmol/mol|ILIAC LYMPH NODE|LATERAL|HIND|ETDRS EYE CHART|||Y|VENDOR|ADJUDICATOR 1|3|Visit_3|40|7|TREATMENT|2020-12-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|7|ERV|Expiratory Reserve Volume|[?]|PRONE|[?]|/month|[?]|1|/5x10^4 WBC|BASILIC VEIN|CONTRALATERAL|VOLAR|GEL ELECTROPHORESIS||||ADJUDICATOR|ENDOCRINOLOGIST|4|Visit_4|65|6|TREATMENT|2021-01-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|8|MEPPP|Percent Predicted MEP|[?]|LEFT LATERAL DECUBITUS|[?]|PIXELS/in|[?]|1|JAR|MUSCLE|UNILATERAL|LOWER EXTENSOR SURFACE|WEBER GREEN STAIN||||FRIEND|HEMATOLOGIST|4|Visit_4|65|6|WASHOUT|2021-01-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|9|PEFREV|PEF Reversibility|[?]|DECUBITUS|[?]|10^6 IU|[?]|1|10^9 organisms/g|RESPIRATORY SYSTEM|IPSILATERAL|UPPER|MOUSE PROTECTION ASSAY||||DOMESTIC PARTNER|ONCOLOGIST 2|5|Visit_5|90|7|SCREENING|2021-02-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|d4d79f6a-ba90-4503-934b-8a86286d83d3|10|FEV1SVC|FEV1/SVC|[?]|SITTING, LEGS DEPENDENT|[?]|mL/mmHg/min/L|[?]|1|Ci|INTERNAL ILIAC ARTERY|RIGHT|SUPERFICIAL|HIGH RESOLUTION MELT ANALYSIS||||INTERVIEWER|CLINICAL PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2021-02-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mL/m2/min|[?]|1|anti-Xa IU|LATERAL HUMERAL EPICONDYLE|CONTRALATERAL|FACIAL|OPTICAL COHERENCE TOMOGRAPHY||||PARENT|CLINICAL PATHOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-08-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|2|LCI|Lung Clearance Index|[?]|SEMI-RECUMBENT|||[?]|1|EIA unit|SALIVARY GLAND|LATERAL|UPPER EXTENSOR SURFACE|CONTRAST ENHANCED X-RAY|||Y|DOMESTIC PARTNER|RATER 1|1|Visit_1|10|3|TREATMENT|2020-08-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|3|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|mOsm|[?]|1|eq|METATARSOPHALANGEAL JOINT 3|RIGHT|CRANIAL|POPULATION SEQUENCING||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|2|Visit_2|25|2|WASHOUT|2020-08-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|DECUBITUS|[?]|10^3 CFU|[?]|1|mOsm/kg|PROXIMAL URETHRA|BILATERAL|MIDLINE|RADIOGRAPHY|Y|Y||PROXY|OPHTHALMOLOGIST|2|Visit_2|25|7|SCREENING|2020-08-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-RECUMBENT|[?]|ug/m2/h|[?]|1|mg/mL/day|PULMONARY VALVE|RIGHT|LOWER|AUTOREFRACTION||Y||FRIEND|RATER|3|Visit_3|40|1|TREATMENT|2020-09-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|6|AWWVOL|Airway Wall Volume|[?]|LATERAL DECUBITUS|||[?]|1|bel|AORTIC VALVE, RIGHT CORONARY CUSP|IPSILATERAL|VOLAR|IMMUNO-PET SCAN|||Y|PARENT|INTERNIST|3|Visit_3|40|7|FOLLOW-UP|2020-09-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|7|DLCOPP|Percent Predicted DLCO|[?]|STANDING, BENT FORWARD|[?]|mL/animal/day|[?]|1|1/(s*kPa)|LUMBAR REGION|LATERAL|PROXIMAL|SIZE EXCLUSION CHROMATOGRAPHY||Y||INDEPENDENT ASSESSOR|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|8|PEFREV|PEF Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|kIU|[?]|1|log10 PFU/mL|FOREBRAIN|IPSILATERAL|DISTAL VOLAR|CELL OF ORIGIN ASSAY||||SIGNIFICANT OTHER|ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2020-10-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|9|FEV1FVC6|FEV1/FVC6|[?]|PRONE|||[?]|1|10^3 organisms|SKIN FOLD|RIGHT|FACIAL|QUANTITATIVE ULTRASOUND|Y||Y|INDEPENDENT ASSESSOR|DERMATOLOGIST|5|Visit_5|90|3|WASHOUT|2020-11-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|a329c350-49e2-415d-ba3c-e1ee929aec86|10|PLMXRS|Pulmonary Reactance|[?]|DECUBITUS|[?]|Sv|[?]|1|mEq/kg|SECOND OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|VOLAR|ORCHIDOMETERY||||STUDY SUBJECT|READER 2|5|Visit_5|90|3|TREATMENT|2020-11-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|[?]|pg/dL|[?]|1|scm|LUMBRICAL MUSCLES OF THE HAND|RIGHT|INNER|FLOW CYTOMETRY||Y||CAREGIVER|MICROSCOPIST 1|1|Visit_1|10|7|TREATMENT|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|||[?]|1|sec|PAROTID GLAND|BILATERAL|PARIETO-OCCIPITAL|FLUORESCEIN STAIN|||Y|PARENT|RADIOLOGIST 2|1|Visit_1|10|3|WASHOUT|2020-10-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|3|FEV3FVC|FEV3/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ug|COLON, TRANSVERSE|BILATERAL|VENTROLATERAL|PHOROPTER|||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|2|Visit_2|25|6|SCREENING|2020-10-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|4|OXYPULSE|Oxygen Pulse|[?]|STANDING, BENT FORWARD|[?]|dpm/100mg|[?]|1|10^6 organisms|PENIS, BODY|IPSILATERAL|UPPER EXTENSOR SURFACE|NON-CONTACT SPECULAR MICROSCOPY|Y|Y||CHILD|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|WASHOUT|2020-10-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|5|ELSTNCE|Elastance|[?]|LEFT LATERAL DECUBITUS|[?]|QUANTITY SUFFICIENT|[?]|1|10^5/hpf|PERIFACIAL LYMPH NODE|RIGHT|INFERIOR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||ADJUDICATOR|NEUROLOGIST 1|3|Visit_3|40|4|SCREENING|2020-10-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|[?]|PRESSOR UNITS|[?]|1|nmol/L/min|NASAL SEPTUM|LATERAL|ANTEROMEDIAL|PYROSEQUENCING||||FRIEND|NEUROLOGIST 2|3|Visit_3|40|1|SCREENING|2020-10-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|7|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|fmol|[?]|1|GBq/g|PECTORALIS MAJOR MUSCLE|CONTRALATERAL|SUPERFICIAL|PAP STAIN|Y|||DOMESTIC PARTNER|PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-11-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|||[?]|1|mg/g/min|METATARSOPHALANGEAL JOINT 1|IPSILATERAL|VOLAR|CLIP SEQUENCING|||Y|PROXY|CARDIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-11-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|[?]|U/kg|[?]|1|pm|FOREHEAD|LATERAL|PARIETO-OCCIPITAL|CONTACT SPECULAR MICROSCOPY|Y|Y||CHILD|UROLOGIST|5|Visit_5|90|6|TREATMENT|2020-12-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|ff0e3543-c1f3-47f8-987f-7b00a4a33704|10|SALKB|Salazar-Knowles Equation Parameter B|[?]|SUPINE|[?]|DISK|[?]|1|MPL U|RADIAL ARTERY|IPSILATERAL|UPPER FLEXOR SURFACE|ACID FAST STAIN||Y||ADJUDICATOR|INTERNIST|5|Visit_5|90|6|TREATMENT|2020-12-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|[?]|WEEKS|[?]|1|mm/min|MUCOSA|CONTRALATERAL|FACIAL|FLUORESCENCE ANGIOGRAPHY||||SIGNIFICANT OTHER|READER 2|1|Visit_1|10|4|TREATMENT|2021-01-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|2|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|%(w/v)|[?]|1|Arbitrary U|FINGER FLEXOR MUSCLES|BILATERAL|APICAL|MICROBIAL CULTURE||||CLINICAL STUDY SPONSOR|DERMATOLOGIST|1|Visit_1|10|7|WASHOUT|2021-01-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-17
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|3|INTP|Interpretation|[?]|SITTING, LEGS DEPENDENT|||[?]|1|damol/L|GLUTEAL MUSCLE|RIGHT|DISTAL|COMPUTERIZED CORNEAL TOPOGRAPHY|||Y|STUDY SUBJECT|RATER 1|2|Visit_2|25|2|SCREENING|2021-01-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|4|FEF50|Forced Expiratory Flow 50%|[?]|SUPINE|[?]|mg/mL/min|[?]|1|mol/mL|TYMPANIC MEMBRANE|LATERAL|FORE|MAGNETIC RESONANCE ENTEROGRAPHY||||FAMILY MEMBER|ADJUDICATOR 1|2|Visit_2|25|4|WASHOUT|2021-01-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|5|IRVPP|Percent Predicted IRV|[?]|TRENDELENBURG|[?]|10^11/L|[?]|1|pmol/10^10 cells|LEFT MAIN CORONARY ARTERY BODY|UNILATERAL|OUTER|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|3|Visit_3|40|5|TREATMENT|2021-02-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LATERAL DECUBITUS|||[?]|1|ng/L|MEDIAL FEMORAL CONDYLE|BILATERAL|PERIVENTRICULAR|LEAD CITRATE STAIN||Y|Y|INTERVIEWER|CARDIOLOGIST|3|Visit_3|40|6|TREATMENT|2021-02-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|DRINK|[?]|1|kUSP|CORPUS LUTEUM|IPSILATERAL|OCCIPITAL|AURAMINE STAIN|Y|||FAMILY MEMBER|MICROSCOPIST 2|4|Visit_4|65|5|FOLLOW-UP|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|8|EFFIND|Effusion Indicator|[?]|SLING|[?]|mCi/L|[?]|1|HOMEOPATHIC DILUTION|COLON, RECTOSIGMOID|IPSILATERAL|POSTERIOR|PALPATION||||FRIEND|MICROSCOPIST 1|4|Visit_4|65|4|SCREENING|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-21
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|mg/g/h|[?]|1|MASK|LIVER, RIGHT LOBE|UNILATERAL|FACIAL|IMMUNO-PET SCAN||||INTERVIEWER|READER 2|5|Visit_5|90|6|TREATMENT|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|128153ce-7bee-4f8d-bb60-fb1776370b6d|10|INTP|Interpretation|[?]|PRONE|[?]|EID 50/dose|[?]|1|MdFI|STERNAL MANUBRIUM|CONTRALATERAL|ANTEROMEDIAL|INCISION-INDUCED BLEEDING METHOD|Y|||INVESTIGATOR|RATER|5|Visit_5|90|5|TREATMENT|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|PEF|Peak Expiratory Flow|[?]|LATERAL DECUBITUS|[?]|mm|[?]|1|lm|LOWER RESPIRATORY SYSTEM|RIGHT|TIP|DIFFUSION TENSOR MRI|Y|||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|1|Visit_1|10|7|SCREENING|2020-06-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|||[?]|1|g/kg/day|PARASYMPATHETIC GANGLIA|CONTRALATERAL|FRONTAL|NON-INVASIVE DIELECTRIC SENSING||Y|Y|SIBLING|UROLOGIST|1|Visit_1|10|1|TREATMENT|2020-06-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SLING|||[?]|1|Torr|OMENTUM|CONTRALATERAL|HIND|MICROPARTICLE ENZYME IMMUNOASSAY|Y||Y|NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LATERAL DECUBITUS|[?]|mg/mL/day|[?]|1|Bq/ug|ILIAC FOSSA|IPSILATERAL|UPPER EXTENSOR SURFACE|GRADIENT DIFFUSION||||CLINICAL RESEARCH COORDINATOR|READER 3|2|Visit_2|25|7|TREATMENT|2020-07-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|5|FVC|Forced Vital Capacity|[?]|SITTING|[?]|Newton|[?]|1|CAN|RIB 1|IPSILATERAL|ANTEROPOSTERIOR|PERCUSSION||||CAREGIVER|NEUROLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|6|OXYPULSE|Oxygen Pulse|[?]|PRONE|[?]|PACKET|[?]|1|TRANSDUCING UNIT/mL|PAW|UNILATERAL|POSTERIOR|POPULATION SEQUENCING||Y||FAMILY MEMBER|MICROSCOPIST|3|Visit_3|40|6|SCREENING|2020-07-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|nmol/L/min|[?]|1|Gy|T8 VERTEBRA|LEFT|NASAL|CONTACT SPECULAR MICROSCOPY||||FAMILY MEMBER|ADJUDICATOR 2|4|Visit_4|65|5|TREATMENT|2020-08-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|dpm/mL|[?]|1|deg2|BLADDER, NECK|LATERAL|MIDLINE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|4|Visit_4|65|5|SCREENING|2020-08-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|9|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING, LEGS DEPENDENT|[?]|Ci/g|[?]|1|cm H2O|BILIARY TRACT|RIGHT|SUBCORTICAL|ICP-MS||||SPOUSE|RADIOLOGIST 2|5|Visit_5|90|1|WASHOUT|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|22ee2f20-4a66-458f-a153-9d7e871e1db2|10|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|MASK|HEAD|LEFT|SUBCORTICAL|GRAM STAIN||Y|Y|INVESTIGATOR|READER 2|5|Visit_5|90|7|TREATMENT|2020-09-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|1|DLCO|Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|V|[?]|1|mg/kg/h|TUNICA INTIMA|CONTRALATERAL|INNER|MODIFIED ACID FAST STAIN||Y||ADJUDICATION COMMITTEE|NEUROLOGIST 2|1|Visit_1|10|7|WASHOUT|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|2|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|TRENDELENBURG|||[?]|1|MET*min|BILE DUCT|CONTRALATERAL|PERIPHERAL|POPULATION SEQUENCING||Y|Y|CAREGIVER|PATHOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|3|AWVOL|Airway Volume|[?]|STANDING, BENT FORWARD|[?]|GBq/g|[?]|1|deg|COLON, HEPATIC FLEXURE|LEFT|UPPER FLEXOR SURFACE|THICK SMEAR||Y||ADJUDICATOR|PATHOLOGIST|2|Visit_2|25|5|SCREENING|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|4|ERVPP|Percent Predicted ERV|[?]|STANDING|[?]|BEAM BREAKS|[?]|1|L/s|MENINGES|LEFT|SUBCORTICAL|IMMUNOBLOT||||VENDOR|RATER 1|2|Visit_2|25|7|SCREENING|2020-07-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|5|MIPPP|Percent Predicted MIP|[?]|SLING|[?]|/500 WBC|[?]|1|cycle/min|FOOT DIGIT 5|BILATERAL|SURFACE|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||CAREGIVER|PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|mV2/Hz|[?]|1|WAFER|PERIRECTAL LYMPH NODE|UNILATERAL|FRONTAL|IMMUNOBLOT||||INTERVIEWER|READER 1|3|Visit_3|40|2|SCREENING|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|7|RER|Respiratory Exchange Ratio|[?]|SEMI-RECUMBENT|[?]|PFU/dose|[?]|1|cP|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|IPSILATERAL|PERIVENTRICULAR|KINYOUN STAIN||||DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|1|SCREENING|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|8|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|[?]|mmHg/sec|[?]|1|cy/cm|METACARPOPHALANGEAL JOINT 2|IPSILATERAL|UPPER FLEXOR SURFACE|EEG||||ADJUDICATOR|PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|9|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|ELISA unit|[?]|1|mol/g|MUSCULOSKELETAL SYSTEM|LEFT|POSTERIOR|MICROBIAL CULTURE, SOLID|Y|||INTERVIEWER|READER|5|Visit_5|90|3|TREATMENT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|b7caaa04-bcc7-4350-ad98-85670a19778f|10|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|[?]|MnFI|[?]|1|NFIU|BUCCAL LYMPH NODE|BILATERAL|PERIPHERAL|OSCILLOMETRY||||FRIEND|INTERNIST|5|Visit_5|90|1|TREATMENT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|FEF2575|Forced Expiratory Flow 25-75%|[?]|UNCONSTRAINED|||[?]|1|BOX|CILIARY BODY|IPSILATERAL|INNER|NEURAMINIDASE INHIBITION ASSAY||Y|Y|ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-12-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|2|INERTANC|Inertance|[?]|UNCONSTRAINED|[?]|nmol/mL/min|[?]|1|GBq|PANCREAS, ENDOCRINE|UNILATERAL|OCCIPITAL|INCISION-INDUCED BLEEDING METHOD||||SPOUSE|HEMATOLOGIST|1|Visit_1|10|6|TREATMENT|2020-12-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|3|FEV6PP|Percent Predicted FEV6|[?]|SLING|[?]|mg/L FEU|[?]|1|STEPS|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|VENTRAL|DOPPLER ULTRASOUND||Y||PROXY|READER 3|2|Visit_2|25|2|TREATMENT|2021-01-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|[?]|ks|[?]|1|nm|RADIUS-LUNATE JOINT|IPSILATERAL|OUTER|QUANTITATIVE ULTRASOUND||||CHILD|UROLOGIST|2|Visit_2|25|6|TREATMENT|2021-01-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|5|IC|Inspiratory Capacity|[?]|STANDING|[?]|mL/beat|[?]|1|mg/mL/day|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|PERIVENTRICULAR|NEXT GENERATION SEQUENCING||||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|WASHOUT|2021-01-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|6|MEPPP|Percent Predicted MEP|[?]|DECUBITUS|[?]|10^9 organisms/mg|[?]|1|ug/mL/h|MALLEUS|LATERAL|ANTEROMEDIAL|DYNAMIC LIGHT SCATTERING||||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|3|Visit_3|40|2|WASHOUT|2021-01-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|7|TSUELAS|Tissue Elastance|[?]|FOWLERS|||[?]|1|mmol/min/kPa/L|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|DORSOLATERAL|MOUSE PROTECTION ASSAY|||Y|FAMILY MEMBER|ONCOLOGIST 2|4|Visit_4|65|2|SCREENING|2021-02-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|8|SVC|Slow Vital Capacity|[?]|FOWLERS|||[?]|1|pptr|DISTAL INTERPHALANGEAL JOINT 2|CONTRALATERAL|SURFACE|INTRAVASCULAR ULTRASOUND|Y|Y|Y|PARENT|OPTOMETRIST|4|Visit_4|65|5|TREATMENT|2021-02-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|9|OXYPULSE|Oxygen Pulse|[?]|UNCONSTRAINED|[?]|gpELISA unit/mL|[?]|1|L/min/m2|RECTOVAGINAL SPACE|CONTRALATERAL|SURFACE|URANYL ACETATE STAIN||||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|5|Visit_5|90|7|TREATMENT|2021-03-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|2b58d5fd-3ec8-415b-bb53-a252049f228a|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING, BENT FORWARD|[?]|10^6 organisms|[?]|1|mCi/kg|SPLENIC HILAR LYMPH NODE|BILATERAL|NASAL|SCINTIGRAPHY||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|TREATMENT|2021-03-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|1|RV|Residual Volume|[?]|SUPINE|||[?]|1|Rad|GONAD|IPSILATERAL|TIP|PHOTOMETRY||Y|Y|FAMILY MEMBER|RADIOLOGIST 1|1|Visit_1|10|5|TREATMENT|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|2|FIF25|Forced Inspiratory Flow at 25%|[?]|DECUBITUS|[?]|L/h/m2|[?]|1|BAR|HAIR ROOT|LEFT|PROXIMAL VOLAR|DUKE INCISION METHOD||||ADJUDICATOR|OPTOMETRIST|1|Visit_1|10|1|TREATMENT|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-09
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|3|TVPP|Percent Predicted Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|km/h|GENITAL TUBERCLE|LEFT|INFERIOR|ACRIDINE ORANGE STAIN|||Y|CHILD|NEUROLOGIST|2|Visit_2|25|5|TREATMENT|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING|[?]|AMPULE|[?]|1|kg/L|EXTENSOR HALLUCIS BREVIS MUSCLE|UNILATERAL|VOLAR|PELLI-ROBSON EYE CHART||Y||VENDOR|INTERNIST|2|Visit_2|25|1|TREATMENT|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|5|SRAW|Specific Airway Resistance|[?]|SLING|[?]|CCID 50/dose|[?]|1|mCi/kg|PELVIC BONE|UNILATERAL|PARIETO-OCCIPITAL|FLUORESCEIN STAIN||||CHILD|DERMATOLOGIST|3|Visit_3|40|1|WASHOUT|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING|||[?]|1|mmHg/sec|TIBIA|IPSILATERAL|TIP|ANTIBIOTIC AGAR SCREEN|||Y|INDEPENDENT ASSESSOR|OPTOMETRIST|3|Visit_3|40|5|TREATMENT|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|7|FEV3FVC|FEV3/FVC|[?]|PRONE|||[?]|1|mL/mmHg|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|IPSILATERAL|PERIVENTRICULAR|MAGNETIC RESONANCE ENTEROGRAPHY|||Y|ADJUDICATION COMMITTEE|DERMATOLOGIST|4|Visit_4|65|6|SCREENING|2021-03-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|8|EVC|Expiratory Vital Capacity|[?]|FOWLERS|[?]|mU/L|[?]|1|umol/mol|THIRD DIAGONAL BRANCH ARTERY|LATERAL|OUTER|PEAK FLOWMETRY||||ADJUDICATOR|ADJUDICATOR 3|4|Visit_4|65|7|TREATMENT|2021-03-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|9|FEF50|Forced Expiratory Flow 50%|[?]|REVERSE TRENDELENBURG|[?]|uIU/dL|[?]|1|kIU|FEMALE GENITALIA|UNILATERAL|DISTAL VOLAR|CALCULATION||Y||PARENT|MICROSCOPIST 2|5|Visit_5|90|7|TREATMENT|2021-04-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|60b23345-43f6-42eb-9225-5a674456c9b9|10|FEV1FVC6|FEV1/FVC6|[?]|SUPINE|[?]|/cmH2O|[?]|1|fL|RIB 5|CONTRALATERAL|OUTER|NO INFORMATION|Y|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-04-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|1|MIP|Maximal Inspiratory Pressure|[?]|LEFT LATERAL DECUBITUS|||[?]|1|vg/kg|TRICUSPID VALVE ANNULUS|LEFT|ROSTRAL|PYROSEQUENCING|||Y|FAMILY MEMBER|CARDIOLOGIST|1|Visit_1|10|3|WASHOUT|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|2|FEF50|Forced Expiratory Flow 50%|[?]|FOWLERS|[?]|lm|[?]|1|scm|POSTEROLATERAL SEGMENTAL ARTERY|LATERAL|OUTER|FLUORIMETRY|Y|Y||PROXY|MICROSCOPIST 3|1|Visit_1|10|2|TREATMENT|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|3|FRC|Functional Residual Capacity|[?]|SLING|[?]|nkat/g Hb|[?]|1|nL|HEART, RIGHT VENTRICULAR FREE WALL|LEFT|PROXIMAL VOLAR|MAPH||Y||FAMILY MEMBER|RADIOLOGIST 1|2|Visit_2|25|7|TREATMENT|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|4|SGAW|Specific Airway Conductance|[?]|LATERAL DECUBITUS|||[?]|1|Tbsp|KIDNEY, MEDULLA|LATERAL|MIDLINE|MICRO BROTH DILUTION||Y|Y|NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|2|Visit_2|25|6|WASHOUT|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|5|EFFVOL|Effusion Volume|[?]|SEMI-FOWLERS|[?]|mL/cage/wk|[?]|1|/5x10^4 WBC|BRACHIAL LYMPH NODE|CONTRALATERAL|MIDLINE|CAPILLARY ELECTROPHORESIS|Y|||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|TREATMENT|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|6|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-FOWLERS|[?]|FINGERTIP UNIT|[?]|1|umol/min|ULNAR ARTERY|LEFT|TEMPORAL|PHOTOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|3|Visit_3|40|3|TREATMENT|2021-02-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|7|ALVVOL|Alveolar Volume|[?]|REVERSE TRENDELENBURG|[?]|% INHIBITION|[?]|1|CFU/g|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|LEFT|ANTEROPOSTERIOR|SLOAN LETTER EYE CHART 2.5%||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|4|Visit_4|65|5|TREATMENT|2021-03-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|8|MIPPP|Percent Predicted MIP|[?]|LATERAL DECUBITUS|[?]|LOZENGE|[?]|1|U/cL|METACARPAL BONE 3|BILATERAL|FACIAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|||FAMILY MEMBER|UROLOGIST|4|Visit_4|65|4|TREATMENT|2021-03-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING, BENT FORWARD|[?]|APL U/mL|[?]|1|kUSP|SUBCLAVIAN VEIN|IPSILATERAL|LATERAL|POLYMERASE CHAIN REACTION||||CAREGIVER|RATER|5|Visit_5|90|5|TREATMENT|2021-04-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|RE|7979239e-2a6b-48e3-9d11-41c97b33d229|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|uIU/L|[?]|1|Henry|ILEUM LYMPH NODE|RIGHT|PERIPHERAL|ECHOCARDIOGRAPHY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-04-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|EFFIND|Effusion Indicator|[?]|STANDING, BENT FORWARD|[?]|kIU|[?]|1|F|JUGULAR VEIN|LEFT|ANTEROTEMPORAL|IMMUNO-PET SCAN||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|1|Visit_1|10|6|TREATMENT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|[?]|HOMEOPATHIC DILUTION|[?]|1|ECL unit|LUNATE BONE|LEFT|TIP|CONTRAST ENHANCED PET SCAN||||INTERVIEWER|MICROSCOPIST 3|1|Visit_1|10|5|SCREENING|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|[?]|MPS U|[?]|1|/VF|PERIANAL REGION|LATERAL|LOWER|POLYMERASE CHAIN REACTION||||VENDOR|CLINICAL PATHOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-08-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|4|IC|Inspiratory Capacity|[?]|STANDING|[?]|MPL U/mL|[?]|1|nsec|LUNG, LEFT UPPER LOBE|CONTRALATERAL|FACIAL|RIA|Y|||INVESTIGATOR|NEUROLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-08-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|5|OXYPULSE|Oxygen Pulse|[?]|RIGHT LATERAL DECUBITUS|[?]|mmol/kg|[?]|1|s*kPa|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|LEFT|ANTEROLATERAL|HPLC-UV|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-09-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|6|ERVPP|Percent Predicted ERV|[?]|SEMI-FOWLERS|[?]|ug/L DDU|[?]|1|CFU/g|JEJUNUM|BILATERAL|MIDLINE|CINEANGIOGRAPHY|Y|Y||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST|3|Visit_3|40|2|TREATMENT|2020-09-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|7|DLCOPP|Percent Predicted DLCO|[?]|SUPINE|||[?]|1|PRESSOR UNITS|CAPITATE BONE|LATERAL|PROXIMAL|MICROBIAL CONCENTRATION|||Y|ADJUDICATION COMMITTEE|NEUROLOGIST 2|4|Visit_4|65|6|FOLLOW-UP|2020-09-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|8|MALIND|Malignancy Indicator|[?]|SITTING|[?]|ukat/L|[?]|1|WAFER|RIB 11|UNILATERAL|INTERMEDIATE|GRADIENT DIFFUSION|Y|||VENDOR|RADIOLOGIST|4|Visit_4|65|6|TREATMENT|2020-09-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|9|AWVOL|Airway Volume|[?]|DECUBITUS|[?]|nmol/day|[?]|1|ug/day|SUPRACLAVICULAR LYMPH NODE|LEFT|ROSTRAL|INTRAVASCULAR ULTRASOUND||||INVESTIGATOR|NEUROLOGIST|5|Visit_5|90|7|WASHOUT|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|10|FEV1PP|Percent Predicted FEV1|[?]|UNCONSTRAINED|[?]|mL/100g/min|[?]|1|BP|ANTERIOR CINGULATE CORTEX|UNILATERAL|PARIETO-OCCIPITAL|DUCTOGRAPHY||||INTERVIEWER|READER 2|5|Visit_5|90|1|WASHOUT|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-FOWLERS|[?]|10^6 organisms/g|[?]|1|USP U|SMALL SAPHENOUS VEIN|CONTRALATERAL|SUBCORTICAL|ELISPOT||||GUARDIAN|RATER 1|1|Visit_1|10|5|TREATMENT|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|2|FEV3PP|Percent Predicted FEV3|[?]|SEMI-RECUMBENT|[?]|CUP|[?]|1|10^7 PFU|LATERAL SECOND DIAGONAL BRANCH ARTERY|UNILATERAL|DISTAL|ETDRS EYE CHART||||SIBLING|MICROSCOPIST 3|1|Visit_1|10|7|SCREENING|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|3|IRV|Inspiratory Reserve Volume|[?]|SUPINE|[?]|vg/dose|[?]|1|/sec|SECOND DIAGONAL BRANCH ARTERY|BILATERAL|DISTAL|ALCIAN BLUE STAIN||||FRIEND|NEUROLOGIST 1|2|Visit_2|25|2|TREATMENT|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|4|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|mg/kg|[?]|1|10^6 organisms/g|RIB 12|RIGHT|INFERIOR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|||SIBLING|PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-FOWLERS|[?]|L/day|[?]|1|L/min|MIDDLE PHALANX 3 OF THE HAND|BILATERAL|LOWER MEDIAL|FUNDUS PHOTOGRAPHY||||FAMILY MEMBER|ADJUDICATOR 3|3|Visit_3|40|4|TREATMENT|2021-02-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|6|PCF|Peak Cough Flow|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^3 CFU/g|C5 VERTEBRA|RIGHT|CENTRAL|MRI WITHOUT CONTRAST|||Y|SIBLING|READER 3|3|Visit_3|40|7|WASHOUT|2021-02-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SLING|[?]|mm2|[?]|1|U/cL|COCCYGEAL VERTEBRA|RIGHT|POSTERIOR|VIRUS PLAQUE ASSAY||||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|4|WASHOUT|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|8|EFFVOL|Effusion Volume|[?]|SEMI-RECUMBENT|[?]|CUP|[?]|1|mEq|PANCREAS, TAIL|LEFT|DORSOLATERAL|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY||||GUARDIAN|ADJUDICATOR|4|Visit_4|65|2|SCREENING|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|9|IRV|Inspiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|10^3/L|[?]|1|pmol/day|MITRAL VALVE, POSTERIOR CUSP|RIGHT|DISTAL VOLAR|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||Y||ADJUDICATOR|ENDOCRINOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|RE|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|10|FEV1REV|FEV1 Reversibility|[?]|SEMI-FOWLERS|[?]|STEPS|[?]|1|mL/animal/wk|MIDDLE PHALANX 3 OF THE HAND|CONTRALATERAL|DORSAL|PULMONARY ANGIOGRAPHY||Y||CLINICAL STUDY SPONSOR|READER 2|5|Visit_5|90|4|TREATMENT|2021-03-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-04
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|cmH2O*s2/mL|[?]|1|ppb|APPENDICEAL TIP|LATERAL|ANTERIOR|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||Y||CLINICAL STUDY SPONSOR|INTERNIST|1|Visit_1|10|5|FOLLOW-UP|2020-07-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|2|TSUELAS|Tissue Elastance|[?]|UNCONSTRAINED|||[?]|1|CFU/mL|PARAPHARYNGEAL LYMPH NODE|BILATERAL|DISTAL VOLAR|AUDIOMETRY|Y|Y|Y|ADJUDICATOR|MICROSCOPIST|1|Visit_1|10|1|TREATMENT|2020-07-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|3|FIVC|Forced Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|mU|[?]|1|nmol BCE/nmol|HEPATIC LYMPH NODE|CONTRALATERAL|CENTRAL|IMPULSE OSCILLOMETRY||||PROXY|READER 3|2|Visit_2|25|7|WASHOUT|2020-08-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|4|TSUHYS|Tissue Hysteresivity|[?]|SITTING, LEGS DEPENDENT|[?]|SFC/10^6 PBMC|[?]|1|CFU/g|SUBMANDIBULAR LYMPH NODE|LATERAL|PROXIMAL|MACRO BROTH DILUTION||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|2|Visit_2|25|3|TREATMENT|2020-08-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|5|IVCPP|Percent Predicted IVC|[?]|SITTING|[?]|Enzyme U/g Hb|[?]|1|mol/mg|DISTAL PHALANX 2 OF THE HAND|LATERAL|APICAL|DUKE INCISION METHOD||Y||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|3|Visit_3|40|4|TREATMENT|2020-08-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|6|ERV|Expiratory Reserve Volume|[?]|FOWLERS|[?]|ppth|[?]|1|genEq|PHARYNGEAL TONSIL|LATERAL|PERIVENTRICULAR|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|3|Visit_3|40|2|FOLLOW-UP|2020-08-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|LEFT LATERAL DECUBITUS|[?]|cm2|[?]|1|ug/m2/day|PELVIC LYMPH NODE|LEFT|MIDLINE|SPECT/CT SCAN||||CHILD|RATER 1|4|Visit_4|65|4|SCREENING|2020-09-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|8|FVC|Forced Vital Capacity|[?]|FOWLERS|||[?]|1|ug/dL|EPICARDIUM|BILATERAL|PROXIMAL|HPLC|||Y|CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|4|Visit_4|65|5|SCREENING|2020-09-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|9|PEFTIME|Peak Expiratory Flow Time|[?]|PRONE|[?]|ug/g/min|[?]|1|gtt|FEMUR|IPSILATERAL|APICAL|CELL OF ORIGIN ASSAY||||PROXY|READER 1|5|Visit_5|90|5|SCREENING|2020-10-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|da35fc01-4258-4e4d-99d9-4172e84c46e8|10|SVC|Slow Vital Capacity|[?]|DECUBITUS|||[?]|1|ug/m2/h|GLOBUS PALLIDUS|BILATERAL|SUPERFICIAL|RADIOGRAPHY|Y||Y|GUARDIAN|HEMATOLOGIST|5|Visit_5|90|2|WASHOUT|2020-10-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|FOWLERS|[?]|10^4 CFU|[?]|1|PFU/dose|LEG|BILATERAL|LOWER|FLUOROSCOPY||||GUARDIAN|RATER|1|Visit_1|10|2|TREATMENT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|2|PLMXRS|Pulmonary Reactance|[?]|UNCONSTRAINED|||[?]|1|um|MOTOR CORTEX|BILATERAL|SUBCORTICAL|ULTRASONOGRAPHIC ELASTOGRAPHY||Y|Y|INTERVIEWER|PATHOLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|3|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|SYRINGE|[?]|1|km/h|ANKLE JOINT|IPSILATERAL|ROSTRAL|INFRARED SPECTROMETRY||||VENDOR|MICROSCOPIST|2|Visit_2|25|2|SCREENING|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|4|FEV3PP|Percent Predicted FEV3|[?]|SITTING|[?]|U/10^12 RBC|[?]|1|kg/cm|MEDIASTINUM, SUPERIOR|LATERAL|CENTRAL|URANYL ACETATE STAIN|Y|Y||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|2|Visit_2|25|6|SCREENING|2020-08-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|5|FEV3FVC|FEV3/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|L/h/m2|[?]|1|MdFI|CARDIAC VALVE|LATERAL|PROXIMAL|CELLULOSE TAPE|Y|||SPOUSE|RATER 2|3|Visit_3|40|7|TREATMENT|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|L|[?]|1|IU/L|OMENTUM|BILATERAL|LOWER|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||DOMESTIC PARTNER|HEMATOLOGIST|3|Visit_3|40|6|SCREENING|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|7|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SITTING, LEGS DEPENDENT|||[?]|1|U/g/min|T2 VERTEBRA|UNILATERAL|ANTERIOR|GC/MS-CI|Y||Y|SIBLING|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|8|IRVPP|Percent Predicted IRV|[?]|LEFT LATERAL DECUBITUS|[?]|copies/ug|[?]|1|kUSP|BICEPS BRACHII MUSCLE|LATERAL|UPPER|PET/CT SCAN WITHOUT CONTRAST||||NON-HEALTH CARE PROFESSIONAL|HEMATOLOGIST|4|Visit_4|65|3|SCREENING|2020-09-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|9|FEV1SVC|FEV1/SVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|log10 CFU/mL|C7 VERTEBRA|LATERAL|CRANIAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|||Y|CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|SCREENING|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|||[?]|1|mL/s/m2|ESOPHAGUS, THORACIC|LEFT|DORSAL|PEAK FLOWMETRY|||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 3|5|Visit_5|90|5|SCREENING|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|mL/beat|[?]|1|10^6/Ejaculate U|PERICARDIAL LYMPH NODE|LEFT|UPPER|TRIPLE-PHASE MRI SCAN||||SIBLING|READER 3|1|Visit_1|10|7|TREATMENT|2020-12-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|[?]|atm|[?]|1|ft|CHOROID PLEXUS|LATERAL|OUTER|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||Y||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|1|Visit_1|10|2|TREATMENT|2020-12-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|3|FEV1FVC|FEV1/FVC|[?]|DECUBITUS|[?]|PIXELS/in|[?]|1|Rad|STOMACH|LEFT|FACIAL|CLIP||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|2|Visit_2|25|6|TREATMENT|2020-12-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|4|FEV1SVC|FEV1/SVC|[?]|SITTING, LEGS DEPENDENT|[?]|mmHg*min/L|[?]|1|U/animal|MITRAL VALVE, ANTERIOR CUSP|UNILATERAL|INNER|LC/MS||||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|2|Visit_2|25|1|WASHOUT|2020-12-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|||[?]|1|cmol|PERIRECTAL LYMPH NODE|IPSILATERAL|LOWER|CALCULATION|Y||Y|SIGNIFICANT OTHER|ADJUDICATOR|3|Visit_3|40|4|SCREENING|2021-01-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|FOWLERS|[?]|ELISA unit/mL|[?]|1|DRUM|HEART, LEFT ATRIUM|BILATERAL|INFERIOR|PET/SPECT SCAN||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|TREATMENT|2021-01-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|7|DLCOVA|DLCO/VA|[?]|SEMI-FOWLERS|[?]|kg|[?]|1|Gauss|FLEXOR DIGITORUM LONGUS MUSCLE|LATERAL|DISTAL|IMPULSE OSCILLOMETRY|Y|Y||PARENT|ONCOLOGIST 1|4|Visit_4|65|1|TREATMENT|2021-02-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|DECUBITUS|[?]|ug/mol|[?]|1|ug/L FEU|BUCCAL MUCOSA|LEFT|VENTROLATERAL|HPLC-FL|Y|||SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|3|TREATMENT|2021-02-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|9|LCI|Lung Clearance Index|[?]|LEFT LATERAL DECUBITUS|[?]|uEq/L|[?]|1|ag|ESOPHAGUS, UPPER THIRD|BILATERAL|HIND|CISH||||INDEPENDENT ASSESSOR|ADJUDICATOR 1|5|Visit_5|90|7|TREATMENT|2021-03-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|10|ALVVOL|Alveolar Volume|[?]|FOWLERS|[?]|CFU/mL|[?]|1|nkat/g Hb|INFRACLAVICULAR LYMPH NODE|RIGHT|MEDIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|5|Visit_5|90|7|WASHOUT|2021-03-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|[?]|CIGARETTE|[?]|1|grain|SENSORIMOTOR CORTEX|LEFT|BASAL|IMMUNOCHEMILUMINOMETRIC ASSAY||Y||SPOUSE|ONCOLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|2|TGV|Thoracic Gas Volume|[?]|FOWLERS|||[?]|1|10^9 organisms/mg|SECOND OBTUSE MARGINAL BRANCH ARTERY|RIGHT|VENTROLATERAL|WESTERN BLOT||Y|Y|PARENT|ADJUDICATOR 3|1|Visit_1|10|6|TREATMENT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|3|TGV|Thoracic Gas Volume|[?]|STANDING|[?]|log10 TCID 50/mL|[?]|1|Sv|MUCOSA|BILATERAL|NASAL|GC/MS/MS||||HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|2|WASHOUT|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|4|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING|||[?]|1|yd|TROCHANTER|UNILATERAL|MEDIAL|PHOTOMETRIC CLOT DETECTION||Y|Y|ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|7|SCREENING|2020-06-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|DECUBITUS|[?]|g/dL|[?]|1|Bq/g|PERIFACIAL LYMPH NODE|RIGHT|INNER|ELLA||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|||[?]|1|cg|PARAMETRIUM|IPSILATERAL|SUBCORTICAL|DUKE INCISION METHOD|||Y|SIBLING|DERMATOLOGIST|3|Visit_3|40|6|TREATMENT|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|7|RV|Residual Volume|[?]|SITTING, LEGS DEPENDENT|[?]|DROP|[?]|1|pmol/dL|KIDNEY, UPPER LOBE|LATERAL|INTERMEDIATE|SPECTROPHOTOMETRY||||SIBLING|CARDIOLOGIST|4|Visit_4|65|3|WASHOUT|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|8|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-RECUMBENT|[?]|uV2|[?]|1|pL|HYPOPHARYNX|RIGHT|DISTAL|AUDIOMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|RATER 2|4|Visit_4|65|4|TREATMENT|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|9|TGV|Thoracic Gas Volume|[?]|REVERSE TRENDELENBURG|[?]|Hounsfield Unit|[?]|1|g/cage|SUBARACHNOID SPACE|IPSILATERAL|ANTEROPOSTERIOR|PERFUSION MRI|Y|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|5|Visit_5|90|1|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|UNCONSTRAINED|[?]|10^9/L|[?]|1|in2|METATARSOPHALANGEAL JOINT 5|UNILATERAL|ANTEROTEMPORAL|REVERSE TRANSCRIPTASE PCR||Y||ADJUDICATION COMMITTEE|NEUROLOGIST 1|5|Visit_5|90|5|SCREENING|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mL/s/m2|ALVEOLUS|LEFT|OCCIPITAL|IHC|||Y|SIGNIFICANT OTHER|MICROSCOPIST 1|1|Visit_1|10|4|WASHOUT|2020-05-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|2|FEF2575P|Percent Predicted FEF25-75|[?]|TRENDELENBURG|||[?]|1|RING|SMALL SAPHENOUS VEIN|IPSILATERAL|CENTRAL|KLEIHAUER-BETKE|||Y|PARENT|ADJUDICATOR 3|1|Visit_1|10|6|FOLLOW-UP|2020-05-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|3|FRCPP|Percent Predicted FRC|[?]|STANDING|[?]|10^6 RNA copies/mL|[?]|1|mol|LEFT VENTRICULAR MID ANTERIOR SEGMENT|LATERAL|VENTRAL|PLETHYSMOGRAPHY||||INVESTIGATOR|CLINICAL PATHOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|4|FRCPP|Percent Predicted FRC|[?]|STANDING, BENT FORWARD|[?]|pt_br|[?]|1|Ci/g|OLFACTORY MUCOSA|UNILATERAL|PARIETO-OCCIPITAL|NUCLEIC ACID AMPLIFICATION TEST||||DOMESTIC PARTNER|NEUROLOGIST 1|2|Visit_2|25|6|WASHOUT|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|5|SALKB|Salazar-Knowles Equation Parameter B|[?]|SLING|[?]|kat|[?]|1|g/cage/wk|FIBULA|LEFT|SUPERIOR|SLOAN LETTER EYE CHART 100%||Y||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-06-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|6|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|APL U|[?]|1|10^5/L|KIDNEY|LATERAL|ANTEROPOSTERIOR|HILLMEN COLOR CHART||||CLINICAL STUDY SPONSOR|ADJUDICATOR|3|Visit_3|40|4|FOLLOW-UP|2020-06-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-14
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SLING|[?]|mL/g/day|[?]|1|nmol/g|AORTIC VALVE ANNULUS|BILATERAL|DORSAL|ACRIDINE ORANGE STAIN||||SIBLING|ENDOCRINOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|8|FEV1SVC|FEV1/SVC|[?]|REVERSE TRENDELENBURG|||[?]|1|Log10 ELISA unit|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|LATERAL|LOWER FLEXOR SURFACE|CONTRAST ENHANCED SPIRAL CT SCAN|||Y|INTERVIEWER|READER|4|Visit_4|65|2|SCREENING|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|kcal/day|[?]|1|g/cm2|PYRAMIDAL TRACTS, BRAINSTEM|BILATERAL|PARIETO-OCCIPITAL|PET/MRI SCAN||||GUARDIAN|READER 2|5|Visit_5|90|1|TREATMENT|2020-08-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|10|EFFIND|Effusion Indicator|[?]|LATERAL DECUBITUS|[?]|L/h|[?]|1|SPRAY|GINGIVAL MUCOSA|UNILATERAL|OCCIPITAL|LAPAROSCOPY||||STUDY SUBJECT|ADJUDICATOR 3|5|Visit_5|90|5|FOLLOW-UP|2020-08-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|1|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|||[?]|1|mL*cmH2O|FINGER FLEXOR MUSCLES|LATERAL|PROXIMAL VOLAR|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y||Y|DOMESTIC PARTNER|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|2|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-FOWLERS|[?]|10^9 CFU/g|[?]|1|mU|SPINOUS PROCESS|LEFT|UPPER FLEXOR SURFACE|X-RAY||Y||DOMESTIC PARTNER|NEUROLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-09-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|3|SVC|Slow Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|GPL U/mL|TEMPOROMANDIBULAR JOINT|IPSILATERAL|PROXIMAL VOLAR|DIFFUSION WEIGHTED MRI||Y|Y|INDEPENDENT ASSESSOR|CARDIOLOGIST|2|Visit_2|25|2|TREATMENT|2020-10-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|4|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING|[?]|cGy|[?]|1|ug/m2/h|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|RIGHT|NASAL|NO INFORMATION||||CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|2|Visit_2|25|1|WASHOUT|2020-10-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-16
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|5|IVC|Inspiratory Vital Capacity|[?]|STANDING|||[?]|1|APS U|SUPRAPUBIC REGION|BILATERAL|BASAL|SPECT/CT SCAN||Y|Y|SIGNIFICANT OTHER|PATHOLOGIST 2|3|Visit_3|40|5|WASHOUT|2020-10-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|6|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|[?]|umol/mg/min|[?]|1|gtt|METACARPOPHALANGEAL JOINT 4|UNILATERAL|CRANIAL|TURBIDIMETRY||Y||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-10-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|7|ELSTNCE|Elastance|[?]|SEMI-FOWLERS|[?]|Newton|[?]|1|cm/min|DISTAL LAD ARTERY|LEFT|CAUDAL|PHASE-CONTRAST MRI||||FRIEND|ADJUDICATOR 3|4|Visit_4|65|7|TREATMENT|2020-11-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|8|MALEVDES|Malignancy Evidence Description|[?]|DECUBITUS|[?]|log10 PFU/mL|[?]|1|L/min|BUTTOCK|RIGHT|ANTEROPOSTERIOR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y||ADJUDICATION COMMITTEE|ADJUDICATOR 2|4|Visit_4|65|7|TREATMENT|2020-11-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|steps/min|[?]|1|ag|NUCLEUS ACCUMBENS|UNILATERAL|INFERIOR|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||INTERVIEWER|RADIOLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|136d59c6-9645-447a-a047-68d33dbb708e|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|ft|[?]|1|uU/L|SCAPULA|LEFT|DISTAL|AUSCULTATION|Y|||VENDOR|RATER|5|Visit_5|90|4|WASHOUT|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|1|RAW|Airway Resistance|[?]|FOWLERS|[?]|10^6 copies/mL|[?]|1|mL/h|HEEL OF THE HAND|RIGHT|ANTEROMEDIAL|NUCLEIC ACID SEQUENCING|Y|Y||FAMILY MEMBER|DERMATOLOGIST|1|Visit_1|10|5|WASHOUT|2020-06-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|2|LCI|Lung Clearance Index|[?]|SEMI-RECUMBENT|[?]|kg/cm2|[?]|1|mL*cmH2O|URETHRA, PENILE|LATERAL|VENTROLATERAL|CONTACT SPECULAR MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|[?]|mL/mmHg/min/L|[?]|1|h/wk|L3-L4 INTERVERTEBRAL SPACE|LEFT|MIDLINE|TARGETED TRANSCRIPTOME SEQUENCING||Y||INTERVIEWER|READER|2|Visit_2|25|7|TREATMENT|2020-07-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|4|IRV|Inspiratory Reserve Volume|[?]|SLING|[?]|nU/cL|[?]|1|V/sec|VOCAL CORD|LATERAL|LATERAL|ROMANOWSKY STAIN||||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-07-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|5|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING, LEGS DEPENDENT|[?]|mg/m2/min|[?]|1|/10^3|CORNEAL ENDOTHELIUM|BILATERAL|VOLAR|WHOLE TRANSCRIPTOME SEQUENCING||||ADJUDICATOR|RADIOLOGIST 1|3|Visit_3|40|5|FOLLOW-UP|2020-07-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|6|INERTANC|Inertance|[?]|LEFT LATERAL DECUBITUS|[?]|L/s|[?]|1|U/10^12 RBC|MIDDLE PHALANX 5 OF THE HAND|LATERAL|VOLAR|GC/MS-CI||||ADJUDICATOR|READER|3|Visit_3|40|3|TREATMENT|2020-07-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|7|INTP|Interpretation|[?]|REVERSE TRENDELENBURG|[?]|g/kg/day|[?]|1|PIXELS/cm|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LEFT|DISTAL VOLAR|FLUORESCEIN STAIN||||HEALTH CARE PROFESSIONAL|DERMATOLOGIST|4|Visit_4|65|7|WASHOUT|2020-08-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING|||[?]|1|mmol/mol|METATARSOPHALANGEAL JOINT 5|BILATERAL|TEMPORAL|CONTRAST ENHANCED PET SCAN|||Y|HEALTH CARE PROFESSIONAL|PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-21
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|9|RELSZCHG|Relative Size Change|[?]|SEMI-RECUMBENT|[?]|U/cL|[?]|1|atm|VULVOVAGINAL REGION|UNILATERAL|DISTAL|OPTICAL COHERENCE TOMOGRAPHY|Y|||SIBLING|READER 2|5|Visit_5|90|5|TREATMENT|2020-09-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|2e393b90-213c-4661-ad55-cabb2008bf14|10|RER|Respiratory Exchange Ratio|[?]|SEMI-FOWLERS|[?]|CAPSULE|[?]|1|GPL U/mL|INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|OUTER|DIFFUSION TENSOR MRI||Y||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|5|SCREENING|2020-09-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|1|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|[?]|km|[?]|1|ms2|NASOPHARYNX|BILATERAL|SUPERIOR|MICRO BROTH DILUTION|Y|Y||INTERVIEWER|RADIOLOGIST 2|1|Visit_1|10|2|WASHOUT|2020-10-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|2|FEV_PEF|FEV at PEF|[?]|STANDING, BENT FORWARD|[?]|deg/s|[?]|1|in2|DUODENUM|LEFT|PERIPHERAL|MAGNETIC RESONANCE ANGIOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|1|Visit_1|10|5|FOLLOW-UP|2020-10-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|3|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|WAFER|[?]|1|kcal|INTERNAL ILIAC LYMPH NODE|IPSILATERAL|MIDLINE|TELLER ACUITY CARDS||Y||SIGNIFICANT OTHER|ADJUDICATOR 2|2|Visit_2|25|7|TREATMENT|2020-10-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|4|FEV3PP|Percent Predicted FEV3|[?]|TRENDELENBURG|[?]|mol/mg|[?]|1|MBP|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|UPPER FLEXOR SURFACE|LAPAROSCOPY||||STUDY SUBJECT|DERMATOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-10-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|5|EXPRELTM|Expiration Relaxation Time|[?]|REVERSE TRENDELENBURG|||[?]|1|g/L|AORTIC VALVE, LEFT CORONARY CUSP|LATERAL|PROXIMAL|ANGIOGRAPHY||Y|Y|CLINICAL STUDY SPONSOR|ONCOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-11-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|10^3 CFU|[?]|1|ELISA unit/mL|CARPAL BONE|UNILATERAL|INFERIOR|PUPILLOMETRY||||SPOUSE|ONCOLOGIST|3|Visit_3|40|1|WASHOUT|2020-11-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|7|INERTANC|Inertance|[?]|UNCONSTRAINED|[?]|ng/L|[?]|1|Gauss|FEMORAL VEIN|BILATERAL|VENTRAL|PET/CT SCAN WITHOUT CONTRAST||Y||SIBLING|MICROSCOPIST 3|4|Visit_4|65|4|TREATMENT|2020-12-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|8|AWVOL|Airway Volume|[?]|FOWLERS|[?]|ft|[?]|1|ohm|OLFACTORY BULB|IPSILATERAL|SURFACE|ROMANOWSKY STAIN|Y|Y||STUDY SUBJECT|PATHOLOGIST|4|Visit_4|65|3|WASHOUT|2020-12-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-FOWLERS|[?]|nsec|[?]|1|PRESSOR UNITS|LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT|LEFT|NASAL|FLUORESCENT IMMUNOASSAY||||GUARDIAN|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2021-01-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|f72002d8-262b-49da-84a4-42e6011286f0|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|TRENDELENBURG|[?]|mm3/mm2/year|[?]|1|cy/cm|DUCTUS ARTERIOSUS|BILATERAL|CAUDAL|SANGER SEQUENCING||||CHILD|ONCOLOGIST|5|Visit_5|90|6|SCREENING|2021-01-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|1|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|[?]|dpm/0.5 mL|[?]|1|VIRTUAL PIXEL|CORPUS LUTEUM|UNILATERAL|UPPER EXTENSOR SURFACE|LC/MS/MS|Y|||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|3|SCREENING|2020-12-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|2|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|mol/mg|[?]|1|mg/dL|HEPATIC VEIN|LATERAL|CAUDAL|CONFOCAL MICROSCOPY|Y|||INTERVIEWER|ENDOCRINOLOGIST|1|Visit_1|10|2|TREATMENT|2020-12-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|3|INTP|Interpretation|[?]|STANDING|[?]|QUANTITY SUFFICIENT|[?]|1|Log10 ELISA unit/dose|PLACENTA|LEFT|CAUDAL|IODINE STAIN||||INDEPENDENT ASSESSOR|DERMATOLOGIST|2|Visit_2|25|2|TREATMENT|2020-12-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|4|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|P|[?]|1|10^6 U|RIB 7|UNILATERAL|CENTRAL|ROMANOWSKY STAIN||Y||FAMILY MEMBER|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2020-12-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|5|FRC|Functional Residual Capacity|[?]|STANDING, BENT FORWARD|[?]|INHALATION|[?]|1|mL/dose|LATERAL RAMUS INTERMEDIUS ARTERY|LATERAL|LOWER EXTENSOR SURFACE|VIRUS PLAQUE ASSAY|Y|Y||ADJUDICATION COMMITTEE|ONCOLOGIST 1|3|Visit_3|40|7|FOLLOW-UP|2021-01-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|RING|[?]|1|pkat|INFRARENAL AORTA|LEFT|INTERMEDIATE|SINGLE-MOLECULE ARRAY||||FRIEND|READER|3|Visit_3|40|6|WASHOUT|2021-01-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-18
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|7|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SEMI-RECUMBENT|[?]|cmH2O*s2/mL|[?]|1|10^6/Ejaculate U|HAND DIGIT 5|CONTRALATERAL|DORSOLATERAL|BAC ACGH||||PARENT|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2021-02-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|8|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|10^6 CFU|[?]|1|ka_u/dL|CEREBRAL CORTEX|UNILATERAL|ANTEROMEDIAL|MYELOPEROXIDASE STAIN||||GUARDIAN|FORENSIC PATHOLOGIST|4|Visit_4|65|7|SCREENING|2021-02-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|SLING|||[?]|1|ppth|TRICUSPID VALVE, POSTERIOR ANNULUS|RIGHT|LOWER FLEXOR SURFACE|DOUBLE IMMUNODIFFUSION||Y|Y|FAMILY MEMBER|RATER 2|5|Visit_5|90|1|SCREENING|2021-02-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|68869dda-531d-4218-b2b0-4f5f46825569|10|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|||[?]|1|MHz|CORONARY VEIN|LATERAL|NASAL|MECHANICAL CLOT DETECTION|||Y|SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|WASHOUT|2021-02-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|1|FIVC|Forced Inspiratory Vital Capacity|[?]|PRONE|||[?]|1|MET*h|MEDIASTINUM, POSTERIOR|RIGHT|INTERMEDIATE|IMMUNO-PET SCAN||Y|Y|STUDY SUBJECT|PATHOLOGIST 1|1|Visit_1|10|4|TREATMENT|2021-01-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|2|ICPP|Percent Predicted Inspiratory Capacity|[?]|SUPINE|||[?]|1|%(w/w)|SUPERIOR PUBIC RAMUS|LEFT|ROSTRAL|CYSTOSCOPY|||Y|VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|5|SCREENING|2021-01-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|3|GAW|Airway Conductance|[?]|FOWLERS|[?]|nmol BCE/mmol|[?]|1|/5x10^4 WBC|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|LEFT|SUPERFICIAL|PUPILLOMETRY||Y||GUARDIAN|RADIOLOGIST 1|2|Visit_2|25|7|WASHOUT|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|4|MEPPP|Percent Predicted MEP|[?]|LEFT LATERAL DECUBITUS|[?]|10^7 CFU/mL|[?]|1|log10 TCID 50/dose|MIDDLE PHALANX 3 OF THE HAND|RIGHT|DORSOLATERAL|CT SCAN WITHOUT CONTRAST||||PARENT|NEUROLOGIST|2|Visit_2|25|2|FOLLOW-UP|2021-01-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-19
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|5|DLCOHC|HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|[?]|10^4 CFU/mL|[?]|1|JAR|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|DORSAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y||FAMILY MEMBER|READER|3|Visit_3|40|3|TREATMENT|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|6|DLCO|Diffusion Capacity of Lung for CO|[?]|SLING|[?]|usec|[?]|1|g/cm2|CRANIAL NERVE|IPSILATERAL|OCCIPITAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||GUARDIAN|UROLOGIST|3|Visit_3|40|7|TREATMENT|2021-02-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|DECUBITUS|[?]|10^9/L|[?]|1|cd*s/m2|CORNEAL STROMA|RIGHT|DISTAL VOLAR|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||Y||DOMESTIC PARTNER|NEUROLOGIST 2|4|Visit_4|65|1|SCREENING|2021-03-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|8|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|CIGAR|[?]|1|10^6 organisms|VAGINAL WALL|UNILATERAL|ANTEROLATERAL|ELECTROPHORESIS||||CAREGIVER|NEUROLOGIST 1|4|Visit_4|65|4|TREATMENT|2021-03-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-07
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|9|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|umol/L|[?]|1|umol/day|ARM|LATERAL|VENTRAL|HPLC/MS/MS||||CAREGIVER|NEUROLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2021-04-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|68888445-1819-4f4c-bd0c-a445906476fb|10|FEV1REV|FEV1 Reversibility|[?]|DECUBITUS|[?]|log10 CCID 50/dose|[?]|1|/40 HPFs|FLEXOR DIGITORUM PROFUNDUS MUSCLE|RIGHT|PARIETO-OCCIPITAL|SINGLE-MOLECULE ARRAY|Y|||INVESTIGATOR|READER 2|5|Visit_5|90|5|TREATMENT|2021-04-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|UNCONSTRAINED|[?]|/kg|[?]|1|AMPULE|PANCREAS, TAIL|LEFT|UPPER FLEXOR SURFACE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||INDEPENDENT ASSESSOR|RADIOLOGIST|1|Visit_1|10|7|SCREENING|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|FOWLERS|[?]|Ejaculate U|[?]|1|uL/dose|MASTOID PROCESS|CONTRALATERAL|UPPER EXTENSOR SURFACE|REFLECTANCE SPECTROSCOPY||Y||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|1|Visit_1|10|4|WASHOUT|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|3|FIF25|Forced Inspiratory Flow at 25%|[?]|SEMI-FOWLERS|[?]|EVENTS|[?]|1|U/m2/min|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LATERAL|LOWER MEDIAL|LC/MS/MS||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|2|Visit_2|25|5|SCREENING|2020-07-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|4|FEV1SVC|FEV1/SVC|[?]|SLING|[?]|psi|[?]|1|fmol/g|RETROPHARYNGEAL LYMPH NODE|RIGHT|ROSTRAL|MACRO BROTH DILUTION|Y|||ADJUDICATION COMMITTEE|OPTOMETRIST|2|Visit_2|25|5|FOLLOW-UP|2020-07-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|5|ERVPP|Percent Predicted ERV|[?]|FOWLERS|[?]|PHERESIS UNIT|[?]|1|log10 IU/mL|JUGULAR VEIN|BILATERAL|LOWER FLEXOR SURFACE|FLUORIMETRY|Y|||CHILD|ONCOLOGIST|3|Visit_3|40|6|SCREENING|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|ng/day|[?]|1|nkat/g Hb|PORTAL VEIN|RIGHT|ANTEROTEMPORAL|IMMUNOTURBIDIMETRY|Y|Y||HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|3|Visit_3|40|1|WASHOUT|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|7|INFLTIND|Infiltrates Indicator|[?]|REVERSE TRENDELENBURG|[?]|10^6 organisms/mL|[?]|1|Ci/g|T10 VERTEBRA|BILATERAL|PROXIMAL VOLAR|GEL ELECTROPHORESIS||||INTERVIEWER|ENDOCRINOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-08-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|8|SRAW|Specific Airway Resistance|[?]|DECUBITUS|[?]|cy/cm|[?]|1|ugEq/L|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|UNILATERAL|DEEP|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|||INTERVIEWER|RADIOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-08-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|9|IRV|Inspiratory Reserve Volume|[?]|FOWLERS|||[?]|1|pg/dL|HAIR ROOT|LATERAL|ANTERIOR|ENZYMATIC ULTRACENTRIFUGATION|Y||Y|ADJUDICATOR|HEMATOLOGIST|5|Visit_5|90|1|TREATMENT|2020-09-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|b2ce31a0-513a-449a-aa2c-7c9668fde275|10|FVC|Forced Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|10^4 CFU|[?]|1|U/mg|ABDUCTOR POLLICIS BREVIS MUSCLE|LATERAL|INNER|FUNCTIONAL MRI||||PROXY|READER 3|5|Visit_5|90|7|SCREENING|2020-09-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|LCI|Lung Clearance Index|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|AgU/mL|VASTUS LATERALIS MUSCLE|UNILATERAL|DORSAL|ATOMIC ABSORPTION SPECTROMETRY|||Y|CHILD|DERMATOLOGIST|1|Visit_1|10|4|WASHOUT|2020-10-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|2|DLCO|Diffusion Capacity of Lung for CO|[?]|STANDING, BENT FORWARD|[?]|rpm|[?]|1|BAR|METATARSOPHALANGEAL JOINT 1|IPSILATERAL|DISTAL VOLAR|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|||STUDY SUBJECT|MICROSCOPIST 2|1|Visit_1|10|1|SCREENING|2020-10-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|3|DLCOVA|DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|FFU|[?]|1|PATCH|FALCIFORM LIGAMENT|LEFT|FORE|DC SHEATH FLOW||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|SCREENING|2020-10-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SLING|[?]|SFC/10^6 PBMC|[?]|1|uV*sec|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|RIGHT|PARIETO-OCCIPITAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|Y||ADJUDICATOR|PATHOLOGIST|2|Visit_2|25|7|SCREENING|2020-10-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|5|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|Tbsp|SKIN FOLD|UNILATERAL|ANTEROPOSTERIOR|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION|||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-11-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|PRONE|[?]|USP U|[?]|1|Bq|FIRST OBTUSE MARGINAL BRANCH ARTERY|BILATERAL|CENTRAL|RAJI CELL RIA||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|3|Visit_3|40|3|TREATMENT|2020-11-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|7|FIF50|Forced Inspiratory Flow at 50%|[?]|PRONE|[?]|VOXEL|[?]|1|10^6 CFU|PERICARDIAL LYMPH NODE|BILATERAL|OCCIPITAL|NON-INVASIVE DIELECTRIC SENSING||||GUARDIAN|ADJUDICATOR 3|4|Visit_4|65|1|WASHOUT|2020-11-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|8|FVCPP|Percent Predicted Forced Vital Capacity|[?]|UNCONSTRAINED|[?]|mL/100g/min|[?]|1|Antibody Unit|EYE BULGE|LEFT|DISTAL VOLAR|TRANSCRIPTION-MEDIATED AMPLIFICATION||||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|4|Visit_4|65|6|FOLLOW-UP|2020-11-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-26
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|9|SVC|Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|tuberculin unit/mL|[?]|1|m/sec|SOFT PALATE|BILATERAL|INNER|TRIPLE-PHASE SPIRAL CT SCAN||||PARENT|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-12-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|6c1d481b-985a-4be0-97ca-ecd06a81b456|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|SEMI-RECUMBENT|[?]|s^-1(%O2)^-1|[?]|1|ug/m2/day|CEREBRAL SUBCORTEX|UNILATERAL|SUPERIOR|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||STUDY SUBJECT|MICROSCOPIST 2|5|Visit_5|90|5|WASHOUT|2020-12-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|LATERAL DECUBITUS|[?]|PUFF|[?]|1|10^4 CFU|MALE GENITALIA|BILATERAL|BASAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||INTERVIEWER|PHYSIOTHERAPIST|1|Visit_1|10|1|TREATMENT|2020-12-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|2|ERVPP|Percent Predicted ERV|[?]|LEFT LATERAL DECUBITUS|[?]|kBq/uL|[?]|1|mol/mL|CECUM|RIGHT|DORSOLATERAL|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|1|Visit_1|10|3|SCREENING|2020-12-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|DECUBITUS|[?]|dmol|[?]|1|ppm|URETHRA, POSTERIOR|RIGHT|INFERIOR|SANGER SEQUENCING||Y||PROXY|PEDIATRIC NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|4|DLCOPP|Percent Predicted DLCO|[?]|STANDING|[?]|mL/m2/h|[?]|1|ug/mol|PAW|UNILATERAL|PROXIMAL VOLAR|FARR ASSAY||||VENDOR|INTERNIST|2|Visit_2|25|7|TREATMENT|2021-01-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|5|FEF2575P|Percent Predicted FEF25-75|[?]|SUPINE|[?]|10^3 CFU/g|[?]|1|nmol/kg/day|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|UNILATERAL|DEEP|SPECT SCAN|Y|||CAREGIVER|RATER|3|Visit_3|40|2|TREATMENT|2021-01-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|6|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|||[?]|1|U/g Hb|GANGLION|BILATERAL|UPPER|CELL OF ORIGIN ASSAY||Y|Y|PARENT|NEUROLOGIST 1|3|Visit_3|40|2|TREATMENT|2021-01-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|7|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|mL/min/1.73m2|[?]|1|DNA copies/ug|HYPOTHALAMUS|IPSILATERAL|DISTAL|PUPILLOMETRY|Y|||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|4|Visit_4|65|2|SCREENING|2021-02-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|STANDING, BENT FORWARD|[?]|mL/cm H2O|[?]|1|Ci|PREFRONTAL CORTEX|LEFT|DORSOLATERAL|CYSTOMETRY|Y|||SPOUSE|ONCOLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-02-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|9|TGV|Thoracic Gas Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|U/m2/day|BRONCHUS|BILATERAL|LOWER FLEXOR SURFACE|SCANNING ELECTRON MICROSCOPY|Y|Y|Y|NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|5|Visit_5|90|7|FOLLOW-UP|2021-03-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|645a9247-efcb-4641-9514-58d6e28560e0|10|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING|[?]|PNU/mL|[?]|1|/sec|SCAPHOID-LUNATE JOINT|LATERAL|CAUDAL|ELLA|Y|||PROXY|ENDOCRINOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2021-03-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|UNCONSTRAINED|||[?]|1|umol|INFRACLAVICULAR LYMPH NODE|IPSILATERAL|VENTROLATERAL|PHOTOMETRY||Y|Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|1|Visit_1|10|6|WASHOUT|2020-09-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|2|TVPP|Percent Predicted Tidal Volume|[?]|LATERAL DECUBITUS|[?]|mU/L|[?]|1|PIXEL|LEFT POSTEROLATERAL DESCENDING ARTERY|CONTRALATERAL|ANTEROPOSTERIOR|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||CAREGIVER|FORENSIC PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-09-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-10
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|3|FEV1FVC6|FEV1/FVC6|[?]|LATERAL DECUBITUS|||[?]|1|/min|PONS VAROLII|LATERAL|PERIPHERAL|TOTAL BODY RADIOGRAPHY|Y||Y|CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|2|Visit_2|25|2|TREATMENT|2020-09-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|4|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|[?]|MHz|[?]|1|pmol/L/h|SPINAL CORD|LEFT|CRANIAL|URANYL ACETATE STAIN||||VENDOR|NEUROLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-09-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|5|TSUHYS|Tissue Hysteresivity|[?]|UNCONSTRAINED|[?]|Hz/s|[?]|1|mL/m2/h|FINGER EXTENSOR TENDONS|BILATERAL|CAUDAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||GUARDIAN|PATHOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-10-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|6|INTP|Interpretation|[?]|LEFT LATERAL DECUBITUS|[?]|tsp eq|[?]|1|dpm/mg|TONGUE|CONTRALATERAL|DEEP|AUDIOMETRY||Y||INVESTIGATOR|ONCOLOGIST 2|3|Visit_3|40|7|FOLLOW-UP|2020-10-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|7|FEF2575P|Percent Predicted FEF25-75|[?]|SLING|[?]|Ci/L|[?]|1|BAU|DIAPHRAGMATIC LYMPH NODE|LEFT|PROXIMAL VOLAR|NO INFORMATION||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|4|Visit_4|65|3|WASHOUT|2020-11-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|8|FIV1PP|Percent Predicted FIV1|[?]|SLING|||[?]|1|U/kg/day|BONE MARROW|RIGHT|ANTEROPOSTERIOR|FLAME PHOTOMETRY|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR|4|Visit_4|65|2|FOLLOW-UP|2020-11-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|9|MALIND|Malignancy Indicator|[?]|SEMI-RECUMBENT|[?]|mL/kg/day|[?]|1|U/g Hb|FACET JOINT|IPSILATERAL|ANTEROLATERAL|DOUBLE IMMUNODIFFUSION|Y|||SIBLING|HEMATOLOGIST|5|Visit_5|90|7|TREATMENT|2020-12-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|10|MEPPP|Percent Predicted MEP|[?]|SLING|[?]|10^3 copies/mL|[?]|1|mPa|LATISSIMUS DORSI MUSCLE|RIGHT|POSTERIOR|WHOLE EXOME SEQUENCING||Y||FAMILY MEMBER|MICROSCOPIST 2|5|Visit_5|90|1|SCREENING|2020-12-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-RECUMBENT|[?]|GPS U|[?]|1|Joule|HAND PHALANX|UNILATERAL|SURFACE|HPLC-UV||||SPOUSE|ADJUDICATOR 1|1|Visit_1|10|6|TREATMENT|2020-07-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|2|INTP|Interpretation|[?]|PRONE|[?]|nmol/L/min|[?]|1|mAmp|ESOPHAGUS, MIDDLE THIRD|LEFT|INTERMEDIATE|HIGH RESOLUTION CT||||ADJUDICATION COMMITTEE|INTERNIST|1|Visit_1|10|2|WASHOUT|2020-07-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|3|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|ug/day|[?]|1|mL/m2/min|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|UNILATERAL|PARIETO-OCCIPITAL|OBSERVATION|Y|||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|2|Visit_2|25|2|TREATMENT|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|4|FEV_PEF|FEV at PEF|[?]|SITTING, LEGS DEPENDENT|[?]|10^6 organisms/mL|[?]|1|LOZENGE|SUBTALAR JOINT|UNILATERAL|SUPERIOR|FARR ASSAY||||PROXY|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|5|SCREENING|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-11
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING, LEGS DEPENDENT|[?]|mL/m2/h|[?]|1|mEq/L|OPTIC NERVE|LEFT|NASAL|SPECTROPHOTOMETRY|Y|||SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|3|WASHOUT|2020-08-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|6|TV|Tidal Volume|[?]|SEMI-RECUMBENT|[?]|IU/mL|[?]|1|mEq|MAXILLARY SINUS|UNILATERAL|SUBCORTICAL|TRIPLE-PHASE SPIRAL CT SCAN||Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-08-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SLING|[?]|pmol/day|[?]|1|CFU/mL|MID-CIRCUMFLEX ARTERY|CONTRALATERAL|VENTROLATERAL|SANGER SEQUENCING||Y||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|4|Visit_4|65|7|WASHOUT|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|8|DLCOPP|Percent Predicted DLCO|[?]|SLING|||[?]|1|anti-Xa IU/mL|DISTAL CIRCUMFLEX ARTERY|LEFT|MIDLINE|KINETIC CHROMOGENIC ASSAY||Y|Y|STUDY SUBJECT|ADJUDICATOR 2|4|Visit_4|65|7|TREATMENT|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|9|FRCPP|Percent Predicted FRC|[?]|SITTING|||[?]|1|damol/L|MUSCLE|LEFT|INNER|IRON HEMATOXYLIN STAIN|||Y|ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-10-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|05b05951-b1ba-4c51-b50f-9c842532bc4e|10|MALEVDES|Malignancy Evidence Description|[?]|STANDING|[?]|psi|[?]|1|cycle/min|EARLOBE|BILATERAL|PROXIMAL|ELECTROCHEMILUMINESCENCE||||STUDY SUBJECT|PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2020-10-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|[?]|MnFI|[?]|1|EU|LUNG, HILUM|BILATERAL|OCCIPITAL|OBSERVATION|Y|Y||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|3|WASHOUT|2020-10-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|2|AIRTRAP|Air Trapping|[?]|UNCONSTRAINED|[?]|DAgU|[?]|1|Enzyme U|SUBMANDIBULAR GLAND|IPSILATERAL|PROXIMAL VOLAR|POPULATION SEQUENCING||||INTERVIEWER|CARDIOLOGIST|1|Visit_1|10|1|SCREENING|2020-10-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|NEBULE|[?]|1|cm/s|JUGULAR VEIN|LATERAL|DORSAL|HANSEL STAIN||Y||SIGNIFICANT OTHER|MICROSCOPIST 1|2|Visit_2|25|1|TREATMENT|2020-11-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|4|TLC|Total Lung Capacity|[?]|PRONE|[?]|mL/mmHg|[?]|1|cg|MYOMETRIUM|BILATERAL|INTERMEDIATE|SURFACE PLASMON RESONANCE||||FAMILY MEMBER|DERMATOLOGIST|2|Visit_2|25|4|TREATMENT|2020-11-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|5|TLC|Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|EIA unit|[?]|1|mg/kg/min|HEART, LEFT VENTRICLE|CONTRALATERAL|SUPERIOR|ELECTROPHORESIS||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-11-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|6|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|[?]|10^7 PFU|[?]|1|g/U|POPLITEAL LYMPH NODE|BILATERAL|PARIETO-OCCIPITAL|HPLC/MS/MS||||CAREGIVER|NEUROLOGIST 1|3|Visit_3|40|7|SCREENING|2020-11-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|7|FEV1SVC|FEV1/SVC|[?]|LATERAL DECUBITUS|||[?]|1|Pack Year|INTESTINE|LATERAL|NASAL|IMMUNOTURBIDIMETRY||Y|Y|CLINICAL RESEARCH COORDINATOR|OPHTHALMOLOGIST|4|Visit_4|65|7|TREATMENT|2020-12-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|8|DLCOVA|DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|mg/kg/min|[?]|1|mMU/mL|DISTAL FEMUR R1|LATERAL|LOWER MEDIAL|WHOLE TRANSCRIPTOME SEQUENCING|Y|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|4|Visit_4|65|2|WASHOUT|2020-12-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|9|GAW|Airway Conductance|[?]|STANDING|[?]|Ci/g|[?]|1|steps/min|TRICEPS BRACHII MUSCLE|UNILATERAL|ANTEROLATERAL|PH METER MEASUREMENT METHOD||||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|ab38e976-8c2b-48ff-bdba-5a056637ecdd|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|FOWLERS|||[?]|1|cd/m2|BLADDER, FUNDUS|LATERAL|ANTEROMEDIAL|QUANTITATIVE COMPUTED TOMOGRAPHY|||Y|INTERVIEWER|DERMATOLOGIST|5|Visit_5|90|2|TREATMENT|2021-01-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|UNCONSTRAINED|[?]|10^8 PFU|[?]|1|%|ANKLE MORTISE|BILATERAL|UPPER EXTENSOR SURFACE|REFLECTANCE SPECTROSCOPY||||SIBLING|RADIOLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|LATERAL DECUBITUS|||[?]|1|gtt|SPLENIC VEIN|CONTRALATERAL|ANTERIOR|PET/CT SCAN||Y|Y|DOMESTIC PARTNER|ONCOLOGIST 1|1|Visit_1|10|4|SCREENING|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING, BENT FORWARD|||[?]|1|oz eq|PARACOLIC GUTTER|BILATERAL|INTERMEDIATE|VENTILATION PERFUSION LUNG SCAN|||Y|CLINICAL RESEARCH ASSOCIATE|READER 2|2|Visit_2|25|7|WASHOUT|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|4|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING|[?]|/40 HPFs|[?]|1|10^3 organisms/g|ANKLE MORTISE|BILATERAL|UPPER EXTENSOR SURFACE|MULTIPLE BREATH WASHOUT||Y||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|2|Visit_2|25|1|TREATMENT|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|5|OXYPULSE|Oxygen Pulse|[?]|SEMI-FOWLERS|[?]|L/h|[?]|1|umol/dL|SYNOVIAL FLUID|UNILATERAL|FACIAL|CLIP SEQUENCING||||SIGNIFICANT OTHER|RADIOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|6|PNIF|Peak Nasal Inspiratory Flow|[?]|UNCONSTRAINED|[?]|TUBE|[?]|1|mg/h|BRAIN, PERIVENTRICULAR REGION|LEFT|DORSAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||PARENT|ADJUDICATOR 1|3|Visit_3|40|2|WASHOUT|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-29
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|7|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|GBq/mg|[?]|1|g/animal/wk|ANTRUM PYLORI|LATERAL|PROXIMAL|AUTOMATED COUNT||||FAMILY MEMBER|READER 1|4|Visit_4|65|6|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|8|LOBVOL|Lobar Volume|[?]|STANDING|||[?]|1|Osm|PARACAVAL LYMPH NODE|CONTRALATERAL|LOWER FLEXOR SURFACE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y||Y|GUARDIAN|ONCOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|REVERSE TRENDELENBURG|[?]|kg/cm2|[?]|1|mg2/dL2|RETINAL ARTERY|RIGHT|SURFACE|SMEAR|Y|||PROXY|ADJUDICATOR|5|Visit_5|90|1|SCREENING|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|10|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|USP U|[?]|1|g/m2|RETINAL NERVE FIBER LAYER|LATERAL|LOWER MEDIAL|INDIRECT IMMUNOFLUORESCENCE||||VENDOR|RATER|5|Visit_5|90|2|WASHOUT|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|1|MALIND|Malignancy Indicator|[?]|SITTING|[?]|mL/animal/day|[?]|1|ug/dL|DELTOID MUSCLE|UNILATERAL|VOLAR|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||SPOUSE|OPHTHALMOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2021-01-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|2|AWWVOL|Airway Wall Volume|[?]|SITTING|||[?]|1|nmol BCE/nmol|FOOT DIGIT 3|LEFT|PERIVENTRICULAR|MICROBIAL CULTURE, SOLID|Y||Y|STUDY SUBJECT|PATHOLOGIST 1|1|Visit_1|10|4|FOLLOW-UP|2021-01-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|3|SALKK|Salazar-Knowles Equation, K|[?]|SEMI-FOWLERS|[?]|PIXELS/cm|[?]|1|U/kg/h|WRIST JOINT FLEXOR TENDONS|IPSILATERAL|APICAL|IMPULSE OSCILLOMETRY||||SIGNIFICANT OTHER|UROLOGIST|2|Visit_2|25|3|SCREENING|2021-01-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|PRONE|||[?]|1|cmHg|HEPATIC LYMPH NODE|LATERAL|TEMPORAL|RAJI CELL EIA|Y|Y|Y|PROXY|FORENSIC PATHOLOGIST|2|Visit_2|25|1|WASHOUT|2021-01-31|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|log EID 50/dose|[?]|1|mmol/day|FINGER FLEXOR MUSCLES|LEFT|FORE|DIFFUSION WEIGHTED MRI||Y||STUDY SUBJECT|CLINICAL PATHOLOGIST|3|Visit_3|40|1|WASHOUT|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|6|MALIND|Malignancy Indicator|[?]|TRENDELENBURG|[?]|pkat|[?]|1|VIRTUAL PIXEL|PARAPHARYNGEAL LYMPH NODE|IPSILATERAL|ANTEROTEMPORAL|STATIC PERIMETRY||||INTERVIEWER|NEUROLOGIST 2|3|Visit_3|40|1|TREATMENT|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|tsp|[?]|1|10^4/L|C3 VERTEBRA|RIGHT|LATERAL|OSCILLOMETRY||||SPOUSE|NEUROLOGIST 2|4|Visit_4|65|2|TREATMENT|2021-03-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|8|RER|Respiratory Exchange Ratio|[?]|UNCONSTRAINED|[?]|MBP|[?]|1|kHz|GREAT TROCHANTER|CONTRALATERAL|ROSTRAL|NON-INVASIVE DIELECTRIC SENSING||Y||ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|4|Visit_4|65|2|TREATMENT|2021-03-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|9|TSUELAS|Tissue Elastance|[?]|FOWLERS|[?]|cm|[?]|1|JAR|MANDIBLE|UNILATERAL|PROXIMAL|DNA MICROARRAY|Y|||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|51a49847-6405-4842-b549-0e2ab99f61b2|10|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|[?]|Enzyme U|[?]|1|mmHg*min/L|MESENTERY|LEFT|MIDLINE|TWO-COLOR MICROARRAY||Y||NON-HEALTH CARE PROFESSIONAL|RATER|5|Visit_5|90|5|TREATMENT|2021-04-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|FEV1FVC|FEV1/FVC|[?]|FOWLERS|[?]|INHALATION|[?]|1|Absorbance U|METACARPAL BONE 4|IPSILATERAL|FORE|INCISION-INDUCED BLEEDING METHOD|Y|||NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-05-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|2|AWWVOL|Airway Wall Volume|[?]|SLING|[?]|tuberculin unit|[?]|1|mCi/L|ILIAC VEIN|IPSILATERAL|DISTAL VOLAR|CLINICAL EVALUATION||Y||CAREGIVER|READER|1|Visit_1|10|4|TREATMENT|2020-05-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SUPINE|||[?]|1|POINT|HIP|LATERAL|PERIVENTRICULAR|MODIFIED ACID FAST STAIN|||Y|SPOUSE|READER 2|2|Visit_2|25|7|TREATMENT|2020-06-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|4|LOBVOL|Lobar Volume|[?]|PRONE|[?]|PRESSOR UNITS|[?]|1|ug/g/min|SCAPHOID-CAPITATE JOINT|IPSILATERAL|SUPERIOR|NEXT GENERATION TARGETED SEQUENCING||||CAREGIVER|READER|2|Visit_2|25|2|TREATMENT|2020-06-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|5|FIVC|Forced Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|ug/cm2|[?]|1|g/kg/day|TIBIALIS ANTERIOR MUSCLE|UNILATERAL|DISTAL VOLAR|CISH||||STUDY SUBJECT|PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-06-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|KIT|[?]|1|mm/min|ISCHIORECTAL FOSSA|BILATERAL|OCCIPITAL|IMMUNODIFFUSION||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|3|Visit_3|40|7|FOLLOW-UP|2020-06-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-30
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|7|DLCO|Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|||[?]|1|mol/L|SKULL, BASE|UNILATERAL|PARIETO-OCCIPITAL|OLIGO ACGH|Y||Y|GUARDIAN|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|SEMI-RECUMBENT|[?]|P|[?]|1|GBq/mg|DISTAL PHALANX 4 OF THE HAND|LEFT|UPPER EXTENSOR SURFACE|PYROSEQUENCING|Y|||PROXY|RADIOLOGIST 2|4|Visit_4|65|6|SCREENING|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|9|RVPP|Percent Predicted Residual Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Bq/mg|HEART, RIGHT VENTRICULAR FREE WALL|LEFT|INFERIOR|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y||Y|FRIEND|ADJUDICATOR 2|5|Visit_5|90|1|SCREENING|2020-08-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|44dcfb9a-c590-4826-a28c-b5e9f83129d5|10|SALKK|Salazar-Knowles Equation, K|[?]|SITTING, LEGS DEPENDENT|[?]|EID 50/dose|[?]|1|WAFER|EXTENSOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|FORE|MASS SPECTROMETRY||Y||PROXY|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-08-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|1|SALKA|Salazar-Knowles Equation Parameter A|[?]|DECUBITUS|[?]|NEEDLE GAUGE|[?]|1|MASK|UNCINATE PROCESS OF PANCREAS|LEFT|APICAL|TRANSTHORACIC ECHOCARDIOGRAPHY||Y||PARENT|UROLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|2|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|[?]|kcal/day|[?]|1|PIPE|THIGH|LEFT|PARIETO-OCCIPITAL|DROPLET DIGITAL PCR||Y||VENDOR|ONCOLOGIST 1|1|Visit_1|10|4|SCREENING|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|3|DLCO|Diffusion Capacity of Lung for CO|[?]|SLING|[?]|U/m2|[?]|1|mL|GLENOID FOSSA|UNILATERAL|FACIAL|GC/MS-EI||Y||INTERVIEWER|UROLOGIST|2|Visit_2|25|5|TREATMENT|2021-01-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|CARTRIDGE|[?]|1|10^3 organisms/mL|FEMUR SHAFT|LEFT|MIDLINE|EIA||Y||SIBLING|OPHTHALMOLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|5|INFLTIND|Infiltrates Indicator|[?]|UNCONSTRAINED|||[?]|1|U/kg/min|ESOPHAGUS, ABDOMINAL|LEFT|PERIVENTRICULAR|TEST STRIP|||Y|INVESTIGATOR|ADJUDICATOR|3|Visit_3|40|5|WASHOUT|2021-02-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|6|FEF50|Forced Expiratory Flow 50%|[?]|LEFT LATERAL DECUBITUS|[?]|mL/cage/wk|[?]|1|foz_us|SOFT PALATE|LEFT|PARIETO-OCCIPITAL|DNA MICROARRAY||||SIBLING|MICROSCOPIST 1|3|Visit_3|40|6|SCREENING|2021-02-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|7|EXPRELTM|Expiration Relaxation Time|[?]|SUPINE|[?]|mV/sec|[?]|1|PIXELS/cm|ILIOPSOAS MUSCLE|IPSILATERAL|PERIVENTRICULAR|DYNAMIC CONTRAST ENHANCED MRI||||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2021-03-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|8|ALVVOL|Alveolar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|/day|RETROAURICULAR LYMPH NODE|UNILATERAL|DORSOLATERAL|DIFFUSION TENSOR MRI|||Y|HEALTH CARE PROFESSIONAL|PATHOLOGIST|4|Visit_4|65|2|SCREENING|2021-03-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|9|IRV|Inspiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|[?]|PELLET|[?]|1|log10 CFU/g|POSTERIOR TIBIAL ARTERY|LEFT|MIDLINE|ICC||||CAREGIVER|RADIOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|98166d74-caa7-4693-a817-b2cbae947ff8|10|FEV3PP|Percent Predicted FEV3|[?]|STANDING|[?]|10^3 DNA copies/mL|[?]|1|MET|HEEL OF THE FOOT|BILATERAL|TEMPORAL|TWO-COLOR MICROARRAY|Y|||PROXY|OPHTHALMOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-04-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|1|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|||[?]|1|10^11/L|GASTRIC CARDIA|RIGHT|HIND|PALPATION|Y||Y|HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|1|Visit_1|10|5|TREATMENT|2020-12-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|DECUBITUS|[?]|DPM|[?]|1|mg/g/h|PERITONEUM|UNILATERAL|INFERIOR|INFRARED SPECTROMETRY||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|1|Visit_1|10|4|FOLLOW-UP|2020-12-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SUPINE|[?]|Bq/uL|[?]|1|U/m2|METACARPAL BONE 4|LATERAL|ANTEROTEMPORAL|CINEANGIOGRAPHY||||FRIEND|OTOLARYNGOLOGIST|2|Visit_2|25|4|TREATMENT|2020-12-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|4|TVPP|Percent Predicted Tidal Volume|[?]|SEMI-RECUMBENT|[?]|umol/L/h|[?]|1|cmH2O*s/mL|HEART, RIGHT VENTRICLE|LEFT|POSTERIOR|BETA LACTAMASE||||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|2|WASHOUT|2020-12-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-12
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|5|IVC|Inspiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mEq/day|ANTERIOR TIBIAL ARTERY|RIGHT|PERIPHERAL|PHOTOMETRY|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|3|Visit_3|40|5|FOLLOW-UP|2021-01-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|6|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|UNCONSTRAINED|[?]|ugEq/L|[?]|1|mL/kg|ENTORHINAL CORTEX|BILATERAL|FORE|SXA SCAN||||SIBLING|READER 2|3|Visit_3|40|4|TREATMENT|2021-01-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|7|MALEVDES|Malignancy Evidence Description|[?]|UNCONSTRAINED|[?]|s/h|[?]|1|BU/mL|LARGE INTESTINE|CONTRALATERAL|VOLAR|DUCTOGRAPHY||||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2021-01-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|8|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|U/kg/h|[?]|1|nmol BCE/nmol|ALVEOLUS|RIGHT|MIDLINE|AGAR DILUTION||||SPOUSE|CARDIOLOGIST|4|Visit_4|65|3|TREATMENT|2021-01-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|9|FIF75|Forced Inspiratory Flow at 75%|[?]|SEMI-FOWLERS|[?]|Joule|[?]|1|mCi/kg|PROXIMAL INTERPHALANGEAL JOINT 4|RIGHT|INTERMEDIATE|PET/CT SCAN||||VENDOR|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2021-02-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|cb07675a-2042-44da-a1f9-8b7783347e88|10|MIPPP|Percent Predicted MIP|[?]|STANDING|[?]|TAMPON|[?]|1|ft|COLON, HEPATIC FLEXURE|RIGHT|SUPERFICIAL|PH METER MEASUREMENT METHOD||||GUARDIAN|HEMATOLOGIST|5|Visit_5|90|3|TREATMENT|2021-02-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|PCF|Peak Cough Flow|[?]|SLING|[?]|Gravitational Unit|[?]|1|uEq/L|URETHRAL SPHINCTER|LATERAL|LOWER EXTENSOR SURFACE|FLUORESCENT MICROSCOPY||Y||VENDOR|CLINICAL PATHOLOGIST|1|Visit_1|10|6|WASHOUT|2020-07-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|2|FEV1FVC6|FEV1/FVC6|[?]|DECUBITUS|||[?]|1|Joule|BILIARY TRACT|BILATERAL|PERIPHERAL|FLOCCULATION|Y|Y|Y|CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|1|Visit_1|10|5|WASHOUT|2020-07-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|3|EVC|Expiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|h*%|[?]|1|mg/L FEU|SCROTUM|RIGHT|POSTERIOR|CONTACT SPECULAR MICROSCOPY||||CHILD|HEMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|4|FEV1FVC6|FEV1/FVC6|[?]|SUPINE|||[?]|1|msec|TROCHLEAR NERVE|LATERAL|SUBCORTICAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN|||Y|CAREGIVER|PHYSIOTHERAPIST|2|Visit_2|25|6|FOLLOW-UP|2020-07-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|5|AWWVOL|Airway Wall Volume|[?]|SUPINE|[?]|mL/sec/1.73m2|[?]|1|NEBULE|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|BILATERAL|MEDIAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||FRIEND|RATER 2|3|Visit_3|40|2|WASHOUT|2020-07-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|6|FEV_PEF|FEV at PEF|[?]|SEMI-FOWLERS|||[?]|1|uCi/kg|TIBIALIS POSTERIOR MUSCLE|RIGHT|VENTRAL|BIOPSY|Y|Y|Y|ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|7|TREATMENT|2020-07-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|7|SRAW|Specific Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|10^3/hpf|[?]|1|kg/cm|SKIN OF THE UPPER LIMB|CONTRALATERAL|ANTEROMEDIAL|MICRO BROTH DILUTION||||CHILD|CARDIOLOGIST|4|Visit_4|65|2|SCREENING|2020-08-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|8|DLCOHC|HGB Corrected DLCO|[?]|SEMI-RECUMBENT|[?]|Log10 ELISA unit/dose|[?]|1|mg/mL/day|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|RIGHT|PROXIMAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|Y|||ADJUDICATION COMMITTEE|ONCOLOGIST|4|Visit_4|65|5|WASHOUT|2020-08-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|PRONE|[?]|gMFI|[?]|1|CAPFUL|PARS COMPACTA|RIGHT|ROSTRAL|SLIT LAMP PHOTOGRAPHY|Y|Y||ADJUDICATOR|HEMATOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|a8a14aa1-4484-4bbc-86bf-c44257146a26|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|DECUBITUS|[?]|fmol/L|[?]|1|COAT|LEPTOMENINGES|RIGHT|ANTEROPOSTERIOR|AMSLER GRID||||PROXY|MICROSCOPIST 1|5|Visit_5|90|5|TREATMENT|2020-09-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SLING|[?]|10^3 CFU|[?]|1|10^7 PFU|CORPUS CALLOSUM|LEFT|ANTEROPOSTERIOR|HIGH RESOLUTION MELT ANALYSIS||||ADJUDICATION COMMITTEE|CARDIOLOGIST|1|Visit_1|10|2|SCREENING|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|PRONE|[?]|cs|[?]|1|breaths/min|ILIOPSOAS MUSCLE|CONTRALATERAL|DEEP|MICROARRAY||||CLINICAL RESEARCH COORDINATOR|RATER|1|Visit_1|10|7|WASHOUT|2020-06-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|3|RELSZCHG|Relative Size Change|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^11/L|GLUTEUS MAXIMUS|UNILATERAL|PROXIMAL VOLAR|IN SITU HYBRIDIZATION|Y||Y|SIGNIFICANT OTHER|ADJUDICATOR 3|2|Visit_2|25|7|WASHOUT|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|PRONE|[?]|kg/cm|[?]|1|IU/L|UPPER RESPIRATORY SYSTEM|RIGHT|UPPER|CHROMATOGRAPHY||Y||ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|2|Visit_2|25|5|SCREENING|2020-06-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|5|MIP|Maximal Inspiratory Pressure|[?]|FOWLERS|[?]|umol/kg/min|[?]|1|bel|FINGER EXTENSOR TENDONS|CONTRALATERAL|LATERAL|QUANTITATIVE ULTRASOUND||||PARENT|CLINICAL PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|nU/cL|[?]|1|U/g|INTERPHALANGEAL JOINT 2 OF THE FOOT|LATERAL|DISTAL|TRIPLE-PHASE SPIRAL CT SCAN|Y|Y||ADJUDICATOR|ONCOLOGIST 1|3|Visit_3|40|7|TREATMENT|2020-07-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|7|IRVPP|Percent Predicted IRV|[?]|SEMI-RECUMBENT|[?]|ug/L DDU|[?]|1|ug/kg/min|BLADDER, TRIGONE|LATERAL|PROXIMAL VOLAR|LC/MS/MS|Y|||INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-07-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|8|GAW|Airway Conductance|[?]|STANDING|||[?]|1|nmol/L/h|URETHRA, PENILE|LEFT|VENTROLATERAL|TRANSVAGINAL ULTRASOUND||Y|Y|INVESTIGATOR|RADIOLOGIST|4|Visit_4|65|4|TREATMENT|2020-07-29|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-15
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|9|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|[?]|ug/h|[?]|1|pmol/10^9 cells|LUNG, LEFT LOWER LOBE|LEFT|CRANIAL|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|||CHILD|OTOLARYNGOLOGIST|5|Visit_5|90|1|TREATMENT|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|dfa4c661-9317-4bec-b307-a31eeadcaba6|10|FRC|Functional Residual Capacity|[?]|LATERAL DECUBITUS|[?]|mg/mL/day|[?]|1|10^4/hpf|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|IPSILATERAL|CENTRAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y||NON-HEALTH CARE PROFESSIONAL|CARDIOLOGIST|5|Visit_5|90|7|SCREENING|2020-08-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-28
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|ERVPP|Percent Predicted ERV|[?]|SEMI-FOWLERS|[?]|MET*h|[?]|1|cd/m2|FEMORO-POPLITEAL PERIPHERAL ARTERY|BILATERAL|CENTRAL|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|||DOMESTIC PARTNER|RATER 1|1|Visit_1|10|3|TREATMENT|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|2|MEP|Maximal Expiratory Pressure|[?]|STANDING|||[?]|1|nU/cL|BICEPS FEMORIS MUSCLE|LEFT|ROSTRAL|MANUAL CLOT DETECTION|||Y|CAREGIVER|INTERNIST|1|Visit_1|10|7|TREATMENT|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|3|PLMXRS|Pulmonary Reactance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|nkat|GLUTEUS MAXIMUS|LEFT|POSTERIOR|INDIA INK STAIN||Y|Y|CAREGIVER|READER|2|Visit_2|25|6|FOLLOW-UP|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|4|EFFIND|Effusion Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|U.CARR|[?]|1|umol/kg/min|T2 VERTEBRA|CONTRALATERAL|UPPER FLEXOR SURFACE|DNA MICROARRAY|Y|||SIBLING|CLINICAL PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|PRONE|||[?]|1|CUP|LACRIMAL BONE|CONTRALATERAL|ANTEROPOSTERIOR|CELLULAR PROLIFERATION ASSAY||Y|Y|CLINICAL RESEARCH COORDINATOR|RATER 1|3|Visit_3|40|2|FOLLOW-UP|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LATERAL DECUBITUS|[?]|mL/min/1.73m2|[?]|1|JDF Unit|ACUTE MARGINAL ARTERY|RIGHT|OCCIPITAL|IMMUNOFIXATION ELECTROPHORESIS|Y|||PARENT|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|7|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|[?]|BAR|[?]|1|Log10 ELISA unit|SPINAL ACCESSORY NERVE|LEFT|UPPER|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||VENDOR|MICROSCOPIST 2|4|Visit_4|65|2|TREATMENT|2020-10-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|8|FIVC|Forced Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|TRANSDUCING UNIT/mL|[?]|1|PLUG|SKIN OF THE EAR|CONTRALATERAL|PERIPHERAL|INFRARED SPECTROMETRY||||DOMESTIC PARTNER|PHYSIOTHERAPIST|4|Visit_4|65|5|WASHOUT|2020-10-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|9|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING, BENT FORWARD|||[?]|1|% INHIBITION|ENDOMETRIUM|LATERAL|VOLAR|FLAME PHOTOMETRY||Y|Y|NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-11-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|9ed984a9-c153-4729-9dc9-3bb3d9059919|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|/MBP|[?]|1|Enzyme U|LUNG, RIGHT LOWER LOBE|RIGHT|OCCIPITAL|STATIC PERIMETRY|Y|Y||GUARDIAN|RATER 2|5|Visit_5|90|2|TREATMENT|2020-11-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|AWVOL|Airway Volume|[?]|STANDING|[?]|mL/sec/1.73m2|[?]|1|mU/L|PROXIMAL PHALANX 4 OF THE HAND|LATERAL|TEMPORAL|SLIT LAMP PHOTOGRAPHY||||SIBLING|ADJUDICATOR|1|Visit_1|10|5|TREATMENT|2021-01-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|2|AWVOL|Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|SACHET|[?]|1|EIA unit|NOSTRIL|CONTRALATERAL|SUPERIOR|PERIPHERAL ANGIOGRAPHY||||FAMILY MEMBER|READER 2|1|Visit_1|10|4|WASHOUT|2021-01-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|3|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|gpELISA unit/mL|[?]|1|10^4/L|EYE|LEFT|UPPER|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|||FAMILY MEMBER|MICROSCOPIST 3|2|Visit_2|25|7|FOLLOW-UP|2021-01-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/s|[?]|1|NFIU|SPLENIC VEIN|CONTRALATERAL|ANTEROLATERAL|BAC ACGH||||CLINICAL RESEARCH ASSOCIATE|CLINICAL PATHOLOGIST|2|Visit_2|25|5|SCREENING|2021-01-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|5|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|cd/m2|[?]|1|10^9/L|MAXILLA|LATERAL|LOWER FLEXOR SURFACE|TRICHROME STAIN|Y|||CAREGIVER|READER|3|Visit_3|40|4|TREATMENT|2021-02-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|6|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING|[?]|10^6/L|[?]|1|kV|URINARY SYSTEM|RIGHT|ANTEROLATERAL|STATIC PERIMETRY||Y||PROXY|RADIOLOGIST 1|3|Visit_3|40|6|TREATMENT|2021-02-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|7|ALVVOL|Alveolar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|U/m2/day|[?]|1|% INHIBITION|PONS VAROLII|LATERAL|LOWER|PAP STAIN||||CAREGIVER|ONCOLOGIST|4|Visit_4|65|2|SCREENING|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|8|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|DAgU|PARACAVAL LYMPH NODE|IPSILATERAL|OUTER|COMPUTERIZED CORNEAL TOPOGRAPHY|Y||Y|INVESTIGATOR|READER 1|4|Visit_4|65|5|TREATMENT|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|9|PNIF|Peak Nasal Inspiratory Flow|[?]|TRENDELENBURG|[?]|mL/animal/day|[?]|1|Torr|FLANK|CONTRALATERAL|ANTEROMEDIAL|EIA||||SIGNIFICANT OTHER|PATHOLOGIST 1|5|Visit_5|90|1|TREATMENT|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|fb234b67-3c81-4d55-bc63-2389a23d67b2|10|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|[?]|L/s/kPa|[?]|1|10^8/L|INFERIOR PUBIC RAMUS|IPSILATERAL|ANTEROPOSTERIOR|SPECT SCAN||||CHILD|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|1|RER|Respiratory Exchange Ratio|[?]|LATERAL DECUBITUS|||[?]|1|/mm2|ABDOMINAL LYMPH NODE|LEFT|OCCIPITAL|HPLC/MS/MS|||Y|STUDY SUBJECT|PATHOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-07-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|2|AWVOLPP|Percent Predicted Airway Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|vg/mL|ILIAC CREST|BILATERAL|UPPER|SLOAN LETTER EYE CHART 100%||Y|Y|HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|1|Visit_1|10|1|TREATMENT|2020-07-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|3|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|[?]|APS U|[?]|1|Mile|VASTUS MEDIALIS MUSCLE|LATERAL|DISTAL VOLAR|ULTRASOUND||||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|4|IVCPP|Percent Predicted IVC|[?]|UNCONSTRAINED|||[?]|1|g/animal|CAUDATE NUCLEUS|LATERAL|OCCIPITAL|DARK FIELD MICROSCOPY|||Y|GUARDIAN|ONCOLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|5|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING|||[?]|1|mL/m2/day|HEART, RIGHT VENTRICULAR WALL|LATERAL|FACIAL|TRYPAN BLUE STAIN|||Y|INVESTIGATOR|READER 2|3|Visit_3|40|7|FOLLOW-UP|2020-08-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|6|TV|Tidal Volume|[?]|DECUBITUS|[?]|pmol/10^10 cells|[?]|1|nkat|BRAIN VENTRICLE|CONTRALATERAL|LOWER FLEXOR SURFACE|CONGO RED STAIN||||PARENT|MICROSCOPIST 1|3|Visit_3|40|5|TREATMENT|2020-08-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|7|GAW|Airway Conductance|[?]|UNCONSTRAINED|[?]|L/s|[?]|1|100 IU/mL|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LEFT|MIDLINE|MACRO BROTH DILUTION|Y|||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|8|FEV1FVC6|FEV1/FVC6|[?]|STANDING|||[?]|1|dB|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|UNILATERAL|LOWER FLEXOR SURFACE|PERIPHERAL ANGIOGRAPHY|||Y|SIBLING|MICROSCOPIST 3|4|Visit_4|65|7|SCREENING|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|9|FVC|Forced Vital Capacity|[?]|DECUBITUS|[?]|Henry|[?]|1|10^5/L|HEAD AND NECK|IPSILATERAL|MIDLINE|MAMMOGRAPHY|Y|||FAMILY MEMBER|ADJUDICATOR 2|5|Visit_5|90|5|WASHOUT|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|84d7ff44-cbe2-446f-b667-5bc539de519b|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|PRONE|[?]|ug/m2|[?]|1|pmol/L|BRONCHUS|LATERAL|VOLAR|DC SHEATH FLOW||||CHILD|READER 1|5|Visit_5|90|7|TREATMENT|2020-09-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|INFLTIND|Infiltrates Indicator|[?]|SEMI-FOWLERS|[?]|MESF|[?]|1|MPS U|PANCREATIC DUCT|IPSILATERAL|TIP|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||Y||CHILD|NEUROLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-09-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|ug/kg/h|[?]|1|mL/dose|LEFT MAIN CORONARY ARTERY BIFURCATION|LATERAL|INTERMEDIATE|CELLULAR PROLIFERATION ASSAY||||FRIEND|RATER 1|1|Visit_1|10|5|TREATMENT|2020-09-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|3|FIO2|Fraction of Inspired Oxygen|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Weber|LEFT MAIN CORONARY ARTERY OSTIUM|BILATERAL|INNER|TRANSTHORACIC ECHOCARDIOGRAPHY|Y||Y|GUARDIAN|RATER 1|2|Visit_2|25|6|TREATMENT|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|4|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING|[?]|mgEq|[?]|1|U/m2/day|LEPTOMENINGES|BILATERAL|CENTRAL|MEDIASTINOSCOPY|Y|||INVESTIGATOR|RATER|2|Visit_2|25|4|FOLLOW-UP|2020-10-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|5|FEV1PP|Percent Predicted FEV1|[?]|STANDING|[?]|/sec|[?]|1|ug|SCAPHOID-CAPITATE JOINT|LEFT|INNER|TRANSCRIPTION-MEDIATED AMPLIFICATION||||PARENT|PEDIATRIC NEUROLOGIST|3|Visit_3|40|1|TREATMENT|2020-10-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|6|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-RECUMBENT|||[?]|1|mEq/g|TRIANGULAR-HAMATE JOINT|UNILATERAL|ANTEROTEMPORAL|RAJI CELL RIA|||Y|ADJUDICATOR|ENDOCRINOLOGIST|3|Visit_3|40|4|WASHOUT|2020-10-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|7|RAW|Airway Resistance|[?]|PRONE|[?]|Gy/h|[?]|1|vp/mL|RETINAL ARTERY|RIGHT|PROXIMAL VOLAR|FUNDUS PHOTOGRAPHY||||SPOUSE|PEDIATRIC NEUROLOGIST|4|Visit_4|65|6|SCREENING|2020-11-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|TRENDELENBURG|||[?]|1|h*%|PULMONARY ARTERY BRANCH|CONTRALATERAL|UPPER EXTENSOR SURFACE|SPIROMETRY|||Y|FAMILY MEMBER|PATHOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-11-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|9|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING|||[?]|1|Bq/L|CALCANEUS|RIGHT|DEEP|TWO-COLOR MICROARRAY||Y|Y|STUDY SUBJECT|DERMATOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|c96e4485-4aff-4c18-9c65-5f1a800cc6db|10|INTP|Interpretation|[?]|UNCONSTRAINED|||[?]|1|umol/mol|MANDIBLE|IPSILATERAL|ANTERIOR|GC/MS/MS||Y|Y|FRIEND|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-12-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|MEP|Maximal Expiratory Pressure|[?]|PRONE|[?]|APL U/mL|[?]|1|Anson U|ILEUM|UNILATERAL|DISTAL|MICRODENSITOMETRY|Y|||PROXY|MICROSCOPIST 3|1|Visit_1|10|4|TREATMENT|2020-12-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|2|TV|Tidal Volume|[?]|SITTING|[?]|Frames/s|[?]|1|pkat/L|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|IPSILATERAL|MEDIAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||CHILD|OPTOMETRIST|1|Visit_1|10|2|TREATMENT|2020-12-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|3|AWWVOL|Airway Wall Volume|[?]|REVERSE TRENDELENBURG|[?]|mL/kg/day|[?]|1|beats/min|ORAL MUCOSA|BILATERAL|PROXIMAL|ACCELERATOR MASS SPECTROMETRY||||PARENT|NEUROLOGIST 1|2|Visit_2|25|6|WASHOUT|2020-12-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|4|MIP|Maximal Inspiratory Pressure|[?]|TRENDELENBURG|[?]|m2|[?]|1|log10 CCID 50/dose|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|SURFACE|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||CAREGIVER|RATER|2|Visit_2|25|1|SCREENING|2020-12-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|5|LOBVOLPP|Percent Predicted Lobar Volume|[?]|TRENDELENBURG|[?]|FFU|[?]|1|/500 WBC|METATARSOPHALANGEAL JOINT 5|UNILATERAL|UPPER FLEXOR SURFACE|LC-FL||||PROXY|ADJUDICATOR 3|3|Visit_3|40|2|FOLLOW-UP|2021-01-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|UNCONSTRAINED|||[?]|1|h*%|LEG SKIN|BILATERAL|ROSTRAL|IMMUNOASSAY|Y||Y|PROXY|PATHOLOGIST 2|3|Visit_3|40|3|TREATMENT|2021-01-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|7|FEV1FVC|FEV1/FVC|[?]|SEMI-FOWLERS|||[?]|1|U/g/min|EYE, ANTERIOR SEGMENT|RIGHT|ANTERIOR|INFRARED SPECTROMETRY|||Y|CAREGIVER|MICROSCOPIST 3|4|Visit_4|65|7|TREATMENT|2021-02-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|8|RVPP|Percent Predicted Residual Volume|[?]|SEMI-FOWLERS|[?]|/10^4|[?]|1|10^3 copies/mL|GENITALIA|RIGHT|PARIETO-OCCIPITAL|JAEGER EYE CHART|Y|||FAMILY MEMBER|NEUROLOGIST 1|4|Visit_4|65|2|TREATMENT|2021-02-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|9|LCI|Lung Clearance Index|[?]|LEFT LATERAL DECUBITUS|[?]|10^9 CFU|[?]|1|anti-Xa IU/mL|LIVER, QUADRATE LOBE|UNILATERAL|INTERMEDIATE|CELLULAR PROLIFERATION ASSAY|Y|||SPOUSE|PATHOLOGIST 2|5|Visit_5|90|7|TREATMENT|2021-03-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|955188f1-b434-40ab-94c8-0c0fb7f23e84|10|GAW|Airway Conductance|[?]|LATERAL DECUBITUS|||[?]|1|mg/mol|HAND DIGIT 4|RIGHT|MIDLINE|DIFFUSION WEIGHTED MRI|Y||Y|SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|WASHOUT|2021-03-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|FIV1PP|Percent Predicted FIV1|[?]|SLING|[?]|cmH2O*s2/mL|[?]|1|v/v|FACIAL BONE|LATERAL|INNER|KLEIHAUER-BETKE|Y|||FAMILY MEMBER|HEMATOLOGIST|1|Visit_1|10|3|TREATMENT|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|2|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|[?]|DNA copies/ug|[?]|1|%(w/v)|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL|DISTAL VOLAR|SURFACE PLASMON RESONANCE|Y|||CAREGIVER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|3|FIF75|Forced Inspiratory Flow at 75%|[?]|SITTING|[?]|U/10^12 RBC|[?]|1|ppm|GANGLION|CONTRALATERAL|PARIETO-OCCIPITAL|TRYPAN BLUE STAIN||||HEALTH CARE PROFESSIONAL|RATER 1|2|Visit_2|25|7|WASHOUT|2020-10-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|4|PCF|Peak Cough Flow|[?]|PRONE|[?]|PLUG|[?]|1|Newton|BICEPS BRACHII MUSCLE|BILATERAL|VENTROLATERAL|CLAUSS METHOD|Y|||FAMILY MEMBER|NEUROLOGIST 2|2|Visit_2|25|3|FOLLOW-UP|2020-10-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|5|SVC|Slow Vital Capacity|[?]|STANDING|[?]|PFU|[?]|1|ohm|FIRST RIGHT POSTEROLATERAL ARTERY|UNILATERAL|OCCIPITAL|IVY INCISION METHOD||Y||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|2|WASHOUT|2020-11-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|6|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|||[?]|1|NFIU|DISTAL RADIOULNAR JOINT|RIGHT|DORSAL|DROPLET DIGITAL PCR|||Y|INDEPENDENT ASSESSOR|MICROSCOPIST 3|3|Visit_3|40|1|WASHOUT|2020-11-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|7|SRAW|Specific Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|/MBP|[?]|1|mL/day|PERICARDIUM|LEFT|PERIVENTRICULAR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||CLINICAL RESEARCH COORDINATOR|RATER|4|Visit_4|65|5|TREATMENT|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|8|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING|||[?]|1|FIU|SKIN BETWEEN EYEBROWS|LEFT|DEEP|GEL ELECTROPHORESIS|||Y|SPOUSE|ADJUDICATOR|4|Visit_4|65|6|WASHOUT|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|9|IRV|Inspiratory Reserve Volume|[?]|DECUBITUS|||[?]|1|psec|THORAX|IPSILATERAL|FACIAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|||Y|INDEPENDENT ASSESSOR|READER|5|Visit_5|90|5|FOLLOW-UP|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|5a384b5e-954c-4af9-bd60-96aadc72ca44|10|PEFTIME|Peak Expiratory Flow Time|[?]|LATERAL DECUBITUS|[?]|Henry|[?]|1|mEq|LUMBRICAL MUSCLES OF THE HAND|BILATERAL|ANTEROMEDIAL|IMMUNOPRECIPITATION|Y|||FAMILY MEMBER|OTOLARYNGOLOGIST|5|Visit_5|90|7|FOLLOW-UP|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|FIF25|Forced Inspiratory Flow at 25%|[?]|DECUBITUS|||[?]|1|mV2/Hz|CERVIX UTERI|LATERAL|POSTERIOR|PHOTOMETRIC CLOT DETECTION|||Y|SPOUSE|INTERNIST|1|Visit_1|10|5|WASHOUT|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|2|SAWVOL|Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|mg/dL|[?]|1|mg/g/min|PROSTATE GLAND, MIDDLE LOBE|RIGHT|PERIVENTRICULAR|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||Y||VENDOR|NEUROLOGIST|1|Visit_1|10|5|TREATMENT|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|3|FEV1FVC6|FEV1/FVC6|[?]|PRONE|[?]|ug/dose|[?]|1|Absorbance U/min|HIP JOINT|UNILATERAL|FRONTAL|THERMAL IONIZATION MASS SPECTROMETRY|Y|||PARENT|PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-07-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|FOWLERS|[?]|umol/min|[?]|1|10^3 RNA copies/mL|MESENTERY|LEFT|DEEP|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||GUARDIAN|CLINICAL PATHOLOGIST|2|Visit_2|25|7|WASHOUT|2020-07-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|5|INFLTIND|Infiltrates Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|10^9 CFU|[?]|1|pkat|RAMUS INTERMEDIUS ARTERY|BILATERAL|SUBCORTICAL|IVY INCISION METHOD||||CLINICAL RESEARCH COORDINATOR|READER 1|3|Visit_3|40|2|TREATMENT|2020-08-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|6|RER|Respiratory Exchange Ratio|[?]|REVERSE TRENDELENBURG|[?]|GBq/mg|[?]|1|MASK|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|CONTRALATERAL|CRANIAL|SANGER SEQUENCING||||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|3|Visit_3|40|5|TREATMENT|2020-08-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|pg/dL|[?]|1|mJoule/cm2|DIGIT|UNILATERAL|INNER|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y||CAREGIVER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|8|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|[?]|Ci/L|[?]|1|mmHg/sec|MUCOSA OF THE LIP|UNILATERAL|PERIVENTRICULAR|AUDIOMETRY||||CLINICAL STUDY SPONSOR|READER 2|4|Visit_4|65|7|TREATMENT|2020-08-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|DECUBITUS|||[?]|1|mol/g|CINGULATE CORTEX|LATERAL|SURFACE|CENTRIFUGATION|||Y|SIBLING|ONCOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-09-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|10|MALEVDES|Malignancy Evidence Description|[?]|SEMI-RECUMBENT|||[?]|1|pt_us|INTERNAL ILIAC LYMPH NODE|RIGHT|SUPERIOR|DIGITAL PCR|||Y|INTERVIEWER|OTOLARYNGOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|1|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|[?]|mL/min|[?]|1|/HPF|VASTUS INTERMEDIUS MUSCLE|IPSILATERAL|HIND|TEST STRIP||||NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|1|Visit_1|10|4|TREATMENT|2020-11-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|umol/L/min|[?]|1|CUP|RECTOSIGMOID JUNCTION|IPSILATERAL|OCCIPITAL|SANGER SEQUENCING||||CHILD|NEUROLOGIST|1|Visit_1|10|3|TREATMENT|2020-11-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^6/hpf|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|VOLAR|BAC ACGH|||Y|CLINICAL RESEARCH ASSOCIATE|READER 1|2|Visit_2|25|3|WASHOUT|2020-12-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|4|SALKK|Salazar-Knowles Equation, K|[?]|PRONE|[?]|kPa|[?]|1|fg|HEPATOBILIARY SYSTEM|LATERAL|PERIVENTRICULAR|NO INFORMATION||||HEALTH CARE PROFESSIONAL|READER|2|Visit_2|25|5|TREATMENT|2020-12-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|5|IRVPP|Percent Predicted IRV|[?]|LATERAL DECUBITUS|[?]|PHERESIS UNIT|[?]|1|gMFI|MITRAL VALVE, ANTERIOR ANNULUS|LATERAL|INNER|IMMUNO-PET SCAN||Y||CLINICAL RESEARCH COORDINATOR|RATER|3|Visit_3|40|6|TREATMENT|2020-12-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|6|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SITTING|||[?]|1|10^3 CFU/g|PERIPHERAL NERVE|RIGHT|LATERAL|APPLANATION TONOMETRY|||Y|CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|3|Visit_3|40|5|TREATMENT|2020-12-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|7|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|[?]|AFU|[?]|1|mL/m2/min|LENS|CONTRALATERAL|SURFACE|PHASE-CONTRAST MRI||||INTERVIEWER|RATER 2|4|Visit_4|65|1|SCREENING|2021-01-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|8|IRVPP|Percent Predicted IRV|[?]|SITTING|||[?]|1|log10 TCID 50/uL|CORPUS STRIATUM|IPSILATERAL|DEEP|WRIGHT STAIN|||Y|CAREGIVER|RADIOLOGIST|4|Visit_4|65|6|WASHOUT|2021-01-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|9|LCI|Lung Clearance Index|[?]|SEMI-FOWLERS|[?]|mL/m2|[?]|1|pmol/g|PULMONARY ARTERY BRANCH|CONTRALATERAL|SUBCORTICAL|OBSERVATION|Y|||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2021-02-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|f9432d72-f7d7-4cdf-a173-2e2029258474|10|IRVPP|Percent Predicted IRV|[?]|STANDING|[?]|/LPF|[?]|1|kPa/L/sec|RECTOSIGMOID JUNCTION|LATERAL|PERIVENTRICULAR|TRIPLE-PHASE MRI SCAN||||ADJUDICATION COMMITTEE|MICROSCOPIST 2|5|Visit_5|90|1|TREATMENT|2021-02-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|mol/L|[?]|1|Hounsfield Unit|TRAPEZOID-CAPITATE JOINT|RIGHT|LOWER|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST 1|1|Visit_1|10|6|WASHOUT|2020-12-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|2|MIPPP|Percent Predicted MIP|[?]|STANDING, BENT FORWARD|[?]|MAC50|[?]|1|BOX|TRICEPS BRACHII MUSCLE|UNILATERAL|LOWER|ELISPOT|Y|||INDEPENDENT ASSESSOR|ONCOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-12-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|3|IRV|Inspiratory Reserve Volume|[?]|SEMI-RECUMBENT|||[?]|1|kat|PRONATOR QUADRATUS MUSCLE|IPSILATERAL|CRANIAL|MASS SPECTROMETRY|||Y|CLINICAL RESEARCH ASSOCIATE|READER 1|2|Visit_2|25|2|TREATMENT|2021-01-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|4|PNEUMIND|Pneumonia Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|1/(s*kPa)|[?]|1|g/kg|PROXIMAL PHALANX 1 OF THE HAND|UNILATERAL|VENTROLATERAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||DOMESTIC PARTNER|NEUROLOGIST 2|2|Visit_2|25|5|SCREENING|2021-01-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|APPLICATION|[?]|1|ug/m2/h|PROFUNDA FEMORIS VEIN|IPSILATERAL|HIND|FISH||||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2021-01-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|6|FEV1FVC|FEV1/FVC|[?]|PRONE|[?]|10^9/L|[?]|1|log10 PFU|GASTROINTESTINAL TRACT|LEFT|CRANIAL|WRIGHT-GIEMSA STAIN||||STUDY SUBJECT|RADIOLOGIST 1|3|Visit_3|40|3|SCREENING|2021-01-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|7|IRVPP|Percent Predicted IRV|[?]|DECUBITUS|[?]|nL|[?]|1|um/day|APPENDICULAR SKELETON|UNILATERAL|HIND|IMMUNODIFFUSION|Y|||INVESTIGATOR|OPTOMETRIST|4|Visit_4|65|4|TREATMENT|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|8|SVCPP|Percent Predicted Slow Vital Capacity|[?]|TRENDELENBURG|||[?]|1|pmol|SCAPHOID BONE|RIGHT|CRANIAL|DXA SCAN|||Y|CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|9|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|||[?]|1|CCID 50/dose|BLOOD VESSEL|IPSILATERAL|INNER|MRS|||Y|CAREGIVER|NEUROLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|RE|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|10|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|DECUBITUS|[?]|INHALATION|[?]|1|mJoule/cm2|GLOBUS PALLIDUS|BILATERAL|VENTRAL|DIGITAL PCR||||VENDOR|OTOLARYNGOLOGIST|5|Visit_5|90|1|TREATMENT|2021-03-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-26
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|1|DLCOHC|HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|kat|[?]|1|sec|STERNOCLAVICULAR JOINT|LEFT|ANTEROTEMPORAL|IMMUNOPRECIPITATION||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-08-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|2|FRCPP|Percent Predicted FRC|[?]|PRONE|[?]|uIU/L|[?]|1|uL/dose|BLADDER, DOME|BILATERAL|INTERMEDIATE|ANTIBIOTIC AGAR SCREEN|Y|||CLINICAL STUDY SPONSOR|READER|1|Visit_1|10|5|FOLLOW-UP|2020-08-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|Weber|[?]|1|IU/L|FIBULA|RIGHT|INTERMEDIATE|AURAMINE STAIN||||SPOUSE|ADJUDICATOR 2|2|Visit_2|25|4|TREATMENT|2020-09-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|TRENDELENBURG|[?]|mEq/g|[?]|1|LENS|LUNG, HILUM|BILATERAL|UPPER EXTENSOR SURFACE|TRANSTHORACIC ECHOCARDIOGRAPHY||||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|2|Visit_2|25|6|TREATMENT|2020-09-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|[?]|mEq/ug|[?]|1|MBq/uL|SUBLINGUAL REGION|UNILATERAL|POSTERIOR|DYNAMIC CONTRAST ENHANCED MRI||||SIBLING|RATER 1|3|Visit_3|40|5|TREATMENT|2020-09-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|6|FEV1PP|Percent Predicted FEV1|[?]|SLING|[?]|mOsm|[?]|1|10^6/hpf|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|SUPERIOR|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||ADJUDICATION COMMITTEE|RATER|3|Visit_3|40|4|WASHOUT|2020-09-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|7|RRS|Total Respiratory System Resistance|[?]|STANDING, BENT FORWARD|[?]|TCID 50/dose|[?]|1|mL/m2/h|TRIANGULAR-HAMATE JOINT|BILATERAL|LATERAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|||INVESTIGATOR|ONCOLOGIST|4|Visit_4|65|3|WASHOUT|2020-10-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|PRESSOR UNITS|[?]|1|mg/mol|PROFUNDA FEMORIS ARTERY|IPSILATERAL|PROXIMAL VOLAR|MALDI-TOF|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 3|4|Visit_4|65|4|SCREENING|2020-10-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|9|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|L/h|[?]|1|ug/g/min|HYPOPHARYNX|IPSILATERAL|NASAL|ATOMIC ABSORPTION SPECTROMETRY||Y||INDEPENDENT ASSESSOR|ONCOLOGIST 1|5|Visit_5|90|1|FOLLOW-UP|2020-11-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|0fc0650f-ed95-422d-b407-dcee93178780|10|RVPP|Percent Predicted Residual Volume|[?]|SITTING|[?]|L/kg|[?]|1|MET*h|SCLERA|IPSILATERAL|APICAL|AUSCULTATION||||CLINICAL RESEARCH COORDINATOR|RATER|5|Visit_5|90|5|SCREENING|2020-11-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|DECUBITUS|[?]|PFU/dose|[?]|1|LOZENGE|LATISSIMUS DORSI MUSCLE|LATERAL|VENTRAL|MICRO BROTH DILUTION|Y|||INDEPENDENT ASSESSOR|OPTOMETRIST|1|Visit_1|10|2|WASHOUT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|2|PEFREV|PEF Reversibility|[?]|PRONE|||[?]|1|mCi/L|SUPRAPUBIC REGION|RIGHT|OCCIPITAL|ICC|||Y|CLINICAL STUDY SPONSOR|PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|3|TV|Tidal Volume|[?]|TRENDELENBURG|[?]|mEq/day|[?]|1|in2|EXTRAHEPATIC BILE DUCT|UNILATERAL|HIND|FLUORESCEIN STAIN||||INTERVIEWER|PHYSIOTHERAPIST|2|Visit_2|25|5|SCREENING|2020-06-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|4|MEP|Maximal Expiratory Pressure|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|%/min|MIDDLE EAR|LATERAL|VENTRAL|IMMUNOCHEMILUMINOMETRIC ASSAY|Y||Y|INDEPENDENT ASSESSOR|READER 3|2|Visit_2|25|3|FOLLOW-UP|2020-06-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|5|FIFMAX|Maximum Forced Inspiratory Flow|[?]|TRENDELENBURG|[?]|GBq/ug|[?]|1|g/g|EYE, ANTERIOR SEGMENT|UNILATERAL|ANTEROPOSTERIOR|X-RAY||Y||FAMILY MEMBER|RADIOLOGIST 1|3|Visit_3|40|2|SCREENING|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|6|FIFMAXPP|Percent Predicted FIFmax|[?]|FOWLERS|[?]|dpm/100mg|[?]|1|ug/kg/h|GINGIVA|LEFT|ANTEROLATERAL|MS/MS|Y|||VENDOR|RATER 1|3|Visit_3|40|7|WASHOUT|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|7|SGAW|Specific Airway Conductance|[?]|STANDING|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|MBP|SCIATIC NERVE|LATERAL|PERIPHERAL|IN VITRO GENE EXPRESSION ASSAY||Y||GUARDIAN|READER 1|4|Visit_4|65|1|WASHOUT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|8|DLCOPP|Percent Predicted DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|mol|[?]|1|L/kg|CORPUS CALLOSUM, GENU|LEFT|NASAL|WRIGHT STAIN|Y|||STUDY SUBJECT|PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|9|DLCOVA|DLCO/VA|[?]|PRONE|||[?]|1|mL|OSTIOMEATAL COMPLEX|LATERAL|VENTROLATERAL|CONTRAST ENHANCED PET/CT SCAN|Y|Y|Y|VENDOR|ONCOLOGIST 1|5|Visit_5|90|2|FOLLOW-UP|2020-08-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|RE|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|10|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|%/s|[?]|1|Gravitational Unit|BODY OF STOMACH|CONTRALATERAL|TEMPORAL|OPHTHALMOSCOPY||||CHILD|HEMATOLOGIST|5|Visit_5|90|7|TREATMENT|2020-08-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mAnson U/mL|FLOOR OF MOUTH|LATERAL|PERIVENTRICULAR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|Y|Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|1|Visit_1|10|3|SCREENING|2021-01-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|2|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|[?]|10^4 CFU|[?]|1|mL/s/m2|CORPUS UTERI|UNILATERAL|PROXIMAL VOLAR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|1|Visit_1|10|5|TREATMENT|2021-01-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-25
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|3|IRVPP|Percent Predicted IRV|[?]|SEMI-FOWLERS|[?]|mEq/day|[?]|1|mEq/L|ACCESSORY RENAL ARTERY|RIGHT|SURFACE|DYNAMOMETRY|Y|Y||STUDY SUBJECT|READER 3|2|Visit_2|25|5|FOLLOW-UP|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|aMFI|[?]|1|mCi/L|LUNG, LEFT UPPER LOBE|LEFT|DORSAL|GEL ELECTROPHORESIS|Y|||STUDY SUBJECT|CARDIOLOGIST|2|Visit_2|25|1|TREATMENT|2021-02-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-10
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|5|PIF|Peak Inspiratory Flow|[?]|SEMI-RECUMBENT|||[?]|1|g/kg/day|HEPATIC VEIN|RIGHT|DORSAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||Y|Y|CLINICAL RESEARCH COORDINATOR|READER 3|3|Visit_3|40|5|TREATMENT|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|6|FEV_PEF|FEV at PEF|[?]|SITTING|||[?]|1|Bq/kg|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|CONTRALATERAL|PARIETO-OCCIPITAL|OPTICAL MAPPING|||Y|CAREGIVER|OPTOMETRIST|3|Visit_3|40|7|FOLLOW-UP|2021-02-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-26
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|7|FEV1REV|FEV1 Reversibility|[?]|STANDING|[?]|mL/s|[?]|1|POUCH|DISTAL EXTRAHEPATIC BILE DUCT REGION|LEFT|MIDLINE|NEPHELOMETRY||Y||STUDY SUBJECT|PHYSIOTHERAPIST|4|Visit_4|65|5|SCREENING|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|8|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SUPINE|[?]|1/(s*kPa)|[?]|1|MPL U/mL|PULMONARY VALVE, RIGHT CUSP|CONTRALATERAL|POSTERIOR|KINETIC MICROPARTICLE IMMUNOASSAY||||DOMESTIC PARTNER|RATER|4|Visit_4|65|4|WASHOUT|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|9|DLCOHC|HGB Corrected DLCO|[?]|DECUBITUS|[?]|mm3/mm2/year|[?]|1|10^10/L|LINGULA OF THE LUNG|BILATERAL|FACIAL|MANUAL COUNT||Y||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|5|Visit_5|90|4|TREATMENT|2021-04-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|a6f48290-787a-46ad-bee1-ae263ad3c121|10|FEV1REV|FEV1 Reversibility|[?]|SLING|[?]|fraction of 1|[?]|1|dram|THYROID GLAND, RIGHT LOBE|UNILATERAL|UPPER EXTENSOR SURFACE|SNELLEN EYE CHART|Y|||SIGNIFICANT OTHER|HEMATOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-04-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|565e5c83-9c67-4718-bd54-af34be936427|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|PRONE|[?]|ukat/L|[?]|1|GPS U|ANTERIOR TIBIAL VEIN|UNILATERAL|LOWER EXTENSOR SURFACE|CELLULAR PROLIFERATION ASSAY||||SIBLING|ONCOLOGIST 2|1|Visit_1|10|6|SCREENING|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|565e5c83-9c67-4718-bd54-af34be936427|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SLING|||[?]|1|log10 copies/mL|HARD PALATE|RIGHT|OCCIPITAL|LINE PROBE ASSAY|||Y|ADJUDICATION COMMITTEE|READER 3|1|Visit_1|10|2|TREATMENT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|565e5c83-9c67-4718-bd54-af34be936427|3|TV|Tidal Volume|[?]|REVERSE TRENDELENBURG|[?]|mU/g|[?]|1|ukat/10^12 RBC|GONAD|UNILATERAL|NASAL|CENTRIFUGATION||Y||INTERVIEWER|RADIOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|565e5c83-9c67-4718-bd54-af34be936427|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|[?]|U/animal|[?]|1|umol/L|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|UNILATERAL|TIP|FLOCCULATION, CHARCOAL ENHANCED||||CLINICAL RESEARCH ASSOCIATE|RATER|2|Visit_2|25|2|TREATMENT|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|565e5c83-9c67-4718-bd54-af34be936427|5|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|[?]|F|[?]|1|STEPS|INCUS|LATERAL|UPPER EXTENSOR SURFACE|ELLA|Y|||FAMILY MEMBER|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|565e5c83-9c67-4718-bd54-af34be936427|6|SAWVOL|Specific Airway Volume|[?]|SITTING|[?]|copies/ug|[?]|1|mL/g/h|ELBOW EXTENSOR MUSCLES|UNILATERAL|LOWER EXTENSOR SURFACE|TRIPLE-PHASE SPIRAL CT SCAN||||VENDOR|RADIOLOGIST 2|3|Visit_3|40|2|TREATMENT|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|565e5c83-9c67-4718-bd54-af34be936427|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|cmol/L|[?]|1|dB|EPICONDYLE|CONTRALATERAL|INFERIOR|ECHOCARDIOGRAPHY||||HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|565e5c83-9c67-4718-bd54-af34be936427|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|DECUBITUS|[?]|mL/beat|[?]|1|COAT|T1 VERTEBRA|UNILATERAL|SURFACE|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|6|TREATMENT|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|565e5c83-9c67-4718-bd54-af34be936427|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|10^3/L|[?]|1|Shock Wave|C3 VERTEBRA|BILATERAL|SUPERFICIAL|ELECTROPHORESIS||Y||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|565e5c83-9c67-4718-bd54-af34be936427|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|BAU|[?]|1|BOX|RIB 11|IPSILATERAL|DISTAL|PERIPHERAL ANGIOGRAPHY||||INDEPENDENT ASSESSOR|RADIOLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|FIF75|Forced Inspiratory Flow at 75%|[?]|PRONE|||[?]|1|/LSQN|INTERPHALANGEAL JOINT 1|LATERAL|DORSAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN|||Y|VENDOR|NEUROLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|2|IVC|Inspiratory Vital Capacity|[?]|SITTING|[?]|s*kPa|[?]|1|Siemens|RADIUS SHAFT|RIGHT|DORSAL|SLOAN LETTER EYE CHART 1.25%||Y||INDEPENDENT ASSESSOR|ADJUDICATOR 2|1|Visit_1|10|3|TREATMENT|2021-01-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|FOWLERS|[?]|mEq/mmol|[?]|1|PELLET|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|LATERAL|APICAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||Y||PARENT|ADJUDICATOR 2|2|Visit_2|25|2|FOLLOW-UP|2021-01-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|4|ERV|Expiratory Reserve Volume|[?]|SEMI-FOWLERS|||[?]|1|foz_br|BUCCAL MUCOSA|UNILATERAL|DORSOLATERAL|ANGIOGRAPHY|||Y|DOMESTIC PARTNER|RATER|2|Visit_2|25|7|FOLLOW-UP|2021-01-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|5|INFLTIND|Infiltrates Indicator|[?]|SUPINE|||[?]|1|U.CARR|KIDNEY, CORTEX|RIGHT|ROSTRAL|COMPLEMENT FIXATION||Y|Y|INDEPENDENT ASSESSOR|RADIOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|6|SVCPP|Percent Predicted Slow Vital Capacity|[?]|TRENDELENBURG|[?]|kIU|[?]|1|ug/dose|SUBGLOTTIS|LEFT|PERIVENTRICULAR|PYROSEQUENCING||||PROXY|FORENSIC PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2021-02-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-30
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|[?]|MAC50|[?]|1|mL/(min*100mL)|ACROMION|UNILATERAL|VENTRAL|SMEAR||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|4|Visit_4|65|5|TREATMENT|2021-03-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|8|SGAW|Specific Airway Conductance|[?]|SEMI-RECUMBENT|[?]|ug/dL|[?]|1|hPa|HIP|IPSILATERAL|LATERAL|SINGLE-SLICE SPIRAL CT||Y||SIGNIFICANT OTHER|RADIOLOGIST 1|4|Visit_4|65|5|WASHOUT|2021-03-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|9|INTP|Interpretation|[?]|SITTING|[?]|ppth|[?]|1|U|SUBLINGUAL REGION|RIGHT|PARIETO-OCCIPITAL|LIGHT SCATTERING SPECTROSCOPY||||INDEPENDENT ASSESSOR|PATHOLOGIST 1|5|Visit_5|90|1|SCREENING|2021-03-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|b238304c-15ef-4c6e-a32c-9cd583a233a9|10|OXYPULSE|Oxygen Pulse|[?]|UNCONSTRAINED|||[?]|1|TRACE|RETINA|LATERAL|INFERIOR|OBSERVATION||Y|Y|SIBLING|PATHOLOGIST 2|5|Visit_5|90|1|WASHOUT|2021-03-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-06
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|FEV1SVC|FEV1/SVC|[?]|SLING|[?]|ug/min|[?]|1|10^10/L|HEART, RIGHT VENTRICLE|BILATERAL|MEDIAL|RAJI CELL EIA||||SIBLING|OTOLARYNGOLOGIST|1|Visit_1|10|4|TREATMENT|2020-09-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|2|GAW|Airway Conductance|[?]|SITTING|||[?]|1|nmol|THIRD RIGHT POSTEROLATERAL ARTERY|LEFT|VENTROLATERAL|SLOAN LETTER EYE CHART 2.5%|||Y|NON-HEALTH CARE PROFESSIONAL|UROLOGIST|1|Visit_1|10|1|TREATMENT|2020-09-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-FOWLERS|[?]|pmol/L|[?]|1|Enzyme U/L|INTERNAL MAMMARY LYMPH NODE|CONTRALATERAL|SURFACE|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|2|Visit_2|25|2|TREATMENT|2020-10-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|UNCONSTRAINED|[?]|ELISA unit/mL|[?]|1|/h|BLADDER, FUNDUS|BILATERAL|PARIETO-OCCIPITAL|FLAME PHOTOMETRY|Y|||SIGNIFICANT OTHER|ADJUDICATOR|2|Visit_2|25|1|FOLLOW-UP|2020-10-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|5|FEV1SVC|FEV1/SVC|[?]|FOWLERS|[?]|mN|[?]|1|RATIO|SUBTALAR JOINT|IPSILATERAL|INNER|AUDIOMETRY|Y|||CAREGIVER|ONCOLOGIST 2|3|Visit_3|40|3|WASHOUT|2020-10-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|6|FRCPP|Percent Predicted FRC|[?]|STANDING, BENT FORWARD|||[?]|1|uL|TRAPEZIAL BONE|RIGHT|PERIPHERAL|IMPEDANCE CONDUCTIVITY|Y|Y|Y|CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|3|Visit_3|40|7|TREATMENT|2020-10-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|7|FEV1PP|Percent Predicted FEV1|[?]|LATERAL DECUBITUS|[?]|pmol/dL|[?]|1|Arbitrary U|PROSTATE GLAND|BILATERAL|HIND|DROPLET DIGITAL PCR|Y|||CHILD|CLINICAL PATHOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-11-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|8|INFLTIND|Infiltrates Indicator|[?]|SEMI-RECUMBENT|[?]|ug/m2/min|[?]|1|fmol|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|UNILATERAL|CAUDAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|UROLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-11-17|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|9|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|[?]|IU|[?]|1|g|SACRUM|CONTRALATERAL|MIDLINE|TOLUIDINE BLUE STAIN||Y||ADJUDICATION COMMITTEE|RADIOLOGIST|5|Visit_5|90|6|TREATMENT|2020-12-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|c273f039-bca9-4d55-8620-5c5db32a6c4b|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|UNCONSTRAINED|||[?]|1|rpm|EYE, VITREOUS CHAMBER|CONTRALATERAL|LOWER|SPECULAR MICROSCOPY|||Y|SIBLING|RATER|5|Visit_5|90|6|WASHOUT|2020-12-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|100 IU/mL|[?]|1|10^11/L|AORTIC VALVE, RIGHT CORONARY CUSP|UNILATERAL|PERIPHERAL|PERFUSION MRI||||CAREGIVER|PATHOLOGIST 1|1|Visit_1|10|3|WASHOUT|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|2|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|[?]|ELISA unit|[?]|1|Coulomb|CORPUS CALLOSUM, GENU|IPSILATERAL|PERIVENTRICULAR|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||Y||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|1|Visit_1|10|2|WASHOUT|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|3|FEF50|Forced Expiratory Flow 50%|[?]|STANDING|[?]|Gy/h|[?]|1|cm|STOMACH|LATERAL|DEEP|FLOCCULATION, CHARCOAL ENHANCED||Y||VENDOR|INTERNIST|2|Visit_2|25|2|TREATMENT|2020-09-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|ka_u/dL|[?]|1|10^4 CFU/mL|ESOPHAGEAL LYMPH NODE|CONTRALATERAL|TEMPORAL|IMMUNOBLOT||Y||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|6|TREATMENT|2020-09-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|5|RER|Respiratory Exchange Ratio|[?]|RIGHT LATERAL DECUBITUS|[?]|ms/mmHg|[?]|1|10^4/L|OLFACTORY BULB|RIGHT|ANTEROPOSTERIOR|DUKE INCISION METHOD||||STUDY SUBJECT|OTOLARYNGOLOGIST|3|Visit_3|40|2|TREATMENT|2020-09-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|6|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|v/v|[?]|1|mCi/kg|BUCCAL LYMPH NODE|LATERAL|LATERAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|||STUDY SUBJECT|PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|7|ICREV|IC Reversibility|[?]|FOWLERS|[?]|P|[?]|1|MnFI|HEART, RIGHT VENTRICULAR FREE WALL|CONTRALATERAL|DORSAL|KARYOTYPING||Y||FAMILY MEMBER|MICROSCOPIST 3|4|Visit_4|65|2|FOLLOW-UP|2020-10-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-FOWLERS|[?]|cycle/min|[?]|1|U/animal|TEMPLE|LATERAL|INTERMEDIATE|MULTIPLEXED BEAD BASED IMMUNOASSAY||||SIBLING|OPTOMETRIST|4|Visit_4|65|6|TREATMENT|2020-10-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|9|RAW|Airway Resistance|[?]|DECUBITUS|||[?]|1|ug/g/min|AORTA|IPSILATERAL|LATERAL|FREEZING POINT DEPRESSION|Y||Y|FAMILY MEMBER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|1|TREATMENT|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|2cdb5053-2108-4f50-8906-8afabc855a36|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|[?]|Siemens|[?]|1|log10 CFU/mL|CLITORIS|LEFT|LOWER EXTENSOR SURFACE|EIA|Y|||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|5|Visit_5|90|3|SCREENING|2020-11-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|FEF2575P|Percent Predicted FEF25-75|[?]|LEFT LATERAL DECUBITUS|[?]|10^8 PFU|[?]|1|10^4 CFU|ABDUCENS NERVE|UNILATERAL|BASAL|TELLER ACUITY CARDS||||FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|2|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|SUPPOSITORY|[?]|1|CIGAR|INTERPHALANGEAL JOINT 5|CONTRALATERAL|SURFACE|IMMUNOCHROMATOGRAPHY|Y|||SPOUSE|READER|1|Visit_1|10|1|TREATMENT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|3|FEV1FVC6|FEV1/FVC6|[?]|RIGHT LATERAL DECUBITUS|[?]|cy/cm|[?]|1|SUPPOSITORY|FUNDUS UTERI|CONTRALATERAL|MEDIAL|CONTRAST ENHANCED SPIRAL CT SCAN||||NON-HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|7|TREATMENT|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|4|SVC|Slow Vital Capacity|[?]|STANDING|[?]|ukat/L|[?]|1|cal|PROXIMAL URETHRA|LATERAL|LOWER MEDIAL|LINE PROBE ASSAY||Y||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|SCREENING|2020-08-21|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-06
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|5|ELSTNCE|Elastance|[?]|LEFT LATERAL DECUBITUS|[?]|kHz|[?]|1|/LPF|AXILLARY ARTERY|IPSILATERAL|CAUDAL|TRYPAN BLUE STAIN|Y|Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-09-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|6|FEV1FVC6|FEV1/FVC6|[?]|STANDING, BENT FORWARD|[?]|OD Unit|[?]|1|kat|LOWER RESPIRATORY SYSTEM|LATERAL|LOWER|PYROSEQUENCING|Y|||PARENT|OTOLARYNGOLOGIST|3|Visit_3|40|7|TREATMENT|2020-09-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|7|FEF2575P|Percent Predicted FEF25-75|[?]|TRENDELENBURG|[?]|Absorbance U|[?]|1|U/g/min|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL|VOLAR|MULTIPLE BREATH WASHOUT||||SIGNIFICANT OTHER|NEUROLOGIST 1|4|Visit_4|65|7|SCREENING|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|8|DLCOVA|DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|BAR|[?]|1|10^6 organisms/mL|T10 VERTEBRA|BILATERAL|NASAL|NO INFORMATION||||VENDOR|MICROSCOPIST 3|4|Visit_4|65|2|TREATMENT|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-22
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|9|MEP|Maximal Expiratory Pressure|[?]|FOWLERS|||[?]|1|pg|BUCCAL LYMPH NODE|LEFT|FORE|TONOMETRY|||Y|FAMILY MEMBER|RADIOLOGIST 2|5|Visit_5|90|3|TREATMENT|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|fce7149a-503e-4209-8c62-8044a2ad1c1c|10|FEV1FVC6|FEV1/FVC6|[?]|DECUBITUS|||[?]|1|sec|CORPUS CALLOSUM, GENU|CONTRALATERAL|LOWER|NEXT GENERATION SEQUENCING|Y|Y|Y|ADJUDICATION COMMITTEE|OPTOMETRIST|5|Visit_5|90|6|TREATMENT|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|1|PEFREV|PEF Reversibility|[?]|FOWLERS|||[?]|1|usec|SKIN OF THE TRUNK|UNILATERAL|ANTERIOR|AGAR PROPORTION|||Y|CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|1|Visit_1|10|3|TREATMENT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|2|RAW|Airway Resistance|[?]|SUPINE|[?]|mL/mmHg|[?]|1|uEq|HAND|LEFT|MEDIAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|1|Visit_1|10|3|SCREENING|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|3|FEV6PP|Percent Predicted FEV6|[?]|UNCONSTRAINED|[?]|mol|[?]|1|10^6 IU|PRESACRAL LYMPH NODE|LEFT|PERIPHERAL|FARNSWORTH-MUNSELL 100 HUE TEST|Y|Y||VENDOR|INTERNIST|2|Visit_2|25|1|WASHOUT|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|4|ELSTNCE|Elastance|[?]|FOWLERS|[?]|% INHIBITION|[?]|1|mg/L|MUSCLE|LEFT|VOLAR|HIGH RESOLUTION MELT ANALYSIS||||CHILD|RATER 2|2|Visit_2|25|7|SCREENING|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|5|SRAW|Specific Airway Resistance|[?]|FOWLERS|[?]|mg/cm2|[?]|1|lx|SPINAL ACCESSORY NERVE|LEFT|APICAL|MOUSE PROTECTION ASSAY||||SIBLING|ADJUDICATOR 1|3|Visit_3|40|7|SCREENING|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|||[?]|1|U/m2|TARSAL JOINT|CONTRALATERAL|UPPER EXTENSOR SURFACE|ATOMIC ABSORPTION SPECTROMETRY|Y|Y|Y|FAMILY MEMBER|ONCOLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|7|ELSTNCE|Elastance|[?]|LATERAL DECUBITUS|||[?]|1|min/day|RETINAL PIGMENTED EPITHELIAL LAYER|LATERAL|SUPERFICIAL|FLUORESCENT SPOT TEST|||Y|PARENT|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|8|ALVVOL|Alveolar Volume|[?]|PRONE|[?]|Frames/s|[?]|1|cg|L3 VERTEBRA|IPSILATERAL|HIND|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|Y||SIBLING|MICROSCOPIST 3|4|Visit_4|65|5|WASHOUT|2020-08-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-28
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|9|LCI|Lung Clearance Index|[?]|SITTING|||[?]|1|BAG|GASTROINTESTINAL TRACT, UPPER, WALL|RIGHT|INFERIOR|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|FRIEND|ONCOLOGIST|5|Visit_5|90|4|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|RE|c8aad550-11a1-4473-8b35-79b7dfb08122|10|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|ppm|[?]|1|mL/m2|LEG SKIN|BILATERAL|UPPER EXTENSOR SURFACE|MODIFIED ACID FAST STAIN||||DOMESTIC PARTNER|ENDOCRINOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-16
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|1|PEFTIME|Peak Expiratory Flow Time|[?]|PRONE|||[?]|1|VIAL|COLON WALL|CONTRALATERAL|UPPER EXTENSOR SURFACE|FARR ASSAY|||Y|PARENT|ADJUDICATOR 1|1|Visit_1|10|7|TREATMENT|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|2|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|/500 WBC|[?]|1|Farad|FLEXOR DIGITORUM PROFUNDUS MUSCLE|IPSILATERAL|INTERMEDIATE|MULTIPLE BREATH WASHOUT||Y||SIBLING|ADJUDICATOR 1|1|Visit_1|10|4|TREATMENT|2021-01-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|3|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|pkat/L|[?]|1|mL/cm H2O|EYELID|LATERAL|SUPERIOR|FLUOROSCOPY||||FRIEND|NEUROLOGIST 1|2|Visit_2|25|2|TREATMENT|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|4|RVPP|Percent Predicted Residual Volume|[?]|SLING|[?]|cmH2O*s/mL|[?]|1|Gy/min|HAND DIGIT 4|IPSILATERAL|TEMPORAL|FLUORESCENT MICROSCOPY||||PROXY|OTOLARYNGOLOGIST|2|Visit_2|25|4|SCREENING|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|5|IC|Inspiratory Capacity|[?]|SLING|[?]|Weber|[?]|1|scm|SOFT PALATE|BILATERAL|TEMPORAL|PET/CT SCAN WITHOUT CONTRAST|Y|Y||FRIEND|READER 2|3|Visit_3|40|6|TREATMENT|2021-02-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|6|FEV3FVC|FEV3/FVC|[?]|DECUBITUS|[?]|mL/min/mmHg|[?]|1|L/L|SUBSCAPULARIS MUSCLE|UNILATERAL|PROXIMAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|||SIBLING|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|DECUBITUS|[?]|10^6/hpf|[?]|1|cm|LEFT POSTEROLATERAL DESCENDING ARTERY|BILATERAL|PROXIMAL|CELL BASED BIOASSAY||Y||ADJUDICATION COMMITTEE|RADIOLOGIST 2|4|Visit_4|65|2|TREATMENT|2021-03-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|8|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|sec|TYMPANIC MEMBRANE|LEFT|DEEP|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y|Y|ADJUDICATION COMMITTEE|ADJUDICATOR 2|4|Visit_4|65|2|TREATMENT|2021-03-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|9|FIF25|Forced Inspiratory Flow at 25%|[?]|SEMI-FOWLERS|[?]|mEq/kg|[?]|1|% INHIBITION|METACARPAL BONE 2|UNILATERAL|FACIAL|SINGLE-SLICE SPIRAL CT|Y|||CLINICAL STUDY SPONSOR|INTERNIST|5|Visit_5|90|7|SCREENING|2021-03-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|f1967c6e-c520-4482-be7e-01ada4380d87|10|AWWVOL|Airway Wall Volume|[?]|REVERSE TRENDELENBURG|[?]|amu|[?]|1|anti-Xa IU|TOE|LATERAL|INNER|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||FAMILY MEMBER|READER 2|5|Visit_5|90|5|TREATMENT|2021-03-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|g/m2/day|ORAL MUCOSA|RIGHT|LATERAL|MICRO BROTH DILUTION||Y|Y|INVESTIGATOR|UROLOGIST|1|Visit_1|10|6|WASHOUT|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|2|DLCOPP|Percent Predicted DLCO|[?]|PRONE|[?]|mCi/kg|[?]|1|dmol|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|ANTEROMEDIAL|SINGLE-MOLECULE ARRAY||Y||CLINICAL RESEARCH ASSOCIATE|READER|1|Visit_1|10|7|TREATMENT|2021-01-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|3|FEF2575|Forced Expiratory Flow 25-75%|[?]|FOWLERS|[?]|nm|[?]|1|pt_us|INFRATENTORIAL BRAIN|IPSILATERAL|DEEP|NUCLEIC ACID HYBRIDIZATION||Y||INTERVIEWER|READER 2|2|Visit_2|25|5|FOLLOW-UP|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|4|DLCOHC|HGB Corrected DLCO|[?]|PRONE|[?]|days/wk|[?]|1|ug/L FEU|PAROTID GLAND LYMPH NODE|RIGHT|INNER|HPLC/MS||||INTERVIEWER|CLINICAL PATHOLOGIST|2|Visit_2|25|3|SCREENING|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-RECUMBENT|[?]|cup eq|[?]|1|U/mg|TEMPLE|LATERAL|MEDIAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|SCREENING|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|6|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|L|[?]|1|U/kg/day|EYE BULGE|IPSILATERAL|FORE|COULOMETRIC TITRATION||Y||FAMILY MEMBER|MICROSCOPIST 2|3|Visit_3|40|5|TREATMENT|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|7|SALKB|Salazar-Knowles Equation Parameter B|[?]|LATERAL DECUBITUS|[?]|mEq|[?]|1|mL/m2/min|PHARYNX|RIGHT|DORSOLATERAL|HEMAGGLUTINATION ASSAY||||VENDOR|PATHOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|8|PEF|Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|nmol BCE/mmol|[?]|1|mg/cm2|CRANIAL CAVITY|LATERAL|CRANIAL|PERIPHERAL ANGIOGRAPHY||||INTERVIEWER|HEMATOLOGIST|4|Visit_4|65|6|TREATMENT|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-24
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|9|INFLTIND|Infiltrates Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|anti-Xa IU/mL|[?]|1|umol|PUPIL|BILATERAL|DORSAL|MALDI-TOF||||VENDOR|RATER|5|Visit_5|90|1|FOLLOW-UP|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|2a5a1c03-f54e-47da-8dda-2104c9423e94|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|USP U|[?]|1|mL/sec/1.73m2|SPLENIC LYMPH NODE|LEFT|PERIPHERAL|PELLI-ROBSON EYE CHART||||PROXY|PHYSIOTHERAPIST|5|Visit_5|90|4|SCREENING|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-05
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|MALEVDES|Malignancy Evidence Description|[?]|TRENDELENBURG|[?]|pmol/day|[?]|1|U/kg|CINGULATE CORTEX|IPSILATERAL|VOLAR|GEL ELECTROPHORESIS||||SIGNIFICANT OTHER|OPTOMETRIST|1|Visit_1|10|4|TREATMENT|2020-06-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|2|MEP|Maximal Expiratory Pressure|[?]|STANDING|||[?]|1|10^3/hpf|MAIN BRONCHUS, RIGHT|RIGHT|LATERAL|POLYGRAPHY||Y|Y|STUDY SUBJECT|UROLOGIST|1|Visit_1|10|2|SCREENING|2020-06-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|3|MEPPP|Percent Predicted MEP|[?]|REVERSE TRENDELENBURG|[?]|ug/mol|[?]|1|Bq/ug|INSULAR CORTEX|CONTRALATERAL|ROSTRAL|ECHOCARDIOGRAPHY||||VENDOR|MICROSCOPIST|2|Visit_2|25|5|TREATMENT|2020-07-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|4|DLCOVA|DLCO/VA|[?]|UNCONSTRAINED|||[?]|1|ng/mol|LEG SKIN|CONTRALATERAL|TEMPORAL|CT SCAN WITHOUT CONTRAST|||Y|SIGNIFICANT OTHER|ADJUDICATOR 1|2|Visit_2|25|5|WASHOUT|2020-07-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|5|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|Roentgen|[?]|1|SQU/mL|SCAPHOID-RADIUS JOINT|RIGHT|PROXIMAL|CONTRAST ENHANCED MRI|Y|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|1|FOLLOW-UP|2020-07-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|6|AWVOLPP|Percent Predicted Airway Volume|[?]|SLING|[?]|PUFF|[?]|1|AgU/mL|FOREHEAD|IPSILATERAL|DISTAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||SIBLING|READER|3|Visit_3|40|1|TREATMENT|2020-07-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SUPINE|[?]|nsec|[?]|1|PACK|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|IPSILATERAL|ANTEROMEDIAL|MICROBIAL BIOCHEMICAL IDENTIFICATION||||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|8|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-RECUMBENT|[?]|PNU/mL|[?]|1|tuberculin unit|RIB 3|LATERAL|LOWER EXTENSOR SURFACE|MECHANICAL CLOT DETECTION||||STUDY SUBJECT|READER|4|Visit_4|65|6|TREATMENT|2020-08-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|ug/cm2|[?]|1|/day|SKIN OF THE TRUNK|LEFT|VOLAR|MULTI-SLICE SPIRAL CT||Y||CAREGIVER|NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|RE|8f98bac3-8010-4902-8ae1-783dc5fea72d|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|DECUBITUS|[?]|U/m2/day|[?]|1|mL/mmHg/min/L|URETHRA, POSTERIOR|LEFT|PARIETO-OCCIPITAL|SLOAN LETTER EYE CHART 100%||Y||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|5|Visit_5|90|7|WASHOUT|2020-09-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-24
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|EXPRELTM|Expiration Relaxation Time|[?]|SITTING|[?]|kHz|[?]|1|tuberculin unit|HILAR LYMPH NODE|CONTRALATERAL|TEMPORAL|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|Y||PARENT|RATER 1|1|Visit_1|10|4|TREATMENT|2020-12-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|2|AWVOLPP|Percent Predicted Airway Volume|[?]|SUPINE|||[?]|1|mg/mL/day|HYOID BONE|LEFT|NASAL|SCINTIGRAPHY|||Y|FAMILY MEMBER|ADJUDICATOR 2|1|Visit_1|10|5|TREATMENT|2020-12-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|3|FEV1REV|FEV1 Reversibility|[?]|SUPINE|[?]|days/month|[?]|1|mmol/day|BLADDER, FUNDUS|LATERAL|TEMPORAL|POPULATION SEQUENCING||||PROXY|ONCOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-12-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|4|AWWVOL|Airway Wall Volume|[?]|PRONE|||[?]|1|mm3/mm2/year|ENDOCARDIUM|IPSILATERAL|HIND|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y||Y|CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|TREATMENT|2020-12-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|5|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|kPa|[?]|1|Rad|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|UNILATERAL|DISTAL|OPTICAL DENSITY MEASUREMENT||||PROXY|READER|3|Visit_3|40|2|FOLLOW-UP|2021-01-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|6|RER|Respiratory Exchange Ratio|[?]|STANDING|[?]|10^12 IU/L|[?]|1|g/cm2|SPHENOID SINUS|RIGHT|LATERAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||STUDY SUBJECT|OPHTHALMOLOGIST|3|Visit_3|40|7|TREATMENT|2021-01-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|7|RVPP|Percent Predicted Residual Volume|[?]|LATERAL DECUBITUS|||[?]|1|MPS U|TRANSVERSE TARSAL JOINT|CONTRALATERAL|CAUDAL|SPECT SCAN|||Y|ADJUDICATOR|FORENSIC PATHOLOGIST|4|Visit_4|65|4|TREATMENT|2021-02-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|8|ELSTNCE|Elastance|[?]|SLING|[?]|vg/dose|[?]|1|g/kg|METACARPOPHALANGEAL JOINT 2|RIGHT|UPPER|ELECTROPHORESIS|Y|||CLINICAL STUDY SPONSOR|DERMATOLOGIST|4|Visit_4|65|4|SCREENING|2021-02-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING|||[?]|1|ohm|LUNG, RIGHT MIDDLE LOBE|CONTRALATERAL|INTERMEDIATE|PEAK FLOWMETRY|||Y|INTERVIEWER|PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|0fd7cece-4d9d-4d8c-82e0-df0c75613888|10|INERTANC|Inertance|[?]|SUPINE|[?]|mm|[?]|1|U/kg|MIDBRAIN|RIGHT|PERIPHERAL|ENZYMATIC SPECTROPHOTOMETRY|Y|||STUDY SUBJECT|PATHOLOGIST 1|5|Visit_5|90|5|WASHOUT|2021-03-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|FEV1REV|FEV1 Reversibility|[?]|SITTING|[?]|nmol BCE/L|[?]|1|U/m2|CEREBRUM|RIGHT|PERIVENTRICULAR|ENZYMATIC COLORIMETRY|Y|||HEALTH CARE PROFESSIONAL|PATHOLOGIST|1|Visit_1|10|7|SCREENING|2020-06-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|2|MEP|Maximal Expiratory Pressure|[?]|SEMI-RECUMBENT|||[?]|1|mm/sec|TRICUSPID VALVE, SEPTAL CUSP|LEFT|DEEP|MS/MS|||Y|STUDY SUBJECT|ADJUDICATOR 3|1|Visit_1|10|5|SCREENING|2020-06-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|3|FEV1FVC6|FEV1/FVC6|[?]|STANDING, BENT FORWARD|[?]|10^6 RNA copies/mL|[?]|1|U/kg|PONS VAROLII|BILATERAL|TEMPORAL|IMPULSE OSCILLOMETRY||||DOMESTIC PARTNER|ONCOLOGIST 2|2|Visit_2|25|4|SCREENING|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|4|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-RECUMBENT|[?]|s^-1(%O2)^-1|[?]|1|ug/day|FACE|BILATERAL|DORSOLATERAL|AURAMINE STAIN||||FAMILY MEMBER|ONCOLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-06-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|5|FEV1FVC|FEV1/FVC|[?]|SITTING|[?]|mg/min|[?]|1|mL/cm3/min|METATARSAL BONE|CONTRALATERAL|FORE|FUNDUS PHOTOGRAPHY||||ADJUDICATOR|MICROSCOPIST 1|3|Visit_3|40|1|WASHOUT|2020-07-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|[?]|IU/mmol|[?]|1|cmol|SKIN OF THE NECK|UNILATERAL|CRANIAL|INDIA INK STAIN||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-07-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|cmH2O*s/mL|[?]|1|Bq/mL|SUPRAGLOTTIS|RIGHT|ANTEROLATERAL|HANSEL STAIN|Y|||PROXY|ADJUDICATOR 2|4|Visit_4|65|2|SCREENING|2020-08-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|8|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|[?]|STEPS|[?]|1|HOURS|HAIR SHAFT|LEFT|CAUDAL|IMPULSE OSCILLOMETRY||||CAREGIVER|ONCOLOGIST|4|Visit_4|65|1|TREATMENT|2020-08-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|9|RAWPP|Percent Predicted Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|g/mol|[?]|1|s*kPa|RIB 8|CONTRALATERAL|OCCIPITAL|DOPPLER ULTRASOUND||Y||INDEPENDENT ASSESSOR|RADIOLOGIST 2|5|Visit_5|90|4|SCREENING|2020-09-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|[?]|kIU|[?]|1|g/U|RIB 6|LATERAL|TIP|HPLC/MS/MS||||VENDOR|READER 2|5|Visit_5|90|2|SCREENING|2020-09-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|1|EFFIND|Effusion Indicator|[?]|SEMI-FOWLERS|||[?]|1|cm|GASTRIC CURVATURE LYMPH NODE|IPSILATERAL|CENTRAL|HPLC/IEX|Y||Y|SPOUSE|ADJUDICATOR 3|1|Visit_1|10|1|FOLLOW-UP|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|2|FEV3FVC|FEV3/FVC|[?]|DECUBITUS|||[?]|1|mL/kg/day|NUCHAL LYMPH NODE|IPSILATERAL|DEEP|CALCOFLUOR WHITE STAIN|||Y|CHILD|CARDIOLOGIST|1|Visit_1|10|3|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-26
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|3|FIF75|Forced Inspiratory Flow at 75%|[?]|SUPINE|[?]|cpm|[?]|1|beats/min|RADIUS SHAFT|RIGHT|VENTRAL|CYSTOMETRY||||PROXY|READER 3|2|Visit_2|25|5|TREATMENT|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|4|MEPPP|Percent Predicted MEP|[?]|REVERSE TRENDELENBURG|[?]|EP U|[?]|1|dpm/mg|VENOUS SINUS|CONTRALATERAL|HIND|TOTAL BODY IRRADIATION||Y||GUARDIAN|READER 3|2|Visit_2|25|7|TREATMENT|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-12
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|[?]|U.CARR|[?]|1|mL/mmHg/min/L|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|BILATERAL|FACIAL|FLUORESCENT IMMUNOASSAY||||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|4|WASHOUT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|6|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|[?]|cm2|[?]|1|OI50|URETHRA|IPSILATERAL|VOLAR|SPIROMETRY||||VENDOR|ADJUDICATOR 3|3|Visit_3|40|5|TREATMENT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|7|MIP|Maximal Inspiratory Pressure|[?]|DECUBITUS|[?]|/mm|[?]|1|ELISA unit/mL|GASTROINTESTINAL TRACT, UPPER|IPSILATERAL|MEDIAL|DYNAMIC LIGHT SCATTERING|Y|Y||INTERVIEWER|NEUROLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|8|AWWVOL|Airway Wall Volume|[?]|UNCONSTRAINED|[?]|mkat|[?]|1|VIRTUAL PIXEL|CERVICAL SPINE|UNILATERAL|APICAL|HPLC||||SIBLING|ADJUDICATOR 2|4|Visit_4|65|6|TREATMENT|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|9|FEV3FVC|FEV3/FVC|[?]|LATERAL DECUBITUS|[?]|kN/cm2|[?]|1|mAmp|ABDUCENS NERVE|BILATERAL|NASAL|TOLUIDINE BLUE STAIN||||PROXY|NEUROLOGIST 2|5|Visit_5|90|3|FOLLOW-UP|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|4be1ea69-9baf-45b4-873b-13a879544d9c|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|GPS U|[?]|1|mL/kg/min|NUCLEUS ACCUMBENS|UNILATERAL|ANTEROTEMPORAL|NEURAMINIDASE INHIBITION ASSAY||||INVESTIGATOR|READER 1|5|Visit_5|90|6|TREATMENT|2021-04-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-RECUMBENT|[?]|m2|[?]|1|mg/mL/min|PROXIMAL PHALANX 4 OF THE HAND|UNILATERAL|ROSTRAL|IMMUNOFIXATION ELECTROPHORESIS|Y|||ADJUDICATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-10-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|2|MALEVDES|Malignancy Evidence Description|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mmHg*min/L|LEFT VENTRICULAR MID ANTERIOR SEGMENT|RIGHT|LOWER|MICROARRAY|||Y|PROXY|PATHOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-10-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|3|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|%/s|[?]|1|amol|TRAPEZIUS MUSCLE|UNILATERAL|TEMPORAL|RIA||Y||FAMILY MEMBER|CLINICAL PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|4|FVC|Forced Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|ug/kg/day|[?]|1|Log10 ELISA unit|HAND PHALANX|LEFT|UPPER EXTENSOR SURFACE|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||SIBLING|READER 2|2|Visit_2|25|5|WASHOUT|2020-11-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|5|PEFREV|PEF Reversibility|[?]|UNCONSTRAINED|[?]|PIXELS/in|[?]|1|MPL U|LATERAL THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL|SUBCORTICAL|REFLECTANCE SPECTROSCOPY||||ADJUDICATOR|INTERNIST|3|Visit_3|40|7|SCREENING|2020-11-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|6|AIRTRAP|Air Trapping|[?]|SEMI-FOWLERS|[?]|DAgU/mL|[?]|1|log10 CFU/mL|MESENTERY|RIGHT|TIP|INDIA INK STAIN||||INTERVIEWER|ADJUDICATOR 3|3|Visit_3|40|2|TREATMENT|2020-11-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|7|DLCOHC|HGB Corrected DLCO|[?]|SEMI-FOWLERS|[?]|cs|[?]|1|amp|HAND DIGIT 4|RIGHT|FACIAL|DROPLET DIGITAL PCR||Y||CHILD|READER 2|4|Visit_4|65|2|TREATMENT|2020-12-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|8|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|||[?]|1|pkat/L|POSTERIOR CINGULATE CORTEX|UNILATERAL|DORSAL|DIFFUSION TENSOR MRI|Y||Y|PARENT|ADJUDICATOR 1|4|Visit_4|65|3|WASHOUT|2020-12-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SLING|||[?]|1|bel|AORTO-ILIAC PERIPHERAL ARTERY|LATERAL|DEEP|NUCLEIC ACID AMPLIFICATION TEST|||Y|SIBLING|UROLOGIST|5|Visit_5|90|2|SCREENING|2021-01-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|10|LOBVOL|Lobar Volume|[?]|TRENDELENBURG|||[?]|1|m/sec2|BLADDER WALL|UNILATERAL|PERIVENTRICULAR|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY|||Y|FRIEND|PEDIATRIC NEUROLOGIST|5|Visit_5|90|5|WASHOUT|2021-01-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|1|ELSTNCE|Elastance|[?]|REVERSE TRENDELENBURG|[?]|mL/dose|[?]|1|10^6 organisms/mg|LIMB|LEFT|LOWER|PHASE-CONTRAST MRI||Y||INTERVIEWER|CLINICAL PATHOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2021-01-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|2|SVC|Slow Vital Capacity|[?]|TRENDELENBURG|[?]|mL/m2/h|[?]|1|kg|ILEUM LYMPH NODE|LATERAL|BASAL|FARNSWORTH-MUNSELL 100 HUE TEST||||GUARDIAN|OPHTHALMOLOGIST|1|Visit_1|10|7|SCREENING|2021-01-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|3|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|LATERAL DECUBITUS|[?]|kBq/uL|[?]|1|mL/cage/day|INTERNAL ILIAC LYMPH NODE|UNILATERAL|ANTEROPOSTERIOR|TRICHROME STAIN||||FAMILY MEMBER|NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2021-01-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|4|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|[?]|10^6/hpf|[?]|1|cg|CERVICAL VERTEBRA|LATERAL|PROXIMAL VOLAR|TEMPLATE INCISION METHOD||||NON-HEALTH CARE PROFESSIONAL|READER 2|2|Visit_2|25|4|TREATMENT|2021-01-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-20
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|5|LCI|Lung Clearance Index|[?]|SEMI-FOWLERS|||[?]|1|Osm|MEDIASTINUM, MIDDLE|BILATERAL|INNER|ICP-MS||Y|Y|SPOUSE|OPTOMETRIST|3|Visit_3|40|3|TREATMENT|2021-02-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|UNCONSTRAINED|[?]|copies/ug|[?]|1|cm/s|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|UNILATERAL|PARIETO-OCCIPITAL|ENZYMATIC COLORIMETRY||Y||CAREGIVER|ADJUDICATOR 3|3|Visit_3|40|2|FOLLOW-UP|2021-02-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|7|FEV3PP|Percent Predicted FEV3|[?]|UNCONSTRAINED|[?]|mAnson U/mL|[?]|1|mAnson U/mL|CARPOMETACARPAL JOINT 4|IPSILATERAL|PERIPHERAL|ULTRASOUND||Y||CHILD|READER 3|4|Visit_4|65|1|TREATMENT|2021-03-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|8|AWWVOL|Airway Wall Volume|[?]|LEFT LATERAL DECUBITUS|[?]|Joule|[?]|1|mL/min/1.73m2|CRANIAL NERVE|CONTRALATERAL|BASAL|TRICHROME STAIN|Y|||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|4|Visit_4|65|6|TREATMENT|2021-03-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|FOWLERS|[?]|mm2|[?]|1|STRIP|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|INNER|MICROARRAY||||ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|TREATMENT|2021-03-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|16720f71-55b5-478f-b041-00b61ae19ac9|10|VO2|Oxygen Consumption|[?]|SITTING|||[?]|1|pmol|SKIN OF THE THIGH|CONTRALATERAL|CAUDAL|WHOLE EXOME SEQUENCING||Y|Y|GUARDIAN|CARDIOLOGIST|5|Visit_5|90|4|TREATMENT|2021-03-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|MALIND|Malignancy Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|Gy|[?]|1|U/g/h|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LATERAL|VENTRAL|PANENDOSCOPY||||CHILD|RATER 2|1|Visit_1|10|2|SCREENING|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|UNCONSTRAINED|[?]|nkat/g Hb|[?]|1|BOTTLE|ULNA SHAFT|BILATERAL|SUPERFICIAL|IMMUNOFIXATION ELECTROPHORESIS|Y|||INTERVIEWER|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2021-01-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|3|PIF|Peak Inspiratory Flow|[?]|SITTING|[?]|mL/cage|[?]|1|HOMEOPATHIC DILUTION|FEMORAL NECK|RIGHT|APICAL|ACCELERATOR MASS SPECTROMETRY||||CHILD|OTOLARYNGOLOGIST|2|Visit_2|25|6|TREATMENT|2021-01-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|4|FRC|Functional Residual Capacity|[?]|LATERAL DECUBITUS|||[?]|1|Tbsp|CORNEAL ENDOTHELIUM|CONTRALATERAL|CRANIAL|EIA|Y||Y|SIGNIFICANT OTHER|RADIOLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-04
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|5|FVC|Forced Vital Capacity|[?]|PRONE|[?]|mol/day|[?]|1|Siemens|HEART, LEFT VENTRICULAR WALL|LATERAL|DISTAL VOLAR|SNP ARRAY||||HEALTH CARE PROFESSIONAL|RATER 2|3|Visit_3|40|2|TREATMENT|2021-02-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|6|IVCPP|Percent Predicted IVC|[?]|LATERAL DECUBITUS|[?]|kg/L|[?]|1|ug/mol|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|UNILATERAL|LOWER FLEXOR SURFACE|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|||STUDY SUBJECT|READER 1|3|Visit_3|40|6|SCREENING|2021-02-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|7|RELSZCHG|Relative Size Change|[?]|UNCONSTRAINED|[?]|ug/g/h|[?]|1|mmHg*min/L|TONGUE|LATERAL|SUPERFICIAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||ADJUDICATOR|RADIOLOGIST 2|4|Visit_4|65|4|TREATMENT|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|TRENDELENBURG|[?]|mm3/mm2/year|[?]|1|Bq/mg|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|IPSILATERAL|LATERAL|DIGITAL PCR ARRAY|Y|||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-03-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|9|INERTANC|Inertance|[?]|RIGHT LATERAL DECUBITUS|[?]|MBq/uL|[?]|1|ppm|FLEXOR DIGITORUM BREVIS MUSCLE|CONTRALATERAL|NASAL|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|||CAREGIVER|RADIOLOGIST|5|Visit_5|90|2|SCREENING|2021-04-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|4349f45e-f18b-4606-9a72-fd45e64e17dc|10|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|APPLICATION|SUPERIOR VENA CAVA|LATERAL|CAUDAL|OLIGO ACGH||Y|Y|INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|TREATMENT|2021-04-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|1|LCI|Lung Clearance Index|[?]|SUPINE|[?]|/2500 WBC|[?]|1|U/m2/day|SKIN OF THE ELBOW|CONTRALATERAL|INNER|PHYSICAL EXAMINATION||||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|1|Visit_1|10|6|TREATMENT|2020-09-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|2|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING|||[?]|1|PIXELS/in|PARALARYNGEAL LYMPH NODE|RIGHT|TIP|CENTRIFUGATION|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|1|Visit_1|10|4|TREATMENT|2020-09-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-30
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|Ci/ug|[?]|1|keV|ESOPHAGUS, UPPER THIRD|IPSILATERAL|LOWER FLEXOR SURFACE|SINGLE-MOLECULE ARRAY||Y||ADJUDICATION COMMITTEE|READER 1|2|Visit_2|25|5|TREATMENT|2020-09-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|4|FEV1SVC|FEV1/SVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|Enzyme U/L|LIMB|IPSILATERAL|ANTEROPOSTERIOR|MICROBIAL BIOCHEMICAL IDENTIFICATION|||Y|STUDY SUBJECT|RATER|2|Visit_2|25|2|TREATMENT|2020-09-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|5|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|[?]|umol/L/min|[?]|1|mU/L|PARAPHARYNGEAL LYMPH NODE|LEFT|SUBCORTICAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||HEALTH CARE PROFESSIONAL|INTERNIST|3|Visit_3|40|2|SCREENING|2020-10-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|6|FEV6PP|Percent Predicted FEV6|[?]|SEMI-RECUMBENT|||[?]|1|mph|EYE, ANTERIOR SEGMENT|RIGHT|CAUDAL|CLAUSS METHOD|Y|Y|Y|INDEPENDENT ASSESSOR|RADIOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-10-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|7|FEV6PP|Percent Predicted FEV6|[?]|STANDING|[?]|g|[?]|1|uU/dL|ILIAC CREST|UNILATERAL|TEMPORAL|IODINE STAIN||||PROXY|MICROSCOPIST 2|4|Visit_4|65|3|WASHOUT|2020-10-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|8|AWVOL|Airway Volume|[?]|FOWLERS|[?]|mJoule/cm2|[?]|1|10^3 RNA copies/mL|BODY OF STOMACH|LATERAL|ANTEROMEDIAL|FLUORESCENT MICROSCOPY||||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-10-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|9|FEV_PEF|FEV at PEF|[?]|FOWLERS|[?]|min|[?]|1|10^7 TCID 50/dose|URETHRA, POSTERIOR|BILATERAL|ANTEROLATERAL|CLINICAL EVALUATION||||DOMESTIC PARTNER|RADIOLOGIST 1|5|Visit_5|90|4|SCREENING|2020-11-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|32e36ec1-6895-42ff-bf33-52977e72b338|10|PCF|Peak Cough Flow|[?]|LEFT LATERAL DECUBITUS|[?]|pmol/10^10 cells|[?]|1|nmol BCE/mmol|RIGHT ATRIAL ENDOCARDIUM|CONTRALATERAL|FACIAL|ENZYMATIC ULTRACENTRIFUGATION|Y|||SPOUSE|PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2020-11-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SLING|[?]|EID 50/mL|[?]|1|copies/ug|ISCHIORECTAL FOSSA|CONTRALATERAL|APICAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||INDEPENDENT ASSESSOR|DERMATOLOGIST|1|Visit_1|10|3|SCREENING|2020-10-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|2|AWVOL|Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|CAN|[?]|1|SYRINGE|INTRATHORACIC LYMPH NODE|CONTRALATERAL|CRANIAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||INTERVIEWER|READER 2|1|Visit_1|10|3|SCREENING|2020-10-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|3|RVPP|Percent Predicted Residual Volume|[?]|PRONE|[?]|mg/m2/day|[?]|1|pptr|MEDIASTINUM, ANTERIOR|LATERAL|DORSOLATERAL|GRAM STAIN|Y|||INTERVIEWER|ADJUDICATOR 1|2|Visit_2|25|1|TREATMENT|2020-11-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|4|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|%/min|[?]|1|Osm|GUT-ASSOCIATED LYMPHOID TISSUE|IPSILATERAL|MEDIAL|HPLC-UV|Y|||FAMILY MEMBER|INTERNIST|2|Visit_2|25|5|TREATMENT|2020-11-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|5|FEV1FVC6|FEV1/FVC6|[?]|SUPINE|||[?]|1|kcal|LIP, UPPER|LATERAL|LOWER FLEXOR SURFACE|FLOW MICROSCOPY|||Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|3|Visit_3|40|3|WASHOUT|2020-11-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|6|INFLTIND|Infiltrates Indicator|[?]|TRENDELENBURG|||[?]|1|10^5/L|CORONARY SINUS|LEFT|ANTEROPOSTERIOR|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY|Y||Y|CHILD|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2020-11-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|7|DLCO|Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|ug/kg/min|[?]|1|sec|MESENTERIC ARTERY|IPSILATERAL|MEDIAL|REBOUND TONOMETRY||Y||CLINICAL RESEARCH COORDINATOR|READER 2|4|Visit_4|65|2|WASHOUT|2020-12-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SLING|[?]|10^3 CFU/g|[?]|1|DAYS|CELIAC ARTERY|UNILATERAL|BASAL|SLOAN LETTER EYE CHART 100%||||PROXY|MICROSCOPIST 3|4|Visit_4|65|6|TREATMENT|2020-12-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|9|PCF|Peak Cough Flow|[?]|LEFT LATERAL DECUBITUS|[?]|mL/h|[?]|1|copies/uL|CALF|CONTRALATERAL|INNER|CLIP||||CAREGIVER|DERMATOLOGIST|5|Visit_5|90|4|SCREENING|2021-01-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|e546f2d8-baea-4a6e-93cb-c7ec7292b423|10|AWVOL|Airway Volume|[?]|PRONE|[?]|oz|[?]|1|PIXELS/in|ANTERIOR TIBIAL ARTERY|UNILATERAL|OUTER|MALDI-TOF||||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|3|WASHOUT|2021-01-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|LATERAL DECUBITUS|[?]|10^3/L|[?]|1|ukat/L|FIRST DIAGONAL BRANCH ARTERY|CONTRALATERAL|UPPER|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-09-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING|||[?]|1|U/kg|DIAPHRAGM|CONTRALATERAL|ROSTRAL|ELISPOT|||Y|INVESTIGATOR|OPTOMETRIST|1|Visit_1|10|4|TREATMENT|2020-09-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|3|PEFREV|PEF Reversibility|[?]|SEMI-RECUMBENT|||[?]|1|10^6/L|SUPRACLAVICULAR LYMPH NODE|UNILATERAL|TIP|POPULATION SEQUENCING|||Y|CAREGIVER|PATHOLOGIST 2|2|Visit_2|25|1|FOLLOW-UP|2020-10-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|4|INERTANC|Inertance|[?]|REVERSE TRENDELENBURG|||[?]|1|Weber|HEPATIC LYMPH NODE|RIGHT|CRANIAL|CARDIAC THERMODILUTION|||Y|INDEPENDENT ASSESSOR|MICROSCOPIST 3|2|Visit_2|25|3|TREATMENT|2020-10-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|5|DLCOHC|HGB Corrected DLCO|[?]|SEMI-RECUMBENT|||[?]|1|10^3 CFU/g|BASILIC VEIN|LATERAL|SURFACE|KINETIC CHROMOGENIC ASSAY|||Y|PROXY|FORENSIC PATHOLOGIST|3|Visit_3|40|1|SCREENING|2020-10-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|6|RER|Respiratory Exchange Ratio|[?]|LEFT LATERAL DECUBITUS|[?]|pt_us|[?]|1|CAPLET|TUNICA INTIMA|LATERAL|PERIVENTRICULAR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||Y||PROXY|NEUROLOGIST 2|3|Visit_3|40|1|SCREENING|2020-10-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|7|EVC|Expiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|mL/mmHg|LATERAL SECOND DIAGONAL BRANCH ARTERY|LEFT|TIP|HIGH RESOLUTION MELT ANALYSIS||Y|Y|ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|1|TREATMENT|2020-11-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|8|MALIND|Malignancy Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|vp/mL|[?]|1|APS U|HAMATE BONE|RIGHT|VENTRAL|COLORIMETRY||Y||VENDOR|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2020-11-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|9|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|mL/dose|[?]|1|vg/kg|PANCREAS|LATERAL|LOWER FLEXOR SURFACE|PERCUSSION||||CAREGIVER|RATER 2|5|Visit_5|90|7|TREATMENT|2020-12-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|0329de16-fc7a-4941-900c-b390dac637aa|10|IRVPP|Percent Predicted IRV|[?]|SLING|[?]|L/kg|[?]|1|TAMPON|NECK|RIGHT|INFERIOR|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||FAMILY MEMBER|CARDIOLOGIST|5|Visit_5|90|5|TREATMENT|2020-12-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|89d364c9-1338-472b-af0b-19280e45508b|1|RELSZCHG|Relative Size Change|[?]|TRENDELENBURG|[?]|uU/dL|[?]|1|Frames/s|CLAW|LEFT|PROXIMAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|Y||CAREGIVER|CARDIOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|89d364c9-1338-472b-af0b-19280e45508b|2|ICREV|IC Reversibility|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/kg/min|L1 VERTEBRA|UNILATERAL|SUPERFICIAL|MASS SPECTROMETRY|||Y|FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|89d364c9-1338-472b-af0b-19280e45508b|3|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|[?]|mL/dose|[?]|1|Ci/mg|FOOT DIGIT 4|LATERAL|VENTRAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||SPOUSE|ENDOCRINOLOGIST|2|Visit_2|25|3|TREATMENT|2020-10-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|89d364c9-1338-472b-af0b-19280e45508b|4|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|V|[?]|1|10^6 organisms|CRANIAL CAVITY|CONTRALATERAL|SURFACE|REFRACTOMETRY||Y||DOMESTIC PARTNER|ADJUDICATOR 3|2|Visit_2|25|2|WASHOUT|2020-10-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|89d364c9-1338-472b-af0b-19280e45508b|5|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|log10 CFU/g|[?]|1|um/s|FOOT PHALANX|IPSILATERAL|INFERIOR|IN SITU HYBRIDIZATION||||PROXY|CARDIOLOGIST|3|Visit_3|40|2|TREATMENT|2020-11-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|89d364c9-1338-472b-af0b-19280e45508b|6|TVPP|Percent Predicted Tidal Volume|[?]|FOWLERS|[?]|mg/animal|[?]|1|PFU/dose|INTERATRIAL SEPTUM|RIGHT|PERIVENTRICULAR|EEG|Y|Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|2|TREATMENT|2020-11-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|89d364c9-1338-472b-af0b-19280e45508b|7|FEV1PP|Percent Predicted FEV1|[?]|SLING|[?]|STEPS|[?]|1|anti-Xa IU|HAND DIGIT 2|RIGHT|ANTEROMEDIAL|FREEZING POINT DEPRESSION||||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|4|Visit_4|65|1|FOLLOW-UP|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|89d364c9-1338-472b-af0b-19280e45508b|8|SAWVOL|Specific Airway Volume|[?]|PRONE|[?]|%(w/v)|[?]|1|PUFF|ESOPHAGUS, ABDOMINAL|LATERAL|TEMPORAL|ZIEHL NEELSEN ACID FAST STAIN|Y|||CLINICAL RESEARCH COORDINATOR|READER|4|Visit_4|65|6|FOLLOW-UP|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|89d364c9-1338-472b-af0b-19280e45508b|9|SAWVOL|Specific Airway Volume|[?]|SUPINE|[?]|umol/dL|[?]|1|Enzyme U/m2|FAT PAD|IPSILATERAL|VENTRAL|CONTRAST ENHANCED SPIRAL CT SCAN|Y|||INVESTIGATOR|RADIOLOGIST|5|Visit_5|90|1|TREATMENT|2021-01-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|89d364c9-1338-472b-af0b-19280e45508b|10|LCI|Lung Clearance Index|[?]|STANDING|||[?]|1|Bq/mg|JAW|LATERAL|DORSOLATERAL|GC/MS-CI|Y|Y|Y|DOMESTIC PARTNER|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2021-01-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|Ci/uL|[?]|1|mAnson U/mL|PERIFACIAL LYMPH NODE|LEFT|SURFACE|SLIT LAMP||||SPOUSE|READER|1|Visit_1|10|5|FOLLOW-UP|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|2|IVC|Inspiratory Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|uV2|PERIPANCREATIC LYMPH NODE|RIGHT|PARIETO-OCCIPITAL|HPLC/MS||Y|Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING, BENT FORWARD|||[?]|1|GPL U/mL|CEREBRAL ARTERY|LEFT|ROSTRAL|IMMUNE REPERTOIRE DEEP SEQUENCING|||Y|SIBLING|ONCOLOGIST|2|Visit_2|25|5|WASHOUT|2020-06-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|mAmp|[?]|1|Bq/mL|CLAW|RIGHT|TIP|MULTIPLE BREATH WASHOUT||Y||DOMESTIC PARTNER|NEUROLOGIST 2|2|Visit_2|25|5|WASHOUT|2020-06-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-21
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|5|FEV3FVC|FEV3/FVC|[?]|TRENDELENBURG|[?]|in2|[?]|1|10^3 organisms/mL|SKULL, BASE|UNILATERAL|INTERMEDIATE|PH METER MEASUREMENT METHOD||||ADJUDICATOR|CARDIOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|6|IRVPP|Percent Predicted IRV|[?]|SLING|[?]|ug/min|[?]|1|QUANTITY SUFFICIENT|CORPUS UTERI|UNILATERAL|FORE|MALDI-TOF||Y||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|7|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|mEq/L|SKIN OF THE FACE|LATERAL|FRONTAL|COLORIMETRY|Y||Y|STUDY SUBJECT|ONCOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|8|FEV1FVC|FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|mg/L|[?]|1|ukat/L|RIB 12|LEFT|TEMPORAL|FLUORESCENT SPOT TEST||||ADJUDICATOR|MICROSCOPIST 3|4|Visit_4|65|1|TREATMENT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-04
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|9|MALIND|Malignancy Indicator|[?]|DECUBITUS|[?]|mm/min|[?]|1|g/cage|DISTAL COMMON BILE DUCT|LATERAL|LOWER MEDIAL|CARDIAC THERMODILUTION|Y|Y||STUDY SUBJECT|NEUROLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|10|FIV1PP|Percent Predicted FIV1|[?]|FOWLERS|[?]|VIAL|[?]|1|fraction of 1|DISTAL RIGHT CORONARY ARTERY CONDUIT|LEFT|ANTERIOR|SPIRAL CT SCAN WITHOUT CONTRAST||||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|TREATMENT|2020-08-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|[?]|COAT|[?]|1|cm/s|INTERPHALANGEAL JOINT 1|BILATERAL|SUPERIOR|MRS||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|1|Visit_1|10|5|TREATMENT|2020-10-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|U/m2/min|[?]|1|GBq/g|PREFRONTAL CORTEX|CONTRALATERAL|FACIAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||STUDY SUBJECT|RADIOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-10-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-31
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|3|PCF|Peak Cough Flow|[?]|DECUBITUS|||[?]|1|mol/mol|OROPHARYNX|CONTRALATERAL|APICAL|RULER MEASUREMENT METHOD|||Y|PARENT|DERMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-10-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|4|TGV|Thoracic Gas Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|DDU|HEART, RIGHT VENTRICLE|LATERAL|INFERIOR|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y||Y|SIBLING|READER 1|2|Visit_2|25|3|WASHOUT|2020-10-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-18
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|5|IRVPP|Percent Predicted IRV|[?]|SEMI-RECUMBENT|[?]|mL/breath|[?]|1|usec|PARACOLIC GUTTER|IPSILATERAL|SUPERFICIAL|SINGLE-MOLECULE ARRAY||Y||CAREGIVER|MICROSCOPIST|3|Visit_3|40|6|TREATMENT|2020-11-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|DECUBITUS|[?]|U/m2|[?]|1|mL/animal/wk|PANCREATIC DUCT|LEFT|INFERIOR|KNEMOMETRY||||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|3|Visit_3|40|1|SCREENING|2020-11-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|7|EVC|Expiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|anti-Xa IU/mL|[?]|1|U/kg|RIB 5|CONTRALATERAL|HIND|WESTERGREN||||DOMESTIC PARTNER|RADIOLOGIST|4|Visit_4|65|7|TREATMENT|2020-12-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|8|RAWPP|Percent Predicted Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|10^6/g|[?]|1|kg/L|T8 VERTEBRA|BILATERAL|POSTERIOR|MICRO BROTH DILUTION||||INDEPENDENT ASSESSOR|MICROSCOPIST 3|4|Visit_4|65|7|TREATMENT|2020-12-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|9|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|Hz|[?]|1|ng|INFERIOR PUBIC RAMUS|LATERAL|TEMPORAL|HEMAGGLUTINATION ASSAY||||STUDY SUBJECT|RATER|5|Visit_5|90|6|SCREENING|2020-12-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SUPINE|||[?]|1|cL|FEMORAL VEIN|BILATERAL|OUTER|LC/MS|||Y|CAREGIVER|MICROSCOPIST|5|Visit_5|90|3|SCREENING|2020-12-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|mOsm|[?]|1|cmH2O*s2/mL|URETHRA, ANTERIOR|IPSILATERAL|UPPER FLEXOR SURFACE|MAGNETIC RESONANCE ELASTOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|1|Visit_1|10|2|WASHOUT|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|GPS U|[?]|1|mmol/min/kPa|ARM SKIN|LATERAL|LOWER|IHC||||CLINICAL STUDY SPONSOR|NEUROLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-05-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|3|INFLTIND|Infiltrates Indicator|[?]|PRONE|[?]|uCi/L|[?]|1|BOTTLE|SKIN OF THE FACE|LEFT|DISTAL VOLAR|FREEZING POINT DEPRESSION|Y|||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|2|Visit_2|25|4|TREATMENT|2020-06-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|4|IRV|Inspiratory Reserve Volume|[?]|UNCONSTRAINED|[?]|10^9 organisms/g|[?]|1|10^6 organisms|ANTERIOR INFERIOR CEREBELLAR ARTERY|RIGHT|CRANIAL|SLOAN LETTER EYE CHART 100%|Y|Y||PROXY|OPTOMETRIST|2|Visit_2|25|4|TREATMENT|2020-06-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|TRENDELENBURG|||[?]|1|foz_us|DISTAL PHALANX 2 OF THE HAND|UNILATERAL|UPPER FLEXOR SURFACE|TEST STRIP||Y|Y|NON-HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|3|Visit_3|40|6|TREATMENT|2020-06-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|kUSP|[?]|1|mMU/mL|DISTAL INTERPHALANGEAL JOINT 2|LATERAL|DORSOLATERAL|HEMAGGLUTINATION INHIBITION ASSAY||||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|4|SCREENING|2020-06-27|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|7|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING, BENT FORWARD|[?]|mol/L|[?]|1|pg|VAGUS NERVE|IPSILATERAL|MEDIAL|PANENDOSCOPY||||CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|4|Visit_4|65|2|TREATMENT|2020-07-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|8|IRV|Inspiratory Reserve Volume|[?]|SUPINE|[?]|PNU/mL|[?]|1|atm|ILEUM LYMPH NODE|LATERAL|PARIETO-OCCIPITAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y|||NON-HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-07-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|9|RV|Residual Volume|[?]|REVERSE TRENDELENBURG|[?]|mL/min|[?]|1|mL/animal/day|METATARSOPHALANGEAL JOINT 1|UNILATERAL|LOWER|OPTICAL MAPPING||||SIBLING|RADIOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|0c103005-efae-48ed-91e3-35d38fa1d359|10|RVPP|Percent Predicted Residual Volume|[?]|SITTING, LEGS DEPENDENT|[?]|VOXEL|[?]|1|ug/animal|RESPIRATORY SYSTEM|RIGHT|SUPERIOR|MAGNETIC RESONANCE ELASTOGRAPHY||||FAMILY MEMBER|INTERNIST|5|Visit_5|90|4|TREATMENT|2020-08-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|c9808184-3432-448c-a5e5-50176715effa|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SUPINE|[?]|mL|[?]|1|g/animal/day|HEART|IPSILATERAL|LOWER MEDIAL|DIGITAL PCR||Y||INVESTIGATOR|ENDOCRINOLOGIST|1|Visit_1|10|2|TREATMENT|2020-12-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|c9808184-3432-448c-a5e5-50176715effa|2|SALKB|Salazar-Knowles Equation Parameter B|[?]|PRONE|[?]|hr/day|[?]|1|mOsm|RENAL FOSSA|LATERAL|LATERAL|NO INFORMATION||||ADJUDICATOR|HEMATOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-12-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|c9808184-3432-448c-a5e5-50176715effa|3|DLCOVA|DLCO/VA|[?]|UNCONSTRAINED|[?]|Ci/mg|[?]|1|nsec|SKIN AROUND THE MOUTH|LATERAL|ANTEROPOSTERIOR|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||FRIEND|INTERNIST|2|Visit_2|25|6|TREATMENT|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|c9808184-3432-448c-a5e5-50176715effa|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|10^12 IU/L|[?]|1|PLUG|T7 VERTEBRA|LATERAL|DEEP|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||Y||ADJUDICATION COMMITTEE|MICROSCOPIST 3|2|Visit_2|25|1|FOLLOW-UP|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|c9808184-3432-448c-a5e5-50176715effa|5|FEV1SVC|FEV1/SVC|[?]|UNCONSTRAINED|||[?]|1|10^3/L|TIBIO-PERONEAL TRUNK|UNILATERAL|TIP|OLIGO ACGH||Y|Y|STUDY SUBJECT|READER 2|3|Visit_3|40|5|WASHOUT|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|c9808184-3432-448c-a5e5-50176715effa|6|PEFTIME|Peak Expiratory Flow Time|[?]|TRENDELENBURG|||[?]|1|ka_u/dL|GASTRIC CURVATURE LYMPH NODE|LEFT|DISTAL VOLAR|CLIP|||Y|FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|7|SCREENING|2021-01-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|c9808184-3432-448c-a5e5-50176715effa|7|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|[?]|BU|[?]|1|10^9/L|DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND|IPSILATERAL|INNER|MASS SPECTROMETRY||Y||FAMILY MEMBER|OTOLARYNGOLOGIST|4|Visit_4|65|1|TREATMENT|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|c9808184-3432-448c-a5e5-50176715effa|8|FVC|Forced Vital Capacity|[?]|SLING|[?]|kPa|[?]|1|10^12 IU/L|MIDBRAIN|IPSILATERAL|LOWER MEDIAL|ENDPOINT DILUTION ASSAY||Y||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|3|TREATMENT|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|c9808184-3432-448c-a5e5-50176715effa|9|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|FOWLERS|||[?]|1|/day|SARTORIUS MUSCLE|RIGHT|OUTER|IMMUNOCHROMATOGRAPHY||Y|Y|SIBLING|NEUROLOGIST 2|5|Visit_5|90|2|SCREENING|2021-03-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|c9808184-3432-448c-a5e5-50176715effa|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-RECUMBENT|||[?]|1|mAmp|LYMPH NODE HILUM|UNILATERAL|PROXIMAL|INFRARED SPECTROMETRY|||Y|CLINICAL STUDY SPONSOR|READER 1|5|Visit_5|90|2|TREATMENT|2021-03-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-05
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|||[?]|1|Ci/mL|ENTORHINAL CORTEX|LATERAL|DORSAL|AURAMINE STAIN||Y|Y|GUARDIAN|RADIOLOGIST 1|1|Visit_1|10|3|TREATMENT|2021-01-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|2|FEF50|Forced Expiratory Flow 50%|[?]|FOWLERS|[?]|dpm/100mg|[?]|1|10^3 RNA copies/mL|SACRAL TUBEROSITY|UNILATERAL|VOLAR|RADIOGRAPHY||Y||CAREGIVER|HEMATOLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|3|IRV|Inspiratory Reserve Volume|[?]|SITTING|[?]|CAPSULE|[?]|1|psec|METATARSOPHALANGEAL JOINT 5|IPSILATERAL|SUPERIOR|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN|Y|||INDEPENDENT ASSESSOR|NEUROLOGIST 2|2|Visit_2|25|1|SCREENING|2021-01-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|DECUBITUS|[?]|MASK|[?]|1|Sv|STERNEBRA|IPSILATERAL|MEDIAL|MICROBIAL CULTURE, SOLID||||ADJUDICATOR|ONCOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2021-01-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING, BENT FORWARD|[?]|m3|[?]|1|ft2|FINGERNAIL|CONTRALATERAL|VENTRAL|PERCUSSION||||ADJUDICATION COMMITTEE|RATER 2|3|Visit_3|40|4|TREATMENT|2021-02-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|6|RV|Residual Volume|[?]|PRONE|||[?]|1|/2000 RBC|LOWER GASTROINTESTINAL TRACT LYMPH NODE|BILATERAL|NASAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|||Y|DOMESTIC PARTNER|MICROSCOPIST 3|3|Visit_3|40|5|WASHOUT|2021-02-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-11
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|uV|[?]|1|/4.0 mL|HUMERAL EPICONDYLE|RIGHT|LOWER FLEXOR SURFACE|BETA LACTAMASE||||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2021-02-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|[?]|/10^5|[?]|1|mg/L|KIDNEY, UPPER LOBE|LATERAL|SUPERIOR|ELECTROCHEMILUMINESCENCE|Y|Y||STUDY SUBJECT|OPTOMETRIST|4|Visit_4|65|3|SCREENING|2021-02-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|9|DLCOHC|HGB Corrected DLCO|[?]|DECUBITUS|[?]|10^6 U|[?]|1|um|SCAPHOID-LUNATE JOINT|RIGHT|OUTER|SMEAR||Y||ADJUDICATOR|RATER|5|Visit_5|90|5|TREATMENT|2021-03-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|c3d7d293-975f-44de-bd35-0168eec40ac9|10|ICREV|IC Reversibility|[?]|SITTING, LEGS DEPENDENT|[?]|fL|[?]|1|U/g/min|LUNG, RIGHT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|DORSAL|REBOUND TONOMETRY|Y|||ADJUDICATION COMMITTEE|INTERNIST|5|Visit_5|90|4|WASHOUT|2021-03-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|[?]|RNA copies/mL|[?]|1|10^6 CFU/g|L2 VERTEBRA|LEFT|OUTER|TARGETED GENOME SEQUENCING||||SIGNIFICANT OTHER|PATHOLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-06-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|2|INTP|Interpretation|[?]|STANDING, BENT FORWARD|[?]|ng/dL|[?]|1|ng|PALATE|BILATERAL|NASAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|||SPOUSE|ENDOCRINOLOGIST|1|Visit_1|10|7|WASHOUT|2020-06-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|3|MALIND|Malignancy Indicator|[?]|SEMI-RECUMBENT|[?]|log10 TCID 50/uL|[?]|1|m/sec|RIB 11|LEFT|APICAL|NEPHELOMETRY||Y||FRIEND|READER|2|Visit_2|25|3|WASHOUT|2020-06-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|4|RV|Residual Volume|[?]|STANDING, BENT FORWARD|[?]|U/mmol|[?]|1|mmHg*min/L|COLON, RIGHT|CONTRALATERAL|VOLAR|POLYMERASE CHAIN REACTION||Y||PROXY|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|5|LOBVOLPP|Percent Predicted Lobar Volume|[?]|FOWLERS|[?]|pmol/g|[?]|1|mol/g|INTERPHALANGEAL JOINT 4|IPSILATERAL|LATERAL|MRS||||CHILD|HEMATOLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|6|LCI|Lung Clearance Index|[?]|TRENDELENBURG|[?]|Ci/ug|[?]|1|IU/kg/h|AXILLARY LYMPH NODE|RIGHT|ANTEROMEDIAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||HEALTH CARE PROFESSIONAL|CARDIOLOGIST|3|Visit_3|40|4|WASHOUT|2020-07-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|7|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-FOWLERS|||[?]|1|L/day|SECOND RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|VENTRAL|AGAR PROPORTION||Y|Y|ADJUDICATOR|ADJUDICATOR 1|4|Visit_4|65|4|WASHOUT|2020-08-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING|[?]|cmH2O*s2/mL|[?]|1|nmol BCE/nmol|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|UNILATERAL|TIP|MYELOPEROXIDASE STAIN||||SIBLING|PATHOLOGIST 2|4|Visit_4|65|5|TREATMENT|2020-08-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|9|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|REVERSE TRENDELENBURG|[?]|um2|[?]|1|mEq/dL|RETROCRURAL LYMPH NODE|UNILATERAL|UPPER|SIZE EXCLUSION CHROMATOGRAPHY||Y||ADJUDICATION COMMITTEE|DERMATOLOGIST|5|Visit_5|90|1|TREATMENT|2020-08-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|2db1f07d-a7db-4cc3-8943-536e24378f08|10|RVPP|Percent Predicted Residual Volume|[?]|REVERSE TRENDELENBURG|[?]|nsec|[?]|1|10^3 CFU|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|UNILATERAL|ANTEROTEMPORAL|RULER MEASUREMENT METHOD|Y|Y||PARENT|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-08-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|RAWPP|Percent Predicted Airway Resistance|[?]|UNCONSTRAINED|[?]|s/h|[?]|1|uOsm|WRIST JOINT EXTENSOR TENDONS|UNILATERAL|LATERAL|ELECTROCHEMILUMINESCENCE||||FAMILY MEMBER|NEUROLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-12-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|2|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|STANDING|[?]|mmol/min/kPa/L|[?]|1|FFU|BRAIN STEM|BILATERAL|ROSTRAL|NUCLEIC ACID BASED METHOD||Y||CHILD|RATER|1|Visit_1|10|1|TREATMENT|2020-12-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|3|FIF25|Forced Inspiratory Flow at 25%|[?]|REVERSE TRENDELENBURG|[?]|CCID 50/mL|[?]|1|mm/min|T11 VERTEBRA|UNILATERAL|DORSOLATERAL|DROPLET DIGITAL PCR||Y||DOMESTIC PARTNER|OPHTHALMOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|4|MIPPP|Percent Predicted MIP|[?]|STANDING, BENT FORWARD|[?]|oz eq|[?]|1|10^6 IU/mL|HEART, BASE|UNILATERAL|SUBCORTICAL|WRIGHT STAIN||Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|2|Visit_2|25|1|TREATMENT|2020-12-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|5|FIF75|Forced Inspiratory Flow at 75%|[?]|UNCONSTRAINED|[?]|log10 CFU/g|[?]|1|CAPFUL|ADDUCTOR POLLICIS MUSCLE|BILATERAL|LOWER EXTENSOR SURFACE|ENZYMATIC COLORIMETRY||Y||CAREGIVER|PATHOLOGIST 1|3|Visit_3|40|4|TREATMENT|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|6|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|DDU|[?]|1|kg/mol|RAMUS INTERMEDIUS ARTERY|IPSILATERAL|CRANIAL|HILLMEN COLOR CHART||||PROXY|ONCOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2021-01-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|10^3/L|[?]|1|TCID 50/dose|LACRIMAL GLAND|UNILATERAL|UPPER|DUCTOGRAPHY||||CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-02-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|8|FEV3FVC|FEV3/FVC|[?]|FOWLERS|||[?]|1|mg/min|GREAT SAPHENOUS VEIN|RIGHT|NASAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y|Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|4|Visit_4|65|2|TREATMENT|2021-02-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|9|FIFMAXPP|Percent Predicted FIFmax|[?]|UNCONSTRAINED|[?]|10^6 organisms/mL|[?]|1|/day|HEART, BASE|UNILATERAL|PROXIMAL|PET/SPECT SCAN||||INVESTIGATOR|RATER 1|5|Visit_5|90|4|SCREENING|2021-03-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|c343ba98-87d7-40bc-b0e8-b866e42d3a21|10|ELSTNCE|Elastance|[?]|SEMI-FOWLERS|[?]|ngEq/L|[?]|1|ukat/L|SOLEUS MUSCLE|LEFT|LATERAL|ISHIHARA COLOR PLATES||||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|[?]|mol/mg|[?]|1|Ci/uL|SCAPHOID-TRAPEZIUM JOINT|IPSILATERAL|LOWER|NUCLEIC ACID SEQUENCING||||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|1|Visit_1|10|2|WASHOUT|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|2|SALKB|Salazar-Knowles Equation Parameter B|[?]|FOWLERS|[?]|pmol/L/h|[?]|1|lm|MIDBRAIN|RIGHT|LOWER|SLOAN LETTER EYE CHART 100%||||CLINICAL STUDY SPONSOR|MICROSCOPIST|1|Visit_1|10|2|FOLLOW-UP|2020-12-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|3|FEV1REV|FEV1 Reversibility|[?]|UNCONSTRAINED|[?]|genEq/mL|[?]|1|uOsm|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|RIGHT|DISTAL VOLAR|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|Y|||ADJUDICATION COMMITTEE|MICROSCOPIST|2|Visit_2|25|6|TREATMENT|2020-12-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|4|INFLTIND|Infiltrates Indicator|[?]|SEMI-FOWLERS|[?]|cg|[?]|1|CUP|INTESTINE|BILATERAL|LOWER MEDIAL|SPECULAR MICROSCOPY||Y||FAMILY MEMBER|MICROSCOPIST 3|2|Visit_2|25|3|WASHOUT|2020-12-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|5|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|[?]|10^9/dose|[?]|1|ka_u/dL|KIDNEY, HILUM|CONTRALATERAL|LOWER MEDIAL|GIEMSA STAIN|Y|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|3|Visit_3|40|5|SCREENING|2021-01-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|6|MIP|Maximal Inspiratory Pressure|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|umol/L|ISCHIUM|IPSILATERAL|SURFACE|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||Y|CLINICAL RESEARCH COORDINATOR|READER|3|Visit_3|40|5|FOLLOW-UP|2021-01-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|7|IRV|Inspiratory Reserve Volume|[?]|TRENDELENBURG|[?]|/10^3|[?]|1|mg/animal|POPLITEAL ARTERY BELOW KNEE|UNILATERAL|BASAL|SICKLE CELL SOLUBILITY TEST|Y|||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|FOLLOW-UP|2021-01-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|Ejaculate U|[?]|1|10^4/hpf|STERNAL MANUBRIUM|RIGHT|DEEP|NON-CONTACT SPECULAR MICROSCOPY||||ADJUDICATION COMMITTEE|CARDIOLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|[?]|pmol/dL|[?]|1|pmol|INTERTROCHANTERIC REGION|CONTRALATERAL|LOWER EXTENSOR SURFACE|OPTICAL COHERENCE TOMOGRAPHY||||ADJUDICATOR|ENDOCRINOLOGIST|5|Visit_5|90|7|SCREENING|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|d2b31ba9-9718-43ce-82ca-3276c28ac42a|10|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SUPINE|[?]|hr/day|[?]|1|mmHg/L/min|CERVIX UTERI|LEFT|LOWER|DIRECT SEQUENCING|Y|Y||SIGNIFICANT OTHER|OPHTHALMOLOGIST|5|Visit_5|90|6|TREATMENT|2021-02-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|LOBVOL|Lobar Volume|[?]|FOWLERS|[?]|10^6/Ejaculate U|[?]|1|mol/L|HUMERUS SHAFT|LATERAL|PROXIMAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|Y||DOMESTIC PARTNER|NEUROLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-07-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|2|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|||[?]|1|IU/g|T8 VERTEBRA|IPSILATERAL|PERIVENTRICULAR|MICROBIAL CONCENTRATION|||Y|SPOUSE|MICROSCOPIST 2|1|Visit_1|10|2|WASHOUT|2020-07-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|TRENDELENBURG|||[?]|1|fmol/L/sec|GUT-ASSOCIATED LYMPHOID TISSUE|LEFT|DISTAL|CLAUSS METHOD|||Y|DOMESTIC PARTNER|PATHOLOGIST|2|Visit_2|25|5|WASHOUT|2020-08-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|4|FEF2575|Forced Expiratory Flow 25-75%|[?]|SUPINE|||[?]|1|POINT|LIVER, LEFT LOBE|CONTRALATERAL|NASAL|CT SCAN|Y||Y|SIBLING|READER 1|2|Visit_2|25|6|FOLLOW-UP|2020-08-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-28
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|5|SAWVOL|Specific Airway Volume|[?]|UNCONSTRAINED|[?]|PHERESIS UNIT|[?]|1|mm2|LEFT POSTERIOR DESCENDING ARTERY|LEFT|SUPERIOR|GC/MS||Y||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|1|WASHOUT|2020-08-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|FOWLERS|||[?]|1|log10 TCID 50/dose|SOFT PALATE|BILATERAL|UPPER FLEXOR SURFACE|OPTICAL COHERENCE TOMOGRAPHY|||Y|CHILD|MICROSCOPIST 3|3|Visit_3|40|5|SCREENING|2020-08-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|7|ICPP|Percent Predicted Inspiratory Capacity|[?]|SLING|||[?]|1|VOXEL|AXILLARY LYMPH NODE LEVEL III|UNILATERAL|SUPERFICIAL|KLEIHAUER-BETKE|||Y|CHILD|READER 3|4|Visit_4|65|6|FOLLOW-UP|2020-09-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|8|RELSZCHG|Relative Size Change|[?]|UNCONSTRAINED|||[?]|1|ug/day|HAND DIGIT 4|RIGHT|ANTEROPOSTERIOR|SPECT/CT SCAN|||Y|HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-09-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-19
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|9|MIPPP|Percent Predicted MIP|[?]|UNCONSTRAINED|[?]|/10^5|[?]|1|m2|MYOMETRIUM|LEFT|UPPER EXTENSOR SURFACE|SPIROMETRY|Y|||GUARDIAN|READER 2|5|Visit_5|90|6|TREATMENT|2020-10-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|10|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SUPINE|[?]|pmol/day|[?]|1|pkat|PHARYNX|LEFT|DORSAL|DUCTOGRAPHY|Y|||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|TREATMENT|2020-10-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|AWWVOL|Airway Wall Volume|[?]|SEMI-FOWLERS|[?]|V|[?]|1|10^7 CFU/mL|PALPEBRAL FISSURE|RIGHT|UPPER|DYNAMOMETRY||||SIBLING|NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|2|EFFIND|Effusion Indicator|[?]|PRONE|||[?]|1|IU/mL|NASOPHARYNX|LATERAL|TEMPORAL|CALIPER MEASUREMENT METHOD|Y||Y|GUARDIAN|PEDIATRIC NEUROLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|3|DLCOPP|Percent Predicted DLCO|[?]|UNCONSTRAINED|[?]|10^8/L|[?]|1|PELLET|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|CONTRALATERAL|SUBCORTICAL|PEAK FLOWMETRY||Y||SIBLING|OPHTHALMOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|4|MIP|Maximal Inspiratory Pressure|[?]|SEMI-RECUMBENT|||[?]|1|dpm/mL|FEMORAL HEAD|CONTRALATERAL|SURFACE|CLINICAL EVALUATION|||Y|INTERVIEWER|INTERNIST|2|Visit_2|25|4|SCREENING|2021-02-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-21
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|5|TSUHYS|Tissue Hysteresivity|[?]|TRENDELENBURG|[?]|mL/kg/min|[?]|1|g/cage/wk|RADIUS|UNILATERAL|UPPER|DUKE INCISION METHOD||||INTERVIEWER|PATHOLOGIST|3|Visit_3|40|7|WASHOUT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|6|FEV_PEF|FEV at PEF|[?]|REVERSE TRENDELENBURG|[?]|g|[?]|1|%(w/v)|PRONATOR QUADRATUS MUSCLE|LEFT|DORSOLATERAL|MICRODENSITOMETRY||||VENDOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|3|TREATMENT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-10
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|7|INTP|Interpretation|[?]|SUPINE|[?]|pptr|[?]|1|10^6 organisms|COMMON ILIAC ARTERY|LEFT|VENTRAL|PH METER MEASUREMENT METHOD|Y|||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|4|Visit_4|65|7|SCREENING|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|8|RVPP|Percent Predicted Residual Volume|[?]|SUPINE|[?]|sec|[?]|1|10^3 CFU/mL|CEREBRUM|UNILATERAL|ANTEROPOSTERIOR|TURBIDIMETRY|Y|||STUDY SUBJECT|RATER|4|Visit_4|65|4|TREATMENT|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-30
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|9|PLMBLFLW|Pulmonary Blood Flow|[?]|REVERSE TRENDELENBURG|[?]|10^6/hpf|[?]|1|MET*h|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|LEFT|INFERIOR|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||CAREGIVER|ONCOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-17
e|RE|0a42f96a-49c3-492f-a272-bf9989e53e9d|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|FOWLERS|||[?]|1|YEARS|SKIN OF THE SOLE|LATERAL|ANTERIOR|PULSE OXIMETRY|Y||Y|CHILD|MICROSCOPIST 3|5|Visit_5|90|7|SCREENING|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-17
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|FEV1FVC|FEV1/FVC|[?]|SLING|[?]|APL U/mL|[?]|1|GPL U/mL|LOWER RESPIRATORY SYSTEM|BILATERAL|ROSTRAL|LEAD CITRATE STAIN|Y|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|1|Visit_1|10|2|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|2|PNEUMIND|Pneumonia Indicator|[?]|PRONE|||[?]|1|mL*cmH2O|INTERPHALANGEAL JOINT 4 OF THE HAND|BILATERAL|CAUDAL|NEXT GENERATION SEQUENCING|||Y|CAREGIVER|FORENSIC PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|3|FEV1PP|Percent Predicted FEV1|[?]|STANDING|[?]|uL/kg/day|[?]|1|EID 50/dose|EYELID|CONTRALATERAL|INFERIOR|CAPILLARY ELECTROPHORESIS||Y||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|2|Visit_2|25|5|TREATMENT|2021-01-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|4|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|DECUBITUS|[?]|IU/g|[?]|1|SBE/mL|HEART, RIGHT VENTRICULAR OUTFLOW TRACT|BILATERAL|VENTROLATERAL|HPLC/MS/MS||||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|4|TREATMENT|2021-01-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|5|MEP|Maximal Expiratory Pressure|[?]|SUPINE|[?]|ug/g/min|[?]|1|BAU|RIGHT POSTERIOR DESCENDING ARTERY|LATERAL|UPPER EXTENSOR SURFACE|BRDU CELLULAR PROLIFERATION ASSAY||Y||DOMESTIC PARTNER|READER|3|Visit_3|40|3|SCREENING|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|6|ERV|Expiratory Reserve Volume|[?]|UNCONSTRAINED|||[?]|1|Ci/mL|SPLENIC VEIN|CONTRALATERAL|BASAL|WRIGHT STAIN|||Y|CLINICAL STUDY SPONSOR|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2021-02-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|7|IVC|Inspiratory Vital Capacity|[?]|STANDING|[?]|h*%|[?]|1|/kg|ILEUM WALL|IPSILATERAL|PERIPHERAL|VIRUS PLAQUE ASSAY|Y|Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|7|WASHOUT|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|8|IRV|Inspiratory Reserve Volume|[?]|FOWLERS|||[?]|1|mg/h|OCCIPITAL LYMPH NODE|UNILATERAL|HIND|IMMUNODIFFUSION|||Y|CAREGIVER|ONCOLOGIST 1|4|Visit_4|65|2|FOLLOW-UP|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|9|FIVC|Forced Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|psec|[?]|1|/VF|TIBIOTARSAL JOINT|RIGHT|FACIAL|FUNCTIONAL MRI|Y|||SPOUSE|ONCOLOGIST 1|5|Visit_5|90|2|SCREENING|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|a78e7287-581c-4bf2-b3ca-ad2476c010cd|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|APL U/mL|[?]|1|pptr|T5 VERTEBRA|BILATERAL|ROSTRAL|INTERRUPTER TECHNIQUE||Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|5|SCREENING|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|PNEUMIND|Pneumonia Indicator|[?]|SITTING|||[?]|1|m3|C5 VERTEBRA|LATERAL|INTERMEDIATE|CELL OF ORIGIN ASSAY|Y||Y|INTERVIEWER|RADIOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-07-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|2|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|FOWLERS|||[?]|1|USP U|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|LEFT|TEMPORAL|SCINTIGRAPHY|||Y|DOMESTIC PARTNER|RADIOLOGIST|1|Visit_1|10|7|TREATMENT|2020-07-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|3|EFFIND|Effusion Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|RNA copies/mL|[?]|1|log10 CCID 50/dose|LIVER, CAUDATE LOBE|RIGHT|OCCIPITAL|NEURAMINIDASE INHIBITION ASSAY||||PROXY|OPTOMETRIST|2|Visit_2|25|1|SCREENING|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|4|LCI|Lung Clearance Index|[?]|REVERSE TRENDELENBURG|[?]|Bq|[?]|1|Absorbance U/min|ORAL CAVITY|BILATERAL|NASAL|RADIOIMMUNOPRECIPITATION ASSAY|Y|Y||STUDY SUBJECT|ONCOLOGIST 2|2|Visit_2|25|6|FOLLOW-UP|2020-08-12|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|5|GAW|Airway Conductance|[?]|TRENDELENBURG|[?]|BOWL|[?]|1|L/h|OPTIC DISC|LATERAL|MIDLINE|SIZE EXCLUSION CHROMATOGRAPHY||Y||GUARDIAN|INTERNIST|3|Visit_3|40|7|TREATMENT|2020-08-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|6|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|[?]|U/mL|[?]|1|JAR|TRICUSPID VALVE|IPSILATERAL|UPPER EXTENSOR SURFACE|CHROMATOGRAPHY|Y|||INTERVIEWER|ADJUDICATOR 1|3|Visit_3|40|2|SCREENING|2020-08-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|7|EXPRELTM|Expiration Relaxation Time|[?]|SUPINE|[?]|pmol/10^10 cells|[?]|1|m|COLON, HEPATIC FLEXURE|LEFT|LOWER EXTENSOR SURFACE|FLUORESCENT SPOT TEST||Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|4|Visit_4|65|6|SCREENING|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|8|INTP|Interpretation|[?]|RIGHT LATERAL DECUBITUS|[?]|BOWL|[?]|1|SBE/mL|POSTERIOR SUPERIOR ILIAC SPINE|UNILATERAL|SUPERIOR|NEPHELOMETRY||Y||PARENT|FORENSIC PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-09-21|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|9|IRVPP|Percent Predicted IRV|[?]|REVERSE TRENDELENBURG|[?]|eq|[?]|1|dL|C2 VERTEBRA|BILATERAL|ANTERIOR|NUCLEIC ACID AMPLIFICATION TEST||||SPOUSE|OPHTHALMOLOGIST|5|Visit_5|90|5|TREATMENT|2020-10-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|d3651e5f-bc38-4c96-afbf-5a65873ff306|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|||[?]|1|log10 CFU/g|LUNG, LEFT|IPSILATERAL|FORE|FISH||Y|Y|DOMESTIC PARTNER|HEMATOLOGIST|5|Visit_5|90|3|TREATMENT|2020-10-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|cm|[?]|1|umol/h/mmol|CALF MUSCULAR VEIN|LATERAL|NASAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||ADJUDICATOR|PEDIATRIC NEUROLOGIST|1|Visit_1|10|3|WASHOUT|2020-06-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|2|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|[?]|CAPFUL|[?]|1|cd|HIPPOCAMPUS|IPSILATERAL|ANTEROMEDIAL|QUANTITATIVE ULTRASOUND||||INTERVIEWER|RATER 2|1|Visit_1|10|5|TREATMENT|2020-06-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|DECUBITUS|||[?]|1|U/kg/h|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|VOLAR|TOLUIDINE BLUE STAIN|Y||Y|SIGNIFICANT OTHER|NEUROLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-06-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|4|DLCOHC|HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|ng/mol|[?]|1|ukat|HEART, LEFT VENTRICULAR OUTFLOW TRACT|CONTRALATERAL|FORE|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||Y||HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|1|TREATMENT|2020-06-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|5|EVC|Expiratory Vital Capacity|[?]|TRENDELENBURG|[?]|mU/g|[?]|1|U/cL|SKIN OF THE KNEE|UNILATERAL|LATERAL|JAFFE REACTION||||PROXY|OTOLARYNGOLOGIST|3|Visit_3|40|2|TREATMENT|2020-07-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|6|TVPP|Percent Predicted Tidal Volume|[?]|SLING|||[?]|1|U/m2|INGUINAL REGION|BILATERAL|NASAL|STATIC PERIMETRY|Y||Y|INTERVIEWER|CLINICAL PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-23
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|7|EFFIND|Effusion Indicator|[?]|SITTING|[?]|/kg|[?]|1|in2|MAIN BRONCHUS, RIGHT|LEFT|FACIAL|SPECT SCAN||||GUARDIAN|ADJUDICATOR 3|4|Visit_4|65|3|SCREENING|2020-08-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|8|DLCOHCVA|HGB Corrected DLCO/VA|[?]|FOWLERS|[?]|mg/m2/h|[?]|1|/100 WBC|GANGLION|CONTRALATERAL|INTERMEDIATE|MANUAL COUNT|Y|Y||ADJUDICATOR|MICROSCOPIST|4|Visit_4|65|6|FOLLOW-UP|2020-08-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|||[?]|1|10^6/Ejaculate U|DISTANT LYMPH NODE|CONTRALATERAL|INNER|EEG|||Y|INTERVIEWER|MICROSCOPIST 3|5|Visit_5|90|6|TREATMENT|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SLING|[?]|g/kg/day|[?]|1|mAnson U/mL|SUPRASPINATUS MUSCLE|IPSILATERAL|CRANIAL|MICROBIAL CULTURE, LIQUID||Y||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|7|SCREENING|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|1|DLCOPP|Percent Predicted DLCO|[?]|SUPINE|[?]|pm|[?]|1|mV|SECOND OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|VOLAR|TRYPAN BLUE STAIN||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|1|Visit_1|10|6|TREATMENT|2020-12-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|2|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|kg/L|[?]|1|grain|LUNG, LEFT, INFERIOR LOBE, SUPERIOR SEGMENT|LATERAL|DORSOLATERAL|MUGA||Y||STUDY SUBJECT|ONCOLOGIST 2|1|Visit_1|10|2|SCREENING|2020-12-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-30
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|3|EVC|Expiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/g/day|[?]|1|DIOPTER|COCCYX|LATERAL|SUBCORTICAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|2|Visit_2|25|4|SCREENING|2020-12-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|4|ELSTNCE|Elastance|[?]|UNCONSTRAINED|[?]|BAG|[?]|1|umol/mol|INTERPHALANGEAL THUMB JOINT|RIGHT|DISTAL VOLAR|SLOAN LETTER EYE CHART 1.25%||||CHILD|ADJUDICATOR 1|2|Visit_2|25|3|FOLLOW-UP|2020-12-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-15
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|5|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|10^8 PFU|[?]|1|mg2/dL2|HEAD AND NECK|LATERAL|CRANIAL|TEST STRIP||||STUDY SUBJECT|PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2021-01-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|6|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|ug/dose|[?]|1|/2500 WBC|HEART, VENTRICLE|BILATERAL|LOWER EXTENSOR SURFACE|SPECT/CT SCAN||||STUDY SUBJECT|ONCOLOGIST|3|Visit_3|40|2|TREATMENT|2021-01-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-03
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SITTING|[?]|10^9 organisms/mg|[?]|1|TCID 50/dose|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|IPSILATERAL|CAUDAL|GC/MS/MS||Y||PROXY|PHYSIOTHERAPIST|4|Visit_4|65|1|TREATMENT|2021-01-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|8|RRS|Total Respiratory System Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|Enzyme U/g Hb|[?]|1|mJoule/cm2|HAND DIGIT 5|CONTRALATERAL|SURFACE|NEXT GENERATION SEQUENCING||Y||CHILD|ONCOLOGIST 1|4|Visit_4|65|6|FOLLOW-UP|2021-01-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|9|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|ug/dL|[?]|1|MBq|RAMUS INTERMEDIUS ARTERY|LEFT|PERIVENTRICULAR|PERFUSION MRI||||VENDOR|ADJUDICATOR 3|5|Visit_5|90|1|TREATMENT|2021-02-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|f50537d2-e098-4dae-8f91-16f2357d709c|10|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SLING|[?]|cm/s|[?]|1|10^3 DNA copies/mL|ABDUCTOR HALLUCIS MUSCLE|UNILATERAL|ANTEROPOSTERIOR|QUANTITATIVE ULTRASOUND||||GUARDIAN|DERMATOLOGIST|5|Visit_5|90|6|WASHOUT|2021-02-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|LATERAL DECUBITUS|[?]|mm/min|[?]|1|Gauss|C3 VERTEBRA|BILATERAL|MIDLINE|COMPUTERIZED CORNEAL TOPOGRAPHY|Y|||SPOUSE|RATER|1|Visit_1|10|7|TREATMENT|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LATERAL DECUBITUS|[?]|hr/day|[?]|1|L/h/m2|VOMER|BILATERAL|OCCIPITAL|SEQUENCING|Y|||INDEPENDENT ASSESSOR|CARDIOLOGIST|1|Visit_1|10|3|TREATMENT|2020-07-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|3|SALKK|Salazar-Knowles Equation, K|[?]|TRENDELENBURG|[?]|pmol/10^9 cells|[?]|1|JAR|SENSORIMOTOR CORTEX|LEFT|SUBCORTICAL|ISHIHARA COLOR PLATES|Y|||INDEPENDENT ASSESSOR|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|4|DLCO|Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|DRUM|[?]|1|CAPLET|ASCENDING AORTA, SINOTUBULAR JUNCTION|LEFT|VENTRAL|INTERRUPTER TECHNIQUE||Y||FRIEND|MICROSCOPIST 2|2|Visit_2|25|2|SCREENING|2020-08-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-24
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|5|FRCPP|Percent Predicted FRC|[?]|UNCONSTRAINED|||[?]|1|TUBE|CAUDAL VERTEBRA|RIGHT|NASAL|FLOCCULATION, CHARCOAL ENHANCED|||Y|SPOUSE|OTOLARYNGOLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|6|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|[?]|mm/h|[?]|1|10^9 CFU/g|SUPRASPINATUS MUSCLE|CONTRALATERAL|LOWER EXTENSOR SURFACE|NEPHELOMETRY||||CAREGIVER|NEUROLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-08-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|7|MEPPP|Percent Predicted MEP|[?]|FOWLERS|[?]|/MBP|[?]|1|mL/dL|PERIFACIAL LYMPH NODE|LATERAL|FRONTAL|CONTRAST ENHANCED PET/CT SCAN||Y||SIBLING|ADJUDICATOR 3|4|Visit_4|65|7|FOLLOW-UP|2020-09-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING|[?]|10^8 PFU|[?]|1|mU/g|NERVE|IPSILATERAL|LOWER EXTENSOR SURFACE|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|4|Visit_4|65|3|WASHOUT|2020-09-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|9|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|deg/mm|[?]|1|GBq/mg|JEJUNUM|RIGHT|ROSTRAL|IRON HEMATOXYLIN STAIN||Y||INDEPENDENT ASSESSOR|READER 2|5|Visit_5|90|3|TREATMENT|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SITTING|[?]|U/g Hb|[?]|1|V|KIDNEY, MEDULLA|BILATERAL|NASAL|SMEAR||||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|5|Visit_5|90|5|WASHOUT|2020-10-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|1|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|g/kg/day|GREAT SAPHENOUS VEIN|BILATERAL|FORE|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY|||Y|SPOUSE|INTERNIST|1|Visit_1|10|7|SCREENING|2020-07-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/g/h|[?]|1|Bq|PROXIMAL INTERPHALANGEAL JOINT 2|LATERAL|SUPERFICIAL|SLOAN LETTER EYE CHART 100%||Y||GUARDIAN|DERMATOLOGIST|1|Visit_1|10|1|WASHOUT|2020-07-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|3|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|Bq|[?]|1|L/min/m2|PISIFORM BONE|BILATERAL|ROSTRAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|2|Visit_2|25|6|TREATMENT|2020-08-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|4|EFFIND|Effusion Indicator|[?]|SEMI-FOWLERS|[?]|CUP|[?]|1|LENS|VASTUS MEDIALIS MUSCLE|IPSILATERAL|INFERIOR|TARGETED GENOME SEQUENCING|Y|||ADJUDICATION COMMITTEE|OPTOMETRIST|2|Visit_2|25|1|TREATMENT|2020-08-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-FOWLERS|||[?]|1|ag|RADIAL ARTERY|BILATERAL|MIDLINE|DOUBLE IMMUNODIFFUSION|||Y|FRIEND|ONCOLOGIST 2|3|Visit_3|40|7|SCREENING|2020-08-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|6|PEFREV|PEF Reversibility|[?]|UNCONSTRAINED|[?]|mL/dose|[?]|1|10^3 CFU/mL|SKIN OF THE INFRASCAPULAR REGION|RIGHT|PROXIMAL VOLAR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|3|Visit_3|40|5|SCREENING|2020-08-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|7|MIPPP|Percent Predicted MIP|[?]|SEMI-FOWLERS|[?]|Enzyme U/g Hb|[?]|1|g/animal/wk|TONSIL|BILATERAL|LOWER|COULOMETRIC TITRATION||||INVESTIGATOR|READER 1|4|Visit_4|65|5|TREATMENT|2020-09-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|8|SALKK|Salazar-Knowles Equation, K|[?]|TRENDELENBURG|[?]|STEPS|[?]|1|mgEq|FIRST RIGHT POSTEROLATERAL ARTERY|LATERAL|ROSTRAL|HIGH RESOLUTION CT||||SIBLING|ONCOLOGIST|4|Visit_4|65|5|WASHOUT|2020-09-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|9|FIVC|Forced Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|U/g/min|BRACHIAL ARTERY|UNILATERAL|TEMPORAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|||Y|CLINICAL STUDY SPONSOR|ONCOLOGIST 2|5|Visit_5|90|5|FOLLOW-UP|2020-10-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|489870ed-9da5-4df6-a5ef-17821c449c84|10|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|[?]|kcal/day|[?]|1|cmH2O/mL|EYE BULGE|LEFT|UPPER FLEXOR SURFACE|CELLULAR PROLIFERATION ASSAY|Y|||ADJUDICATION COMMITTEE|MICROSCOPIST|5|Visit_5|90|4|WASHOUT|2020-10-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|1|TVPP|Percent Predicted Tidal Volume|[?]|SEMI-RECUMBENT|[?]|U/kg/h|[?]|1|10^9 organisms/mg|ANASTOMOSIS|IPSILATERAL|CAUDAL|FORCED OSCILLATION TECHNIQUE|Y|||GUARDIAN|ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2020-09-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|2|TVPP|Percent Predicted Tidal Volume|[?]|REVERSE TRENDELENBURG|[?]|dL|[?]|1|/ms|HEART, LEFT ATRIUM|BILATERAL|INTERMEDIATE|RADIATION DOSIMETRY||||PARENT|RADIOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-09-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-02
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|3|RRS|Total Respiratory System Resistance|[?]|STANDING|[?]|mg/m2/h|[?]|1|RFU|URETHRA, ANTERIOR|LEFT|DISTAL|AGAR DILUTION|Y|||VENDOR|READER 2|2|Visit_2|25|3|FOLLOW-UP|2020-10-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|4|FEV6PP|Percent Predicted FEV6|[?]|PRONE|[?]|Siemens|[?]|1|mg/m2/day|LUMBAR VERTEBRA|RIGHT|PROXIMAL|COLORIMETRY||||SPOUSE|PATHOLOGIST 2|2|Visit_2|25|2|FOLLOW-UP|2020-10-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|5|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|||[?]|1|MPL U|ULNAR ARTERY|LATERAL|NASAL|TRANSVAGINAL ULTRASOUND||Y|Y|FAMILY MEMBER|RADIOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-10-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|6|PLMXRS|Pulmonary Reactance|[?]|LEFT LATERAL DECUBITUS|[?]|U/g/day|[?]|1|ug/kg/min|WRIST JOINT FLEXOR MUSCLES|RIGHT|DORSAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||ADJUDICATION COMMITTEE|MICROSCOPIST|3|Visit_3|40|7|SCREENING|2020-10-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|7|EXPRELTM|Expiration Relaxation Time|[?]|SITTING|[?]|ks|[?]|1|s^-1(%O2)^-1|PERICARDIAL CAVITY|CONTRALATERAL|DISTAL|FLUORESCENT MICROSCOPY||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|4|Visit_4|65|1|SCREENING|2020-11-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|8|FVC|Forced Vital Capacity|[?]|SITTING|[?]|s/h|[?]|1|GPL U|FEMUR SHAFT|IPSILATERAL|LATERAL|RIA||||CHILD|NEUROLOGIST 1|4|Visit_4|65|4|FOLLOW-UP|2020-11-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|9|ERVPP|Percent Predicted ERV|[?]|SITTING, LEGS DEPENDENT|[?]|TCID 50/dose|[?]|1|min*mg/mL|MEDIAN NERVE|IPSILATERAL|ANTEROLATERAL|LIGHT MICROSCOPY||||FRIEND|READER 1|5|Visit_5|90|6|FOLLOW-UP|2020-12-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|90fe992f-5a11-4829-b3b0-1c8314f53012|10|RELSZCHG|Relative Size Change|[?]|SUPINE|[?]|uL/dose|[?]|1|NEEDLE GAUGE|SHIN|LEFT|PROXIMAL VOLAR|PERIODIC ACID SCHIFF STAIN||||SIBLING|READER 2|5|Visit_5|90|4|TREATMENT|2020-12-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|10^3/hpf|[?]|1|PHERESIS UNIT|RIB 5|RIGHT|VENTROLATERAL|VENTILATION PERFUSION LUNG SCAN||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|1|Visit_1|10|5|SCREENING|2020-10-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|mL/mmHg|[?]|1|pmol/day|POSTERIOR TIBIAL VEIN|BILATERAL|DORSAL|TRYPAN BLUE STAIN||||PROXY|MICROSCOPIST|1|Visit_1|10|6|TREATMENT|2020-10-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-12
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|3|FIFMAXPP|Percent Predicted FIFmax|[?]|FOWLERS|||[?]|1|Enzyme U/L|ADDUCTOR POLLICIS MUSCLE|RIGHT|PERIVENTRICULAR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|Y|Y|ADJUDICATOR|READER 1|2|Visit_2|25|1|TREATMENT|2020-11-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|4|INERTANC|Inertance|[?]|PRONE|[?]|nCi|[?]|1|mm/2h|NOSE|IPSILATERAL|ROSTRAL|MODIFIED ACID FAST STAIN|Y|||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|2|Visit_2|25|2|SCREENING|2020-11-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|5|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|Ci/mL|[?]|1|U/g Hb|SKULL|LEFT|OCCIPITAL|MULTI-SLICE SPIRAL CT||||SIGNIFICANT OTHER|INTERNIST|3|Visit_3|40|3|TREATMENT|2020-11-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|6|FRC|Functional Residual Capacity|[?]|PRONE|||[?]|1|s^-1(%O2)^-1|TRICUSPID VALVE, ANTERIOR CUSP|CONTRALATERAL|INFERIOR|BIOPSY|||Y|GUARDIAN|READER 3|3|Visit_3|40|6|WASHOUT|2020-11-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|7|MIPPP|Percent Predicted MIP|[?]|LEFT LATERAL DECUBITUS|[?]|cGy|[?]|1|g/animal/wk|GALLBLADDER|LEFT|PERIPHERAL|PET/CT SCAN WITHOUT CONTRAST||Y||STUDY SUBJECT|PHYSIOTHERAPIST|4|Visit_4|65|2|TREATMENT|2020-12-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|8|FRC|Functional Residual Capacity|[?]|SITTING|[?]|g/dL|[?]|1|nkat|METATARSOPHALANGEAL JOINT 4|RIGHT|SURFACE|RADIOGRAPHY||||CHILD|INTERNIST|4|Visit_4|65|1|TREATMENT|2020-12-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|9|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|LATERAL DECUBITUS|[?]|VIAL|[?]|1|Gravitational Unit|HAND DIGIT 5|BILATERAL|PROXIMAL|PUPILLOMETRY||Y||HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|5|Visit_5|90|7|TREATMENT|2021-01-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|74be8de0-3307-4cc3-9044-05068b60f7e0|10|FEV1FVC|FEV1/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|ft2|PELVIC BONE|UNILATERAL|TEMPORAL|POLYMERASE CHAIN REACTION|||Y|FAMILY MEMBER|ENDOCRINOLOGIST|5|Visit_5|90|5|TREATMENT|2021-01-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|ALVVOL|Alveolar Volume|[?]|DECUBITUS|[?]|m/sec|[?]|1|DIP|RADIUS-LUNATE JOINT|IPSILATERAL|ANTEROPOSTERIOR|CENTRIFUGATION|Y|Y||STUDY SUBJECT|HEMATOLOGIST|1|Visit_1|10|5|SCREENING|2020-06-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|2|EFFVOL|Effusion Volume|[?]|SITTING|||[?]|1|mOsm/kg|HIPPOCAMPUS|LEFT|SUPERIOR|MULTIPLE BREATH WASHOUT||Y|Y|CLINICAL STUDY SPONSOR|HEMATOLOGIST|1|Visit_1|10|3|SCREENING|2020-06-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-12
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|3|MEP|Maximal Expiratory Pressure|[?]|RIGHT LATERAL DECUBITUS|[?]|g/g|[?]|1|Bq/uL|HEART, LEFT ATRIUM|LEFT|APICAL|THIN SMEAR||||INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|6|WASHOUT|2020-06-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|4|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|g/cage|[?]|1|mmHg*min/L|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|IPSILATERAL|APICAL|DUKE INCISION METHOD||||INTERVIEWER|RATER 1|2|Visit_2|25|5|SCREENING|2020-06-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|TRENDELENBURG|||[?]|1|10^6 organisms/mg|ANTERIOR HORN OF THE LATERAL VENTRICLE|BILATERAL|MIDLINE|CAPILLARY ELECTROPHORESIS|||Y|INDEPENDENT ASSESSOR|MICROSCOPIST|3|Visit_3|40|2|TREATMENT|2020-07-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|6|PEFREV|PEF Reversibility|[?]|PRONE|[?]|WAFER|[?]|1|ngEq/L|BILE DUCT|IPSILATERAL|LATERAL|CYSTOSCOPY||Y||PARENT|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|1|TREATMENT|2020-07-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|7|SGAW|Specific Airway Conductance|[?]|SEMI-RECUMBENT|[?]|psec|[?]|1|foz_us|PERIHILAR LYMPH NODE|BILATERAL|POSTERIOR|NEXT GENERATION SEQUENCING||||CAREGIVER|RADIOLOGIST 2|4|Visit_4|65|4|TREATMENT|2020-08-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SLING|[?]|/month|[?]|1|%(w/v)|MITRAL VALVE, ANTERIOR CUSP|RIGHT|SUPERIOR|ANALYTICAL ULTRACENTRIFUGATION||Y||PROXY|RADIOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|9|RRS|Total Respiratory System Resistance|[?]|LATERAL DECUBITUS|||[?]|1|vg/kg|HYPOTHALAMUS|BILATERAL|MEDIAL|ANTIMICROBIAL COMBINATION TESTING|||Y|SIGNIFICANT OTHER|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|UNCONSTRAINED|[?]|mL/cm3/min|[?]|1|WEEKS|COLON, SIGMOID|UNILATERAL|VOLAR|ELECTRONEUROGRAPHY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|5|Visit_5|90|6|WASHOUT|2020-08-30|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-24
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|TRENDELENBURG|[?]|KIT|[?]|1|/LPF|OCULOMOTOR NERVE|LEFT|UPPER|ELISA||||VENDOR|INTERNIST|1|Visit_1|10|7|SCREENING|2020-08-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|NEBULE|[?]|1|ECL unit|DISTAL COMMON BILE DUCT|CONTRALATERAL|UPPER|KINYOUN STAIN|Y|||DOMESTIC PARTNER|CLINICAL PATHOLOGIST|1|Visit_1|10|7|WASHOUT|2020-08-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|3|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|[?]|DAgU|[?]|1|g/animal/day|RIB|RIGHT|POSTERIOR|SLOAN LETTER EYE CHART 1.25%||||VENDOR|READER 3|2|Visit_2|25|4|WASHOUT|2020-09-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|4|TV|Tidal Volume|[?]|SEMI-FOWLERS|[?]|10^3 RNA copies/mL|[?]|1|mg/L FEU|RADIUS|UNILATERAL|VOLAR|WRIGHT-GIEMSA STAIN||||GUARDIAN|RADIOLOGIST 1|2|Visit_2|25|4|SCREENING|2020-09-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-27
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|SITTING, LEGS DEPENDENT|||[?]|1|TCID 50/dose|SUPRACLAVICULAR LYMPH NODE|LATERAL|MIDLINE|JAEGER EYE CHART|||Y|SPOUSE|RATER 1|3|Visit_3|40|4|WASHOUT|2020-09-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|6|IVC|Inspiratory Vital Capacity|[?]|STANDING|[?]|g/U|[?]|1|IU/mmol|FACET JOINT|RIGHT|DISTAL VOLAR|AGAR PROPORTION||||CLINICAL RESEARCH COORDINATOR|PHYSIOTHERAPIST|3|Visit_3|40|7|WASHOUT|2020-09-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-28
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|7|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|kg/m2|[?]|1|NEBULE|PROSTATE GLAND, POSTERIOR LOBE|LEFT|CAUDAL|OLIGO ACGH||Y||PROXY|PATHOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-10-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|8|TLCPP|Percent Predicted Total Lung Capacity|[?]|DECUBITUS|[?]|PELLET|[?]|1|pkat/L|NUCLEUS OF DIAGONAL BAND|IPSILATERAL|CRANIAL|MICROARRAY||||ADJUDICATOR|ONCOLOGIST|4|Visit_4|65|4|WASHOUT|2020-10-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-13
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|9|PEF|Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|IU/L|[?]|1|VIAL|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LEFT|INTERMEDIATE|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||PARENT|RATER 2|5|Visit_5|90|7|TREATMENT|2020-11-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|8825b806-fa76-49d7-b281-d36fc42fee1e|10|IRVPP|Percent Predicted IRV|[?]|RIGHT LATERAL DECUBITUS|[?]|mV/sec|[?]|1|10^3 organisms/g|ENTORHINAL CORTEX|CONTRALATERAL|ANTEROTEMPORAL|AMSLER GRID|Y|||CAREGIVER|MICROSCOPIST|5|Visit_5|90|4|TREATMENT|2020-11-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|PIXEL|[?]|1|mL/s|CHOROID|UNILATERAL|HIND|IN VITRO GENE EXPRESSION ASSAY||Y||FRIEND|MICROSCOPIST 3|1|Visit_1|10|7|SCREENING|2020-05-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|2|FEV3PP|Percent Predicted FEV3|[?]|PRONE|[?]|IU/g|[?]|1|g/m2/day|PROXIMAL PHALANX 1 OF THE HAND|UNILATERAL|ANTEROMEDIAL|IMMUNOBLOT||||CHILD|NEUROLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-05-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|3|PEFREV|PEF Reversibility|[?]|SLING|||[?]|1|U/mg|PERICARDIAL WALL|UNILATERAL|LOWER|CONTRAST ENHANCED PET SCAN|Y||Y|ADJUDICATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2020-06-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|4|PCF|Peak Cough Flow|[?]|REVERSE TRENDELENBURG|[?]|fmol/g|[?]|1|mm|T7 VERTEBRA|IPSILATERAL|MIDLINE|ETDRS EYE CHART|Y|||VENDOR|MICROSCOPIST 2|2|Visit_2|25|4|FOLLOW-UP|2020-06-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|5|TSUHYS|Tissue Hysteresivity|[?]|SLING|[?]|Tesla|[?]|1|ukat/10^12 RBC|COLON, RECTOSIGMOID|LATERAL|SUBCORTICAL|TRANSTHORACIC ECHOCARDIOGRAPHY||||FRIEND|PATHOLOGIST 2|3|Visit_3|40|7|TREATMENT|2020-06-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-13
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|6|SAWVOL|Specific Airway Volume|[?]|SLING|[?]|pptr|[?]|1|foz_us|HUMERAL EPICONDYLE|LATERAL|VENTROLATERAL|IVY INCISION METHOD|Y|Y||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-06-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-13
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|IU/mL|[?]|1|IU/day|METACARPAL BONE 4|LATERAL|MIDLINE|MYELOPEROXIDASE STAIN||||GUARDIAN|UROLOGIST|4|Visit_4|65|1|SCREENING|2020-07-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|8|AWVOL|Airway Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|tuberculin unit|INTRAHEPATIC LARGE BILE DUCT|IPSILATERAL|POSTERIOR|CONTRAST ENHANCED MRI|Y||Y|INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-07-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|9|LOBVOL|Lobar Volume|[?]|SUPINE|[?]|U/g/day|[?]|1|EVENTS|METACARPOPHALANGEAL JOINT 3|UNILATERAL|LATERAL|BRDU CELLULAR PROLIFERATION ASSAY||Y||PARENT|INTERNIST|5|Visit_5|90|3|TREATMENT|2020-08-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|10|FEV1SVC|FEV1/SVC|[?]|TRENDELENBURG|[?]|IU|[?]|1|TCID 50/dose|BASILIC VEIN|LEFT|NASAL|NUCLEIC ACID HYBRIDIZATION||||GUARDIAN|PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-FOWLERS|||[?]|1|10^6 organisms/mL|SUPRARENAL AORTA|RIGHT|FACIAL|MICROBIAL CONCENTRATION|||Y|FAMILY MEMBER|UROLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|2|FEV1REV|FEV1 Reversibility|[?]|DECUBITUS|[?]|/ms|[?]|1|10^6 RNA copies/mL|LUNG, RIGHT UPPER LOBE|LATERAL|ANTEROLATERAL|SLIT LAMP||||DOMESTIC PARTNER|NEUROLOGIST 1|1|Visit_1|10|3|WASHOUT|2021-01-14|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|3|FEF2575|Forced Expiratory Flow 25-75%|[?]|TRENDELENBURG|[?]|ELISA unit/mL|[?]|1|BOLUS|CLAW|RIGHT|NASAL|FLUOROSCOPY||||SIBLING|RATER 2|2|Visit_2|25|5|TREATMENT|2021-01-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|4|TLC|Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|ug/mL/h|[?]|1|s*kPa|CERVIX UTERI|UNILATERAL|DISTAL VOLAR|MICRODENSITOMETRY||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|2|Visit_2|25|6|TREATMENT|2021-01-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-31
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|5|INFLTIND|Infiltrates Indicator|[?]|FOWLERS|[?]|gMFI|[?]|1|mL/s/m2|MALLEUS|BILATERAL|PERIPHERAL|BIOPSY|Y|||FAMILY MEMBER|CLINICAL PATHOLOGIST|3|Visit_3|40|7|SCREENING|2021-02-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|6|FEV1FVC6|FEV1/FVC6|[?]|STANDING, BENT FORWARD|[?]|s*kPa|[?]|1|Newton|SPINOUS PROCESS|BILATERAL|VOLAR|SXA SCAN||||INVESTIGATOR|READER 1|3|Visit_3|40|2|TREATMENT|2021-02-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-21
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|REVERSE TRENDELENBURG|||[?]|1|10^12/L|SCROTUM|UNILATERAL|LATERAL|CYSTOMETRY|||Y|INTERVIEWER|INTERNIST|4|Visit_4|65|6|TREATMENT|2021-03-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|8|RAWPP|Percent Predicted Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|in|[?]|1|Hz|MAMMARY GLAND|IPSILATERAL|SUPERIOR|SPIROMETRY|Y|||CLINICAL RESEARCH ASSOCIATE|READER 2|4|Visit_4|65|5|TREATMENT|2021-03-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|9|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|FOWLERS|[?]|BISCUIT|[?]|1|GPL U/mL|LEFT CIRCUMFLEX ARTERY OSTIUM|RIGHT|TEMPORAL|PELLI-ROBSON EYE CHART|Y|||CAREGIVER|NEUROLOGIST|5|Visit_5|90|1|SCREENING|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|10|PIF|Peak Inspiratory Flow|[?]|SITTING|[?]|log10 CFU/g|[?]|1|nmol/mol|THYMUS GLAND|BILATERAL|ANTEROTEMPORAL|FISH||||SPOUSE|MICROSCOPIST 1|5|Visit_5|90|6|TREATMENT|2021-04-04|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|1|FIO2|Fraction of Inspired Oxygen|[?]|SITTING, LEGS DEPENDENT|[?]|g/L|[?]|1|MBP|SPINAL ACCESSORY NERVE|IPSILATERAL|SUPERFICIAL|DUKE INCISION METHOD||Y||ADJUDICATION COMMITTEE|PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-05-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|2|ELSTNCE|Elastance|[?]|PRONE|[?]|mL/kg/min|[?]|1|days/wk|COLON LYMPH NODE|UNILATERAL|FACIAL|RAJI CELL EIA||Y||GUARDIAN|RATER|1|Visit_1|10|5|FOLLOW-UP|2020-05-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-23
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|3|SGAW|Specific Airway Conductance|[?]|REVERSE TRENDELENBURG|[?]|OD Unit|[?]|1|g/cage|BRACHIORADIALIS MUSCLE|BILATERAL|DORSOLATERAL|IMMUNOPRECIPITATION|Y|||CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|2|Visit_2|25|3|FOLLOW-UP|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|4|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|Hounsfield Unit|[?]|1|TRACE|PANCREAS, HEAD|UNILATERAL|UPPER|MS/MS|Y|Y||SIBLING|PHYSIOTHERAPIST|2|Visit_2|25|7|WASHOUT|2020-06-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-17
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|UNCONSTRAINED|[?]|mmHg/L/min|[?]|1|Absorbance U|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|IPSILATERAL|FORE|ENDOSCOPY||||SIGNIFICANT OTHER|ADJUDICATOR 2|3|Visit_3|40|3|TREATMENT|2020-06-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/kg/h|[?]|1|ng|MEDIAN NERVE|LATERAL|PERIVENTRICULAR|FLUORESCENT ENZYME IMMUNOASSAY|Y|Y||GUARDIAN|MICROSCOPIST 3|3|Visit_3|40|5|TREATMENT|2020-06-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-15
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|7|EFFIND|Effusion Indicator|[?]|SEMI-FOWLERS|||[?]|1|mEq/uL|CHEST|IPSILATERAL|LOWER MEDIAL|ELECTRONEUROGRAPHY|Y||Y|NON-HEALTH CARE PROFESSIONAL|RATER 1|4|Visit_4|65|2|FOLLOW-UP|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|8|INFLTIND|Infiltrates Indicator|[?]|DECUBITUS|||[?]|1|atm|FINGER FLEXOR MUSCLES|CONTRALATERAL|ANTEROMEDIAL|FLOCCULATION, CHARCOAL ENHANCED|||Y|INVESTIGATOR|RADIOLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-07-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|9|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|[?]|Bq/uL|[?]|1|IU/L|LESSER TROCHANTER|IPSILATERAL|MIDLINE|CHROMATOGRAPHY|Y|||ADJUDICATION COMMITTEE|UROLOGIST|5|Visit_5|90|4|TREATMENT|2020-08-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|b36220d8-c129-48bf-8c41-542a954b819a|10|ICREV|IC Reversibility|[?]|FOWLERS|[?]|umol/min|[?]|1|Henry|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|RIGHT|VENTROLATERAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|5|Visit_5|90|1|SCREENING|2020-08-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|INERTANC|Inertance|[?]|FOWLERS|[?]|cm/min|[?]|1|IMPLANT|BRACHIOCEPHALIC ARTERY|LEFT|SUBCORTICAL|DIGITAL PCR|Y|||FRIEND|MICROSCOPIST|1|Visit_1|10|7|TREATMENT|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|PUFF|[?]|1|uOsm|CONJUNCTIVA|BILATERAL|BASAL|PEAK FLOWMETRY||||ADJUDICATOR|UROLOGIST|1|Visit_1|10|6|WASHOUT|2020-08-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|3|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|PRESSOR UNITS|APPENDICULAR SKELETON|UNILATERAL|APICAL|PANENDOSCOPY||Y|Y|VENDOR|OPTOMETRIST|2|Visit_2|25|2|FOLLOW-UP|2020-08-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|4|LCI|Lung Clearance Index|[?]|STANDING, BENT FORWARD|||[?]|1|10^9 organisms|DENTAL ARCH|LATERAL|INNER|REFRACTOMETRY|||Y|ADJUDICATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2020-08-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|mg/m2|[?]|1|ng/mol|ESOPHAGUS|IPSILATERAL|ROSTRAL|CONFOCAL MICROSCOPY||||GUARDIAN|RADIOLOGIST|3|Visit_3|40|3|SCREENING|2020-09-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|6|DLCOVA|DLCO/VA|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uL|CORONARY ARTERY, ANTERIOR DESCENDING|UNILATERAL|CRANIAL|GRADIENT DIFFUSION|||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|3|Visit_3|40|2|SCREENING|2020-09-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|7|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|g/g|[?]|1|Gauss|PROSTATE GLAND|BILATERAL|BASAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||INVESTIGATOR|PHYSIOTHERAPIST|4|Visit_4|65|2|TREATMENT|2020-10-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|8|RV|Residual Volume|[?]|LATERAL DECUBITUS|[?]|uIU/L|[?]|1|ug/h|CEREBRAL HEMISPHERE, LEFT|UNILATERAL|OCCIPITAL|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||ADJUDICATOR|ADJUDICATOR 3|4|Visit_4|65|3|FOLLOW-UP|2020-10-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|9|FIV1PP|Percent Predicted FIV1|[?]|SITTING, LEGS DEPENDENT|[?]|BOTTLE|[?]|1|mL/mmHg|CORNEAL EPITHELIUM|BILATERAL|LOWER MEDIAL|NEXT GENERATION SEQUENCING||||GUARDIAN|MICROSCOPIST 1|5|Visit_5|90|2|TREATMENT|2020-11-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|92d3477b-7460-4ce8-b237-38ca4c55fc91|10|FIF25|Forced Inspiratory Flow at 25%|[?]|LEFT LATERAL DECUBITUS|[?]|MBq/uL|[?]|1|PHERESIS UNIT|URETHRA, POSTERIOR|IPSILATERAL|PERIPHERAL|OSCILLOMETRY||||DOMESTIC PARTNER|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2020-11-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|LOBVOL|Lobar Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|TABLET|FLEXOR CARPI ULNARIS MUSCLE|IPSILATERAL|FACIAL|BIOIMPEDANCE SPECTROSCOPY|||Y|CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|2|EFFIND|Effusion Indicator|[?]|DECUBITUS|[?]|cg|[?]|1|PUFF|FLEXOR DIGITORUM BREVIS MUSCLE|IPSILATERAL|UPPER EXTENSOR SURFACE|IRON HEMATOXYLIN STAIN||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-12-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|3|RRS|Total Respiratory System Resistance|[?]|STANDING|[?]|ug/cm2|[?]|1|Roentgen|VASTUS MEDIALIS MUSCLE|IPSILATERAL|DORSOLATERAL|ATOMIC ABSORPTION SPECTROMETRY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|/wk|[?]|1|U/g Hb|RIB 11|LATERAL|UPPER|FLUORESCENT MICROSCOPY||||GUARDIAN|NEUROLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-12-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|5|FIV1PP|Percent Predicted FIV1|[?]|TRENDELENBURG|[?]|kg/mol|[?]|1|ug/m2/day|HEART, RIGHT ATRIUM|UNILATERAL|FRONTAL|ELLA||||NON-HEALTH CARE PROFESSIONAL|READER 3|3|Visit_3|40|4|FOLLOW-UP|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-FOWLERS|[?]|mOsm/L|[?]|1|PIXELS/cm|UMBILICAL CORD|IPSILATERAL|OCCIPITAL|OPHTHALMOSCOPY||||PARENT|NEUROLOGIST 2|3|Visit_3|40|5|TREATMENT|2021-01-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|7|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|TRENDELENBURG|[?]|umol/L/h|[?]|1|% INHIBITION|CAPITATE BONE|CONTRALATERAL|TIP|IMMUNOPRECIPITATION|Y|||FAMILY MEMBER|RATER 2|4|Visit_4|65|5|WASHOUT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|8|LCI|Lung Clearance Index|[?]|REVERSE TRENDELENBURG|||[?]|1|mPa|PARATHYROID GLAND|LEFT|UPPER FLEXOR SURFACE|COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|Y||Y|ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SUPINE|||[?]|1|mkat|SUPRACLAVICULAR FOSSA|LATERAL|SUBCORTICAL|PERIPHERAL ANGIOGRAPHY||Y|Y|SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|5|FOLLOW-UP|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|10|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|PIXELS/cm|[?]|1|mgEq|BRONCHUS|BILATERAL|PERIVENTRICULAR|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y||FAMILY MEMBER|MICROSCOPIST|5|Visit_5|90|7|SCREENING|2021-03-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING, BENT FORWARD|[?]|sec|[?]|1|nmol/kg/day|HEART, VENTRICLE|CONTRALATERAL|OCCIPITAL|LINE PROBE ASSAY|Y|||SIBLING|RADIOLOGIST 1|1|Visit_1|10|2|WASHOUT|2020-08-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|||[?]|1|mg/mol|BRACHIAL LYMPH NODE|LEFT|CENTRAL|STRESS ECHOCARDIOGRAPHY|Y||Y|GUARDIAN|CLINICAL PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-08-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|3|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|||[?]|1|10^3 CFU/mL|THIGH|LATERAL|TEMPORAL|HPLC/IEX|||Y|SIBLING|READER 3|2|Visit_2|25|4|FOLLOW-UP|2020-09-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|||[?]|1|/ms|ESOPHAGUS, MIDDLE THIRD|BILATERAL|ROSTRAL|NEXT GENERATION SEQUENCING||Y|Y|SIBLING|ONCOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-09-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|5|ERV|Expiratory Reserve Volume|[?]|STANDING, BENT FORWARD|[?]|Gy/h|[?]|1|mL/day|PRETRACHEAL LYMPH NODE|RIGHT|ANTEROLATERAL|ELASTOGRAPHY||Y||INVESTIGATOR|READER 2|3|Visit_3|40|5|TREATMENT|2020-09-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|10^7 CFU/mL|CAPITATE-LUNATE JOINT|LATERAL|DORSAL|PHOTOMETRIC CLOT DETECTION|||Y|CAREGIVER|PATHOLOGIST 1|3|Visit_3|40|6|SCREENING|2020-09-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|7|ERVPP|Percent Predicted ERV|[?]|SITTING, LEGS DEPENDENT|[?]|km/h|[?]|1|pg|BILE DUCT|BILATERAL|VENTROLATERAL|IMMUNOTURBIDIMETRY|Y|||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 3|4|Visit_4|65|3|WASHOUT|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|8|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING|[?]|uEq|[?]|1|uU/dL|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|PARIETO-OCCIPITAL|GC/FID|Y|||PARENT|ADJUDICATOR 1|4|Visit_4|65|5|WASHOUT|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|9|PEF|Peak Expiratory Flow|[?]|SLING|[?]|L/s/kPa|[?]|1|Watt|VAGINAL WALL|RIGHT|LOWER EXTENSOR SURFACE|ELISPOT||||CLINICAL STUDY SPONSOR|MICROSCOPIST 3|5|Visit_5|90|7|FOLLOW-UP|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|db13afe0-14f6-445b-869a-b0d9fe87e5b9|10|FEF50|Forced Expiratory Flow 50%|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/dL|[?]|1|uCi/kg|CECUM|CONTRALATERAL|VOLAR|PET/CT SCAN WITHOUT CONTRAST||Y||SIBLING|ADJUDICATOR 1|5|Visit_5|90|7|TREATMENT|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|PRONE|[?]|mL/min|[?]|1|MBq|CEREBELLUM|IPSILATERAL|VENTRAL|SNELLEN EYE CHART||||SIBLING|CLINICAL PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2020-07-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|2|INFLTIND|Infiltrates Indicator|[?]|SUPINE|[?]|mg/m2/min|[?]|1|genEq|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|CONTRALATERAL|DORSAL|TRANSVAGINAL ULTRASOUND|Y|||CAREGIVER|MICROSCOPIST|1|Visit_1|10|4|FOLLOW-UP|2020-07-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|3|FEV6PP|Percent Predicted FEV6|[?]|DECUBITUS|[?]|ELISA unit/mL|[?]|1|vg/dose|METACARPAL BONE 1|IPSILATERAL|PERIPHERAL|MRI|Y|||VENDOR|RADIOLOGIST|2|Visit_2|25|6|WASHOUT|2020-07-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|UNCONSTRAINED|[?]|POUCH|[?]|1|mg/m2/day|DISTAL INTERPHALANGEAL JOINT 5|BILATERAL|MEDIAL|JAEGER EYE CHART||||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-07-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-17
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|5|GAW|Airway Conductance|[?]|TRENDELENBURG|[?]|ug/g/h|[?]|1|ug/g/day|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|LATERAL|MEDIAL|PELLI-ROBSON EYE CHART||||SIBLING|PATHOLOGIST 2|3|Visit_3|40|2|WASHOUT|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|6|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|PRESSOR UNITS|[?]|1|km/h|HYPOGLOSSAL NERVE|CONTRALATERAL|SURFACE|HEMATOXYLIN AND EOSIN STAIN||||ADJUDICATOR|INTERNIST|3|Visit_3|40|1|SCREENING|2020-08-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|7|FEV3PP|Percent Predicted FEV3|[?]|REVERSE TRENDELENBURG|[?]|km|[?]|1|DAgU|FEMALE GENITALIA|CONTRALATERAL|LOWER EXTENSOR SURFACE|BALLPOINT PEN TECHNIQUE|Y|Y||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST|4|Visit_4|65|2|SCREENING|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|8|ERV|Expiratory Reserve Volume|[?]|SITTING|[?]|/LPF|[?]|1|QUANTITY SUFFICIENT|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|PERIVENTRICULAR|AUDIOMETRY||||ADJUDICATOR|ADJUDICATOR 1|4|Visit_4|65|1|FOLLOW-UP|2020-09-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|9|SVCPP|Percent Predicted Slow Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|Roentgen|CALCANEUS|LATERAL|DISTAL|PALPATION|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 3|5|Visit_5|90|2|TREATMENT|2020-09-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|3f75a463-1348-4c7f-8b29-7472d29628c8|10|PEF|Peak Expiratory Flow|[?]|TRENDELENBURG|||[?]|1|pmol/day|INFERIOR PUBIC RAMUS|LEFT|FORE|CONTRAST ENHANCED SPIRAL CT SCAN|||Y|SIGNIFICANT OTHER|HEMATOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|RV|Residual Volume|[?]|SITTING, LEGS DEPENDENT|[?]|PIXEL|[?]|1|nmol/mL/min|LUNG|BILATERAL|TIP|SLOAN LETTER EYE CHART 2.5%|Y|||ADJUDICATOR|ONCOLOGIST 2|1|Visit_1|10|6|WASHOUT|2021-01-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|SUPINE|||[?]|1|grain|PROXIMAL PHALANX 2 OF THE HAND|UNILATERAL|ANTEROMEDIAL|MRI|Y||Y|SIBLING|NEUROLOGIST|1|Visit_1|10|7|FOLLOW-UP|2021-01-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|3|PLMBLFLW|Pulmonary Blood Flow|[?]|TRENDELENBURG|[?]|/40 HPFs|[?]|1|Pa|INGUINAL REGION|UNILATERAL|SURFACE|AUSCULTATION|Y|Y||FAMILY MEMBER|MICROSCOPIST 1|2|Visit_2|25|7|SCREENING|2021-02-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|4|IRV|Inspiratory Reserve Volume|[?]|FOWLERS|||[?]|1|nmol/L/min|NASAL BONE|IPSILATERAL|DISTAL VOLAR|IMMUNOASSAY|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR|2|Visit_2|25|7|SCREENING|2021-02-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-04
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|5|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-FOWLERS|[?]|BOTTLE|[?]|1|U|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LEFT|UPPER EXTENSOR SURFACE|DUKE INCISION METHOD||||PROXY|CARDIOLOGIST|3|Visit_3|40|2|SCREENING|2021-03-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|6|FIVC|Forced Inspiratory Vital Capacity|[?]|FOWLERS|[?]|APL U/mL|[?]|1|gpELISA unit/mL|CHEST|BILATERAL|SUBCORTICAL|ANALYTICAL ULTRACENTRIFUGATION|Y|||PROXY|MICROSCOPIST|3|Visit_3|40|3|SCREENING|2021-03-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|7|DLCO|Diffusion Capacity of Lung for CO|[?]|DECUBITUS|[?]|mL/day|[?]|1|V/sec|CILIARY BODY|RIGHT|INFERIOR|IRON HEMATOXYLIN STAIN||Y||NON-HEALTH CARE PROFESSIONAL|OTOLARYNGOLOGIST|4|Visit_4|65|6|SCREENING|2021-03-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|8|OXYPULSE|Oxygen Pulse|[?]|LATERAL DECUBITUS|[?]|mkat|[?]|1|IU|STERNOCLAVICULAR JOINT|CONTRALATERAL|DEEP|KINETIC MICROPARTICLE IMMUNOASSAY||||CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|4|Visit_4|65|3|WASHOUT|2021-03-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-16
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|9|FIV1PP|Percent Predicted FIV1|[?]|STANDING|||[?]|1|Hz|ABDUCENS NERVE|IPSILATERAL|VENTROLATERAL|INFRARED SPECTROMETRY||Y|Y|INDEPENDENT ASSESSOR|NEUROLOGIST 1|5|Visit_5|90|1|SCREENING|2021-04-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|RE|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|PRONE|[?]|mL/cm H2O|[?]|1|kat|INFERIOR PUBIC RAMUS|UNILATERAL|SURFACE|CONGO RED STAIN||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|5|Visit_5|90|1|TREATMENT|2021-04-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-18
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|OD Unit|[?]|1|mCi|TEMPORAL LOBE|RIGHT|DISTAL VOLAR|INCISION-INDUCED BLEEDING METHOD||||INTERVIEWER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|6|WASHOUT|2020-07-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|2|TSUELAS|Tissue Elastance|[?]|SITTING, LEGS DEPENDENT|[?]|RFU|[?]|1|uSiemens|ILIAC CREST|LEFT|MIDLINE|INTERRUPTER TECHNIQUE||Y||DOMESTIC PARTNER|PATHOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-07-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|3|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|IMPLANT|[?]|1|ug/g/day|CARPOMETACARPAL JOINT 4|RIGHT|FRONTAL|INTERRUPTER TECHNIQUE|Y|Y||SPOUSE|CLINICAL PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-08-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|psi|[?]|1|mL/g/day|SPLEEN|LATERAL|PROXIMAL VOLAR|FLUOROSCOPY||||GUARDIAN|ADJUDICATOR 3|2|Visit_2|25|5|TREATMENT|2020-08-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|5|VO2|Oxygen Consumption|[?]|STANDING, BENT FORWARD|[?]|g/animal/day|[?]|1|mg/kg/day|ANTERIOR HORN OF THE LATERAL VENTRICLE|CONTRALATERAL|LOWER|MICROBIAL CONCENTRATION||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-08-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|FOWLERS|[?]|nmol|[?]|1|10^9 organisms|METACARPOPHALANGEAL JOINT 4|BILATERAL|ANTEROPOSTERIOR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|||DOMESTIC PARTNER|RADIOLOGIST 2|3|Visit_3|40|6|SCREENING|2020-08-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|7|LOBVOL|Lobar Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|%/s|THROAT|UNILATERAL|VENTROLATERAL|DIGITAL PCR|||Y|VENDOR|ENDOCRINOLOGIST|4|Visit_4|65|5|WASHOUT|2020-09-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|kUSP|[?]|1|U/L|LYMPH NODE HILUM|UNILATERAL|MEDIAL|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||GUARDIAN|READER 1|4|Visit_4|65|1|SCREENING|2020-09-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|9|FIF75|Forced Inspiratory Flow at 75%|[?]|UNCONSTRAINED|[?]|/wk|[?]|1|mU|PARIETAL LOBE|LATERAL|OCCIPITAL|NUCLEIC ACID HYBRIDIZATION||||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|TREATMENT|2020-10-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|4b00b9ef-ddc3-4669-8a73-f69c73743bce|10|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|||[?]|1|g/cm2|METATARSOPHALANGEAL JOINT 5|BILATERAL|UPPER FLEXOR SURFACE|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y||Y|ADJUDICATOR|HEMATOLOGIST|5|Visit_5|90|2|TREATMENT|2020-10-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|FIFMAXPP|Percent Predicted FIFmax|[?]|SUPINE|[?]|mL/(min*100mL)|[?]|1|L/h|GASTROCNEMIUS MUSCLE, MEDIAL HEAD|CONTRALATERAL|ANTEROMEDIAL|ARTERIAL SPIN LABELING FUNCTIONAL MRI||||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-09-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|2|PLMBLFLW|Pulmonary Blood Flow|[?]|UNCONSTRAINED|[?]|uV|[?]|1|U/10^12 RBC|PROXIMAL INTERPHALANGEAL JOINT 3|LATERAL|LOWER EXTENSOR SURFACE|CLAUSS METHOD||Y||STUDY SUBJECT|PATHOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-09-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|3|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SLING|[?]|IU/kg|[?]|1|ukat/10^12 RBC|KIDNEY, LOWER LOBE|LATERAL|SUPERIOR|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||Y||CAREGIVER|PHYSIOTHERAPIST|2|Visit_2|25|1|WASHOUT|2020-10-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|4|DLCOPP|Percent Predicted DLCO|[?]|SEMI-RECUMBENT|[?]|10^7/L|[?]|1|v/v|THIRD OBTUSE MARGINAL BRANCH ARTERY|LEFT|SUBCORTICAL|COLORIMETRY||Y||GUARDIAN|HEMATOLOGIST|2|Visit_2|25|1|WASHOUT|2020-10-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|5|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|dyn|[?]|1|BE/mL|SIGMOID SINUS|LEFT|MIDLINE|MICROBIAL CULTURE, LIQUID||||ADJUDICATOR|ONCOLOGIST|3|Visit_3|40|1|WASHOUT|2020-10-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|PRONE|[?]|/10^4|[?]|1|U/mL|T1 VERTEBRA|LATERAL|PROXIMAL|FLUORESCENT MICROSCOPY||||CAREGIVER|ADJUDICATOR 3|3|Visit_3|40|3|TREATMENT|2020-10-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|7|DLCO|Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|pmol|PERITONEUM|IPSILATERAL|ANTEROPOSTERIOR|SNELLEN EYE CHART||Y|Y|CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-11-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|8|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|FOWLERS|[?]|CIGAR|[?]|1|Ci/L|RETROCRURAL LYMPH NODE|RIGHT|BASAL|COULOMETRIC TITRATION||||VENDOR|UROLOGIST|4|Visit_4|65|2|TREATMENT|2020-11-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|9|RRS|Total Respiratory System Resistance|[?]|SEMI-RECUMBENT|||[?]|1|U.CARR|VAGINAL WALL|LEFT|ANTERIOR|RIA||Y|Y|FAMILY MEMBER|RATER 2|5|Visit_5|90|4|TREATMENT|2020-12-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|a125efdf-aec8-47a1-b492-cdaf8b619a78|10|FRC|Functional Residual Capacity|[?]|SUPINE|||[?]|1|/500 WBC|UMBILICAL CORD|IPSILATERAL|TEMPORAL|CARDIAC THERMODILUTION|Y||Y|INVESTIGATOR|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2020-12-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-30
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SLING|[?]|PACKET|[?]|1|kg/mol|COSTOCHONDRAL JOINT 1|LATERAL|ANTEROPOSTERIOR|MACRO BROTH DILUTION|Y|||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2021-01-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|2|SVC|Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|%(w/v)|COLON, TRANSVERSE|CONTRALATERAL|INTERMEDIATE|DUKE INCISION METHOD|||Y|CAREGIVER|ONCOLOGIST 1|1|Visit_1|10|1|FOLLOW-UP|2021-01-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|3|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|||[?]|1|HOURS|MID-CIRCUMFLEX ARTERY|RIGHT|CAUDAL|DIFFUSION TENSOR MRI|||Y|STUDY SUBJECT|NEUROLOGIST 2|2|Visit_2|25|1|TREATMENT|2021-01-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SITTING|[?]|min/day|[?]|1|/HPF|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|BASAL|PERCUSSION|Y|||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2021-01-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|5|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|10^6 organisms/mL|[?]|1|mmol|METACARPOPHALANGEAL JOINT 3|RIGHT|ANTEROPOSTERIOR|CLAUSS METHOD||||CAREGIVER|CARDIOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|6|TVPP|Percent Predicted Tidal Volume|[?]|SEMI-FOWLERS|[?]|DRUM|[?]|1|mV/sec|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|IPSILATERAL|DEEP|SLIT LAMP|Y|Y||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|2|TREATMENT|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|7|FEV1REV|FEV1 Reversibility|[?]|SUPINE|[?]|TAMPON|[?]|1|AgU/mL|ILIUM|RIGHT|OCCIPITAL|OPTICAL MAPPING||Y||FRIEND|ENDOCRINOLOGIST|4|Visit_4|65|2|TREATMENT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|8|TSUELAS|Tissue Elastance|[?]|PRONE|[?]|Bq/L|[?]|1|m3|PROXIMAL PHALANX 5 OF THE HAND|IPSILATERAL|FORE|CYSTOSCOPY||Y||NON-HEALTH CARE PROFESSIONAL|RATER 1|4|Visit_4|65|5|WASHOUT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-22
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|9|FEV1REV|FEV1 Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|NEEDLE GAUGE|[?]|1|h/wk|GLOBUS PALLIDUS|UNILATERAL|VENTRAL|DUKE INCISION METHOD||||FAMILY MEMBER|MICROSCOPIST|5|Visit_5|90|1|TREATMENT|2021-04-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|RE|9171362e-0166-46f2-ab2d-2748d8c291d5|10|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|DECUBITUS|||[?]|1|eq|MAMMARY GLAND|CONTRALATERAL|PROXIMAL VOLAR|RADIOIMMUNOPRECIPITATION ASSAY||Y|Y|ADJUDICATOR|NEUROLOGIST|5|Visit_5|90|2|SCREENING|2021-04-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-08
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|1|MALEVDES|Malignancy Evidence Description|[?]|PRONE|[?]|ELISA unit/dose|[?]|1|kcal/day|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|RIGHT|UPPER EXTENSOR SURFACE|RADIOIMMUNOPRECIPITATION ASSAY||||FAMILY MEMBER|RATER 2|1|Visit_1|10|2|TREATMENT|2020-07-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|2|PNIF|Peak Nasal Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|mg/kg|[?]|1|mmol/s|DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT|BILATERAL|BASAL|MASS SPECTROMETRY|Y|||GUARDIAN|ONCOLOGIST 1|1|Visit_1|10|6|FOLLOW-UP|2020-07-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|3|MIP|Maximal Inspiratory Pressure|[?]|PRONE|[?]|Hounsfield Unit|[?]|1|nmol BCE/L|HAIR|UNILATERAL|OCCIPITAL|GC/MS||Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|2|Visit_2|25|4|TREATMENT|2020-08-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|4|FIVC|Forced Inspiratory Vital Capacity|[?]|TRENDELENBURG|||[?]|1|mg/m2/min|VULVOVAGINAL REGION|IPSILATERAL|CENTRAL|SINGLE-MOLECULE ARRAY|Y||Y|PARENT|FORENSIC PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-08-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|5|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|F|[?]|1|ng/dL|GLENOID FOSSA|LATERAL|OCCIPITAL|MUGA||||CHILD|OPTOMETRIST|3|Visit_3|40|7|TREATMENT|2020-08-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING|[?]|Ci|[?]|1|10^3/hpf|BLADDER WALL|UNILATERAL|LOWER FLEXOR SURFACE|FLOW MICROSCOPY||||DOMESTIC PARTNER|RATER 1|3|Visit_3|40|1|WASHOUT|2020-08-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-02
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|7|EVC|Expiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|mgEq|[?]|1|BAG|HEART, LEFT VENTRICULAR OUTFLOW TRACT|BILATERAL|PARIETO-OCCIPITAL|CLOT DETECTION||||PARENT|OPTOMETRIST|4|Visit_4|65|7|TREATMENT|2020-09-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|8|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING|||[?]|1|10^6/Ejaculate U|LUNG, RIGHT LOWER LOBE|CONTRALATERAL|LOWER MEDIAL|HEMOCYTOMETRY|||Y|VENDOR|RATER 1|4|Visit_4|65|5|SCREENING|2020-09-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-21
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|9|LCI|Lung Clearance Index|[?]|SUPINE|||[?]|1|mU/g|EPITROCHLEAR LYMPH NODE|CONTRALATERAL|ANTERIOR|HPLC/MS/MS|Y|Y|Y|CLINICAL STUDY SPONSOR|INTERNIST|5|Visit_5|90|6|FOLLOW-UP|2020-10-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|9b150e38-dc85-4a28-aad3-43f7620be460|10|EFFVOL|Effusion Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mCi|CALCANEAL TUBEROSITY|CONTRALATERAL|INFERIOR|ULTRASOUND|||Y|STUDY SUBJECT|PHYSIOTHERAPIST|5|Visit_5|90|2|SCREENING|2020-10-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|||[?]|1|nmol/mol|LESSER TROCHANTER|CONTRALATERAL|CENTRAL|POLYSOMNOGRAPHY||Y|Y|CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|2|AIRTRAP|Air Trapping|[?]|STANDING|[?]|/mm|[?]|1|lm|SYMPATHETIC GANGLIA|LEFT|VOLAR|VIRUS PLAQUE ASSAY||||CAREGIVER|FORENSIC PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-10-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-24
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|[?]|100 IU/mL|[?]|1|/min|SCROTUM|CONTRALATERAL|MIDLINE|SURFACE PLASMON RESONANCE|Y|||FAMILY MEMBER|MICROSCOPIST|2|Visit_2|25|6|TREATMENT|2020-11-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|4|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SLING|[?]|cs|[?]|1|MESF|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|UNILATERAL|UPPER FLEXOR SURFACE|HPLC-UV||Y||GUARDIAN|ENDOCRINOLOGIST|2|Visit_2|25|7|TREATMENT|2020-11-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|FOWLERS|[?]|BEAM BREAKS|[?]|1|CCID 50/dose|SUBMANDIBULAR GLAND|LATERAL|LOWER EXTENSOR SURFACE|MRI WITHOUT CONTRAST|Y|||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-11-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|6|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|g/m2|[?]|1|days/month|ORAL MUCOSA|CONTRALATERAL|OCCIPITAL|ICC||Y||SIBLING|CARDIOLOGIST|3|Visit_3|40|3|TREATMENT|2020-11-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|7|FEV3FVC|FEV3/FVC|[?]|REVERSE TRENDELENBURG|[?]|kBq|[?]|1|nCi|THORACIC ARTERY|UNILATERAL|VENTROLATERAL|ELISA||||DOMESTIC PARTNER|RATER|4|Visit_4|65|1|TREATMENT|2020-12-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|8|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|mmol/L|[?]|1|CAPLET|SKIN OF THE HEAD|LATERAL|HIND|LUXOL FAST BLUE AND CRESYL VIOLET STAIN||||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|9|MALEVDES|Malignancy Evidence Description|[?]|SLING|[?]|EIA unit|[?]|1|10^3 DNA copies/mL|THALAMUS|UNILATERAL|ANTEROTEMPORAL|LC/MS/MS||Y||INTERVIEWER|CARDIOLOGIST|5|Visit_5|90|2|SCREENING|2021-01-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|2a595fc0-7621-4ec9-bd77-74444886052e|10|FIV1PP|Percent Predicted FIV1|[?]|STANDING, BENT FORWARD|[?]|L/min|[?]|1|min/day|ESOPHAGUS, MIDDLE THIRD|RIGHT|MIDLINE|MICROBIAL BIOCHEMICAL IDENTIFICATION||||SIBLING|RADIOLOGIST 2|5|Visit_5|90|5|SCREENING|2021-01-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|IU/mmol|[?]|1|/10^5|HEEL OF THE FOOT|RIGHT|PROXIMAL VOLAR|REBOUND TONOMETRY||||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-12-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-RECUMBENT|||[?]|1|BOLUS|FEMORAL CONDYLE|UNILATERAL|PARIETO-OCCIPITAL|PULMONARY ANGIOGRAPHY|||Y|STUDY SUBJECT|NEUROLOGIST 2|1|Visit_1|10|2|WASHOUT|2020-12-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|3|FEF2575|Forced Expiratory Flow 25-75%|[?]|REVERSE TRENDELENBURG|[?]|ELISA unit/mL|[?]|1|pL|RIB 9|IPSILATERAL|LOWER FLEXOR SURFACE|WHOLE TRANSCRIPTOME SEQUENCING||||CHILD|INTERNIST|2|Visit_2|25|5|SCREENING|2021-01-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|[?]|APL U|[?]|1|FIU|FOOT DIGIT 5|IPSILATERAL|TIP|FLUORESCENT IMMUNOASSAY|Y|||PROXY|NEUROLOGIST 2|2|Visit_2|25|7|TREATMENT|2021-01-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|5|ICPP|Percent Predicted Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|MET|[?]|1|U/g/day|CORONARY SINUS|CONTRALATERAL|APICAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||Y||PROXY|READER 2|3|Visit_3|40|1|WASHOUT|2021-01-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|6|ELSTNCE|Elastance|[?]|DECUBITUS|[?]|L/h|[?]|1|/5x10^4 WBC|SPLENIC ARTERY|BILATERAL|CRANIAL|APPLANATION TONOMETRY|Y|||ADJUDICATOR|ENDOCRINOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2021-01-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|mg|[?]|1|kg|HEAD AND NECK|LATERAL|VOLAR|TRICHROME STAIN||||PROXY|RATER 2|4|Visit_4|65|5|FOLLOW-UP|2021-02-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|DECUBITUS|[?]|/wk|[?]|1|m/sec|LUNG, LEFT LOWER LOBE|UNILATERAL|UPPER|THIN SMEAR||||FRIEND|UROLOGIST|4|Visit_4|65|4|FOLLOW-UP|2021-02-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-30
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|9|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SEMI-RECUMBENT|[?]|m|[?]|1|U/mL|INTERPHALANGEAL JOINT 3|IPSILATERAL|UPPER EXTENSOR SURFACE|TURBIDIMETRY|Y|||PROXY|ADJUDICATOR|5|Visit_5|90|7|SCREENING|2021-03-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|0bab89c8-cf57-4d19-9b95-884a2e9da523|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SUPINE|||[?]|1|mmol|TRICUSPID VALVE, SEPTAL CUSP|UNILATERAL|PARIETO-OCCIPITAL|ELECTRONEUROGRAPHY|||Y|CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-03-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-18
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|1|FRCPP|Percent Predicted FRC|[?]|STANDING|[?]|lm|[?]|1|Gy/h|INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|DORSAL|FLUORESCENT SPOT TEST|Y|||GUARDIAN|PATHOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-05-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-16
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|2|EFFVOL|Effusion Volume|[?]|SITTING|[?]|/100 HPFs|[?]|1|U/g/day|INTERNAL ILIAC ARTERY|IPSILATERAL|MIDLINE|PEAK FLOWMETRY||||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|1|WASHOUT|2020-05-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-16
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|3|TVPP|Percent Predicted Tidal Volume|[?]|FOWLERS|[?]|uCi/L|[?]|1|Pa|OCCIPITAL LYMPH NODE|CONTRALATERAL|BASAL|IMMUNOBLOT||Y||GUARDIAN|UROLOGIST|2|Visit_2|25|4|TREATMENT|2020-05-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|4|RER|Respiratory Exchange Ratio|[?]|LATERAL DECUBITUS|||[?]|1|pt_br|EXTRAHEPATIC PERIHILAR BILE DUCT REGION|IPSILATERAL|INNER|CHROMATOGRAPHY|||Y|CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-05-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-11
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|5|MALIND|Malignancy Indicator|[?]|SEMI-RECUMBENT|[?]|Gy/h|[?]|1|MAC50|HAIR|UNILATERAL|ANTEROPOSTERIOR|DOPPLER ULTRASOUND||Y||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|3|Visit_3|40|2|TREATMENT|2020-06-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-10
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|6|ALVVOL|Alveolar Volume|[?]|SEMI-RECUMBENT|[?]|Tesla|[?]|1|10^11/L|METATARSOPHALANGEAL JOINT 2|LATERAL|LOWER MEDIAL|CONFOCAL MICROSCOPY|Y|||ADJUDICATOR|MICROSCOPIST 1|3|Visit_3|40|6|FOLLOW-UP|2020-06-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-10
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|7|EVC|Expiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|||[?]|1|umol/mg/min|MITRAL VALVE, ANTERIOR ANNULUS|LEFT|FORE|AURAMINE STAIN|||Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|4|Visit_4|65|4|WASHOUT|2020-07-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|8|IVCPP|Percent Predicted IVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|U/mL|PULMONARY VALVE, RIGHT CUSP|LATERAL|ANTEROLATERAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS|Y|Y|Y|CHILD|OPTOMETRIST|4|Visit_4|65|6|TREATMENT|2020-07-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-19
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|SEMI-FOWLERS|[?]|10^5/hpf|[?]|1|mg/kg/day|CORNEA|LEFT|NASAL|X-RAY|Y|||NON-HEALTH CARE PROFESSIONAL|RATER 2|5|Visit_5|90|5|WASHOUT|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|84edaa9d-ce48-4866-ab43-af91bee126ae|10|RAW|Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|IU/kg/h|[?]|1|Pack Year|BLADDER, DOME|RIGHT|POSTERIOR|ZIEHL NEELSEN ACID FAST STAIN||||INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2020-07-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|SBE/mL|[?]|1|pt_us|LYMPH NODE|UNILATERAL|LOWER MEDIAL|MICRO BROTH DILUTION|Y|||STUDY SUBJECT|READER 3|1|Visit_1|10|2|TREATMENT|2020-08-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|2|EFFIND|Effusion Indicator|[?]|SLING|[?]|kV|[?]|1|Pa|CALCARINE SULCUS|LATERAL|OCCIPITAL|PULSE OXIMETRY||||FRIEND|ONCOLOGIST 2|1|Visit_1|10|5|SCREENING|2020-08-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|DECUBITUS|||[?]|1|10^10/L|EXTENSOR HALLUCIS BREVIS MUSCLE|LATERAL|PARIETO-OCCIPITAL|SURFACE PLASMON RESONANCE|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|2|Visit_2|25|4|FOLLOW-UP|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|4|RAW|Airway Resistance|[?]|TRENDELENBURG|[?]|mEq/uL|[?]|1|h/wk|LIMB, LOWER|UNILATERAL|SUBCORTICAL|ANTIBIOTIC AGAR SCREEN|Y|||CHILD|PHYSIOTHERAPIST|2|Visit_2|25|3|TREATMENT|2020-08-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-07
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|5|FEV1REV|FEV1 Reversibility|[?]|PRONE|[?]|m/sec2|[?]|1|mg|AORTIC ARCH|LATERAL|OCCIPITAL|IMPULSE OSCILLOMETRY||||CLINICAL STUDY SPONSOR|DERMATOLOGIST|3|Visit_3|40|5|TREATMENT|2020-09-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|SITTING, LEGS DEPENDENT|||[?]|1|ug/L FEU|THYROID GLAND, LEFT LOBE|RIGHT|SURFACE|KINYOUN STAIN|Y|Y|Y|ADJUDICATION COMMITTEE|OTOLARYNGOLOGIST|3|Visit_3|40|4|SCREENING|2020-09-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|7|IC|Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|L/min/m2|[?]|1|L/s|FEMUR|RIGHT|PROXIMAL|MICROSCOPY||||FAMILY MEMBER|RADIOLOGIST 1|4|Visit_4|65|4|TREATMENT|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|8|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SUPINE|||[?]|1|KALLIKREIN INHIBITOR UNIT|DISTAL PHALANX 3 OF THE HAND|LATERAL|CAUDAL|AURAMINE STAIN|||Y|INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|9|VO2|Oxygen Consumption|[?]|SEMI-RECUMBENT|||[?]|1|uU/dL|AXILLA|LATERAL|LATERAL|WRIGHT-GIEMSA STAIN|||Y|SPOUSE|ONCOLOGIST 2|5|Visit_5|90|1|TREATMENT|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|10|EFFIND|Effusion Indicator|[?]|SITTING, LEGS DEPENDENT|[?]|uCi|[?]|1|um2|CORNEAL EPITHELIUM|RIGHT|ROSTRAL|PH METER MEASUREMENT METHOD||||INDEPENDENT ASSESSOR|READER 2|5|Visit_5|90|7|FOLLOW-UP|2020-10-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|1|ELSTNCE|Elastance|[?]|STANDING|||[?]|1|mg/kg/min|ILIUM|UNILATERAL|ANTEROLATERAL|FLOCCULATION, CHARCOAL ENHANCED|||Y|CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|1|Visit_1|10|6|WASHOUT|2020-09-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|2|IVCPP|Percent Predicted IVC|[?]|SLING|||[?]|1|Tesla|SKIN OF THE FOOT|CONTRALATERAL|DISTAL VOLAR|TELLER ACUITY CARDS|||Y|DOMESTIC PARTNER|OTOLARYNGOLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|3|TV|Tidal Volume|[?]|STANDING, BENT FORWARD|||[?]|1|SUPPOSITORY|SKIN OF THE CHEST|RIGHT|DEEP|AGAR DILUTION||Y|Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|2|Visit_2|25|5|TREATMENT|2020-10-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|4|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|mEq/kg|[?]|1|%/s|PRESACRAL SPACE|LEFT|CAUDAL|CONFOCAL MICROSCOPY|Y|Y||STUDY SUBJECT|OPTOMETRIST|2|Visit_2|25|3|TREATMENT|2020-10-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|5|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|IU/mmol|[?]|1|pmol|PROFUNDA FEMORIS VEIN|CONTRALATERAL|CAUDAL|TELLER ACUITY CARDS||Y||CHILD|CLINICAL PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-10-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-FOWLERS|[?]|ug/kg/h|[?]|1|BAR|TRACHEOBRONCHIAL TREE|UNILATERAL|FORE|INTERRUPTER TECHNIQUE|Y|||SPOUSE|CARDIOLOGIST|3|Visit_3|40|1|SCREENING|2020-10-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|7|TVPP|Percent Predicted Tidal Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|mol|SAPHENOUS VEIN|RIGHT|ANTEROPOSTERIOR|DIFFUSION WEIGHTED MRI|||Y|CAREGIVER|RADIOLOGIST 1|4|Visit_4|65|4|FOLLOW-UP|2020-11-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|tsp eq|[?]|1|MHz|MALE GENITALIA|UNILATERAL|LOWER FLEXOR SURFACE|MICROSCOPY||||GUARDIAN|PATHOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-11-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|9|PEFTIME|Peak Expiratory Flow Time|[?]|LEFT LATERAL DECUBITUS|||[?]|1|Gy/min|NERVE|RIGHT|MEDIAL|CALIPER MEASUREMENT METHOD||Y|Y|FAMILY MEMBER|NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-12-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|9734ec2a-d06b-43e1-82a5-37764af17890|10|PLMBLFLW|Pulmonary Blood Flow|[?]|TRENDELENBURG|[?]|10^6 organisms/mg|[?]|1|Sv|ABDOMINAL SKIN|IPSILATERAL|FORE|AGAR DILUTION||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|TREATMENT|2020-12-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|RRS|Total Respiratory System Resistance|[?]|STANDING, BENT FORWARD|[?]|CIGAR|[?]|1|MET|SMALL SAPHENOUS VEIN|RIGHT|POSTERIOR|QUANTITATIVE CORONARY ANGIOGRAPHY||||INVESTIGATOR|RADIOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-11-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|2|RAW|Airway Resistance|[?]|TRENDELENBURG|[?]|fg|[?]|1|ug/L FEU|LUNG, RIGHT MIDDLE LOBE|LATERAL|DORSAL|IMPULSE OSCILLOMETRY||||INTERVIEWER|UROLOGIST|1|Visit_1|10|6|WASHOUT|2020-11-28|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|3|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|||[?]|1|mIU/L|PRONATOR TERES MUSCLE|IPSILATERAL|OUTER|ANGIOGRAPHY|Y||Y|SIBLING|PEDIATRIC NEUROLOGIST|2|Visit_2|25|6|WASHOUT|2020-12-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|4|FIF25|Forced Inspiratory Flow at 25%|[?]|SLING|[?]|BAG|[?]|1|PIXEL|CEREBRAL CORTEX|CONTRALATERAL|UPPER EXTENSOR SURFACE|IMMUNODIFFUSION||||CHILD|PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|5|FVC|Forced Vital Capacity|[?]|TRENDELENBURG|[?]|ug/mol|[?]|1|dram|RIB 9|BILATERAL|LOWER FLEXOR SURFACE|SLOAN LETTER EYE CHART 1.25%||||CHILD|ONCOLOGIST 2|3|Visit_3|40|3|TREATMENT|2020-12-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|6|SAWVOL|Specific Airway Volume|[?]|SLING|||[?]|1|PHERESIS UNIT|INFERIOR VENA CAVA|IPSILATERAL|LOWER FLEXOR SURFACE|MRS|||Y|INDEPENDENT ASSESSOR|INTERNIST|3|Visit_3|40|6|TREATMENT|2020-12-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|7|EFFVOL|Effusion Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|dpm/mg|[?]|1|Bq/g|OVARIAN FOLLICLE|IPSILATERAL|NASAL|SURFACE PLASMON RESONANCE||||CLINICAL RESEARCH ASSOCIATE|READER 2|4|Visit_4|65|4|TREATMENT|2021-01-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|8|RAW|Airway Resistance|[?]|SEMI-FOWLERS|[?]|fmol/L/sec|[?]|1|mL/kg/h|SPLENIC VEIN|CONTRALATERAL|ANTEROTEMPORAL|PHYSICAL EXAMINATION||Y||ADJUDICATOR|UROLOGIST|4|Visit_4|65|7|SCREENING|2021-01-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|9|RRS|Total Respiratory System Resistance|[?]|LATERAL DECUBITUS|||[?]|1|ug/g/h|BRAIN VENTRICLE, LATERAL|UNILATERAL|BASAL|U-HPLC/MS/MS|Y||Y|CHILD|READER 3|5|Visit_5|90|5|SCREENING|2021-02-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|9a0ce525-7f10-4651-885a-f64bd9c8925e|10|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SEMI-FOWLERS|||[?]|1|INHALATION|POPLITEAL ARTERY ABOVE KNEE|UNILATERAL|INFERIOR|CLINICAL EVALUATION|||Y|CLINICAL STUDY SPONSOR|DERMATOLOGIST|5|Visit_5|90|2|WASHOUT|2021-02-16|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|TRENDELENBURG|||[?]|1|pmol/L|TONSIL|RIGHT|SURFACE|WESTERGREN|||Y|SIGNIFICANT OTHER|READER 1|1|Visit_1|10|3|WASHOUT|2020-07-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING|[?]|Watt|[?]|1|cd/m2|TYMPANIC MEMBRANE|UNILATERAL|FORE|ACID FAST STAIN||||PROXY|ONCOLOGIST|1|Visit_1|10|5|TREATMENT|2020-07-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-07
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|3|INTP|Interpretation|[?]|DECUBITUS|[?]|mL/cage|[?]|1|WEEKS|PUTAMEN|LATERAL|UPPER EXTENSOR SURFACE|U-HPLC/MS/MS||||VENDOR|MICROSCOPIST 1|2|Visit_2|25|3|SCREENING|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|4|LCI|Lung Clearance Index|[?]|LATERAL DECUBITUS|[?]|ng/day|[?]|1|log10 CFU/mL|MUSCULOSKELETAL SYSTEM|IPSILATERAL|CENTRAL|MODIFIED ACID FAST STAIN||||SPOUSE|ONCOLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|5|RV|Residual Volume|[?]|SEMI-FOWLERS|[?]|%(w/v)|[?]|1|cg|THIRD OBTUSE MARGINAL BRANCH ARTERY|LEFT|TEMPORAL|FLUORESCENT ENZYME IMMUNOASSAY|Y|||PARENT|RATER 1|3|Visit_3|40|5|FOLLOW-UP|2020-08-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|6|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|nmol/L/min|[?]|1|F|LEFT VENTRICULAR MID ANTERIOR SEGMENT|BILATERAL|DEEP|AURAMINE STAIN|Y|||STUDY SUBJECT|UROLOGIST|3|Visit_3|40|6|TREATMENT|2020-08-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|7|ALVVOL|Alveolar Volume|[?]|DECUBITUS|||[?]|1|mg/cm2|MITRAL VALVE, POSTERIOR ANNULUS|UNILATERAL|NASAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|||Y|SIBLING|RADIOLOGIST 2|4|Visit_4|65|7|TREATMENT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|8|AIRTRAP|Air Trapping|[?]|SEMI-FOWLERS|[?]|ka_u/dL|[?]|1|mg/kg/h|GASTROINTESTINAL TRACT, WALL|RIGHT|MEDIAL|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|||HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|9|FIF50|Forced Inspiratory Flow at 50%|[?]|LEFT LATERAL DECUBITUS|[?]|%|[?]|1|vp/dose|PROXIMAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|APICAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||GUARDIAN|ONCOLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|10|PLMXRS|Pulmonary Reactance|[?]|DECUBITUS|[?]|mV|[?]|1|/40 HPFs|BRACHIAL VEIN|LATERAL|SUBCORTICAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||STUDY SUBJECT|MICROSCOPIST 1|5|Visit_5|90|2|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|1|SVC|Slow Vital Capacity|[?]|SITTING|[?]|ng/dL|[?]|1|pmol/10^10 cells|MIDDLE PHALANX 5 OF THE HAND|RIGHT|PROXIMAL VOLAR|WRIGHT STAIN||||SPOUSE|ADJUDICATOR 1|1|Visit_1|10|7|WASHOUT|2020-09-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|2|FIF75|Forced Inspiratory Flow at 75%|[?]|SEMI-RECUMBENT|[?]|EIA unit|[?]|1|/10^5|FORELIMB|UNILATERAL|TEMPORAL|PHOTOGRAPHY||||PARENT|READER 3|1|Visit_1|10|6|TREATMENT|2020-09-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|3|PEFREV|PEF Reversibility|[?]|FOWLERS|[?]|uEq|[?]|1|ELISA unit|FLEXOR CARPI ULNARIS MUSCLE|IPSILATERAL|ANTEROMEDIAL|COMPUTERIZED CORNEAL TOPOGRAPHY||||SIBLING|MICROSCOPIST 1|2|Visit_2|25|6|SCREENING|2020-09-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|genEq|[?]|1|mL/animal|FIRST DIAGONAL BRANCH ARTERY|IPSILATERAL|HIND|PH METER MEASUREMENT METHOD||||DOMESTIC PARTNER|PATHOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-09-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|5|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|PIXELS/cm|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|BILATERAL|PROXIMAL|NEURAMINIDASE INHIBITION ASSAY||Y|Y|SIBLING|RATER 2|3|Visit_3|40|3|WASHOUT|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|6|FIF25|Forced Inspiratory Flow at 25%|[?]|UNCONSTRAINED|||[?]|1|GBq|FRONTAL SINUS|RIGHT|UPPER EXTENSOR SURFACE|LASER CAPTURE MICRODISSECTION||Y|Y|INDEPENDENT ASSESSOR|RADIOLOGIST|3|Visit_3|40|5|SCREENING|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|7|FEV6PP|Percent Predicted FEV6|[?]|SITTING|[?]|eq|[?]|1|Enzyme U|PARATRACHEAL LYMPH NODE|LATERAL|SUPERIOR|FARNSWORTH-MUNSELL 100 HUE TEST||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|4|Visit_4|65|6|TREATMENT|2020-10-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|8|FVC|Forced Vital Capacity|[?]|TRENDELENBURG|[?]|mL/breath|[?]|1|umol|FOOT DIGIT 3|LATERAL|INNER|OLIGO ACGH||Y||PARENT|UROLOGIST|4|Visit_4|65|6|TREATMENT|2020-10-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|9|AIRTRAP|Air Trapping|[?]|PRONE|||[?]|1|log10 PFU/mL|PERIRECTAL LYMPH NODE|UNILATERAL|VOLAR|ENZYMATIC ULTRACENTRIFUGATION|Y||Y|FRIEND|RATER 1|5|Visit_5|90|1|TREATMENT|2020-11-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|4ba88073-0003-461a-a950-4504ef7680e7|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|||[?]|1|vp/dose|PANCREAS|LATERAL|ANTEROLATERAL|FISH|Y||Y|FAMILY MEMBER|UROLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-11-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-04
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|[?]|nL|[?]|1|CIGAR|PAROTID GLAND LYMPH NODE|LEFT|MEDIAL|REBOUND TONOMETRY|Y|||INDEPENDENT ASSESSOR|PATHOLOGIST 2|1|Visit_1|10|5|TREATMENT|2020-09-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|2|RELSZCHG|Relative Size Change|[?]|REVERSE TRENDELENBURG|[?]|/cmH2O|[?]|1|SYRINGE|CHEST|UNILATERAL|CRANIAL|TRANSTHORACIC ECHOCARDIOGRAPHY||||INDEPENDENT ASSESSOR|MICROSCOPIST|1|Visit_1|10|4|TREATMENT|2020-09-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|3|MIPPP|Percent Predicted MIP|[?]|STANDING|[?]|min/day|[?]|1|kcal|RETROPERITONEAL LYMPH NODE|UNILATERAL|SUBCORTICAL|FLUORESCENT IMMUNOASSAY||||INVESTIGATOR|READER 2|2|Visit_2|25|1|FOLLOW-UP|2020-09-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|4|VO2|Oxygen Consumption|[?]|FOWLERS|[?]|mm/min|[?]|1|mmol/day|BLADDER, TRIGONE|LATERAL|LOWER|VIRUS PLAQUE ASSAY||||PARENT|MICROSCOPIST 3|2|Visit_2|25|4|TREATMENT|2020-09-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-23
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|FOWLERS|[?]|vg/mL|[?]|1|mg/kg/day|UNCINATE PROCESS OF PANCREAS|CONTRALATERAL|LOWER FLEXOR SURFACE|CYSTOSCOPY||||CLINICAL STUDY SPONSOR|CARDIOLOGIST|3|Visit_3|40|2|TREATMENT|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|6|EFFIND|Effusion Indicator|[?]|PRONE|||[?]|1|10^7 TCID 50/dose|PARIETAL LOBE|RIGHT|DISTAL|PHOROPTER|||Y|HEALTH CARE PROFESSIONAL|RATER 2|3|Visit_3|40|3|TREATMENT|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|7|PIF|Peak Inspiratory Flow|[?]|FOWLERS|[?]|Shock Wave|[?]|1|10^5/L|SINUS|IPSILATERAL|PROXIMAL|REBOUND TONOMETRY||||ADJUDICATOR|MICROSCOPIST 3|4|Visit_4|65|3|FOLLOW-UP|2020-10-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|8|FIV1PP|Percent Predicted FIV1|[?]|STANDING|[?]|BLOCKS|[?]|1|umol/L/sec|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|BILATERAL|APICAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||VENDOR|PHYSIOTHERAPIST|4|Visit_4|65|4|FOLLOW-UP|2020-10-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|9|RER|Respiratory Exchange Ratio|[?]|TRENDELENBURG|[?]|ft2|[?]|1|ppb|LEFT VENTRICULAR APEX SEGMENT|BILATERAL|CAUDAL|REVERSE TRANSCRIPTASE PCR|Y|||SIBLING|MICROSCOPIST 1|5|Visit_5|90|1|FOLLOW-UP|2020-11-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|10|EVC|Expiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|MET*min|[?]|1|U/g/min|SKIN AROUND THE EYE|CONTRALATERAL|OUTER|ENDPOINT DILUTION ASSAY||||STUDY SUBJECT|RATER 2|5|Visit_5|90|3|TREATMENT|2020-11-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|1|OXYPULSE|Oxygen Pulse|[?]|SLING|[?]|Ejaculate U|[?]|1|BU/mL|INTERVENTRICULAR SEPTUM|IPSILATERAL|FRONTAL|MALDI-TOF||Y||ADJUDICATOR|OPHTHALMOLOGIST|1|Visit_1|10|4|TREATMENT|2020-10-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|2|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|[?]|EVENTS|[?]|1|days/wk|CLITORIS|RIGHT|MEDIAL|IMMUNO-PET SCAN||||VENDOR|MICROSCOPIST 3|1|Visit_1|10|1|TREATMENT|2020-10-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|pg|[?]|1|BEAM BREAKS|CERVICAL SPINE|IPSILATERAL|TEMPORAL|PERCUSSION||Y||SPOUSE|PATHOLOGIST 2|2|Visit_2|25|1|SCREENING|2020-10-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|4|LCI|Lung Clearance Index|[?]|SITTING|[?]|ug/cm2|[?]|1|cd*s/m2|PANCREAS|LEFT|UPPER|HEMAGGLUTINATION INHIBITION ASSAY||Y||INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|2|WASHOUT|2020-10-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|5|FIV1PP|Percent Predicted FIV1|[?]|LATERAL DECUBITUS|[?]|10^3 organisms/g|[?]|1|10^9 organisms/mg|RADIUS SHAFT|BILATERAL|FACIAL|ELISA||||INDEPENDENT ASSESSOR|HEMATOLOGIST|3|Visit_3|40|5|SCREENING|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|dpm/100mg|[?]|1|nm|ESOPHAGUS, CERVICAL|LEFT|VOLAR|CELLULOSE TAPE|Y|||VENDOR|OPHTHALMOLOGIST|3|Visit_3|40|3|TREATMENT|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|SLING|[?]|deg2|[?]|1|IU/kg/h|DIAPHRAGM|BILATERAL|NASAL|ELISPOT||||CHILD|CARDIOLOGIST|4|Visit_4|65|2|TREATMENT|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|8|AWVOLPP|Percent Predicted Airway Volume|[?]|STANDING|[?]|L/L|[?]|1|atm|CEREBRAL ARTERY|UNILATERAL|MEDIAL|HPLC-UV||Y||SIGNIFICANT OTHER|MICROSCOPIST 2|4|Visit_4|65|7|WASHOUT|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|9|FEV1FVC6|FEV1/FVC6|[?]|LEFT LATERAL DECUBITUS|[?]|% INHIBITION|[?]|1|log10 TCID 50/uL|NOSTRIL|BILATERAL|ANTEROLATERAL|QUANTITATIVE ULTRASOUND||||INTERVIEWER|RADIOLOGIST 1|5|Visit_5|90|4|WASHOUT|2020-12-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|f552fa78-d78f-44c5-9590-30a737e6652d|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|U.CARR|[?]|1|cd*s/m2|SUPERIOR VENA CAVA|RIGHT|SUPERIOR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|Y||FAMILY MEMBER|OTOLARYNGOLOGIST|5|Visit_5|90|1|TREATMENT|2020-12-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|PRONE|[?]|mL/g/min|[?]|1|deg/s|MUSCULOSKELETAL SYSTEM|BILATERAL|LOWER EXTENSOR SURFACE|BRDU CELLULAR PROLIFERATION ASSAY||Y||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|1|Visit_1|10|3|SCREENING|2020-08-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|2|SGAW|Specific Airway Conductance|[?]|RIGHT LATERAL DECUBITUS|[?]|DPM|[?]|1|mm/sec|WRIST JOINT FLEXOR MUSCLES|CONTRALATERAL|FACIAL|HEMAGGLUTINATION INHIBITION ASSAY||||SIGNIFICANT OTHER|ADJUDICATOR 3|1|Visit_1|10|5|FOLLOW-UP|2020-08-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|DAYS|[?]|1|cal|HYOID BONE|RIGHT|APICAL|ICC||||ADJUDICATION COMMITTEE|READER 3|2|Visit_2|25|3|SCREENING|2020-09-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|TRENDELENBURG|[?]|km/h|[?]|1|Arbitrary U|TIBIALIS POSTERIOR MUSCLE|LATERAL|UPPER EXTENSOR SURFACE|ANTIMICROBIAL COMBINATION TESTING|Y|Y||FAMILY MEMBER|NEUROLOGIST 1|2|Visit_2|25|1|SCREENING|2020-09-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-03
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SITTING|[?]|U/m2/min|[?]|1|mol/mL|LUNG, LEFT, SUPERIOR LOBE, SUPERIOR LINGULAR SEGMENT|LEFT|VENTROLATERAL|CT SCAN WITHOUT CONTRAST|Y|||CAREGIVER|RATER 2|3|Visit_3|40|4|TREATMENT|2020-09-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING|||[?]|1|nU/cL|VULVA|IPSILATERAL|DEEP|BIOIMPEDANCE SPECTROSCOPY|Y||Y|HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-09-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|7|AWWVOL|Airway Wall Volume|[?]|UNCONSTRAINED|[?]|mL/kg/h|[?]|1|BP|PRESACRAL LYMPH NODE|CONTRALATERAL|OUTER|CISH||Y||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|1|SCREENING|2020-10-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|8|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|[?]|mg/kg/h|[?]|1|uL/kg/day|BRACHIAL LYMPH NODE|RIGHT|PERIPHERAL|TRANSCRIPTION-MEDIATED AMPLIFICATION|Y|||SIBLING|INTERNIST|4|Visit_4|65|5|TREATMENT|2020-10-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-01
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|9|FEV1REV|FEV1 Reversibility|[?]|STANDING, BENT FORWARD|[?]|mg/m2/day|[?]|1|APPLICATION|LUNG, LEFT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|UNILATERAL|OUTER|IMPEDANCE CONDUCTIVITY||||ADJUDICATOR|MICROSCOPIST 1|5|Visit_5|90|1|WASHOUT|2020-11-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|38d83f86-d8ce-461a-a288-95aebe498d22|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|h/wk|[?]|1|mV*min|SUPRASPINATUS MUSCLE|UNILATERAL|DISTAL|GC/MS-CI||||SIBLING|ONCOLOGIST|5|Visit_5|90|2|TREATMENT|2020-11-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|FEV3PP|Percent Predicted FEV3|[?]|SUPINE|[?]|U/g/min|[?]|1|copies/mL|ESOPHAGUS, UPPER THIRD|LEFT|INTERMEDIATE|NUCLEIC ACID AMPLIFICATION TEST|Y|||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-08-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|2|FEV_PEF|FEV at PEF|[?]|LEFT LATERAL DECUBITUS|[?]|log10 IU/mL|[?]|1|umol/L/sec|OMENTUM|BILATERAL|MIDLINE|MICRONEUTRALIZATION ASSAY||||CHILD|RADIOLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-08-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|3|PNIF|Peak Nasal Inspiratory Flow|[?]|FOWLERS|[?]|CFU/g|[?]|1|g/g/day|PERITONEUM|BILATERAL|ANTEROLATERAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|||SPOUSE|ONCOLOGIST 2|2|Visit_2|25|1|FOLLOW-UP|2020-08-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|4|GAW|Airway Conductance|[?]|FOWLERS|[?]|mg/g/h|[?]|1|mL/g/min|FINGER EXTENSOR TENDONS|RIGHT|ANTERIOR|TRYPAN BLUE STAIN|Y|Y||FAMILY MEMBER|READER 2|2|Visit_2|25|4|FOLLOW-UP|2020-08-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-27
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|5|PCF|Peak Cough Flow|[?]|STANDING, BENT FORWARD|[?]|ng/mol|[?]|1|PFU/mL|GONAD|CONTRALATERAL|PROXIMAL VOLAR|SLIT LAMP PHOTOGRAPHY||||CHILD|ONCOLOGIST 1|3|Visit_3|40|3|FOLLOW-UP|2020-09-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|6|FEV1FVC|FEV1/FVC|[?]|REVERSE TRENDELENBURG|[?]|nkat/L|[?]|1|mm/min|HEART, RIGHT VENTRICULAR FREE WALL|UNILATERAL|SUPERIOR|BAC ACGH||||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|3|Visit_3|40|3|SCREENING|2020-09-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-24
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|7|FEF50|Forced Expiratory Flow 50%|[?]|SITTING|[?]|Tbsp|[?]|1|tsp|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|BILATERAL|ANTERIOR|DYNAMIC LIGHT SCATTERING||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|8|FIVC|Forced Inspiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|MnFI|[?]|1|POINT|RIB 10|IPSILATERAL|UPPER|GC/MS-CI||||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|3|WASHOUT|2020-10-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-24
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|9|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|[?]|kg/cm|[?]|1|nmol|BILIARY TRACT|IPSILATERAL|UPPER EXTENSOR SURFACE|IMMUNE REPERTOIRE DEEP SEQUENCING|Y|Y||CAREGIVER|UROLOGIST|5|Visit_5|90|1|SCREENING|2020-11-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|b31e8820-cc17-4ce5-af30-358dbeb12ba2|10|FEF50|Forced Expiratory Flow 50%|[?]|SUPINE|[?]|uV|[?]|1|mmol/g|INTERPHALANGEAL JOINT 4 OF THE FOOT|IPSILATERAL|SUPERIOR|CAPILLARY ELECTROPHORESIS||Y||PROXY|ADJUDICATOR 1|5|Visit_5|90|5|FOLLOW-UP|2020-11-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|1|IRV|Inspiratory Reserve Volume|[?]|SEMI-RECUMBENT|[?]|DPM|[?]|1|MAC50|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LATERAL|VENTRAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||PARENT|NEUROLOGIST 1|1|Visit_1|10|4|FOLLOW-UP|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|2|RAW|Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kPa|BLADDER|LATERAL|TEMPORAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY|Y|Y|Y|FRIEND|ENDOCRINOLOGIST|1|Visit_1|10|3|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|3|MIP|Maximal Inspiratory Pressure|[?]|REVERSE TRENDELENBURG|[?]|mg/g/h|[?]|1|ukat|ANTERIOR SUPERIOR ILIAC SPINE|RIGHT|UPPER|PHASE CONTRAST MICROSCOPY||Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|2|Visit_2|25|4|TREATMENT|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-06
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|4|EVC|Expiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|Rad|[?]|1|ugEq/L|HEART, RIGHT ATRIAL APPENDAGE|BILATERAL|VOLAR|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT|Y|||VENDOR|ENDOCRINOLOGIST|2|Visit_2|25|6|TREATMENT|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-06
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|5|RER|Respiratory Exchange Ratio|[?]|SEMI-RECUMBENT|[?]|ug/kg|[?]|1|TRACE|CORPUS STRIATUM|LATERAL|LOWER FLEXOR SURFACE|MAMMOGRAPHY|Y|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|3|Visit_3|40|3|TREATMENT|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|6|FEF50|Forced Expiratory Flow 50%|[?]|REVERSE TRENDELENBURG|[?]|mL/cage|[?]|1|10^6/hpf|CORONARY ARTERY, LEFT|CONTRALATERAL|DORSAL|CLOT DETECTION|Y|||FRIEND|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-29
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|7|RRS|Total Respiratory System Resistance|[?]|REVERSE TRENDELENBURG|[?]|ka_u/dL|[?]|1|mEq|SCAPHOID BONE|UNILATERAL|ANTEROMEDIAL|ELASTOGRAPHY|Y|Y||PARENT|CLINICAL PATHOLOGIST|4|Visit_4|65|5|WASHOUT|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|8|MALIND|Malignancy Indicator|[?]|SITTING|[?]|uEq|[?]|1|IU/mmol|TRACHEA|LATERAL|LATERAL|PALM METHOD||||CLINICAL RESEARCH ASSOCIATE|READER 3|4|Visit_4|65|7|SCREENING|2021-03-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|9|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|[?]|PFU|[?]|1|IU|SKIN OF THE FOOT|LEFT|OUTER|FLAME PHOTOMETRY||||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|cf39d5bd-7682-4546-8495-5bcf48600a69|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|[?]|uOsm|[?]|1|pg/dL|HEART|CONTRALATERAL|VENTRAL|IN SITU HYBRIDIZATION|Y|||INVESTIGATOR|ADJUDICATOR 1|5|Visit_5|90|4|SCREENING|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|GAW|Airway Conductance|[?]|STANDING, BENT FORWARD|[?]|mg/kg/week|[?]|1|mEq/day|CORONARY ARTERY, ANTERIOR DESCENDING|IPSILATERAL|VENTROLATERAL|DARK FIELD MICROSCOPY||||INVESTIGATOR|READER 2|1|Visit_1|10|5|WASHOUT|2020-11-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|2|SAWVOL|Specific Airway Volume|[?]|PRONE|[?]|g/L|[?]|1|mL/m2/min|DUCTUS ARTERIOSUS|RIGHT|TIP|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||CHILD|READER 3|1|Visit_1|10|4|WASHOUT|2020-11-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-25
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|3|RV|Residual Volume|[?]|STANDING, BENT FORWARD|[?]|BLOCKS|[?]|1|Bq/kg|FUNDUS OF THE STOMACH|RIGHT|PROXIMAL|PET/CT SCAN WITHOUT CONTRAST|Y|||FRIEND|ADJUDICATOR 2|2|Visit_2|25|4|SCREENING|2020-12-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|4|FEF50|Forced Expiratory Flow 50%|[?]|LATERAL DECUBITUS|[?]|Linear ft*LB|[?]|1|10^3 CFU/g|UPPER URINARY SYSTEM|BILATERAL|LATERAL|TRICHROME STAIN||Y||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|5|WASHOUT|2020-12-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-14
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|cal|[?]|1|ELISA unit|CENTRAL NERVOUS SYSTEM|LEFT|BASAL|POLYSOMNOGRAPHY||Y||PROXY|UROLOGIST|3|Visit_3|40|2|SCREENING|2020-12-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|6|TLCPP|Percent Predicted Total Lung Capacity|[?]|SLING|||[?]|1|dL|LEFT ATRIOVENTRICULAR ARTERY|BILATERAL|UPPER FLEXOR SURFACE|GC/MS-CI|Y||Y|CAREGIVER|RATER|3|Visit_3|40|2|TREATMENT|2020-12-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|7|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|||[?]|1|tsp eq|BODY|LATERAL|PERIPHERAL|BAC ACGH|||Y|ADJUDICATION COMMITTEE|READER|4|Visit_4|65|4|TREATMENT|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|8|IRVPP|Percent Predicted IRV|[?]|SITTING|[?]|ug/day|[?]|1|copies/uL|JAW|IPSILATERAL|DISTAL VOLAR|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||INDEPENDENT ASSESSOR|RATER 2|4|Visit_4|65|5|SCREENING|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-01
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|9|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|10^4 CFU/mL|[?]|1|GPL U/mL|DISTAL FEMUR R1|IPSILATERAL|LOWER EXTENSOR SURFACE|IMMUNOFLUORESCENT STAIN||||PARENT|OTOLARYNGOLOGIST|5|Visit_5|90|6|WASHOUT|2021-02-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|84c17e7b-8d56-4726-96a5-9ca41fb9d894|10|ELSTNCE|Elastance|[?]|SITTING|||[?]|1|TRANSDUCING UNIT|CARPOMETACARPAL JOINT 1|UNILATERAL|SUPERFICIAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||Y|VENDOR|NEUROLOGIST|5|Visit_5|90|3|WASHOUT|2021-02-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SUPINE|[?]|TUBE|[?]|1|L/day|RIB 4|LATERAL|CRANIAL|DUKE INCISION METHOD|Y|||SPOUSE|ONCOLOGIST 1|1|Visit_1|10|2|WASHOUT|2021-01-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|2|PCF|Peak Cough Flow|[?]|TRENDELENBURG|[?]|10^9/L|[?]|1|cGy|RECTOVAGINAL SPACE|UNILATERAL|OUTER|LASER CAPTURE MICRODISSECTION||||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|4|SCREENING|2021-01-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|3|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SLING|[?]|nL|[?]|1|BP|SKIN AROUND THE MOUTH|IPSILATERAL|OUTER|KINETIC CHROMOGENIC ASSAY|Y|Y||FAMILY MEMBER|NEUROLOGIST 1|2|Visit_2|25|2|WASHOUT|2021-02-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING|||[?]|1|10^3/L|GLOBUS PALLIDUS|BILATERAL|INTERMEDIATE|BALLPOINT PEN TECHNIQUE|Y|Y|Y|CAREGIVER|INTERNIST|2|Visit_2|25|3|FOLLOW-UP|2021-02-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-07
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|5|ICREV|IC Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|POUCH|[?]|1|%(w/v)|RENAL ARTERY|LATERAL|UPPER FLEXOR SURFACE|RAJI CELL RIA||||DOMESTIC PARTNER|OPHTHALMOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-19
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|6|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|10^3/hpf|[?]|1|nkat/L|RIGHT CORONARY ARTERY OSTIUM|UNILATERAL|OCCIPITAL|MYELOPEROXIDASE STAIN||||INDEPENDENT ASSESSOR|UROLOGIST|3|Visit_3|40|3|FOLLOW-UP|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-19
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SLING|||[?]|1|BAU/mL|MUCOSA OF THE LIP|BILATERAL|MIDLINE|TARGETED GENOME SEQUENCING||Y|Y|SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING|[?]|mL/min/1.73m2|[?]|1|Log10 ELISA unit|MITRAL VALVE|BILATERAL|LOWER FLEXOR SURFACE|QUANTITATIVE COMPUTED TOMOGRAPHY||||DOMESTIC PARTNER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-09
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|9|SRAW|Specific Airway Resistance|[?]|TRENDELENBURG|[?]|g/cage|[?]|1|lm|CHEEK|LEFT|DISTAL VOLAR|MICROPARTICLE ENZYME IMMUNOASSAY||||CAREGIVER|MICROSCOPIST 1|5|Visit_5|90|2|TREATMENT|2021-04-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|6e557fd7-efaf-4c86-806d-9bd66c7de7da|10|MALEVDES|Malignancy Evidence Description|[?]|DECUBITUS|||[?]|1|mg/g/h|EYELASH|BILATERAL|APICAL|ELLA|||Y|CHILD|RATER 1|5|Visit_5|90|7|FOLLOW-UP|2021-04-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|FOWLERS|[?]|U/g|[?]|1|v/v|SKIN OF THE FACE|CONTRALATERAL|ANTEROTEMPORAL|DIRECT SEQUENCING|Y|||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-10-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|2|TSUELAS|Tissue Elastance|[?]|SUPINE|[?]|/ms|[?]|1|days/month|SUBSTANTIA NIGRA|UNILATERAL|TEMPORAL|ELECTROMYOGRAPHY||Y||PARENT|READER 3|1|Visit_1|10|5|SCREENING|2020-10-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|3|AWVOL|Airway Volume|[?]|LATERAL DECUBITUS|[?]|Pack Year|[?]|1|ug/mL/h|PANCREAS, HEAD|IPSILATERAL|DORSOLATERAL|CLIP||||NON-HEALTH CARE PROFESSIONAL|RATER 1|2|Visit_2|25|6|FOLLOW-UP|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|4|DLCOHC|HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|U/g|[?]|1|MONTHS|HEPATIC ARTERY|RIGHT|DORSAL|TARGETED GENOME SEQUENCING|Y|||INVESTIGATOR|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-11-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|5|MIPPP|Percent Predicted MIP|[?]|SEMI-FOWLERS|||[?]|1|uL/kg/day|TRICUSPID VALVE|UNILATERAL|VOLAR|IMMUNOBLOT|||Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|ug/kg/h|[?]|1|ug/m2/min|VOCAL CORD|RIGHT|SUPERIOR|LASER CAPTURE MICRODISSECTION||Y||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-11-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-16
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|STANDING|[?]|vg/dose|[?]|1|10^4/hpf|COLON, ASCENDING|LEFT|HIND|LASER CAPTURE MICRODISSECTION||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|4|Visit_4|65|5|WASHOUT|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|8|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|mV|[?]|1|10^3 CFU/mL|PORTA HEPATIS LYMPH NODE|UNILATERAL|TEMPORAL|IMMUNOASSAY||||PROXY|NEUROLOGIST|4|Visit_4|65|2|TREATMENT|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|9|FEF50|Forced Expiratory Flow 50%|[?]|STANDING|||[?]|1|GPL U/mL|RENAL ARTERY|BILATERAL|APICAL|INDIRECT IMMUNOFLUORESCENCE|||Y|PARENT|RATER 2|5|Visit_5|90|7|WASHOUT|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|2b25e1f9-929c-4bdc-8758-79f33b832026|10|FEV3PP|Percent Predicted FEV3|[?]|SEMI-RECUMBENT|[?]|Ejaculate U|[?]|1|Gauss|FAT PAD|LATERAL|CENTRAL|CISH|Y|||GUARDIAN|PATHOLOGIST|5|Visit_5|90|7|WASHOUT|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|mU|[?]|1|ugEq/L|ASCENDING AORTA|IPSILATERAL|UPPER EXTENSOR SURFACE|MICROBIAL CULTURE, LIQUID||Y||INVESTIGATOR|READER 3|1|Visit_1|10|4|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|2|ERV|Expiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|% INHIBITION|[?]|1|PFU/dose|METACARPAL BONE 1|LATERAL|DORSOLATERAL|HEMAGGLUTINATION INHIBITION ASSAY|Y|||ADJUDICATOR|READER 1|1|Visit_1|10|1|TREATMENT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-03
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|3|MEPPP|Percent Predicted MEP|[?]|SUPINE|[?]|ag|[?]|1|ng/mol|HEART, LEFT ATRIAL APPENDAGE|RIGHT|LOWER EXTENSOR SURFACE|MICROPARTICLE ENZYME IMMUNOASSAY||||FRIEND|CLINICAL PATHOLOGIST|2|Visit_2|25|7|WASHOUT|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|4|RV|Residual Volume|[?]|STANDING|[?]|10^7 CFU/mL|[?]|1|vg/dose|SKULL, BASE|RIGHT|UPPER EXTENSOR SURFACE|GEL ELECTROPHORESIS||||CHILD|INTERNIST|2|Visit_2|25|6|TREATMENT|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-18
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|REVERSE TRENDELENBURG|||[?]|1|TABLET|OCCIPITAL SCALP|BILATERAL|POSTERIOR|APPLANATION TONOMETRY||Y|Y|CLINICAL RESEARCH ASSOCIATE|READER|3|Visit_3|40|6|TREATMENT|2021-02-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|6|FEV1FVC6|FEV1/FVC6|[?]|STANDING, BENT FORWARD|[?]|uCi/L|[?]|1|BOX|LIP, LOWER|IPSILATERAL|CRANIAL|OLIGO ACGH||Y||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|3|Visit_3|40|4|TREATMENT|2021-02-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-27
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SEMI-FOWLERS|||[?]|1|deg2|PERIANAL REGION|RIGHT|VENTRAL|IHC|||Y|INDEPENDENT ASSESSOR|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|8|MEPPP|Percent Predicted MEP|[?]|SEMI-RECUMBENT|[?]|IU/mmol|[?]|1|kcal/day|GALLBLADDER|LATERAL|TIP|QUANTITATIVE COMPUTED TOMOGRAPHY||||ADJUDICATION COMMITTEE|CLINICAL PATHOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2021-03-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-02
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|9|RVPP|Percent Predicted Residual Volume|[?]|SLING|[?]|mAmp|[?]|1|in2|EPIGASTRIC LYMPH NODE|CONTRALATERAL|VOLAR|FARNSWORTH-MUNSELL 100 HUE TEST||Y||PROXY|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-23
e|RE|d02c7553-17f5-44ec-8c24-469234d080e8|10|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|[?]|10^6 U|[?]|1|Ejaculate U|HAIR|LEFT|LOWER EXTENSOR SURFACE|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y||PARENT|ENDOCRINOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-23
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|Gy/min|[?]|1|Tesla|STERNEBRA|RIGHT|LOWER|CELL BASED BIOASSAY||||GUARDIAN|RATER 2|1|Visit_1|10|7|SCREENING|2020-09-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|2|RAW|Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|kN/cm2|[?]|1|/100 WBC|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|UNILATERAL|LOWER|FLOCCULATION||||ADJUDICATION COMMITTEE|ADJUDICATOR|1|Visit_1|10|6|TREATMENT|2020-09-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-18
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|3|AWVOLPP|Percent Predicted Airway Volume|[?]|SLING|[?]|/cmH2O|[?]|1|pg/dL|PENIS, BODY|CONTRALATERAL|TIP|MICROSCOPY||||INTERVIEWER|INTERNIST|2|Visit_2|25|1|FOLLOW-UP|2020-09-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|4|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SUPINE|[?]|anti-Xa IU/mL|[?]|1|g/animal/wk|AORTIC VALVE, RIGHT CORONARY CUSP|UNILATERAL|MEDIAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|||FRIEND|READER|2|Visit_2|25|3|WASHOUT|2020-09-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|5|RV|Residual Volume|[?]|PRONE|[?]|/LPF|[?]|1|Log10 ELISA unit|T7 VERTEBRA|LEFT|UPPER FLEXOR SURFACE|GC/MS-CI||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|3|Visit_3|40|4|FOLLOW-UP|2020-10-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|6|AWWVOL|Airway Wall Volume|[?]|UNCONSTRAINED|[?]|g/animal|[?]|1|mAmp|SUPERIOR SAGITTAL SINUS|RIGHT|NASAL|THICK SMEAR|Y|||SIBLING|CARDIOLOGIST|3|Visit_3|40|6|WASHOUT|2020-10-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|7|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|[?]|Enzyme U|[?]|1|ug/g/h|ANTERIOR CINGULATE CORTEX|RIGHT|OUTER|NUCLEIC ACID SEQUENCING||||DOMESTIC PARTNER|RADIOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-11-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|8|PCF|Peak Cough Flow|[?]|STANDING|[?]|g/g|[?]|1|ug/kg/h|SPLEEN|RIGHT|SUBCORTICAL|MRS||||PARENT|READER 3|4|Visit_4|65|5|TREATMENT|2020-11-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|9|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING|[?]|/h|[?]|1|h/wk|INTERPHALANGEAL JOINT 4 OF THE HAND|LATERAL|FRONTAL|RADIAL IMMUNODIFFUSION||||CAREGIVER|NEUROLOGIST 2|5|Visit_5|90|2|WASHOUT|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|e819939e-548d-4e05-83e3-7976790de7e1|10|FRCPP|Percent Predicted FRC|[?]|LEFT LATERAL DECUBITUS|[?]|mL/(min*100mL)|[?]|1|fmol/g|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|LOWER EXTENSOR SURFACE|RADIOGRAPHY|Y|||INVESTIGATOR|ADJUDICATOR 3|5|Visit_5|90|3|SCREENING|2020-11-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|MEPPP|Percent Predicted MEP|[?]|STANDING, BENT FORWARD|||[?]|1|ag|SUPRATENTORIAL BRAIN|LATERAL|INFERIOR|STRESS ECHOCARDIOGRAPHY|||Y|SIGNIFICANT OTHER|ADJUDICATOR|1|Visit_1|10|3|TREATMENT|2020-08-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|2|MALIND|Malignancy Indicator|[?]|SUPINE|||[?]|1|Gy/min|LUNG, LEFT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LEFT|SUPERIOR|DOUBLE IMMUNODIFFUSION|||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-08-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|3|TSUELAS|Tissue Elastance|[?]|SLING|[?]|U/mmol|[?]|1|copies/mL|INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|PERIPHERAL|ENDPOINT DILUTION ASSAY||Y||GUARDIAN|NEUROLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-09-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|4|FIVC|Forced Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|atm|[?]|1|U/g Hb|LUNG LOBE|BILATERAL|MEDIAL|LASER CAPTURE MICRODISSECTION||||SPOUSE|ONCOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-09-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|5|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|CIGAR|[?]|1|MET*h|LUNG, LEFT, SUPERIOR LOBE, ANTERIOR SEGMENT|BILATERAL|ANTEROPOSTERIOR|ULTRASONOGRAPHIC ELASTOGRAPHY||||FAMILY MEMBER|NEUROLOGIST 2|3|Visit_3|40|7|SCREENING|2020-09-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|6|FIFMAXPP|Percent Predicted FIFmax|[?]|RIGHT LATERAL DECUBITUS|[?]|FIU|[?]|1|MPL U/mL|OBTURATOR MUSCLE|LATERAL|TIP|MAMMOGRAPHY|Y|||INVESTIGATOR|HEMATOLOGIST|3|Visit_3|40|3|TREATMENT|2020-09-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|7|MEP|Maximal Expiratory Pressure|[?]|SEMI-FOWLERS|[?]|Enzyme U/L|[?]|1|mL/s/m2|RETROCRURAL LYMPH NODE|BILATERAL|NASAL|PH METER MEASUREMENT METHOD||||ADJUDICATION COMMITTEE|PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-10-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|LATERAL DECUBITUS|[?]|mL/cage/wk|[?]|1|QUANTITY SUFFICIENT|TRIGEMINAL NERVE|IPSILATERAL|DORSAL|AUDIOMETRY||||SIBLING|HEMATOLOGIST|4|Visit_4|65|3|TREATMENT|2020-10-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|9|RELSZCHG|Relative Size Change|[?]|DECUBITUS|[?]|BOWL|[?]|1|kg/L|COLON, DESCENDING|LEFT|FORE|TRANSTHORACIC ECHOCARDIOGRAPHY||||INVESTIGATOR|PATHOLOGIST 1|5|Visit_5|90|7|WASHOUT|2020-11-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|10|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-RECUMBENT|||[?]|1|ft2|ANKLE JOINT|LATERAL|FACIAL|FLUORESCENT IMMUNOASSAY||Y|Y|FRIEND|OPHTHALMOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-11-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|1|PIF|Peak Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|vg/kg|[?]|1|psec|RIB 9|LATERAL|INFERIOR|LASER CAPTURE MICRODISSECTION||Y||GUARDIAN|OPTOMETRIST|1|Visit_1|10|5|TREATMENT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|2|LCI|Lung Clearance Index|[?]|SLING|[?]|CAPFUL|[?]|1|ft3|SECOND LEFT POSTEROLATERAL BRANCH ARTERY|CONTRALATERAL|ROSTRAL|AUSCULTATION||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-05
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|3|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|FOWLERS|||[?]|1|STRIP|UMBILICAL CORD|LEFT|OCCIPITAL|BAC ACGH|||Y|FRIEND|ADJUDICATOR 3|2|Visit_2|25|2|SCREENING|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|4|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SEMI-RECUMBENT|[?]|mg/kg/day|[?]|1|Bq/mg|CORPUS CALLOSUM, BODY|LATERAL|POSTERIOR|SMEAR||Y||ADJUDICATION COMMITTEE|HEMATOLOGIST|2|Visit_2|25|4|SCREENING|2020-06-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|5|DLCO|Diffusion Capacity of Lung for CO|[?]|DECUBITUS|[?]|U/g/min|[?]|1|Gauss|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|IPSILATERAL|ANTEROTEMPORAL|MANUAL COUNT||||SPOUSE|RADIOLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|6|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-FOWLERS|[?]|nmol/g|[?]|1|CCID 50/mL|PROSTATE GLAND, MIDDLE LOBE|CONTRALATERAL|CENTRAL|SCANNING ELECTRON MICROSCOPY||||INDEPENDENT ASSESSOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|7|FEV1FVC|FEV1/FVC|[?]|STANDING, BENT FORWARD|||[?]|1|Absorbance U|MEDIAN OR LOWER CERVICAL LYMPH NODE|IPSILATERAL|PROXIMAL VOLAR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|4|Visit_4|65|5|TREATMENT|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|8|LOBVOL|Lobar Volume|[?]|SEMI-FOWLERS|[?]|mol/mg|[?]|1|mm/sec|PANCREAS|LATERAL|SUPERFICIAL|PAP STAIN|Y|||ADJUDICATION COMMITTEE|RADIOLOGIST 1|4|Visit_4|65|6|TREATMENT|2020-08-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|PRONE|[?]|log10 PFU/mL|[?]|1|mL/100g/min|ENTORHINAL CORTEX|RIGHT|OUTER|POLYSOMNOGRAPHY||||STUDY SUBJECT|RADIOLOGIST 1|5|Visit_5|90|4|SCREENING|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|ea5229ad-6469-4147-be40-546d27c04c4c|10|RV|Residual Volume|[?]|TRENDELENBURG|[?]|CCID 50/mL|[?]|1|CYLINDER|INSULAR CORTEX|RIGHT|ANTEROMEDIAL|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||ADJUDICATION COMMITTEE|RADIOLOGIST|5|Visit_5|90|6|TREATMENT|2020-08-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-18
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|1|FEV3FVC|FEV3/FVC|[?]|SEMI-FOWLERS|[?]|gtt|[?]|1|log10 CCID 50/dose|PELVIS|LATERAL|INFERIOR|MICRO BROTH DILUTION|Y|Y||ADJUDICATION COMMITTEE|READER 3|1|Visit_1|10|1|SCREENING|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|2|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|FOWLERS|[?]|pmol/L/h|[?]|1|cd/m2|PORTAL VEIN BIFURCATION|CONTRALATERAL|NASAL|HIGH RESOLUTION CT||||INVESTIGATOR|HEMATOLOGIST|1|Visit_1|10|2|WASHOUT|2021-01-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|3|FEF2575|Forced Expiratory Flow 25-75%|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|Pack Year|DIAPHRAGM|LATERAL|FACIAL|PULMONARY ANGIOGRAPHY|Y||Y|CAREGIVER|ADJUDICATOR 2|2|Visit_2|25|5|TREATMENT|2021-01-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|4|RRS|Total Respiratory System Resistance|[?]|SLING|[?]|10^9 CFU|[?]|1|Antibody Unit|LIVER|IPSILATERAL|PROXIMAL|FLOCCULATION||||SIBLING|ADJUDICATOR|2|Visit_2|25|1|WASHOUT|2021-01-23|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|5|FIF75|Forced Inspiratory Flow at 75%|[?]|PRONE|[?]|g/animal/wk|[?]|1|/200 HPFs|INTERPHALANGEAL JOINT 4 OF THE FOOT|IPSILATERAL|DORSOLATERAL|CLIP SEQUENCING||||SIBLING|ENDOCRINOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2021-02-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|6|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|[?]|10^6 CFU/g|[?]|1|U/mmol|RADIUS-LUNATE JOINT|IPSILATERAL|PARIETO-OCCIPITAL|RAJI CELL RIA||||FRIEND|OPHTHALMOLOGIST|3|Visit_3|40|1|SCREENING|2021-02-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|7|AWVOL|Airway Volume|[?]|UNCONSTRAINED|[?]|DNA copies/ug|[?]|1|mL/cage/day|PALM|BILATERAL|OCCIPITAL|IMMUNO-PET SCAN|Y|Y||INTERVIEWER|RADIOLOGIST 2|4|Visit_4|65|3|TREATMENT|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|8|LOBVOL|Lobar Volume|[?]|STANDING|[?]|mol/mL|[?]|1|ug/L/h|TRACHEOBRONCHIAL TREE|UNILATERAL|CRANIAL|INDIA INK STAIN|Y|||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|4|Visit_4|65|1|TREATMENT|2021-03-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-01
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|9|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|||[?]|1|mg/m2/day|CORONARY ARTERY, ANTERIOR DESCENDING|IPSILATERAL|SUPERFICIAL|FLUORESCEIN STAIN|||Y|CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|0a566742-0f71-4603-85f0-875e2c3395e7|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|UNCONSTRAINED|||[?]|1|Sv|METACARPAL 1 BASE|UNILATERAL|BASAL|CLAUSS METHOD|||Y|ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|4|FOLLOW-UP|2021-03-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|ERV|Expiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|Enzyme U|[?]|1|ug/animal|FIRST DIAGONAL BRANCH ARTERY|LATERAL|PERIVENTRICULAR|MICROBIAL CULTURE, SOLID||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-05-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|2|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|[?]|Enzyme U/g Hb|[?]|1|mg|CELIAC LYMPH NODE|LATERAL|DISTAL|TEMPLATE INCISION METHOD||||PROXY|FORENSIC PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-05-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING|[?]|kg/mol|[?]|1|/5x10^4 WBC|CEREBELLUM|LEFT|VENTRAL|HEMOCYTOMETRY||||HEALTH CARE PROFESSIONAL|RADIOLOGIST|2|Visit_2|25|4|WASHOUT|2020-05-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-09
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|4|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|anti-Xa IU|STERNAL MANUBRIUM|RIGHT|CAUDAL|MULTIPLE BREATH WASHOUT|||Y|HEALTH CARE PROFESSIONAL|READER 2|2|Visit_2|25|1|TREATMENT|2020-05-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-09
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|5|FEF2575P|Percent Predicted FEF25-75|[?]|SLING|||[?]|1|mmAL|FINGERNAIL|RIGHT|OCCIPITAL|CLIP|||Y|STUDY SUBJECT|OTOLARYNGOLOGIST|3|Visit_3|40|7|TREATMENT|2020-06-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|6|LCI|Lung Clearance Index|[?]|LATERAL DECUBITUS|[?]|mm2|[?]|1|U/cL|THALAMUS|CONTRALATERAL|LOWER EXTENSOR SURFACE|BIOPSY||||PROXY|NEUROLOGIST|3|Visit_3|40|7|SCREENING|2020-06-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-20
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|7|DLCOHCVA|HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|DNA copies/mL|[?]|1|FEU|UMBILICAL CORD|IPSILATERAL|ANTEROPOSTERIOR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|Y|||ADJUDICATOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|1|WASHOUT|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-11
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|mol/L|[?]|1|U/m2|UPPER RESPIRATORY SYSTEM|BILATERAL|ANTEROPOSTERIOR|COLORIMETRY||||INTERVIEWER|ENDOCRINOLOGIST|4|Visit_4|65|1|TREATMENT|2020-07-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-11
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SEMI-FOWLERS|[?]|uCi/kg|[?]|1|DISK|THORACIC CAVITY|LATERAL|TIP|PULMONARY ANGIOGRAPHY||||PROXY|ONCOLOGIST|5|Visit_5|90|7|TREATMENT|2020-08-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-19
e|RE|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING|[?]|DROP|[?]|1|POUCH|THIRD OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|PERIVENTRICULAR|CELLULOSE TAPE|Y|||VENDOR|DERMATOLOGIST|5|Visit_5|90|7|WASHOUT|2020-08-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-19
e|RE|48103500-0f3d-4108-9167-6afee1098773|1|PEFREV|PEF Reversibility|[?]|FOWLERS|[?]|umol/L/min|[?]|1|U/mL|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|UNILATERAL|ANTEROTEMPORAL|HIGH RESOLUTION MELT ANALYSIS||||PARENT|NEUROLOGIST 1|1|Visit_1|10|7|FOLLOW-UP|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|48103500-0f3d-4108-9167-6afee1098773|2|SVC|Slow Vital Capacity|[?]|LATERAL DECUBITUS|[?]|log10 CCID 50/dose|[?]|1|mL/min|SEMITENDINOSUS MUSCLE|IPSILATERAL|UPPER|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|4|TREATMENT|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|48103500-0f3d-4108-9167-6afee1098773|3|RER|Respiratory Exchange Ratio|[?]|DECUBITUS|[?]|kcal|[?]|1|uV|INCISOR|CONTRALATERAL|PERIPHERAL|LIQUID SCINTILLATION COUNTING||||INVESTIGATOR|OTOLARYNGOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-05-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|48103500-0f3d-4108-9167-6afee1098773|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|g/kg/day|[?]|1|g/m2/day|AORTIC ARCH|IPSILATERAL|DISTAL|LISSAMINE GREEN STAIN||||SPOUSE|PHYSIOTHERAPIST|2|Visit_2|25|1|TREATMENT|2020-05-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|48103500-0f3d-4108-9167-6afee1098773|5|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|DECUBITUS|[?]|damol/L|[?]|1|V|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|APICAL|POLYSOMNOGRAPHY||||STUDY SUBJECT|RADIOLOGIST 1|3|Visit_3|40|4|TREATMENT|2020-06-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-19
e|RE|48103500-0f3d-4108-9167-6afee1098773|6|ERVPP|Percent Predicted ERV|[?]|SEMI-FOWLERS|[?]|uL|[?]|1|SPRAY|PROSTATE GLAND, POSTERIOR LOBE|BILATERAL|VENTRAL|FLUORIMETRY||||SPOUSE|MICROSCOPIST 3|3|Visit_3|40|5|TREATMENT|2020-06-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-19
e|RE|48103500-0f3d-4108-9167-6afee1098773|7|FIO2|Fraction of Inspired Oxygen|[?]|FOWLERS|[?]|kPa|[?]|1|/min|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|POSTERIOR|OLIGO ACGH|Y|||CLINICAL STUDY SPONSOR|READER 3|4|Visit_4|65|6|TREATMENT|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|48103500-0f3d-4108-9167-6afee1098773|8|OXYPULSE|Oxygen Pulse|[?]|SITTING, LEGS DEPENDENT|[?]|uL/dose|[?]|1|ug/m2/day|MAXILLARY SINUS|BILATERAL|POSTERIOR|PUPILLOMETRY|Y|||STUDY SUBJECT|MICROSCOPIST 3|4|Visit_4|65|6|WASHOUT|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|48103500-0f3d-4108-9167-6afee1098773|9|TVPP|Percent Predicted Tidal Volume|[?]|STANDING|[?]|P|[?]|1|umol/min|LOWER GASTROINTESTINAL TRACT LYMPH NODE|UNILATERAL|PERIPHERAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||SIGNIFICANT OTHER|ADJUDICATOR 2|5|Visit_5|90|3|WASHOUT|2020-08-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|48103500-0f3d-4108-9167-6afee1098773|10|RVPP|Percent Predicted Residual Volume|[?]|UNCONSTRAINED|||[?]|1|fmol/L/sec|CEREBRAL CORTEX|BILATERAL|SUBCORTICAL|MRI WITHOUT CONTRAST|||Y|PARENT|ONCOLOGIST|5|Visit_5|90|4|TREATMENT|2020-08-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-16
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|FEV1SVC|FEV1/SVC|[?]|SEMI-RECUMBENT|[?]|genEq/mL|[?]|1|TAMPON|COLON, ASCENDING|IPSILATERAL|LOWER EXTENSOR SURFACE|IHC||Y||FAMILY MEMBER|CLINICAL PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-07-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|2|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|vp/mL|SOFT TISSUE|LATERAL|DORSOLATERAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|||Y|SIBLING|RADIOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-07-25|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|3|MALIND|Malignancy Indicator|[?]|FOWLERS|[?]|10^12/L|[?]|1|Gy/min|RECTOSIGMOID JUNCTION|CONTRALATERAL|NASAL|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||SIGNIFICANT OTHER|PATHOLOGIST 1|2|Visit_2|25|2|SCREENING|2020-08-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|4|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|||[?]|1|g/animal|FEMORAL NECK|IPSILATERAL|VOLAR|LEAD CITRATE STAIN|||Y|HEALTH CARE PROFESSIONAL|READER 3|2|Visit_2|25|7|TREATMENT|2020-08-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-06
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|5|FEV1SVC|FEV1/SVC|[?]|SLING|[?]|ukat/10^12 RBC|[?]|1|mV*min|DISTAL PHALANX 3 OF THE HAND|RIGHT|SURFACE|EPSILOMETER||||INDEPENDENT ASSESSOR|READER|3|Visit_3|40|6|FOLLOW-UP|2020-08-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|6|FIV1PP|Percent Predicted FIV1|[?]|STANDING|||[?]|1|cd|FINGER EXTENSOR TENDONS|LEFT|CRANIAL|RULER MEASUREMENT METHOD||Y|Y|CHILD|NEUROLOGIST 2|3|Visit_3|40|3|TREATMENT|2020-08-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SLING|||[?]|1|ug/mol|DISTAL INTERPHALANGEAL JOINT 5|CONTRALATERAL|TIP|FREEZING POINT DEPRESSION|||Y|DOMESTIC PARTNER|ADJUDICATOR 1|4|Visit_4|65|3|WASHOUT|2020-09-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LATERAL DECUBITUS|[?]|cm/s|[?]|1|MdFI|BILIARY TRACT|UNILATERAL|DISTAL|EIA||||CAREGIVER|RATER 1|4|Visit_4|65|3|FOLLOW-UP|2020-09-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|9|PEFREV|PEF Reversibility|[?]|SITTING|[?]|ug/m2|[?]|1|10^8/L|HIP|IPSILATERAL|INTERMEDIATE|RADIOGRAPHY||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-10-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|9855fc59-f162-48ba-8c51-e8c6c54b72f3|10|FIF75|Forced Inspiratory Flow at 75%|[?]|REVERSE TRENDELENBURG|[?]|nmol/L/min|[?]|1|breaths/min|ANKLE MORTISE|LEFT|SURFACE|HEMAGGLUTINATION ASSAY||||CAREGIVER|MICROSCOPIST 2|5|Visit_5|90|6|WASHOUT|2020-10-13|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|1|FEV1SVC|FEV1/SVC|[?]|STANDING|[?]|mg/m2/h|[?]|1|10^3 CFU|ASCENDING AORTA|IPSILATERAL|CENTRAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||Y||CLINICAL STUDY SPONSOR|READER|1|Visit_1|10|1|WASHOUT|2020-06-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|2|IRV|Inspiratory Reserve Volume|[?]|SUPINE|[?]|mmol/L|[?]|1|mL/kg/h|FINGER FLEXOR TENDONS|BILATERAL|VENTRAL|DISK DIFFUSION|Y|||STUDY SUBJECT|ADJUDICATOR 3|1|Visit_1|10|7|TREATMENT|2020-06-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|3|MIPPP|Percent Predicted MIP|[?]|SEMI-FOWLERS|[?]|ug/dL|[?]|1|Henry|RIB 8|LATERAL|INTERMEDIATE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||PROXY|OPTOMETRIST|2|Visit_2|25|1|TREATMENT|2020-07-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|4|MEP|Maximal Expiratory Pressure|[?]|PRONE|[?]|nmol/day|[?]|1|10^9 organisms/g|FACIAL BONE|LEFT|DISTAL VOLAR|ACRIDINE ORANGE STAIN||||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|2|TREATMENT|2020-07-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|5|FIVC|Forced Inspiratory Vital Capacity|[?]|TRENDELENBURG|[?]|GBq/ug|[?]|1|BOLUS|METACARPAL BONE|BILATERAL|SURFACE|CRYOSCOPY||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|3|Visit_3|40|3|TREATMENT|2020-07-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|6|FIF25|Forced Inspiratory Flow at 25%|[?]|TRENDELENBURG|[?]|/min|[?]|1|nsec|SOLE|CONTRALATERAL|CAUDAL|TRIPLE-PHASE MRI SCAN||||CAREGIVER|CLINICAL PATHOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-07-21|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-31
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|7|IRV|Inspiratory Reserve Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|mV*min|BRAIN, THIRD VENTRICLE|LEFT|UPPER FLEXOR SURFACE|NEURAMINIDASE INHIBITION ASSAY||Y|Y|STUDY SUBJECT|PATHOLOGIST 1|4|Visit_4|65|1|SCREENING|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|8|EFFVOL|Effusion Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|uCi|[?]|1|PELLET|AMYGDALA|IPSILATERAL|VENTROLATERAL|PHOTOMETRY||||STUDY SUBJECT|ADJUDICATOR|4|Visit_4|65|7|WASHOUT|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-14
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|9|DLCOVA|DLCO/VA|[?]|LATERAL DECUBITUS|[?]|JAR|[?]|1|CONTAINER|LARGE INTESTINE|IPSILATERAL|VENTROLATERAL|GC/MS||||ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2020-09-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|ceab42b0-3a7e-4aad-b599-5da311398148|10|FEV3FVC|FEV3/FVC|[?]|STANDING|[?]|pmol/g|[?]|1|C|METATARSOPHALANGEAL JOINT 1|UNILATERAL|PROXIMAL VOLAR|TRANSVAGINAL ULTRASOUND||||GUARDIAN|ONCOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-09-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|L/s|SKIN OF THE FOREARM|LATERAL|UPPER EXTENSOR SURFACE|POLYSOMNOGRAPHY|||Y|FRIEND|ENDOCRINOLOGIST|1|Visit_1|10|2|TREATMENT|2020-07-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|TRENDELENBURG|[?]|U/m2/min|[?]|1|kat|ULNA SHAFT|CONTRALATERAL|PROXIMAL|FREEZING POINT DEPRESSION|Y|||DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|SCREENING|2020-07-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|3|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|[?]|PLUG|[?]|1|amu|ADDUCTOR BREVIS MUSCLE|UNILATERAL|LOWER FLEXOR SURFACE|MICROBIAL CULTURE, LIQUID||Y||SIGNIFICANT OTHER|MICROSCOPIST|2|Visit_2|25|3|SCREENING|2020-07-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|4|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|kDa|[?]|1|tuberculin unit|VAGUS NERVE|UNILATERAL|DISTAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|Y|||STUDY SUBJECT|RADIOLOGIST|2|Visit_2|25|6|TREATMENT|2020-07-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|5|ICPP|Percent Predicted Inspiratory Capacity|[?]|SLING|||[?]|1|10^6 U|NAIL BED|UNILATERAL|TEMPORAL|TEMPLATE INCISION METHOD|||Y|DOMESTIC PARTNER|CARDIOLOGIST|3|Visit_3|40|3|WASHOUT|2020-08-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|6|FEV6PP|Percent Predicted FEV6|[?]|FOWLERS|[?]|ms2|[?]|1|nmol BCE/L|SCAPHOID-TRAPEZIUM JOINT|CONTRALATERAL|LOWER|HIGH RESOLUTION MELT ANALYSIS||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2020-08-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|7|IVCPP|Percent Predicted IVC|[?]|REVERSE TRENDELENBURG|||[?]|1|10^6 organisms/g|KIDNEY, LOWER LOBE|LATERAL|PARIETO-OCCIPITAL|BIOIMPEDANCE SPECTROSCOPY|||Y|STUDY SUBJECT|PATHOLOGIST 2|4|Visit_4|65|2|WASHOUT|2020-09-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|APS U|DUCTUS ARTERIOSUS|UNILATERAL|OUTER|MICRO BROTH DILUTION|||Y|GUARDIAN|RATER 1|4|Visit_4|65|4|TREATMENT|2020-09-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|VIAL|[?]|1|LB|SUPRAPUBIC REGION|CONTRALATERAL|CRANIAL|REVERSE TRANSCRIPTASE PCR||||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|1|SCREENING|2020-09-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|10|RRS|Total Respiratory System Resistance|[?]|SEMI-FOWLERS|[?]|g|[?]|1|BLOCKS|CARDIOVASCULAR SYSTEM|LEFT|APICAL|AUTOMATED COUNT||||DOMESTIC PARTNER|READER 2|5|Visit_5|90|1|FOLLOW-UP|2020-09-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|FEF50|Forced Expiratory Flow 50%|[?]|UNCONSTRAINED|||[?]|1|U/animal|RETROAURICULAR LYMPH NODE|IPSILATERAL|HIND|ANGIOGRAPHY|||Y|GUARDIAN|ONCOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-07-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|2|INFLTIND|Infiltrates Indicator|[?]|PRONE|||[?]|1|umol/mol|PANCREAS|IPSILATERAL|PERIVENTRICULAR|WHOLE GENOME SEQUENCING|||Y|HEALTH CARE PROFESSIONAL|READER 2|1|Visit_1|10|5|SCREENING|2020-07-10|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|3|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|mmAL|[?]|1|ks|PENIS, GLANS|BILATERAL|CRANIAL|CONTRAST ENHANCED CT SCAN||||SIGNIFICANT OTHER|HEMATOLOGIST|2|Visit_2|25|3|SCREENING|2020-07-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|LATERAL DECUBITUS|||[?]|1|kDa|RENAL FOSSA|LEFT|LOWER|CONTRAST ENHANCED SPIRAL CT SCAN|Y||Y|STUDY SUBJECT|READER|2|Visit_2|25|3|SCREENING|2020-07-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|||[?]|1|sec|VOMER|RIGHT|PERIPHERAL|SPIRAL CT SCAN WITHOUT CONTRAST|||Y|DOMESTIC PARTNER|PATHOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-08-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|RIGHT LATERAL DECUBITUS|[?]|WEEKS|[?]|1|QUANTITY SUFFICIENT|OBTURATOR MUSCLE|LEFT|UPPER FLEXOR SURFACE|CYSTOSCOPY||||ADJUDICATOR|DERMATOLOGIST|3|Visit_3|40|3|SCREENING|2020-08-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|7|FIFMAXPP|Percent Predicted FIFmax|[?]|DECUBITUS|[?]|nmol/L|[?]|1|Log10 ELISA unit/dose|NOSTRIL|LATERAL|DISTAL VOLAR|TONOMETRY||||FAMILY MEMBER|ONCOLOGIST 2|4|Visit_4|65|5|SCREENING|2020-09-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|8|PEFREV|PEF Reversibility|[?]|PRONE|[?]|10^6 U|[?]|1|10^6 CFU/mL|SPLEEN, HILUM|CONTRALATERAL|TEMPORAL|SANGER SEQUENCING||||SIGNIFICANT OTHER|NEUROLOGIST 1|4|Visit_4|65|6|FOLLOW-UP|2020-09-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/kg/h|[?]|1|nmol/mol|ILEUM LYMPH NODE|LATERAL|LATERAL|MULTIPLEXED BEAD BASED IMMUNOASSAY||||CHILD|READER 1|5|Visit_5|90|6|TREATMENT|2020-09-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|10|PEFREV|PEF Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/g/h|[?]|1|mg/g/min|AORTOCAVAL LYMPH NODE|UNILATERAL|MIDLINE|FLUORESCENCE ANGIOGRAPHY||||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|5|Visit_5|90|4|TREATMENT|2020-09-28|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|1|RV|Residual Volume|[?]|TRENDELENBURG|[?]|GPL U/mL|[?]|1|10^6/g|LUNG, RIGHT, SUPERIOR LOBE, APICAL SEGMENT|BILATERAL|TEMPORAL|CYSTOSCOPY||||ADJUDICATOR|RATER 1|1|Visit_1|10|5|TREATMENT|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|2|FEV1FVC6|FEV1/FVC6|[?]|FOWLERS|||[?]|1|mL/dose|ANTERIOR INFERIOR CEREBELLAR ARTERY|LEFT|MIDLINE|AMSLER GRID|||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|1|Visit_1|10|5|SCREENING|2020-05-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-07
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LATERAL DECUBITUS|[?]|/min|[?]|1|lx|VOCAL CORD|BILATERAL|ROSTRAL|SINGLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|Y||INDEPENDENT ASSESSOR|RATER 1|2|Visit_2|25|2|TREATMENT|2020-05-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|4|FIV1|Forced Inspiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|amu|[?]|1|mN|OBTURATOR MUSCLE|BILATERAL|FACIAL|ERGOSPIROMETRY||Y||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|WASHOUT|2020-05-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|5|FRCPP|Percent Predicted FRC|[?]|SITTING, LEGS DEPENDENT|[?]|fmol/L|[?]|1|nmol/mL/min|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND|UNILATERAL|PROXIMAL VOLAR|ACCELERATOR MASS SPECTROMETRY||||DOMESTIC PARTNER|ONCOLOGIST 2|3|Visit_3|40|1|WASHOUT|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|PRONE|[?]|TROCHE|[?]|1|IU/L|PALPEBRAL CONJUNCTIVA|LATERAL|SURFACE|IMMUNOASSAY||Y||ADJUDICATOR|READER 2|3|Visit_3|40|2|SCREENING|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|7|LOBVOL|Lobar Volume|[?]|DECUBITUS|[?]|mL/cage/day|[?]|1|ft|POSTERIOR SUPERIOR ILIAC SPINE|LATERAL|SUBCORTICAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||SIGNIFICANT OTHER|MICROSCOPIST 1|4|Visit_4|65|7|SCREENING|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|8|IRV|Inspiratory Reserve Volume|[?]|STANDING|||[?]|1|ag|SKULL|UNILATERAL|FORE|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y|Y|CAREGIVER|NEUROLOGIST 2|4|Visit_4|65|5|TREATMENT|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-11
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|9|PNEUMIND|Pneumonia Indicator|[?]|SEMI-FOWLERS|||[?]|1|BAU|FUNDUS OF THE STOMACH|BILATERAL|UPPER FLEXOR SURFACE|CARDIAC THERMODILUTION|Y||Y|CHILD|ONCOLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|36a54b72-6368-460e-ab4c-952923e0fd14|10|FEV6PP|Percent Predicted FEV6|[?]|STANDING|||[?]|1|10^7 PFU|AXILLARY LYMPH NODE LEVEL III|RIGHT|PROXIMAL VOLAR|ANALYTICAL ULTRACENTRIFUGATION|||Y|INVESTIGATOR|RADIOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-08-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|1|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING, LEGS DEPENDENT|||[?]|1|days/month|SKIN AROUND THE MOUTH|LATERAL|CRANIAL|DOPPLER ULTRASOUND|Y||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|1|Visit_1|10|2|FOLLOW-UP|2020-12-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|2|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING|[?]|ELISA unit/mL|[?]|1|cP|L4 VERTEBRA|BILATERAL|TEMPORAL|TARGETED TRANSCRIPTOME SEQUENCING||Y||SIGNIFICANT OTHER|DERMATOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-01
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|3|TSUHYS|Tissue Hysteresivity|[?]|TRENDELENBURG|[?]|mL/100g/min|[?]|1|mOsm/L|VENA CAVA|CONTRALATERAL|MEDIAL|QUANTITATIVE ULTRASOUND|Y|Y||DOMESTIC PARTNER|UROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2021-01-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SITTING|||[?]|1|POUCH|C1 VERTEBRA|BILATERAL|PROXIMAL|LC/MS/MS|||Y|CLINICAL RESEARCH ASSOCIATE|RATER 2|2|Visit_2|25|6|FOLLOW-UP|2021-01-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|[?]|um|[?]|1|cs|VULVOVAGINAL REGION|RIGHT|LOWER FLEXOR SURFACE|MOUSE PROTECTION ASSAY|Y|Y||CHILD|INTERNIST|3|Visit_3|40|3|TREATMENT|2021-01-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|6|DLCOPP|Percent Predicted DLCO|[?]|DECUBITUS|||[?]|1|10^9 organisms/mg|SCAPHOID BONE|CONTRALATERAL|BASAL|PHOTOGRAPHY|||Y|CAREGIVER|PHYSIOTHERAPIST|3|Visit_3|40|5|TREATMENT|2021-01-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|7|PNEUMIND|Pneumonia Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/mmHg|[?]|1|kcal|TRAPEZIUM-TRAPEZOID JOINT|UNILATERAL|FORE|PET/CT SCAN WITHOUT CONTRAST||||FAMILY MEMBER|FORENSIC PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|8|FIV1PP|Percent Predicted FIV1|[?]|LATERAL DECUBITUS|[?]|DISK|[?]|1|L/min/m2|LEFT VENTRICULAR APEX SEGMENT|UNILATERAL|SUPERIOR|MEDIASTINOSCOPY|Y|||FRIEND|ADJUDICATOR 3|4|Visit_4|65|2|TREATMENT|2021-02-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|9|VO2|Oxygen Consumption|[?]|LATERAL DECUBITUS|[?]|/10^5|[?]|1|mV*min|L6 VERTEBRA|LEFT|NASAL|PHYSICAL EXAMINATION||Y||FRIEND|MICROSCOPIST|5|Visit_5|90|2|TREATMENT|2021-03-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|84e56692-9a33-472a-9ddc-545d3342da34|10|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-FOWLERS|[?]|/500 WBC|[?]|1|Coulomb|VERTEBRAL ARTERY|CONTRALATERAL|UPPER|DYNAMOMETRY||||INDEPENDENT ASSESSOR|INTERNIST|5|Visit_5|90|3|TREATMENT|2021-03-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|||[?]|1|U|BLADDER, DOME|BILATERAL|CENTRAL|NON-CONTACT SPECULAR MICROSCOPY||Y|Y|INDEPENDENT ASSESSOR|MICROSCOPIST 1|1|Visit_1|10|7|SCREENING|2020-05-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|2|INTP|Interpretation|[?]|SITTING|||[?]|1|CYLINDER|IRIS|RIGHT|NASAL|THICK SMEAR|||Y|GUARDIAN|ONCOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-05-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|3|IVC|Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|mL/animal/day|UVEA|LATERAL|PERIVENTRICULAR|IMPULSE OSCILLOMETRY|||Y|HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|2|Visit_2|25|5|WASHOUT|2020-06-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|[?]|Mile|[?]|1|MdFI|CERVICAL SPINE|LATERAL|ANTEROTEMPORAL|GC/MS-EI|Y|||INDEPENDENT ASSESSOR|READER|2|Visit_2|25|6|FOLLOW-UP|2020-06-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|5|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|PIXEL|[?]|1|mol/mg|OBTURATOR INTERNUS MUSCLE|IPSILATERAL|FORE|LANDOLT RING||||INVESTIGATOR|OTOLARYNGOLOGIST|3|Visit_3|40|4|TREATMENT|2020-06-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|PRONE|||[?]|1|umol/L/h|CHOROID PLEXUS|BILATERAL|HIND|GRAM STAIN|||Y|ADJUDICATION COMMITTEE|NEUROLOGIST|3|Visit_3|40|6|SCREENING|2020-06-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-20
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|7|INERTANC|Inertance|[?]|SITTING|[?]|mg/kg/h|[?]|1|10^3/hpf|EPICONDYLE|BILATERAL|ANTEROLATERAL|GC/FID||||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|4|Visit_4|65|3|SCREENING|2020-07-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|8|PEF|Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|10^9 CFU|[?]|1|mg/mL/day|ELBOW FLEXOR MUSCLES|UNILATERAL|ANTERIOR|TURBIDIMETRY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|4|Visit_4|65|2|TREATMENT|2020-07-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|9|FEV1|Forced Expiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|deg/s|INTERPHALANGEAL JOINT 1|BILATERAL|LOWER FLEXOR SURFACE|MEDIASTINOSCOPY|Y||Y|CHILD|RATER|5|Visit_5|90|1|TREATMENT|2020-08-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|RE|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|10|TSUELAS|Tissue Elastance|[?]|STANDING, BENT FORWARD|[?]|/5x10^4 WBC|[?]|1|mEq/kg|FEMORAL LYMPH NODE|CONTRALATERAL|UPPER|FARNSWORTH-MUNSELL 100 HUE TEST||||FAMILY MEMBER|MICROSCOPIST 3|5|Visit_5|90|7|WASHOUT|2020-08-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-10
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|FEV1PP|Percent Predicted FEV1|[?]|STANDING, BENT FORWARD|||[?]|1|g/cm2|COMMON ILIAC LYMPH NODE|CONTRALATERAL|UPPER EXTENSOR SURFACE|TRANSMISSION ELECTRON MICROSCOPY|||Y|VENDOR|PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-06-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|2|IRVPP|Percent Predicted IRV|[?]|SEMI-FOWLERS|[?]|BAR|[?]|1|TRACE|HUMERAL EPICONDYLE|IPSILATERAL|FORE|NEPHELOMETRY||||PARENT|FORENSIC PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|[?]|Ci/mL|[?]|1|Frames/s|PHARYNGEAL TONSIL|LEFT|INTERMEDIATE|REVERSE TRANSCRIPTASE PCR||||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-06-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|4|FVCPP|Percent Predicted Forced Vital Capacity|[?]|UNCONSTRAINED|||[?]|1|ug/dose|LUMBAR REGION|LATERAL|DISTAL|ENZYMATIC ULTRACENTRIFUGATION|||Y|SIBLING|OPHTHALMOLOGIST|2|Visit_2|25|5|WASHOUT|2020-06-25|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|5|INTP|Interpretation|[?]|FOWLERS|||[?]|1|g/day|WRIST JOINT EXTENSOR MUSCLES|CONTRALATERAL|DORSOLATERAL|CONTRAST ENHANCED MRI|||Y|INVESTIGATOR|RADIOLOGIST 2|3|Visit_3|40|4|FOLLOW-UP|2020-07-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|6|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING|[?]|mL/dL|[?]|1|10^6 CFU/mL|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|BILATERAL|POSTERIOR|SINGLE-SLICE SPIRAL CT|Y|||SIGNIFICANT OTHER|OPTOMETRIST|3|Visit_3|40|4|FOLLOW-UP|2020-07-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-15
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|7|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|pptr|[?]|1|mL/cage|SKIN|RIGHT|CAUDAL|LC/MS|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|4|Visit_4|65|3|WASHOUT|2020-08-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|8|FIO2|Fraction of Inspired Oxygen|[?]|SLING|[?]|cal|[?]|1|%(w/v)|PENIS|CONTRALATERAL|APICAL|IMMUNOPRECIPITATION||Y||SIBLING|PEDIATRIC NEUROLOGIST|4|Visit_4|65|5|WASHOUT|2020-08-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|9|SALKA|Salazar-Knowles Equation Parameter A|[?]|SEMI-FOWLERS|||[?]|1|mkat|HAIR ROOT|BILATERAL|FORE|RULER MEASUREMENT METHOD|||Y|GUARDIAN|ONCOLOGIST 1|5|Visit_5|90|2|TREATMENT|2020-08-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|10|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|mmol/mol|T9 VERTEBRA|LATERAL|POSTERIOR|NO INFORMATION|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|OXYPULSE|Oxygen Pulse|[?]|STANDING, BENT FORWARD|||[?]|1|ug/L FEU|FACIAL NERVE|LATERAL|CRANIAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||Y|Y|SIGNIFICANT OTHER|RADIOLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|mL/cage/wk|[?]|1|vg/dose|LATERAL RAMUS INTERMEDIUS ARTERY|RIGHT|UPPER FLEXOR SURFACE|GC/MS-CI||||DOMESTIC PARTNER|RADIOLOGIST 2|1|Visit_1|10|1|WASHOUT|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-25
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|3|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SUPINE|||[?]|1|U/g/min|APPENDICULAR SKELETON|RIGHT|NASAL|GC/MS-EI|||Y|INVESTIGATOR|READER 3|2|Visit_2|25|7|FOLLOW-UP|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SLING|||[?]|1|kUSP|ANTERIOR INFERIOR CEREBELLAR ARTERY|IPSILATERAL|INTERMEDIATE|SPECULAR MICROSCOPY|||Y|INTERVIEWER|FORENSIC PATHOLOGIST|2|Visit_2|25|3|SCREENING|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-10
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|5|EFFVOL|Effusion Volume|[?]|UNCONSTRAINED|||[?]|1|nmol/L/h|ILIAC VEIN|LEFT|VENTRAL|PET SCAN|||Y|SIBLING|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|1|TREATMENT|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|6|RRS|Total Respiratory System Resistance|[?]|SLING|[?]|log10 IU/mL|[?]|1|U/m2/h|BICEPS BRACHII MUSCLE|IPSILATERAL|SUPERIOR|BAC ACGH||||SPOUSE|MICROSCOPIST|3|Visit_3|40|4|SCREENING|2021-02-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-08
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|7|MALEVDES|Malignancy Evidence Description|[?]|LEFT LATERAL DECUBITUS|[?]|U/g/day|[?]|1|mg/m2/min|SPLENIC HILAR LYMPH NODE|RIGHT|SURFACE|CALCOFLUOR WHITE STAIN||||GUARDIAN|ADJUDICATOR 3|4|Visit_4|65|3|FOLLOW-UP|2021-03-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|8|RAW|Airway Resistance|[?]|TRENDELENBURG|[?]|ug/day|[?]|1|ug/kg|METACARPOPHALANGEAL JOINT 3|BILATERAL|DEEP|PULSE OXIMETRY|Y|||FAMILY MEMBER|READER 1|4|Visit_4|65|7|TREATMENT|2021-03-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-08
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|9|RV|Residual Volume|[?]|FOWLERS|[?]|cycle/min|[?]|1|uCi/kg|THYROID GLAND|RIGHT|CRANIAL|GRADIENT DIFFUSION||||CAREGIVER|RATER 2|5|Visit_5|90|2|TREATMENT|2021-04-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|ae0e05c1-3953-4406-bfae-299295c1fa4c|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|UNCONSTRAINED|[?]|/7.5 mL|[?]|1|mg/m2|POSTERIOR CINGULATE CORTEX|CONTRALATERAL|PARIETO-OCCIPITAL|WHOLE GENOME SEQUENCING||||SIBLING|HEMATOLOGIST|5|Visit_5|90|3|WASHOUT|2021-04-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|||[?]|1|10^8/L|EARLOBE|RIGHT|PARIETO-OCCIPITAL|LIGHT MICROSCOPY|||Y|FAMILY MEMBER|DERMATOLOGIST|1|Visit_1|10|2|TREATMENT|2021-01-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-13
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|2|TSUHYS|Tissue Hysteresivity|[?]|SUPINE|[?]|umol/L|[?]|1|Henry|LUNG, LEFT|LEFT|APICAL|EEG||||SIGNIFICANT OTHER|ADJUDICATOR|1|Visit_1|10|2|TREATMENT|2021-01-16|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-13
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|[?]|Bq/mg|[?]|1|CONTAINER|ABDOMINAL CAVITY|RIGHT|PARIETO-OCCIPITAL|CONGO RED STAIN||Y||ADJUDICATOR|FORENSIC PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|mg/cm2|[?]|1|10^6 organisms/mg|RADIAL NERVE|BILATERAL|TIP|TRICHROME STAIN||||NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|2|Visit_2|25|1|SCREENING|2021-01-31|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-10
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|5|FEV1REV|FEV1 Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|10^6/L|[?]|1|GBq/g|PYLORIC SPHINCTER|CONTRALATERAL|UPPER|FARR ASSAY||||PROXY|READER 3|3|Visit_3|40|4|SCREENING|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|6|AIRTRAP|Air Trapping|[?]|STANDING|[?]|Siemens|[?]|1|10^6/g|PARACOLIC GUTTER|CONTRALATERAL|UPPER EXTENSOR SURFACE|SLOAN LETTER EYE CHART 1.25%||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|SCREENING|2021-02-15|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|7|AIRTRAP|Air Trapping|[?]|FOWLERS|[?]|DPM|[?]|1|/HPF|COMMON ILIAC LYMPH NODE|BILATERAL|SUPERIOR|POPULATION SEQUENCING||Y||SIBLING|NEUROLOGIST|4|Visit_4|65|7|SCREENING|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|8|IVC|Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|g/mol|MID-LAD ARTERY|LEFT|INFERIOR|MAGNETIC RESONANCE ELASTOGRAPHY|||Y|ADJUDICATOR|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2021-03-12|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|TRENDELENBURG|[?]|mOsm|[?]|1|pmol/g|TIBIA SHAFT|CONTRALATERAL|FORE|HEMAGGLUTINATION INHIBITION ASSAY||||PARENT|MICROSCOPIST|5|Visit_5|90|6|TREATMENT|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|10|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|Roentgen|[?]|1|DIP|ANKLE JOINT ANTERIOR FLEXOR TENDONS|LEFT|LOWER|CISH||||SIBLING|OTOLARYNGOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|DLCOVA|DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|tuberculin unit|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LATERAL|TEMPORAL|PHOTOGRAPHY|||Y|INVESTIGATOR|RATER 2|1|Visit_1|10|1|TREATMENT|2020-12-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|2|OXYPULSE|Oxygen Pulse|[?]|STANDING|[?]|Enzyme U/g Hb|[?]|1|vg/mL|SKIN OF THE INGUINAL REGION|UNILATERAL|CENTRAL|MAMMOGRAPHY|Y|||VENDOR|READER|1|Visit_1|10|6|WASHOUT|2020-12-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|3|FRCPP|Percent Predicted FRC|[?]|UNCONSTRAINED|||[?]|1|CUP|L3 VERTEBRA|LATERAL|LATERAL|APPLANATION TONOMETRY|||Y|VENDOR|RATER|2|Visit_2|25|6|SCREENING|2021-01-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|4|MALEVDES|Malignancy Evidence Description|[?]|SITTING, LEGS DEPENDENT|[?]|DDU|[?]|1|ug/L DDU|CLITORIS|BILATERAL|OCCIPITAL|CONTRAST ENHANCED PET SCAN||||DOMESTIC PARTNER|OPHTHALMOLOGIST|2|Visit_2|25|7|WASHOUT|2021-01-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|5|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SUPINE|[?]|fmol/g|[?]|1|/sec|HEART, BASE|LEFT|VENTROLATERAL|GC/MS-EI|Y|||CLINICAL STUDY SPONSOR|RATER 2|3|Visit_3|40|6|FOLLOW-UP|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|6|FEF2575|Forced Expiratory Flow 25-75%|[?]|SITTING|[?]|CAPSULE|[?]|1|IU|T4 VERTEBRA|LEFT|SUPERIOR|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||Y||CLINICAL STUDY SPONSOR|ADJUDICATOR|3|Visit_3|40|6|FOLLOW-UP|2021-01-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|TRENDELENBURG|[?]|foz_us|[?]|1|fmol/L/sec|ESOPHAGUS, CERVICAL|IPSILATERAL|DISTAL|FLUORESCEIN STAIN||||PROXY|HEMATOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|8|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|||[?]|1|mAnson U/mL|VEIN|RIGHT|OUTER|PET SCAN|Y||Y|ADJUDICATOR|ONCOLOGIST 1|4|Visit_4|65|2|WASHOUT|2021-02-18|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|9|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|kUSP|[?]|1|ug/kg/day|CERVICAL SPINE|LATERAL|ANTEROMEDIAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||||INDEPENDENT ASSESSOR|READER 1|5|Visit_5|90|1|TREATMENT|2021-03-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|ab09e76d-8bbf-4126-a60d-08d6b5292836|10|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|[?]|mEq/g|[?]|1|mU/g|GLUTEUS MAXIMUS|LEFT|SUPERIOR|FUNCTIONAL MRI||||INVESTIGATOR|MICROSCOPIST 3|5|Visit_5|90|3|FOLLOW-UP|2021-03-15|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-02
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|UNCONSTRAINED|[?]|pmol/day|[?]|1|ug/mol|PROSTATE GLAND, LATERAL LOBE|CONTRALATERAL|PERIPHERAL|LISSAMINE GREEN STAIN|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST|1|Visit_1|10|1|WASHOUT|2020-07-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING|[?]|PIXEL|[?]|1|U/mmol|HEPATIC ARTERY|BILATERAL|VENTROLATERAL|GIEMSA STAIN||Y||INTERVIEWER|HEMATOLOGIST|1|Visit_1|10|3|SCREENING|2020-07-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|3|ERVPP|Percent Predicted ERV|[?]|REVERSE TRENDELENBURG|[?]|cup eq|[?]|1|Linear ft*LB|KIDNEY, CORTEX|IPSILATERAL|PARIETO-OCCIPITAL|CISH||||STUDY SUBJECT|MICROSCOPIST 2|2|Visit_2|25|6|FOLLOW-UP|2020-07-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|4|SALKA|Salazar-Knowles Equation Parameter A|[?]|FOWLERS|[?]|10^9 CFU|[?]|1|log10 IU/mL|LUMBAR SPINE|IPSILATERAL|HIND|FUNDUS PHOTOGRAPHY||||FRIEND|MICROSCOPIST 3|2|Visit_2|25|6|FOLLOW-UP|2020-07-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|5|SVCPP|Percent Predicted Slow Vital Capacity|[?]|LATERAL DECUBITUS|||[?]|1|mV2/Hz|CERVICAL LYMPH NODE|IPSILATERAL|PARIETO-OCCIPITAL|STATIC PERIMETRY|||Y|STUDY SUBJECT|ONCOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-08-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|6|VO2|Oxygen Consumption|[?]|LATERAL DECUBITUS|||[?]|1|PIXELS/cm|LEFT MAIN CORONARY ARTERY BIFURCATION|LEFT|DORSAL|PHASE-CONTRAST MRI|Y||Y|ADJUDICATION COMMITTEE|HEMATOLOGIST|3|Visit_3|40|1|TREATMENT|2020-08-10|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|7|TGV|Thoracic Gas Volume|[?]|SEMI-RECUMBENT|[?]|uCi|[?]|1|10^9 CFU/g|FUNDUS OF THE STOMACH|CONTRALATERAL|PERIPHERAL|SLOAN LETTER EYE CHART 1.25%|Y|Y||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|TREATMENT|2020-09-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|PRONE|[?]|Ci/mL|[?]|1|mU/L|CAPITATE-LUNATE JOINT|BILATERAL|SUBCORTICAL|TRYPAN BLUE STAIN||||PROXY|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2020-09-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|mL/cm|[?]|1|AgU/mL|CARPOMETACARPAL JOINT|RIGHT|SUPERIOR|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||PARENT|CARDIOLOGIST|5|Visit_5|90|6|WASHOUT|2020-09-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|8b7e3909-4115-4736-b07a-e0b6c382aa7e|10|SGAW|Specific Airway Conductance|[?]|SLING|[?]|PACK|[?]|1|g/L|LEFT VENTRICULAR BASAL ANTERIOR SEGMENT|RIGHT|INFERIOR|ZIEHL NEELSEN ACID FAST STAIN||||DOMESTIC PARTNER|MICROSCOPIST 3|5|Visit_5|90|7|SCREENING|2020-09-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|1|LOBVOLPP|Percent Predicted Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|CYLINDER|TRICUSPID VALVE, POSTERIOR ANNULUS|BILATERAL|VENTROLATERAL|CONFOCAL MICROSCOPY|||Y|NON-HEALTH CARE PROFESSIONAL|INTERNIST|1|Visit_1|10|6|TREATMENT|2020-06-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|TRENDELENBURG|[?]|VIAL|[?]|1|MASK|ESOPHAGEAL LYMPH NODE|BILATERAL|ANTEROLATERAL|COMPLEMENT FIXATION||||ADJUDICATION COMMITTEE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|3|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|LATERAL DECUBITUS|||[?]|1|h*%|ENDOCERVIX|LATERAL|ROSTRAL|STATIC PERIMETRY||Y|Y|HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|5|TREATMENT|2020-07-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|4|PEFREV|PEF Reversibility|[?]|REVERSE TRENDELENBURG|[?]|/40 HPFs|[?]|1|kg/m2|MIDDLE PHALANX 2 OF THE HAND|UNILATERAL|TEMPORAL|SMEAR|Y|||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-07-06|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|5|RER|Respiratory Exchange Ratio|[?]|SLING|||[?]|1|grain|CORRUGATOR SUPERCILII MUSCLE|BILATERAL|INNER|ETDRS EYE CHART|Y||Y|ADJUDICATOR|INTERNIST|3|Visit_3|40|5|TREATMENT|2020-07-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|[?]|in|[?]|1|GPL U/mL|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|LOWER|CYSTOSCOPY||||CHILD|FORENSIC PATHOLOGIST|3|Visit_3|40|5|SCREENING|2020-07-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|7|FEV1FVC6|FEV1/FVC6|[?]|TRENDELENBURG|[?]|ft|[?]|1|fmol|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|UNILATERAL|FACIAL|ANALYTICAL ULTRACENTRIFUGATION||Y||INVESTIGATOR|ONCOLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|8|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|ELISA unit/dose|[?]|1|mg/m2|COMMON FEMORAL VEIN|CONTRALATERAL|DORSAL|NON-INVASIVE DIELECTRIC SENSING||||INDEPENDENT ASSESSOR|DERMATOLOGIST|4|Visit_4|65|2|SCREENING|2020-08-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SITTING, LEGS DEPENDENT|||[?]|1|g/cage/day|LEFT VENTRICULAR APICAL LATERAL SEGMENT|BILATERAL|INTERMEDIATE|MANUAL COUNT|||Y|SIBLING|PHYSIOTHERAPIST|5|Visit_5|90|7|TREATMENT|2020-09-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|187b2279-526f-4978-89d4-d2da56cc2257|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING|[?]|U/L|[?]|1|bel|URETHRA, ANTERIOR|RIGHT|OCCIPITAL|SLIT LAMP||Y||PROXY|RADIOLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-09-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|1|OXYPULSE|Oxygen Pulse|[?]|FOWLERS|[?]|Watt|[?]|1|mmol/g|METATARSOPHALANGEAL JOINT 1|UNILATERAL|VOLAR|TOTAL BODY RADIOGRAPHY||||SIGNIFICANT OTHER|PATHOLOGIST 2|1|Visit_1|10|7|FOLLOW-UP|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|2|EXPRELTM|Expiration Relaxation Time|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|oz eq|PALPEBRAL FISSURE|LATERAL|PERIVENTRICULAR|MOUSE PROTECTION ASSAY|||Y|SPOUSE|MICROSCOPIST|1|Visit_1|10|7|SCREENING|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|3|RRS|Total Respiratory System Resistance|[?]|PRONE|[?]|mg/kg/day|[?]|1|mEq/day|SKULL, BASE|LATERAL|VOLAR|ENZYMATIC COLORIMETRY|Y|||HEALTH CARE PROFESSIONAL|UROLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|4|FEF2575P|Percent Predicted FEF25-75|[?]|FOWLERS|||[?]|1|g/m2/day|LEFT MAIN CORONARY ARTERY BIFURCATION|CONTRALATERAL|BASAL|ENDPOINT DILUTION ASSAY|||Y|ADJUDICATOR|RATER|2|Visit_2|25|3|TREATMENT|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|5|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|nm|[?]|1|10^3 DNA copies/mL|FUNDUS UTERI|LATERAL|PROXIMAL|HPLC|Y|||CLINICAL RESEARCH ASSOCIATE|RATER 1|3|Visit_3|40|7|WASHOUT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|6|TV|Tidal Volume|[?]|SITTING|||[?]|1|g/mol|GLUTEAL MUSCLE|LEFT|UPPER|LINE PROBE ASSAY|Y||Y|CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|3|Visit_3|40|5|TREATMENT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|7|TVPP|Percent Predicted Tidal Volume|[?]|STANDING, BENT FORWARD|[?]|AgU/mL|[?]|1|Log10 ELISA unit/dose|FLEXOR HALLUCIS LONGUS MUSCLE|UNILATERAL|CENTRAL|MANUAL COUNT||Y||PARENT|ONCOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|8|RER|Respiratory Exchange Ratio|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/cm H2O|[?]|1|uEq|HEART, ATRIUM|BILATERAL|DEEP|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY||||FRIEND|DERMATOLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-18
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SUPINE|||[?]|1|10^6 organisms/g|MAMMARY GLAND|RIGHT|POSTERIOR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||Y|CLINICAL RESEARCH ASSOCIATE|READER 3|5|Visit_5|90|1|WASHOUT|2021-01-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|53506a04-dedb-495b-8e35-0576cdf1b323|10|AWVOL|Airway Volume|[?]|FOWLERS|[?]|IU/g|[?]|1|vg/mL|WARDS TRIANGLE|CONTRALATERAL|SUPERFICIAL|RADIOIMMUNOPRECIPITATION ASSAY||||INTERVIEWER|CARDIOLOGIST|5|Visit_5|90|2|SCREENING|2021-01-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|defa600c-4205-476e-a40c-690cb16769b3|1|ALVVOL|Alveolar Volume|[?]|DECUBITUS|||[?]|1|cd|CORPUS CALLOSUM, GENU|RIGHT|VENTRAL|CONGO RED STAIN|||Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST|1|Visit_1|10|2|FOLLOW-UP|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|defa600c-4205-476e-a40c-690cb16769b3|2|FIO2|Fraction of Inspired Oxygen|[?]|STANDING, BENT FORWARD|[?]|ukat/L|[?]|1|copies/uL|DISTAL EXTRAHEPATIC BILE DUCT REGION|IPSILATERAL|ANTERIOR|THICK SMEAR||||SPOUSE|PHYSIOTHERAPIST|1|Visit_1|10|4|SCREENING|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-05
e|RE|defa600c-4205-476e-a40c-690cb16769b3|3|PEFTIME|Peak Expiratory Flow Time|[?]|LEFT LATERAL DECUBITUS|[?]|ft3|[?]|1|Tbsp|FEMUR SHAFT|RIGHT|ANTEROLATERAL|ELECTROGASTROGRAPHY|Y|||SIBLING|READER 3|2|Visit_2|25|2|SCREENING|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|defa600c-4205-476e-a40c-690cb16769b3|4|QUASCOMP|Quasi-Static Compliance|[?]|RIGHT LATERAL DECUBITUS|[?]|/500 WBC|[?]|1|10^6 DNA copies/mL|TRICUSPID VALVE, SEPTAL CUSP|CONTRALATERAL|FRONTAL|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y||CLINICAL STUDY SPONSOR|RATER 2|2|Visit_2|25|1|TREATMENT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|defa600c-4205-476e-a40c-690cb16769b3|5|EFFIND|Effusion Indicator|[?]|DECUBITUS|[?]|/sec|[?]|1|Ci/mL|TIBIO-PERONEAL TRUNK|UNILATERAL|ROSTRAL|IVY INCISION METHOD||||INTERVIEWER|OPHTHALMOLOGIST|3|Visit_3|40|3|TREATMENT|2021-02-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|defa600c-4205-476e-a40c-690cb16769b3|6|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-FOWLERS|[?]|deg|[?]|1|/500 WBC|BACK|LATERAL|UPPER EXTENSOR SURFACE|SURFACE PLASMON RESONANCE||||FRIEND|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|FOLLOW-UP|2021-02-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|defa600c-4205-476e-a40c-690cb16769b3|7|VO2|Oxygen Consumption|[?]|FOWLERS|[?]|uCi/kg|[?]|1|AFU|PARASPINAL REGION|LEFT|PROXIMAL VOLAR|ELASTOGRAPHY||||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|4|Visit_4|65|4|WASHOUT|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|defa600c-4205-476e-a40c-690cb16769b3|8|IRVPP|Percent Predicted IRV|[?]|SITTING, LEGS DEPENDENT|[?]|PIXEL|[?]|1|mg/g/min|CARPOMETACARPAL JOINT 5|LEFT|DEEP|PHASE CONTRAST MICROSCOPY||||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|4|Visit_4|65|2|WASHOUT|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|defa600c-4205-476e-a40c-690cb16769b3|9|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|CYLINDER|[?]|1|BAG|SINUS|UNILATERAL|POSTERIOR|DC SHEATH FLOW||||ADJUDICATION COMMITTEE|RADIOLOGIST|5|Visit_5|90|1|SCREENING|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|defa600c-4205-476e-a40c-690cb16769b3|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SITTING|[?]|STEPS|[?]|1|ELISA unit|LEFT MAIN CORONARY ARTERY OSTIUM|IPSILATERAL|LOWER|WRIGHT STAIN||||GUARDIAN|DERMATOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING|||[?]|1|pmol/10^10 cells|TARSUS BONE|UNILATERAL|MEDIAL|KINETIC CHROMOGENIC ASSAY|||Y|CLINICAL STUDY SPONSOR|ONCOLOGIST|1|Visit_1|10|4|TREATMENT|2020-09-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|2|AIRTRAP|Air Trapping|[?]|SITTING|[?]|/100 WBC|[?]|1|nmol/mol|STERNOCLAVICULAR JOINT|LATERAL|CRANIAL|CHROMATOGRAPHY||||CHILD|HEMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LATERAL DECUBITUS|||[?]|1|ug/L|REGIONAL LYMPH NODE|LATERAL|FRONTAL|IMMUNORADIOMETRIC ASSAY|||Y|SIGNIFICANT OTHER|RATER 1|2|Visit_2|25|2|WASHOUT|2020-10-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|4|IVC|Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|PA|[?]|1|/wk|TRACHEA|BILATERAL|ANTEROTEMPORAL|MANUAL COUNT||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|2|Visit_2|25|1|TREATMENT|2020-10-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|5|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|[?]|pmol/L/h|[?]|1|ug/kg/min|METACARPAL BONE 3|IPSILATERAL|HIND|MAGNETIC RESONANCE ANGIOGRAPHY||||DOMESTIC PARTNER|RATER 2|3|Visit_3|40|4|SCREENING|2020-10-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|6|IRV|Inspiratory Reserve Volume|[?]|PRONE|[?]|eq|[?]|1|DAYS|LUNG, RIGHT UPPER LOBE|BILATERAL|UPPER FLEXOR SURFACE|SLOAN LETTER EYE CHART 100%||||CAREGIVER|HEMATOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-10-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|7|EVC|Expiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|Shock Wave|[?]|1|uL|TRIANGULAR-HAMATE JOINT|BILATERAL|POSTERIOR|MULTIPLE BREATH WASHOUT||Y||INTERVIEWER|ENDOCRINOLOGIST|4|Visit_4|65|6|SCREENING|2020-11-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|REVERSE TRENDELENBURG|||[?]|1|pmol/L|FINGERNAIL|CONTRALATERAL|NASAL|MRI WITHOUT CONTRAST|Y||Y|INTERVIEWER|PHYSIOTHERAPIST|4|Visit_4|65|4|TREATMENT|2020-11-10|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-01
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|9|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|[?]|VOXEL|[?]|1|mm3/mm2/year|CERVIX UTERI|LEFT|UPPER FLEXOR SURFACE|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||DOMESTIC PARTNER|DERMATOLOGIST|5|Visit_5|90|7|WASHOUT|2020-12-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|e5092583-4259-40ba-a6a2-eeef6607263b|10|ICREV|IC Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|Anson U|[?]|1|mg/kg/dose|FACET JOINT|RIGHT|CAUDAL|SLIT LAMP||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|5|Visit_5|90|5|WASHOUT|2020-12-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|nmol/L/min|[?]|1|ukat/10^12 RBC|CERVIX UTERI|UNILATERAL|LOWER FLEXOR SURFACE|MS/MS||Y||SPOUSE|MICROSCOPIST|1|Visit_1|10|1|FOLLOW-UP|2020-11-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|2|PEFTIME|Peak Expiratory Flow Time|[?]|LATERAL DECUBITUS|[?]|cpm|[?]|1|PACKAGE|HYPOPHARYNX|LEFT|PERIVENTRICULAR|CONTACT SPECULAR MICROSCOPY||Y||FRIEND|PATHOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-11-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-24
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|3|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-FOWLERS|||[?]|1|mCi|ATRIOVENTRICULAR VALVE|LEFT|PROXIMAL|CELL BASED BIOASSAY|Y||Y|INVESTIGATOR|READER 2|2|Visit_2|25|6|TREATMENT|2020-11-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|4|IC|Inspiratory Capacity|[?]|FOWLERS|[?]|BEAM BREAKS|[?]|1|m2|PROCERUS MUSCLE|LATERAL|CRANIAL|OPTICAL DENSITY MEASUREMENT||||SIGNIFICANT OTHER|MICROSCOPIST 1|2|Visit_2|25|6|TREATMENT|2020-11-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|5|EXPRELTM|Expiration Relaxation Time|[?]|PRONE|[?]|mEq/mL|[?]|1|cg|LYMPH NODE|LEFT|FRONTAL|NEXT GENERATION SEQUENCING||||FAMILY MEMBER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|6|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|Ci/mL|[?]|1|Siemens|RIB 9|BILATERAL|PERIVENTRICULAR|KINYOUN STAIN||Y||PROXY|CLINICAL PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|7|DLCOHC|HGB Corrected DLCO|[?]|SUPINE|[?]|in|[?]|1|NEBULE|ALVEOLUS|IPSILATERAL|PERIVENTRICULAR|BIOIMPEDANCE SPECTROSCOPY||||INVESTIGATOR|ONCOLOGIST 2|4|Visit_4|65|4|TREATMENT|2021-01-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|8|AWVOLPP|Percent Predicted Airway Volume|[?]|SLING|[?]|uL|[?]|1|Enzyme U/m2|MALE REPRODUCTIVE SYSTEM|LATERAL|DORSAL|FLUORESCEIN STAIN|Y|||NON-HEALTH CARE PROFESSIONAL|UROLOGIST|4|Visit_4|65|6|TREATMENT|2021-01-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|9|PEFREV|PEF Reversibility|[?]|LEFT LATERAL DECUBITUS|[?]|ug/h|[?]|1|anti-Xa IU|WAIST|IPSILATERAL|VENTRAL|HPLC/MS||||CHILD|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|FOLLOW-UP|2021-02-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|461196d1-1213-4e5f-9bac-71f097b6cfdb|10|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|[?]|Enzyme U/g Hb|[?]|1|10^3 copies/mL|VOMER|IPSILATERAL|ANTERIOR|MIGET||Y||INDEPENDENT ASSESSOR|INTERNIST|5|Visit_5|90|5|TREATMENT|2021-02-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SLING|||[?]|1|LENS|PANCREATIC DUCT|BILATERAL|CRANIAL|COMPUTERIZED CORNEAL TOPOGRAPHY|Y||Y|DOMESTIC PARTNER|NEUROLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|2|MIPPP|Percent Predicted MIP|[?]|TRENDELENBURG|[?]|10^6 IU/mL|[?]|1|F|FINGER FLEXOR TENDONS|LATERAL|CENTRAL|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||INDEPENDENT ASSESSOR|RATER|1|Visit_1|10|7|FOLLOW-UP|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-FOWLERS|[?]|mAnson U/mL|[?]|1|log10 TCID 50/uL|BLADDER|RIGHT|INNER|REBOUND TONOMETRY||||GUARDIAN|MICROSCOPIST 1|2|Visit_2|25|4|TREATMENT|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING|||[?]|1|STEPS|LATISSIMUS DORSI MUSCLE|CONTRALATERAL|PERIVENTRICULAR|MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY|Y||Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|2|Visit_2|25|3|SCREENING|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|5|INTP|Interpretation|[?]|TRENDELENBURG|[?]|NEEDLE GAUGE|[?]|1|MPL U|INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|VOLAR|OPTICAL DENSITY MEASUREMENT||||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|3|Visit_3|40|2|TREATMENT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|ms/mmHg|[?]|1|nmol/mL/min|PECTORALIS MINOR MUSCLE|RIGHT|SURFACE|CLOT DETECTION||||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|WASHOUT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|7|EFFIND|Effusion Indicator|[?]|SITTING|||[?]|1|DPM|DISTANT LYMPH NODE|IPSILATERAL|PARIETO-OCCIPITAL|COMPUTERIZED CORNEAL TOPOGRAPHY|||Y|CHILD|PATHOLOGIST|4|Visit_4|65|4|WASHOUT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|RNA copies/mL|[?]|1|U/10^12 RBC|ILEUM, TERMINAL|BILATERAL|LOWER EXTENSOR SURFACE|SANGER SEQUENCING||Y||VENDOR|READER 2|4|Visit_4|65|6|TREATMENT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-03
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|9|RRS|Total Respiratory System Resistance|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^6 DNA copies/mL|ABDOMINAL LYMPH NODE|IPSILATERAL|UPPER FLEXOR SURFACE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|5|Visit_5|90|2|SCREENING|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|4c82922a-55d0-45b9-a7bb-4edac32b0f68|10|INERTANC|Inertance|[?]|LATERAL DECUBITUS|[?]|nL|[?]|1|pmol/L|HEART, LEFT VENTRICULAR OUTFLOW TRACT|IPSILATERAL|INFERIOR|TEMPLATE INCISION METHOD||||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|5|Visit_5|90|5|TREATMENT|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-04
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|1|VO2|Oxygen Consumption|[?]|SUPINE|[?]|CYLINDER|[?]|1|/40 HPFs|RIB 3|BILATERAL|PERIPHERAL|WEBER GREEN STAIN||||PARENT|ADJUDICATOR 2|1|Visit_1|10|3|TREATMENT|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|2|FVC|Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|10^3 organisms/mL|[?]|1|g/animal/day|SUBCUTIS|LATERAL|UPPER|ELECTRONEUROGRAPHY||||INVESTIGATOR|ADJUDICATOR|1|Visit_1|10|1|TREATMENT|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|3|IRV|Inspiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|[?]|ppb|[?]|1|mL/m2/min|THORACIC ARTERY|LATERAL|APICAL|CONGO RED STAIN||||SIBLING|PHYSIOTHERAPIST|2|Visit_2|25|4|WASHOUT|2020-06-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|4|MEP|Maximal Expiratory Pressure|[?]|TRENDELENBURG|[?]|BAU|[?]|1|mL/s|NUCLEUS ACCUMBENS|CONTRALATERAL|ANTEROTEMPORAL|OLIGO ACGH||||PROXY|RATER 1|2|Visit_2|25|3|TREATMENT|2020-06-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-19
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|5|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mV*min|FINGER EXTENSOR TENDONS|CONTRALATERAL|DISTAL|NUCLEAR RADIOLOGY|Y|Y|Y|GUARDIAN|MICROSCOPIST 3|3|Visit_3|40|1|SCREENING|2020-06-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|6|ELSTNCE|Elastance|[?]|STANDING|||[?]|1|TRACE|GASTROINTESTINAL TRACT, LOWER, WALL|IPSILATERAL|DORSAL|DYNAMOMETRY|||Y|SPOUSE|CARDIOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-06-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|7|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LATERAL DECUBITUS|[?]|Anson U|[?]|1|nmol|PLACENTA|UNILATERAL|FACIAL|MICROARRAY|Y|||SIBLING|CLINICAL PATHOLOGIST|4|Visit_4|65|2|SCREENING|2020-07-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|8|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|Anson U|[?]|1|PACKET|NAIL|CONTRALATERAL|FACIAL|MOUSE PROTECTION ASSAY||||SIBLING|FORENSIC PATHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2020-07-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|9|OXYPULSE|Oxygen Pulse|[?]|STANDING|[?]|Bq|[?]|1|EVENTS|METATARSOPHALANGEAL JOINT 3|BILATERAL|INNER|NUCLEIC ACID AMPLIFICATION TEST|Y|||HEALTH CARE PROFESSIONAL|READER|5|Visit_5|90|6|TREATMENT|2020-08-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|57971bdc-14df-4d9e-a59a-2665703c12ab|10|VO2|Oxygen Consumption|[?]|REVERSE TRENDELENBURG|[?]|log10 TCID 50/mL|[?]|1|10^6 IU/mL|LUMBAR SPINE|CONTRALATERAL|LOWER MEDIAL|MUGA||||ADJUDICATION COMMITTEE|INTERNIST|5|Visit_5|90|5|FOLLOW-UP|2020-08-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|1|AWVOL|Airway Volume|[?]|PRONE|||[?]|1|g/day|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|DISTAL VOLAR|DC SHEATH FLOW||Y|Y|PARENT|PHYSIOTHERAPIST|1|Visit_1|10|7|TREATMENT|2020-10-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|2|MEP|Maximal Expiratory Pressure|[?]|FOWLERS|[?]|mL/min|[?]|1|ppb|FEMORAL NECK|BILATERAL|ANTEROLATERAL|CARDIAC THERMODILUTION||||CLINICAL STUDY SPONSOR|ONCOLOGIST|1|Visit_1|10|1|SCREENING|2020-10-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|3|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|[?]|U/kg|[?]|1|BLOCKS|SUPERIOR VENA CAVA|CONTRALATERAL|FRONTAL|BAC ACGH||||ADJUDICATION COMMITTEE|READER 1|2|Visit_2|25|4|TREATMENT|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|4|QUASCOMP|Quasi-Static Compliance|[?]|UNCONSTRAINED|[?]|h/wk|[?]|1|Enzyme U/m2|ANKLE JOINT ANTERIOR FLEXOR TENDONS|UNILATERAL|OUTER|RADIOGRAPHY||||PARENT|ONCOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-10-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|5|GAW|Airway Conductance|[?]|SITTING, LEGS DEPENDENT|[?]|anti-Xa IU|[?]|1|Bq/L|WAIST|RIGHT|CAUDAL|ELECTRONEUROGRAPHY|Y|Y||INDEPENDENT ASSESSOR|ADJUDICATOR|3|Visit_3|40|3|WASHOUT|2020-11-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|STEPS|[?]|1|nkat|INTRATHORACIC LYMPH NODE|UNILATERAL|PROXIMAL VOLAR|AUDIOMETRY||Y||VENDOR|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-11-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-09
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|7|FIVC|Forced Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|||[?]|1|umol/L/h|PROFUNDA FEMORIS VEIN|CONTRALATERAL|HIND|NO INFORMATION|Y||Y|INVESTIGATOR|PATHOLOGIST 2|4|Visit_4|65|6|SCREENING|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|SITTING|[?]|%|[?]|1|V/sec|CORPUS CALLOSUM, SPLENIUM|BILATERAL|CAUDAL|WHOLE TRANSCRIPTOME SEQUENCING||||CHILD|RATER 2|4|Visit_4|65|3|FOLLOW-UP|2020-12-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|9|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING, BENT FORWARD|[?]|gpELISA unit/mL|[?]|1|s^-1(%O2)^-1|T6 VERTEBRA|LEFT|PERIPHERAL|ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN||Y||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|dacea2da-9101-41e9-97aa-1cb8445b1320|10|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mEq/L|GLUTEAL MUSCLE|RIGHT|LOWER|IMMUNOPRECIPITATION|Y||Y|STUDY SUBJECT|ADJUDICATOR 1|5|Visit_5|90|2|TREATMENT|2020-12-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|1|RAW|Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|LOZENGE|[?]|1|EU|VENOUS SINUS|CONTRALATERAL|SURFACE|LIQUID SCINTILLATION COUNTING|Y|Y||CAREGIVER|READER|1|Visit_1|10|3|WASHOUT|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|2|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING|[?]|log10 IU/mL|[?]|1|mOsm/L|NAIL BED|LATERAL|LOWER EXTENSOR SURFACE|OBSERVATION||||VENDOR|OPTOMETRIST|1|Visit_1|10|4|WASHOUT|2020-11-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|3|FEF50|Forced Expiratory Flow 50%|[?]|PRONE|[?]|ug/g/min|[?]|1|umol/mg/min|DORSAL MOTOR NUCLEUS|LEFT|TEMPORAL|CRYOSCOPY||||DOMESTIC PARTNER|NEUROLOGIST 1|2|Visit_2|25|7|WASHOUT|2020-11-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|4|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|mgEq|[?]|1|DIP|PRELARYNGEAL LYMPH NODE|BILATERAL|MEDIAL|ELISPOT|Y|Y||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|2|Visit_2|25|3|FOLLOW-UP|2020-11-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|5|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|kPa/L/sec|[?]|1|DROP|FOREARM|LEFT|DORSAL|QUANTITATIVE ULTRASOUND||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|4|FOLLOW-UP|2020-12-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|6|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|U|[?]|1|mL/mmHg|ILIOPSOAS MUSCLE|UNILATERAL|APICAL|BALLPOINT PEN TECHNIQUE||||SPOUSE|CARDIOLOGIST|3|Visit_3|40|7|TREATMENT|2020-12-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|7|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|UNCONSTRAINED|[?]|steps/min|[?]|1|copies/mL|SKIN OF THE CHEST|IPSILATERAL|INNER|THICK SMEAR||||SIBLING|ADJUDICATOR 3|4|Visit_4|65|4|WASHOUT|2020-12-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|8|ICREV|IC Reversibility|[?]|FOWLERS|[?]|MET|[?]|1|psi|SKULL|LEFT|MIDLINE|WESTERGREN|Y|Y||STUDY SUBJECT|OPHTHALMOLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-31|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-02
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|9|TV|Tidal Volume|[?]|SEMI-RECUMBENT|[?]|INHALATION|[?]|1|TRANSDUCING UNIT|FEMORAL LYMPH NODE|BILATERAL|DORSOLATERAL|HPLC/MS||||GUARDIAN|ADJUDICATOR 3|5|Visit_5|90|4|WASHOUT|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|cbf5d05e-e934-4946-b991-5fef63a01888|10|FEV6PP|Percent Predicted FEV6|[?]|DECUBITUS|||[?]|1|EIA unit|FOOT DIGIT 3|UNILATERAL|UPPER|HIGH RESOLUTION CT|Y||Y|INTERVIEWER|ONCOLOGIST|5|Visit_5|90|1|WASHOUT|2021-01-25|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-19
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|DLCOVA|DLCO/VA|[?]|STANDING|[?]|ECL unit|[?]|1|ppth|DISTAL FEMUR R1|UNILATERAL|UPPER FLEXOR SURFACE|CHROMATOGRAPHY|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST 2|1|Visit_1|10|5|TREATMENT|2020-10-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|2|FRCPP|Percent Predicted FRC|[?]|SUPINE|||[?]|1|cmH2O*s2/mL|MIDDLE PHALANX 5 OF THE HAND|LEFT|INFERIOR|PET/MRI SCAN|||Y|STUDY SUBJECT|RADIOLOGIST 1|1|Visit_1|10|2|SCREENING|2020-10-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|3|TV|Tidal Volume|[?]|LEFT LATERAL DECUBITUS|[?]|10^6 copies/mL|[?]|1|mL/kg/h|PRECUNEUS|RIGHT|BASAL|GIEMSA STAIN||||SPOUSE|MICROSCOPIST|2|Visit_2|25|1|FOLLOW-UP|2020-11-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|4|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|in|[?]|1|BAU/mL|EPITROCHLEAR LYMPH NODE|LATERAL|DEEP|ELLA||||SIBLING|NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|5|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|||[?]|1|kDa|OCULOMOTOR NERVE|IPSILATERAL|VOLAR|URANYL ACETATE STAIN|Y||Y|GUARDIAN|READER 3|3|Visit_3|40|1|WASHOUT|2020-11-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|mL/cm H2O|[?]|1|log10 IU/mL|PROFUNDA FEMORIS ARTERY|LATERAL|PERIPHERAL|NUCLEAR RADIOLOGY|Y|||DOMESTIC PARTNER|READER 1|3|Visit_3|40|6|TREATMENT|2020-11-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|7|DLCO|Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|ug/dL|[?]|1|/mm|MID-JUGULAR LYMPH NODE|LEFT|UPPER FLEXOR SURFACE|BIOIMPEDANCE SPECTROSCOPY|Y|||GUARDIAN|HEMATOLOGIST|4|Visit_4|65|3|TREATMENT|2020-12-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|8|FEF50|Forced Expiratory Flow 50%|[?]|REVERSE TRENDELENBURG|[?]|mL/g/min|[?]|1|cg|FLEXOR DIGITORUM SUPERFICIALIS MUSCLE|LEFT|CENTRAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||||INTERVIEWER|MICROSCOPIST 1|4|Visit_4|65|2|TREATMENT|2020-12-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|9|FEV6PP|Percent Predicted FEV6|[?]|UNCONSTRAINED|||[?]|1|m/sec|SKIN OF THE BACK|RIGHT|DEEP|PERIPHERAL ANGIOGRAPHY||Y|Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2021-01-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|be18633c-0ff9-4775-9737-dc8a9524fd2c|10|FEV6PP|Percent Predicted FEV6|[?]|SLING|||[?]|1|m3|FLEXOR CARPI RADIALIS MUSCLE|CONTRALATERAL|SUBCORTICAL|COMPLEMENT FIXATION|||Y|SIGNIFICANT OTHER|PATHOLOGIST 2|5|Visit_5|90|5|WASHOUT|2021-01-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-14
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|AWVOL|Airway Volume|[?]|FOWLERS|[?]|ug/m2/h|[?]|1|psi|PYLORIC SPHINCTER|LEFT|LOWER MEDIAL|INTRAVASCULAR ULTRASOUND||||FAMILY MEMBER|READER 3|1|Visit_1|10|3|TREATMENT|2020-05-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|[?]|U/m2/h|[?]|1|10^3 organisms/mL|INTERVENTRICULAR SEPTUM|LATERAL|ANTEROLATERAL|KINYOUN STAIN|Y|||ADJUDICATION COMMITTEE|RATER 1|1|Visit_1|10|5|FOLLOW-UP|2020-05-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-23
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|3|PEFREV|PEF Reversibility|[?]|SITTING|[?]|mg|[?]|1|mL/kg/day|FINGER EXTENSOR MUSCLES|CONTRALATERAL|VENTROLATERAL|MAGNETIC RESONANCE ELASTOGRAPHY||Y||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|2|Visit_2|25|3|TREATMENT|2020-05-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-05
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|4|FIO2|Fraction of Inspired Oxygen|[?]|SEMI-FOWLERS|||[?]|1|DNA copies/mL|ISCHIUM|IPSILATERAL|CAUDAL|DC SHEATH FLOW|Y||Y|PARENT|MICROSCOPIST|2|Visit_2|25|3|WASHOUT|2020-05-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-05
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|REVERSE TRENDELENBURG|[?]|IU/kg|[?]|1|U/g|AXILLARY LYMPH NODE LEVEL III|IPSILATERAL|DEEP|ELASTOGRAPHY||||SIGNIFICANT OTHER|ADJUDICATOR 1|3|Visit_3|40|1|TREATMENT|2020-06-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|6|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|UNCONSTRAINED|[?]|mg/g/h|[?]|1|IU/kg/h|SEMITENDINOSUS MUSCLE|BILATERAL|ANTERIOR|CONTRAST ENHANCED SPIRAL CT SCAN|Y|||SPOUSE|FORENSIC PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-06-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|7|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|[?]|nmol/mol|[?]|1|ng/L|PINEAL GLAND|LEFT|SUPERFICIAL|FREEZING POINT DEPRESSION|Y|||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|4|Visit_4|65|1|TREATMENT|2020-07-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-08
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|8|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|DECUBITUS|||[?]|1|CFU/mL|PROXIMAL INTERPHALANGEAL JOINT 3|BILATERAL|LATERAL|ELECTRICAL IMPEDANCE MYOGRAPHY|Y||Y|SIGNIFICANT OTHER|ADJUDICATOR 1|4|Visit_4|65|6|TREATMENT|2020-07-06|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-08
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|9|PNIF|Peak Nasal Inspiratory Flow|[?]|DECUBITUS|[?]|PELLET|[?]|1|cup eq|POPLITEAL FOSSA|BILATERAL|SUBCORTICAL|MAGNETIC RESONANCE ENTEROGRAPHY|Y|||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|3|TREATMENT|2020-07-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|f7eba9b8-94fb-46b8-842a-0322eb68a355|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|[?]|BISCUIT|[?]|1|MBq/uL|FRONTAL SINUS|RIGHT|ANTERIOR|KINETIC MICROPARTICLE IMMUNOASSAY||||PARENT|MICROSCOPIST 1|5|Visit_5|90|6|WASHOUT|2020-07-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|1|FRCPP|Percent Predicted FRC|[?]|DECUBITUS|||[?]|1|yd|HEPATIC VEIN|BILATERAL|HIND|ELECTROPHORESIS|Y||Y|STUDY SUBJECT|READER|1|Visit_1|10|4|SCREENING|2021-01-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|STANDING, BENT FORWARD|||[?]|1|MdFI|FACE|LATERAL|PERIVENTRICULAR|CELL OF ORIGIN ASSAY||Y|Y|SPOUSE|OPTOMETRIST|1|Visit_1|10|6|WASHOUT|2021-01-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-13
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|3|TSUELAS|Tissue Elastance|[?]|RIGHT LATERAL DECUBITUS|[?]|GBq|[?]|1|DIOPTER|BILE DUCT|UNILATERAL|PROXIMAL|CINEANGIOGRAPHY||||INTERVIEWER|MICROSCOPIST 2|2|Visit_2|25|3|FOLLOW-UP|2021-02-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|4|INFLTIND|Infiltrates Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|vg/dose|[?]|1|mL/beat|STERNEBRA|RIGHT|VENTRAL|SINGLE-MOLECULE ARRAY|Y|||PARENT|FORENSIC PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2021-02-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-23
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|5|INTP|Interpretation|[?]|STANDING|[?]|steps/min|[?]|1|mm/h|FLEXOR DIGITORUM PROFUNDUS MUSCLE|BILATERAL|VOLAR|TRYPAN BLUE STAIN||||SIGNIFICANT OTHER|ADJUDICATOR|3|Visit_3|40|2|TREATMENT|2021-02-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|6|IVC|Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|mV|[?]|1|mPa|L5 VERTEBRA|BILATERAL|PARIETO-OCCIPITAL|LINE PROBE ASSAY|Y|||HEALTH CARE PROFESSIONAL|NEUROLOGIST|3|Visit_3|40|7|FOLLOW-UP|2021-02-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|PA|[?]|1|10^3 copies/mL|CAPITATE-LUNATE JOINT|RIGHT|POSTERIOR|NO INFORMATION||Y||CLINICAL RESEARCH ASSOCIATE|READER 1|4|Visit_4|65|3|TREATMENT|2021-03-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|8|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|||[?]|1|um2|UVEA|IPSILATERAL|LOWER MEDIAL|ALCIAN BLUE STAIN|Y|Y|Y|ADJUDICATION COMMITTEE|MICROSCOPIST 2|4|Visit_4|65|6|WASHOUT|2021-03-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-23
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|9|PNEUMIND|Pneumonia Indicator|[?]|TRENDELENBURG|[?]|psec|[?]|1|mmHg*min/L|MID-CIRCUMFLEX ARTERY|LATERAL|INTERMEDIATE|MASS SPECTROMETRY||Y||FRIEND|RADIOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|903199e2-56e1-41e4-8904-d33cc6846ee3|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|SQU/mL|[?]|1|LENS|FOREBRAIN|LEFT|SUPERFICIAL|PELLI-ROBSON EYE CHART||Y||ADJUDICATOR|FORENSIC PATHOLOGIST|5|Visit_5|90|3|WASHOUT|2021-04-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-06
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|ERV|Expiratory Reserve Volume|[?]|LATERAL DECUBITUS|[?]|/7.5 mL|[?]|1|copies/ug|CHOROID|CONTRALATERAL|MEDIAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|Y|||SPOUSE|READER 3|1|Visit_1|10|1|SCREENING|2020-11-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|2|EXPRELTM|Expiration Relaxation Time|[?]|TRENDELENBURG|[?]|mPa|[?]|1|tuberculin unit/mL|ETHMOID SINUS|UNILATERAL|ANTERIOR|FLUORESCENT SPOT TEST||||FRIEND|READER|1|Visit_1|10|3|TREATMENT|2020-11-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|3|FRCPP|Percent Predicted FRC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|F|FINGER EXTENSOR TENDONS|UNILATERAL|CENTRAL|DIRECT SEQUENCING|||Y|CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|2|Visit_2|25|7|FOLLOW-UP|2020-11-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|4|EVC|Expiratory Vital Capacity|[?]|SITTING|||[?]|1|% INHIBITION|ANKLE JOINT ANTERIOR FLEXOR TENDONS|UNILATERAL|CAUDAL|ELECTRICAL IMPEDANCE MYOGRAPHY|||Y|CHILD|CLINICAL PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2020-11-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|5|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING, LEGS DEPENDENT|||[?]|1|ug/dose|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|CONTRALATERAL|PROXIMAL|FUNDUS PHOTOGRAPHY|||Y|CHILD|PATHOLOGIST 2|3|Visit_3|40|2|TREATMENT|2020-12-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|6|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|[?]|IU/g|[?]|1|dpm/mg|CINGULATE CORTEX|BILATERAL|OUTER|MUGA||||CHILD|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|7|MIPPP|Percent Predicted MIP|[?]|DECUBITUS|[?]|lm|[?]|1|/5x10^4 WBC|PANCREAS, HEAD|LATERAL|ANTEROPOSTERIOR|IMMUNOASSAY||||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|3|TREATMENT|2020-12-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|8|AWWVOL|Airway Wall Volume|[?]|LATERAL DECUBITUS|[?]|FIU|[?]|1|ppth|INFRACLAVICULAR LYMPH NODE|IPSILATERAL|CRANIAL|SEQUENCING||||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-12-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|9|RAW|Airway Resistance|[?]|STANDING|[?]|ukat/L|[?]|1|Ci/L|JOINT|LEFT|DEEP|IRON HEMATOXYLIN STAIN||Y||PARENT|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2021-01-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|32567f8d-e746-44e1-a269-d95ba3bb0b11|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kUSP|COMMON ILIAC ARTERY|UNILATERAL|ANTEROTEMPORAL|MICRO BROTH DILUTION|||Y|CLINICAL RESEARCH ASSOCIATE|READER 1|5|Visit_5|90|1|TREATMENT|2021-01-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|PLMXRS|Pulmonary Reactance|[?]|SLING|||[?]|1|mgEq|SKIN OF THE FINGER|LATERAL|PROXIMAL VOLAR|LEAD CITRATE STAIN|Y||Y|ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|7|FOLLOW-UP|2020-11-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SLING|[?]|PACK|[?]|1|umol/L|DISTAL PHALANX 2 OF THE HAND|LATERAL|ANTEROLATERAL|WHOLE GENOME SEQUENCING||Y||INVESTIGATOR|READER 1|1|Visit_1|10|1|TREATMENT|2020-11-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|3|INFLTIND|Infiltrates Indicator|[?]|TRENDELENBURG|[?]|/LSQN|[?]|1|fmol/L|URINARY SYSTEM|RIGHT|OUTER|PERCUSSION||||SIGNIFICANT OTHER|ONCOLOGIST 2|2|Visit_2|25|4|FOLLOW-UP|2020-11-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|4|FRCPP|Percent Predicted FRC|[?]|SITTING, LEGS DEPENDENT|[?]|log10 CFU/mL|[?]|1|/LSQN|PERITONEAL CAVITY|LEFT|PARIETO-OCCIPITAL|IMPEDANCE CONDUCTIVITY||Y||SIGNIFICANT OTHER|RADIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-11-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|5|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING|[?]|10^7 CFU|[?]|1|mEq/mL|PITUITARY GLAND|UNILATERAL|DISTAL VOLAR|MICROBIAL CONCENTRATION|Y|||GUARDIAN|OPTOMETRIST|3|Visit_3|40|6|TREATMENT|2020-12-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|6|VO2|Oxygen Consumption|[?]|TRENDELENBURG|[?]|Roentgen|[?]|1|deg2|PERITONEUM|LATERAL|OUTER|REBOUND TONOMETRY||||STUDY SUBJECT|READER 1|3|Visit_3|40|1|WASHOUT|2020-12-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|7|INERTANC|Inertance|[?]|FOWLERS|[?]|uV*sec|[?]|1|mCi|LEFT CIRCUMFLEX ARTERY OSTIUM|LEFT|VOLAR|CLOT DETECTION||||VENDOR|NEUROLOGIST 2|4|Visit_4|65|6|TREATMENT|2021-01-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|8|INFLTIND|Infiltrates Indicator|[?]|STANDING|[?]|U/g Hb|[?]|1|kat|GLOBUS PALLIDUS|BILATERAL|OUTER|RYAN BLUE STAIN||||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|4|Visit_4|65|1|WASHOUT|2021-01-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|9|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SLING|||[?]|1|Enzyme U|FUNDUS UTERI|LATERAL|MIDLINE|FLOCCULATION, CHARCOAL ENHANCED|Y||Y|NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR 3|5|Visit_5|90|6|TREATMENT|2021-01-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|ecdc54eb-c02f-4112-8e85-8a3352470b3b|10|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-FOWLERS|[?]|Ci|[?]|1|m/sec2|UTERUS|BILATERAL|SUBCORTICAL|KINYOUN STAIN|Y|||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 1|5|Visit_5|90|4|SCREENING|2021-01-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|SVC|Slow Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|mV|[?]|1|IU/L|RIB 10|IPSILATERAL|ANTEROMEDIAL|GRADIENT DIFFUSION||||SIBLING|PATHOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-07-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|2|DLCOHC|HGB Corrected DLCO|[?]|STANDING|[?]|cmH2O*s2/mL|[?]|1|mmHg/L/min|ILEUM WALL|RIGHT|TIP|MULTI-SLICE SPIRAL CT||||INTERVIEWER|ENDOCRINOLOGIST|1|Visit_1|10|4|SCREENING|2020-07-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|3|TLCPP|Percent Predicted Total Lung Capacity|[?]|STANDING, BENT FORWARD|[?]|mol/mg|[?]|1|pt_br|INFRARENAL AORTA|CONTRALATERAL|SUPERIOR|FLOCCULATION, CHARCOAL ENHANCED|Y|||SIBLING|READER 3|2|Visit_2|25|6|FOLLOW-UP|2020-07-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|4|MEPPP|Percent Predicted MEP|[?]|RIGHT LATERAL DECUBITUS|[?]|LOZENGE|[?]|1|10^4 CFU|GLOBUS PALLIDUS|IPSILATERAL|LOWER MEDIAL|LIQUID SCINTILLATION COUNTING||||CLINICAL STUDY SPONSOR|RATER|2|Visit_2|25|1|TREATMENT|2020-07-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|5|FEV1PP|Percent Predicted FEV1|[?]|FOWLERS|[?]|EVENTS|[?]|1|log10 TCID 50/mL|CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY|LEFT|SUBCORTICAL|DYNAMOMETRY||||CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-08-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|6|LOBVOL|Lobar Volume|[?]|SITTING, LEGS DEPENDENT|[?]|nkat/L|[?]|1|U/L|DISTAL EXTRAHEPATIC BILE DUCT REGION|BILATERAL|INFERIOR|TOLUIDINE BLUE STAIN||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|3|Visit_3|40|2|FOLLOW-UP|2020-08-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|nCi|[?]|1|mm/sec|MAXILLARY SINUS|LATERAL|LOWER FLEXOR SURFACE|PAP STAIN|Y|||CHILD|HEMATOLOGIST|4|Visit_4|65|1|SCREENING|2020-09-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|8|LOBVOL|Lobar Volume|[?]|FOWLERS|[?]|m3|[?]|1|STRIP|BRACHIAL LYMPH NODE|LATERAL|DORSAL|CYSTOMETRY|Y|Y||HEALTH CARE PROFESSIONAL|READER 3|4|Visit_4|65|1|TREATMENT|2020-09-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|9|TGV|Thoracic Gas Volume|[?]|UNCONSTRAINED|||[?]|1|GPL U|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE HAND|LATERAL|DEEP|HEMOCYTOMETRY|||Y|ADJUDICATOR|UROLOGIST|5|Visit_5|90|4|TREATMENT|2020-09-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|10|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|mU|[?]|1|mg/kg/min|SUPRACLAVICULAR FOSSA|BILATERAL|CAUDAL|THERMAL IONIZATION MASS SPECTROMETRY||||PROXY|CLINICAL PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|IVCPP|Percent Predicted IVC|[?]|FOWLERS|[?]|mg/kg/dose|[?]|1|h/wk|FEMALE REPRODUCTIVE SYSTEM|BILATERAL|LOWER EXTENSOR SURFACE|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY||||CHILD|CLINICAL PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|mg/kg/day|[?]|1|U/kg/min|HAIR FOLLICLE|RIGHT|FORE|U-HPLC/MS/MS||Y||SPOUSE|PEDIATRIC NEUROLOGIST|1|Visit_1|10|2|TREATMENT|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|3|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|ppm|[?]|1|g/animal|FINGER|IPSILATERAL|PERIPHERAL|SPIRAL CT SCAN WITHOUT CONTRAST||Y||DOMESTIC PARTNER|MICROSCOPIST 2|2|Visit_2|25|3|TREATMENT|2020-08-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|4|EXPRELTM|Expiration Relaxation Time|[?]|SITTING|[?]|NEEDLE GAUGE|[?]|1|fL|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|CONTRALATERAL|ANTEROPOSTERIOR|ELISA|Y|||NON-HEALTH CARE PROFESSIONAL|READER 3|2|Visit_2|25|1|WASHOUT|2020-08-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|5|IVCPP|Percent Predicted IVC|[?]|SEMI-FOWLERS|||[?]|1|KIT|TRIANGULAR-LUNATE JOINT|UNILATERAL|FRONTAL|CALCOFLUOR WHITE STAIN|Y||Y|CLINICAL RESEARCH COORDINATOR|OPHTHALMOLOGIST|3|Visit_3|40|3|SCREENING|2020-08-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|6|SGAW|Specific Airway Conductance|[?]|STANDING|||[?]|1|IU/kg|GASTROINTESTINAL TRACT, WALL|LATERAL|PARIETO-OCCIPITAL|COULOMETRIC TITRATION|||Y|CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|3|Visit_3|40|3|TREATMENT|2020-08-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|7|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|||[?]|1|EU|PULMONARY VALVE, RIGHT CUSP|CONTRALATERAL|NASAL|AHG-ENHANCED COMPLEMENT-DEPENDENT LYMPHOCYTOTOXICITY ASSAY|||Y|CHILD|CLINICAL PATHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|8|GAW|Airway Conductance|[?]|SITTING, LEGS DEPENDENT|[?]|uOsm|[?]|1|mL/animal/wk|MAXILLARY SINUS|LEFT|CRANIAL|FORCED OSCILLATION TECHNIQUE||Y||CHILD|MICROSCOPIST 3|4|Visit_4|65|3|FOLLOW-UP|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|9|AWVOL|Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|pkat|[?]|1|U/g/day|THIGH|IPSILATERAL|BASAL|PHOTOGRAPHY|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|5|Visit_5|90|6|TREATMENT|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|5d7241ec-120d-486d-ab39-b9e14ab4ce90|10|IVCPP|Percent Predicted IVC|[?]|FOWLERS|[?]|ft2|[?]|1|L/L|HAIR ROOT|UNILATERAL|HIND|DARK FIELD MICROSCOPY||Y||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|5|Visit_5|90|4|TREATMENT|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|STANDING|[?]|umol/day|[?]|1|Gy|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|UNILATERAL|ANTERIOR|STATIC PERIMETRY||Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|1|Visit_1|10|3|WASHOUT|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|2|RAWPP|Percent Predicted Airway Resistance|[?]|LATERAL DECUBITUS|[?]|DRINK|[?]|1|pg/L|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|LATERAL|PROXIMAL VOLAR|INTRAVASCULAR ULTRASOUND||Y||SPOUSE|ADJUDICATOR 2|1|Visit_1|10|3|SCREENING|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-08
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|3|IVC|Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|genEq/mL|[?]|1|MBq/uL|KIDNEY, LOWER LOBE|LATERAL|VENTROLATERAL|LC-FL|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST 2|2|Visit_2|25|3|FOLLOW-UP|2020-06-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|4|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|||[?]|1|copies/ug|THORACIC VERTEBRA|CONTRALATERAL|LATERAL|PET/CT SCAN|||Y|SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-06-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SLING|[?]|kDa|[?]|1|mL/g/min|SKULL, BASE|CONTRALATERAL|PERIVENTRICULAR|ANALYTICAL ULTRACENTRIFUGATION||Y||ADJUDICATOR|READER 3|3|Visit_3|40|6|TREATMENT|2020-07-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|6|LOBVOL|Lobar Volume|[?]|SLING|[?]|km|[?]|1|10^5/L|TRICEPS BRACHII MUSCLE|BILATERAL|SURFACE|NUCLEIC ACID BASED METHOD||||INVESTIGATOR|MICROSCOPIST 3|3|Visit_3|40|1|TREATMENT|2020-07-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|7|FIVC|Forced Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|uEq/L|[?]|1|PFU/mL|PELVIC BONE|IPSILATERAL|OCCIPITAL|CLAUSS METHOD||||GUARDIAN|ONCOLOGIST 2|4|Visit_4|65|5|FOLLOW-UP|2020-07-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|8|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING, LEGS DEPENDENT|[?]|10^4 CFU|[?]|1|MET*h|TROCHANTER|UNILATERAL|TEMPORAL|PET/SPECT SCAN||||GUARDIAN|RATER 2|4|Visit_4|65|1|WASHOUT|2020-07-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-09
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|9|TV|Tidal Volume|[?]|STANDING, BENT FORWARD|[?]|titer|[?]|1|copies/mL|RENAL FOSSA|LATERAL|POSTERIOR|IMMUNOBLOT||||HEALTH CARE PROFESSIONAL|ENDOCRINOLOGIST|5|Visit_5|90|7|WASHOUT|2020-08-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|10|RVPP|Percent Predicted Residual Volume|[?]|SEMI-RECUMBENT|[?]|ugEq/L|[?]|1|BAU/mL|INGUINAL REGION|CONTRALATERAL|CRANIAL|EEG|Y|||SPOUSE|ONCOLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2020-08-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|DLCOHC|HGB Corrected DLCO|[?]|SLING|[?]|MAC50|[?]|1|BAG|MITRAL VALVE ANNULUS|IPSILATERAL|PERIVENTRICULAR|ELECTROCHEMILUMINESCENCE||||GUARDIAN|READER|1|Visit_1|10|2|TREATMENT|2020-07-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|2|PNEUMIND|Pneumonia Indicator|[?]|PRONE|||[?]|1|mg/L|EXTERNAL ILIAC LYMPH NODE|IPSILATERAL|POSTERIOR|TRANSCRIPTION-MEDIATED AMPLIFICATION||Y|Y|SIBLING|RATER 2|1|Visit_1|10|1|FOLLOW-UP|2020-07-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|3|FIO2|Fraction of Inspired Oxygen|[?]|STANDING|[?]|fmol/L|[?]|1|usec|SKIN OF THE AXILLA|CONTRALATERAL|CENTRAL|MODIFIED ACID FAST STAIN||||CLINICAL STUDY SPONSOR|ADJUDICATOR|2|Visit_2|25|2|SCREENING|2020-07-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|4|FEV1PP|Percent Predicted FEV1|[?]|SEMI-FOWLERS|[?]|pg/dL|[?]|1|fmol/L|ACUTE MARGINAL ARTERY|LEFT|FRONTAL|POPULATION SEQUENCING||||SIGNIFICANT OTHER|MICROSCOPIST 1|2|Visit_2|25|6|WASHOUT|2020-07-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-16
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|5|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|Antibody Unit|[?]|1|10^5/L|GLUTEUS MAXIMUS|CONTRALATERAL|UPPER FLEXOR SURFACE|NEXT GENERATION SEQUENCING||||STUDY SUBJECT|OPTOMETRIST|3|Visit_3|40|7|FOLLOW-UP|2020-08-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|6|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|FOWLERS|[?]|TRACE|[?]|1|EID 50/mL|CORNEA|IPSILATERAL|DORSOLATERAL|HANSEL STAIN||||VENDOR|OPTOMETRIST|3|Visit_3|40|3|WASHOUT|2020-08-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-18
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SLING|[?]|pt_br|[?]|1|gMFI|INTERPHALANGEAL JOINT 4 OF THE HAND|CONTRALATERAL|ANTERIOR|SPIROMETRY||||INTERVIEWER|READER|4|Visit_4|65|4|SCREENING|2020-08-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|LEFT LATERAL DECUBITUS|[?]|U.CARR|[?]|1|ug/L/h|LUNG, LEFT|RIGHT|LOWER|FARNSWORTH-MUNSELL 100 HUE TEST||||FRIEND|RATER 2|4|Visit_4|65|1|TREATMENT|2020-08-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|9|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|U/L|THYROID GLAND, RIGHT LOBE|CONTRALATERAL|DORSAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|||Y|ADJUDICATOR|CARDIOLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|DECUBITUS|[?]|10^9/g|[?]|1|ELISA unit|FLEXOR DIGITORUM LONGUS MUSCLE|RIGHT|INTERMEDIATE|CYSTOMETRY||||CHILD|RATER 2|5|Visit_5|90|1|TREATMENT|2020-09-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|1|SRAW|Specific Airway Resistance|[?]|PRONE|||[?]|1|g/L|PHARYNGEAL TONSIL|RIGHT|CENTRAL|GRAM STAIN|Y||Y|STUDY SUBJECT|PATHOLOGIST 2|1|Visit_1|10|5|TREATMENT|2020-08-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|2|FVC|Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|PA|[?]|1|mL/min/mmHg|TRIGEMINAL NERVE|RIGHT|CAUDAL|TARGETED GENOME SEQUENCING||||CHILD|NEUROLOGIST 1|1|Visit_1|10|5|WASHOUT|2020-08-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|3|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|[?]|Siemens|[?]|1|g/m2/day|ORBIT|LATERAL|PARIETO-OCCIPITAL|CHROMOGENIC ASSAY||||INVESTIGATOR|READER 2|2|Visit_2|25|7|FOLLOW-UP|2020-08-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|4|SGAW|Specific Airway Conductance|[?]|FOWLERS|[?]|mL/animal/wk|[?]|1|mmAL|TIBIALIS POSTERIOR MUSCLE|CONTRALATERAL|UPPER EXTENSOR SURFACE|SINGLE-MOLECULE ARRAY|Y|||PROXY|ENDOCRINOLOGIST|2|Visit_2|25|4|SCREENING|2020-08-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|5|EFFIND|Effusion Indicator|[?]|TRENDELENBURG|[?]|U/dL|[?]|1|mL/sec/1.73m2|C2 VERTEBRA|UNILATERAL|SUPERFICIAL|EPSILOMETER|Y|Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|3|Visit_3|40|1|WASHOUT|2020-09-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|6|SRAW|Specific Airway Resistance|[?]|SEMI-FOWLERS|[?]|cd|[?]|1|hr/day|FEMUR|LEFT|TIP|DXA SCAN|Y|||PROXY|PATHOLOGIST|3|Visit_3|40|1|FOLLOW-UP|2020-09-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|7|RAWPP|Percent Predicted Airway Resistance|[?]|UNCONSTRAINED|[?]|kUSP|[?]|1|DAYS|BRACHIORADIALIS MUSCLE|BILATERAL|ANTEROMEDIAL|DNA MICROARRAY||||SPOUSE|RADIOLOGIST 1|4|Visit_4|65|3|SCREENING|2020-10-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|8|AWWVOL|Airway Wall Volume|[?]|STANDING, BENT FORWARD|[?]|cd/m2|[?]|1|Hz|LUNATE BONE|IPSILATERAL|SUBCORTICAL|CONTRAST ENHANCED CT SCAN||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 1|4|Visit_4|65|3|TREATMENT|2020-10-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-12
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|9|EFFIND|Effusion Indicator|[?]|FOWLERS|[?]|kV|[?]|1|U/g|HEAD|LATERAL|ROSTRAL|TURBIDIMETRY|Y|||CHILD|MICROSCOPIST 3|5|Visit_5|90|1|WASHOUT|2020-10-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|a69c6182-9c35-4365-b732-b238e0584ba7|10|ELSTNCE|Elastance|[?]|SUPINE|[?]|cpm|[?]|1|U/m2|DIAPHRAGMATIC LYMPH NODE|UNILATERAL|ANTEROPOSTERIOR|INTERRUPTER TECHNIQUE||||ADJUDICATION COMMITTEE|RADIOLOGIST 1|5|Visit_5|90|1|SCREENING|2020-10-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-06
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|1|MALEVDES|Malignancy Evidence Description|[?]|PRONE|[?]|10^5/L|[?]|1|Bq/mg|LUNG|LEFT|UPPER FLEXOR SURFACE|PHYSICAL EXAMINATION||||CLINICAL RESEARCH ASSOCIATE|INTERNIST|1|Visit_1|10|7|SCREENING|2020-12-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|2|SRAW|Specific Airway Resistance|[?]|UNCONSTRAINED|[?]|pkat/L|[?]|1|10^6 IU/mL|MITRAL VALVE|CONTRALATERAL|ANTEROMEDIAL|ATOMIC ABSORPTION SPECTROMETRY||||CHILD|ONCOLOGIST 1|1|Visit_1|10|1|SCREENING|2020-12-11|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|3|TSUHYS|Tissue Hysteresivity|[?]|SEMI-RECUMBENT|[?]|U/kg/min|[?]|1|umol/dL|L5 VERTEBRA|IPSILATERAL|TIP|CALIPER MEASUREMENT METHOD||||INDEPENDENT ASSESSOR|RADIOLOGIST 1|2|Visit_2|25|6|FOLLOW-UP|2020-12-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|4|MALIND|Malignancy Indicator|[?]|SEMI-FOWLERS|[?]|10^8/L|[?]|1|mEq/g|CAROTID ARTERY|LEFT|CAUDAL|SCINTIGRAPHY|Y|||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|2|Visit_2|25|6|WASHOUT|2020-12-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|5|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|log10 TCID 50/uL|HEART|BILATERAL|FRONTAL|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|Y|Y|GUARDIAN|ONCOLOGIST 2|3|Visit_3|40|3|SCREENING|2021-01-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|6|ELSTNCE|Elastance|[?]|SEMI-RECUMBENT|||[?]|1|10^7 CFU|ALVEOLUS|LEFT|INFERIOR|SANGER SEQUENCING|||Y|NON-HEALTH CARE PROFESSIONAL|RATER|3|Visit_3|40|7|TREATMENT|2021-01-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|m/sec2|[?]|1|L/day|RIB 10|LATERAL|DEEP|CONTRAST ENHANCED X-RAY|Y|Y||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|4|Visit_4|65|4|TREATMENT|2021-02-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|8|PLMXRS|Pulmonary Reactance|[?]|STANDING|[?]|mmHg|[?]|1|CAN|CHOROID PLEXUS|IPSILATERAL|INFERIOR|MAGNETIC RESONANCE ENTEROGRAPHY||Y||SIBLING|ADJUDICATOR 2|4|Visit_4|65|2|FOLLOW-UP|2021-02-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-28
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|9|FIF75|Forced Inspiratory Flow at 75%|[?]|REVERSE TRENDELENBURG|[?]|MPS U|[?]|1|10^6/L|TIBIO-PERONEAL TRUNK|RIGHT|SUPERIOR|FREEZING POINT DEPRESSION||Y||VENDOR|RATER 2|5|Visit_5|90|4|TREATMENT|2021-03-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|1b9896cf-160e-4a56-8737-9759cd83e784|10|TLCPP|Percent Predicted Total Lung Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|/LPF|[?]|1|mEq/kg|HILAR LYMPH NODE|RIGHT|VENTRAL|WESTERGREN||Y||INTERVIEWER|OTOLARYNGOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2021-03-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|1|EFFIND|Effusion Indicator|[?]|SEMI-FOWLERS|[?]|keV|[?]|1|Log10 ELISA unit|ILIAC LYMPH NODE|IPSILATERAL|LOWER MEDIAL|CELLULOSE TAPE||||VENDOR|CLINICAL PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-08-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|2|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|[?]|ug/m2/min|[?]|1|Newton|ELBOW EXTENSOR MUSCLES|LEFT|TIP|KARYOTYPING||Y||SIBLING|CLINICAL PATHOLOGIST|1|Visit_1|10|1|SCREENING|2020-08-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-15
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|||[?]|1|mEq/ug|SKIN OF THE BACK|LEFT|PROXIMAL|MAGNETIC RESONANCE ENTEROGRAPHY|||Y|SIBLING|CARDIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-08-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|||[?]|1|s/h|QUADRICEPS MUSCLE|BILATERAL|OUTER|PAP STAIN|Y||Y|HEALTH CARE PROFESSIONAL|NEUROLOGIST|2|Visit_2|25|1|WASHOUT|2020-08-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|5|FEF2575P|Percent Predicted FEF25-75|[?]|DECUBITUS|[?]|nL|[?]|1|g/g/day|BRAIN, PERIVENTRICULAR REGION|IPSILATERAL|PARIETO-OCCIPITAL|KINETIC MICROPARTICLE IMMUNOASSAY|Y|||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|3|Visit_3|40|6|SCREENING|2020-09-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|6|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|PRONE|[?]|L/day|[?]|1|10^3 organisms/g|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|LOWER|MICROBIAL CULTURE, SOLID||Y||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|3|Visit_3|40|5|TREATMENT|2020-09-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-05
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|7|LCI|Lung Clearance Index|[?]|SITTING|[?]|U/kg/h|[?]|1|pg/dL|SKIN OF THE PALM|LEFT|ANTEROPOSTERIOR|IMMUNE REPERTOIRE DEEP SEQUENCING||||FRIEND|NEUROLOGIST|4|Visit_4|65|4|WASHOUT|2020-09-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|8|AWWVOL|Airway Wall Volume|[?]|REVERSE TRENDELENBURG|[?]|mg/kg|[?]|1|TROCHE|NUCLEUS OF DIAGONAL BAND|LATERAL|LOWER|ENDOSCOPY||||INTERVIEWER|UROLOGIST|4|Visit_4|65|7|TREATMENT|2020-09-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|PRONE|||[?]|1|/10^3|RIB 3|RIGHT|SUBCORTICAL|LANDOLT RING|||Y|SPOUSE|ENDOCRINOLOGIST|5|Visit_5|90|3|WASHOUT|2020-10-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|ea87b553-e331-40cf-bd86-d2bd22694476|10|PLMXRS|Pulmonary Reactance|[?]|SEMI-RECUMBENT|[?]|mL/mmHg/min/L|[?]|1|CAPLET|ILIUM|LEFT|SUPERIOR|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||Y||GUARDIAN|RATER 1|5|Visit_5|90|3|TREATMENT|2020-10-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|LOBVOL|Lobar Volume|[?]|SUPINE|[?]|U/m2/min|[?]|1|U/cL|FOOT DIGIT 5|UNILATERAL|INTERMEDIATE|CHROMATOGRAPHY||||STUDY SUBJECT|NEUROLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-07-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|2|FEV3FVC|FEV3/FVC|[?]|REVERSE TRENDELENBURG|[?]|P|[?]|1|SBE/mL|CHEST|CONTRALATERAL|HIND|PHOTOMETRIC CLOT DETECTION||||SIGNIFICANT OTHER|PHYSIOTHERAPIST|1|Visit_1|10|7|FOLLOW-UP|2020-07-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|3|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LATERAL DECUBITUS|||[?]|1|breaths/30s|SCAPHOID-CAPITATE JOINT|RIGHT|LOWER FLEXOR SURFACE|SLOAN LETTER EYE CHART 2.5%|||Y|STUDY SUBJECT|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2020-08-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-RECUMBENT|[?]|uL|[?]|1|m|SEBACEOUS GLAND|BILATERAL|TEMPORAL|REBOUND TONOMETRY||||INDEPENDENT ASSESSOR|RADIOLOGIST|2|Visit_2|25|7|SCREENING|2020-08-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|DECUBITUS|[?]|DAgU/mL|[?]|1|nm|PROSTATE GLAND|CONTRALATERAL|HIND|WESTERN BLOT||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|3|Visit_3|40|2|SCREENING|2020-08-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|6|IC|Inspiratory Capacity|[?]|TRENDELENBURG|[?]|L/kg|[?]|1|BOWL|AXILLARY LYMPH NODE LEVEL III|RIGHT|MEDIAL|FUNCTIONAL MRI||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|3|Visit_3|40|1|TREATMENT|2020-08-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|7|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING|[?]|mg/day|[?]|1|mg/g/h|FLANK|LATERAL|DISTAL VOLAR|ULTRASONOGRAPHIC ELASTOGRAPHY||||CHILD|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|1|TREATMENT|2020-09-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|8|OXYPULSE|Oxygen Pulse|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|DISK|PHARYNX|IPSILATERAL|UPPER EXTENSOR SURFACE|ELISPOT|Y|Y|Y|FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|9|INFLTIND|Infiltrates Indicator|[?]|SEMI-FOWLERS|[?]|deg|[?]|1|GBq/ug|ILIOPSOAS MUSCLE|IPSILATERAL|CENTRAL|DIGITAL PCR ARRAY|Y|||STUDY SUBJECT|RADIOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-10-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|10|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|[?]|HEP|[?]|1|damol/L|SUBMENTAL LYMPH NODE|UNILATERAL|VENTRAL|ALCIAN BLUE STAIN|Y|||DOMESTIC PARTNER|RADIOLOGIST 1|5|Visit_5|90|6|TREATMENT|2020-10-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|DECUBITUS|[?]|10^9/g|[?]|1|PIXELS/in|RIB 9|RIGHT|DISTAL|HPLC/MS/MS||||SIGNIFICANT OTHER|ENDOCRINOLOGIST|1|Visit_1|10|3|TREATMENT|2020-07-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|2|ERV|Expiratory Reserve Volume|[?]|UNCONSTRAINED|[?]|10^6 organisms/g|[?]|1|mPa|COMMON FEMORAL VEIN|LEFT|UPPER EXTENSOR SURFACE|POLYGRAPHY||||NON-HEALTH CARE PROFESSIONAL|INTERNIST|1|Visit_1|10|1|TREATMENT|2020-07-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|3|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|cm H2O|[?]|1|/ms|CEREBRAL SUBCORTEX|LEFT|OCCIPITAL|FLOCCULATION, CHARCOAL ENHANCED||||ADJUDICATION COMMITTEE|RATER|2|Visit_2|25|5|TREATMENT|2020-07-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|4|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|uL|[?]|1|U/m2/min|BRAIN, THIRD VENTRICLE|CONTRALATERAL|CENTRAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||||CLINICAL RESEARCH ASSOCIATE|INTERNIST|2|Visit_2|25|3|TREATMENT|2020-07-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-05
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|5|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|pmol/day|[?]|1|/cmH2O|ASCENDING AORTA, AORTIC ROOT|IPSILATERAL|ROSTRAL|DXA SCAN||||FAMILY MEMBER|MICROSCOPIST 1|3|Visit_3|40|3|TREATMENT|2020-08-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|6|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|10^3 CFU/mL|[?]|1|NEBULE|SPLEEN, HILUM|IPSILATERAL|FORE|WRIGHT-GIEMSA STAIN||||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|3|Visit_3|40|7|TREATMENT|2020-08-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|7|IVCPP|Percent Predicted IVC|[?]|SEMI-RECUMBENT|[?]|L/L|[?]|1|BP|LATISSIMUS DORSI MUSCLE|LATERAL|DISTAL VOLAR|APPLANATION TONOMETRY|Y|||GUARDIAN|OPTOMETRIST|4|Visit_4|65|3|TREATMENT|2020-09-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|8|SVC|Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|TAMPON|[?]|1|mph|PATELLA|UNILATERAL|LOWER EXTENSOR SURFACE|OPTICAL COHERENCE TOMOGRAPHY|Y|||SIGNIFICANT OTHER|MICROSCOPIST 1|4|Visit_4|65|7|TREATMENT|2020-09-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|9|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING|[?]|/40 HPFs|[?]|1|CAPLET|LEFT ATRIOVENTRICULAR ARTERY|LEFT|TIP|SISH|Y|||INVESTIGATOR|RATER 1|5|Visit_5|90|7|WASHOUT|2020-09-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|051dc064-be6f-43eb-aa51-7ed8634d6e23|10|TV|Tidal Volume|[?]|TRENDELENBURG|||[?]|1|mg/g/min|HEART, LEFT ATRIUM|RIGHT|DEEP|OBSERVATION|||Y|FRIEND|ADJUDICATOR|5|Visit_5|90|2|FOLLOW-UP|2020-09-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-09
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|RER|Respiratory Exchange Ratio|[?]|UNCONSTRAINED|||[?]|1|mg/dose|COLON, HEPATIC FLEXURE|RIGHT|ANTEROPOSTERIOR|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|||Y|HEALTH CARE PROFESSIONAL|ADJUDICATOR|1|Visit_1|10|7|FOLLOW-UP|2020-06-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|2|FIVC|Forced Inspiratory Vital Capacity|[?]|STANDING|[?]|mmol/min/kPa/L|[?]|1|ng/day|MITRAL VALVE, ANTERIOR ANNULUS|CONTRALATERAL|DISTAL VOLAR|CENTRIFUGATION|Y|||DOMESTIC PARTNER|READER 1|1|Visit_1|10|5|TREATMENT|2020-06-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-RECUMBENT|||[?]|1|kg/L|RETROPHARYNGEAL LYMPH NODE|IPSILATERAL|ANTEROMEDIAL|SLIT LAMP|Y||Y|ADJUDICATION COMMITTEE|ONCOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|4|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|FOWLERS|||[?]|1|bel|PENIS, RADIX|BILATERAL|HIND|AUTOREFRACTION|||Y|GUARDIAN|PATHOLOGIST|2|Visit_2|25|4|TREATMENT|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|5|INTP|Interpretation|[?]|REVERSE TRENDELENBURG|||[?]|1|U/mg|MESENTERY|IPSILATERAL|DISTAL VOLAR|CRYOSCOPY||Y|Y|SPOUSE|ADJUDICATOR|3|Visit_3|40|1|FOLLOW-UP|2020-07-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|6|FEV_PEF|FEV at PEF|[?]|STANDING|[?]|in|[?]|1|mCi|LOWER RESPIRATORY SYSTEM|LATERAL|VENTROLATERAL|FLUORESCENT IMMUNOASSAY||||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|3|Visit_3|40|6|TREATMENT|2020-07-03|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|7|PLMXRS|Pulmonary Reactance|[?]|DECUBITUS|||[?]|1|10^9 organisms/mg|BLADDER WALL|UNILATERAL|MIDLINE|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||Y|Y|CLINICAL RESEARCH COORDINATOR|UROLOGIST|4|Visit_4|65|6|WASHOUT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|8|SVC|Slow Vital Capacity|[?]|DECUBITUS|[?]|mol/mol|[?]|1|pL|CORPUS CALLOSUM, BODY|RIGHT|ANTEROPOSTERIOR|WHOLE EXOME SEQUENCING||||CLINICAL STUDY SPONSOR|READER 1|4|Visit_4|65|4|WASHOUT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|[?]|mL/cm H2O|[?]|1|cm H2O|AXILLARY LYMPH NODE|UNILATERAL|UPPER FLEXOR SURFACE|HPLC/MS||Y||DOMESTIC PARTNER|OTOLARYNGOLOGIST|5|Visit_5|90|1|TREATMENT|2020-08-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|10|FIFMAX|Maximum Forced Inspiratory Flow|[?]|DECUBITUS|[?]|/4.0 mL|[?]|1|log EID 50/dose|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|LATERAL|ANTEROPOSTERIOR|SPIROMETRY||Y||PROXY|RADIOLOGIST 1|5|Visit_5|90|1|FOLLOW-UP|2020-08-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|DLCOPP|Percent Predicted DLCO|[?]|STANDING, BENT FORWARD|[?]|/min|[?]|1|nmol BCE/mmol|AXILLA|UNILATERAL|SUPERFICIAL|ELECTROPHORESIS|Y|||STUDY SUBJECT|DERMATOLOGIST|1|Visit_1|10|2|SCREENING|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SUPINE|[?]|ng/day|[?]|1|/cmH2O|AORTO-ILIAC PERIPHERAL ARTERY|LATERAL|VENTRAL|FLOW MICROSCOPY||||GUARDIAN|ADJUDICATOR|1|Visit_1|10|3|SCREENING|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-18
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|REVERSE TRENDELENBURG|[?]|SUPPOSITORY|[?]|1|APS U|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|LEFT|APICAL|MIGET||||INTERVIEWER|ONCOLOGIST 1|2|Visit_2|25|3|TREATMENT|2020-09-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|4|PEF|Peak Expiratory Flow|[?]|SLING|[?]|kPa|[?]|1|g/mol|PULMONARY VALVE|IPSILATERAL|FRONTAL|DYNAMOMETRY|Y|||CHILD|NEUROLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-09-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-08
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|5|FEV1FVC6|FEV1/FVC6|[?]|TRENDELENBURG|||[?]|1|BAR|EPITROCHLEAR LYMPH NODE|RIGHT|PERIPHERAL|SINGLE-MOLECULE ARRAY|||Y|CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|WASHOUT|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|6|MALIND|Malignancy Indicator|[?]|LATERAL DECUBITUS|[?]|mg/kg/day|[?]|1|Joule|CHOROID|IPSILATERAL|LOWER FLEXOR SURFACE|DYNAMIC CONTRAST ENHANCED MRI||||ADJUDICATION COMMITTEE|PATHOLOGIST|3|Visit_3|40|7|SCREENING|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-20
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|10^9 organisms/mL|[?]|1|10^3/L|CORONARY ARTERY|IPSILATERAL|MIDLINE|PHOTOGRAPHY||||STUDY SUBJECT|NEUROLOGIST 1|4|Visit_4|65|3|SCREENING|2020-10-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|8|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LEFT LATERAL DECUBITUS|[?]|g/L|[?]|1|s*kPa|PERICARDIAL LYMPH NODE|UNILATERAL|MIDLINE|TELLER ACUITY CARDS||||DOMESTIC PARTNER|PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-10-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-02
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|9|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|PRONE|||[?]|1|Bq|COMMON ILIAC ARTERY|UNILATERAL|DORSOLATERAL|ETDRS EYE CHART|Y|Y|Y|SIGNIFICANT OTHER|ADJUDICATOR 3|5|Visit_5|90|1|FOLLOW-UP|2020-11-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|7a17fe21-b640-4bc5-bf19-b1bceb393dab|10|LCI|Lung Clearance Index|[?]|SEMI-FOWLERS|[?]|cP|[?]|1|EID 50/mL|ASCENDING AORTA, SINOTUBULAR JUNCTION|BILATERAL|MEDIAL|MRI WITHOUT CONTRAST|Y|||CLINICAL STUDY SPONSOR|OPTOMETRIST|5|Visit_5|90|1|TREATMENT|2020-11-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|PEFTIME|Peak Expiratory Flow Time|[?]|TRENDELENBURG|[?]|eq|[?]|1|CIGARETTE|CORONARY VEIN|UNILATERAL|TEMPORAL|IMMUNOASSAY||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|1|Visit_1|10|1|WASHOUT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|2|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|GBq/g|[?]|1|kUSP|FEMUR SHAFT|BILATERAL|UPPER|CARDIAC THERMODILUTION|Y|||FAMILY MEMBER|INTERNIST|1|Visit_1|10|5|TREATMENT|2021-01-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|3|AWVOL|Airway Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|in2|TRICUSPID VALVE|IPSILATERAL|ANTEROLATERAL|ELECTROGASTROGRAPHY|Y||Y|SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|5|FOLLOW-UP|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|4|TVPP|Percent Predicted Tidal Volume|[?]|LATERAL DECUBITUS|||[?]|1|uL/dose|CHEST WALL|BILATERAL|MEDIAL|DIFFUSION WEIGHTED MRI|||Y|FAMILY MEMBER|ENDOCRINOLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|5|PIF|Peak Inspiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|deg|[?]|1|mL/h|LUNG, LEFT, INFERIOR LOBE, LATERAL BASAL SEGMENT|CONTRALATERAL|APICAL|ACRIDINE ORANGE STAIN||Y||ADJUDICATION COMMITTEE|INTERNIST|3|Visit_3|40|6|FOLLOW-UP|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|6|MALEVDES|Malignancy Evidence Description|[?]|SEMI-FOWLERS|||[?]|1|mL/cage|T1 VERTEBRA|UNILATERAL|SUPERFICIAL|FORCED OSCILLATION TECHNIQUE|Y||Y|GUARDIAN|ONCOLOGIST 1|3|Visit_3|40|3|FOLLOW-UP|2021-02-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-13
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SITTING|[?]|fmol/g|[?]|1|Arbitrary U|TEMPOROMANDIBULAR JOINT|LEFT|MIDLINE|INDIRECT IMMUNOFLUORESCENCE||||NON-HEALTH CARE PROFESSIONAL|INTERNIST|4|Visit_4|65|5|TREATMENT|2021-03-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|8|FEV1FVC|FEV1/FVC|[?]|SLING|[?]|ugEq|[?]|1|BP|C1 VERTEBRA|BILATERAL|PROXIMAL|PLETHYSMOGRAPHY||||GUARDIAN|RADIOLOGIST 1|4|Visit_4|65|3|FOLLOW-UP|2021-03-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-11
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|9|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|uCi|[?]|1|IU/kg/h|LOCUS CERULEUS|UNILATERAL|INFERIOR|FARR ASSAY||||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|5|Visit_5|90|3|TREATMENT|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|10|PEFREV|PEF Reversibility|[?]|REVERSE TRENDELENBURG|[?]|ug/g/day|[?]|1|mg/day|ABDOMINAL CAVITY|UNILATERAL|BASAL|TONOMETRY||||INDEPENDENT ASSESSOR|RADIOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-12
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SITTING|[?]|/100 WBC|[?]|1|10^6 organisms/mL|INTERTROCHANTERIC REGION|LATERAL|UPPER|RADIAL IMMUNODIFFUSION|Y|||ADJUDICATOR|ADJUDICATOR 1|1|Visit_1|10|1|TREATMENT|2020-06-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|2|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING|[?]|kg|[?]|1|s^-1(%O2)^-1|INTERNAL MAMMARY ARTERY|LEFT|MIDLINE|EIA||||FRIEND|DERMATOLOGIST|1|Visit_1|10|2|WASHOUT|2020-06-23|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-04
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|3|EFFIND|Effusion Indicator|[?]|SLING|[?]|ukat/L|[?]|1|g|COMMON ILIAC ARTERY|CONTRALATERAL|VOLAR|FLUORESCENT MICROSCOPY||Y||INTERVIEWER|ONCOLOGIST 2|2|Visit_2|25|6|SCREENING|2020-07-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|4|INTP|Interpretation|[?]|STANDING, BENT FORWARD|[?]|ug/mol|[?]|1|dpm/0.5 mL|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|LATERAL|POSTERIOR|REFLECTANCE SPECTROSCOPY||||SIGNIFICANT OTHER|PATHOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-07-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|5|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|Sv|[?]|1|ohm|LEFT VENTRICULAR APICAL SEPTAL SEGMENT|CONTRALATERAL|UPPER|INTRAVASCULAR ULTRASOUND||||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|3|Visit_3|40|5|SCREENING|2020-07-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|pmol/L/h|[?]|1|100 IU/mL|OBTURATOR INTERNUS MUSCLE|LATERAL|LOWER MEDIAL|SURFACE PLASMON RESONANCE||||FRIEND|UROLOGIST|3|Visit_3|40|4|WASHOUT|2020-07-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-25
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|7|FIV1|Forced Inspiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|WEEKS|[?]|1|mV|TARSAL JOINT|CONTRALATERAL|FRONTAL|TARGETED GENOME SEQUENCING||||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-08-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|8|IVC|Inspiratory Vital Capacity|[?]|FOWLERS|||[?]|1|damol/L|RIGHT ATRIAL ENDOCARDIUM|IPSILATERAL|ANTEROLATERAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY|Y|Y|Y|SIBLING|PHYSIOTHERAPIST|4|Visit_4|65|4|WASHOUT|2020-08-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|9|AWWVOL|Airway Wall Volume|[?]|DECUBITUS|[?]|mL|[?]|1|amol|POSTERIOR INFERIOR CEREBELLAR ARTERY|LEFT|DORSAL|CISH|Y|||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|TREATMENT|2020-09-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|f1d0daec-aa97-4838-9c53-e16dae3e17b2|10|FEV1SVC|FEV1/SVC|[?]|TRENDELENBURG|||[?]|1|Ci/kg|PERIPHERAL NERVE|IPSILATERAL|PROXIMAL|MIGET|||Y|HEALTH CARE PROFESSIONAL|READER|5|Visit_5|90|4|WASHOUT|2020-09-11|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|1|FEV6PP|Percent Predicted FEV6|[?]|FOWLERS|[?]|Watt|[?]|1|Rad|WRIST JOINT EXTENSOR TENDONS|BILATERAL|BASAL|GEL ELECTROPHORESIS|Y|||INDEPENDENT ASSESSOR|OPTOMETRIST|1|Visit_1|10|7|TREATMENT|2020-11-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|2|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|ug/mol|[?]|1|RFU|COMMON ILIAC ARTERY|UNILATERAL|SUPERFICIAL|SURFACE PLASMON RESONANCE||||VENDOR|MICROSCOPIST 2|1|Visit_1|10|4|SCREENING|2020-11-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-07
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|3|FIV1|Forced Inspiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|mmol/L|[?]|1|/VF|ACHILLES TENDON|CONTRALATERAL|CRANIAL|LASER CAPTURE MICRODISSECTION||||DOMESTIC PARTNER|MICROSCOPIST 2|2|Visit_2|25|1|FOLLOW-UP|2020-11-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|4|PEFREV|PEF Reversibility|[?]|UNCONSTRAINED|[?]|log10 PFU/mL|[?]|1|/10^4|MAXILLA|RIGHT|OCCIPITAL|NUCLEAR RADIOLOGY|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST|2|Visit_2|25|4|TREATMENT|2020-11-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|SLING|[?]|mg/m2/h|[?]|1|cm2|GLUTEAL MUSCLE|LATERAL|LATERAL|AGAR DILUTION|Y|||FRIEND|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-12-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|6|PIF|Peak Inspiratory Flow|[?]|UNCONSTRAINED|||[?]|1|oz eq|ISCHIAL TUBEROSITY|BILATERAL|VENTRAL|CLINICAL EVALUATION|||Y|CHILD|OPHTHALMOLOGIST|3|Visit_3|40|3|SCREENING|2020-12-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|7|PNIF|Peak Nasal Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|umol/L/min|[?]|1|ug/g/h|T6 VERTEBRA|BILATERAL|OCCIPITAL|MANUAL CLOT DETECTION|Y|Y||DOMESTIC PARTNER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-12-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|FOWLERS|[?]|QUANTITY SUFFICIENT|[?]|1|OI50|LUNG, RIGHT, INFERIOR LOBE, MEDIAL BASAL SEGMENT|CONTRALATERAL|HIND|THICK SMEAR||Y||FRIEND|PEDIATRIC NEUROLOGIST|4|Visit_4|65|7|TREATMENT|2020-12-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-19
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SUPINE|[?]|10^4 CFU|[?]|1|breaths/min|LEFT VENTRICULAR APICAL LATERAL SEGMENT|UNILATERAL|LOWER FLEXOR SURFACE|PLAQUE REDUCTION NEUTRALIZATION ASSAY||||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|TREATMENT|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|835594ab-e93c-402b-8129-6af659be5ae1|10|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|mV2/Hz|[?]|1|MONTHS|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|UNILATERAL|FORE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y||STUDY SUBJECT|RATER 1|5|Visit_5|90|1|TREATMENT|2021-01-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|MEPPP|Percent Predicted MEP|[?]|STANDING, BENT FORWARD|[?]|mCi/L|[?]|1|TRANSDUCING UNIT|LUNG, LEFT|RIGHT|UPPER FLEXOR SURFACE|FARR ASSAY|Y|Y||FRIEND|DERMATOLOGIST|1|Visit_1|10|2|WASHOUT|2020-10-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING|||[?]|1|mL/animal|SAPHENOUS VEIN|BILATERAL|NASAL|IMMUNE REPERTOIRE DEEP SEQUENCING|||Y|VENDOR|RADIOLOGIST 2|1|Visit_1|10|2|FOLLOW-UP|2020-10-07|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|PRONE|[?]|/mm|[?]|1|MBq/uL|ASCENDING AORTA, SINUS OF VALSALVA|RIGHT|PARIETO-OCCIPITAL|PET SCAN||Y||PARENT|MICROSCOPIST|2|Visit_2|25|4|FOLLOW-UP|2020-10-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|UNCONSTRAINED|||[?]|1|HEP|RIB 6|UNILATERAL|DISTAL VOLAR|MECHANICAL CLOT DETECTION||Y|Y|INTERVIEWER|ADJUDICATOR 3|2|Visit_2|25|6|SCREENING|2020-10-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|5|FEF2575P|Percent Predicted FEF25-75|[?]|STANDING, BENT FORWARD|[?]|mL/min/mmHg|[?]|1|pL|AXILLA|UNILATERAL|DEEP|CONTRAST ENHANCED CT SCAN||||SPOUSE|UROLOGIST|3|Visit_3|40|7|WASHOUT|2020-11-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|6|PEFREV|PEF Reversibility|[?]|SITTING|[?]|U/m2/day|[?]|1|U/m2/min|TRAPEZOID-CAPITATE JOINT|LATERAL|SUPERFICIAL|ELECTROPHORESIS||||CLINICAL STUDY SPONSOR|RADIOLOGIST 2|3|Visit_3|40|2|FOLLOW-UP|2020-11-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|7|OXYPULSE|Oxygen Pulse|[?]|FOWLERS|||[?]|1|pmol/g|ANKLE JOINT|IPSILATERAL|VENTROLATERAL|TRYPAN BLUE STAIN|||Y|VENDOR|ONCOLOGIST 1|4|Visit_4|65|5|TREATMENT|2020-12-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|8|FEV1FVC|FEV1/FVC|[?]|UNCONSTRAINED|||[?]|1|uL/dose|HAIR SHAFT|UNILATERAL|FRONTAL|SISH|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|READER 2|4|Visit_4|65|6|TREATMENT|2020-12-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|9|ICREV|IC Reversibility|[?]|PRONE|[?]|Bq|[?]|1|cm/min|GREAT SAPHENOUS VEIN|RIGHT|TIP|MAPH||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|5|Visit_5|90|7|TREATMENT|2020-12-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|c3c85786-d24b-4620-9ee0-c13b1cc4f951|10|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SITTING|[?]|AU/mL|[?]|1|10^9/g|ACROMIOCLAVICULAR JOINT|BILATERAL|NASAL|CYSTOMETRY||||INVESTIGATOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|7|WASHOUT|2020-12-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|dpm/100mg|[?]|1|g/g/day|ELBOW EXTENSOR MUSCLES|RIGHT|APICAL|ANTIBIOTIC AGAR SCREEN||||VENDOR|RADIOLOGIST 2|1|Visit_1|10|1|WASHOUT|2020-11-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|2|TSUHYS|Tissue Hysteresivity|[?]|PRONE|[?]|nm|[?]|1|/5x10^4 WBC|AORTIC ARCH|LEFT|ANTEROLATERAL|HEMAGGLUTINATION INHIBITION ASSAY||||FAMILY MEMBER|CARDIOLOGIST|1|Visit_1|10|5|TREATMENT|2020-11-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-RECUMBENT|[?]|fmol/g|[?]|1|Shock Wave|CEREBRAL HEMISPHERE, LEFT|LEFT|MEDIAL|PATHOLOGICAL EVALUATION||||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-11-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|4|IRVPP|Percent Predicted IRV|[?]|SEMI-FOWLERS|[?]|mg/kg/dose|[?]|1|mCi|GINGIVAL MUCOSA|IPSILATERAL|UPPER EXTENSOR SURFACE|AUTOMATED COUNT||||PARENT|NEUROLOGIST 2|2|Visit_2|25|6|SCREENING|2020-11-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|5|PNIF|Peak Nasal Inspiratory Flow|[?]|UNCONSTRAINED|||[?]|1|MHz|INCUS|CONTRALATERAL|ANTEROTEMPORAL|ACCELERATOR MASS SPECTROMETRY|||Y|INDEPENDENT ASSESSOR|READER 3|3|Visit_3|40|6|TREATMENT|2020-12-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|6|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|mL/m2|[?]|1|mmHg|MUSCULOSKELETAL SYSTEM|IPSILATERAL|INFERIOR|PATHOLOGICAL EVALUATION||||CHILD|CLINICAL PATHOLOGIST|3|Visit_3|40|4|FOLLOW-UP|2020-12-15|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|7|ALVVOL|Alveolar Volume|[?]|SLING|[?]|ng/mol|[?]|1|deg/s|INTERTROCHANTERIC REGION|BILATERAL|VENTROLATERAL|ELECTROMYOGRAPHY||||DOMESTIC PARTNER|CARDIOLOGIST|4|Visit_4|65|7|TREATMENT|2021-01-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|8|IC|Inspiratory Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|RING|[?]|1|Anson U|SPLEEN|BILATERAL|FRONTAL|IHC|Y|Y||DOMESTIC PARTNER|RATER 1|4|Visit_4|65|3|FOLLOW-UP|2021-01-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|9|SVC|Slow Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|ka_u/dL|GASTROINTESTINAL TRACT, WALL|CONTRALATERAL|MIDLINE|HILLMEN COLOR CHART|||Y|SIBLING|OPTOMETRIST|5|Visit_5|90|6|TREATMENT|2021-02-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|5354e3c4-4106-4e4c-85c3-2dbbd001688c|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SEMI-FOWLERS|[?]|gMFI|[?]|1|mmol/mol|BODY|LATERAL|VOLAR|CELL OF ORIGIN ASSAY||Y||DOMESTIC PARTNER|RATER|5|Visit_5|90|4|FOLLOW-UP|2021-02-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-06
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|ELSTNCE|Elastance|[?]|SITTING|[?]|%/s|[?]|1|h*%|ORAL CAVITY|BILATERAL|INNER|DIRECT SEQUENCING||||CHILD|READER 2|1|Visit_1|10|5|TREATMENT|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|2|ELSTNCE|Elastance|[?]|DECUBITUS|[?]|kg/cm|[?]|1|MPL U|LAD SEPTAL PERFORATOR ARTERY|UNILATERAL|LOWER|URANYL ACETATE STAIN||||FAMILY MEMBER|RATER|1|Visit_1|10|2|TREATMENT|2020-06-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-25
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|3|TGV|Thoracic Gas Volume|[?]|LEFT LATERAL DECUBITUS|[?]|m/sec2|[?]|1|mPa|TRIANGULAR-LUNATE JOINT|CONTRALATERAL|TIP|AMSLER GRID|Y|||CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|6|WASHOUT|2020-07-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|4|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|||[?]|1|/VF|ACROMIOCLAVICULAR JOINT|LEFT|PROXIMAL VOLAR|NEPHELOMETRY|||Y|SIGNIFICANT OTHER|MICROSCOPIST 1|2|Visit_2|25|2|TREATMENT|2020-07-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|5|IRVPP|Percent Predicted IRV|[?]|REVERSE TRENDELENBURG|[?]|Enzyme U/m2|[?]|1|GBq/mg|LOWER JUGULAR LYMPH NODE|LEFT|DORSOLATERAL|IMMUNOFLUORESCENT STAIN||Y||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|3|TREATMENT|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|6|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|Gy|[?]|1|mg/cm2|HARD PALATE|IPSILATERAL|CENTRAL|SCANNING ELECTRON MICROSCOPY||||GUARDIAN|DERMATOLOGIST|3|Visit_3|40|3|WASHOUT|2020-07-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|7|ERVPP|Percent Predicted ERV|[?]|DECUBITUS|||[?]|1|/40 HPFs|RETROAURICULAR LYMPH NODE|RIGHT|INFERIOR|ENZYMATIC SPECTROPHOTOMETRY|Y||Y|INTERVIEWER|MICROSCOPIST|4|Visit_4|65|3|TREATMENT|2020-08-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|8|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-FOWLERS|[?]|mg/day|[?]|1|Hz|HEEL OF THE FOOT|CONTRALATERAL|PERIPHERAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||PROXY|ADJUDICATOR 2|4|Visit_4|65|5|FOLLOW-UP|2020-08-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|9|AWVOL|Airway Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|ELISA unit/dose|SCALP|CONTRALATERAL|SUPERFICIAL|INCISION-INDUCED BLEEDING METHOD||Y|Y|CHILD|INTERNIST|5|Visit_5|90|5|TREATMENT|2020-09-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|f10e9188-ef7b-46f9-a80a-0669436eb4dd|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|LATERAL DECUBITUS|||[?]|1|10^3 organisms/mL|METACARPOPHALANGEAL JOINT 2|LEFT|SUPERFICIAL|OLIGO ACGH|||Y|VENDOR|OPTOMETRIST|5|Visit_5|90|2|TREATMENT|2020-09-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|RELSZCHG|Relative Size Change|[?]|REVERSE TRENDELENBURG|[?]|10^3 CFU|[?]|1|g/U|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|LATERAL|OCCIPITAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|Y|||STUDY SUBJECT|NEUROLOGIST|1|Visit_1|10|3|TREATMENT|2020-08-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|FOWLERS|[?]|cm/min|[?]|1|%(w/v)|CORONARY VEIN|IPSILATERAL|MEDIAL|VENTILATION PERFUSION LUNG SCAN||||VENDOR|NEUROLOGIST 1|1|Visit_1|10|7|TREATMENT|2020-08-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|3|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|U|[?]|1|BAR|COCCYGEAL VERTEBRA|RIGHT|UPPER|LC/MS||||SIBLING|ONCOLOGIST|2|Visit_2|25|7|TREATMENT|2020-08-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|4|AWVOL|Airway Volume|[?]|UNCONSTRAINED|[?]|nsec|[?]|1|RATIO|GINGIVA|IPSILATERAL|DORSAL|CT SCAN WITHOUT CONTRAST|Y|||NON-HEALTH CARE PROFESSIONAL|READER 3|2|Visit_2|25|3|TREATMENT|2020-08-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-14
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|5|PLMXRS|Pulmonary Reactance|[?]|SEMI-RECUMBENT|[?]|titer|[?]|1|mg/h|BACK|BILATERAL|LOWER|GC/MS-CI|Y|||DOMESTIC PARTNER|OTOLARYNGOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-09-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|6|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|/10^4|[?]|1|steps/min|INTERPHALANGEAL JOINT 3 OF THE HAND|RIGHT|PROXIMAL|DOPPLER ULTRASOUND||||INTERVIEWER|RATER|3|Visit_3|40|3|TREATMENT|2020-09-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|7|IVC|Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|EIA unit|[?]|1|fg|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|ANTEROMEDIAL|DARK FIELD MICROSCOPY|Y|||VENDOR|INTERNIST|4|Visit_4|65|7|SCREENING|2020-10-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|8|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|mmol/L|[?]|1|RNA copies/mL|LEFT MAIN CORONARY ARTERY OSTIUM|CONTRALATERAL|SURFACE|MRS|Y|||CLINICAL STUDY SPONSOR|RADIOLOGIST|4|Visit_4|65|1|WASHOUT|2020-10-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-19
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|9|ERVPP|Percent Predicted ERV|[?]|STANDING|[?]|mL/m2/day|[?]|1|in2|L3 VERTEBRA|LEFT|PROXIMAL|LC/MS/MS|Y|||SPOUSE|OPTOMETRIST|5|Visit_5|90|7|TREATMENT|2020-11-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|10|IVC|Inspiratory Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|nL|[?]|1|FFU|COLON, SPLENIC FLEXURE|BILATERAL|CAUDAL|MYELOPEROXIDASE STAIN||||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2020-11-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|FRC|Functional Residual Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|/wk|[?]|1|ug/min|DISTAL EXTRAHEPATIC BILE DUCT REGION|CONTRALATERAL|UPPER FLEXOR SURFACE|VENTILATION PERFUSION LUNG SCAN||Y||FAMILY MEMBER|CARDIOLOGIST|1|Visit_1|10|6|TREATMENT|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|2|ELSTNCE|Elastance|[?]|SLING|[?]|uCi/kg|[?]|1|EVENTS|GASTROESOPHAGEAL JUNCTION|IPSILATERAL|LOWER FLEXOR SURFACE|FLOCCULATION||||STUDY SUBJECT|UROLOGIST|1|Visit_1|10|3|TREATMENT|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|3|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|[?]|BE/mL|[?]|1|mol/L|MALLEUS|CONTRALATERAL|MEDIAL|GC/MS/MS||||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|2|Visit_2|25|5|TREATMENT|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|4|OXYPULSE|Oxygen Pulse|[?]|STANDING|||[?]|1|fmol/L/sec|MID-JUGULAR LYMPH NODE|BILATERAL|OUTER|MICROARRAY||Y|Y|INVESTIGATOR|RADIOLOGIST 1|2|Visit_2|25|3|WASHOUT|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|5|DLCO|Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|fraction of 1|[?]|1|s*kPa|CARPOMETACARPAL JOINT 2|RIGHT|FACIAL|INDIRECT IMMUNOFLUORESCENCE||||GUARDIAN|ENDOCRINOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|6|MEPPP|Percent Predicted MEP|[?]|REVERSE TRENDELENBURG|[?]|log10 CCID 50/dose|[?]|1|ohm|FEMUR|LEFT|FRONTAL|KARYOTYPING||||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-11-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|7|DLCOVA|DLCO/VA|[?]|SLING|[?]|10^4 CFU/mL|[?]|1|L/s|HEEL OF THE HAND|CONTRALATERAL|LOWER FLEXOR SURFACE|MICRONEUTRALIZATION ASSAY||||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|4|Visit_4|65|5|WASHOUT|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|8|INFLTIND|Infiltrates Indicator|[?]|LATERAL DECUBITUS|[?]|fmol/L|[?]|1|mL/100g/min|RADIUS SHAFT|UNILATERAL|ANTERIOR|FLUORESCENT MICROSCOPY|Y|||ADJUDICATOR|CARDIOLOGIST|4|Visit_4|65|2|TREATMENT|2020-12-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|FOWLERS|[?]|pg|[?]|1|g/kg|FEMORAL VEIN|BILATERAL|CENTRAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|6|SCREENING|2021-01-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|000b5b99-a92d-4c84-9edc-ee08930d8a2e|10|IVCPP|Percent Predicted IVC|[?]|REVERSE TRENDELENBURG|||[?]|1|mg/g/h|AORTIC VALVE, RIGHT CORONARY CUSP|CONTRALATERAL|SUBCORTICAL|OPTICAL COHERENCE TOMOGRAPHY|Y||Y|NON-HEALTH CARE PROFESSIONAL|RATER|5|Visit_5|90|3|SCREENING|2021-01-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-27
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|PNEUMIND|Pneumonia Indicator|[?]|UNCONSTRAINED|[?]|L/s|[?]|1|PACK|CORNEAL ENDOTHELIUM|BILATERAL|ROSTRAL|QUANTITATIVE ULTRASOUND|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|1|Visit_1|10|7|FOLLOW-UP|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|2|INERTANC|Inertance|[?]|STANDING, BENT FORWARD|||[?]|1|CUP|COLON LYMPH NODE|IPSILATERAL|LOWER MEDIAL|RADIOGRAPHY|Y||Y|ADJUDICATION COMMITTEE|ADJUDICATOR 1|1|Visit_1|10|4|TREATMENT|2020-06-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|3|RVPP|Percent Predicted Residual Volume|[?]|TRENDELENBURG|[?]|ug/L|[?]|1|mEq/L|MESENTERIC ARTERY|BILATERAL|UPPER EXTENSOR SURFACE|TONOMETRY|Y|||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-06-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|4|SVCPP|Percent Predicted Slow Vital Capacity|[?]|FOWLERS|||[?]|1|cmH2O/mL|APPENDICULAR SKELETON|CONTRALATERAL|ANTEROLATERAL|DUKE INCISION METHOD|||Y|CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|5|FOLLOW-UP|2020-06-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-31
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|DECUBITUS|[?]|FFU|[?]|1|/LSQN|SHOULDER JOINT TENDONS|BILATERAL|ANTEROMEDIAL|MAGNETIC RESONANCE ANGIOGRAPHY||Y||ADJUDICATION COMMITTEE|RADIOLOGIST 1|3|Visit_3|40|7|FOLLOW-UP|2020-07-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|6|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING|[?]|L/s|[?]|1|Hounsfield Unit|PRELARYNGEAL LYMPH NODE|UNILATERAL|ANTEROLATERAL|IMMUNE REPERTOIRE DEEP SEQUENCING||||ADJUDICATOR|RADIOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-07-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|7|TSUHYS|Tissue Hysteresivity|[?]|REVERSE TRENDELENBURG|[?]|fL|[?]|1|U/g/h|T12 VERTEBRA|LATERAL|VENTROLATERAL|NEPHELOMETRY||||VENDOR|NEUROLOGIST 1|4|Visit_4|65|7|WASHOUT|2020-07-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|PRONE|[?]|nmol/g|[?]|1|h/wk|SUBCLAVIAN VEIN|BILATERAL|INTERMEDIATE|SPECTROPHOTOMETRY||||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|FOLLOW-UP|2020-07-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-31
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|9|LCI|Lung Clearance Index|[?]|SLING|||[?]|1|g/cage/wk|T11 VERTEBRA|IPSILATERAL|DORSOLATERAL|IODINE STAIN||Y|Y|ADJUDICATION COMMITTEE|ADJUDICATOR|5|Visit_5|90|5|WASHOUT|2020-08-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|10|IVCPP|Percent Predicted IVC|[?]|SEMI-RECUMBENT|[?]|mg/kg|[?]|1|mEq/mmol|RIGHT ATRIAL ENDOCARDIUM|RIGHT|CENTRAL|REVERSE TRANSCRIPTASE PCR||Y||GUARDIAN|OPTOMETRIST|5|Visit_5|90|5|SCREENING|2020-08-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SEMI-FOWLERS|[?]|AgU/mL|[?]|1|L/kg|CORONARY VEIN|UNILATERAL|ANTEROLATERAL|STRESS ECHOCARDIOGRAPHY||||GUARDIAN|UROLOGIST|1|Visit_1|10|2|WASHOUT|2020-09-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|2|INERTANC|Inertance|[?]|FOWLERS|[?]|km/h|[?]|1|U/g|BODY|UNILATERAL|INFERIOR|ACRIDINE ORANGE STAIN|Y|||INDEPENDENT ASSESSOR|ONCOLOGIST 2|1|Visit_1|10|3|TREATMENT|2020-09-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-11
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|3|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-RECUMBENT|[?]|10^9 organisms|[?]|1|msec|GENITOURINARY SYSTEM|BILATERAL|ANTERIOR|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||GUARDIAN|READER|2|Visit_2|25|3|TREATMENT|2020-10-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SEMI-RECUMBENT|[?]|ug/L DDU|[?]|1|hr/day|LOWER GASTROINTESTINAL TRACT LYMPH NODE|LATERAL|ANTEROTEMPORAL|HIGH RESOLUTION CT|Y|||STUDY SUBJECT|READER|2|Visit_2|25|6|WASHOUT|2020-10-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|5|TLCPP|Percent Predicted Total Lung Capacity|[?]|PRONE|[?]|TRANSDUCING UNIT/mL|[?]|1|mL/day|BLADDER, TRIGONE|RIGHT|PERIVENTRICULAR|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||Y||CAREGIVER|READER 1|3|Visit_3|40|1|WASHOUT|2020-10-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|6|ALVVOL|Alveolar Volume|[?]|SLING|[?]|mg/g/min|[?]|1|/2000 RBC|BLADDER|BILATERAL|CAUDAL|EPSILOMETER|Y|||INTERVIEWER|DERMATOLOGIST|3|Visit_3|40|4|SCREENING|2020-10-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|7|PNIF|Peak Nasal Inspiratory Flow|[?]|SUPINE|[?]|HOURS|[?]|1|mm3/mm2/year|SCAPHOID BONE|RIGHT|POSTERIOR|CLIP SEQUENCING|Y|||ADJUDICATION COMMITTEE|CARDIOLOGIST|4|Visit_4|65|1|WASHOUT|2020-11-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|8|PIF|Peak Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|10^6 DNA copies/mL|MESENTERY|LEFT|TIP|KARYOTYPING|||Y|INDEPENDENT ASSESSOR|ADJUDICATOR 1|4|Visit_4|65|2|TREATMENT|2020-11-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-28
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|9|IVCPP|Percent Predicted IVC|[?]|TRENDELENBURG|[?]|g/L|[?]|1|min|APPENDICULAR SKELETON|IPSILATERAL|ANTEROMEDIAL|PEAK FLOWMETRY||Y||VENDOR|ENDOCRINOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-12-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|11b2b359-d4a1-411d-a676-075b26e1453c|10|SVCPP|Percent Predicted Slow Vital Capacity|[?]|LATERAL DECUBITUS|[?]|ug/L/h|[?]|1|INHALATION|RIGHT ATRIAL ENDOCARDIUM|LATERAL|PERIPHERAL|MRI||||DOMESTIC PARTNER|MICROSCOPIST 2|5|Visit_5|90|5|TREATMENT|2020-12-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|1|PCF|Peak Cough Flow|[?]|SLING|[?]|DDU|[?]|1|mmol/min/kPa/L|MITRAL VALVE, ANTERIOR ANNULUS|CONTRALATERAL|FORE|IODINE STAIN|Y|Y||NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|1|Visit_1|10|7|SCREENING|2020-10-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|PRONE|[?]|Ci/kg|[?]|1|nU/cL|RIB|RIGHT|PERIPHERAL|AURAMINE STAIN||Y||SIBLING|CLINICAL PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-10-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|3|MEP|Maximal Expiratory Pressure|[?]|LEFT LATERAL DECUBITUS|[?]|kat|[?]|1|vg/dose|CEPHALIC VEIN|LEFT|MIDLINE|NUCLEIC ACID HYBRIDIZATION||||INDEPENDENT ASSESSOR|NEUROLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-11-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|4|AWVOL|Airway Volume|[?]|SLING|[?]|10^6 U|[?]|1|CFU/g|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|LEFT|VENTROLATERAL|IN VITRO GENE EXPRESSION ASSAY|Y|||GUARDIAN|NEUROLOGIST|2|Visit_2|25|1|SCREENING|2020-11-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-22
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SITTING, LEGS DEPENDENT|[?]|mEq/kg|[?]|1|CYLINDER|DIAPHRAGMATIC LYMPH NODE|BILATERAL|LOWER EXTENSOR SURFACE|HPLC/MS||||ADJUDICATOR|CLINICAL PATHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-11-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|6|FEV1FVC6|FEV1/FVC6|[?]|PRONE|[?]|U/g/min|[?]|1|SPRAY|DISTAL RIGHT CORONARY ARTERY CONDUIT|RIGHT|INNER|COULOMETRIC TITRATION||Y||VENDOR|RADIOLOGIST 1|3|Visit_3|40|1|TREATMENT|2020-11-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-12
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|7|AWVOLPP|Percent Predicted Airway Volume|[?]|SEMI-FOWLERS|[?]|pmol/g|[?]|1|NEEDLE GAUGE|CAUDAL VERTEBRA|UNILATERAL|VENTROLATERAL|CONTRAST ENHANCED CT SCAN||Y||INVESTIGATOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|8|GAW|Airway Conductance|[?]|LATERAL DECUBITUS|[?]|Bq|[?]|1|/min|TESTIS|BILATERAL|HIND|COULOMETRIC TITRATION||||VENDOR|RADIOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-12-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|9|IC|Inspiratory Capacity|[?]|STANDING|[?]|TRANSDUCING UNIT/mL|[?]|1|mV/sec|RIB 7|LEFT|VENTRAL|MAMMOGRAPHY|Y|||SIBLING|MICROSCOPIST 3|5|Visit_5|90|3|TREATMENT|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|293f673d-af6a-473e-8bce-118bb85bbd9e|10|PLMXRS|Pulmonary Reactance|[?]|LATERAL DECUBITUS|||[?]|1|10^3 RNA copies/mL|OMENTUM|RIGHT|CENTRAL|LAPAROSCOPY|||Y|FRIEND|READER 1|5|Visit_5|90|6|TREATMENT|2021-01-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-16
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|1|ICPP|Percent Predicted Inspiratory Capacity|[?]|UNCONSTRAINED|||[?]|1|mg/dose|PERIURETHRAL REGION|CONTRALATERAL|INNER|NUCLEAR RADIOLOGY|||Y|INTERVIEWER|RATER|1|Visit_1|10|1|SCREENING|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|2|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|[?]|/100 HPFs|[?]|1|/7.5 mL|SCAPHOID BONE|UNILATERAL|TIP|NEPHELOMETRY||Y||CHILD|RADIOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-07-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|PRONE|[?]|ng/L|[?]|1|mL/m2|COLON, TRANSVERSE|BILATERAL|TIP|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||||ADJUDICATOR|ONCOLOGIST|2|Visit_2|25|3|WASHOUT|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|TRENDELENBURG|[?]|10^8 PFU|[?]|1|dram|PARATRACHEAL LYMPH NODE|UNILATERAL|CAUDAL|COULOMETRIC TITRATION|Y|||INVESTIGATOR|RATER|2|Visit_2|25|2|WASHOUT|2020-07-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|5|OXYPULSE|Oxygen Pulse|[?]|SLING|[?]|ms2|[?]|1|Bq/mL|INTERTROCHANTERIC REGION|CONTRALATERAL|LOWER|FLOCCULATION, CHARCOAL ENHANCED||||PARENT|UROLOGIST|3|Visit_3|40|1|WASHOUT|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|6|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|VOXEL|[?]|1|g/m2/day|COCCYX|LEFT|PERIVENTRICULAR|GEL ELECTROPHORESIS||||STUDY SUBJECT|READER 3|3|Visit_3|40|6|TREATMENT|2020-08-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|7|LOBVOL|Lobar Volume|[?]|REVERSE TRENDELENBURG|[?]|mL/breath|[?]|1|cm/min|RIB 11|LEFT|ANTEROMEDIAL|OPTICAL MAPPING|Y|||CHILD|PATHOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|8|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING, LEGS DEPENDENT|||[?]|1|/sec|LEFT VENTRICULAR MID INFEROLATERAL SEGMENT|BILATERAL|APICAL|KINYOUN STAIN|Y||Y|INTERVIEWER|NEUROLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-08-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|UNCONSTRAINED|[?]|pkat|[?]|1|g/U|FINGER EXTENSOR TENDONS|LEFT|SUPERFICIAL|SLOAN LETTER EYE CHART 2.5%||||VENDOR|PATHOLOGIST 2|5|Visit_5|90|1|TREATMENT|2020-09-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|0f60ab31-ee13-4846-93d2-6bcac139006f|10|MIPPP|Percent Predicted MIP|[?]|SITTING|[?]|mg/m2/min|[?]|1|U/dL|T6 VERTEBRA|BILATERAL|ANTEROLATERAL|NUCLEIC ACID BASED METHOD||||STUDY SUBJECT|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2020-09-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|||[?]|1|BAU|PALATE|BILATERAL|FACIAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y||Y|PARENT|CLINICAL PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|2|FIF75|Forced Inspiratory Flow at 75%|[?]|PRONE|[?]|pkat/L|[?]|1|log10 CFU/mL|TYMPANIC MEMBRANE|IPSILATERAL|ROSTRAL|TONOMETRY||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-08-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-23
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LATERAL DECUBITUS|[?]|ug/dL|[?]|1|ug/g/min|DISTANT LYMPH NODE|UNILATERAL|UPPER|SINGLE-MOLECULE ARRAY||||CAREGIVER|MICROSCOPIST 3|2|Visit_2|25|5|FOLLOW-UP|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|4|GAW|Airway Conductance|[?]|SUPINE|[?]|ECL unit|[?]|1|TRACE|IRIS|BILATERAL|VENTRAL|WRIGHT STAIN||||ADJUDICATOR|OPTOMETRIST|2|Visit_2|25|7|TREATMENT|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|5|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|Sv|[?]|1|umol/mg/min|INTERPHALANGEAL JOINT 3|LATERAL|DISTAL VOLAR|GC/MS/MS||||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|3|Visit_3|40|7|FOLLOW-UP|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|6|ICREV|IC Reversibility|[?]|DECUBITUS|[?]|/month|[?]|1|/MBP|EYE BULGE|BILATERAL|SUPERFICIAL|ACRIDINE ORANGE STAIN|Y|||HEALTH CARE PROFESSIONAL|UROLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-11
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|7|DLCOHC|HGB Corrected DLCO|[?]|SEMI-RECUMBENT|[?]|10^5/L|[?]|1|ng|MITRAL VALVE, ANTERIOR CUSP|LATERAL|FACIAL|ENZYMATIC SPECTROPHOTOMETRY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|4|Visit_4|65|1|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|8|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|EVENTS|[?]|1|fL|SKIN AROUND THE MOUTH|LATERAL|UPPER EXTENSOR SURFACE|NUCLEAR RADIOLOGY||||NON-HEALTH CARE PROFESSIONAL|READER 3|4|Visit_4|65|5|FOLLOW-UP|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|9|ALVVOL|Alveolar Volume|[?]|DECUBITUS|[?]|pmol/dL|[?]|1|cd|LEFT VENTRICULAR MID ANTERIOR SEGMENT|BILATERAL|INNER|FLOCCULATION||Y||FRIEND|PATHOLOGIST|5|Visit_5|90|2|WASHOUT|2020-11-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|d49f37ce-2d6e-4ebb-91af-7ed32322f824|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|IU/dL|TEMPORAL BONE|BILATERAL|PROXIMAL VOLAR|KLEIHAUER-BETKE|Y||Y|SIGNIFICANT OTHER|DERMATOLOGIST|5|Visit_5|90|1|TREATMENT|2020-11-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-RECUMBENT|[?]|g/animal|[?]|1|IU/kg|POPLITEAL LYMPH NODE|IPSILATERAL|SURFACE|TRANSMISSION ELECTRON MICROSCOPY||||CHILD|MICROSCOPIST 1|1|Visit_1|10|6|FOLLOW-UP|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|2|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|STANDING|[?]|Ci/g|[?]|1|anti-Xa IU/mL|LEPTOMENINGES|BILATERAL|CAUDAL|CELL OF ORIGIN ASSAY||||CLINICAL STUDY SPONSOR|DERMATOLOGIST|1|Visit_1|10|7|SCREENING|2020-07-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|3|DLCOVA|DLCO/VA|[?]|SLING|[?]|Bq/mL|[?]|1|mV|SPHENOID SINUS|UNILATERAL|TEMPORAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||CHILD|OPHTHALMOLOGIST|2|Visit_2|25|7|TREATMENT|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|4|FIF25|Forced Inspiratory Flow at 25%|[?]|TRENDELENBURG|[?]|g/kg|[?]|1|mg/animal|GREAT TROCHANTER|IPSILATERAL|LATERAL|CELL BASED BIOASSAY||||FAMILY MEMBER|ADJUDICATOR 1|2|Visit_2|25|6|TREATMENT|2020-07-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|5|PEFREV|PEF Reversibility|[?]|DECUBITUS|[?]|DNA copies/mL|[?]|1|ug/L/h|PROXIMAL PHALANX 3 OF THE HAND|UNILATERAL|UPPER FLEXOR SURFACE|REBOUND TONOMETRY|Y|||FAMILY MEMBER|RADIOLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|KIT|[?]|1|mmHg|TRICEPS BRACHII MUSCLE|IPSILATERAL|MIDLINE|RAJI CELL RIA||||INDEPENDENT ASSESSOR|NEUROLOGIST 2|3|Visit_3|40|3|TREATMENT|2020-08-05|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-12
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|7|LOBVOL|Lobar Volume|[?]|PRONE|[?]|copies/ug|[?]|1|L/min/m2|INTERPHALANGEAL JOINT 1|BILATERAL|DORSOLATERAL|U-HPLC/MS/MS||||SPOUSE|MICROSCOPIST|4|Visit_4|65|2|TREATMENT|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|8|FIVC|Forced Inspiratory Vital Capacity|[?]|SLING|[?]|BAU/mL|[?]|1|vg/kg|HEART, RIGHT VENTRICULAR FREE WALL|LEFT|FRONTAL|FLAME PHOTOMETRY||Y||HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|4|Visit_4|65|1|WASHOUT|2020-08-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-26
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|MdFI|POSTERIOR SUPERIOR ILIAC SPINE|IPSILATERAL|TEMPORAL|BRDU CELLULAR PROLIFERATION ASSAY|||Y|FRIEND|RADIOLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|76dd2fe2-bc9e-48e4-870c-af7ece70009a|10|AWWVOL|Airway Wall Volume|[?]|LATERAL DECUBITUS|[?]|ug/m2/day|[?]|1|copies/ug|INFERIOR PUBIC RAMUS|RIGHT|OUTER|SURFACE PLASMON RESONANCE||||CHILD|RATER|5|Visit_5|90|7|TREATMENT|2020-09-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-02
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|AIRTRAP|Air Trapping|[?]|REVERSE TRENDELENBURG|[?]|IMPLANT|[?]|1|VIRTUAL PIXEL|OCCIPITAL LOBE|UNILATERAL|VOLAR|FARNSWORTH-MUNSELL 100 HUE TEST||||DOMESTIC PARTNER|FORENSIC PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-11-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|2|ERVPP|Percent Predicted ERV|[?]|SEMI-RECUMBENT|[?]|NEBULE|[?]|1|10^9 CFU|INTERPHALANGEAL JOINT 2|CONTRALATERAL|SUBCORTICAL|PHYSICAL EXAMINATION|Y|||ADJUDICATOR|OPHTHALMOLOGIST|1|Visit_1|10|5|TREATMENT|2020-11-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|3|EFFIND|Effusion Indicator|[?]|SEMI-RECUMBENT|[?]|Weber|[?]|1|amp|LOCUS CERULEUS|LEFT|LOWER|IMPULSE OSCILLOMETRY||||INVESTIGATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|TREATMENT|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|IU/g Hb|[?]|1|mL|RAPHE|RIGHT|OUTER|AGAR PROPORTION|Y|Y||CLINICAL STUDY SPONSOR|CARDIOLOGIST|2|Visit_2|25|5|WASHOUT|2020-12-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-23
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|5|PLMXRS|Pulmonary Reactance|[?]|SEMI-FOWLERS|[?]|MPS U|[?]|1|mg/g/min|UMBILICUS|RIGHT|DISTAL|SCANNING ELECTRON MICROSCOPY||||PROXY|MICROSCOPIST 2|3|Visit_3|40|6|TREATMENT|2020-12-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|kBq/uL|PERITONEUM|BILATERAL|PROXIMAL|FLOCCULATION||Y|Y|FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|6|SCREENING|2020-12-24|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|7|PNIF|Peak Nasal Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|uCi/L|[?]|1|ng/day|PERIURETHRAL REGION|UNILATERAL|PROXIMAL|INTRAVASCULAR ULTRASOUND|Y|||STUDY SUBJECT|MICROSCOPIST 1|4|Visit_4|65|1|TREATMENT|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|8|FIF50|Forced Inspiratory Flow at 50%|[?]|SLING|[?]|BOLUS|[?]|1|KALLIKREIN INHIBITOR UNIT|WRIST JOINT FLEXOR MUSCLES|IPSILATERAL|LOWER FLEXOR SURFACE|APPLANATION TONOMETRY|Y|Y||CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|4|Visit_4|65|2|TREATMENT|2021-01-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-16
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|9|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|[?]|pL|[?]|1|DRINK|GASTRIC CURVATURE LYMPH NODE|IPSILATERAL|FACIAL|DYNAMIC CONTRAST ENHANCED MRI||Y||SIBLING|PATHOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-02-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|10|ERV|Expiratory Reserve Volume|[?]|UNCONSTRAINED|[?]|dyn|[?]|1|10^9/g|ENDOCARDIUM|UNILATERAL|LOWER EXTENSOR SURFACE|ZIEHL NEELSEN ACID FAST STAIN||||ADJUDICATOR|MICROSCOPIST 3|5|Visit_5|90|4|WASHOUT|2021-02-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SLING|[?]|g/animal/wk|[?]|1|10^6 CFU|C2 VERTEBRA|RIGHT|LATERAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y||GUARDIAN|NEUROLOGIST 1|1|Visit_1|10|4|WASHOUT|2020-05-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-21
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|2|RV|Residual Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Farad|SAPHENOUS VEIN|CONTRALATERAL|SUPERIOR|MAGNETIC RESONANCE ANGIOGRAPHY||Y|Y|ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|1|Visit_1|10|3|SCREENING|2020-05-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-21
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|3|ALVVOL|Alveolar Volume|[?]|STANDING, BENT FORWARD|[?]|uL|[?]|1|% INHIBITION|CORPUS CALLOSUM, BODY|CONTRALATERAL|LOWER MEDIAL|ROMANOWSKY STAIN||||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|2|Visit_2|25|4|TREATMENT|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-12
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|4|RAW|Airway Resistance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|PIXEL|DISTAL RIGHT CORONARY ARTERY CONDUIT|LATERAL|FACIAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||Y|FAMILY MEMBER|RATER 1|2|Visit_2|25|1|SCREENING|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-12
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|5|EVC|Expiratory Vital Capacity|[?]|PRONE|[?]|nkat|[?]|1|ug/mol|LUNG, LEFT LOWER LOBE|RIGHT|PROXIMAL VOLAR|IMMUNODIFFUSION||||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-06-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|6|FIFMAXPP|Percent Predicted FIFmax|[?]|TRENDELENBURG|||[?]|1|mg/dL|INTERPHALANGEAL JOINT 5 OF THE HAND|RIGHT|SUPERIOR|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|Y|Y|SPOUSE|READER 1|3|Visit_3|40|4|SCREENING|2020-06-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-15
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|7|MALIND|Malignancy Indicator|[?]|SEMI-RECUMBENT|[?]|/7.5 mL|[?]|1|um|SPLENIC VEIN|UNILATERAL|SUPERIOR|CLIP SEQUENCING||||PARENT|OPHTHALMOLOGIST|4|Visit_4|65|6|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|8|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|MHz|LEFT POSTERIOR DESCENDING ARTERY|LEFT|FRONTAL|ACID FAST STAIN|Y||Y|HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|3|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|[?]|10^6 organisms/g|[?]|1|ug/m2/h|TRICUSPID VALVE, POSTERIOR CUSP|BILATERAL|FRONTAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||STUDY SUBJECT|MICROSCOPIST 1|5|Visit_5|90|6|TREATMENT|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|78778706-6b5b-4ad8-90af-f56d602863ae|10|MEP|Maximal Expiratory Pressure|[?]|SEMI-RECUMBENT|[?]|EP U|[?]|1|mCi/L|LIMB, LOWER|CONTRALATERAL|DORSAL|CALCULATION|Y|||PROXY|UROLOGIST|5|Visit_5|90|1|TREATMENT|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-29
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|1|FRCPP|Percent Predicted FRC|[?]|RIGHT LATERAL DECUBITUS|[?]|SBE/mL|[?]|1|mV2/Hz|DELTOID MUSCLE|UNILATERAL|LATERAL|CAPILLARY ELECTROPHORESIS||||INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|1|Visit_1|10|4|TREATMENT|2020-09-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|2|RRS|Total Respiratory System Resistance|[?]|SITTING|||[?]|1|GBq/ug|CARDIAC WALL|RIGHT|LOWER|ANTIMICROBIAL COMBINATION TESTING|Y|Y|Y|FRIEND|READER 2|1|Visit_1|10|3|TREATMENT|2020-09-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-08
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|3|IC|Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|dpm/0.5 mL|[?]|1|kN/cm2|FOOT PHALANX|UNILATERAL|LOWER FLEXOR SURFACE|CONTRAST ENHANCED CT SCAN||||CAREGIVER|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-10-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|ft|[?]|1|MBP|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|IPSILATERAL|CENTRAL|WESTERGREN|Y|||CLINICAL STUDY SPONSOR|ONCOLOGIST|2|Visit_2|25|2|TREATMENT|2020-10-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-22
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|5|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SUPINE|[?]|Rad|[?]|1|mg2/dL2|KIDNEY, MEDULLA|LATERAL|NASAL|AMSLER GRID||||CAREGIVER|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2020-10-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SEMI-FOWLERS|[?]|uV*sec|[?]|1|kBq/uL|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|LEFT|SUBCORTICAL|MICRONEUTRALIZATION ASSAY||||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|3|Visit_3|40|3|TREATMENT|2020-10-17|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-09
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|STANDING, BENT FORWARD|[?]|mmol/mol|[?]|1|mg/m2/min|LOWER JUGULAR LYMPH NODE|LATERAL|SUPERFICIAL|MIGET||||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-11-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|8|MIP|Maximal Inspiratory Pressure|[?]|TRENDELENBURG|[?]|g/animal/wk|[?]|1|lx|ILIOPSOAS MUSCLE|LEFT|DEEP|MYELOPEROXIDASE STAIN||||SPOUSE|ADJUDICATOR 2|4|Visit_4|65|6|FOLLOW-UP|2020-11-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-07
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|9|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|umol/min|[?]|1|/2000 RBC|DISTAL PHALANX 5 OF THE HAND|IPSILATERAL|VOLAR|VENTILATION PERFUSION LUNG SCAN||||INVESTIGATOR|NEUROLOGIST|5|Visit_5|90|7|TREATMENT|2020-12-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|a6954aa1-4860-412a-b988-7f708aca2ab2|10|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|[?]|mm/sec|[?]|1|mg/dose|METACARPAL BONE 2|LATERAL|PERIPHERAL|NUCLEIC ACID AMPLIFICATION TEST||||INDEPENDENT ASSESSOR|READER|5|Visit_5|90|3|TREATMENT|2020-12-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|ELSTNCE|Elastance|[?]|STANDING|[?]|Hz/s|[?]|1|L/day|T4 VERTEBRA|BILATERAL|MIDLINE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION|Y|||INVESTIGATOR|RATER 1|1|Visit_1|10|5|TREATMENT|2020-05-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|2|PLMBLFLW|Pulmonary Blood Flow|[?]|DECUBITUS|[?]|mL/m2/h|[?]|1|mg/m2/min|ENDOCERVIX|LATERAL|PROXIMAL VOLAR|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|||SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|1|Visit_1|10|5|WASHOUT|2020-05-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|[?]|P|[?]|1|cGy|MALE GENITALIA|CONTRALATERAL|HIND|ELISA||Y||GUARDIAN|OPHTHALMOLOGIST|2|Visit_2|25|3|TREATMENT|2020-05-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|4|LOBVOLPP|Percent Predicted Lobar Volume|[?]|STANDING|[?]|Bq/g|[?]|1|BAG|EPICONDYLE|IPSILATERAL|UPPER|NUCLEIC ACID BASED METHOD|Y|||PROXY|RATER 2|2|Visit_2|25|5|WASHOUT|2020-05-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING|[?]|mU/g|[?]|1|/ms|MITRAL VALVE, POSTERIOR ANNULUS|LATERAL|POSTERIOR|FLUORESCENT ENZYME IMMUNOASSAY|Y|||SIBLING|MICROSCOPIST 2|3|Visit_3|40|1|TREATMENT|2020-06-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|6|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SLING|||[?]|1|PFU/dose|PHARYNX|CONTRALATERAL|LOWER MEDIAL|BIOIMPEDANCE SPECTROSCOPY|Y||Y|VENDOR|ONCOLOGIST|3|Visit_3|40|2|TREATMENT|2020-06-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-08
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|7|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|%(v/v)|[?]|1|FFU|ANAL VERGE|LEFT|CAUDAL|SIZE EXCLUSION CHROMATOGRAPHY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-07-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|8|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|MPL U|[?]|1|PFU/dose|METATARSOPHALANGEAL JOINT 2|UNILATERAL|LATERAL|GIEMSA STAIN||||FRIEND|MICROSCOPIST 2|4|Visit_4|65|2|SCREENING|2020-07-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-13
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|9|EFFIND|Effusion Indicator|[?]|SLING|[?]|mL/mmHg/min/L|[?]|1|anti-Xa IU|HUMERAL EPICONDYLE|LATERAL|ANTERIOR|HEMATOXYLIN AND EOSIN STAIN||||DOMESTIC PARTNER|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2020-08-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|0a970eb4-f958-42ad-ad8b-60bb427c9cba|10|AWWVOL|Airway Wall Volume|[?]|LEFT LATERAL DECUBITUS|[?]|APPLICATION|[?]|1|mL/100g/min|INTRATHORACIC LYMPH NODE|UNILATERAL|PERIPHERAL|HIGH RESOLUTION CT||||PARENT|ADJUDICATOR 3|5|Visit_5|90|3|TREATMENT|2020-08-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-22
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|TSUHYS|Tissue Hysteresivity|[?]|SLING|||[?]|1|dpm/mg|MUSCULOSKELETAL SYSTEM|CONTRALATERAL|SUPERIOR|LIGHT MICROSCOPY|||Y|PARENT|ADJUDICATOR 1|1|Visit_1|10|4|WASHOUT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|L/min|[?]|1|fL|AORTIC VALVE ANNULUS|CONTRALATERAL|OCCIPITAL|MICRODENSITOMETRY||Y||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|1|Visit_1|10|1|WASHOUT|2021-01-26|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-14
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|3|FIO2|Fraction of Inspired Oxygen|[?]|SITTING|[?]|FINGERTIP UNIT|[?]|1|10^6/hpf|CUBOID BONE|LATERAL|BASAL|NEXT GENERATION SEQUENCING||||FRIEND|READER 2|2|Visit_2|25|2|TREATMENT|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|4|FIF25|Forced Inspiratory Flow at 25%|[?]|LEFT LATERAL DECUBITUS|[?]|VIAL|[?]|1|VOXEL|COLON, RIGHT|UNILATERAL|INFERIOR|APPLANATION TONOMETRY||||CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|2|Visit_2|25|6|SCREENING|2021-02-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-07
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|5|FEV1FVC6|FEV1/FVC6|[?]|FOWLERS|[?]|ug/dL|[?]|1|ug/dose|ANAL VERGE|RIGHT|VOLAR|TRANSCRIPTION-MEDIATED AMPLIFICATION||||CAREGIVER|READER 1|3|Visit_3|40|6|TREATMENT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|6|MEPPP|Percent Predicted MEP|[?]|RIGHT LATERAL DECUBITUS|[?]|F|[?]|1|pg/dL|RECTO-UTERINE POUCH|BILATERAL|DEEP|KLEIHAUER-BETKE||||INTERVIEWER|RADIOLOGIST 1|3|Visit_3|40|3|TREATMENT|2021-02-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|7|PNEUMIND|Pneumonia Indicator|[?]|STANDING, BENT FORWARD|[?]|days/wk|[?]|1|10^7 PFU|FIRST OBTUSE MARGINAL BRANCH ARTERY|LEFT|LOWER EXTENSOR SURFACE|IMMUNE REPERTOIRE DEEP SEQUENCING||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|4|Visit_4|65|7|SCREENING|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|8|DLCOVA|DLCO/VA|[?]|UNCONSTRAINED|[?]|g/cage/wk|[?]|1|mol/g|MAXILLARY SINUS|LEFT|VENTRAL|THICK SMEAR||||SIBLING|ENDOCRINOLOGIST|4|Visit_4|65|6|WASHOUT|2021-03-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-31
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|9|FEV6PP|Percent Predicted FEV6|[?]|RIGHT LATERAL DECUBITUS|[?]|cs|[?]|1|cm/min|PALM|LATERAL|UPPER EXTENSOR SURFACE|FLUORESCENCE ANGIOGRAPHY||Y||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|5|Visit_5|90|7|TREATMENT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|RE|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|10|FIFMAX|Maximum Forced Inspiratory Flow|[?]|DECUBITUS|||[?]|1|CFU/mL|VULVA|IPSILATERAL|INFERIOR|OSCILLOMETRY|||Y|INDEPENDENT ASSESSOR|READER 2|5|Visit_5|90|2|WASHOUT|2021-04-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-03
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|MHz|[?]|1|USP U|MOTOR CORTEX|UNILATERAL|HIND|FLOCCULATION, CHARCOAL ENHANCED||||CLINICAL RESEARCH COORDINATOR|INTERNIST|1|Visit_1|10|7|SCREENING|2020-08-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|2|IVCPP|Percent Predicted IVC|[?]|RIGHT LATERAL DECUBITUS|[?]|STEPS|[?]|1|Absorbance U/mL|LIMB, LOWER|UNILATERAL|PROXIMAL|TWO-COLOR MICROARRAY||||INDEPENDENT ASSESSOR|HEMATOLOGIST|1|Visit_1|10|6|WASHOUT|2020-08-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-13
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|BAR|[?]|1|10^3 CFU/mL|MIDDLE PHALANX 3 OF THE HAND|CONTRALATERAL|LOWER MEDIAL|IMPULSE OSCILLOMETRY||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-09-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|4|PEFREV|PEF Reversibility|[?]|TRENDELENBURG|[?]|uL/mL|[?]|1|10^3/hpf|SKIN OF THE FACE|BILATERAL|LATERAL|OBSERVATION||Y||SIBLING|MICROSCOPIST|2|Visit_2|25|6|FOLLOW-UP|2020-09-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-03
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|5|MALIND|Malignancy Indicator|[?]|STANDING|||[?]|1|/10^4|SCAPHOID-CAPITATE JOINT|CONTRALATERAL|DORSOLATERAL|CRYOSCOPY||Y|Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-09-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|6|FIV1PP|Percent Predicted FIV1|[?]|SUPINE|[?]|hPa|[?]|1|cal|AXIAL SKELETON|RIGHT|NASAL|IVY INCISION METHOD||||INDEPENDENT ASSESSOR|NEUROLOGIST|3|Visit_3|40|7|TREATMENT|2020-09-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|7|EFFIND|Effusion Indicator|[?]|SLING|||[?]|1|mg|LOCUS CERULEUS|LATERAL|CAUDAL|SINGLE-MOLECULE ARRAY|||Y|FAMILY MEMBER|MICROSCOPIST|4|Visit_4|65|7|TREATMENT|2020-10-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SUPINE|||[?]|1|mV2/Hz|GINGIVA|UNILATERAL|INTERMEDIATE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||Y|PARENT|PATHOLOGIST|4|Visit_4|65|2|SCREENING|2020-10-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|9|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|||[?]|1|g/m2|ACETABULUM|CONTRALATERAL|CENTRAL|CRYOSCOPY|||Y|PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|TREATMENT|2020-11-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|10|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SUPINE|[?]|cm|[?]|1|Hounsfield Unit|DENTAL ARCH|BILATERAL|SURFACE|LIGHT MICROSCOPY||Y||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-11-12|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-01
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|TVPP|Percent Predicted Tidal Volume|[?]|DECUBITUS|[?]|genEq/mL|[?]|1|umol/kg/min|SYMPATHETIC GANGLIA|LEFT|ANTERIOR|NUCLEIC ACID HYBRIDIZATION||||PROXY|RADIOLOGIST|1|Visit_1|10|7|SCREENING|2020-05-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|2|FEF50|Forced Expiratory Flow 50%|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/m2/day|[?]|1|mL/kg/day|LIVER, CAUDATE LOBE|RIGHT|NASAL|OPHTHALMOSCOPY||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-04
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|3|MEP|Maximal Expiratory Pressure|[?]|DECUBITUS|[?]|IU/L|[?]|1|APL U|T4 VERTEBRA|CONTRALATERAL|SUPERIOR|PLETHYSMOGRAPHY||||SIBLING|MICROSCOPIST|2|Visit_2|25|1|TREATMENT|2020-05-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|4|PEFTIME|Peak Expiratory Flow Time|[?]|RIGHT LATERAL DECUBITUS|[?]|kg|[?]|1|10^6 CFU/mL|OVARY|LEFT|ANTEROTEMPORAL|IODINE STAIN||||PARENT|RATER 1|2|Visit_2|25|1|SCREENING|2020-05-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|5|FRC|Functional Residual Capacity|[?]|SITTING|[?]|umol/L|[?]|1|grain|HEART, VENTRICLE|LATERAL|ANTEROPOSTERIOR|MICROPARTICLE ENZYME IMMUNOASSAY||||FAMILY MEMBER|RADIOLOGIST 2|3|Visit_3|40|4|FOLLOW-UP|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|6|TSUELAS|Tissue Elastance|[?]|SEMI-FOWLERS|[?]|10^12/L|[?]|1|ukat/10^12 RBC|MAIN BRONCHUS, LEFT|LATERAL|UPPER|THICK SMEAR||||INTERVIEWER|MICROSCOPIST 3|3|Visit_3|40|7|FOLLOW-UP|2020-06-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-04
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|7|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|breaths/min|MIDDLE PHALANX 4 OF THE HAND|RIGHT|INTERMEDIATE|SNELLEN EYE CHART||Y|Y|SIGNIFICANT OTHER|READER 1|4|Visit_4|65|3|WASHOUT|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|8|TSUHYS|Tissue Hysteresivity|[?]|RIGHT LATERAL DECUBITUS|[?]|/200 HPFs|[?]|1|Siemens|LIVER, CAUDATE LOBE|CONTRALATERAL|ANTEROPOSTERIOR|CELL OF ORIGIN ASSAY||||CHILD|MICROSCOPIST|4|Visit_4|65|7|SCREENING|2020-07-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-06
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|9|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-RECUMBENT|||[?]|1|EVENTS|RIB|LATERAL|VOLAR|MODIFIED ACID FAST STAIN|||Y|FAMILY MEMBER|PHYSIOTHERAPIST|5|Visit_5|90|7|TREATMENT|2020-08-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|9b268a13-dc40-4eb6-8729-c131ac302dd3|10|DLCOHC|HGB Corrected DLCO|[?]|LATERAL DECUBITUS|[?]|Bq/mg|[?]|1|mL/100g/min|SHOULDER JOINT TENDONS|LATERAL|CAUDAL|LC/MS/MS||Y||SIBLING|ADJUDICATOR 3|5|Visit_5|90|1|TREATMENT|2020-08-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|1|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|UNCONSTRAINED|[?]|BOWL|[?]|1|mMU/mL|PRELARYNGEAL LYMPH NODE|UNILATERAL|VENTROLATERAL|SLOAN LETTER EYE CHART 1.25%||||HEALTH CARE PROFESSIONAL|NEUROLOGIST|1|Visit_1|10|2|SCREENING|2020-12-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|2|ICPP|Percent Predicted Inspiratory Capacity|[?]|SUPINE|[?]|keV|[?]|1|JAR|PELVIC BONE|LATERAL|ANTEROLATERAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||SIGNIFICANT OTHER|INTERNIST|1|Visit_1|10|5|WASHOUT|2020-12-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-19
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|3|RVPP|Percent Predicted Residual Volume|[?]|TRENDELENBURG|[?]|AMPULE|[?]|1|mV|BRAIN STEM|RIGHT|FORE|POLYSOMNOGRAPHY||||SPOUSE|NEUROLOGIST|2|Visit_2|25|2|TREATMENT|2020-12-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|4|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|Absorbance U/min|[?]|1|mg/g/min|C1 VERTEBRA|BILATERAL|HIND|FLOW MICROSCOPY||||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|2|Visit_2|25|2|SCREENING|2020-12-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|5|TV|Tidal Volume|[?]|STANDING|||[?]|1|SYRINGE|COMMON ILIAC LYMPH NODE|RIGHT|SUPERFICIAL|MANUAL COUNT|||Y|PROXY|READER 3|3|Visit_3|40|2|TREATMENT|2021-01-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|6|RAWPP|Percent Predicted Airway Resistance|[?]|SEMI-FOWLERS|||[?]|1|Bq|COLON LYMPH NODE|IPSILATERAL|INNER|CELL OF ORIGIN ASSAY|||Y|STUDY SUBJECT|PHYSIOTHERAPIST|3|Visit_3|40|4|TREATMENT|2021-01-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|7|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|LATERAL DECUBITUS|||[?]|1|mmAL|FEMUR|LEFT|ANTEROTEMPORAL|IMMUNOFIXATION ELECTROPHORESIS|Y||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 2|4|Visit_4|65|5|TREATMENT|2021-02-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|8|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING, BENT FORWARD|[?]|AMPULE|[?]|1|DIOPTER|PALPEBRAL FISSURE|IPSILATERAL|LOWER FLEXOR SURFACE|ULTRASOUND||||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|4|Visit_4|65|4|TREATMENT|2021-02-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|9|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SLING|||[?]|1|mg2/dL2|PECTORALIS MINOR MUSCLE|CONTRALATERAL|DISTAL VOLAR|HEMAGGLUTINATION ASSAY|||Y|CLINICAL RESEARCH COORDINATOR|OPTOMETRIST|5|Visit_5|90|1|TREATMENT|2021-03-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|fa11534a-92f9-4887-828b-25b7637b8f57|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|DECUBITUS|||[?]|1|/2000 RBC|ENDOMETRIUM|LATERAL|POSTERIOR|ELECTROMYOGRAPHY|||Y|SPOUSE|ONCOLOGIST 1|5|Visit_5|90|7|TREATMENT|2021-03-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-25
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|HOURS|[?]|1|APL U|SCALP|UNILATERAL|PERIVENTRICULAR|SMEAR||||CAREGIVER|ONCOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-10-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|2|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|mOsm/L|[?]|1|nmol/mL/min|ESOPHAGUS, UPPER THIRD|UNILATERAL|PERIPHERAL|DC SHEATH FLOW|Y|||HEALTH CARE PROFESSIONAL|READER 3|1|Visit_1|10|6|TREATMENT|2020-10-04|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|3|MIPPP|Percent Predicted MIP|[?]|SLING|[?]|POINT|[?]|1|YEARS|PARATRACHEAL LYMPH NODE|BILATERAL|NASAL|HANSEL STAIN||||ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|2|Visit_2|25|2|SCREENING|2020-10-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|4|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|[?]|Absorbance U/mL|[?]|1|umol/min|ULNA|CONTRALATERAL|PERIPHERAL|GRADIENT DIFFUSION||||SPOUSE|MICROSCOPIST 1|2|Visit_2|25|6|TREATMENT|2020-10-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|PRONE|[?]|mm3/mm2/year|[?]|1|mm/h|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|LATERAL|CENTRAL|FLUORESCENCE ANGIOGRAPHY||||ADJUDICATOR|PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-11-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|6|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|[?]|mEq/L|[?]|1|genEq|METACARPAL BONE 4|LATERAL|ANTERIOR|MAMMOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|PEDIATRIC NEUROLOGIST|3|Visit_3|40|6|WASHOUT|2020-11-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|7|FEF50|Forced Expiratory Flow 50%|[?]|SEMI-FOWLERS|||[?]|1|PELLET|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|BILATERAL|PROXIMAL VOLAR|FLUORIMETRY|||Y|FAMILY MEMBER|CARDIOLOGIST|4|Visit_4|65|3|WASHOUT|2020-11-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|8|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|||[?]|1|beats/min|MUCOSA|LEFT|SUPERIOR|POLYGRAPHY|Y||Y|HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-11-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-23
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|9|MIP|Maximal Inspiratory Pressure|[?]|DECUBITUS|[?]|psec|[?]|1|pmol/day|AORTIC VALVE, NON-CORONARY CUSP|BILATERAL|DISTAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||Y||SIBLING|MICROSCOPIST 1|5|Visit_5|90|3|TREATMENT|2020-12-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|f305f7a3-8c8b-4eca-afb2-4a376f811170|10|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LATERAL DECUBITUS|||[?]|1|LOZENGE|WALDEYER'S TONSILLAR RING|LATERAL|PROXIMAL VOLAR|TRIPLE-PHASE SPIRAL CT SCAN|||Y|INDEPENDENT ASSESSOR|NEUROLOGIST 1|5|Visit_5|90|1|WASHOUT|2020-12-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-05
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|FEF50|Forced Expiratory Flow 50%|[?]|UNCONSTRAINED|[?]|ug/L|[?]|1|dmol|COMMON ILIAC ARTERY|BILATERAL|PROXIMAL|MUGA|Y|||PROXY|RADIOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|2|LCI|Lung Clearance Index|[?]|FOWLERS|[?]|ukat/L|[?]|1|pg/cell|CARPOMETACARPAL JOINT 1|RIGHT|CAUDAL|SLOAN LETTER EYE CHART 1.25%|Y|||GUARDIAN|PATHOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-21
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|TRENDELENBURG|[?]|pg/cell|[?]|1|pkat|SPLENIC ARTERY|RIGHT|LOWER FLEXOR SURFACE|AUDIOMETRY||||GUARDIAN|OPHTHALMOLOGIST|2|Visit_2|25|2|WASHOUT|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|copies/mL|[?]|1|/mm2|FINGERNAIL|LATERAL|VENTRAL|REFLECTANCE SPECTROSCOPY||||NON-HEALTH CARE PROFESSIONAL|RATER 2|2|Visit_2|25|2|TREATMENT|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-05
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|5|DLCO|Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|ka_u/dL|[?]|1|yd|LEFT VENTRICULAR APEX SEGMENT|IPSILATERAL|SUPERFICIAL|DC SHEATH FLOW||Y||FRIEND|NEUROLOGIST 1|3|Visit_3|40|2|TREATMENT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|6|FEV3PP|Percent Predicted FEV3|[?]|PRONE|[?]|uL|[?]|1|BOX|EYE|CONTRALATERAL|NASAL|ELASTOGRAPHY||||FRIEND|OPTOMETRIST|3|Visit_3|40|5|TREATMENT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-03
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|7|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|10^6 U|[?]|1|SYRINGE|WRIST JOINT EXTENSOR TENDONS|LEFT|APICAL|NUCLEIC ACID SEQUENCING|Y|||INDEPENDENT ASSESSOR|ONCOLOGIST|4|Visit_4|65|4|SCREENING|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|8|MEP|Maximal Expiratory Pressure|[?]|SUPINE|[?]|log10 IU/mL|[?]|1|10^7 TCID 50/dose|OSTIOMEATAL COMPLEX|LEFT|OUTER|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||Y||NON-HEALTH CARE PROFESSIONAL|RATER 2|4|Visit_4|65|2|TREATMENT|2020-08-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-31
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|9|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|||[?]|1|L/h/m2|SKIN OF THE KNEE|UNILATERAL|LATERAL|MASS SPECTROMETRY|||Y|CAREGIVER|READER 2|5|Visit_5|90|7|FOLLOW-UP|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|6e4ed6b3-e419-464c-a40e-f100a6894baa|10|INERTANC|Inertance|[?]|STANDING, BENT FORWARD|[?]|kg/cm2|[?]|1|nmol/L/h|PENIS|LEFT|HIND|TRICHROME STAIN|Y|||GUARDIAN|ONCOLOGIST|5|Visit_5|90|6|TREATMENT|2020-08-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-17
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|DLCOVA|DLCO/VA|[?]|SLING|[?]|/min|[?]|1|mV*min|EPIGASTRIC REGION|BILATERAL|CAUDAL|ULTRASONOGRAPHIC ELASTOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|1|Visit_1|10|2|TREATMENT|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|2|GAW|Airway Conductance|[?]|TRENDELENBURG|[?]|mL/m2/min|[?]|1|PNU/mL|AXILLARY ARTERY|BILATERAL|SUBCORTICAL|CELL OF ORIGIN ASSAY|Y|||FRIEND|READER 2|1|Visit_1|10|5|TREATMENT|2020-08-08|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|3|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SLING|[?]|ng/day|[?]|1|ugEq|ILIAC CREST|UNILATERAL|PERIVENTRICULAR|CHROMOGENIC ASSAY||Y||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|2|Visit_2|25|7|TREATMENT|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|4|PIF|Peak Inspiratory Flow|[?]|SEMI-RECUMBENT|[?]|L/kg|[?]|1|mol/mL|PORTAL LYMPH NODE|BILATERAL|SUPERFICIAL|ULTRASONOGRAPHIC ELASTOGRAPHY||Y||SPOUSE|ONCOLOGIST 2|2|Visit_2|25|2|TREATMENT|2020-08-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|5|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|||[?]|1|/HPF|LEFT VENTRICULAR BASAL INFERIOR SEGMENT|BILATERAL|OUTER|MS/MS|||Y|CAREGIVER|NEUROLOGIST 1|3|Visit_3|40|5|WASHOUT|2020-09-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|6|MALIND|Malignancy Indicator|[?]|STANDING, BENT FORWARD|[?]|U/m2/min|[?]|1|/day|PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT|RIGHT|ROSTRAL|AUSCULTATION||||VENDOR|FORENSIC PATHOLOGIST|3|Visit_3|40|6|WASHOUT|2020-09-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|7|EXPRELTM|Expiration Relaxation Time|[?]|REVERSE TRENDELENBURG|[?]|FFU|[?]|1|MAC50|GLOSSOPHARYNGEAL NERVE|LATERAL|LOWER EXTENSOR SURFACE|HEMAGGLUTINATION INHIBITION ASSAY||||ADJUDICATION COMMITTEE|RATER|4|Visit_4|65|3|SCREENING|2020-10-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SUPINE|[?]|umol/mol|[?]|1|mg/dL|INTERPHALANGEAL JOINT 5|UNILATERAL|ANTERIOR|CONTRAST ENHANCED MRI||Y||SIBLING|INTERNIST|4|Visit_4|65|5|TREATMENT|2020-10-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-21
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|9|FEV1FVC6|FEV1/FVC6|[?]|LEFT LATERAL DECUBITUS|[?]|MBq|[?]|1|g/cage|OLECRANON|CONTRALATERAL|UPPER|TRANSTHORACIC ECHOCARDIOGRAPHY||||CHILD|RADIOLOGIST 2|5|Visit_5|90|7|TREATMENT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LATERAL DECUBITUS|||[?]|1|nm|FORELIMB|BILATERAL|APICAL|SPIRAL CT SCAN WITHOUT CONTRAST|Y||Y|STUDY SUBJECT|OPTOMETRIST|5|Visit_5|90|1|TREATMENT|2020-10-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-30
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|SITTING, LEGS DEPENDENT|[?]|V/sec|[?]|1|ms2|TRAPEZOID BONE|UNILATERAL|ANTEROMEDIAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|Y|||CLINICAL STUDY SPONSOR|CLINICAL PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|2|SRAW|Specific Airway Resistance|[?]|TRENDELENBURG|[?]|SQU/mL|[?]|1|Newton|COSTOCHONDRAL JOINT 1|LATERAL|PROXIMAL VOLAR|CALIPER MEASUREMENT METHOD||||DOMESTIC PARTNER|READER 2|1|Visit_1|10|1|WASHOUT|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-08
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|3|PIF|Peak Inspiratory Flow|[?]|FOWLERS|[?]|U/g/h|[?]|1|ugEq/L|AORTIC VALVE, NON-CORONARY CUSP|RIGHT|ROSTRAL|WHOLE EXOME SEQUENCING||Y||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|6|SCREENING|2020-05-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-05
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|4|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SEMI-RECUMBENT|||[?]|1|ug/g/h|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|BILATERAL|POSTERIOR|POLYGRAPHY|Y||Y|GUARDIAN|OTOLARYNGOLOGIST|2|Visit_2|25|4|SCREENING|2020-05-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-05
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|UNCONSTRAINED|[?]|FINGERTIP UNIT|[?]|1|Bq/g|METACARPAL 1 BASE|LATERAL|ANTERIOR|CONTRAST ENHANCED PET SCAN||||CLINICAL STUDY SPONSOR|READER|3|Visit_3|40|7|TREATMENT|2020-06-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|6|IVC|Inspiratory Vital Capacity|[?]|DECUBITUS|[?]|MHz|[?]|1|Hounsfield Unit|ADDUCTOR MAGNUS MUSCLE|LEFT|LOWER MEDIAL|DIGITAL PCR||||SPOUSE|RADIOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-06-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|7|AWWVOL|Airway Wall Volume|[?]|REVERSE TRENDELENBURG|[?]|ug/h|[?]|1|cmol/L|NOSTRIL|LATERAL|INNER|ELECTRONEUROGRAPHY||Y||HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|4|Visit_4|65|6|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|8|IRVPP|Percent Predicted IRV|[?]|RIGHT LATERAL DECUBITUS|[?]|mJoule/cm2|[?]|1|EIA unit|CERVICAL LYMPH NODE|BILATERAL|LOWER EXTENSOR SURFACE|CENTRIFUGATION||||INDEPENDENT ASSESSOR|READER|4|Visit_4|65|2|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|9|LOBVOL|Lobar Volume|[?]|UNCONSTRAINED|[?]|cs|[?]|1|mg/m2|TEMPORAL BONE|CONTRALATERAL|DORSOLATERAL|CISH||||VENDOR|ONCOLOGIST 2|5|Visit_5|90|7|SCREENING|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|5d25ac6d-428d-41eb-9549-c23df035a54e|10|MALEVDES|Malignancy Evidence Description|[?]|SITTING|[?]|HOURS|[?]|1|tuberculin unit/mL|BRAIN VENTRICLE, LATERAL|BILATERAL|INNER|MICROSCOPY||Y||SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|EFFIND|Effusion Indicator|[?]|UNCONSTRAINED|[?]|kPa|[?]|1|MdFI|PYLORIC SPHINCTER|LEFT|SUPERIOR|AURAMINE STAIN||||STUDY SUBJECT|CARDIOLOGIST|1|Visit_1|10|7|WASHOUT|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|2|AWVOLPP|Percent Predicted Airway Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mmol2/L2|[?]|1|U/g/day|PERIUMBILICAL REGION|IPSILATERAL|OCCIPITAL|COMPLEMENT FIXATION||Y||FAMILY MEMBER|MICROSCOPIST 1|1|Visit_1|10|2|FOLLOW-UP|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|3|FEF50|Forced Expiratory Flow 50%|[?]|PRONE|[?]|g/kg|[?]|1|CAPSULE|RIB 7|CONTRALATERAL|FRONTAL|SCANNING ELECTRON MICROSCOPY||||STUDY SUBJECT|PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|4|MEP|Maximal Expiratory Pressure|[?]|FOWLERS|||[?]|1|BOWL|PALATINE BONE|UNILATERAL|DORSAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|2|Visit_2|25|6|TREATMENT|2020-11-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-18
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|5|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|[?]|CCID 50/mL|[?]|1|mV2/Hz|HUMERUS SHAFT|BILATERAL|MEDIAL|REFLECTANCE SPECTROSCOPY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|3|Visit_3|40|5|WASHOUT|2020-11-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|6|PIF|Peak Inspiratory Flow|[?]|SLING|[?]|fmol/g|[?]|1|CONTAINER|CHOROID|UNILATERAL|FRONTAL|FARNSWORTH-MUNSELL 100 HUE TEST||Y||CLINICAL RESEARCH ASSOCIATE|RATER 2|3|Visit_3|40|7|TREATMENT|2020-11-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|7|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-FOWLERS|[?]|OI50|[?]|1|AU/mL|PRESACRAL SPACE|IPSILATERAL|ANTEROLATERAL|PATHOLOGICAL EVALUATION||||STUDY SUBJECT|MICROSCOPIST 2|4|Visit_4|65|6|TREATMENT|2020-12-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|8|OXYPULSE|Oxygen Pulse|[?]|LATERAL DECUBITUS|[?]|ppm|[?]|1|PHERESIS UNIT|LEFT VENTRICULAR MID INFERIOR SEGMENT|UNILATERAL|TIP|PHOROPTER|Y|Y||CHILD|ADJUDICATOR 1|4|Visit_4|65|5|WASHOUT|2020-12-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|9|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SEMI-FOWLERS|||[?]|1|vg/kg|SKIN OF THE FACE|LEFT|TIP|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||Y|Y|CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|5|Visit_5|90|3|TREATMENT|2021-01-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|/10^5|[?]|1|umol/L|ELBOW EXTENSOR MUSCLES|CONTRALATERAL|UPPER EXTENSOR SURFACE|CLINICAL EVALUATION||||CHILD|RADIOLOGIST|5|Visit_5|90|1|WASHOUT|2021-01-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-29
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|RAW|Airway Resistance|[?]|SEMI-FOWLERS|[?]|WAFER|[?]|1|100 IU/mL|LUMBAR SPINE|IPSILATERAL|VENTRAL|NEPHELOMETRY|Y|||CHILD|NEUROLOGIST 1|1|Visit_1|10|1|WASHOUT|2020-10-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING|||[?]|1|MBP|FOOT DIGIT 1|CONTRALATERAL|INTERMEDIATE|CELLULOSE TAPE|Y||Y|FAMILY MEMBER|OTOLARYNGOLOGIST|1|Visit_1|10|6|WASHOUT|2020-10-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|nCi|THIRD OBTUSE MARGINAL BRANCH ARTERY|RIGHT|SUPERFICIAL|COMPUTERIZED CORNEAL TOPOGRAPHY|Y||Y|FAMILY MEMBER|FORENSIC PATHOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-10-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|4|TGV|Thoracic Gas Volume|[?]|DECUBITUS|[?]|fmol|[?]|1|GBq|STERNEBRA|UNILATERAL|VOLAR|CT SCAN||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|2|Visit_2|25|5|TREATMENT|2020-10-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-04
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|5|QUASCOMP|Quasi-Static Compliance|[?]|PRONE|[?]|min/day|[?]|1|/day|STERNUM|UNILATERAL|FORE|SCANNING ELECTRON MICROSCOPY|Y|||STUDY SUBJECT|CLINICAL PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-11-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|6|IVC|Inspiratory Vital Capacity|[?]|SLING|[?]|ug/g/min|[?]|1|mg/m2/day|LYMPH NODE|BILATERAL|PERIPHERAL|SPECULAR MICROSCOPY||||FAMILY MEMBER|PATHOLOGIST 1|3|Visit_3|40|6|FOLLOW-UP|2020-11-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-09
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|7|EFFVOL|Effusion Volume|[?]|UNCONSTRAINED|[?]|DPM|[?]|1|mmHg|CORNEAL STROMA|IPSILATERAL|INTERMEDIATE|MASS SPECTROMETRY||||ADJUDICATOR|CARDIOLOGIST|4|Visit_4|65|3|WASHOUT|2020-12-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|8|DLCOPP|Percent Predicted DLCO|[?]|SLING|||[?]|1|oz eq|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|BILATERAL|INFERIOR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION|||Y|CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-12-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-23
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|9|VO2|Oxygen Consumption|[?]|DECUBITUS|||[?]|1|RING|THORACIC LYMPH NODE|CONTRALATERAL|LOWER MEDIAL|CONTRAST ENHANCED PET/CT SCAN|||Y|CAREGIVER|OPTOMETRIST|5|Visit_5|90|2|SCREENING|2021-01-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|173aea61-964d-4f4a-8d48-56a1a58de6d8|10|FIV1PP|Percent Predicted FIV1|[?]|REVERSE TRENDELENBURG|[?]|mL*cmH2O|[?]|1|g/L|SECOND RIGHT POSTEROLATERAL ARTERY|BILATERAL|LATERAL|NEXT GENERATION SEQUENCING||Y||INVESTIGATOR|ONCOLOGIST|5|Visit_5|90|1|WASHOUT|2021-01-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-06
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|1|RV|Residual Volume|[?]|DECUBITUS|[?]|PIPE|[?]|1|/10^5|ELBOW FLEXOR MUSCLES|LATERAL|FRONTAL|MAGNETIC RESONANCE ANGIOGRAPHY||||FRIEND|ADJUDICATOR 3|1|Visit_1|10|6|SCREENING|2020-07-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|2|RV|Residual Volume|[?]|SITTING|[?]|Osm|[?]|1|U/g/day|CRANIAL NERVE|BILATERAL|ANTEROTEMPORAL|LC/MS/MS||||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|FOLLOW-UP|2020-07-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|3|MEP|Maximal Expiratory Pressure|[?]|TRENDELENBURG|||[?]|1|mL/m2/day|RIB 3|IPSILATERAL|INFERIOR|CELLULAR PROLIFERATION ASSAY|Y||Y|PROXY|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-08-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|4|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SUPINE|||[?]|1|atm|COLON, LEFT|LATERAL|PARIETO-OCCIPITAL|TOTAL BODY IRRADIATION|Y||Y|FAMILY MEMBER|ONCOLOGIST|2|Visit_2|25|7|WASHOUT|2020-08-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|5|IVC|Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|ngEq/L|[?]|1|Bq/ug|ILIAC CREST|CONTRALATERAL|LOWER EXTENSOR SURFACE|IVY INCISION METHOD||||GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|3|WASHOUT|2020-08-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|6|FIV1PP|Percent Predicted FIV1|[?]|SUPINE|[?]|mg/m2/min|[?]|1|kBq|EPICARDIUM|CONTRALATERAL|VENTRAL|GIEMSA STAIN||Y||SPOUSE|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2020-08-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|7|ICREV|IC Reversibility|[?]|SEMI-RECUMBENT|[?]|100 IU/mL|[?]|1|SYRINGE|PERIPHERAL NERVE|IPSILATERAL|MEDIAL|ENDPOINT DILUTION ASSAY||||FAMILY MEMBER|PATHOLOGIST 1|4|Visit_4|65|4|TREATMENT|2020-09-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|8|EVC|Expiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|JDF Unit|GALLBLADDER|IPSILATERAL|VENTROLATERAL|ENDPOINT DILUTION ASSAY|||Y|INDEPENDENT ASSESSOR|OPTOMETRIST|4|Visit_4|65|3|FOLLOW-UP|2020-09-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|9|OXYPULSE|Oxygen Pulse|[?]|LEFT LATERAL DECUBITUS|||[?]|1|umol/L/h|REGIONAL LYMPH NODE|BILATERAL|VENTROLATERAL|HEMAGGLUTINATION ASSAY|||Y|INDEPENDENT ASSESSOR|NEUROLOGIST 2|5|Visit_5|90|3|SCREENING|2020-10-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|45d1adb8-9b3b-4f06-87cb-740205448680|10|ICREV|IC Reversibility|[?]|STANDING, BENT FORWARD|[?]|h/wk|[?]|1|mg/L FEU|GASTRIC CURVATURE LYMPH NODE|BILATERAL|LOWER EXTENSOR SURFACE|SPECT/CT SCAN||||SPOUSE|OPTOMETRIST|5|Visit_5|90|4|TREATMENT|2020-10-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|1|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|PRONE|[?]|pmol/dL|[?]|1|mN|AORTIC VALVE, NON-CORONARY CUSP|CONTRALATERAL|FRONTAL|CAPILLARY ELECTROPHORESIS||||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|2|WASHOUT|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|2|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING|[?]|mL/day|[?]|1|GBq/g|GINGIVAL MUCOSA|CONTRALATERAL|TEMPORAL|LIGHT SCATTERING SPECTROSCOPY||||PARENT|PATHOLOGIST|1|Visit_1|10|1|SCREENING|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-11
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|STANDING, BENT FORWARD|[?]|uCi/kg|[?]|1|kDa|FEMALE REPRODUCTIVE SYSTEM|RIGHT|LATERAL|WESTERGREN||Y||SIBLING|OTOLARYNGOLOGIST|2|Visit_2|25|1|TREATMENT|2020-06-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|4|MALEVDES|Malignancy Evidence Description|[?]|SITTING, LEGS DEPENDENT|[?]|mL/min/1.73m2|[?]|1|h*%|SKIN OF THE LIP|LEFT|MEDIAL|TWO-COLOR MICROARRAY|Y|||GUARDIAN|PHYSIOTHERAPIST|2|Visit_2|25|4|TREATMENT|2020-06-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|5|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|10^8 PFU|[?]|1|TRANSDUCING UNIT|SCROTUM|CONTRALATERAL|DISTAL|QUANTITATIVE ULTRASOUND||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST|3|Visit_3|40|4|SCREENING|2020-06-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|6|FEV3FVC|FEV3/FVC|[?]|TRENDELENBURG|[?]|vg/mL|[?]|1|usec|COMMON ILIAC ARTERY|LATERAL|BASAL|ULTRASOUND||||FRIEND|MICROSCOPIST 1|3|Visit_3|40|7|FOLLOW-UP|2020-06-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-25
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|7|RV|Residual Volume|[?]|FOWLERS|||[?]|1|MPL U/mL|NUCLEUS ACCUMBENS|IPSILATERAL|LOWER MEDIAL|KINYOUN STAIN|||Y|CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-07-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|8|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|TRENDELENBURG|[?]|U/kg/day|[?]|1|10^9 organisms/mg|HUMERAL EPICONDYLE|CONTRALATERAL|INTERMEDIATE|ISHIHARA COLOR PLATES||||ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|4|Visit_4|65|7|TREATMENT|2020-07-24|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-07
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|9|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|vp/mL|[?]|1|Bq/uL|MALLEUS|CONTRALATERAL|LATERAL|DOUBLE IMMUNODIFFUSION||||VENDOR|PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|7403ad67-7ed5-4716-a874-c360429845bc|10|RRS|Total Respiratory System Resistance|[?]|LATERAL DECUBITUS|||[?]|1|Torr|TOOTH|CONTRALATERAL|VOLAR|WHOLE TRANSCRIPTOME SEQUENCING|Y||Y|FRIEND|ENDOCRINOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-08-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|1|MIP|Maximal Inspiratory Pressure|[?]|SEMI-FOWLERS|[?]|10^12/L|[?]|1|mg/g/min|METACARPAL 1 BASE|IPSILATERAL|UPPER FLEXOR SURFACE|PHYSICAL EXAMINATION||||CLINICAL STUDY SPONSOR|READER 3|1|Visit_1|10|4|SCREENING|2021-01-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|2|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|REVERSE TRENDELENBURG|||[?]|1|BOX|BLOOD|LATERAL|INNER|DC SHEATH FLOW|Y||Y|ADJUDICATOR|ONCOLOGIST 1|1|Visit_1|10|6|TREATMENT|2021-01-13|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|3|FIV1PP|Percent Predicted FIV1|[?]|PRONE|||[?]|1|TROCHE|DIAPHRAGMATIC LYMPH NODE|IPSILATERAL|ANTEROPOSTERIOR|FARR ASSAY|||Y|INDEPENDENT ASSESSOR|CLINICAL PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2021-01-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|STANDING, BENT FORWARD|[?]|10^4 CFU|[?]|1|MET*h|CALF|IPSILATERAL|LATERAL|LC/MS/MS||||FAMILY MEMBER|RATER|2|Visit_2|25|2|FOLLOW-UP|2021-01-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|5|MALEVDES|Malignancy Evidence Description|[?]|LATERAL DECUBITUS|[?]|QUANTITY SUFFICIENT|[?]|1|g/kg|SPHENOID SINUS|UNILATERAL|NASAL|HEMATOXYLIN AND EOSIN STAIN||||FRIEND|PATHOLOGIST 1|3|Visit_3|40|1|TREATMENT|2021-02-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|6|ERV|Expiratory Reserve Volume|[?]|STANDING|||[?]|1|MASK|ADDUCTOR LONGUS MUSCLE|RIGHT|PERIVENTRICULAR|IMMUNOBLOT|||Y|SIBLING|MICROSCOPIST 3|3|Visit_3|40|6|SCREENING|2021-02-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|7|MEPPP|Percent Predicted MEP|[?]|SEMI-RECUMBENT|[?]|kcal|[?]|1|PNU/mL|GASTROINTESTINAL TRACT, WALL|LEFT|UPPER|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY|Y|Y||CLINICAL RESEARCH ASSOCIATE|RATER 1|4|Visit_4|65|6|TREATMENT|2021-03-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|8|EVC|Expiratory Vital Capacity|[?]|SITTING|[?]|CFU/g|[?]|1|CFU/mL|SPLEEN, HILUM|CONTRALATERAL|CENTRAL|IVY INCISION METHOD|Y|||NON-HEALTH CARE PROFESSIONAL|READER|4|Visit_4|65|4|WASHOUT|2021-03-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|9|FEV1REV|FEV1 Reversibility|[?]|FOWLERS|[?]|v/v|[?]|1|m2|SUPRACLAVICULAR LYMPH NODE|BILATERAL|ANTERIOR|MRI WITHOUT CONTRAST|Y|||CLINICAL RESEARCH COORDINATOR|FORENSIC PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2021-04-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|8be919ce-34da-4e49-ac7a-3679c7af632d|10|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SLING|||[?]|1|ng/day|PREAURICULAR LYMPH NODE|RIGHT|BASAL|MYELOPEROXIDASE STAIN|||Y|GUARDIAN|UROLOGIST|5|Visit_5|90|5|WASHOUT|2021-04-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|1|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SLING|[?]|mol/mg|[?]|1|HEP|SECOND RIGHT POSTEROLATERAL ARTERY|CONTRALATERAL|BASAL|THERMAL IONIZATION MASS SPECTROMETRY||Y||INDEPENDENT ASSESSOR|PATHOLOGIST 2|1|Visit_1|10|2|SCREENING|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|2|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|/100 WBC|[?]|1|mL/day|KIDNEY, CORTEX|UNILATERAL|UPPER EXTENSOR SURFACE|HPLC/IEX|Y|||INDEPENDENT ASSESSOR|READER|1|Visit_1|10|7|TREATMENT|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-09
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|3|RAWPP|Percent Predicted Airway Resistance|[?]|STANDING|[?]|10^3 CFU/mL|[?]|1|mOsm|WAIST|UNILATERAL|LOWER FLEXOR SURFACE|PHOTOMETRIC CLOT DETECTION||||HEALTH CARE PROFESSIONAL|READER 2|2|Visit_2|25|2|TREATMENT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|4|DLCOPP|Percent Predicted DLCO|[?]|LATERAL DECUBITUS|[?]|U/animal|[?]|1|/mm|LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT|CONTRALATERAL|TEMPORAL|IMMUNORADIOMETRIC ASSAY||||GUARDIAN|PATHOLOGIST 2|2|Visit_2|25|2|WASHOUT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-09
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|5|PEF|Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|scm|[?]|1|mAnson U/mL|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|BILATERAL|LATERAL|CONTRAST ENHANCED MRI||||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|3|Visit_3|40|7|SCREENING|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-16
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|6|INFLTIND|Infiltrates Indicator|[?]|LATERAL DECUBITUS|[?]|SFC/10^6 PBMC|[?]|1|ug/mL/h|ANTERIOR TIBIAL ARTERY|LEFT|CENTRAL|REFRACTOMETRY|Y|||GUARDIAN|ADJUDICATOR 2|3|Visit_3|40|2|TREATMENT|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-16
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|7|LCI|Lung Clearance Index|[?]|TRENDELENBURG|[?]|log10 TCID 50/mL|[?]|1|cm/s|CHEEK|IPSILATERAL|PROXIMAL VOLAR|WHOLE TRANSCRIPTOME SEQUENCING||||STUDY SUBJECT|PATHOLOGIST 2|4|Visit_4|65|7|SCREENING|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|8|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING, BENT FORWARD|[?]|MAC50|[?]|1|pg/L|LEFT VENTRICULAR APICAL ANTERIOR SEGMENT|CONTRALATERAL|UPPER EXTENSOR SURFACE|MS/MS||||STUDY SUBJECT|HEMATOLOGIST|4|Visit_4|65|6|SCREENING|2021-03-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-23
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|PRONE|[?]|EP U|[?]|1|amu|LUNG, RIGHT LOWER LOBE|LEFT|SUPERFICIAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|Y|||INDEPENDENT ASSESSOR|DERMATOLOGIST|5|Visit_5|90|1|SCREENING|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|9c44967b-914e-43d5-be1e-6829804e04ab|10|AWVOLPP|Percent Predicted Airway Volume|[?]|PRONE|[?]|log10 IU/mL|[?]|1|nmol/L/min|SMALL INTESTINE|CONTRALATERAL|LOWER MEDIAL|LIGHT SCATTERING SPECTROSCOPY|Y|||VENDOR|CLINICAL PATHOLOGIST|5|Visit_5|90|4|TREATMENT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SEMI-FOWLERS|||[?]|1|umol/dL|THORACIC ARTERY|CONTRALATERAL|OCCIPITAL|LC/MS/MS|Y||Y|HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|1|TREATMENT|2020-07-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|2|EVC|Expiratory Vital Capacity|[?]|TRENDELENBURG|[?]|ppm|[?]|1|/min|SKIN|IPSILATERAL|LOWER|DARK FIELD MICROSCOPY||Y||SPOUSE|PATHOLOGIST 2|1|Visit_1|10|4|TREATMENT|2020-07-31|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|3|AWWVOL|Airway Wall Volume|[?]|SUPINE|[?]|10^8/L|[?]|1|TROCHE|ADRENAL GLAND|IPSILATERAL|FRONTAL|ENZYMATIC ULTRACENTRIFUGATION||||ADJUDICATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|TRENDELENBURG|[?]|ug/mol|[?]|1|ppb|AXILLARY LYMPH NODE LEVEL II|CONTRALATERAL|DORSOLATERAL|SISH||||PARENT|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|TREATMENT|2020-08-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-08
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|5|PEF|Peak Expiratory Flow|[?]|SEMI-RECUMBENT|[?]|mL/kg/day|[?]|1|10^6/Ejaculate U|HEART, APEX|IPSILATERAL|OCCIPITAL|CONFOCAL MICROSCOPY||||HEALTH CARE PROFESSIONAL|DERMATOLOGIST|3|Visit_3|40|3|WASHOUT|2020-08-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|6|FIFMAX|Maximum Forced Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|mL/m2/day|[?]|1|uCi/kg|SACRAL TUBEROSITY|BILATERAL|LATERAL|POLYSOMNOGRAPHY|Y|Y||CAREGIVER|UROLOGIST|3|Visit_3|40|1|SCREENING|2020-08-30|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|7|FEV_PEF|FEV at PEF|[?]|FOWLERS|||[?]|1|g|LEFT POSTEROLATERAL DESCENDING ARTERY|LATERAL|ANTEROPOSTERIOR|SNP ARRAY|||Y|VENDOR|ADJUDICATOR 1|4|Visit_4|65|5|FOLLOW-UP|2020-09-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|8|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|ft2|[?]|1|V/sec|METACARPAL BONE 3|IPSILATERAL|PERIVENTRICULAR|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||Y||ADJUDICATOR|RADIOLOGIST 1|4|Visit_4|65|1|FOLLOW-UP|2020-09-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|9|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|NEEDLE GAUGE|[?]|1|cup eq|STRIATUM|LATERAL|OCCIPITAL|ELASTOGRAPHY||||FRIEND|NEUROLOGIST 1|5|Visit_5|90|2|WASHOUT|2020-10-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|10|FIF75|Forced Inspiratory Flow at 75%|[?]|RIGHT LATERAL DECUBITUS|[?]|GLOBULE|[?]|1|log10 TCID 50/uL|LEFT VENTRICULAR APICAL LATERAL SEGMENT|IPSILATERAL|CENTRAL|PH METER MEASUREMENT METHOD||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|5|Visit_5|90|2|TREATMENT|2020-10-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-28
e|RE|cad8c553-739f-4046-a898-d939eb286dba|1|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING|[?]|10^3 CFU|[?]|1|U/g|CEREBRAL CORTEX|IPSILATERAL|UPPER FLEXOR SURFACE|LYMPHANGIOGRAPHY||||GUARDIAN|ADJUDICATOR|1|Visit_1|10|6|WASHOUT|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|cad8c553-739f-4046-a898-d939eb286dba|2|FEV1FVC|FEV1/FVC|[?]|DECUBITUS|[?]|JAR|[?]|1|PHERESIS UNIT|MAIN BRONCHUS, RIGHT|BILATERAL|ANTEROMEDIAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||NON-HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|1|TREATMENT|2020-05-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|cad8c553-739f-4046-a898-d939eb286dba|3|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|IU/L|[?]|1|mCi/kg|ATRIOVENTRICULAR VALVE|LEFT|INTERMEDIATE|FLUORESCENT IMMUNOASSAY||||HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|4|FOLLOW-UP|2020-06-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|cad8c553-739f-4046-a898-d939eb286dba|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|uV*sec|[?]|1|hr/day|GREAT TROCHANTER|RIGHT|FORE|SCINTIGRAPHY||||PARENT|READER 3|2|Visit_2|25|1|TREATMENT|2020-06-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|cad8c553-739f-4046-a898-d939eb286dba|5|SALKK|Salazar-Knowles Equation, K|[?]|SITTING|[?]|vg/kg|[?]|1|Newton|THIGH|RIGHT|PERIVENTRICULAR|MANUAL CLOT DETECTION|Y|||PROXY|ADJUDICATOR|3|Visit_3|40|3|FOLLOW-UP|2020-06-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|cad8c553-739f-4046-a898-d939eb286dba|6|AWVOLPP|Percent Predicted Airway Volume|[?]|SLING|[?]|ft3|[?]|1|CAN|HEART, LEFT VENTRICULAR OUTFLOW TRACT|RIGHT|UPPER EXTENSOR SURFACE|ELLA||||SPOUSE|PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-06-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-27
e|RE|cad8c553-739f-4046-a898-d939eb286dba|7|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|10^9 organisms|[?]|1|PFU/mL|C2 VERTEBRA|BILATERAL|LOWER|WRIGHT STAIN|Y|||CLINICAL RESEARCH COORDINATOR|OTOLARYNGOLOGIST|4|Visit_4|65|7|TREATMENT|2020-07-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|cad8c553-739f-4046-a898-d939eb286dba|8|DLCOHC|HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|10^9 CFU/g|[?]|1|Mile|LEFT CIRCUMFLEX ARTERY OSTIUM|IPSILATERAL|BASAL|IMMUNORADIOMETRIC ASSAY||Y||PARENT|DERMATOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-07-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|cad8c553-739f-4046-a898-d939eb286dba|9|FEF2575|Forced Expiratory Flow 25-75%|[?]|PRONE|[?]|U/m2/day|[?]|1|/LPF|AXILLARY LYMPH NODE|CONTRALATERAL|TIP|CLINICAL EVALUATION||||ADJUDICATION COMMITTEE|READER|5|Visit_5|90|3|TREATMENT|2020-08-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|RE|cad8c553-739f-4046-a898-d939eb286dba|10|EFFIND|Effusion Indicator|[?]|SITTING|||[?]|1|mL/cm|ADDUCTOR HALLUCIS MUSCLE, OBLIQUE HEAD|RIGHT|INFERIOR|RIA|Y||Y|INVESTIGATOR|MICROSCOPIST 1|5|Visit_5|90|5|FOLLOW-UP|2020-08-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-14
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|FEF50|Forced Expiratory Flow 50%|[?]|LEFT LATERAL DECUBITUS|||[?]|1|dB|MEDULLA OBLONGATA|CONTRALATERAL|UPPER|SPECTROPHOTOMETRY|Y||Y|CLINICAL STUDY SPONSOR|PATHOLOGIST 1|1|Visit_1|10|4|WASHOUT|2020-09-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|2|TVPP|Percent Predicted Tidal Volume|[?]|UNCONSTRAINED|[?]|100 IU/mL|[?]|1|10^7 CFU/mL|LYMPH NODE|IPSILATERAL|POSTERIOR|MULTIPLEXED BEAD BASED IMMUNOASSAY||Y||PARENT|DERMATOLOGIST|1|Visit_1|10|4|TREATMENT|2020-09-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|3|ERV|Expiratory Reserve Volume|[?]|SUPINE|[?]|Shock Wave|[?]|1|ug/kg/day|MAXILLARY SINUS|CONTRALATERAL|SUPERFICIAL|FLUOROSCOPY|Y|Y||FAMILY MEMBER|RATER 1|2|Visit_2|25|1|TREATMENT|2020-09-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|4|ICPP|Percent Predicted Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|EIA unit|[?]|1|g/animal/day|FAT PAD|UNILATERAL|INFERIOR|POLYMERASE CHAIN REACTION|Y|||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-09-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|5|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SUPINE|[?]|MET*min|[?]|1|/5x10^4 WBC|HAMSTRING MUSCLE|UNILATERAL|PERIVENTRICULAR|CINEANGIOGRAPHY||||FRIEND|CLINICAL PATHOLOGIST|3|Visit_3|40|4|WASHOUT|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|6|IRVPP|Percent Predicted IRV|[?]|DECUBITUS|[?]|PFU|[?]|1|PHERESIS UNIT|LIGAMENT|RIGHT|FORE|FLUORESCEIN STAIN||Y||DOMESTIC PARTNER|OPTOMETRIST|3|Visit_3|40|5|SCREENING|2020-10-11|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-11
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|||[?]|1|ug|HEART, RIGHT ATRIAL APPENDAGE|CONTRALATERAL|INNER|LC/MS/MS|||Y|FRIEND|ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2020-11-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|8|SALKK|Salazar-Knowles Equation, K|[?]|PRONE|[?]|min|[?]|1|IU|FUNDUS UTERI|LATERAL|ANTERIOR|MACRO BROTH DILUTION||||DOMESTIC PARTNER|ADJUDICATOR|4|Visit_4|65|2|TREATMENT|2020-11-05|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|9|IVC|Inspiratory Vital Capacity|[?]|STANDING|[?]|L/day|[?]|1|ug/h|CEREBRAL HEMISPHERE, LEFT|BILATERAL|NASAL|CALCULATION||||HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|5|Visit_5|90|4|WASHOUT|2020-11-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|10|IVCPP|Percent Predicted IVC|[?]|SLING|||[?]|1|deg/s|TOOTH|LEFT|SURFACE|MASS SPECTROMETRY|||Y|PROXY|READER 2|5|Visit_5|90|7|FOLLOW-UP|2020-11-30|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SUPINE|[?]|Ci/mL|[?]|1|kBq|L3 VERTEBRA|UNILATERAL|BASAL|INCISION-INDUCED BLEEDING METHOD||||INVESTIGATOR|MICROSCOPIST|1|Visit_1|10|3|WASHOUT|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|2|PNIF|Peak Nasal Inspiratory Flow|[?]|SLING|||[?]|1|Absorbance U/min|SKIN AROUND THE MOUTH|CONTRALATERAL|CRANIAL|SEQUENCING|||Y|INDEPENDENT ASSESSOR|OTOLARYNGOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2021-01-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-06
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|3|PEF|Peak Expiratory Flow|[?]|LATERAL DECUBITUS|||[?]|1|km/h|COLON, DESCENDING|UNILATERAL|ANTEROMEDIAL|TWO-COLOR MICROARRAY||Y|Y|FAMILY MEMBER|OPHTHALMOLOGIST|2|Visit_2|25|7|TREATMENT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|4|SGAW|Specific Airway Conductance|[?]|FOWLERS|||[?]|1|cmHg|BRAIN VENTRICLE, LATERAL|BILATERAL|LOWER|ALCIAN BLUE STAIN|||Y|CHILD|RATER 2|2|Visit_2|25|2|TREATMENT|2021-02-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|5|FIF50|Forced Inspiratory Flow at 50%|[?]|FOWLERS|||[?]|1|FIU|INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|ANTEROMEDIAL|CENTRIFUGATION|||Y|ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|3|Visit_3|40|7|WASHOUT|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|6|RRS|Total Respiratory System Resistance|[?]|SUPINE|||[?]|1|GBq/g|LATISSIMUS DORSI MUSCLE|BILATERAL|FRONTAL|HEMATOXYLIN AND EOSIN STAIN||Y|Y|PARENT|RADIOLOGIST 1|3|Visit_3|40|4|WASHOUT|2021-02-23|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|7|AWVOL|Airway Volume|[?]|TRENDELENBURG|[?]|nsec|[?]|1|mCi|GENITAL TUBERCLE|LATERAL|DISTAL|SPECT/CT SCAN||||DOMESTIC PARTNER|DERMATOLOGIST|4|Visit_4|65|7|WASHOUT|2021-03-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING, LEGS DEPENDENT|[?]|MBq/uL|[?]|1|mg/g/min|CEREBRAL HEMISPHERE, LEFT|IPSILATERAL|UPPER EXTENSOR SURFACE|CYSTOMETRY||Y||STUDY SUBJECT|ADJUDICATOR|4|Visit_4|65|1|TREATMENT|2021-03-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|9|MALIND|Malignancy Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|scm|[?]|1|umol/h/mmol|MEDIASTINUM, ANTERIOR|LATERAL|CAUDAL|RADIATION DOSIMETRY|Y|Y||CHILD|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|5|WASHOUT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|81e934f8-7bcc-48d2-8d15-5270e51f2870|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|pmol/10^10 cells|[?]|1|ag|C2 VERTEBRA|CONTRALATERAL|BASAL|FISH|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST 2|5|Visit_5|90|1|TREATMENT|2021-04-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|1|FEV1FVC6|FEV1/FVC6|[?]|UNCONSTRAINED|||[?]|1|/2000 RBC|INTERPHALANGEAL JOINT 5|LATERAL|PROXIMAL VOLAR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING|||Y|VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|7|SCREENING|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|2|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|mJoule/cm2|[?]|1|10^4/L|SKIN OF THE HEAD|UNILATERAL|INFERIOR|REFRACTOMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|1|Visit_1|10|3|TREATMENT|2020-09-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-02
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|3|SALKK|Salazar-Knowles Equation, K|[?]|LEFT LATERAL DECUBITUS|||[?]|1|MBq/uL|ESOPHAGUS, THORACIC|LEFT|FRONTAL|ANTIMICROBIAL COMBINATION TESTING|||Y|CHILD|FORENSIC PATHOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LEFT LATERAL DECUBITUS|[?]|EU|[?]|1|uL/mL|PAW|CONTRALATERAL|UPPER|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||Y||ADJUDICATION COMMITTEE|PATHOLOGIST 1|2|Visit_2|25|5|SCREENING|2020-09-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|5|EVC|Expiratory Vital Capacity|[?]|DECUBITUS|[?]|mph|[?]|1|mL/min/1.73m2|CILIARY BODY|UNILATERAL|DISTAL VOLAR|ELECTROCHEMILUMINESCENCE||Y||PARENT|FORENSIC PATHOLOGIST|3|Visit_3|40|6|SCREENING|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|6|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|||[?]|1|ks|ANTERIOR TIBIAL ARTERY|UNILATERAL|DISTAL VOLAR|FREEZING POINT DEPRESSION|||Y|ADJUDICATION COMMITTEE|MICROSCOPIST 2|3|Visit_3|40|4|SCREENING|2020-10-09|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|7|TLCPP|Percent Predicted Total Lung Capacity|[?]|UNCONSTRAINED|||[?]|1|ft2|PERICARDIUM|BILATERAL|INFERIOR|CONTRAST ENHANCED PET SCAN||Y|Y|FAMILY MEMBER|READER|4|Visit_4|65|3|TREATMENT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|8|DLCOVA|DLCO/VA|[?]|SEMI-RECUMBENT|||[?]|1|mg/kg/min|ADDUCTOR LONGUS MUSCLE|LATERAL|OCCIPITAL|MULTIPLE BREATH WASHOUT|Y||Y|CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|4|Visit_4|65|3|WASHOUT|2020-11-03|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|9|RAWPP|Percent Predicted Airway Resistance|[?]|TRENDELENBURG|||[?]|1|pmol/10^9 cells|THIRD DIAGONAL BRANCH ARTERY|LATERAL|CAUDAL|BIOPSY|||Y|SIGNIFICANT OTHER|MICROSCOPIST|5|Visit_5|90|5|TREATMENT|2020-11-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|5713cabe-4d79-4f77-8ddc-daad1242a837|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|um/day|[?]|1|ECL unit|TALUS|LATERAL|OCCIPITAL|TEST STRIP||Y||DOMESTIC PARTNER|RADIOLOGIST 1|5|Visit_5|90|2|WASHOUT|2020-11-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-10
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|[?]|mm3/mm2/year|[?]|1|mol/mol|MID-LAD ARTERY|BILATERAL|FACIAL|PLETHYSMOGRAPHY||||ADJUDICATION COMMITTEE|MICROSCOPIST 3|1|Visit_1|10|5|SCREENING|2020-07-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|2|PNIF|Peak Nasal Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|cycle/min|[?]|1|L/kg|CORPUS UTERI|LATERAL|LOWER FLEXOR SURFACE|PLETHYSMOGRAPHY||||SPOUSE|CARDIOLOGIST|1|Visit_1|10|5|SCREENING|2020-07-10|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-09
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|3|AWWVOL|Airway Wall Volume|[?]|PRONE|[?]|mL/kg/day|[?]|1|g/m2/day|PREFRONTAL CORTEX|IPSILATERAL|UPPER EXTENSOR SURFACE|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||GUARDIAN|DERMATOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-07-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|4|PLMXRS|Pulmonary Reactance|[?]|SLING|||[?]|1|COAT|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|BILATERAL|VENTROLATERAL|INDIA INK STAIN|||Y|CAREGIVER|RADIOLOGIST 2|2|Visit_2|25|4|FOLLOW-UP|2020-07-25|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-08
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|5|RER|Respiratory Exchange Ratio|[?]|FOWLERS|[?]|mg/kg/dose|[?]|1|gpELISA unit/mL|MAXILLA|BILATERAL|ANTEROLATERAL|STATIC PERIMETRY||Y||NON-HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|3|Visit_3|40|5|TREATMENT|2020-08-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|6|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING, BENT FORWARD|[?]|10^7/L|[?]|1|10^8/L|BLADDER, TRIGONE|IPSILATERAL|LOWER EXTENSOR SURFACE|RADIAL IMMUNODIFFUSION||||SIGNIFICANT OTHER|ONCOLOGIST 2|3|Visit_3|40|1|TREATMENT|2020-08-09|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|7|FEV1SVC|FEV1/SVC|[?]|RIGHT LATERAL DECUBITUS|[?]|mEq/day|[?]|1|log10 IU/mL|CORPUS CALLOSUM, SPLENIUM|BILATERAL|POSTERIOR|MULTIPLEXED BEAD BASED IMMUNOASSAY||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 2|4|Visit_4|65|7|WASHOUT|2020-09-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|8|PLMBLFLW|Pulmonary Blood Flow|[?]|LATERAL DECUBITUS|[?]|ug/m2/h|[?]|1|v/v|PROSTATE GLAND, MIDDLE LOBE|RIGHT|FORE|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||||FAMILY MEMBER|OPHTHALMOLOGIST|4|Visit_4|65|7|TREATMENT|2020-09-03|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|9|EXPRELTM|Expiration Relaxation Time|[?]|LEFT LATERAL DECUBITUS|[?]|pm|[?]|1|PATCH|PANCREAS, TAIL|CONTRALATERAL|ANTEROTEMPORAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||CHILD|ENDOCRINOLOGIST|5|Visit_5|90|4|WASHOUT|2020-09-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|414d20c7-8dc8-49ad-8ae9-f113b9610109|10|FEV1REV|FEV1 Reversibility|[?]|SEMI-FOWLERS|[?]|mL/h|[?]|1|L/h/m2|FRONTAL LOBE|CONTRALATERAL|INNER|FUNCTIONAL MRI|Y|Y||PARENT|INTERNIST|5|Visit_5|90|1|SCREENING|2020-09-28|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-17
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|1|DLCOPP|Percent Predicted DLCO|[?]|LEFT LATERAL DECUBITUS|[?]|mol/day|[?]|1|GBq|SKIN OF THE TRUNK|LEFT|LATERAL|TRICHROME STAIN||Y||VENDOR|ADJUDICATOR|1|Visit_1|10|5|WASHOUT|2020-09-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|2|TVPP|Percent Predicted Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mCi/L|[?]|1|/sec|PROXIMAL RIGHT CORONARY ARTERY CONDUIT|LEFT|DORSOLATERAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|||ADJUDICATOR|MICROSCOPIST|1|Visit_1|10|4|FOLLOW-UP|2020-09-17|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|3|SVC|Slow Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|mol/mg|PROXIMAL INTERPHALANGEAL JOINT 3|BILATERAL|LOWER EXTENSOR SURFACE|IN SITU HYBRIDIZATION|||Y|FRIEND|PEDIATRIC NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2020-10-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|4|FIVC|Forced Inspiratory Vital Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|Pack Year|[?]|1|Enzyme U/g Hb|BRAIN VENTRICLE|RIGHT|DORSAL|CONTRAST ENHANCED SPIRAL CT SCAN||Y||ADJUDICATOR|ONCOLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-10-02|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|5|INTP|Interpretation|[?]|STANDING|[?]|Enzyme U|[?]|1|nm|PARANASAL SINUS|IPSILATERAL|BASAL|FLOCCULATION, CHARCOAL ENHANCED||||INVESTIGATOR|RATER 2|3|Visit_3|40|6|TREATMENT|2020-10-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|6|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING, BENT FORWARD|[?]|LB|[?]|1|h/wk|SUBCARINAL LYMPH NODE|RIGHT|VENTROLATERAL|FLUOROSCOPY|Y|Y||GUARDIAN|NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2020-10-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|7|RRS|Total Respiratory System Resistance|[?]|FOWLERS|[?]|STRIP|[?]|1|Bq/mL|BRONCHUS|LATERAL|OUTER|OPTICAL DENSITY MEASUREMENT|Y|||CHILD|OPTOMETRIST|4|Visit_4|65|7|TREATMENT|2020-11-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|8|PEF|Peak Expiratory Flow|[?]|STANDING|[?]|/10^5|[?]|1|mCi/L|ARM|LEFT|POSTERIOR|IMMUNORADIOMETRIC ASSAY||Y||SIGNIFICANT OTHER|MICROSCOPIST 3|4|Visit_4|65|2|SCREENING|2020-11-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-24
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|9|GAW|Airway Conductance|[?]|REVERSE TRENDELENBURG|||[?]|1|mV2/Hz|KIDNEY|LATERAL|VOLAR|RYAN BLUE STAIN|Y||Y|STUDY SUBJECT|CLINICAL PATHOLOGIST|5|Visit_5|90|6|FOLLOW-UP|2020-12-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|21e16094-23bd-4d20-b5f8-10d45858160e|10|OXYPULSE|Oxygen Pulse|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|dpm/0.5 mL|ASCENDING AORTA, AORTIC ROOT|IPSILATERAL|PROXIMAL|DIGITAL PCR ARRAY|||Y|CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|5|Visit_5|90|4|TREATMENT|2020-12-06|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|2346613e-6734-476a-a414-511606c2d753|1|OXYPULSE|Oxygen Pulse|[?]|FOWLERS|[?]|mOsm|[?]|1|COAT|SPLENIC VEIN|RIGHT|HIND|KLEIHAUER-BETKE||Y||GUARDIAN|ONCOLOGIST 1|1|Visit_1|10|2|FOLLOW-UP|2020-09-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|2346613e-6734-476a-a414-511606c2d753|2|INERTANC|Inertance|[?]|FOWLERS|[?]|AFU|[?]|1|mmol/min/kPa/L|CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLATERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES|CONTRALATERAL|ANTEROPOSTERIOR|CONTRAST ENHANCED MRI||||FRIEND|MICROSCOPIST 3|1|Visit_1|10|1|TREATMENT|2020-09-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|2346613e-6734-476a-a414-511606c2d753|3|SVC|Slow Vital Capacity|[?]|SEMI-FOWLERS|||[?]|1|Absorbance U/mL|SKIN OF THE CHEST|CONTRALATERAL|TIP|MICRONEUTRALIZATION ASSAY|||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST|2|Visit_2|25|3|WASHOUT|2020-10-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|2346613e-6734-476a-a414-511606c2d753|4|ALVVOL|Alveolar Volume|[?]|SITTING, LEGS DEPENDENT|[?]|nkat/L|[?]|1|g/m2/day|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LATERAL|SUPERIOR|MICROARRAY||||GUARDIAN|OPTOMETRIST|2|Visit_2|25|5|TREATMENT|2020-10-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|2346613e-6734-476a-a414-511606c2d753|5|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|[?]|IU/mmol|[?]|1|usec|TRACHEA|BILATERAL|DEEP|KARYOTYPING|Y|||INVESTIGATOR|PATHOLOGIST 2|3|Visit_3|40|7|SCREENING|2020-10-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|2346613e-6734-476a-a414-511606c2d753|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|UNCONSTRAINED|[?]|FEU|[?]|1|mL/cage|FEMUR SHAFT|IPSILATERAL|FORE|MRI WITHOUT CONTRAST||||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|3|Visit_3|40|7|WASHOUT|2020-10-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|2346613e-6734-476a-a414-511606c2d753|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|STANDING, BENT FORWARD|[?]|10^9/L|[?]|1|g/g/day|HEAD AND NECK|CONTRALATERAL|DISTAL VOLAR|WRIGHT-GIEMSA STAIN||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|4|Visit_4|65|7|TREATMENT|2020-11-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|2346613e-6734-476a-a414-511606c2d753|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|STANDING|[?]|fmol/g|[?]|1|/10^4|RIB 6|LEFT|ROSTRAL|SNELLEN EYE CHART||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR|4|Visit_4|65|4|FOLLOW-UP|2020-11-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-20
e|RE|2346613e-6734-476a-a414-511606c2d753|9|MALEVDES|Malignancy Evidence Description|[?]|SUPINE|[?]|mm|[?]|1|mV/sec|AXILLARY VEIN|LATERAL|TEMPORAL|ISHIHARA COLOR PLATES||Y||INVESTIGATOR|PATHOLOGIST 1|5|Visit_5|90|2|WASHOUT|2020-12-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|2346613e-6734-476a-a414-511606c2d753|10|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|TRENDELENBURG|[?]|umol/day|[?]|1|mL/m2/min|LATISSIMUS DORSI MUSCLE|IPSILATERAL|TEMPORAL|MACRO BROTH DILUTION||||ADJUDICATION COMMITTEE|UROLOGIST|5|Visit_5|90|6|SCREENING|2020-12-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|POINT|[?]|1|GPL U/mL|CORNEAL EPITHELIUM|BILATERAL|INTERMEDIATE|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||DOMESTIC PARTNER|NEUROLOGIST|1|Visit_1|10|4|WASHOUT|2020-11-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|2|ELSTNCE|Elastance|[?]|LATERAL DECUBITUS|||[?]|1|dpm/mg|SUPERFICIAL FEMORAL ARTERY|BILATERAL|MIDLINE|IMMUNE REPERTOIRE DEEP SEQUENCING|Y||Y|CHILD|RATER 1|1|Visit_1|10|3|SCREENING|2020-11-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-08
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|DECUBITUS|[?]|uV|[?]|1|L/s|OMENTUM|LEFT|MIDLINE|IMMUNOBLOT|Y|||GUARDIAN|NEUROLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-12-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|4|DLCOVA|DLCO/VA|[?]|STANDING, BENT FORWARD|[?]|ng/day|[?]|1|pt_br|EYE BULGE|IPSILATERAL|DEEP|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|READER 2|2|Visit_2|25|3|WASHOUT|2020-12-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|5|ERVPP|Percent Predicted ERV|[?]|SLING|[?]|mL/m2/day|[?]|1|Gravitational Unit|LUNG, LEFT LOWER LOBE|UNILATERAL|ROSTRAL|ELECTROPHORESIS||||CAREGIVER|RADIOLOGIST 1|3|Visit_3|40|7|FOLLOW-UP|2020-12-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|6|OXYPULSE|Oxygen Pulse|[?]|LEFT LATERAL DECUBITUS|[?]|QUANTITY SUFFICIENT|[?]|1|SBE/mL|ILIOPSOAS MUSCLE|IPSILATERAL|ANTEROPOSTERIOR|FLUORESCENT MICROSCOPY||Y||STUDY SUBJECT|FORENSIC PATHOLOGIST|3|Visit_3|40|1|TREATMENT|2020-12-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|7|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|Bq/mL|[?]|1|mEq/dL|PROCERUS MUSCLE|UNILATERAL|LOWER FLEXOR SURFACE|CELL BASED BIOASSAY||||INVESTIGATOR|NEUROLOGIST 1|4|Visit_4|65|6|TREATMENT|2021-01-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|8|TV|Tidal Volume|[?]|SEMI-FOWLERS|[?]|Linear ft*LB|[?]|1|DRINK|L5-S1 INTERVERTEBRAL SPACE|IPSILATERAL|PARIETO-OCCIPITAL|DUKE INCISION METHOD||||VENDOR|CLINICAL PATHOLOGIST|4|Visit_4|65|4|FOLLOW-UP|2021-01-20|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|9|PIF|Peak Inspiratory Flow|[?]|STANDING|[?]|U/m2/day|[?]|1|/VF|RIB 5|LEFT|SUBCORTICAL|GRADIENT DIFFUSION||||ADJUDICATOR|ONCOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2021-02-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|6a8bda83-1b5a-481e-af4f-77fe74bc37be|10|INFLTIND|Infiltrates Indicator|[?]|SEMI-RECUMBENT|[?]|C|[?]|1|pptr|FINGERNAIL|CONTRALATERAL|LOWER FLEXOR SURFACE|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y||INVESTIGATOR|PHYSIOTHERAPIST|5|Visit_5|90|1|WASHOUT|2021-02-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|748ef401-3def-4674-8d5e-4a198709d672|1|TGV|Thoracic Gas Volume|[?]|FOWLERS|[?]|%(w/v)|[?]|1|amu|PROFUNDA FEMORIS ARTERY|LEFT|FORE|MS/MS||||GUARDIAN|FORENSIC PATHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|748ef401-3def-4674-8d5e-4a198709d672|2|IVCPP|Percent Predicted IVC|[?]|SITTING, LEGS DEPENDENT|||[?]|1|pmol/L/h|PAROTID GLAND LYMPH NODE|BILATERAL|ANTERIOR|JAEGER EYE CHART|Y||Y|INVESTIGATOR|ADJUDICATOR 3|1|Visit_1|10|5|TREATMENT|2020-06-08|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-04
e|RE|748ef401-3def-4674-8d5e-4a198709d672|3|MALIND|Malignancy Indicator|[?]|SEMI-RECUMBENT|[?]|uL|[?]|1|copies/ug|RADIUS-LUNATE JOINT|LATERAL|INNER|ENDOSCOPY||||FRIEND|ADJUDICATOR 2|2|Visit_2|25|3|SCREENING|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|748ef401-3def-4674-8d5e-4a198709d672|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|deg|[?]|1|g/cage/day|NOSTRIL|LEFT|INNER|MODIFIED ACID FAST STAIN||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|2|Visit_2|25|5|SCREENING|2020-06-23|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-26
e|RE|748ef401-3def-4674-8d5e-4a198709d672|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|MASK|[?]|1|10^6 organisms|DORSAL MOTOR NUCLEUS|RIGHT|PROXIMAL|MRI WITHOUT CONTRAST||||CLINICAL RESEARCH ASSOCIATE|READER 2|3|Visit_3|40|2|TREATMENT|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|748ef401-3def-4674-8d5e-4a198709d672|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|TRENDELENBURG|[?]|pg/dL|[?]|1|U.CARR|TAIL|UNILATERAL|UPPER|SLOAN LETTER EYE CHART 100%||||FAMILY MEMBER|ONCOLOGIST 1|3|Visit_3|40|6|SCREENING|2020-07-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-16
e|RE|748ef401-3def-4674-8d5e-4a198709d672|7|PLMXRS|Pulmonary Reactance|[?]|SITTING|||[?]|1|DAgU|BLOOD|IPSILATERAL|DORSAL|BRDU CELLULAR PROLIFERATION ASSAY|||Y|VENDOR|ADJUDICATOR 2|4|Visit_4|65|5|TREATMENT|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|748ef401-3def-4674-8d5e-4a198709d672|8|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|U/g/day|[?]|1|SFC/10^6 PBMC|RECTUS FEMORIS MUSCLE|LATERAL|MIDLINE|IMPEDANCE CONDUCTIVITY||||DOMESTIC PARTNER|ADJUDICATOR 2|4|Visit_4|65|7|TREATMENT|2020-08-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-15
e|RE|748ef401-3def-4674-8d5e-4a198709d672|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-RECUMBENT|[?]|/MBP|[?]|1|Mile|RIB 2|CONTRALATERAL|DISTAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y||CLINICAL STUDY SPONSOR|ONCOLOGIST|5|Visit_5|90|2|TREATMENT|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|748ef401-3def-4674-8d5e-4a198709d672|10|FEV1SVC|FEV1/SVC|[?]|STANDING, BENT FORWARD|||[?]|1|10^6/hpf|GASTRIC CARDIA|BILATERAL|UPPER EXTENSOR SURFACE|MICROBIAL CULTURE, SOLID|Y||Y|STUDY SUBJECT|OPHTHALMOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-08-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|REVERSE TRENDELENBURG|[?]|/500 WBC|[?]|1|Antibody Unit|FINGER|UNILATERAL|FRONTAL|FORCED OSCILLATION TECHNIQUE||||SPOUSE|CLINICAL PATHOLOGIST|1|Visit_1|10|4|WASHOUT|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|UNCONSTRAINED|||[?]|1|uV2|GLOSSOPHARYNGEAL NERVE|RIGHT|PERIPHERAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|||Y|DOMESTIC PARTNER|HEMATOLOGIST|1|Visit_1|10|6|SCREENING|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|LATERAL DECUBITUS|[?]|mL/m2/min|[?]|1|amp|MAMMARY GLAND|IPSILATERAL|DISTAL|GC/MS-EI||||PARENT|RATER|2|Visit_2|25|7|TREATMENT|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|4|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SITTING|[?]|mV2/Hz|[?]|1|pg/cell|SKIN OF THE THIGH|LATERAL|FORE|ZIEHL NEELSEN ACID FAST STAIN||Y||CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|5|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|STANDING, BENT FORWARD|||[?]|1|U/kg|MUSCLE|BILATERAL|CRANIAL|SINGLE-SLICE SPIRAL CT|||Y|SIBLING|PEDIATRIC NEUROLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|6|EFFVOL|Effusion Volume|[?]|STANDING, BENT FORWARD|||[?]|1|g/cage|PERICARDIAL WALL|CONTRALATERAL|DEEP|ELLA|||Y|INVESTIGATOR|ENDOCRINOLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|YEARS|[?]|1|U/g/day|GINGIVA|LEFT|PERIPHERAL|NUCLEIC ACID SEQUENCING||||CAREGIVER|HEMATOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|8|TSUELAS|Tissue Elastance|[?]|RIGHT LATERAL DECUBITUS|[?]|APS U|[?]|1|10^6/Ejaculate U|MID-JUGULAR LYMPH NODE|CONTRALATERAL|ROSTRAL|AUTOREFRACTION||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|5|SCREENING|2020-09-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|9|FEV6PP|Percent Predicted FEV6|[?]|STANDING, BENT FORWARD|[?]|mg/h|[?]|1|PACKET|SACROILIAC JOINT|IPSILATERAL|ANTERIOR|TARGETED TRANSCRIPTOME SEQUENCING||||CHILD|ADJUDICATOR 2|5|Visit_5|90|4|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|03c399c1-77b9-4879-a6e8-42ba58ca68d4|10|DLCOVA|DLCO/VA|[?]|DECUBITUS|[?]|g/m2|[?]|1|APS U|RETROAURICULAR LYMPH NODE|LATERAL|VENTRAL|HPLC/MS/MS||||GUARDIAN|ONCOLOGIST 2|5|Visit_5|90|3|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|GAW|Airway Conductance|[?]|SEMI-FOWLERS|[?]|%/s|[?]|1|FEU|RECTOVAGINAL SPACE|LATERAL|UPPER EXTENSOR SURFACE|ROMANOWSKY STAIN|Y|||SIGNIFICANT OTHER|OPTOMETRIST|1|Visit_1|10|1|FOLLOW-UP|2020-11-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|2|FVC|Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|nmol/day|[?]|1|pmol/g|HEPATOBILIARY SYSTEM|BILATERAL|FACIAL|HPLC-UV|Y|||FRIEND|HEMATOLOGIST|1|Visit_1|10|1|FOLLOW-UP|2020-11-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|3|DLCOVA|DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|kDa|[?]|1|U/g/day|UMBILICAL CORD|UNILATERAL|HIND|INTRAVASCULAR ULTRASOUND||||INVESTIGATOR|PATHOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-11-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|4|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SITTING|[?]|ug/m2|[?]|1|kcal/day|FEMORAL HEAD|CONTRALATERAL|FORE|IMMUNO-PET SCAN||||SIBLING|CARDIOLOGIST|2|Visit_2|25|6|TREATMENT|2020-11-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-20
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|5|MEPPP|Percent Predicted MEP|[?]|PRONE|[?]|cs|[?]|1|nL|MESENTERIC VEIN|LATERAL|LOWER|OPTICAL COHERENCE TOMOGRAPHY||||PARENT|READER 1|3|Visit_3|40|7|TREATMENT|2020-12-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|6|DLCO|Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|nmol BCE/nmol|[?]|1|uCi/L|PREPUTIAL GLAND|LATERAL|FORE|PHOTOMETRY||Y||VENDOR|NEUROLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-12-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-11
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|||[?]|1|EU|LOWER RESPIRATORY SYSTEM|IPSILATERAL|APICAL|SEQUENCING|||Y|CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|8|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-RECUMBENT|[?]|nkat/g Hb|[?]|1|mL/beat|FEMUR SHAFT|LATERAL|UPPER EXTENSOR SURFACE|ALCIAN BLUE STAIN||||FAMILY MEMBER|MICROSCOPIST|4|Visit_4|65|3|WASHOUT|2021-01-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|9|PEFTIME|Peak Expiratory Flow Time|[?]|SITTING|||[?]|1|mEq/L|PENIS, GLANS|RIGHT|ROSTRAL|SNP ARRAY|||Y|PARENT|ADJUDICATOR 2|5|Visit_5|90|4|WASHOUT|2021-02-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|b8afdaf1-5c4d-408f-b8ba-381461f15bde|10|INFLTIND|Infiltrates Indicator|[?]|PRONE|[?]|kHz|[?]|1|V|OPPONENS POLLICIS MUSCLE|LATERAL|TEMPORAL|GC/MS-EI||||GUARDIAN|NEUROLOGIST|5|Visit_5|90|5|TREATMENT|2021-02-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|AIRTRAP|Air Trapping|[?]|STANDING|||[?]|1|V|MALE REPRODUCTIVE SYSTEM|IPSILATERAL|ANTEROPOSTERIOR|MICROBIAL BIOCHEMICAL IDENTIFICATION|Y|Y|Y|INVESTIGATOR|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2020-11-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|2|VO2|Oxygen Consumption|[?]|SITTING|[?]|mm3/mm2/year|[?]|1|10^6 IU/mL|CHEST WALL|UNILATERAL|LATERAL|TEMPLATE INCISION METHOD||||CLINICAL RESEARCH ASSOCIATE|ENDOCRINOLOGIST|1|Visit_1|10|7|TREATMENT|2020-11-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|3|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|REVERSE TRENDELENBURG|[?]|uCi/L|[?]|1|10^7 TCID 50/dose|HEART, VENTRICLE|RIGHT|SURFACE|AUDIOMETRY||||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|WASHOUT|2020-12-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|4|FEV3PP|Percent Predicted FEV3|[?]|SITTING|||[?]|1|ug/mol|AXILLARY LYMPH NODE|RIGHT|VENTROLATERAL|VIRUS PLAQUE ASSAY|||Y|VENDOR|READER 1|2|Visit_2|25|3|WASHOUT|2020-12-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-29
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SEMI-FOWLERS|||[?]|1|mm|ANKLE JOINT ANTERIOR FLEXOR TENDONS|IPSILATERAL|VOLAR|IMMUNOCHEMILUMINOMETRIC ASSAY|Y||Y|FRIEND|MICROSCOPIST 2|3|Visit_3|40|6|TREATMENT|2020-12-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|6|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|PIXELS/cm|MEDIAL FEMORAL CONDYLE|RIGHT|ANTEROTEMPORAL|TRYPAN BLUE STAIN|||Y|NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST|3|Visit_3|40|2|TREATMENT|2020-12-28|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|7|INERTANC|Inertance|[?]|LATERAL DECUBITUS|[?]|mL/s/m2|[?]|1|mL/min/mmHg|SIGMOID SINUS|LATERAL|UPPER EXTENSOR SURFACE|IMMUNORADIOMETRIC ASSAY||||PARENT|ADJUDICATOR|4|Visit_4|65|3|WASHOUT|2021-01-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|Linear ft*LB|[?]|1|Mile|COLON, TRANSVERSE|IPSILATERAL|UPPER EXTENSOR SURFACE|MUGA||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|4|Visit_4|65|2|FOLLOW-UP|2021-01-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|9|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING, BENT FORWARD|[?]|Frames/s|[?]|1|kBq/uL|MIDDLE PHALANX 2 OF THE HAND|BILATERAL|SURFACE|DOPPLER ULTRASOUND|Y|||FAMILY MEMBER|RADIOLOGIST 1|5|Visit_5|90|5|WASHOUT|2021-02-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|8115d6e8-0908-4491-a82a-08f43ccf1f0d|10|RER|Respiratory Exchange Ratio|[?]|LEFT LATERAL DECUBITUS|[?]|SACHET|[?]|1|mg2/dL2|UTERINE ARTERY|BILATERAL|ROSTRAL|ELECTRONEUROGRAPHY||Y||INDEPENDENT ASSESSOR|ADJUDICATOR 3|5|Visit_5|90|6|WASHOUT|2021-02-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-02
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|DECUBITUS|[?]|bel|[?]|1|IU|FINGER EXTENSOR MUSCLES|CONTRALATERAL|VENTROLATERAL|REBOUND TONOMETRY||||CLINICAL RESEARCH ASSOCIATE|OTOLARYNGOLOGIST|1|Visit_1|10|3|WASHOUT|2020-06-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|2|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-RECUMBENT|[?]|g/cage/day|[?]|1|kg/m2|HUMERAL EPICONDYLE|RIGHT|MEDIAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||FRIEND|READER 2|1|Visit_1|10|4|TREATMENT|2020-06-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-07
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|3|FIVC|Forced Inspiratory Vital Capacity|[?]|SLING|||[?]|1|CARTRIDGE|NERVE|BILATERAL|OUTER|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|||Y|ADJUDICATOR|ADJUDICATOR|2|Visit_2|25|7|TREATMENT|2020-07-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|4|FEV1FVC6|FEV1/FVC6|[?]|SUPINE|[?]|HEP|[?]|1|tuberculin unit/mL|SKIN OF THE ELBOW|IPSILATERAL|OCCIPITAL|WHOLE EXOME SEQUENCING|Y|||ADJUDICATOR|ONCOLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-07-15|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-26
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|5|LOBVOL|Lobar Volume|[?]|STANDING|[?]|PACK|[?]|1|mm|SKIN AROUND THE MOUTH|LATERAL|TIP|ENZYMATIC COLORIMETRY|Y|||ADJUDICATOR|FORENSIC PATHOLOGIST|3|Visit_3|40|2|SCREENING|2020-07-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|6|LOBVOL|Lobar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|DAgU/mL|[?]|1|mL/cage/wk|POSTERIOR CERVICAL LYMPH NODE|UNILATERAL|TEMPORAL|NUCLEIC ACID BASED METHOD||Y||GUARDIAN|RADIOLOGIST 2|3|Visit_3|40|3|SCREENING|2020-07-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|7|PLMXRS|Pulmonary Reactance|[?]|SITTING|[?]|PA|[?]|1|APL U|TIBIA|BILATERAL|VOLAR|POTENTIOMETRY||||CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|4|Visit_4|65|5|SCREENING|2020-08-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|8|SRAW|Specific Airway Resistance|[?]|DECUBITUS|[?]|KIT|[?]|1|ug/m2/min|DISTAL COMMON BILE DUCT|UNILATERAL|LOWER EXTENSOR SURFACE|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||Y||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|4|Visit_4|65|4|WASHOUT|2020-08-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-15
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|9|PCF|Peak Cough Flow|[?]|SITTING, LEGS DEPENDENT|[?]|TABLET|[?]|1|EID 50/dose|METATARSOPHALANGEAL JOINT|IPSILATERAL|INTERMEDIATE|CHROMOGENIC ASSAY|Y|||ADJUDICATION COMMITTEE|DERMATOLOGIST|5|Visit_5|90|7|SCREENING|2020-09-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|fbd7ecb2-905f-40a9-babc-ebaf310cc372|10|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|[?]|cm/min|[?]|1|U/g/min|LYMPH NODE|LEFT|DISTAL|COULOMETRIC TITRATION||Y||NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|5|Visit_5|90|3|TREATMENT|2020-09-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-21
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|TGV|Thoracic Gas Volume|[?]|STANDING|||[?]|1|ELISA unit/mL|MANDIBLE|RIGHT|APICAL|NEURAMINIDASE INHIBITION ASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|1|Visit_1|10|6|TREATMENT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|2|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|[?]|10^6 copies/mL|[?]|1|AU/mL|HEART, BASE|LEFT|TIP|ECHOCARDIOGRAPHY||Y||SIGNIFICANT OTHER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-12-09|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LEFT LATERAL DECUBITUS|[?]|10^7 CFU|[?]|1|10^9 organisms/g|INTERPHALANGEAL OF THE FOOT|IPSILATERAL|VOLAR|MULTI-SLICE SPIRAL CT|Y|||INTERVIEWER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|5|SCREENING|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|4|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|DAYS|[?]|1|GBq/g|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|CONTRALATERAL|CAUDAL|INTERRUPTER TECHNIQUE||||PARENT|RADIOLOGIST 2|2|Visit_2|25|2|SCREENING|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|5|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|mm/2h|[?]|1|CONTAINER|EYE BULGE|UNILATERAL|VOLAR|TURBIDIMETRY||||INTERVIEWER|RATER 2|3|Visit_3|40|7|TREATMENT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|6|LOBVOL|Lobar Volume|[?]|PRONE|[?]|PUFF|[?]|1|10^6 RNA copies/mL|PERIURETERAL REGION|RIGHT|FACIAL|COULOMETRIC TITRATION|Y|||ADJUDICATOR|ADJUDICATOR 2|3|Visit_3|40|1|WASHOUT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-23
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|DPM|INSULAR CORTEX|RIGHT|DISTAL|ELECTROCHEMILUMINESCENCE||Y|Y|NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|4|Visit_4|65|6|WASHOUT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|8|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|[?]|Tbsp|[?]|1|log10 CFU/mL|PARACOLIC GUTTER|RIGHT|DISTAL|NEXT GENERATION TARGETED SEQUENCING||||INVESTIGATOR|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|||[?]|1|mg/g/h|MID-JUGULAR LYMPH NODE|CONTRALATERAL|FACIAL|IMMUNOFLUORESCENT STAIN|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|READER 1|5|Visit_5|90|5|WASHOUT|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|1a0e1a66-82dd-4945-9c9f-179fba9d781e|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|||[?]|1|nmol/mL/min|ANAL VERGE|LEFT|LOWER MEDIAL|FORCED OSCILLATION TECHNIQUE||Y|Y|HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|5|Visit_5|90|2|TREATMENT|2021-02-27|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-21
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|FEV1SVC|FEV1/SVC|[?]|SUPINE|||[?]|1|g/U|HEART, LEFT VENTRICULAR WALL|RIGHT|APICAL|NUCLEIC ACID BASED METHOD|||Y|GUARDIAN|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-11-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|PRONE|||[?]|1|DAgU/mL|MALE REPRODUCTIVE SYSTEM|RIGHT|INTERMEDIATE|SIZE EXCLUSION CHROMATOGRAPHY|||Y|PROXY|MICROSCOPIST 2|1|Visit_1|10|6|WASHOUT|2020-11-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|3|FRC|Functional Residual Capacity|[?]|STANDING, BENT FORWARD|[?]|g|[?]|1|umol/mg/min|XIPHOID PROCESS|LATERAL|TIP|CHROMATOGRAPHY|Y|Y||INTERVIEWER|ADJUDICATOR 3|2|Visit_2|25|6|WASHOUT|2020-12-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|4|TV|Tidal Volume|[?]|SITTING|[?]|uIU/dL|[?]|1|vp/mL|CORNEAL EPITHELIUM|RIGHT|LOWER EXTENSOR SURFACE|IMMUNOFLUORESCENT STAIN||||SPOUSE|MICROSCOPIST 3|2|Visit_2|25|4|SCREENING|2020-12-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|5|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|PRONE|[?]|pkat/L|[?]|1|/wk|HIP|BILATERAL|SUPERFICIAL|CLINICAL EVALUATION|Y|||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|3|Visit_3|40|5|WASHOUT|2020-12-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|6|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SITTING|[?]|km|[?]|1|pL|PARIETAL LOBE|IPSILATERAL|FORE|BRDU CELLULAR PROLIFERATION ASSAY||Y||INVESTIGATOR|READER|3|Visit_3|40|6|TREATMENT|2020-12-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-03
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|7|TLCPP|Percent Predicted Total Lung Capacity|[?]|REVERSE TRENDELENBURG|[?]|mol/L|[?]|1|dram|URETHRA, ANTERIOR|IPSILATERAL|DORSOLATERAL|PERCUSSION||||ADJUDICATOR|ENDOCRINOLOGIST|4|Visit_4|65|5|TREATMENT|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|8|MIPPP|Percent Predicted MIP|[?]|SUPINE|[?]|sec|[?]|1|yd|WRIST JOINT|RIGHT|BASAL|NUCLEAR RADIOLOGY|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 2|4|Visit_4|65|1|SCREENING|2021-01-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|9|AIRTRAP|Air Trapping|[?]|STANDING|[?]|mEq/kg|[?]|1|g/animal/day|INTERPHALANGEAL JOINT 5 OF THE FOOT|LEFT|PROXIMAL VOLAR|INDIRECT IMMUNOFLUORESCENCE||||INVESTIGATOR|MICROSCOPIST 3|5|Visit_5|90|4|FOLLOW-UP|2021-02-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|b3ab1879-3dc7-41fa-be53-f4484af21fbd|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/kg/day|[?]|1|BU/mL|POSTERIOR INFERIOR CEREBELLAR ARTERY|CONTRALATERAL|CRANIAL|CALCOFLUOR WHITE STAIN||||VENDOR|RATER|5|Visit_5|90|7|TREATMENT|2021-02-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|1|PNIF|Peak Nasal Inspiratory Flow|[?]|STANDING|[?]|10^3 RNA copies/mL|[?]|1|min*mg/mL|PORTAL VEIN BIFURCATION|LATERAL|ANTEROMEDIAL|GC/MS||||VENDOR|NEUROLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-07-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|2|RV|Residual Volume|[?]|PRONE|||[?]|1|uL/dose|VAGUS NERVE|IPSILATERAL|LOWER|RADIOIMMUNOPRECIPITATION ASSAY|||Y|STUDY SUBJECT|RATER|1|Visit_1|10|7|TREATMENT|2020-07-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|pmol/L|EARLOBE|UNILATERAL|OUTER|CISH|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-07-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|4|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-RECUMBENT|[?]|MnFI|[?]|1|kBq|LOWER RESPIRATORY SYSTEM|RIGHT|PROXIMAL VOLAR|CAPILLARY ELECTROPHORESIS||Y||VENDOR|ENDOCRINOLOGIST|2|Visit_2|25|1|TREATMENT|2020-07-26|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|5|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|[?]|uV*sec|[?]|1|mL/kg/h|PERIURETERAL REGION|LEFT|DORSOLATERAL|MODIFIED ACID FAST STAIN|Y|Y||FRIEND|NEUROLOGIST 2|3|Visit_3|40|2|TREATMENT|2020-08-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|6|RV|Residual Volume|[?]|FOWLERS|[?]|AU/mL|[?]|1|cP|CEPHALIC VEIN|RIGHT|VENTRAL|KINYOUN STAIN||||FAMILY MEMBER|MICROSCOPIST 2|3|Visit_3|40|7|FOLLOW-UP|2020-08-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|7|LCI|Lung Clearance Index|[?]|UNCONSTRAINED|[?]|Pack Year|[?]|1|FIU|XIPHOID PROCESS|LATERAL|ANTERIOR|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|||STUDY SUBJECT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|6|SCREENING|2020-09-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|8|PCF|Peak Cough Flow|[?]|PRONE|||[?]|1|10^6 organisms/mL|AORTA|BILATERAL|ANTEROLATERAL|GC/FID|||Y|CAREGIVER|RATER 2|4|Visit_4|65|1|TREATMENT|2020-09-04|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|9|OXYPULSE|Oxygen Pulse|[?]|DECUBITUS|||[?]|1|GPL U|GASTROINTESTINAL SYSTEM|RIGHT|TEMPORAL|DNA MICROARRAY||Y|Y|GUARDIAN|ADJUDICATOR 3|5|Visit_5|90|6|TREATMENT|2020-09-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|bc71ddfa-c71c-447b-9684-005e4c112172|10|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|VIAL|[?]|1|gMFI|AORTO-ILIAC PERIPHERAL ARTERY|LATERAL|INTERMEDIATE|HEMAGGLUTINATION INHIBITION ASSAY||||FRIEND|NEUROLOGIST 2|5|Visit_5|90|4|TREATMENT|2020-09-29|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-10
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|SALKB|Salazar-Knowles Equation Parameter B|[?]|SUPINE|[?]|mmol/day|[?]|1|MBP|T5 VERTEBRA|IPSILATERAL|DORSAL|TEMPLATE INCISION METHOD||||SPOUSE|CLINICAL PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|2|FIO2|Fraction of Inspired Oxygen|[?]|UNCONSTRAINED|[?]|ngEq/L|[?]|1|deg/s|CAPITATE BONE|IPSILATERAL|OUTER|ZIEHL NEELSEN ACID FAST STAIN||||STUDY SUBJECT|MICROSCOPIST|1|Visit_1|10|5|TREATMENT|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-09
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|3|FIV1PP|Percent Predicted FIV1|[?]|LEFT LATERAL DECUBITUS|[?]|Torr|[?]|1|ft2|LIVER, CAUDATE LOBE|CONTRALATERAL|SUPERFICIAL|SNP ARRAY||Y||FAMILY MEMBER|ADJUDICATOR|2|Visit_2|25|6|TREATMENT|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|4|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|[?]|ng/mol|[?]|1|%(w/v)|SKIN OF THE LIP|IPSILATERAL|ANTEROTEMPORAL|FORCED OSCILLATION TECHNIQUE||||ADJUDICATION COMMITTEE|PATHOLOGIST 2|2|Visit_2|25|6|WASHOUT|2020-12-24|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|5|FEV_PEF|FEV at PEF|[?]|LEFT LATERAL DECUBITUS|||[?]|1|ng/mol|POSTERIOR SUPERIOR ILIAC SPINE|LATERAL|DORSOLATERAL|NUCLEIC ACID SEQUENCING|||Y|CHILD|PATHOLOGIST 2|3|Visit_3|40|6|WASHOUT|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|6|FEV1FVC6|FEV1/FVC6|[?]|SITTING|[?]|/mm2|[?]|1|L/s|ABDOMINAL WALL|CONTRALATERAL|NASAL|OPTICAL COHERENCE TOMOGRAPHY||Y||VENDOR|READER 1|3|Visit_3|40|3|TREATMENT|2021-01-08|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|STANDING, BENT FORWARD|||[?]|1|10^6 organisms/g|GENITAL TUBERCLE|UNILATERAL|PARIETO-OCCIPITAL|CARDIAC THERMODILUTION|||Y|NON-HEALTH CARE PROFESSIONAL|RATER 2|4|Visit_4|65|6|TREATMENT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|8|ICREV|IC Reversibility|[?]|REVERSE TRENDELENBURG|||[?]|1|umol/h/mmol|BONE MARROW|LATERAL|PERIVENTRICULAR|MODIFIED ACID FAST STAIN|Y||Y|INDEPENDENT ASSESSOR|MICROSCOPIST 2|4|Visit_4|65|6|WASHOUT|2021-02-02|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|9|FEV1PP|Percent Predicted FEV1|[?]|STANDING, BENT FORWARD|[?]|/mm2|[?]|1|GBq|ATRIOVENTRICULAR VALVE|RIGHT|PERIVENTRICULAR|OPTICAL DENSITY MEASUREMENT||Y||INTERVIEWER|CLINICAL PATHOLOGIST|5|Visit_5|90|2|TREATMENT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING|||[?]|1|g/cage|DISTAL PHALANX 5 OF THE HAND|UNILATERAL|LOWER MEDIAL|DIGITAL PCR ARRAY|Y||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 2|5|Visit_5|90|3|TREATMENT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-05
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|DLCO|Diffusion Capacity of Lung for CO|[?]|STANDING|||[?]|1|WEEKS|SEBACEOUS GLAND|CONTRALATERAL|LATERAL|SIZE EXCLUSION CHROMATOGRAPHY|||Y|DOMESTIC PARTNER|ADJUDICATOR 3|1|Visit_1|10|2|FOLLOW-UP|2020-09-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|2|PNEUMIND|Pneumonia Indicator|[?]|RIGHT LATERAL DECUBITUS|[?]|COAT|[?]|1|Absorbance U|EXTRAOCULAR MUSCLE|CONTRALATERAL|PARIETO-OCCIPITAL|FLAME PHOTOMETRY||||FRIEND|FORENSIC PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-09
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|3|FEV1PP|Percent Predicted FEV1|[?]|DECUBITUS|[?]|/HPF|[?]|1|ng/day|AXILLARY LYMPH NODE|BILATERAL|DORSAL|VENTILATION PERFUSION LUNG SCAN|Y|||INVESTIGATOR|READER 1|2|Visit_2|25|4|TREATMENT|2020-09-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|4|SAWVOL|Specific Airway Volume|[?]|DECUBITUS|[?]|1/(s*kPa)|[?]|1|/month|FASCIA|RIGHT|MIDLINE|LC/MS||||SIBLING|ADJUDICATOR 3|2|Visit_2|25|1|WASHOUT|2020-09-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|5|SALKA|Salazar-Knowles Equation Parameter A|[?]|SEMI-FOWLERS|[?]|ms2|[?]|1|ng/mol|BASAL GANGLIA|LATERAL|DISTAL VOLAR|MOUSE PROTECTION ASSAY|Y|||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2020-10-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|6|IVCPP|Percent Predicted IVC|[?]|DECUBITUS|[?]|anti-Xa IU/mL|[?]|1|damol/L|SCALP|LATERAL|VENTROLATERAL|OBSERVATION|Y|||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-10-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-30
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|7|ICPP|Percent Predicted Inspiratory Capacity|[?]|FOWLERS|||[?]|1|uU/L|LUNG, LEFT UPPER LOBE|IPSILATERAL|VENTRAL|CALCOFLUOR WHITE STAIN||Y|Y|CHILD|OPTOMETRIST|4|Visit_4|65|6|TREATMENT|2020-10-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|8|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SEMI-RECUMBENT|[?]|h/wk|[?]|1|mmol/min/kPa|SUPERIOR SAGITTAL SINUS|RIGHT|CRANIAL|OPTICAL DENSITY MEASUREMENT||||INTERVIEWER|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2020-10-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-31
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|9|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-FOWLERS|[?]|ug/dL|[?]|1|uEq/L|DURAL VENOUS SINUS|RIGHT|DISTAL VOLAR|GEL ELECTROPHORESIS||||INDEPENDENT ASSESSOR|ENDOCRINOLOGIST|5|Visit_5|90|4|WASHOUT|2020-11-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|10|FRC|Functional Residual Capacity|[?]|STANDING, BENT FORWARD|[?]|Log10 ELISA unit/dose|[?]|1|mg/dose|RADIUS|RIGHT|DISTAL VOLAR|MICROBIAL CONCENTRATION|Y|||SIBLING|CARDIOLOGIST|5|Visit_5|90|5|FOLLOW-UP|2020-11-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|1|PLMXRS|Pulmonary Reactance|[?]|RIGHT LATERAL DECUBITUS|[?]|PFU/animal|[?]|1|mL/g/h|INFERIOR VENA CAVA|LATERAL|LOWER FLEXOR SURFACE|NUCLEIC ACID HYBRIDIZATION|Y|||PARENT|MICROSCOPIST 3|1|Visit_1|10|1|SCREENING|2021-01-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|2|TSUHYS|Tissue Hysteresivity|[?]|STANDING|[?]|MdFI|[?]|1|TRANSDUCING UNIT/mL|MITRAL VALVE, POSTERIOR ANNULUS|BILATERAL|ANTEROTEMPORAL|CAPILLARY ELECTROPHORESIS||||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|5|SCREENING|2021-01-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-26
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|3|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SEMI-RECUMBENT|||[?]|1|POUCH|LEFT CIRCUMFLEX ARTERY OSTIUM|LATERAL|TEMPORAL|MODIFIED ACID FAST STAIN|||Y|FRIEND|RATER|2|Visit_2|25|6|FOLLOW-UP|2021-02-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|4|FEV1REV|FEV1 Reversibility|[?]|TRENDELENBURG|[?]|Frames/s|[?]|1|mU/L|ILEUM, TERMINAL|LEFT|INNER|NEPHELOMETRY|Y|||INTERVIEWER|ADJUDICATOR 3|2|Visit_2|25|7|TREATMENT|2021-02-11|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-17
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|5|FIVC|Forced Inspiratory Vital Capacity|[?]|FOWLERS|[?]|vg/dose|[?]|1|BOX|PRONATOR TERES MUSCLE|LEFT|DORSAL|ANTIMICROBIAL COMBINATION TESTING||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|6|SALKB|Salazar-Knowles Equation Parameter B|[?]|SITTING, LEGS DEPENDENT|[?]|ms/mmHg|[?]|1|m/sec2|VEIN|CONTRALATERAL|MEDIAL|CONTRAST ENHANCED CT SCAN||||PROXY|OTOLARYNGOLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-26|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-08
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|7|TVPP|Percent Predicted Tidal Volume|[?]|LEFT LATERAL DECUBITUS|[?]|mL/(min*100mL)|[?]|1|MnFI|HEART, RIGHT ATRIAL APPENDAGE|RIGHT|FRONTAL|OPTICAL DENSITY MEASUREMENT||||INTERVIEWER|ADJUDICATOR 1|4|Visit_4|65|4|TREATMENT|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|8|TV|Tidal Volume|[?]|UNCONSTRAINED|||[?]|1|beats/min|TRAPEZIUS MUSCLE|CONTRALATERAL|APICAL|SPECULAR MICROSCOPY|||Y|SPOUSE|ADJUDICATOR 2|4|Visit_4|65|6|WASHOUT|2021-03-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-24
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|9|GAW|Airway Conductance|[?]|PRONE|[?]|CCID 50/mL|[?]|1|ppm|PENIS, RADIX|LATERAL|ROSTRAL|KNEMOMETRY||||ADJUDICATION COMMITTEE|ADJUDICATOR 1|5|Visit_5|90|5|TREATMENT|2021-04-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|b1b3e113-8c73-4446-8095-3341f8912bd7|10|FIO2|Fraction of Inspired Oxygen|[?]|STANDING, BENT FORWARD|||[?]|1|mL/cage/wk|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|BILATERAL|VENTROLATERAL|FREEZING POINT DEPRESSION|||Y|INDEPENDENT ASSESSOR|PATHOLOGIST 1|5|Visit_5|90|5|TREATMENT|2021-04-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-21
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|UNCONSTRAINED|[?]|m2|[?]|1|ug/h|RADIAL ARTERY|CONTRALATERAL|ANTEROTEMPORAL|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||||PROXY|FORENSIC PATHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-11-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|2|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|||[?]|1|mmHg|AXILLARY LYMPH NODE LEVEL III|BILATERAL|LATERAL|MICRODENSITOMETRY|||Y|INVESTIGATOR|MICROSCOPIST 1|1|Visit_1|10|6|WASHOUT|2020-11-22|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-11
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|3|ICPP|Percent Predicted Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|10^9 organisms/mL|[?]|1|nmol/g|OROPHARYNX|LEFT|INFERIOR|CAPILLARY ELECTROPHORESIS|Y|Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|2|Visit_2|25|4|WASHOUT|2020-12-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|4|RVPP|Percent Predicted Residual Volume|[?]|PRONE|[?]|mmol/min/kPa/L|[?]|1|PHERESIS UNIT|LEFT CIRCUMFLEX CORONARY ARTERY|LATERAL|PROXIMAL VOLAR|SNP ARRAY||||STUDY SUBJECT|FORENSIC PATHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-12-07|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|5|RELSZCHG|Relative Size Change|[?]|SITTING, LEGS DEPENDENT|||[?]|1|dpm/mL|FLEXOR HALLUCIS BREVIS MUSCLE|RIGHT|VENTRAL|IN VITRO GENE EXPRESSION ASSAY|||Y|INDEPENDENT ASSESSOR|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2020-12-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|6|MALIND|Malignancy Indicator|[?]|SITTING|[?]|tsp eq|[?]|1|mL/s|HYPOTHALAMUS|UNILATERAL|UPPER FLEXOR SURFACE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||INTERVIEWER|OPHTHALMOLOGIST|3|Visit_3|40|3|FOLLOW-UP|2020-12-22|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|7|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING, BENT FORWARD|[?]|nkat/g Hb|[?]|1|mg/day|BREAST|RIGHT|PERIPHERAL|CELL BASED BIOASSAY||||INDEPENDENT ASSESSOR|ONCOLOGIST|4|Visit_4|65|2|TREATMENT|2021-01-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|8|SALKA|Salazar-Knowles Equation Parameter A|[?]|LEFT LATERAL DECUBITUS|[?]|m|[?]|1|10^6 CFU/g|MUSCULOSKELETAL SYSTEM|IPSILATERAL|ANTEROMEDIAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||CLINICAL RESEARCH COORDINATOR|CARDIOLOGIST|4|Visit_4|65|2|WASHOUT|2021-01-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|9|IVC|Inspiratory Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|mm/h|CARPOMETACARPAL JOINT 1|BILATERAL|SUPERIOR|OBSERVATION|||Y|CLINICAL STUDY SPONSOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|6|SCREENING|2021-02-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|10|TLC|Total Lung Capacity|[?]|DECUBITUS|||[?]|1|/40 HPFs|SUPRACLAVICULAR LYMPH NODE|RIGHT|LOWER MEDIAL|FLOW MICROSCOPY|||Y|CLINICAL STUDY SPONSOR|OPTOMETRIST|5|Visit_5|90|2|SCREENING|2021-02-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|ALVVOL|Alveolar Volume|[?]|FOWLERS|[?]|TCID 50/dose|[?]|1|uOsm|SUBSTANTIA NIGRA|BILATERAL|ANTEROPOSTERIOR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|2|FEV1REV|FEV1 Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|10^12 IU/L|[?]|1|SQU/mL|CARPAL BONE|BILATERAL|BASAL|FARR ASSAY||||INDEPENDENT ASSESSOR|ADJUDICATOR 2|1|Visit_1|10|3|SCREENING|2020-08-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-07
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|LEFT LATERAL DECUBITUS|[?]|L/min|[?]|1|U.CARR|INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|UPPER EXTENSOR SURFACE|ELECTRICAL IMPEDANCE MYOGRAPHY||||INDEPENDENT ASSESSOR|OPTOMETRIST|2|Visit_2|25|1|SCREENING|2020-08-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|4|FIFMAXPP|Percent Predicted FIFmax|[?]|UNCONSTRAINED|[?]|copies/uL|[?]|1|10^7 CFU|METACARPOPHALANGEAL JOINT 1|LEFT|PARIETO-OCCIPITAL|ELECTROCHEMILUMINESCENCE||||CLINICAL STUDY SPONSOR|OPHTHALMOLOGIST|2|Visit_2|25|3|SCREENING|2020-08-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-04
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|5|RAW|Airway Resistance|[?]|REVERSE TRENDELENBURG|[?]|fmol/L|[?]|1|km|MIDDLE PHALANX 2 OF THE HAND|UNILATERAL|ANTERIOR|FARNSWORTH-MUNSELL 100 HUE TEST|Y|||INDEPENDENT ASSESSOR|NEUROLOGIST 1|3|Visit_3|40|3|SCREENING|2020-09-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|6|MEPPP|Percent Predicted MEP|[?]|LATERAL DECUBITUS|||[?]|1|ug/L|AMYGDALA|CONTRALATERAL|VOLAR|ISHIHARA COLOR PLATES|||Y|SPOUSE|NEUROLOGIST 2|3|Visit_3|40|4|WASHOUT|2020-09-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-17
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-RECUMBENT|[?]|uL/mL|[?]|1|cal|WARDS TRIANGLE|CONTRALATERAL|ANTEROMEDIAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|Y|||CLINICAL RESEARCH ASSOCIATE|RATER|4|Visit_4|65|4|TREATMENT|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|8|INFLTIND|Infiltrates Indicator|[?]|SITTING, LEGS DEPENDENT|||[?]|1|GBq|BLADDER, FUNDUS|BILATERAL|PROXIMAL|FLOW MICROSCOPY|||Y|CLINICAL RESEARCH ASSOCIATE|READER 2|4|Visit_4|65|6|TREATMENT|2020-09-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|9|FIF25|Forced Inspiratory Flow at 25%|[?]|DECUBITUS|[?]|fmol/L|[?]|1|mL/cage/wk|SUPRACLAVICULAR LYMPH NODE|RIGHT|POSTERIOR|NEURAMINIDASE INHIBITION ASSAY|Y|||INVESTIGATOR|READER 2|5|Visit_5|90|1|TREATMENT|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|UNCONSTRAINED|[?]|anti-Xa IU/mL|[?]|1|IMPLANT|SHOULDER JOINT TENDONS|BILATERAL|PERIPHERAL|TARGETED GENOME SEQUENCING||||INVESTIGATOR|CARDIOLOGIST|5|Visit_5|90|4|WASHOUT|2020-10-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-17
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|1|PCF|Peak Cough Flow|[?]|SITTING|[?]|ft3|[?]|1|days/month|HAIR SHAFT|IPSILATERAL|DISTAL VOLAR|IRON HEMATOXYLIN STAIN||||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|1|Visit_1|10|1|WASHOUT|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|2|EXPRELTM|Expiration Relaxation Time|[?]|UNCONSTRAINED|||[?]|1|atm|TONGUE|BILATERAL|FACIAL|FLOW MICROSCOPY|||Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-09-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-15
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|3|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LEFT LATERAL DECUBITUS|||[?]|1|PLUG|CELIAC ARTERY|BILATERAL|ANTEROTEMPORAL|IMMUNE REPERTOIRE DEEP SEQUENCING||Y|Y|CAREGIVER|READER|2|Visit_2|25|5|FOLLOW-UP|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|4|PIF|Peak Inspiratory Flow|[?]|PRONE|[?]|mmol/g|[?]|1|U/mmol|AORTIC VALVE, NON-CORONARY CUSP|IPSILATERAL|TIP|ELISPOT||||SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|FOLLOW-UP|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-15
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|5|QUASCOMP|Quasi-Static Compliance|[?]|REVERSE TRENDELENBURG|[?]|10^3 CFU/mL|[?]|1|ECL unit|EYE, ANTERIOR CHAMBER|LATERAL|LOWER FLEXOR SURFACE|AUTOMATED COUNT||||FRIEND|READER 1|3|Visit_3|40|4|SCREENING|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|6|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|FOWLERS|||[?]|1|mm3/mm2/year|VASTUS LATERALIS MUSCLE|BILATERAL|INFERIOR|ETDRS EYE CHART||Y|Y|SIBLING|PATHOLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-10-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-02
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|7|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SUPINE|[?]|mol/mol|[?]|1|BLOCKS|ACCESSORY RENAL ARTERY|LATERAL|MIDLINE|ALCIAN BLUE STAIN|Y|||VENDOR|READER 3|4|Visit_4|65|5|SCREENING|2020-10-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|8|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|mL/animal|[?]|1|10^8 PFU|AORTIC VALVE, LEFT CORONARY CUSP|UNILATERAL|PERIVENTRICULAR|PHYSICAL EXAMINATION||Y||CHILD|PATHOLOGIST 2|4|Visit_4|65|1|SCREENING|2020-10-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-01
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|9|SVC|Slow Vital Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|m2|PYRAMIDAL TRACTS, INTERNAL CAPSULE|LEFT|MEDIAL|SPIROMETRY|||Y|CAREGIVER|FORENSIC PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-11-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|3b83c7a0-e22b-45b1-b065-71971f014039|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|FOWLERS|||[?]|1|U/kg/h|SACRAL VERTEBRA|CONTRALATERAL|UPPER EXTENSOR SURFACE|PHOTOGRAPHY|Y||Y|CLINICAL STUDY SPONSOR|DERMATOLOGIST|5|Visit_5|90|6|TREATMENT|2020-11-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|1|FRCPP|Percent Predicted FRC|[?]|SUPINE|[?]|vg/mL|[?]|1|uL/dose|RENAL FOSSA|LEFT|VOLAR|WEBER GREEN STAIN|Y|||STUDY SUBJECT|NEUROLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|2|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|U/mg|PANCREAS|BILATERAL|CENTRAL|FISH|||Y|CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|1|Visit_1|10|3|TREATMENT|2020-11-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|3|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|UNCONSTRAINED|[?]|mL/m2/h|[?]|1|/mm2|ESOPHAGUS, CERVICAL|BILATERAL|VENTROLATERAL|ELECTROCHEMILUMINESCENCE||||VENDOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|1|FOLLOW-UP|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|STANDING, BENT FORWARD|[?]|SFC/10^6 PBMC|[?]|1|days/month|PERITONEAL CAVITY|CONTRALATERAL|MEDIAL|POLYMERASE CHAIN REACTION|Y|Y||DOMESTIC PARTNER|READER 3|2|Visit_2|25|7|TREATMENT|2020-11-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-05
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|5|FEF2575P|Percent Predicted FEF25-75|[?]|LATERAL DECUBITUS|[?]|Log10 ELISA unit/dose|[?]|1|CAPLET|RETROPERITONEAL LYMPH NODE|UNILATERAL|UPPER FLEXOR SURFACE|BAC ACGH|Y|Y||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|6|ALVVOL|Alveolar Volume|[?]|SEMI-FOWLERS|[?]|10^7 CFU/mL|[?]|1|GBq/mg|TRIGEMINAL NERVE|LATERAL|SUPERFICIAL|SLOAN LETTER EYE CHART 1.25%|Y|||SIGNIFICANT OTHER|HEMATOLOGIST|3|Visit_3|40|2|TREATMENT|2020-12-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|7|SALKB|Salazar-Knowles Equation Parameter B|[?]|UNCONSTRAINED|[?]|Torr|[?]|1|keV|AORTIC VALVE, RIGHT CORONARY CUSP|LATERAL|INNER|ANTIMICROBIAL COMBINATION TESTING||Y||FAMILY MEMBER|CARDIOLOGIST|4|Visit_4|65|1|TREATMENT|2021-01-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|8|EVC|Expiratory Vital Capacity|[?]|DECUBITUS|[?]|mIU/L|[?]|1|VIRTUAL PIXEL|INTERNAL MAMMARY LYMPH NODE|LATERAL|OUTER|DIGITAL PCR ARRAY||||FRIEND|CLINICAL PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-01-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|9|DLCOVAPP|Percent Predicted DLCO/VA|[?]|UNCONSTRAINED|[?]|dL|[?]|1|mEq/dL|PORTACAVAL LYMPH NODE|LEFT|LATERAL|PLETHYSMOGRAPHY|Y|||NON-HEALTH CARE PROFESSIONAL|READER 2|5|Visit_5|90|2|TREATMENT|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|92c849ce-12b8-4c38-baab-f91c44a007b9|10|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|REVERSE TRENDELENBURG|[?]|log EID 50/dose|[?]|1|U.CARR|PELVIS|RIGHT|POSTERIOR|HILLMEN COLOR CHART||||SPOUSE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|4|TREATMENT|2021-01-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-06
e|RE|f2101018-c983-435e-a453-148f182388f7|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|FOWLERS|[?]|PATCH|[?]|1|nU/cL|SHOULDER JOINT|RIGHT|TEMPORAL|KLEIHAUER-BETKE|Y|Y||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-09-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|f2101018-c983-435e-a453-148f182388f7|2|PCF|Peak Cough Flow|[?]|SLING|[?]|cmH2O/mL|[?]|1|damol/L|METACARPAL BONE 4|RIGHT|UPPER EXTENSOR SURFACE|IN VITRO GENE EXPRESSION ASSAY||Y||CHILD|READER|1|Visit_1|10|5|SCREENING|2020-09-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|f2101018-c983-435e-a453-148f182388f7|3|LOBVOL|Lobar Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|100 IU/mL|[?]|1|RNA copies/mL|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|CONTRALATERAL|NASAL|ELECTRICAL IMPEDANCE MYOGRAPHY||Y||SIGNIFICANT OTHER|PATHOLOGIST 2|2|Visit_2|25|4|SCREENING|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|f2101018-c983-435e-a453-148f182388f7|4|RAW|Airway Resistance|[?]|FOWLERS|[?]|uV2|[?]|1|BISCUIT|PANCREAS, TAIL|BILATERAL|NASAL|TOTAL BODY IRRADIATION|Y|||SIBLING|READER 1|2|Visit_2|25|3|WASHOUT|2020-09-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-04
e|RE|f2101018-c983-435e-a453-148f182388f7|5|SVC|Slow Vital Capacity|[?]|SUPINE|||[?]|1|cGy|LATISSIMUS DORSI MUSCLE|LATERAL|NASAL|LANDOLT RING|||Y|CLINICAL STUDY SPONSOR|RATER 1|3|Visit_3|40|7|TREATMENT|2020-10-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|f2101018-c983-435e-a453-148f182388f7|6|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|LATERAL DECUBITUS|[?]|%/min|[?]|1|DNA copies/mL|EYELASH|BILATERAL|ANTERIOR|NEPHELOMETRY||||SIGNIFICANT OTHER|ONCOLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-10-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|f2101018-c983-435e-a453-148f182388f7|7|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|uEq/L|[?]|1|EID 50/dose|HEART, VENTRICLE|LEFT|ANTEROMEDIAL|CELLULOSE TAPE||||INVESTIGATOR|MICROSCOPIST|4|Visit_4|65|2|FOLLOW-UP|2020-10-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|f2101018-c983-435e-a453-148f182388f7|8|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|10^3 copies/mL|[?]|1|10^9 organisms|ULNA SHAFT|CONTRALATERAL|ANTEROMEDIAL|ULTRASOUND||Y||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|5|TREATMENT|2020-10-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|f2101018-c983-435e-a453-148f182388f7|9|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|mL/min/1.73m2|[?]|1|ppth|SCIATIC NERVE|UNILATERAL|VOLAR|CORONARY ANGIOGRAPHY||||PROXY|ADJUDICATOR 1|5|Visit_5|90|6|FOLLOW-UP|2020-11-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|f2101018-c983-435e-a453-148f182388f7|10|RAW|Airway Resistance|[?]|FOWLERS|||[?]|1|10^6 RNA copies/mL|ABDOMINAL CAVITY|IPSILATERAL|VOLAR|THICK SMEAR|Y||Y|FAMILY MEMBER|ADJUDICATOR 3|5|Visit_5|90|5|TREATMENT|2020-11-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|1|AIRTRAP|Air Trapping|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|PFU/mL|NASAL BONE|RIGHT|OUTER|CONTRAST ENHANCED PET SCAN|Y||Y|CLINICAL STUDY SPONSOR|NEUROLOGIST 2|1|Visit_1|10|7|WASHOUT|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|2|EFFVOL|Effusion Volume|[?]|LATERAL DECUBITUS|[?]|mol|[?]|1|titer|PONS VAROLII|LATERAL|PROXIMAL|SPECULAR MICROSCOPY||||SPOUSE|ADJUDICATOR 3|1|Visit_1|10|7|SCREENING|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|3|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|STANDING, BENT FORWARD|[?]|/LSQN|[?]|1|MnFI|SCAPHOID-LUNATE JOINT|UNILATERAL|MEDIAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||SPOUSE|HEMATOLOGIST|2|Visit_2|25|7|SCREENING|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|4|FEV1REV|FEV1 Reversibility|[?]|SUPINE|[?]|mg/kg/min|[?]|1|%/min|COLON WALL|CONTRALATERAL|PERIPHERAL|WRIGHT-GIEMSA STAIN||Y||STUDY SUBJECT|PATHOLOGIST 1|2|Visit_2|25|4|TREATMENT|2020-11-22|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|5|FEF2575|Forced Expiratory Flow 25-75%|[?]|PRONE|[?]|mL/animal|[?]|1|cm2|THALAMUS|BILATERAL|UPPER FLEXOR SURFACE|SPECT/CT SCAN||||NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|3|Visit_3|40|6|TREATMENT|2020-12-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|6|TSUELAS|Tissue Elastance|[?]|SLING|[?]|Ci/mL|[?]|1|U|AORTO-ILIAC PERIPHERAL ARTERY|LEFT|LOWER EXTENSOR SURFACE|HEMOCYTOMETRY|Y|||CHILD|NEUROLOGIST 2|3|Visit_3|40|3|WASHOUT|2020-12-07|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-28
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|7|IRV|Inspiratory Reserve Volume|[?]|TRENDELENBURG|[?]|BU/mL|[?]|1|10^6 organisms|FIBULA SHAFT|LATERAL|DEEP|DISK DIFFUSION||||ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|4|Visit_4|65|1|WASHOUT|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|8|SAWVOL|Specific Airway Volume|[?]|FOWLERS|[?]|oz|[?]|1|Bq/mL|LIP|LATERAL|DISTAL|OPHTHALMOSCOPY||Y||PROXY|PATHOLOGIST 1|4|Visit_4|65|4|TREATMENT|2021-01-01|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|9|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/beat|[?]|1|PA|VESTIBULOCOCHLEAR NERVE|BILATERAL|ROSTRAL|TOLUIDINE BLUE STAIN|Y|||DOMESTIC PARTNER|ADJUDICATOR 3|5|Visit_5|90|3|WASHOUT|2021-01-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|613284eb-edbe-446b-b4fe-f96f1510e626|10|DLCOHCVA|HGB Corrected DLCO/VA|[?]|PRONE|[?]|TROCHE|[?]|1|TUBE|FLEXOR DIGITORUM PROFUNDUS MUSCLE|UNILATERAL|NASAL|THIN SMEAR|Y|||CHILD|MICROSCOPIST|5|Visit_5|90|5|TREATMENT|2021-01-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-08
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|SAWVOL|Specific Airway Volume|[?]|DECUBITUS|[?]|g/cage/day|[?]|1|BLOCKS|LATISSIMUS DORSI MUSCLE|LEFT|PROXIMAL VOLAR|PERCUSSION||Y||SIGNIFICANT OTHER|RATER 1|1|Visit_1|10|4|SCREENING|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|2|FRCPP|Percent Predicted FRC|[?]|SITTING|[?]|10^8/L|[?]|1|APL U|NASAL CAVITY|RIGHT|DORSOLATERAL|MICROARRAY||||CAREGIVER|ADJUDICATOR 1|1|Visit_1|10|2|TREATMENT|2020-07-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-25
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|DECUBITUS|||[?]|1|L/h/m2|PROXIMAL INTERPHALANGEAL JOINT 5|UNILATERAL|ANTERIOR|RADIATION DOSIMETRY|||Y|INVESTIGATOR|ADJUDICATOR 2|2|Visit_2|25|6|SCREENING|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|4|FEV1SVC|FEV1/SVC|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mg/min|CAPITATE-HAMATE JOINT|RIGHT|OCCIPITAL|PHASE CONTRAST MICROSCOPY|||Y|ADJUDICATION COMMITTEE|INTERNIST|2|Visit_2|25|2|TREATMENT|2020-07-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|5|ICREV|IC Reversibility|[?]|TRENDELENBURG|[?]|mOsm|[?]|1|aMFI|MIDDLE PHALANX 5 OF THE HAND|BILATERAL|SUPERIOR|POLYMERASE CHAIN REACTION|Y|||CAREGIVER|ADJUDICATOR 1|3|Visit_3|40|5|WASHOUT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|6|PNIF|Peak Nasal Inspiratory Flow|[?]|SUPINE|[?]|L/h|[?]|1|uOsm|FLOOR OF MOUTH|LATERAL|FACIAL|FLUOROSCOPY||||GUARDIAN|READER 1|3|Visit_3|40|1|TREATMENT|2020-08-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|7|SRAW|Specific Airway Resistance|[?]|LATERAL DECUBITUS|[?]|kDa|[?]|1|V|PENIS|UNILATERAL|SURFACE|RYAN BLUE STAIN||||STUDY SUBJECT|INTERNIST|4|Visit_4|65|7|FOLLOW-UP|2020-09-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|8|AIRTRAP|Air Trapping|[?]|LEFT LATERAL DECUBITUS|[?]|nU/cL|[?]|1|Bq/g|CORONARY ARTERY|LATERAL|CRANIAL|SEQUENCE-BASED TYPING POLYMERASE CHAIN REACTION||||CHILD|PATHOLOGIST 2|4|Visit_4|65|1|TREATMENT|2020-09-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-19
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|9|EFFIND|Effusion Indicator|[?]|SEMI-FOWLERS|[?]|PA|[?]|1|mL/kg/day|UMBILICUS|IPSILATERAL|LOWER EXTENSOR SURFACE|WRIGHT-GIEMSA STAIN||||ADJUDICATION COMMITTEE|RADIOLOGIST 2|5|Visit_5|90|7|WASHOUT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|65e8391b-0c34-4687-a0ab-cb291a4cdf36|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SLING|[?]|cmH2O*s2/mL|[?]|1|kIU|SKIN OF THE THIGH|RIGHT|UPPER|SANGER SEQUENCING||||CLINICAL RESEARCH ASSOCIATE|READER 1|5|Visit_5|90|2|TREATMENT|2020-10-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-10
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|SALKK|Salazar-Knowles Equation, K|[?]|RIGHT LATERAL DECUBITUS|[?]|mJoule/cm2|[?]|1|/7.5 mL|L2 VERTEBRA|LEFT|LOWER FLEXOR SURFACE|MAPH||||ADJUDICATION COMMITTEE|RATER 2|1|Visit_1|10|1|SCREENING|2020-08-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|2|FIFMAXPP|Percent Predicted FIFmax|[?]|SEMI-RECUMBENT|||[?]|1|Absorbance U|SACRAL VERTEBRA|BILATERAL|SUPERFICIAL|FLUORESCENT ENZYME IMMUNOASSAY|||Y|INTERVIEWER|READER 3|1|Visit_1|10|1|TREATMENT|2020-08-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|[?]|kcal|[?]|1|mL/cage|PANCREAS, BODY|LEFT|TIP|CELL BASED BIOASSAY||Y||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|2|Visit_2|25|5|FOLLOW-UP|2020-09-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|4|ICREV|IC Reversibility|[?]|LATERAL DECUBITUS|[?]|cmH2O*s/mL|[?]|1|uCi/L|TRANSVERSE TARSAL JOINT|UNILATERAL|ANTERIOR|CT SCAN WITHOUT CONTRAST||||CHILD|ADJUDICATOR|2|Visit_2|25|4|FOLLOW-UP|2020-09-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|5|TSUHYS|Tissue Hysteresivity|[?]|STANDING, BENT FORWARD|[?]|IU/dL|[?]|1|s/h|DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND|LATERAL|BASAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||GUARDIAN|ADJUDICATOR 1|3|Visit_3|40|2|TREATMENT|2020-09-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|6|INERTANC|Inertance|[?]|SITTING, LEGS DEPENDENT|[?]|TAMPON|[?]|1|psi|MOTOR CORTEX|UNILATERAL|PROXIMAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE|Y|||PROXY|MICROSCOPIST|3|Visit_3|40|5|FOLLOW-UP|2020-09-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|7|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|FOWLERS|[?]|mL/beat|[?]|1|rpm|INFRATENTORIAL BRAIN|IPSILATERAL|FORE|OPTICAL COHERENCE TOMOGRAPHY||||ADJUDICATOR|PHYSIOTHERAPIST|4|Visit_4|65|3|TREATMENT|2020-10-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|8|FEV3PP|Percent Predicted FEV3|[?]|UNCONSTRAINED|[?]|deg/mm|[?]|1|ft|ANTECUBITAL FOSSA|UNILATERAL|DORSAL|FLUORESCEIN STAIN||||GUARDIAN|PATHOLOGIST 2|4|Visit_4|65|2|WASHOUT|2020-10-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-24
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|9|FIO2|Fraction of Inspired Oxygen|[?]|TRENDELENBURG|[?]|atm|[?]|1|10^3 copies/mL|LIP, LOWER|IPSILATERAL|UPPER EXTENSOR SURFACE|DROPLET DIGITAL PCR||||CAREGIVER|MICROSCOPIST 1|5|Visit_5|90|5|FOLLOW-UP|2020-11-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|2350438a-0bc8-4da5-b6c9-99a6c012b454|10|DLCOVA|DLCO/VA|[?]|TRENDELENBURG|[?]|mL|[?]|1|10^6/g|NAIL|UNILATERAL|INNER|POPULATION SEQUENCING|Y|||SPOUSE|PEDIATRIC NEUROLOGIST|5|Visit_5|90|1|WASHOUT|2020-11-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-03
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|DECUBITUS|[?]|log10 TCID 50/uL|[?]|1|aMFI|MEDIASTINUM, POSTERIOR|LATERAL|ANTEROMEDIAL|FARR ASSAY||||INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|1|Visit_1|10|7|WASHOUT|2020-11-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|2|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-RECUMBENT|||[?]|1|pt_br|SINUS|IPSILATERAL|INNER|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|||Y|PARENT|ONCOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-11-16|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|3|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING, BENT FORWARD|[?]|foz_br|[?]|1|mm/h|BACK|IPSILATERAL|TIP|FLUORESCENT IMMUNOASSAY||||ADJUDICATOR|PATHOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-12-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|4|PEFREV|PEF Reversibility|[?]|DECUBITUS|[?]|ng/L|[?]|1|ug/mL/h|C4 VERTEBRA|CONTRALATERAL|FORE|APPLANATION TONOMETRY||||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|2|SCREENING|2020-12-01|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|5|FRC|Functional Residual Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|mmHg/L/min|SKIN OF THE BACK|BILATERAL|DEEP|SLOAN LETTER EYE CHART 100%|||Y|GUARDIAN|PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-12-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|6|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-FOWLERS|||[?]|1|nmol/day|PROSTATE GLAND, LATERAL LOBE|LEFT|OCCIPITAL|TWO-COLOR MICROARRAY|Y||Y|PROXY|DERMATOLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|7|VO2|Oxygen Consumption|[?]|UNCONSTRAINED|[?]|log10 CFU/g|[?]|1|eq|HIP ADDUCTORS|LEFT|LOWER EXTENSOR SURFACE|FLUORESCENT MICROSCOPY||||PARENT|PEDIATRIC NEUROLOGIST|4|Visit_4|65|7|FOLLOW-UP|2021-01-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|FOWLERS|||[?]|1|hPa|COMMON FEMORAL ARTERY|BILATERAL|DORSOLATERAL|X-RAY FLUORESCENCE SPECTROMETRY|||Y|FRIEND|OTOLARYNGOLOGIST|4|Visit_4|65|1|TREATMENT|2021-01-10|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-12
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|[?]|BAU/mL|[?]|1|10^3 RNA copies/mL|T7 VERTEBRA|UNILATERAL|LOWER MEDIAL|NUCLEIC ACID AMPLIFICATION TEST||Y||CLINICAL STUDY SPONSOR|READER 3|5|Visit_5|90|1|FOLLOW-UP|2021-02-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|10|FEV1FVC6|FEV1/FVC6|[?]|TRENDELENBURG|[?]|/month|[?]|1|fL|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|LEFT|ANTEROMEDIAL|MICROPARTICLE ENZYME IMMUNOASSAY|Y|||CLINICAL STUDY SPONSOR|READER 1|5|Visit_5|90|4|TREATMENT|2021-02-04|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|AIRTRAP|Air Trapping|[?]|SUPINE|[?]|beats/min|[?]|1|DNA copies/mL|PERIPHERAL NERVE|CONTRALATERAL|VOLAR|DC SHEATH FLOW||Y||STUDY SUBJECT|UROLOGIST|1|Visit_1|10|4|TREATMENT|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|2|SAWVOL|Specific Airway Volume|[?]|FOWLERS|[?]|nmol/L/min|[?]|1|Bq/L|MID-CIRCUMFLEX ARTERY|LATERAL|UPPER FLEXOR SURFACE|EPSILOMETER||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-08-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-23
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|3|QUASCOMP|Quasi-Static Compliance|[?]|TRENDELENBURG|[?]|ug/mL/h|[?]|1|PELLET|EPICONDYLE|RIGHT|ANTEROPOSTERIOR|IMMUNORADIOMETRIC ASSAY||||INDEPENDENT ASSESSOR|RATER 2|2|Visit_2|25|1|FOLLOW-UP|2020-09-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|4|ELSTNCE|Elastance|[?]|FOWLERS|||[?]|1|cm/s|INTERNAL ILIAC LYMPH NODE|BILATERAL|SUPERIOR|STATIC PERIMETRY||Y|Y|FRIEND|MICROSCOPIST 2|2|Visit_2|25|6|WASHOUT|2020-09-12|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|5|FEV3PP|Percent Predicted FEV3|[?]|UNCONSTRAINED|[?]|mm/h|[?]|1|EID 50/dose|ILEUM|BILATERAL|HIND|GC/MS-EI||||SPOUSE|MICROSCOPIST 3|3|Visit_3|40|6|FOLLOW-UP|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|6|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|copies/ug|[?]|1|DIOPTER|CHIN|IPSILATERAL|HIND|SNELLEN EYE CHART||Y||STUDY SUBJECT|CLINICAL PATHOLOGIST|3|Visit_3|40|1|WASHOUT|2020-09-27|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|7|FEV3FVC|FEV3/FVC|[?]|PRONE|||[?]|1|IU/g|FIBULA|LEFT|NASAL|WRIGHT STAIN|Y||Y|INVESTIGATOR|ADJUDICATOR 1|4|Visit_4|65|7|TREATMENT|2020-10-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|8|RAW|Airway Resistance|[?]|SEMI-RECUMBENT|||[?]|1|CCID 50/dose|ASCENDING AORTA, SINOTUBULAR JUNCTION|RIGHT|SURFACE|PATHOLOGICAL EVALUATION||Y|Y|CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|4|Visit_4|65|1|SCREENING|2020-10-22|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|9|TGV|Thoracic Gas Volume|[?]|SITTING|[?]|g/cage/wk|[?]|1|K|LIVER FISSURE|BILATERAL|PERIVENTRICULAR|CALCOFLUOR WHITE STAIN||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|5|Visit_5|90|6|FOLLOW-UP|2020-11-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|416fe99b-1258-4e72-b1df-48b989f8f8ed|10|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mg/dose|FLANK|BILATERAL|ANTERIOR|CT SCAN|||Y|STUDY SUBJECT|RATER|5|Visit_5|90|6|SCREENING|2020-11-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|FEV6PP|Percent Predicted FEV6|[?]|SLING|[?]|JDF Unit|[?]|1|Arbitrary U|PERIPANCREATIC LYMPH NODE|LATERAL|UPPER|PERIODIC ACID SCHIFF STAIN||||SIGNIFICANT OTHER|NEUROLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|2|IRVPP|Percent Predicted IRV|[?]|RIGHT LATERAL DECUBITUS|[?]|DIOPTER|[?]|1|/HPF|INTERPHALANGEAL JOINT 2 OF THE FOOT|IPSILATERAL|DORSOLATERAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||Y||SIGNIFICANT OTHER|ADJUDICATOR 3|1|Visit_1|10|6|TREATMENT|2020-05-26|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|3|PEFTIME|Peak Expiratory Flow Time|[?]|PRONE|||[?]|1|mmol/s|RIB 2|CONTRALATERAL|CAUDAL|SURFACE PLASMON RESONANCE||Y|Y|FRIEND|RATER|2|Visit_2|25|3|SCREENING|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|4|RAW|Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|10^3/hpf|[?]|1|YEARS|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|BILATERAL|SUBCORTICAL|VIRUS PLAQUE ASSAY|Y|||PROXY|ONCOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-06-10|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|5|FVC|Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|kat|[?]|1|10^3/hpf|ACHILLES TENDON|LATERAL|TEMPORAL|HEMAGGLUTINATION ASSAY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 2|3|Visit_3|40|7|TREATMENT|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SEMI-RECUMBENT|||[?]|1|fmol/L/sec|AXILLA|LEFT|OCCIPITAL|ANALYTICAL ULTRACENTRIFUGATION||Y|Y|ADJUDICATION COMMITTEE|MICROSCOPIST 3|3|Visit_3|40|4|FOLLOW-UP|2020-06-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|7|ERV|Expiratory Reserve Volume|[?]|SUPINE|||[?]|1|Farad|LIP|LATERAL|FACIAL|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||Y|Y|SPOUSE|CARDIOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|8|FIF50|Forced Inspiratory Flow at 50%|[?]|STANDING|[?]|genEq/mL|[?]|1|MdFI|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|CONTRALATERAL|SURFACE|ENZYMATIC COLORIMETRY||||INVESTIGATOR|ADJUDICATOR 2|4|Visit_4|65|1|TREATMENT|2020-07-20|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-02
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|9|MIP|Maximal Inspiratory Pressure|[?]|PRONE|[?]|VIRTUAL PIXEL|[?]|1|mmHg*min/L|TRICUSPID VALVE, ANTERIOR CUSP|CONTRALATERAL|ROSTRAL|SPECT SCAN||||STUDY SUBJECT|ONCOLOGIST 1|5|Visit_5|90|3|TREATMENT|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|16a9e070-3e5d-444c-9ac1-6a1abfac0370|10|RVPP|Percent Predicted Residual Volume|[?]|SITTING|[?]|g/U|[?]|1|umol/kg/min|PARALARYNGEAL LYMPH NODE|LATERAL|PROXIMAL|PYROSEQUENCING||||HEALTH CARE PROFESSIONAL|READER 3|5|Visit_5|90|1|FOLLOW-UP|2020-08-14|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-02
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|1|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|UNCONSTRAINED|||[?]|1|uIU/L|FLANK|RIGHT|VENTROLATERAL|HPLC|||Y|SIGNIFICANT OTHER|RADIOLOGIST 1|1|Visit_1|10|5|WASHOUT|2021-01-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|2|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|[?]|TCID 50/dose|[?]|1|hPa|PERICARDIAL WALL|BILATERAL|VOLAR|FREEZING POINT DEPRESSION||||NON-HEALTH CARE PROFESSIONAL|RATER 1|1|Visit_1|10|6|TREATMENT|2021-01-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|3|SRAW|Specific Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|steps/min|[?]|1|PIXELS/cm|BRAIN STEM|RIGHT|UPPER FLEXOR SURFACE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||CHILD|CARDIOLOGIST|2|Visit_2|25|2|SCREENING|2021-02-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|||[?]|1|Ci/L|ANASTOMOSIS|RIGHT|OCCIPITAL|FISH|||Y|SIGNIFICANT OTHER|ADJUDICATOR 2|2|Visit_2|25|4|WASHOUT|2021-02-09|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|5|AWVOLPP|Percent Predicted Airway Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|kBq|BACK|CONTRALATERAL|NASAL|OPTICAL MAPPING||Y|Y|FAMILY MEMBER|OPHTHALMOLOGIST|3|Visit_3|40|1|WASHOUT|2021-02-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|6|INTP|Interpretation|[?]|STANDING, BENT FORWARD|[?]|mg2/dL2|[?]|1|cup eq|LIVER FISSURE|IPSILATERAL|INNER|FREEZING POINT DEPRESSION||||INVESTIGATOR|FORENSIC PATHOLOGIST|3|Visit_3|40|2|TREATMENT|2021-02-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-27
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|7|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING|[?]|/LPF|[?]|1|IU/day|SKIN OF THE BACK|RIGHT|SUBCORTICAL|ZIEHL NEELSEN ACID FAST STAIN||Y||STUDY SUBJECT|RADIOLOGIST 1|4|Visit_4|65|7|TREATMENT|2021-03-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|8|MALEVDES|Malignancy Evidence Description|[?]|SITTING|[?]|nmol/kg/day|[?]|1|Enzyme U/L|TRICEPS BRACHII MUSCLE|RIGHT|SUBCORTICAL|MASS SPECTROMETRY||Y||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-03-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-13
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SEMI-RECUMBENT|||[?]|1|copies/uL|PROXIMAL PHALANX 1 OF THE HAND|IPSILATERAL|APICAL|CHROMATOGRAPHY|Y||Y|CAREGIVER|ADJUDICATOR 2|5|Visit_5|90|2|TREATMENT|2021-04-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|1497a00d-55b1-4e02-a957-cf15e3d15512|10|FEV1PP|Percent Predicted FEV1|[?]|STANDING, BENT FORWARD|[?]|mL/g/h|[?]|1|PIXELS/in|MITRAL VALVE ANNULUS|LEFT|FACIAL|CONTRAST ENHANCED CT SCAN||||CLINICAL STUDY SPONSOR|RADIOLOGIST 1|5|Visit_5|90|4|SCREENING|2021-04-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-13
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|RRS|Total Respiratory System Resistance|[?]|UNCONSTRAINED|[?]|GLOBULE|[?]|1|cL|LEFT VENTRICULAR EPICARDIUM|LATERAL|INNER|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|7|WASHOUT|2020-07-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|2|DLCOHC|HGB Corrected DLCO|[?]|SLING|[?]|uSiemens|[?]|1|ng|SOFT PALATE|RIGHT|NASAL|STRESS ECHOCARDIOGRAPHY||||VENDOR|MICROSCOPIST 3|1|Visit_1|10|6|TREATMENT|2020-07-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-30
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|3|TLC|Total Lung Capacity|[?]|STANDING, BENT FORWARD|[?]|Ci/mL|[?]|1|RNA copies/mL|LEFT POSTEROLATERAL DESCENDING ARTERY|RIGHT|TEMPORAL|IMPEDANCE CONDUCTIVITY||||GUARDIAN|PATHOLOGIST 1|2|Visit_2|25|2|WASHOUT|2020-08-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|4|RELSZCHG|Relative Size Change|[?]|STANDING|[?]|pt_us|[?]|1|MnFI|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LATERAL|LATERAL|RADIOIMMUNOPRECIPITATION ASSAY|Y|||STUDY SUBJECT|PHYSIOTHERAPIST|2|Visit_2|25|7|SCREENING|2020-08-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-12
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|5|INERTANC|Inertance|[?]|SEMI-FOWLERS|[?]|ug/kg/min|[?]|1|breaths/min|VERTEBRAL COLUMN|IPSILATERAL|TIP|AGAR DILUTION|Y|||SIGNIFICANT OTHER|NEUROLOGIST|3|Visit_3|40|5|SCREENING|2020-08-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|6|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|RIGHT LATERAL DECUBITUS|[?]|gpELISA unit/mL|[?]|1|mV/sec|DENTAL ARCH|CONTRALATERAL|ANTEROTEMPORAL|REFRACTOMETRY||Y||SPOUSE|UROLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|7|EVC|Expiratory Vital Capacity|[?]|SUPINE|[?]|kPa/L/sec|[?]|1|MHz|WAIST|BILATERAL|ANTERIOR|ELECTROGASTROGRAPHY||||VENDOR|ONCOLOGIST 2|4|Visit_4|65|3|WASHOUT|2020-09-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|8|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|[?]|TAMPON|[?]|1|Torr|GANGLION|RIGHT|FACIAL|TRICHROME STAIN||Y||FAMILY MEMBER|PEDIATRIC NEUROLOGIST|4|Visit_4|65|4|SCREENING|2020-09-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-30
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|9|INTP|Interpretation|[?]|STANDING|||[?]|1|damol/L|TRAPEZOID-CAPITATE JOINT|IPSILATERAL|NASAL|NUCLEIC ACID BASED METHOD|||Y|VENDOR|MICROSCOPIST|5|Visit_5|90|3|WASHOUT|2020-10-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|10|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|STANDING|[?]|MBq|[?]|1|nmol/mL/min|CRANIAL NERVE|RIGHT|DORSAL|MECHANICAL CLOT DETECTION|Y|Y||FAMILY MEMBER|OPTOMETRIST|5|Visit_5|90|7|TREATMENT|2020-10-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-10
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|ALVVOL|Alveolar Volume|[?]|TRENDELENBURG|[?]|/ms|[?]|1|mmHg/sec|INTERPHALANGEAL JOINT 5|BILATERAL|PROXIMAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION||Y||SIGNIFICANT OTHER|CLINICAL PATHOLOGIST|1|Visit_1|10|5|TREATMENT|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|2|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|FOWLERS|[?]|CYLINDER|[?]|1|log10 PFU|POSTERIOR TIBIAL VEIN|IPSILATERAL|PERIVENTRICULAR|TOTAL BODY RADIOGRAPHY||Y||NON-HEALTH CARE PROFESSIONAL|RATER 2|1|Visit_1|10|5|FOLLOW-UP|2020-12-09|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-01
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|3|INFLTIND|Infiltrates Indicator|[?]|STANDING|[?]|g/g/day|[?]|1|mg/kg/dose|DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT|LATERAL|ANTEROMEDIAL|ROMANOWSKY STAIN||||ADJUDICATION COMMITTEE|RADIOLOGIST 2|2|Visit_2|25|3|SCREENING|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|4|EVC|Expiratory Vital Capacity|[?]|PRONE|[?]|mol|[?]|1|mCi/L|ENTORHINAL CORTEX|BILATERAL|MEDIAL|DROPLET DIGITAL PCR||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-12-24|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-21
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|5|MEP|Maximal Expiratory Pressure|[?]|UNCONSTRAINED|[?]|U/mL|[?]|1|ug|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|LATERAL|SURFACE|CONTRAST ENHANCED TRANSTHORACIC ECHOCARDIOGRAPHY||||VENDOR|MICROSCOPIST 1|3|Visit_3|40|3|TREATMENT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|6|TLC|Total Lung Capacity|[?]|SUPINE|||[?]|1|cm2|HYPOTHALAMUS|LEFT|INFERIOR|MRI WITHOUT CONTRAST|||Y|INDEPENDENT ASSESSOR|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2021-01-08|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|7|FVC|Forced Vital Capacity|[?]|DECUBITUS|[?]|mL/cm|[?]|1|cy/cm|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LEFT|TEMPORAL|HEMAGGLUTINATION INHIBITION ASSAY||||SIGNIFICANT OTHER|MICROSCOPIST|4|Visit_4|65|2|TREATMENT|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|8|FIV1|Forced Inspiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|EID 50/dose|[?]|1|10^7 CFU/mL|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|UNILATERAL|FRONTAL|PULSE OXIMETRY||||GUARDIAN|ONCOLOGIST 1|4|Visit_4|65|7|SCREENING|2021-02-02|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-03
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|9|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING|[?]|10^7 CFU/mL|[?]|1|/VF|EPIDIDYMIS|LATERAL|HIND|MOUSE PROTECTION ASSAY|Y|Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|5|Visit_5|90|4|WASHOUT|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|10|SALKA|Salazar-Knowles Equation Parameter A|[?]|DECUBITUS|[?]|mL/day|[?]|1|ms2|DURAL VENOUS SINUS|IPSILATERAL|OCCIPITAL|MRI WITHOUT CONTRAST|Y|||SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|5|Visit_5|90|3|SCREENING|2021-02-27|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-02
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|ICREV|IC Reversibility|[?]|SLING|[?]|10^8/L|[?]|1|Coulomb|MEDIASTINUM, POSTERIOR|UNILATERAL|ROSTRAL|AUSCULTATION||||SIGNIFICANT OTHER|MICROSCOPIST 1|1|Visit_1|10|1|SCREENING|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|2|TLCPP|Percent Predicted Total Lung Capacity|[?]|SLING|[?]|umol/kg/min|[?]|1|nmol BCE/nmol|RIB 12|RIGHT|ANTEROTEMPORAL|SURFACE PLASMON RESONANCE||Y||SIGNIFICANT OTHER|ONCOLOGIST|1|Visit_1|10|2|WASHOUT|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-05
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|3|TV|Tidal Volume|[?]|SEMI-RECUMBENT|[?]|um2|[?]|1|kg|LUNG|BILATERAL|VENTRAL|SLOAN LETTER EYE CHART 1.25%|Y|||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 3|2|Visit_2|25|4|WASHOUT|2020-11-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|4|FIF50|Forced Inspiratory Flow at 50%|[?]|REVERSE TRENDELENBURG|[?]|mL/m2|[?]|1|/day|COSTAL CARTILAGE|LEFT|PROXIMAL VOLAR|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||ADJUDICATOR|RADIOLOGIST 2|2|Visit_2|25|7|TREATMENT|2020-11-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|5|FEF50|Forced Expiratory Flow 50%|[?]|SITTING, LEGS DEPENDENT|[?]|PA|[?]|1|RFU|PRETRACHEAL LYMPH NODE|BILATERAL|INFERIOR|PERIODIC ACID SCHIFF STAIN|Y|Y||VENDOR|PHYSIOTHERAPIST|3|Visit_3|40|7|WASHOUT|2020-12-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|6|FEV3PP|Percent Predicted FEV3|[?]|LEFT LATERAL DECUBITUS|[?]|EID 50/dose|[?]|1|mg/kg|LEFT CIRCUMFLEX CORONARY ARTERY|CONTRALATERAL|UPPER FLEXOR SURFACE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||STUDY SUBJECT|HEMATOLOGIST|3|Visit_3|40|7|WASHOUT|2020-12-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|7|IVCPP|Percent Predicted IVC|[?]|SLING|[?]|DDU|[?]|1|Hz/s|GANGLION|CONTRALATERAL|HIND|STATIC PERIMETRY|Y|||INDEPENDENT ASSESSOR|RADIOLOGIST 1|4|Visit_4|65|2|TREATMENT|2020-12-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|8|EVC|Expiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|L/min/m2|[?]|1|10^7 CFU/mL|PROXIMAL PHALANX 1 OF THE HAND|LATERAL|OUTER|HPLC/IEX||||VENDOR|INTERNIST|4|Visit_4|65|1|TREATMENT|2020-12-30|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-18
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|9|FEV1FVC6|FEV1/FVC6|[?]|REVERSE TRENDELENBURG|||[?]|1|fmol|LUNG, RIGHT MIDDLE LOBE|IPSILATERAL|DISTAL|NEXT GENERATION TARGETED SEQUENCING|||Y|FRIEND|RADIOLOGIST 2|5|Visit_5|90|7|SCREENING|2021-01-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|10|IC|Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|ohm|GASTROCNEMIUS MUSCLE|RIGHT|MIDLINE|MS/MS|||Y|SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|7|SCREENING|2021-01-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-10
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|FEV6PP|Percent Predicted FEV6|[?]|SITTING, LEGS DEPENDENT|[?]|log10 PFU/mL|[?]|1|g/m2|POSTERIOR POLE OF THE EYE|BILATERAL|INFERIOR|LIGHT SCATTERING SPECTROSCOPY||||DOMESTIC PARTNER|PATHOLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|2|DLCOPP|Percent Predicted DLCO|[?]|SEMI-FOWLERS|[?]|Anson U|[?]|1|days/wk|HEAD OF THE HUMERUS|LATERAL|DEEP|WRIGHT-GIEMSA STAIN|Y|Y||GUARDIAN|HEMATOLOGIST|1|Visit_1|10|4|TREATMENT|2020-05-27|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|3|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|||[?]|1|cGy|ARM|IPSILATERAL|LOWER FLEXOR SURFACE|BETA LACTAMASE|||Y|PARENT|OPTOMETRIST|2|Visit_2|25|2|WASHOUT|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|DECUBITUS|[?]|100 IU/mL|[?]|1|mL/kg|URETHRAL SPHINCTER|LEFT|MIDLINE|INTERRUPTER TECHNIQUE||||CAREGIVER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|TREATMENT|2020-06-11|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|5|SGAW|Specific Airway Conductance|[?]|PRONE|[?]|log10 PFU/mL|[?]|1|SUPPOSITORY|THYROID GLAND, RIGHT LOBE|LATERAL|INNER|KNEMOMETRY||||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|3|Visit_3|40|3|FOLLOW-UP|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|6|AIRTRAP|Air Trapping|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|TABLET|INTERVENTRICULAR SEPTUM|IPSILATERAL|PROXIMAL|STRESS ECHOCARDIOGRAPHY||Y|Y|INVESTIGATOR|MICROSCOPIST 1|3|Visit_3|40|4|TREATMENT|2020-06-26|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-05
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|7|AWVOL|Airway Volume|[?]|SUPINE|[?]|OI50|[?]|1|ug/g/min|GLOSSOPHARYNGEAL NERVE|LEFT|SURFACE|SEQUENCING|Y|||PARENT|PATHOLOGIST|4|Visit_4|65|7|WASHOUT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|8|INERTANC|Inertance|[?]|SEMI-RECUMBENT|[?]|mm/h|[?]|1|Bq/ug|HAMSTRING MUSCLE|UNILATERAL|CAUDAL|QUANTITATIVE PERIPHERAL ANGIOGRAPHY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST 2|4|Visit_4|65|2|WASHOUT|2020-07-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-26
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|9|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SEMI-RECUMBENT|[?]|Mile|[?]|1|fmol/L/sec|CARDIOVASCULAR SYSTEM|LEFT|VOLAR|TOTAL BODY RADIOGRAPHY||||DOMESTIC PARTNER|OPHTHALMOLOGIST|5|Visit_5|90|1|FOLLOW-UP|2020-08-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|RE|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|10|MALEVDES|Malignancy Evidence Description|[?]|UNCONSTRAINED|||[?]|1|MET|ABDUCTOR POLLICIS BREVIS MUSCLE|IPSILATERAL|MEDIAL|SPIRAL CT SCAN WITHOUT CONTRAST|||Y|SIBLING|NEUROLOGIST|5|Visit_5|90|2|WASHOUT|2020-08-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-24
e|RE|2216086b-197e-4780-8e10-28123eb090c5|1|PNIF|Peak Nasal Inspiratory Flow|[?]|SITTING|[?]|Gy/h|[?]|1|Bq/uL|HEART, RIGHT VENTRICLE|IPSILATERAL|CENTRAL|FLOCCULATION, CHARCOAL ENHANCED||||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|1|Visit_1|10|3|TREATMENT|2020-12-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|2216086b-197e-4780-8e10-28123eb090c5|2|ICPP|Percent Predicted Inspiratory Capacity|[?]|LATERAL DECUBITUS|||[?]|1|pmol/10^9 cells|TIBIALIS ANTERIOR MUSCLE|UNILATERAL|OUTER|LC-FL||Y|Y|HEALTH CARE PROFESSIONAL|READER 2|1|Visit_1|10|5|TREATMENT|2020-12-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-09
e|RE|2216086b-197e-4780-8e10-28123eb090c5|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|deg/mm|[?]|1|v/v|COSTAL CARTILAGE|UNILATERAL|CENTRAL|STRESS ECHOCARDIOGRAPHY||||INDEPENDENT ASSESSOR|RATER 2|2|Visit_2|25|1|FOLLOW-UP|2020-12-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|2216086b-197e-4780-8e10-28123eb090c5|4|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-FOWLERS|[?]|ng/day|[?]|1|ug/m2/min|RAMUS INTERMEDIUS ARTERY|RIGHT|OCCIPITAL|HIGH RESOLUTION CT||||NON-HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|2|Visit_2|25|1|SCREENING|2020-12-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-12
e|RE|2216086b-197e-4780-8e10-28123eb090c5|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|CAN|PARIETAL LOBE|LEFT|DISTAL|CALCULATION|Y||Y|NON-HEALTH CARE PROFESSIONAL|READER 2|3|Visit_3|40|6|FOLLOW-UP|2021-01-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|2216086b-197e-4780-8e10-28123eb090c5|6|SALKK|Salazar-Knowles Equation, K|[?]|STANDING, BENT FORWARD|[?]|10^3 organisms/mL|[?]|1|MET*h|CLITORIS|RIGHT|ROSTRAL|PANENDOSCOPY|Y|Y||DOMESTIC PARTNER|READER 2|3|Visit_3|40|5|SCREENING|2021-01-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-06
e|RE|2216086b-197e-4780-8e10-28123eb090c5|7|TSUELAS|Tissue Elastance|[?]|STANDING|[?]|ka_u/dL|[?]|1|mL|TENTORIUM CEREBELLI|UNILATERAL|LOWER MEDIAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY|Y|||SIBLING|PEDIATRIC NEUROLOGIST|4|Visit_4|65|6|SCREENING|2021-02-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|2216086b-197e-4780-8e10-28123eb090c5|8|FEV1REV|FEV1 Reversibility|[?]|LATERAL DECUBITUS|||[?]|1|grain|KNEE JOINT|IPSILATERAL|ANTEROPOSTERIOR|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y||Y|GUARDIAN|PATHOLOGIST|4|Visit_4|65|6|WASHOUT|2021-02-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|2216086b-197e-4780-8e10-28123eb090c5|9|FVC|Forced Vital Capacity|[?]|SLING|||[?]|1|mN|HUMERAL EPICONDYLE|LEFT|DISTAL|ULTRASONOGRAPHIC ELASTOGRAPHY|||Y|STUDY SUBJECT|NEUROLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-03-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|2216086b-197e-4780-8e10-28123eb090c5|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|PRONE|[?]|mL/cage|[?]|1|PFU|SACROILIAC JOINT|UNILATERAL|DISTAL VOLAR|ETDRS EYE CHART||||PARENT|CLINICAL PATHOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2021-03-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-19
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|1|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SLING|[?]|10^7/L|[?]|1|TRANSDUCING UNIT|GLOSSOPHARYNGEAL NERVE|BILATERAL|CENTRAL|INDIA INK STAIN||||DOMESTIC PARTNER|PATHOLOGIST 2|1|Visit_1|10|6|WASHOUT|2020-08-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|2|SVCPP|Percent Predicted Slow Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|mmol|SPLEEN, HILUM|LEFT|DISTAL|IMMUNORADIOMETRIC ASSAY|||Y|ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-08-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-09
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|LATERAL DECUBITUS|||[?]|1|mU|CRANIAL NERVE|IPSILATERAL|SUBCORTICAL|PYROSEQUENCING|||Y|CAREGIVER|RADIOLOGIST 1|2|Visit_2|25|5|FOLLOW-UP|2020-09-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|4|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|||[?]|1|fmol|BILE DUCT|LEFT|PERIVENTRICULAR|AGAR DILUTION|||Y|CLINICAL RESEARCH COORDINATOR|ENDOCRINOLOGIST|2|Visit_2|25|5|SCREENING|2020-09-03|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-15
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|5|AWVOL|Airway Volume|[?]|SLING|||[?]|1|g/cage/day|UMBILICAL CORD|LEFT|UPPER|NEPHELOMETRY|Y|Y|Y|SPOUSE|RADIOLOGIST 2|3|Visit_3|40|7|WASHOUT|2020-09-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|6|PIF|Peak Inspiratory Flow|[?]|LATERAL DECUBITUS|[?]|10^3 organisms/mL|[?]|1|um/s|NASAL CAVITY|LEFT|NASAL|INTERRUPTER TECHNIQUE||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 1|3|Visit_3|40|2|SCREENING|2020-09-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-22
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING, BENT FORWARD|[?]|Farad|[?]|1|L/day|EYELID|UNILATERAL|NASAL|HILLMEN COLOR CHART|Y|||CLINICAL STUDY SPONSOR|READER 1|4|Visit_4|65|1|SCREENING|2020-10-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|8|EXPRELTM|Expiration Relaxation Time|[?]|LATERAL DECUBITUS|||[?]|1|CAPLET|ESOPHAGUS, UPPER THIRD|LEFT|NASAL|HPLC-FL|||Y|INDEPENDENT ASSESSOR|PATHOLOGIST|4|Visit_4|65|5|SCREENING|2020-10-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|9|PNIF|Peak Nasal Inspiratory Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|PFU/dose|[?]|1|mol/g|FLEXOR HALLUCIS LONGUS MUSCLE|RIGHT|INNER|X-RAY||Y||INTERVIEWER|UROLOGIST|5|Visit_5|90|1|TREATMENT|2020-11-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|7280f69c-a0f4-48b5-b714-1e272193168c|10|FIO2|Fraction of Inspired Oxygen|[?]|UNCONSTRAINED|[?]|uV*sec|[?]|1|HEP|FACIAL BONE|IPSILATERAL|LOWER MEDIAL|FREEZING POINT DEPRESSION||||PARENT|MICROSCOPIST|5|Visit_5|90|5|WASHOUT|2020-11-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|PIF|Peak Inspiratory Flow|[?]|PRONE|||[?]|1|ft2|BRACHIALIS MUSCLE|IPSILATERAL|CENTRAL|LASER CAPTURE MICRODISSECTION|||Y|CLINICAL RESEARCH COORDINATOR|RATER|1|Visit_1|10|1|TREATMENT|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|2|IVC|Inspiratory Vital Capacity|[?]|LATERAL DECUBITUS|[?]|Bq/g|[?]|1|mL/g/h|HEPATIC ARTERY|LATERAL|FACIAL|EPSILOMETER||||HEALTH CARE PROFESSIONAL|ADJUDICATOR 2|1|Visit_1|10|4|SCREENING|2020-08-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-20
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|3|PLMBLFLW|Pulmonary Blood Flow|[?]|SITTING|||[?]|1|CARTRIDGE|INTRAHEPATIC BILE DUCT|LEFT|TIP|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|Y|Y|CHILD|MICROSCOPIST|2|Visit_2|25|3|TREATMENT|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|4|FIF50|Forced Inspiratory Flow at 50%|[?]|SEMI-RECUMBENT|[?]|s*kPa|[?]|1|tuberculin unit|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|LATERAL|SUBCORTICAL|BIOPSY||||GUARDIAN|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|FOLLOW-UP|2020-08-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-06
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|5|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|LEFT LATERAL DECUBITUS|||[?]|1|TABLET|URETHRA, PENILE|CONTRALATERAL|SUBCORTICAL|KINYOUN STAIN|Y||Y|INVESTIGATOR|READER 3|3|Visit_3|40|5|TREATMENT|2020-08-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|FOWLERS|||[?]|1|L/h|WALDEYER'S TONSILLAR RING|IPSILATERAL|DISTAL|FLOW MICROSCOPY|||Y|FRIEND|FORENSIC PATHOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-08-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|7|TGV|Thoracic Gas Volume|[?]|SLING|||[?]|1|ug/animal|EYE BULGE|CONTRALATERAL|ANTERIOR|CONTRAST ENHANCED CT SCAN|||Y|STUDY SUBJECT|RADIOLOGIST|4|Visit_4|65|4|TREATMENT|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|8|AWVOLPP|Percent Predicted Airway Volume|[?]|STANDING, BENT FORWARD|[?]|Bq/mg|[?]|1|mL/g/h|ULNA|LATERAL|PARIETO-OCCIPITAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||||STUDY SUBJECT|INTERNIST|4|Visit_4|65|7|SCREENING|2020-09-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-05
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|9|TSUELAS|Tissue Elastance|[?]|PRONE|[?]|V/sec|[?]|1|LB|URETER|LEFT|BASAL|CISH|Y|||DOMESTIC PARTNER|OTOLARYNGOLOGIST|5|Visit_5|90|5|TREATMENT|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|10|SVCPP|Percent Predicted Slow Vital Capacity|[?]|STANDING, BENT FORWARD|[?]|mg/mL/day|[?]|1|ug/kg|HAND DIGIT 2|LEFT|HIND|ELECTRICAL IMPEDANCE MYOGRAPHY||Y||PROXY|CARDIOLOGIST|5|Visit_5|90|3|TREATMENT|2020-10-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|1|AWVOL|Airway Volume|[?]|DECUBITUS|[?]|g/dL|[?]|1|Newton|INTERPHALANGEAL JOINT 5 OF THE HAND|UNILATERAL|TEMPORAL|IRON HEMATOXYLIN STAIN||||GUARDIAN|ADJUDICATOR 3|1|Visit_1|10|3|FOLLOW-UP|2020-12-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|2|FVC|Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|ECL unit|[?]|1|psec|PELVIS|LATERAL|OUTER|PUPILLOMETRY||Y||INVESTIGATOR|ONCOLOGIST|1|Visit_1|10|2|TREATMENT|2020-12-24|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|3|FVC|Forced Vital Capacity|[?]|STANDING, BENT FORWARD|||[?]|1|mCi/kg|NECK|RIGHT|OCCIPITAL|FLAME PHOTOMETRY|||Y|FRIEND|CLINICAL PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|4|EFFIND|Effusion Indicator|[?]|SEMI-RECUMBENT|[?]|mg/kg/min|[?]|1|mL/cm|RIB 2|BILATERAL|ROSTRAL|FUNCTIONAL MRI||||PROXY|UROLOGIST|2|Visit_2|25|2|FOLLOW-UP|2021-01-08|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-28
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|5|FVC|Forced Vital Capacity|[?]|SLING|[?]|DIP|[?]|1|Henry|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND|BILATERAL|FACIAL|SURFACE PLASMON RESONANCE||||INTERVIEWER|READER 3|3|Visit_3|40|2|TREATMENT|2021-01-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|6|FVC|Forced Vital Capacity|[?]|SEMI-FOWLERS|[?]|Ci/g|[?]|1|cg|ABDUCTOR DIGITI MINIMI MUSCLE OF THE HAND|LEFT|MEDIAL|OLIGO ACGH|Y|Y||STUDY SUBJECT|UROLOGIST|3|Visit_3|40|2|SCREENING|2021-01-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-17
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|7|EXPRELTM|Expiration Relaxation Time|[?]|STANDING, BENT FORWARD|[?]|s*kPa|[?]|1|FIU|HAND DIGIT 4|LEFT|CENTRAL|CLINICAL EVALUATION||Y||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|7|TREATMENT|2021-02-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|8|AWVOL|Airway Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|nU/cL|PRESACRAL LYMPH NODE|LATERAL|TEMPORAL|KINETIC MICROPARTICLE IMMUNOASSAY||Y|Y|GUARDIAN|RADIOLOGIST 2|4|Visit_4|65|3|FOLLOW-UP|2021-02-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|9|FEF2575P|Percent Predicted FEF25-75|[?]|SUPINE|||[?]|1|cm2|HAND PHALANX|UNILATERAL|UPPER|CONFOCAL MICROSCOPY|Y||Y|NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|5|Visit_5|90|2|FOLLOW-UP|2021-03-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|25c6812b-9200-4dc4-a954-6879183a2c54|10|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|SUPINE|[?]|nmol/mol|[?]|1|10^6 U|CONJUNCTIVA|LEFT|UPPER EXTENSOR SURFACE|MICROBIAL CULTURE, LIQUID||Y||FAMILY MEMBER|READER 3|5|Visit_5|90|2|SCREENING|2021-03-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-07
e|RE|10dca475-f364-42f3-9192-faf762832adf|1|EFFVOL|Effusion Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|uOsm|AORTO-ILIAC PERIPHERAL ARTERY|BILATERAL|DISTAL VOLAR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||Y|Y|INTERVIEWER|PHYSIOTHERAPIST|1|Visit_1|10|6|SCREENING|2020-09-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|10dca475-f364-42f3-9192-faf762832adf|2|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|SITTING|[?]|uEq|[?]|1|Bq/kg|WRIST JOINT|IPSILATERAL|POSTERIOR|WEBER GREEN STAIN||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|1|Visit_1|10|6|WASHOUT|2020-09-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|10dca475-f364-42f3-9192-faf762832adf|3|RAWPP|Percent Predicted Airway Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|U/L|[?]|1|ug/dose|GREAT VESSELS|CONTRALATERAL|TEMPORAL|CT SCAN WITHOUT CONTRAST||Y||ADJUDICATION COMMITTEE|PATHOLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-10-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|10dca475-f364-42f3-9192-faf762832adf|4|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|U/g/h|[?]|1|GBq|HEART, LEFT VENTRICLE|RIGHT|MIDLINE|SPECT SCAN||||VENDOR|NEUROLOGIST 1|2|Visit_2|25|7|WASHOUT|2020-10-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-20
e|RE|10dca475-f364-42f3-9192-faf762832adf|5|MIPPP|Percent Predicted MIP|[?]|RIGHT LATERAL DECUBITUS|[?]|fraction of 1|[?]|1|tuberculin unit|RENAL FOSSA|UNILATERAL|ROSTRAL|LIGHT MICROSCOPY||||ADJUDICATION COMMITTEE|ADJUDICATOR 2|3|Visit_3|40|1|SCREENING|2020-10-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|10dca475-f364-42f3-9192-faf762832adf|6|IVC|Inspiratory Vital Capacity|[?]|SEMI-FOWLERS|[?]|cP|[?]|1|10^4 CFU/mL|KIDNEY, LOWER LOBE|UNILATERAL|PROXIMAL|SLIT LAMP PHOTOGRAPHY||||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-10-25|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-29
e|RE|10dca475-f364-42f3-9192-faf762832adf|7|FEV3FVC|FEV3/FVC|[?]|STANDING, BENT FORWARD|[?]|ngEq/L|[?]|1|MASK|HIPPOCAMPUS|LATERAL|HIND|HEMAGGLUTINATION ASSAY||||INVESTIGATOR|PHYSIOTHERAPIST|4|Visit_4|65|7|TREATMENT|2020-11-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|10dca475-f364-42f3-9192-faf762832adf|8|SALKB|Salazar-Knowles Equation Parameter B|[?]|DECUBITUS|[?]|Sv|[?]|1|MASK|UMBILICAL CORD|LEFT|SUPERIOR|MIGET||||INTERVIEWER|MICROSCOPIST|4|Visit_4|65|3|TREATMENT|2020-11-19|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|10dca475-f364-42f3-9192-faf762832adf|9|EFFIND|Effusion Indicator|[?]|UNCONSTRAINED|||[?]|1|PACK|LEFT VENTRICULAR APICAL LATERAL SEGMENT|LATERAL|INFERIOR|CONTRAST ENHANCED PET/CT SCAN|||Y|CLINICAL RESEARCH ASSOCIATE|RATER 1|5|Visit_5|90|2|FOLLOW-UP|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|10dca475-f364-42f3-9192-faf762832adf|10|FIF75|Forced Inspiratory Flow at 75%|[?]|LEFT LATERAL DECUBITUS|[?]|DRINK|[?]|1|nmol/L|FALCIFORM LIGAMENT|LATERAL|PERIVENTRICULAR|ZIEHL NEELSEN ACID FAST STAIN||||STUDY SUBJECT|ENDOCRINOLOGIST|5|Visit_5|90|2|TREATMENT|2020-12-14|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|1|MEPPP|Percent Predicted MEP|[?]|STANDING|[?]|MET*min|[?]|1|ft2|MANDIBLE|UNILATERAL|FACIAL|CLIP SEQUENCING||Y||ADJUDICATION COMMITTEE|ONCOLOGIST|1|Visit_1|10|6|SCREENING|2020-12-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|2|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|FOWLERS|[?]|pptr|[?]|1|APPLICATION|SACRUM|BILATERAL|UPPER FLEXOR SURFACE|IMMUNOMAGNETIC FLUORESCENCE MICROSCOPY||||DOMESTIC PARTNER|NEUROLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-12-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|3|MEPPP|Percent Predicted MEP|[?]|DECUBITUS|[?]|CFU/mL|[?]|1|U/m2/min|SCALP|LATERAL|LOWER MEDIAL|MRI WITHOUT CONTRAST||||INVESTIGATOR|ADJUDICATOR|2|Visit_2|25|5|TREATMENT|2021-01-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|4|FEV1PP|Percent Predicted FEV1|[?]|TRENDELENBURG|||[?]|1|um2|ANTERIOR TIBIAL ARTERY|UNILATERAL|TEMPORAL|ERGOSPIROMETRY|||Y|FRIEND|RADIOLOGIST 1|2|Visit_2|25|4|TREATMENT|2021-01-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-28
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|5|DLCOHC|HGB Corrected DLCO|[?]|STANDING, BENT FORWARD|[?]|PFU/dose|[?]|1|cycle/min|DELTOID MUSCLE|LATERAL|DORSAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|3|Visit_3|40|5|FOLLOW-UP|2021-01-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING, LEGS DEPENDENT|[?]|days/wk|[?]|1|mg/kg/day|ABDOMINAL SKIN|UNILATERAL|SURFACE|JAFFE REACTION||||SIBLING|RADIOLOGIST 1|3|Visit_3|40|6|WASHOUT|2021-01-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-18
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|7|LCI|Lung Clearance Index|[?]|FOWLERS|[?]|mL/g/day|[?]|1|ms/mmHg|RIB 1|BILATERAL|PROXIMAL|OSCILLOMETRY||||STUDY SUBJECT|NEUROLOGIST 1|4|Visit_4|65|1|SCREENING|2021-02-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|8|DLCOPP|Percent Predicted DLCO|[?]|STANDING, BENT FORWARD|||[?]|1|DRINK|INFRATENTORIAL BRAIN|CONTRALATERAL|ANTEROPOSTERIOR|SNELLEN EYE CHART|||Y|CLINICAL STUDY SPONSOR|RATER 2|4|Visit_4|65|2|SCREENING|2021-02-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|9|RELSZCHG|Relative Size Change|[?]|SITTING|[?]|10^9/dose|[?]|1|PACK|THIRD POSTEROLATERAL DESCENDING ARTERY|IPSILATERAL|POSTERIOR|OSCILLOMETRY|Y|||SPOUSE|ONCOLOGIST 2|5|Visit_5|90|2|TREATMENT|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|caf54095-56c3-428f-8342-ce45c6c9a287|10|TSUHYS|Tissue Hysteresivity|[?]|SUPINE|[?]|CCID 50/mL|[?]|1|/month|CARPOMETACARPAL JOINT 4|IPSILATERAL|INFERIOR|FLOCCULATION, CHARCOAL ENHANCED|Y|||HEALTH CARE PROFESSIONAL|READER|5|Visit_5|90|6|SCREENING|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|1|FIF25|Forced Inspiratory Flow at 25%|[?]|SUPINE|||[?]|1|10^7 CFU|BONE MARROW|LEFT|LATERAL|ERGOSPIROMETRY|||Y|VENDOR|ONCOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-06-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|cmH2O/mL|FEMORAL CONDYLE|LATERAL|CRANIAL|SNP ARRAY|||Y|NON-HEALTH CARE PROFESSIONAL|READER|1|Visit_1|10|4|SCREENING|2020-06-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|3|SAWVOL|Specific Airway Volume|[?]|STANDING, BENT FORWARD|[?]|cy/cm|[?]|1|mg/kg/h|HEAD|LATERAL|VENTROLATERAL|COLORIMETRY||||SIBLING|CARDIOLOGIST|2|Visit_2|25|1|TREATMENT|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|4|EFFIND|Effusion Indicator|[?]|DECUBITUS|[?]|uV*sec|[?]|1|10^3 CFU/mL|CELIAC ARTERY|CONTRALATERAL|OCCIPITAL|ENZYMATIC ULTRACENTRIFUGATION||Y||ADJUDICATOR|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-08
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|5|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|mL*cmH2O|[?]|1|ug/min|ABDOMINAL REGION|IPSILATERAL|APICAL|TEST STRIP||Y||FRIEND|NEUROLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-07-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|6|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SEMI-RECUMBENT|[?]|mph|[?]|1|deg/mm|TRACHEOBRONCHIAL TREE|RIGHT|POSTERIOR|FLUORESCEIN STAIN||||FAMILY MEMBER|MICROSCOPIST 1|3|Visit_3|40|2|TREATMENT|2020-07-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|7|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|STANDING, BENT FORWARD|||[?]|1|Arbitrary U|SPLENIC LYMPH NODE|BILATERAL|SUPERFICIAL|DISK DIFFUSION|Y||Y|ADJUDICATOR|HEMATOLOGIST|4|Visit_4|65|6|TREATMENT|2020-08-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|8|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SLING|||[?]|1|BEAM BREAKS|VAGINAL WALL|IPSILATERAL|DEEP|KLEIHAUER-BETKE|||Y|INVESTIGATOR|RADIOLOGIST 2|4|Visit_4|65|4|TREATMENT|2020-08-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|9|MEPPP|Percent Predicted MEP|[?]|UNCONSTRAINED|||[?]|1|L/h/m2|SUPRATENTORIAL BRAIN|BILATERAL|MIDLINE|INCISION-INDUCED BLEEDING METHOD|||Y|SIBLING|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2020-09-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|f833ca56-d426-420b-a6d3-fedeabc02734|10|IRVPP|Percent Predicted IRV|[?]|DECUBITUS|[?]|dpm/mL|[?]|1|10^7 CFU/mL|TIBIOTARSAL JOINT|LEFT|INFERIOR|OPTICAL MAPPING||Y||CHILD|READER 1|5|Visit_5|90|5|SCREENING|2020-09-08|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|1|FVC|Forced Vital Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/dose|[?]|1|g/g/day|FAT PAD|BILATERAL|LOWER|TRIPLE-PHASE MRI SCAN||||CAREGIVER|RADIOLOGIST|1|Visit_1|10|6|WASHOUT|2020-11-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|2|VO2|Oxygen Consumption|[?]|SLING|[?]|g/cage/wk|[?]|1|mL/h|FUNDUS OF THE EYE|CONTRALATERAL|LOWER MEDIAL|PALM METHOD||Y||ADJUDICATOR|UROLOGIST|1|Visit_1|10|7|WASHOUT|2020-11-29|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-13
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|3|IRVPP|Percent Predicted IRV|[?]|DECUBITUS|||[?]|1|mL/100g/min|BRONCHUS|BILATERAL|ANTEROLATERAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y||Y|SIBLING|OTOLARYNGOLOGIST|2|Visit_2|25|5|TREATMENT|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|4|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SLING|[?]|mL/g/h|[?]|1|pmol/L|C2 VERTEBRA|IPSILATERAL|UPPER EXTENSOR SURFACE|DYNAMIC CONTRAST ENHANCED MRI||||SIBLING|PATHOLOGIST|2|Visit_2|25|5|SCREENING|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|5|FEV3FVC|FEV3/FVC|[?]|SITTING|[?]|mEq/mmol|[?]|1|BAU|SIGMOID SINUS|UNILATERAL|SUBCORTICAL|ACCELERATOR MASS SPECTROMETRY||||SPOUSE|CARDIOLOGIST|3|Visit_3|40|7|TREATMENT|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|6|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-FOWLERS|[?]|uIU/dL|[?]|1|s*kPa|MIDDLE PHALANX 5 OF THE HAND|BILATERAL|LOWER MEDIAL|HPLC-UV|Y|||SIBLING|ADJUDICATOR 1|3|Visit_3|40|4|WASHOUT|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-09
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|7|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|[?]|bel|[?]|1|breaths/min|GASTROCNEMIUS MUSCLE, LATERAL HEAD|CONTRALATERAL|LOWER|ERGOSPIROMETRY||Y||INVESTIGATOR|PATHOLOGIST 2|4|Visit_4|65|7|TREATMENT|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|8|FIF75|Forced Inspiratory Flow at 75%|[?]|REVERSE TRENDELENBURG|[?]|cm2|[?]|1|Gy/h|SYNOVIAL FLUID|LATERAL|UPPER|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS||||STUDY SUBJECT|RATER 1|4|Visit_4|65|6|TREATMENT|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-29
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|9|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|copies/uL|[?]|1|SFC/10^6 PBMC|SOFT PALATE|RIGHT|TEMPORAL|PHASE CONTRAST MICROSCOPY||Y||SPOUSE|PATHOLOGIST 2|5|Visit_5|90|6|SCREENING|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|03c8e2c7-b70d-4d46-8064-c99370eab232|10|AWWVOL|Airway Wall Volume|[?]|PRONE|||[?]|1|/wk|PERIANAL REGION|CONTRALATERAL|UPPER|FLOCCULATION, CHARCOAL ENHANCED|||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST|5|Visit_5|90|4|TREATMENT|2021-02-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-19
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|1|TSUELAS|Tissue Elastance|[?]|SLING|[?]|mCi/L|[?]|1|MPL U|GASTROINTESTINAL TRACT, LOWER|RIGHT|PERIVENTRICULAR|TRICHROME STAIN|Y|||CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-10-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|2|SGAW|Specific Airway Conductance|[?]|SUPINE|||[?]|1|ukat|PELVIC BONE|UNILATERAL|PROXIMAL VOLAR|IMMUNORADIOMETRIC ASSAY||Y|Y|SPOUSE|ONCOLOGIST 1|1|Visit_1|10|1|TREATMENT|2020-10-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-15
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|3|FEV3FVC|FEV3/FVC|[?]|RIGHT LATERAL DECUBITUS|[?]|MBq|[?]|1|m/sec2|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|CONTRALATERAL|MIDLINE|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|2|Visit_2|25|2|TREATMENT|2020-11-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|4|IVCPP|Percent Predicted IVC|[?]|FOWLERS|[?]|tuberculin unit|[?]|1|kat|ABDOMINAL SKIN|RIGHT|UPPER FLEXOR SURFACE|IMMUNOASSAY||||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|3|TREATMENT|2020-11-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-30
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|5|PLMBLFLW|Pulmonary Blood Flow|[?]|SUPINE|[?]|CAPLET|[?]|1|mg/animal|RENAL PELVIS|IPSILATERAL|POSTERIOR|CYSTOMETRY||Y||SPOUSE|RADIOLOGIST 1|3|Visit_3|40|6|WASHOUT|2020-11-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|6|ALVVOL|Alveolar Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|L|SUBMENTAL LYMPH NODE|LATERAL|LOWER|ANTIMICROBIAL COMBINATION TESTING|||Y|PROXY|READER 1|3|Visit_3|40|5|FOLLOW-UP|2020-11-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|7|FIV1|Forced Inspiratory Volume in 1 Second|[?]|SUPINE|[?]|BAG|[?]|1|amp|FLEXOR POLLICIS LONGUS MUSCLE|LEFT|UPPER FLEXOR SURFACE|MULTI-SLICE SPIRAL CT||||CLINICAL STUDY SPONSOR|PATHOLOGIST 2|4|Visit_4|65|5|TREATMENT|2020-12-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|8|ERV|Expiratory Reserve Volume|[?]|SITTING|[?]|umol|[?]|1|ukat|CEREBRAL HEMISPHERE, LEFT|LEFT|DORSAL|RULER MEASUREMENT METHOD|Y|||ADJUDICATION COMMITTEE|ADJUDICATOR 1|4|Visit_4|65|5|TREATMENT|2020-12-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|9|PEFTIME|Peak Expiratory Flow Time|[?]|UNCONSTRAINED|[?]|ug/kg/day|[?]|1|cmHg|TIBIOTARSAL JOINT|RIGHT|OCCIPITAL|PHOTOMETRIC CLOT DETECTION||Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|5|Visit_5|90|7|TREATMENT|2021-01-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|944617c7-c5e6-4e06-b114-499c3020dbbd|10|FEV3PP|Percent Predicted FEV3|[?]|SEMI-RECUMBENT|||[?]|1|Bq/L|ULNA SHAFT|UNILATERAL|ANTERIOR|TOTAL BODY IRRADIATION|||Y|PROXY|OPHTHALMOLOGIST|5|Visit_5|90|3|TREATMENT|2021-01-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-28
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|1|ALVVOL|Alveolar Volume|[?]|UNCONSTRAINED|[?]|cy/cm|[?]|1|mL/min/mmHg|REGIONAL LYMPH NODE|UNILATERAL|MIDLINE|DC SHEATH FLOW||||SIGNIFICANT OTHER|ONCOLOGIST 1|1|Visit_1|10|4|TREATMENT|2020-10-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|2|FVCPP|Percent Predicted Forced Vital Capacity|[?]|SUPINE|[?]|nsec|[?]|1|g/kg|LUNG, RIGHT UPPER LOBE|CONTRALATERAL|VOLAR|ICC||||CAREGIVER|OTOLARYNGOLOGIST|1|Visit_1|10|5|TREATMENT|2020-10-21|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-25
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|3|PNIF|Peak Nasal Inspiratory Flow|[?]|DECUBITUS|[?]|bel|[?]|1|10^9 organisms|HEPATIC ARTERY|LATERAL|LOWER EXTENSOR SURFACE|FLAME PHOTOMETRY||||ADJUDICATION COMMITTEE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|FOLLOW-UP|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|4|IVCPP|Percent Predicted IVC|[?]|SEMI-RECUMBENT|[?]|L/L|[?]|1|/HPF|TRICUSPID VALVE|LEFT|UPPER|FLUORESCENT LIFETIME IMAGING MICROSCOPY|Y|Y||INDEPENDENT ASSESSOR|RATER 1|2|Visit_2|25|2|TREATMENT|2020-11-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-24
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|5|SALKB|Salazar-Knowles Equation Parameter B|[?]|LEFT LATERAL DECUBITUS|[?]|fraction of 1|[?]|1|kg|RETINAL ARTERY|LEFT|FORE|ELECTROPHORESIS||||DOMESTIC PARTNER|PATHOLOGIST 2|3|Visit_3|40|3|TREATMENT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|6|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-FOWLERS|||[?]|1|Frames/s|PANCREAS, EXOCRINE|BILATERAL|ANTEROTEMPORAL|MULTIPLEXED BEAD BASED IMMUNOASSAY|||Y|CLINICAL RESEARCH ASSOCIATE|UROLOGIST|3|Visit_3|40|1|WASHOUT|2020-11-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|7|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SITTING, LEGS DEPENDENT|[?]|uU/L|[?]|1|umol/L/h|L2 VERTEBRA|IPSILATERAL|DISTAL|REBOUND TONOMETRY||||PROXY|RATER|4|Visit_4|65|3|SCREENING|2020-12-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|8|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SEMI-FOWLERS|[?]|10^9/dose|[?]|1|L/s/kPa|PRONATOR TERES MUSCLE|UNILATERAL|FRONTAL|TOTAL BODY RADIOGRAPHY||Y||SPOUSE|HEMATOLOGIST|4|Visit_4|65|6|SCREENING|2020-12-15|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-04
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|9|FEV3FVC|FEV3/FVC|[?]|REVERSE TRENDELENBURG|[?]|IU/g|[?]|1|ug/dose|SPINAL ACCESSORY NERVE|UNILATERAL|NASAL|SLOAN LETTER EYE CHART 2.5%|Y|||ADJUDICATOR|PEDIATRIC NEUROLOGIST|5|Visit_5|90|1|TREATMENT|2021-01-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|e4878c66-1e2b-49bb-838e-85139d160dd4|10|FIV1PP|Percent Predicted FIV1|[?]|PRONE|||[?]|1|mAnson U/mL|CORONARY ARTERY, RIGHT|LEFT|TEMPORAL|FORCED OSCILLATION TECHNIQUE|Y||Y|ADJUDICATOR|ONCOLOGIST 1|5|Visit_5|90|6|TREATMENT|2021-01-09|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|1|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|LEFT LATERAL DECUBITUS|[?]|m/sec|[?]|1|mV2/Hz|FEMUR|IPSILATERAL|DISTAL|QUANTITATIVE ULTRASOUND||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-06-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|2|ERV|Expiratory Reserve Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|QUANTITY SUFFICIENT|FEMORAL VEIN|RIGHT|NASAL|DIFFUSION WEIGHTED MRI|Y|Y|Y|INTERVIEWER|OPHTHALMOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-06-06|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-07
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|3|MIPPP|Percent Predicted MIP|[?]|TRENDELENBURG|[?]|h*%|[?]|1|log10 TCID 50/mL|URETHRA|CONTRALATERAL|CAUDAL|JAEGER EYE CHART||||FRIEND|FORENSIC PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-06-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|4|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-RECUMBENT|[?]|Bq/mg|[?]|1|mU/g|HILAR|IPSILATERAL|INFERIOR|FLUORESCEIN STAIN||||INTERVIEWER|NEUROLOGIST 2|2|Visit_2|25|2|TREATMENT|2020-06-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-19
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|5|IRVPP|Percent Predicted IRV|[?]|UNCONSTRAINED|[?]|km/h|[?]|1|kg|FINGERNAIL|LEFT|LOWER MEDIAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||SIGNIFICANT OTHER|RATER|3|Visit_3|40|6|WASHOUT|2020-07-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|6|TGV|Thoracic Gas Volume|[?]|SITTING|[?]|mg/m2/min|[?]|1|Osm|METATARSOPHALANGEAL JOINT 3|LEFT|UPPER|PERCUSSION||||SIBLING|CLINICAL PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-07-06|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|7|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|[?]|BU/mL|[?]|1|anti-Xa IU|CAPITATE-HAMATE JOINT|UNILATERAL|POSTERIOR|VIRUS PLAQUE ASSAY||Y||HEALTH CARE PROFESSIONAL|FORENSIC PATHOLOGIST|4|Visit_4|65|5|WASHOUT|2020-07-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|8|TVPP|Percent Predicted Tidal Volume|[?]|SLING|||[?]|1|mL/min|VOMER|LEFT|ANTEROMEDIAL|GEL ELECTROPHORESIS|||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-07-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-19
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|9|MALEVDES|Malignancy Evidence Description|[?]|STANDING, BENT FORWARD|[?]|ug/kg/min|[?]|1|eq|SPLENIC ARTERY|LEFT|SUPERIOR|TURBIDIMETRY|Y|Y||NON-HEALTH CARE PROFESSIONAL|RADIOLOGIST 2|5|Visit_5|90|3|WASHOUT|2020-08-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|6873e227-baef-4d6e-8600-0bb61d60fe49|10|ELSTNCE|Elastance|[?]|SEMI-RECUMBENT|[?]|pmol/L/h|[?]|1|oz eq|MUCOSA|LEFT|INNER|AMSLER GRID||||HEALTH CARE PROFESSIONAL|RATER 2|5|Visit_5|90|4|TREATMENT|2020-08-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-25
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|1|MALIND|Malignancy Indicator|[?]|SITTING|[?]|um/s|[?]|1|Bq/L|POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY|LEFT|DEEP|LASER CAPTURE MICRODISSECTION||||SIBLING|PHYSIOTHERAPIST|1|Visit_1|10|1|TREATMENT|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|2|FIVC|Forced Inspiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|uV2|[?]|1|/40 HPFs|PERIURETERAL REGION|RIGHT|FRONTAL|FREEZING POINT DEPRESSION||||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-10-15|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-25
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|3|AWWVOL|Airway Wall Volume|[?]|SEMI-RECUMBENT|[?]|OI50|[?]|1|ng/L|URETHRA|LATERAL|PERIVENTRICULAR|TRICHROME STAIN|Y|||STUDY SUBJECT|RADIOLOGIST 2|2|Visit_2|25|4|WASHOUT|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|4|AWVOL|Airway Volume|[?]|SEMI-FOWLERS|[?]|mg/mL/min|[?]|1|Gy|INTERPHALANGEAL THUMB JOINT|CONTRALATERAL|UPPER FLEXOR SURFACE|IMMUNO-PET SCAN||||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|2|Visit_2|25|1|WASHOUT|2020-10-30|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-08
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|5|FRC|Functional Residual Capacity|[?]|PRONE|[?]|msec|[?]|1|GPL U|HEART, LEFT ATRIAL APPENDAGE|LATERAL|PERIPHERAL|AUSCULTATION||||NON-HEALTH CARE PROFESSIONAL|MICROSCOPIST 3|3|Visit_3|40|7|WASHOUT|2020-11-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|6|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING|[?]|foz_us|[?]|1|damol/L|LAD SEPTAL PERFORATOR ARTERY|LATERAL|MEDIAL|IMMUNOFIXATION ELECTROPHORESIS||||FAMILY MEMBER|NEUROLOGIST 2|3|Visit_3|40|7|WASHOUT|2020-11-14|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-09
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|7|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|DECUBITUS|[?]|Antibody Unit|[?]|1|log10 copies/mL|COCCYX|BILATERAL|PERIPHERAL|TRIPLE-PHASE SPIRAL CT SCAN|Y|Y||CAREGIVER|READER 3|4|Visit_4|65|5|TREATMENT|2020-12-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|8|FEV1SVC|FEV1/SVC|[?]|RIGHT LATERAL DECUBITUS|[?]|tuberculin unit|[?]|1|V/sec|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|UNILATERAL|SUBCORTICAL|LISSAMINE GREEN STAIN||||STUDY SUBJECT|READER 1|4|Visit_4|65|2|WASHOUT|2020-12-09|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-21
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|9|TLC|Total Lung Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|FIU|DISTAL RIGHT CORONARY ARTERY CONDUIT|RIGHT|UPPER FLEXOR SURFACE|ARTERIAL SPIN LABELING FUNCTIONAL MRI|||Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|5|Visit_5|90|7|TREATMENT|2021-01-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|bad01879-9b97-4d9c-9eec-58871168bd57|10|FIFMAXPP|Percent Predicted FIFmax|[?]|RIGHT LATERAL DECUBITUS|[?]|kUSP|[?]|1|L/s/kPa|NAIL BED|LATERAL|FACIAL|PET SCAN||||INDEPENDENT ASSESSOR|READER|5|Visit_5|90|2|FOLLOW-UP|2021-01-03|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|/2000 RBC|[?]|1|mph|HEART, LEFT ATRIAL APPENDAGE|IPSILATERAL|FACIAL|TOLUIDINE BLUE STAIN|Y|Y||STUDY SUBJECT|RATER 2|1|Visit_1|10|5|SCREENING|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|2|FEV1REV|FEV1 Reversibility|[?]|SLING|[?]|Enzyme U|[?]|1|mm|PUTAMEN|BILATERAL|ROSTRAL|NON-CONTACT SPECULAR MICROSCOPY||||SIBLING|OTOLARYNGOLOGIST|1|Visit_1|10|6|TREATMENT|2020-11-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-19
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|3|EXPRELTM|Expiration Relaxation Time|[?]|SITTING, LEGS DEPENDENT|||[?]|1|min/day|SPHENOID SINUS|IPSILATERAL|OUTER|JAFFE REACTION||Y|Y|SPOUSE|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-11-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|4|SVC|Slow Vital Capacity|[?]|SITTING|||[?]|1|nmol/L/min|LARYNX|CONTRALATERAL|VENTRAL|FISH|||Y|DOMESTIC PARTNER|OPHTHALMOLOGIST|2|Visit_2|25|5|FOLLOW-UP|2020-11-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-06
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|5|FRC|Functional Residual Capacity|[?]|DECUBITUS|[?]|damol/L|[?]|1|AMPULE|LACRIMAL BONE|LEFT|NASAL|LIGHT SCATTERING SPECTROSCOPY||||PARENT|MICROSCOPIST|3|Visit_3|40|6|SCREENING|2020-12-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|6|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|Absorbance U/mL|[?]|1|%/s|OCCIPITAL LOBE|RIGHT|ANTEROMEDIAL|PERIPHERAL ANGIOGRAPHY|Y|||CAREGIVER|MICROSCOPIST 2|3|Visit_3|40|3|TREATMENT|2020-12-05|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|7|RELSZCHG|Relative Size Change|[?]|LATERAL DECUBITUS|[?]|/2000 RBC|[?]|1|kPa/L/sec|METACARPOPHALANGEAL JOINT 1|LEFT|ANTEROMEDIAL|COULOMETRIC TITRATION||Y||INVESTIGATOR|ADJUDICATOR 2|4|Visit_4|65|4|SCREENING|2020-12-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|8|PCF|Peak Cough Flow|[?]|SUPINE|[?]|umol/mol|[?]|1|ms/mmHg|T12 VERTEBRA|IPSILATERAL|UPPER|OLIGO ACGH|Y|||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|4|Visit_4|65|1|TREATMENT|2020-12-30|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-29
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|9|ERV|Expiratory Reserve Volume|[?]|SITTING, LEGS DEPENDENT|[?]|RFU|[?]|1|mg/kg/min|RENAL FOSSA|BILATERAL|TEMPORAL|ENZYMATIC SPECTROPHOTOMETRY||||VENDOR|PATHOLOGIST|5|Visit_5|90|2|SCREENING|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|10|DLCOHC|HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uCi/kg|LINGULA OF THE LUNG|RIGHT|DORSOLATERAL|ANALYTICAL ULTRACENTRIFUGATION|Y||Y|ADJUDICATION COMMITTEE|UROLOGIST|5|Visit_5|90|7|TREATMENT|2021-01-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-13
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|1|FEV_PEF|FEV at PEF|[?]|LATERAL DECUBITUS|||[?]|1|ugEq/L|CERVICAL SPINE|IPSILATERAL|DEEP|MULTI-SLICE SPIRAL CT|Y|Y|Y|FAMILY MEMBER|RADIOLOGIST 2|1|Visit_1|10|6|FOLLOW-UP|2020-08-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|2|PLMBLFLW|Pulmonary Blood Flow|[?]|FOWLERS|[?]|/LPF|[?]|1|/5x10^4 WBC|PUBIC BONE|BILATERAL|VENTROLATERAL|SINGLE-MOLECULE ARRAY||||ADJUDICATOR|OPTOMETRIST|1|Visit_1|10|3|TREATMENT|2020-08-24|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|3|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|ug/g/day|[?]|1|cycle/min|FUNDUS OF THE STOMACH|RIGHT|SUPERIOR|POLYMERASE CHAIN REACTION|Y|Y||STUDY SUBJECT|CARDIOLOGIST|2|Visit_2|25|5|TREATMENT|2020-09-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|4|MALEVDES|Malignancy Evidence Description|[?]|REVERSE TRENDELENBURG|||[?]|1|NEEDLE GAUGE|FIRST DORSAL INTEROSSEOUS MUSCLE OF THE FOOT|IPSILATERAL|CENTRAL|BALLPOINT PEN TECHNIQUE|||Y|CAREGIVER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|TREATMENT|2020-09-08|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|5|INFLTIND|Infiltrates Indicator|[?]|UNCONSTRAINED|||[?]|1|10^9/L|ABDOMINAL CAVITY|IPSILATERAL|OCCIPITAL|IMMUNOFLUORESCENT STAIN|Y||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST 3|3|Visit_3|40|4|SCREENING|2020-09-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|6|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-RECUMBENT|[?]|m/sec|[?]|1|FINGERTIP UNIT|T4 VERTEBRA|LATERAL|SURFACE|THICK SMEAR||||CLINICAL STUDY SPONSOR|PATHOLOGIST 1|3|Visit_3|40|3|TREATMENT|2020-09-23|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-13
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|7|IC|Inspiratory Capacity|[?]|SLING|[?]|ngEq/L|[?]|1|ng/day|SPLEEN, HILUM|LATERAL|PERIVENTRICULAR|FLOW MICROSCOPY||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|4|Visit_4|65|2|SCREENING|2020-10-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|8|TSUHYS|Tissue Hysteresivity|[?]|STANDING|[?]|s*kPa|[?]|1|MdFI|MEDIAN OR LOWER CERVICAL LYMPH NODE|RIGHT|ANTEROPOSTERIOR|FLUORESCENT SPOT TEST||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|4|Visit_4|65|2|WASHOUT|2020-10-18|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|9|FRCPP|Percent Predicted FRC|[?]|LATERAL DECUBITUS|[?]|10^9 organisms/g|[?]|1|cm|LUMBAR REGION|BILATERAL|OCCIPITAL|MICROSCOPY|Y|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST|5|Visit_5|90|6|TREATMENT|2020-11-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|0df77775-6e65-4f77-9f8f-7faaa1471141|10|RELSZCHG|Relative Size Change|[?]|SEMI-RECUMBENT|[?]|dmol|[?]|1|10^3 DNA copies/mL|INTERNAL MAMMARY LYMPH NODE|IPSILATERAL|DEEP|CARDIAC THERMODILUTION||Y||PROXY|CLINICAL PATHOLOGIST|5|Visit_5|90|5|TREATMENT|2020-11-12|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|FIV1|Forced Inspiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|MONTHS|[?]|1|yd|OPTIC NERVE|LEFT|TEMPORAL|REBOUND TONOMETRY||Y||INVESTIGATOR|PATHOLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-08-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|2|PEF|Peak Expiratory Flow|[?]|SITTING, LEGS DEPENDENT|[?]|mm|[?]|1|APPLICATION|SIGMOID SINUS|BILATERAL|BASAL|KLEIHAUER-BETKE||||GUARDIAN|ONCOLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-08-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-17
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|3|RAW|Airway Resistance|[?]|UNCONSTRAINED|||[?]|1|mEq/dL|PANCREAS, EXOCRINE|CONTRALATERAL|CRANIAL|OPTICAL COHERENCE TOMOGRAPHY|Y||Y|STUDY SUBJECT|INTERNIST|2|Visit_2|25|5|FOLLOW-UP|2020-09-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|4|INTP|Interpretation|[?]|UNCONSTRAINED|||[?]|1|10^4 CFU/mL|LEFT POSTEROLATERAL DESCENDING ARTERY|UNILATERAL|BASAL|CYSTOMETRY|Y||Y|ADJUDICATOR|READER 2|2|Visit_2|25|6|FOLLOW-UP|2020-09-06|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|5|DLCOPP|Percent Predicted DLCO|[?]|SLING|[?]|DNA copies/ug|[?]|1|Hz/s|PARALARYNGEAL LYMPH NODE|RIGHT|VENTRAL|NUCLEAR RADIOLOGY||||CHILD|MICROSCOPIST 1|3|Visit_3|40|4|SCREENING|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|6|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|LEFT LATERAL DECUBITUS|[?]|IU|[?]|1|Farad|LACRIMAL GLAND|LATERAL|DISTAL|FLUORESCENT MICROSCOPY||||CLINICAL RESEARCH COORDINATOR|OPHTHALMOLOGIST|3|Visit_3|40|3|SCREENING|2020-09-21|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|7|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SITTING|||[?]|1|mCi/L|INTERPHALANGEAL JOINT OF THE HAND|RIGHT|VOLAR|CT SCAN WITHOUT CONTRAST||Y|Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 1|4|Visit_4|65|6|FOLLOW-UP|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|8|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-RECUMBENT|||[?]|1|mm/min|PRONATOR TERES MUSCLE|LATERAL|ANTEROMEDIAL|GC/MS|||Y|CAREGIVER|PHYSIOTHERAPIST|4|Visit_4|65|6|WASHOUT|2020-10-16|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-13
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|9|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-FOWLERS|[?]|oz|[?]|1|APPLICATION|RIGHT ATRIAL ENDOCARDIUM|RIGHT|LOWER|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y||CHILD|MICROSCOPIST 2|5|Visit_5|90|6|FOLLOW-UP|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|adc5359a-f1d5-428b-97d8-fce67cfeeaea|10|TV|Tidal Volume|[?]|UNCONSTRAINED|[?]|ft3|[?]|1|m3|L3-L4 INTERVERTEBRAL SPACE|LEFT|ANTERIOR|ELLA||||VENDOR|RADIOLOGIST 1|5|Visit_5|90|7|TREATMENT|2020-11-10|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-21
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|1|RAWPP|Percent Predicted Airway Resistance|[?]|UNCONSTRAINED|[?]|CAPFUL|[?]|1|EID 50/dose|TIBIOTARSAL JOINT|LATERAL|PERIVENTRICULAR|FLUORESCENT IMMUNOASSAY|Y|||SIBLING|ADJUDICATOR 1|1|Visit_1|10|1|TREATMENT|2020-12-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|2|SALKK|Salazar-Knowles Equation, K|[?]|STANDING|||[?]|1|mg/m2|INTERPHALANGEAL JOINT 3|LATERAL|ANTEROLATERAL|SIZE EXCLUSION CHROMATOGRAPHY||Y|Y|GUARDIAN|DERMATOLOGIST|1|Visit_1|10|2|SCREENING|2020-12-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|3|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|ug/dL|[?]|1|mol/g|FLEXOR HALLUCIS BREVIS MUSCLE|LEFT|SUPERFICIAL|MAGNETIC RESONANCE ANGIOGRAPHY||Y||ADJUDICATION COMMITTEE|ADJUDICATOR 1|2|Visit_2|25|6|TREATMENT|2021-01-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|4|INTP|Interpretation|[?]|FOWLERS|[?]|U/animal|[?]|1|DPM|L5-S1 INTERVERTEBRAL SPACE|RIGHT|ANTEROPOSTERIOR|OBSERVATION||||HEALTH CARE PROFESSIONAL|HEMATOLOGIST|2|Visit_2|25|3|TREATMENT|2021-01-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-31
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|5|TV|Tidal Volume|[?]|STANDING, BENT FORWARD|[?]|/kg|[?]|1|GPL U|HYPOGLOSSAL NERVE|IPSILATERAL|UPPER EXTENSOR SURFACE|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||||HEALTH CARE PROFESSIONAL|READER 1|3|Visit_3|40|4|TREATMENT|2021-01-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|6|ELSTNCE|Elastance|[?]|SEMI-FOWLERS|[?]|/mm|[?]|1|Torr|PERIFACIAL LYMPH NODE|BILATERAL|HIND|MAMMOGRAPHY||||STUDY SUBJECT|MICROSCOPIST 1|3|Visit_3|40|6|TREATMENT|2021-01-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-14
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|7|PNEUMIND|Pneumonia Indicator|[?]|SLING|[?]|ug/cm2|[?]|1|g/g/day|METACARPOPHALANGEAL JOINT 3|LEFT|FACIAL|GC/MS-EI||||INDEPENDENT ASSESSOR|RADIOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2021-02-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|8|FEV1PP|Percent Predicted FEV1|[?]|SEMI-RECUMBENT|||[?]|1|10^12 IU/L|MEDULLA OBLONGATA|RIGHT|LOWER EXTENSOR SURFACE|CALIPER MEASUREMENT METHOD|Y||Y|ADJUDICATOR|CLINICAL PATHOLOGIST|4|Visit_4|65|5|FOLLOW-UP|2021-02-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|9|PNEUMIND|Pneumonia Indicator|[?]|FOWLERS|[?]|mmol2/L2|[?]|1|v/v|PRONATOR QUADRATUS MUSCLE|RIGHT|FRONTAL|DIRECT SEQUENCING||||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|5|Visit_5|90|3|TREATMENT|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|cd68296c-95d4-489e-8b64-b2404f16316c|10|TV|Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|/min|[?]|1|DIP|PROFUNDA FEMORIS ARTERY|CONTRALATERAL|DISTAL|IMMUNOTURBIDIMETRY||Y||NON-HEALTH CARE PROFESSIONAL|READER 2|5|Visit_5|90|7|SCREENING|2021-03-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-20
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|1|PIF|Peak Inspiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|um|[?]|1|mCi/kg|CELIAC ARTERY|BILATERAL|APICAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||INDEPENDENT ASSESSOR|OPHTHALMOLOGIST|1|Visit_1|10|3|SCREENING|2020-07-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|2|RRS|Total Respiratory System Resistance|[?]|TRENDELENBURG|[?]|Gy|[?]|1|pmol/10^9 cells|EXTERNAL ILIAC LYMPH NODE|IPSILATERAL|PERIVENTRICULAR|DUCTOGRAPHY||||SIBLING|ONCOLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-07-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-12
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|3|AIRTRAP|Air Trapping|[?]|PRONE|[?]|ug/animal|[?]|1|Gauss|T10 VERTEBRA|BILATERAL|POSTERIOR|ETDRS EYE CHART||||PROXY|ONCOLOGIST 2|2|Visit_2|25|1|TREATMENT|2020-07-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|4|RAW|Airway Resistance|[?]|SLING|[?]|10^6/L|[?]|1|10^9 CFU/mL|JAW|UNILATERAL|CENTRAL|SNELLEN EYE CHART|Y|Y||CAREGIVER|RADIOLOGIST 1|2|Visit_2|25|1|FOLLOW-UP|2020-07-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-09
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|5|TSUHYS|Tissue Hysteresivity|[?]|TRENDELENBURG|||[?]|1|U/kg|HEART, APEX|BILATERAL|FRONTAL|DROPLET DIGITAL PCR||Y|Y|INDEPENDENT ASSESSOR|RADIOLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|6|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|[?]|ug/animal|[?]|1|10^9 CFU|LACRIMAL GLAND|UNILATERAL|CENTRAL|IMPEDANCE CONDUCTIVITY||||ADJUDICATOR|NEUROLOGIST 1|3|Visit_3|40|2|FOLLOW-UP|2020-08-02|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-14
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|7|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING|||[?]|1|mEq/mmol|MESENTERY|CONTRALATERAL|DISTAL VOLAR|PULMONARY ANGIOGRAPHY|||Y|INVESTIGATOR|CARDIOLOGIST|4|Visit_4|65|4|TREATMENT|2020-08-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|8|FIO2|Fraction of Inspired Oxygen|[?]|REVERSE TRENDELENBURG|||[?]|1|10^6 CFU/mL|RECTOVAGINAL SPACE|LATERAL|ANTEROMEDIAL|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|||Y|GUARDIAN|CARDIOLOGIST|4|Visit_4|65|3|SCREENING|2020-08-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|9|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|UNCONSTRAINED|||[?]|1|g/U|GINGIVAL MUCOSA|RIGHT|PARIETO-OCCIPITAL|BAC ACGH|Y||Y|PARENT|NEUROLOGIST 2|5|Visit_5|90|3|WASHOUT|2020-09-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|fe137506-d1ce-4b08-a043-9366d86c421e|10|FIFMAXPP|Percent Predicted FIFmax|[?]|DECUBITUS|[?]|nmol/day|[?]|1|Enzyme U/g Hb|MESENTERY|LEFT|DISTAL VOLAR|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||CHILD|ADJUDICATOR|5|Visit_5|90|7|TREATMENT|2020-09-21|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-28
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|1|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|U.CARR|CORPUS CALLOSUM, GENU|LATERAL|DISTAL|AUDIOMETRY|||Y|VENDOR|HEMATOLOGIST|1|Visit_1|10|4|WASHOUT|2021-01-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|2|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|LEFT LATERAL DECUBITUS|[?]|BOX|[?]|1|anti-Xa IU|GREAT TROCHANTER|RIGHT|NASAL|CONTRAST ENHANCED SPIRAL CT SCAN|Y|||ADJUDICATION COMMITTEE|PHYSIOTHERAPIST|1|Visit_1|10|5|TREATMENT|2021-01-03|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-16
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SITTING|[?]|umol/dL|[?]|1|s^-1(%O2)^-1|RIB 12|LEFT|ANTEROMEDIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||Y||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST|2|Visit_2|25|3|SCREENING|2021-01-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|4|FEV1REV|FEV1 Reversibility|[?]|SEMI-FOWLERS|[?]|10^3/L|[?]|1|log EID 50/dose|ABDUCTOR POLLICIS BREVIS MUSCLE|LEFT|POSTERIOR|GC/MS-CI||||INTERVIEWER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|5|TREATMENT|2021-01-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-19
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|5|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING, BENT FORWARD|[?]|U/g|[?]|1|USP U|AORTIC VALVE|LEFT|DEEP|CONTRAST ENHANCED PET SCAN||Y||STUDY SUBJECT|PEDIATRIC NEUROLOGIST|3|Visit_3|40|4|FOLLOW-UP|2021-02-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|6|FIF50|Forced Inspiratory Flow at 50%|[?]|PRONE|||[?]|1|mg|DORSAL MOTOR NUCLEUS|RIGHT|ANTEROMEDIAL|ELECTROCHEMILUMINESCENCE IMMUNOASSAY|||Y|VENDOR|INTERNIST|3|Visit_3|40|1|WASHOUT|2021-02-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-28
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|7|FIFMAXPP|Percent Predicted FIFmax|[?]|RIGHT LATERAL DECUBITUS|[?]|cm H2O|[?]|1|mEq/dL|FOREARM|IPSILATERAL|BASAL|MACRO BROTH DILUTION||||STUDY SUBJECT|ADJUDICATOR 2|4|Visit_4|65|3|TREATMENT|2021-02-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|8|SGAW|Specific Airway Conductance|[?]|SEMI-FOWLERS|[?]|cmH2O*s/mL|[?]|1|cmH2O/mL|LEG SKIN|BILATERAL|CAUDAL|COLORIMETRY||||FAMILY MEMBER|OTOLARYNGOLOGIST|4|Visit_4|65|3|TREATMENT|2021-02-27|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|9|SRAW|Specific Airway Resistance|[?]|SLING|[?]|nmol BCE/nmol|[?]|1|umol/kg/min|BONE|RIGHT|LATERAL|SPIRAL CT||Y||CHILD|RATER|5|Visit_5|90|5|FOLLOW-UP|2021-03-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|b112c524-42c8-4e9e-8699-209e739972a7|10|EFFVOL|Effusion Volume|[?]|STANDING|[?]|mCi|[?]|1|uU/dL|CERVICAL VERTEBRA|IPSILATERAL|LOWER MEDIAL|MAGNETIC RESONANCE ELASTOGRAPHY|Y|||SIBLING|OPHTHALMOLOGIST|5|Visit_5|90|2|TREATMENT|2021-03-24|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-25
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|SRAW|Specific Airway Resistance|[?]|UNCONSTRAINED|[?]|ug/h|[?]|1|/min|PROCERUS MUSCLE|LEFT|ANTEROLATERAL|STRESS ECHOCARDIOGRAPHY||||FRIEND|INTERNIST|1|Visit_1|10|1|TREATMENT|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SUPINE|||[?]|1|EU|ILEUM, TERMINAL|CONTRALATERAL|DISTAL|PH METER MEASUREMENT METHOD||Y|Y|INVESTIGATOR|PHYSIOTHERAPIST|1|Visit_1|10|3|WASHOUT|2020-09-02|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-11
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|3|SRAW|Specific Airway Resistance|[?]|SITTING|||[?]|1|m|OLFACTORY NERVE|RIGHT|PERIPHERAL|MICRODENSITOMETRY|Y||Y|ADJUDICATION COMMITTEE|MICROSCOPIST|2|Visit_2|25|1|SCREENING|2020-09-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|4|OXYPULSE|Oxygen Pulse|[?]|SUPINE|[?]|cal|[?]|1|mEq/day|SPINOUS PROCESS|RIGHT|SUPERFICIAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||||HEALTH CARE PROFESSIONAL|PHYSIOTHERAPIST|2|Visit_2|25|7|TREATMENT|2020-09-17|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-16
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|5|PLMBLFLW|Pulmonary Blood Flow|[?]|LEFT LATERAL DECUBITUS|[?]|dL|[?]|1|/2500 WBC|SIGMOID SINUS|UNILATERAL|PERIVENTRICULAR|PHYSICAL EXAMINATION||||VENDOR|RADIOLOGIST 1|3|Visit_3|40|7|FOLLOW-UP|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|6|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|UNCONSTRAINED|[?]|CFU/mL|[?]|1|mMU/mL|HYPOGLOSSAL NERVE|RIGHT|SUPERFICIAL|SISH||Y||CLINICAL STUDY SPONSOR|OTOLARYNGOLOGIST|3|Visit_3|40|1|TREATMENT|2020-10-02|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-22
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|7|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|SITTING|||[?]|1|10^9 organisms|CORNEA|BILATERAL|INTERMEDIATE|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y||Y|CLINICAL RESEARCH ASSOCIATE|FORENSIC PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-10-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|8|IVC|Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|mL/cm H2O|[?]|1|cmol/L|EXTERNAL ILIAC LYMPH NODE|UNILATERAL|CRANIAL|CINEANGIOGRAPHY||||INTERVIEWER|ADJUDICATOR|4|Visit_4|65|6|TREATMENT|2020-10-27|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-07
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|9|ERVPP|Percent Predicted ERV|[?]|STANDING, BENT FORWARD|[?]|10^4 CFU/mL|[?]|1|amol|LEFT VENTRICULAR APICAL INFERIOR SEGMENT|LATERAL|POSTERIOR|FUNCTIONAL MRI||Y||STUDY SUBJECT|NEUROLOGIST 1|5|Visit_5|90|6|TREATMENT|2020-11-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|e6e32df8-8b66-49a5-a626-fd385297dd6f|10|EFFIND|Effusion Indicator|[?]|SEMI-RECUMBENT|[?]|CAPFUL|[?]|1|CFU/mL|PENIS, BODY|LATERAL|TEMPORAL|CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY||Y||GUARDIAN|ADJUDICATOR 2|5|Visit_5|90|3|TREATMENT|2020-11-21|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-18
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|steps/min|[?]|1|mg/kg/dose|ANAL CANAL|IPSILATERAL|LATERAL|CELLULAR PROLIFERATION ASSAY|Y|Y||PARENT|RADIOLOGIST 2|1|Visit_1|10|4|WASHOUT|2020-09-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|2|TGV|Thoracic Gas Volume|[?]|PRONE|||[?]|1|nm|SENSORIMOTOR CORTEX|RIGHT|CRANIAL|MALDI-TOF|Y||Y|HEALTH CARE PROFESSIONAL|RADIOLOGIST|1|Visit_1|10|5|WASHOUT|2020-09-18|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-13
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|3|INFLTIND|Infiltrates Indicator|[?]|SEMI-RECUMBENT|[?]|umol/h/mmol|[?]|1|mL/h|SACROILIAC JOINT|LEFT|DORSOLATERAL|MICROBIAL CONCENTRATION||Y||ADJUDICATION COMMITTEE|ADJUDICATOR 3|2|Visit_2|25|1|WASHOUT|2020-10-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|4|TSUELAS|Tissue Elastance|[?]|PRONE|[?]|EVENTS|[?]|1|mU|RIGHT VENTRICULAR BRANCH|LATERAL|ROSTRAL|POLYSOMNOGRAPHY||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|2|Visit_2|25|7|TREATMENT|2020-10-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|5|PCF|Peak Cough Flow|[?]|SLING|[?]|RING|[?]|1|kcal/day|PULMONARY VALVE, ANTERIOR CUSP|IPSILATERAL|APICAL|GC/FID||||FAMILY MEMBER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|3|TREATMENT|2020-10-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|6|FIV1PP|Percent Predicted FIV1|[?]|STANDING, BENT FORWARD|[?]|gpELISA unit/mL|[?]|1|BAU|URETHRA, PROSTATIC|LEFT|DISTAL VOLAR|IMMUNOTURBIDIMETRY||||CAREGIVER|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|7|FOLLOW-UP|2020-10-18|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-19
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|7|EXPRELTM|Expiration Relaxation Time|[?]|SEMI-RECUMBENT|[?]|mEq/mL|[?]|1|10^5/hpf|DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND|IPSILATERAL|SURFACE|LISSAMINE GREEN STAIN||Y||FAMILY MEMBER|MICROSCOPIST 2|4|Visit_4|65|2|SCREENING|2020-11-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|8|RVPP|Percent Predicted Residual Volume|[?]|STANDING, BENT FORWARD|[?]|cmH2O*s2/mL|[?]|1|mV/sec|THYROID GLAND|RIGHT|DORSAL|POLYSOMNOGRAPHY||||FRIEND|CLINICAL PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-11-12|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-27
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|9|PEFTIME|Peak Expiratory Flow Time|[?]|SLING|||[?]|1|100 IU/mL|ETHMOID BONE|RIGHT|ANTEROLATERAL|PET/CT SCAN|||Y|DOMESTIC PARTNER|ONCOLOGIST|5|Visit_5|90|6|TREATMENT|2020-12-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|10|FVC6|Forced Vital Capacity in 6 Seconds|[?]|TRENDELENBURG|[?]|U/g Hb|[?]|1|RING|SCAPHOID-RADIUS JOINT|IPSILATERAL|UPPER EXTENSOR SURFACE|ELECTROMYOGRAPHY|Y|||HEALTH CARE PROFESSIONAL|OPTOMETRIST|5|Visit_5|90|4|SCREENING|2020-12-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-12
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|1|AWVOLPP|Percent Predicted Airway Volume|[?]|PRONE|[?]|pt_us|[?]|1|nmol/kg/day|PECTORALIS MINOR MUSCLE|LATERAL|DISTAL VOLAR|ELISA||||PARENT|OTOLARYNGOLOGIST|1|Visit_1|10|7|FOLLOW-UP|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|2|FIV1PP|Percent Predicted FIV1|[?]|SEMI-FOWLERS|||[?]|1|mmol/s|MEDIASTINAL LYMPH NODE|CONTRALATERAL|TIP|PERCUSSION|||Y|HEALTH CARE PROFESSIONAL|DERMATOLOGIST|1|Visit_1|10|5|TREATMENT|2021-01-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|3|IC|Inspiratory Capacity|[?]|REVERSE TRENDELENBURG|[?]|mOsm/kg|[?]|1|10^6 RNA copies/mL|SALIVARY GLAND|UNILATERAL|CAUDAL|PULMONARY ANGIOGRAPHY||||NON-HEALTH CARE PROFESSIONAL|ONCOLOGIST 2|2|Visit_2|25|1|TREATMENT|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|4|AIRTRAP|Air Trapping|[?]|STANDING, BENT FORWARD|[?]|10^4/L|[?]|1|MET*h|LIGAMENT|RIGHT|ANTERIOR|HPLC/MS|Y|||STUDY SUBJECT|PATHOLOGIST|2|Visit_2|25|6|FOLLOW-UP|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-16
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|5|FEV3FVC|FEV3/FVC|[?]|UNCONSTRAINED|[?]|mm2|[?]|1|mL/cage|BASAL GANGLIA|CONTRALATERAL|INNER|SNELLEN EYE CHART|Y|||CLINICAL RESEARCH ASSOCIATE|RATER|3|Visit_3|40|3|SCREENING|2021-02-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|6|GAW|Airway Conductance|[?]|SITTING|||[?]|1|kN/cm2|KIDNEY, MEDULLA|RIGHT|MEDIAL|FLOW MICROSCOPY|||Y|SIBLING|ADJUDICATOR 1|3|Visit_3|40|4|TREATMENT|2021-02-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-12
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|7|FRCPP|Percent Predicted FRC|[?]|LEFT LATERAL DECUBITUS|[?]|vp/mL|[?]|1|dpm/mL|DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT|UNILATERAL|DORSAL|SLIT LAMP PHOTOGRAPHY||||GUARDIAN|PATHOLOGIST 2|4|Visit_4|65|3|TREATMENT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|8|IC|Inspiratory Capacity|[?]|DECUBITUS|||[?]|1|U/g/day|CORONARY ARTERY, LEFT|UNILATERAL|APICAL|HANSEL STAIN|||Y|NON-HEALTH CARE PROFESSIONAL|UROLOGIST|4|Visit_4|65|4|SCREENING|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-04
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|9|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|LEFT LATERAL DECUBITUS|||[?]|1|L/kg|LEFT CIRCUMFLEX CORONARY ARTERY|BILATERAL|INFERIOR|IMMUNOFLUORESCENT STAIN|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 3|5|Visit_5|90|7|WASHOUT|2021-04-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|5002de57-45df-4525-a6b7-b6cc33c22229|10|MIP|Maximal Inspiratory Pressure|[?]|TRENDELENBURG|[?]|Enzyme U|[?]|1|L/day|NASAL SEPTUM|IPSILATERAL|SURFACE|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|5|Visit_5|90|7|TREATMENT|2021-04-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|1|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|SLING|[?]|IU/dL|[?]|1|uCi/L|LEFT ANTERIOR DESCENDING ARTERY OSTIUM|CONTRALATERAL|DORSOLATERAL|MICROSCOPY||Y||STUDY SUBJECT|MICROSCOPIST 1|1|Visit_1|10|3|TREATMENT|2020-10-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|REVERSE TRENDELENBURG|||[?]|1|U/m2/h|PARACAVAL LYMPH NODE|LATERAL|INTERMEDIATE|HPLC/MS|||Y|SIGNIFICANT OTHER|ADJUDICATOR|1|Visit_1|10|7|TREATMENT|2020-10-05|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-14
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|3|SVCPP|Percent Predicted Slow Vital Capacity|[?]|PRONE|[?]|Shock Wave|[?]|1|SPRAY|THYROID GLAND|CONTRALATERAL|LOWER|CONTRAST ENHANCED CT SCAN||||PARENT|RATER 2|2|Visit_2|25|3|TREATMENT|2020-10-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|4|FVC6|Forced Vital Capacity in 6 Seconds|[?]|TRENDELENBURG|[?]|ug/h|[?]|1|kg|THORACIC ARTERY|LEFT|LATERAL|SIZE EXCLUSION CHROMATOGRAPHY||||PROXY|PATHOLOGIST|2|Visit_2|25|3|WASHOUT|2020-10-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-04
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|5|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|||[?]|1|mL/m2/day|ELBOW FLEXOR MUSCLES|IPSILATERAL|UPPER FLEXOR SURFACE|SPECT SCAN|||Y|GUARDIAN|RADIOLOGIST|3|Visit_3|40|7|TREATMENT|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|6|AWVOL|Airway Volume|[?]|SUPINE|[?]|dL|[?]|1|mm3/mm2/year|SEMINAL VESICLE|IPSILATERAL|LOWER MEDIAL|URANYL ACETATE STAIN||||CLINICAL RESEARCH ASSOCIATE|READER 1|3|Visit_3|40|2|FOLLOW-UP|2020-11-04|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|7|SALKK|Salazar-Knowles Equation, K|[?]|REVERSE TRENDELENBURG|[?]|mEq/uL|[?]|1|pmol|MAMMARY GLAND|RIGHT|NASAL|MICROSCOPY|Y|||ADJUDICATION COMMITTEE|PATHOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|8|MALEVDES|Malignancy Evidence Description|[?]|SEMI-RECUMBENT|[?]|mL/kg/day|[?]|1|cg|PAW|IPSILATERAL|MEDIAL|COLORIMETRY||||STUDY SUBJECT|DEVELOPMENTAL PSYCHOLOGIST|4|Visit_4|65|6|FOLLOW-UP|2020-11-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-02
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|9|MEP|Maximal Expiratory Pressure|[?]|PRONE|[?]|mEq/kg|[?]|1|mmol/min/kPa|PALATINE BONE|UNILATERAL|TIP|MOUSE PROTECTION ASSAY||Y||PARENT|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|2|TREATMENT|2020-12-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|298f2081-bb11-4856-9e88-4be3b9b2250d|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|RIGHT LATERAL DECUBITUS|[?]|Absorbance U|[?]|1|SBE/mL|OMENTUM|CONTRALATERAL|VENTROLATERAL|ACCELERATOR MASS SPECTROMETRY||||PROXY|NEUROLOGIST 1|5|Visit_5|90|6|WASHOUT|2020-12-24|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-31
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|ERVPP|Percent Predicted ERV|[?]|TRENDELENBURG|[?]|TROCHE|[?]|1|ng/dL|HAND DIGIT 3|BILATERAL|ANTERIOR|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||NON-HEALTH CARE PROFESSIONAL|DERMATOLOGIST|1|Visit_1|10|4|FOLLOW-UP|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|2|PLMBLFLW|Pulmonary Blood Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|ppb|[?]|1|APL U/mL|INFRATENTORIAL BRAIN|IPSILATERAL|NASAL|CELL CYTOTOXICITY NEUTRALIZATION ASSAY||||GUARDIAN|RADIOLOGIST 1|1|Visit_1|10|3|TREATMENT|2020-12-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-13
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|3|AWVOLPP|Percent Predicted Airway Volume|[?]|SITTING|[?]|10^5/hpf|[?]|1|ppm|SUPRAPUBIC REGION|UNILATERAL|DEEP|PELLI-ROBSON EYE CHART||Y||DOMESTIC PARTNER|PATHOLOGIST|2|Visit_2|25|1|SCREENING|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|4|DLCOVAPP|Percent Predicted DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|IU/L|[?]|1|cm/s|LUNG, LEFT LOWER LOBE|BILATERAL|DORSAL|ANTIBIOTIC AGAR SCREEN|Y|||FAMILY MEMBER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|3|WASHOUT|2021-01-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-05
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|5|FIFMAX|Maximum Forced Inspiratory Flow|[?]|FOWLERS|[?]|ug/dose|[?]|1|ug|PAROTID GLAND|LATERAL|ANTEROPOSTERIOR|SISH|Y|||HEALTH CARE PROFESSIONAL|NEUROLOGIST|3|Visit_3|40|1|FOLLOW-UP|2021-01-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|6|FEV1SVC|FEV1/SVC|[?]|SUPINE|[?]|QUANTITY SUFFICIENT|[?]|1|/200 HPFs|ESOPHAGEAL LYMPH NODE|CONTRALATERAL|INNER|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||FRIEND|ADJUDICATOR 2|3|Visit_3|40|3|WASHOUT|2021-01-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-23
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|7|ICREV|IC Reversibility|[?]|STANDING|[?]|h*%|[?]|1|Log10 ELISA unit/dose|PANCREAS, ENDOCRINE|CONTRALATERAL|DORSAL|IMPULSE OSCILLOMETRY||||SPOUSE|OTOLARYNGOLOGIST|4|Visit_4|65|5|TREATMENT|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|8|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|FOWLERS|[?]|mV2/Hz|[?]|1|cmH2O*s2/mL|METACARPAL BONE 4|LEFT|DORSOLATERAL|SINGLE-MOLECULE ARRAY||Y||DOMESTIC PARTNER|MICROSCOPIST 1|4|Visit_4|65|3|SCREENING|2021-02-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-26
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|9|INFLTIND|Infiltrates Indicator|[?]|STANDING|[?]|MPS U|[?]|1|DAgU|POSTERIOR CERVICAL LYMPH NODE|BILATERAL|APICAL|DIFFUSION TENSOR MRI||||GUARDIAN|CARDIOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|10|DLCOVAPP|Percent Predicted DLCO/VA|[?]|FOWLERS|[?]|mL/kg/h|[?]|1|MPL U|PERIURETHRAL REGION|IPSILATERAL|POSTERIOR|SLOAN LETTER EYE CHART 2.5%|Y|Y||SPOUSE|READER|5|Visit_5|90|5|TREATMENT|2021-03-19|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-28
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|UNCONSTRAINED|[?]|BOWL|[?]|1|TRANSDUCING UNIT|APPENDICULAR SKELETON|CONTRALATERAL|SUPERFICIAL|PERCUSSION||||CHILD|ONCOLOGIST|1|Visit_1|10|1|TREATMENT|2020-05-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|2|FEV3FVC|FEV3/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|CIGAR|[?]|1|/4.0 mL|PLEURAL CAVITY|LATERAL|ROSTRAL|LUXOL FAST BLUE AND CRESYL VIOLET STAIN|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|1|Visit_1|10|3|FOLLOW-UP|2020-05-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-20
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|3|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|SUPINE|[?]|/100 WBC|[?]|1|mg/kg/min|EPIGASTRIC REGION|CONTRALATERAL|OUTER|PHASE CONTRAST MICROSCOPY|Y|||VENDOR|ENDOCRINOLOGIST|2|Visit_2|25|4|FOLLOW-UP|2020-05-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|4|FEV3PP|Percent Predicted FEV3|[?]|LEFT LATERAL DECUBITUS|[?]|cy/cm|[?]|1|mEq/L|FEMORAL VEIN|BILATERAL|SURFACE|POLYMERASE CHAIN REACTION||Y||FRIEND|PATHOLOGIST 2|2|Visit_2|25|3|WASHOUT|2020-05-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-31
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|5|IRV|Inspiratory Reserve Volume|[?]|STANDING|[?]|/2500 WBC|[?]|1|MPS U|UMBILICUS|RIGHT|ANTEROTEMPORAL|NUCLEIC ACID AMPLIFICATION TEST||Y||FRIEND|ONCOLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-06-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-16
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|6|TVPP|Percent Predicted Tidal Volume|[?]|TRENDELENBURG|[?]|/day|[?]|1|mmol/g|CALCARINE SULCUS|UNILATERAL|APICAL|ALCIAN BLUE STAIN|Y|||SPOUSE|MICROSCOPIST|3|Visit_3|40|1|WASHOUT|2020-06-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-16
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|7|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|PRONE|||[?]|1|IU/mL|ACCESSORY RENAL ARTERY|BILATERAL|ANTEROMEDIAL|RAJI CELL EIA|Y||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST 2|4|Visit_4|65|3|TREATMENT|2020-07-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-06
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|8|RAWPP|Percent Predicted Airway Resistance|[?]|SLING|[?]|mL/animal|[?]|1|ng/dL|AZYGOS VEIN|BILATERAL|SUPERIOR|PATHOLOGICAL EVALUATION||||DOMESTIC PARTNER|READER 2|4|Visit_4|65|7|TREATMENT|2020-07-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-06
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|9|AIRTRAP|Air Trapping|[?]|SITTING, LEGS DEPENDENT|[?]|GBq/g|[?]|1|mL/animal/wk|PARATHYROID GLAND|CONTRALATERAL|INFERIOR|EIA|Y|||STUDY SUBJECT|FORENSIC PATHOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-07-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-06
e|RE|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|10|ICPP|Percent Predicted Inspiratory Capacity|[?]|SEMI-RECUMBENT|[?]|umol/L|[?]|1|10^3 DNA copies/mL|LUNG, LEFT, INFERIOR LOBE, ANTERIOR BASAL SEGMENT|LEFT|PERIPHERAL|CONGO RED STAIN||||DOMESTIC PARTNER|READER|5|Visit_5|90|5|FOLLOW-UP|2020-07-31|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-05-06
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|1|ELSTNCE|Elastance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|mL/min|NASAL SEPTUM|RIGHT|LOWER MEDIAL|MULTI-SLICE SPIRAL CT||Y|Y|SIGNIFICANT OTHER|NEUROLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-08-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|2|INTP|Interpretation|[?]|STANDING|[?]|mg/g/min|[?]|1|cm2|HEEL OF THE HAND|LATERAL|ANTEROLATERAL|IMPEDANCE CONDUCTIVITY||||INTERVIEWER|PATHOLOGIST 2|1|Visit_1|10|7|TREATMENT|2020-08-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|3|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|STANDING, BENT FORWARD|[?]|DAgU|[?]|1|Linear ft*LB|HEPATIC LYMPH NODE|LEFT|TEMPORAL|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY|Y|||CLINICAL STUDY SPONSOR|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-09-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|4|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SEMI-FOWLERS|[?]|ug/kg/day|[?]|1|ug/day|RETINAL NERVE FIBER LAYER|UNILATERAL|DEEP|IN SITU HYBRIDIZATION||Y||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|3|TREATMENT|2020-09-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-26
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|5|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SEMI-FOWLERS|||[?]|1|BOLUS|ISCHIUM|RIGHT|BASAL|GC/MS/MS|||Y|INTERVIEWER|ADJUDICATOR 1|3|Visit_3|40|4|TREATMENT|2020-09-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|6|DLCOHC|HGB Corrected DLCO|[?]|SLING|[?]|kg/cm2|[?]|1|km|FLEXOR DIGITORUM PROFUNDUS MUSCLE|CONTRALATERAL|MIDLINE|CISH|Y|Y||INVESTIGATOR|PATHOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-09-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-26
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|7|TV|Tidal Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|RING|TIBIA|IPSILATERAL|ANTEROTEMPORAL|PET/CT SCAN WITHOUT CONTRAST|||Y|INDEPENDENT ASSESSOR|READER 3|4|Visit_4|65|5|TREATMENT|2020-10-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|8|SGAW|Specific Airway Conductance|[?]|RIGHT LATERAL DECUBITUS|[?]|kBq/uL|[?]|1|uCi|PERITONEUM|LEFT|VENTROLATERAL|TRICHROME STAIN||Y||INVESTIGATOR|OPTOMETRIST|4|Visit_4|65|2|TREATMENT|2020-10-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|9|FEF2575P|Percent Predicted FEF25-75|[?]|SEMI-RECUMBENT|[?]|10^3 DNA copies/mL|[?]|1|/min|AXILLARY ARTERY|RIGHT|FRONTAL|NON-CONTACT SPECULAR MICROSCOPY|Y|||ADJUDICATION COMMITTEE|HEMATOLOGIST|5|Visit_5|90|6|TREATMENT|2020-11-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|18c21176-db5e-4650-a1af-beb2042c31d8|10|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|[?]|BE/mL|[?]|1|EU|T7 VERTEBRA|LATERAL|TIP|KLEIHAUER-BETKE||Y||INDEPENDENT ASSESSOR|ADJUDICATOR 2|5|Visit_5|90|2|TREATMENT|2020-11-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-22
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|1|FIFMAXPP|Percent Predicted FIFmax|[?]|DECUBITUS|[?]|mL/m2/day|[?]|1|PACKAGE|RETROPERITONEAL LYMPH NODE|UNILATERAL|SUPERFICIAL|COLORIMETRY||Y||ADJUDICATION COMMITTEE|READER|1|Visit_1|10|5|TREATMENT|2020-06-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|2|ALVVOL|Alveolar Volume|[?]|TRENDELENBURG|[?]|Hz|[?]|1|FEU|OPHTHALMIC ARTERY|IPSILATERAL|DISTAL|ENZYMATIC ULTRACENTRIFUGATION||||SPOUSE|NEUROLOGIST|1|Visit_1|10|3|TREATMENT|2020-06-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-04
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|3|DLCOHC|HGB Corrected DLCO|[?]|SEMI-FOWLERS|[?]|10^3 RNA copies/mL|[?]|1|10^6 IU/mL|ABDUCTOR HALLUCIS MUSCLE|RIGHT|SURFACE|SPIROMETRY||||NON-HEALTH CARE PROFESSIONAL|OPTOMETRIST|2|Visit_2|25|2|FOLLOW-UP|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|4|GAW|Airway Conductance|[?]|REVERSE TRENDELENBURG|[?]|days/wk|[?]|1|%|ILIAC LYMPH NODE|LEFT|UPPER|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||SIGNIFICANT OTHER|READER 1|2|Visit_2|25|2|SCREENING|2020-07-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-13
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|5|TVPP|Percent Predicted Tidal Volume|[?]|STANDING|[?]|RFU|[?]|1|mgEq|STERNOCLAVICULAR JOINT|UNILATERAL|LOWER MEDIAL|ELISPOT|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 1|3|Visit_3|40|7|WASHOUT|2020-07-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|6|LCI|Lung Clearance Index|[?]|FOWLERS|[?]|kHz|[?]|1|Hounsfield Unit|GUT-ASSOCIATED LYMPHOID TISSUE|CONTRALATERAL|VENTRAL|FLAME PHOTOMETRY||||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|3|Visit_3|40|4|TREATMENT|2020-07-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-08
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|7|FEV1|Forced Expiratory Volume in 1 Second|[?]|TRENDELENBURG|[?]|eq|[?]|1|MET*h|MALLEUS|LATERAL|VENTROLATERAL|HANSEL STAIN||Y||ADJUDICATOR|MICROSCOPIST 1|4|Visit_4|65|6|SCREENING|2020-08-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|8|PLMXRS|Pulmonary Reactance|[?]|FOWLERS|[?]|pmol/10^10 cells|[?]|1|nU/cL|PUPIL|BILATERAL|DORSAL|DISK DIFFUSION||||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-14|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-28
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|9|EFFVOL|Effusion Volume|[?]|DECUBITUS|[?]|10^7 CFU|[?]|1|10^3 RNA copies/mL|ANTERIOR CINGULATE GYRUS|IPSILATERAL|SURFACE|ELISPOT||||SIGNIFICANT OTHER|ADJUDICATOR|5|Visit_5|90|5|SCREENING|2020-09-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|7808abd1-7d6f-4090-aa08-916a804c95f5|10|FEV3FVC|FEV3/FVC|[?]|PRONE|[?]|ug/g/day|[?]|1|mL/mmHg|HAND DIGIT 2|BILATERAL|NASAL|ANGIOGRAPHY||||PROXY|DERMATOLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-09-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-27
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|1|FRC|Functional Residual Capacity|[?]|SEMI-FOWLERS|[?]|U/10^12 RBC|[?]|1|Bq/mg|SKIN OF THE HEAD|UNILATERAL|ROSTRAL|ELLA||Y||FAMILY MEMBER|CLINICAL PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|2|FRC|Functional Residual Capacity|[?]|STANDING, BENT FORWARD|[?]|mCi|[?]|1|HEP|OPTIC DISC|LATERAL|FACIAL|BETA LACTAMASE|Y|Y||DOMESTIC PARTNER|OPTOMETRIST|1|Visit_1|10|1|WASHOUT|2021-01-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-07
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|3|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-RECUMBENT|||[?]|1|10^9 organisms/mg|T8 VERTEBRA|LEFT|VENTRAL|ISHIHARA COLOR PLATES|||Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|2|Visit_2|25|1|TREATMENT|2021-01-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|4|FEV1FVC6|FEV1/FVC6|[?]|STANDING|[?]|U/kg|[?]|1|10^5/L|HAND DIGIT 4|UNILATERAL|PERIVENTRICULAR|INFRARED SPECTROMETRY|Y|Y||CHILD|RATER 1|2|Visit_2|25|1|TREATMENT|2021-01-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-16
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|5|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING|[?]|mol/mg|[?]|1|mg/min|PARIETAL LOBE|LATERAL|OUTER|LASER CAPTURE MICRODISSECTION|Y|||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|3|Visit_3|40|4|FOLLOW-UP|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|6|TGV|Thoracic Gas Volume|[?]|SITTING, LEGS DEPENDENT|||[?]|1|uV|PERONEAL ARTERY|IPSILATERAL|POSTERIOR|CISH|||Y|STUDY SUBJECT|OPHTHALMOLOGIST|3|Visit_3|40|4|WASHOUT|2021-01-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-13
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|7|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SEMI-FOWLERS|[?]|yd|[?]|1|GLOBULE|DORSAL MOTOR NUCLEUS|RIGHT|ANTEROPOSTERIOR|MICROPARTICLE ENZYME IMMUNOASSAY||||SPOUSE|READER 2|4|Visit_4|65|2|SCREENING|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|8|FEV3PP|Percent Predicted FEV3|[?]|LEFT LATERAL DECUBITUS|||[?]|1|uV|ANAL VERGE|CONTRALATERAL|ANTEROMEDIAL|ENZYMATIC SPECTROPHOTOMETRY|||Y|SIBLING|PATHOLOGIST|4|Visit_4|65|1|TREATMENT|2021-02-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-17
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|9|PNEUMIND|Pneumonia Indicator|[?]|REVERSE TRENDELENBURG|[?]|Gy/min|[?]|1|/40 HPFs|RECTOSIGMOID JUNCTION|BILATERAL|LOWER MEDIAL|MOUSE PROTECTION ASSAY||||PARENT|ONCOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|57553b78-e761-4577-aae2-5c693a2dc303|10|INFLTIND|Infiltrates Indicator|[?]|DECUBITUS|[?]|DAgU/mL|[?]|1|10^6/hpf|ISCHIUM|UNILATERAL|INNER|ELISA|Y|||ADJUDICATOR|READER 1|5|Visit_5|90|3|FOLLOW-UP|2021-03-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-12
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|1|AWVOLPP|Percent Predicted Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mOsm|[?]|1|MET*min|METACARPOPHALANGEAL JOINT 3|LEFT|ROSTRAL|CONTRAST ENHANCED SPIRAL CT SCAN|Y|Y||CHILD|MICROSCOPIST 1|1|Visit_1|10|2|TREATMENT|2020-10-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|2|SGAW|Specific Airway Conductance|[?]|DECUBITUS|[?]|PIXEL|[?]|1|uOsm|URETHRA, PROSTATIC|BILATERAL|INFERIOR|RAJI CELL RIA||Y||FAMILY MEMBER|HEMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-10-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-25
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|3|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|||[?]|1|DRUM|CAROTID ARTERY|RIGHT|UPPER EXTENSOR SURFACE|LISSAMINE GREEN STAIN|||Y|GUARDIAN|PATHOLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-10-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|4|ELSTNCE|Elastance|[?]|SUPINE|[?]|U/m2/h|[?]|1|ng|CAPITATE-LUNATE JOINT|RIGHT|VOLAR|BRDU CELLULAR PROLIFERATION ASSAY||||PROXY|ADJUDICATOR|2|Visit_2|25|1|TREATMENT|2020-10-28|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-27
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|5|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|FOWLERS|||[?]|1|scm|CAUDAL VERTEBRA|CONTRALATERAL|MIDLINE|SLIT LAMP||Y|Y|CLINICAL STUDY SPONSOR|MICROSCOPIST|3|Visit_3|40|3|SCREENING|2020-11-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|6|INFLTIND|Infiltrates Indicator|[?]|SUPINE|||[?]|1|mg/m2|PROXIMAL URETHRA|RIGHT|PROXIMAL VOLAR|NEURAMINIDASE INHIBITION ASSAY|||Y|PROXY|MICROSCOPIST|3|Visit_3|40|5|SCREENING|2020-11-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-06
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|7|FRC|Functional Residual Capacity|[?]|FOWLERS|[?]|mmol/min/kPa/L|[?]|1|L/min|GENITAL TUBERCLE|BILATERAL|BASAL|STRESS ECHOCARDIOGRAPHY|Y|Y||ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-12-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|8|RRS|Total Respiratory System Resistance|[?]|STANDING|[?]|%(v/v)|[?]|1|mg/mL/min|SHOULDER|UNILATERAL|DORSAL|IODINE STAIN|Y|||NON-HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|2|SCREENING|2020-12-07|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|9|DLCOHCVA|HGB Corrected DLCO/VA|[?]|FOWLERS|[?]|10^6 organisms|[?]|1|mg/kg/dose|TRAPEZIUM-TRAPEZOID JOINT|LEFT|VOLAR|FLOW CYTOMETRY||Y||CHILD|MICROSCOPIST 2|5|Visit_5|90|5|SCREENING|2021-01-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|40883550-4627-4f92-974a-7eeb5bde74c5|10|PLMXRS|Pulmonary Reactance|[?]|DECUBITUS|[?]|uCi|[?]|1|Ejaculate U|LEFT MAIN CORONARY ARTERY BIFURCATION|IPSILATERAL|BASAL|MOUSE PROTECTION ASSAY|Y|Y||CLINICAL RESEARCH COORDINATOR|MICROSCOPIST|5|Visit_5|90|1|SCREENING|2021-01-01|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|4199b549-d021-4bfd-97e6-95630d407183|1|GAW|Airway Conductance|[?]|SEMI-FOWLERS|||[?]|1|ug/mL/h|GONAD|UNILATERAL|POSTERIOR|TOLUIDINE BLUE STAIN|Y||Y|CLINICAL STUDY SPONSOR|MICROSCOPIST 3|1|Visit_1|10|1|TREATMENT|2020-12-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|4199b549-d021-4bfd-97e6-95630d407183|2|FEV1FVC|FEV1/FVC|[?]|SEMI-RECUMBENT|[?]|ng/mol|[?]|1|mL/m2|INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|CENTRAL|QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION|Y|||INVESTIGATOR|READER 2|1|Visit_1|10|4|FOLLOW-UP|2020-12-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-03
e|RE|4199b549-d021-4bfd-97e6-95630d407183|3|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|log10 CCID 50/dose|[?]|1|cmH2O*s2/mL|PERITONEAL CAVITY|CONTRALATERAL|BASAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||PARENT|MICROSCOPIST|2|Visit_2|25|5|WASHOUT|2020-12-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|4199b549-d021-4bfd-97e6-95630d407183|4|IVC|Inspiratory Vital Capacity|[?]|PRONE|[?]|kHz|[?]|1|rpm|FOOT PHALANX|IPSILATERAL|SURFACE|DYNAMIC LIGHT SCATTERING||||ADJUDICATION COMMITTEE|ADJUDICATOR 3|2|Visit_2|25|1|TREATMENT|2020-12-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-22
e|RE|4199b549-d021-4bfd-97e6-95630d407183|5|EFFIND|Effusion Indicator|[?]|LEFT LATERAL DECUBITUS|[?]|/10^3|[?]|1|g/animal/wk|L3 VERTEBRA|RIGHT|ANTEROTEMPORAL|DIFFUSION WEIGHTED MRI|Y|||INDEPENDENT ASSESSOR|RATER|3|Visit_3|40|6|TREATMENT|2021-01-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|4199b549-d021-4bfd-97e6-95630d407183|6|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|FOWLERS|[?]|mg/min|[?]|1|eq|DORSAL MOTOR NUCLEUS|UNILATERAL|SUBCORTICAL|REVERSE TRANSCRIPTASE PCR||||FAMILY MEMBER|ADJUDICATOR 1|3|Visit_3|40|5|TREATMENT|2021-01-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-02
e|RE|4199b549-d021-4bfd-97e6-95630d407183|7|TGV|Thoracic Gas Volume|[?]|SUPINE|[?]|pmol|[?]|1|GBq|ANTERIOR HORN OF THE LATERAL VENTRICLE|CONTRALATERAL|INFERIOR|MACRO BROTH DILUTION||||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|4|Visit_4|65|6|TREATMENT|2021-01-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|4199b549-d021-4bfd-97e6-95630d407183|8|FEF2575|Forced Expiratory Flow 25-75%|[?]|SEMI-RECUMBENT|[?]|BAR|[?]|1|Newton|RIB 10|CONTRALATERAL|ANTEROTEMPORAL|MOUSE PROTECTION ASSAY||||INDEPENDENT ASSESSOR|NEUROLOGIST|4|Visit_4|65|2|FOLLOW-UP|2021-01-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-26
e|RE|4199b549-d021-4bfd-97e6-95630d407183|9|MIP|Maximal Inspiratory Pressure|[?]|PRONE|[?]|breaths/min|[?]|1|mCi|BRAIN VENTRICLE, LATERAL|RIGHT|TIP|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|Y|||VENDOR|READER 1|5|Visit_5|90|6|FOLLOW-UP|2021-02-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|4199b549-d021-4bfd-97e6-95630d407183|10|AIRTRAP|Air Trapping|[?]|UNCONSTRAINED|[?]|Shock Wave|[?]|1|cmol/L|METACARPAL BONE 2|IPSILATERAL|BASAL|MAPH||Y||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 1|5|Visit_5|90|5|SCREENING|2021-02-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-17
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|1|EVC|Expiratory Vital Capacity|[?]|DECUBITUS|[?]|kV|[?]|1|nU/cL|METATARSOPHALANGEAL JOINT 4|CONTRALATERAL|NASAL|ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE||Y||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-07-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|2|PEFTIME|Peak Expiratory Flow Time|[?]|SEMI-RECUMBENT|[?]|ukat/10^12 RBC|[?]|1|TRACE|TROCHANTER|UNILATERAL|PERIVENTRICULAR|NUCLEIC ACID AMPLIFICATION TEST||||INDEPENDENT ASSESSOR|RADIOLOGIST 2|1|Visit_1|10|2|TREATMENT|2020-07-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-21
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|3|DLCOVA|DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|[?]|FIU|[?]|1|genEq|EXTRAHEPATIC BILE DUCT|IPSILATERAL|CRANIAL|AUTOREFRACTION||||CHILD|HEMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-07-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|4|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|SEMI-FOWLERS|||[?]|1|mg/L FEU|FOOT DIGIT 5|UNILATERAL|ANTEROTEMPORAL|ENZYMATIC COLORIMETRY|||Y|FAMILY MEMBER|UROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-07-29|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-29
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|5|PLMXRS|Pulmonary Reactance|[?]|SUPINE|[?]|L|[?]|1|10^6 organisms/g|MOTOR CORTEX|RIGHT|VENTRAL|FLUORESCEIN STAIN|Y|||SIBLING|ADJUDICATOR 1|3|Visit_3|40|5|TREATMENT|2020-08-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|6|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING|[?]|mL/kg|[?]|1|L|SKIN OF THE FOREARM|BILATERAL|DORSAL|ETDRS EYE CHART||Y||ADJUDICATION COMMITTEE|RATER|3|Visit_3|40|3|TREATMENT|2020-08-13|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-29
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|7|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|[?]|tuberculin unit/mL|[?]|1|/month|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|LEFT|PROXIMAL|VIRUS PLAQUE ASSAY||||ADJUDICATOR|READER 1|4|Visit_4|65|7|TREATMENT|2020-09-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|8|IC|Inspiratory Capacity|[?]|SEMI-FOWLERS|[?]|DIOPTER|[?]|1|ms/mmHg|INTERNAL ILIAC LYMPH NODE|LEFT|ANTEROPOSTERIOR|MECHANICAL CLOT DETECTION||||GUARDIAN|PATHOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-09-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|9|MIP|Maximal Inspiratory Pressure|[?]|STANDING|||[?]|1|g/mol|ULNA|LEFT|ANTEROPOSTERIOR|REFLECTANCE SPECTROSCOPY|||Y|ADJUDICATOR|ENDOCRINOLOGIST|5|Visit_5|90|7|TREATMENT|2020-10-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|6366647f-62fa-48dc-9d77-1677fce62fc7|10|FVCPP|Percent Predicted Forced Vital Capacity|[?]|PRONE|[?]|kN/cm2|[?]|1|mg/dL|TRAPEZOID BONE|LATERAL|PERIPHERAL|PALM METHOD||Y||SPOUSE|RATER|5|Visit_5|90|4|TREATMENT|2020-10-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-08
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|SAWVOL|Specific Airway Volume|[?]|TRENDELENBURG|[?]|K|[?]|1|GBq|ALVEOLUS|LATERAL|LOWER FLEXOR SURFACE|EIA||Y||INVESTIGATOR|CLINICAL PATHOLOGIST|1|Visit_1|10|5|SCREENING|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|2|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|STANDING, BENT FORWARD|[?]|mg/cm2|[?]|1|sec|METATARSOPHALANGEAL JOINT 5|IPSILATERAL|APICAL|IMMUNO-PET SCAN||||CHILD|RADIOLOGIST 2|1|Visit_1|10|6|SCREENING|2020-05-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|pg/L|AORTOCAVAL LYMPH NODE|LEFT|FACIAL|ELISA|Y||Y|INVESTIGATOR|OTOLARYNGOLOGIST|2|Visit_2|25|4|TREATMENT|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|REVERSE TRENDELENBURG|[?]|nkat/L|[?]|1|nL|FACIAL NERVE|RIGHT|VOLAR|ALCIAN BLUE STAIN|Y|Y||SPOUSE|MICROSCOPIST|2|Visit_2|25|4|TREATMENT|2020-05-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-30
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|5|INFLTIND|Infiltrates Indicator|[?]|STANDING, BENT FORWARD|[?]|cP|[?]|1|U/m2/h|URETHRAL SPHINCTER|LEFT|CRANIAL|OPTICAL COHERENCE TOMOGRAPHY||Y||DOMESTIC PARTNER|OPTOMETRIST|3|Visit_3|40|1|TREATMENT|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|6|MIP|Maximal Inspiratory Pressure|[?]|STANDING, BENT FORWARD|[?]|IU/day|[?]|1|log10 TCID 50/uL|PROFUNDA FEMORIS VEIN|UNILATERAL|UPPER EXTENSOR SURFACE|MULTI-SLICE SPIRAL CT|Y|||SPOUSE|INTERNIST|3|Visit_3|40|2|FOLLOW-UP|2020-06-12|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-10
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|7|SAWVOL|Specific Airway Volume|[?]|REVERSE TRENDELENBURG|||[?]|1|PACKAGE|LUNG, LEFT, SUPERIOR LOBE, APICOPOSTERIOR SEGMENT|IPSILATERAL|LOWER EXTENSOR SURFACE|RADIOGRAPHY|||Y|PROXY|PATHOLOGIST|4|Visit_4|65|5|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|8|FEV1REV|FEV1 Reversibility|[?]|SUPINE|[?]|U/animal|[?]|1|vg/dose|POSTERIOR TIBIAL VEIN|LEFT|UPPER FLEXOR SURFACE|CHROMOGENIC ASSAY||||CLINICAL RESEARCH ASSOCIATE|CLINICAL PATHOLOGIST|4|Visit_4|65|2|TREATMENT|2020-07-07|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-17
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|9|PEF|Peak Expiratory Flow|[?]|DECUBITUS|[?]|mg/cm2|[?]|1|uCi/kg|RADIUS|UNILATERAL|NASAL|PHOTOGRAPHY||||CLINICAL STUDY SPONSOR|ONCOLOGIST 2|5|Visit_5|90|5|TREATMENT|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|RE|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|10|FEV1|Forced Expiratory Volume in 1 Second|[?]|DECUBITUS|||[?]|1|OD Unit|SUDORIFEROUS GLAND|IPSILATERAL|DEEP|INFRARED SPECTROMETRY|||Y|HEALTH CARE PROFESSIONAL|DERMATOLOGIST|5|Visit_5|90|4|WASHOUT|2020-08-01|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-09
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|RELSZCHG|Relative Size Change|[?]|RIGHT LATERAL DECUBITUS|[?]|ks|[?]|1|mL/min/1.73m2|CARPOMETACARPAL JOINT 5|UNILATERAL|PARIETO-OCCIPITAL|TOLUIDINE BLUE STAIN||||VENDOR|READER 3|1|Visit_1|10|6|WASHOUT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|2|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SLING|[?]|mg|[?]|1|10^12 IU/L|MANDIBLE|LATERAL|FRONTAL|PERIPHERAL ANGIOGRAPHY||||INTERVIEWER|ADJUDICATOR 3|1|Visit_1|10|3|TREATMENT|2020-06-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|3|FEV3FVC|FEV3/FVC|[?]|DECUBITUS|[?]|mN|[?]|1|TROCHE|UMBILICAL CORD|CONTRALATERAL|MEDIAL|PHASE CONTRAST MICROSCOPY||Y||PARENT|PEDIATRIC NEUROLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|4|RV|Residual Volume|[?]|FOWLERS|[?]|%/s|[?]|1|g/animal/day|PARANASAL SINUS|RIGHT|MIDLINE|FLUORESCEIN STAIN||||FRIEND|PEDIATRIC NEUROLOGIST|2|Visit_2|25|1|SCREENING|2020-06-18|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-05
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|5|DLCOHCPP|Percent Predicted HGB Corrected DLCO|[?]|FOWLERS|[?]|BU/mL|[?]|1|LENS|PARALARYNGEAL LYMPH NODE|CONTRALATERAL|SURFACE|FLUORESCEIN STAIN|Y|||GUARDIAN|OPHTHALMOLOGIST|3|Visit_3|40|6|SCREENING|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|6|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|FOWLERS|[?]|pmol/day|[?]|1|fraction of 1|LESSER TROCHANTER|BILATERAL|CAUDAL|ROMANOWSKY STAIN||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|3|Visit_3|40|2|WASHOUT|2020-07-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-29
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|7|MIP|Maximal Inspiratory Pressure|[?]|SITTING, LEGS DEPENDENT|[?]|10^7 CFU/mL|[?]|1|ppm|OPPONENS POLLICIS MUSCLE|CONTRALATERAL|MIDLINE|PERCUSSION||||SPOUSE|RADIOLOGIST 2|4|Visit_4|65|3|TREATMENT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|8|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|DECUBITUS|[?]|100 IU/mL|[?]|1|beats/min|SKULL|LEFT|INFERIOR|LANDOLT RING||||SPOUSE|PATHOLOGIST 2|4|Visit_4|65|1|TREATMENT|2020-07-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-03
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|9|LOBVOL|Lobar Volume|[?]|LEFT LATERAL DECUBITUS|[?]|LB|[?]|1|IU/dL|WALDEYER'S TONSILLAR RING|CONTRALATERAL|VENTROLATERAL|HIGH LEVEL AMINOGLYCOSIDE SCREEN||||CLINICAL RESEARCH ASSOCIATE|PHYSIOTHERAPIST|5|Visit_5|90|3|TREATMENT|2020-08-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|637d7d5f-78d3-47fb-b6dc-d877d92b9001|10|AWVOLPP|Percent Predicted Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|CAPLET|[?]|1|g/g/day|ABDUCENS NERVE|LATERAL|NASAL|JAEGER EYE CHART||||PARENT|READER|5|Visit_5|90|7|FOLLOW-UP|2020-08-22|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-10
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|1|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|GLOBULE|[?]|1|ELISA unit/dose|INTERPHALANGEAL JOINT OF THE HAND|BILATERAL|ROSTRAL|ORCHIDOMETERY|Y|||VENDOR|CARDIOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-08-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|2|ERV|Expiratory Reserve Volume|[?]|TRENDELENBURG|[?]|log10 copies/mL|[?]|1|mN|AXILLARY LYMPH NODE|BILATERAL|ROSTRAL|PET SCAN||||FRIEND|MICROSCOPIST 3|1|Visit_1|10|6|TREATMENT|2020-08-31|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-03
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|3|INFLTIND|Infiltrates Indicator|[?]|STANDING|[?]|nmol/mol|[?]|1|FIU|PARATHYROID GLAND|LATERAL|DISTAL VOLAR|KNEMOMETRY||||CAREGIVER|UROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|4|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|DROP|[?]|1|Gy|LUNATE BONE|LATERAL|SUPERIOR|PHYSICAL EXAMINATION|Y|||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|TREATMENT|2020-09-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-18
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|5|FIO2|Fraction of Inspired Oxygen|[?]|STANDING|||[?]|1|EID 50/mL|ANTERIOR TIBIAL VEIN|RIGHT|ANTEROTEMPORAL|ENZYMATIC COLORIMETRY|Y||Y|SPOUSE|PATHOLOGIST 2|3|Visit_3|40|1|FOLLOW-UP|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|6|FIF75|Forced Inspiratory Flow at 75%|[?]|LEFT LATERAL DECUBITUS|||[?]|1|anti-Xa IU|THORACIC CAVITY|LEFT|DORSAL|HPLC|||Y|ADJUDICATION COMMITTEE|RATER|3|Visit_3|40|6|FOLLOW-UP|2020-09-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-21
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|7|PIF|Peak Inspiratory Flow|[?]|UNCONSTRAINED|[?]|uEq|[?]|1|pmol/dL|ANTERIOR INFERIOR CEREBELLAR ARTERY|BILATERAL|VENTRAL|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY||||ADJUDICATOR|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|8|AWVOL|Airway Volume|[?]|STANDING, BENT FORWARD|[?]|10^6/hpf|[?]|1|cm/min|THYROID GLAND|LEFT|FACIAL|WHOLE TRANSCRIPTOME SEQUENCING||||CHILD|NEUROLOGIST 2|4|Visit_4|65|6|SCREENING|2020-10-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-02
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|9|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SITTING, LEGS DEPENDENT|[?]|kBq|[?]|1|pmol/dL|DISTAL FEMUR R1|CONTRALATERAL|PERIPHERAL|IMMUNOASSAY||||PROXY|FORENSIC PATHOLOGIST|5|Visit_5|90|2|FOLLOW-UP|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|696cd04a-cde7-4481-b5e2-fad1877ec284|10|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|REVERSE TRENDELENBURG|[?]|mL/kg/day|[?]|1|U/g/h|UPPER RESPIRATORY SYSTEM|LEFT|CAUDAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||||SIGNIFICANT OTHER|MICROSCOPIST 2|5|Visit_5|90|5|TREATMENT|2020-11-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-26
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|1|DLCO|Diffusion Capacity of Lung for CO|[?]|STANDING|[?]|mMU/mL|[?]|1|MnFI|INTERATRIAL SEPTUM|RIGHT|PROXIMAL|ZIEHL NEELSEN ACID FAST STAIN||||CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST|1|Visit_1|10|4|TREATMENT|2020-12-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|2|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING, LEGS DEPENDENT|[?]|log10 PFU|[?]|1|10^9 organisms/g|PECTORALIS MINOR MUSCLE|IPSILATERAL|VOLAR|KINYOUN STAIN||||DOMESTIC PARTNER|RATER|1|Visit_1|10|7|WASHOUT|2020-12-02|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|3|TVPP|Percent Predicted Tidal Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/dose|[?]|1|10^7 PFU|FOOT PHALANX|UNILATERAL|UPPER FLEXOR SURFACE|CONTRAST ENHANCED PET SCAN|Y|||CLINICAL RESEARCH ASSOCIATE|RATER 2|2|Visit_2|25|1|SCREENING|2020-12-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|4|QUASCOMP|Quasi-Static Compliance|[?]|SEMI-FOWLERS|[?]|MESF|[?]|1|tuberculin unit|PRESACRAL LYMPH NODE|BILATERAL|TIP|GRADIENT DIFFUSION||Y||FRIEND|PEDIATRIC NEUROLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-12-17|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|5|IC|Inspiratory Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|DISK|[?]|1|amol|RETROAURICULAR LYMPH NODE|UNILATERAL|FRONTAL|HIGH RESOLUTION CT|Y|||CLINICAL RESEARCH ASSOCIATE|NEUROLOGIST 2|3|Visit_3|40|4|TREATMENT|2021-01-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|6|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|[?]|TROCHE|[?]|1|10^9/g|SOFT PALATE|UNILATERAL|APICAL|ACCELERATOR MASS SPECTROMETRY||Y||ADJUDICATOR|OTOLARYNGOLOGIST|3|Visit_3|40|5|SCREENING|2021-01-01|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-23
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|7|FEV1FVC|FEV1/FVC|[?]|TRENDELENBURG|[?]|kcal/day|[?]|1|cpm|TRACHEA|LATERAL|VENTRAL|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY||||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|4|Visit_4|65|5|SCREENING|2021-01-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|8|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|10^6 organisms|[?]|1|10^12 IU/L|PERITONEAL CAVITY|LEFT|CAUDAL|GC/MS||||ADJUDICATOR|DERMATOLOGIST|4|Visit_4|65|2|SCREENING|2021-01-26|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-10
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|9|PIF|Peak Inspiratory Flow|[?]|SEMI-FOWLERS|[?]|10^3/hpf|[?]|1|AFU|SUPRARENAL AORTA|LEFT|ANTERIOR|CELLULOSE TAPE||||HEALTH CARE PROFESSIONAL|MICROSCOPIST|5|Visit_5|90|5|TREATMENT|2021-02-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|ce4699cb-66f1-4c13-8428-84064255b765|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|STANDING|||[?]|1|ug/kg/min|TRIANGULAR BONE|CONTRALATERAL|INTERMEDIATE|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y||Y|NON-HEALTH CARE PROFESSIONAL|READER|5|Visit_5|90|3|TREATMENT|2021-02-20|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|RAW|Airway Resistance|[?]|LATERAL DECUBITUS|[?]|uIU/L|[?]|1|PFU/animal|MYOMETRIUM|IPSILATERAL|INTERMEDIATE|PELLI-ROBSON EYE CHART|Y|||ADJUDICATION COMMITTEE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|4|TREATMENT|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|2|ERVPP|Percent Predicted ERV|[?]|STANDING|[?]|U/g/day|[?]|1|APL U/mL|BLADDER, NECK|BILATERAL|ROSTRAL|SMEAR||||CAREGIVER|CARDIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-11-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-11
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|3|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING|[?]|cm/min|[?]|1|10^3 CFU/g|LUNG, RIGHT, SUPERIOR LOBE, ANTERIOR SEGMENT|IPSILATERAL|SUPERIOR|CORONARY ANGIOGRAPHY||Y||CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|2|Visit_2|25|2|TREATMENT|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|4|RER|Respiratory Exchange Ratio|[?]|FOWLERS|[?]|cmol|[?]|1|JAR|CELIAC ARTERY|LEFT|TEMPORAL|KARYOTYPING||||NON-HEALTH CARE PROFESSIONAL|RATER|2|Visit_2|25|4|FOLLOW-UP|2020-12-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-11
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|5|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|LATERAL DECUBITUS|||[?]|1|uEq/L|RENAL PELVIS|LATERAL|ANTEROLATERAL|SXA SCAN|||Y|SIBLING|READER 2|3|Visit_3|40|3|WASHOUT|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|6|MEPPP|Percent Predicted MEP|[?]|SITTING|[?]|uOsm|[?]|1|mg/kg/day|CARPOMETACARPAL JOINT 1|LATERAL|MEDIAL|PET/MRI SCAN||||PARENT|RADIOLOGIST|3|Visit_3|40|2|FOLLOW-UP|2020-12-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-04
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|7|TLC|Total Lung Capacity|[?]|DECUBITUS|[?]|L/h|[?]|1|10^11/L|EYE|LATERAL|FRONTAL|BIOIMPEDANCE SPECTROSCOPY||||FAMILY MEMBER|ONCOLOGIST 1|4|Visit_4|65|3|TREATMENT|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|8|PLMXRS|Pulmonary Reactance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|PIPE|BRAIN|BILATERAL|DISTAL VOLAR|PET/SPECT SCAN|||Y|CLINICAL RESEARCH COORDINATOR|READER 3|4|Visit_4|65|6|WASHOUT|2021-01-23|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-15
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|9|FEV1FVC6|FEV1/FVC6|[?]|REVERSE TRENDELENBURG|||[?]|1|mmol/day|5TH LUMBAR SPINOUS PROCESS|BILATERAL|TIP|MULTI-SLICE SPIRAL CT|||Y|CAREGIVER|RADIOLOGIST 2|5|Visit_5|90|6|TREATMENT|2021-02-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|015b391b-23c7-478d-b9d1-226d3cb9edcf|10|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SEMI-FOWLERS|[?]|gpELISA unit/mL|[?]|1|1/(s*kPa)|SCAPHOID-TRAPEZOID JOINT|LEFT|SUPERFICIAL|BIOPSY||||INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|FOLLOW-UP|2021-02-17|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-27
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|AIRTRAP|Air Trapping|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|uIU/dL|XIPHOID PROCESS|LATERAL|UPPER EXTENSOR SURFACE|SLIT LAMP|||Y|CLINICAL STUDY SPONSOR|PATHOLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|2|ICREV|IC Reversibility|[?]|STANDING, BENT FORWARD|[?]|kat|[?]|1|mL/m2/min|TIBIA|UNILATERAL|ANTEROPOSTERIOR|PHASE CONTRAST MICROSCOPY||Y||CAREGIVER|INTERNIST|1|Visit_1|10|4|TREATMENT|2020-06-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SLING|||[?]|1|mL/min|SKIN OF THE LIP|BILATERAL|ANTERIOR|FARNSWORTH-MUNSELL 100 HUE TEST|||Y|HEALTH CARE PROFESSIONAL|PATHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|4|VO2|Oxygen Consumption|[?]|PRONE|[?]|/MBP|[?]|1|g/kg/day|THORACIC CAVITY|BILATERAL|FRONTAL|ANALYTICAL ULTRACENTRIFUGATION||||FRIEND|PATHOLOGIST 2|2|Visit_2|25|3|FOLLOW-UP|2020-06-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-20
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|5|TV|Tidal Volume|[?]|SUPINE|[?]|um/day|[?]|1|kg/L|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|RIGHT|UPPER EXTENSOR SURFACE|HPLC-FL||||CAREGIVER|ADJUDICATOR 1|3|Visit_3|40|5|TREATMENT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|6|FEV1FVCP|Percent Predicted FEV1/FVC|[?]|LATERAL DECUBITUS|||[?]|1|10^9/dose|STERNEBRA|LEFT|LOWER MEDIAL|POPULATION SEQUENCING||Y|Y|FRIEND|FORENSIC PATHOLOGIST|3|Visit_3|40|5|WASHOUT|2020-07-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|7|RV|Residual Volume|[?]|LATERAL DECUBITUS|[?]|/HPF|[?]|1|mg/kg|LIVER, QUADRATE LOBE|LATERAL|ANTEROTEMPORAL|SNELLEN EYE CHART|Y|||SIBLING|RATER|4|Visit_4|65|3|TREATMENT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|8|RELSZCHG|Relative Size Change|[?]|UNCONSTRAINED|[?]|CAPLET|[?]|1|CUP|HINDLIMB|CONTRALATERAL|PARIETO-OCCIPITAL|ANGIOGRAPHY|Y|||INDEPENDENT ASSESSOR|ONCOLOGIST 1|4|Visit_4|65|4|TREATMENT|2020-08-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-03
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|9|PEFREV|PEF Reversibility|[?]|REVERSE TRENDELENBURG|[?]|mg/g/min|[?]|1|mL/m2|AORTIC VALVE ANNULUS|LEFT|SUBCORTICAL|COLORIMETRY||Y||PROXY|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|5|TREATMENT|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|b510a277-c5ee-4a32-b111-b2dbc72c8a27|10|FIV1|Forced Inspiratory Volume in 1 Second|[?]|TRENDELENBURG|||[?]|1|GPS U|PENIS|CONTRALATERAL|PERIVENTRICULAR|MULTIPLEXED DIGITAL GENE EXPRESSION ANALYSIS|||Y|CLINICAL RESEARCH COORDINATOR|MICROSCOPIST 1|5|Visit_5|90|2|TREATMENT|2020-08-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-04
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|vp/dose|[?]|1|BOTTLE|HEART, RIGHT VENTRICULAR WALL|BILATERAL|INNER|CONTRAST ENHANCED SPIRAL CT SCAN||||GUARDIAN|ENDOCRINOLOGIST|1|Visit_1|10|6|TREATMENT|2020-08-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|2|FEV6PP|Percent Predicted FEV6|[?]|TRENDELENBURG|||[?]|1|IU/g Hb|CHEST WALL|RIGHT|DORSAL|CYSTOSCOPY|Y|Y|Y|GUARDIAN|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|1|TREATMENT|2020-08-20|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-18
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|3|PCF|Peak Cough Flow|[?]|SEMI-RECUMBENT|||[?]|1|mg/kg/day|ABDUCTOR POLLICIS BREVIS MUSCLE|BILATERAL|VOLAR|KINETIC MICROPARTICLE IMMUNOASSAY|||Y|SPOUSE|OPTOMETRIST|2|Visit_2|25|4|TREATMENT|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|4|DLCOVA|DLCO/VA|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|log EID 50/dose|INTERVENTRICULAR SEPTUM|IPSILATERAL|PARIETO-OCCIPITAL|PET/CT SCAN||Y|Y|FAMILY MEMBER|READER 3|2|Visit_2|25|6|TREATMENT|2020-09-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-12
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|5|RV|Residual Volume|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|nCi|HIP|UNILATERAL|VOLAR|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI|Y|Y|Y|INTERVIEWER|READER 1|3|Visit_3|40|5|TREATMENT|2020-09-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|6|EXPRELTM|Expiration Relaxation Time|[?]|SLING|||[?]|1|CCID 50/mL|SACROILIAC JOINT|LEFT|ANTEROLATERAL|GC/MS-CI|Y|Y|Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-09-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-05
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|7|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING, LEGS DEPENDENT|||[?]|1|nU/cL|LOWER GASTROINTESTINAL TRACT LYMPH NODE|CONTRALATERAL|UPPER FLEXOR SURFACE|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y||Y|ADJUDICATION COMMITTEE|RATER 1|4|Visit_4|65|2|WASHOUT|2020-10-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|8|FEV1FVC6|FEV1/FVC6|[?]|SEMI-FOWLERS|[?]|mOsm/kg|[?]|1|Mile|L2-L3 INTERVERTEBRAL SPACE|IPSILATERAL|OCCIPITAL|ULTRASONOGRAPHIC ELASTOGRAPHY||||GUARDIAN|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|1|TREATMENT|2020-10-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-20
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|9|TSUHYS|Tissue Hysteresivity|[?]|DECUBITUS|[?]|bel|[?]|1|log10 CFU/g|OBTURATOR EXTERNUS MUSCLE|LEFT|DISTAL|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||FRIEND|RATER 2|5|Visit_5|90|5|FOLLOW-UP|2020-11-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|9e9acf6b-d29a-4c11-96d6-b580c721f462|10|VO2|Oxygen Consumption|[?]|PRONE|[?]|MdFI|[?]|1|mg/day|LACRIMAL GLAND|IPSILATERAL|ANTEROLATERAL|KNEMOMETRY|Y|Y||PARENT|ADJUDICATOR 2|5|Visit_5|90|7|FOLLOW-UP|2020-11-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-17
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|FEF2575|Forced Expiratory Flow 25-75%|[?]|SUPINE|||[?]|1|s^-1(%O2)^-1|INTERPHALANGEAL JOINT 5|CONTRALATERAL|DEEP|PHOTOMETRY||Y|Y|FAMILY MEMBER|NEUROLOGIST|1|Visit_1|10|1|WASHOUT|2020-07-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|2|ICREV|IC Reversibility|[?]|TRENDELENBURG|||[?]|1|nmol BCE/L|PREPUTIAL GLAND|UNILATERAL|SURFACE|TELLER ACUITY CARDS|||Y|CLINICAL RESEARCH ASSOCIATE|OPHTHALMOLOGIST|1|Visit_1|10|1|TREATMENT|2020-07-18|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-16
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|3|QUASCOMP|Quasi-Static Compliance|[?]|SITTING, LEGS DEPENDENT|||[?]|1|Newton|LIMB|CONTRALATERAL|FACIAL|HEMOCYTOMETRY||Y|Y|STUDY SUBJECT|MICROSCOPIST 2|2|Visit_2|25|4|SCREENING|2020-08-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|4|FRCPP|Percent Predicted FRC|[?]|SUPINE|[?]|MnFI|[?]|1|PIXELS/in|CARDIOVASCULAR SYSTEM|CONTRALATERAL|ANTEROMEDIAL|NUCLEAR RADIOLOGY||||CAREGIVER|OPTOMETRIST|2|Visit_2|25|3|SCREENING|2020-08-02|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-01
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|5|AIRTRAP|Air Trapping|[?]|SEMI-RECUMBENT|[?]|mg/g/min|[?]|1|GPL U/mL|SUPERIOR PUBIC RAMUS|BILATERAL|SUPERFICIAL|INTERRUPTER TECHNIQUE||||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-08-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|6|DLCO|Diffusion Capacity of Lung for CO|[?]|SEMI-RECUMBENT|[?]|mEq/L|[?]|1|10^4 CFU|HAIR|RIGHT|APICAL|TOTAL BODY RADIOGRAPHY||||DOMESTIC PARTNER|ADJUDICATOR 1|3|Visit_3|40|2|TREATMENT|2020-08-17|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-14
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|7|PCF|Peak Cough Flow|[?]|DECUBITUS|[?]|mL/min|[?]|1|PATCH|ILIUM|IPSILATERAL|DISTAL|SPIRAL CT||||ADJUDICATOR|READER 3|4|Visit_4|65|7|TREATMENT|2020-09-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|8|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|U/mL|[?]|1|pt_us|LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT|UNILATERAL|BASAL|CONTRAST ENHANCED TRANSESOPHAGEAL ECHOCARDIOGRAPHY||Y||GUARDIAN|UROLOGIST|4|Visit_4|65|7|FOLLOW-UP|2020-09-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-14
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|9|FIO2|Fraction of Inspired Oxygen|[?]|REVERSE TRENDELENBURG|||[?]|1|IU/L|URETHRA, POSTERIOR|CONTRALATERAL|DISTAL|POLYGRAPHY|Y||Y|STUDY SUBJECT|NEUROLOGIST 1|5|Visit_5|90|4|WASHOUT|2020-10-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|da69b157-7dab-49c5-b8fb-bd312a21fcf0|10|FEV1SVC|FEV1/SVC|[?]|RIGHT LATERAL DECUBITUS|[?]|10^8/L|[?]|1|cm|ILIAC VEIN|IPSILATERAL|LOWER MEDIAL|WRIGHT STAIN||||PROXY|OPTOMETRIST|5|Visit_5|90|6|TREATMENT|2020-10-06|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-23
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|FEV1SVC|FEV1/SVC|[?]|SITTING, LEGS DEPENDENT|[?]|pt_br|[?]|1|deg2|LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT|LATERAL|HIND|HEMAGGLUTINATION INHIBITION ASSAY||Y||PARENT|CARDIOLOGIST|1|Visit_1|10|4|SCREENING|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|2|DLCOHC|HGB Corrected DLCO|[?]|REVERSE TRENDELENBURG|[?]|yd|[?]|1|dyn|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND|BILATERAL|SURFACE|TRICHROME STAIN|Y|||INDEPENDENT ASSESSOR|MICROSCOPIST 2|1|Visit_1|10|5|FOLLOW-UP|2020-05-29|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|FOWLERS|||[?]|1|/5x10^4 WBC|ANKLE JOINT ANTERIOR EXTENSOR TENDONS|CONTRALATERAL|CAUDAL|OPTICAL MAPPING|||Y|HEALTH CARE PROFESSIONAL|ONCOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|4|ALVVOL|Alveolar Volume|[?]|SEMI-FOWLERS|||[?]|1|copies/ug|LUMBAR REGION|BILATERAL|BASAL|MULTIPLEX REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y||Y|INVESTIGATOR|READER 1|2|Visit_2|25|3|TREATMENT|2020-06-13|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-22
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|5|FIVC|Forced Inspiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|IU/mmol|[?]|1|mm/min|RADIUS|CONTRALATERAL|MEDIAL|PHASE CONTRAST MICROSCOPY||||VENDOR|CLINICAL PATHOLOGIST|3|Visit_3|40|6|TREATMENT|2020-06-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|6|DLCO|Diffusion Capacity of Lung for CO|[?]|SITTING|[?]|ng/day|[?]|1|m|PROCERUS MUSCLE|IPSILATERAL|BASAL|MALDI-TOF||Y||STUDY SUBJECT|RATER|3|Visit_3|40|5|WASHOUT|2020-06-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|7|RER|Respiratory Exchange Ratio|[?]|FOWLERS|||[?]|1|L/s/kPa|PROXIMAL INTERPHALANGEAL JOINT 3|BILATERAL|TIP|FLUORESCENT LIFETIME IMAGING MICROSCOPY||Y|Y|PARENT|PATHOLOGIST 2|4|Visit_4|65|2|TREATMENT|2020-07-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|8|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|||[?]|1|/500 WBC|RIGHT CORONARY ARTERY OSTIUM|CONTRALATERAL|APICAL|FARNSWORTH-MUNSELL 100 HUE TEST|Y|Y|Y|CLINICAL RESEARCH COORDINATOR|READER 1|4|Visit_4|65|1|TREATMENT|2020-07-23|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-18
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|9|FEV1REV|FEV1 Reversibility|[?]|PRONE|[?]|kat|[?]|1|L/min/m2|ELBOW EXTENSOR MUSCLES|IPSILATERAL|CAUDAL|LYMPHANGIOGRAPHY||||SIBLING|NEUROLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-08-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|10|AWVOL|Airway Volume|[?]|SEMI-RECUMBENT|||[?]|1|mg/g/h|URETER|LEFT|MIDLINE|SNP ARRAY|||Y|SPOUSE|MICROSCOPIST 2|5|Visit_5|90|5|WASHOUT|2020-08-17|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|STANDING|[?]|Tesla|[?]|1|ug/dL|SECOND OBTUSE MARGINAL BRANCH ARTERY|LATERAL|PERIVENTRICULAR|TEMPLATE INCISION METHOD||||SIBLING|HEMATOLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|2|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING, BENT FORWARD|||[?]|1|log10 TCID 50/dose|DUCTUS ARTERIOSUS|IPSILATERAL|MEDIAL|IMMUNOCHEMILUMINOMETRIC ASSAY|||Y|FRIEND|READER 1|1|Visit_1|10|6|TREATMENT|2020-06-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-21
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|3|PIF|Peak Inspiratory Flow|[?]|SITTING|[?]|pmol/g|[?]|1|ug/cm2|SMALL INTESTINE|CONTRALATERAL|ANTERIOR|ACID FAST STAIN||||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|2|Visit_2|25|5|TREATMENT|2020-07-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|4|SVC|Slow Vital Capacity|[?]|STANDING|||[?]|1|kHz|TRICUSPID VALVE, SEPTAL CUSP|CONTRALATERAL|MIDLINE|ELECTROGASTROGRAPHY|Y||Y|VENDOR|OPHTHALMOLOGIST|2|Visit_2|25|2|SCREENING|2020-07-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|5|DLCOVAPP|Percent Predicted DLCO/VA|[?]|LATERAL DECUBITUS|||[?]|1|IU/dL|POPLITEAL ARTERY BELOW KNEE|LEFT|PARIETO-OCCIPITAL|DIGITAL PCR ARRAY|||Y|SIBLING|ADJUDICATOR 2|3|Visit_3|40|5|WASHOUT|2020-07-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|6|AIRTRAP|Air Trapping|[?]|SEMI-FOWLERS|||[?]|1|BU/mL|SCAPHOID-TRAPEZIUM JOINT|LEFT|PROXIMAL VOLAR|CYSTOMETRY||Y|Y|GUARDIAN|CARDIOLOGIST|3|Visit_3|40|6|WASHOUT|2020-07-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-27
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|7|PIF|Peak Inspiratory Flow|[?]|SUPINE|[?]|pt_br|[?]|1|10^9 CFU/mL|SCROTUM|CONTRALATERAL|VENTRAL|COMPLEMENT FIXATION|Y|Y||SIGNIFICANT OTHER|OTOLARYNGOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|8|SAWVOL|Specific Airway Volume|[?]|UNCONSTRAINED|||[?]|1|AgU/mL|POSTERIOR TIBIAL ARTERY|BILATERAL|UPPER|STRESS ECHOCARDIOGRAPHY||Y|Y|CHILD|READER 1|4|Visit_4|65|6|TREATMENT|2020-08-13|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-22
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|DECUBITUS|[?]|nmol/L|[?]|1|10^6 IU/mL|SIGMOID SINUS|IPSILATERAL|APICAL|GRAM STAIN||||CHILD|DERMATOLOGIST|5|Visit_5|90|2|TREATMENT|2020-09-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|77c97d1e-e223-4485-b2de-59daa4e5b01f|10|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|TRENDELENBURG|[?]|Enzyme U/g Hb|[?]|1|ppth|DURAL VENOUS SINUS|CONTRALATERAL|UPPER FLEXOR SURFACE|ELECTRONEUROGRAPHY||||ADJUDICATION COMMITTEE|OPHTHALMOLOGIST|5|Visit_5|90|3|TREATMENT|2020-09-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-16
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|DLCOVA|DLCO/VA|[?]|PRONE|[?]|mg/g/h|[?]|1|/kg|SMALL INTESTINE|CONTRALATERAL|DISTAL|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||Y||CLINICAL RESEARCH COORDINATOR|RATER 2|1|Visit_1|10|3|WASHOUT|2020-10-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|2|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SITTING, LEGS DEPENDENT|[?]|U/mL|[?]|1|kUSP|INTERPHALANGEAL JOINT 3|LATERAL|PARIETO-OCCIPITAL|IVY INCISION METHOD||||FRIEND|MICROSCOPIST|1|Visit_1|10|6|FOLLOW-UP|2020-10-14|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-06
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|3|PEFTIME|Peak Expiratory Flow Time|[?]|SLING|[?]|mg/m2/day|[?]|1|/7.5 mL|TRIANGULAR BONE|LATERAL|PERIPHERAL|TRANSVAGINAL ULTRASOUND||||SIGNIFICANT OTHER|HEMATOLOGIST|2|Visit_2|25|7|TREATMENT|2020-10-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|4|MEPPP|Percent Predicted MEP|[?]|RIGHT LATERAL DECUBITUS|[?]|log10 CCID 50/dose|[?]|1|Linear ft*LB|LATERAL RAMUS INTERMEDIUS ARTERY|BILATERAL|VENTROLATERAL|CLINICAL EVALUATION||Y||FAMILY MEMBER|READER 1|2|Visit_2|25|4|FOLLOW-UP|2020-10-29|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|5|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SLING|||[?]|1|nmol|SUBCLAVIAN VEIN|LATERAL|INTERMEDIATE|ELLA||Y|Y|SPOUSE|RADIOLOGIST 1|3|Visit_3|40|5|FOLLOW-UP|2020-11-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|6|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|[?]|cd*s/m2|[?]|1|RATIO|COLON, TRANSVERSE|RIGHT|PROXIMAL|PERFUSION MRI||Y||FAMILY MEMBER|RATER 2|3|Visit_3|40|4|FOLLOW-UP|2020-11-13|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-29
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|7|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|SEMI-RECUMBENT|[?]|EP U|[?]|1|U/L|MAXILLARY SINUS|LATERAL|CRANIAL|FUNDUS PHOTOGRAPHY|Y|Y||CLINICAL STUDY SPONSOR|FORENSIC PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2020-12-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|8|FEV1PP|Percent Predicted FEV1|[?]|SEMI-RECUMBENT|||[?]|1|mg/m2/h|T1 VERTEBRA|IPSILATERAL|FORE|CYSTOMETRY|||Y|INTERVIEWER|READER 1|4|Visit_4|65|2|FOLLOW-UP|2020-12-08|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|9|FEV6PP|Percent Predicted FEV6|[?]|SITTING, LEGS DEPENDENT|[?]|U/animal|[?]|1|mg/L FEU|CORPUS CALLOSUM, BODY|RIGHT|CAUDAL|CT SCAN WITHOUT CONTRAST|Y|||STUDY SUBJECT|ONCOLOGIST 1|5|Visit_5|90|5|TREATMENT|2021-01-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|10|PNEUMIND|Pneumonia Indicator|[?]|LATERAL DECUBITUS|||[?]|1|uL|TOE|UNILATERAL|FORE|MUGA|Y||Y|STUDY SUBJECT|ADJUDICATOR 3|5|Visit_5|90|4|FOLLOW-UP|2021-01-02|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-10
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|FRC|Functional Residual Capacity|[?]|FOWLERS|[?]|aMFI|[?]|1|10^9 CFU/mL|JOINT|CONTRALATERAL|LOWER EXTENSOR SURFACE|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|4|WASHOUT|2020-11-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|2|ERVPP|Percent Predicted ERV|[?]|PRONE|[?]|U/animal|[?]|1|TCID 50/dose|EYE, ANTERIOR SEGMENT|BILATERAL|BASAL|ANGIOGRAPHY||||PROXY|ENDOCRINOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-11-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-15
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|3|LOBVOLPP|Percent Predicted Lobar Volume|[?]|LATERAL DECUBITUS|[?]|cycle/min|[?]|1|IU/day|RIB 9|RIGHT|ROSTRAL|TRANSESOPHAGEAL ECHOCARDIOGRAPHY||||CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|2|Visit_2|25|1|TREATMENT|2020-11-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|4|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-FOWLERS|[?]|MBq/uL|[?]|1|deg2|UVEA|UNILATERAL|FORE|SINGLE-MOLECULE ARRAY||||ADJUDICATOR|ONCOLOGIST|2|Visit_2|25|1|WASHOUT|2020-11-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-21
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|5|TVPP|Percent Predicted Tidal Volume|[?]|STANDING|||[?]|1|dB|MID-JUGULAR LYMPH NODE|UNILATERAL|ROSTRAL|LIQUID SCINTILLATION COUNTING|||Y|PARENT|READER|3|Visit_3|40|7|TREATMENT|2020-12-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|6|AWVOL|Airway Volume|[?]|FOWLERS|[?]|PIXELS/cm|[?]|1|pmol|FIBULAR VEIN|UNILATERAL|DISTAL|LAPAROSCOPY||||ADJUDICATION COMMITTEE|READER 2|3|Visit_3|40|6|FOLLOW-UP|2020-12-01|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-30
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|7|EVC|Expiratory Vital Capacity|[?]|REVERSE TRENDELENBURG|[?]|ng/dL|[?]|1|um|CERVICAL LYMPH NODE|LEFT|INFERIOR|SNELLEN EYE CHART|Y|Y||CAREGIVER|READER|4|Visit_4|65|6|TREATMENT|2020-12-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|8|FEV1REV|FEV1 Reversibility|[?]|SLING|[?]|tsp eq|[?]|1|Log10 ELISA unit|RENAL PELVIS|CONTRALATERAL|OUTER|ULTRASONOGRAPHIC ELASTOGRAPHY|Y|||INDEPENDENT ASSESSOR|PATHOLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-12-26|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-01
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|9|INTP|Interpretation|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|BOTTLE|COLON|LEFT|TEMPORAL|BIOIMPEDANCE SPECTROSCOPY|Y|Y|Y|SIGNIFICANT OTHER|ADJUDICATOR|5|Visit_5|90|5|TREATMENT|2021-01-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|10|IVC|Inspiratory Vital Capacity|[?]|STANDING|[?]|DNA copies/ug|[?]|1|mMU/mL|ILIAC VEIN|CONTRALATERAL|DISTAL|HPLC-FL||||GUARDIAN|CARDIOLOGIST|5|Visit_5|90|1|SCREENING|2021-01-20|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-01
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|1|PNIF|Peak Nasal Inspiratory Flow|[?]|UNCONSTRAINED|[?]|kHz|[?]|1|ug/animal|THYMUS GLAND|RIGHT|DORSAL|TARGETED GENOME SEQUENCING||Y||VENDOR|DERMATOLOGIST|1|Visit_1|10|1|TREATMENT|2020-06-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|umol/mol|SHIN|RIGHT|PERIVENTRICULAR|FLUORESCENCE ANGIOGRAPHY|||Y|PROXY|RADIOLOGIST|1|Visit_1|10|6|TREATMENT|2020-06-28|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|3|DLCOHC|HGB Corrected DLCO|[?]|SITTING|[?]|mAmp|[?]|1|cm/s|CHEEK|BILATERAL|CENTRAL|LASER CAPTURE MICRODISSECTION||||DOMESTIC PARTNER|MICROSCOPIST|2|Visit_2|25|6|SCREENING|2020-07-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|4|FRCPP|Percent Predicted FRC|[?]|TRENDELENBURG|[?]|FINGERTIP UNIT|[?]|1|10^8 PFU|FIRST DIAGONAL BRANCH ARTERY|RIGHT|ANTEROLATERAL|CALCULATION|Y|||FRIEND|ONCOLOGIST 1|2|Visit_2|25|6|TREATMENT|2020-07-13|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-13
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|5|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|DECUBITUS|||[?]|1|mg|HAND DIGIT 2|IPSILATERAL|INTERMEDIATE|ENDOSCOPY|||Y|CLINICAL RESEARCH COORDINATOR|PEDIATRIC NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|6|FEV6PP|Percent Predicted FEV6|[?]|SEMI-FOWLERS|[?]|CYLINDER|[?]|1|umol/mg/min|L3 VERTEBRA|IPSILATERAL|OCCIPITAL|REFRACTOMETRY||Y||SIGNIFICANT OTHER|PEDIATRIC NEUROLOGIST|3|Visit_3|40|6|FOLLOW-UP|2020-07-28|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-18
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|7|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SLING|[?]|PIPE|[?]|1|mL/sec/1.73m2|RENAL ARTERY|LEFT|DEEP|RADIOIMMUNOPRECIPITATION ASSAY||||CLINICAL STUDY SPONSOR|MICROSCOPIST 2|4|Visit_4|65|5|SCREENING|2020-08-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|8|QUASCOMP|Quasi-Static Compliance|[?]|UNCONSTRAINED|[?]|g/day|[?]|1|MPS U|TUNICA INTIMA|RIGHT|ANTEROPOSTERIOR|OLIGO ACGH||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST 1|4|Visit_4|65|7|TREATMENT|2020-08-22|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-31
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|9|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|mL/animal/wk|[?]|1|g/animal/day|PUPIL|LEFT|APICAL|SXA SCAN||Y||GUARDIAN|UROLOGIST|5|Visit_5|90|3|FOLLOW-UP|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|9eb6e591-d266-4e05-85b6-230e8a02d494|10|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|SITTING|[?]|uL|[?]|1|Henry|SKIN OF THE INFRASCAPULAR REGION|CONTRALATERAL|ANTEROPOSTERIOR|IODINE STAIN||Y||HEALTH CARE PROFESSIONAL|CLINICAL PATHOLOGIST|5|Visit_5|90|3|SCREENING|2020-09-16|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-12
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|PEF|Peak Expiratory Flow|[?]|UNCONSTRAINED|[?]|ECL unit|[?]|1|10^7 TCID 50/dose|AORTIC VALVE, RIGHT CORONARY CUSP|IPSILATERAL|SUPERFICIAL|EEG||||VENDOR|RADIOLOGIST|1|Visit_1|10|1|TREATMENT|2020-06-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|2|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SLING|||[?]|1|TRANSDUCING UNIT|LEFT CIRCUMFLEX ARTERY OSTIUM|UNILATERAL|INFERIOR|FLUOROSCOPY||Y|Y|FRIEND|RATER|1|Visit_1|10|6|TREATMENT|2020-06-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-01
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|3|FRC|Functional Residual Capacity|[?]|SUPINE|[?]|mV*min|[?]|1|Newton|AORTIC ARCH|BILATERAL|TEMPORAL|ORCHIDOMETERY||||PARENT|PATHOLOGIST 1|2|Visit_2|25|7|TREATMENT|2020-07-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|4|IVCPP|Percent Predicted IVC|[?]|STANDING|[?]|mm/2h|[?]|1|10^6 organisms/mg|ENDOCARDIUM|CONTRALATERAL|FACIAL|CELL OF ORIGIN ASSAY|Y|||GUARDIAN|RATER|2|Visit_2|25|3|SCREENING|2020-07-15|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-27
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|5|SAWVOL|Specific Airway Volume|[?]|SLING|||[?]|1|SUPPOSITORY|TIBIALIS ANTERIOR MUSCLE|LEFT|INFERIOR|FLAME PHOTOMETRY|Y||Y|CHILD|PHYSIOTHERAPIST|3|Visit_3|40|6|TREATMENT|2020-07-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|6|FIO2|Fraction of Inspired Oxygen|[?]|LATERAL DECUBITUS|||[?]|1|kBq|INTERPHALANGEAL THUMB JOINT|CONTRALATERAL|INNER|IMPULSE OSCILLOMETRY|Y|Y|Y|ADJUDICATOR|PATHOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-07-30|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-23
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|7|EFFIND|Effusion Indicator|[?]|FOWLERS|[?]|10^9/g|[?]|1|tuberculin unit|TIBIA|RIGHT|FORE|KNEMOMETRY||||CHILD|ADJUDICATOR 2|4|Visit_4|65|3|TREATMENT|2020-08-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|8|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|[?]|U/g|[?]|1|U/m2|RIB 5|LEFT|ANTEROLATERAL|REFRACTOMETRY||||SIGNIFICANT OTHER|ADJUDICATOR 3|4|Visit_4|65|5|WASHOUT|2020-08-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-23
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|TRENDELENBURG|[?]|Enzyme U|[?]|1|/month|PORTAL LYMPH NODE|LEFT|CAUDAL|CRYOSCOPY||||INVESTIGATOR|PHYSIOTHERAPIST|5|Visit_5|90|4|WASHOUT|2020-09-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|6a6e040d-6a09-4004-9fab-f4f82ba00eae|10|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|STANDING, BENT FORWARD|[?]|10^12 IU/L|[?]|1|pmol/L/h|MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES|BILATERAL|CRANIAL|PEAK FLOWMETRY||||SPOUSE|MICROSCOPIST 2|5|Visit_5|90|4|WASHOUT|2020-09-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-16
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|[?]|Gy|[?]|1|mmol/L|L3-L4 INTERVERTEBRAL SPACE|UNILATERAL|DISTAL|INTERRUPTER TECHNIQUE||||DOMESTIC PARTNER|DERMATOLOGIST|1|Visit_1|10|6|TREATMENT|2020-08-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|2|IRVPP|Percent Predicted IRV|[?]|FOWLERS|[?]|g/kg/day|[?]|1|ms/mmHg|BULBAR CONJUNCTIVA|UNILATERAL|POSTERIOR|CLOT DETECTION||||FAMILY MEMBER|NEUROLOGIST 1|1|Visit_1|10|6|TREATMENT|2020-08-17|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-22
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|3|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|SLING|[?]|uCi|[?]|1|mg/L FEU|EXTRAOCULAR MUSCLE|CONTRALATERAL|APICAL|DISK DIFFUSION||Y||ADJUDICATION COMMITTEE|RATER|2|Visit_2|25|1|TREATMENT|2020-09-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|STANDING|[?]|U/kg/min|[?]|1|kN/cm2|THYROID GLAND, RIGHT LOBE|LEFT|FRONTAL|REFLECTANCE SPECTROSCOPY||||DOMESTIC PARTNER|READER|2|Visit_2|25|1|SCREENING|2020-09-01|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-20
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|5|PO2FIO2|PP Arterial O2/Fraction Inspired O2|[?]|LEFT LATERAL DECUBITUS|[?]|kDa|[?]|1|um2|OVARY|RIGHT|CENTRAL|SPECT/CT SCAN||||CHILD|RADIOLOGIST 1|3|Visit_3|40|4|FOLLOW-UP|2020-09-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|6|AWVOLPP|Percent Predicted Airway Volume|[?]|SLING|[?]|nmol/L|[?]|1|10^7 PFU|RENAL PELVIS|LEFT|LOWER MEDIAL|NO INFORMATION|Y|||CLINICAL RESEARCH ASSOCIATE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|4|FOLLOW-UP|2020-09-16|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-11-07
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|7|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|[?]|mV2/Hz|[?]|1|10^7 CFU|HEART, LEFT VENTRICLE|UNILATERAL|MEDIAL|CONTRAST ENHANCED CT SCAN||Y||CHILD|OPTOMETRIST|4|Visit_4|65|7|WASHOUT|2020-10-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|8|FIF50|Forced Inspiratory Flow at 50%|[?]|TRENDELENBURG|[?]|GBq/mg|[?]|1|IU/L|PRECUNEUS|LEFT|DEEP|PHENOTYPIC MULTIPLE ANTIGEN BEAD-BASED MULTIPLEX ASSAY||||VENDOR|NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2020-10-11|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-04
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|9|SALKB|Salazar-Knowles Equation Parameter B|[?]|SEMI-FOWLERS|||[?]|1|%/min|LUNG, RIGHT, MIDDLE LOBE, MEDIAL SEGMENT|BILATERAL|LOWER MEDIAL|CLOT DETECTION|||Y|CLINICAL RESEARCH COORDINATOR|DERMATOLOGIST|5|Visit_5|90|3|TREATMENT|2020-11-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|10|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|UNCONSTRAINED|[?]|copies/mL|[?]|1|10^4/L|BONE|BILATERAL|MIDLINE|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY||||INTERVIEWER|PHYSIOTHERAPIST|5|Visit_5|90|5|TREATMENT|2020-11-05|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-16
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|GAW|Airway Conductance|[?]|SITTING, LEGS DEPENDENT|[?]|EVENTS|[?]|1|OI50|GLUTEUS MAXIMUS|IPSILATERAL|MIDLINE|PHYSICAL EXAMINATION||||ADJUDICATOR|ADJUDICATOR|1|Visit_1|10|4|WASHOUT|2021-01-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|2|FEV1FVC|FEV1/FVC|[?]|SEMI-FOWLERS|[?]|TAMPON|[?]|1|BLOCKS|NIPPLE|LEFT|VOLAR|CORONARY ANGIOGRAPHY||||FRIEND|NEUROLOGIST 2|1|Visit_1|10|2|FOLLOW-UP|2021-01-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-14
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|3|FEV1SVC|FEV1/SVC|[?]|UNCONSTRAINED|[?]|IU/kg|[?]|1|umol/L/min|PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT|UNILATERAL|LOWER|MICRODENSITOMETRY|Y|||NON-HEALTH CARE PROFESSIONAL|NEUROLOGIST 1|2|Visit_2|25|2|FOLLOW-UP|2021-02-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|4|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|SUPINE|[?]|mg/min|[?]|1|m/sec|BLADDER|LEFT|PARIETO-OCCIPITAL|TRYPAN BLUE STAIN||Y||CLINICAL RESEARCH ASSOCIATE|READER 2|2|Visit_2|25|5|TREATMENT|2021-02-03|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-14
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|5|RELSZCHG|Relative Size Change|[?]|UNCONSTRAINED|[?]|umol/dL|[?]|1|ug/kg/h|ESOPHAGUS, MIDDLE THIRD|BILATERAL|INTERMEDIATE|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||PROXY|RATER|3|Visit_3|40|6|SCREENING|2021-02-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|6|TV|Tidal Volume|[?]|SLING|[?]|mL/s|[?]|1|mm/min|BRACHIAL PLEXUS|RIGHT|OCCIPITAL|FLUORESCENT IMMUNOASSAY||||PARENT|ADJUDICATOR 2|3|Visit_3|40|2|TREATMENT|2021-02-18|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|7|RVPP|Percent Predicted Residual Volume|[?]|FOWLERS|[?]|mL/kg/min|[?]|1|FINGERTIP UNIT|VAS DEFERENS|UNILATERAL|MIDLINE|ELECTRONEUROGRAPHY||||CLINICAL RESEARCH COORDINATOR|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|8|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|[?]|scm|[?]|1|log10 IU/mL|RIB 5|UNILATERAL|PERIVENTRICULAR|WEBER GREEN STAIN||||PROXY|NEUROLOGIST|4|Visit_4|65|2|WASHOUT|2021-03-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-25
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|9|DLCO|Diffusion Capacity of Lung for CO|[?]|FOWLERS|[?]|U/kg/h|[?]|1|log10 CCID 50/dose|PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT|LATERAL|VENTRAL|SPECT SCAN||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|5|Visit_5|90|4|SCREENING|2021-04-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|10|IVC|Inspiratory Vital Capacity|[?]|SUPINE|[?]|DNA copies/ug|[?]|1|%/min|THYROID GLAND|CONTRALATERAL|TEMPORAL|BRDU CELLULAR PROLIFERATION ASSAY|Y|||STUDY SUBJECT|NEUROLOGIST 1|5|Visit_5|90|5|TREATMENT|2021-04-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|[?]|U/g Hb|[?]|1|fmol/L/sec|PELVIC LYMPH NODE|IPSILATERAL|LOWER FLEXOR SURFACE|ROMANOWSKY STAIN||||CLINICAL STUDY SPONSOR|NEUROLOGIST 2|1|Visit_1|10|1|TREATMENT|2020-05-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|2|MEP|Maximal Expiratory Pressure|[?]|TRENDELENBURG|[?]|mph|[?]|1|/VF|DIGIT|BILATERAL|ANTERIOR|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 1|1|Visit_1|10|6|FOLLOW-UP|2020-05-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|3|TGV|Thoracic Gas Volume|[?]|TRENDELENBURG|[?]|mg|[?]|1|DROP|CEREBELLUM|LEFT|TIP|ANALYTICAL ULTRACENTRIFUGATION||||ADJUDICATION COMMITTEE|NEUROLOGIST 2|2|Visit_2|25|4|TREATMENT|2020-05-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|4|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|mmHg*min/L|[?]|1|10^6/L|ESOPHAGUS, LOWER THIRD|RIGHT|UPPER|THICK SMEAR||Y||GUARDIAN|ADJUDICATOR 1|2|Visit_2|25|4|FOLLOW-UP|2020-05-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-08
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|5|PNIF|Peak Nasal Inspiratory Flow|[?]|FOWLERS|||[?]|1|kPa/L/sec|THROAT|CONTRALATERAL|PROXIMAL VOLAR|AURAMINE STAIN|Y|Y|Y|CHILD|PATHOLOGIST|3|Visit_3|40|3|TREATMENT|2020-06-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|6|SALKA|Salazar-Knowles Equation Parameter A|[?]|SLING|[?]|10^6/Ejaculate U|[?]|1|DAgU|VEIN|LEFT|DISTAL VOLAR|DIFFUSION WEIGHTED MRI||||GUARDIAN|READER|3|Visit_3|40|2|TREATMENT|2020-06-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-11
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|7|FIF25|Forced Inspiratory Flow at 25%|[?]|STANDING, BENT FORWARD|[?]|pmol/10^10 cells|[?]|1|PACKAGE|SUBCUTIS|IPSILATERAL|FACIAL|CARDIAC THERMODILUTION||||PARENT|DERMATOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-07-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-13
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|8|TLCPP|Percent Predicted Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|10^10/L|[?]|1|cpm|PERIURETHRAL REGION|IPSILATERAL|ANTEROLATERAL|FLUORESCENCE ANGIOGRAPHY||||ADJUDICATOR|NEUROLOGIST|4|Visit_4|65|1|WASHOUT|2020-07-06|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-13
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|9|ICREV|IC Reversibility|[?]|FOWLERS|[?]|fmol/L|[?]|1|BEAM BREAKS|TONSIL|LEFT|LATERAL|TOTAL BODY IRRADIATION||||CAREGIVER|RATER 2|5|Visit_5|90|3|WASHOUT|2020-07-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|10|FEV6PP|Percent Predicted FEV6|[?]|RIGHT LATERAL DECUBITUS|[?]|uV|[?]|1|uV2|CORONARY VEIN|IPSILATERAL|UPPER EXTENSOR SURFACE|NUCLEIC ACID AMPLIFICATION TEST|Y|||SPOUSE|READER 2|5|Visit_5|90|7|WASHOUT|2020-07-31|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-27
e|RE|ba99022a-d398-4c60-828c-876f119459e1|1|DLCOVA|DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|pg/L|[?]|1|U/m2/day|HEPATIC ARTERY|CONTRALATERAL|MEDIAL|FLUORIMETRY||Y||VENDOR|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|TREATMENT|2020-12-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|ba99022a-d398-4c60-828c-876f119459e1|2|RELSZCHG|Relative Size Change|[?]|SUPINE|[?]|V|[?]|1|PUFF|LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT|RIGHT|UPPER FLEXOR SURFACE|THERMAL IONIZATION MASS SPECTROMETRY||||CLINICAL RESEARCH ASSOCIATE|RATER 1|1|Visit_1|10|3|TREATMENT|2020-12-01|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-03
e|RE|ba99022a-d398-4c60-828c-876f119459e1|3|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|UNCONSTRAINED|[?]|g/U|[?]|1|cpm|PARATRACHEAL LYMPH NODE|LATERAL|NASAL|SCANNING ELECTRON MICROSCOPY||Y||CLINICAL RESEARCH COORDINATOR|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|2|SCREENING|2020-12-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|ba99022a-d398-4c60-828c-876f119459e1|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SUPINE|[?]|mJoule/cm2|[?]|1|mL/(min*100mL)|PALATINE BONE|LATERAL|SUPERFICIAL|TRICHROME STAIN||||FAMILY MEMBER|DEVELOPMENTAL PSYCHOLOGIST|2|Visit_2|25|6|TREATMENT|2020-12-16|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-15
e|RE|ba99022a-d398-4c60-828c-876f119459e1|5|FEV1|Forced Expiratory Volume in 1 Second|[?]|LEFT LATERAL DECUBITUS|[?]|RFU|[?]|1|/5x10^4 WBC|DISTAL PHALANX 5 OF THE HAND|LEFT|SUBCORTICAL|WEBER GREEN STAIN|Y|||ADJUDICATION COMMITTEE|HEMATOLOGIST|3|Visit_3|40|3|TREATMENT|2020-12-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|ba99022a-d398-4c60-828c-876f119459e1|6|ELSTNCE|Elastance|[?]|DECUBITUS|[?]|Antibody Unit|[?]|1|mmol/min/kPa/L|LEFT CIRCUMFLEX ARTERY OSTIUM|IPSILATERAL|SURFACE|DUCTOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|3|Visit_3|40|6|TREATMENT|2020-12-31|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-22
e|RE|ba99022a-d398-4c60-828c-876f119459e1|7|FIFMAXPP|Percent Predicted FIFmax|[?]|SITTING, LEGS DEPENDENT|[?]|mOsm/L|[?]|1|ug/L DDU|PALPEBRAL FISSURE|LATERAL|MEDIAL|HPLC-FL||Y||FAMILY MEMBER|INTERNIST|4|Visit_4|65|5|FOLLOW-UP|2021-01-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|ba99022a-d398-4c60-828c-876f119459e1|8|FEV_2|Forced Expiratory Volume in 0.2 Second|[?]|TRENDELENBURG|[?]|mg/L FEU|[?]|1|ug/kg/h|TEMPORAL ARTERY|UNILATERAL|PROXIMAL VOLAR|KARYOTYPING||||INDEPENDENT ASSESSOR|OPTOMETRIST|4|Visit_4|65|6|SCREENING|2021-01-25|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-25
e|RE|ba99022a-d398-4c60-828c-876f119459e1|9|FEV_05|Forced Expiratory Volume in 0.05 Second|[?]|PRONE|||[?]|1|IU/dL|CEREBRAL VEIN|LEFT|CAUDAL|SXA SCAN|||Y|SIBLING|PEDIATRIC NEUROLOGIST|5|Visit_5|90|2|TREATMENT|2021-02-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|ba99022a-d398-4c60-828c-876f119459e1|10|FRCPP|Percent Predicted FRC|[?]|STANDING|[?]|10^6 organisms/mL|[?]|1|INHALATION|ELBOW EXTENSOR MUSCLES|LATERAL|LOWER|LASER CAPTURE MICRODISSECTION||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|5|Visit_5|90|2|TREATMENT|2021-02-19|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-11
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|AWVOLPP|Percent Predicted Airway Volume|[?]|UNCONSTRAINED|[?]|amu|[?]|1|mPa|THYROID GLAND|LEFT|VENTROLATERAL|IMPULSE OSCILLOMETRY||Y||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST 2|1|Visit_1|10|3|SCREENING|2020-06-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|2|FRCPP|Percent Predicted FRC|[?]|STANDING, BENT FORWARD|[?]|U/m2|[?]|1|Ejaculate U|LIGAMENT|IPSILATERAL|INTERMEDIATE|REFLECTANCE SPECTROSCOPY||||NON-HEALTH CARE PROFESSIONAL|ADJUDICATOR|1|Visit_1|10|4|TREATMENT|2020-06-06|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|3|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|REVERSE TRENDELENBURG|||[?]|1|L/min|ESOPHAGUS, MIDDLE THIRD|CONTRALATERAL|PERIVENTRICULAR|MULTI-SLICE SPIRAL CT||Y|Y|CLINICAL RESEARCH COORDINATOR|PATHOLOGIST|2|Visit_2|25|6|SCREENING|2020-06-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|4|MEPPP|Percent Predicted MEP|[?]|REVERSE TRENDELENBURG|||[?]|1|uL|CEREBRAL HEMISPHERE, RIGHT|RIGHT|INTERMEDIATE|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION|||Y|VENDOR|MICROSCOPIST 3|2|Visit_2|25|4|FOLLOW-UP|2020-06-21|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-26
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|5|FEF2575P|Percent Predicted FEF25-75|[?]|LATERAL DECUBITUS|||[?]|1|uV2|CHEST|BILATERAL|BASAL|MRS|||Y|VENDOR|UROLOGIST|3|Visit_3|40|5|TREATMENT|2020-07-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|6|FEF2575P|Percent Predicted FEF25-75|[?]|SUPINE|[?]|Shock Wave|[?]|1|Tesla|JUGULAR VEIN|RIGHT|ANTERIOR|MICROBIAL CONCENTRATION||||SIGNIFICANT OTHER|ADJUDICATOR|3|Visit_3|40|5|SCREENING|2020-07-06|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-02
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|7|FVC6|Forced Vital Capacity in 6 Seconds|[?]|SEMI-FOWLERS|[?]|ELISA unit/mL|[?]|1|U.CARR|INTERPHALANGEAL OF THE FOOT|UNILATERAL|APICAL|HIGH RESOLUTION MELT ANALYSIS||||SIBLING|READER 2|4|Visit_4|65|1|SCREENING|2020-07-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|8|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING|[?]|OD Unit|[?]|1|IMPLANT|PLEURA|LATERAL|VENTROLATERAL|ACCELERATOR MASS SPECTROMETRY||Y||GUARDIAN|MICROSCOPIST|4|Visit_4|65|4|TREATMENT|2020-07-31|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-21
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|9|EXPRELTM|Expiration Relaxation Time|[?]|DECUBITUS|[?]|U/kg/day|[?]|1|log EID 50/dose|ANTRUM PYLORI|CONTRALATERAL|PARIETO-OCCIPITAL|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||Y||CHILD|READER|5|Visit_5|90|6|SCREENING|2020-08-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|d713869e-061c-4e95-8a50-da2e1ec47b3c|10|FRC|Functional Residual Capacity|[?]|SITTING, LEGS DEPENDENT|[?]|um/s|[?]|1|h/wk|TARSAL JOINT|CONTRALATERAL|SURFACE|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY||||VENDOR|READER|5|Visit_5|90|5|TREATMENT|2020-08-25|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-FOWLERS|[?]|vp/dose|[?]|1|/cmH2O|GREAT TROCHANTER|UNILATERAL|TIP|FLUORESCENT MICROSCOPY|Y|Y||FRIEND|ONCOLOGIST|1|Visit_1|10|3|FOLLOW-UP|2020-07-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|2|FEV1|Forced Expiratory Volume in 1 Second|[?]|STANDING|||[?]|1|mm|HEAD AND NECK|IPSILATERAL|MEDIAL|TOTAL BODY RADIOGRAPHY|||Y|ADJUDICATION COMMITTEE|ENDOCRINOLOGIST|1|Visit_1|10|6|TREATMENT|2020-07-11|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-06
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|3|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|mg|[?]|1|mg/L FEU|SPLEEN, HILUM|LEFT|ANTERIOR|PET/CT SCAN WITHOUT CONTRAST|Y|||CLINICAL RESEARCH COORDINATOR|RATER|2|Visit_2|25|7|TREATMENT|2020-07-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|4|RER|Respiratory Exchange Ratio|[?]|REVERSE TRENDELENBURG|[?]|nmol/L/min|[?]|1|anti-Xa IU/mL|SKIN OF THE CHEST|CONTRALATERAL|FORE|PALM METHOD|Y|||FRIEND|ADJUDICATOR 1|2|Visit_2|25|5|SCREENING|2020-07-26|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-01
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|5|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING|[?]|10^3/L|[?]|1|uCi/kg|STERNEBRA|BILATERAL|TIP|FUNCTIONAL MRI|Y|Y||CLINICAL STUDY SPONSOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|2|TREATMENT|2020-08-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|6|RAW|Airway Resistance|[?]|SLING|[?]|RING|[?]|1|mmol/g|FEMORAL HEAD|CONTRALATERAL|DORSOLATERAL|RAJI CELL EIA||||SIGNIFICANT OTHER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|SCREENING|2020-08-10|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-05
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|7|SALKA|Salazar-Knowles Equation Parameter A|[?]|RIGHT LATERAL DECUBITUS|[?]|nkat/g Hb|[?]|1|m3|DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT|RIGHT|POSTERIOR|AURAMINE STAIN||||INTERVIEWER|NEUROLOGIST 1|4|Visit_4|65|3|TREATMENT|2020-09-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|8|FEV1PP|Percent Predicted FEV1|[?]|SITTING|[?]|PATCH|[?]|1|dyn|SCROTUM|RIGHT|FACIAL|PHOROPTER||||SIGNIFICANT OTHER|MICROSCOPIST 1|4|Visit_4|65|2|TREATMENT|2020-09-04|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-09
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|9|FEV6PP|Percent Predicted FEV6|[?]|SEMI-FOWLERS|[?]|SFC/10^6 PBMC|[?]|1|DAgU/mL|SMALL INTESTINE|UNILATERAL|ANTEROLATERAL|NUCLEIC ACID HYBRIDIZATION||Y||CLINICAL RESEARCH COORDINATOR|RATER 2|5|Visit_5|90|6|WASHOUT|2020-09-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|fcebb64c-e0e6-4f29-9c52-15fa91f60018|10|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|[?]|AU/mL|[?]|1|Osm|ISCHIORECTAL FOSSA|LATERAL|SUPERFICIAL|TONOMETRY||||FAMILY MEMBER|READER 1|5|Visit_5|90|6|TREATMENT|2020-09-29|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-04
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|FEF2575P|Percent Predicted FEF25-75|[?]|SITTING|[?]|BAR|[?]|1|cd|POSTERIOR SUPERIOR ILIAC SPINE|LEFT|MEDIAL|TRANSCRIPTION-MEDIATED AMPLIFICATION||||SIBLING|PATHOLOGIST|1|Visit_1|10|4|TREATMENT|2021-01-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|2|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|SLING|[?]|mOsm|[?]|1|IU/g|HIPPOCAMPUS|LATERAL|PROXIMAL|HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY|Y|||SPOUSE|RATER|1|Visit_1|10|6|SCREENING|2021-01-01|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|3|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|LATERAL DECUBITUS|||[?]|1|dL|LATERAL THIRD DIAGONAL BRANCH ARTERY|IPSILATERAL|DORSAL|MICRODENSITOMETRY|||Y|ADJUDICATOR|RADIOLOGIST|2|Visit_2|25|2|TREATMENT|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|4|FIVC|Forced Inspiratory Vital Capacity|[?]|UNCONSTRAINED|[?]|eq|[?]|1|mEq/uL|METATARSAL BONE|IPSILATERAL|FACIAL|TARGETED GENOME SEQUENCING||Y||CAREGIVER|RADIOLOGIST 1|2|Visit_2|25|6|FOLLOW-UP|2021-01-16|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-25
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|5|IC|Inspiratory Capacity|[?]|STANDING|||[?]|1|EVENTS|FOOT DIGIT 1|BILATERAL|CRANIAL|CELLULOSE TAPE||Y|Y|STUDY SUBJECT|RADIOLOGIST 1|3|Visit_3|40|5|SCREENING|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|6|PIF|Peak Inspiratory Flow|[?]|DECUBITUS|[?]|OD Unit|[?]|1|mEq/g|POSTEROLATERAL SEGMENTAL ARTERY|IPSILATERAL|VOLAR|NUCLEIC ACID BASED METHOD||||PARENT|READER 2|3|Visit_3|40|1|TREATMENT|2021-01-31|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-20
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|7|DLCOVAPP|Percent Predicted DLCO/VA|[?]|UNCONSTRAINED|[?]|nm|[?]|1|g/m2/day|CARDIAC VALVE|RIGHT|BASAL|QUANTITATIVE CORONARY ANGIOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|OPHTHALMOLOGIST|4|Visit_4|65|5|SCREENING|2021-02-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|8|VO2|Oxygen Consumption|[?]|SEMI-RECUMBENT|[?]|mg/min|[?]|1|U/kg/min|CERVICAL SPINE|IPSILATERAL|FACIAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||PARENT|RATER 2|4|Visit_4|65|2|TREATMENT|2021-02-25|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|9|VO2MAXE|Maximal Oxygen Consumption, Estimated|[?]|FOWLERS|[?]|deg/mm|[?]|1|MdFI|BUTTOCK|RIGHT|NASAL|SPIRAL CT SCAN WITHOUT CONTRAST|Y|Y||PROXY|MICROSCOPIST 1|5|Visit_5|90|5|WASHOUT|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|e443f82e-43a8-4710-bff4-fd2b2f4d512f|10|FEV_1|Forced Expiratory Volume in 0.1 Second|[?]|SITTING|[?]|KIT|[?]|1|EID 50/mL|LYMPH NODE|CONTRALATERAL|TIP|OPHTHALMOSCOPY||||CLINICAL RESEARCH ASSOCIATE|RATER 2|5|Visit_5|90|3|TREATMENT|2021-03-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-07
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|FEV1|Forced Expiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|kBq|[?]|1|%(w/v)|HEEL OF THE FOOT|BILATERAL|VENTRAL|CISH|Y|||DOMESTIC PARTNER|OPHTHALMOLOGIST|1|Visit_1|10|2|TREATMENT|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|2|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|SUPINE|||[?]|1|ug/m2/day|SUBGLOTTIS|BILATERAL|INFERIOR|RADIOGRAPHY||Y|Y|INVESTIGATOR|RATER 2|1|Visit_1|10|4|TREATMENT|2020-06-22|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-06
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|3|RER|Respiratory Exchange Ratio|[?]|SITTING, LEGS DEPENDENT|[?]|mL/g/min|[?]|1|AFU|L1 VERTEBRA|BILATERAL|FACIAL|MEDIASTINOSCOPY||||FRIEND|READER 1|2|Visit_2|25|6|TREATMENT|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|4|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|REVERSE TRENDELENBURG|[?]|GPS U|[?]|1|nmol BCE/L|RIB 4|BILATERAL|DEEP|TOLUIDINE BLUE STAIN||||FRIEND|RADIOLOGIST 1|2|Visit_2|25|2|TREATMENT|2020-07-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-26
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|5|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|dyn|[?]|1|mg/h|PARACOLIC GUTTER|RIGHT|CAUDAL|REFRACTOMETRY||||INVESTIGATOR|RATER 2|3|Visit_3|40|5|TREATMENT|2020-07-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|6|PLMBLFLW|Pulmonary Blood Flow|[?]|DECUBITUS|[?]|mEq/g|[?]|1|sec|LUNG, LEFT UPPER LOBE|IPSILATERAL|PERIPHERAL|DYNAMIC SUSCEPTIBILITY-CONTRAST MRI||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|3|Visit_3|40|5|SCREENING|2020-07-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-01
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|7|FEV1FVC6|FEV1/FVC6|[?]|SITTING|||[?]|1|mg/h|LOWER RESPIRATORY SYSTEM|RIGHT|VOLAR|DYNAMIC LIGHT SCATTERING|||Y|HEALTH CARE PROFESSIONAL|OPHTHALMOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|8|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SLING|[?]|keV|[?]|1|kg/mol|LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT|CONTRALATERAL|ANTEROLATERAL|SPECTROPHOTOMETRY||||SPOUSE|MICROSCOPIST 1|4|Visit_4|65|5|WASHOUT|2020-08-16|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-10
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|9|FIV1PP|Percent Predicted FIV1|[?]|PRONE|||[?]|1|uEq/L|PARAMETRIUM|CONTRALATERAL|VOLAR|HEMATOXYLIN AND EOSIN STAIN|||Y|INTERVIEWER|DERMATOLOGIST|5|Visit_5|90|4|FOLLOW-UP|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|10|FEV1FVC|FEV1/FVC|[?]|SLING|[?]|psec|[?]|1|cmH2O*s2/mL|MEDIAN NERVE|UNILATERAL|PERIVENTRICULAR|CT SCAN|Y|Y||PARENT|ADJUDICATOR|5|Visit_5|90|3|TREATMENT|2020-09-10|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-26
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|1|FEF_2|Forced Expiratory Flow in 0.2 Second|[?]|PRONE|||[?]|1|ug/kg/min|URETHRA, POSTERIOR|IPSILATERAL|PARIETO-OCCIPITAL|PHASE CONTRAST MICROSCOPY|||Y|SIBLING|READER 3|1|Visit_1|10|3|WASHOUT|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|2|LOBVOLPP|Percent Predicted Lobar Volume|[?]|FOWLERS|[?]|Ci/ug|[?]|1|uU/L|FIRST LEFT POSTEROLATERAL BRANCH ARTERY|IPSILATERAL|ANTEROTEMPORAL|VIRUS PLAQUE ASSAY|Y|Y||PARENT|PHYSIOTHERAPIST|1|Visit_1|10|4|TREATMENT|2020-10-30|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-17
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|3|QUASCOMP|Quasi-Static Compliance|[?]|FOWLERS|[?]|kIU|[?]|1|10^7 TCID 50/dose|CEREBRAL HEMISPHERE, LEFT|CONTRALATERAL|VENTRAL|FARNSWORTH-MUNSELL 100 HUE TEST||||INTERVIEWER|NEUROLOGIST|2|Visit_2|25|7|FOLLOW-UP|2020-11-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|4|RELSZCHG|Relative Size Change|[?]|STANDING, BENT FORWARD|[?]|tuberculin unit/mL|[?]|1|g/cage/wk|PULMONARY VALVE|UNILATERAL|MEDIAL|ENDPOINT DILUTION ASSAY|Y|Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST|2|Visit_2|25|5|WASHOUT|2020-11-14|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-13
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|5|INFLTIND|Infiltrates Indicator|[?]|SEMI-RECUMBENT|[?]|ng/day|[?]|1|v/v|TIBIOTARSAL JOINT|LATERAL|ANTEROLATERAL|CINEANGIOGRAPHY||||CHILD|ONCOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-11-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|6|PLMXRS|Pulmonary Reactance|[?]|PRONE|[?]|mEq/L|[?]|1|ng/L|URETHRA, ANTERIOR|LEFT|TIP|SLIT LAMP||Y||FAMILY MEMBER|ONCOLOGIST 1|3|Visit_3|40|2|WASHOUT|2020-11-29|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-27
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|7|SRAW|Specific Airway Resistance|[?]|SITTING, LEGS DEPENDENT|[?]|10^3/hpf|[?]|1|umol/mol|RIB 4|BILATERAL|SUBCORTICAL|TOTAL BODY RADIOGRAPHY|Y|||FAMILY MEMBER|OPTOMETRIST|4|Visit_4|65|6|SCREENING|2020-12-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|8|FVC6|Forced Vital Capacity in 6 Seconds|[?]|LATERAL DECUBITUS|[?]|10^7 CFU|[?]|1|GBq/g|CALF|BILATERAL|ANTEROPOSTERIOR|ELECTROCHEMILUMINESCENCE IMMUNOASSAY||||FRIEND|ADJUDICATOR 3|4|Visit_4|65|6|WASHOUT|2020-12-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-23
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|9|PEFREV|PEF Reversibility|[?]|RIGHT LATERAL DECUBITUS|[?]|mg/mL/min|[?]|1|ug/dL|EPITROCHLEAR LYMPH NODE|LEFT|OCCIPITAL|CONTRAST ENHANCED CT SCAN||||INTERVIEWER|MICROSCOPIST 2|5|Visit_5|90|3|SCREENING|2021-01-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|8a2147b1-2deb-410e-a298-d028a5efc555|10|FEV1FVC6|FEV1/FVC6|[?]|LATERAL DECUBITUS|[?]|pmol/L|[?]|1|cycle/min|CORPUS STRIATUM|BILATERAL|ROSTRAL|ELECTROPHORESIS||Y||FRIEND|PATHOLOGIST 1|5|Visit_5|90|4|TREATMENT|2021-01-18|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-24
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|SVCPP|Percent Predicted Slow Vital Capacity|[?]|UNCONSTRAINED|[?]|U/g Hb|[?]|1|ohm|GASTROINTESTINAL TRACT, WALL|RIGHT|ANTEROTEMPORAL|MICRO-LATEX PARTICLE-MEDIATED IMMUNOASSAY||||INDEPENDENT ASSESSOR|ADJUDICATOR 3|1|Visit_1|10|3|SCREENING|2020-07-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|2|FIFMAXPP|Percent Predicted FIFmax|[?]|STANDING, BENT FORWARD|[?]|copies/ug|[?]|1|BAU|LIVER, QUADRATE LOBE|RIGHT|UPPER|PALPATION||||INVESTIGATOR|ENDOCRINOLOGIST|1|Visit_1|10|2|TREATMENT|2020-07-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-15
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|3|DLCOVAPP|Percent Predicted DLCO/VA|[?]|REVERSE TRENDELENBURG|[?]|Ci|[?]|1|log10 TCID 50/mL|TRANSVERSE TARSAL JOINT|UNILATERAL|MIDLINE|CAPILLARY ELECTROPHORESIS|Y|||INTERVIEWER|PEDIATRIC NEUROLOGIST|2|Visit_2|25|4|TREATMENT|2020-07-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SEMI-RECUMBENT|[?]|mEq/ug|[?]|1|deg2|MIDDLE PHALANX 3 OF THE HAND|RIGHT|ANTEROTEMPORAL|INFRARED SPECTROMETRY||Y||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|2|Visit_2|25|6|TREATMENT|2020-07-20|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|5|ICREV|IC Reversibility|[?]|FOWLERS|||[?]|1|kBq/uL|CALF|LATERAL|CENTRAL|HPLC/MS|||Y|CLINICAL RESEARCH ASSOCIATE|ONCOLOGIST 2|3|Visit_3|40|4|TREATMENT|2020-08-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|6|FEV_PEF|FEV at PEF|[?]|STANDING|||[?]|1|mL/sec/1.73m2|CERVICAL VERTEBRA|LEFT|SUBCORTICAL|RAJI CELL RIA|Y|Y|Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|3|Visit_3|40|6|SCREENING|2020-08-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|7|VO2|Oxygen Consumption|[?]|STANDING, BENT FORWARD|||[?]|1|kg|CORONARY VEIN|LEFT|LOWER|SCINTIGRAPHY|Y||Y|ADJUDICATOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|6|WASHOUT|2020-08-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|8|FEV1PP|Percent Predicted FEV1|[?]|PRONE|[?]|steps/min|[?]|1|FIU|GLOSSOPHARYNGEAL NERVE|LATERAL|FORE|EPSILOMETER|Y|||CLINICAL RESEARCH ASSOCIATE|RADIOLOGIST|4|Visit_4|65|7|TREATMENT|2020-08-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-22
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|9|IRV|Inspiratory Reserve Volume|[?]|LEFT LATERAL DECUBITUS|||[?]|1|100 IU/mL|DISTAL PHALANX 5 OF THE HAND|LEFT|INNER|PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY|||Y|SIBLING|FORENSIC PATHOLOGIST|5|Visit_5|90|6|TREATMENT|2020-09-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|033db3bf-17fb-4872-afdb-1eea3dac6d85|10|TLC|Total Lung Capacity|[?]|FOWLERS|[?]|Newton|[?]|1|eq|SIGMOID SINUS|LATERAL|DEEP|STRESS ECHOCARDIOGRAPHY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST 1|5|Visit_5|90|4|TREATMENT|2020-09-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-26
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|TGV|Thoracic Gas Volume|[?]|LATERAL DECUBITUS|[?]|STEPS|[?]|1|DRINK|METATARSOPHALANGEAL JOINT|IPSILATERAL|VENTRAL|PH METER MEASUREMENT METHOD|Y|||GUARDIAN|RATER 2|1|Visit_1|10|2|WASHOUT|2020-06-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|2|RVPP|Percent Predicted Residual Volume|[?]|DECUBITUS|||[?]|1|m/sec2|CORPUS CALLOSUM, GENU|IPSILATERAL|LOWER FLEXOR SURFACE|TOTAL BODY IRRADIATION|Y||Y|VENDOR|PATHOLOGIST 1|1|Visit_1|10|6|WASHOUT|2020-06-19|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-03
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SEMI-RECUMBENT|[?]|10^6 RNA copies/mL|[?]|1|mMU/mL|URETHRA|RIGHT|FORE|IMPULSE OSCILLOMETRY||||CLINICAL STUDY SPONSOR|PHYSIOTHERAPIST|2|Visit_2|25|1|FOLLOW-UP|2020-07-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|4|FEV1FVC|FEV1/FVC|[?]|PRONE|[?]|ug/m2|[?]|1|dmol|SUPERFICIAL LYMPH NODE|IPSILATERAL|ANTEROTEMPORAL|MEDIASTINOSCOPY||Y||ADJUDICATOR|ENDOCRINOLOGIST|2|Visit_2|25|6|WASHOUT|2020-07-04|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-17
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|5|QUASCOMP|Quasi-Static Compliance|[?]|PRONE|[?]|/day|[?]|1|10^3 organisms|PALPEBRAL CONJUNCTIVA|RIGHT|ANTEROLATERAL|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|||GUARDIAN|NEUROLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-07-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|6|ALVVOL|Alveolar Volume|[?]|STANDING|||[?]|1|fg|MEDIASTINUM, POSTERIOR|LEFT|LOWER FLEXOR SURFACE|NEXT GENERATION TARGETED SEQUENCING|||Y|SIGNIFICANT OTHER|RADIOLOGIST|3|Visit_3|40|2|WASHOUT|2020-07-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-06-14
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|7|MALIND|Malignancy Indicator|[?]|LATERAL DECUBITUS|[?]|psec|[?]|1|Torr|AXILLA|LATERAL|VOLAR|LOOP-MEDIATED ISOTHERMAL AMPLIFICATION||||FAMILY MEMBER|ONCOLOGIST|4|Visit_4|65|3|TREATMENT|2020-08-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|8|FIF25|Forced Inspiratory Flow at 25%|[?]|RIGHT LATERAL DECUBITUS|[?]|KALLIKREIN INHIBITOR UNIT|[?]|1|nmol/L/min|LYMPH NODE|LEFT|VENTROLATERAL|MAMMOGRAPHY||||PROXY|HEMATOLOGIST|4|Visit_4|65|2|TREATMENT|2020-08-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-14
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|9|FEV1SVC|FEV1/SVC|[?]|UNCONSTRAINED|[?]|TRANSDUCING UNIT|[?]|1|copies/mL|CORNEAL EPITHELIUM|LATERAL|BASAL|BRDU CELLULAR PROLIFERATION ASSAY||||GUARDIAN|ADJUDICATOR 1|5|Visit_5|90|2|SCREENING|2020-09-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|10|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|SITTING, LEGS DEPENDENT|[?]|BAR|[?]|1|uCi/L|INTERPHALANGEAL JOINT 2|LEFT|INNER|MALDI-TOF||||CLINICAL RESEARCH ASSOCIATE|INTERNIST|5|Visit_5|90|6|WASHOUT|2020-09-07|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-24
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|1|RV|Residual Volume|[?]|RIGHT LATERAL DECUBITUS|[?]|ukat/L|[?]|1|PIXEL|ESOPHAGUS, LOWER THIRD|IPSILATERAL|SURFACE|SPIROMETRY||Y||ADJUDICATOR|MICROSCOPIST 2|1|Visit_1|10|6|SCREENING|2021-01-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|2|FEV1PP|Percent Predicted FEV1|[?]|LEFT LATERAL DECUBITUS|||[?]|1|10^6 organisms/mg|METACARPAL BONE|BILATERAL|ANTEROMEDIAL|POLYSOMNOGRAPHY|||Y|INDEPENDENT ASSESSOR|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|1|TREATMENT|2021-01-12|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-16
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|3|SALKB|Salazar-Knowles Equation Parameter B|[?]|SLING|||[?]|1|U/g Hb|VAGINAL WALL|BILATERAL|OUTER|WHOLE TRANSCRIPTOME SEQUENCING|||Y|FRIEND|RATER 1|2|Visit_2|25|6|SCREENING|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|4|FEV_PEF|FEV at PEF|[?]|SITTING|[?]|ug/mol|[?]|1|mL/cage/wk|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|LEFT|ANTEROTEMPORAL|SURFACE PLASMON RESONANCE||||ADJUDICATOR|READER 2|2|Visit_2|25|4|SCREENING|2021-01-27|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-16
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|5|FEF2575P|Percent Predicted FEF25-75|[?]|REVERSE TRENDELENBURG|[?]|steps/min|[?]|1|nkat/g Hb|SYNOVIAL FLUID|IPSILATERAL|PERIVENTRICULAR|REAL-TIME POLYMERASE CHAIN REACTION ASSAY|Y|||SIGNIFICANT OTHER|MICROSCOPIST|3|Visit_3|40|2|FOLLOW-UP|2021-02-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|6|VO2|Oxygen Consumption|[?]|RIGHT LATERAL DECUBITUS|[?]|in|[?]|1|ohm|CEREBRAL SUBCORTEX|RIGHT|DISTAL|NUCLEAR RADIOLOGY||||DOMESTIC PARTNER|RADIOLOGIST 2|3|Visit_3|40|1|WASHOUT|2021-02-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|7|FIVC|Forced Inspiratory Vital Capacity|[?]|SITTING|[?]|APPLICATION|[?]|1|CFU/g|PALATE|LEFT|PERIVENTRICULAR|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||||SPOUSE|PHYSIOTHERAPIST|4|Visit_4|65|3|WASHOUT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|8|LOBVOLPP|Percent Predicted Lobar Volume|[?]|SITTING|[?]|%/min|[?]|1|10^9 CFU/mL|UMBILICUS|LEFT|ANTERIOR|ANTIBIOTIC AGAR SCREEN||Y||DOMESTIC PARTNER|ADJUDICATOR 3|4|Visit_4|65|5|TREATMENT|2021-03-08|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-27
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|9|IRV|Inspiratory Reserve Volume|[?]|FOWLERS|[?]|BAG|[?]|1|ngEq/L|KNEE JOINT TENDONS|LEFT|LOWER FLEXOR SURFACE|REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS||||NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 2|5|Visit_5|90|5|WASHOUT|2021-04-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|8dd493b7-a892-4cab-8f69-701471c51d99|10|DLCOPP|Percent Predicted DLCO|[?]|SITTING, LEGS DEPENDENT|[?]|Gy|[?]|1|vg/dose|PROXIMAL INTERPHALANGEAL JOINT 4|UNILATERAL|PERIVENTRICULAR|ULTRASONOGRAPHIC ELASTOGRAPHY||Y||HEALTH CARE PROFESSIONAL|RADIOLOGIST|5|Visit_5|90|5|TREATMENT|2021-04-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-05
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|FVC6|Forced Vital Capacity in 6 Seconds|[?]|STANDING|[?]|fL|[?]|1|cm/min|INTERPHALANGEAL JOINT 3 OF THE FOOT|IPSILATERAL|LOWER EXTENSOR SURFACE|ZIEHL NEELSEN ACID FAST STAIN|Y|||HEALTH CARE PROFESSIONAL|READER 1|1|Visit_1|10|3|TREATMENT|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|2|FIF25|Forced Inspiratory Flow at 25%|[?]|RIGHT LATERAL DECUBITUS|[?]|EP U|[?]|1|10^3 CFU/mL|HEPATIC ARTERY|CONTRALATERAL|UPPER FLEXOR SURFACE|LC/MS||||DOMESTIC PARTNER|RADIOLOGIST 2|1|Visit_1|10|5|WASHOUT|2020-11-07|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-17
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|3|IRVPP|Percent Predicted IRV|[?]|STANDING, BENT FORWARD|[?]|/2000 RBC|[?]|1|in2|SKIN OF THE HEAD|RIGHT|INTERMEDIATE|MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING||||GUARDIAN|ONCOLOGIST 2|2|Visit_2|25|6|TREATMENT|2020-11-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|STANDING, BENT FORWARD|[?]|WEEKS|[?]|1|mU/g|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|UNILATERAL|INNER|PSEUDOVIRION-BASED NEUTRALIZATION ASSAY|Y|Y||INTERVIEWER|MICROSCOPIST 2|2|Visit_2|25|1|FOLLOW-UP|2020-11-22|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-24
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|5|TSUELAS|Tissue Elastance|[?]|STANDING|[?]|RING|[?]|1|ms/mmHg|TENTORIUM CEREBELLI|CONTRALATERAL|LOWER|TURBIDIMETRY||||HEALTH CARE PROFESSIONAL|NEUROLOGIST|3|Visit_3|40|5|TREATMENT|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|6|ICPP|Percent Predicted Inspiratory Capacity|[?]|STANDING|||[?]|1|mmol|SCAPHOID-LUNATE-CAPITATE JOINT|LEFT|FRONTAL|IMMUNOCHEMILUMINOMETRIC ASSAY|Y|Y|Y|CLINICAL STUDY SPONSOR|ENDOCRINOLOGIST|3|Visit_3|40|2|SCREENING|2020-12-07|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|7|ICREV|IC Reversibility|[?]|SLING|[?]|Ci/g|[?]|1|CCID 50/mL|LUNG, RIGHT, MIDDLE LOBE, LATERAL SEGMENT|BILATERAL|UPPER EXTENSOR SURFACE|NUCLEIC ACID BASED METHOD||||INTERVIEWER|RATER|4|Visit_4|65|2|TREATMENT|2021-01-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|8|FEV1FVC6|FEV1/FVC6|[?]|REVERSE TRENDELENBURG|[?]|L/s/kPa|[?]|1|10^9 organisms/mg|TIBIA SHAFT|LEFT|LOWER EXTENSOR SURFACE|GC/MS|Y|||SPOUSE|FORENSIC PATHOLOGIST|4|Visit_4|65|6|TREATMENT|2021-01-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-24
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|9|TSUHYS|Tissue Hysteresivity|[?]|SITTING|[?]|/7.5 mL|[?]|1|cd*s/m2|PANCREATIC DUCT|BILATERAL|ANTEROMEDIAL|CORONARY ANGIOGRAPHY||||CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|5|Visit_5|90|3|TREATMENT|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|10|GAW|Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|U/L|[?]|1|kIU|FOOT PHALANX|RIGHT|FORE|REAL-TIME POLYMERASE CHAIN REACTION ASSAY||||DOMESTIC PARTNER|ADJUDICATOR 1|5|Visit_5|90|6|TREATMENT|2021-01-26|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-08
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|SRAW|Specific Airway Resistance|[?]|SEMI-FOWLERS|[?]|CAPLET|[?]|1|ug/day|PERIPHERAL NERVE|IPSILATERAL|INNER|SLOAN LETTER EYE CHART 2.5%|Y|||STUDY SUBJECT|PHYSIOTHERAPIST|1|Visit_1|10|5|TREATMENT|2020-09-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|2|AIRTRAP|Air Trapping|[?]|SITTING, LEGS DEPENDENT|[?]|pkat/L|[?]|1|U/g/min|HEART|BILATERAL|DISTAL|DISK DIFFUSION||||STUDY SUBJECT|ONCOLOGIST|1|Visit_1|10|2|FOLLOW-UP|2020-09-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-18
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|3|GAW|Airway Conductance|[?]|FOWLERS|[?]|GBq/ug|[?]|1|dmol|SECOND RIGHT POSTEROLATERAL ARTERY|LEFT|DISTAL|DIFFUSION WEIGHTED MRI||||INVESTIGATOR|OPHTHALMOLOGIST|2|Visit_2|25|4|TREATMENT|2020-09-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|4|FIO2|Fraction of Inspired Oxygen|[?]|LATERAL DECUBITUS|[?]|mg/kg/week|[?]|1|10^3 CFU/g|LOWER JUGULAR LYMPH NODE|UNILATERAL|VENTROLATERAL|MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION||Y||ADJUDICATION COMMITTEE|PATHOLOGIST 1|2|Visit_2|25|1|SCREENING|2020-09-19|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-10-29
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|5|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|LEFT LATERAL DECUBITUS|[?]|SYRINGE|[?]|1|/500 WBC|ORBICULARIS OCULI MUSCLE|LEFT|INNER|FLUORESCENT SPOT TEST||Y||PROXY|MICROSCOPIST 1|3|Visit_3|40|5|TREATMENT|2020-10-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|6|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|10^6 organisms|[?]|1|mEq|INTRAHEPATIC BILE DUCT|CONTRALATERAL|VENTROLATERAL|ENDOSCOPY||||PARENT|NEUROLOGIST 2|3|Visit_3|40|6|TREATMENT|2020-10-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-29
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|7|TLC|Total Lung Capacity|[?]|SEMI-RECUMBENT|[?]|kg/cm|[?]|1|eq|PANCREAS, HEAD|LATERAL|DORSAL|AUTOMATED CAPILLARY ELECTROPHORESIS WESTERN BLOT||Y||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-10-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|8|PEFTIME|Peak Expiratory Flow Time|[?]|STANDING|||[?]|1|mEq/ug|MIDDLE PHALANX 5 OF THE HAND|UNILATERAL|CRANIAL|HPLC/IEX|||Y|SIBLING|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|4|Visit_4|65|4|SCREENING|2020-10-29|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-05
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|9|FEV6PP|Percent Predicted FEV6|[?]|RIGHT LATERAL DECUBITUS|[?]|mmol/g|[?]|1|GPS U|MALE REPRODUCTIVE SYSTEM|LATERAL|SURFACE|PUPILLOMETRY||||STUDY SUBJECT|CLINICAL PATHOLOGIST|5|Visit_5|90|5|WASHOUT|2020-11-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|10|FVC|Forced Vital Capacity|[?]|TRENDELENBURG|||[?]|1|mol|UMBILICAL CORD|UNILATERAL|PERIPHERAL|PHASE-CONTRAST MRI|Y|Y|Y|PARENT|RATER|5|Visit_5|90|3|SCREENING|2020-11-23|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-21
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|TRENDELENBURG|[?]|g/L|[?]|1|dyn|LIVER FISSURE|RIGHT|FRONTAL|SLOAN LETTER EYE CHART 100%||Y||SIBLING|DEVELOPMENTAL PSYCHOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-11-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|2|FEF2575|Forced Expiratory Flow 25-75%|[?]|REVERSE TRENDELENBURG|||[?]|1|CCID 50/mL|LUMBRICAL MUSCLES OF THE HAND|UNILATERAL|INFERIOR|X-RAY FLUORESCENCE SPECTROMETRY|||Y|CAREGIVER|ADJUDICATOR 1|1|Visit_1|10|7|TREATMENT|2020-11-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-15
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|3|PEFTIME|Peak Expiratory Flow Time|[?]|SUPINE|[?]|JDF Unit|[?]|1|IU/mmol|GENITALIA|LATERAL|VENTRAL|SLIT LAMP PHOTOGRAPHY||Y||FAMILY MEMBER|READER|2|Visit_2|25|2|TREATMENT|2020-12-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|4|FEF_1|Forced Expiratory Flow in 0.1 Second|[?]|SUPINE|[?]|dpm/mL|[?]|1|Bq/mL|LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT|LATERAL|CENTRAL|MANUAL COUNT||Y||ADJUDICATION COMMITTEE|MICROSCOPIST 3|2|Visit_2|25|6|SCREENING|2020-12-05|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-09
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|5|PLMBLFLW|Pulmonary Blood Flow|[?]|LEFT LATERAL DECUBITUS|[?]|cd*s/m2|[?]|1|nm|TIBIALIS ANTERIOR MUSCLE|CONTRALATERAL|MEDIAL|MOUSE PROTECTION ASSAY||||HEALTH CARE PROFESSIONAL|RATER 1|3|Visit_3|40|4|FOLLOW-UP|2020-12-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|6|FVC|Forced Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|OI50|[?]|1|ug/dose|PARA-AORTIC LYMPH NODE|UNILATERAL|PROXIMAL|CISH|Y|Y||STUDY SUBJECT|ONCOLOGIST 2|3|Visit_3|40|4|SCREENING|2020-12-20|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-12-15
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|7|SGAW|Specific Airway Conductance|[?]|TRENDELENBURG|[?]|HOURS|[?]|1|Newton|COLON|IPSILATERAL|VENTRAL|GC/MS-CI||||FAMILY MEMBER|ONCOLOGIST|4|Visit_4|65|2|TREATMENT|2021-01-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|8|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING|[?]|cL|[?]|1|dmol|SCAPHOID-TRAPEZIUM JOINT|LEFT|APICAL|WESTERGREN||||INTERVIEWER|OPTOMETRIST|4|Visit_4|65|6|TREATMENT|2021-01-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-15
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|9|SALKK|Salazar-Knowles Equation, K|[?]|PRONE|[?]|10^6 copies/mL|[?]|1|pg/dL|INFRATENTORIAL BRAIN|CONTRALATERAL|UPPER EXTENSOR SURFACE|NO INFORMATION|Y|||INDEPENDENT ASSESSOR|PATHOLOGIST 2|5|Visit_5|90|5|TREATMENT|2021-02-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|10|FIV1PP|Percent Predicted FIV1|[?]|SEMI-RECUMBENT|[?]|RING|[?]|1|mL/h|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|RIGHT|ANTEROMEDIAL|QUANTITATIVE COMPUTED TOMOGRAPHY||||PROXY|ADJUDICATOR|5|Visit_5|90|6|TREATMENT|2021-02-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-02
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|SRAW|Specific Airway Resistance|[?]|SLING|[?]|ng/mol|[?]|1|m/sec|LEFT CIRCUMFLEX CORONARY ARTERY|LATERAL|SUPERIOR|SPIRAL CT||||CLINICAL RESEARCH ASSOCIATE|ADJUDICATOR 1|1|Visit_1|10|5|FOLLOW-UP|2021-01-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|2|EV_05FVC|Forced Expiratory Volume in 0.05 S/FVC|[?]|STANDING, BENT FORWARD|[?]|deg|[?]|1|PA|DIAPHRAGMATIC LYMPH NODE|RIGHT|VOLAR|GC/MS-EI|Y|Y||SPOUSE|OTOLARYNGOLOGIST|1|Visit_1|10|3|SCREENING|2021-01-05|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-06
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|3|FIV1|Forced Inspiratory Volume in 1 Second|[?]|RIGHT LATERAL DECUBITUS|[?]|titer|[?]|1|g/kg|MESENTERIC LYMPH NODE|UNILATERAL|INTERMEDIATE|DIGITAL PCR ARRAY||||CHILD|PHYSIOTHERAPIST|2|Visit_2|25|7|TREATMENT|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|4|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SUPINE|[?]|in|[?]|1|mmol/mol|RIB 8|IPSILATERAL|CRANIAL|AUDIOMETRY||||ADJUDICATOR|READER 3|2|Visit_2|25|5|WASHOUT|2021-01-20|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-03-28
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|5|RAW|Airway Resistance|[?]|STANDING|[?]|uCi|[?]|1|in2|BRACHIAL VEIN|UNILATERAL|UPPER EXTENSOR SURFACE|OPTICAL DENSITY MEASUREMENT||||STUDY SUBJECT|ADJUDICATOR 3|3|Visit_3|40|3|SCREENING|2021-02-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|6|RV|Residual Volume|[?]|PRONE|||[?]|1|L/kg|AORTIC VALVE, RIGHT CORONARY CUSP|IPSILATERAL|VENTRAL|BAC ACGH|||Y|SPOUSE|PATHOLOGIST 2|3|Visit_3|40|3|TREATMENT|2021-02-04|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-01
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|7|PEF|Peak Expiratory Flow|[?]|STANDING, BENT FORWARD|||[?]|1|BOWL|GREAT TROCHANTER|CONTRALATERAL|DORSOLATERAL|POTENTIOMETRY|||Y|PROXY|ADJUDICATOR 2|4|Visit_4|65|2|TREATMENT|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|8|ICREV|IC Reversibility|[?]|LEFT LATERAL DECUBITUS|||[?]|1|kBq|METACARPAL BONE 4|RIGHT|SURFACE|PALPATION|||Y|VENDOR|READER 1|4|Visit_4|65|7|FOLLOW-UP|2021-03-01|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-29
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|9|TLCPP|Percent Predicted Total Lung Capacity|[?]|PRONE|[?]|10^6 organisms|[?]|1|pmol/10^9 cells|RIB 7|RIGHT|LOWER MEDIAL|FREEZING POINT DEPRESSION||||HEALTH CARE PROFESSIONAL|RATER 2|5|Visit_5|90|4|TREATMENT|2021-03-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|b49ef90c-a17e-4554-9fa6-af72b4d56a06|10|FEV1SVC|FEV1/SVC|[?]|LEFT LATERAL DECUBITUS|[?]|VIAL|[?]|1|mg/L FEU|OCCIPITAL LYMPH NODE|LEFT|DEEP|ELISPOT||||SPOUSE|DERMATOLOGIST|5|Visit_5|90|6|TREATMENT|2021-03-26|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-12
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|1|FEV1FVC|FEV1/FVC|[?]|SUPINE|||[?]|1|in2|GRACILIS MUSCLE|IPSILATERAL|VENTRAL|MICROSCOPY|||Y|CLINICAL RESEARCH ASSOCIATE|MICROSCOPIST 1|1|Visit_1|10|3|TREATMENT|2020-11-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|2|FIF25|Forced Inspiratory Flow at 25%|[?]|SUPINE|[?]|mg/mol|[?]|1|ng/dL|PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT|BILATERAL|ROSTRAL|IMMUNORADIOMETRIC ASSAY||Y||ADJUDICATION COMMITTEE|ONCOLOGIST 2|1|Visit_1|10|2|SCREENING|2020-11-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-02
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|3|PLMBLFLW|Pulmonary Blood Flow|[?]|SLING|[?]|BEAM BREAKS|[?]|1|kg/m2|ASCENDING AORTA, AORTIC ROOT|IPSILATERAL|PROXIMAL VOLAR|SPIROMETRY||||INTERVIEWER|OTOLARYNGOLOGIST|2|Visit_2|25|7|TREATMENT|2020-12-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|4|FIF50|Forced Inspiratory Flow at 50%|[?]|FOWLERS|[?]|fg|[?]|1|PIXELS/cm|VAGINA|LATERAL|NASAL|MICRO BROTH DILUTION||||GUARDIAN|RATER|2|Visit_2|25|3|TREATMENT|2020-12-10|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-14
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|5|ERV|Expiratory Reserve Volume|[?]|TRENDELENBURG|[?]|pptr|[?]|1|BAU|LUNG, RIGHT, INFERIOR LOBE, SUPERIOR SEGMENT|IPSILATERAL|CRANIAL|MUGA||||ADJUDICATOR|DEVELOPMENTAL PSYCHOLOGIST|3|Visit_3|40|4|TREATMENT|2020-12-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|6|FIF50|Forced Inspiratory Flow at 50%|[?]|RIGHT LATERAL DECUBITUS|[?]|s/h|[?]|1|BAU|RETROPERITONEUM|UNILATERAL|DEEP|DIGITAL PCR||||FAMILY MEMBER|MICROSCOPIST 1|3|Visit_3|40|5|FOLLOW-UP|2020-12-25|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-03
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|7|RER|Respiratory Exchange Ratio|[?]|STANDING, BENT FORWARD|[?]|log10 IU/mL|[?]|1|mL/kg/day|EYE|UNILATERAL|PARIETO-OCCIPITAL|MRI WITHOUT CONTRAST||||CLINICAL RESEARCH COORDINATOR|NEUROLOGIST|4|Visit_4|65|4|TREATMENT|2021-01-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|8|ALVVOL|Alveolar Volume|[?]|SEMI-FOWLERS|||[?]|1|K|PYRAMIDAL TRACTS, BRAINSTEM|RIGHT|CRANIAL|QUANTITATIVE COMPUTED TOMOGRAPHY|Y||Y|CLINICAL RESEARCH COORDINATOR|ADJUDICATOR 3|4|Visit_4|65|2|SCREENING|2021-01-19|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-21
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|9|SALKK|Salazar-Knowles Equation, K|[?]|FOWLERS|||[?]|1|MASK|ESOPHAGUS, ABDOMINAL|IPSILATERAL|PROXIMAL|PERIPHERAL ANGIOGRAPHY||Y|Y|SIBLING|FORENSIC PATHOLOGIST|5|Visit_5|90|7|WASHOUT|2021-02-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|df041193-ee4e-4835-8db9-5be9b832ded0|10|ERV|Expiratory Reserve Volume|[?]|SUPINE|||[?]|1|mL/cm3/min|THORACIC ARTERY|BILATERAL|LOWER FLEXOR SURFACE|HPLC-UV|Y||Y|PROXY|READER 1|5|Visit_5|90|2|TREATMENT|2021-02-13|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-16
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|IVC|Inspiratory Vital Capacity|[?]|PRONE|[?]|/cmH2O|[?]|1|MASK|POPLITEAL LYMPH NODE|UNILATERAL|PROXIMAL VOLAR|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||ADJUDICATOR|ADJUDICATOR 1|1|Visit_1|10|7|SCREENING|2021-01-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|2|AIRTRAP|Air Trapping|[?]|TRENDELENBURG|[?]|cm|[?]|1|PIXELS/cm|CHEST|LATERAL|SUPERFICIAL|NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY||Y||FAMILY MEMBER|MICROSCOPIST 3|1|Visit_1|10|1|FOLLOW-UP|2021-01-13|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-27
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|3|FEV6PP|Percent Predicted FEV6|[?]|REVERSE TRENDELENBURG|||[?]|1|nCi|BLOOD VESSEL|BILATERAL|APICAL|LINE PROBE ASSAY|||Y|SIBLING|OPHTHALMOLOGIST|2|Visit_2|25|4|TREATMENT|2021-01-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|4|IVC|Inspiratory Vital Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|PIPE|[?]|1|cm/min|MESENTERIC ARTERY|IPSILATERAL|CRANIAL|IN VITRO GENE EXPRESSION ASSAY|Y|||CLINICAL RESEARCH COORDINATOR|CLINICAL PATHOLOGIST|2|Visit_2|25|7|TREATMENT|2021-01-28|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|5|FEV3FVC|FEV3/FVC|[?]|SLING|||[?]|1|10^9 CFU|CHOROID PLEXUS|IPSILATERAL|SURFACE|SLOAN LETTER EYE CHART 100%|||Y|CLINICAL STUDY SPONSOR|NEUROLOGIST|3|Visit_3|40|4|TREATMENT|2021-02-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|6|RRS|Total Respiratory System Resistance|[?]|RIGHT LATERAL DECUBITUS|[?]|umol/mol|[?]|1|Sv|MUCOSA OF THE LIP|CONTRALATERAL|TEMPORAL|MALDI-TOF||||DOMESTIC PARTNER|ADJUDICATOR 1|3|Visit_3|40|5|FOLLOW-UP|2021-02-12|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-11
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|7|MEPPP|Percent Predicted MEP|[?]|SUPINE|[?]|KIT|[?]|1|MdFI|UNCINATE PROCESS OF PANCREAS|IPSILATERAL|ANTEROTEMPORAL|WRIGHT-GIEMSA STAIN|Y|||CHILD|CARDIOLOGIST|4|Visit_4|65|1|SCREENING|2021-03-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|8|RV|Residual Volume|[?]|SLING|[?]|10^6 organisms/g|[?]|1|10^4 CFU|COLON, LEFT|UNILATERAL|APICAL|TURBIDIMETRY|Y|||INTERVIEWER|UROLOGIST|4|Visit_4|65|6|WASHOUT|2021-03-09|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-10
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|9|ICPP|Percent Predicted Inspiratory Capacity|[?]|DECUBITUS|[?]|Torr|[?]|1|%/s|ELBOW JOINT|LEFT|TEMPORAL|PEAK FLOWMETRY||||ADJUDICATION COMMITTEE|FORENSIC PATHOLOGIST|5|Visit_5|90|5|WASHOUT|2021-04-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|e41a4505-a5aa-4cac-895b-04fe85737ca9|10|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|[?]|Absorbance U|[?]|1|APL U/mL|LEFT VENTRICULAR APICAL LATERAL SEGMENT|RIGHT|OCCIPITAL|HEMAGGLUTINATION INHIBITION ASSAY|Y|||DOMESTIC PARTNER|DERMATOLOGIST|5|Visit_5|90|4|SCREENING|2021-04-03|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-08
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|FEF50|Forced Expiratory Flow 50%|[?]|RIGHT LATERAL DECUBITUS|[?]|nkat/L|[?]|1|mg/animal|PRELARYNGEAL LYMPH NODE|LEFT|CRANIAL|GEL ELECTROPHORESIS||||ADJUDICATOR|FORENSIC PATHOLOGIST|1|Visit_1|10|5|WASHOUT|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|2|PEF|Peak Expiratory Flow|[?]|TRENDELENBURG|||[?]|1|ohm|BLADDER, DOME|CONTRALATERAL|PARIETO-OCCIPITAL|MANUAL CLOT DETECTION||Y|Y|CLINICAL RESEARCH ASSOCIATE|PATHOLOGIST 2|1|Visit_1|10|5|SCREENING|2021-01-15|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-20
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|3|FEV1PP|Percent Predicted FEV1|[?]|SUPINE|[?]|mg/cm2|[?]|1|10^12/L|C5 VERTEBRA|CONTRALATERAL|PERIPHERAL|ANGIOGRAPHY|Y|||CLINICAL RESEARCH COORDINATOR|RADIOLOGIST|2|Visit_2|25|3|TREATMENT|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|4|FEF_05|Forced Expiratory Flow in 0.05 Second|[?]|SITTING, LEGS DEPENDENT|[?]|log10 copies/mL|[?]|1|Bq/kg|CONJUNCTIVA|LATERAL|CAUDAL|FREEZING POINT DEPRESSION||Y||VENDOR|UROLOGIST|2|Visit_2|25|5|FOLLOW-UP|2021-01-30|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-02-28
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|5|PNIF|Peak Nasal Inspiratory Flow|[?]|DECUBITUS|[?]|mg/g/h|[?]|1|dpm/mg|CALCANEAL TUBEROSITY|CONTRALATERAL|APICAL|HILLMEN COLOR CHART||||SPOUSE|MICROSCOPIST 1|3|Visit_3|40|7|TREATMENT|2021-02-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|6|PEFREV|PEF Reversibility|[?]|TRENDELENBURG|[?]|log10 copies/mL|[?]|1|mol/mL|CLAVICLE|LATERAL|PROXIMAL|HPLC-FL||Y||CLINICAL RESEARCH COORDINATOR|HEMATOLOGIST|3|Visit_3|40|6|TREATMENT|2021-02-14|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-22
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|7|EXPRELTM|Expiration Relaxation Time|[?]|FOWLERS|[?]|kPa|[?]|1|L/kg|ANAL VERGE|BILATERAL|ANTEROLATERAL|FLUORESCENT LIFETIME IMAGING MICROSCOPY||||INDEPENDENT ASSESSOR|READER 1|4|Visit_4|65|1|SCREENING|2021-03-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|8|FEV1FVC|FEV1/FVC|[?]|DECUBITUS|[?]|MASK|[?]|1|/2000 RBC|LUNG, RIGHT|IPSILATERAL|POSTERIOR|WHOLE TRANSCRIPTOME SEQUENCING||||SPOUSE|READER 2|4|Visit_4|65|2|TREATMENT|2021-03-11|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-03-11
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|9|GAW|Airway Conductance|[?]|SEMI-FOWLERS|||[?]|1|IU/kg|METACARPAL BONE 4|UNILATERAL|SUPERIOR|JAFFE REACTION|||Y|ADJUDICATION COMMITTEE|NEUROLOGIST 1|5|Visit_5|90|5|FOLLOW-UP|2021-04-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|10|FRC|Functional Residual Capacity|[?]|RIGHT LATERAL DECUBITUS|[?]|nkat/L|[?]|1|IU/dL|GASTROINTESTINAL TRACT, LOWER, WALL|IPSILATERAL|VOLAR|NUCLEIC ACID AMPLIFICATION TEST||||PROXY|RATER 2|5|Visit_5|90|6|FOLLOW-UP|2021-04-05|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-19
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|FIF75|Forced Inspiratory Flow at 75%|[?]|STANDING|||[?]|1|mol/g|TIBIA SHAFT|BILATERAL|BASAL|TARGETED GENOME SEQUENCING|||Y|ADJUDICATOR|ENDOCRINOLOGIST|1|Visit_1|10|3|SCREENING|2020-12-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|2|ERVPP|Percent Predicted ERV|[?]|SEMI-RECUMBENT|[?]|g/animal|[?]|1|ug/kg/h|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|LEFT|FORE|IMMUNOTURBIDIMETRY||||FRIEND|CLINICAL PATHOLOGIST|1|Visit_1|10|3|WASHOUT|2020-12-12|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-01-07
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|3|DLCOHVAP|Percent Predicted HGB Corrected DLCO/VA|[?]|PRONE|[?]|10^8 PFU|[?]|1|ug/m2/day|PRONATOR TERES MUSCLE|LATERAL|LOWER EXTENSOR SURFACE|POTENTIOMETRY||||HEALTH CARE PROFESSIONAL|ONCOLOGIST|2|Visit_2|25|6|TREATMENT|2020-12-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|4|EVC|Expiratory Vital Capacity|[?]|SEMI-RECUMBENT|[?]|U/kg|[?]|1|U/m2/day|OPTIC DISC|CONTRALATERAL|ROSTRAL|IMMUNOCHEMILUMINOMETRIC ASSAY||||GUARDIAN|READER 3|2|Visit_2|25|2|TREATMENT|2020-12-27|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-10
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|5|FRCPP|Percent Predicted FRC|[?]|REVERSE TRENDELENBURG|||[?]|1|dpm/mg|TYMPANIC MEMBRANE|IPSILATERAL|FRONTAL|CT SCAN WITHOUT CONTRAST|Y||Y|FAMILY MEMBER|CARDIOLOGIST|3|Visit_3|40|2|TREATMENT|2021-01-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|6|PNEUMIND|Pneumonia Indicator|[?]|DECUBITUS|[?]|PACK|[?]|1|mm3/mm2/year|GREAT TROCHANTER|UNILATERAL|TIP|FARR ASSAY|Y|||SIBLING|RADIOLOGIST|3|Visit_3|40|7|WASHOUT|2021-01-11|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-22
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|7|VO2|Oxygen Consumption|[?]|LATERAL DECUBITUS|[?]|uSiemens|[?]|1|km|L4 VERTEBRA|LEFT|PARIETO-OCCIPITAL|FLUORESCEIN STAIN||Y||VENDOR|MICROSCOPIST 2|4|Visit_4|65|7|TREATMENT|2021-02-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|8|FEV1|Forced Expiratory Volume in 1 Second|[?]|SITTING|[?]|mN|[?]|1|g/kg|QUADRICEPS MUSCLE|LATERAL|TIP|FLOW MICROSCOPY||||PROXY|ADJUDICATOR 3|4|Visit_4|65|3|TREATMENT|2021-02-05|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-02-26
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|9|IC|Inspiratory Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|uCi/L|[?]|1|nkat/L|RIB|IPSILATERAL|FACIAL|POTENTIOMETRY||||SPOUSE|PHYSIOTHERAPIST|5|Visit_5|90|2|FOLLOW-UP|2021-03-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|10|FIO2|Fraction of Inspired Oxygen|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|s*kPa|HEAD AND NECK|RIGHT|MEDIAL|RADIOIMMUNOPRECIPITATION ASSAY|||Y|CLINICAL STUDY SPONSOR|ADJUDICATOR 3|5|Visit_5|90|7|FOLLOW-UP|2021-03-02|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-29
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|ALVVOL|Alveolar Volume|[?]|FOWLERS|||[?]|1|CIGARETTE|TYMPANIC MEMBRANE|BILATERAL|CRANIAL|AUTOREFRACTION|Y||Y|INVESTIGATOR|OPHTHALMOLOGIST|1|Visit_1|10|7|TREATMENT|2021-01-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|2|RAW|Airway Resistance|[?]|SITTING|[?]|Siemens|[?]|1|IU/g|PINEAL GLAND|CONTRALATERAL|INTERMEDIATE|ATOMIC ABSORPTION SPECTROMETRY|Y|||ADJUDICATOR|NEUROLOGIST 2|1|Visit_1|10|2|WASHOUT|2021-01-25|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-30
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|3|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|SLING|[?]|mg/mL/day|[?]|1|um/s|RIGHT POSTERIOR DESCENDING ARTERY|UNILATERAL|DORSAL|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|Y|||SPOUSE|PHYSIOTHERAPIST|2|Visit_2|25|2|SCREENING|2021-02-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|4|DLCOHCVA|HGB Corrected DLCO/VA|[?]|SUPINE|[?]|Hz/s|[?]|1|nmol/kg/day|SKULL, BASE|RIGHT|UPPER EXTENSOR SURFACE|DOUBLE IMMUNODIFFUSION|Y|||STUDY SUBJECT|ADJUDICATOR 3|2|Visit_2|25|2|WASHOUT|2021-02-09|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-10
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|5|PNIF|Peak Nasal Inspiratory Flow|[?]|PRONE|||[?]|1|mm2|THYROID GLAND, RIGHT LOBE|IPSILATERAL|UPPER|PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY|||Y|NON-HEALTH CARE PROFESSIONAL|READER|3|Visit_3|40|3|FOLLOW-UP|2021-02-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|6|SRAW|Specific Airway Resistance|[?]|LEFT LATERAL DECUBITUS|[?]|WAFER|[?]|1|mL/cm H2O|LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY|IPSILATERAL|FACIAL|OSCILLOMETRY||||DOMESTIC PARTNER|PATHOLOGIST 2|3|Visit_3|40|2|TREATMENT|2021-02-24|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-01-20
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|7|FRC|Functional Residual Capacity|[?]|LEFT LATERAL DECUBITUS|[?]|RFU|[?]|1|ug/kg/day|LUNG, LEFT, SUPERIOR LOBE, INFERIOR LINGULAR SEGMENT|CONTRALATERAL|MEDIAL|GIEMSA STAIN|Y|||HEALTH CARE PROFESSIONAL|RATER|4|Visit_4|65|1|TREATMENT|2021-03-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|8|FRC|Functional Residual Capacity|[?]|LEFT LATERAL DECUBITUS|||[?]|1|um|OCCIPITAL LYMPH NODE|LEFT|MIDLINE|SCANNING ELECTRON MICROSCOPY|Y||Y|STUDY SUBJECT|ENDOCRINOLOGIST|4|Visit_4|65|4|TREATMENT|2021-03-21|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2021-04-11
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|9|EV_1FVC|Forced Expiratory Volume in 0.1 S/FVC|[?]|DECUBITUS|||[?]|1|g/cage/wk|TOOTH|RIGHT|SUBCORTICAL|HEMAGGLUTINATION INHIBITION ASSAY|||Y|PARENT|MICROSCOPIST|5|Visit_5|90|3|TREATMENT|2021-04-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-20
e|RE|5abbbb78-2eeb-4d21-85ac-f5d18294c603|10|SGAW|Specific Airway Conductance|[?]|LEFT LATERAL DECUBITUS|[?]|Tbsp|[?]|1|kHz|SPINAL ACCESSORY NERVE|LATERAL|MEDIAL|RADIATION DOSIMETRY||Y||PROXY|INTERNIST|5|Visit_5|90|7|TREATMENT|2021-04-15|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2021-04-20
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|FIFMAX|Maximum Forced Inspiratory Flow|[?]|SITTING|[?]|mL/mmHg|[?]|1|POINT|ADDUCTOR HALLUCIS MUSCLE, TRANSVERSE HEAD|CONTRALATERAL|CAUDAL|FLUORESCENT ENZYME IMMUNOASSAY||Y||SPOUSE|OPHTHALMOLOGIST|1|Visit_1|10|6|FOLLOW-UP|2020-05-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|2|FIV1|Forced Inspiratory Volume in 1 Second|[?]|DECUBITUS|||[?]|1|TCID 50/dose|PROXIMAL URETHRA|RIGHT|INFERIOR|ENDOSCOPY|||Y|FRIEND|PHYSIOTHERAPIST|1|Visit_1|10|7|TREATMENT|2020-05-20|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-12
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|3|FIF75|Forced Inspiratory Flow at 75%|[?]|SLING|[?]|mg/g/h|[?]|1|TCID 50/dose|SKIN OF THE BACK|CONTRALATERAL|PROXIMAL|PET/CT SCAN||Y||SPOUSE|UROLOGIST|2|Visit_2|25|2|TREATMENT|2020-06-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|4|TSUHYS|Tissue Hysteresivity|[?]|PRONE|[?]|pmol/10^9 cells|[?]|1|Frames/s|THYROID GLAND, LEFT LOBE|RIGHT|VENTRAL|ELISA|Y|||SIGNIFICANT OTHER|FORENSIC PATHOLOGIST|2|Visit_2|25|5|TREATMENT|2020-06-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-13
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|5|FIF25|Forced Inspiratory Flow at 25%|[?]|TRENDELENBURG|[?]|/10^4|[?]|1|cmol|OPTIC DISC|IPSILATERAL|APICAL|PLETHYSMOGRAPHY||||ADJUDICATOR|RADIOLOGIST 2|3|Visit_3|40|5|TREATMENT|2020-06-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|6|IC|Inspiratory Capacity|[?]|STANDING|[?]|g/cage/wk|[?]|1|mEq/L|PROXIMAL PHALANX 5 OF THE HAND|CONTRALATERAL|CRANIAL|MICROBIAL CULTURE, SOLID|Y|Y||VENDOR|RATER|3|Visit_3|40|1|FOLLOW-UP|2020-06-19|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-18
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|7|FIF50|Forced Inspiratory Flow at 50%|[?]|SUPINE|[?]|10^9/dose|[?]|1|gtt|CEREBRAL HEMISPHERE, LEFT|LATERAL|LATERAL|TRIPLE-PHASE MRI SCAN||||CLINICAL RESEARCH ASSOCIATE|DERMATOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-07-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|8|EXPRELTM|Expiration Relaxation Time|[?]|TRENDELENBURG|[?]|Enzyme U/m2|[?]|1|umol/min|SYMPATHETIC GANGLIA|IPSILATERAL|UPPER EXTENSOR SURFACE|FLUORESCENT ENZYME IMMUNOASSAY|Y|||FRIEND|OTOLARYNGOLOGIST|4|Visit_4|65|3|TREATMENT|2020-07-14|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|9|FEV6|Forced Expiratory Volume in 6 Seconds|[?]|UNCONSTRAINED|[?]|mgEq|[?]|1|ppb|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|BILATERAL|UPPER|NUCLEIC ACID AMPLIFICATION TEST||Y||STUDY SUBJECT|MICROSCOPIST 2|5|Visit_5|90|6|TREATMENT|2020-08-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|109fe46d-ac1f-47fe-8ecb-6049a577d38c|10|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|LEFT LATERAL DECUBITUS|[?]|OI50|[?]|1|10^3 organisms/g|THORACIC AORTA|LEFT|TEMPORAL|MANUAL COUNT||||SIGNIFICANT OTHER|NEUROLOGIST|5|Visit_5|90|3|TREATMENT|2020-08-08|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-06-28
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|RAWPP|Percent Predicted Airway Resistance|[?]|SITTING|[?]|pg/dL|[?]|1|uL/dose|RETINAL ARTERY|CONTRALATERAL|POSTERIOR|IHC||Y||INVESTIGATOR|HEMATOLOGIST|1|Visit_1|10|5|TREATMENT|2020-09-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|2|DLCOM|Mean Diffusion Capacity of Lung for CO|[?]|RIGHT LATERAL DECUBITUS|||[?]|1|RFU|LUNG, RIGHT, INFERIOR LOBE, POSTERIOR BASAL SEGMENT|LATERAL|POSTERIOR|IN SITU HYBRIDIZATION|Y||Y|CLINICAL RESEARCH COORDINATOR|ONCOLOGIST 2|1|Visit_1|10|3|FOLLOW-UP|2020-09-03|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-11-14
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|3|FRCPP|Percent Predicted FRC|[?]|PRONE|[?]|U/g/min|[?]|1|/7.5 mL|INTERPHALANGEAL JOINT 3|CONTRALATERAL|VENTRAL|TRANSTHORACIC ECHOCARDIOGRAPHY|Y|Y||SPOUSE|MICROSCOPIST 1|2|Visit_2|25|2|TREATMENT|2020-09-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|4|VO2|Oxygen Consumption|[?]|RIGHT LATERAL DECUBITUS|[?]|pptr|[?]|1|ukat|COLON, SPLENIC FLEXURE|UNILATERAL|TEMPORAL|COMPLEMENT FIXATION|Y|||FRIEND|MICROSCOPIST 3|2|Visit_2|25|3|TREATMENT|2020-09-18|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-30
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|5|IVCPP|Percent Predicted IVC|[?]|STANDING|[?]|10^7 TCID 50/dose|[?]|1|U.CARR|EPIDURAL SPACE|CONTRALATERAL|CAUDAL|ETDRS EYE CHART|Y|||CHILD|PATHOLOGIST|3|Visit_3|40|7|TREATMENT|2020-10-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|6|TLC|Total Lung Capacity|[?]|SUPINE|[?]|%(w/w)|[?]|1|Frames/s|ASCENDING AORTA, SINUS OF VALSALVA|CONTRALATERAL|LOWER EXTENSOR SURFACE|REFLECTANCE SPECTROSCOPY||||CHILD|MICROSCOPIST 1|3|Visit_3|40|7|TREATMENT|2020-10-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-12-01
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|7|SVCPP|Percent Predicted Slow Vital Capacity|[?]|SEMI-RECUMBENT|[?]|GPS U|[?]|1|bel|TENTORIUM CEREBELLI|RIGHT|NASAL|CYSTOSCOPY||||PARENT|ONCOLOGIST|4|Visit_4|65|1|FOLLOW-UP|2020-10-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|8|FEV1FVC6|FEV1/FVC6|[?]|SITTING, LEGS DEPENDENT|[?]|dmol|[?]|1|dL|NASAL BONE|BILATERAL|LOWER MEDIAL|FLUORESCENT ANTIBODY VIRUS NEUTRALIZATION ASSAY||||INVESTIGATOR|PATHOLOGIST|4|Visit_4|65|3|TREATMENT|2020-10-28|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-27
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|9|FEV_PEF|FEV at PEF|[?]|TRENDELENBURG|[?]|U/g/min|[?]|1|10^6 organisms/mL|LUNG, RIGHT, SUPERIOR LOBE, POSTERIOR SEGMENT|BILATERAL|DORSOLATERAL|ULTRASOUND||Y||INVESTIGATOR|ADJUDICATOR 1|5|Visit_5|90|3|TREATMENT|2020-11-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|cdb18d0a-5fca-4437-9b6e-0e46b0930521|10|EXPRELTM|Expiration Relaxation Time|[?]|SUPINE|||[?]|1|FFU|INTERNAL MAMMARY LYMPH NODE|IPSILATERAL|ANTERIOR|POTENTIOMETRY|||Y|INDEPENDENT ASSESSOR|ADJUDICATOR 2|5|Visit_5|90|1|WASHOUT|2020-11-22|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-06
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|1|SAWVOLPP|Percent Predicted Specific Airway Volume|[?]|SUPINE|[?]|U/g|[?]|1|APS U|MIDDLE PHALANX 5 OF THE HAND|BILATERAL|INNER|REFLECTANCE SPECTROSCOPY||Y||PROXY|ADJUDICATOR|1|Visit_1|10|7|WASHOUT|2020-05-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|2|RAW|Airway Resistance|[?]|SITTING|[?]|Bq/kg|[?]|1|kIU|VULVOVAGINAL REGION|BILATERAL|MIDLINE|TARGETED GENOME SEQUENCING|Y|Y||HEALTH CARE PROFESSIONAL|PATHOLOGIST|1|Visit_1|10|7|TREATMENT|2020-05-23|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-11
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|3|FEF2575|Forced Expiratory Flow 25-75%|[?]|REVERSE TRENDELENBURG|||[?]|1|HEP|SKIN OF THE PALM|LATERAL|UPPER EXTENSOR SURFACE|MICROARRAY|||Y|INTERVIEWER|DERMATOLOGIST|2|Visit_2|25|3|FOLLOW-UP|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|4|ERVPP|Percent Predicted ERV|[?]|SLING|[?]|Arbitrary U|[?]|1|pkat/L|AXILLARY ARTERY|CONTRALATERAL|OUTER|PET/MRI SCAN|Y|||PROXY|RADIOLOGIST 2|2|Visit_2|25|3|TREATMENT|2020-06-07|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|5|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|SITTING, LEGS DEPENDENT|||[?]|1|LENS|PROCERUS MUSCLE|IPSILATERAL|SUPERFICIAL|ENZYMATIC COLORIMETRY|||Y|ADJUDICATOR|RATER 2|3|Visit_3|40|1|TREATMENT|2020-06-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|6|FEF2575|Forced Expiratory Flow 25-75%|[?]|SLING|[?]|U/g|[?]|1|/cmH2O|PISIFORM BONE|IPSILATERAL|OUTER|FLOCCULATION, CHARCOAL ENHANCED||||CLINICAL RESEARCH ASSOCIATE|CARDIOLOGIST|3|Visit_3|40|5|FOLLOW-UP|2020-06-22|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-24
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|7|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|STANDING, BENT FORWARD|||[?]|1|PNU/mL|HYPOGLOSSAL NERVE|RIGHT|VENTRAL|DUCTOGRAPHY|Y||Y|CLINICAL RESEARCH COORDINATOR|INTERNIST|4|Visit_4|65|1|FOLLOW-UP|2020-07-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|8|EV_2FVC|Forced Expiratory Volume in 0.2 S/FVC|[?]|SITTING|[?]|IU/mL|[?]|1|10^6 organisms|METACARPOPHALANGEAL JOINT 2|CONTRALATERAL|CENTRAL|CELL BASED BIOASSAY||||VENDOR|RATER|4|Visit_4|65|5|WASHOUT|2020-07-17|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-22
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|9|LCI|Lung Clearance Index|[?]|STANDING, BENT FORWARD|[?]|% INHIBITION|[?]|1|KIT|HYPOGLOSSAL NERVE|CONTRALATERAL|ANTEROMEDIAL|IMMUNOTURBIDIMETRY|Y|||CLINICAL STUDY SPONSOR|ADJUDICATOR 1|5|Visit_5|90|6|WASHOUT|2020-08-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|e515b916-5d28-4236-8835-2ff43b498ab3|10|RRS|Total Respiratory System Resistance|[?]|PRONE|||[?]|1|mOsm|SUBSCAPULARIS MUSCLE|BILATERAL|DISTAL|MULTIPLEXED OPSONOPHAGOCYTIC KILLING ASSAY|||Y|CAREGIVER|OPTOMETRIST|5|Visit_5|90|7|SCREENING|2020-08-11|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-29
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|1|ELSTNCE|Elastance|[?]|FOWLERS|||[?]|1|mmHg|POSTERIOR CERVICAL LYMPH NODE|IPSILATERAL|DEEP|FLUORESCENT LIFETIME IMAGING MICROSCOPY|||Y|SPOUSE|OTOLARYNGOLOGIST|1|Visit_1|10|5|FOLLOW-UP|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|2|TVPP|Percent Predicted Tidal Volume|[?]|SEMI-RECUMBENT|||[?]|1|TCID 50/dose|PARATHYROID GLAND|RIGHT|HIND|WRIGHT STAIN|||Y|PROXY|READER 3|1|Visit_1|10|2|TREATMENT|2020-05-30|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-29
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|3|LOBVOL|Lobar Volume|[?]|STANDING, BENT FORWARD|[?]|Ejaculate U|[?]|1|log10 IU/mL|HINDLIMB|RIGHT|VENTROLATERAL|GRAM STAIN||||SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|2|Visit_2|25|4|SCREENING|2020-06-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|4|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|TRENDELENBURG|[?]|/100 WBC|[?]|1|mmol/mol|RAPHE|UNILATERAL|PROXIMAL|MICROPARTICLE ENZYME IMMUNOASSAY||||FAMILY MEMBER|CLINICAL PATHOLOGIST|2|Visit_2|25|1|FOLLOW-UP|2020-06-14|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-05-30
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|5|AWVOLPP|Percent Predicted Airway Volume|[?]|STANDING, BENT FORWARD|[?]|m/sec2|[?]|1|10^6 IU/mL|ETHMOID SINUS|UNILATERAL|LOWER MEDIAL|SXA SCAN||||NON-HEALTH CARE PROFESSIONAL|PEDIATRIC NEUROLOGIST|3|Visit_3|40|3|TREATMENT|2020-06-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|6|ERVPP|Percent Predicted ERV|[?]|SUPINE|[?]|dpm/mL|[?]|1|umol|T3 VERTEBRA|LATERAL|UPPER FLEXOR SURFACE|NEXT GENERATION SEQUENCING||Y||DOMESTIC PARTNER|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|4|WASHOUT|2020-06-29|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-07-12
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|7|DLCOVA|DLCO/VA|[?]|SEMI-RECUMBENT|[?]|Ci/L|[?]|1|PUFF|THYROID GLAND, RIGHT LOBE|IPSILATERAL|LATERAL|REFRACTOMETRY||||PROXY|INTERNIST|4|Visit_4|65|7|SCREENING|2020-07-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|8|PLMXRS|Pulmonary Reactance|[?]|LEFT LATERAL DECUBITUS|[?]|g/m2|[?]|1|GBq/g|APPENDICEAL TIP|IPSILATERAL|ANTEROLATERAL|IN VITRO GENE EXPRESSION ASSAY||||PARENT|RADIOLOGIST|4|Visit_4|65|5|TREATMENT|2020-07-24|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-23
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|9|SAO2FIO2|Oxygen Saturation/Fraction Inspired O2|[?]|RIGHT LATERAL DECUBITUS|[?]|deg/s|[?]|1|pptr|LACRIMAL GLAND|BILATERAL|FORE|CONGO RED STAIN||Y||FAMILY MEMBER|OPTOMETRIST|5|Visit_5|90|5|TREATMENT|2020-08-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|158af2a8-d447-45e5-8c58-3b950f1bd889|10|PEFTIME|Peak Expiratory Flow Time|[?]|SLING|[?]|cm|[?]|1|log10 CFU/g|SYMPATHETIC GANGLIA|IPSILATERAL|PERIPHERAL|MEDIASTINOSCOPY||||SPOUSE|RATER 2|5|Visit_5|90|1|TREATMENT|2020-08-18|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|e9a930d5-ca57-4069-8251-c164273df082|1|AIRTRAP|Air Trapping|[?]|REVERSE TRENDELENBURG|||[?]|1|/min|OPTIC DISC|RIGHT|LOWER|DARK FIELD MICROSCOPY|||Y|FAMILY MEMBER|UROLOGIST|1|Visit_1|10|7|FOLLOW-UP|2020-05-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|e9a930d5-ca57-4069-8251-c164273df082|2|FEV_PEF|FEV at PEF|[?]|RIGHT LATERAL DECUBITUS|[?]|g/kg|[?]|1|mmol/g|LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY|CONTRALATERAL|PARIETO-OCCIPITAL|FLUOROSCOPY||Y||HEALTH CARE PROFESSIONAL|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|1|Visit_1|10|5|FOLLOW-UP|2020-05-21|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|e9a930d5-ca57-4069-8251-c164273df082|3|RV|Residual Volume|[?]|PRONE|||[?]|1|titer|RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES|CONTRALATERAL|MEDIAL|DIRECT SEQUENCING||Y|Y|INDEPENDENT ASSESSOR|FORENSIC PATHOLOGIST|2|Visit_2|25|2|TREATMENT|2020-06-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|e9a930d5-ca57-4069-8251-c164273df082|4|FEV1|Forced Expiratory Volume in 1 Second|[?]|LATERAL DECUBITUS|[?]|mL/(min*100mL)|[?]|1|U/kg/h|ASCENDING AORTA, AORTIC ROOT|RIGHT|INNER|IMMUNODIFFUSION||||SIBLING|MICROSCOPIST 1|2|Visit_2|25|7|TREATMENT|2020-06-05|25|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-10
e|RE|e9a930d5-ca57-4069-8251-c164273df082|5|FIF25|Forced Inspiratory Flow at 25%|[?]|REVERSE TRENDELENBURG|||[?]|1|m/sec2|INTERNAL MAMMARY LYMPH NODE|UNILATERAL|FACIAL|POLYSOMNOGRAPHY|||Y|DOMESTIC PARTNER|FORENSIC PATHOLOGIST|3|Visit_3|40|2|SCREENING|2020-06-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|e9a930d5-ca57-4069-8251-c164273df082|6|FEV_5|Forced Expiratory Volume in 0.5 Second|[?]|DECUBITUS|[?]|%(v/v)|[?]|1|Roentgen|WRIST JOINT FLEXOR MUSCLES|CONTRALATERAL|UPPER EXTENSOR SURFACE|SODIUM LAUREL SULFATE-METHEMOGLOBIN COMPLEX DETECTION PHOTOMETRY||||FRIEND|MICROSCOPIST 3|3|Visit_3|40|2|TREATMENT|2020-06-20|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-13
e|RE|e9a930d5-ca57-4069-8251-c164273df082|7|PLMBLFLW|Pulmonary Blood Flow|[?]|SEMI-RECUMBENT|[?]|ukat/10^12 RBC|[?]|1|nkat/L|LIVER LOBE|LATERAL|PERIVENTRICULAR|GEL ELECTROPHORESIS|Y|||FRIEND|NEUROLOGIST 1|4|Visit_4|65|5|TREATMENT|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|e9a930d5-ca57-4069-8251-c164273df082|8|FEV3|Forced Expiratory Volume in 3 Seconds|[?]|SEMI-FOWLERS|[?]|10^6 organisms/mL|[?]|1|PNU/mL|KIDNEY, LOWER LOBE|LATERAL|SURFACE|ANTIMICROBIAL COMBINATION TESTING||||CLINICAL RESEARCH ASSOCIATE|HEMATOLOGIST|4|Visit_4|65|5|TREATMENT|2020-07-15|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-17
e|RE|e9a930d5-ca57-4069-8251-c164273df082|9|FEV1FVC|FEV1/FVC|[?]|LATERAL DECUBITUS|[?]|g/L|[?]|1|FFU|SKIN OF THE CHIN|CONTRALATERAL|FACIAL|SPECULAR MICROSCOPY||||FRIEND|PATHOLOGIST 2|5|Visit_5|90|6|TREATMENT|2020-08-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|e9a930d5-ca57-4069-8251-c164273df082|10|FEF2575|Forced Expiratory Flow 25-75%|[?]|STANDING, BENT FORWARD|[?]|MHz|[?]|1|uU/L|RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY|LEFT|DISTAL VOLAR|KINYOUN STAIN|Y|Y||ADJUDICATION COMMITTEE|ONCOLOGIST 2|5|Visit_5|90|7|SCREENING|2020-08-09|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-13
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|1|DLCOPP|Percent Predicted DLCO|[?]|SITTING, LEGS DEPENDENT|[?]|Enzyme U/g Hb|[?]|1|umol/L|PECTORALIS MAJOR MUSCLE|UNILATERAL|BASAL|FISH||||SIGNIFICANT OTHER|READER 3|1|Visit_1|10|5|TREATMENT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|2|FEV1PP|Percent Predicted FEV1|[?]|SLING|||[?]|1|CYLINDER|SKIN OF THE HAND|LEFT|PARIETO-OCCIPITAL|CT SCAN|||Y|DOMESTIC PARTNER|PATHOLOGIST 1|1|Visit_1|10|5|TREATMENT|2020-08-04|10|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-10-30
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|3|FRC|Functional Residual Capacity|[?]|REVERSE TRENDELENBURG|[?]|APPLICATION|[?]|1|ug/dL|ORBICULARIS OCULI MUSCLE|BILATERAL|DISTAL VOLAR|CONTRAST ENHANCED SPIRAL CT SCAN|Y|||VENDOR|HEMATOLOGIST|2|Visit_2|25|5|TREATMENT|2020-08-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|4|FEV1PP|Percent Predicted FEV1|[?]|SUPINE|[?]|mol/day|[?]|1|mm3/mm2/year|VAGUS NERVE|IPSILATERAL|FORE|HEMOCYTOMETRY|Y|Y||NON-HEALTH CARE PROFESSIONAL|RATER 2|2|Visit_2|25|7|FOLLOW-UP|2020-08-19|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-22
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|5|SALKB|Salazar-Knowles Equation Parameter B|[?]|TRENDELENBURG|||[?]|1|deg|SKIN OF THE BACK|LATERAL|INTERMEDIATE|GC/MS-EI|||Y|NON-HEALTH CARE PROFESSIONAL|PATHOLOGIST 1|3|Visit_3|40|6|TREATMENT|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|6|MEPPP|Percent Predicted MEP|[?]|SITTING, LEGS DEPENDENT|[?]|BOX|[?]|1|ng/day|SKIN OF THE FOREARM|LEFT|LATERAL|WRIGHT-GIEMSA STAIN|Y|||SPOUSE|DEVELOPMENTAL BEHAVIORAL PEDIATRICIAN|3|Visit_3|40|5|TREATMENT|2020-09-03|40|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-07
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|7|PIF|Peak Inspiratory Flow|[?]|STANDING, BENT FORWARD|[?]|F|[?]|1|deg2|HEPATIC VEIN|LEFT|SUPERIOR|SICKLE CELL SOLUBILITY TEST||||SPOUSE|PATHOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-09-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|8|FIF25|Forced Inspiratory Flow at 25%|[?]|LEFT LATERAL DECUBITUS|[?]|mol/mL|[?]|1|mol/g|CONJUNCTIVA|UNILATERAL|BASAL|DC SHEATH FLOW||||GUARDIAN|OPHTHALMOLOGIST|4|Visit_4|65|3|FOLLOW-UP|2020-09-28|65|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-09-24
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|9|FVC6|Forced Vital Capacity in 6 Seconds|[?]|FOWLERS|[?]|mAmp|[?]|1|V/sec|VAGUS NERVE|UNILATERAL|LOWER MEDIAL|JAFFE REACTION||Y||ADJUDICATOR|DERMATOLOGIST|5|Visit_5|90|1|SCREENING|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|e654e37e-1c95-4f25-83b1-9233186626c6|10|PCF|Peak Cough Flow|[?]|RIGHT LATERAL DECUBITUS|[?]|Ci/mL|[?]|1|GLOBULE|FUNDUS OF THE EYE|CONTRALATERAL|VENTROLATERAL|WRIGHT STAIN||||FRIEND|PHYSIOTHERAPIST|5|Visit_5|90|4|TREATMENT|2020-10-23|90|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-09-25
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|FVCPP|Percent Predicted Forced Vital Capacity|[?]|LATERAL DECUBITUS|[?]|/month|[?]|1|PFU/animal|FLEXOR POLLICIS LONGUS MUSCLE|CONTRALATERAL|LOWER FLEXOR SURFACE|SEQUENCE-SPECIFIC OLIGONUCLEOTIDE PROBE POLYMERASE CHAIN REACTION||||CLINICAL RESEARCH ASSOCIATE|OPTOMETRIST|1|Visit_1|10|7|TREATMENT|2020-06-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|2|FEF2575P|Percent Predicted FEF25-75|[?]|PRONE|[?]|deg/s|[?]|1|IU/kg/h|CRANIAL CAVITY|UNILATERAL|DISTAL VOLAR|CONGO RED STAIN|Y|Y||SIGNIFICANT OTHER|ADJUDICATOR 1|1|Visit_1|10|4|TREATMENT|2020-06-19|10|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-01
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|3|FIF25|Forced Inspiratory Flow at 25%|[?]|REVERSE TRENDELENBURG|[?]|deg2|[?]|1|mph|HAMATE BONE|LATERAL|VENTRAL|PERCUSSION||||ADJUDICATOR|OPTOMETRIST|2|Visit_2|25|5|TREATMENT|2020-07-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|4|SALKK|Salazar-Knowles Equation, K|[?]|STANDING|[?]|log10 CCID 50/dose|[?]|1|aMFI|PYRAMIDAL TRACTS, INTERNAL CAPSULE|LEFT|SURFACE|NEXT GENERATION TARGETED SEQUENCING||||ADJUDICATION COMMITTEE|OPTOMETRIST|2|Visit_2|25|4|FOLLOW-UP|2020-07-04|25|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-25
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|5|FEV_75|Forced Expiratory Volume in 0.75 Second|[?]|SITTING|[?]|USP U|[?]|1|%/s|SPLENIC VEIN|BILATERAL|INTERMEDIATE|HEMOCYTOMETRY||||HEALTH CARE PROFESSIONAL|RADIOLOGIST 1|3|Visit_3|40|5|TREATMENT|2020-07-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|6|FEV3PP|Percent Predicted FEV3|[?]|TRENDELENBURG|[?]|genEq|[?]|1|dpm/100mg|ENDOCERVIX|RIGHT|INFERIOR|SINGLE-STRAND CONFORMATION POLYMERASE CHAIN REACTION||||ADJUDICATOR|ONCOLOGIST 2|3|Visit_3|40|3|TREATMENT|2020-07-19|40|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-07-20
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|7|PEFPP|Percent Predicted Peak Expiratory Flow|[?]|TRENDELENBURG|[?]|APL U/mL|[?]|1|days/month|HEART, BASE|UNILATERAL|DISTAL|VIRUS PLAQUE ASSAY||||SIGNIFICANT OTHER|DERMATOLOGIST|4|Visit_4|65|2|FOLLOW-UP|2020-08-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|8|IRVPP|Percent Predicted IRV|[?]|SEMI-FOWLERS|[?]|ug/m2/day|[?]|1|kDa|STERNUM|BILATERAL|BASAL|CISH||||INTERVIEWER|ADJUDICATOR 1|4|Visit_4|65|4|TREATMENT|2020-08-13|65|PREVIUOUS DOSE|1|P1Y2M10DT2H30M|PREVIOUS DOSE|2020-08-20
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|9|SALKK|Salazar-Knowles Equation, K|[?]|SEMI-FOWLERS|[?]|log10 TCID 50/uL|[?]|1|CUP|COLON, RIGHT|UNILATERAL|PROXIMAL|CLAUSS METHOD|Y|||FAMILY MEMBER|MICROSCOPIST|5|Visit_5|90|6|FOLLOW-UP|2020-09-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
e|RE|808ee0ac-e668-4e8e-aa0a-889476cbe631|10|SRAWPP|Percent Predicted Sp Airway Resistance|[?]|PRONE|[?]|10^8 PFU|[?]|1|10^6 CFU|ADDUCTOR POLLICIS MUSCLE|LEFT|VENTRAL|KINETIC CHROMOGENIC ASSAY||||VENDOR|ENDOCRINOLOGIST|5|Visit_5|90|1|TREATMENT|2020-09-07|90|PREVIOUS MEAL|2|P1Y2M10DT2H30M|PREVIOUS MEAL|2020-08-03
